PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Ovsyanikova, E; Fedutin, I; Belonovich, O; Burdin, A; Burkanov, V; Dolgova, E; Filatova, O; Fomin, S; Hoyt, E; Mamaev, E; Richard, G; Savenko, O; Sekiguchi, K; Shpak, O; Sidorenko, M; Titova, O				Ovsyanikova, Ekaterina; Fedutin, Ivan; Belonovich, Olga; Burdin, Alexander; Burkanov, Vladimir; Dolgova, Evgenia; Filatova, Olga; Fomin, Sergey; Hoyt, Erich; Mamaev, Evgeny; Richard, Gaetan; Savenko, Oksana; Sekiguchi, Keiko; Shpak, Olga; Sidorenko, Maksim; Titova, Olga			Opportunistic sightings of the endangered North Pacific right whales (Eubalaena japonica) in Russian waters in 2003-2014	MARINE MAMMAL SCIENCE			English	Article							ATLANTIC RIGHT WHALES; SOVIET CATCHES; GLACIALIS; RATES		[Ovsyanikova, Ekaterina] Univ Canterbury, Gateway Antarctica, Christchurch 8041, New Zealand; [Ovsyanikova, Ekaterina; Dolgova, Evgenia; Shpak, Olga] Marine Mammal Council, Moscow 117218, Russia; [Fedutin, Ivan; Filatova, Olga] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Fedutin, Ivan] Pacific Inst Geog DVO RAS, Kamchatka Branch, Petropavlovsk Kamchatski 683000, Russia; [Belonovich, Olga] Kamchatka Res Inst Fisheries & Oceanog, Petropavlovsk Kamchatski, Russia; [Burdin, Alexander; Burkanov, Vladimir; Fomin, Sergey] Pacific Geog Inst, Kamchatka Branch, Petropavlovsk Kamchatski 683000, Russia; [Burkanov, Vladimir] NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, NMFS, Seattle, WA 98115 USA; [Hoyt, Erich] WDC, Far East Russia Orca Project, Russian Cetacean Habitat Project, Chippenham SN15 1LJ, Wilts, England; [Mamaev, Evgeny] SV Marakov Commander Isl Nat & Biosphere Reserve, Nikolskoye, Commander Islan, Russia; [Richard, Gaetan] Univ Bretagne Occidentale, UFR Sci & Tech, Brest, France; [Savenko, Oksana] Natl Acad Sci Ukraine, II Schmalhausen Inst Zool, UA-01601 Kiev, Ukraine; [Sekiguchi, Keiko] Int Christian Univ, Grad Sch Arts & Sci, Mitaka, Tokyo 1818585, Japan; [Shpak, Olga] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Moscow 117218, Russia; [Sidorenko, Maksim] VI Ilichev Pacific Oceanol Inst, Vladivostok, Russia; [Titova, Olga] Pacific Inst Geog RAS, Kamchatka Branch, Petropavlovsk Kamchatski, Russia	Ovsyanikova, E (reprint author), Univ Canterbury, Gateway Antarctica, 20 Kirkwood Ave, Christchurch 8041, New Zealand.	katya.ovsyanikova@gmail.com					Allen B. M., 2012, ALASKA MARINE MAMMAL, P203; Sekiguchi K, 2014, MAR MAMMAL SCI, V30, P1199, DOI 10.1111/mms.12105; Josephson E, 2008, FISH FISH, V9, P155, DOI 10.1111/j.1467-2979.2008.00275.x; Ivashchenko Y. V., 2013, Journal of Cetacean Research and Management, V13, P59; Wade PR, 2011, BIOL LETTERS, V7, P83, DOI 10.1098/rsbl.2010.0477; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Knowlton AR, 2012, MAR ECOL PROG SER, V466, P293, DOI 10.3354/meps09923; Ivashchenko Yulia V., 2012, Endangered Species Research, V18, P201, DOI 10.3354/esr00443; Gregr EJ, 2009, PROG OCEANOGR, V80, P188, DOI 10.1016/j.pocean.2008.12.004; Belonovich O. A., 2012, 7 C MAR MAMM HOL SUZ; Brownell Robert L. Jr, 2001, Journal of Cetacean Research and Management Special Issue, V2, P269; Burdin A. M., 2004, SC56BRG41; Burdin A. M., 2004, 3 INT C MAR MAMM HOL; Clapham P. J., 2009, IWC SCI COMM M UNPUB; Clapham Phillip J., 2004, Journal of Cetacean Research and Management, V6, P1; Fisheries and Oceans Canada, 2014, SPECIES RISK ACT REC; Fomin S. V., 2012, REPORTS SCI PROGRAMM; Gendron Diane, 1999, Aquatic Mammals, V25, P31; Gregr Edward James, 2011, Endangered Species Research, V15, P223, DOI 10.3354/esr00381; Hoyt E., 2011, MARINE PROTECTED ARE; KRAUS SD, 1990, MAR MAMMAL SCI, V6, P278, DOI 10.1111/j.1748-7692.1990.tb00358.x; Matsuoka K., 2012, IWC SCI COMM J UNPUB; Matsuoka K., 2014, IWC SCI COMM JUN 201; Miyashita T., 1998, IWC SPEC M SCI COMM; NMFS (National Marine Fisheries Service), 2013, FIN REC PLAN N PAC R; Omura H., 1958, Scientific Reports of the Whales Research Institute Tokyo, VNo. 13, P1; Omura H., 1986, REP INT WHAL COMMN, V10, P35; Scarff J. E., 1991, REPORT INT WHALING C, V41, P467; Shpak O. V., 2012, 7 C MAR MAMM HOL SUZ; Shulezhko T., 2012, 26 EUR CET SOC C GAL; TOWNSEND CHARLES HASKINS, 1935, ZOOLOGICA [NEW YORK], V19, P1	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-0469	1748-7692		MAR MAMMAL SCI	Mar. Mamm. Sci.	OCT	2015	31	4					1559	1567		10.1111/mms.12243		9	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CU1MB	WOS:000363284900015		
J	Hines, E; Chansang, H; Cherdsukjai, P; Thongsukdee, S; Boonyanate, P; Monanunsap, S; Manopawitr, P; Ponnampalam, L; Ilangakoon, A; Akamatsu, T; Ichikawa, K; Kwan, D; Dearden, P				Hines, Ellen; Chansang, Hansa; Cherdsukjai, Phaothep; Thongsukdee, Surasak; Boonyanate, Potchana; Monanunsap, Somchai; Manopawitr, Petch; Ponnampalam, Louisa; Ilangakoon, Anouk; Akamatsu, Tomanari; Ichikawa, Kotaro; Kwan, Donna; Dearden, Phil			DR. KANJANA ADULYANUKOSOL (14 April 1962-10 January 2015)	MARINE MAMMAL SCIENCE			English	Biographical-Item							DUGONG DUGONG-DUGON; CONSERVATION NEEDS; ANDAMAN COAST; THAILAND		[Hines, Ellen] San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Dept Geog & Environm, Tiburon, CA 94920 USA; [Chansang, Hansa] Phuket Marine Biol Ctr, Dept Marine & Coastal Resources, Phuket 83000, Thailand; [Cherdsukjai, Phaothep; Thongsukdee, Surasak] Upper Gulf Thailand, Marine & Coastal Resource Res & Dev Ctr, Dept Marine & Coastal Resources, Samut Sakhon, Thailand; [Boonyanate, Potchana] Eastern Gulf Marine & Coastal Resources Res Ctr, Dept Marine & Coastal Resources, Klaeng, Rayong, Thailand; [Monanunsap, Somchai] Southern Marine & Coastal Resources Res Ctr, Dept Marine & Coastal Resources, Songkhla, Thailand; [Manopawitr, Petch] IUCN Asia Reg Off, Bangkok, Thailand; [Ponnampalam, Louisa] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Ponnampalam, Louisa] MareCet Res Org, Shah Alam, Malaysia; [Akamatsu, Tomanari] Fisheries Res Agcy, Kanagana, Japan; [Ichikawa, Kotaro] Kyoto Univ, Kyoto, Japan; [Kwan, Donna] UNEP CMS Dugong MoU Secretariat, Abu Dhabi, U Arab Emirates; [Dearden, Phil] Univ Victoria, Dept Geog, Victoria, BC V8W 2Y2, Canada	Hines, E (reprint author), San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Dept Geog & Environm, Tiburon, CA 94920 USA.	ehines@sfsu.edu					Adulyanukosol K., 2014, BRYDES WHALES UPPER; Adulyanukosol K., 2003, J ENV RES MAHIDOL U, V1, P112; Adulyanukosol Kanjana, 1997, Thai Fisheries Gazette, V50, P359; Adulyanukosol K., 2011, GUIDELINES WHALE WAT; Adulyanukosol K., 1998, P 4 INT SCI S ROL OC, P369; Adulyanukosol K., 2004, NUI LEARN SURVIVE WI; Adulyanukosol K, 2010, THESIS U RYUKYUS OKI; Adulyanukosol K., 2011, BRYDES WHALES THAILA; Adulyanukosol K., 2002, P 6 BRT ANN C 9 12 O, P302; Adulyanukosol K., 1995, P SEM FISH 1995 ROYA, P385; Adulyanukosol K., 2000, P 1 SEASTAR2000 WORK, P33; Adulyanukosol K, 2011, LITTLE EDEN HAPPY SE; Adulyanukosol K., 1999, REPORT AERIAL SURVEY; Adulyanukosol K., 1997, P SEM FISH ROYAL THA; Adulyanukosol K, 2002, THAI FISH GAZ, V55, P47; Adulyanukosol K., 2012, DOLPHIN WHALE WATCHI; Adulyanukosol K., 2002, DUGONG THAILAND STAT; Adulyanukosol K., 2000, Biologia Marina Mediterranea, V7, P191; Adulyanukosol K., 1994, P SEM FISH ROYAL THA, P386; Adulyanukosol K., 2007, CUTE DUGONG; Adulyanukosol K., 1999, P 1 KOR THAIL JOINT; Adulyanukosol K., 1998, DUGONG THAILAND; Amamoto N., 2009, P 4 INT S SEASTAR200, P41; Ichikawa K, 2006, J ACOUST SOC AM, V119, P3726, DOI 10.1121/1.2201468; Hines E, 2005, ENVIRON MANAGE, V36, P654, DOI 10.1007/s00267-003-0287-8; Ichikawa K, 2011, J ACOUST SOC AM, V129, P3623, DOI 10.1121/1.3586791; Hines EM, 2005, MAR MAMMAL SCI, V21, P536, DOI 10.1111/j.1748-7692.2005.tb01247.x; Adulyanukosol K, 2007, MAR BIOL, V151, P1887, DOI 10.1007/s00227-007-0619-y; Hines E, 2008, ORYX, V42, P113, DOI 10.1017/S0030605308000094; Chantrapornsyl S., 1994, P SEM FISH ROYAL THA, P380; Hines E., 2003, POPULATION HABITAT A; Hines E., 2004, CONSERVATION DUGONGS; Hines E., 2001, POPULATION HABITAT A; Ichikawa K., 2012, P AC 2012 FREM, P130; Ichikawa K., 2003, P 4 SEASTAR 2000 WOR, P72; Ichikawa K., 2009, J ACOUST SOC AM, V126, P954; Okumura N., 2006, P OCEANS 2006 AS PAC, DOI [10.1109/OCEANSAP.2006.4393936, DOI 10.1109/OCEANSAP.2006.4393936]; Ponnampalam LS, 2015, ORYX, V49, P743, DOI 10.1017/S0030605313001580; Ponnampalam L., 2013, AQUAT MAMM, V39, P401; Poovachiranon S., 1999, P 1 KOREATHAILAND JO, P84; Sakamoto S., 2005, P 3 INT S SEASTAR200, P69; Shiraki R., 2009, P 4 INT S SEASTAR200, P59; Tsutsumi C., 2006, J ACOUST SOC AM, V120, P1256; Wiayasak W., 1993, 31 TECHN C KAS U SCI, P263	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-0469	1748-7692		MAR MAMMAL SCI	Mar. Mamm. Sci.	OCT	2015	31	4					1587	1593		10.1111/mms.12265		7	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CU1MB	WOS:000363284900018		
J	Bannister, J; Findlay, K; Brownell, RL; Butterworth, D; Cawthorn, M; Donovan, G; Gambell, R; Kato, H; Mate, B; Moore, M; Ohsumi, S; Perrin, W; Reeb, D; Reeves, R; Rowntree, V; Shaughnessy, P				Bannister, John; Findlay, Ken; Brownell, Robert L.; Butterworth, Doug; Cawthorn, Martin; Donovan, Greg; Gambell, Ray; Kato, Hidehiro; Mate, Bruce; Moore, Michael; Ohsumi, Seiji; Perrin, William; Reeb, Desray; Reeves, Randall; Rowntree, Vicky; Shaughnessy, Peter			PETER B. BEST (1939-2015) Memories	MARINE MAMMAL SCIENCE			English	Biographical-Item									[Bannister, John] Western Australian Museum, Welshpool Dc, WA 6986, Australia; [Findlay, Ken] Univ Pretoria, Whale Unit, Mammal Res Inst, ZA-0001 Pretoria, South Africa; [Brownell, Robert L.] NOAA, Granite Canyon Res Stn, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Monterey, CA 93940 USA; [Butterworth, Doug] Univ Cape Town, Dept Math & Appl Math, ZA-7701 Rondebosch, South Africa; [Donovan, Greg] Int Whaling Commiss, Cambridge CB24 9NP, England; [Kato, Hidehiro] Tokyo Univ Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Mate, Bruce] Oregon State Univ, Marine Mammal Inst, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Moore, Michael] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Ohsumi, Seiji] Inst Cetacean Res, Chuou Ku, Tokyo 1040055, Japan; [Reeb, Desray] Bur Ocean Energy Management, Off Renewable Energy Programs, Sterling, VA 20166 USA; [Reeves, Randall] Okapi Wildlife Associates, Hudson, PQ JOP 1HO, Canada; [Rowntree, Vicky] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Shaughnessy, Peter] South Australian Museum, Adelaide, SA 5000, Australia	Bannister, J (reprint author), Western Australian Museum, Locked Bag 49, Welshpool Dc, WA 6986, Australia.	bannisj@bigpond.com						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-0469	1748-7692		MAR MAMMAL SCI	Mar. Mamm. Sci.	OCT	2015	31	4					1594	1597		10.1111/mms.12277		4	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CU1MB	WOS:000363284900019		
J	Chapellier, B; Tange, S; Tasaki, H; Yoshida, K; Zhou, Y; Sakon, N; Katayama, K; Nakanishi, A				Chapellier, Benoit; Tange, Shoichiro; Tasaki, Hidetaka; Yoshida, Kazuhiro; Zhou, Yan; Sakon, Naomi; Katayama, Kazuhiko; Nakanishi, Akira			Examination of a plasmid-based reverse genetics system for human astrovirus	MICROBIOLOGY AND IMMUNOLOGY			English	Article						animal RNA virus; human astrovirus; reverse genetics system	TERMINAL NSP1A PROTEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; RNA; CELL; DNA; EXPRESSION; SEQUENCE; GENOME; VIRUS; TRANSCRIPTION	A plasmid-based reverse genetics system for human astrovirus type 1 (HAstV1) is examined. Upon transfection into 293T cells, the plasmid vector, which harbors a HAstV1 expression cassette, expressed astroviral RNA that appeared to be capable of viral RNA replication, as indicated by the production of subgenomic RNA and capsid protein expression irrespective of the heterologous 5 ends of the transcribed RNA. Particles infectious to Caco-2 cells were made in this system; however, their infectivity was much lower than would be expected from the amount of particles apparently produced. Using Huh-7 cells as the transfection host with the aim of improving viral capsid processing for virion maturation partially restored the efficiency of infectious particle formation. Our results support the possibility that the DNA transfection process induces a cellular response that targets late, but not early, stages of HAstV1 infection.	[Chapellier, Benoit; Tange, Shoichiro; Tasaki, Hidetaka; Yoshida, Kazuhiro; Zhou, Yan; Nakanishi, Akira] Natl Ctr Geriatr & Gerontol, Dept Aging Intervent, Lab Gene Therapy, Obu, Aichi 4748522, Japan; [Sakon, Naomi] Osaka Prefectural Inst Publ Hlth, Osaka, Osaka 5370025, Japan; [Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Lab Gastroenteritis Viruses, Tokyo 2080011, Japan	Nakanishi, A (reprint author), Natl Ctr Geriatr & Gerontol, Dept Aging Intervent, Sect Gene Therapy, 7-430 Morioka, Obu, Aichi 4748522, Japan.	nakanish@ncgg.go.jp			Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [NIBIO-05-27]; Health Labour Sciences Research Grant for Research on Emerging and Re-emerging Infectious Diseases	We thank Drs. Mituaki Oseto (Ehime Hygiene Environmental Institute) and Albert Bosch (University of Barcelona) for providing the HAstV1 virus and pAVIC V DNA, respectively. The initial stages of the study were supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO-05-27 to A.N.), and the later stages, by a Health Labour Sciences Research Grant for Research on Emerging and Re-emerging Infectious Diseases (to A.N.).	Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Mendez E, 2004, J VIROL, V78, P8601, DOI 10.1128/JVI.78.16.8601-8608.2004; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006; MARCZINKE B, 1994, J VIROL, V68, P5588; Trask SD, 2010, P NATL ACAD SCI USA, V107, P18652, DOI 10.1073/pnas.1011948107; NIWA H, 1991, GENE, V108, P193; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Banos-Lara MD, 2010, VIROLOGY, V401, P322, DOI 10.1016/j.virol.2010.02.028; TSURIMOTO T, 1987, P NATL ACAD SCI USA, V84, P444, DOI 10.1073/pnas.84.2.444; ROLLAND V, 1995, J BIOL CHEM, V270, P1102; JIANG BM, 1993, P NATL ACAD SCI USA, V90, P10539, DOI 10.1073/pnas.90.22.10539; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Geigenmuller U, 2002, J GEN VIROL, V83, P1691; PHILIPPE J, 1991, P NATL ACAD SCI USA, V88, P7224, DOI 10.1073/pnas.88.16.7224; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; Katayama K, 2014, P NATL ACAD SCI USA, V111, pE4043, DOI 10.1073/pnas.1415096111; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Nakanishi A, 2008, VIROLOGY, V379, P110, DOI 10.1016/j.virol.2008.06.032; Claeyssens S, 2003, AM J PHYSIOL-GASTR L, V285, pG840, DOI 10.1152/ajpgi.00060.2003; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; Guix S, 2005, VIROLOGY, V333, P124, DOI 10.1016/j.virol.2004.12.023; Guix S, 2004, J VIROL, V78, P13627, DOI 10.1128/JVI.78.24.13627-13636.2004; Geigenmuller U, 2002, J VIROL, V76, P2003, DOI 10.1128/JVI.76.4.2003-2008.2002; Bass DM, 2000, J VIROL, V74, P1810, DOI 10.1128/JVI.74.4.1810-1814.2000; Walter JE, 2003, CURR OPIN INFECT DIS, V16, P247, DOI 10.1097/01.qco.0000073775.11390.60; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Guix S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123087; Iwasaki A., 2013, FIELDS VIROLOGY; Mendez E., 2013, FIELDS VIROLOGY; Sumpter Rhea Jr, 2005, Journal of Virology, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tange S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-153; Velazquez-Moctezuma R, 2012, J VIROL METHODS, V179, P295, DOI 10.1016/j.jviromet.2011.11.005	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					586	596		10.1111/1348-0421.12317		11	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100002		
J	Tsurudome, Y; Kimachi, K; Okada, Y; Matsuura, K; Ooyama, Y; Ibaragi, K; Kino, Y; Ueda, K				Tsurudome, Yukari; Kimachi, Kazuhiko; Okada, Yusuke; Matsuura, Kenta; Ooyama, Yusuke; Ibaragi, Kayo; Kino, Yoichiro; Ueda, Kohji			Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan	MICROBIOLOGY AND IMMUNOLOGY			English	Article						immunogenicity; inactivated quadrivalent vaccine; influenza; safety	AGED GREATER-THAN-OR-EQUAL-TO-18 YEARS; RANDOMIZED CONTROLLED-TRIAL; COST-EFFECTIVENESS; CHILDREN; CANDIDATE; REACTOGENICITY; LINEAGES	Two antigenically distinct B strain lineages of influenza virus have co-circulated since the mid-1980s; however, inactivated trivalent influenza vaccines contain only one B lineage. The mismatch between the circulating and vaccine lineages has been a worldwide issue. In this study, an inactivated quadrivalent influenza vaccine (QIV) candidate containing two B lineages was manufactured and its immunogenicity and safety evaluated in an open-label, uncontrolled trial. In this phase II trial, 50 subjects aged 20-64 years received two doses of QIV s.c. 1 to 4 weeks apart. Sera were collected pre- and post-vaccination and safety assessed from the first vaccination to 21 +/- 7 days after the second vaccination. After the first vaccination, hemagglutination inhibition titers against each strain increased markedly; the seroconversion rate, geometric mean titer ratio and seroprotection rate being 94.0%, 24.93, and 100.0%, respectively, for the A/H1N1pdm09 strain; 94.0%, 12.47, and 98.0%, respectively, for the A/H3N2 strain; 54.0%, 4.99, and 66.0%, respectively, for B/Yamagata strain, and 72.0%, 6.23 and 80.0%, respectively, for the B/Victoria strain, thus fulfilling the criteria of the European Medical Agency's Committee for Medicinal Products for Human Use. Also, the QIV induced sufficient single radial hemolysis and neutralizing antibodies against all four vaccine strains. No noteworthy adverse events were noted. The results of this trial demonstrate that QIV is well tolerated and immunogenic for each strain, suggesting that QIV potentially improves protection against influenza B by resolving the issue of B lineage mismatch.	[Tsurudome, Yukari; Kimachi, Kazuhiko; Okada, Yusuke; Ibaragi, Kayo; Kino, Yoichiro] Chemo Sero Therapeut Res Inst Kaketsuken, Kikuchi Res Ctr, Kikuchi 8691298, Japan; [Matsuura, Kenta; Ooyama, Yusuke] Chemo Sero Therapeut Res Inst KAKETSUKEN, Kumamoto 8608568, Japan; [Ueda, Kohji] Seinan Jo Gakuin Univ, Kitakyushu, Fukuoka 8030835, Japan	Tsurudome, Y (reprint author), Chemo Sero Therapeut Res Inst Kaketsuken, 1314-1 Kyokushi Kawabe, Kikuchi 8691298, Japan.	tsurudome-yu@kaketsuken.or.jp			Kaketsuken	Yukari Tsurudome, Kazuhiko Kimachi, Yusuke Okada, Kenta Matsuura, Yusuke Ooyama, Kayo Ibaragi and Yoichiro Kino are employees of Kaketsuken. Kohji Ueda belongs to Seinan Jo Gakuin University and advised us about the conduct of this clinical trial. The authors have no potential conflicts of interest. Kaketsuken designed and implemented this trial and evaluated the trial results. Data analysis for this trial was performed by EPS Corporation. Kaketsuken was the sole funding source for this trial.	Greenberg DP, 2013, VACCINE, V31, P770, DOI 10.1016/j.vaccine.2012.11.074; Ikeno D, 2010, MICROBIOL IMMUNOL, V54, P81, DOI 10.1111/j.1348-0421.2009.00191.x; [Anonymous], 2013, ANAL INFLUENZA STRAI, V34, P328; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Block SL, 2012, PEDIATR INFECT DIS J, V31, P745, DOI 10.1097/INF.0b013e31825687b0; Walter EB, 2006, PEDIATRICS, V118, pE570, DOI 10.1542/peds.2006-0198; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; [Anonymous], 2014, ANAL INFLUENZA STRAI, V35, P254; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Clements KM, 2014, HUM VACC IMMUNOTHER, V10, P1171, DOI 10.4161/hv.28221; Pepin S, 2013, VACCINE, V31, P5572, DOI 10.1016/j.vaccine.2013.08.069; Skowronski DM, 2011, PEDIATR INFECT DIS J, V30, P833, DOI 10.1097/INF.0b013e31822db4dc; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Block SL, 2011, VACCINE, V29, P9391, DOI 10.1016/j.vaccine.2011.09.109; Tinoco JC, 2014, VACCINE, V32, P1480, DOI 10.1016/j.vaccine.2014.01.022; Traynor K, 2012, AM J HEALTH-SYST PH, V69, P538, DOI 10.2146/news120021; Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Langley JM, 2013, J INFECT DIS, V208, P544, DOI 10.1093/infdis/jit263; [Anonymous], 2012, ANAL INFLUENZA STRAI, V33, P288; Suryadevara M, 2014, HUM VACC IMMUNOTHER, V10, P596, DOI 10.4161/hv.27115; European Medicines Agency, 1997, CPMPBWP21496 EUR MED; Kieninger D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-343; Lo YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058222; Meier G., 2015, J MED ECON, V1, P1; National Institute of Infectious Diseases (NIID), 2010, ANN REP 2010 NAT EP; Newall AT, 2014, VACCINE, V32, P1323, DOI 10.1016/j.vaccine.2014.01.017; Odagiri T., 2012, PEDIATR JPN, V53, P1355; Van Bellinghen LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098437; WHO, REC COMP INFL VIR VA; WHO, 2002, WHO MAN AN INFL DIAG; You JHS, 2015, HUM VACC IMMUNOTHER, V11, P564, DOI 10.1080/21645515.2015.1011016	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					597	604		10.1111/1348-0421.12316		8	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100003		
J	Do, LP; Doan, YH; Nakagomi, T; Gauchan, P; Kaneko, M; Agbemabiese, C; Dang, AD; Nakagomi, O				Do, Loan Phuong; Doan, Yen Hai; Nakagomi, Toyoko; Gauchan, Punita; Kaneko, Miho; Agbemabiese, Chantal; Anh Duc Dang; Nakagomi, Osamu			Whole genome analysis of Vietnamese G2P[4] rotavirus strains possessing the NSP2 gene sharing an ancestral sequence with Chinese sheep and goat rotavirus strains	MICROBIOLOGY AND IMMUNOLOGY			English	Article						NSP2; NSP4; rotavirus; Vietnam	MOLECULAR EPIDEMIOLOGY; VACCINATION PROGRAMS; GENOTYPE; CHILDREN; CIRCULATION; POPULATION; FOOTPRINTS; DIVERSITY; DS-1-LIKE; AFRICA	Because imminent introduction into Vietnam of a vaccine against Rotavirus A is anticipated, baseline information on the whole genome of representative strains is needed to understand changes in circulating strains that may occur after vaccine introduction. In this study, the whole genomes of two G2P[4] strains detected in Nha Trang, Vietnam in 2008 were sequenced, this being the last period during which virtually no rotavirus vaccine was used in this country. The two strains were found to be > 99.9% identical in sequence and had a typical DS-1 like G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2 genotype constellation. Analysis of the Vietnamese strains with > 184 G2P[4] strains retrieved from GenBank/EMBL/DDBJ DNA databases placed the Vietnamese strains in one of the lineages commonly found among contemporary strains, with the exception of the NSP2 and NSP4 genes. The NSP2 genes were found to belong to a previously undescribed lineage that diverged from Chinese sheep and goat rotavirus strains, including a Chinese rotavirus vaccine strain LLR with 95% nucleotide identity; the time of their most recent common ancestor was 1975. The NSP4 genes were found to belong, together with Thai and USA strains, to an emergent lineage (VIII), adding further diversity to ever diversifying NSP4 lineages. Thus, there is a need to enhance surveillance of locallycirculating strains from both children and animals at the whole genome level to address the effect of rotavirus vaccines on changing strain distribution.	[Do, Loan Phuong; Doan, Yen Hai; Nakagomi, Toyoko; Gauchan, Punita; Kaneko, Miho; Agbemabiese, Chantal; Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, Nagasaki 8528523, Japan; [Do, Loan Phuong; Anh Duc Dang] Natl Inst Hyg & Epidemiol, Hanoi 112800, Vietnam	Nakagomi, O (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	onakagom@nagasaki-u.ac.jp			Ministry of Health, Labour, and Welfare, Japan; Japan Agency for Medical Research and Development	This study was supported in part by a grant-in-aid for scientific research from the Ministry of Health, Labour, and Welfare, Japan, and a grant from the Japan Agency for Medical Research and Development.	Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004; Nakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z; Doan YH, 2015, INFECT GENET EVOL, V34, P423, DOI 10.1016/j.meegid.2015.05.026; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; Chen YJ, 2009, VIRUS GENES, V38, P302, DOI 10.1007/s11262-009-0332-7; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Luchs A, 2015, J MED VIROL, V87, P1881, DOI 10.1002/jmv.24241; Doan YH, 2012, INFECT GENET EVOL, V12, P1202, DOI 10.1016/j.meegid.2012.04.023; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Dennis AF, 2014, J VIROL, V88, P3789, DOI 10.1128/JVI.03516-13; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276; Page NA, 2004, J CLIN MICROBIOL, V42, P595, DOI 10.1128/JCM.42.2.595-600.2004; Hemming M, 2013, EUR J PEDIATR, V172, P739, DOI 10.1007/s00431-013-1945-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Matsushima Y, 2012, J VIROL, V86, P10236, DOI 10.1128/JVI.01588-12; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Wu FT, 2014, INFECT GENET EVOL, V28, P530, DOI 10.1016/j.meegid.2014.09.033; Nakagomi T, 2009, VACCINE, V27, pF93, DOI 10.1016/j.vaccine.2009.08.067; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Cunliffe N. A., 2012, Medical microbiology: a guide to microbial infections: pathogenesis, immunity, laboratory investigation and control, P559; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Estes M. K., 2013, FIELDS VIROLOGY, P1347; Koo Hoonmo L, 2013, J Pediatric Infect Dis Soc, V2, P57, DOI 10.1093/jpids/pis070; Le T. L., 2013, J PREV MED, V13, P73; Nei M., 2000, MOL EVOLUTION PHYLOG; Nyaga MM, 2014, VIRUS GENES, V49, P196, DOI 10.1007/s11262-014-1091-7; Page NA, 2004, J MED VIROL, V72, P320, DOI 10.1002/jmv.10571; Papp Hajnalka, 2014, VirusDisease, V25, P215, DOI 10.1007/s13337-014-0203-2; Rambaut A, 2014, TRACER V1 6; Van Trang Nguyen, 2014, J Clin Microbiol, V52, P1366, DOI 10.1128/JCM.02927-13; World Health Organisation, 2009, WKLY EPIDEMIOL REC, V86, P533; World Health Organisation, 2012, GLOB ROT INF SURV B	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					605	613		10.1111/1348-0421.12323		9	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100004		
J	Hasibuan, FM; Shiratori, B; Senoputra, MA; Chagan-Yasutan, H; Koesoemadinata, RC; Apriani, L; Takahashi, Y; Niki, T; Alisjahbana, B; Hattori, T				Hasibuan, Fakhrial Mirwan; Shiratori, Beata; Senoputra, Muhammad Andrian; Chagan-Yasutan, Haorile; Koesoemadinata, Raspati Cundarani; Apriani, Lika; Takahashi, Yayoi; Niki, Toshiro; Alisjahbana, Bachti; Hattori, Toshio			Evaluation of matricellular proteins in systemic and local immune response to Mycobacterium tuberculosis infection	MICROBIOLOGY AND IMMUNOLOGY			English	Article						galectin-9; osteopontin; tenascin-C; tuberculosis	TENASCIN-C; LATENT TUBERCULOSIS; IFN-GAMMA; OSTEOPONTIN; GALECTIN-9; DISEASE; EXPRESSION; CELLS; MICE; INFLAMMATION	Matricellular proteins such as osteopontin (OPN), galectin-9 (Gal-9), and tenascin-C (TN-C) are expressed not only under normal physiological conditions, but also during infection, inflammation and tumorigenesis. Plasma concentrations of matricellular proteins were studied to determine their diagnostic value as potential markers of tuberculosis (TB) activity. It was found that concentrations of OPN and TN-C were higher in patients with active TB than in healthy controls and individuals with latent infection. Moreover, LTBI patients had higher concentrations of OPN than did healthy controls. Gal-9 concentrations did not differ significantly between groups. Concentrations of matricellular proteins were higher in pleural fluid than in the plasma of patients with TB. Expression of matricellular proteins was also investigated in TB granulomas and other granulomatous diseases. Positive OPN and Gal-9 staining was observed in TB and sarcoidosis granulomas, but not in Crohn disease granulomas. The fibrotic ring around granulomas stained positive for TN-C in TB and sarcoidosis, but not in Crohn disease. Of the three matricellular proteins studied, OPN and TN-C may serve as reliable plasma markers for monitoring TB activity, whereas Gal-9 seems to be expressed more at the site of infection than in the systemic circulation.	[Hasibuan, Fakhrial Mirwan; Shiratori, Beata; Senoputra, Muhammad Andrian; Chagan-Yasutan, Haorile; Hattori, Toshio] Tohoku Univ, Grad Sch Med, Div Emerging Infect Dis, Sendai, Miyagi 9808574, Japan; [Hasibuan, Fakhrial Mirwan; Senoputra, Muhammad Andrian; Hattori, Toshio] Tohoku Univ, Int Res Inst Disaster Sci, Publ Hlth Sci Program, Sendai, Miyagi 9808574, Japan; [Shiratori, Beata; Chagan-Yasutan, Haorile] Tohoku Univ, Int Res Inst Disaster Sci, Div Disaster Related Infect Dis, Sendai, Miyagi 9808574, Japan; [Koesoemadinata, Raspati Cundarani; Apriani, Lika; Alisjahbana, Bachti] Padjadjaran State Univ, Fac Med, TB HIV Res Ctr, Bandung 40161, West Java, Indonesia; [Takahashi, Yayoi] Tohoku Univ Hosp, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Niki, Toshiro] GalPharma Co, Div Res, Takamatsu, Kagawa 7600301, Japan	Hattori, T (reprint author), Tohoku Univ, Int Res Inst Disaster Sci, Div Disaster Related Infect Dis, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	toshatto@med.tohoku.ac.jp			Scientific Research Expenses for Health and Welfare program from the Ministry of Health, Labour and Welfare, Japan; Science and Technology Research Partnership for Sustainable Development from the Japan Science and Technology Agency, Japan; Research Centre for Zoonosis Control at Hokkaido University; International Research Institute of Disaster Science of Tohoku University (IRIDeS)	This work was supported by the Scientific Research Expenses for Health and Welfare program from the Ministry of Health, Labour and Welfare, Japan, the Science and Technology Research Partnership for Sustainable Development from the Japan Science and Technology Agency, Japan, collaborative funding from the Research Centre for Zoonosis Control at Hokkaido University and a special research grant from the International Research Institute of Disaster Science of Tohoku University (IRIDeS). We are grateful to Professor Kiyoshi Ito from Tohoku University, Disaster Obstetrics and Gynecology, for providing histopathological specimens.	Kuriyama N, 2011, HEPATOLOGY, V54, P2125, DOI 10.1002/hep.24639; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Ellis SL, 2013, EXP HEMATOL, V41, P1050, DOI 10.1016/j.exphem.2013.09.009; Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414; Wada J, 1997, J BIOL CHEM, V272, P6078; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Uede T, 1997, MICROBIOL IMMUNOL, V41, P641; Koguchi Y, 2003, AM J RESP CRIT CARE, V167, P1355, DOI 10.1164/rccm.200209-1113OC; Kaarteenaho-Wiik R, 2007, HUM PATHOL, V38, P147, DOI 10.1016/j.humpath.2006.07.001; Udalova IA, 2011, CRIT REV IMMUNOL, V31, P115; Gieseke F, 2013, EUR J IMMUNOL, V43, P2741, DOI 10.1002/eji.201343335; Khajoee V, 2006, CLIN EXP IMMUNOL, V143, P260, DOI 10.1111/j.1365-2249.2005.02985.x; Chagan-Yasutan H, 2011, LEUKEMIA RES, V35, P1484, DOI 10.1016/j.leukres.2011.05.011; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279; Nau GJ, 2000, AM J PATHOL, V157, P37, DOI 10.1016/S0002-9440(10)64514-2; Nau GJ, 1999, INFECT IMMUN, V67, P4223; O'Regan AW, 2001, AM J RESP CRIT CARE, V164, P2243, DOI 10.1164/rccm2104139; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Ridruechai C, 2011, SE ASIAN J TROP MED, V42, P876; Ungerer C, 2014, STEM CELLS DEV, V23, P755, DOI 10.1089/scd.2013.0335; Kaarteenaho-Wiik R, 2000, J HISTOCHEM CYTOCHEM, V48, P1257, DOI 10.1177/002215540004800909; Sada-Ovalle I, 2012, J IMMUNOL, V189, P5896, DOI 10.4049/jimmunol.1200990; Shiratori B, 2012, ANTIMICROB AGENTS CH, V56, P2868, DOI 10.1128/AAC.06062-11; Bornstein P, 2000, MATRIX BIOL, V19, P555, DOI 10.1016/S0945-053X(00)00103-7; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Imanaka-Yoshida K, 2012, CIRC J, V76, P2513, DOI 10.1253/circj.CJ-12-1033; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Siawaya JFD, 2007, INT J INFECT DIS, V11, P289, DOI 10.1016/j.ijid.2007.02.001; Rabinovich GA, 2002, J LEUKOCYTE BIOL, V71, P741; Al Shammari B, 2015, J INFECT DIS, V212, P463, DOI 10.1093/infdis/jiv076; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Ladel CH, 1997, INFECT IMMUN, V65, P4843; Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Cowan J., 2011, CLIN EXP IMMUNOL, V167, P317; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69; Senoputra MA, 2015, DIAGN MICR INFEC DIS, V83, P278, DOI 10.1016/j.diagmicrobio.2015.07.021; Shiratori B, 2014, MEDIAT INFLAMM, V2014; World Health Organization, GLOB TUB REP 2013	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					623	632		10.1111/1348-0421.12320		10	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100006		
J	Sato, H; Oshiumi, H; Takaki, H; Hikono, H; Seya, T				Sato, Haruko; Oshiumi, Hiroyuki; Takaki, Hiromi; Hikono, Hirokazu; Seya, Tsukasa			Evolution of the DEAD box helicase family in chicken: chickens have no DHX9 ortholog	MICROBIOLOGY AND IMMUNOLOGY			English	Article						chicken innate immunity; DEAD box helicase; phylogeny; type I interferon	PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; RIG-I; INNATE IMMUNITY; RNA HELICASE; TRANSCRIPTIONAL REGULATION; VIRUS-INFECTION; GENE FAMILY; INFLUENZA; IDENTIFICATION	Viral RNA represents a pattern molecule that can be recognized by RNA sensors in innate immunity. Humans and mice possess cytoplasmic DNA/RNA sensors for detecting viral replication. There are a number of DEAD (Asp-Glu-Ala-Asp; DExD/H) box-type helicases in mammals, among which retinoic acid-inducible gene 1 (RIG-I) and melanoma differentiation-associated protein 5 (MDA50) are indispensable for RNA sensing; however, they are functionally supported by a number of sensors that directly bind viral RNA or replicative RNA intermediates to convey signals to RIG-I and MDA5. Some DEAD box helicase members recognize DNA irrespective of the origin. These sensors transmit IFN-inducing signals through adaptors, including mitochondrial antiviral signaling. Viral double-stranded RNAs are reportedly sensed by the helicases DDX1, DDX21, DHX36, DHX9, DDX3, DDX41, LGP2 and DDX60, in addition to RIG-I and MDA5, and induce type I IFNs, thereby blocking viral replication. Humans and mice have all nucleic acid sensors listed here. In the RNA sensing system in chicken, it was found in the present study that most DEAD box helicases are conserved; however, DHX9 is genetically deficient in addition to reported RIG-I. Based on the current genome databases, similar DHX9 deficiency was observed in ducks and several other bird species. Because chicken, but not duck, was found to be deficient in RIG-I, the RNA-sensing system of chicken lacks RIG-I and DHX9 and is thus more fragile than that of duck or mammal. DHX9 may generally compensate for the function of RIG-I and deficiency of DHX9 possibly participates in exacerbations of viral infection such as influenza in chickens.	[Sato, Haruko; Oshiumi, Hiroyuki; Takaki, Hiromi; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Hikono, Hirokazu] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3058642, Japan	Seya, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	seya-tu@pop.med.hokudai.ac.jp	OSHIUMI, HIROYUKI/G-1645-2012		Ministry of Agriculture, Forestry, and Fisheries of Japan	We are grateful to our laboratory colleagues for their invaluable discussions and to Drs. H. Kida (CZC, Hokkaido University, Sapporo), T. Saito (National Institute of Animal Health, Tsukuba) and H. Hasegawa (National Institute of Infectious Diseases, Tokyo) for valuable discussions. This work was supported in part by a Grant-in-Aid for Scientific Research from the Zoonoses Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Oshiumi H, 2015, CELL REP, V11, P1193, DOI 10.1016/j.celrep.2015.04.047; Oshiumi H, 2005, J IMMUNOL, V175, P1724; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Hikono H, 2013, VET IMMUNOL IMMUNOP, V151, P83, DOI 10.1016/j.vetimm.2012.10.005; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Fujii R, 2001, J BIOL CHEM, V276, P5445, DOI 10.1074/jbc.M006892200; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Kotani M, 2010, HYBRIDOMA, V29, P259, DOI 10.1089/hyb.2009.0107; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Fuchsova B, 2002, J CELL BIOL, V158, P463, DOI 10.1083/jcb.200202035; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Keestra AM, 2013, DEV COMP IMMUNOL, V41, P316, DOI 10.1016/j.dci.2013.04.009; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Cornelissen JBWJ, 2013, AVIAN PATHOL, V42, P347, DOI 10.1080/03079457.2013.807325; Liu Y, 2014, CELL MOL IMMUNOL, V11, P49, DOI 10.1038/cmi.2013.40; Lin L, 2012, J VIROL, V86, P1942, DOI 10.1128/JVI.06362-11; Honda K, 2006, IUBMB LIFE, V58, P290, DOI 10.1080/15216540600702206; Ariumi Yasuo, 2014, Frontiers in Genetics, V5, P423, DOI 10.3389/fgene.2014.00423; Fuku A, 2001, J BIOL CHEM, V276, P47143, DOI 10.1074/jbc.M103902200; Kuchipudi SV, 2014, VET RES, V45, DOI 10.1186/s13567-014-0118-3; Rahman MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003465; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SEYA T, 1985, J IMMUNOL, V135, P2661; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	OCT	2015	59	10					633	640		10.1111/1348-0421.12322		8	Immunology; Microbiology	Immunology; Microbiology	CU2EV	WOS:000363337100007		
J	Kanaly, RA; Micheletto, R; Matsuda, T; Utsuno, Y; Ozeki, Y; Hamamura, N				Kanaly, Robert A.; Micheletto, Ruggero; Matsuda, Tomonari; Utsuno, Youko; Ozeki, Yasuhiro; Hamamura, Natsuko			Application of DNA adductomics to soil bacterium Sphingobium sp strain KK22	MICROBIOLOGYOPEN			English	Article						Acrolein; bacterium; DNA adductomics; DNA adducts; LC-MS/MS; Sphingobium	TANDEM MASS-SPECTROMETRY; LIPID-PEROXIDATION; ESCHERICHIA-COLI; 1,N(2)-PROPANODEOXYGUANOSINE ADDUCTS; 1,N-2-PROPANODEOXYGUANOSINE ADDUCTS; DEOXYGUANOSINE ADDUCTS; PURINE NUCLEOSIDES; MUTATION ASSAY; CROSS-LINKS; HUMAN LUNG	Toward the development of ecotoxicology methods to investigate microbial markers of impacts of hydrocarbon processing activities, DNA adductomic analyses were conducted on a sphingomonad soil bacterium. From growing cells that were exposed or unexposed to acrolein, a commonly used biocide in hydraulic fracturing processes, DNA was extracted, digested to 2'-deoxynucleosides and analyzed by liquid chromatography-positive ionization electrospray-tandem mass spectrometry in selected reaction monitoring mode transmitting the [M + H](+) > [M + H - 116](+) transition over 100 transitions. Overall data shown as DNA adductome maps revealed numerous putative DNA adducts under both conditions with some occurring specifically for each condition. Adductomic analyses of triplicate samples indicated that elevated levels of some targeted putative adducts occurred in exposed cells. Two exposure-specific adducts were identified in exposed cells as 3-(2'-deoxyribosyl)-5,6,7,8-tetrahydro-6-hydroxy- (and 8-hydroxy-)pyrimido[1,2-a]-purine-(3H)-one (6- and 8-hydroxy-PdG) following synthesis of authentic standards of these compounds and subsequent analyses. A time course experiment showed that 6- and 8-hydroxy-PdG were detected in bacterial DNA within 30 min of acrolein exposure but were not detected in unexposed cells. This work demonstrated the first application of DNA adductomics to examine DNA damage in a bacterium and sets a foundation for future work.	[Kanaly, Robert A.; Utsuno, Youko; Ozeki, Yasuhiro] Yokohama City Univ, Dept Life & Environm Syst Sci, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Micheletto, Ruggero] Yokohama City Univ, Dept Nanosyst Sci, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga 5200811, Japan; [Hamamura, Natsuko] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan; [Hamamura, Natsuko] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Kanaly, RA (reprint author), Yokohama City Univ, Dept Life & Environm Syst Sci, Grad Sch Nanobiosci, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.	kanaly@yokohama-cu.ac.jp			Yokohama City University Strategic Research Grant [K20002]; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [26505010]; JSPS NEXT Program Grant [GS023]	This work was supported in part by Yokohama City University Strategic Research Grant, K20002 and the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 26505010 to R. K., and the JSPS NEXT Program Grant GS023 to N. H.	Szyf M, 2011, TOXICOL SCI, V120, P235, DOI 10.1093/toxsci/kfr024; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Nath RG, 1996, CANCER RES, V56, P452; Zhang SY, 2007, CHEM RES TOXICOL, V20, P565, DOI 10.1021/tx700023z; Hua YS, 2001, J AM SOC MASS SPECTR, V12, P80, DOI 10.1016/S1044-0305(00)00191-4; Kanaly R, 1997, APPL ENVIRON MICROB, V63, P4511; Kanaly RA, 2013, CHEMOSPHERE, V92, P1442, DOI 10.1016/j.chemosphere.2013.03.054; Tompkins EM, 2008, RAPID COMMUN MASS SP, V22, P19, DOI 10.1002/rcm.3328; Yang IY, 2001, J BIOL CHEM, V276, P9071, DOI 10.1074/jbc.M008918200; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; Maeda AH, 2014, MICROB BIOTECHNOL, V7, P114, DOI 10.1111/1751-7915.12102; MARINELLI ER, 1990, CHEM RES TOXICOL, V3, P49, DOI 10.1021/tx00013a009; Kawai K, 2010, CHEM RES TOXICOL, V23, P630, DOI 10.1021/tx9003819; Swenberg JA, 2008, CHEM RES TOXICOL, V21, P253, DOI 10.1021/tx700408t; FUJII T, 1990, CHEM PHARM BULL, V38, P3326; Bendall ML, 2013, J BACTERIOL, V195, P4966, DOI 10.1128/JB.00935-13; Gaskell M, 2004, MUTAT RES-FUND MOL M, V554, P387, DOI 10.1016/j.mrfmmm.2004.06.032; Singh R, 2010, RAPID COMMUN MASS SP, V24, P2329, DOI 10.1002/rcm.4645; Wu KY, 1999, CARCINOGENESIS, V20, P1787, DOI 10.1093/carcin/20.9.1787; FOILES PG, 1989, CARCINOGENESIS, V10, P87, DOI 10.1093/carcin/10.1.87; Loureiro APM, 2004, CHEM RES TOXICOL, V17, P641, DOI 10.1021/tx034225; Nath RG, 1998, CANCER RES, V58, P581; Kanaly RA, 2007, MUTAT RES-FUND MOL M, V625, P83, DOI 10.1016/j.mrfmmm.2007.05.006; Kanaly RA, 2000, APPL ENVIRON MICROB, V66, P4205, DOI 10.1128/AEM.66.10.4205-4211.2000; Chung FL, 1999, MUTAT RES-FUND MOL M, V424, P71, DOI 10.1016/S0027-5107(99)00009-3; Chen HJC, 1996, CHEM RES TOXICOL, V9, P306, DOI 10.1021/tx9501389; Pradenas GA, 2012, MICROBIOL-SGM, V158, P1279, DOI 10.1099/mic.0.056903-0; Nakamura J, 2014, DNA REPAIR, V19, P3, DOI 10.1016/j.dnarep.2014.03.031; Yang IY, 2002, BIOCHEMISTRY-US, V41, P13826, DOI 10.1021/bi0264723; Kamat SS, 2011, J AM CHEM SOC, V133, P2080, DOI 10.1021/ja110157u; Kanaly RA, 2006, ANTIOXID REDOX SIGN, V8, P993, DOI 10.1089/ars.2006.8.993; Beland FA, 2005, CHEM RES TOXICOL, V18, P1306, DOI 10.1021/tx050068y; Li HY, 2009, J MASS SPECTROM, V44, P641, DOI 10.1002/jms.1539; Kadlubar FF, 1998, MUTAT RES-FUND MOL M, V405, P125, DOI 10.1016/S0027-5107(98)00129-8; CHUNG FL, 1984, CANCER RES, V44, P990; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Beach DG, 2011, ANAL CHEM, V83, P9107, DOI 10.1021/ac202044h; Pradenas GA, 2013, BIOMED RES INT, DOI 10.1155/2013/563756; KAMBARA H, 1982, ANAL CHEM, V54, P143, DOI 10.1021/ac00238a044; Cheng G, 2003, CHEM RES TOXICOL, V16, P145, DOI 10.1021/tx025614r; Balbo S, 2014, CHEM RES TOXICOL, V27, P356, DOI 10.1021/tx4004352; Spilsberg B, 2010, J AGR FOOD CHEM, V58, P6370, DOI 10.1021/jf903065a; Nordone AJ, 1996, CHEMOSPHERE, V32, P807, DOI 10.1016/0045-6535(95)00371-1; Cunliffe M, 2006, APPL MICROBIOL BIOT, V72, P1083, DOI 10.1007/s00253-006-0374-x; Matsuda T, 2013, CARCINOGENESIS, V34, P121, DOI 10.1093/carcin/bgs327; Balbo S, 2014, ANAL CHEM, V86, P1744, DOI 10.1021/ac403565m; FARMER PB, 1973, BIOCHEM J, V135, P203; Nakao LS, 1998, CHEM RES TOXICOL, V11, P888, DOI 10.1021/tx9800351; Chou PH, 2010, CHEM RES TOXICOL, V23, P1442, DOI 10.1021/tx100047d; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; Kunihiro M, 2013, APPL ENVIRON MICROB, V79, P4410, DOI 10.1128/AEM.01129-13; Tretyakova N, 2013, CHEM REV, V113, P2395, DOI 10.1021/cr300391r; Dudley E, 2004, RAPID COMMUN MASS SP, V18, P2730, DOI 10.1002/rcm.1685; Singh R, 2006, CARCINOGENESIS, V27, P178, DOI 10.1093/carcin/bgi260; DONNELLY KC, 1995, ENVIRON TOXICOL CHEM, V14, P1281, DOI 10.1897/1552-8618(1995)14[1281:MPOESB]2.0.CO;2; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Vandegehuchte MB, 2014, MUTAT RES-GEN TOX EN, V764, P36, DOI 10.1016/j.mrgentox.2013.08.008; Chen HJC, 2010, ANAL CHEM, V82, P4486, DOI 10.1021/ac100391f; Kanuri M, 2002, CHEM RES TOXICOL, V15, P1572, DOI 10.1021/tx025591g; Ishii Y, 2014, ANAL BIOANAL CHEM, V406, P2467, DOI 10.1007/s00216-014-7621-2; Nechev LV, 2000, CHEM RES TOXICOL, V13, P421, DOI 10.1021/tx990167+; HEMMINKI K, 1980, ARCH TOXICOL, V46, P277, DOI 10.1007/BF00310445; Selzer RR, 1996, CHEM RES TOXICOL, V9, P875, DOI 10.1021/tx960039a; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Kim YH, 2003, ARCH BIOCHEM BIOPHYS, V416, P209, DOI 10.1016/S0003-9861(03)00297-2; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Bessette E. E., 2008, ANAL CHEM, V81, P809; Cabiscol E., 2010, J INT MICROBIOL, V3, P3; CHENNA A, 1993, CHEM RES TOXICOL, V6, P261, DOI 10.1021/tx00033a003; da Costa GG, 2003, CHEM RES TOXICOL, V16, P1328, DOI 10.1021/tx034108e; Kertesz M. A., 2010, HDB HYDROCARBON LIPI, P1694; Maeda AH, 2015, INT J SYST EVOL MICR, V65, P2919, DOI 10.1099/ijs.0.000356; Maeda A. H., 2013, GENOME ANNOUNC, V1; Pawowicz A. J., 2006, BIOORG CHEM, V34, P39; Pawowicz A. J, 2008, CHEM BIODIVERS, V5, P177; Penkala J., 2004, CORROSION; US EPA (United States Environmental Protection Agency), 2000, EPA453R000005 OFF PL; vansDorst J, 2014, APPL ENVIRON MICROB, V80, P4021	80	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-8827			MICROBIOLOGYOPEN	MicrobiologyOpen	OCT	2015	4	5					841	856		10.1002/mbo3.283		16	Microbiology	Microbiology	CU3LS	WOS:000363427500012		
J	Fujiki, M; Miyamoto, S; Sakuraba, M				Fujiki, Masahide; Miyamoto, Shimpei; Sakuraba, Minoru			Flow-through anastomosis for both the artery and vein in leg free flap transfer	MICROSURGERY			English	Article							END-TO-SIDE; FREE-TISSUE TRANSFERS; LOWER-EXTREMITY; RECONSTRUCTION; SELECTION; VELOCITY; DEFECTS; PATENCY	ObjectiveFree flap transfer is an essential part of limb-sparing surgery for leg sarcoma; however, this procedure is associated with a high failure rate. The aim of this study was to identify factors that contribute to microvascular compromise and flap failure for leg free flap transfer, while focusing on anastomotic techniques (end-to-end, end-to-side, and flow-through anastomoses). Patients and methodsData from 56 consecutive patients who underwent leg free flap transfer after oncologic resection were retrospectively reviewed. Of these patients, flow-through anastomosis was performed with the artery in 29 and the vein in 24, whereas conventional techniques were performed in others. The variables contributing to microvascular compromise and flap failure were statistically analyzed. ResultsVenous thrombosis (four patients, 7.1%) was more frequent than arterial thrombosis (one patient, 1.8%) and (4 patients, 7.1%) resulted in flap loss. All anastomotic failures occurred in end-to-end anastomoses. All flow-through anastomoses achieved patency both for the artery and vein. No anastomotic failure or flap loss occurred in 22 flaps which were transferred with flow-through anastomosis for both the artery and vein. Flow-through venous anastomosis tended to have a lower rate of microvascular compromise and flap loss than conventional techniques (P=0.13 and 0.25, respectively). ConclusionThe key to successful leg free flap transfer is to prevent venous failure; thus, flow-through venous anastomosis may be a breakthrough solution. Preferential use of flow-through anastomosis for both the artery and vein can provide predictable results in leg free flap transfer. (c) 2015 Wiley Periodicals, Inc. Microsurgery 35:536-540, 2015.	[Fujiki, Masahide; Miyamoto, Shimpei] Natl Canc Ctr, Div Plast & Reconstruct Surg, Chuo Ku, Tokyo 1040045, Japan; [Sakuraba, Minoru] Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, Kashiwa, Chiba, Japan	Fujiki, M (reprint author), Natl Canc Ctr, Div Plast & Reconstruct Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	mfujiki@ncc.go.jp					Dotson RJN, 1998, MICROSURG, V18, P125, DOI 10.1002/(SICI)1098-2752(1998)18:2<125::AID-MICR11>3.0.CO;2-#; ALBERTENGO JB, 1981, PLAST RECONSTR SURG, V67, P194, DOI 10.1097/00006534-198167020-00009; Koshima I, 1999, PLAST RECONSTR SURG, V103, P1483, DOI 10.1097/00006534-199904050-00021; Muramatsu K, 2001, MICROSURG, V21, P362, DOI 10.1002/micr.21807; Hanasono MM, 2009, J RECONSTR MICROSURG, V25, P417, DOI 10.1055/s-0029-1223850; Barner-Rasmussen I, 2009, BRIT J SURG, V96, P482, DOI 10.1002/bjs.6581; Koshima I, 2005, PLAST RECONSTR SURG, V115, P155, DOI 10.1097/01.PRS.0000146870.33661.E7; GODINA M, 1979, PLAST RECONSTR SURG, V64, P673, DOI 10.1097/00006534-197964050-00013; Miyamoto S, 2008, PLAST RECONSTR SURG, V122, P449, DOI 10.1097/PRS.0b013e31817d62c5; Fischer JP, 2013, J RECONSTR MICROSURG, V29, P407, DOI 10.1055/s-0033-1343952; Kim JT, 2008, J PLAST RECONSTR AES, V61, P1157, DOI 10.1016/j.bjps.2008.03.048; Jang YJ, 2014, J PLAST RECONSTR AES, V67, P1136, DOI 10.1016/j.bjps.2014.04.021; Ridgway EB, 2010, J RECONSTR MICROSURG, V26, P559, DOI 10.1055/s-0030-1263292; Bodor R, 1997, J RECONSTR MICROSURG, V13, P463, DOI 10.1055/s-2007-1006426; Wettstein R, 2008, J PLAST RECONSTR AES, V61, P772, DOI 10.1016/j.bjps.2007.11.037; Lorenzo AR, 2011, J PLAST RECONSTR AES, V64, P649, DOI 10.1016/j.bjps.2010.07.028; Sakurai H, 2009, MICROSURG, V29, P101, DOI 10.1002/micr.20570; FRODEL J L, 1986, Microsurgery, V7, P117, DOI 10.1002/micr.1920070304; Miyamoto S, 2014, PLAST RECONSTR SURG, V7, pe127	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	OCT	2015	35	7					536	540		10.1002/micr.22476		5	Surgery	Surgery	CU3IN	WOS:000363418000006		
J	Yamamoto, T; Mito, D; Hayashi, A; Narushima, M				Yamamoto, Takumi; Mito, Daisuke; Hayashi, Akitatsu; Narushima, Mitsunaga			Multiple-in-one concept for lymphatic supermicrosurgery	MICROSURGERY			English	Letter							ANASTOMOSIS		[Yamamoto, Takumi; Mito, Daisuke; Hayashi, Akitatsu; Narushima, Mitsunaga] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2015, MICROSURG, V35, P129, DOI 10.1002/micr.22272	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	OCT	2015	35	7					588	589		10.1002/micr.22345		2	Surgery	Surgery	CU3IN	WOS:000363418000015		
J	Miyamoto, Y; Torii, T; Takada, S; Ohno, N; Saitoh, Y; Nakamura, K; Ito, A; Ogata, T; Terada, N; Tanoue, A; Yamauchi, J				Miyamoto, Yuki; Torii, Tomohiro; Takada, Shuji; Ohno, Nobuhiko; Saitoh, Yurika; Nakamura, Kazuaki; Ito, Akihito; Ogata, Toru; Terada, Nobuo; Tanoue, Akito; Yamauchi, Junji			Involvement of the Tyro3 receptor and its intracellular partner Fyn signaling in Schwann cell myelination	MOLECULAR BIOLOGY OF THE CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; TYROSINE KINASE; PROTEIN-S; GAS6; PHOSPHORYLATION; MIGRATION; FAMILY; SRC; DEMYELINATION; NEUREGULIN-1	During early development of the peripheral nervous system, Schwann cell precursors proliferate, migrate, and differentiate into premyelinating Schwann cells. After birth, Schwann cells envelop neuronal axons with myelin sheaths. Although some molecular mechanisms underlying myelination by Schwann cells have been identified, the whole picture remains unclear. Here we show that signaling through Tyro3 receptor tyrosine kinase and its binding partner, Fyn nonreceptor cytoplasmic tyrosine kinase, is involved in myelination by Schwann cells. Impaired formation of myelin segments is observed in Schwann cell neuronal cultures established from Tyro3-knockout mouse dorsal root ganglia (DRG). Indeed, Tyro3-knockout mice exhibit reduced myelin thickness. By affinity chromatography, Fyn was identified as the binding partner of the Tyro3 intracellular domain, and activity of Fyn is downregulated in Tyro3-knockout mice, suggesting that Tyro3, acting through Fyn, regulates myelination. Ablating Fyn in mice results in reduced myelin thickness. Decreased myelin formation is observed in cultures established from Fyn-knockout mouse DRG. Furthermore, decreased kinase activity levels and altered expression of myelination-associated transcription factors are observed in these knockout mice. These results suggest the involvement of Tyro3 receptor and its binding partner Fyn in Schwann cell myelination. This constitutes a newly recognized receptor-linked signaling mechanism that can control Schwann cell myelination.	[Miyamoto, Yuki; Torii, Tomohiro; Nakamura, Kazuaki; Tanoue, Akito; Yamauchi, Junji] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo 1578535, Japan; [Takada, Shuji] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Setagaya Ku, Tokyo 1578535, Japan; [Ohno, Nobuhiko; Saitoh, Yurika] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi 4093898, Japan; [Ito, Akihito] Nissei Bilis, Res Ctr, Koga, Shiga 5280052, Japan; [Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama 3598555, Japan; [Terada, Nobuo] Shinshu Univ, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Yamauchi, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan	Yamauchi, J (reprint author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo 1578535, Japan.	yamauchi-j@ncchd.go.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor, and Welfare; Takeda Foundation	We thank K. Ikenaka, Y. Matsubara, H. Saito, and A. Umezawa for helpful discussions and acknowledge H. Sakonjo and T. Amano for measuring the nerve conduction velocity. We also thank C. Rowthorn and W. Fumanski for reading the manuscript. This work was supported by Grants-in-Aid for Young Scientist Research B, Scientific Research C, Scientific Research B, and Scientific Research on Innovative Areas (Glial assembly: a new regulatory machinery of brain function and disorders) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. This work was also supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor, and Welfare and partially by the Takeda Foundation.	Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Li RH, 1996, J NEUROSCI, V16, P2012; Miyamoto Y, 2012, CELL SIGNAL, V24, P2061, DOI 10.1016/j.cellsig.2012.06.013; Binder MD, 2009, NEUROSIGNALS, V17, P277, DOI 10.1159/000231894; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Hossain S, 2010, EXP NEUROL, V226, P47, DOI 10.1016/j.expneurol.2010.08.002; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Sperber BR, 2001, J NEUROSCI, V21, P2039; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Terada N, 2013, HISTOCHEM CELL BIOL, V140, P213, DOI 10.1007/s00418-012-1073-6; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Ratner N, 2006, METHOD ENZYMOL, V407, P22, DOI 10.1016/S0076-6879(05)07003-5; Yamauchi J, 2010, J NEUROSCI RES, V88, P3189, DOI 10.1002/jnr.22460; Torii T, 2013, J MOL NEUROSCI, V51, P522, DOI 10.1007/s12031-013-0018-4; Taniguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P151, DOI 10.1016/S0006-291X(03)00923-9; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327; Novak N, 2011, J CELL BIOL, V192, P243, DOI 10.1083/jcb.201010013; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Fritsch R, 2013, CELL, V154, P940, DOI 10.1016/j.cell.2013.07.045; Klein C, 2002, J NEUROSCI, V22, P698; TOSHIMA J, 1995, BIOCHEM BIOPH RES CO, V209, P656, DOI 10.1006/bbrc.1995.1549; Monje PV, 2009, GLIA, V57, P947, DOI 10.1002/glia.20819; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Binder MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017727; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; Krishnan A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003945; Macklin WB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3140pe32; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; Miyamoto Y, 2014, SCHWANN CELL DEV PAT, P5; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Ness JK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2928; Tsiperson V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015748; Yamauchi J, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002802	47	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	OCT 1	2015	26	19					3489	3503		10.1091/mbc.E14-05-1020		15	Cell Biology	Cell Biology	CT8AA	WOS:000363035900011		
J	Sato, T; Shimosato, T; Ueda, A; Ishigatsubo, Y; Klinman, DM				Sato, Takashi; Shimosato, Takeshi; Ueda, Atsuhisa; Ishigatsubo, Yoshiaki; Klinman, Dennis M.			Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors	MOLECULAR CANCER THERAPEUTICS			English	Article							RECEPTOR 9 AGONIST; TLR9 AGONIST; T-CELLS; DENDRITIC CELLS; DRUG-DELIVERY; CONTAINING OLIGODEOXYNUCLEOTIDES; POLYKETAL MICROPARTICLES; INHALED DOXORUBICIN; COMPUTED-TOMOGRAPHY; ESTABLISHED TUMORS	CpG oligonucleotides (ODN) stimulate the innate immune system by triggering cells that express TLR9. The resulting response promotes tumor regression, an effect optimized by delivery of CpG ODN to the tumor site. This work examines the effect of instilling CpG ODN adsorbed onto polyketal microparticles (CpG-MP) into the lungs of mice with non-small cell lung cancer. Intrapulmonary delivery of CpG-MP improved ODN uptake and retention at the tumor site, thereby inducing a stronger Th1 response than systemically administered or unadsorbed CpG ODN. CpG-MP reversed the immunosuppression that characterized the tumor microenvironment by (i) decreasing the number of immunosuppressive Tregs and M2 macrophages while (ii) increasing the number of tumoricidal CD8(+) T cells and M1 macrophages. These effects promoted tumor regression and culminated in 82% permanent survival of mice with otherwise fatal Lewis lung cancer. (C) 2015 AACR.	[Sato, Takashi; Klinman, Dennis M.] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Sato, Takashi; Ueda, Atsuhisa; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Shimosato, Takeshi] Shinshu Univ, Grad Sch Agr, Nagano, Japan	Klinman, DM (reprint author), NCI, Bldg 567,Room 205, Frederick, MD 21702 USA.	klinmand@mail.nih.gov			NCI; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21790778, 23790917, 15K09224]	D.M. Klinman's lab is internally funded by the NCI. T. Sato received grants (no. 21790778, 23790917, and 15K09224) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Arndt CAS, 2010, CLIN CANCER RES, V16, P4024, DOI 10.1158/1078-0432.CCR-10-0662; Tahara K, 2008, INT J PHARM, V354, P210, DOI 10.1016/j.ijpharm.2007.11.002; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Kawarada Y, 2001, J IMMUNOL, V167, P5247; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Lee S, 2007, BIOCONJUGATE CHEM, V18, P4, DOI 10.1021/bc060259s; Guiducci C, 2005, CANCER RES, V65, P3437; Heffernan MJ, 2009, BIOMATERIALS, V30, P910, DOI 10.1016/j.biomaterials.2008.10.034; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; Manegold C, 2012, ANN ONCOL, V23, P72, DOI 10.1093/annonc/mdr030; Sorrentino R, 2011, AM J RESP CRIT CARE, V183, P1369, DOI 10.1164/rccm.201010-1738OC; Heffernan MJ, 2005, BIOCONJUGATE CHEM, V16, P1340, DOI 10.1021/bc050176w; Savai R, 2005, AM J PATHOL, V167, P937, DOI 10.1016/S0002-9440(10)61184-4; Belani CP, 2013, CANCER BIOL THER, V14, P557, DOI 10.4161/cbt.24598; Petersen RP, 2006, CANCER, V107, P2866, DOI 10.1002/cncr.22282; Otterson GA, 2007, CLIN CANCER RES, V13, P1246, DOI 10.1158/1078-0432.CCR-06-1096; Ohtaki Y, 2010, J THORAC ONCOL, V5, P1507, DOI 10.1097/JTO.0b013e3181eba692; Shimizu K, 2010, J THORAC ONCOL, V5, P585, DOI 10.1097/JTO.0b013e3181d60fd7; TATSUMURA T, 1993, BRIT J CANCER, V68, P1146, DOI 10.1038/bjc.1993.495; Wang HY, 1997, ANN THORAC SURG, V64, P216, DOI 10.1016/S0003-4975(97)00343-3; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Lonsdorf AS, 2003, J IMMUNOL, V171, P3941; Otterson GA, 2010, CLIN CANCER RES, V16, P2466, DOI 10.1158/1078-0432.CCR-09-3015; Bradbury PA, 2008, J THORAC ONCOL, V3, pS164, DOI 10.1097/JTO.0b013e318174e9a7; Hirsh V, 2011, J CLIN ONCOL, V29, P2667, DOI 10.1200/JCO.2010.32.8971; Chang GJ, 2012, J CLIN ONCOL, V30, P3165, DOI 10.1200/JCO.2012.43.5743; Heckelsmiller K, 2002, J IMMUNOL, V169, P3892; Yamada K, 2010, CANCER SCI, V101, P188, DOI 10.1111/j.1349-7006.2009.01361.x; Manegold C, 2008, J CLIN ONCOL, V26, P3979, DOI 10.1200/JCO.2007.12.5807; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Baines J, 2003, CLIN CANCER RES, V9, P2693; Fiore VF, 2010, BIOMATERIALS, V31, P810, DOI 10.1016/j.biomaterials.2009.09.100; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x; Sorrentino R, 2010, J IMMUNOL, V185, P4641, DOI 10.4049/jimmunol.1000881; Zeni E, 2007, EUR RESPIR J, V30, P627, DOI 10.1183/09031936.00129306; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Ballester M, 2011, VACCINE, V29, P6959, DOI 10.1016/j.vaccine.2011.07.039; Klinman Dennis M, 2004, Nat Rev Immunol, V4, P249, DOI 10.1038/nri1329; Klinman DM, 1994, CURRENT PROTOCOLS IM; Langer R, 1998, NATURE, V392, P5; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Nierkens S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008368; Verhoef C, 2011, EJC SUPPL, V3, pS61; Weeratna RD, 2004, J CLIN ONCOL, V22, p702S	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2198	2205		10.1158/1535-7163.MCT-15-0401		8	Oncology	Oncology	CU3EA	WOS:000363405600004		
J	Tsukamoto, S; Huang, YH; Kumazoe, M; Lesnick, C; Yamada, S; Ueda, N; Suzuki, T; Yamashita, S; Kim, YH; Fujimura, Y; Miura, D; Kay, NE; Shanafelt, TD; Tachibana, H				Tsukamoto, Shuntaro; Huang, Yuhui; Kumazoe, Motofumi; Lesnick, Connie; Yamada, Shuhei; Ueda, Naoki; Suzuki, Takashi; Yamashita, Shuya; Kim, Yoon Hee; Fujimura, Yoshinori; Miura, Daisuke; Kay, Neil E.; Shanafelt, Tait D.; Tachibana, Hirofumi			Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs	MOLECULAR CANCER THERAPEUTICS			English	Article							GROWTH-FACTOR-I; TEA POLYPHENOL EGCG; GREEN TEA; LAMININ RECEPTOR; CELL-DEATH; THERAPEUTIC IMPLICATIONS; QUANTITATIVE-ANALYSIS; PROSTATE-CANCER; UP-REGULATION; TUMOR-CELLS	Activation of acid sphingomyelinase (ASM) leads to ceramide accumulation and induces apoptotic cell death in cancer cells. In the present study, we demonstrate that the activation of ASM by targeting cancer-overexpressed 67-kDa laminin receptors (67LR) induces lipid raft disruption and inhibits receptor tyrosine kinase (RTK) activation in multiple myeloma cells. Sphingosine kinase 1 (SphK1), a negative regulator of ceramide accumulation with antiapoptotic effects, was markedly elevated in multiple myeloma cells. The silencing of SphK1 potentiated the apoptotic effects of the green tea polyphenol epigallocatechin-3-O-gallate (EGCG), an activator of ASM through 67LR. Furthermore, the SphK1 inhibitor safingol synergistically sensitized EGCG-induced proapoptotic cell death and tumor suppression in multiple myeloma cells by promoting the prevention of RTK phosphorylation and activation of death-associated protein kinase 1 (DAPK1). We propose that targeting 67LR/ASM and SphK1 may represent a novel therapeutic strategy against multiple myeloma. (C) 2015 AACR.	[Tsukamoto, Shuntaro; Huang, Yuhui; Kumazoe, Motofumi; Yamada, Shuhei; Ueda, Naoki; Suzuki, Takashi; Yamashita, Shuya; Kim, Yoon Hee; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Appl Biol Chem, Fukuoka 812, Japan; [Lesnick, Connie; Kay, Neil E.; Shanafelt, Tait D.] Mayo Clin, Dept Med, Rochester, MN USA; [Fujimura, Yoshinori; Miura, Daisuke; Tachibana, Hirofumi] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Tachibana, Hirofumi] Kyushu Univ, Food Funct Design Res Ctr, Fukuoka 812, Japan	Tachibana, H (reprint author), 6-10-1 Hakozaki,Higashi Ku, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp			Japan Society for the Promotion of Science [22228002, 15H02448, 11J01340, 13J03437]; International Myeloma Foundation (IMF) Japan's grants; MEXT	This work was kindly supported in part by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science to H. Tachibana (grants 22228002 and 15H02448); International Myeloma Foundation (IMF) Japan's grants to H. Tachibana; Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science DC2 (11J01340) to S. Tsukamoto and DC1 (13J03437) to Y. Huang; and MEXT Funding-Project for Developing Innovation Systems-Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in Japan to Y. Fujimura and D. Miura.	Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Giuliani N, 2004, LEUKEMIA, V18, P628, DOI 10.1038/sj.leu.2403269; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Gombos I, 2008, CYTOM PART A, V73A, P220, DOI 10.1002/cyto.a.20516; Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; Widau RC, 2010, J BIOL CHEM, V285, P13827, DOI 10.1074/jbc.M109.085076; Tsukamoto S, 2012, BIOCHEM J, V443, P525, DOI 10.1042/BJ20111837; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; KEDDERIS LB, 1995, FUND APPL TOXICOL, V25, P201, DOI 10.1006/faat.1995.1056; Frassanito MA, 2001, BLOOD, V97, P483, DOI 10.1182/blood.V97.2.483; Kyle RA, 2009, CLIN LYMPHOMA MYELOM, V9, P278, DOI 10.3816/CLM.2009.n.056; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Schwartz GK, 1997, CLIN CANCER RES, V3, P537; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Britschgi A, 2010, BRIT J HAEMATOL, V149, P55, DOI 10.1111/j.1365-2141.2009.08040.x; McLarty J, 2009, CANCER PREV RES, V2, P673, DOI 10.1158/1940-6207.CAPR-08-0167; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Shimizu M, 2005, BIOCHEM BIOPH RES CO, V334, P947, DOI 10.1016/j.bbrc.2005.06.182; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Hong S, 2004, CELL DEATH DIFFER, V11, P714, DOI 10.1038/sj.cdd.4401405; Ogata A, 1997, J IMMUNOL, V159, P2212; Liu LL, 2009, INT J CANCER, V124, P1707, DOI 10.1002/ijc.24135; Viacava P, 1997, J PATHOL, V182, P36, DOI 10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W; Ito J, 2000, J LIPID RES, V41, P894; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Dimanche-Boitrel MT, 2005, DRUG RESIST UPDATE, V8, P5, DOI 10.1016/j.drup.2005.02.003; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Berenson JR, 2001, SEMIN ONCOL, V28, P626, DOI 10.1016/S0093-7754(01)90036-3; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Cuvillier Olivier, 2010, Curr Mol Pharmacol, V3, P53; GeorgiiHemming P, 1996, BLOOD, V88, P2250; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011051; Mahtouk K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-198; Megha, 2004, J Biol Chem, V279, P9997; Megha, 2007, BBA-BIOMEMBRANES, V1768, P2205, DOI 10.1016/j.bbamem.2007.05.007; Scheiman J, 2009, MOL THER, V18, P63; Tagoug I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022641	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2303	2312		10.1158/1535-7163.MCT-15-0185		10	Oncology	Oncology	CU3EA	WOS:000363405600014		
J	Kiyonari, S; Iimori, M; Matsuoka, K; Watanabe, S; Morikawa-Ichinose, T; Miura, D; Niimi, S; Saeki, H; Tokunaga, E; Oki, E; Morita, M; Kadomatsu, K; Maehara, Y; Kitao, H				Kiyonari, Shinichi; Iimori, Makoto; Matsuoka, Kazuaki; Watanabe, Sugiko; Morikawa-Ichinose, Tomomi; Miura, Daisuke; Niimi, Shinichiro; Saeki, Hiroshi; Tokunaga, Eriko; Oki, Eiji; Morita, Masaru; Kadomatsu, Kenji; Maehara, Yoshihiko; Kitao, Hiroyuki			The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis	MOLECULAR CANCER THERAPEUTICS			English	Article							COLON-CANCER CELLS; INDUCED DNA-DAMAGE; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; CYCLE PROGRESSION; P53; EXPRESSION; 5-FLUOROURACIL; SURVIVAL; THERAPY	Platinum-based chemotherapeutic drugs are widely used as components of combination chemotherapy in the treatment of cancer. One such drug, oxaliplatin, exerts a synergistic effect against advanced colorectal cancer in combination with 5-fluorouracil (5-FU) and leucovorin. In the p53-proficient colorectal cancer cell line HCT116, oxaliplatin represses the expression of deoxyuridine triphosphatase (dUTPase), a ubiquitous pyrophosphatase that catalyzes the hydrolysis of dUTP to dUMP and inhibits dUTP-mediated cytotoxicity. However, the underlying mechanism of this activity has not been completely elucidated, and it remains unclear whether factors other than downregulation of dUTPase contribute to the synergistic effect of 5-FU and oxaliplatin. In this study, we found that oxaliplatin and dachplatin, platinum-based drugs containing the 1,2-diaminocyclohexane (DACH) carrier ligand, repressed the expression of nuclear isoform of dUTPase (DUT-N), whereas cisplatin and carboplatin did not. Oxaliplatin induced early p53 accumulation, upregulation of primary miR-34a transcript expression, and subsequent downregulation of E2F3 and E2F1. Nutlin-3a, which activates p53 nongenotoxically, had similar effects. Introduction of miR-34a mimic also repressed E2F1 and DUT-N expression, indicating that this miRNA plays a causative role. In addition to DUT-N, oxaliplatin repressed, in a p53-dependent manner, the expression of genes encoding enzymes involved in thymidylate biosynthesis. Consequently, oxaliplatin significantly decreased the level of dTTP in the dNTP pool in a p53-dependent manner. These data indicate that the DACH carrier ligand in oxaliplatin triggers signaling via the p53-miR-34a-E2F axis, leading to transcriptional regulation that ultimately results in accumulation of dUTP and reduced dTTP biosynthesis, potentially enhancing 5-FU cytotoxicity. (C) 2015 AACR.	[Kiyonari, Shinichi; Matsuoka, Kazuaki; Watanabe, Sugiko; Niimi, Shinichiro; Maehara, Yoshihiko; Kitao, Hiroyuki] Kyushu Univ, Innovat Ctr Med Redox Nav, Innovat Anticanc Strategy Therapeut & Diag Grp, Fukuoka, Kyushu 8128582, Japan; [Kiyonari, Shinichi; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan; [Iimori, Makoto; Kitao, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Fukuoka, Kyushu 8128582, Japan; [Matsuoka, Kazuaki; Niimi, Shinichiro] Taiho Pharmaceut Co Ltd, Tokushima, Japan; [Morikawa-Ichinose, Tomomi; Miura, Daisuke] Kyushu Univ, Innovat Ctr Med Redox Nav, Metab Profiling Res Grp, Fukuoka, Kyushu 8128582, Japan; [Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Kyushu 8128582, Japan; [Tokunaga, Eriko] Kyushu Univ, Grad Sch Med Sci, Dept Comprehens Clin Oncol, Fukuoka, Kyushu 8128582, Japan	Kitao, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Kyushu 8128582, Japan.	hkitao@surg2.med.kyushu-u.ac.jp	Kiyonari, Shinichi/I-7329-2014; Kadomatsu, Kenji/G-8083-2012		Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan (JSPS KAKENHI) [24701028]	This work was supported by the Science and Technology Incubation Program in Advanced Regions from the funding program "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" from the Japan Science and Technology Agency, commissioned by the Ministry of Education, Culture, Sports, Science, and Technology. This work was also supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. Kiyonari, JSPS KAKENHI grant number 24701028).	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Kim ST, 2010, CANCER CHEMOTH PHARM, V66, P659, DOI 10.1007/s00280-009-1206-3; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Tommasi S, 1997, J BIOL CHEM, V272, P30483, DOI 10.1074/jbc.272.48.30483; Wilson PM, 2008, MOL CANCER THER, V7, P3029, DOI 10.1158/1535-7163.MCT-08-0280; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Setoyama D, 2013, GENES CELLS, V18, P1107, DOI 10.1111/gtc.12098; Zaanan A, 2010, ANN ONCOL, V21, P772, DOI 10.1093/annonc/mdp383; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Ladner RD, 2000, CANCER RES, V60, P3493; Alcindor T, 2011, CURR ONCOL, V18, P18; Koehler SE, 2004, MOL PHARMACOL, V66, P620; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc.1074; Zauli G, 2011, CLIN CANCER RES, V17, P2712, DOI 10.1158/1078-0432.CCR-10-3244; Liu HF, 2010, CHEM-BIOL INTERACT, V188, P535, DOI 10.1016/j.cbi.2010.08.001; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539; Wilson PM, 2012, MOL CANCER THER, V11, P616, DOI 10.1158/1535-7163.MCT-11-0781; Paris R, 2008, CELL CYCLE, V7, P2427; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; de Bruijn MT, 2010, BRIT J CANCER, V102, P1254, DOI 10.1038/sj.bjc.6605633; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Yeh KH, 2004, ANTI-CANCER DRUG, V15, P371, DOI 10.1097/01.cad.0000125225.57491.8b; Matsuoka K, 2015, MOL CANCER THER, V14, P1004, DOI 10.1158/1535-7163.MCT-14-0236; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Voland C, 2006, MOL CANCER THER, V5, P2149, DOI 10.1158/1535-7163.MCT-05-0212; McEntee G, 2011, P NATL ACAD SCI USA, V108, P15157, DOI 10.1073/pnas.1103605108; Dong S, 2000, J CELL BIOCHEM, V77, P50, DOI 10.1002/(SICI)1097-4644(20000401)77:1<50::AID-JCB6>3.0.CO;2-C; Wilson PM, 2009, NUCLEIC ACIDS RES, V37, P78, DOI 10.1093/nar/gkn910; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Kato H, 2012, J BIOSCI BIOENG, V113, P665, DOI 10.1016/j.jbiosc.2011.12.013; He GG, 2011, GYNECOL ONCOL, V122, P402, DOI 10.1016/j.ygyno.2011.04.034; Takatori H, 2010, LIVER INT, V30, P438, DOI 10.1111/j.1478-3231.2009.02177.x; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Munch-Petersen B, 2010, NUCLEOS NUCLEOT NUCL, V29, P363, DOI 10.1080/15257771003729591	44	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2332	2342		10.1158/1535-7163.MCT-14-0748		11	Oncology	Oncology	CU3EA	WOS:000363405600017		
J	Ono, YJ; Tanabe, A; Tanaka, T; Tanaka, Y; Hayashi, M; Terai, Y; Ohmichi, M				Ono, Yoshihiro Joshua; Tanabe, Akiko; Tanaka, Tomohito; Tanaka, Yoshimichi; Hayashi, Masami; Terai, Yoshito; Ohmichi, Masahide			Met Signaling Cascade Is Amplified by the Recruitment of Phosphorylated Met to Lipid Rafts via CD24 and Leads to Drug Resistance in Endometrial Cancer Cell Lines	MOLECULAR CANCER THERAPEUTICS			English	Article							INDEPENDENT PROGNOSTIC MARKER; MULTIDRUG-RESISTANCE; PATIENT SURVIVAL; OVARIAN-CANCER; BREAST-CANCER; P-SELECTIN; IN-VITRO; EXPRESSION; CARCINOMA; PACLITAXEL	Endometrial cancer is the most prevalent gynecologic cancer in the Western world, and the number of advanced chemotherapy-resistant cancers is increasing with the absolute increase in patients. The development of resistance to chemotherapeutic drugs by cancer cells represents a major challenge in the clinical cure of advanced and metastatic cancers. CD24 has been reported to be a marker for a poor prognosis in several tumors, and we herein examined the functions of CD24 in human endometrioid adenocarcinoma cell lines and evaluated how it contributes to cancer drug resistance. We demonstrated that CD24 was responsible for the recruitment of phosphorylated Met to the lipid raft domain of the cell membrane, resulting in amplification of the Met signaling cascade, ultimately leading endometrial cancer cells to express higher levels of ATP-binding cassette (ABC) transporters. Our findings suggest that CD24-mediated amplification of the Met cascade may contribute to the drug resistance of endometrial cancer. (C) 2015 AACR.	[Ono, Yoshihiro Joshua; Tanabe, Akiko; Tanaka, Tomohito; Tanaka, Yoshimichi; Hayashi, Masami; Terai, Yoshito; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka 5698686, Japan	Ono, YJ (reprint author), Osaka Med Coll, Dept Obstet & Gynecol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	bigfootman@mac.com			JSPS KAKENHI [22591869]	This work was supported by JSPS KAKENHI grant number 22591869 (to Y. Terai).	Ahmedin J, 2006, CA CANC J CLIN, V56, P106; Ohmichi M, 2005, TRENDS PHARMACOL SCI, V26, P113, DOI 10.1016/j.tips.2005.01.002; Kim KH, 2009, HISTOL HISTOPATHOL, V24, P309; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; Zarn JA, 1996, BIOCHEM BIOPH RES CO, V225, P384, DOI 10.1006/bbrc.1996.1184; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Weichert W, 2005, CLIN CANCER RES, V11, P6574, DOI 10.1158/1078-0432.CCR-05-0606; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Allen JD, 2000, CANCER RES, V60, P5761; Roberg K, 2007, HEAD NECK-J SCI SPEC, V29, P325, DOI 10.1002/hed.20520; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Sammar M, 1997, BBA-PROTEIN STRUCT M, V1337, P287, DOI 10.1016/S0167-4838(96)00177-X; Karahan N, 2006, EUR J GYNAECOL ONCOL, V27, P500; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Baumann P, 2012, CELL MOL LIFE SCI, V69, P435, DOI 10.1007/s00018-011-0756-9; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Friederichs J, 2000, CANCER RES, V60, P6714; Hiramatsu HP, 2000, ANTI-CANCER DRUG, V11, P573, DOI 10.1097/00001813-200008000-00009; Aigner S, 1997, BLOOD, V89, P3385; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Frederic A, 2005, LANCET, V366, P491; Milas L, 2005, SEMIN ONCOL, V32, P78, DOI 10.1053/j.seminoncol.2005.04.028	36	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2353	2363		10.1158/1535-7163.MCT-15-0187		11	Oncology	Oncology	CU3EA	WOS:000363405600019		
J	Stintzing, S; Zhang, W; Heinemann, V; Neureiter, D; Kemmerling, R; Kirchner, T; Jung, A; Folwaczny, M; Yang, DY; Ning, Y; Sebio, A; Stremitzer, S; Sunakawa, Y; Matsusaka, S; Yamauchi, S; Loupakis, F; Cremolini, C; Falcone, A; Lenz, HJ				Stintzing, Sebastian; Zhang, Wu; Heinemann, Volker; Neureiter, Daniel; Kemmerling, Ralf; Kirchner, Thomas; Jung, Andreas; Folwaczny, Matthias; Yang, Dongyun; Ning, Yan; Sebio, Ana; Stremitzer, Stefan; Sunakawa, Yu; Matsusaka, Satoshi; Yamauchi, Shinichi; Loupakis, Fotios; Cremolini, Chiara; Falcone, Alfredo; Lenz, Heinz-Josef			Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer	MOLECULAR CANCER THERAPEUTICS			English	Article							GROWTH-FACTOR RECEPTOR; ACQUIRED-RESISTANCE; TYROSINE KINASES; DOWN-REGULATION; ERBB FAMILY; DEGRADATION; UBIQUITINATION; MUTATIONS; THERAPY; UBIQUITYLATION	Transmembrane receptors, such as the EGFR, are regulated by their turnover, which is dependent on the ubiquitin-proteasome system. We tested in two independent study cohorts whether SNPs in genes involved in EGFR turnover predict clinical outcome in cetuximab-treated metastatic colorectal cancer (mCRC) patients. The following SNPs involved in EGFR degradation were analyzed in a screening cohort of 108 patients treated with cetuximab in the chemorefractory setting: c-CBL (rs7105971; rs4938637; rs4938638; rs251837), EPS15 (rs17567; rs7308; rs1065754), NAE1 (rs363169; rs363170; rs363172), SH3KBP1 (rs7051590; rs5955820; rs1017874; rs11795873), SGIP1 (rs604737; rs6570808; rs7526812), UBE2M (rs895364; rs895374), and UBE2L3 (rs5754216). SNPs showing an association with response or survival were analyzed in BRAF and RAS wild-type samples from the FIRE-3 study. One hundred and fifty-three FOLFIRI plus cetuximab-treated patients served as validation set, and 168 patients of the FOLFIRI plus bevacizumab arm served as controls. EGFR FISH was done in 138 samples to test whether significant SNPs were associated with EGFR expression. UBE2M rs895374 was significantly associated with progression-free survival (log-rank P = 0.005; HR, 0.60) within cetuximab-treated patients. No association with bevacizumab-treated patients (n = 168) could be established (P = 0.56; HR, 0.90). rs895374 genotype did not affect EGFR FISH measurements. EGFR recycling is an interesting mechanism of secondary resistance to cetuximab in mCRC. This is the first report suggesting that germline polymorphisms in the degradation process predict efficacy of cetuximab in patients with mCRC. Genes involved in EGFR turnover may be new targets in the treatment of mCRC. (C) 2015 AACR.	[Stintzing, Sebastian; Zhang, Wu; Ning, Yan; Sebio, Ana; Stremitzer, Stefan; Sunakawa, Yu; Matsusaka, Satoshi; Yamauchi, Shinichi; Lenz, Heinz-Josef] USC Norris Comprehens Canc Ctr, Keck Sch Med, Sharon Carpenter Laboatory, Los Angeles, CA USA; [Stintzing, Sebastian; Heinemann, Volker] Univ Munich, Dept Med Oncol, D-81377 Munich, Germany; [Stintzing, Sebastian; Heinemann, Volker] Univ Munich, Ctr Comprehens Canc, D-81377 Munich, Germany; [Heinemann, Volker; Kirchner, Thomas] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Neureiter, Daniel; Kemmerling, Ralf] Paracelsus Med Univ, Salzburger Landeskliniken SALK, Inst Pathol, Salzburg, Austria; [Kemmerling, Ralf] Med Versorgungszentrum Histol Zytol & Mol Diagnos, Trier, Germany; [Kirchner, Thomas; Jung, Andreas] Univ Munich, Inst Pathol, D-81377 Munich, Germany; [Folwaczny, Matthias] Univ Munich, Dept Prevent Dent & Periodontol, D-81377 Munich, Germany; [Yang, Dongyun; Lenz, Heinz-Josef] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Sebio, Ana] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Yamauchi, Shinichi] Tokyo Med & Dent Univ, Grad Sch, Tokyo, Japan; [Loupakis, Fotios; Cremolini, Chiara; Falcone, Alfredo] Univ Pisana, Aziendo Osped, UO Oncol Med 2, Pisa, Italy	Stintzing, S (reprint author), Univ Munich, Marchioninistr 15, D-81377 Munich, Germany.	sebastian.stintzing@med.uni-muenchen.de			NCI [P30CA014089]; Wunderglo foundation; German Cancer Aid (Mildred-Scheel-Foundation)	H.-J. Lenz was funded by the NCI (award number P30CA014089) and the Wunderglo foundation. S. Stintzing has been granted a postdoctoral fellowship by the German Cancer Aid (Mildred-Scheel-Foundation).	Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Chi SS, 2011, J BIOL CHEM, V286, P35196, DOI 10.1074/jbc.M111.247577; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Stintzing S, 2014, CLIN CANCER RES, V20, P3064, DOI 10.1158/1078-0432.CCR-13-3175; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Bulusu KC, 2014, NUCLEIC ACIDS RES, V42, pD1040, DOI 10.1093/nar/gkt1182; McWhinney SR, 2009, PHARMACOGENOMICS, V10, P489, DOI 10.2217/14622416.10.3.489; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Cercek A, 2011, CURR TREAT OPTION ON, V12, P126, DOI 10.1007/s11864-011-0147-3; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Loupakis F, 2014, PHARMACOGENOMICS J, V14, P322, DOI 10.1038/tpj.2014.1; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Cancer Genome Atlas Research Network, 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; Consortium EP, 2004, SCIENCE, V306, P636, DOI DOI 10.1126/SCIENCE.1105136; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Iida Mari, 2013, Neoplasia, V15, P1196; Jiang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056205; Oliner KS, 2013, J CLIN ONCOL S; Schmidt MH, 2006, SCI STKE SIGNAL TRAN, V2006, pe50; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stintzing S, 2013, ANN ONCOL, V24, pLBA17; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214	45	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	OCT	2015	14	10					2374	2381		10.1158/1535-7163.MCT-15-0121		8	Oncology	Oncology	CU3EA	WOS:000363405600021		
J	Ochi, A; Mori, K; Nakatani, S; Emoto, M; Morioka, T; Motoyama, K; Fukumoto, S; Imanishi, Y; Shoji, T; Ishimura, E; Inaba, M				Ochi, Akinobu; Mori, Katsuhito; Nakatani, Shinya; Emoto, Masanori; Morioka, Tomoaki; Motoyama, Koka; Fukumoto, Shinya; Imanishi, Yasuo; Shoji, Tetsuo; Ishimura, Eiji; Inaba, Masaaki			Indoxyl sulfate suppresses hepatic fetuin-A expression via the aryl hydrocarbon receptor in HepG2 cells	NEPHROLOGY DIALYSIS TRANSPLANTATION			English	Article						AHSG; fetuin-A; hepatocyte; indoxyl sulfate	CONTAINING CALCIPROTEIN PARTICLES; CHRONIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; P-CRESYL SULFATE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; GLYCOPROTEIN/FETUIN-A; DIALYSIS PATIENTS; UREMIC TOXICITY; MINERAL COMPLEX	Background. Fetuin-A is a liver-derived circulating protein that has potent calcification-inhibitory activity. Uraemic patients exhibit decreased serum fetuin-A levels, increased vascular calcification and elevated cardiovascular mortality. Because the mechanisms for fetuin-A deficiency are unknown, we hypothesized that some uraemic toxins suppressed hepatic fetuin-A production, which resulted in accelerated vascular calcification and poor outcome. Among these potential candidates, indoxyl sulfate (IS) has highly toxic properties. Methods. We examined the direct effects of IS on hepatic fetuin-A expression using the human hepatoma HepG2 cell line. Results. IS, but not p-cresyl sulfate, suppressed the mRNA and protein expression of fetuin-A in a dose-and time-dependent manner. As reported previously, IS stimulated p38 MAPK phosphorylation and reactive oxygen species (ROS) production, although the knockdown of p38 and inhibition of ROS generation had no effect on IS-induced fetuin-A suppression. Then, because IS is a potent endogenous ligand of the aryl hydrocarbon receptor (AhR), we assessed whether IS suppresses fetuin-A production via AhR. The knockdown of AhR prevented IS-induced fetuin-A suppression. However, some attention should be paid to no effect of IS on fetuin-A expression in mouse and human primary cultured hepatocytes. Conclusions. These findings suggest that IS could suppress hepatic fetuin-A expression by activating AhR, suggesting a relationship between uraemia and fetuin-A deficiency.	[Ochi, Akinobu; Mori, Katsuhito; Nakatani, Shinya; Emoto, Masanori; Morioka, Tomoaki; Motoyama, Koka; Fukumoto, Shinya; Imanishi, Yasuo; Ishimura, Eiji; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan; [Shoji, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Osaka 558, Japan	Mori, K (reprint author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan.	ktmori@med.osaka-cu.ac.jp					Mori K, 2005, MOL CELL ENDOCRINOL, V230, P39, DOI 10.1016/j.mce.2004.11.004; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Takata H, 2009, J ATHEROSCLER THROMB, V16, P448; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Niwa T, 2010, NAGOYA J MED SCI, V72, P1; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Masai N, 2010, CIRC J, V74, P2216, DOI 10.1253/circj.CJ-10-0117; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; Dou L, 2015, J AM SOC NEPHROL, V26, P876, DOI 10.1681/ASN.2013121283; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Sallee M, 2014, TOXINS, V6, P934, DOI 10.3390/toxins6030934; Gangneux C, 2003, NUCLEIC ACIDS RES, V31, P5957, DOI 10.1093/nar/gkg788; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Woltje M, 2006, J MOL ENDOCRINOL, V36, P261, DOI 10.1677/jme.1.02001; Watanabe I, 2013, CIRC J, V77, P224, DOI 10.1253/circj.CJ-12-0647; Carrero JJ, 2013, J RENAL NUTR, V23, P77, DOI 10.1053/j.jrn.2013.01.001; Smith ER, 2013, NEPHROLOGY, V18, P215, DOI 10.1111/nep.12021; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI200317202; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Mori K, 2012, ADV CLIN CHEM, V56, P175, DOI 10.1016/B978-0-12-394317-0.00010-8; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Hamano T, 2010, J AM SOC NEPHROL, V21, P1998, DOI 10.1681/ASN.2009090944; Schinke T, 1996, J BIOL CHEM, V271, P20789; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; Ichii O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108448; Mori Katsuhito, 2011, Recent Pat Endocr Metab Immune Drug Discov, V5, P124; Ng HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091517; Ochi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088704	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0931-0509	1460-2385		NEPHROL DIAL TRANSPL	Nephrol. Dial. Transplant.	OCT	2015	30	10					1683	1692		10.1093/ndt/gfv250		11	Transplantation; Urology & Nephrology	Transplantation; Urology & Nephrology	CT9YG	WOS:000363171900012		
J	Momosaki, R; Abo, M; Watanabe, S; Kakuda, W; Yamada, N; Kinoshita, S				Momosaki, Ryo; Abo, Masahiro; Watanabe, Shu; Kakuda, Wataru; Yamada, Naoki; Kinoshita, Shoji			Repetitive Peripheral Magnetic Stimulation With Intensive Swallowing Rehabilitation for Poststroke Dysphagia: An Open-Label Case Series	NEUROMODULATION			English	Article						Dysphagia; magnetic stimulation; stroke	ELECTRICAL-STIMULATION; STROKE PATIENTS; OROPHARYNGEAL DYSPHAGIA; MOTOR FUNCTION; BRAIN; SCALE; RELIABILITY; ASPIRATION; MANAGEMENT; VALIDITY	ObjectiveThe purpose of this pilot study was to determine the safety and feasibility of a six-day protocol of in-hospital repetitive peripheral magnetic stimulation combined with intensive swallowing rehabilitation (rPMS-ISR) for poststroke dysphagia. MethodsThe subjects were eight patients with dysphagia caused by bilateral cerebral infarction (age: 62-70; time from onset of stroke: 27-39 months). rPMS was applied to the suprahyoid muscles, at strength set at 90% of the minimal intensity that elicited pain with a parabolic coil. One train of stimuli comprised 20Hz for 3 sec followed by 27-sec rest. A single session included delivery of repetitive 20 trains of stimuli over 10min, followed by 20 min of swallowing rehabilitation. Each patient received this combination treatment twice daily, morning and afternoon, over six consecutive days. Swallowing function was evaluated before and after intervention. ResultsrPMS-ISR induced significant improvement in swallowing ability, laryngeal elevation delay time, penetration aspiration scale, and swallowing quality of life (p < 0.01), but had no significant effect on the functional oral intake scale. ConclusionThe six-day in-hospital RPMS-ISR protocol seems safe and feasible for poststroke patients with dysphagia. The combination protocol improved swallowing function. Further larger studies are needed to confirm its efficacy.	[Momosaki, Ryo; Abo, Masahiro; Watanabe, Shu; Kakuda, Wataru; Yamada, Naoki; Kinoshita, Shoji] Jikei Univ Sch Med, Dept Rehabil Med, Minato Ku, Tokyo, Japan; [Momosaki, Ryo; Abo, Masahiro; Watanabe, Shu; Kakuda, Wataru; Yamada, Naoki; Kinoshita, Shoji] Jikei Univ, Dept Rehabil Med, Sch Med, Minato Ku, Tokyo 1058461, Japan	Momosaki, R (reprint author), Jikei Univ, Dept Rehabil Med, Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	momosakiryo@gmail.com			Magnetic Health Science Foundation; Japan Society for the Promotion of Science	This work was supported by The Magnetic Health Science Foundation. The Japan Society for the Promotion of Science provided funding for the study.	Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Park JW, 2012, DYSPHAGIA, V27, P521, DOI 10.1007/s00455-012-9403-3; Bulow M, 2008, DYSPHAGIA, V23, P302, DOI 10.1007/s00455-007-9145-9; Struppler A, 2007, NEUROIMAGE, V36, pT174, DOI 10.1016/j.neuroimage.2007.03.033; Krewer C, 2014, ARCH PHYS MED REHAB, V95, P1039, DOI 10.1016/j.apmr.2014.02.003; McHorney CA, 2002, DYSPHAGIA, V17, P97, DOI 10.1007/s00455-001-0109-1; Heldmann B, 2000, NEUROREPORT, V11, P3193, DOI 10.1097/00001756-200009280-00029; Beom Jaewon, 2011, Ann Rehabil Med, V35, P322, DOI 10.5535/arm.2011.35.3.322; Lim KB, 2009, J REHABIL MED, V41, P174, DOI 10.2340/16501977-0317; Permsirivanich Wutichai, 2009, Journal of the Medical Association of Thailand, V92, P259; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Kawai S, 2003, DYSPHAGIA, V18, P1, DOI 10.1007/s00547-002-0074-z; Lin VW, 2001, ARCH PHYS MED REHAB, V82, P167, DOI 10.1053/apmr.2001.18215; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Verin E, 2009, DYSPHAGIA, V24, P204, DOI 10.1007/s00455-008-9195-7; Khedr EM, 2010, J NEUROL NEUROSUR PS, V81, P495, DOI 10.1136/jnnp.2009.188482; Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919; Verin E, 2012, ARCH PHYS MED REHAB, V93, P1987, DOI 10.1016/j.apmr.2011.10.020; Kim SJ, 2009, NEUROMODULATION, V12, P134, DOI 10.1111/j.1525-1403.2009.00200.x; Kiger M, 2006, DYSPHAGIA, V21, P243, DOI 10.1007/s00455-006-9056-1; Logemann JA, 1997, OTOLARYNG HEAD NECK, V116, P335, DOI 10.1016/S0194-5998(97)70269-9; Antunes EB, 2012, GERODONTOLOGY, V29, P247, DOI 10.1111/j.1741-2358.2012.00638.x; Lin VWH, 2002, ARCH PHYS MED REHAB, V83, P806, DOI 10.1053/apmr.2002.32644; Chiu CM, 2009, J REHABIL MED, V41, P1085, DOI 10.2340/16501977-0456; Szecsi J, 2009, ARCH PHYS MED REHAB, V90, P564, DOI 10.1016/j.apmr.2008.09.572; Michou E, 2014, BRAIN STIMUL, V7, P66, DOI 10.1016/j.brs.2013.09.005; Miller M, 2008, ARCH PHYS MED REHAB, V89, P2031, DOI 10.1016/j.apmr.2008.03.025; Hamdy S, 2003, NEUROGASTROENT MOTIL, V15, P69, DOI 10.1046/j.1365-2982.2003.00390.x; Hubsher CP, 2012, CAN J UROL, V19, P6480; Beaulieu LD, 2013, NEUROPHYSIOL CLIN, V43, P251, DOI 10.1016/j.neucli.2013.05.003; Krause P, 2008, NEUROL RES, V30, P690, DOI 10.1179/174313208X297959; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Gallas S, 2010, DYSPHAGIA, V25, P291, DOI 10.1007/s00455-009-9259-3; Gonzalez-Fernandez M, 2011, AM J SPEECH-LANG PAT, V20, P331, DOI 10.1044/1058-0360(2011/10-0082); Keith R A, 1987, Adv Clin Rehabil, V1, P6; Momosaki R, 2013, NEUROMODULATION, V17, P637; Park JW, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12063; Flamand VH, 2014, ARCH PHYS MED REHAB, V95, P1984, DOI 10.1016/j.apmr.2014.05.014	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	OCT	2015	18	7					630	635		10.1111/ner.12308		6	Medicine, Research & Experimental; Clinical Neurology	Research & Experimental Medicine; Neurosciences & Neurology	CU1FH	WOS:000363264900013		
J	Jang, S; Takata, T; Yamaguchi, A; Uchibori, A; Kurihara, A; Ohshima, H				Jang, Sunghyon; Takata, Takashi; Yamaguchi, Akira; Uchibori, Akihiro; Kurihara, Akikazu; Ohshima, Hiroyuki			NUMERICAL APPROACH FOR QUANTIFICATION OF SELFWASTAGE PHENOMENA IN SODIUM-COOLED FAST REACTOR	NUCLEAR ENGINEERING AND TECHNOLOGY			English	Article						Computational Fluid Dynamics; Self-Wastage Phenomena; Sodium Faster Breeder Reactor; Sodium-Water Reaction	WATER REACTION	Sodium-cooled fast breeder reactors use liquid sodium as a moderator and coolant to transfer heat from the reactor core. The main hazard associated with sodium is its rapid reaction with water. Sodium-water reaction (SWR) takes place when water or vapor leak into the sodium side through a crack on a heat-transfer tube in a steam generator. If the SWR continues for some time, the SWR will damage the surface of the defective area, causing it to enlarge. This self-enlargement of the crack is called "self-wastage phenomena." A stepwise numerical evaluation model of the self-wastage phenomena was devised using a computational code of multicomponent multiphase flow involving a sodium-water chemical reaction: sodiumwater reaction analysis physics of interdisciplinary multiphase flow (SERAPHIM). The temperature of gas mixture and the concentration of NaOH at the surface of the tube wall are obtained by a numerical calculation using SERAPHIM. Averaged thermophysical properties are used to assess the local wastage depth at the tube surface. By reflecting the wastage depth to the computational grid, the self-wastage phenomena are evaluated. A two-dimensional benchmark analysis of an SWAT (Sodium-Water reAction Test rig) experiment is carried out to evaluate the feasibility of the numerical model. Numerical results show that the geometry and scale of enlarged cracks show good agreement with the experimental result. Enlarged cracks appear to taper inward to a significantly smaller opening on the inside of the tube wall. The enlarged outer diameter of the crack is 4.72 mm, which shows good agreement with the experimental data (4.96 mm). Copyright (C) 2015, Published by Elsevier Korea LLC on behalf of Korean Nuclear Society.	[Jang, Sunghyon; Takata, Takashi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Yamaguchi, Akira] Univ Tokyo, Grad Sch Engn, Tokai, Ibaraki 3191188, Japan; [Uchibori, Akihiro; Kurihara, Akikazu; Ohshima, Hiroyuki] Japan Atom Energy Agcy, Higashiibaraki, Ibaraki 3111393, Japan	Jang, S (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	jang_s@qe.see.eng.osaka-u.ac.jp					Jeong JY, 2009, KOREAN J CHEM ENG, V26, P1004, DOI 10.2478/s11814-009-0167-x; Takata T, 2003, J NUCL SCI TECHNOL, V40, P708, DOI 10.3327/jnst.40.708; Perry J, 2003, J PRESS VESS-T ASME, V125, P248, DOI 10.1115/1.1593078; Currie R., 1990, P IAEA IWGFR SPEC M; Dumm K., 1974, IAEA STUD GROUP M ST; Green D. A., 1976, INT C LIQ MET TECHN; Hori M., 1980, ATOM ENERGY REV, V183, P707; Kozlov F. A., 1976, INT C LIQ MET TECHN; Kurihara A., 2001, P AESJ 2011 FALL M S, P781; Kuroha M., 1982, PNCTN94182101; Mott R. L., 2002, APPL STRENGTH MAT; Neely H. H., 1990, P IAEA IWGFR SPEC M; Okano Y., 2001, 2001 ANN M AT EN SOC; Sandusky D. W., 1976, INT C LIQ MET TECHN	14	0	0	KOREAN NUCLEAR SOC	DAEJEON	NUTOPIA BLDG, 342-1 JANGDAE-DONG, DAEJEON, 305-308, SOUTH KOREA	1738-5733			NUCL ENG TECHNOL	Nucl. Eng. Technol.	OCT	2015	47	6					700	711		10.1016/j.net.2015.06.008		12	Nuclear Science & Technology	Nuclear Science & Technology	CU1JR	WOS:000363277800005		
J	Arita, R; Morishige, N; Shirakawa, R; Sato, Y; Amano, S				Arita, Reiko; Morishige, Naoyuki; Shirakawa, Rika; Sato, Yoichi; Amano, Shiro			Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction	OCULAR SURFACE			English	Article						dry eye; eyelid warming; meibomian gland; meibomian gland dysfunction; meibography; tear film	LIPID LAYER THICKNESS; DRY EYE; INTERNATIONAL WORKSHOP; THERMODYNAMIC TREATMENT; SURFACE-TEMPERATURE; OCULAR SURFACE; PREVALENCE; SYSTEM; SUBCOMMITTEE; COMPRESSION	Purpose: To evaluate the effects of commercially available eyelid warming devices on ocular temperatures, tear film function, and meibomian glands in normal subjects and patients with meibomian gland dysfunction (MGD). Methods: Ten healthy volunteers were enrolled to evaluate the effects of a single warming and of repeated warming for 2 weeks. Ten MGD patients were enrolled for evaluation of repeated warming over 1 month. Two non-wet (Azuki no Chikara, Eye Hot R) and three wet (hot towel, Hot Eye Mask, Memoto Este) devices were compared in a masked manner. Visual analog scale (VAS) score for ocular symptoms, tear film breakup time (TFBUT), meibum grade, temperatures (eyelid skin, tarsal conjunctiva, central cornea), Schirmer test value, and meibomian gland area were measured before and after warming application. Results: The single application of the five warming devices improved the VAS score, TFBUT, and ocular temperatures. In the repeated warming application, Azuki no Chikara as a representative non-wet warming device induced a stable and significant improvement in TFBUT and increased the tarsal conjunctival temperature and meibomian gland area in both normal subjects and MGD patients. It also improved meibum grade in MGD patients. Conclusion: Our results suggest that repeated eyelid warming with a non-wet device improves tear film function in normal individuals and may have beneficial effects on both tear film and meibomian gland function in MGD patients.	[Arita, Reiko] Itoh Clin, Dept Ophthalmol, Saitama 3370042, Japan; [Arita, Reiko; Shirakawa, Rika] Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan; [Arita, Reiko] Keio Univ, Dept Ophthalmol, Tokyo, Japan; [Arita, Reiko; Morishige, Naoyuki; Shirakawa, Rika] Lid & Meibomian Gland Working Grp, Saitama, Japan; [Morishige, Naoyuki] Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Yamaguchi, Japan; [Sato, Yoichi] Yamaguchi Univ, Yamaguchi, Japan; [Amano, Shiro] Inoue Eye Hosp, Tokyo, Japan; [Amano, Shiro] Miyata Eye Hosp, Miyazaki, Japan	Arita, R (reprint author), Itoh Clin, Dept Ophthalmol, 626-11 Minami Nakano, Saitama 3370042, Japan.	ritoh@za2.so-net.ne.jp					Mitra M, 2005, EYE, V19, P657, DOI 10.1038/sj.eye.6701611; BRON AJ, 1968, ARCH OPHTHALMOL-CHIC, V79, P119; Borchman D, 2011, INVEST OPHTH VIS SCI, V52, P3805, DOI 10.1167/iovs.10-6514; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Blackie CA, 2008, OPTOMETRY VISION SCI, V85, P675, DOI 10.1097/OPX.0b013e318181adef; Mori A, 2003, JPN J OPHTHALMOL, V47, P578, DOI 10.1016/S0021-5155(03)00142-4; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Borchman D, 2007, CHEM PHYS LIPIDS, V147, P87, DOI 10.1016/j.chemphyslip.2007.04.001; MORGAN PB, 1995, EYE, V9, P615; Lane SS, 2012, CORNEA, V31, P396, DOI 10.1097/ICO.0b013e318239aaea; Arita R, 2014, BRIT J OPHTHALMOL, V98, P746, DOI 10.1136/bjophthalmol-2012-303014; Greiner JV, 2012, CURR EYE RES, V37, P272, DOI 10.3109/02713683.2011.631721; Efron N, 2013, INVEST OPHTH VIS SCI, V54, P98, DOI 10.1167/iovs.13-13187; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Goto E, 2002, ADV EXP MED BIOL, V506, P1149; Korb DR, 2013, EYE CONTACT LENS, V39, pE1, DOI 10.1097/ICL.0b013e31824ccbda; Arita R, 2013, JAMA OPHTHALMOL, V131, P818, DOI 10.1001/jamaophthalmol.2013.1895; Friedland BR, 2011, CURR EYE RES, V36, P79, DOI 10.3109/02713683.2010.509529; Solomon JD, 2007, OPTOMETRY VISION SCI, V84, P580, DOI 10.1097/OPX.0b013e3180dc99d5; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; BRON AJ, 1969, BRIT J OPHTHALMOL, V53, P760, DOI 10.1136/bjo.53.11.760; Goto E, 2002, BRIT J OPHTHALMOL, V86, P1403, DOI 10.1136/bjo.86.12.1403; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Lekhanont K, 2006, CORNEA, V25, P1162, DOI 10.1097/01.ico.0000244875.92879.1a; Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a; Nagymihalyi A, 2004, EXP EYE RES, V78, P367, DOI 10.1016/S0014-4835(03)00197-0; McCulley JP, 1998, ADV EXP MED BIOL, V438, P319; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Blackie CA, 2013, CORNEA, V32, pE146, DOI 10.1097/ICO.0b013e318292a7b7; Matsumoto Y, 2006, CORNEA, V25, P644; Geerling G, 2011, INVEST OPHTH VIS SCI, V52, P2050, DOI 10.1167/iovs.10-6997g; Mori A, 1999, CORNEA, V18, P188, DOI 10.1097/00003226-199903000-00008; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI [10.1016/j.ophtha.2007.06.031, 10.1016/j.ophtha.2007.06.03]; BRON AJ, 1968, BRIT J OPHTHALMOL, V52, P659, DOI 10.1136/bjo.52.9.659; Bron A J, 2004, Ocul Surf, V2, P149; Finis D, 2014, OCUL SURF, V12, P146, DOI 10.1016/j.jtos.2013.12.001; Ishida R, 2008, OPTOMETRY VISION SCI, V85, P684, DOI 10.1097/OPX.0b013e318181ae83; Miyashita K, 1991, JPN J CLIN OPHTHAL, V45, P1017; Olson Mary Catherine, 2003, Eye Contact Lens, V29, P96, DOI 10.1097/01.ICL.0000060998.20142.8D; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE1035, DOI 10.1097/OPX.0b013e31825c3479; Record NB, 2015, JAMA-J AM MED ASSOC, V313, P147, DOI 10.1001/jama.2014.16969; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266; Terada Osamu, 2004, Nippon Ganka Gakkai Zasshi, V108, P690	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1542-0124	1937-5913		OCUL SURF	Ocul. Surf.	OCT	2015	13	4					321	330				10	Ophthalmology	Ophthalmology	CU1KW	WOS:000363281300007		
J	Brown, DM; Schmidt-Erfurth, U; Do, DV; Holz, FG; Boyer, DS; Midena, E; Heier, JS; Terasaki, H; Kaiser, PK; Marcus, DM; Nguyen, QD; Jaffe, GJ; Slakter, JS; Simader, C; Soo, Y; Schmelter, T; Yancopoulos, GD; Stahl, N; Vitti, R; Berliner, AJ; Zeitz, O; Metzig, C; Korobelnik, JF				Brown, David M.; Schmidt-Erfurth, Ursula; Do, Diana V.; Holz, Frank G.; Boyer, David S.; Midena, Edoardo; Heier, Jeffrey S.; Terasaki, Hiroko; Kaiser, Peter K.; Marcus, Dennis M.; Nguyen, Quan D.; Jaffe, Glenn J.; Slakter, Jason S.; Simader, Christian; Soo, Yuhwen; Schmelter, Thomas; Yancopoulos, George D.; Stahl, Neil; Vitti, Robert; Berliner, Alyson J.; Zeitz, Oliver; Metzig, Carola; Korobelnik, Jean-Francois			Intravitreal Aflibercept for Diabetic Macular Edema 100-Week Results From the VISTA and VIVID Studies	OPHTHALMOLOGY			English	Article							RANIBIZUMAB PLUS PROMPT; VEGF TRAP-EYE; DEFERRED LASER; RANDOMIZED-TRIAL; GROWTH-FACTOR; DA VINCI; BEVACIZUMAB; RETINOPATHY; PREVALENCE; MANAGEMENT	Purpose: To compare efficacy and safety of 2 dosing regimens of intravitreal aflibercept injection (IAI) with macular laser photocoagulation for diabetic macular edema (DME). Design: Two similarly designed, randomized, phase 3 trials, VISTA(DME) and VIVIDDME. Participants: Patients (eyes; n = 872) with type 1 or 2 diabetes mellitus who had DME with central involvement. Methods: Eyes received IAI 2 mg every 4 weeks (2q4), IAI 2 mg every 8 weeks after 5 monthly doses (2q8), or laser control. Main Outcome Measures: The primary end point was mean change from baseline in best-corrected visual acuity (BCVA) at week 52. This report presents the 100-week results including mean change from baseline in BCVA, proportion of eyes that gained >= 15 letters, and proportion of eyes with a >= 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) score. Results: Mean BCVA gain from baseline to week 100 with IAI 2q4, IAI 2q8, and laser control was 11.5, 11.1, and 0.9 letters (P < 0.0001) in VISTA and 11.4, 9.4, and 0.7 letters (P < 0.0001) in VIVID, respectively. The proportion of eyes that gained >= 15 letters from baseline at week 100 was 38.3%, 33.1%, and 13.0% (P < 0.0001) in VISTA and 38.2%, 31.1%, and 12.1% (P <= 0.0001) in VIVID. The proportion of eyes that lost >= 15 letters at week 100 was 3.2%, 0.7%, and 9.7% (P <= 0.0220) in VISTA and 2.2%, 1.5%, and 12.9%(P <= 0.0008) in VIVID. Significantly more eyes in the IAI 2q4 and 2q8 groups versus those in the laser control group had a >= 2 step improvement in the DRSS score in both VISTA (37.0% and 37.1% vs. 15.6%; P < 0.0001) and VIVID (29.3% and 32.6% vs. 8.2%; P <= 0.0004). In an integrated safety analysis, the most frequent serious ocular adverse event was cataract (2.4%, 1.0%, and 0.3% for 2q4, 2q8, and control). Conclusions: In both VISTA and VIVID, the 52-week visual and anatomic superiority of IAI over laser control was sustained through week 100, with similar efficacy in the 2q4 and 2q8 groups. Safety in these studies was consistent with the known safety profile of IAI. (C) 2015 by the American Academy of Ophthalmology.	[Brown, David M.] Retina Consultants Houston, Houston, TX USA; [Schmidt-Erfurth, Ursula; Simader, Christian] Med Univ Vienna, Vienna, Austria; [Do, Diana V.; Nguyen, Quan D.] Univ Nebraska Med Ctr, Truhlsen Eye Inst, Omaha, NE USA; [Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA; [Midena, Edoardo] Univ Padua, Dept Ophthalmol, Padua, Italy; [Heier, Jeffrey S.] Ophthalm Consultants Boston, Boston, MA USA; [Heier, Jeffrey S.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Terasaki, Hiroko] Nagoya Univ Hosp, Nagoya, Aichi, Japan; [Kaiser, Peter K.] Cole Eye Inst, Cleveland, OH USA; [Marcus, Dennis M.] Southeast Retina Ctr, Augusta, GA USA; [Jaffe, Glenn J.] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Slakter, Jason S.] Vitreous Retina Macula Consultants New York, New York, NY USA; [Soo, Yuhwen; Yancopoulos, George D.; Stahl, Neil; Vitti, Robert; Berliner, Alyson J.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Schmelter, Thomas; Zeitz, Oliver; Metzig, Carola] Bayer HealthCare, Berlin, Germany; [Zeitz, Oliver] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Korobelnik, Jean-Francois] CHU Bordeaux, Hop Pellegrin, Serv Ophtalmol, Bordeaux, France; [Korobelnik, Jean-Francois] Univ Bordeaux Segalen, Bordeaux, France; [Korobelnik, Jean-Francois] INSERM, Ctr INSERM Epidemiol Biostat U897, ISPED, Bordeaux, France	Korobelnik, JF (reprint author), CHU Bordeaux, Serv Ophtalmol, Hop Pellegrin, Pl Amelie Raba Leon, F-33000 Bordeaux, France.	jean-francois.korobelnik@chu-bordeaux.fr			Regeneron Pharmaceuticals, Inc, Tarrytown, New York; Bayer HealthCare, Berlin, Germany	The VISTA and VIVID studies were funded by Regeneron Pharmaceuticals, Inc, Tarrytown, New York, and Bayer HealthCare, Berlin, Germany. The sponsors participated in the design and conduct of the study, analysis of the data, and preparation of the manuscript.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P823; Do DV, 2011, OPHTHALMOLOGY, V118, P1819, DOI 10.1016/j.ophtha.2011.02.018; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Rajendram R, 2012, ARCH OPHTHALMOL-CHIC, V130, P972, DOI 10.1001/archophthalmol.2012.393; Kocur I, 2002, BRIT J OPHTHALMOL, V86, P716, DOI 10.1136/bjo.86.7.716; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Nepomuceno AB, 2013, AM J OPHTHALMOL, V156, P502, DOI 10.1016/j.ajo.2013.04.026; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; [Anonymous], 1996, ICH HARM TRIP GUID G; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P1045, DOI 10.1016/j.ophtha.2013.11.041; Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; Ciulla TA, 2014, EXPERT OPIN PHARMACO, V15, P953, DOI 10.1517/14656566.2014.896899; Antcliff R J, 1999, Semin Ophthalmol, V14, P223, DOI 10.3109/08820539909069541; Boyer David S, 2013, Ther Adv Endocrinol Metab, V4, P151, DOI 10.1177/2042018813512360; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006; Photocoagulation for diabetic macular edema, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796; Shikari H, 2014, SEMIN OPHTHALMOL, V29, P276, DOI 10.3109/08820538.2014.962167	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	OCT	2015	122	10					2044	2052		10.1016/j.ophtha.2015.06.017		9	Ophthalmology	Ophthalmology	CU4IP	WOS:000363491500021		
J	Watanabe, S; Oie, Y; Fujimoto, H; Soma, T; Koh, S; Tsujikawa, M; Maeda, N; Nishida, K				Watanabe, Shinya; Oie, Yoshinori; Fujimoto, Hisataka; Soma, Takeshi; Koh, Shizuka; Tsujikawa, Motokazu; Maeda, Naoyuki; Nishida, Kohji			Relationship between Corneal Guttae and Quality of Vision in Patients with Mild Fuchs' Endothelial Corneal Dystrophy	OPHTHALMOLOGY			English	Article							COMPENSATION COMPARISON METHOD; RETINAL STRAYLIGHT; INTRAOCULAR STRAYLIGHT; CATARACT-SURGERY; FOLLOW-UP; KERATOPLASTY	Purpose: To investigate the effect of the severity of corneal guttae on quality of vision (QOV) in patients with mild Fuchs' endothelial corneal dystrophy (FECD). Design: Cross-sectional study. Participants: Twenty-three eyes of 14 patients with mild FECD without corneal edema on slit-lamp examination (5 pseudophakic eyes and 18 phakic eyes with mild lens opacity; grade 1.0-2.0 nuclear opalescence, grade 1.0-2.0 nuclear color, grade 1.0 cortical cataract, and grade 1.0 posterior subcapsular cataract on the Lens Opacities Classification System, version III). Methods: The area ratio of the corneal guttae (ARCG) in the endothelial cells was measured by multifocal specular microscopy. The QOV parameters, that is, corrected distance visual acuity (CDVA), letter contrast sensitivity (LCS), and intraocular straylight, also were measured. The correlations were assessed between the ARCG and QOV parameters and between the straylight and CDVA and LCS. Main Outcome Measures: The ARCG, logarithm of the minimum angle of resolution CDVA, LCS, and straylight. Results: Univariate analysis showed that the ARCG was correlated significantly with the CDVA, LCS, and straylight (R-2 = 0.41, P = 0.001; R-2 = 0.55, P = 0.001; and R-2 = 0.39, P = 0.002, respectively). Univariate analysis also showed that straylight was correlated significantly with the CDVA and LCS (R-2 = 0.47, P = 0.001 and R-2 = 0.41, P = 0.001, respectively). Conclusions: Corneal guttae without edema caused the QOV to deteriorate in eyes with FECD. Patients with higher straylight had worse CDVA or LCS. Intraocular forward light scatter caused by corneal guttae may result in visual disturbances. Quantification of corneal guttae can be useful to evaluate the effect of guttae on the QOV and determine the surgical indications of endothelial keratoplasty for eyes with mild FECD. (C) 2015 by the American Academy of Ophthalmology.	[Watanabe, Shinya; Oie, Yoshinori; Fujimoto, Hisataka; Soma, Takeshi; Koh, Shizuka; Tsujikawa, Motokazu; Maeda, Naoyuki; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka 5650871, Japan	Oie, Y (reprint author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Room E7,Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	yoie@ophthal.med.osaka-u.ac.jp			Japanese Ministry of the Education, Culture, Sports, Science and Technology (Tokyo, Japan); Health, Labour and Welfare Ministry (Tokyo, Japan); Japanese Society for the Promotion of Science (Tokyo, Japan); New Energy and Industrial Technology Development Organization (Kawasaki, Japan)	Supported in part by the Japanese Ministry of the Education, Culture, Sports, Science and Technology (N.M., K.N., Tokyo, Japan); the Health, Labour and Welfare Ministry (K.N., Tokyo, Japan); Japanese Society for the Promotion of Science (K.N., Tokyo, Japan); and the New Energy and Industrial Technology Development Organization (K.N., Kawasaki, Japan). NIDEK (Hiroishi, Japan) and Chuo Sangio Co (Nishinomiya, Japan), respectively, provided the noncontact multifocal specular microscope (CEM 530) and the C-Quant Straylight Meter (Oculus, Wetzlar, Germany) without cost.	van der Meulen IJE, 2012, CORNEA, V31, P380, DOI 10.1097/ICO.0b013e31823f8ab7; Guber I, 2011, GRAEF ARCH CLIN EXP, V249, P1367, DOI 10.1007/s00417-011-1704-y; Wright AF, 2010, NEW ENGL J MED, V363, P1072, DOI 10.1056/NEJMe1007495; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; de Vries NE, 2008, J CATARACT REFR SURG, V34, P957, DOI 10.1016/j.jcrs.2008.02.016; Repp DJ, 2013, OPHTHALMOLOGY, V120, P687, DOI 10.1016/j.ophtha.2012.09.022; Schmedt T, 2012, EXP EYE RES, V95, P24, DOI 10.1016/j.exer.2011.08.002; van den Berg TJTP, 2013, Z MED PHYS, V23, P6, DOI 10.1016/j.zemedi.2012.10.009; Eghrari AO, 2010, CURR OPIN OPHTHALMOL, V21, P15, DOI 10.1097/ICU.0b013e328333e9d6; Van den Berg TJTP, 2007, AM J OPHTHALMOL, V144, P358, DOI 10.1016/j.ajo.2007.05.037; WARING GO, 1982, OPHTHALMOLOGY, V89, P531; WILSON SE, 1988, CORNEA, V7, P2; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Guerra FP, 2011, OPHTHALMOLOGY, V118, P2368, DOI 10.1016/j.ophtha.2011.06.002; ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; BURNS RR, 1981, INVEST OPHTH VIS SCI, V20, P77; VANDENBERG TJTP, 1986, DOC OPHTHALMOL, V61, P327; Tourtas T, 2012, AM J OPHTHALMOL, V153, P1082, DOI 10.1016/j.ajo.2011.12.012; Melles GRJ, 2006, CORNEA, V25, P987; Franssen L, 2007, INVEST OPHTH VIS SCI, V48, P2375, DOI 10.1167/iovs.06-0759; Feng MT, 2013, CORNEA, V32, P1080, DOI 10.1097/ICO.0b013e318292a7e5; Price MO, 2013, CURR OPIN OPHTHALMOL, V24, P329, DOI 10.1097/ICU.0b013e32836229ab; van der Meulen IJE, 2011, ARCH OPHTHALMOL-CHIC, V129, P1537, DOI 10.1001/archophthalmol.2011.247; Elhalis H, 2010, OCUL SURF, V8, P173; Trousdale ER, 2014, OPHTHALMOLOGY, V121, P2147, DOI 10.1016/j.ophtha.2014.04.046; Franssen L, 2006, INVEST OPHTH VIS SCI, V47, P768, DOI 10.1167/iovs.05-0690; Lapid-Gortzak R, 2010, J CATARACT REFR SURG, V36, P465, DOI 10.1016/j.jcrs.2009.10.029; Chaurasia S, 2014, OPHTHALMOLOGY, V121, P454, DOI 10.1016/j.ophtha.2013.09.032; van Gaalen KW, 2010, J CATARACT REFR SURG, V36, P923, DOI 10.1016/j.jcrs.2009.12.048; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831; Chogyoji S, 2006, FOLIA OPHTHALMOL JPN, V57, P655; Fuchs E., 1910, GRAEFES ARCH CLIN EX, P478; Fujimoto H, 2014, INVEST OPHTH VIS SCI, V24, P5090; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036; LORENZET.DW, 1967, AM J OPHTHALMOL, V64, P1155; VANDENBERG TJTP, 1995, OPTOMETRY VISION SCI, V72, P52, DOI 10.1097/00006324-199502000-00003	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	OCT	2015	122	10					2103	2109		10.1016/j.ophtha.2015.06.019		7	Ophthalmology	Ophthalmology	CU4IP	WOS:000363491500027		
J	Saito, M; Tokutsu, I				Saito, Mika; Tokutsu, Ichiro			Revisiting the 'great trade collapse' with the endogenous input-choice model	OXFORD ECONOMIC PAPERS-NEW SERIES			English	Article							WORLD-TRADE; VERTICAL SPECIALIZATION; GROWTH	We revisit the role of vertical specialization and supply constraints during the 'great trade collapse' with new data and a new model that allows us to resolve some of the conceptual and data limitations faced by previous studies. We find that (i) demand factors explain a smaller (than previously understood) fraction of the collapse in trade during 2008-9; and (ii) models tend to over-estimate (or under-estimate) the decline in the demand for domestic (or imported) inputs. These model errors are equivalent to an increase of about 4% in the export price premium, on average.	[Saito, Mika] Int Monetary Fund, Washington, DC 20431 USA; [Tokutsu, Ichiro] Kobe Univ, Grad Sch Business Adm, Kobe, Hyogo 6578501, Japan	Saito, M (reprint author), Int Monetary Fund, Washington, DC 20431 USA.	tokutsu@port.kobe-u.ac.jp			Japan Society for the Promotion of Science [23530254]	Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (23530254 to I.T.)	HOUTHAKKER HS, 1969, REV ECON STAT, V51, P111, DOI 10.2307/1926720; Hummels D, 2001, J INT ECON, V54, P75, DOI 10.1016/S0022-1996(00)00093-3; Levchenko AA, 2010, IMF ECON REV, V58, P214, DOI 10.1057/imfer.2010.11; Yi KM, 2003, J POLIT ECON, V111, P52, DOI 10.1086/344805; Bems R, 2010, IMF ECON REV, V58, P295, DOI 10.1057/imfer.2010.15; Johnson RC, 2012, J INT ECON, V86, P224, DOI 10.1016/j.jinteco.2011.10.003; Daudin G, 2011, CAN J ECON, V44, P1403, DOI 10.1111/j.1540-5982.2011.01679.x; Bems R, 2011, AM ECON REV, V101, P308, DOI 10.1257/aer.101.3.308; Ahn J, 2011, AM ECON REV, V101, P298, DOI 10.1257/aer.101.3.298; Baldwin R., 2009, GREAT TRADE COLLAPSE; Eaton J., 2013, EC WORKING PAPER SER, V2013-21; Freund C., 2009, WORLD BANK POLICY RE, V5015; Hummels David, 1998, FEDERAL RESERVE BANK, V4, P79; Irwin D. A., 2002, WORLD TRADE REV, V1, P89; Koopman R., 2010, 16426 NBER; SAITO M, 1971, REV ECON STAT, V53, P11, DOI 10.2307/1925375; Timmer M., 2012, 10 WORLD INP OUTP DA; Yi K. M., 2009, COLLAPSE GLOBAL TRAD	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0030-7653	1464-3812		OXFORD ECON PAP	Oxf. Econ. Pap.-New Ser.	OCT	2015	67	4					1123	1145		10.1093/oep/gpv044		23	Economics	Business & Economics	CU0EC	WOS:000363187800014		
J	Cameron, D; Polgar, E; Gutierrez-Mecinas, M; Gomez-Lima, M; Watanabe, M; Todd, AJ				Cameron, Darren; Polgar, Erika; Gutierrez-Mecinas, Maria; Gomez-Lima, Maria; Watanabe, Masahiko; Todd, Andrew J.			The organisation of spinoparabrachial neurons in the mouse	PAIN			English	Article						Spinal cord; Lamina I; Neurokinin 1 receptor; Giant cell; Lateral parabrachial area; Substance P	RAT SPINAL-CORD; SUBSTANCE-P RECEPTOR; NEUROKININ 1 RECEPTOR; I PROJECTION NEURONS; SUPERFICIAL DORSAL-HORN; LAMINA-I; PARABRACHIAL NUCLEUS; MESSENGER-RNAS; BRAIN-STEM; MORPHOLOGICAL CHARACTERIZATION	The anterolateral tract (ALT), which originates from neurons in lamina I and the deep dorsal horn, represents a major ascending output through which nociceptive information is transmitted to brain areas involved in pain perception. Although there is detailed quantitative information concerning the ALT in the rat, much less is known about this system in the mouse, which is increasingly being used for studies of spinal pain mechanisms because of the availability of genetically modified lines. The aim of this study was therefore to determine the extent to which information about the ALT in the rat can be extrapolated to the mouse. Our results suggest that as in the rat, most lamina I ALT projection neurons in the lumbar enlargement can be retrogradely labelled from the lateral parabrachial area, that the majority of these cells (similar to 90%) express the neurokinin 1 receptor (NK1r), and that these are larger than other NK1r-expressing neurons in this lamina. This means that many lamina I spinoparabrachial cells can be identified in NK1r-immunostained sections from animals that have not received retrograde tracer injections. However, we also observed certain species differences, in particular we found that many spinoparabrachial cells in laminae III and IV lack the NK1r, meaning that they cannot be identified based solely on the expression of this receptor. We also provide evidence that the majority of spinoparabrachial cells are glutamatergic and that some express substance P. These findings will be important for studies designed to unravel the complex neuronal circuitry that underlies spinal pain processing.	[Cameron, Darren; Polgar, Erika; Gutierrez-Mecinas, Maria; Gomez-Lima, Maria; Todd, Andrew J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan	Todd, AJ (reprint author), Univ Glasgow, Spinal Cord Grp, West Med Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	andrew.todd@glasgow.ac.uk	Todd, Andrew/A-6855-2011		MAC [MR/L003430/1]; Wellcome Trust [102645]	The work was supported by grants from the MAC (MR/L003430/1) and the Wellcome Trust (102645).	HYLDEN JLK, 1989, NEUROSCIENCE, V28, P27, DOI 10.1016/0306-4522(89)90229-7; VIGNA SR, 1994, J NEUROSCI, V14, P834; CLIFFER KD, 1988, BRAIN RES, V460, P356, DOI 10.1016/0006-8993(88)90381-2; STANDAERT DG, 1986, J NEUROSCI, V6, P1220; Polgar E, 2010, BRAIN RES, V1308, P58, DOI 10.1016/j.brainres.2009.10.041; CORTES R, 1990, SYNAPSE, V6, P369, DOI 10.1002/syn.890060410; GRIFFOND B, 1993, NEUROSCI LETT, V156, P91, DOI 10.1016/0304-3940(93)90447-S; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Puskar Z, 2001, NEUROSCIENCE, V102, P167, DOI 10.1016/S0306-4522(00)00445-0; MCMAHON SB, 1985, BRAIN RES, V333, P19, DOI 10.1016/0006-8993(85)90119-2; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; Naim MM, 1998, EUR J NEUROSCI, V10, P3012; Szucs P, 2010, J COMP NEUROL, V518, P2645, DOI 10.1002/cne.22391; Miura E, 2006, J NEUROCHEM, V97, P1431, DOI 10.1111/j.1471-4159.2006.03835.x; Al Ghamdi KS, 2009, NEUROSCIENCE, V164, P1794, DOI 10.1016/j.neuroscience.2009.09.071; Bester H, 2000, J NEUROPHYSIOL, V83, P2239; DING YQ, 1995, BRAIN RES, V674, P336, DOI 10.1016/0006-8993(95)00022-I; Polgar E, 2006, NEUROSCIENCE, V139, P687, DOI 10.1016/j.neuroscience.2005.12.021; Todd AJ, 2002, J NEUROSCI, V22, P4103; SLUGG RM, 1994, J COMP NEUROL, V339, P49, DOI 10.1002/cne.903390106; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Polgar E, 2008, J NEUROSCI, V28, P13150, DOI 10.1523/JNEUROSCI.4053-08.2008; Davidson S, 2010, J COMP NEUROL, V518, P3193, DOI 10.1002/cne.22392; Al-Khater KM, 2008, J COMP NEUROL, V511, P1, DOI 10.1002/cne.21811; McLeod AL, 2000, J COMP NEUROL, V420, P349; BLEAZARD L, 1994, J NEUROSCI, V14, P7655; Naim M, 1997, J NEUROSCI, V17, P5536; Andrew D, 2009, J PHYSIOL-LONDON, V587, P2005, DOI 10.1113/jphysiol.2009.170290; Al-Khater KM, 2009, J COMP NEUROL, V515, P629, DOI 10.1002/cne.22081; Polgar E, 1999, J NEUROSCI, V19, P2637; Polgar E, 2011, J COMP NEUROL, V519, P1007, DOI 10.1002/cne.22570; Baseer N, 2012, J NEUROSCI, V32, P11854, DOI 10.1523/JNEUROSCI.2707-12.2012; WARDEN MK, 1988, J COMP NEUROL, V272, P90, DOI 10.1002/cne.902720107; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Almarestani L, 2007, J COMP NEUROL, V504, P287, DOI 10.1002/cne.21410; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; LITTLEWOOD NK, 1995, NEUROSCIENCE, V66, P597, DOI 10.1016/0306-4522(95)00039-L; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Gamboa-Esteves FO, 2004, J CHEM NEUROANAT, V27, P251, DOI 10.1016/j.jchemneu.2004.04.001; Spike RC, 2003, EUR J NEUROSCI, V18, P2433, DOI 10.1046/j.1460-9568.2003.02981.x; Todd AJ, 1998, NEUROSCIENCE, V85, P459, DOI 10.1016/S0306-4522(97)00669-6; BLOMQVIST A, 1995, NEUROREPORT, V6, P605, DOI 10.1097/00001756-199503000-00005; Guillery RW, 2002, J COMP NEUROL, V447, P1, DOI 10.1002/cne.10221; BROWN JL, 1995, J COMP NEUROL, V356, P327, DOI 10.1002/cne.903560302; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; RETHELYI M, 1991, NEUROSCIENCE, V42, P531, DOI 10.1016/0306-4522(91)90395-5; Kardon AP, 2014, NEURON, V82, P573, DOI 10.1016/j.neuron.2014.02.046; Fell K, 1995, J COMP NEUROL, V353, P506; Franklin K. B. J., 2007, MOUSE BRAIN STEREOTA; Gutierrez-Mecinas M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-79; LIU HT, 1994, P NATL ACAD SCI USA, V91, P1009, DOI 10.1073/pnas.91.3.1009; Polgar E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078309; Polgar E, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-4	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	OCT	2015	156	10					2061	2071		10.1097/j.pain.0000000000000270		11	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CU2OG	WOS:000363362200025		
J	Soga, A; Lin, HY; Su, BH				Soga, Akiko; Lin, Hsiang-Yu; Su, Bai-Horng			Thumbprint Sign in the Colon: A Diagnostic Finding of Necrotizing Enterocolitis in Premature Infants	PEDIATRICS AND NEONATOLOGY			English	Editorial Material							TWIN TRANSFUSION SYNDROME		[Soga, Akiko] Nihon Univ Hosp, Dept Pediat Surg, Tokyo, Japan; [Lin, Hsiang-Yu; Su, Bai-Horng] China Med Univ, Dept Neonatol, Childrens Hosp, Taichung 404, Taiwan; [Su, Bai-Horng] China Med Univ, Coll Med, Taichung 404, Taiwan	Su, BH (reprint author), China Med Univ, Dept Neonatol, Childrens Hosp, 2 Yuh Der Rd, Taichung 404, Taiwan.	subh1168@gmail.com					LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Mosquera C, 2012, SEMIN PERINATOL, V36, P182, DOI 10.1053/j.semperi.2012.02.006; Simpson LL, 2013, AM J OBSTET GYNECOL, V208, P3, DOI 10.1016/j.ajog.2012.10.880	3	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1875-9572			PEDIATR NEONATOL	Pediatr. Neonatol.	OCT	2015	56	5					360	361		10.1016/j.pedneo.2015.04.003		2	Pediatrics	Pediatrics	CU3QD	WOS:000363439000015		
J	Kimura, H; Kolokolova, L; Li, AG; Augereau, JC; Kaneda, H; Jager, C				Kimura, Hiroshi; Kolokolova, Ludmilla; Li, Aigen; Augereau, Jean-Charles; Kaneda, Hidehiro; Jaeger, Cornelia			Cosmic Dust VII	PLANETARY AND SPACE SCIENCE			English	Editorial Material							ACTIVE GALACTIC NUCLEI; STARDUST SPACECRAFT; COMET 81P/WILD-2; WATER ICE; PARTICLES; SPECTRA; GRAINS; EVOLUTION; ORIGIN; DISKS		[Kimura, Hiroshi] Kobe Univ, Grad Sch Sci, CPS, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kolokolova, Ludmilla] Univ Maryland, Dept Astron, Planetary Data Syst Grp, College Pk, MD 20742 USA; [Li, Aigen] Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA; [Augereau, Jean-Charles] Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France; [Augereau, Jean-Charles] CNRS, IPAG, F-38000 Grenoble, France; [Kaneda, Hidehiro] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Jaeger, Cornelia] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Jaeger, Cornelia] Univ Jena, Lab Astrophys & Clusterphys Grp, D-07743 Jena, Germany; [Jaeger, Cornelia] Univ Jena, Inst Solid State Phys, D-07743 Jena, Germany	Kimura, H (reprint author), Kobe Univ, Grad Sch Sci, CPS, Chuo Ku, Minatojima Minamimachi 7-1-48, Kobe, Hyogo 6500047, Japan.						A'Hearn M.F., 2014, COSM DUST 7; Terada H, 2007, ASTROPHYS J, V667, P303, DOI 10.1086/520951; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Fabian D, 2001, ASTRON ASTROPHYS, V378, P228, DOI 10.1051/0004-6361:20011196; Nikutta R, 2009, ASTROPHYS J, V707, P1550, DOI 10.1088/0004-637X/707/2/1550; Kimura H, 2014, ICARUS, V232, P133, DOI 10.1016/j.icarus.2014.01.009; Protopapa S, 2014, ICARUS, V238, P191, DOI 10.1016/j.icarus.2014.04.008; Koike C, 2006, ASTRON ASTROPHYS, V449, P583, DOI 10.1051/0004-6361:20053256; Kimura H, 2014, PLANET SPACE SCI, V100, P1, DOI 10.1016/j.pss.2014.02.009; Cami J, 1998, ASTROPHYS SPACE SCI, V255, P339; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; Pontoppidan KM, 2008, ASTROPHYS J, V678, P1005, DOI 10.1086/533431; Westphal AJ, 2014, SCIENCE, V345, P786, DOI 10.1126/science.1252496; Keller LP, 2011, GEOCHIM COSMOCHIM AC, V75, P5336, DOI 10.1016/j.gca.2011.06.040; A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; Busemann H, 2009, EARTH PLANET SC LETT, V288, P44, DOI 10.1016/j.epsl.2009.09.007; Flynn GJ, 2013, EARTH PLANETS SPACE, V65, P1159, DOI 10.5047/eps.2013.05.007; Kaneda H, 2014, PLANET SPACE SCI, V100, P6, DOI 10.1016/j.pss.2014.01.017; ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; Do Duy T., 2015, PLANET SPACE SCI; Gibb E, 2014, COSM DUST 7; Gonzalez JF, 2015, PLANET SPACE SCI, V116, P48, DOI 10.1016/j.pss.2015.05.018; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Hammonds M, 2015, PLANET SPACE SCI, V116, P73, DOI 10.1016/j.pss.2015.05.010; Hattori Y, 2015, PLANET SPACE SCI, V116, P57, DOI 10.1016/j.pss.2015.04.006; Jones AP, 2014, PLANET SPACE SCI, V100, P26, DOI 10.1016/j.pss.2013.11.011; Juvela M, 2015, PLANET SPACE SCI, V116, P64, DOI 10.1016/j.pss.2015.03.005; Kokusho T, 2015, PLANET SPACE SCI, V116, P92, DOI 10.1016/j.pss.2015.04.009; Kolokolova L, 2015, PLANET SPACE SCI, V116, P30, DOI 10.1016/j.pss.2015.03.006; Krelowski J., 2015, PLANET SP SCI; Mason RE, 2015, PLANET SPACE SCI, V116, P97, DOI 10.1016/j.pss.2015.02.013; Moores JE, 2015, PLANET SPACE SCI, V116, P6, DOI 10.1016/j.pss.2015.01.001; Mori S., 2014, COSM DUST 7; Nozawa T, 2014, COSM DUST 7; Oberg KI, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/109; Olofsson J., 2014, COSM DUST 7; Onaka T, 2015, PLANET SPACE SCI, V116, P84, DOI 10.1016/j.pss.2015.03.025; Onaka T., 2014, COSM DUST 7; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Senshu H, 2015, PLANET SPACE SCI, V116, P18, DOI 10.1016/j.pss.2015.03.009; Shalima P, 2015, PLANET SPACE SCI, V116, P39, DOI 10.1016/j.pss.2015.03.017; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; Yamagishi M., 2014, COSM DUST 7	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		1	5		10.1016/j.pss.2015.03.002		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900001		
J	Senshu, H; Kimura, H; Yamamoto, T; Wada, K; Kobayashi, M; Namiki, N; Matsui, T				Senshu, H.; Kimura, H.; Yamamoto, T.; Wada, K.; Kobayashi, M.; Namiki, N.; Matsui, T.			Photoelectric dust levitation around airless bodies revised using realistic photoelectron velocity distributions	PLANETARY AND SPACE SCIENCE			English	Article						Dust; Levitation; Photoelectron emission; Dusty plasma	SOLAR-WIND; LUNAR DUST; SURFACE; GRAINS; SHEATH; PHOTOEMISSION; SATELLITE; SPECTROSCOPY; TERMINATOR; TRANSPORT	The velocity distribution function of photoelectrons from a surface exposed to solar UV radiation is fundamental to the electrostatic status of the surface. There is one and only one laboratory measurement of photoelectron emission from astronomically relevant material, but the energy distribution function was measured only in the emission angle from the normal to the surface of 0 to about pi/4. Therefore, the measured distribution is not directly usable to estimate the vertical structure of a photoelectric sheath above the surface. In this study, we develop a new analytical method to calculate an angle-resolved velocity distribution function of photoelectrons from the laboratory measurement data. We find that the photoelectric current and yield for lunar surface fines measured in a laboratory have been underestimated by a factor of two. We apply our new energy distribution function of photoelectrons to model the formation of photoelectric sheath above the surface of asteroid 433 Eros. Our model shows that a 0.1 mu m-radius dust grain can librate above the surface of asteroid 433 Eros regardless of its launching velocity. In addition, a 0.5 mu m grain can hover over the surface if the grain was launched at a velocity slower than 0.4 m/s, which is a more stringent condition for levitation than previous studies. However, a lack of high-energy data on the photoelectron energy distribution above 6 eV prevents us from firmly placing a constraint on the levitation condition. (C) 2015 Elsevier Ltd. All rights reserved.	[Senshu, H.; Wada, K.; Kobayashi, M.; Matsui, T.] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan; [Kimura, H.] Kobe Univ, Grad Sch Sci, CPS, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Yamamoto, T.] Kobe Univ, Integrated Res Ctr, CPS, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Namiki, N.] Natl Astron Observ Japan, RISE Project Off, Mitaka, Tokyo 1818588, Japan; [Namiki, N.] Grad Univ Adv Studies SOKENDAI, Dept Astron Sci, Miura, Kanagawa, Japan	Senshu, H (reprint author), Chiba Inst Technol, Planetary Explorat Res Ctr, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	hsenshu@gmail.com			MEXT [23103004]; JSPS [21340040, 26400230]	We thank anonymous reviewer 1 for helpful comments on the manuscript. H.K. is grateful to JSPS's Grants-in-Aid for Scientific Research (#21340040, #26400230). T.Y. acknowledges the support by Grant-in-Aid Scientific Research on Innovative Area (23103004) from MEXT.	Grun E, 2011, PLANET SPACE SCI, V59, P1672, DOI 10.1016/j.pss.2011.04.005; MUKAI T, 1981, ASTRON ASTROPHYS, V99, P1; WYATT SP, 1969, PLANET SPACE SCI, V17, P155, DOI 10.1016/0032-0633(69)90034-8; Poppe A, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015286; Meyer-Vernet N, 1998, J GEOPHYS RES-SPACE, V103, P29705, DOI 10.1029/98JA02853; BERG OE, 1978, EARTH PLANET SC LETT, V39, P377, DOI 10.1016/0012-821X(78)90025-0; Lee P, 1996, ICARUS, V124, P181, DOI 10.1006/icar.1996.0197; Poppe AR, 2012, ICARUS, V221, P135, DOI 10.1016/j.icarus.2012.07.018; REASONER DL, 1972, J GEOPHYS RES, V77, P6671, DOI 10.1029/JA077i034p06671; GRARD RJL, 1973, J GEOPHYS RES, V78, P2885, DOI 10.1029/JA078i016p02885; ROHATGI VK, 1957, J APPL PHYS, V28, P951, DOI 10.1063/1.1722919; Kohnlein W, 1996, SOL PHYS, V169, P209, DOI 10.1007/BF00153841; Hirata N, 2012, ICARUS, V220, P106, DOI 10.1016/j.icarus.2012.03.028; Le Chat G, 2011, SOL PHYS, V271, P141, DOI 10.1007/s11207-011-9797-3; Kimura H, 1998, ASTROPHYS J, V499, P454, DOI 10.1086/305613; MENDIS DA, 1981, ASTROPHYS J, V249, P787, DOI 10.1086/159337; Colwell JE, 2005, ICARUS, V175, P159, DOI 10.1016/j.icarus.2004.11.001; Hechenblaikner G, 2012, J APPL PHYS, V111, DOI 10.1063/1.4730638; SHULL JM, 1978, ASTROPHYS J, V226, P858, DOI 10.1086/156666; Richardson JE, 2004, SCIENCE, V306, P1526, DOI 10.1126/science.1104731; Stubbs TJ, 2006, ADV SPACE RES, V37, P59, DOI 10.1016/j.asr.2005.04.048; Kimura H, 2014, PLANET SPACE SCI, V100, P64, DOI 10.1016/j.pss.2014.03.017; Nitter T, 1998, J GEOPHYS RES-SPACE, V103, P6605, DOI 10.1029/97JA03523; Pei ZT, 2002, JPN J APPL PHYS 2, V41, pL52, DOI 10.1143/JJAP.41.L52; GRARD RJL, 1971, J GEOPHYS RES, V76, P2498, DOI 10.1029/JA076i010p02498; DRAINE BT, 1979, ASTROPHYS J, V231, P77, DOI 10.1086/157165; Veverka J, 2001, SCIENCE, V292, P484, DOI 10.1126/science.1058651; REASONER DL, 1973, J GEOPHYS RES, V78, P5844; GUERNSEY RL, 1970, J GEOPHYS RES, V75, P3193, DOI 10.1029/JA075i016p03193; HAVNES O, 1987, J GEOPHYS RES, V92, P2281, DOI 10.1029/JA092iA03p02281; Bergstrom D, 2007, J APPL PHYS, V101, DOI 10.1063/1.2738417; FADLEY CS, 1974, J ELECTRON SPECTROSC, V4, P93, DOI 10.1016/0368-2048(74)90001-2; Fadley C.S., 1976, PROGR SOLID STATE CH, V11, P265, DOI 10.1016/0079-6786(76)90013-3; FEUERBAC.B, 1972, J APPL PHYS, V43, P1563, DOI 10.1063/1.1661362; Feuerbacher B., 1972, GEOCHIM COSM SUPPL, V3, P2655; Katz I., 1977, CR135256 NASA, P334; Willis R.F., PHOTON PARTICLE INTE, P389	37	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		18	29		10.1016/j.pss.2015.03.009		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900003		
J	Shalima, P; Wada, K; Kimura, H				Shalima, P.; Wada, K.; Kimura, H.			Ejecta curtain radiative transfer modeling for probing its geometry and dust optical properties	PLANETARY AND SPACE SCIENCE			English	Article						Dust; ScatteringImpact ejecta; Impact ejecta	MICROSCOPII DEBRIS DISK; DEEP IMPACT; METEORITE PARTICLES; SCATTERING; DENSITY; LIGHT; SAND	An ejecta curtain is produced as a result of impact cratering of celestial bodies that excavates and ejects their surface and underground material. Since ejecta particles are thought to reflect the interior materials and structures of celestial bodies, ejecta and ejecta curtains provide us with valuable information about the interior of the bodies. Following the Deep Impact mission, more and more in situ data on ejecta curtains are expected to become available in future space missions. To draw valuable information from such in situ measurements, a radiative-transfer model of the ejecta curtain plays an important role. This urges us to carefully assess the model parameters with experimental results as well as understand the contribution of each model parameter to the predicted intensities of the radiative calculations. In this work, we study the dependences of the projected intensity images of the ejecta on the scattering phase function and the geometry of an ejecta curtain produced by impact on an airless-body's surface, as a first step toward a correct interpretation of ejecta observations. Using the Monte-Carlo multiple scattering method, we have calculated the scattered intensities for three different orientations of the ejecta curtain. We have also computed the intensities for ejecta material using different phase functions. We find that the scattered intensities are highest for the isotropic phase function irrespective of the orientation of the ejecta cone for the scattering angles and geometry considered here. Observations from the other side could lead to higher intensities for forward scattering grains that are typical for asteroids. Therefore in situ observations of ejecta-curtains at different angles will enable us to use our model predictions to extract the phase functions as well as column densities of its component dust grains. (C) 2015 Elsevier Ltd. All rights reserved.	[Shalima, P.] Indian Inst Astrophys, Bangalore 560034, Karnataka, India; [Wada, K.] Chiba Inst Technol, Planetary Explorat Res Ctr, Chiba, Japan; [Kimura, H.] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan	Shalima, P (reprint author), Indian Inst Astrophys, Bangalore 560034, Karnataka, India.	shalima.p@gmail.com			DST-SERB FAST Track Program [SR/FTP/PS-68/2008]; JSPS (Japan Society for the Promotion of Science) [21340040, 26400230]	SP would like to thank the DST-SERB FAST Track Program (SR/FTP/PS-68/2008) for financial support. We are grateful to JSPS (Japan Society for the Promotion of Science) under Grants-in-Aid for Scientific Research (B) #21340040 and (C) #26400230.	Anderson JLB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002075; OBERBECK VR, 1975, REV GEOPHYS, V13, P337, DOI 10.1029/RG013i002p00337; Kuppers M, 2005, NATURE, V437, P987, DOI 10.1038/nature04236; Wada K, 2006, ICARUS, V180, P528, DOI 10.1016/j.icarus.2005.10.002; Richardson JE, 2007, ICARUS, V190, P357, DOI 10.1016/j.icarus.2007.08.001; Augereau JC, 2006, ASTRON ASTROPHYS, V455, P987, DOI 10.1051/0004-6361:20054250; Kolokolova L, 2007, ASTRON ASTROPHYS, V463, P1189, DOI 10.1051/0004-6361:20065069; Kimura H, 2006, ASTRON ASTROPHYS, V449, P1243, DOI 10.1051/0004-6361:20051783; MILLIS RL, 1982, ASTRON J, V87, P1310, DOI 10.1086/113218; Cintala MJ, 1999, METEORIT PLANET SCI, V34, P605; Graham JR, 2007, ASTROPHYS J, V654, P595, DOI 10.1086/509318; Piironen J, 1998, PLANET SPACE SCI, V46, P937, DOI 10.1016/S0032-0633(98)00035-X; Tiscareno MS, 2013, SCIENCE, V340, P460, DOI 10.1126/science.1233524; Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246; Shalima P, 2004, MON NOT R ASTRON SOC, V352, P1319, DOI 10.1111/j.1365-2966.2004.08022.x; Hermalyn B, 2010, ICARUS, V209, P866, DOI 10.1016/j.icarus.2010.05.025; A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Housen KR, 2011, ICARUS, V211, P856, DOI 10.1016/j.icarus.2010.09.017; Nagdimunov L, 2014, PLANET SPACE SCI, V100, P73, DOI 10.1016/j.pss.2014.05.018; Bohren C.F., 1995, HDB OPTICS, V1; Divine N., 1981, ESA SP, V174, P47; HONG SS, 1985, ASTRON ASTROPHYS, V146, P67; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Kadono T, 2015, ICARUS, V250, P215, DOI 10.1016/j.icarus.2014.11.030; Marcus Joseph N, 2007, International Comet Quarterly, V29; Meech KJ, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L1; Metropolis N., 1949, J AM STAT ASSOC, V44, P247; Munoz O, 2000, ASTRON ASTROPHYS, V360, P777; Veillet C., 2007, LUN PLAN SCI C LUN P, V38, P1520	29	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		39	47		10.1016/j.pss.2015.03.017		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900005		
J	Hattori, Y; Kaneda, H; Ishihara, D; Yamagishi, M; Kondo, T; Sano, H				Hattori, Y.; Kaneda, H.; Ishihara, D.; Yamagishi, M.; Kondo, T.; Sano, H.			An AKARI infrared study of dust emission in Galactic bubbles indicative of large-scale cloud-cloud collisions	PLANETARY AND SPACE SCIENCE			English	Article						Infrared; Interstellar dust; Galactic bubbles; Massive stars	MOLECULAR CLOUDS; CLUSTER FORMATION; STARS; SHOCKS	We report our systematic study on dust emission in massive star-forming regions indicative of large-scale cloud-cloud collisions, using the AKARI infrared (IR) all-sky survey data at wavelengths of 9, 18, 65, 90, 140, and 160 pm. We focus on the Galactic bubbles catalogued by Spitzer, which are categorized into two types of morphology, closed and broken bubbles. A broken bubble has a possibility of being created by a cloud-cloud collision, judging from its morphological similarity to the structure theoretically predicted as a product of the collision. Therefore we search for systematic differences in IR properties between the two types. We performed aperture photometry for 111 Spitzer bubbles and created the spectral energy distribution (SED) of each bubble. We decomposed the SED into polycyclic aromatic hydrocarbon (PAH), warm and cold dust components by model fitting, and calculated their luminosities, L-PAH, L-warm and L-cold respectively, by integrating each SED component as a function of the wavelength. We then investigated the total IR luminosity (L-TIR = L-PAH + L-warm + L-cold), the ratio of L-PAH to L-TIR and the ratio of L-warm to L-TIR as a function of the bubble radius. As a result, we find systematic differences between the closed and broken bubbles for the former two relations. We discuss the implications of the differences for the scenario of the large-scale cloud-cloud collisions. (C) 2015 Elsevier Ltd. All rights reserved.	[Hattori, Y.; Kaneda, H.; Ishihara, D.; Yamagishi, M.; Kondo, T.; Sano, H.] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Hattori, Y (reprint author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	hattori@u.phys.nagoya-u.ac.jp			JSPS KAKENHI [25247020]	This research is based on observations with AKARI, a JAXA project with the participation of ESA. The authors thank all the members of the AKARI project, particularly the all-sky survey data reduction team. This research was supported by JSPS KAKENHI Grant Number 25247020.	HABE A, 1992, PUBL ASTRON SOC JPN, V44, P203; Watson C, 2010, ASTROPHYS J, V716, P1478, DOI 10.1088/0004-637X/716/2/1478; ELMEGREEN BG, 1977, ASTROPHYS J, V214, P725, DOI 10.1086/155302; Zhang CF, 2013, CHIN CONT DECIS CONF, P550; Vacca WD, 1996, ASTROPHYS J, V460, P914, DOI 10.1086/177020; Furukawa N, 2009, ASTROPHYS J LETT, V696, pL115, DOI 10.1088/0004-637X/696/2/L115; Ishihara D, 2007, PUBL ASTRON SOC JPN, V59, pS443; Churchwell E, 2006, ASTROPHYS J, V649, P759, DOI 10.1086/507015; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Beaumont C.N., 2009, ASTROPHYS J, V709, P791; Deharveng L., 2010, ASTRON ASTROPHYS, V523, P6; Fukui Y, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/36; Inoue T, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L31; Micelotta ER, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200911682; Pavel MD, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/150; Torii K, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/46	18	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		57	63		10.1016/j.pss.2015.04.006		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900007		
J	Hammonds, M; Mori, T; Usui, F; Onaka, T				Hammonds, M.; Mori, T.; Usui, F.; Onaka, T.			Variations in the 3.3 mu m feature and carbonaceous dust in AKARI data	PLANETARY AND SPACE SCIENCE			English	Article						Interstellar medium; H II regions; Astrochemistry; Infrared spectroscopy; Interstellar dust	POLYCYCLIC AROMATIC-HYDROCARBONS; UNIDENTIFIED EMISSION BANDS; INFRARED-EMISSION; INTERSTELLAR-MEDIUM; FUNCTIONAL-GROUPS; RED RECTANGLE; SPECTROSCOPY; SPECTRUM; EVOLUTION; NGC-7027	A wealth of near infrared spectroscopic data for a large number of galactic objects was recorded with AKARI during its active lifetime. The hydrocarbon emission features around 3.3-3.5 m are modelled here as a series of 6 Voigt profiles arising due to hydrogen atoms found in different molecular structures within the emitting spectroscopic carriers. This model is compared and contrasted with a model consisting of 3 Gaussian profiles and found to produce a superior fit to AKARI data. Analysis of the 6 Voigt model shows that the 3.3 m aromatic hydrocarbon band is well described by two components at 3.28 m and 3.30 m. We confirm that the 3.28 pm band is due to emission from aromatic molecules, and find a good correlation between the 3.28 mu m and 3.41 m bands, assigned to bay-hydrogen sites and linking methylene groups respectively. Results are discussed in terms of molecular processing and dust formation. (C) 2015 Elsevier Ltd. All rights reserved.	[Hammonds, M.; Mori, T.; Usui, F.; Onaka, T.] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Hammonds, M (reprint author), Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hammonds@astron.s.u-tokyo.ac.jp			 [P13771]	The authors thank Ronin Wu for excellent suggestions and advice, Aigen Li and Christine Joblin for interesting and insightful discussions, and the two anonymous referees for helpful suggestions. This work is supported by a Grand-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows (ID: P13771). This research is based on observations with AKARI, a JAXA project with the participation of ESA. Quoted quantum chemical calculations were performed using the University of Nottingham High Performance Computing Facility.	ALLAMANDOLA LJ, 1989, ASTROPHYS J SUPPL S, V71, P733, DOI 10.1086/191396; Angus J., 1987, HYDROGENATED AMORPHO; GEBALLE TR, 1985, ASTROPHYS J, V292, P500, DOI 10.1086/163182; West B, 2012, J PHYS CHEM A, V116, P10999, DOI 10.1021/jp3091705; Imanishi M, 2010, ASTROPHYS J, V721, P1233, DOI 10.1088/0004-637X/721/2/1233; Khramtsova MS, 2014, MON NOT R ASTRON SOC, V444, P757, DOI 10.1093/mnras/stu1482; SANDFORD SA, 1991, ASTROPHYS J, V376, P599, DOI 10.1086/170307; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; Hrivnak BJ, 2007, ASTROPHYS J, V662, P1059, DOI 10.1086/518109; HUMMER DG, 1987, MON NOT R ASTRON SOC, V224, P801; NAGATA T, 1988, ASTROPHYS J, V326, P157, DOI 10.1086/166076; Duley WW, 2001, ASTROPHYS J, V554, pL209, DOI 10.1086/321704; Boersma C, 2009, ASTROPHYS J, V690, P1208, DOI 10.1088/0004-637X/690/2/1208; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Kwok S, 2011, NATURE, V479, P80, DOI 10.1038/nature10542; Kaneda H, 2009, ADV SPACE RES, V44, P1038, DOI 10.1016/j.asr.2009.07.002; GILLETT FC, 1973, ASTROPHYS J, V183, P87, DOI 10.1086/152211; Rapacioli M, 2005, ASTRON ASTROPHYS, V429, P193, DOI 10.1051/0004-6361:20041247; BARKER JR, 1987, ASTROPHYS J, V315, pL61, DOI 10.1086/184861; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; Candian A, 2012, MON NOT R ASTRON SOC, V426, P389, DOI 10.1111/j.1365-2966.2012.21760.x; Chiar JE, 2000, ASTROPHYS J, V537, P749, DOI 10.1086/309047; TOKUNAGA AT, 1991, ASTROPHYS J, V380, P452, DOI 10.1086/170603; Pauzat F, 1999, MON NOT R ASTRON SOC, V304, P241, DOI 10.1046/j.1365-8711.1999.02240.x; Sloan GC, 1997, ASTROPHYS J, V474, P735, DOI 10.1086/303484; DULEY WW, 1981, MON NOT R ASTRON SOC, V196, P269; Hammonds M, 2009, PHYS CHEM CHEM PHYS, V11, P4458, DOI 10.1039/b903237a; Wagner DR, 2000, ASTROPHYS J, V545, P854, DOI 10.1086/317868; ALLAMANDOLA LJ, 1989, ASTROPHYS J, V345, pL59, DOI 10.1086/185552; Joblin C, 1996, ASTROPHYS J, V458, P610, DOI 10.1086/176843; PAINTER PC, 1981, APPL SPECTROSC, V35, P475, DOI 10.1366/0003702814732256; Bauschlicher CW, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/102; Candian A, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/1/L10; Chiar JE, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/78; Dartois E., 2007, MOL SPACE LAB; Gadallah KAK, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219248; Garcia-Hernandez DA, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/2/L30; GIARD M, 1988, ASTRON ASTROPHYS, V201, pL1; Imanishi M., 2011, PASJ, V63, P447; Joblin C., 2011, EAS PUBLICATIONS SER, V46; Jones AP, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321686; Kwok S, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/5; Li AG, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L35; Micelotta ER, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/35; Mori TI, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/53; Onaka T., 2012, SPIE SPIE C SERIES, V8442; Onaka T., 2012, PUBL KOREAN ASTRON S, V27, P187; Onaka T., 2007, PASJ, V59, P401; Pilleri P, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425590; SAKATA A, 1984, ASTROPHYS J, V287, pL51, DOI 10.1086/184396; Sandford SA, 2013, ASTROPHYS J SUPPL S, V205, DOI 10.1088/0067-0049/205/1/8; Shao Y., 2006, PHYS CHEM CHEM PHYS; Song IO, 2003, MON NOT R ASTRON SOC, V346, pL1, DOI 10.1046/j.1365-2966.2003.07148.x; Steglich M, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/26; Wexler A.S., 1967, APPL SPECTROSC REV, V1, P29, DOI DOI 10.1080/05704926708547581; Yang XP, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-3	57	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		73	83		10.1016/j.pss.2015.05.010		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900009		
J	Onaka, T; Mori, TI; Okada, Y				Onaka, Takashi; Mori, Tamami I.; Okada, Yoko			Dust processing in the Carina nebula region	PLANETARY AND SPACE SCIENCE			English	Article						Infrared; ISM; Lines and bands; Dust; Abundances; Carina nebula	POLYCYCLIC AROMATIC-HYDROCARBON; SPECTRAL ENERGY-DISTRIBUTION; DIFFUSE GALACTIC EMISSION; STAR-FORMING GALAXIES; INTERSTELLAR-MEDIUM; INFRARED-EMISSION; PHOTODISSOCIATION REGIONS; WAVELENGTH SPECTROMETER; ELLIPTIC GALAXIES; GLOBAL PROPERTIES	Dust processing in the Carina nebula is investigated based on mid-to far-infrared spectroscopy with Infrared Space Observatory (ISO). Mapping observations over a central 40' x 20' area of the nebula with PHT-S, SWS, and LWS onboard ISO not only reveal spectroscopically that the mid-infrared unidentified infrared (UIR) bands at 6.2, 7.7, 8.6, and 11.3 mu m are absent in the ionized region, but also indicate that the 11.3 mu m may behave differently from the other three UIR bands near the edge of the ionized region, suggesting a variation either in the size distribution or in the ionization fraction of the band carriers. The correlation of [NII]122 mu m and [SiII]35 mu m line emissions observed with SWS and LWS is reinvestigated based on the recent atomic data as well as the latest cosmic abundance, suggesting that a large fraction (>70%), if not all, of silicon returns to the gas phase in the Carina nebula, suggesting that silicates cannot survive under harsh conditions, such as massive star-forming regions. The present observations clearly show dust processing taking place in active regions in the Galaxy. (C) 2015 Elsevier Ltd. All rights reserved.	[Onaka, Takashi; Mori, Tamami I.] Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo 1130033, Japan; [Okada, Yoko] Univ Cologne, Phys Inst 1, D-50937 Cologne, Germany	Onaka, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo 1130033, Japan.	onaka@astron.s.u-tokyo.ac.jp			JSPS KAKENHI [23244021]; JSPS Research Fellowship	This work is supported in part by JSPS KAKENHI (23244021). T.I.M. is supported by a JSPS Research Fellowship for Young Scientist.	Berne O, 2007, ASTRON ASTROPHYS, V469, P575, DOI 10.1051/0004-6361:20066282; Allain T, 1996, ASTRON ASTROPHYS, V305, P602; Hudson CE, 2004, MON NOT R ASTRON SOC, V348, P1275, DOI 10.1111/j.1365-2966.2004.07461.x; Mizutani M, 2002, ASTRON ASTROPHYS, V382, P610, DOI 10.1051/0004-6361:20011611; Sakon I, 2004, ASTROPHYS J, V609, P203, DOI 10.1086/420919; Galliano F, 2008, ASTROPHYS J, V679, P310, DOI 10.1086/587051; Povich MS, 2007, ASTROPHYS J, V660, P346, DOI 10.1086/513073; LEISAWITZ D, 1988, ASTROPHYS J, V332, P954, DOI 10.1086/166704; Bautista MA, 2009, ASTRON ASTROPHYS, V508, P1527, DOI 10.1051/0004-6361/200913179; Dale DA, 2001, ASTROPHYS J, V549, P215, DOI 10.1086/319077; Onaka T, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913770; Aggarwal KM, 2014, MON NOT R ASTRON SOC, V442, P388, DOI 10.1093/mnras/stu883; Okada Y, 2006, ASTROPHYS J, V640, P383, DOI 10.1086/499801; Kaneda H, 2008, ASTROPHYS J, V684, P270, DOI 10.1086/590243; Draine BT, 2001, ASTROPHYS J, V551, P807, DOI 10.1086/320227; Smith JDT, 2007, ASTROPHYS J, V656, P770, DOI 10.1086/510549; BERNARD JP, 1994, ASTRON ASTROPHYS, V289, P524; BENTLEY AF, 1984, ASTROPHYS J, V278, P665, DOI 10.1086/161834; Lemke D, 1996, ASTRON ASTROPHYS, V315, pL64; Miller A, 2007, ASTROPHYS J, V659, P441, DOI 10.1086/512178; Bradford CM, 2002, APPL OPTICS, V41, P2561, DOI 10.1364/AO.41.002561; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Rosenthal D, 2000, ASTRON ASTROPHYS, V356, P705; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Irwin JA, 2006, ASTRON ASTROPHYS, V445, P123, DOI 10.1051/0004-6361:20053233; Sakon I, 2007, PUBL ASTRON SOC JPN, V59, pS483; Kwok S, 2011, NATURE, V479, P80, DOI 10.1038/nature10542; Clegg PE, 1996, ASTRON ASTROPHYS, V315, pL38; Onaka T, 1996, PUBL ASTRON SOC JPN, V48, pL59; Rapacioli M, 2005, ASTRON ASTROPHYS, V429, P193, DOI 10.1051/0004-6361:20041247; Mattila K, 1996, ASTRON ASTROPHYS, V315, pL353; Onaka T, 2007, PUBL ASTRON SOC JPN, V59, pS401; Smith N, 2007, MON NOT R ASTRON SOC, V379, P1279, DOI 10.1111/j.1365-2966.2007.12021.x; Jones AP, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117623; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Onaka T, 2007, ASTROPHYS J, V654, P844, DOI 10.1086/509113; Okada Y, 2003, ASTRON ASTROPHYS, V412, P199, DOI 10.1051/0004-6361:20031415; Kaufman MJ, 2006, ASTROPHYS J, V644, P283, DOI 10.1086/503596; Fuente A, 2000, ASTRON ASTROPHYS, V354, P1053; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Cartledge SIB, 2006, ASTROPHYS J, V641, P327, DOI 10.1086/500297; Okada Y, 2008, ASTROPHYS J, V682, P416, DOI 10.1086/589229; Matsumoto H, 2008, ASTROPHYS J, V677, P1120, DOI 10.1086/533526; Onaka T, 2000, ADV SPACE RES, V25, P2167, DOI 10.1016/S0273-1177(99)01149-7; COHEN M, 1986, ASTROPHYS J, V302, P737, DOI 10.1086/164035; Oberst TE, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/100; deGraauw T, 1996, ASTRON ASTROPHYS, V315, pL49; SCHUTTE WA, 1993, ASTROPHYS J, V415, P397, DOI 10.1086/173173; Bregman JD, 2008, ASTR SOC P, V381, P34; Berne O, 2009, ASTROPHYS J LETT, V706, pL160, DOI 10.1088/0004-637X/706/1/L160; Bocchio M, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219705; Bocchio M, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424368; Boulanger F, 1998, ASTR SOC P, V132, P15; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; GIARD M, 1988, ASTRON ASTROPHYS, V201, pL1; Helou G., 2000, APJ, V532, P21; Jenkins EB, 2009, ASTROPHYS J, V700, P1299, DOI 10.1088/0004-637X/700/2/1299; Jones AP, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201014440; Jones A. P., 2004, ASP C SER, V309, P347; Jones AP, 2000, J GEOPHYS RES-SPACE, V105, P10257, DOI 10.1029/1999JA900264; Jones AP, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321686; Jones AP, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117624; Jones AP, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118483; Kaneda H., 2005, APJ, V632, P83; Kessler M.F., 1996, ASTRON ASTROPHYS, V315, P27; Meixner M., 2006, AJ, V132, P2288; Micelotta ER, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200911682; Micelotta ER, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200911683; Mizutani M., 2004, Astronomy & Astrophysics, V423, DOI 10.1051/0004-6361:20041063; Mori TI, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/68; Mori TI, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/53; Nieva MF, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118158; Onaka T., 2013, P IAU S, V292, P259; Preibisch T, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201218851; Sandstrom KM, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/20; Sellgren K., ASTROPHYS J, V349, P120; Tanaka M, 1996, PUBL ASTRON SOC JPN, V48, pL53; Tielens AGGM, 2005, PHYSICS AND CHEMISTRY OF THE INTERSTELLAR MEDIUM, P1, DOI 10.1017/CBO9780511819056	79	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		84	91		10.1016/j.pss.2015.03.025		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900010		
J	Kokusho, T; Nagayama, T; Kaneda, H; Ishihara, D; Lee, HG; Onaka, T				Kokusho, Takuma; Nagayama, Takahiro; Kaneda, Hidehiro; Ishihara, Daisuke; Lee, Ho-Gyu; Onaka, Takashi			A study of iron and dust in the supernova remnant IC 443	PLANETARY AND SPACE SCIENCE			English	Article						Supernova remnant; Interstellar dust; Iron; IRSF; AKARI; Suzaku	X-RAY-STRUCTURE; GRAIN DESTRUCTION; IC-443; SPECTROSCOPY; SHOCK; CASSIOPEIA; SPECTRUM; NEBULA; GAS	We performed near-infrared line mapping of the supernova remnant IC 443 with the IRSF 1.4-m telescope, using the narrow-band filters tuned for [Fe II] 1.257 mu m, [Fe II] 1.644 mu m, and Pa beta. We detected the [Fe II] and Pa beta emissions from a very wide area of the observed region (30' x 35'). These line intensity maps reveal a global correlation between [Fe II] and Pa beta. Kokusho et al. (2013) found that the [Fe II] emission is notably strong while dust emission is faint in inner regions of IC 443. These results indicate that the abundant Fe+ is likely to be of interstellar origins through shock destruction of dust, rather than of ejecta origins. From the X-ray intensity map of the 6.7 key Fe-K line obtained with Suzaku, we find that highly ionized He-like Fe ions exist in the inner regions of IC 443, toward which Fe+ is detected. The presence of the He-like Fe ions and the faint dust emission indicates that Fe is likely to be interacting with X-ray plasma for a time long enough to be highly ionized. We discuss the implications of the detection of the lowly ionized Fe ions in such regions for the processing and composition of dust in the interstellar environment around IC 443. (C) 2015 Elsevier Ltd. All rights reserved.	[Kokusho, Takuma; Kaneda, Hidehiro; Ishihara, Daisuke] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Nagayama, Takahiro] Kagoshima Univ, Dept Astrophys, Kagoshima 8900065, Japan; [Lee, Ho-Gyu] Korea Astron & Space Sci Inst, Daejeon 305348, South Korea; [Onaka, Takashi] Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo 1130033, Japan	Kokusho, T (reprint author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan.	kokusho@u.phys.nagoya-u.ac.jp			Sumitomo foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [10147207, 10147214]; Joint Development Research of National Astronomical Observatory of Japan; Optical Near-Infrared Astronomy Inter-University Cooperation Program; MEXT of Japan; space agencies of Japan (JAXA); USA (NASA);  [26003136]	The IRSF project was financially supported by the Sumitomo foundation and Grants-in-Aid for Scientific Research on Priority Areas (A) (Nos. 10147207 and 10147214) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The operation of IRSF is supported by Joint Development Research of National Astronomical Observatory of Japan, and Optical Near-Infrared Astronomy Inter-University Cooperation Program, funded by the MEXT of Japan. This research is based on observations with AKARI, a JAXA project with the participation of ESA, and with Spitzer, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. This research has made use of data obtained from the Suzaku satellite, a collaborative mission between the space agencies of Japan (JAXA) and the USA (NASA). T.K. is financially supported by Grantsin-Aid for JSPS Fellows No. 26003136.	PETRE R, 1988, ASTROPHYS J, V335, P215, DOI 10.1086/166922; Rho J, 2008, ASTROPHYS J, V673, P271, DOI 10.1086/523835; RICHTER MJ, 1995, ASTROPHYS J, V454, P277, DOI 10.1086/176481; Draine BT, 1995, ASTROPHYS SPACE SCI, V233, P111, DOI 10.1007/BF00627339; Matsuura M, 2011, SCIENCE, V333, P1258, DOI 10.1126/science.1205983; Troja E, 2008, ASTRON ASTROPHYS, V485, P777, DOI 10.1051/0004-6361:20079123; Hughes JP, 2000, ASTROPHYS J, V528, pL109, DOI 10.1086/312438; Olbert CM, 2001, ASTROPHYS J, V554, pL205, DOI 10.1086/321708; GRAHAM JR, 1987, ASTROPHYS J, V313, P847, DOI 10.1086/165023; Bykov AM, 2008, ASTROPHYS J, V676, P1050, DOI 10.1086/529117; Welsh BY, 2003, ASTRON ASTROPHYS, V408, P545, DOI 10.1051/0004-6361:20030908; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Rho J, 2001, ASTROPHYS J, V547, P885, DOI 10.1086/318398; Kushino A, 2002, PUBL ASTRON SOC JPN, V54, P327; LOWE RP, 1979, ASTROPHYS J, V228, P191, DOI 10.1086/156835; Yamaguchi H, 2009, ASTROPHYS J LETT, V705, pL6, DOI 10.1088/0004-637X/705/1/L6; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Gaensler BM, 2006, ASTROPHYS J, V648, P1037, DOI 10.1086/506246; TIELENS AGGM, 1994, ASTROPHYS J, V431, P321, DOI 10.1086/174488; Castelletti G, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201016081; Henning T, 2010, ANNU REV ASTRON ASTR, V48, P21, DOI 10.1146/annurev-astro-081309-130815; Kokusho T, 2013, ASTROPHYS J LETT, V768, DOI 10.1088/2041-8205/768/1/L8; Koyama K., 2007, PASJ, V59, P23; Lee JJ, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/34; McDonald I, 2010, ASTROPHYS J LETT, V717, pL92, DOI 10.1088/2041-8205/717/2/L92; Nagashima C., 1999, STAR FORMATION 1999, P397; Nagayama T, 2003, P SOC PHOTO-OPT INS, V4841, P459, DOI 10.1117/12.460770; Noriega-Crespo A., 2009, EVOLVING ISM MILKY W; Shinn JH, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/124	30	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	OCT	2015	116				SI		92	96		10.1016/j.pss.2015.04.009		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CU2JX	WOS:000363350900011		
J	Takatori, K; Matsumoto, D				Takatori, Katsuhiko; Matsumoto, Daisuke			Relationships Between Simple Toe Elevation Angle in the Standing Position and Dynamic Balance and Fall Risk Among Community-Dwelling Older Adults	PM&R			English	Article								Objective: To investigate the relationships between toe elevation ability in the standing position and dynamic balance and fall risk among community-dwelling older adults. Design: Cross-sectional survey. Setting: General community. Participants: Community-dwelling older adults (N = 287). Main Outcome Measure: Toe elevation angles in the standing position. Results: Intra-rater and inter-rater reliability of measurements of the toe elevation angle was high (internal coefficient of correlation [ICC] (1,2) = 0.94 for the former and ICC (2,1) = 0.90 for the latter). Significant correlations were found between the toe elevation angle and age (r = -0.20, P < .01), 5-m walking time (r = -0.31, P < .01), Functional Reach Test (r = 0.36, P < .01), Timed Up and Go Test (r = -0.36, P < .01), and Chair Stand Test (r = 0.26, P < .01). Subjects who experienced a fall in the previous 6 months had a significantly lower toe elevation angle compared with subjects who did not experience a fall (t = 2.19, P < .05). Multiple regression analysis revealed that results of the Functional Reach Test (beta = 2.19, P < .001) and Timed Up and Go Test (beta = -0.74, P < .001) were significantly associated with the toe elevation angle. Conclusions: Toe elevation angle was an index of dynamic balance ability and appears to be a simple screening test for fall risk in community-dwelling older adults.	[Takatori, Katsuhiko; Matsumoto, Daisuke] Kio Univ, Fac Hlth Sci, Dept Phys Therapy, Koryo, Nara, Japan	Takatori, K (reprint author), Kio Univ, Fac Hlth Sci, Dept Phys Therapy, 4-2-2 Umami Naka, Koryo, Nara, Japan.	k.takatori@kio.ac.jp					Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113; Shumway-Cook A, 2000, PHYS THER, V80, P896; Juras G, 2008, J HUM KINET, V19, P39; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Toba K, 2012, GERIATR GERONTOL INT, V12, P563, DOI 10.1111/j.1447-0594.2011.00787.x; Jonsson E, 2003, J REHABIL MED, V35, P26, DOI 10.1080/16501970306099; Arai Takeshi, 2010, Nihon Ronen Igakkai Zasshi, V47, P585, DOI 10.3143/geriatrics.47.585; Duncan PW, 1990, J GERONTOL, V45, P192; Khasnis A, 2003, J Postgrad Med, V49, P169; Ministry of Health Labour and Welfare, 2014, ANN HLTH LAB WELF RE; World Health Organization, WORLD HLTH STAT 2014	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2015	7	10					1059	1063		10.1016/j.pmrj.2015.04.006		5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CU5WP	WOS:000363603000006		
J	Hassan, MM; Koyama, K				Hassan, Mohammad Mahbubul; Koyama, Kiyohito			Thermal, physico-mechanical, and morphological properties of HDPE graft-copolymerized with polystyrene	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article						graft copolymerization; PS-grafted HDPE; thermal properties; mechanical properties; contact angle	HIGH-DENSITY POLYETHYLENE; CROSS-LINKING; GLYCIDYL METHACRYLATE; MECHANICAL-PROPERTIES; MALEIC-ANHYDRIDE; ACRYLIC-ACID; SURFACE-PROPERTIES; ELECTRON-BEAM; MOLTEN STATE; RADIATION	In this study, polystyrene was graft-copolymerized onto high-density polyethylene (HDPE) by in situ polymerization of styrene monomer to change the physico-mechanical and thermal properties of HDPE. The grafting was carried out in a Brabender-type static mixer by injecting styrene monomer directly into the molten HDPE in the presence of a free-radical initiator (lauroyl peroxide or LP). The effect of wt% of styrene and initiator concentrations on thermal, physico-mechanical, and morphological properties of HDPE was investigated. The neat and modified HDPE was characterized by differential scanning calorimetry, thermogravimetric analysis, scanning electron microscopy, Fourier transform infrared spectroscopy, scanning electron microscopy, and also by tensile strength and contact angle measurements. It was found that the increase in wt% of styrene and LP dosage reduced elongation at break, hygroscopic expansion and also the melting, and the crystallization temperatures of HDPE but increased its tensile strength. The tensile strength was increased from 14.6MPa for the neat HDPE to 20.6MPA for the 10 wt% of styrene grafted onto HDPE using 0.8% LP. Scanning electron microscopy results show that there was no phase separation, and the grafted polystyrene became integral part of HDPE. The results demonstrate that styrene could be used in melt compounding to improve various properties of HDPE. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Hassan, Mohammad Mahbubul; Koyama, Kiyohito] Yamagata Univ, Venture Business Lab, Yonezawa, Yamagata, Japan; [Koyama, Kiyohito] Yamagata Univ, Dept Polymer Sci & Engn, Yonezawa, Yamagata, Japan; [Hassan, Mohammad Mahbubul] AgResearch Ltd, Food & Biobased Prod Grp, Christchurch 7608, New Zealand	Hassan, MM (reprint author), AgResearch Ltd, Food & Biobased Prod Grp, Cnr Springs Rd & Gerald St, Christchurch 7608, New Zealand.	mahbubul.hassan@agresearch.co.nz					Ao YH, 2007, POLYM BULL, V59, P279, DOI 10.1007/s00289-007-0764-y; Kang TK, 2000, POLYM TEST, V19, P773, DOI 10.1016/S0142-9418(99)00048-3; Wang HL, 2004, J POLYM SCI POL CHEM, V42, P253, DOI 10.1002/pola.11022; Yamada K, 2012, J APPL POLYM SCI, V125, P2614, DOI 10.1002/app.36399; Park JS, 2015, MATERIALS, V8, P1626, DOI 10.3390/ma8041626; Zu JH, 2005, RADIAT PHYS CHEM, V72, P759, DOI 10.1016/j.radphyschem.2004.05.021; Huang CY, 2002, SURF COAT TECH, V153, P194, DOI 10.1016/S0257-8972(01)01675-9; Krause B, 2006, J APPL POLYM SCI, V99, P260, DOI 10.1002/app.22471; HO RM, 1993, POLYMER, V34, P3264, DOI 10.1016/0032-3861(93)90400-5; LUCAS EF, 1992, J APPL POLYM SCI, V46, P733, DOI 10.1002/app.1992.070460420; Qiu WL, 2005, EUR POLYM J, V41, P1979, DOI 10.1016/j.eurpolumj.2005.03.016; Nagesh N, 1999, J PHYS D APPL PHYS, V32, P1189, DOI 10.1088/0022-3727/32/11/301; Heinen W, 1996, MACROMOLECULES, V29, P1151, DOI 10.1021/ma951015y; Maillard D, 2011, NANO LETT, V11, P4569, DOI 10.1021/nl202651u; Dikobe DG, 2009, EXPRESS POLYM LETT, V3, P190, DOI 10.3144/expresspolymlett.2009.24; Jose S, 2004, EUR POLYM J, V40, P2105, DOI 10.1016/j.eurpolymj.2004.02.026; Torres N, 2001, J APPL POLYM SCI, V81, P581, DOI 10.1002/app.1473; CHEN CJ, 1991, COLLOID POLYM SCI, V269, P353, DOI 10.1007/BF00654582; Torres N, 2001, J APPL POLYM SCI, V81, P2377, DOI 10.1002/app.1678; Cheng S, 2009, RADIAT PHYS CHEM, V78, P563, DOI 10.1016/j.radphyschem.2009.03.043; Ahirwal D, 2014, J RHEOL, V58, P635, DOI 10.1122/1.4867555; QU BJ, 1995, POLYM ENG SCI, V35, P1161, DOI 10.1002/pen.760351406; Anbarasan R, 2004, J APPL POLYM SCI, V93, P75, DOI 10.1002/app.20390; Pages P, 1996, J APPL POLYM SCI, V60, P153, DOI 10.1002/(SICI)1097-4628(19960411)60:2<153::AID-APP2>3.0.CO;2-R; Senna MMH, 2013, J IND ENG CHEM, V19, P48, DOI 10.1016/j.jiec.2012.06.022; Stadler FJ, 2009, RHEOL ACTA, V48, P479, DOI 10.1007/s00397-008-0334-8; Sugimoto M, 2001, MACROMOLECULES, V34, P6056, DOI 10.1021/ma0015525; Zu JH, 2006, J APPL POLYM SCI, V99, P3396, DOI 10.1002/app.23033; Khonakdar HA, 2003, POLYMER, V44, P4301, DOI 10.1016/S0032-3861(03)00363-X; Li ZR, 2005, J APPL POLYM SCI, V96, P772, DOI 10.1002/app.21508; BARENTSE.WM, 1973, POLYMER, V14, P579, DOI 10.1016/0032-3861(73)90143-2; BERNETT MK, 1977, POLYM ENG SCI, V17, P450, DOI 10.1002/pen.760170706; Dimitrova T. L., 2005, BULGAR J PHYS, V32, P214; Fasce L. A., 2010, EXPRESS POLYM LETT, V2, P779; Huff T., 1964, J APPL POLYM SCI, V8, P825, DOI 10.1002/app.1964.070080222; LIANG CY, 1956, J CHEM PHYS, V25, P543, DOI 10.1063/1.1742962; Pasto D. J., 1967, ORGANIC STRUCTURE DE, P133; Siripattanasak T., 2013, ADV CHEM ENG SCI, V3, P202	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	OCT	2015	26	10					1285	1293		10.1002/pat.3566		9	Polymer Science	Polymer Science	CU3VX	WOS:000363455200010		
J	Doi, R; Kuwahara, T				Doi, Rieko; Kuwahara, Takuo			Combustion of Aluminum Particles near the Burning Surface in AP/AN Composite Propellants	PROPELLANTS EXPLOSIVES PYROTECHNICS			English	Article						Agglomerate; Aluminum particle; Luminous flame; Burning rate; Activation energy	POCKET MODEL; AGGLOMERATION	Aluminum (Al) particles are commonly used in ammonium perchlorate (AP) composite propellants of solid rockets for increasing performance. When propellants including Al particles burn, Al particles easily agglomerate on the burning surface of the propellant. The diameters of agglomerated Al particles are greater than those of mixed particles. The combustion efficiency of the propellant decreases with increasing burning time of the agglomerated Al particles. Therefore, it is important to observe how the agglomerated Al particles burn on the burning surface of AP composite propellant. A lot of researchers have studied Al agglomerate characteristics. Previous studies clarified the relation between the agglomerated Al particle diameter and luminous flame diameter around Al particles near the burning surface. The shapes of luminous flames around agglomerated Al particles are spherical or elliptical. This study evaluates the shapes of the luminous flame around agglomerated Al particles at a constant diameter or a different diameter. When the proportion of the luminous flame diameter (D-f) to the diameter of agglomerated Al particles (D-0) is 1.54-1.71 at a constant D-0, the luminous flames are almost perfectly spherical. Otherwise, the luminous flames are elliptical at a constant D-0. Furthermore, when D-f/D-0 is close to the mean value, the luminous flame is more spherical than elliptical at different D-0. The evaporation rate and the burning rate of Al vapor are inversely proportional to D-0. The oxidation gas temperatures were changed and the activation energy of Al vapor was obtained as 39.2 kJ mol(-1).	[Doi, Rieko; Kuwahara, Takuo] Nihon Univ, Coll Sci & Technol, Dept Aerosp Engn, Funabashi, Chiba 2748501, Japan	Doi, R (reprint author), Nihon Univ, Coll Sci & Technol, Dept Aerosp Engn, 7-24-1 Narashinodai, Funabashi, Chiba 2748501, Japan.	csri11083@g.nihon-u.ac.jp			Foundation for the Promotion of the Industrial Explosives Technology	This work was sponsored by the Foundation for the Promotion of the Industrial Explosives Technology.	De Luca LT, 2010, J PROPUL POWER, V26, P724, DOI 10.2514/1.45262; Gallier S, 2009, PROPELL EXPLOS PYROT, V34, P97, DOI 10.1002/prep.200700260; Rashkovskii SA, 2002, COMBUST EXPLO SHOCK+, V38, P435, DOI 10.1023/A:1016211215981; Cai WD, 2008, COMBUST SCI TECHNOL, V180, P2143, DOI 10.1080/00102200802414915; COHEN NS, 1983, AIAA J, V21, P720, DOI 10.2514/3.8139; Babuk VA, 1999, J PROPUL POWER, V15, P783, DOI 10.2514/2.5497; Beckstead M. W., 2004, RTO VKI SPECIAL COUR; Bucher P, 1996, TWENTY-SIXTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P1899; Cerri S., 2009, CENT EUR J ENERG MAT, V6, P149; DeLuca L. D., 2010, 46 AIAA ASME ASE ASE; Gordon S., 1994, NASA REFERENCE PUBLI; Habu H., 2008, J JAPAN I LIGHT META, V58, P162, DOI 10.2464/jilm.58.162; Kubota N., 2007, PROPELL EXPLOS PYROT, P186; Kuwahara T., 2013, JPN EXPLOS SOC, V2013; Lengelle G., 2002, RTO VKI SPECIAL COUR; Maggi F., 2012, ACTA ASTRONAUTICA; Melcher J. C., 2001, 37 AIAA ASME ASE ASE; Oide S., 2012, 48 AIAA ASME SAE ASE, P2012; Oide S., 2013, THESIS NIHON U JAPAN; Propellant Committee, 2005, PROP HDB, P142; Sasaki T., 2013, 9 HIGH EN MAT HEMS S, P115; Takahashi K., 2013, PROPELL EXPLOS PYROT, V38, P1; Takahashi K., 2013, THESIS NIHON U JAPAN; Walfhard H.G., 1964, AM I AERONAUTICS AST, V15, P44	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0721-3115	1521-4087		PROPELL EXPLOS PYROT	Propellants Explos. Pyrotech.	OCT	2015	40	5					765	771		10.1002/prep.201400270		7	Chemistry, Applied; Engineering, Chemical	Chemistry; Engineering	CU2FH	WOS:000363338500021		
J	Kainuma, S; Tokuda, H; Kuroyanagi, G; Yamamoto, N; Ohguchi, R; Fujita, K; Matsushima-Nishiwaki, R; Kozawa, O; Otsuka, T				Kainuma, Shingo; Tokuda, Haruhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Ohguchi, Reou; Fujita, Kazuhiko; Matsushima-Nishiwaki, Rie; Kozawa, Osamu; Otsuka, Takanobu			PGD(2) stimulates osteoprotegerin synthesis via AMP-activated protein kinase in osteoblasts: Regulation of ERK and SAPK/JNK	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						AMP-activated protein kinase; PGD(2); Osteoprotegerin; Osteoblast	D-2-STIMULATED HEAT-SHOCK-PROTEIN-27 INDUCTION; PROSTANOID RECEPTORS; OVARIECTOMIZED RATS; PROSTAGLANDIN D-2; CYCLIC-AMP; CELLS; DIFFERENTIATION; CALCIFICATION; RESVERATROL; INVOLVEMENT	AMP-activated protein kinase (AMPK), a key enzyme sensing cellular energy metabolism, is currently known to regulate multiple metabolic pathways. Osteoprotegerin plays a pivotal role in the regulation of bone metabolism by inhibiting osteoclast activation. We have previously reported that prostaglandin D-2 (PGD(2)) stimulates the synthesis of osteoprotegerin through the activation of p38 mitogen-activated protein (MAP) kinase, p44/p42 MAP kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in osteoblast-like MC3T3-E1 cells. On the basis of these findings, we herein investigated the implication of AMPK in PGD(2)-stimulated osteoprotegerin synthesis in these cells. PGD2 induced the phosphorylation of AMPK alpha (Thr-172) and AMPK beta (Ser-108), and the phosphorylation of acetyl-coenzyme A carboxylase, a direct AMPK substrate. Compound C, an AMPK inhibitor, which suppressed the phosphorylation of acetyl-coenzyme A carboxylase, significantly attenuated both the release and the mRNA levels of osteoprotegerin stimulated by PGD2. The PGD(2)-induced phosphorylation of p44/p42 MAP kinase and SAPK/JNK but not p38 MAP kinase were markedly inhibited by compound C. These results strongly suggest that AMPK regulates the PGD2-stimulated osteoprotegerin synthesis at a point upstream of p44/p42 MAP kinase and SAPK/JNK in osteoblasts. (C) 2015 Elsevier Ltd. All rights reserved.	[Kainuma, Shingo; Kuroyanagi, Gen; Yamamoto, Naohiro; Ohguchi, Reou; Fujita, Kazuhiko; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi 4678601, Japan; [Kainuma, Shingo; Tokuda, Haruhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Ohguchi, Reou; Fujita, Kazuhiko; Matsushima-Nishiwaki, Rie; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi 4748511, Japan	Tokuda, H (reprint author), Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi 4748511, Japan.	tokuda@ncgg.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19591042]; Ministry of Health, Labour and Welfare [H25-Aging-General-004]; National Center for Geriatrics and Gerontology (NCGC), Japan [25-4, 26-12]	We are very grateful to Yumiko Kurokawa for her skillful technical assistance. This investigation was supported in part by a Grant-in-Aid for Scientific Research (19591042) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant in Aid for Scientific Research (H25-Aging-General-004) from the Ministry of Health, Labour and Welfare, and the Research Funding for Longevity Sciences (25-4, 26-12) from National Center for Geriatrics and Gerontology (NCGC), Japan.	Kyriakis JM, 2001, PHYSIOL REV, V81, P807; Ram A, 1997, BRAIN RES, V751, P81, DOI 10.1016/S0006-8993(96)01401-1; Hawley SA, 1996, J BIOL CHEM, V271, P27879; Kozawa O, 2001, CELL SIGNAL, V13, P535, DOI 10.1016/S0898-6568(01)00180-2; Takeda S, 2001, J BONE MINER METAB, V19, P195, DOI 10.1007/s007740170042; Widmann C, 1999, PHYSIOL REV, V79, P143; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Kanazawa I, 2008, BIOCHEM BIOPH RES CO, V375, P414, DOI 10.1016/j.bbrc.2008.08.034; Kato K, 2010, BIOCHEM BIOPH RES CO, V400, P123, DOI 10.1016/j.bbrc.2010.08.024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Kuroyanagi G, 2014, PROSTAG LEUKOTR ESS, V91, P73, DOI 10.1016/j.plefa.2014.04.003; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Yoshida M, 2004, PROSTAG LEUKOTR ESS, V71, P351, DOI 10.1016/j.plefa.2004.06.003; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; TAKAGI T, 1993, CALCIFIED TISSUE INT, V52, P442, DOI 10.1007/BF00571334; Yue L, 2012, BONE, V51, P338, DOI 10.1016/j.bone.2012.06.003; Jang WG, 2011, BIOCHEM BIOPH RES CO, V404, P1004, DOI 10.1016/j.bbrc.2010.12.099; Mai QG, 2011, J CELL BIOCHEM, V112, P2902, DOI 10.1002/jcb.23206; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; Hikiji H, 2008, PROG LIPID RES, V47, P107, DOI 10.1016/j.plipres.2007.12.003; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Kato K, 2012, LIFE SCI, V90, P71, DOI 10.1016/j.lfs.2011.10.023; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; TASAKI Y, 1991, PROSTAGLANDINS, V41, P303, DOI 10.1016/0090-6980(91)90001-V; Narumiya S, 1999, PHYSIOL REV, V79, P1193; Kato K, 1996, J NEUROCHEM, V66, P946; Kong YY, 1999, NATURE, V397, P315; KOZAWA O, 1992, EXP CELL RES, V198, P130, DOI 10.1016/0014-4827(92)90158-5; Yamamoto N, 2014, INT J MOL MED, V34, P1439, DOI 10.3892/ijmm.2014.1934	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	OCT	2015	101						23	29		10.1016/j.plefa.2015.08.003		7	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	CU2LR	WOS:000363355500004		
J	Shimizu, N; Ooka, M; Takagi, T; Takeda, S; Hirota, K				Shimizu, Naoto; Ooka, Masato; Takagi, Tokiyo; Takeda, Shunichi; Hirota, Kouji			Distinct DNA Damage Spectra Induced by Ionizing Radiation in Normoxic and Hypoxic Cells	RADIATION RESEARCH			English	Article							DOUBLE-STRAND BREAKS; FACILITATE HOMOLOGOUS RECOMBINATION; CROSS-LINKING AGENTS; TRANSLESION SYNTHESIS; VERTEBRATE CELLS; CELLULAR-DNA; REPAIR; MECHANISMS; INDUCTION; OXIDATION	Ionizing radiation induces more cell death under normoxic conditions than under hypoxic conditions. This phenomenon, which is known as the oxygen enhancement effect, occurs primarily because ionizing radiation causes more DNA lesions in the presence of oxygen than in its absence. However, the roles these lesions play in terms of cell survival and chromosome damage have not been fully characterized. We exposed a panel of chicken DT40 mutant cells to ionizing radiation to categorize the type of lesion induced and the DNA-repair pathway involved under both normoxic and hypoxic conditions. Among the mutant panel, RAD54(-/-)/KU70(-/-) cells exhibited the greatest radiosensitivity, which was found to be significantly higher under normoxic conditions. This indicates that double-strand breaks (DSBs) were the major cause of cell death and that ionizing radiation induces more DSBs under normoxic condition. Interestingly, the sensitivity of the REV3(-/-) cells increased under hypoxic conditions. Indeed, the REV3(-/-) mutant exhibited a greater number of chromosomal aberrations under hypoxic conditions than under normoxic conditions. These results suggest that the Rev3-mediated translesion-synthesis pathway is more critical for cellular tolerance to ionizing radiation in hypoxic cells than in normoxic cells, and that more chemically modified DNA might be induced under hypoxic conditions. In this study, we identify a previously unappreciated radiation-induced pattern of DNA damage under hypoxic conditions. (C) 2015 by Radiation Research Society	[Shimizu, Naoto; Ooka, Masato; Takagi, Tokiyo; Hirota, Kouji] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan	Hirota, K (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Minamiosawa 1-1, Hachioji, Tokyo 1920397, Japan.	khirota@tmu.ac.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [RF-1005, C-0801]	We would like to acknowledge the Radioisotope Research Center, Tokyo Metropolitan University for its help with the use of isotopes. This work was supported by grants from the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [grant nos. RF-1005 (KH) and C-0801 (ST)]. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; [Anonymous], 1985, INT SYSTEM HUMAN CYT; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Cadet J, 2014, INT J RADIAT BIOL, V90, P423, DOI 10.3109/09553002.2013.877176; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; Hirota K, 2015, NUCLEIC ACIDS RES, V43, P1671, DOI 10.1093/nar/gkv023; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; GRAY LH, 1953, BRIT J RADIOL, V26, P638; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Nakano T, 2015, MUTAT RES-FUND MOL M, V771, P45, DOI 10.1016/j.mrfmmm.2014.12.003; Dedon PC, 2008, CHEM RES TOXICOL, V21, P206, DOI 10.1021/tx700283c; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Kobayashi S, 2015, ONCOGENE, V34, P4403, DOI 10.1038/onc.2014.371; Cadet J, 2014, ARCH BIOCHEM BIOPHYS, V557, P47, DOI 10.1016/j.abb.2014.05.001; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Yamamoto KN, 2011, ENVIRON MOL MUTAGEN, V52, P547, DOI 10.1002/em.20656; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Kikuchi K, 2009, J BIOL CHEM, V284, P26360, DOI 10.1074/jbc.M109.029348; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; BRYANT PE, 1993, MUTAT RES, V299, P289, DOI 10.1016/0165-1218(93)90105-M; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; BENDER MA, 1974, MUTAT RES, V23, P197, DOI 10.1016/0165-1218(74)90277-8; Richardson C, 2000, NATURE, V405, P697; Fujita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060043; Georgakilas Alexandros, 2011, World J Biol Chem, V2, P173, DOI 10.4331/wjbc.v2.i7.173; Hirota K, 2010, PLOS GENET, V6	33	0	0	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	OCT	2015	184	4					442	448		10.1667/RR14117.1		7	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	CU0QB	WOS:000363221200010		
J	Nakai, N; Otsuka, S; Myung, JW; Takumi, T				Nakai, Nobuhiro; Otsuka, Susumu; Myung, Jihwan; Takumi, Toru			Autism spectrum disorder model mice: Focus on copy number variation and epigenetics	SCIENCE CHINA-LIFE SCIENCES			English	Review						copy number variations; DNA methylation; histone modification; ASD model mouse	FRAGILE-X-SYNDROME; DE-NOVO MUTATIONS; MOUSE MODEL; RETT-SYNDROME; SYNAPTIC FUNCTION; MAMMALIAN DNA; KNOCKOUT MICE; VALPROIC ACID; BRAIN; CHILDREN	Autism spectrum disorder (ASD) is gathering concerns in socially developed countries. ASD is a neuropsychiatric disorder of genetic origin with high prevalence of 1%-2%. The patients with ASD characteristically show impaired social skills. Today, many genetic studies identify numerous susceptible genes and genetic loci associated with ASD. Although some genetic factors can lead to abnormal brain function linked to ASD phenotypes, the pathogenic mechanism of ASD is still unclear. Here, we discuss a new mouse model for ASD as an advanced tool to understand the mechanism of ASD.	[Nakai, Nobuhiro; Otsuka, Susumu; Myung, Jihwan; Takumi, Toru] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima 7348553, Japan; [Nakai, Nobuhiro] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Nakai, Nobuhiro; Myung, Jihwan; Takumi, Toru] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Takumi, Toru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan	Takumi, T (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima 7348553, Japan.	toru.takumi@riken.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology KAKENHI; Core Research for Evolutional Science and Technology, Strategic International Cooperative Program of Japan Science and Technology Agency; Takeda Science Foundation; Naito Foundation; Terumo Life Science Foundation	The authors acknowledge all members of Takumi laboratory. This work was supported in part by a grant from Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science and Technology KAKENHI, Core Research for Evolutional Science and Technology, Strategic International Cooperative Program of Japan Science and Technology Agency, and by research grants from Takeda Science Foundation, the Naito Foundation and Terumo Life Science Foundation.	Allis C.D., 2007, EPIGENETICS; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Gropman AL, 2010, J DEV BEHAV PEDIATR, V31, P582, DOI 10.1097/DBP.0b013e3181ee384e; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Machado-Vieira R, 2011, CNS NEUROSCI THER, V17, P699, DOI 10.1111/j.1755-5949.2010.00203.x; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; van der Weyden L, 2006, ANNU REV GENOM HUM G, V7, P247, DOI 10.1146/annurev.genom.7.080505.115741; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sultan FA, 2011, EPIGENOMICS-UK, V3, P157, DOI [10.2217/epi.11.6, 10.2217/EPI.11.6]; Kemper TL, 2002, MOL PSYCHIATR, V7, pS12, DOI 10.1038/sj.mp.4001165; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Scherer SW, 2011, HUM GENET, V130, P123, DOI 10.1007/s00439-011-1037-2; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1046/j.1601-183X.2003.00037.x; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; James SJ, 2010, AM J MED GENET B, V153B, P1209, DOI 10.1002/ajmg.b.31094; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; BAKKER CE, 1994, CELL, V78, P23; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Kataoka S, 2013, INT J NEUROPSYCHOPH, V16, P91, DOI 10.1017/S1461145711001714; Kappeler L, 2010, BIOESSAYS, V32, P818, DOI 10.1002/bies.201000015; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; [Anonymous], 1999, NAT GENET, DOI DOI 10.1038/13810; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Sharma RP, 2006, SCHIZOPHR RES, V88, P227, DOI 10.1016/j.schres.2006.07.015; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.00123.x; Nguyen A, 2010, FASEB J, V24, P3036, DOI [10.1096/fj.10-154484, 10.1096/fj.09-154484]; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Autism Developmental Disabilities Monitoring Network Surveillance Year Principal I Centers for Disease C Prevention, 2012, MMWR-MORBID MORTAL W, V61, P1; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Tamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015126; WARD AJ, 1990, CHILD PSYCHIAT HUM D, V20, P279, DOI 10.1007/BF00706020	91	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	OCT	2015	58	10					976	984		10.1007/s11427-015-4891-7		9	Biology	Life Sciences & Biomedicine - Other Topics	CU1HB	WOS:000363270200006		
J	Tanaka, M; Nakamura, M				Tanaka, Motonobu; Nakamura, Masahiro			Spatially distinct responses within willow to bark stripping by deer: effects on insect herbivory	SCIENCE OF NATURE			English	Article						Canopy; Bark-stripping intensity; Defensive compounds; Induced response; Opposite plant-mediated interactions; Resprouting; Whole-plant scale	BOTTOM-UP CASCADES; TRI-TROPHIC SYSTEM; QUERCUS-ROBUR L; APICAL DOMINANCE; RESOURCE HETEROGENEITY; NITROGEN-CONTENT; HOST-PLANT; TREES; CHEMISTRY; EVOLUTION	Within individual plants, cervid herbivory may cause positive or negative plant-mediated effects on insect herbivores, depending on where it occurs. Using a combination of field observations and artificial bark-stripping experiments in Hokkaido, Japan, we examined the plant-mediated effects of bark stripping by sika deer (Cervus nippon yesoensis) on insect herbivory in two spatially distinct parts of willow (Salix udensis) trees: resprouting leaves below bark-stripping wounds and canopy leaves above. Natural and artificial bark stripping stimulated resprouting from trunks below wounds. Resprouting leaves on bark-stripped trees had lower total phenolics, condensed tannin, and C/N ratios than did canopy leaves on control trees. Herbivory rates were higher in resprouting leaves on bark-stripped trees than in canopy leaves on controls. Conversely, above-wound canopy leaves on bark-stripped trees had higher total phenolics than did those on controls, while herbivory rates were lower in the canopy leaves of bark-stripped trees than in those on controls. These results demonstrate that plant-mediated effects of bark stripping diverge between plant tissues below and above wounds in individual willow trees. We submit that focusing on multiple plant parts can elucidate plant-mediated effects at the whole-plant scale.	[Tanaka, Motonobu] Hokkaido Univ, Grad Sch Environm Sci, Nayoro, Hokkaido 0960071, Japan; [Nakamura, Masahiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Nakagawa Expt Forest, Otoineppu, Nakagawa 0982501, Japan	Nakamura, M (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Nakagawa Expt Forest, Otoineppu, Nakagawa 0982501, Japan.	masahiro@fsc.hokudai.ac.jp			Japan Society for the Promotion of Science [26450188]; Environment Research and Technology Development Fund [S-9-3]	This study was funded by grants from the Japan Society for the Promotion of Science (No 26450188 to MN) and the Environment Research and Technology Development Fund (S-9-3).	Johnson SN, 2013, J ANIM ECOL, V82, P1021, DOI 10.1111/1365-2656.12070; Cline M, 1997, PLANT CELL PHYSIOL, V38, P659; Nakamura M, 2008, CAN J FOREST RES, V38, P1603, DOI 10.1139/X08-006; Roininen H, 1997, OIKOS, V80, P481, DOI 10.2307/3546621; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; NOEL ARA, 1970, BOT REV, V36, P162, DOI 10.1007/BF02858959; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Nakamura M, 2003, FUNCT ECOL, V17, P851, DOI 10.1111/j.1365-2435.2003.00786.x; Lind EM, 2012, ENVIRON ENTOMOL, V41, P1409, DOI 10.1603/EN12094; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331; Jordan MO, 1996, J EXP BOT, V47, P79, DOI 10.1093/jxb/47.1.79; den Herder M, 2009, ANN ZOOL FENN, V46, P63; Kersch-Becker MF, 2012, ECOLOGY, V93, P9, DOI 10.1890/11-0756.1; BRYANT JP, 1987, OECOLOGIA, V72, P510, DOI 10.1007/BF00378975; Orians CM, 2001, OIKOS, V94, P493, DOI 10.1034/j.1600-0706.2001.940311.x; Utsumi S, 2009, J ANIM ECOL, V78, P953, DOI 10.1111/j.1365-2656.2009.01570.x; AARSSEN LW, 1995, OIKOS, V74, P149, DOI 10.2307/3545684; Hiura T, 2013, BASIC APPL ECOL, V14, P480, DOI 10.1016/j.baae.2013.06.004; ELMQVIST T, 1987, ECOLOGY, V68, P1623, DOI 10.2307/1939854; WATERMAN PG, 1984, J CHEM ECOL, V10, P387, DOI 10.1007/BF00988087; WIGNALL TA, 1987, FORESTRY, V60, P45, DOI 10.1093/forestry/60.1.45; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; BROWN CL, 1967, AM J BOT, V54, P153, DOI 10.2307/2440793; ORIANS CM, 1995, J CHEM ECOL, V21, P1245, DOI 10.1007/BF02027559; GILL RMA, 1992, FORESTRY, V65, P363, DOI 10.1093/forestry/65.4.363-a; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Martinsen GD, 1998, ECOLOGY, V79, P192, DOI 10.2307/176874; Li CY, 2003, ANN BOT-LONDON, V92, P137, DOI 10.1093/aob.mcg108; LARSSON S, 1986, OIKOS, V47, P205, DOI 10.2307/3566047; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; DANELL K, 1985, OIKOS, V44, P75, DOI 10.2307/3544046; Bailey JK, 2006, ECOL ENTOMOL, V31, P294, DOI 10.1111/j.1365-2311.2006.00774.x; GANGE AC, 1989, OECOLOGIA, V81, P38, DOI 10.1007/BF00377007; WIGNALL TA, 1988, J EXP BOT, V39, P1667, DOI 10.1093/jxb/39.12.1667; Nakamura M, 2005, J ANIM ECOL, V74, P683, DOI 10.1111/j.1365-2656.2005.00960.x; Bezemer TM, 2003, OIKOS, V101, P555, DOI 10.1034/j.1600-0706.2003.12424.x; Meier AR, 2012, TREE PHYSIOL, V32, P565, DOI 10.1093/treephys/tps040; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Kaji K, 2006, CONSERVATION MANAGEM; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Nakamura M, 2006, OIKOS, V113, P259, DOI 10.1111/j.2006.0030-1299.14251.x	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0028-1042	1432-1904		SCI NAT-HEIDELBERG	Sci. Nat.	OCT	2015	102	9-10							46	10.1007/s00114-015-1296-1		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CT8EC	WOS:000363046800001		
J	Yamaguchi, N; Sekiguchi, T				Yamaguchi, Naofumi; Sekiguchi, Tomohiro			Effects of tsunami magnitude and terrestrial topography on sedimentary processes and distribution of tsunami deposits in flume experiments	SEDIMENTARY GEOLOGY			English	Article						Tsunami deposit; Flume experiment; Sediment transport; Coastal lowland	TOHOKU-OKI TSUNAMI; INDIAN-OCEAN-TSUNAMI; BRITISH-COLUMBIA; VANCOUVER-ISLAND; SUBDUCTION ZONE; SENDAI PLAIN; LAKE; JAPAN; FLOW; INUNDATION	To identify and interpret tsunami deposits correctly, a better understanding of the effects of both tsunami magnitude and topographic setting are required. In the present study, laboratory experiments were performed to model these effects on sedimentary processes and the distribution of tsunami deposits on coastal lowlands. The experiments directed tsunamis of eight different magnitudes on to three different models of terrestrial topography: one with flat topography, one with a shallow water-filled pool, and one with a deep water-filled pool. The results suggested a relationship between the distribution of tsunami deposits and the hydraulic condition of the tsunami flow onto the terrestrial topography. In particular, the tsunami deposits in the pools were spatially more variable than those on land because of the variation in flow intensity associated with transformation of the flow from supercritical to subcritical with a hydraulic jump. We observed a gap between the landward extent of deposits and the tsunami inundation distance, particularly in the experiments with a pool. The total amount of sediment in tsunami deposits on the terrestrial area was found to depend on the magnitude of the tsunami, but the thickness of the deposits at any one given spot did not always depend on the tsunami magnitude, even in the same topographic. These results show that terrestrial topography has significant effects on the spatial distribution of tsunami deposits that must be taken into consideration when interpreting the history and magnitude of paleotsunami events from tsunami deposits. (C) 2015 Elsevier B.V. All rights reserved.	[Yamaguchi, Naofumi] Ibaraki Univ, Ctr Water Environm Studies, Itako, Ibaraki 3112402, Japan; [Sekiguchi, Tomohiro] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki 3058577, Japan	Yamaguchi, N (reprint author), Ibaraki Univ, Ctr Water Environm Studies, Ohu 1375, Itako, Ibaraki 3112402, Japan.	naofumi.yamaguchi.sci@vc.ibaraki.ac.jp			Sasagawa Scientific Grant from the Japan Science Society	The authors thank Kazuhisa Goto (International Research Institute of Disaster Science, Tohoku University) and Kentaro Imai (Japan Agency for Marine-Earth Science and Technology) for valuable comments about the experimental design. The authors also thank anonymous reviewers and journal editor Jasper Knight for their helpful comments, which improved this paper. This work was partly supported by Sasagawa Scientific Grant from the Japan Science Society.	Sawai Y, 2002, J ASIAN EARTH SCI, V20, P903, DOI 10.1016/S1367-9120(01)00077-3; Matsutomi H, 2006, COAST ENG J, V48, P167, DOI 10.1142/S0578563406001350; Sugawara D, 2008, TSUNAMIITES: FEATURES AND IMPLICATIONS, P9, DOI 10.1016/B978-0-444-51552-0.00003-5; Gelfenbaum G, 2003, PURE APPL GEOPHYS, V160, P1969, DOI 10.1007/s00024-003-2416-y; Donato SV, 2009, MAR GEOL, V257, P54, DOI 10.1016/j.margeo.2008.10.012; Bondevik S, 1997, SEDIMENTOLOGY, V44, P1115, DOI 10.1046/j.1365-3091.1997.d01-63.x; Kobayashi N, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002084; Namegaya Y, 2014, GEOPHYS RES LETT, V41, P2297, DOI 10.1002/2013GL058678; Clague JJ, 1999, J COASTAL RES, V15, P45; Goto K, 2012, EARTH PLANETS SPACE, V64, P1247, DOI 10.5047/eps.2012.02.007; MINOURA K, 1991, J GEOL, V99, P265; Sawai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053692; Nanayama F, 2003, NATURE, V424, P660, DOI 10.1038/nature01864; Apotsos A, 2011, EARTH-SCI REV, V107, P1, DOI 10.1016/j.earscirev.2010.11.001; Hutchinson I, 1997, J COASTAL RES, V13, P545; Fujino S, 2008, TSUNAMIITES: FEATURES AND IMPLICATIONS, P123, DOI 10.1016/B978-0-444-51552-0.00008-4; Hutchinson I, 2000, HOLOCENE, V10, P429, DOI 10.1191/095968300666654539; Jaffe BE, 2007, SEDIMENT GEOL, V200, P347, DOI 10.1016/j.sedgeo.2007.01.013; MacInnes BT, 2009, GEOLOGY, V37, P995, DOI 10.1130/G30172A.1; Takashimizu Y, 2012, SEDIMENT GEOL, V282, P124, DOI 10.1016/j.sedgeo.2012.07.004; Lopez GI, 2012, NAT HAZARDS, V60, P43, DOI 10.1007/s11069-011-9952-z; Morton RA, 2011, SEDIMENT GEOL, V242, P34, DOI 10.1016/j.sedgeo.2011.09.004; Matsumoto D, 2010, SEDIMENT GEOL, V230, P95, DOI 10.1016/j.sedgeo.2010.06.021; Young YL, 2010, MAR GEOL, V269, P107, DOI 10.1016/j.margeo.2009.12.009; Tsujimoto G, 2008, INT OFFSHORE POLAR E, P523; Chen J, 2012, J COASTAL RES, V28, P1303, DOI 10.2112/JCOASTRES-D-11-00180.1; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Smith DE, 2007, SEDIMENT GEOL, V200, P362, DOI 10.1016/j.sedgeo.2007.01.014; Cheng W, 2013, EARTH PLANET SC LETT, V362, P305, DOI 10.1016/j.epsl.2012.12.004; Abe T, 2012, SEDIMENT GEOL, V282, P142, DOI 10.1016/j.sedgeo.2012.05.004; Kelsey HM, 2005, GEOL SOC AM BULL, V117, P1009, DOI 10.1130/B25452.1; Furusato E, 2014, MAR GEOL, V353, P128, DOI 10.1016/j.margeo.2014.04.006; Naruse H, 2012, SEDIMENT GEOL, V282, P199, DOI 10.1016/j.sedgeo.2012.08.012; Sawai Y, 2008, HOLOCENE, V18, P517, DOI 10.1177/0959683608089206; Chague-Goff C, 2012, SEDIMENT GEOL, V282, P65, DOI 10.1016/j.sedgeo.2012.05.021; Goto K, 2014, MAR GEOL, V358, P2, DOI 10.1016/j.margeo.2014.08.008; Goto K, 2014, MAR GEOL, V358, P38; Hasegawa F., 2001, P COASTAL ENG JSCE, V48, P311; Jaffe BE, 2006, EARTHQ SPECTRA, V22, pS105, DOI 10.1193/1.2207724; Shishikura M., 2012, INLAND LIMIT TSUNAMI, V12, P45; Sugawara D., 2004, GEOL SOC JPN MEM, V58, P153; Sugawara D, 2014, MAR GEOL, V358, P18, DOI 10.1016/j.margeo.2014.05.005	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0037-0738	1879-0968		SEDIMENT GEOL	Sediment. Geol.	OCT	2015	328						115	121		10.1016/j.sedgeo.2015.08.008		7	Geology	Geology	CT8QT	WOS:000363081800008		
J	Ge, N; Nakajima, S; Pantel, M				Ge, Ning; Nakajima, Shin; Pantel, Marc			Online diagnosis of accidental faults for real-time embedded systems using a hidden Markov model	SIMULATION-TRANSACTIONS OF THE SOCIETY FOR MODELING AND SIMULATION INTERNATIONAL			English	Article						Real-time embedded system; simulation; online diagnosis; accidental fault; hidden Markov model	ALGORITHM	This article proposes an approach for the online analysis of accidental faults for real-time embedded systems using hidden Markov models (HMMs). By introducing reasonable and appropriate abstraction of complex systems, HMMs are used to describe the healthy or faulty states of system's hardware components. They are parametrized to statistically simulate the real system's behavior. As it is not easy to obtain rich accidental fault data from a system, the Baum-Welch algorithm cannot be employed here to train the parameters in HMMs. Inspired by the principles of fault tree analysis and the maximum entropy in Bayesian probability theory, we propose to compute the failure propagation distribution to estimate the parameters in HMMs and to adapt the parameters using a backward algorithm. The parameterized HMMs are then used to online diagnose accidental faults using a vote algorithm integrated with a low-pass filter. We design a specific test bed to analyze the sensitivity, specificity, precision, accuracy and F1-score measures by generating a large amount of test cases. The test results show that the proposed approach is robust, efficient and accurate.	[Ge, Ning; Pantel, Marc] Univ Toulouse, IRIT, Toulouse, France; [Nakajima, Shin] Natl Inst Informat, Tokyo, Japan	Ge, N (reprint author), Univ Toulouse, IRIT, Toulouse, France.	ning.ge@enseeiht.fr			Japan NII Scholarship; French ministry of Industry; French ministry of Research	This work is supported by the Japan NII Scholarship and the French ministries of Industry and Research and the Midi-Pyrenees regional authorities through the ITEA2 OPEES project.	SMYTH P, 1994, PATTERN RECOGN, V27, P149, DOI 10.1016/0031-3203(94)90024-8; Tobon-Mejia DA, 2012, IEEE T RELIAB, V61, P491, DOI 10.1109/TR.2012.2194177; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Clarke EM, 2011, LECT NOTES COMPUT SC, V6996, P1, DOI 10.1007/978-3-642-24372-1_1; Madan BB, 2004, PERFORM EVALUATION, V56, P167, DOI 10.1016/j.peva.2003.07.008; Boutros T, 2011, MECH SYST SIGNAL PR, V25, P2102, DOI 10.1016/j.ymssp.2011.01.013; Isermann R, 1997, CONTROL ENG PRACT, V5, P709, DOI 10.1016/S0967-0661(97)00053-1; Ying J, 2000, IEEE T SYST MAN CY C, V30, P463, DOI 10.1109/5326.897073; Avizienis A, 2004, IEEE T DEPEND SECURE, V1, P11, DOI 10.1109/TDSC.2004.2; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Avizienis A, 2001, TECHNICAL REPORT SER; Baum L. E., 1972, INEQUALITIES, V3, P1; Elliott R. J., 1995, HIDDEN MARKOV MODELS; Ge N, P S THEOR MOD SIM DE, P16; Ge N, 4 IEEE INT C SOFTW E, P184; Gertler J., 1998, FAULT DETECTION DIAG; Hertz J., 1991, INTRO THEORY NEURAL, V1; Isermann R, 2005, ANNU REV CONTROL, V29, P71, DOI 10.1016/j.arcontrol.2004.12.002; Lee EA, 11 IEEE INT S OBJ OR, P363; Rabiner L. R., 1986, IEEE ASSP Magazine, V3, DOI 10.1109/MASSP.1986.1165342; ROSENBLATT M, 1956, P NATL ACAD SCI USA, V42, P43, DOI 10.1073/pnas.42.1.43; Silverman B, 1986, DENSITY ESTIMATION S, V26; Venkatsubramanian V, 2003, COMPUT CHEM ENG, V27, P293, DOI 10.1016/S0098-1354(02)00160-6	24	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0037-5497	1741-3133		SIMUL-T SOC MOD SIM	Simul.-Trans. Soc. Model. Simul. Int.	OCT	2015	91	10					851	868		10.1177/0037549715590598		18	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering	Computer Science	CU1XA	WOS:000363314400001		
J	Okamura, M; Bhandary, NP; Mori, S; Marasini, N; Hazarika, H				Okamura, Mitsu; Bhandary, Netra P.; Mori, Shinichiro; Marasini, Narayan; Hazarika, Hemanta			Report on a reconnaissance survey of damage in Kathmandu caused by the 2015 Gorkha Nepal earthquake	SOILS AND FOUNDATIONS			English	Article						Gorkha Nepal earthquake; Earthquake damage survey; Natural frequency; Liquefaction; Road embankment	GREAT EARTHQUAKES; 1905 KANGRA; HIMALAYA; REGION	Nepal was hit by the M7.8 Gorkha earthquake on April 25, 2015, which was the largest earthquake in Nepal's history since 1934. The recent report presented by the Government of Nepal indicates that the recorded death toll has reached about 8800. Following the earthquake, the Japanese Geotechnical Society (JGS), Asian Technical Committee of ISSMGE on Geotechnical Natural Hazards (ATC3), Japan Society of Civil Engineers (JSCE) and Japan Association for Earthquake Engineering (JAEE) decided to jointly dispatch a survey team to Nepal to conduct a reconnaissance survey of the major damage caused by the earthquake. This report summarizes the results of the survey of the geotechnical and structural damage in the Kathmandu valley, which were observed by the survey sub-team between May 1 and 8, 2015. Geotechnical and geological characteristics of a deep soil profile up to 600 m and a shallow profile up to 30 m are also described with the help of the database system established by Bhandary et al. (2012). In order to study the correlation between building damage ratios and the predominant period of ground vibration, a partial exhaustive type survey was conducted along NS line where microtremor measurements had been previously conducted in 2008. The predominant period of ground vibration was short at the ridge of the valley and long at its center, ranging from 1.2 to 4.5 s. A total of 532 buildings were assessed and more than 90% were classified as "No damage" or "Negligible to slight Damage" (Grade 0 and Grade 1), whereas only 5% of buildings were assessed as "Substantial to heavy damage" to "Destruction" (Grade 3 to Grade 5). Five locations were identified where the soil had liquefied. Liquefaction-induced damage to structures at these locations was not found, except at Nepal Engineering College where minor settlement of the college building was observed. During the 1934 earthquake, foundation liquefaction was observed in Tundhikhel area, but in the 2015 earthquake no evidence of liquefaction was detected in this area. The Kathmandu-Bhaktapur Road of Araniko Highway was heavily damaged in the Lokanthali area. The subsidence of soft soils and their lateral spreading in this area may have exacerbated the damage to this road. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Okamura, Mitsu; Bhandary, Netra P.; Mori, Shinichiro; Marasini, Narayan] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 790, Japan; [Hazarika, Hemanta] Kyushu Univ, Fac Engn, Fukuoka 812, Japan	Okamura, M (reprint author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 790, Japan.	okamura@cee.ehime-u.ac.jp; netra@ehime-u.ac.jp; mori@ehime-u.ac.jp; narayanmarasini@gmail.com; hazarika@civil.kyushu-u.ac.jp					Hough SE, 2008, J EARTH SYST SCI, V117, P773; CHANDER R, 1988, TECTONOPHYSICS, V149, P289, DOI 10.1016/0040-1951(88)90179-5; PANDEY MR, 1995, GEOPHYS RES LETT, V22, P751, DOI 10.1029/94GL02971; Ambraseys NN, 2004, GEOPHYS J INT, V159, P165, DOI 10.1111/j.1365-246X.2004.02323.x; MOLNAR P, 1989, P INDIAN AS-EARTH, V98, P61; Bettinelli P, 2006, J GEODESY, V80, P567, DOI 10.1007/s00190-006-0030-3; CHANDER R, 1989, TECTONOPHYSICS, V170, P115, DOI 10.1016/0040-1951(89)90106-6; Banerjee P., 2002, GEOPHYS RES LETT, V29, P3; Bhandary N.P., 2012, P AWAM INT C CIV ENG, P860; Bilham R., 2008, AM I PHYS C P, P224; Bilham R, 1995, J NEPAL GEOL SOC, V11, P73; Dunn JA, 1939, MEM GEOL SURV INDIA, V73, P391; GoN, 1994, NEP NAT BUILD COD NB; GoN, 2015, NEP DIS RISK RED POR; Grunthal G., 1998, EUR MACR SCAL 1998 E; JICA, 2002, STUD EARTHQ DIS MIT, VII; JICA, 2002, STUD EARTHQ DIS MIT, VIII; JICA (Japan International cooperation Agency), 2002, STUD EARTHQ DIS MIT, VIV; JICA Japan International Cooperation Agency, 2002, STUD EARTHQ DIS MIT, V1; JICA (Japan International cooperation Agency), 2007, PLANN IMPR KATHM BHA; KHATTRI KN, 1987, TECTONOPHYSICS, V138, P79, DOI 10.1016/0040-1951(87)90067-9; KHATTRI KN, 1992, CURR SCI INDIA, V62, P109; Kukidome T., 2009, P 44 ANN C JAP GEOT, P1543; MoHA DPNet Nepal UNDP Oxfam, 2009, NEP DIS REP HAZ VULN, P116; Molnar P., 1990, HIMAL GEOL, V1, P131; NSET GHI, 1999, NAT SOC EARTHQ TECHN; Pandey M.R., 1988, J NEPAL GEOL SOC, V5, P22; Rana BJB, 1935, NEPAL KO MAHA BHUKAM; Sakai H., 2001, J NEPAL GEOLOGICAL S, V25, P19; Seeber L., 1981, Zagros - Hindu Kush - Himalaya - Geodynamic evolution; Seeber L., 1981, M EWING SERIES, V4, P259, DOI DOI 10.1029/ME004P0259; UNDP/HMG/UNCHS (Habitt), 1994, SEISM HAZ MAPP RISK; USGS, 2011, MAGN 6 9 IND NEP BOR	33	1	1	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1015	1029		10.1016/j.sandf.2015.09.005		15	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500009		
J	Chiaro, G; Kiyota, T; Pokhrel, RM; Goda, K; Katagiri, T; Sharma, K				Chiaro, Gabriele; Kiyota, Takashi; Pokhrel, Rama Mohan; Goda, Katsuichiro; Katagiri, Toshihiko; Sharma, Keshab			Reconnaissance report on geotechnical and structural damage caused by the 2015 Gorkha Earthquake, Nepal	SOILS AND FOUNDATIONS			English	Article						2015 Gorkha Nepal earthquake; Earthquake damage survey; Liquefaction; Embankment; Historical monuments; Masonry structures; Landslide		On 25 April 2015, a moment magnitude (M-w) 7.8 earthquake struck the Gorkha District of Nepal. Two major aftershocks (M-w 6.6 and M-w 6.7) followed the mainshock contributing to devastation in many villages in mountainous areas north of Kathmandu. This report summarizes geotechnical and structural damage features caused by the earthquake, which were observed during a field investigation conducted by a survey team dispatched by the Japan Geotechnical Society (JGS), the Asian Technical Committee of ISSMGE on Geotechnical Natural Hazards (ATC3) and the Japan Society of Civil Engineers (JSCE). The post-earthquake damage survey was conducted in Kathmandu, Trishuli, Melamchi, Baluwa (epicentral area) and Pokhara from 1 to 6 May 2015. A significant damage to the historical architectures in the Durbar Square of Downtown Kathmandu was observed, while the damage to masonry structures in the surrounding area was limited. In mountainous areas including epicentral area, non-engineered masonry structures were severely damaged, and traces of medium to large scale landslides and rock falls were frequently observed. Dam embankment in Trishuli suffered from cracking at the reservoir side along its entire length. Such damages to the structures and slopes are posing risks of secondary disasters to the local residents. Based on the field survey, recommendations related to immediate policy following the earthquake and addressed to policy makers are made in the conclusion. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Chiaro, Gabriele] Univ Canterbury, Dept Civil & Nat Resources Engn, Christchurch 8140, New Zealand; [Kiyota, Takashi; Pokhrel, Rama Mohan; Katagiri, Toshihiko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538585, Japan; [Goda, Katsuichiro] Univ Bristol, Dept Civil Engn, Bristol BS8 1TR, Avon, England; [Sharma, Keshab] Univ Alberta, Dept Civil & Environm Engn, NREF, Edmonton, AB T6G 2W2, Canada; [Chiaro, Gabriele] Univ Tokyo, Inst Ind Sci, Tokyo 1538585, Japan	Kiyota, T (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538585, Japan.	gabriele.chiaro@canterbury.ac.nz; kiyota@iis.u-tokyo.ac.jp; pokhrel@iis.u-tokyo.ac.jp; Katsu.Goda@bristol.ac.uk; toshi@iis.u-tokyo.ac.jp; keshab@ualberta.ca		Chiaro, Gabriele/0000-0001-7328-2932	JSPS [15H02631]; Engineering and Physical Sciences Research Council [EP/M001067/1]	The authors thank Mr. Pradeep Pokhrel for his great assistance during the field survey. Financial support by the JSPS KAKENHI Grant number 15H02631 is greatly acknowledged. Katsuichiro Goda was funded by the Engineering and Physical Sciences Research Council (EP/M001067/1).	Sakai H, 2002, J ASIAN EARTH SCI, V20, P267, DOI 10.1016/S1367-9120(01)00046-3; Ambraseys NN, 2004, GEOPHYS J INT, V159, P165, DOI 10.1111/j.1365-246X.2004.02323.x; Avouac JP, 2003, ADV GEOPHYS, V46, P1, DOI 10.1016/S0065-2687(03)46001-9; Ader T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009071; Sapkota SN, 2013, NAT GEOSCI, V6, P71, DOI [10.1038/ngeo1669, 10.1038/NGEO1669]; Chaulagain H, 2015, STRUCT ENG MECH, V53, P791; Goda K., 2015, FRONT BUILT ENV, V1, P1; JICA Japan International Cooperation Agency, 2002, STUD EARTHQ DIS MIT, V1; NAKATA T., 2002, ACTIVE FAULT RES, V22, P7; Okamura M, 2015, SOILS FOUND, V55, P1015, DOI 10.1016/j.sandf.2015.09.005; Pokhrel R.M., 2015, P INT C GEOT ENG AUG, P109	11	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1030	1043		10.1016/j.sandf.2015.09.006		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500010		
J	Nguyen, HS; Tashiro, M; Inagaki, M; Yamada, S; Noda, T				Nguyen, Hong-Son; Tashiro, Mutsumi; Inagaki, Motohiro; Yamada, Shotaro; Noda, Toshihiro			Simulation and evaluation of improvement effects by vertical drains/vacuum consolidation on peat ground under embankment loading based on a macro-element method with water absorption and discharge functions	SOILS AND FOUNDATIONS			English	Article						Peat; Embankment loading; Vertical drain; Vacuum consolidation; Soil water coupled analysis; Macro-element method	VACUUM CONSOLIDATION; RESIDUAL SETTLEMENT; DEFORMATION; SOIL; FAILURE; DRAIN	The authors previously extended the macro-element method proposed by Sekiguchi to include water absorption and discharge functions and incorporated this into a soil water coupled finite deformation analysis code capable of accounting for inertial forces. The primary objective of this study is to validate the ability of the proposed method to simulate actual ground behavior by comparing the simulation results with the actual measurements of the embankment loading of a soft peat ground improved with vertical drains and vacuum consolidation. It was found that the proposed method is capable of comprehensively and closely simulating not only the magnitude of settlement, but also various ground behaviors, including the deformation of the surrounding ground and pore water pressure distributions. Furthermore, additional simulations were performed to elucidate the effect of a continuous middle sand layer found to exist and to span the entire improved area at an actual embankment site. The next objective of this study is to investigate the impact of ground improvement, using vertical drains and vacuum consolidation with embankment loading on a soft ground, placing a particular focus on the effect of drain spacing. In this case, an ultra-soft ground with alternating peat and clay layers was modeled to represent a typical ground to which vacuum consolidation would be applied. Based on a series of simulations, it was found that, although the use of vacuum consolidation in combination with vertical drains is effective in cases where it is necessary to limit the deformation of the surrounding ground, the same reduction in residual settlement can be achieved using vertical drains alone, provided that the drains are deployed at a sufficient frequency. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Nguyen, Hong-Son; Noda, Toshihiro] Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tashiro, Mutsumi; Yamada, Shotaro] Nagoya Univ, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Inagaki, Motohiro] Cent Nippon Expressway Co Ltd, Tsuruga Construct Off, Nagoya, Aichi, Japan	Nguyen, HS (reprint author), Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hongsondc3005@gmail.com					Asaoka A, 2002, SOILS FOUND, V42, P47; Indraratna B, 2005, CAN GEOTECH J, V42, P994, DOI 10.1139/T05-029; Chai JC, 2008, GEOTEXT GEOMEMBRANES, V26, P220, DOI 10.1016/j.geotexmem.2007.10.004; Takaine T, 2010, SOILS FOUND, V50, P245, DOI 10.3208/sandf.50.245; Tashiro M, 2011, SOILS FOUND, V51, P133, DOI 10.3208/sandf.51.133; Chai JC, 2006, CAN GEOTECH J, V43, P985, DOI 10.1139/T06-056; Chai JC, 2005, J GEOTECH GEOENVIRON, V131, P1552, DOI 10.1061/(ASCE)1090-0241(2005)131:12(1552); Saowapakpiboon J, 2011, GEOTEXT GEOMEMBRANES, V29, P74, DOI 10.1016/j.geotexmem.2010.06.008; Noda T, 2008, SOILS FOUND, V48, P771, DOI 10.3208/sandf.48.771; Noda T, 2005, SOILS FOUND, V45, P39; Indraratna B, 2004, CAN GEOTECH J, V41, P1098, DOI 10.1139/T04-054; Tashiro M, 2015, SOILS FOUND, V55, P343, DOI 10.1016/j.sandf.2015.02.010; Rujikiatkamjorn C, 2007, CAN GEOTECH J, V44, P326, DOI 10.1139/T06-124; BARRON RA, 1948, T AM SOC CIV ENG, V113, P718; Ariyarathna P.R.C., 2010, ANN T IESL, P27; Asaoka A., 1995, SOILS FOUND, V35, P43; Asaoka A., 2007, P INT WORKSH CONST M, P11; Association of vacuum consolidation technology, 2013, TECHN MAT KOUSH N H; Bergman David, 1998, PUBLIC SEX GAY SPACE, P95; Cognon J.M., 1994, ASCE SPECIAL PUBLICA, V40, P1237; Karunawardena A., 2013, P 18 INT C SOIL MECH, P2949; Kosaka T., 2011, P INT C GEOT SUST DE, P65; Mersi G., 2012, J GEOTECH GEOENVIRON, V138, P680; Nakano M., 2010, GEOTECHNICAL SPECIAL, V201, P139; Noda T., 2008, THEOR APPL MECH JPN, V57, P41; Noda T., 2015, SOILS FOUND, V55, P1130; Osorio J.P., 2010, P JOINT S BRIDG INFR, P255; Sekiguchi H., 1986, P 31 S JSSMFE, P111; Taylor D. W., 1948, FUNDAMENTALS SOIL ME; Yamada S., 2013, P 18 INT C SOIL MECH, P841; Yamada S, 2015, SOILS FOUND, V55, P1113, DOI 10.1016/j.sandf.2015.09.012	31	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1044	1057		10.1016/j.sandf.2015.09.007		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500011		
J	Sakai, T; Nakano, M				Sakai, Takayuki; Nakano, Masaki			Interpretation of the mechanical behavior of embankments having various compaction properties based on the soil skeleton structure	SOILS AND FOUNDATIONS			English	Article						Compaction; Embankment; FEM analysis; Soil water coupled analysis; Soil skeleton structure; Triaxial test	CAM-CLAY MODEL; CRITICAL-STATE; SUBLOADING SURFACE; EQUATION; SHEAR	After the Hanshin Awaji Earthquake disaster, the seismic resistance of embankments was evaluated, and design principles were changed from specification-based to performance-based. However, compaction properties and the mechanical behavior of compacted soil were not sufficiently considered in the Manual of Highway Earthworks on Embankments. The first objective of the present study is to reproduce the mechanical behavior of three embankment materials having different compaction properties. A series of triaxial compression tests and oedometer tests is carried out. The mechanical behavior is reproduced by the SYS Cam-clay model and the influence of compaction on the mechanical behavior is interpreted based on the soil skeleton structure. The second objective is to evaluate the seismic stability of the embankment, which depends on the compaction properties of the embankment material, using GEOASIA, a soil water coupled finite deformation analysis code. The primary conclusions are as follows. (1) Through the triaxial tests, the maximum deviator stress increases as the degree of compaction, Dc, increases. However, the trends in the increase differ depending on the material. (2) Based on one-dimensional consolidation tests, the compression curve is approximately a straight line with a large vertical effective stress. In the present study, a greater maximum dry density corresponds to less compressibility and a lower compression curve. (3) The mechanical behavior of each material is reproduced by the SYS Camclay model using one set of material constants for each material and representing the differences in Dc by different initial conditions for the structure and overconsolidation. An increase in Dc causes the decay of the structure, as well as the accumulation of overconsolidation. In the case of material A, the decay of the structure and the loss of overconsolidation occur quickly, whereas in the case of material C, the decay of the structure is slight and the loss of overconsolidation is moderate. (4) The seismic response analysis reveals different deformations of the embankment for different materials, even for the same Dc. The seismic stability of the embankments was increased by increasing Dc. Materials, such as material A, that have fast decay of the structure and fast loss of overconsolidation produce embankments with high seismic stability. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Sakai, Takayuki] Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nakano, Masaki] Nagoya Univ, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Sakai, T (reprint author), Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	t-sakai@civil.nagoya-u.ac.jp; nakano@civil.nagoya-u.ac.jp					Toll DG, 2003, GEOTECHNIQUE, V53, P93, DOI 10.1680/geot.53.1.93.37255; Maatouk A, 1995, GEOTECHNIQUE, V45, P465; Asaoka A, 2002, SOILS FOUND, V42, P47; Wheeler SJ, 2000, GEOTECHNIQUE, V50, P369; Alonso EE, 2013, GEOTECHNIQUE, V63, P463, DOI [10.1680/geot.11.P134, 10.1680/geot.11.P.134]; Hashiguchi K, 1998, INT J NUMER ANAL MET, V22, P197, DOI 10.1002/(SICI)1096-9853(199803)22:3<197::AID-NAG914>3.3.CO;2-K; Wheeler SJ, 1995, GEOTECHNIQUE, V45, P35; JOYNER WB, 1975, B SEISMOL SOC AM, V65, P1315; Noda T, 2008, SOILS FOUND, V48, P771, DOI 10.3208/sandf.48.771; HASHIGUCHI K, 1989, INT J SOLIDS STRUCT, V25, P917, DOI 10.1016/0020-7683(89)90038-3; Nakano M, 2005, SOILS FOUND, V45, P141; ESCARIO V, 1986, GEOTECHNIQUE, V36, P453; Noda T, 2009, SOILS FOUND, V49, P739, DOI 10.3208/sandf.49.739; Asaoka A., 2000, SOILS FOUND, V40, P99; Asaoka A, 1998, P 4 EUR C NUM METH G, V98, P232; Asaoka A., 1997, SOILS FOUND, V37, P13; Asaoka A., 2007, P INT WORKSH CONST M, P11; Cokca E., 2004, GEOTECHNICAL GEOLOGI, V22, P285, DOI DOI 10.1023/B:GEGE.0000018349.40866.3E; Green AE, 1965, ARCH RATION MECH AN, V18, P251, DOI DOI 10.1007/BF00251666; Hashiguchi K., 1978, P US JAP SEM CONT ME, P321; Heitor A., 2013, P 18 INT C SOIL MECH, P1007; Japan Road Association, 2010, MAN HIGHW EARTHW EMB; Japan Road Association, 2012, ACC WAV US DYN AN AS; Kong L.W., 2000, P AS C UNS SOILS SIN, P515; Kuno G., 1974, TSUCHI TO KISO, V22, P5; Mikuni E., 1963, SOILS FOUND, V3, P3; Nakamura H., 2012, P 47 JAP NAT C GEOT, P1005; Proctor R.R., 1933, ENG NEWS-REC, V111, P348; Sekiguchi H., 1977, P 9 ICSMFE SPEC SESS, P229; Shima H., 1980, TSUCHI TO KISO, V28, P4; Zhou A., 2014, COMPUT GEOTECH, V63, P46	31	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1069	1085		10.1016/j.sandf.2015.09.009		17	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500013		
J	Uchimura, T; Towhata, I; Wang, L; Nishie, S; Yamaguchi, H; Seko, I; Qiao, J				Uchimura, Taro; Towhata, Ikuo; Wang, Lin; Nishie, Shunsaku; Yamaguchi, Hiroshi; Seko, Ichiro; Qiao, Jianping			Precaution and early warning of surface failure of slopes using tilt sensors	SOILS AND FOUNDATIONS			English	Article						Slope failure; Monitoring; Early warning; Tilt angle; Sensor network	LANDSLIDE; RAINFALL	A simple monitoring method for the early warning of rainfall-induced landslides is proposed. Tilting angles in the surface layer of the slope are mainly monitored in this method. In the first stage of this study with a scaled model slope, distinct behaviors were observed in the tilt angles monitored on the surface of the slope prior to failure. Hence, a set of equipment has been developed for practical use, which is equipped with a Micro Electro Mechanical Systems (MEMS) tilt sensor and a volumetric water content sensor. An optional arrangement of tilt sensors has also been developed in order to investigate the deformation of the deeper layers. These sets of equipment have been deployed at several slope sites in Japan and China, and their performances have been recorded. Slope failure tests were also conducted on a natural slope by applying artificial heavy rainfall. The developed system detected distinct behaviors in the tilting angles at these sites in the pre-failure stages. Considering the behaviors of tilting monitored on the surfaces of these slopes, it is proposed that a precaution be issued at a tilting rate of 0.01 degrees per hour and a warning be issued at a tilting rate of 0.1 degrees per hour, to be on the conservative side. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Uchimura, Taro; Towhata, Ikuo] Univ Tokyo, Dept Civil Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Wang, Lin; Nishie, Shunsaku; Yamaguchi, Hiroshi; Seko, Ichiro] Chuo Kaihatsu Corp, Tokyo, Japan; [Qiao, Jianping] Inst Mt Hazards & Environm, Chengdu, Peoples R China	Uchimura, T (reprint author), Univ Tokyo, Dept Civil Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.				Japan Society for the Promotion of Science (JSPS); Ministry of Land, Infrastructure, Transport and Tourism of Japan; International Cooperate Project of the Chinese Ministry of Science and Technology [07 (2007DFA21150), 09(2009M-1320190)]	This research was supported by Grants-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS), Core-to-Core Program "B. Asia-Africa Science Platforms" (JSPS), Construction Technology Research and Development Subsidy Program of the Ministry of Land, Infrastructure, Transport and Tourism of Japan, and the International Cooperate Project of the Chinese Ministry of Science and Technology (07 (2007DFA21150) and 09(2009M-1320190)). The slope model tests were conducted with the cooperation of Dr. K. Furumoto, Dr. H. Mori, and Ms. Y. Saito of the Public Works Research Institute, Tsukuba, Japan.	KEEFER DK, 1987, SCIENCE, V238, P921, DOI 10.1126/science.238.4829.921; Ochiai H, 2004, LANDSLIDES, V1, P211, DOI 10.1007/s10346-004-0030-4; [Anonymous], 2003, 14332003 JGS; Yin YP, 2010, LANDSLIDES, V7, P359, DOI 10.1007/s10346-010-0225-9; Orense R, 2004, SOILS FOUND, V44, P15; [Anonymous], 1995, P 8 ISRM C TOK SEPT; Uchimura T, 2010, LANDSLIDES, V7, P351, DOI 10.1007/s10346-009-0178-z; Casagli N, 2010, LANDSLIDES, V7, P291, DOI 10.1007/s10346-010-0215-y; Osanai N, 2010, LANDSLIDES, V7, P325, DOI 10.1007/s10346-010-0229-5; Azzam R., 2011, P 5 INT C EARTHQ GEO; Baum L.B., 2010, LANDSLIDES, V7, P259, DOI [10.1007/s10346-009-0177-0., DOI 10.1007/S10346-009-0177-0]; Fukuzono T., 1985, P 4 INT C FIELD WORK, P145, DOI DOI 10.1016/0148-9062(87)91524-5; Ishihara Y., 1979, B DISASTER PREVENTIO, V29, P27; Maruyama K., 1994, J JAPAN LANDSLIDE SO, V31; Nishiyama S., 2012, P INT WORKSH ICT GEO, P251; Okada K., 2001, SOIL WATER INDEX SOK; Orense R.P., 2003, P INT C FAST SLOP MO; Osanai N., 2009, 530 NAT I LAND INFR; Saito M, 1965, P 6 ICSMFE, V2, P537; Saito M., 1987, J JAPAN LANDSLIDE SO, V24, P30; Sawada M., 2012, P INT WORKSH ICT GEO, P89; Uchimura T, 2009, P 17 ISSMGE AL, V3, P1897; Uchimura T., 2011, INTERPRETATION MONIT, P807; Uchimura T., 2011, P 14 AS REG C SOIL M; Wang L., 2012, P INT WORKSH ICT GEO, P267	25	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1086	1099		10.1016/j.sandf.2015.09.010		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500014		
J	Yamada, S; Noda, T; Tashiro, M; Nguyen, HS				Yamada, Shotaro; Noda, Toshihiro; Tashiro, Mutsumi; Nguyen, Hong-Son			Macro-element method with water absorption and discharge functions for vertical drains	SOILS AND FOUNDATIONS			English	Article						Macro-element method; Vertical drain method; Vacuum consolidation method; Well resistance; Soil water coupled analysis; Finite element method; Finite deformation theory; Elasto-plasticity; Multilayered ground	SUBLOADING SURFACE; SOILS; EMBANKMENTS	When simulating the vertical drain method using a soil water coupled finite element analysis, a macro-element method can be used as a means of approximately applying the water absorption function of drains to individual elements. In this paper, the discharge function of vertical drains was added to the method by treating the water pressure in the drain as an unknown and adding a continuity equation for the drains to the governing equations. By extending the method in this way, the analytical results came to exhibit the well-resistance phenomenon automatically, depending on the analytical conditions. Numerical analyses were conducted after incorporating the proposed macro-element method into a quasistatic soil water coupled elasto-plastic finite element method based on the finite deformation theory. The main conclusions are as follows: (1) the proposed method enables highly accurate approximations for problems involving material and/or geometrical nonlinearity and multilayered grounds; (2) the proposed macro-element method is capable of reproducing various phenomena that occur when the vacuum consolidation method is applied to a clayey ground containing a middle sand layer; (3) by following the formulation used in this paper, it is unnecessary to match the mesh division width to the drain arrangement and spacing. In addition, it is possible to obtain solutions that are minimally affected by the mesh size. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Yamada, Shotaro; Tashiro, Mutsumi; Nguyen, Hong-Son] Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan; [Noda, Toshihiro] Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan	Yamada, S (reprint author), Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan.	s-yamada@civil.nagoya-u.ac.jp					Aasoka A., 1995, SOILS FOUND, V35, P43; Akai K., 1978, P JSCE, V269, P95; Chai JC, 2001, J GEOTECH GEOENVIRON, V127, P965, DOI 10.1061/(ASCE)1090-0241(2001)127:11(965); Asaoka A, 2002, SOILS FOUND, V42, P47; Hashiguchi K, 1998, INT J NUMER ANAL MET, V22, P197, DOI 10.1002/(SICI)1096-9853(199803)22:3<197::AID-NAG914>3.3.CO;2-K; Noda T, 2005, SOILS FOUND, V45, P51; HASHIGUCHI K, 1989, INT J SOLIDS STRUCT, V25, P917, DOI 10.1016/0020-7683(89)90038-3; Borges JL, 2004, COMPUT GEOTECH, V31, P665, DOI 10.1016/j.compgeo.2004.11.001; Indraratna B, 2004, CAN GEOTECH J, V41, P1098, DOI 10.1139/T04-054; HIRD CC, 1992, GEOTECHNIQUE, V42, P499; Arai A., 2008, P 43 ANN C JSCE 2, P889; Asaoka A., 2000, SOILS FOUND, V40, P99; Asaoka A., 1994, SOILS FOUND, V34, P91; Asaoka A, 1997, SOILS FOUND, V37, P29; Asaoka A., 1997, SOILS FOUND, V37, P13; Asaoka A., 1998, P 4 EUR C NUM METH G, P233; Barron, 1948, T ASCE, V113, P718; Chai J.C., 2013, GROUND IMPROV, V166, P65; Christian J.T., 1970, J SOIL MECH FOUND DI, V96, P1435; Hansbo S, 1979, GROUND ENG, V2, P16; Hashiguchi K., 1978, P US JAP SEM CONT ME, P321; Hirata M., 2010, J APPL MECH, V13, P431; Roscoe K. H., 1968, ENG PLASTICITY, P535; Sekiguchi H., 1988, BEHAV SEAWALL BRIDGE, P123; Sekiguchi H., 1986, P 31 S JSSMFE, P111; Sekiguchi H., 1977, P 9 ICSMFE SPEC SESS, P229; Shinsha H., 1982, JAPANESE SOC SOIL ME, V30, P7; Takeyama T., 2008, P 43 ANN C JSCE 1, P887; Yoshikuni H, 1979, THESIS; Yoshikuni H, 1974, SOILS FOUND, V14, P35, DOI DOI 10.3208/SANDF1972.14.2_35	30	2	2	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1113	1128		10.1016/j.sandf.2015.09.012		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500016		
J	Noda, T; Yamada, S; Nonaka, T; Tashiro, M				Noda, Toshihiro; Yamada, Shotaro; Nonaka, Toshihiro; Tashiro, Mutsumi			Study on the pore water pressure dissipation method as a liquefaction countermeasure using soil water coupled finite deformation analysis equipped with a macro-element method	SOILS AND FOUNDATIONS			English	Article						Pore water pressure dissipation method; Liquefaction countermeasure; Soil water coupled analysis; Macro-element method	BEHAVIOR	A numerical simulation of the pore water pressure dissipation method was performed using the GEOASIA soil water coupled finite deformation analysis code, which is capable of accounting for inertial forces, together with the elasto-plastic constitutive SYS Cam-clay model based on the soil skeleton structure concept, with the goal of quantitatively assessing the effects of this method as a countermeasure to liquefaction. At the same time, an effort was made to improve/enhance the calculation efficiency of the GEOASIA analysis code by incorporating a macro-element method, which up to this point has only been applied to consolidation problems. The main findings of this study are as follows: (1) the macro-element method is capable of yielding highly accurate approximations even for dynamic problems, (2) the method is capable of reproducing the suppression effect of the increase in pore water pressure associated with the pore water pressure dissipation method, even when a relatively coarse mesh is used, (3) the method is capable of reproducing the suppression effect of the decrease in effective stress due to the pore water pressure dissipation method, along with the resulting reduction in shear stiffness, lateral ground movement, and settlement and (4) it is possible to efficiently design the pore water pressure dissipation method with this method by first performing calculations using a 1-D mesh to determine the effective drain spacing prior to performing calculations using 2-D or 3-D meshes. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Noda, Toshihiro; Nonaka, Toshihiro] Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan; [Yamada, Shotaro; Tashiro, Mutsumi] Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan	Noda, T (reprint author), Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan.	noda@nagoya-u.jp			JSPS [21226012, 25249064]	This paper reports on research carried out by the Technical Committee for the Mechanisms of Earthquake-Induced Ground Deformations (Chairman Akira Asaoka), a committee for seismic response research operating under the Japanese Geotechnical Society. In addition, this work was supported by JSPS KAKENHI Grant numbers 21226012 and 25249064.	Asaoka A, 2002, SOILS FOUND, V42, P47; Takaine T, 2010, SOILS FOUND, V50, P245, DOI 10.3208/sandf.50.245; Noda T, 2005, SOILS FOUND, V45, P51; Noda T, 2009, SOILS FOUND, V49, P739, DOI 10.3208/sandf.49.739; Lysmer J., 1969, ASCE J ENG MECH DIV, V95, P859; Noda T., 2008, SOILS FOUND, V45, P771; Sekiguchi H., 1988, ANN DISAS PREV RES I, V32, P123; Sekiguchi H., P 31 S JGS 1986, P111; Tanaka Y., 1984, P JSCE, V352, p[89, 98]; Unno T., 2012, P JSCE B, V68, pI_480; Yamada S, 2015, SOILS FOUND, V55, P1113, DOI 10.1016/j.sandf.2015.09.012	11	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1129	1138		10.1016/j.sandf.2015.09.013		10	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500017		
J	Ahmed, A; Soliman, AM; El Naggar, MH; Kamei, T				Ahmed, Aly; Soliman, Ahmed M.; El Naggar, M. Hesham; Kamei, Takeshi			An assessment of geo-environmental properties for utilization of recycled gypsum in earthwork projects	SOILS AND FOUNDATIONS			English	Article						Geo-environment; Gypsum wastes; Earthworks; Stabilization; Soft clay soil	SOFT CLAY; BASSANITE; DURABILITY; ETTRINGITE; STRENGTH; SYSTEM	This paper presents an assessment of geo-environmental properties for the incorporation of recycled gypsum, produced from gypsum waste, as an additive material in earthwork projects. In this study, the solubility of Fluorine, Boron and hexavalent Chromium and the emission of hydrogen sulfide gas refer to geo-environmental properties. To achieve this objective, the tested soil was mixed with recycled gypsum in conjunction with lime and cement in different proportions to overcome the solubility of gypsum and to reduce the solubility of harmful substances. The results of the study show that the utilization of recycled gypsum alone, as an additive material for earthwork projects, has a negative effect on the emission of hydrogen sulfide, while the addition of a solidification agent, such as cement or lime, to the recycled gypsum reduced the emission of hydrogen sulfide gas. The suggested contents and ratios for the gypsum cement and gypsum lime admixtures used in this study are safe against the emission of hydrogen sulfide because their measurements were found to be below the standard limits. Increasing the proportion of cement or lime in a gypsum soil mixture has a significant effect on the reduction in Fluorine solubility. The content of the admixture has a significant effect on the reduction in Fluorine solubility in the case of gypsum cement, while there is not much difference in the measured values of Fluorine in the gypsum lime admixture. The intensity of ettringite increases with the increase in admixture content and the decrease in the admixture ratio, while the intensity of calcite increases with increases in both the content and the ratio of the admixture. The formation of ettringite has a significant effect on the capture of Fluorine, namely, the solubility of Fluorine decreases with the increase in ettringite intensity. The measured values for the solubility of harmful substances, including Fluorine, Boron and hexavalent Chromium and the emission of hydrogen sulfide gas, were found to lie within the standards for the investigated limits of the gypsum soil mixture treated with cement or lime in the present study. This proves that the utilization of recycled gypsum in conjunction with cement or lime, as a stabilizer material and within the investigated limits, is safe and meets the environmental standards. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Ahmed, Aly; Soliman, Ahmed M.; El Naggar, M. Hesham] Univ Western Ontario, Dept Civil & Environm Engn, London, ON, Canada; [Kamei, Takeshi] Miyazaki Univ, Dept Civil & Environm Engn, Miyazaki, Japan; [Ahmed, Aly] Beni Suef Univ, Dept Civil Engn, Bani Suwayf, Egypt; [Soliman, Ahmed M.] Ain Shams Univ, Dept Civil Engn, Cairo, Egypt	Ahmed, A (reprint author), Univ Western Ontario, Dept Civil & Environm Engn, London, ON, Canada.	aly_76@hotmail.com					Ahmed A., 2014, J SOILS FDN, V54, P405; Ahmed A., 2011, GEOTECHNICAL SPECIAL, V217, P9; Ahmed A., 2010, P 6 INT C ENV GEOT 2, V2, P1469; DAMIDOT D, 1992, CEMENT CONCRETE RES, V22, P1179, DOI 10.1016/0008-8846(92)90047-Y; Ahmed A, 2011, COLD REG SCI TECHNOL, V66, P84, DOI 10.1016/j.coldregions.2010.12.004; Kamei T, 2013, SOILS FOUND, V53, P155, DOI 10.1016/j.sandf.2012.12.011; Ahmed A, 2011, SOILS FOUND, V51, P975, DOI 10.3208/sandf.51.975; Chrysochoou M, 2006, J HAZARD MATER, V136, P20, DOI 10.1016/j.jhazmat.2005.11.008; Kamei T, 2012, COLD REG SCI TECHNOL, V82, P124, DOI 10.1016/j.coldregions.2012.05.016; SOLEMTISHMACK JK, 1995, CEMENT CONCRETE RES, V25, P658, DOI 10.1016/0008-8846(95)00054-G; [Anonymous], 2013, ENV QUAL STAND SOIL; Kamei T, 2013, CONSTR BUILD MATER, V38, P224, DOI 10.1016/j.conbuildmat.2012.08.028; DAMIDOT D, 1993, CEMENT CONCRETE RES, V23, P1195, DOI 10.1016/0008-8846(93)90180-H; Kamei T., 2011, P 14 PAN C SOIL MECH; Kamei T., 2007, GEOTECHNICAL SOC ELE, V2, P245; Kamei T., 2008, JAPANESE GEOTECHNICA, V4, P91; Keller I.R.A., 2002, THESIS SWISS FEDERAL; Wang L., 2002, THESIS LOUISIANA STA; Waste & Resources Action Programme (WRAP), PLAST CAS STUD INT P; Waste & Resources Action Program (WRAP), 2007, PLAST TECHN REP US R	20	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1139	1147		10.1016/j.sandf.2015.09.014		9	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500018		
J	Watabe, Y; Sassa, S; Kaneko, T; Nakata, Y				Watabe, Yoichi; Sassa, Shinji; Kaneko, Takashi; Nakata, Yukio			Mechanical characteristics of reconstituted coral gravel soils with different fractions of finger-coral fragments and silt matrix	SOILS AND FOUNDATIONS			English	Article						Coral gravel soil; Coral fragments; Silt matrix; Particle crush; Mechanical properties; Triaxial test	GRANULAR-MATERIALS; SHEAR-STRENGTH; MIXTURES; CLAY; TESTS	Coral gravel soils, which are composite soils consisting of finger-coral fragments and silt matrix, are often found in coastal regions of subtropical islands. In this study, for reconstituted soils with various volumetric percentages of coral fragments up to 44% (coral particle fraction of 59%) as the densest package, a series of triaxial CU-bar and CD tests was conducted to study the determination method for the soil design parameters in consideration of the interaction between the soil skeleton, consisting of coral fragments, and the silt matrix. For samples with volumetric percentages of coral fragments less than 20% (coral particle fraction of 31%), the shear strength obtained from the CD tests was slightly larger than that obtained from the CU-bar tests; however, the difference between the two tests was very small. For samples with volumetric percentages of fragments more than 20% (coral particle fraction of 31%), the shear strength obtained from the CU-bar tests was significantly overestimated because of the unrealistically large negative excess pore pressure in the field corresponding to significant dilation. The shear strength obtained from the CD tests also showed a similar tendency corresponding to volume expansion; however, these values are much smaller than those obtained from the CU-bar tests. For the samples with a dense package of coral fragments, shear resistance angle 0 was much larger than that for normal soils; however, it tended to decrease in association with the particle crush of coral fragments. The tendency of the particle crush was visually evidenced through CT-images taken before and after the triaxial tests. The soil parameters were significantly influenced by the volumetric percentages of the coral fragments in association with particle interaction and particle crush, when the percentage was more than 20% (coral particle fraction of 31%) for the coral gravel soils examined in this study. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Watabe, Yoichi; Kaneko, Takashi] Port & Airport Res Inst, Soil Mech & Geoenvironm Grp, Yokosuka, Kanagawa 2390826, Japan; [Sassa, Shinji] Port & Airport Res Inst, Soil Dynam Grp, Yokosuka, Kanagawa 2390826, Japan; [Nakata, Yukio] Yamaguchi Univ, Dept Environm Geotech Engn, Ube, Yamaguchi 7558611, Japan	Watabe, Y (reprint author), Port & Airport Res Inst, Soil Mech & Geoenvironm Grp, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan.	watabe@ipc.pari.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23360208]	The authors thank Mr. Kazufumi Yonamine and Mr. Norikazu Maekochi of the Okinawa General Bureau, Cabinet Office, Government of Japan for providing the coral gravel soils and active discussions on this study from engineering viewpoints. We also thank Mr Shinichi Yamada of Kisojiban Consultants Co., Ltd., Japan for his kind help in the preparation of the reconstituted samples, Mr Akihiko Yanagisawa and Mr. Ikuro Nozaki of Toa Corporation for assistance with the laboratory tests, and Dr. Takaaki Mizutani of the Port and Airport Research Institute for the CT scanning. This research work was supported by Grant-in-Aid for Scientific Research (No. 23360208) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Crawford BR, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004634; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kumar GV, 1999, GEOTECHNIQUE, V49, P727; Lobo-Guerrero S, 2005, GEOTECHNIQUE, V55, P617, DOI 10.1680/geot.2005.55.8.617; Vallejo LE, 2001, CAN GEOTECH J, V38, P1097, DOI 10.1139/cgj-38-5-1097; Vallejo LE, 2000, ENG GEOL, V58, P125, DOI 10.1016/S0013-7952(00)00051-X; Lobo-Guerrero S, 2006, SOILS FOUND, V46, P147, DOI 10.3208/sandf.46.147; Watabe Y, 2011, GEOTECHNIQUE, V61, P211, DOI 10.1680/geot.8.R087; CHALKER B, 1985, CORAL REEFS, V4, P95, DOI 10.1007/BF00300867; FRAGASZY RJ, 1992, J GEOTECH ENG-ASCE, V118, P920, DOI 10.1061/(ASCE)0733-9410(1992)118:6(920); Fragaszy R.J., 1990, ASTM GEOTECH TEST J, V13, P106; Jones N, 2011, NATURE; Lade PV, 1996, J GEOTECH ENG-ASCE, V122, P309, DOI 10.1061/(ASCE)0733-9410(1996)122:4(309); Oyadomari Zen, 2004, J GEOTECH ENG JPN SO, P1; Simoni A., 2006, GEOTECHNICAL GEOLOGI, V24, P523, DOI DOI 10.1007/S10706-004-5832-6; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	16	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1233	1242		10.1016/j.sandf.2015.09.022		10	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500026		
J	Eab, KH; Likitlersuang, S; Takahashi, A				Eab, Kreng Hav; Likitlersuang, Suched; Takahashi, Akihiro			Laboratory and modelling investigation of root-reinforced system for slope stabilisation	SOILS AND FOUNDATIONS			English	Article						Centrifuge modelling; Laboratory tests; Slopes; Vegetation	SOIL; VEGETATION; STRENGTH	Most natural slope failures are induced by seepage and/or rainfall. Soil bioengineering is an environmentally friendly method which employs vegetation to reinforce the soil in sloping terrain. The vegetation can contribute to slope stability in two ways, mechanical and hydrological. This paper demonstrates the effect of a vegetation root matrix on a soil slope and focuses on mechanical reinforcement using an example of vetiver grass. Vetiver grass (Vetiveria nemoralis A. Camus) specimens, grown for under a year, were used in this study. The investigation programme includes root observations, direct shear tests and centrifuge model tests. The growing rate of the vetiver roots and the root area ratios were observed during the tests. The cohesion and angle of internal friction of root-reinforced soils were determined from a standard direct shear apparatus and a large direct shear apparatus. A series of centrifuge tests was carried out to demonstrate the effect of vegetation on seepage- and rainfall-induced slope failures. The results indicate that the vetiver roots showed rapid growth within a year and that the shear strength of the root-reinforced soil was significantly increased by the bundle of roots. The results also reveal that the bundle of root fibres in the centrifuge model tests helped to reduce the deformation of the soil slope due to instability by increasing the shear strength of the slope. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Eab, Kreng Hav] Chulalongkorn Univ, Fac Engn, Dept Civil Engn, Bangkok 10330, Thailand; [Takahashi, Akihiro] Tokyo Inst Technol, Dept Civil Engn, Tokyo 152, Japan; [Likitlersuang, Suched] Chulalongkorn Univ, Fac Engn, Dept Civil Engn, Geotech Res Unit, Bangkok 10330, Thailand	Likitlersuang, S (reprint author), Chulalongkorn Univ, Fac Engn, Dept Civil Engn, Geotech Res Unit, Bangkok 10330, Thailand.	krenghav_eab@yahoo.com; fceslk@eng.chula.ac.th; takihiro@cv.titech.ac.jp	Takahashi, Akihiro/B-9306-2015	Takahashi, Akihiro/0000-0003-1206-5066	Thailand Research Fund under the TRF Research Scholar Award [RSA-5880023]; AUN/SEED-Net (JICA)	This research was supported by the Thailand Research Fund under the TRF Research Scholar Award Grant no. RSA-5880023. The first author would like to acknowledge the AUN/SEED-Net (JICA) for his Ph.D. scholarship during his study. The work was also conducted under the research and development project on landslide prevention and protection according to the Royal Initiatives of the Chaipattana Foundation.	Alsheimer L., 2007, BLACK WHITE PHOTOSHO, P91, DOI 10.1016/B978-0-240-52084-1.50011-8; Sonnenberg R, 2010, CAN GEOTECH J, V47, P1415, DOI 10.1139/T10-037; WU TH, 1979, CAN GEOTECH J, V16, P19; Ali FH, 2008, SOILS FOUND, V48, P587, DOI 10.3208/sandf.48.587; [Anonymous], 1998, D3080 ASTM; Ng CWW, 1998, COMPUT GEOTECH, V22, P1, DOI 10.1016/S0266-352X(97)00036-0; Cerato A. B., 2006, GEOTECH TEST J, V29, P1, DOI DOI 10.1520/GTJ100312; Chinapan W., 1997, STUDY ECOTYPE COMP V; Coppin N.J., 1990, USE VEGETATION CIVIL; Eab KH, 2014, GEOTECH LETT, V4, P211, DOI 10.1680/geolett.14.00029; Gray D., 1996, BIOTECHNICAL SOIL BI; Gray D.H., 1982, BIOTECHNICAL SLOPE P; Greenfield J.C., 1996, P 1 INT C VET CHIANG, P1; Greenway D.R., 1978, SLOPE STABILITY; Hengchaovanich D., 1998, P 1 INT C VET MIR GR, P153; Kaewsaeng W., 2000, THESIS KING MONGKUTS; LDD, 1998, VET GRASS OV; Lyr H., 1967, Int. Rev. For Res., N. Y., V2, P181; Takahashi A., 2014, P 8 INT C PHYS MOD G, P1233; Taylor R. N., 1995, GEOTECHNICAL CENTRIF; Wu T.H., 1995, SLOPE STABILIZATION	21	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1270	1281		10.1016/j.sandf.2015.09.025		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500029		
J	Goto, H; Tanaka, N; Sawada, S; Inatani, H				Goto, Hiroyuki; Tanaka, Nobuaki; Sawada, Sumio; Inatani, Hideki			S-wave impedance measurements of the uppermost material in surface ground layers: Vertical load excitation on a circular disk	SOILS AND FOUNDATIONS			English	Article						S-wave impedance; Elastic wave exploration; Numerical experiment (IGC: C02, E08, G08)	NORMALIZED ENERGY DENSITY; SEISMIC SITE CONDITIONS; TOHOKU EARTHQUAKE; PACIFIC COAST; EMBEDDED FOUNDATIONS; ARRAY OBSERVATIONS; JAPAN; AMPLIFICATION; LIQUEFACTION; MOTION	S-wave impedance is one of the most effective parameters used to study the ground motion amplification of soil deposits. We propose a new approach to measure the S-wave impedance of the uppermost material in surface ground layers. First, a circular disk is set on the ground surface, and it is vertically loaded by sinusoidal wave excitation. When the time series of the loading velocity is synchronized with the reaction force, the ratio of the reaction force to the loading velocity is proportional to the S-wave impedance. We then estimate the proportionality coefficient from numerical experiments and check its accuracy. The measurement error is estimated to be within 1% for the homogeneous half-space case. We also discuss the applicability of this new approach and its limitations on the basis of numerical experiments for inhomogeneous media: a two-layered medium and a one-dimensional (1-D) random medium. The proposed approach is effective for both cases if we select the appropriate circular disk size. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Goto, Hiroyuki; Sawada, Sumio] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Tanaka, Nobuaki] Chem Grouting Co Ltd, Minato Ward, Tokyo 1050001, Japan; [Inatani, Hideki] Katsujima Co Ltd, Katsushika Ward, Tokyo 1250063, Japan	Goto, H (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan.	goto@catfish.dpri.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25709039]	We thank the editor and anonymous reviewers for their fruitful comments. The research was supported by a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (JSPS) (No. 25709039).	Aki K., 1957, B EARTHQ RES I TOKYO, V35, P415; Jia R, 2013, SOILS FOUND, V53, P671, DOI 10.1016/j.sandf.2013.08.005; Park CB, 1999, GEOPHYSICS, V64, P800, DOI 10.1190/1.1444590; Allen TI, 2009, B SEISMOL SOC AM, V99, P935, DOI 10.1785/0120080255; Lee VW, 2010, SOIL DYN EARTHQ ENG, V30, P1250, DOI 10.1016/j.soildyn.2010.05.007; Yasuda S, 2012, SOILS FOUND, V52, P793, DOI 10.1016/j.sandf.2012.11.004; Unjoh S, 2012, SOILS FOUND, V52, P830, DOI 10.1016/j.sandf.2012.11.006; Gerolymos N, 2006, SOIL DYN EARTHQ ENG, V26, P347, DOI 10.1016/j.soildyn.2005.12.003; Wald DJ, 2007, B SEISMOL SOC AM, V97, P1379, DOI 10.1785/0120060267; JOYNER WB, 1981, B SEISMOL SOC AM, V71, P1333; Liu HP, 2000, B SEISMOL SOC AM, V90, P666, DOI 10.1785/0119980186; Thompson EM, 2014, B SEISMOL SOC AM, V104, P2313, DOI 10.1785/0120130312; Whitcombe DN, 2002, GEOPHYSICS, V67, P60, DOI 10.1190/1.1451331; AKI K, 1965, GEOPHYSICS, V30, P665, DOI 10.1190/1.1439640; Kausel E, 2010, SOIL DYN EARTHQ ENG, V30, P822, DOI 10.1016/j.soildyn.2009.11.001; ALLEN SJ, 1980, GEOPHYSICS, V45, P1619, DOI 10.1190/1.1441053; Goto H, 2012, SEISMOL RES LETT, V83, P765, DOI 10.1785/0220120044; Castellaro S, 2008, SEISMOL RES LETT, V79, P540, DOI 10.1785/gssrl.79.4.540; Lu SM, 2004, GEOPHYSICS, V69, P164, DOI 10.1190/1.1649385; Mori T, 2012, SOILS FOUND, V52, P910, DOI 10.1016/j.sandf.2012.11.011; Goto H, 2013, GEOPHYS J INT, V194, P488, DOI 10.1093/gji/ggt104; GAZETAS G, 1987, J GEOTECH ENG-ASCE, V113, P458; WOLF JP, 1986, EARTHQUAKE ENG STRUC, V14, P683, DOI 10.1002/eqe.4290140502; Goto H, 2009, SOILS FOUND, V49, P651, DOI 10.3208/sandf.49.651; Nakagawa K, 1997, GEOTECHNIQUE, V47, P133; Yang J, 2000, B SEISMOL SOC AM, V90, P275, DOI 10.1785/0119990068; Yokokura T, 1995, J PHYS EARTH, V43, P321; Boore DM, 2007, SOIL DYN EARTHQ ENG, V27, P971, DOI 10.1016/j.soildyn.2007.03.005; Goto H, 2011, WAVE MOTION, V48, P603, DOI 10.1016/j.wavemoti.2011.04.011; Goto H, 2012, SOILS FOUND, V52, P769, DOI 10.1016/j.sandf.2012.11.002; Boore D.M., 2006, P 3 INT S EFF SURF G; Borcherdt R.D., 1994, EARTHQ SPECTRA, V10, P617, DOI DOI 10.1193/1.1585791; Boussinesq J., 1885, APPL POTENTIELS ETUD; Bouzorgnia Y., 2004, EARTHQUAKE ENG ENG S; Connolly P, 1999, LEADING EDGE, V18, P438, DOI DOI 10.1190/1.1438307; GAZETAS G, 1984, J ENG MECH-ASCE, V110, P937; GAZETAS G, 1991, J GEOTECH ENG-ASCE, V117, P1363, DOI 10.1061/(ASCE)0733-9410(1991)117:9(1363); Hata Y, 2014, SOILS FOUND, V54, P573, DOI 10.1016/j.sandf.2014.06.003; Kokusho T., 1980, SOILS FOUND, V20, P45; LADE PV, 1987, INT J NUMER ANAL MET, V11, P521, DOI 10.1002/nag.1610110507; Lamb H., 1902, P LOND MATH SOC, V34, P276; Okada H, 2003, MICROTREMOR SURVEY M; Robertson I.A., 1966, MATH P CAMBRIDGE PHI, V62, P547, DOI 10.1017/S0305004100040184; Sato H, 2012, SEISMIC WAVE PROPAGA; Seed H. B., 1971, J SOIL MECHANICS FOU, V107, P1249; Sugano T, 2014, SOILS FOUND, V54, P883, DOI 10.1016/j.sandf.2014.06.018; Towhata I, 2014, SOILS FOUND, V54, P859, DOI 10.1016/j.sandf.2014.06.016; Wakamatsu K., 2006, B EARTHQ RES I TOKYO, V81, P317; Wald D.J., 2010, PAGER RAPID ASSESSME; Wolf JP, 1997, EARTHQUAKE ENG STRUC, V26, P931, DOI 10.1002/(SICI)1096-9845(199709)26:9<931::AID-EQE686>3.0.CO;2-M	50	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1282	1292		10.1016/j.sandf.2015.09.026		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500030		
J	Horikoshi, K; Takahashi, A				Horikoshi, Kazuki; Takahashi, Akihiro			Suffusion-induced change in spatial distribution of fine fractions in embankment subjected to seepage flow	SOILS AND FOUNDATIONS			English	Article						Suffusion; Internal erosion; Seepage; Physical model tests	INTERNAL STABILITY; COHESIONLESS SOIL; BACKWARD EROSION; DAMS; CRITERIA; INITIATION; FILTERS	Suffusion describes the phenomenon whereby finer particles are eroded through the voids of coarse particles by the seepage flow. This may cause the deterioration of the hydraulic structure and, in the worst case, result in the failure of the hydraulic structure. The suffusion process is presented in this paper in an embankment under transient and steady seepage conditions. A series of physical model tests on seepage-induced suffusion on a small-scale model embankment is performed under constant boundary head conditions. A binary mixture, consisting of two Silica sands (Silica sands Nos. 3 and 8), which is categorized as "internally unstable material" by several previous criteria for the seepage-induced internal stability, is used for the model embankment. The cumulative eroded soil mass and the discharged rate of water are recorded during the seepage tests. The spatial extent of the variation in erosion-induced fines contents is discussed through sieve analyzes on subdivided areas of the model embankment after seepage testing. The test results reveal that a decrease in fines propagates along the phreatic surface from downstream in the embankment. Below the phreatic surface, the eroded fines not only move laterally by the seepage flow, but also vertically due to the gravitational force, and are deposited in the foundation. This deposition of the fines results in the expansion of the fine-rich region in the foundation and causes a decrease in the permeability of the whole embankment. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Horikoshi, Kazuki; Takahashi, Akihiro] Tokyo Inst Technol, Dept Civil Engn, Tokyo 152, Japan	Takahashi, A (reprint author), 2-12-1-M1-3 Oh Okayama, Tokyo 1528552, Japan.	takihiro@cv.titech.ac.jp	Takahashi, Akihiro/B-9306-2015	Takahashi, Akihiro/0000-0003-1206-5066	JSPS KAKENHI [25420498]	This work was supported by JSPS KAKENHI, Grant number 25420498.	Tomlinson SS, 2000, CAN GEOTECH J, V37, P1, DOI 10.1139/cgj-37-1-1; Chang DS, 2013, SOILS FOUND, V53, P569, DOI 10.1016/j.sandf.2013.06.008; Fell R, 2013, CIV ENG GEOMECH SER, P1; Lindow N, 2009, EARTH SURF PROC LAND, V34, P1693, DOI 10.1002/esp.1874; Richards KS, 2014, ENVIRON ENG GEOSCI, V20, P85; Bendahmane F, 2008, J GEOTECH GEOENVIRON, V134, P57, DOI 10.1061/(ASCE)1090-0241(2008)134:1(57); Li MX, 2008, CAN GEOTECH J, V45, P1303, DOI 10.1139/T08-046; Wan CF, 2008, J GEOTECH GEOENVIRON, V134, P401, DOI 10.1061/(ASCE)1090-0241(2008)134:3(401); Richards KS, 2007, B ENG GEOL ENVIRON, V66, P381, DOI 10.1007/s10064-007-0095-0; KENNEY TC, 1985, CAN GEOTECH J, V22, P215; Ke L, 2012, SOILS FOUND, V52, P698, DOI 10.1016/j/sandf.2012.07.010; Richards KS, 2012, GEOTECHNIQUE, V62, P933, DOI 10.1680/geot.11.P.058; Moffat R, 2011, CAN GEOTECH J, V48, P399, DOI 10.1139/T10-071; Foster M, 2001, J GEOTECH GEOENVIRON, V127, P398, DOI 10.1061/(ASCE)1090-0241(2001)127:5(398); Foster M, 2000, CAN GEOTECH J, V37, P1000, DOI 10.1139/cgj-37-5-1000; Moffat R, 2011, CAN GEOTECH J, V48, P413, DOI 10.1139/T10-070; Fell R, 2003, J GEOTECH GEOENVIRON, V129, P307, DOI 10.1061/(ASCE)1090-0241(2003)129:4(307); SKEMPTON AW, 1994, GEOTECHNIQUE, V44, P449; Beguin R., 2012, P 6 INT C SCOUR ER P, P1551; Cividini A., 2009, International Journal of Geomechanics, V9, P187, DOI 10.1061/(ASCE)1532-3641(2009)9:4(187); Cividini A., 2004, International Journal of Geomechanics, V4, P191, DOI 10.1061/(ASCE)1532-3641(2004)4:3(191); Foster M., 1999, UNICIV REPORTS; Fry J.J., 2012, P 6 INT C SCOUR ER P, P273; Fry J.J., 2012, EROSION GEOMATERIALS, P1; Honjo Y., 1996, P GEOF 96, P227; Ke L, 2014, SOILS FOUND, V54, P713, DOI 10.1016/j.sandf.2014.06.024; Khomenko V.P., 2006, P 10 IAEG INT C NOTT, P1; Kuwano R., 2012, P 6 INT C SCOUR ER P, P265; Ladd RS, 1978, GEOTECH TEST J, V1, P16, DOI DOI 10.1520/GTJ10364J; Lafleur J., 1999, GEOTEXT GEOMEMBRANES, V17, P299, DOI DOI 10.1016/S0266-1144(99)00007-2; Luo Y., 2012, NAT HAZARDS, V65, P1361; Marot D., 2012, P 6 INT C SCOUR ER P, P887; Moraci N, 2014, CAN GEOTECH J, V51, P1063, DOI 10.1139/cgj-2014-0006; Perzlmaier S, 2007, INTERNAL EROSION DAM, P179; Saito Y., 2012, P 47 JAP NAT C GEOT, P903; Sterpi D., 2003, INT J GEOMECH, V3, P111, DOI 10.1061/(ASCE)1532-3641(2003)3:1(111); Terzaghi K, 1939, J I CIVIL ENG, V12, P106, DOI 10.1680/ijoti.1939.14534; Uzuoka R., 2012, P 6 INT C SCOUR ER P, P655; Zhang X., 2014, ENV EARTH SCI; Zhang X. S., 2013, Geotechnical and Geological Engineering, V31, DOI 10.1007/s10706-012-9600-8	40	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1293	1304		10.1016/j.sandf.2015.09.027		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500031		
J	Tsuchida, T; Athapaththu, AMRG; Hanaoka, T; Kawaguchi, M				Tsuchida, Takashi; Athapaththu, A. M. R. G.; Hanaoka, Takashi; Kawaguchi, Masaki			Investigation of landslide calamity due to torrential rainfall in Shobara City, Japan	SOILS AND FOUNDATIONS			English	Article						Slope failure; Rainfall; Site investigation; Model test; Slope stability		On 16th July 2010, a series of slope failures occurred in the city of Shobara, Japan due to a torrential rainfall. The slope failures were found to have occurred at about 200 locations in a narrow area of 16 km(2). Most of the failures in this catastrophic disaster were due to the collapse of the middle portion of a mountainous slope. The primary purpose of this study was to present the landslide event that took place in Shobara City and to explore the mechanism of the multiple planar slope failures in the region. A series of field tests was carried out using a recently developed lightweight dynamic cone penetrometer in the middle portion of the selected planar slopes. The results revealed that the slopes were composed of two soil layers, weathered Rhyolite and Kuroboku. The failures took place at the boundary of these two soil layers. Laboratory tests were conducted to find the relevant parameters for the stability analysis, and laboratory scale model tests were performed to understand the mechanism of the slope failures in this region. The results of the model tests revealed that the Kuroboku layer led to a rise in the water table in the middle portion of the slope, while preventing the downward flow of groundwater. As a result, the failures are found to have initiated and occurred in the middle portion of the mountainous slope. The factor of safety, evaluated based on a slope stability analysis, was found to be close to 1, when the groundwater level rose to the ground surface and the apparent cohesion of the weathered Rhyolite soil over the Kuroboku layer decreased to 1.3 kPa. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Tsuchida, Takashi; Athapaththu, A. M. R. G.] Hiroshima Univ, Inst Engn, Dept Civil & Environm Engn, Higashihiroshima 7398527, Japan; [Hanaoka, Takashi] Hiroshima Prefectural Hiroshima Tech High Sch, Hiroshima, Japan; [Kawaguchi, Masaki] Tottori City Govt, Tottori, Japan	Tsuchida, T (reprint author), Hiroshima Univ, Inst Engn, Dept Civil & Environm Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	tkstsuchida@mse.biglobe.ne.jp					Aboshhi H., 1972, P 7 ANN M JSSMFE, P507; Yamada M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052174; Tsuchida T, 2011, SOILS FOUND, V51, P497; Uchida T, 2001, HYDROL PROCESS, V15, P2151, DOI 10.1002/hyp.281; Athapaththu A.M.R.G., 2007, J JAPANESE SOC CIV C, V63, P403; Athapaththu A.M.R.G., 2007, J JAPANESE SOC CIV C, V63, P848; Athapaththu A.M.R.G., 2006, INT OFFSHORE POLAR E, V2, P324; Fukuoka H., 2009, NAT DISASTER SCI, V28, P185; Janbu N., 1954, P EUR C STAB EARTH S, P43; Japanese Geotechnical Society, 2000, JAP STAND GEOT GEOEN, P563; Jones J.A.A., 1994, CUATERNARIO GEOMORFO, V8, P77; Kitahara H., 1994, Journal of the Japanese Forestry Society, V76, P10; Langton D.D., 1999, PANDA LIGHTWEIGHT PE; Matsui A., 2010, GROUND CONSTR, V28, P55; Miyabuchi Y., 2012, J GEOGR, V121, P1073; PIERSON TC, 1983, Q J ENG GEOL, V16, P1, DOI 10.1144/GSL.QJEG.1983.016.01.01; Thi H., 2003, P INT S GROUNDW PROB, P181; Tsuchida T, 2014, SOILS FOUND, V54, P806, DOI 10.1016/j.sandf.2014.06.012; Tsuchida T., 2010, J JPN NAT DISASTERS, V29, P245	19	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1305	1317		10.1016/j.sandf.2015.09.028		13	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500032		
J	Nigorikawa, N; Asaka, Y				Nigorikawa, Naohiro; Asaka, Yoshiharu			Leveling of long-term settlement of Holocene clay ground induced by the 2011 off the Pacific coast of Tohoku earthquake	SOILS AND FOUNDATIONS			English	Article						Earthquake; Holocene clay; Leveling survey; Long-term settlement; Reclaimed land; (IGC: E08)		The aim of the study reported in this paper is to reveal the long-term settlement of a Holocene clay ground after the 2011 off the Pacific coast of Tohoku earthquake. The authors took level readings six times across Urayasu City, Chiba Prefecture, during the period from April 2011 to April 2013. The results are a chronological record of changes in settlement of first-order benchmarks and survey points showing that long-term ground settlement was taking place due to the earthquake. In Phase I reclaimed land (which was constructed between 1968 and 1975), the settlement rate is shown to be approximately 6 mm/year, more than twice the rate of the settlement before the earthquake. In Phase II reclaimed land (which was constructed between 1978 and 1980), the settlement behavior is found to differ according to whether the reclaimed land had been improved or not. Furthermore, the natural alluvial lowland has not settled since the earthquake. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Nigorikawa, Naohiro; Asaka, Yoshiharu] Shimizu Corp, Inst Technol, Tokyo 1358530, Japan	Nigorikawa, N (reprint author), Shimizu Corp, Inst Technol, Tokyo 1358530, Japan.	n.nigorikawa@shimz.co.jp					Noda T, 2009, SOILS FOUND, V49, P739, DOI 10.3208/sandf.49.739; Chiba Prefecture, 2015, RESULT ANN LEVELING; Chiba Prefecture, 2015, INFORM BANK GEOLOGIC; Chiba Prefecture Urayasu City, 2015, LAND RECLAMATIONS; Chiba Prefecture Urayasu City, 1986, REPORT BASIC FINDING; Fiegel G.L., 1998, P INT C CENTR, V98, P231; Fukutake K., 2013, J JSCE, V1, P307; Geospatial Information Authority of Japan GSI, 2015, SURV SPEC; Geospatial Information Authority of Japan GSI, 2015, LAND COND MAPS; Geospatial Information Authority of Japan GSI, 2015, GEOD SURV; Hotta H., 1998, ANN M ARCH I JAP, P557; Ishihara K., 1992, SOILS FOUND, V32, P173; Japan Railway Construction Public Corporation, 1991, CONSTR REC JR KEIYO; Japanese Geotechnical Society JGS, 2014, HAND 3 WORKSH CONST; Japanese Geotechnical Society JGS, 2009, JAP STAND EXPL LAB T, P51; Jinbo H., 1994, CIVIL ENG, P56; Koishi Y., 2012, P 47 JGS C SOIL MECH, P265; Matsuda H., 2000, J JSCE DIVISION C, V659, P63; Murakami T., 2013, P 48 JGS C SOIL MECH, P437; Towhata I., 2008, GEOTECHNICAL EARTHQU, P359; Yasuhara K., 1998, TSUCHI TO KISO, V46, P57; Zeevaert L., 1972, FDN ENG DIFFICULT SU, P521	22	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	OCT	2015	55	5					1318	1325		10.1016/j.sandf.2015.09.029		8	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU3OA	WOS:000363433500033		
J	Birkel, A; DeCino, NA; Cozzan, C; Mikhailovsky, AA; Hong, BC; Seshadri, R				Birkel, Alexander; DeCino, Nicholas A.; Cozzan, Clayton; Mikhailovsky, Alexander A.; Hong, Byung-Chul; Seshadri, Ram			A single-phase full-color phosphor based on Ba3MgSi2O8 co-activated with Eu2+, Tb3+, and Mn2+	SOLID STATE SCIENCES			English	Article						Phosphors; Solid-state lighting; Microwave preparation; Merwinite; Full-color	LIGHT-EMITTING-DIODES; RAPID MICROWAVE PREPARATION; INORGANIC-COMPOUNDS; SOLID-SOLUTIONS; BA PHOSPHORS; CA; LUMINESCENCE; FLUORESCENCE; SR; PHOTOLUMINESCENCE	We present a rapid and energy-efficient microwave-assisted approach to prepare a single-phase fullcolor phosphor based on Ba3MgSi2O8. The samples were prepared using a citric acid based sal gel preparation pathway with a microwave-assisted heating step, which reduces the time required for the final heat treatment to less than 30 min. Thermogravimetric analysis was utilized to optimize the solution-based preparation prior to microwave heating. The structural properties of the obtained luminescent materials have been thoroughly investigated by means of X-ray powder diffraction and Rietveld analyses. To study the optical behavior, the excitation and emission spectra were recorded. Full-color emission is achieved using Eu2+ (blue), Tb3+ (green), and Mn2+ (red) as the activator ions. The thermally robust emission was investigated using temperature-dependent luminescence spectroscopy. The energy-transfer processes within the samples were studied using time-dependent spectroscopy, and the quantum yield of this true color phosphor as a function of the composition was determined. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Birkel, Alexander; DeCino, Nicholas A.; Cozzan, Clayton; Seshadri, Ram] Univ Calif Santa Barbara, Mitsubishi Chem Ctr Adv Mat, Santa Barbara, CA 93106 USA; [Birkel, Alexander; DeCino, Nicholas A.; Cozzan, Clayton; Seshadri, Ram] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Mikhailovsky, Alexander A.; Seshadri, Ram] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Hong, Byung-Chul] Mitsubishi Chem Grp, Sci & Technol Res Ctr, Yokohama, Kanagawa 2278502, Japan; [Seshadri, Ram] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Seshadri, R (reprint author), Univ Calif Santa Barbara, Mitsubishi Chem Ctr Adv Mat, Santa Barbara, CA 93106 USA.	seshadri@mrl.ucsb.edu	Seshadri, Ram/C-4205-2013		National Science Foundation [DGE 1144085]; MRSEC Program of the NSF [DMR 1121053]; NSF	We would like to thank Dr. Christina Birkel for the help with the TGA analysis, Dr. Kristin Denault and Dr. Nathan George for useful discussions, and Dr. Jakoah Brgoch for careful reading of the manuscript. CC gratefully acknowledges this material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1144085. The research carried out here made extensive use of shared experimental facilities of the Materials Research Laboratory: The MRL Central Facilities are supported by the MRSEC Program of the NSF under Award No. DMR 1121053; a member of the NSF-funded Materials Research Facilities Network (www.mrfn.org).	Aitasalo T., 2007, Z KRIST S, V26, P461; Dorenbos P, 2000, J LUMIN, V91, P91, DOI 10.1016/S0022-2313(00)00197-6; Kim JS, 2005, SOLID STATE COMMUN, V133, P445, DOI 10.1016/j.ssc.2004.12.002; Kim JS, 2005, SOLID STATE COMMUN, V135, P21, DOI 10.1016/j.ssc.2005.03.068; BLASSE G, 1968, PHILIPS RES REP, V23, P189; BARRY TL, 1968, J ELECTROCHEM SOC, V115, P733, DOI 10.1149/1.2411413; Im WB, 2009, J MATER CHEM, V19, P8761, DOI 10.1039/b912793c; Paulose PI, 2003, J PHYS CHEM SOLIDS, V64, P841, DOI 10.1016/S0022-3697(02)00416-X; Ma L, 2008, ELECTROCHEM SOLID ST, V11, pE1, DOI 10.1149/1.2817472; Chen HY, 2012, CERAM INT, V38, P125, DOI 10.1016/j.ceramint.2011.06.044; Ye S, 2010, MAT SCI ENG R, V71, P1, DOI 10.1016/j.mser.2010.07.001; Birkel A, 2013, SOLID STATE SCI, V19, P51, DOI 10.1016/j.solidstatesciences.2013.02.003; Biswas K, 2011, MATER RES BULL, V46, P2288, DOI 10.1016/j.materresbull.2011.08.058; Chambers MD, 2009, ANNU REV MATER RES, V39, P325, DOI 10.1146/annurev-matsci-112408-125237; Dorenbos P, 2003, J LUMIN, V104, P239, DOI 10.1016/S0022-2313(03)00078-4; Birkel A, 2012, CHEM MATER, V24, P1198, DOI 10.1021/cm3000238; Im WB, 2009, INORG CHEM, V48, P557, DOI 10.1021/ic8012798; Poort SHM, 1997, J PHYS CHEM SOLIDS, V58, P1451, DOI 10.1016/S0022-3697(97)00010-3; ROY R, 1985, J AM CERAM SOC, V68, P392, DOI 10.1111/j.1151-2916.1985.tb10150.x; Birkel CS, 2013, PHYS CHEM CHEM PHYS, V15, P6990, DOI 10.1039/c3cp50918d; LEBAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; Bachmann V, 2009, CHEM MATER, V21, P2077, DOI 10.1021/cm8030768; Birkel A, 2012, SOLID STATE SCI, V14, P739, DOI 10.1016/j.solidstatesciences.2012.03.014; BAGHURST DR, 1988, NATURE, V332, P311, DOI 10.1038/332311a0; Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712; Daldosso M, 2008, OPT MATER, V30, P1162, DOI 10.1016/j.optmat.2007.05.042; Kim JS, 2007, J LUMIN, V122, P583, DOI 10.1016/j.jlumin.2006.01.231; Im WB, 2009, OPT EXPRESS, V17, P22673, DOI 10.1364/OE.17.022673; Im WB, 2009, J MATER CHEM, V19, P1325, DOI 10.1039/b818313a; Yonesaki Y, 2009, J SOLID STATE CHEM, V182, P547, DOI 10.1016/j.jssc.2008.11.032; KLASENS HA, 1957, J ELECTROCHEM SOC, V104, P93, DOI 10.1149/1.2428519; Rack PD, 1998, MAT SCI ENG R, V21, P171, DOI 10.1016/S0927-796X(97)00010-7; Ishigaki T, 2010, MATER SCI ENG B-ADV, V173, P109, DOI 10.1016/j.mseb.2009.11.004; Kim JS, 2004, APPL PHYS LETT, V84, P2931, DOI 10.1063/1.1695441; Birkel CS, 2012, CHEM MATER, V24, P2558, DOI 10.1021/cm3011343; Park CH, 2009, J SOLID STATE CHEM, V182, P496, DOI 10.1016/j.jssc.2008.11.024; Smet PF, 2011, J ELECTROCHEM SOC, V158, pR37, DOI 10.1149/1.3568524; GREENHAM NC, 1995, CHEM PHYS LETT, V241, P89, DOI 10.1016/0009-2614(95)00584-Q; Becker W., 2005, SPRINGER SERIES CHEM, V81; Blasse W., 1994, LUMINESCENT MAT; Coelho A.A., 2007, TOPAS ACAD V4 1; Dorenbos P, 2003, J PHYS-CONDENS MAT, V15, P4797, DOI 10.1088/0953-8984/15/27/311; Dorenbos P, 2005, J PHYS-CONDENS MAT, V17, P8103, DOI 10.1088/0953-8984/17/50/027; George N.C., 2013, ANN REV MATER RES, V43; Im WB, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976138; Lue W., 2011, INORG CHEM, V50, P7846; Pimputkar S., 2009, NAT PHOTONICS, V3, P2; Wang DJ, 2009, ELECTROCHEM SOLID ST, V12, pH179, DOI 10.1149/1.3086729	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	OCT	2015	48						82	89		10.1016/j.solidstatesciences.2015.07.005		8	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CU2IS	WOS:000363347800014		
J	Tachikawa, H; Kawabata, H				Tachikawa, Hiroto; Kawabata, Hiroshi			Electronic states of alkali metal-NTCDA complexes: A DFT study	SOLID STATE SCIENCES			English	Article						Organic-inorganic hybrid complex; Li(NTCDA); Na(NTCDA); Paramagnetic species	ORGANIC SEMICONDUCTOR; FILMS; SYSTEM; ATOM; AL	Structures and electronic states of organic inorganic compound of 1,4,5,8-naphthalene-tetracarboxylic-dianhydride (NTCDA) with alkali metals, M-n(NTCDA) (M=Li and Na, n = 0-2), have been investigated by means of hybrid density functional theory (DFT) calculations. From the DFT calculations, it was found that the electronic state of the complex at the ground state is characterized by a charge-transfer state expressed by (M)(+)(NTCDA)(-). The alkali metals were bound equivalently to the carbonyl oxygen and ether oxygen atoms of NTCDA. The C=O double bond character of NTCDA was changed to a C-O single bond like character by the strong interaction of M to the C=O and O sites. This change was the origin of the red-shift of the IR spectrum. The UV-vis absorption spectra of M-n(NTCDA) were theoretically predicted on the basis of theoretical results. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Tachikawa, Hiroto] Hokkaido Univ, Grad Sch Engn, Div Appl Chem, Sapporo, Hokkaido 0608628, Japan; [Kawabata, Hiroshi] Kyoto Univ, Venture Business Lab, Sakyo Ku, Kyoto 6068501, Japan	Tachikawa, H (reprint author), Hokkaido Univ, Grad Sch Engn, Div Appl Chem, Sapporo, Hokkaido 0608628, Japan.	hiroto@eng.hokudai.ac.jp			JSPS KAKENHI Grant [15K05371]; MEXT KAKENHI Grant [25108004]	The author acknowledges partial support from JSPS KAKENHI Grant Number 15K05371 and MEXT KAKENHI Grant Number 25108004.	Kera S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115204; Forrest SR, 1997, CHEM REV, V97, P1793, DOI 10.1021/cr941014o; Tachikawa H, 2007, J ORGANOMET CHEM, V692, P5541, DOI 10.1016/j.jorganchem.2007.08.041; Azuma Y, 2000, J APPL PHYS, V87, P766, DOI 10.1063/1.371938; Hirose Y, 1996, PHYS REV B, V54, P13748, DOI 10.1103/PhysRevB.54.13748; Katz HE, 2000, NATURE, V404, P478, DOI 10.1038/35006603; Nakayama K, 2003, J APPL PHYS, V94, P3216, DOI 10.1063/1.1599052; HIROSE Y, 1994, APPL PHYS LETT, V64, P3482, DOI 10.1063/1.111247; HASHIMOTO K, 1991, B CHEM SOC JPN, V64, P3245, DOI 10.1246/bcsj.64.3245; Palma A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155314; Tachikawa H, 2005, J PHYS CHEM B, V109, P3139, DOI 10.1021/jp046168e; Heimer K, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2722748; BURROUGHES JH, 1988, NATURE, V335, P137, DOI 10.1038/335137a0; Tsunoyama H, 2001, J AM CHEM SOC, V123, P683, DOI 10.1021/ja002155c; Tsunoyama H, 2000, CHEM PHYS LETT, V316, P442, DOI 10.1016/S0009-2614(99)01308-1; Tachikawa H, 2003, J MATER CHEM, V13, P1293, DOI 10.1039/b301913f; Azuma Y, 2002, J APPL PHYS, V91, P5024, DOI 10.1063/1.1457543; Frisch M.J., 2009, AB INITIO MO PROGRAM; Greenham N.C., 1995, SOLID STATE PHYS, V49, P1; Tachikawa H., 2008, THIN SOLID FILMS, V16, P3287; Wu J., 2011, J AM SOC MASS SPECTR, V12, P1229; Wuesten J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.125205; Wusten J, 2007, J APPL PHYS, V102, DOI 10.1063/1.2756513	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	OCT	2015	48						141	146		10.1016/j.solidstatesciences.2015.08.002		6	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CU2IS	WOS:000363347800022		
J	Inomata, M; Kishida, K; Maruyama, Y; Watanabe, T				Inomata, Masayuki; Kishida, Kazuhisa; Maruyama, Yuki; Watanabe, Tomoaki			Synthesis of a new scheelite-type Eu3+-doped Gd2W2O9 red light emitting phosphor by the polymerized complex method	SOLID STATE SCIENCES			English	Article						Gd2W2O9; Red light emitting phosphor; Scheelite; Raman	OXIDE-ION CONDUCTION; LUMINESCENT PROPERTIES; DIFFRACTION REFINEMENT; NEUTRON-DIFFRACTION; RAMAN-SPECTROSCOPY; CRYSTAL STRUCTURE; TUNGSTATE; EU3+; CAWO4; PBWO4	New scheelite-type Gd2W2O9 and (Gd0.8Eu0.2)(2)W2O9 were synthesized by the polymerized complex method at 700 degrees C for 2 h and were characterized by powder X-ray diffraction (XRD) as well as X-ray photoelectron (XPS), Raman, and luminescence spectroscopies. XRD patterns suggested that the samples crystallized in a scheelite-type structure. XPS results confirmed the existence of Gd3+ and W6+ ions in Gd2W2O9. The scheelite-type samples were expected to exhibit WO4 groups by Raman spectroscopy. Scheelite-type (Gd0.8Eu0.2)(2)W2O9 showed red light emission corresponding to the D-5(0)-F-7(2) transition of Eu3+ under blue light excitation. Its fluorescence lifetime was approximately 1.6 times longer than that of the monoclinic polymorph. These optical properties suggest that scheelite-type Gd2W2O9 may be a suitable host material for phosphors. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Inomata, Masayuki; Kishida, Kazuhisa; Maruyama, Yuki; Watanabe, Tomoaki] Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Watanabe, T (reprint author), Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Tama Ku, 1-1-1 Higashi Mita, Kawasaki, Kanagawa 2148571, Japan.	tomowata@meiji.ac.jp					Rosa ILV, 2006, MATER RES BULL, V41, P1791, DOI 10.1016/j.materresbull.2006.03.026; Qi ZM, 2001, PHYSICA B, V307, P45, DOI 10.1016/S0921-4526(01)00973-5; Errandonea D, 2009, MATER RES BULL, V44, P807, DOI 10.1016/j.materresbull.2008.09.024; Tsaryuk VI, 2001, SPECTROCHIM ACTA A, V57, P355, DOI 10.1016/S1386-1425(00)00378-4; Balaji D, 2014, J LUMIN, V146, P458, DOI 10.1016/j.jlumin.2013.10.008; Su YG, 2009, J MATER CHEM, V19, P2316, DOI 10.1039/b819287a; Wang Y, 2013, OPT MATER, V35, P998, DOI 10.1016/j.optmat.2012.12.003; Al-Kandari H, 2006, J ELECTRON SPECTROSC, V151, P128, DOI 10.1016/j.elspec.2005.11.007; Kim SW, 2011, CHEM LETT, V40, P498, DOI 10.1246/cl.2011.498; Tomaszewicz E, 2009, J RARE EARTH, V27, P569, DOI 10.1016/S1002-0721(08)60290-2; Basiev TT, 2000, OPT MATER, V15, P205, DOI 10.1016/S0925-3467(00)00037-9; ESAKA T, 1992, SOLID STATE IONICS, V57, P319, DOI 10.1016/0167-2738(92)90165-L; Kishida K, 2014, J PHYS CHEM SOLIDS, V75, P486, DOI 10.1016/j.jpcs.2013.12.003; Shen HB, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.112704; Kakihana M, 2009, J CERAM SOC JPN, V117, P857, DOI 10.2109/jcersj2.117.857; GURMEN E, 1971, J CHEM PHYS, V55, P1093; NASSAU K, 1971, J SOLID STATE CHEM, V3, P411, DOI 10.1016/0022-4596(71)90078-8; Chen Y, 2012, J ALLOY COMPD, V511, P123, DOI 10.1016/j.jallcom.2011.09.004; Yang XM, 2015, SUPERLATTICE MICROST, V80, P188, DOI 10.1016/j.spmi.2015.01.008; ZALKIN A, 1964, J CHEM PHYS, V40, P501, DOI 10.1063/1.1725143; TEMPLETON DH, 1963, ACTA CRYSTALLOGR, V16, P762, DOI 10.1107/S0365110X63001985; Voron'ko YK, 2000, INORG MATER+, V36, P947, DOI 10.1007/BF02758711; Su YG, 2008, CHEM MATER, V20, P6060, DOI 10.1021/cm8014435; Kang FW, 2013, J LUMIN, V135, P113, DOI 10.1016/j.jlumin.2012.10.041; Basiev TT, 1999, OPT MATER, V11, P307, DOI 10.1016/S0925-3467(98)00030-5; Kaczmarek SM, 2010, MATER CHEM PHYS, V124, P646, DOI 10.1016/j.matchemphys.2010.07.028; Kang FW, 2013, MATER SCI ENG B-ADV, V178, P477, DOI 10.1016/j.mseb.2013.01.021; Takai S, 1999, MATER RES BULL, V34, P193, DOI 10.1016/S0025-5408(99)00010-0; Du CF, 2013, J COLLOID INTERF SCI, V394, P94, DOI 10.1016/j.jcis.2012.11.012; Liu Y, 2014, INORG CHEM, V53, P11457, DOI 10.1021/ic501284y; ANTOINE P, 1987, REV INT HAUTES TEMP, V24, P43; Meng QY, 2011, J NANOSCI NANOTECHNO, V11, P182, DOI 10.1166/jnn.2011.3078; Esaka T, 1996, SOLID STATE IONICS, V92, P129, DOI 10.1016/S0167-2738(96)00462-6; RAISER D, 1991, J ELECTRON SPECTROSC, V57, P91, DOI 10.1016/0368-2048(91)85016-M; Lou ZD, 2002, MATER RES BULL, V37, P1573, DOI 10.1016/S0025-5408(02)00851-6; KAY MI, 1964, J CHEM PHYS, V40, P504, DOI 10.1063/1.1725144; Burcham LJ, 1998, SPECTROCHIM ACTA A, V54, P1355; Fomichev V.V., 1978, RUSS J INORG CHEM, V23, P47; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; TREADAWA.MJ, 1974, J CHEM PHYS, V61, P4003, DOI 10.1063/1.1681693	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	OCT	2015	48						251	255		10.1016/j.solidstatesciences.2015.08.003		5	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CU2IS	WOS:000363347800038		
J	Ishii, K; Suzuki, N; Mabuchi, Y; Ito, N; Kikura, N; Fukada, S; Okano, H; Takeda, S; Akazawa, C				Ishii, Kana; Suzuki, Nobuharu; Mabuchi, Yo; Ito, Naoki; Kikura, Naomi; Fukada, So-ichiro; Okano, Hideyuki; Takeda, Shin'ichi; Akazawa, Chihiro			Muscle Satellite Cell Protein Teneurin-4 Regulates Differentiation During Muscle Regeneration	STEM CELLS			English	Article						Satellite cell; Muscle stem cell; Regeneration; Muscle; Quiescence; Teneurin-4/Odz4	SKELETAL-MUSCLE; PROGENITOR CELLS; SELF-RENEWAL; PAX7; DISTINCT; SPECIFICATION; MAINTENANCE; POPULATION; QUIESCENCE; PROMOTES	Satellite cells are maintained in an undifferentiated quiescent state, but during muscle regeneration they acquire an activated stage, and initiate to proliferate and differentiate as myoblasts. The transmembrane protein teneurin-4 (Ten-4) is specifically expressed in the quiescent satellite cells; however, its cellular and molecular functions remain unknown. We therefore aimed to elucidate the function of Ten-4 in muscle satellite cells. In the tibialis anterior (TA) muscle of Ten-4-deficient mice, the number and the size of myofibers, as well as the population of satellite cells, were reduced with/without induction of muscle regeneration. Furthermore, we found an accelerated activation of satellite cells in the regenerated Ten-4-deficient TA muscle. The cell culture analysis using primary satellite cells showed that Ten-4 suppressed the progression of myogenic differentiation. Together, our findings revealed that Ten-4 functions as a crucial player in maintaining the quiescence of muscle satellite cells.	[Ishii, Kana; Suzuki, Nobuharu; Mabuchi, Yo; Kikura, Naomi; Akazawa, Chihiro] Tokyo Med & Dent Univ, Dept Biochem & Biophys, Grad Sch Hlth Care Sci, Tokyo 1138510, Japan; [Ito, Naoki; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 187, Japan; [Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Suita, Osaka, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan	Akazawa, C (reprint author), Tokyo Med & Dent Univ, Dept Biochem & Biophys, Grad Sch Hlth Care Sci, Bunkyo Ku, 1-5-45 Yushima,Bldg 3, Tokyo 1138510, Japan.	c.akazawa.bb@tmd.ac.jp	Okano, Hideyuki/J-5973-2013; Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan [25505001]; MEXT in Japan [25860701]; Ministry of Health, Labor and Welfare of Japan [2260201]	We thank Dr. Yoshihiko Yamada (NIDCR, NIH, Bethesda, MD) and Dr. Shinsuke Shibata (Keio University, Tokyo, Japan) for providing the furue mouse line and maintaining the line, respectively. We also thank Dr. Hidetoshi Sakurai (CiRA, Kyoto University, Kyoto, Japan) and Dr. Susana de Vega (Juntendo University, Tokyo, Japan) for his advice regarding the experiment and for critical reading the manuscript, respectively. This work was supported by the Grant-in-Aid for Scientific Research (C) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan (25505001) (C.A., N.S., and Y.M.), the Grant-in-Aid for Young Scientists of the MEXT in Japan (25860701) (N.S.), and the Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan (2260201) (C.A.).	Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Suzuki N, 2014, J ORTHOP RES, V32, P915, DOI 10.1002/jor.22616; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Shin J, 2013, INT J BIOCHEM CELL B, V45, P2266, DOI 10.1016/j.biocel.2013.05.001; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Chacon MR, 2011, CELL ADHES MIGR, V5, P52, DOI 10.4161/cam.5.1.13681; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Suzuki N, 2014, FASEB J, V28, P1386, DOI 10.1096/fj.13-241034; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Yamaguchi M, 2012, J MOL HISTOL, V43, P581, DOI 10.1007/s10735-012-9421-3; Suzuki N, 2012, J NEUROSCI, V32, P11586, DOI 10.1523/JNEUROSCI.2045-11.2012; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Fujimaki S, 2013, STEM CELLS INT, V2013; Kenzelmann-Broz Daniela, 2010, Int J Dev Biol, V54, P1509, DOI 10.1387/ijdb.103139dk; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	OCT	2015	33	10					3017	3027		10.1002/stem.2058		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CU1FD	WOS:000363264500013		
J	Kato, T				Kato, Tsukasa			Frequently Used Coping Scales: A Meta-Analysis	STRESS AND HEALTH			English	Article						COPE; coping behaviour; questionnaire; meta-analysis; ways of coping questionnaire	PRELIMINARY VALIDATION; PAIN PATIENTS; QUESTIONNAIRE; STRATEGIES; INVENTORY; STRESS; COPE; ADJUSTMENT	This article reports the frequency of the use of coping scales in academic journals published from 1998 to 2010. Two thousand empirical journal articles were selected from the EBSCO database. The COPE, Ways of Coping Questionnaire, Coping Strategies Questionnaire, Coping Inventory for Stressful Situations, Religious-COPE and Coping Response Inventory were frequently mentioned. In particular, the COPE (20.2%) and Ways of Coping Questionnaire (13.6%) were used the most frequently. In this literature reviewed, coping scales were most often used to assess coping with health issues (e.g. illness, pain and medical diagnoses) over other types of stressors, and patients were the most frequent participants. Further, alpha coefficients were estimated for the COPE subscales, and correlations between the COPE subscales and coping outcomes were calculated, including depressive symptoms, anxiety, negative affect, psychological distress, physical symptoms and well-being. Copyright (c) 2013 John Wiley & Sons, Ltd.	Toyo Univ, Dept Social Psychol, Bunkyo Ku, Tokyo 1128606, Japan	Kato, T (reprint author), Toyo Univ, Dept Social Psychol, Bunkyo Ku, 5-28-20 Hakusan, Tokyo 1128606, Japan.	mtsukasa@hotmail.com	Kato, Tsukasa/C-2066-2014	Kato, Tsukasa/0000-0002-0827-0051	Amour Science Project in Japan	This research was supported in part by the Amour Science Project in Japan.	Thompson B, 2000, EDUC PSYCHOL MEAS, V60, P174, DOI 10.1177/0013164400602002; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; STONE AA, 1984, J PERS SOC PSYCHOL, V46, P892, DOI 10.1037//0022-3514.46.4.892; LATACK JC, 1986, J APPL PSYCHOL, V71, P377, DOI 10.1037/0021-9010.71.3.377; JALOWIEC A, 1981, NURS RES, V30, P10, DOI 10.1097/00006199-198101000-00003; BENPORATH YS, 1991, J PERS ASSESS, V57, P162; AMIRKHAN JH, 1990, J PERS SOC PSYCHOL, V59, P1066, DOI 10.1037//0022-3514.59.5.1066; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; MCCUBBIN HI, 1983, J MARRIAGE FAM, V45, P359, DOI 10.2307/351514; Endler NS, 1998, PSYCHOL ASSESSMENT, V10, P195, DOI 10.1037/1040-3590.10.3.195; Lyne K, 2000, PERS INDIV DIFFER, V29, P321, DOI 10.1016/S0191-8869(99)00196-8; JENSEN MP, 1995, PAIN, V60, P203, DOI 10.1016/0304-3959(94)00118-X; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Eisengart SP, 2006, PSYCHOL ASSESSMENT, V18, P278, DOI 10.1037/1040-3590.18.3.278; Litman JA, 2006, PERS INDIV DIFFER, V41, P273, DOI 10.1016/j.paid.2005.11.032; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Ghaderi A, 2000, J NERV MENT DIS, V188, P273, DOI 10.1097/00005053-200005000-00004; Reid GJ, 1998, PAIN, V76, P83, DOI 10.1016/S0304-3959(98)00029-3; Harding R, 2011, PSYCHOL HEALTH MED, V16, P564, DOI 10.1080/13548506.2011.580352; Connor-Smith JK, 2000, J CONSULT CLIN PSYCH, V68, P976, DOI 10.1037/0022-006X.68.6.976; Rexrode KR, 2008, EDUC PSYCHOL MEAS, V68, P262, DOI 10.1177/0013164407310128; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.0.CO;2-1; PARGAMENT KI, 1990, AM J COMMUN PSYCHOL, V18, P793, DOI 10.1007/BF00938065; WATSON M, 1988, PSYCHOL MED, V18, P203; TOBIN DL, 1989, COGNITIVE THER RES, V13, P343, DOI 10.1007/BF01173478; Carver C. S, 1981, ATTENTION SELF REGUL; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037//0022-3514.56.2.267; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037//0022-3514.58.5.844; Endler NS, 1990, COPING INVENTORY STR; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; Folkman S., 1988, MANUAL WAYS COPING Q; Folkman S., 1984, STRESS APPRAISAL COP; Frydenberg E., 1993, ADOLESCENT COPING SC; Kraaimaat F. W., 1997, GEDRAGSTHERAPIE, V22, P267; Lazarus R. S., 1999, STRESS EMOTION NEW S; Moos L. H., 1988, COPING RESPONSE INVE; Moos L. H., 1993, COPING RESPONSE INVE; Parker J. D. A., 2000, COPING HLTH INJURIES; PARKER JDA, 1992, EUR J PERSONALITY, V6, P321, DOI 10.1002/per.2410060502; Patterson J. M., 1987, FAMILY ASSESSMENT IN, P225; Schreurs P. J. G., 1984, GEDRAG TIJDSCHRIFT P, V12, P107; Seiffge-Krenke I., 1989, Z DIFFERENTIELLE DIA, V10, P201; Seiffge-Krenke I., 1995, STRESS COPING RELATI	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1532-3005	1532-2998		STRESS HEALTH	Stress Health	OCT	2015	31	4					315	323		10.1002/smi.2557		9	Psychology, Applied; Psychiatry; Psychology	Psychology; Psychiatry	CT8UC	WOS:000363091000008		
J	Miyasaka, K; Mutsuura, M; Miyazaki, K; Okuno, M; Mizu, M; Kawai, T				Miyasaka, Kiyoaki; Mutsuura, Mizuki; Miyazaki, Kohei; Okuno, Masahiro; Mizu, Masami; Kawai, Toshikazu			Difference in taste of Japanese sugars - A taste sensing system and a sensory evaluation method	SUGAR INDUSTRY-ZUCKERINDUSTRIE			English	Editorial Material						sugar; taste; sensory evaluation method; taste model membrane		Japanese traditional cuisine "Washoku" was registered as one of the intangible cultural heritages in December 2013. "Washoku" contains and requires large amount of sugar, therefore, sugar is an important seasoning in taste. Japanese have been using many kinds of sugar such as Granulated sugar, White soft sugar, Brown soft sugar, White crystal sugar and Light brown crystal sugar according to application, for both home cooking and processed foods. Mitsui Sugar is focusing on the difference in taste of sugars to develop new attractive sugar products. With a sensory evaluation method, trained panelists could recognize the difference between these sugars though it is quite difficult to explain. Therefore one attempted to detect the taste difference in these sugars by using a taste sensing system. The system comes with a human taste model membrane and can analyze the density and balance of several tastes such as sweetness, bitterness, umami** and saltiness. The accuracy of the sensing system was evaluated by comparing the results against the sensory evaluation method by trained panelists. The sensing system was able to detect the difference in taste of Japanese sugars, and the results from the sensing system seemed to match with the ones from the sensory evaluation method. The results were plotted on a taste map. This map will be helpful not only in showing the difference between the sugars, but also in explaining the characteristics of the new products.	[Miyasaka, Kiyoaki; Mutsuura, Mizuki; Miyazaki, Kohei; Okuno, Masahiro; Mizu, Masami; Kawai, Toshikazu] Mitsui Sugar Co Ltd, Chou Ku, Tokyo 1038423, Japan	Miyasaka, K (reprint author), Mitsui Sugar Co Ltd, Chou Ku, 36-2 Nihonbashi Hakozakicho, Tokyo 1038423, Japan.	Kiyoaki.Miyasaka@mitsui-sugar.co.jp					Office of Nutrition Cancer Measures and Health Promotion Division Health Service Bureau Ministry of Health Labour and Welfare Japan, 2012, NAT HLTH NUTR SURV J; Yoshikazu Kobayashi, 2010, SENSORS, V10, P3411	2	0	0	VERLAG DR ALBERT BARTENS	BERLIN 38	LUCKHOFFSTRASSE 16, D-14129 BERLIN 38, GERMANY	0344-8657			SUGAR IND	Sugar Ind.	OCT	2015	140	10					624	627				4	Food Science & Technology	Food Science & Technology	CU4JF	WOS:000363493800010		
J	Ogawa, T; Koeda, M; Nitta, K				Ogawa, Tetsuya; Koeda, Misato; Nitta, Kosaku			Left Ventricular Diastolic Dysfunction in End-Stage Kidney Disease: Pathogenesis, Diagnosis, and Treatment	THERAPEUTIC APHERESIS AND DIALYSIS			English	Review						Dialysis; Diastolic dysfunction; Doppler echocardiography; End-stage kidney disease; Mortality	LEFT ATRIAL VOLUME; CHRONIC-HEMODIALYSIS PATIENTS; PRESERVED EJECTION FRACTION; RANDOMIZED CONTROLLED-TRIAL; CONGESTIVE-HEART-FAILURE; GROWTH-FACTOR 23; VITAMIN-D; RENAL-DISEASE; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS	Diastolic dysfunction is frequently observed in end-stage kidney disease (ESKD), and ESKD patients have many risk factors for heart failure (HF), including hypertension, diabetes, and coronary artery disease. Diastolic HF, also called HF with preserved ejection fraction, refers to a clinical syndrome in which patients have symptoms and signs of HF, normal or near normal left ventricular (LV) systolic function, and evidence of diastolic dysfunction manifested by abnormal LV filling and elevated filling pressure. Recent reports suggest that HF with preserved ejection fraction is more common in hemodialysis patients than HF with low ejection fraction. Diastolic HF in ESKD patients is a strong predictor of death. In this article, we review the information available in the literature on the pathogenesis, diagnosis, and potential treatment strategies of diastolic dysfunction or diastolic HF based on evidence obtained in the general population that is potentially applicable to ESKD patients.	Tokyo Womens Med Univ, Dept Med, Med Ctr East, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Kidney Ctr, Tokyo 1628666, Japan	Nitta, K (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo 1628666, Japan.	knitta@kc.twmu.ac.jp					Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Sharma R, 2006, J AM SOC ECHOCARDIOG, V19, P266, DOI 10.1016/j.echo.2005.10.006; Jono S, 2000, CIRC RES, V87, pE10; Saudan P, 2003, NEPHROL DIAL TRANSPL, V18, P2359, DOI 10.1093/ndt/gfg388; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.000017264.66561.3D; Lemmila S, 1998, AM J NEPHROL, V18, P404, DOI 10.1159/000013384; Angomachalelis N, 1996, HEART VESSELS, V11, P303, DOI 10.1007/BF01747189; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Andress DL, 2006, KIDNEY INT, V69, P33, DOI 10.1038/sj.ki.5000045; Hsu HJ, 2009, AM J MED SCI, V337, P116, DOI 10.1097/MAJ.0b013e3181815498; Laviades C, 2000, HYPERTENSION, V36, P517; Cuppari L, 2009, J RENAL NUTR, V19, P38, DOI 10.1053/j.jrn.2008.10.005; Valdivielso JM, 2008, KIDNEY INT, V74, pS44, DOI 10.1038/ki.2008.545; Nagano N, 2006, PHARMACOL THERAPEUT, V109, P339, DOI 10.1016/j.pharmthera.2005.06.019; Barberato SH, 2004, AM J CARDIOL, V94, P1208, DOI 10.1016/j.amjcard.2004.07.100; Drechsler C, 2010, EUR HEART J, V31, P2253, DOI 10.1093/eurheartj/ehq246; MARANTZ PR, 1994, SOUTHERN MED J, V87, P728, DOI 10.1097/00007611-199407000-00011; Yip G, 2002, HEART, V87, P121, DOI 10.1136/heart.87.2.121; Tripepi G, 2006, J HYPERTENS, V24, P1173, DOI 10.1097/01.hjh.0000226208.11184.bb; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Ogata H, 2003, J AM SOC NEPHROL, V14, P959, DOI 10.1097/01.ASN.0000056188.23717.E5; Bucharles S, 2011, NEPHRON CLIN PRACT, V118, pC384, DOI 10.1159/000323664; Park CW, 1999, AM J KIDNEY DIS, V33, P73, DOI 10.1016/S0272-6386(99)70260-X; Artaza JN, 2009, CLIN J AM SOC NEPHRO, V4, P1515, DOI 10.2215/CJN.02260409; Dhingra R, 2010, EUR J HEART FAIL, V12, P812, DOI 10.1093/eurjhf/hfq106; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Fagugli RM, 2006, J NEPHROL, V19, P77; Shizuku J, 2012, INTERNAL MED, V51, P1479, DOI 10.2169/internalmedicine.51.7284; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Parfrey PS, 2009, CLIN J AM SOC NEPHRO, V4, P755, DOI 10.2215/CJN.02730608; Yamamoto K, 2009, CIRC J, V73, P404; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Cottone S, 2007, CLIN NEPHROL, V67, P209; Quiroga B, 2013, BLOOD PURIFICAT, V36, P98, DOI 10.1159/000354080; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Mattioli AV, 2004, INT J CARDIOL, V97, P383, DOI 10.1016/j.ijcard.2003.10.018; Burkhoff D, 2003, CIRCULATION, V107, P656, DOI 10.1161/01.CIR.0000053947.82595.03; Zoccali C, 2011, AM J NEPHROL, V33, P370, DOI 10.1159/000326239; Ortega O, 2004, NEPHRON CLIN PRACT, V97, pC125, DOI 10.1159/000079170; Ohtake T, 2012, THER APHER DIAL, V16, P181, DOI 10.1111/j.1744-9987.2011.01042.x; Koleganova N, 2009, LAB INVEST, V89, P520, DOI 10.1038/labinvest.2009.7; Tyralla K, 2003, KIDNEY INT, V63, pS80; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_1.29; Ferreira-Martins J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/807084; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Sato A, 1999, AM J HYPERTENS, V12, P867, DOI 10.1016/S0895-7061(99)00066-7; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; BONOW RO, 1992, ANN INTERN MED, V117, P502; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Habibi J, 2011, AM J PHYSIOL-HEART C, V300, pH1484, DOI 10.1152/ajpheart.01000.2010; Matias PJ, 2010, CLIN J AM SOC NEPHRO, V5, P905, DOI 10.2215/CJN.06510909; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; AMANN K, 1994, J AM SOC NEPHROL, V4, P1814; Lutsey PL, 2014, AM J CLIN NUTR, V100, P756, DOI 10.3945/ajcn.114.085167; Barberato SH, 2010, ARQ BRAS CARDIOL, V94, P457, DOI 10.1590/S0066-782X2010005000016; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Mitsunami K, 1998, CARDIOVASC DRUG THER, V12, P469, DOI 10.1023/A:1007754100351; Skaluba SJ, 2004, CIRCULATION, V109, P972, DOI 10.1161/01.CIR.0000117405.74491.D2; Barberato SH, 2007, J AM SOC ECHOCARDIOG, V20, P359, DOI 10.1016/j.echo.2006.09.002; Garcia EH, 2006, INT J CARDIOL, V108, P181, DOI 10.1016/j.ijcard.2005.04.026; Hirakata H, 2012, THER APHER DIAL, V16, P387, DOI 10.1111/j.1744-9987.2012.01088.x; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Quarles LD, 2012, EXP CELL RES, V318, P1040, DOI 10.1016/j.yexcr.2012.02.027; Chetow GM, 2010, NEW ENGL J MED, V363, P2287; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Komamura K., 2013, CARDIOL RES PRACT, V2013; Rostand SG, 1999, KIDNEY INT, V56, P383, DOI 10.1046/j.1523-1755.1999.00575.x; Vlahakos DV, 1997, J AM SOC NEPHROL, V8, P1764; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	76	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					427	435		10.1111/1744-9987.12301		9	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700002		
J	Takura, T; Nakanishi, T; Kawanishi, H; Nitta, K; Akizawa, T; Hiramatsu, M; Kawasaki, T; Kukita, K; Soejima, H; Hirakata, H; Yoshida, T; Miyamoto, T; Takahashi, S				Takura, Tomoyuki; Nakanishi, Takeshi; Kawanishi, Hideki; Nitta, Kosaku; Akizawa, Tadao; Hiramatsu, Makoto; Kawasaki, Tadayuki; Kukita, Kazutaka; Soejima, Hidehisa; Hirakata, Hideki; Yoshida, Toyohiko; Miyamoto, Takashi; Takahashi, Susumu			Cost-Effectiveness of Maintenance Hemodialysis in Japan	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Cost effectiveness analysis; Diabetic nephropathy; Hemodialysis; Incremental cost utility ratio; Quality adjusted life year	MORTALITY; THERAPY	The cost-effectiveness according to primary disease or dialysis duration has never been analyzed with respect to maintenance hemodialysis (MHD). Study candidates were>20 years of age and had received hemodialysis for at least 6 months. Hemodialysis patients were prospectively observed for 36 months, and patient utility was assessed based on the Euro-QOL 5-dimensions (EQ-5D), from which the quality adjusted life years (QALYs) were estimated. Medical costs were calculated based on medical service fees. The cost-effectiveness defined as the incremental cost utility ratio (ICUR) was analyzed from a social perspective. A total of 29 patients (mean age; 59.9 +/- 13.1 years) undergoing 437 dialysis sessions were analyzed. Utility based upon the EQ-5D score was 0.75 +/- 0.21, and the estimated total medical cost for one year of MHD treatment was 4.52 +/- 0.88 US$10000. ICUR was 6.88 +/- 4.47 US$10000/QALY on average, and when comparing ICUR based on the causes of kidney failure, the value for diabetic nephropathy was found to be higher than that for glomerulonephritis (8.17 +/- 6.28 vs. 6.82 +/- 4.07). ICUR after 36 months observation increased mainly in the patients below 65 years of age (All; P<0.05, <65; P<0.01, 65; not significant). MHD is a treatment that could improve the socioeconomic state of elderly patients with end-stage kidney disease (ESKD), but the ICUR for diabetic nephropathy was higher than that for glomerulonephritis.	[Takura, Tomoyuki] Osaka Univ, Grad Sch Med, Dept Hlth Econ & Ind Policy, Suita, Osaka 5650871, Japan; [Nakanishi, Takeshi] Hyogo Coll Med, Div Kidney & Dialysis, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Miyamoto, Takashi] Miyamoto Clin, Kobe, Hyogo, Japan; [Kawanishi, Hideki] Tsuchiya Gen Hosp, Hiroshima, Japan; [Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan; [Akizawa, Tadao] Showa Univ, Div Nephrol, Sch Med, Tokyo, Japan; [Takahashi, Susumu] Int Kidney Evaluat Assoc Japan IKEAJ, Tokyo, Japan; [Hiramatsu, Makoto] Okayama Saiseikai Gen Hosp, Dept Nephrol, Okayama, Japan; [Kawasaki, Tadayuki] Maeda Inst Renal Res, Dept Clin Engn, Chiba, Japan; [Yoshida, Toyohiko] Mihama Hosp, Dept Urol, Chiba, Japan; [Kukita, Kazutaka] Sapporo Hokuyu Hosp, Dept Surg, Sapporo, Hokkaido, Japan; [Soejima, Hidehisa] Saiseikai Kumamoto Hosp, Dept Nephrol, Kumamoto, Japan; [Soejima, Hidehisa] Saiseikai Kumamoto Hosp, Urol Ctr, Kumamoto, Japan; [Hirakata, Hideki] Fukuoka Red Cross Hosp, Dept Nephrol, Fukuoka, Japan	Takura, T (reprint author), Osaka Univ, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takura@heip.med.osaka-u.ac.jp			Osaka University Graduate School of Medicine	This study was self-funded by the Osaka University Graduate School of Medicine.	Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kontodimopoulos N, 2008, HEALTH POLICY, V86, P85, DOI 10.1016/j.healthpol.2007.10.002; Wake N, 2000, DIABETES RES CLIN PR, V48, P201, DOI 10.1016/S0168-8227(00)00122-4; Schweitzer EJ, 2007, AM J TRANSPLANT, V7, P1515, DOI 10.1111/j.1600-6143.2007.01769.x; Takura T, 2013, BLOOD PURIFICAT, V35, P85, DOI 10.1159/000346358; Kiberd BA, 1995, BRIT MED J, V311, P1595; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Bleyer AJ, 1999, KIDNEY INT, V55, P1553, DOI 10.1046/j.1523-1755.1999.00391.x; MAYNARD A, 1991, ECON J, V101, P1277, DOI 10.2307/2234443; Liem YS, 2003, RADIOLOGY, V226, P53, DOI 10.1148/radiol.2261011893; Black C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14210; Herman WH, 2005, ANN INTERN MED, V142, P323; Fukuda T, 2013, J NATL I PUBLIC HLTH, V62, P590; Takura T, 2009, TRANSPLANTATION, V44, P60	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					441	449		10.1111/1744-9987.12314		9	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700004		
J	Washida, N; Inoue, S; Kasai, T; Shinozuka, K; Hosoya, K; Morimoto, K; Wakino, S; Hayashi, K; Itoh, H				Washida, Naoki; Inoue, Shuji; Kasai, Takahiro; Shinozuka, Keisuke; Hosoya, Koji; Morimoto, Kohkichi; Wakino, Shu; Hayashi, Koichi; Itoh, Hiroshi			Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Blood pressure; Darbepoetin alfa; Epoetin beta pegol; Iron utilization	ERYTHROPOIETIN RECEPTOR ACTIVATOR; CHRONIC KIDNEY-DISEASE; STABLE HEMOGLOBIN LEVELS; HEMODIALYSIS-PATIENTS; RENAL ANEMIA; PHASE-II; CERA; CONVERSION; EFFICACY; HEPCIDIN	New erythropoiesis-stimulating agents with a longer half-life have been developed for the treatment of anemia in patients with end-stage renal disease. This study evaluated the efficacy of darbepoetin alfa (DA) and long-acting epoetin beta pegol (continuous erythropoietin receptor activator, CERA) in patients on peritoneal dialysis (PD). Twenty-nine patients who had undergone PD for at least 6 months and were iron replacement-naive and negative for inflammatory parameters were enrolled. Hemoglobin (Hgb) levels and blood pressure were evaluated before and after switching from DA to CERA. Percent transferrin saturation (TSAT), serum ferritin levels and blood pressure were also assessed. Twenty-eight patients were subject to the analysis, excluding one patient with a decrease in Hgb by 10%. Switching from DA to CERA did not alter Hgb levels. The doses of DA and CERA after 12 month treatment of each agent were 118.48 +/- 79.63 and 89.88 +/- 47.50g/4 weeks, respectively (conversion ratio, 1:0.76). The CERA dose administered during the final 6 months was abated, compared with that given during the initial 6 months (P=0.035). The frequency of CERA injection over a 12-month period was less than that of DA (10.0 +/- 3.0 vs. 16.4 +/- 5.0, P<0.01). The conversion from DA to CERA did not alter TSAT, but decreased serum ferritin levels (from 202.69 +/- 132.57 to 150.15 +/- 110.07ng/mL, P=0.012) and systolic blood pressure (from 133.8 +/- 17.3 to 129.5 +/- 11.3mm Hg, P=0.024). In PD patients, lower doses and less frequent injection of CERA are sufficient to maintain Hgb at levels similar to those achieved by DA therapy, with improved iron utilization and reduced blood pressure.	[Washida, Naoki; Kasai, Takahiro; Shinozuka, Keisuke; Morimoto, Kohkichi; Wakino, Shu; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Endocrinol Metab & Nephrol, Tokyo 1608582, Japan; [Hosoya, Koji] Saiseikai Cent Hosp, Dept Nephrol, Tokyo, Japan; [Inoue, Shuji] Saitama Med Ctr, Dept Nephrol, Saitama, Japan	Washida, N (reprint author), Keio Univ, Sch Med, Dept Endocrinol Metab & Nephrol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	naoki_washida@yahoo.co.jp			Chugai Pharmaceutical Co., Ltd.; Kyowa-Hakko Kirin Pharmaceutical Co., Ltd.	Naoki Washida, Shuji Inoue, Takahiro Kasai, Keisuke Shinozuka, Koji Hosoya, Kohkichi Morimoto and Shu Wakino declare that they have no conflict of interest. The authors report no conflict of interest in the preparation of this paper. Hiroshi Itoh has received research funding from Chugai Pharmaceutical Co., Ltd. Koichi Hayashi has received consultancy fees from Kyowa-Hakko Kirin Pharmaceutical Co., Ltd.	Sasaki Y, 2014, INT J HEMATOL, V99, P561, DOI 10.1007/s12185-014-1554-6; Hussein AAM, 2012, CAN J PHYSIOL PHARM, V90, P1535, DOI 10.1139/y2012-120; Macdougall IC, 2006, CLIN J AM SOC NEPHRO, V1, P1211, DOI 10.2215/CJN.00730306; Vankar SG, 2014, INDIAN J MED RES, V139, P112; Kubota M, 2011, CLIN EXP NEPHROL, V15, P884, DOI 10.1007/s10157-011-0527-9; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Bradbury BD, 2009, NEPHROL DIAL TRANSPL, V24, P919, DOI 10.1093/ndt/gfn543; Trincavelli ML, 2013, INT J MOL SCI, V14, P2258, DOI 10.3390/ijms14022258; Jonckheere S, 2010, ACTA HAEMATOL-BASEL, V124, P27, DOI 10.1159/000313785; Weinreich T, 2012, HEMODIAL INT, V16, P11, DOI 10.1111/j.1542-4758.2011.00608.x; Levin NW, 2007, LANCET, V370, P1415, DOI 10.1016/S0140-6736(07)61599-2; Besarab A, 2007, CLIN THER, V29, P626, DOI 10.1016/j.clinthera.2007.04.014; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Provenzano R, 2007, CLIN NEPHROL, V67, P306; Gonzalez MT, 2013, RENAL FAILURE, V35, P314, DOI 10.3109/0886022X.2012.755903; Chen CY, 2011, PERITON DIALYSIS INT, V31, P592, DOI 10.3747/PDI.2011.00013; Locatelli F, 2013, J NEPHROL, V26, P1114, DOI 10.5301/jn.5000251; Minutolo R, 2010, BLOOD PURIFICAT, V30, P186, DOI 10.1159/000321486; Galle JC, 2012, NEPHROL DIAL TRANSPL, V27, P2303, DOI 10.1093/ndt/gfr677; Sasaki Y, 2012, INT J HEMATOL, V96, P692, DOI 10.1007/s12185-012-1217-4; Carrera F, 2010, NEPHROL DIAL TRANSPL, V25, P4009, DOI 10.1093/ndt/gfq305; Selby NM, 2012, PERITON DIALYSIS INT, V32, P177, DOI 10.3747/pdi.2010.00299; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Macdougall IC, 1999, J AM SOC NEPHROL, V10, P2392; Jordan Jessica, 2012, Can J Hosp Pharm, V65, P443; Feriani M, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-13; Kakimoto-Shino M, 2014, THER APHER DIAL, V18, P421, DOI 10.1111/1744-9987.12161; Lo WK, 2008, PERITON DIALYSIS INT, V28, pS76; Morikami Y, 2014, THER APHER DIAL, V18, P414, DOI 10.1111/1744-9987.12164; Suzuki Hiromichi, 2011, Adv Perit Dial, V27, P60	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					450	456		10.1111/1744-9987.12306		7	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700005		
J	Tsubakihara, Y; Akizawa, T; Iwasaki, M; Shimazaki, R				Tsubakihara, Yoshiharu; Akizawa, Tadao; Iwasaki, Manabu; Shimazaki, Ryutaro			High Hemoglobin Levels Maintained by an Erythropoiesis-Stimulating Agent Improve Renal Survival in Patients with Severe Renal Impairment	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Anemia; Chronic kidney disease; Erythropoiesis stimulating agents; Renal function	CHRONIC KIDNEY-DISEASE; ANEMIA; FAILURE; TRIAL; ALPHA	Our goal was to investigate the effect modification of maintaining a high Hb target range through erythropoiesis-stimulating agent therapy on the renal outcome with respect to chronic kidney disease (CKD) stage and concurrent diabetes condition in patients with CKD. We used data from a previously reported randomized controlled trial involving 321 CKD patients not on dialysis, with Hb levels of <10g/dL, and serum creatinine (Cr) of 2.0 to 6.0mg/dL, and in which maintaining Hb levels at 11.0-13.0g/dL with darbepoetin- (High Hb group) resulted in a greater renal protective effect than maintaining Hb levels at 9.0-11.0g/dL with epoetin- (Low Hb group). We conducted a post-hoc analysis of the effects of baseline CKD stage and concurrent diabetic condition on the renal composite endpoint, consisting of death, initiation of renal replacement therapy, and doubling of the serum Cr level. Both groups with stage 4 CKD had a 3-year cumulative renal survival rate of 53.8%, whereas in patients with stage 5 CKD, the rate in the High Hb group (31.0%) was significantly (P=0.012) higher than that in the Low Hb group (19.1%). The observations made in patients with stage 5 CKD were maintained on further analysis of non-diabetic patients, but were not seen in those with diabetes or stage 4 CKD. These results suggest that in patients with stage 5 CKD, especially those without diabetes, achieving a higher target Hb level with erythropoiesis-stimulating agents is associated with a greater renoprotective effect.	[Tsubakihara, Yoshiharu] Osaka Univ, Dept Comprehens Kidney Dis Res, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Nephrol, Tokyo 142, Japan; [Iwasaki, Manabu] Seikei Univ, Fac Sci & Technol, Tokyo, Japan; [Shimazaki, Ryutaro] Kyowa Hakko Kirin Co Ltd, R&D Div, Tokyo, Japan	Tsubakihara, Y (reprint author), Osaka Univ, Dept Comprehens Kidney Dis Res, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	cyq06075@nifty.ne.jp			Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan [121, CRG030600049]	This RCT was sponsored by Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan (Registration of Clinical Trials: The Cochrane Renal Group registry: autoid 121, crg_id CRG030600049).	Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Slinin Y, 2010, CLIN J AM SOC NEPHRO, V5, P1574, DOI 10.2215/CJN.01320210; Nakai S, 2008, THER APHER DIAL, V12, P428, DOI 10.1111/j.1744-9987.2008.00634.x; Tsubakihara Y, 2012, THER APHER DIAL, V16, P529, DOI 10.1111/j.1744-9987.2012.01082.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; Kuriyama S, 1997, NEPHRON, V77, P176; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Akizawa T, 2011, CLIN EXP NEPHROL, V15, P248, DOI 10.1007/s10157-010-0396-7; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Akizawa T, 2011, THER APHER DIAL, V15, P431, DOI 10.1111/j.1744-9987.2011.00931.x	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					457	465		10.1111/1744-9987.12308		9	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700006		
J	Kamei, K; Sako, M; Ishikawa, T; Sato, M; Ogura, M; Uno, T; Kiyotani, C; Mori, T; Tanaka, H; Ito, S; Nakamura, H				Kamei, Koichi; Sako, Mayumi; Ishikawa, Tomoaki; Sato, Mai; Ogura, Masao; Uno, Teruaki; Kiyotani, Chikako; Mori, Tetsuya; Tanaka, Hideaki; Ito, Shuichi; Nakamura, Hidefumi			Pharmacokinetics of Carboplatin in a One-Year-Old Anuric Boy Undergoing Hemodialysis and a Review of the Literature	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Carboplatin; Hemodialysis; Hepatoblastoma; Infant; Pharmacokinetic analysis	DEPENDENT RENAL-INSUFFICIENCY; CANCER; CHILDREN; PATIENT; FORMULA; ETOPOSIDE	There have been few reports of carboplatin-based chemotherapy for anuric infants. As we had a chance to treat a one-year-old anuric hepatoblastoma patient with carboplatin, we performed a pharmacokinetic analysis and examined the optimal treatment strategy. A one-year-old anuric boy under peritoneal dialysis was diagnosed with hepatoblastoma. Surgical resection was performed, and administration of carboplatin was scheduled postoperatively aiming at 5mg<bold>min</bold>/mL of the area under the curve from the time of dosing to the time of the last observation (AUC(0-t)). We set the initial dose at 50mg, higher than that calculated by the Calvert formula (34mg); the time from the end of carboplatin infusion to the initiation of hemodialysis at 2h; and the hemodialysis duration at 24h. The actual AUC(0-t) was 3.05mg<bold>min</bold>/mL because the elimination half-lives before and during hemodialysis were shorter than expected. The AUC(0-t) after the second dose (100mg) and the third dose (80mg) were 7.00 and 4.68mg<bold>min</bold>/mL, respectively. The Calvert formula is not suitable for hemodialysis patients because removal of platinum by hemodialysis is not taken into account. It appears that extrarenal clearance in anuric infants is different from that in adults. We obtained an optimal AUC(0-t) using a dose of 80mg (200mg/m(2)), setting the time from the end of carboplatin infusion to the initiation of hemodialysis at 2h, and performing 8-h hemodialysis. Further accumulation of the pharmacokinetic data of carboplatin is necessary for anuric children.	[Kamei, Koichi; Ishikawa, Tomoaki; Sato, Mai; Ogura, Masao; Ito, Shuichi] Natl Ctr Child Hlth & Dev, Dept Nephrol & Rheumatol, Tokyo 1578535, Japan; [Sako, Mayumi; Nakamura, Hidefumi] Natl Ctr Child Hlth & Dev, Div Clin Trials, Dept Dev Strategy, Ctr Social & Clin Res,Natl Res Inst Child Hlth &, Tokyo 1578535, Japan; [Uno, Teruaki; Kiyotani, Chikako; Mori, Tetsuya] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo 1578535, Japan; [Tanaka, Hideaki] Natl Ctr Child Hlth & Dev, Dept Surg, Tokyo 1578535, Japan	Kamei, K (reprint author), Natl Ctr Child Hlth & Dev, Dept Nephrol & Rheumatol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	kamei-k@ncchd.go.jp					Oguri T, 2010, CANCER CHEMOTH PHARM, V66, P813, DOI 10.1007/s00280-010-1366-1; Hiraike M, 2012, CANCER CHEMOTH PHARM, V69, P845, DOI 10.1007/s00280-011-1802-x; ELYAZIGI A, 1995, J CLIN PHARMACOL, V35, P1003; Du Bois D, 1916, ARCH INTERN MED, V17, P863; PENG B, 1995, EUR J CANCER, V31A, P1804, DOI 10.1016/0959-8049(95)00382-S; MOTZER RJ, 1990, CANCER CHEMOTH PHARM, V27, P234, DOI 10.1007/BF00685719; CHATELUT E, 1994, NEPHRON, V66, P157; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748; DOZ F, 1990, MED PEDIATR ONCOL, V18, P459, DOI 10.1002/mpo.2950180605; Mann JR, 2000, J CLIN ONCOL, V18, P3809; NEWELL DR, 1993, J CLIN ONCOL, V11, P2314; English MW, 1996, BRIT J CANCER, V73, P776, DOI 10.1038/bjc.1996.135; Go RS, 1999, J CLIN ONCOL, V17, P409	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					491	496		10.1111/1744-9987.12302		6	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700011		
J	Gu, XZ; Itoh, K				Gu, Xiuzhu; Itoh, Kenji			Construct of Dialysis Employee Satisfaction: Acquiring Satisfaction Factors and Their Contributions	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Dialysis; Job satisfaction; Questionnaires; Satisfaction factors; Validity	JOB-SATISFACTION	We developed a construct of dialysis employees' satisfaction as an assessment framework and identified the crucial factors that contribute to overall job satisfaction. We also seek to capture some important characteristics of dialysis professionals' job satisfaction/dissatisfaction in Japan. A questionnaire was developed, including 35 facet-specific job-related satisfaction and 10 general satisfaction items in closed-ended questions. A questionnaire-based survey was conducted between August and October 2013. A total of 799 valid responses (87% of response rate) were collected from 46 physicians, 470 nurses and 251 technologists in the dialysis department of 43 facilities in Japan. Five satisfaction factors were derived by applying principal component analysis with 61% of cumulative variance accounted for. Physicians, nurses and technologists in the dialysis department shared a similar trend of job satisfaction that they were more satisfied with leadership, and communication and teamwork among the five factors, whereas their satisfaction level was relatively low with salary and welfare conditions. Physicians expressed the strongest satisfaction with any factor while nurses were the least satisfied. Nurses' and technologists' overall job satisfaction was mostly determined by satisfaction with self-actualization, and work demands and workload. A five-factor construct of dialysis employee satisfaction was identified. Overall job satisfaction of dialysis nurses and technologists were not overly high in Japan, and this seems to be caused by their relatively low satisfaction with self-actualization and with work demands and workload. Therefore, it is suggested that their work conditions and environment must be improved to support their self-actualization and to reduce their workload.	[Gu, Xiuzhu; Itoh, Kenji] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Ind Engn & Management, Tokyo 152, Japan	Gu, XZ (reprint author), W9-55,2-12-1 Oh Okayama,Meguro Ku, Tokyo 1528552, Japan.	xiuzhu.g.aa@m.titech.ac.jp			Japan Society for the Promotion of Science [23241048]	This work was in part supported by a Grant-in-Aid for Scientific Research (A) (No. 23241048), Japan Society for the Promotion of Science. We would like to acknowledge Takashi Akiba, Professor, MD, Tokyo Women's Medical University and Satoshi Suzuki, Professor, Kanagawa Institute of Technology, for their insightful discussions and comments. We are grateful to dialysis professionals for their participation in our survey and to hospital staff for their assistance in data collection.	Acorn S, 1999, Can Nurse, V95, P33; Williams ES, 1999, MED CARE, V37, P1140, DOI 10.1097/00005650-199911000-00006; Leigh JP, 2002, ARCH INTERN MED, V162, P1577, DOI 10.1001/archinte.162.14.1577; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Tsang SS, 2012, J NURS RES, V20, P9, DOI 10.1097/JNR.0b013e318247bf11; Brayfield AH, 1951, J APPL PSYCHOL, V35, P307, DOI 10.1037/h0055617; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; Shimazu A, 2004, PSYCHOL REP, V94, P449; Labiris G, 2008, J MED SYST, V32, P333, DOI 10.1007/s10916-008-9138-8; JUDGE TA, 1993, J APPL PSYCHOL, V78, P939, DOI 10.1037//0021-9010.78.6.939; Brokalaki H, 2001, EDTNA ERCA J, V27, P181; Hayes B, 2010, REN CARE, V36, P174; Hofstede Geert H., 1984, CULTURES CONSEQUENCE; Judge T. A., 2007, SCI SUBJECTIVE WELL, P393; Krogstad U, 2006, HUM RESOUR HEALTH, V17, P3; Nakahara N, 2004, EDTNA ERCA J, V30, P217; Nunnaly J.C., 1978, PSYCHOMETRIC THEORY; OECD, 2013, HLTH GLANC 2013 OECD; Perumal Seena, 2003, Nephrol Nurs J, V30, P523; Portoghese Igor, 2014, Saf Health Work, V5, P152, DOI 10.1016/j.shaw.2014.05.004; Ross Jamie, 2009, J Ren Care, V35, P127, DOI 10.1111/j.1755-6686.2009.00102.x; Smith P. C., 1969, MEASUREMENT SATISFAC; Spector P.E., 1997, JOB SATISFACTION APP; The Japanese Society for Dialysis Therapy, 2013, CURR STAT CHRON DIAL; van Saane N, 2003, OCCUP MED-OXFORD, V53, P191, DOI 10.1093/occmed/kqg038; Weiss DJ, 1967, MANUAL MINNESOTA STA	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					503	512		10.1111/1744-9987.12297		10	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700013		
J	Wada, K; Araki, M; Wada, Y				Wada, Kentaro; Araki, Motoo; Wada, Yuko			Rare but Life-Threatening Complication: Delayed Common Iliac Vein Perforation by Hemodialysis Catheter	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Wada, Kentaro] Nippon Kokan Fukuyama Hosp, Div Nephrol & Dialysis, Dept Internal Med, Hiroshima, Japan; [Araki, Motoo] Cent Hosp, Dept Internal Med, Hiroshima, Japan; [Wada, Yuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama, Japan	Wada, K (reprint author), Nippon Kokan Fukuyama Hosp, Div Nephrol & Dialysis, Dept Internal Med, Hiroshima, Japan.	kyw620@hotmail.co.jp					Oliver MJ, 2001, SEMIN DIALYSIS, V14, P432, DOI 10.1046/j.1525-139x.2001.00107.x; Sirvent AE, 2012, HEMODIAL INT, V16, P315, DOI 10.1111/j.1542-4758.2011.00632.x; Kukita K, 2011, J JPN SOC DIAL THER, V44, P855	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					523	524		10.1111/1744-9987.12311		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700017		
J	Kitajima, S; Kaneko, S; Wada, T				Kitajima, Shinji; Kaneko, Shuichi; Wada, Takashi			Septic Pulmonary Embolism Caused by Internal Shunt Infection	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Kitajima, Shinji; Wada, Takashi] Kanazawa Univ, Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Kaneko, Shuichi] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Sch Hlth Sci, Dept Lab Sci, Kanazawa, Ishikawa, Japan	Kitajima, S (reprint author), Kanazawa Univ, Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan.	kitajimajima@ybb.ne.jp					Cook RJ, 2005, CHEST, V128, P162, DOI 10.1378/chest.128.1.162; Schubert Claudia, 2007, Hemodial Int, V11, P379, DOI 10.1111/j.1542-4758.2007.00204.x	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					524	525		10.1111/1744-9987.12309		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700018		
J	Miyazawa, H; Ookawara, S; Tabei, K				Miyazawa, Haruhisa; Ookawara, Susumu; Tabei, Kaoru			Aggravation of Cerebral Oxygenation due to Intradialytic Hypotension Induced by Blood Volume Reduction During Hemodialysis: A Case Report	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Miyazawa, Haruhisa; Ookawara, Susumu; Tabei, Kaoru] Jichi Medial Univ, Saitama Med Ctr, Div Nephrol, Dept Integrated Med 1, Saitama, Japan	Miyazawa, H (reprint author), Jichi Medial Univ, Saitama Med Ctr, Div Nephrol, Dept Integrated Med 1, Saitama, Japan.	su-ooka@hb.tp1.jp					Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; Hoshino T, 2014, NEPHRON CLIN PRACT, V126, P57, DOI 10.1159/000358432; Ishida I, 1999, AM J KIDNEY DIS, V34, P1096, DOI 10.1016/S0272-6386(99)70016-8; Aslid R, 1989, STROKE, V20, P45	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	OCT	2015	19	5					525	527		10.1111/1744-9987.12303		3	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CU3XW	WOS:000363460700019		
J	Kumaragurubaran, S; Nagata, T; Tsunekawa, Y; Takahashi, K; Ri, SG; Suzuki, S; Chikyow, T				Kumaragurubaran, Somu; Nagata, Takahiro; Tsunekawa, Yoshifumi; Takahashi, Kenichiro; Ri, Sung-Gi; Suzuki, Setsu; Chikyow, Toyohiro			Epitaxial growth of high dielectric constant lead-free relaxor ferroelectric for high-temperature operational film capacitor	THIN SOLID FILMS			English	Article						Relaxor ferroelectric; High dielectric constant; High-temperature operational capacitor; Pulsed laser deposition	CERAMICS	An epitaxial thin-film capacitor based on relaxor ferroelectric oxide, BaTiO3-Bi(Mg2/3Nb1/3)O-3 ( BT-BMN), has been realized on Nb:SrTiO3 substrates. A high dielectric constant exceeding 400 was attained on high-temperature annealed films at frequencies below 100 kHz. BT-BMN thin-film exhibited a broad dielectric constant variation against temperature and also the frequency dependent dielectric-constant-maximum temperature. Excellent dielectric constant stability below 10% was achieved in 75-400 degrees C temperature range with a low dielectric loss. This exemplifies BT-BMN as a dielectric for monolithically integrated capacitors that can function up to 400 degrees C, breaking the present 175 degrees C limit of bulky capacitors, in high-power high-temperature electronic devices. (C) 2015 Elsevier B.V. All rights reserved.	[Kumaragurubaran, Somu; Nagata, Takahiro; Tsunekawa, Yoshifumi; Takahashi, Kenichiro; Ri, Sung-Gi; Suzuki, Setsu; Chikyow, Toyohiro] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Tsunekawa, Yoshifumi; Takahashi, Kenichiro; Ri, Sung-Gi; Suzuki, Setsu] Natl Inst Mat Sci, Comet Inc, Tsukuba, Ibaraki 3050044, Japan	Nagata, T (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	NAGATA.Takahiro@nims.go.jp			Japan Science and Technology Agency (JST) - Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP) [AS2315002B]; World Premier International Research Center Initiative Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Funding from Japan Science and Technology Agency (JST) - Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP, No. AS2315002B) and World Premier International Research Center Initiative Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, is gratefully acknowledged.	COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; Matsunami H, 2006, MICROELECTRON ENG, V83, P2, DOI 10.1016/j.mee.2005.10.012; Griggio F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.157604; Szwagierczak D, 2004, J EUR CERAM SOC, V24, P1979, DOI 10.1016/S0955-2219(03)00358-3; Zhao XH, 2008, J AM CERAM SOC, V91, P3031, DOI 10.1111/j.1551-2916.2008.02552.x; Tinberg DS, 2007, J APPL PHYS, V101, DOI 10.1063/1.2430627; Correia TM, 2013, J AM CERAM SOC, V96, P2699, DOI 10.1111/jace.12508; Ohnishi T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146069; Tanaka H, 2012, J APPL PHYS, V111, DOI 10.1063/1.4704384; Kachi T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.100210; Shvartsman VV, 2012, J AM CERAM SOC, V95, P1, DOI 10.1111/j.1551-2916.2011.04952.x; Umezawa H, 2012, DIAM RELAT MATER, V24, P201, DOI 10.1016/j.diamond.2012.01.011; Ohnishi T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2921972; Ikeda K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.011202; Kwon DK, 2004, J AM CERAM SOC, V87, P1088; Prosandeev S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.247602; Ogihara H, 2009, J AM CERAM SOC, V92, P1719, DOI 10.1111/j.1551-2916.2009.03104.x; MORKOC H, 1994, J APPL PHYS, V76, P1363; Yuan Y, 2010, J ELECTROCERAM, V25, P212, DOI 10.1007/s10832-010-9617-4; Huang CC, 2008, J APPL PHYS, V104, DOI 10.1063/1.2960469; Zhao T, 2000, J APPL PHYS, V87, P7442, DOI 10.1063/1.373007; Buttay C, 2011, MATER SCI ENG B-ADV, V176, P283, DOI 10.1016/j.mseb.2010.10.003; Neudeck PG, 2008, IEEE ELECTR DEVICE L, V29, P456, DOI 10.1109/LED.2008.919787; Kumaragurubaran S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DH02; Malhan R. K., 2012, Patent No. [US 8,194,392, B2, 8194392]; Tyunina M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224102; Wicklein S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754112; Yasui S, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MB04; Zang J., 2014, J EUR CERAM SOC, V34, P37	29	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 1	2015	592		A				29	33		10.1016/j.tsf.2015.09.012		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CU1GS	WOS:000363269100005		
J	Tsukamoto, T; Hirose, N; Kasamatsu, A; Mimura, T; Matsui, T; Suda, Y				Tsukamoto, Takahiro; Hirose, Nobumitsu; Kasamatsu, Akifumi; Mimura, Takashi; Matsui, Toshiaki; Suda, Yoshiyuki			Control of surface flatness of Ge layers directly grown on Si (001) substrates by DC sputter epitaxy method	THIN SOLID FILMS			English	Article						Germanium; Sputtering; Crystal growth; Epitaxy	THREADING DISLOCATION DENSITY; DOT ARRAY; HYDROGEN; TEMPERATURE; ROUGHNESS; SI(001); DEPOSITION; QUALITY; FILMS	The formation of Ge layers on Si (001) substrates with 3.5 Omega cm resistivity by the sputter epitaxy method with DC magnetron sputtering has been investigated. The surface morphology of Ge layers grown on Si substrates depends on the sputtering power and the deposited film thickness of Ge. At the initial stage of film deposition, the higher sputtering power yields smaller and more closely packed Ge islands due probably to an increase in the collision rate of the Ge atoms migrating on the Si substrate, which preserves more compressive strains in the films. With the preserved strains, the surface roughening derived from the strain relaxation is reduced. Furthermore, the surface flatness can be improved with the initially smaller islands and additional deposition; this is probably due to the effect of Ge adatom anchoring at concave areas where many bonding sites are available for stable Ge residence. The root-mean-square surface roughness of a 200-nm-thick Ge layer formed at a sputtering power of 100 W is about 0.23 nm. (C) 2015 Elsevier B.V. All rights reserved.	[Tsukamoto, Takahiro; Suda, Yoshiyuki] Tokyo Univ Agr & Technol, Grad Sch Engn, Koganei, Tokyo 1848588, Japan; [Hirose, Nobumitsu; Kasamatsu, Akifumi; Mimura, Takashi; Matsui, Toshiaki] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Tsukamoto, T (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	t-tsuka@cc.tuat.ac.jp	TSUKAMOTO, Takahiro/F-9253-2013		JSPS KAKENHI [25630123, 25820121]	This work was supported by JSPS KAKENHI Grant Numbers 25630123 and 25820121. This work was partly carried out in Advanced ICT Devices Lab in NICT.	Choi D, 2008, J CRYST GROWTH, V310, P4273, DOI 10.1016/j.jcrysgro.2008.07.029; Sun XC, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3170870; Kanakaraju S, 2000, PHYS REV B, V61, P8334, DOI 10.1103/PhysRevB.61.8334; Tsukamoto T, 2015, J MATER SCI, V50, P4366, DOI 10.1007/s10853-015-8990-4; GUPTA P, 1988, PHYS REV B, V37, P8234, DOI 10.1103/PhysRevB.37.8234; Yamamoto Y, 2011, SOLID STATE ELECTRON, V60, P2, DOI 10.1016/j.sse.2011.01.032; SAKAI A, 1994, APPL PHYS LETT, V64, P52, DOI 10.1063/1.110919; Suda Y, 2004, THIN SOLID FILMS, V464, P190, DOI 10.1016/j.stf.2004.06.028; Kobayashi S, 2010, THIN SOLID FILMS, V518, pS136, DOI 10.1016/j.tsf.2009.10.072; Sakai A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1943493; Liu JF, 2010, OPT LETT, V35, P679, DOI 10.1364/OL.35.000679; Liao XZ, 1999, PHYS REV B, V60, P15605, DOI 10.1103/PhysRevB.60.15605; Nayfeh A, 2004, APPL PHYS LETT, V85, P2815, DOI 10.1063/1.1802381; Hanafusa H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.024102; Hanafusa H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.055502; Kitayama D, 2006, THIN SOLID FILMS, V508, P203, DOI 10.1016/j.tsf.2005.08.388; Hanafusa H, 2008, JPN J APPL PHYS, V47, P3020, DOI 10.1143/JJAP.47.3020; Tsukamoto T, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4907863; Shin KW, 2010, THIN SOLID FILMS, V518, P6496, DOI 10.1016/j.tsf.2010.03.148; Kitayama D, 2004, JPN J APPL PHYS 1, V43, P3822, DOI 10.1143/JJAP.43.3822; Olubuyide OO, 2006, THIN SOLID FILMS, V508, P14, DOI 10.1016/j.tsf.2005.06.120; Yoshikawa M, 2012, ECS TRANSACTIONS, V50, P145, DOI 10.1149/05009.0145ecst; Kurdi M.E., 2009, APPL PHYS LETT, V94; Tsukamoto T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826501	24	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 1	2015	592		A				34	38		10.1016/j.tsf.2015.08.044		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CU1GS	WOS:000363269100006		
J	Kamiyama, E; Sueoka, K; Terasawa, K; Yamaha, T; Nakatsuka, O; Zaima, S; Izunome, K; Kashima, K; Uchida, H				Kamiyama, Eiji; Sueoka, Koji; Terasawa, Kengo; Yamaha, Takashi; Nakatsuka, Osamu; Zaima, Shigeaki; Izunome, Koji; Kashima, Kazuhiko; Uchida, Hiroshi			Atom probe tomography study on Ge1-x - ySnxCy hetero-epitaxial film on Ge substrates	THIN SOLID FILMS			English	Article						Atom probe tomography; Ge1- (x -) ySnxCy film; Magnetron sputtering; Zigzag chain; Binding energy	C-INCORPORATION; SOLAR-CELLS	We analyzed the incorporation of C atoms into a ternary alloy Ge1 - x - ySnxCy epitaxial film on Ge substrates on a sub-nanometer scale by using atom probe tomography. Periodic atom distributions from individual (111) atomic planes were observed both in the Ge1 - x - ySnxCy film and at the Ge substrates. Sn/C atoms had non-uniform distributions in the film. They also demonstrated a clear positive correlation in their distributions. Substitutional C atoms were only incorporated into the film when an Sn atom beam was applied onto the substrates under film growth conditions. (C) 2015 Elsevier B.V. All rights reserved.	[Kamiyama, Eiji; Izunome, Koji; Kashima, Kazuhiko] GlobalWafers Japan Corp Ltd, Technol, Niigata 9570197, Japan; [Kamiyama, Eiji; Sueoka, Koji] Okayama Prefectural Univ, Dept Commun Engn, Soja, Okayama 7191197, Japan; [Terasawa, Kengo; Yamaha, Takashi; Nakatsuka, Osamu; Zaima, Shigeaki] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Zaima, Shigeaki] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Uchida, Hiroshi] Toshiba Nanoanal Corp, Phys Anal Technol Ctr, Isogo Ku, Yokohama, Kanagawa 2358522, Japan	Kamiyama, E (reprint author), GlobalWafers Japan Corp Ltd, Technol, 6-861-5 Higashiko, Niigata 9570197, Japan.	ejkamiyama@aol.com			Advanced Low Carbon Technology Research and the Development (ALCA) program; Japan Science and Technology (JST) agency in Japan	This work was partially supported by the Advanced Low Carbon Technology Research and the Development (ALCA) program provided by the Japan Science and Technology (JST) agency in Japan.	Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Seidman DN, 2009, MRS BULL, V34, P717, DOI 10.1557/mrs2009.194; Ronsheim P, 2008, APPL SURF SCI, V255, P1547, DOI 10.1016/j.apsusc.2008.05.247; Shimizu Y, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236673; Okinaka M, 2003, J CRYST GROWTH, V249, P78, DOI 10.1016/S0022-0248(02)02107-3; Chroneos A, 2007, PHYS STATUS SOLIDI B, V244, P3206, DOI 10.1002/pssb.200642622; Kumar A, 2013, ULTRAMICROSCOPY, V132, P171, DOI 10.1016/j.ultramic.2013.02.009; Koelling S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3243461; Matsutani R, 2014, PHYS STATUS SOLIDI C, V11, P1718, DOI 10.1002/pssc.201400029; Cadel E, 2009, J APPL PHYS, V106, DOI 10.1063/1.3186617; Suwa R, 2014, PHYS STATUS SOLIDI B, V251, P2221, DOI 10.1002/pssb.201400030; Fang Q., 2010, P AUSTR SOL EN SOC 4; Gall D, 2000, PHYS REV B, V62, pR7723, DOI 10.1103/PhysRevB.62.R7723; Gault B, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194089; Gault B, 2010, J APPL PHYS, V108, DOI 10.1063/1.3462399; Terasawa K., 2014, 7 INT SIGE TECHN DEV, P179	16	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 1	2015	592		A				54	58		10.1016/j.tsf.2015.09.002		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CU1GS	WOS:000363269100008		
J	Sari, H; Sakakura, H; Kawade, D; Itagaki, M; Sugiyama, M				Sari, Huseyin; Sakakura, Hidenori; Kawade, Daisuke; Itagaki, Masayuki; Sugiyama, Mutsumi			Quantification of sputtering damage during NiO film deposition on a Si/SiO2 substrate using electrochemical impedance spectroscopy	THIN SOLID FILMS			English	Article						Nickel oxide; Impedance spectroscopy; Constant phase element; Sputtering damage; Solar cells	OPTICAL-PROPERTIES; SOLAR-CELL; ADMITTANCE; ABSORPTION; DISPERSION; INTERFACE	Sputtering damage during NiO deposition on SiO2 coated Si+ substrate is investigated using an electrochemical impedance spectroscopy. The degree of sputtering damage for samples located at different positions relative to the sputtering source is evaluated by proposing an equivalent circuit that includes a constant phase element (CPE) to represent the area around the SiO2/NiO interface. By fitting the impedance data, CPE-T and CPE-p index parameters (which are related to the interface uniformity and quality) are obtained. Using these parameters, the capacitance and time constants of the SiO2 layer and the SiO2/NiO interface are estimated. By comparing the CPE-p index values, it is concluded that the sample that is closer to the sputtering target is exposed to more damage than samples located at greater distances during the deposition process. This result is significant because it may help to reduce growth-related defects and improve the quality of NiO films grown using the sputtering technique. (C) 2015 Elsevier B.V. All rights reserved.	[Sari, Huseyin] Ankara Univ, Fac Engn, Dept Engn Phys, TR-06100 Ankara, Turkey; [Sakakura, Hidenori; Kawade, Daisuke; Sugiyama, Mutsumi] Tokyo Univ Sci, Dept Elect Engn, Fac Sci & Technol, Noda, Chiba 2788510, Japan; [Itagaki, Masayuki] Tokyo Univ Sci, Dept Pure & Appl Chem, Fac Sci & Technol, Noda, Chiba 2788510, Japan	Sari, H (reprint author), Ankara Univ, Fac Engn, Dept Engn Phys, TR-06100 Ankara, Turkey.	hsari@eng.ankara.edu.tr			Turkish Council of Higher Education (YOK); Sasakawa Scientific Research Grant from The Japan Science Society; Kurata Memorial Hitachi Science and Technology Foundation; Network Joint Research Center for Materials and Devices; Research Center for Green and Safety Sciences; Photovoltaic Science and Technology Research Division, Research Institute for Science and Technology under Tokyo University of Science	Author H. Sari would like to thank to the Turkish Council of Higher Education (YOK) for the financial support during his research visit in Japan. The authors thank Prof. S. F. Chichibu, Tohoku University and Prof. Y. Watanabe, Tokyo University of Science Suwa for their stimulationg discussions. In addition, the authors thank H. Nakai, A. Ogasawara, R. Maeda, R. Sakai, and K. Moriyama for their assistance in conducting the experiments. This work was supported in part by the Sasakawa Scientific Research Grant from The Japan Science Society, the Kurata Memorial Hitachi Science and Technology Foundation, the Network Joint Research Center for Materials and Devices, the Research Center for Green and Safety Sciences, and the Photovoltaic Science and Technology Research Division, Research Institute for Science and Technology under Tokyo University of Science.	SPEAR WE, 1973, PHYS REV B, V7, P831, DOI 10.1103/PhysRevB.7.831; Ai L, 2008, APPL SURF SCI, V254, P2401, DOI 10.1016/j.apsusc.2007.09.051; SCOFIELD JH, 1995, SOL ENERG MAT SOL C, V37, P217, DOI 10.1016/0927-0248(95)00016-X; Warasawa M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.021102; MANGHI F, 1994, PHYS REV LETT, V73, P3129, DOI 10.1103/PhysRevLett.73.3129; SATO H, 1993, THIN SOLID FILMS, V236, P27, DOI 10.1016/0040-6090(93)90636-4; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Jiang J, 2013, PHYS CHEM CHEM PHYS, V15, P6875, DOI 10.1039/c3cp50197c; Itagaki M, 2011, ELECTROCHIM ACTA, V56, P7975, DOI 10.1016/j.electacta.2011.01.087; Xi YY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2898505; Lu YM, 2002, THIN SOLID FILMS, V420, P54, DOI 10.1016/S0040-6090(02)00654-5; Ohta H, 2003, THIN SOLID FILMS, V445, P317, DOI 10.1016/S0040-6090(03)01178-7; Sugiyama M, 2013, THIN SOLID FILMS, V535, P287, DOI 10.1016/j.tsf.2012.11.070; Adler D, 1970, PHYS REV B-SOLID ST, V2, P3112, DOI 10.1103/PhysRevB.2.3112; Bayhan H, 2006, SOL ENERGY, V80, P1160, DOI 10.1016/j.solener.2005.09.004; Rhee JH, 2009, CHEM PHYS LETT, V477, P345, DOI 10.1016/j.cplett.2009.07.014; Loef R, 2008, SOL ENERG MAT SOL C, V92, P1579, DOI 10.1016/j.solmat.2008.07.005; Cole KS, 1942, J CHEM PHYS, V10, P98, DOI 10.1063/1.1723677; Kobayashi T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.126602; Loef R, 2007, J APPL PHYS, V102, DOI 10.1063/1.2759470; Nomura K., 2004, NATURE, V432, P48892; Reislohner U, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730379; Tsai WC, 2009, PROC SPIE, V7356, DOI 10.1117/12.820546	23	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 1	2015	592		A				150	154		10.1016/j.tsf.2015.09.017		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CU1GS	WOS:000363269100022		
J	Ma, JS; Fukuda, D				Ma, Jiangshan; Fukuda, Daisuke			A hyperpath-based network generalized extreme-value model for route choice under uncertainties	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Hyperpath; Network GEV model; Route choice; Uncertainties	EQUILIBRIUM TRAFFIC ASSIGNMENT; VEHICLE NAVIGATION; TRANSIT NETWORKS; LOGIT MODEL; ALGORITHM; ENUMERATION; PATHS; TRANSPORTATION; ALTERNATIVES; HYPERSTAR	Previous route choice studies treated uncertainties as randomness; however, it is argued that other uncertainties exist beyond random effects. As a general modeling framework for route choice under uncertainties, this paper presents a model of route choice that incorporates hyperpath and network generalized extreme-value-based link choice models. Accounting for the travel time uncertainty, numerical studies of specified models within the proposed framework are conducted. The modeling framework may be helpful in various research contexts dealing with both randomness and other non-probabilistic uncertainties that cannot be exactly perceived. (C) 2015 Elsevier Ltd. All rights reserved.	[Ma, Jiangshan] Shanghai Maritime Univ, Shanghai 201306, Peoples R China; [Ma, Jiangshan; Fukuda, Daisuke] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan	Ma, JS (reprint author), Shanghai Maritime Univ, 1550 Harbour Rd, Shanghai 201306, Peoples R China.	tonny.achilles@gmail.com					Akamatsu T, 1996, TRANSPORT RES B-METH, V30, P369, DOI 10.1016/0191-2615(96)00003-3; Bell MGH, 2012, TRANSPORT RES A-POL, V46, P790, DOI 10.1016/j.tra.2012.02.002; Chorus CG, 2012, TRANSPORTMETRICA, V8, P291, DOI 10.1080/18128602.2010.498391; Miller-Hooks E, 2001, NETWORKS, V37, P35, DOI 10.1002/1097-0037(200101)37:1<35::AID-NET4>3.0.CO;2-G; Papola A, 2013, COMPUT-AIDED CIV INF, V28, P560, DOI 10.1111/mice.12007; Fonzone A, 2012, TRANSPORT RES REC, P119, DOI 10.3141/2322-13; Fosgerau M, 2013, TRANSPORT RES B-METH, V56, P70, DOI 10.1016/j.trb.2013.07.012; Nguyen S, 1998, TRANSPORT SCI, V32, P54, DOI 10.1287/trsc.32.1.54; Dial RB, 2006, TRANSPORT RES B-METH, V40, P917, DOI 10.1016/j.trb.2006.02.008; de Palma A, 2005, TRANSPORT RES A-POL, V39, P295, DOI 10.1016/j.tra.2004.10.001; Daly A, 2006, TRANSPORT RES B-METH, V40, P285, DOI 10.1016/j.trb.2005.03.003; Bell MGH, 1995, TRANSPORT RES B-METH, V29, P287, DOI 10.1016/0191-2615(95)00005-X; Cascetta E, 2001, TRANSPORT RES C-EMER, V9, P249, DOI 10.1016/S0968-090X(00)00036-X; Yai T, 1997, TRANSPORT RES B-METH, V31, P195, DOI 10.1016/S0191-2615(96)00025-2; Razo M, 2013, TRANSPORT RES C-EMER, V27, P117, DOI 10.1016/j.trc.2011.08.009; Ma JS, 2013, TRANSPORTMETRICA A, V9, P925, DOI 10.1080/18128602.2012.719165; Schmocker JD, 2013, TRANSPORT RES C-EMER, V36, P406, DOI 10.1016/j.trc.2013.06.014; Gao S, 2006, TRANSPORT RES B-METH, V40, P93, DOI 10.1016/j.trb.2005.02.001; Bar-Gera H, 2002, TRANSPORT SCI, V36, P398, DOI 10.1287/trsc.36.4.398.549; Bell MGH, 2009, TRANSPORT RES B-METH, V43, P97, DOI 10.1016/j.trb.2008.05.010; Eppstein D, 1998, SIAM J COMPUT, V28, P652, DOI 10.1137/S0097539795290477; Bovy P, 2009, TRANSPORT REV, V29, P43, DOI 10.1080/01441640802078673; Vovsha P, 1998, TRANSPORT RES REC, P133; Levinson D, 2013, TRANSPORT RES C-EMER, V35, P232, DOI 10.1016/j.trc.2013.03.001; Ben Akiva M., 1985, DISCRETE CHOICE ANAL; Ben-Akiva M., 1984, P 9 INT S TRANSP TRA, P299; Ben-Akiva M., 1999, HDB TRANSPORTATION S, P5; Bierlaire M., 2002, P 2 SWISS TRANSP RES; Chriqui C., 1975, Transportation Science, V9, DOI 10.1287/trsc.9.2.115; Daganzo C. F., 1977, Transportation Science, V11, DOI 10.1287/trsc.11.3.253; DIAL RB, 1971, TRANSPORT RES, V5, P83, DOI 10.1016/0041-1647(71)90012-8; Florian M., 2012, EURO J TRANSPORT LOG, V1, P28; Flotterod G, 2013, TRANSPORT RES B-METH, V48, P53, DOI 10.1016/j.trb.2012.11.002; Freginger E., 2009, TRANSPORT RES B-METH, V43, P984; Freginger E., 2007, TRANSPORT RES B-METH, V41, P363; Hare Y., 2012, JSCE P INFRASTRUCT P, V46; Marcotte P, 1998, EQUILIBRIUM AND ADVANCED TRANSPORTATION MODELLING, P175; McFadden D., 1978, SPATIAL INTERACTION, P75; NGUYEN S, 1988, EUR J OPER RES, V37, P176, DOI 10.1016/0377-2217(88)90327-X; Nguyen Sang, 1989, LECT NOTES MATH, V1403, P258; Prato C.G., 2009, J CHOICE MODEL, V2, P65, DOI DOI 10.1016/S1755-5345(13)70005-8; Puterman ML, 2005, MARKOV DECISION PROC; SPIESS H, 1989, TRANSPORT RES B-METH, V23, P83, DOI 10.1016/0191-2615(89)90034-9; Yang JF, 2014, TRANSPORT RES C-EMER, V47, P168, DOI 10.1016/j.trc.2014.06.009	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		19	31		10.1016/j.trc.2015.05.015		13	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800003		
J	Fonzone, A; Schmocker, JD; Liu, RH				Fonzone, Achille; Schmoecker, Jan-Dirk; Liu, Ronghui			A model of bus bunching under reliability-based passenger arrival patterns	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Bus bunching; Passenger arrival process; Service reliability	REAL-TIME INFORMATION; SCHEDULE RELIABILITY; CONTROL STRATEGIES; TRANSIT NETWORKS; HOLDING PROBLEM; SIMULATION; ROUTE; CHOICE; STOPS	If bus service departure times are not completely unknown to the passengers, non-uniform passenger arrival patterns can be expected. We propose that passengers decide their arrival time at stops based on a continuous logit model that considers the risk of missing services. Expected passenger waiting times are derived in a bus system that allows also for overtaking between bus services. We then propose an algorithm to derive the dwell time of subsequent buses serving a stop in order to illustrate when bus bunching might occur. We show that non-uniform arrival patterns can significantly influence the bus bunching process. With case studies we find that, even without exogenous delay, bunching can arise when the boarding rate is insufficient given the level of overall demand. Further, in case of exogenous delay, non-uniform arrivals can either worsen or improve the bunching conditions, depending on the level of delay. We conclude that therefore such effects should be considered when service control measures are discussed. (C) 2015 Elsevier Ltd. All rights reserved.	[Fonzone, Achille] Edinburgh Napier Univ, Transport Res Inst, Edinburgh, Midlothian, Scotland; [Schmoecker, Jan-Dirk] Kyoto Univ, Dept Urban Management, Nishikyo Ku, Kyoto 6158540, Japan; [Liu, Ronghui] Univ Leeds, Inst Transport Studies, Leeds LS2 9JT, W Yorkshire, England	Fonzone, A (reprint author), Edinburgh Napier Univ, Transport Res Inst, Edinburgh, Midlothian, Scotland.	a.fonzone@napier.ac.uk					Daganzo CF, 2011, TRANSPORT RES B-METH, V45, P267, DOI 10.1016/j.trb.2010.06.005; Nesheli MM, 2014, TRANSPORT RES C-EMER, V48, P491, DOI 10.1016/j.trc.2014.09.013; Eberlein XJ, 2001, TRANSPORT SCI, V35, P1, DOI 10.1287/trsc.35.1.1.10143; Hadas Y, 2010, TRANSPORT RES C-EMER, V18, P879, DOI 10.1016/j.trc.2010.04.002; Munoz JC, 2013, TRANSPORT RES C-EMER, V28, P101, DOI 10.1016/j.trc.2012.12.010; Hickman MD, 2001, TRANSPORT SCI, V35, P215, DOI 10.1287/trsc.35.3.215.10150; Nagatani T, 2001, PHYSICA A, V296, P320, DOI 10.1016/S0378-4371(01)00151-0; Hollander Y, 2008, TRANSPORT RES C-EMER, V16, P212, DOI 10.1016/j.trc.2007.07.005; Pelletier MP, 2011, TRANSPORT RES C-EMER, V19, P557, DOI 10.1016/j.trc.2010.12.003; Schmocker JD, 2013, TRANSPORT RES C-EMER, V36, P406, DOI 10.1016/j.trc.2013.06.014; Xuan YG, 2011, TRANSPORT RES B-METH, V45, P1831, DOI 10.1016/j.trb.2011.07.009; Gentile G, 2005, TRANSPORT SCI, V39, P289, DOI 10.1287/trsc.1040.0109; Watkins KE, 2011, TRANSPORT RES A-POL, V45, P839, DOI 10.1016/j.tra.2011.06.010; Liu ZY, 2013, TRANSPORT RES C-EMER, V35, P46, DOI 10.1016/j.trc.2013.06.004; Daganzo CF, 2009, TRANSPORT RES B-METH, V43, P913, DOI 10.1016/j.trb.2009.04.002; Sorratini JA, 2008, TRANSPORT PLAN TECHN, V31, P303, DOI 10.1080/03081060802086512; QUARMBY DA, 1967, J TRANSP ECON POLICY, V1, P273; Meng Q, 2013, TRANSPORT RES C-EMER, V36, P61, DOI 10.1016/j.trc.2013.08.007; Bartholdi JJ, 2012, TRANSPORT RES B-METH, V46, P481, DOI 10.1016/j.trb.2011.11.001; BOWMAN LA, 1981, TRANSPORT RES A-POL, V15, P465, DOI 10.1016/0191-2607(81)90114-X; Boyd C.W., 1987, TRANSPORT RES A-POL, V17, P347; Cats O, 2011, TRANSPORT RES REC, P51, DOI 10.3141/2216-06; Crout D.T., 2007, TRANSP RES BOARD 86; Hollander Y., 2007, P EUR TRANSP C LEID; Khoo H.L., 2013, P E ASIA SOC TRANSPO, V9; Lamp J.D., 2010, TRANSPORT RES B-METH, V44, P646; Larson R., 1981, URBAN OPERATIONS RES; Liu R., 2007, P INT S TRANSP NETW; Luethi M., 2007, TRANSP RES BOARD 86; Newell G. F., 1974, Transportation Science, V8, DOI 10.1287/trsc.8.3.248; Newell G.F., 1964, P 2 AUSTR ROAD RES B, V2, P388; Noekel K., 2009, TRANSP RES REC; Osuna E. E., 1972, Transportation Science, V6, DOI 10.1287/trsc.6.1.52; Pilachowski J.M., 2009, THESIS U CALIFORNIA; Schmocker J-D., 2015, 6 INT S TRANSP NETW; SPIESS H, 1989, TRANSPORT RES B-METH, V23, P83, DOI 10.1016/0191-2615(89)90034-9	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		164	182		10.1016/j.trc.2015.05.020		19	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800011		
J	Shiomi, Y; Taniguchi, T; Uno, N; Shimamoto, H; Nakamura, T				Shiomi, Yasuhiro; Taniguchi, Tomoki; Uno, Nobuhiro; Shimamoto, Hiroshi; Nakamura, Toshiyuki			Multilane first-order traffic flow model with endogenous representation of lane-flow equilibrium	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Multilane traffic flow; Lane flow distribution; LWR model; IT principle; Parameter calibration	BEHAVIORAL-THEORY; 2-LANE	In this study, we develop a multilane first-order traffic flow model for freeway networks. In the model, lane changing is considered as a stochastic behavior that can decrease an individual driver's disutility or cost, and is represented as dynamics toward the equilibrium of lane-flow distribution along with longitudinal traffic dynamics. The proposed method can be differentiated from those in previous studies because in this study, the motivation of lane changing is explicitly considered and it is treated as a utility defined by the current macroscopic traffic state. In addition, the entire process of lane changing is computed macroscopically by an extension of the kinematic wave theory employing IT principle; moreover, in the model framework, the lane-flow equilibrium curve is endogenously generated because of self-motivated lane changes. Furthermore, the parsimonious representation enables parameter calibration using the data collected from conventional loop detectors. The calibration of the data collected at four different sites, including a sag bottleneck, on the Chugoku expressway in Japan reveals that the proposed method can represent the lane-flow distribution of any observation site with high accuracy, and that the estimated parameters can reasonably explain the multilane traffic dynamics and the bottleneck phenomena uphill of sag sections. (C) 2015 Elsevier Ltd. All rights reserved.	[Shiomi, Yasuhiro] Ritsumeikan Univ, Kusatsu 5258577, Japan; [Taniguchi, Tomoki; Nakamura, Toshiyuki] Kyoto Univ, Grad Sch Engn, Katsura 6158530, Japan; [Uno, Nobuhiro] Kyoto Univ, Grad Sch Management, Kyoto 6068501, Japan; [Shimamoto, Hiroshi] Miyazaki Univ, Miyazaki 8892192, Japan	Shiomi, Y (reprint author), Ritsumeikan Univ, 1-1-1 Nojihigashi, Kusatsu 5258577, Japan.	shiomi@fc.ritsumei.ac.jp					Jin WL, 2010, TRANSPORT RES B-METH, V44, P1001, DOI 10.1016/j.trb.2009.12.014; Duret A, 2012, TRANSPORT RES C-EMER, V24, P157, DOI 10.1016/j.trc.2012.02.009; van Lint JWC, 2008, TRANSPORT RES REC, P177, DOI 10.3141/2088-19; Tang TQ, 2009, J ADV TRANSPORT, V43, P245; Shvetsov V, 1999, PHYS REV E, V59, P6328, DOI 10.1103/PhysRevE.59.6328; Yuan YF, 2012, IEEE T INTELL TRANSP, V13, P59, DOI 10.1109/TITS.2011.2178837; MUNJAL PK, 1971, TRANSPORT RES, V5, P241, DOI 10.1016/0041-1647(71)90036-0; Knoop VL, 2012, TRANSPORT RES REC, P31, DOI 10.3141/2278-04; Daganzo CF, 2002, TRANSPORT RES B-METH, V36, P159, DOI 10.1016/S0191-2615(00)00043-6; Patire AD, 2011, TRANSPORT RES B-METH, V45, P656, DOI 10.1016/j.trb.2011.01.003; Jin WL, 2013, TRANSPORT RES B-METH, V57, P361, DOI 10.1016/j.trb.2013.06.002; Laval JA, 2006, TRANSPORT RES B-METH, V40, P251, DOI 10.1016/j.trb.2005.04.003; Wang YB, 2005, TRANSPORT RES B-METH, V39, P141, DOI 10.1016/j.trb.2004.03.003; Daganzo CF, 2002, TRANSPORT RES B-METH, V36, P131, DOI 10.1016/S0191-2615(00)00042-4; Farhi N., 2013, TRB 92 ANN M; GIPPS PG, 1986, TRANSPORT RES B-METH, V20, P403, DOI 10.1016/0191-2615(86)90012-3; Hong S., 2010, SEISAN KENKYU, V62, P158; Hoogendoom S.P., 2001, NETW SPAT ECON, V1, P137, DOI 10.1023/A:1011533228599; Kits H., 1999, TRANSPORT RES A-POL, V33, P305; Knoop V.L., 2010, P 13 INT IEEE C INT, P485; Okaue M., 2011, J JPN SOC CIV ENG, V67; Salvucci Dario D., 2002, TRANSPORT RES F-TRAF, P123, DOI DOI 10.1016/S1369-8478(02)00011-6; Sheffi Y., 1984, URBAN TRANSPORTATION; Shiomi Y., 2013, TRB 92 ANN M; Toledo T, 2009, TRANSPORT RES C-EMER, V17, P365, DOI 10.1016/j.trc.2009.01.005; Webster N.A., 2007, SEISAN KENKYU, V59, P42; Wu N., 2006, TRANSPORT RES REC, V1965, P48, DOI 10.3141/1965-06; Xing J., 2014, INT J INTELL TRANSP, V12, P26	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		198	215		10.1016/j.trc.2015.07.002		18	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800013		
J	Kusakabe, T; Nakano, Y				Kusakabe, Takahiko; Nakano, Yuta			Information provision strategies eliminating deluded equilibrium caused by travellers' misperception	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Deluded equilibrium; Bounded rational choice; Advanced travel information systems; Dynamic assignment	TIME INFORMATION; STOCHASTIC EQUILIBRIUM; TRAFFIC ASSIGNMENT; BEHAVIOR; SYSTEMS; MODEL; STABILITY; NETWORKS; UNCERTAINTY; PERCEPTION	Providing travel time information may be effective at reducing travel costs. However, this information does not always match the actual travel time that travellers will experience. Furthermore, the information is often asymmetrically provided within the network, owing to the limitations of observation devices, prediction model calibration, and uncertainty about road conditions. The purpose of this study is to investigate the effects of predictive travel time information that is asymmetrically provided to travellers. This study formulated a dynamic traffic assignment model in origin-destination (OD) pair with two parallel routes, while considering travellers' learning processes and within-day and day-to-day dynamics. In this study: it is assumed that different information will be provided to each traveller, according to within-day traffic dynamics. Furthermore, the information is provided for only one of two possible routes, because of observation limitations. The effects of information accuracy are also discussed in this study. The results of numerical analysis indicated that information provisions possibly reduced the negative effects of deluded equilibrium state, even when the information was only provided for one of the routes. Different effects of the travel time information and its variation were illustrated according to the allocation of the bottleneck capacities of two routes. (C) 2015 Elsevier Ltd. All rights reserved.	[Kusakabe, Takahiko; Nakano, Yuta] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan	Kusakabe, T (reprint author), Tokyo Inst Technol, Meguro Ku, 2-12-1-M1-20 O Okayama, Tokyo 1528552, Japan.	t.kusakabe@plan.cv.titech.ac.jp	Kusakabe, Takahiko/C-1893-2015	Kusakabe, Takahiko/0000-0003-3019-5243			Avineri E, 2006, TRANSPORTATION, V33, P393, DOI 10.1007/s11116-005-5710-y; Hato E, 1999, TRANSPORT RES C-EMER, V7, P109, DOI 10.1016/S0968-090X(99)00015-7; Watling D, 1999, TRANSPORT RES B-METH, V33, P281, DOI 10.1016/S0191-2615(98)00033-2; Mahmassani HS, 1999, TRANSPORT RES C-EMER, V7, P91, DOI 10.1016/S0968-090X(99)00014-5; Ettema D, 2006, TRANSPORT RES C-EMER, V14, P335, DOI 10.1016/j.trc.2006.09.001; Jha M, 1998, TRANSPORT RES C-EMER, V6, P189, DOI 10.1016/S0968-090X(98)00015-1; Wu JJ, 2013, TRANSPORT RES C-EMER, V31, P73, DOI 10.1016/j.trc.2013.01.010; FRIESZ TL, 1994, OPER RES, V42, P1120, DOI 10.1287/opre.42.6.1120; Guo XL, 2011, TRANSPORT RES B-METH, V45, P1606, DOI 10.1016/j.trb.2011.05.026; Bie J, 2010, TRANSPORT RES B-METH, V44, P90, DOI 10.1016/j.trb.2009.06.007; Peeta S, 2006, TRANSPORT RES C-EMER, V14, P114, DOI 10.1016/j.trc.2006.05.008; MAHMASSANI HS, 1987, TRANSPORT SCI, V21, P89, DOI 10.1287/trsc.21.2.89; Chen R., 2009, EXPANDING SPHERE TRA, P791; Chen R, 2004, TRANSPORT RES REC, P209; Chorus C.G., 2006, 85 ANN M TRANSP RES; Dia H, 2002, TRANSPORT RES C-EMER, V10, P331, DOI 10.1016/S0968-090X(02)00025-6; EMMERINK RHM, 1995, TRANSPORTATION, V22, P21, DOI 10.1007/BF01151617; HOROWITZ JL, 1984, TRANSPORT RES B-METH, V18, P13, DOI 10.1016/0191-2615(84)90003-1; Khattak A., 1996, TRANSPORT RES REC, V1537, P46, DOI DOI 10.3141/1537-07; lida Y., 1994, P VEH NAV INF SYST C, P377, DOI 10.1109/VNIS.1994.396810; Nakayama S., 1999, TRANSPORT RES REC, V1676, P30, DOI DOI 10.3141/1676-04; SMITH MJ, 1984, TRANSPORT SCI, V18, P245, DOI 10.1287/trsc.18.3.245	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		278	291		10.1016/j.trc.2015.05.018		14	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800018		
J	Seo, T; Kusakabe, T				Seo, Toru; Kusakabe, Takahiko			Probe vehicle-based traffic state estimation method with spacing information and conservation law	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article; Proceedings Paper	21st International Symposium on Transportation and Traffic Theory (ISTTT)	AUG 05-07, 2015	Kobe, JAPAN			Probe vehicle; Traffic flow; Traffic state estimation; Conservation law; Spacing measurement; Advanced driver assistance system	FREEWAY; WAVES; FLOW	This paper proposes a method of estimating a traffic state based on probe vehicle data that contain spacing and position of probe vehicles. The probe vehicles were assumed to observe spacing by utilizing an advanced driver assistance system, that has been implemented in practice and is expected to spread in the near future. The proposed method relies on the conservation law of the traffic flow but is independent of a fundamental diagram. The conservation law is utilized for reasonable aggregation of the spacing data to acquire the traffic state, i.e., a flow, density and speed. Its independence from a fundamental diagram means that the proposed method does not require predetermined nor exogenous assumptions with regard to the traffic flow model parameters. The proposed method was validated through a simulation experiment under ideal conditions and a field experiment conducted under actual traffic conditions; and empirical characteristics of the proposed method were investigated. (C) 2015 Elsevier Ltd. All rights reserved.	[Seo, Toru; Kusakabe, Takahiko] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1528552, Japan	Seo, T (reprint author), Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, 2-12-1-M1-20 O Okayama, Tokyo 1528552, Japan.	t.seo@plan.cv.titech.ac.jp	Kusakabe, Takahiko/C-1893-2015	Kusakabe, Takahiko/0000-0003-3019-5243			Daganzo CF, 2008, TRANSPORT RES B-METH, V42, P771, DOI 10.1016/j.trb.2008.06.008; Laval JA, 2013, TRANSPORT RES B-METH, V52, P17, DOI 10.1016/j.trb.2013.02.008; Nanthawichit C, 2003, TRANSPORT RES REC, P49; Laval JA, 2011, TRANSPORT RES B-METH, V45, P385, DOI 10.1016/j.trb.2010.07.006; Mehran B, 2012, TRANSPORT RES C-EMER, V20, P144, DOI 10.1016/j.trc.2011.05.006; Herrera JC, 2010, TRANSPORT RES C-EMER, V18, P568, DOI 10.1016/j.trc.2009.10.006; RICHARDS PI, 1956, OPER RES, V4, P42, DOI 10.1287/opre.4.1.42; Yuan YF, 2012, IEEE T INTELL TRANSP, V13, P59, DOI 10.1109/TITS.2011.2178837; [Anonymous], 1955, PROC R SOC LON SER A, DOI [DOI 10.1098/RSPA.1955.0089, 10.1098/rspa.1955.0089]; Herrera JC, 2010, TRANSPORT RES B-METH, V44, P460, DOI 10.1016/j.trb.2009.10.005; Daganzo C. F., 1997, FUNDAMENTALS TRANSPO; Edie L.C., 1963, P 2 INT S THEOR TRAF, P139; Geroliminis N, 2008, TRANSPORT RES B-METH, V42, P759, DOI 10.1016/j.trb.2008.02.002; GIPPS PG, 1981, TRANSPORT RES B-METH, V15, P105, DOI 10.1016/0191-2615(81)90037-0; Leclercq L., 2007, TRANSPORTATION TRAFF, P735; Makigami Y, 1971, TRANSPORT SCI, V5, P302, DOI 10.1287/trsc.5.3.302; van Wageningen-Kessels F, 2013, TRANSPORT RES C-EMER, V34, P148, DOI 10.1016/j.trc.2011.08.004	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	OCT	2015	59				SI		391	403		10.1016/j.trc.2015.05.019		13	Transportation Science & Technology	Transportation	CU2JM	WOS:000363349800025		
J	Fukuhara, T; Ono, C; Puig-Basagoiti, F; Matsuura, Y				Fukuhara, Takasuke; Ono, Chikako; Puig-Basagoiti, Francesc; Matsuura, Yoshiharu			Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus	TRENDS IN MICROBIOLOGY			English	Review							LOW-DENSITY LIPOPROTEINS; TRIGLYCERIDE-RICH LIPOPROTEINS; VIRION-ASSOCIATED CHOLESTEROL; HYPERVARIABLE REGION 1; B TYPE-I; SCAVENGER RECEPTOR; CELL-CULTURE; HCV INFECTION; EXCHANGEABLE APOLIPOPROTEINS; ENVELOPE GLYCOPROTEINS	More than 160 million people worldwide are infected with hepatitis C virus (HCV), and cirrhosis and hepatocellular carcinoma induced by HCV infection are life-threatening diseases. HCV takes advantage of many aspects of lipid metabolism for an efficient propagation in hepatocytes. Due to the morphological and physiological similarities of HCV particles to lipoproteins, lipid-associated HCV particles are named lipoviroparticles. Recent analyses have revealed that exchangeable apolipoproteins directly interact with the viral membrane to generate infectious HCV particles. In this review, we summarize the roles of lipid metabolism in the life cycle of HCV.	[Fukuhara, Takasuke; Ono, Chikako; Puig-Basagoiti, Francesc; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan	Matsuura, Y (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan.	matsuura@blken.osaka-u.ac.jp			Japan Agency for Medical Research and Development (AMED); Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation	We thank M. Tomiyama for her secretarial work and M. Ishibashi and Y. Sugiyama for their technical assistance. This work was supported in part by grants-in-aid from the Japan Agency for Medical Research and Development (AMED), the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and Takeda Science Foundation.	Albecka A, 2011, HEPATOLOGY, V55, P998; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Forde KA, 2009, WORLD J GASTROENTERO, V15, P5020, DOI 10.3748/wjg.15.5020; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Felmlee DJ, 2013, VIRUSES-BASEL, V5, P1292, DOI 10.3390/v5051292; Zhu QQ, 2013, ANTIVIR RES, V98, P373, DOI 10.1016/j.antiviral.2013.04.009; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Fletcher NF, 2012, GASTROENTEROLOGY, V142, P634, DOI 10.1053/j.gastro.2011.11.028; Bankwitz D, 2014, J VIROL, V88, P12644, DOI 10.1128/JVI.01145-14; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Swift LL, 1996, J BIOL CHEM, V271, P31491; Mancone C, 2011, GUT, V60, P378, DOI 10.1136/gut.2010.211292; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Pecheur EI, 2010, J BIOL CHEM, V285, P25802, DOI 10.1074/jbc.M110.131664; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Yamamoto M, 2011, J GEN VIROL, V92, P2082, DOI 10.1099/vir.0.032391-0; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Bassendine MF, 2011, J HEPATOL, V55, P1428, DOI 10.1016/j.jhep.2011.06.004; Jammart B, 2013, J VIROL, V87, P5065, DOI 10.1128/JVI.01405-12; Barretto N, 2014, J VIROL, V88, P5050, DOI 10.1128/JVI.03241-13; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; GUMBER SC, 1995, ANN INTERN MED, V123, P615; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Shimizu Y, 2011, CURR OPIN VIROL, V1, P19, DOI 10.1016/j.coviro.2011.05.017; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Rozek A, 1999, BIOCHEMISTRY-US, V38, P14475, DOI 10.1021/bi982966h; Fukuhara T, 2013, J GASTROENTEROL, V48, P169, DOI 10.1007/s00535-012-0661-5; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Sundaram M, 2012, ARTERIOSCL THROM VAS, V32, P1073, DOI 10.1161/ATVBAHA.111.241455; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Prentoe J, 2014, J VIROL, V88, P1725, DOI 10.1128/JVI.02017-13; Pan MH, 2002, J BIOL CHEM, V277, P4413, DOI 10.1074/jbc.M107460200; Bader T, 2013, J VIRAL HEPATITIS, V20, P622, DOI 10.1111/jvh.12085; Chan K, 2013, CLIN GASTROENTEROL H, V11, P1503, DOI 10.1016/j.cgh.2013.05.014; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674; Maillard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026637; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; SCHAEFER EJ, 1978, BIOCHEM BIOPH RES CO, V80, P405, DOI 10.1016/0006-291X(78)90691-5; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Bocchetta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092140; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Ding Q, 2014, CELL HOST MICROBE, V16, P562, DOI 10.1016/j.chom.2014.10.009; Frentzen A, 2014, HEPATOLOGY, V59, P78, DOI 10.1002/hep.26626; Fukuhara T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004534; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lefevre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095550; Lin CC, 2014, J HEPATOL, V61, P984, DOI 10.1016/j.jhep.2014.06.026; Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8; Miyanari Y, 2007, NAT CELL BIOL, V9, P961; Pileri P, 1998, SCIENCE; Ploss A, 2009, NATURE, V457; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; SEGREST JP, 1992, J LIPID RES, V33, P141; Steinmann E, 2013, CURR TOP MICROBIOL, V369, P17, DOI 10.1007/978-3-642-27340-7_2; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Tanl H, 2007, J VIROL, V81, P8601; Thi V.L.D., 2012, J BIOL CHEM, V287, P31242, DOI DOI 10.1074/JBC.M112.365924; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Zaldi N, 2013, PROG LIPID RES, V52, P585	98	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0966-842X	1878-4380		TRENDS MICROBIOL	Trends Microbiol.	OCT	2015	23	10					618	629		10.1016/j.tim.2015.07.007		12	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CT8PD	WOS:000363077600009		
J	Dryzek, J; Nojiri, S; Fujinami, M; Dryzek, E; Siemek, K; Pachla, W				Dryzek, Jerzy; Nojiri, Shigehiro; Fujinami, Masanori; Dryzek, Ewa; Siemek, Krzysztof; Pachla, Waclaw			The Positron Probe Microanalyser Studies of Defect Distribution Induced by Machining of Copper, Iron and Titanium	TRIBOLOGY LETTERS			English	Article						Positron probe microanalyser; Subsurface defects; Machining; Titanium; Copper; Iron	SURFACE INTEGRITY; ANNIHILATION; WAFERS; ZONES	We demonstrate the application of the new experimental technique: positron probe microanalyser for studies of the defect profiles induced by milling. Metal foils of Cu, Fe and Ti were subjected to machining in a milling machine with different cutting speed. This technique revealed well-defined profiles of defects below the machined surface which was extended up to hundreds of micrometres. The extent of the profile depended on the metal and the cutting speed. The positron probe microanalyser allowed us to trace the evolution of the profile after annealing in different temperatures. Surprisingly, the high thermal stability of a few tens of micrometres thick layer adjacent to the machined surface was detected.	[Dryzek, Jerzy; Dryzek, Ewa; Siemek, Krzysztof] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland; [Nojiri, Shigehiro; Fujinami, Masanori] Chiba Univ, Dept Appl Chem, Inage Ku, Chiba 2638522, Japan; [Pachla, Waclaw] Polish Acad Sci, Inst High Pressure Phys, PL-01142 Warsaw, Poland	Dryzek, J (reprint author), Polish Acad Sci, Inst Nucl Phys, Ul Radzikowskiego 152, PL-31342 Krakow, Poland.	jerzy.dryzek@ifj.edu.pl					Che-Haron CH, 2005, J MATER PROCESS TECH, V166, P188, DOI 10.1016/j.jmatprotec.2004.08.012; Iino Y, 1996, WEAR, V199, P211, DOI 10.1016/0043-1648(96)06921-9; Dryzek J, 2014, TRIBOL LETT, V56, P101, DOI 10.1007/s11249-014-0389-x; Dryzek J, 2014, APPL PHYS A-MATER, V114, P465, DOI 10.1007/s00339-013-7667-6; Fujinami M, 2008, ANAL SCI, V24, P73, DOI 10.2116/analsci.24.73; Borner F, 1998, J APPL PHYS, V84, P2255, DOI 10.1063/1.368291; Dryzek J, 1997, TRIBOL LETT, V3, P269, DOI 10.1023/A:1019141424218; Horodek P, 2012, TRIBOL LETT, V45, P341, DOI 10.1007/s11249-011-9890-7; McNeil SP, 2003, J ELECTRON MATER, V32, P583, DOI 10.1007/s11664-003-0145-8; Ulutan D, 2011, INT J MACH TOOL MANU, V51, P250, DOI 10.1016/j.ijmachtools.2010.11.003; Dryzek J, 1999, TRIBOL LETT, V7, P57, DOI 10.1023/A:1019196615016; Jawahir IS, 2011, CIRP ANN-MANUF TECHN, V60, P603, DOI 10.1016/j.cirp.2011.05.002; M'Saoubi R, 2005, MAT SCI ENG A-STRUCT, V405, P339, DOI 10.1016/j.msea.2005.06.002; Dryzek J, 2010, TRIBOL INT, V43, P447, DOI 10.1016/j.triboint.2009.07.009; Coleman P. G., 2000, POSITRON BEAMS THEIR; Petropoulos GP, 2010, SURFACE INTEGRITY IN MACHINING, P37, DOI 10.1007/978-1-84882-874-2_2; Elmadagli M, 2003, MAT SCI ENG A-STRUCT, V355, P249, DOI 10.1016/S0921-5093(03)00072-8; Krause-Rehberg R., 1999, POSITRON ANNIHILATIO; Kuiczyk M., 2006, P 9 INT ESA FORM C M; Ni H, 2004, MAT SCI ENG A-STRUCT, V385, P267, DOI 10.1016/j.msea.2004.06.048; Oshima N., 2008, J APPL PHYS, V103; Robles Campillo J.M., 2007, J PHYS CONDENS MATT, V19; Sun J, 2009, J MATER PROCESS TECH, V209, P4036, DOI 10.1016/j.jmatprotec.2008.09.022	23	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	OCT	2015	60	1							16	10.1007/s11249-015-0587-1		7	Engineering, Chemical; Engineering, Mechanical	Engineering	CT8FV	WOS:000363051300011		
J	Itoh, S; Norizuki, Y; Fukuzawa, K; Zhang, HD				Itoh, Shintaro; Norizuki, Yusuke; Fukuzawa, Kenji; Zhang, Hedong			Effect of Chemically Adsorbed Molecules on the Viscous Friction of Nanometer-Thick Liquid Lubricant Films Coated on a Diamond-Like Carbon Surface	TRIBOLOGY LETTERS			English	Article						Nanotribology; Magnetic data storage; Lubricant thin film; Shear thinning; Confinement	ZDOL PERFLUOROPOLYETHER LUBRICANT; FIBER WOBBLING METHOD; HEAD-DISK INTERFACE; ULTRAVIOLET-IRRADIATION; CONFINED FLUIDS; PERFORMANCE; TRIBOLOGY; MEDIA	Nanometer-thick liquid lubricant films are used for lubrication of miniaturized mechanical systems such as hard disk drives and microelectromechanical systems. In particular at the head-disk interface of hard disk drives, the lubricant thin film is coated on a diamond-like carbon surface, and the films are usually composed of both chemically and physically adsorbed lubricant molecules. The combination of these two types of molecules leads to high lubrication performance. However, the detailed mechanism is not fully understood. The aim of this study was to clarify the effect of chemically adsorbed lubricant molecules on the viscous friction of lubricant films. Two different samples were tested: One was the lubricant film composed of both chemically and physically adsorbed molecules, and the other was the lubricant film with only physically adsorbed molecules. We used a fiber wobbling method (FWM), which we developed in our previous study, to measure the viscous friction. The FWM uses a spherical-ended glass fiber as a shearing probe and enables friction forces in the order of 0.1 nN to be measured at precisely controlled nanometer-scale gap widths. For the fair comparison of friction forces between the samples with different compositions, the contact area between the probe tip and the lubricant film must be the same. To determine the contact area in the friction measurement, we improved the FWM system to enable simultaneous measurement of friction force and contact area. Experimental results showed the 1-nm-thick layer of chemically adsorbed molecules in the lubricant film effectively reduced the viscous friction.	[Itoh, Shintaro; Norizuki, Yusuke; Fukuzawa, Kenji] Nagoya Univ, Dept Micro Nano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Zhang, Hedong] Nagoya Univ, Dept Complex Syst Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Itoh, S (reprint author), Nagoya Univ, Dept Micro Nano Syst Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	s_itoh@nuem.nagoya-u.ac.jp			Storage Research Consortium; Asahi Glass Foundation	The present research was partially supported by the Storage Research Consortium and the Asahi Glass Foundation.	Itoh S, 2013, TRIBOL LETT, V49, P1, DOI 10.1007/s11249-012-0067-9; Gui J, 2003, IEEE T MAGN, V39, P716, DOI 10.1109/TMAG.2003.808999; Zhang H, 2007, TRIBOL LETT, V28, P163, DOI 10.1007/s11249-007-9261-6; Rymuza Z, 1999, MICROSYST TECHNOL, V5, P173, DOI 10.1007/s005420050160; Pit R, 2000, PHYS REV LETT, V85, P980, DOI 10.1103/PhysRevLett.85.980; Itoh S, 2008, TRIBOL LETT, V30, P177, DOI 10.1007/s11249-008-9325-2; Ruths M, 1999, TRIBOL LETT, V7, P161, DOI 10.1023/A:1019137824102; Luengo G, 1996, WEAR, V200, P328, DOI 10.1016/S0043-1648(96)07248-1; Zhang H, 2005, TRIBOL LETT, V20, P191, DOI 10.1007/s11249-005-8326-7; Yamada S, 2002, TRIBOL LETT, V13, P167, DOI 10.1023/A:1020151824274; Chen CY, 2001, TRIBOL LETT, V10, P195, DOI 10.1023/A:1016697417275; VURENS GH, 1993, IEEE T MAGN, V29, P282, DOI 10.1109/20.195583; Itoh S, 2005, MICROSYST TECHNOL, V11, P894, DOI 10.1007/s00542-005-0568-7; Waltman RJ, 1998, TRIBOL LETT, V4, P267, DOI 10.1023/A:1019127910531; Chiba H, 2003, TRIBOL INT, V36, P367, DOI 10.1016/S0301-679X(02)00211-6; Eapen KC, 2002, TRIBOL LETT, V12, P35, DOI 10.1023/A:1013971321480; Zhao ZM, 1996, WEAR, V202, P50, DOI 10.1016/S0043-1648(96)07307-3; Tyndall GW, 1998, LANGMUIR, V14, P7527, DOI 10.1021/la9802825; Fukuzawa K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061602; Itoh S, 2009, IEEE T MAGN, V45, P5055, DOI 10.1109/TMAG.2009.2029605; Gennes P.-G.D., 2003, CAPILLARITY WETTING; Hedong Zhang, 2008, IEEE Transactions on Magnetics, V44, DOI 10.1109/TMAG.2008.2001594; Itoh S, 2014, TRIBOL LETT, V53, P555, DOI 10.1007/s11249-014-0294-3; Junho C., 2003, IEEE T MAGN, V39, P2492, DOI 10.1109/TMAG.2003.816450; Lu R., 2013, TRIBOL LETT, V54, P237; Marchon B., 2013, ADV TRIBOL, V2013, P1	26	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	OCT	2015	60	1							7	10.1007/s11249-015-0583-5		9	Engineering, Chemical; Engineering, Mechanical	Engineering	CT8FV	WOS:000363051300007		
J	Nanao, H; Hoshi, Y; Shizuku, T; Takiwatari, K; Mori, S				Nanao, Hidetaka; Hoshi, Yasushi; Shizuku, Takahisa; Takiwatari, Koji; Mori, Shigeyuki			Direct Observation of Lubricant Components Between Wire and Diamond Die for Wire Drawing with a Micro-FTIR	TRIBOLOGY LETTERS			English	Article						Wire drawing; Direct observation; Micro-FTIR; Oil film; Brass wire; Tribochemical reaction; Oleic acid; Soap	MOLECULAR INTERACTION; POLYPROPYLENE GLYCOL; OLEIC-ACID; TEMPERATURE; PRESSURE; CONTACT; STRESS; FILM; OILS	Lubricant oil film between a brass wire and a diamond die was observed directly with a micro-FTIR after drawing the wire. A new method using a diamond die with a side view for the direct observation has been developed using a micro-FTIR. PAO, oleic acid and PAO with 20 mass% of oleic acid were used as a lubricant. The profile of the oil film thickness in the reduction region of the die was obtained from the absorbance of IR spectra. The result shows a good linear relation depending on the semi-reduction angle of the die. A dent of film thickness with PAO was observed at 50-100 mu m of the position from the end of reduction region, and it disappeared when wire drawing was carried out with oleic acid solution. The formation mechanism of the dent was discussed from the viewpoint of lubrication property of the lubricants. It was found from IR measurements that oleic acid reacts with zinc oxide on brass wire and soap as the reaction product was accumulated at the end of reduction region.	[Nanao, Hidetaka; Hoshi, Yasushi; Mori, Shigeyuki] Iwate Univ, Morioka, Iwate 020, Japan; [Shizuku, Takahisa] Bridgestone Holdings, Tokyo, Japan; [Takiwatari, Koji] Ichinoseki Coll, Natl Inst Technol, Ichinoseki, Japan	Mori, S (reprint author), Iwate Univ, Morioka, Iwate 020, Japan.	mori@iwate-u.ac.jp			project on Green Tribology Network Innovation in GRENE Project from MEXT	A part of this work was supported by the project on Green Tribology Network Innovation in GRENE Project from MEXT. The authors would like to appreciate for the support.	El-Domiaty A, 1998, J MATER PROCESS TECH, V83, P72, DOI 10.1016/S0924-0136(98)00045-4; Tomar P, 2013, PROCEDIA ENGINEER, V64, P1320, DOI 10.1016/j.proeng.2013.09.213; Obi AI, 1996, WEAR, V194, P30, DOI 10.1016/0043-1648(95)06664-0; Takiwatari K, 2014, LUBR SCI, V26, P13, DOI 10.1002/ls.1223; Takiwatari K, 2010, LUBR SCI, V22, P89, DOI 10.1002/ls.107; Hsu SM, 2002, TRIBOL LETT, V13, P131, DOI 10.1023/A:1020112901674; Shimotomai N, 2011, J JPN SOC TRIBOLOGIS, V56, P47; Feser T, 2013, WEAR, V303, P465, DOI 10.1016/j.wear.2013.03.047; Mori S, 1996, TRIBOL INT, V29, P35, DOI 10.1016/0301-679X(95)00032-Y; Takiwatari K, 2010, LUBR SCI, V22, P367, DOI 10.1002/ls.132; Felder E, 2012, WEAR, V286, P27, DOI 10.1016/j.wear.2011.05.029; Bech J, 1999, WEAR, V232, P134, DOI 10.1016/S0043-1648(99)00136-2; Azushima A, 2005, TRIBOL INT, V38, P105, DOI 10.1016/j.triboint.2004.04.006; Hollinger S, 2003, WEAR, V255, P1291, DOI 10.1016/S0043-1648(03)00168-6	14	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	OCT	2015	60	1							12	10.1007/s11249-015-0592-4		6	Engineering, Chemical; Engineering, Mechanical	Engineering	CT8FV	WOS:000363051300016		
J	Sasaki, M; Hsu, M; Yeh, MM; Nakanuma, Y				Sasaki, Motoko; Hsu, Maylee; Yeh, Matthew M.; Nakanuma, Yasuni			In recurrent primary biliary cirrhosis after liver transplantation, biliary epithelial cells show increased expression of mitochondrial proteins	VIRCHOWS ARCHIV			English	Article						Primary biliary cirrhosis; Post-liver transplant rejection; Pyruvate dehydrogenase complex-E2 component; Biliary epithelial cell; Autophagy and cellular senescence	SMALL BILE-DUCTS; CELLULAR SENESCENCE; AUTOPHAGY; P21(WAF1/CIP1); REJECTION; TREE	In biliary epithelial lesions in primary biliary cirrhosis (PBC), mitochondrial proteins associated with deregulated autophagy are abnormally expressed. We examined whether this could be used as a diagnostic marker for end-stage PBC and recurrent PBC after liver transplantation. We examined the expression of the mitochondrial protein pyruvate dehydrogenase complex-E2 component and cytochrome c oxidase, subunit I (CCO), the autophagy-related marker microtubule-associated protein-light chain 3 (LC3), and p62/sequestosome-1 and the senescence markers p16(Ink4a) and p21(WAF1/Cip1) in small bile ducts and bile ductules in explanted livers from patients with PBC (n = 20) in comparison with liver tissue from control patients (n = 21) and post-transplant samples including recurrent PBC and cellular rejection (n = 28). Intense granular expression of mitochondrial proteins was significantly more frequent in small bile ducts in explanted livers with PBC than in control livers (p < 0.05). Post-transplant samples comprised of three groups: group A (positive for mitochondrial proteins, n = 7), group B (positive for either autophagy-related or senescence markers but negative for mitochondrial proteins, n = 7), and group C (all negative, n = 14). All but one case of group A were clinically and histologically diagnosed as recurrent PBC. In contrast, all cases of group B were diagnosed as cellular rejection. This study suggests that the expression of mitochondrial proteins in small bile ducts may be a useful diagnostic marker for end-stage PBC and recurrent PBC after liver transplantation.	[Sasaki, Motoko; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan; [Hsu, Maylee; Yeh, Matthew M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Div Pathol, Shizuoka, Japan	Sasaki, M (reprint author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.	m8sasaki@med.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Education, Culture, Sports and Science and Technology of Japan [24590409, 15K08341]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports and Science and Technology of Japan (24590409 and 15K08341).	VandeWater J, 1996, HEPATOLOGY, V24, P1079; Sasaki M, 2013, LIVER INT, V33, P312, DOI 10.1111/liv.12049; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Brain JG, 2013, AM J TRANSPLANT, V13, P1688, DOI 10.1111/ajt.12271; Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348; Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; NEUBERGER J, 1995, HEPATOLOGY, V22, P798, DOI 10.1016/0270-9139(95)90299-6; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; Sasaki M, 2010, LAB INVEST, V90, P835, DOI 10.1038/labinvest.2010.56; Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005; NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326; Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8; Hubscher S, 2012, PATHOLOGY LIVER, P853; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209; Portmann B, 2007, PATHOLOGY LIVER, P517	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	OCT	2015	467	4					417	425		10.1007/s00428-015-1819-3		9	Pathology	Pathology	CT8HM	WOS:000363055900006		
J	Wang, J; Kondo, T; Yamane, T; Nakazawa, T; Oish, N; Mochizuki, K; Katoh, R				Wang, Jieying; Kondo, Tetsuo; Yamane, Tetsu; Nakazawa, Tadao; Oish, Naoki; Mochizuki, Kunio; Katoh, Ryohei			Expression of nuclear membrane proteins in normal, hyperplastic, and neoplastic thyroid epithelial cells	VIRCHOWS ARCHIV			English	Article						Nuclear membrane proteins; Thyroid; Carcinoma; Immunohistochemistry; Polymerase chain reaction (PCR)	LEM-DOMAIN; ENVELOPE; LAMINS; EMERIN; CARCINOMAS; TRANSCRIPTION; ORGANIZATION; ROLES; COMPLEXES; LESIONS	Emerin, lamin A/C, lamin B, and lamin-associated polypeptide 2 (LAP2) are nuclear membrane proteins that play an important role in maintaining nuclear structure and coordinating cell activity. We studied the expression and significance of nuclear membrane proteins in neoplastic thyroid cells by immunohistochemistry, RT-PCR, and real-time PCR. In papillary carcinomas (PCs), the nuclear proteins most frequently expressed at high levels were emerin (82 % positive), lamin A/C (64 %), and LAP2 (82 %). Follicular carcinomas (FCs) most frequently expressed lamin B, while none of the undifferentiated carcinomas (UCs) showed strong expression of emerin or lamin A/C. In all medullary carcinomas (MCs), intermediate to high levels of expression of lamin A/C and LAP2 were found. By RT-PCR analysis, messenger RNA (mRNA) expression of all nuclear membrane proteins except emerin was higher in PC than in normal tissue. Real-time PCR analysis showed that mRNA expression of nuclear membrane protein varied between cell lines. Our findings suggest that expression of nuclear membrane proteins may be related to follicular function in normal and hyperplastic follicles, and we hypothesize that they are also involved in the proliferation and differentiation of neoplastic thyroid cells. We suggest that they reflect the biological nature and/or function of normal, hyperplastic, and neoplastic thyroid cells and may have some value in diagnosing thyroid tumors.	[Wang, Jieying; Kondo, Tetsuo; Yamane, Tetsu; Nakazawa, Tadao; Oish, Naoki; Mochizuki, Kunio; Katoh, Ryohei] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pathol, Chuo Ku, Yamanashi 4093898, Japan	Katoh, R (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pathol, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	rkatoh@yamanashi.ac.jp					Rezk S, 2004, ENDOCR PATHOL, V15, P329, DOI 10.1385/EP:15:4:329; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Mendez-Lopez I, 2012, CHROMOSOMA, V121, P153, DOI 10.1007/s00412-012-0360-2; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Asioli S, 2010, VIRCHOWS ARCH, V457, P43, DOI 10.1007/s00428-010-0910-z; Asioli S, 2009, HISTOPATHOLOGY, V54, P571, DOI 10.1111/j.1365-2559.2009.03259.x; Venables RS, 2001, BRIT J CANCER, V84, P512, DOI 10.1054/bjoc.2000.1632; Sun S, 2010, J PROTEOME RES, V9, P70, DOI 10.1021/pr9002118; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Worman HJ, 2000, J MEMBRANE BIOL, V177, P1, DOI 10.1007/s002320001096; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Fischer AH, 2001, HISTOL HISTOPATHOL, V16, P1; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; AARONSON RP, 1975, P NATL ACAD SCI USA, V72, P1007, DOI 10.1073/pnas.72.3.1007; Hutchison CJ, 2001, J CELL SCI, V114, P9; Kondo T, 2007, HUM PATHOL, V38, P1810, DOI 10.1016/j.humpath.2007.04.014; Coradeghini R, 2006, ONCOL REP, V15, P609; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bis602636m; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; Katoh R, 2000, HUM PATHOL, V31, P386, DOI 10.1016/S0046-8177(00)80255-5; DeLellis RA., 2004, PATHOLOGY GENETICS T; Fisher AH, 2003, AM J SURG PATHOL, V163, P1091; Franke WW, 1981, J CELL BIOL, V91, P39; Kim HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039482; Rubin, 2007, ENDOCRINE SYSTEM, P933; Wang JY, 2014, ACTA HISTOCHEM CYTOC, V47, P289, DOI 10.1267/ahc.14041; Willis N. D., 2008, PLOS ONE, V3	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	OCT	2015	467	4					427	436		10.1007/s00428-015-1816-6		10	Pathology	Pathology	CT8HM	WOS:000363055900007		
J	Taneda, S; Honda, K; Ohno, M; Uchida, K; Nitta, K; Oda, H				Taneda, Sekiko; Honda, Kazuho; Ohno, Mayuko; Uchida, Keiko; Nitta, Kosaku; Oda, Hideaki			Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis	VIRCHOWS ARCHIV			English	Article						Electron microscopy; Focal segmental glomerulosclerosis; Foot process effacement; Podocyte detachment; Subendothelial widening	FOOT PROCESS EFFACEMENT; GLOMERULAR SCLEROSIS; THROMBOTIC MICROANGIOPATHY; TRANSPLANT GLOMERULOPATHY; NEPHROTIC SYNDROME; REMNANT-KIDNEY; PROTEINURIA; HYPERTENSION; PROGRESSION; INHIBITION	Podocyte injury contributes to the development of focal segmental glomerulosclerosis (FSGS). Endocapillary hypercellularity, which is one of the pathological characteristics of FSGS, suggests that glomerular endothelial injury may also be involved in the pathogenesis of FSGS. In electron micrographs of patients with FSGS (n = 43), we conducted morphometric measurements of foot process width (FPW) and podocyte detachment (PD) as markers of podocyte injury and subendothelial widening (SW) of the glomerular basement membrane as a marker of endothelial injury and compared them to those in patients with minimal change nephrotic syndrome (MCNS; n = 11) and control kidney donors (n = 5). Associations between ultrastructural and clinical parameters were analyzed according to the FSGS variants defined by the Columbia classification. FPW was significantly higher in the FSGS group than that in the MCNS and control groups, particularly in the collapsing, tip, and cellular variants of FSGS. Percentage of glomerular basement membrane (GBM) length showing PD and SW was significantly increased in the FSGS group, especially in the collapsing, cellular, and not otherwise specified variants. In FSGS, FPW was inversely correlated with disease duration, but not with proteinuria. Finally, the percentage of GBM length with SW significantly correlated with clinical parameters indicative of poor prognosis, such as lower remission rate and lower estimated glomerular filtration rate at the final observation. Quantitative measurement of podocyte and endothelial injury by electron microscopy might be useful for evaluating histological activity and predicting prognosis in FSGS.	[Taneda, Sekiko; Honda, Kazuho; Ohno, Mayuko; Oda, Hideaki] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Uchida, Keiko; Nitta, Kosaku] Tokyo Womens Med Univ, Kidney Ctr, Dept Internal Med, Tokyo, Japan; [Honda, Kazuho] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan	Taneda, S (reprint author), Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan.	sekikosekiko@gmail.com					Opocensky M, 2006, HYPERTENSION, V48, P965, DOI 10.1161/01.HYP.0000245117.57524.d6; Taneda S, 2012, INT UROL NEPHROL, V44, P183, DOI 10.1007/s11255-011-9932-y; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; GRISHMAN E, 1975, KIDNEY INT, V7, P111, DOI 10.1038/ki.1975.16; Henderson JM, 2009, J AM SOC NEPHROL, V20, P961, DOI 10.1681/ASN.2008060613; SCHWARTZ MM, 1985, KIDNEY INT, V28, P968, DOI 10.1038/ki.1985.225; Sinha A, 2013, CLIN EXP NEPHROL, V17, P66, DOI 10.1007/s10157-012-0656-9; Bolbrinker J, 2006, J PHARMACOL EXP THER, V316, P8, DOI 10.1124/jpet.105.093112; Asanuma K, 2011, AM J NEPHROL, V33, P537, DOI 10.1159/000327995; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; MARYNIAK RK, 1985, KIDNEY INT, V27, P799, DOI 10.1038/ki.1985.83; Zhang QY, 2012, NEPHROLOGY, V17, P338, DOI 10.1111/j.1440-1797.2012.01575.x; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Griffin SV, 2003, NEPHROL DIAL TRANSPL, V18, P8, DOI 10.1093/ndt/gfg1069; Tada M, 2001, PEDIATR NEPHROL, V16, P482; YOSHIKAWA N, 1986, J PEDIATR-US, V109, P65, DOI 10.1016/S0022-3476(86)80574-1; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; KATAFUCHI R, 1984, CLIN NEPHROL, V22, P1; HSU HC, 1980, HISTOPATHOLOGY, V4, P351, DOI 10.1111/j.1365-2559.1980.tb02931.x; Kitamura H, 1998, EXP NEPHROL, V6, P328; Liakopoulos V, 2011, CLIN NEPHROL, V75, P362, DOI 10.5414/CN106544; Duner F, 2008, NEPHROL DIAL TRANSPL, V23, P2504, DOI 10.1093/ndt/gfn100; Lahdenkari AT, 2004, J AM SOC NEPHROL, V15, P2611, DOI 10.1097/01.ASN.0000139478.03463.D9; NEWMAN WJ, 1976, MEDICINE, V55, P67, DOI 10.1097/00005792-197601000-00004; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Daehn I, J CLIN INVEST, V124, P1608; Lee YC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-5; Leontsini M, 2003, HIPPOKRATIA, V7, P147; Miki Yusuke, 2002, Nihon Jinzo Gakkai Shi, V44, P547; Ogino S, 1999, Nihon Jinzo Gakkai Shi, V41, P413; Schwartz, 2007, HEPT PATH KIDN	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	OCT	2015	467	4					449	458		10.1007/s00428-015-1821-9		10	Pathology	Pathology	CT8HM	WOS:000363055900010		
J	Hayashi, N; Naumkin, PI				Hayashi, Nakao; Naumkin, Pavel I.			Factorization technique for the fourth-order nonlinear Schrodinger equation	ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK			English	Article						Fourth-order nonlinear Schrodinger equation; Factorization formula; Large time asymptotics of solutions; Logarithmic phase correction; Critical order of nonlinearity	GLOBAL WELL-POSEDNESS; SCATTERING-THEORY; VORTEX FILAMENT; ASYMPTOTICS; DIMENSIONS; DISPERSION; EXISTENCE	We consider the Cauchy problem for the cubic fourth-order nonlinear Schrodinger equation where We introduce the factorization formula for the free evolution group to prove the global existence of solutions. Also we show that the large time asymptotics of solutions has a logarithmic correction in the phase comparing with the corresponding linear case.	[Hayashi, Nakao] Osaka Univ, Grad Sch Sci, Dept Math, Osaka, Toyonaka 5600043, Japan; [Naumkin, Pavel I.] Ctr Ciencias Matemat, Morelia 58089, Michoacan, Mexico	Hayashi, N (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Osaka, Toyonaka 5600043, Japan.	nhayashi@math.sci.osaka-u.ac.jp; pavelni@matmor.unam.mx			JSPS KAKENHI Grant [25220702]; CONACYT; PAPIIT Project [IN100113]	We would like to thank an unknown referee for useful suggestions and comments. The work of N.H. is supported by JSPS KAKENHI Grant Number 25220702. The work of P.I.N. is partially supported by CONACYT and PAPIIT Project IN100113.	Ben-Artzi M, 2000, CR ACAD SCI I-MATH, V330, P87, DOI 10.1016/S0764-4442(00)00120-8; Guo CH, 2006, APPL MATH LETT, V19, P706, DOI 10.1016/j.aml.2005.10.002; Fukumoto Y, 2001, FLUID MEC A, V59, P211; Huo ZH, 2005, J DIFFER EQUATIONS, V214, P1, DOI 10.1016/j.jde.2004.09.005; Karpman VI, 1996, PHYS REV E, V53, pR1336; Hao CC, 2006, J MATH ANAL APPL, V320, P246, DOI 10.1016/j.jmaa.2005.06.091; HAYASHI N, 1988, ANN I H POINCARE-PHY, V48, P17; Karpman VI, 2000, PHYSICA D, V144, P194, DOI 10.1016/S0167-2789(00)00078-6; Pausader B, 2007, DYNAM PART DIFFER EQ, V4, P197; Hayashi N, 2008, Z ANGEW MATH PHYS, V59, P1002, DOI 10.1007/s00033-007-7008-8; Pausader B, 2013, NONLINEARITY, V26, P2175, DOI 10.1088/0951-7715/26/8/2175; KENIG CE, 1991, INDIANA U MATH J, V40, P33, DOI 10.1512/iumj.1991.40.40003; Wang YZ, 2012, NONLINEAR ANAL-THEOR, V75, P2534, DOI 10.1016/j.na.2011.10.047; Wang YZ, 2012, B AUST MATH SOC, V85, P371, DOI 10.1017/S0004972711003327; DYSTHE KB, 1979, P ROY SOC LOND A MAT, V369, P105, DOI 10.1098/rspa.1979.0154; Fedoryuk M.V., 1987, ASYMPTOTICS INTEGRAL; Hayashi N, 2015, J DIFFER EQUATIONS, V258, P880, DOI 10.1016/j.jde.2014.10.007; HAYASHI N, 1993, COMMUN PART DIFF EQ, V18, P1109, DOI 10.1080/03605309308820965; KENIG CE, 1993, COMMUN PUR APPL MATH, V46, P527, DOI 10.1002/cpa.3160460405; Pausader B, 2010, J HYPERBOL DIFFER EQ, V7, P651, DOI 10.1142/S0219891610002256; Segata J., 2006, MATH METHOD APPL SCI, V26, P1785; Segata J., 2003, DIFFERENTIAL INTEGRA, V16, P841; Stein E.M., 2011, PRINCETON LECT ANAL, V4	23	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0044-2275	1420-9039		Z ANGEW MATH PHYS	Z. Angew. Math. Phys.	OCT	2015	66	5					2343	2377		10.1007/s00033-015-0524-z		35	Mathematics, Applied	Mathematics	CT8JO	WOS:000363062100013		
J	Saito, R; Miselki, Y; Nini, W; Sayama, K				Saito, Rie; Miselki, Yugo; Nini, Wang; Sayama, Kazuhiro			Discovery of Overcoating Metal Oxides on Photoelectrode for Water Splitting by Automated Screening	ACS COMBINATORIAL SCIENCE			English	Article						photoelectrode library; composite multilayer; water splitting metal oxides; automated screening; photocurrent	BIVO4 THIN-FILM; VISIBLE-LIGHT; CARBONATE ELECTROLYTE; EFFICIENT; PHOTOANODES; COMPOSITE; PHOTOOXIDATION; DECOMPOSITION; OXIDATION; CATALYST	We applied an automated semiconductor synthesis and screen system to discover overcoating film materials and optimize coating conditions on the BiVO4/WO3 composite photoelectrode to enhance stability and photocurrent. Thirteen metallic elements for overcoating oxides were examined with various coating amounts. The stability of the BiVO4/WO3 photoelectrode in a highly concentrated carbonate electrolyte aqueous solution was significantly improved by overcoating with Ta2O5 film, which was amorphous and porous when calcined at 550 degrees C. The photocurrent for the water oxidation reaction was only minimally inhibited by the presence of the Ta2O5 film on the BiVO4/WO3 photoelectrode.	[Saito, Rie; Miselki, Yugo; Nini, Wang; Sayama, Kazuhiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Sayama, K (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	k.sayama@aist.go.jp			Next Generation World-Leading Researchers (NEXT Program) from Cabinet Office; Government of Japan; Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies	The present work was partially supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Cabinet Office and by the Government of Japan and the Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies.	Hu S, 2014, SCIENCE, V344, P1005, DOI 10.1126/science.1251428; Arai T, 2007, J COMB CHEM, V9, P574, DOI 10.1021/cc0700142; Fujimoto I, 2014, INT J HYDROGEN ENERG, V39, P2454, DOI 10.1016/j.ijhydene.2013.08.114; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Cowan AJ, 2013, CHEM SOC REV, V42, P2281, DOI 10.1039/c2cs35305a; Zhong DK, 2011, J AM CHEM SOC, V133, P18370, DOI 10.1021/ja207348x; Luo WJ, 2011, ENERG ENVIRON SCI, V4, P4046, DOI 10.1039/c1ee01812d; Kusama H, 2010, J COMB CHEM, V12, P356, DOI 10.1021/cc9001845; Sayama K, 2003, CHEM COMMUN, P2908, DOI 10.1039/b310428a; Lyons MEG, 2011, PHYS CHEM CHEM PHYS, V13, P5314, DOI 10.1039/c0cp02875d; Hong SJ, 2011, ENERG ENVIRON SCI, V4, P1781, DOI 10.1039/c0ee00743a; Saito R, 2013, J PHOTOCH PHOTOBIO A, V258, P51, DOI 10.1016/j.jphotochem.2013.02.019; Li ZS, 2013, ENERG ENVIRON SCI, V6, P347, DOI 10.1039/c2ee22618a; Osterloh FE, 2013, CHEM SOC REV, V42, P2294, DOI 10.1039/c2cs35266d; Liu X, 2012, PHYS CHEM CHEM PHYS, V14, P7894, DOI 10.1039/c2cp40976c; Sayama K, 2010, CHEM LETT, V39, P17, DOI 10.1246/cl.2010.17; Saito R, 2012, CHEM COMMUN, V48, P3833, DOI 10.1039/c2cc30713h; Park Y, 2013, CHEM SOC REV, V42, P2321, DOI 10.1039/c2cs35260e; Sivula K, 2011, CHEMSUSCHEM, V4, P432, DOI 10.1002/cssc.201000416; Seabold JA, 2012, J AM CHEM SOC, V134, P2186, DOI 10.1021/ja209001d; Sayama K, 2006, J PHYS CHEM B, V110, P11352, DOI 10.1021/jp057539+; Xu Y, 2000, AM MINERAL, V85, P543; Matsui Y, 2005, J ELECTROCHEM SOC, V152, pF54, DOI 10.1149/1.1885365	23	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2156-8952	2156-8944		ACS COMB SCI	ACS Comb. Sci.	OCT	2015	17	10					592	599		10.1021/acscombsci.5b00022		8	Chemistry, Applied; Chemistry, Medicinal; Chemistry, Multidisciplinary	Chemistry; Pharmacology & Pharmacy	CT5PT	WOS:000362863200004		
J	Choi, H; Kim, HJ; Matsuura, A; Mikami, B; Yoon, HJ; Lee, HH				Choi, Hwajung; Kim, Hee Jung; Matsuura, Atsushi; Mikami, Bunzo; Yoon, Hye-Jin; Lee, Hyung Ho			Structural and functional studies of a metallo-beta-lactamase unveil a new type of structurally encoded nickel-containing heterodinuclear site	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						metalloenzyme; nickel; phosphodiesterase; antibiotics; X-ray absorption spectroscopy	BINDING-SITES; INHIBITORS; PURIFICATION; RESISTANCE; RESOLUTION; CATALYSIS; SOFTWARE; PROTEINS; ZINC; ION	The selection of correct metal ions with high fidelity against competing cellular cations is crucial for the function of many metalloenzymes; however, the understanding of the principles that govern metal selectivity is still incomplete. In this study, the crystal structure of the Tm1162 protein from Thermotoga maritima, a metallo-beta-lactamase, is reported. Several crystal structures of wildtype Tm1162 and its mutants were solved. Homologues of Tm1162 are widely distributed in bacteria and archaea, including several human pathogens. The monomer possesses an alpha beta/beta alpha fold, with the core beta-strands having the beta-sheet sandwich structure common to the metallo-beta-lactamase superfamily. Tm1162 exists as a trimer in the crystal and this trimeric unit is likely to be present in solution. In the trimer, three active sites reside at the interface between subunits, suggesting that the oligomeric assembly is crucial for catalysis. A new type of structurally encoded heterodinuclear site has been identified by confirming the identity of nickel-containing heteronuclear sites in Tm1162 via X-ray absorption spectroscopy and anomalous difference Fourier maps. The second coordination sphere, including His8 and Glu73, maintains the side-chain orientations of histidines and stabilizes the metal-binding site. Nickel coordination was crucial for the oligomerization of Tm1162. The nickel-dependent and manganese-dependent beta-lactamase and phosphodiesterase activities of Tm1162 have also been characterized.	[Choi, Hwajung; Yoon, Hye-Jin; Lee, Hyung Ho] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea; [Kim, Hee Jung; Matsuura, Atsushi] Kookmin Univ, Dept Bio & Nano Chem, Seoul 136702, South Korea; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Lab Qual Design & Exploitat, Kyoto 6110011, Japan	Lee, HH (reprint author), Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea.	hyungholee@snu.ac.kr			National Research Foundation (NRF) of Korea - Korean government [2013R1A1A1008195, 2015R1A5A1008958]; Korea CCS RD Center (KCRC) [2013M1A8A1038187]; NRF [2014R1A1A3A04050250]	The authors thank the staff of beamlines 5C and 7A at Pohang Light Source and BL44XU at SPring-8, Japan for their assistance during the X-ray experiments. This study was supported by a grant from the National Research Foundation (NRF) of Korea funded by the Korean government (2013R1A1A1008195 and 2015R1A5A1008958) and a grant from the Korea CCS R&D Center (KCRC; 2013M1A8A1038187) to HHL. This study was also supported by an NRF grant (2014R1A1A3A04050250) to HJY.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Garces F, 2010, J MOL BIOL, V398, P715, DOI 10.1016/j.jmb.2010.03.041; Dudev T, 2014, CHEM REV, V114, P538, DOI 10.1021/cr4004665; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Perez-Llarena FJ, 2009, CURR MED CHEM, V16, P3740; Hu Z, 2009, BIOCHEMISTRY-US, V48, P2981, DOI 10.1021/bi802295z; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; de la Torre JG, 2000, BIOPHYS J, V78, P719; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; Wang ZG, 1998, J BIOL CHEM, V273, P22402, DOI 10.1074/jbc.273.35.22402; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; Saito R, 2004, ACTA CRYSTALLOGR D, V60, P792, DOI 10.1107/S0907444904003166; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Feng H, 2014, J AM CHEM SOC, V136, P14694, DOI 10.1021/ja508388e; Ragsdale SW, 2009, J BIOL CHEM, V284, P18571, DOI 10.1074/jbc.R900020200; CHEONG CG, 1995, PROTEINS, V21, P105, DOI 10.1002/prot.340210204; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eidam O, 2012, P NATL ACAD SCI USA, V109, P17448, DOI 10.1073/pnas.1208337109; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Quiroga MI, 2000, CHEMOTHERAPY, V46, P177, DOI 10.1159/000007275; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Punta M, 2011, NUCLEIC ACIDS RES, V40, pD290, DOI DOI 10.1093/NAR/GKR1065; Raj SB, 2014, BIOCHEMISTRY-US, V53, P5791, DOI 10.1021/bi5006442; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068	39	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	OCT	2015	71		10				2054	2065		10.1107/S1399004715014807		12	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CT5LH	WOS:000362851300007		
J	Hasumi, M				Hasumi, Masato			Social interactions during the aquatic breeding phase of the family Hynobiidae (Amphibia: Caudata)	ACTA ETHOLOGICA			English	Review						Increased head width; Mating ball; Midwifing; Parental care; Scramble competition; Territoriality	MALE REPRODUCTIVE-BEHAVIOR; RED-COLLARED WIDOWBIRDS; PARENTAL CARE; SEXUAL-DIMORPHISM; SEASONAL-CHANGES; MALE SALAMANDERS; WATER-DRIVE; BODY-SIZE; SCRAMBLE COMPETITION; TRITURUS-VIRIDESCENS	Social animals with a monophasic life cycle exhibit a more complex social system for reproduction than that of other social animals in which the life cycle is biphasic. The family Hynobiidae (Amphibia: Caudata) is phylogenetically basal to most other salamander families, practices external fertilization, and has a biphasic life cycle alternating between aquatic breeding and terrestrial nonbreeding phases. There are many controversial and specific social interactions during the aquatic breeding phase in several of the inspected species of this family when comparing their sexual or social behaviors with those of other animal species. Some papers describing these social interactions have misled us by erroneously referring to phenomena of territoriality, chase, amplexus/midwifing, mating ball formation, scramble competition, and parental care. Especially, I am skeptical of the male's premating displays (e.g., chase, clasp, snout contact, chin rubbing, tail undulation, smelling, digging) regarded as "courtship" in some papers, except for Ranodon sibiricus that may produce a single large spermatophore, because most of these displays result in the female's escape from the male. Also, I am skeptical of the behavior of a male, staying near deposited egg sacs, regarded as "parental care" because such a male can be predicted to change easily with other males and not to guard eggs or embryos against predators. Thus, I provide a focal review and correct observations on hynobiid sexual and social behavior by incorporating some unignorable descriptions that do not fit with previous descriptions on aquatic social interactions of this family.	Niigata Univ, Inst Biol, Fac Sci, Niigata 9502181, Japan	Hasumi, M (reprint author), Niigata Univ, Inst Biol, Fac Sci, Niigata 9502181, Japan.	mhasumi@bio.sc.niigata-u.ac.jp	Hasumi, Masato/K-2082-2012	Hasumi, Masato/0000-0001-6608-0267			Andersson M., 1994, SEXUAL SELECTION; MAHER CR, 1995, ANIM BEHAV, V49, P1581, DOI 10.1016/0003-3472(95)90080-2; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Park Daesik, 2006, Integrative Biosciences, V10, P137; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Lee TJ, 2011, AM NAT, V178, pE1, DOI 10.1086/660197; SCHWAGMEYER PL, 1986, BEHAV ECOL SOCIOBIOL, V19, P359, DOI 10.1007/BF00295709; HASUMI M, 1993, GEN COMP ENDOCR, V90, P51, DOI 10.1006/gcen.1993.1059; Hasumi M, 2012, ORG DIVERS EVOL, V12, P167, DOI 10.1007/s13127-012-0091-5; Hasumi M, 2007, HERPETOLOGICA, V63, P163, DOI 10.1655/0018-0831(2007)63[163:PAEBMP]2.0.CO;2; HASUMI M, 1994, J HERPETOL, V28, P264, DOI 10.2307/1564635; Hasumi M, 2009, COPEIA, P46, DOI 10.1643/CP-07-237; Rojas B, 2014, BEHAV ECOL SOCIOBIOL, V68, P551, DOI 10.1007/s00265-013-1670-y; COOPER WE, 1989, AM NAT, V133, P729; Hasumi M, 1997, J HERPETOL, V31, P45, DOI 10.2307/1565327; Toll SJ, 2000, COPEIA, P276, DOI 10.1643/0045-8511(2000)2000[0276:SOATSF]2.0.CO;2; VERRELL PA, 1989, HERPETOLOGICA, V45, P265; Chadwick CS, 1941, J EXP ZOOL, V86, P175, DOI 10.1002/jez.1400860203; Kerfoot JR, 2006, ENVIRON BIOL FISH, V76, P1, DOI 10.1007/s10641-006-9000-0; Eom J, 2009, COMP BIOCHEM PHYS A, V154, P61, DOI 10.1016/j.cbpa.2009.05.006; Hou WS, 2010, ECOL ENG, V36, P791, DOI 10.1016/j.ecoleng.2010.02.004; SEVER DM, 1991, J MORPHOL, V207, P283, DOI 10.1002/jmor.1052070306; Cahan SH, 2002, OIKOS, V96, P206, DOI 10.1034/j.1600-0706.2002.960202.x; Hasumi M, 2010, EVOL BIOL, V37, P38, DOI 10.1007/s11692-010-9080-9; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; HASUMI M, 1992, HERPETOLOGICA, V48, P279; GROSS MR, 1981, EVOLUTION, V35, P775, DOI 10.2307/2408247; Pryke SR, 2002, BEHAV ECOL, V13, P622, DOI 10.1093/beheco/13.5.622; Loher T, 2012, FISH B-NOAA, V110, P46; Alcorn MA, 2013, J HERPETOL, V47, P321, DOI 10.1670/11-317; HOWARD RD, 1981, ECOLOGY, V62, P303, DOI 10.2307/1936704; Hasumi M, 1996, HERPETOLOGICA, V52, P598; Kim JK, 2013, ZOOL SCI, V30, P929, DOI 10.2108/zsj.30.929; Moya-Larano J, 2007, BIOLOGY LETT, V3, P475, DOI 10.1098/rsbl.2007.0300; Fiumera AC, 2004, CONSERV BIOL, V18, P94, DOI 10.1111/j.1523-1739.2004.00521.x; Houck Lynne D., 1995, Amphibian Biology, V2, P677; Hasumi M, 1996, HERPETOLOGICA, V52, P605; Komdeur J, 2006, ETHOLOGY, V112, P729, DOI 10.1111/j.1439-0310.2006.01243.x; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; Hasumi M, 2011, LIMNOLOGY, V12, P37, DOI 10.1007/s10201-010-0319-z; Kusano Tamotsu, 2011, Current Herpetology, V30, P129; HASUMI M, 1990, J HERPETOL, V24, P113, DOI 10.2307/1564217; Sever DM, 2002, J EXP ZOOL, V292, P165, DOI 10.1002/jez.1152; Chadwick CS, 1940, P SOC EXP BIOL MED, V45, P335; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Hasumi Masato, 2007, Current Herpetology, V26, P107, DOI 10.3105/1881-1019(2007)26[107:PWTIMS]2.0.CO;2; Pryke SR, 2001, ANIM BEHAV, V62, P695, DOI 10.1006/anbe.2001.1804; Park D, 2008, J HERPETOL, V42, P615, DOI 10.1670/07-285R1.1; Woodley S, 2015, HORM BEHAV, V68, P3, DOI 10.1016/j.yhbeh.2014.06.008; NUSSBAUM RA, 1987, RES POPUL ECOL, V29, P27, DOI 10.1007/BF02515423; Hasumi M, 2014, POLAR BIOL, V37, P459, DOI 10.1007/s00300-013-1443-0; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; Lindstrom L, 1999, EVOL ECOL, V13, P605, DOI 10.1023/A:1011004129607; Edenbrow M, 2011, ANIM BEHAV, V81, P551, DOI 10.1016/j.anbehav.2010.11.026; Kajiura SM, 2001, ENVIRON BIOL FISH, V61, P125, DOI 10.1023/A:1011028312787; Park D, 2000, J HERPETOL, V34, P594, DOI 10.2307/1565276; Zamudio KR, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P300, DOI 10.1017/CBO9780511542602.012; OBIKA M, 1964, SCIENCE, V143, P485, DOI 10.1126/science.143.3605.485; Crump Martha L., 1995, Amphibian Biology, V2, P518; Forester DC, 1998, BEHAVIOUR, V135, P99; STRONG DR, 1973, ECOLOGY, V54, P1383; RIDLEY M, 1978, ANIM BEHAV, V26, P904, DOI 10.1016/0003-3472(78)90156-2; HOLMES WG, 1983, AM SCI, V71, P46; Anthony CD, 1997, BEHAVIOUR, V134, P71, DOI 10.1163/156853997X00287; Hasumi M, 2001, HERPETOLOGICA, V57, P396; Arnold S.J., 1977, P141; Bulakhova NA, 2014, POLAR BIOL, V37, P123, DOI 10.1007/s00300-013-1418-1; Burrowes PA, 2000, HERPETOLOGICA, V56, P375; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; Crews D, 1982, SCI AM, V247, P158, DOI DOI 10.1038/SCIENTIFICAMERICAN1182-158; Crump Martha L., 1996, Advances in the Study of Behavior, V25, P109; Elgar M.A., 1988, P59; Etchison Luke, 2012, International Journal of Biology, V4, P163; Hasumi Masato, 2001, Herpetological Review, V32, P223; HASUMI M, 1990, COPEIA, P367, DOI 10.2307/1446342; Houck Lynne D., 2010, P409; JAEGER RG, 1981, AM NAT, V117, P962, DOI 10.1086/283780; Kami Haji Gholi, 2004, Asiatic Herpetological Research, V10, P182; Kuzmin SL, 2001, ADV AMPHIBIAN RES FO, V6; Lanza B, 1998, ENCY REPTILES AMPHIB, P60; Linder G, 2003, AMPHIBIAN DECLINE IN; Lofts B., 1987, P283; Luddecke Horst, 2000, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P303; Mann T, 1984, SPERMATOPHORES; Moore F.L., 1987, P505; Nakamura D, 1941, BOTANY ZOOLOGY TOKYO, V9, P515; NUSSBAUM R. A., 1985, MISC PUBL MUSEUM ZOO, V169, P1; Olsson M., 1998, P503, DOI 10.1016/B978-012100543-6/50038-6; Paraskiv KP, 1953, IZV AN KAZSSR B, V8, P47; Park Daesik, 2005, Current Herpetology, V24, P7, DOI 10.3105/1345-5834(2005)24[7:TFOOBO]2.0.CO;2; Park Shi-Ryong, 1996, Korean Journal of Zoology, V39, P437; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI 10.1016/B978-012100543-6/50026-X; Petranka J. W., 1998, SALAMANDERS US CANAD; Pough FH, 2001, HERPETOLOGY; Reinhard S, 2013, ZOOL ANZ, V253, P1, DOI 10.1016/j.jcz.2013.06.002; Sasaki M, 1924, J COLL AGR HOKKAIDO, V15, P1; Sato Takanori, 1992, Japanese Journal of Herpetology, V14, P184; Sato T, 1991, B OBIHIRO CENTENNIAL, V9, P15; Serbinova I.A., 1995, Asiatic Herpetological Research, V6, P114; Sparreboom M, 2014, SALAMANDERS OLD WORL; Tago K, 1931, NEWTS SALAMANDERS; Tanaka K., 1989, P437; TANAKA K, 1986, Japanese Journal of Herpetology, V11, P173; Thorn R, 1968, SALAMANDRES EUROPE A; Thorn R., 1994, Russian Journal of Herpetology, V1, P86; Thorn R., 1962, Copeia, V1962, P638, DOI 10.2307/1441191; Usuda Hiroshi, 1993, Japanese Journal of Herpetology, V15, P64; Wells K.D., 2007, ECOLOGY BEHAV AMPHIB; Whittier J.M., 1987, P385; Wilson E.O., 1975, SOCIOBIOLOGY NEW SYN	110	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0873-9749	1437-9546		ACTA ETHOL	Acta Ethol.	OCT	2015	18	3					243	253		10.1007/s10211-015-0214-z		11	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CT5WA	WOS:000362880600001		
J	Kimura, K; Hirano, T; Chiba, S				Kimura, Kazuki; Hirano, Takahiro; Chiba, Satoshi			Assortative mating with respect to size in the simultaneously hermaphroditic land snail Bradybaena pellucida	ACTA ETHOLOGICA			English	Article						Land snails; Mate choice; Simultaneous hermaphrodites; Size-assortative mating; Bradybaena pellucida	EARTHWORM LUMBRICUS-TERRESTRIS; MATE-CHOICE; BODY-SIZE; SEXUAL SELECTION; SUCCESS; GENDER	There is ample evidence that body size is tightly linked with quality and fecundity of individuals in simultaneously hermaphroditic species. Especially in simultaneous hermaphrodites with reciprocal intromission, it has been thought that assortative mating with respect to body size occurs. Contrary to this expectation, studies on size-assortative mating in such simultaneous hermaphrodites have shown inconsistent mating patterns. It is important to gain an understanding of mating patterns with regard to body size in various hermaphroditic species as a first step for considering the causes for such species differences. In the present study, we examined the relationship between body size and fecundity in the simultaneously hermaphroditic land snail Bradybaena pellucida. We also tested size-assortative mating patterns in this species under a laboratory condition. The results of the experiments showed that life-span fecundity was positively correlated with body size and that the snails tended to choose mating partners of similar body size. As we had predicted, size also affected the mating pattern and assortative mating in simultaneous hermaphrodites with reciprocal intromission. This size-assortative mating pattern seems to result from sexual selection processes, not from mechanical constraints and habitat heterogeneity between large and small individuals.	[Kimura, Kazuki; Hirano, Takahiro; Chiba, Satoshi] Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Aoba Ku, Sendai, Miyagi 9800862, Japan	Kimura, K (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Aoba Ku, Kawauchi 41, Sendai, Miyagi 9800862, Japan.	k.kimura.000@gmail.com			Environment Research and Technology Development Fund of Ministry of the Environment [4-1402]	We express our sincere gratitude to Y. Kameda and N. Nyumura for valuable comments on this study. This study was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment (4-1402).	Ferrer M, 2003, ANIM BEHAV, V66, P137, DOI 10.1006/anbe.2003.2158; Koene JM, 2007, ANIM BIOL, V57, P247, DOI 10.1163/157075607780377983; Michiels NK, 2001, BEHAV ECOL, V12, P612, DOI 10.1093/beheco/12.5.612; Scharer L, 2001, J EVOLUTION BIOL, V14, P55, DOI 10.1046/j.1420-9101.2001.00263.x; ENNOS RA, 1987, HEREDITY, V58, P119, DOI 10.1038/hdy.1987.16; Kimura K, 2013, ANIM BEHAV, V85, P631, DOI 10.1016/j.anbehav.2012.12.026; Arnqvist G, 1996, EVOL ECOL, V10, P265, DOI 10.1007/BF01237684; Chaine A, 2005, BEHAV ECOL SOCIOBIOL, V59, P58, DOI 10.1007/s00265-005-0009-8; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; Yu TL, 2013, ETHOLOGY, V119, P738, DOI 10.1111/eth.12114; Vreys C, 1997, P ROY SOC B-BIOL SCI, V264, P1559; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Bollache L, 2004, J ZOOL, V264, P135, DOI 10.1017/S0952836904005643; Peters A, 1996, FRESHWATER BIOL, V36, P623, DOI 10.1046/j.1365-2427.1996.00128.x; Hoefler CD, 2007, ANIM BEHAV, V73, P943, DOI 10.1016/j.anbehav.2006.10.017; Koene JM, 2005, BEHAV ECOL SOCIOBIOL, V59, P243, DOI 10.1007/s00265-005-0030-y; Arak A., 1983, P181; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; BAUR B, 1992, ANIM BEHAV, V43, P511, DOI 10.1016/S0003-3472(05)80109-5; BROWN WD, 1993, BEHAV ECOL SOCIOBIOL, V33, P151, DOI 10.1007/BF00216595; CRESPI BJ, 1989, ANIM BEHAV, V38, P980, DOI 10.1016/S0003-3472(89)80138-1; Han CS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-359; Leonard JL, 2013, CURR ZOOL, V59, P589; R Development Core Team, 2012, R LANG ENV STAT COMP; Ridley M, 1983, EXPLANATION ORGANIC; Tomiyama K, 1996, J MOLLUS STUD, V62, P101, DOI 10.1093/mollus/62.1.101	26	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0873-9749	1437-9546		ACTA ETHOL	Acta Ethol.	OCT	2015	18	3					265	268		10.1007/s10211-014-0211-7		4	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CT5WA	WOS:000362880600003		
J	Kueakhai, P; Changklungmoa, N; Chaichanasak, P; Jaikua, W; Itagaki, T; Sobhon, P				Kueakhai, Pornanan; Changklungmoa, Narin; Chaichanasak, Pannigan; Jaikua, Wipaphorn; Itagaki, Tadashi; Sobhon, Prasert			Vaccine potential of recombinant pro- and mature cathepsinL1 against fasciolosis gigantica in mice	ACTA TROPICA			English	Article						Fasciola gigantica; Cathepsin L1; Vaccine; Mice; Protection	SAPOSIN-LIKE PROTEIN-2; LEUCINE AMINOPEPTIDASE; MOLECULAR-CLONING; IMMUNE-RESPONSES; HEPATICA; PROTECTION; INFECTION; CATTLE; SHEEP; L1	In Fasciola gigantica cathepsin L1 (CatL1) is a family of predominant proteases that is expressed in caecal epithelial cells and secreted into the excretory-secretory products (ES). CatL1 isotypes are expressed in both early and late stages of the life cycle and the parasites use them for migration and digestion. Therefore, CatL1 is a plausible target for vaccination against this parasite. Recombinant pro-F.gigantica CatL1 (rproFgCatL1) and recombinant mature F.gigantica CatL1 (rmatFgCatL1) were expressed in Escherichia coli BL21. The vaccination was performed in Imprinting Control Region (ICR) mice (n=10) by subcutaneous injection with 50 mu g of rproFgCatL1 and rmatFgCatL1 combined with Freund's adjuvant. Two weeks after the second boost, mice were infected with 15 metacercariae by the oral route. The level of protection of rproFgCatL1 and rmatFgCatL1 vaccines was estimated to be 39.1,41.7% and 44.9,47.2% when compared with non vaccinated-infected and adjuvant-infected controls, respectively. Antibodies in the immune sera of vaccinated mice were shown by immuno-blotting to react with the native FgCatL1 in the extract of newly excysted juveniles (NEJ), 4-week-old juveniles and the ES products of 4 week-old juveniles. By determining the levels of IgG1 and IgG2a in the immune sera, which are indicative of Th2 and Th1 immune response, respectively, it was found that both Th1 and Th2 responses were significantly increased in rproFgCatL1- and rmatFgCatL1-immunized groups compared with the control groups, with higher levels of Th2 (IgG1) than Th1 (IgG2a). The levels of serum aspartate aminotransferase (AST) and alanine transaminase (ALT) in rmatFgCatL1-immunized group showed a significant decrease when compared to rproFgCatL1-immunized group, indicating that rmatFgCatL1-vaccinated mice had reduced liver parenchyma damage. The pathological lesions of liver in vaccinated groups were significantly decreased when compared with control groups. This study indicates that rFgCatL1 has a potential as a vaccine candidate against F. gigantica in mice, and this potential will be tested in ruminants. (C) 2015 Elsevier B.V. All rights reserved.	[Kueakhai, Pornanan; Changklungmoa, Narin] Burapha Univ, Fac Allied Hlth Sci, Mueang Dist 20131, Chonburi, Thailand; [Chaichanasak, Pannigan] Mahanakorn Univ Technol, Fac Vet Med, Bangkok 10530, Thailand; [Jaikua, Wipaphorn] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10400, Thailand; [Itagaki, Tadashi] Iwate Univ, Fac Agr, Lab Vet Parasitol, Morioka, Iwate 0208550, Japan; [Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand	Kueakhai, P (reprint author), Burapha Univ, Fac Allied Hlth Sci, Long Hard Bangsaen Rd, Mueang Dist 20131, Chonburi, Thailand.	pornanan@buu.ac.th			Faculty of Allied Health Sciences, Burapha University, Thailand [AHS03/2557]; Burapha University through National Research Council of Thailand [134/2558]	This research was supported by grants from Faculty of Allied Health Sciences, Burapha University, Thailand, to Pornanan Kueakhai (Grant no. AHS03/2557) and the Research Grant of Burapha University through National Research Council of Thailand to Pornanan Kueakhai (Grant no. 134/2558).	Maggioli G, 2011, EXP PARASITOL, V129, P323, DOI 10.1016/j.exppara.2011.09.013; Kueakhai P, 2011, PARASITOL RES, V108, P1493, DOI 10.1007/s00436-010-2201-7; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Clery D, 1996, VET PARASITOL, V62, P71, DOI 10.1016/0304-4017(95)00858-6; Kueakhai P, 2013, ACTA TROP, V125, P157, DOI 10.1016/j.actatropica.2012.11.001; Raadsma HW, 2007, VET PARASITOL, V143, P275, DOI 10.1016/j.vetpar.2006.09.008; Moreau E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/428593; SANDEMAN RM, 1981, RES VET SCI, V30, P294; Changklungmoa N, 2013, PARASITOL RES, V112, P3653, DOI 10.1007/s00436-013-3553-6; Berasain P, 1997, J PARASITOL, V83, P1, DOI 10.2307/3284308; Sethadavit M, 2009, ACTA TROP, V112, P164, DOI 10.1016/j.actatropica.2009.07.016; Espino AM, 2004, J PARASITOL, V90, P876, DOI 10.1645/GE-215R; Lane G, 1998, VET REC, V143, P232; Dalton JP, 2001, VET PARASITOL, V98, P149, DOI 10.1016/S0304-4017(01)00430-7; Norbury LJ, 2011, BIOCHIMIE, V93, P604, DOI 10.1016/j.biochi.2010.12.004; Golden O, 2010, VACCINE, V28, P5551, DOI 10.1016/j.vaccine.2010.06.039; Sansri V, 2015, VACCINE, V33, P1596, DOI 10.1016/j.vaccine.2015.02.010; Espino AM, 2010, ETHNIC DIS, V20, P17; Mulcahy G, 1999, RES VET SCI, V67, P27, DOI 10.1053/rvsc.1998.0270; Kueakhai P, 2013, VACCINE, V31, P5518, DOI 10.1016/j.vaccine.2013.09.027; Moll L, 2000, VET PARASITOL, V91, P153, DOI 10.1016/S0304-4017(00)00267-3; Mulcahy G, 1998, VACCINE, V16, P932, DOI 10.1016/S0264-410X(97)00289-2; Grams R, 2001, PARASITOL INT, V50, P105, DOI 10.1016/S1383-5769(01)00068-X; Maggioli G, 2011, VACCINE, V29, P9057, DOI 10.1016/j.vaccine.2011.09.020; Sansri V, 2013, ACTA TROP, V128, P76, DOI 10.1016/j.actatropica.2013.06.013; Meemon K, 2010, EXP PARASITOL, V125, P371, DOI 10.1016/j.exppara.2010.03.003; Raina OK, 2011, ACTA TROP, V118, P217, DOI 10.1016/j.actatropica.2011.02.008; Jayaraj R, 2009, VET PARASITOL, V160, P230, DOI 10.1016/j.vetpar.2008.10.099; Piacenza L, 1999, INFECT IMMUN, V67, P1954; Chantree P, 2013, EXP PARASITOL, V135, P102, DOI 10.1016/j.exppara.2013.06.010; Dalton JP, 1996, INFECT IMMUN, V64, P5066; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; DALTON JP, 1989, MOL BIOCHEM PARASIT, V35, P161, DOI 10.1016/0166-6851(89)90118-7; FORD EJH, 1974, J COMP PATHOL, V84, P231, DOI 10.1016/0021-9975(74)90064-4; Golden O., 2010, VACCINE, V28, P2557; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Overend D.J., 1995, AUST VET J, V72, P75; Preyavichyapugdee N, 2008, EXP PARASITOL, V119, P229, DOI 10.1016/j.exppara.2008.01.014	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	OCT	2015	150						71	78		10.1016/j.actatropica.2015.06.020		8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CT5OK	WOS:000362859500011		
J	Barroso, PA; Nevot, MC; Hoyos, CL; Locatelli, FM; Lauthier, JJ; Ruybal, P; Cardozo, RM; Russo, PD; Vassiliades, CN; Mora, MC; Estevez, JO; Hashiguchi, Y; Korenaga, M; Basombrio, MA; Marco, JD				Barroso, Paola A.; Cecilia Nevot, M.; Hoyos, Carlos L.; Locatelli, Fabricio M.; Lauthier, Juan J.; Ruybal, Paula; Cardozo, Ruben M.; Russo, Pablo D.; Vassiliades, Carola N.; Mora, Maria C.; Octavio Estevez, J.; Hashiguchi, Yoshihisa; Korenaga, Masataka; Basombrio, Miguel A.; Marco, Jorge D.			Genetic and clinical characterization of canine leishmaniasis caused by Leishmania (Leishmania) infanturn in northeastern Argentina	ACTA TROPICA			English	Article						Leishmania infantum; Argentina; Canine; Typing; Cytochrome b; Dog	CYTOCHROME-B GENE; AMERICAN TEGUMENTARY LEISHMANIASIS; MULTILOCUS ENZYME ELECTROPHORESIS; VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; RESERVOIRS; INFECTION; DOGS; IDENTIFICATION; BRAZILIENSIS	Leishmaniases comprise zoonotic diseases caused by protozoan flagellates of the Leishmania genus. They are endemic to South America, and the visceral form has been recently reported in Argentina. Dogs can play different roles in the Leishmania transmission cycles, depending mainly on the species of parasite involved. Here we focused on the clinical characterization of canine leishmaniasis (CanL) in Northeast Argentina and on the molecular typing of its etiological agent. The nested polymerase chain reaction and sequence analysis of the Leishmania cytochrome b (cyt b) gene was performed on DNA templates purified from lymph nodes, bone marrow or spleen aspirates obtained from 48 dogs previously diagnosed by the observation of Leishmania amastigotes on smears from these aspirates. Their clinical and epidemiological data were also recorded. Systemic abnormalities were observed in 46 subjects (95.8%), most frequently lymphadenopathy, and emaciation (89.6 and 75%). Furthermore, 87% also presented tegumentary abnormalities, such as alopecia (54.2%) or secondary skin lesions (47.9%), among others. Twenty three dogs were positive for cyt b amplification. The sequence analysis showed the presence of two genotypes, LiA1 and LiA2, assigned to Leishmania (Leishmania) infantum, with 99.9 and 100% homology with the reference strain MHOM/TN/80/IPT1 respectively. LiA1 was identified in 18 cases (78.3%) and LiA2 in five (21.7%). Two cyt b variants of L. (L.) infantum were incriminated as the causative agents of CanL cases from three cities: Posadas, Garupa, and Ituzaingo. All three cities are located in the northeastern area of the country, where these parasites seem to be spreading in urban areas. (C) 2015 Elsevier B.V. All rights reserved.	[Barroso, Paola A.; Lauthier, Juan J.; Mora, Maria C.; Basombrio, Miguel A.; Marco, Jorge D.] UNSa, CONICET, Fac Ciencias Salud, Inst Patol Expt, RA-5150 Bolivia, Argentina; [Barroso, Paola A.; Hoyos, Carlos L.] UNSa, Sede Reg Oran, Inst Invest Enfermedades Trop, Salta, Argentina; [Cecilia Nevot, M.; Russo, Pablo D.; Vassiliades, Carola N.; Octavio Estevez, J.] Vet Oeste, Buenos Aires, DF, Argentina; [Locatelli, Fabricio M.; Hashiguchi, Yoshihisa; Korenaga, Masataka] Kochi Univ, Kochi Med Sch, Dept Parasitol, Nanko Ku, Kochi 7838505, Japan; [Ruybal, Paula] Univ Buenos Aires, CONICET, Fac Med, Inst Invest Microbiol & Parasitol Med, RA-2155 Buenos Aires, DF, Argentina; [Cardozo, Ruben M.] Minist Salud Publ, Coordinac Gest Epidemiol, Ctr Civ Grand Bourg, RA-4400 Salta, Argentina; [Hashiguchi, Yoshihisa] Univ Cent Ecuador & Proyecto Prometeo, SNESCYT, Ctr Biomed, Quito, Ecuador; [Marco, Jorge D.] UNSa, Fac Ciencias Exactas, Catedra Microbiol, RA-5150 Bolivia, Argentina	Marco, JD (reprint author), UNSa, CONICET, Fac Ciencias Salud, Inst Patol Expt, A4408FVY Salta, RA-5150 Bolivia, Argentina.	paobarar@yahoo.com.ar; cecilianevot@yahoo.com.ar; carloslhoyos@gmail.com; fm.locatelli@gmail.com; juanjoselauthier@gmail.com; pruybal@gmail.com; cardozo_rm@yahoo.com.ar; veterinariorusso@hotmail.com; laboratoriomisiones@hotmail.com; mariaceliamora@yahoo.com.ar; octavioes2003@yahoo.com.ar; hasiguti@kochi-u.ac.jp; korenaga@kochi-u.ac.jp; basombri@unsa.edu.ar; diegomarcoar@gmail.com			National Agency for Science and Technology, Argentina [PICT-2009-0135]; Research Council of the National University of Salta [2041]; Japanese Society for the Promotion of Science [KAKENHI 18-06242]	We are grateful to Taketoshi Taniguchi, Keiko Morisawa, Jose Gil, Kyoko Imamura, and Daniel Ribble for their contributions and valuable comments. Financial support was obtained from the National Agency for Science and Technology, Argentina (PICT-2009-0135); The Research Council of the National University of Salta (Grant No. 2041); the Japanese Society for the Promotion of Science (KAKENHI 18-06242).	Dantas-Torres F, 2011, EMERG INFECT DIS, V17, P326, DOI 10.3201/eid1702.091823; Acardi SA, 2010, MEM I OSWALDO CRUZ, V105, P796, DOI 10.1590/S0074-02762010000600011; Kato H, 2010, J CLIN MICROBIOL, V48, P3661, DOI 10.1128/JCM.00498-10; Marco JD, 2001, MEM I OSWALDO CRUZ, V96, P649, DOI 10.1590/S0074-02762001000500009; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Chaves LF, 2007, TRENDS PARASITOL, V23, P311, DOI 10.1016/j.pt.2007.05.003; Luyo-Acero GE, 2004, PARASITOLOGY, V128, P483, DOI 10.1017/S0031182004004792; Barroso PA, 2015, AM J TROP MED HYG, V93, P334, DOI 10.4269/ajtmh.14-0267; Amusategui I, 2003, EUR J EPIDEMIOL, V18, P147, DOI 10.1023/A:1023090929302; Padilla AM, 2002, VET PARASITOL, V110, P1, DOI 10.1016/S0304-4017(02)00330-8; Kato H, 2008, AM J TROP MED HYG, V79, P438; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Foulet F, 2007, J CLIN MICROBIOL, V45, P2110, DOI 10.1128/JCM.02555-06; Barrio A, 2012, EMERG INFECT DIS, V18, P354, DOI [10.3291/eid1802.110924, 10.3201/eid1802.110924]; Marco JD, 2006, AM J TROP MED HYG, V75, P261; Marco JD, 2005, AM J TROP MED HYG, V72, P606; Marco JD, 2006, AM J TROP MED HYG, V75, P256; Sobrino R, 2008, VET PARASITOL, V155, P198, DOI 10.1016/j.vetpar.2008.05.003; Cruz I, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-342; Echenique H, 2010, DIRECCION EPIDEMIOLO; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lima IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087742; Locatelli FM, 2014, ACTA TROP, V131, P16, DOI 10.1016/j.actatropica.2013.11.015; Marco J.D., 2007, RES REPORT SERIES, V8, P96; Marco JD, 2015, INFECT GENET EVOL, V30, P308, DOI 10.1016/j.meegid.2014.12.031; Organization WH, 2010, WORLD MAL REP 2010, P1; Souza TD, 2014, VET PARASITOL, V200, P233, DOI 10.1016/j.vetpar.2013.12.025; WHO, 2004, REP JOINT WHO FAO WO, P1	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	OCT	2015	150						218	223		10.1016/j.actatropica.2015.08.007		6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CT5OK	WOS:000362859500033		
J	Iwamoto, A; Izumidate, R; De Craene, LPR				Iwamoto, Akitoshi; Izumidate, Ryoko; De Craene, Louis P. Ronse			Floral anatomy and vegetative development in Ceratophyllum demersum: A morphological picture of an "unsolved" plant	AMERICAN JOURNAL OF BOTANY			English	Article						anisoclady; basal angiosperm; Ceratophyllaceae; Ceratophyllum demersum; floral anatomy; mechanical force; phyllotaxis; vegetative development	BASAL ANGIOSPERMS; GENES; ORIGIN; EXPRESSION; EVOLUTION; FLOWERS	PREMISE OF THE STUDY: The phylogenetic position of Ceratophyllum is still controversial in recent molecular analyses of angiosperms, with various suggestions of a sister group relation to all other angiosperms, eudicots, monocots, eudicots + monocots, and magnoliids. Therefore, the morphological characters of Ceratophyllum are important for resolving the phylogeny of angiosperms. In this study, we observed the detailed developmental anatomy of all lateral organs and their configurations to elucidate the floral development and phyllotactic pattern of Ceratophyllum demersum. METHODS: We observed fixed shoots of C. demersum with scanning electron microscopy and serial sections of the samples with light microscopy. KEY RESULTS: Bract primordia arise first, followed by the stamen primordia in staminate flowers. Both bracts and stamens initiate unidirectionally, first on the abaxial side of the floral apex and later on the adaxial side, most likely due to the contact pressure imposed by the leaf primordium at the superior node. In pistillate flowers, bract primordia on the abaxial side were also initiated first. The configuration of buds at one node showed six patterns and each pattern included at least one vegetative bud, and flower buds were always accompanied by vegetative buds at the same node. CONCLUSIONS: The initiation pattern of organs in the outer whorls of C. demersum flowers is distorted by mechanical pressure, resulting in the phyllotactic variation of staminate flowers. Vegetative buds are the main axillary buds with floral buds as accessory buds, which suggests that the shoot of C. demersum has been modified from a decussate phyllotaxis.	[Iwamoto, Akitoshi; Izumidate, Ryoko] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 1848501, Japan; [De Craene, Louis P. Ronse] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland	Iwamoto, A (reprint author), Tokyo Gakugei Univ, Dept Biol, 4-1-1 Nukui Kita Machi, Koganei, Tokyo 1848501, Japan.	akitoshi@u-gakugei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25119707]	We thank Mr. Koji Okuda and Mr. Michio Usuba for the support to collect materials. Our thanks also go to Dr. Kester Bull and members of FLO-RE-S network for helpful advice on the manuscript, and Dr. Don Les and an anonymous reviewer for helpful suggestions to improve the manuscript. This study was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas (no. 25119707 to AI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aboy H. E., 1936, THESIS CORNEL U ITHA; Robinson S, 2013, J EXP BOT, V64, P4729, DOI 10.1093/jxb/ert199; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Maia VH, 2014, INT J PLANT SCI, V175, P613, DOI 10.1086/676675; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Endress PK, 2011, AM J BOT, V98, P370, DOI 10.3732/ajb.1000299; Katayama N, 2010, PLANT CELL, V22, P2131, DOI 10.1105/tpc.109.073189; LES DH, 1988, TAXON, V37, P326, DOI 10.2307/1222142; Qiu YL, 2005, INT J PLANT SCI, V166, P815, DOI 10.1086/431800; Rutishauser R, 1999, INT J PLANT SCI, V160, pS81, DOI 10.1086/314221; Weber A, 2013, ANN BOT-LONDON, V112, P1577, DOI 10.1093/aob/mct156; Goremykin VV, 2009, J MOL EVOL, V68, P197, DOI 10.1007/s00239-009-9206-9; Naghiloo S, 2012, PLANTA, V235, P793, DOI 10.1007/s00425-011-1538-1; SEHGAL A, 1981, BOT J LINN SOC, V82, P343, DOI 10.1111/j.1095-8339.1981.tb00966.x; JERNSTEDT JA, 1992, ANN BOT-LONDON, V69, P351; Buzgo M, 2000, INT J PLANT SCI, V161, P23, DOI 10.1086/314241; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Iwamoto A, 2003, AM J BOT, V90, P1124, DOI 10.3732/ajb.90.8.1124; Bremer B, 2009, BOT J LINN SOC, V161, P105; Bell A. D., 2008, PLANT FORM; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Endress P. K., 1994, PLANT SYST EVOL S, V8, P175; Endress PK, 2001, INT J PLANT SCI, V162, P1111, DOI 10.1086/321919; Goebel K, 1905, ORGANOGRAPHY PLANT 2; Iwamoto A, 2012, NEW PLANT SYSTEMATIC, P52; JONES EDWARD N., 1931, UNIV IOWA STUDIES NAT HIST, V13, P11; Judd W.S., 1999, PLANT SYSTEMATICS PH; Les D. H., 1986, THESIS OHIO STATE U; Les D. H., 1993, FAMILIES GENERA VASC, V3, P248; Loiseau J. E., 1963, B SOC BOT FRANCE, V110, P76; MAJUMDAR GIRUA P., 1958, PROC INDIAN ACAD SCI SECT B, V48, P211; Raynal Roques A., 1981, THESIS U MONTPELLIER; RUTISHAUSER R, 1987, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V109, P227; SCHAEPPI HANS JAKOB, 1935, PLANTA, V24, P755, DOI 10.1007/BF01910980; Schneider E. L., 1996, CONTRIBUTIONS BOT, V17, P437; SHAMROV I I, 1983, Botanicheskii Zhurnal (St. Petersburg), V68, P1357; SHAMROV I I, 1981, Botanicheskii Zhurnal (St. Petersburg), V66, P1464; Shamrov I. I., 1997, Botanicheskii Zhurnal (St. Petersburg), V82, P1; SOLTIS P. S., 2003, INT J PLANT SCI, V164, pS329; Tucker Shirley C., 1996, P141, DOI 10.1007/978-0-585-23095-5_7	41	0	0	BOTANICAL SOC AMER INC	ST LOUIS	PO BOX 299, ST LOUIS, MO 63166-0299 USA	0002-9122	1537-2197		AM J BOT	Am. J. Bot.	OCT	2015	102	10					1578	1589		10.3732/ajb.1500124		12	Plant Sciences	Plant Sciences	CT5NA	WOS:000362855900003		
J	Thomason, J; Reyes, M; Allen, SR; Jones, RO; Beeram, MR; Kuehl, TJ; Suzuki, F; Uddin, MN				Thomason, Jessica; Reyes, Michelle; Allen, Steven R.; Jones, Richard O.; Beeram, Madhava R.; Kuehl, Thomas J.; Suzuki, Fumiaki; Uddin, Mohammad Nasir			Elevation of (Pro)Renin and (Pro)Renin Receptor in Preeclampsia	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; hypertension; placenta; preeclampsia; (pro)renin; (pro)renin receptor; renin-angiotensin system	RENIN-ANGIOTENSIN SYSTEM; PREGNANCY-INDUCED HYPERTENSION; NONPROTEOLYTIC ACTIVATION; PRORENIN RECEPTOR; GENE-EXPRESSION; BLOOD-PRESSURE; HUMAN PLACENTA; DECOY PEPTIDE; HUMAN TISSUES; ACTIVE RENIN	OBJECTIVE Preeclampsia (preE), a syndrome of hypertension, proteinuria, and edema, has many elusive triggers. The renin-angiotensin system has been implicated in preE pathogenesis. In this study, we test the hypothesis that (pro)renin levels are increased in preE patients and that levels of (pro)renin and (pro)renin receptor ((P)RR) are elevated in a rat model of preE. METHODS We recruited 30 preE and 43 normal pregnant consenting patients. We used normally pregnant rats (NP, n = 10) and pregnant rats receiving weekly injections of desoxycorticosterone acetate and whose drinking water was replaced with 0.9% saline (preE, n = 10). Plasma and placental levels of (pro)renin were assayed by ELISA. Placental and kidney (P)RR was measured both by immunoblotting and immunohistochemistry. RESULTS The mean plasma (pro)renin of 27.1 +/- 5.2 in preE patients differs from that in patients without preE: 14.8 +/- 5.2 ng Ang I/ml/hour (P < 0.0001). In rats, both plasma (NP: 22.7 +/- 4.3 and preE: 49.2 +/- 10.0 ng Ang I/ml/hour) and placental (NP: 152 +/- 24 and preE: 302 +/- 39 ng/g tissue) levels of (pro)renin were higher (P < 0.001) in preE compared to NP rats. (P)RR expression was greater (P < 0.05) in placental tissue of preE rats, while kidney (P)RR expression was similar. CONCLUSION Elevated levels of circulating (pro)renin have been observed in preE patients and in a rat model of preE. We also found the increased expression of placental (P)RR in preE rats.	[Thomason, Jessica; Kuehl, Thomas J.; Uddin, Mohammad Nasir] Texas A&M Univ, Coll Med, Hlth Sci Ctr, Temple, TX 76508 USA; [Reyes, Michelle; Allen, Steven R.; Jones, Richard O.; Kuehl, Thomas J.; Uddin, Mohammad Nasir] Dept Obstet, Temple, TX USA; [Reyes, Michelle; Allen, Steven R.; Jones, Richard O.; Kuehl, Thomas J.; Uddin, Mohammad Nasir] Dept Gynecol, Temple, TX USA; [Beeram, Madhava R.; Kuehl, Thomas J.; Uddin, Mohammad Nasir] Scott & White Healthcare, Texas A&M Hlth Sci Ctr, Dept Pediat, Coll Med, Temple, TX USA; [Suzuki, Fumiaki] Gifu Univ, Dept Appl Biol Sci, Gifu, Japan; [Uddin, Mohammad Nasir] Texas A&M Univ, Coll Med, Dept Internal Med, Hlth Sci Ctr, Temple, TX 76508 USA	Uddin, MN (reprint author), Texas A&M Univ, Coll Med, Hlth Sci Ctr, Temple, TX 76508 USA.	mnuddin@sw.org			Scott, Sherwood and Brindley Foundation [R4047UDDI]; Noble Centennial Endowment for Research in Obstetrics and Gynecology [R4500KUEH]; Scott & White Healthcare; Scott & White Research & Education Division, Temple, TX [R9240UDDI]	Funding for this work was provided by Scott, Sherwood and Brindley Foundation (R4047UDDI to M.N.U.) and the Noble Centennial Endowment for Research in Obstetrics and Gynecology (R4500KUEH to T.J.K.), Scott & White Healthcare, and from the Scott & White Research & Education Division (R9240UDDI), Temple, TX.	Anton L, 2009, ENDOCRINOLOGY, V150, P4316, DOI 10.1210/en.2009-0076; Singh HJ, 2004, PLACENTA, V25, P631, DOI 10.1016/j.placenta.2004.01.013; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCl200421398; ITSKOVITZ J, 1992, J CLIN ENDOCR METAB, V75, P906, DOI 10.1210/jc.75.3.906; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Xia Y, 2002, BIOL REPROD, V66, P135, DOI 10.1095/biolreprod66.1.135; Pridjian G, 2002, OBSTET GYNECOL SURV, V57, P598, DOI 10.1097/01.OGX.0000028585.23086.5E; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; BROWN MA, 1992, AM J HYPERTENS, V5, P366; Suzuki F, 2003, J BIOL CHEM, V278, P22217, DOI 10.1074/jbc.M302579200; Uddin MN, 2008, FRONT BIOSCI-LANDMRK, V13, P745, DOI 10.2741/2716; Anton L, 2008, HYPERTENSION, V51, P1066, DOI 10.1161/HYPERTENSIONAHA.107.103861; Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020; Lenz T, 1996, ACTA OBSTET GYN SCAN, V75, P291, DOI 10.3109/00016349609047104; Uddin MN, 2010, AM J NEPHROL, V31, P171, DOI 10.1159/000267099; Merrill DC, 2002, ENDOCRINE, V18, P239, DOI 10.1385/ENDO:18:3:239; BRAR HS, 1987, AM J OBSTET GYNECOL, V157, P363; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Yoshikawa A, 2011, HYPERTENS RES, V34, P599, DOI 10.1038/hr.2010.284; Kalenga MK, 1996, CLIN ENDOCRINOL, V44, P429, DOI 10.1046/j.1365-2265.1996.703525.x; PAUL M, 1993, J CLIN INVEST, V91, P2058, DOI 10.1172/JCI116428; Kataoka K, 1996, IMMUNOPHARMACOLOGY, V32, P146, DOI 10.1016/0162-3109(95)00077-1; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418; Nielsen AH, 2000, PLACENTA, V21, P468, DOI 10.1053/plac.2000.0535; Uddin MN, 2009, AM J NEPHROL, V30, P26, DOI 10.1159/000193220; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Marques FZ, 2011, PLACENTA, V32, P214, DOI 10.1016/j.placenta.2010.12.006; Ringholm L, 2011, DIABETOLOGIA, V54, P1615, DOI 10.1007/s00125-011-2087-7; Ichihara A, 2006, J AM SOC NEPHROL, V17, P1950, DOI 10.1681/ASN.2006010029; Cooper AC, 1999, PLACENTA, V20, P467, DOI 10.1053/plac.1999.0404; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Shah DM, 2005, AM J PHYSIOL-RENAL, V288, pF614, DOI 10.1152/ajprenal.00410.2003; Hirose T, 2009, AM J HYPERTENS, V22, P294, DOI 10.1038/ajh.2008.357; Ito M, 2002, J CLIN ENDOCR METAB, V87, P1871, DOI 10.1210/jc.87.4.1871; DERKX FHM, 1987, J CLIN ENDOCR METAB, V65, P349; MORRIS BJ, 1992, J HYPERTENS, V10, P209, DOI 10.1097/00004872-199203000-00002; Nabi AH, 2007, FRONT BIOSCI, V12, P4810; Ott C, 2010, PHARMACOGENET GENOM, V21, P347; Tanosi-Irimie M, 2005, CLIN EXP HYPERTENS, V8, P605; Uddin MN, 2005, INT J MOL MED, V16, P1077; Uddin MN, 1998, BIOSCI BIOTECH BIOCH, V62, P338; World Health Organization, 2000, MAT MORT 2000 EST DE	43	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	OCT	2015	28	10					1277	1284		10.1093/ajh/hpv019		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CT5HP	WOS:000362839900012		
J	Hayase, T; Sugino, S; Moriya, H; Yamakage, M				Hayase, T.; Sugino, S.; Moriya, H.; Yamakage, M.			TACR1 gene polymorphism and sex differences in postoperative nausea and vomiting	ANAESTHESIA			English	Article							GENOME-WIDE ASSOCIATION; CHEMOTHERAPY-INDUCED NAUSEA; RISK-FACTORS; ANTAGONIST APREPITANT; TRANSCRIPTION FACTORS; RANDOMIZED-TRIAL; SUBSTANCE-P; III TRIALS; RECEPTOR; SCALE	We hypothesised that the genetic effect of single nucleotide polymorphisms in the TACR1 gene, which encodes NK1 receptors, could influence the sex difference in postoperative nausea and vomiting. Thirty-two selected single nucleotide polymorphisms were genotyped by the Sanger sequencing method in 200 patients who underwent lower abdominal surgery. The incidence and severity of postoperative nausea and vomiting were evaluated after surgery. The rs3755468-SNP showed significant association with the incidence and severity of postoperative nausea and vomiting (p = 0.016). The TT haplotype defined by two single nucleotide polymorphisms, including the rs3755468-SNP, was associated with reduced incidence and severity of postoperative nausea and vomiting in female patients (p = 0.03). The rs3755468-SNP is located within the predicted oestrogen response element and a DNase I hypersensitive site. The single nucleotide polymorphisms in the TACR1 gene are associated with sex differences in postoperative nausea and vomiting and may help to elucidate the mechanisms underlying these differences.	[Hayase, T.; Sugino, S.; Yamakage, M.] Sapporo Med Univ, Sch Med, Dept Anesthesiol, Sapporo, Hokkaido, Japan; [Moriya, H.] Hokkaido Pharmaceut Univ, Sch Pharm, Dept Pharm, Otaru, Hokkaido, Japan	Hayase, T (reprint author), Sapporo Med Univ, Sch Med, Dept Anesthesiol, Sapporo, Hokkaido, Japan.	eric.core2006@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [24791606, 23592301]	This work was supported by a Grant-in-Aid for Young Scientists (B) (no. 24791606, 2012-2014, to T.H.) and a Grant-in-Aid for Scientific Research (C) (no. 23592301, 2011-2013, to S.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. No competing interests declared.	Gan TJ, 2011, ANESTH ANALG, V112, P804, DOI 10.1213/ANE.0b013e31820886c3; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Levran O, 2011, J HUM GENET, V56, P147, DOI 10.1038/jhg.2010.150; Borgeat A, 2003, ANESTHESIOLOGY, V98, P530, DOI 10.1097/00000542-200302000-00036; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Martin AR, 2003, EUR J CANCER, V39, P1395, DOI 10.1016/S0959-8049(03)00299-5; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Janicki PK, 2011, ANESTHESIOLOGY, V115, P54, DOI 10.1097/ALN.0b013e31821810c7; Wengritzky R, 2010, BRIT J ANAESTH, V104, P158, DOI 10.1093/bja/aep370; Nakagawa M, 2008, J ANESTH, V22, P397, DOI 10.1007/s00540-008-0661-z; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Candiotti KA, 2005, ANESTHESIOLOGY, V102, P543, DOI 10.1097/00000542-200503000-00011; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Hesketh PJ, 2006, SUPPORT CARE CANCER, V14, P354, DOI 10.1007/s00520-005-0914-4; Gan TJ, 2007, CNS DRUGS, V21, P813, DOI 10.2165/00023210-200721100-00003; Buchanan FF, 2011, BRIT J ANAESTH, V106, P832, DOI 10.1093/bja/aer094; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Chandrakantan A, 2011, BRIT J ANAESTH, V107, P27, DOI 10.1093/bja/aer358; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Boogaerts JG, 2000, ACTA ANAESTH SCAND, V44, P470, DOI 10.1034/j.1399-6576.2000.440420.x; Apfel CC, 2012, BRIT J ANAESTH, V109, P742, DOI 10.1093/bja/aes276; Nielsen M, 2008, BRIT J ANAESTH, V101, P441, DOI 10.1093/bja/aen246; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Nesher N, 2008, PHARMACOL RES, V58, P38, DOI 10.1016/j.phrs.2008.06.003; Seneviratne C, 2009, NEUROPSYCHOPHARMACOL, V34, P2442, DOI 10.1038/npp.2009.65; MacKenzie A, 2013, TRENDS MOL MED, V19, P99, DOI 10.1016/j.molmed.2012.11.003; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Hesketh PJ, 2010, SUPPORT CARE CANCER, V18, P1171, DOI 10.1007/s00520-009-0737-9; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Janicki PK, 2014, EXP BRAIN RES, V232, P2613, DOI 10.1007/s00221-014-3968-z; Villablanca AC, 1997, MOL CELL ENDOCRINOL, V135, P109, DOI 10.1016/S0303-7207(97)00193-7; Wagner MJ, 2013, PHARMACOGENOMICS, V14, P413, DOI [10.2217/pgs.13.36, 10.2217/PGS.13.36]; Leslie K, 2008, BRIT J ANAESTH, V101, P498, DOI 10.1093/bja/aen230; Qian QH, 2010, CHINESE MED J-PEKING, V123, P478, DOI 10.3760/cma.j.issn.0366-6999.2010.04.017; Renner SP, 2009, GYNECOL ENDOCRINOL, V25, P726, DOI 10.3109/09513590903159631; Singleton AB, 2010, TRENDS GENET, V26, P438, DOI 10.1016/j.tig.2010.07.004; Cheng R, 2005, ANN HUM GENET, V69, P102, DOI 10.1046/j.1529-8817.2004.00140.x; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207; Rueffert H, 2009, ANESTH ANALG, V109, P1442, DOI 10.1213/ane.0b013e3181b2359b; Bradesi S, 2003, PAIN, V102, P227, DOI 10.1016/S0304-3959(02)00056-8; Choi EM, 2010, ANAESTHESIA, V65, P996, DOI 10.1111/j.1365-2044.2010.06476.x; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Le Brun I, 2008, Neuroscience, V152, P56, DOI 10.1016/j.neuroscience.2007.12.024; Lin LH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-473; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NAKANISHI S, 1991, ANNU REV NEUROSCI, V14, P123, DOI 10.1146/annurev.neuro.14.1.123; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	OCT	2015	70	10					1148	1159		10.1111/anae.13082		12	Anesthesiology	Anesthesiology	CT2WY	WOS:000362667400007		
J	Toyama, S				Toyama, S.			Hypotension during spinal anaesthesia for caesarean section	ANAESTHESIA			English	Letter									Tokyo Med & Dent Univ, Hosp Med, Tokyo, Japan	Toyama, S (reprint author), Tokyo Med & Dent Univ, Hosp Med, Tokyo, Japan.	s-toyama@suite.plala.or.jp					Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; Scharwood-Smith G, 2009, BRIT J ANAESTH, V102, P291; Sumikura H, 2008, ANESTHESIOLOGY, V109, pA587; Toyama S, 2013, BRIT J ANAESTH, V36, P219; Yokose M, 2015, ANAESTHESIA, V70, P555, DOI 10.1111/anae.12992	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	OCT	2015	70	10					1208	1209		10.1111/anae.13202		3	Anesthesiology	Anesthesiology	CT2WY	WOS:000362667400016		
J	Yokose, M; Mihara, T; Goto, T				Yokose, M.; Mihara, T.; Goto, T.			Hypotension during spinal anaesthesia for caesarean section - a reply	ANAESTHESIA			English	Letter							INDEX		[Yokose, M.; Mihara, T.; Goto, T.] Kanagawa Childrens Med Ctr, Yokohama, Kanagawa, Japan	Yokose, M (reprint author), Kanagawa Childrens Med Ctr, Yokohama, Kanagawa, Japan.	yokose_p12@yahoo.co.jp					Toyama S, 2013, BRIT J ANAESTH, V111, P235, DOI 10.1093/bja/aet058; Sun S, 2014, INT J OBSTET ANESTH, V23, P324, DOI 10.1016/j.ijoa.2014.05.011; Yokose M, 2015, ANAESTHESIA, V70, P555, DOI 10.1111/anae.12992	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	OCT	2015	70	10					1210	1210		10.1111/anae.13229		1	Anesthesiology	Anesthesiology	CT2WY	WOS:000362667400018		
J	Sugimoto, H; Kakehi, M; Jinno, F				Sugimoto, Hiroshi; Kakehi, Masaaki; Jinno, Fumihiro			Method development for the determination of d and l-isomers of leucine in human plasma by high-performance liquid chromatography tandem mass spectrometry and its application to animal plasma samples	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						D- and L-Leucine; LC/MS/MS; Enantiomer separation; Surrogate matrix; Species difference	D-AMINO ACIDS; CHIRAL STATIONARY PHASES; GAS-CHROMATOGRAPHY; MUSCLE; URINE; SEPARATIONS; DIAGNOSIS; CINCHONA; MAMMALS; RODENTS	We developed a highly sensitive and specific high-performance liquid chromatography tandem mass spectrometry method with an electrospray ionization for the determination of d- and l-isomers of leucine in human plasma. Phosphate-buffered saline was used as the surrogate matrix for preparation of calibration curves and quality control samples. The extraction of d- and l-leucine in plasma samples (100 mu L) was performed using cationic exchange solid-phase extraction. The enantiomer separation of d- and l-leucine was successfully achieved without derivatization using a CHIRALPAK ZWIX(-) with an isocratic mobile phase comprised of methanol/acetonitrile/1 mol/L ammonium formate/formic acid (500:500:25:2, v/v/v/v) at a flow rate of 0.5 mL/min. In addition, the discrimination of dl-leucine from structural isomers dl-isoleucine and dl-allo-isoleucine was performed using the unique precursor and product ion pair transition of dl-leucine (m/z 132.1 > 43.0) and dl-leucine-d (7) (m/z 139.2 > 93.0) in positive electrospray ionization mode. The standard curves were linear throughout the calibration range from 0.001 to 1 mu g/mL for d-leucine and from 1 to 1000 mu g/mL for l-leucine, respectively, with acceptable intra- and inter-day precision and accuracy. The stability of d- and l-leucine in human plasma and solvents was confirmed. The endogenous level of d- and l-leucine in human plasma was 0.00197 similar to 0.00591 and 9.63 similar to 24.7 mu g/mL, respectively. This method was also successfully applied to investigate the species difference in the ratios of d-leucine to total leucine from individual plasma concentrations in humans and various animals. The plasma d-leucine concentrations or their ratio to total leucine in rodents was much higher than that in humans.	[Sugimoto, Hiroshi; Kakehi, Masaaki; Jinno, Fumihiro] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, Fujisawa, Kanagawa 2518555, Japan	Sugimoto, H (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	hiroshi.sugimoto1@takeda.com					Alterman NA, 2012, AMINO ACID HDB; Kirschner DL, 2009, J SEP SCI, V32, P2305, DOI 10.1002/jssc.200900101; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; Jones BR, 2012, BIOANALYSIS, V4, P2343, DOI [10.4155/bio.12.200, 10.4155/BIO.12.200]; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Hoffmann CV, 2009, J CHROMATOGR A, V1216, P1157, DOI 10.1016/j.chroma.2008.12.044; Deng CH, 2003, J CHROMATOGR B, V792, P261, DOI 10.1016/S1570-0232(03)00270-8; Bruckner H, 2001, BIOMED CHROMATOGR, V15, P166, DOI 10.1002/bmc.57; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Zhang T, 2014, J SEP SCI, V37, P1237, DOI 10.1002/jssc.201400149; Houghton R, 2009, BIOANALYSIS, V1, P1365, DOI [10.4155/bio.09.139, 10.4155/BIO.09.139]; Yamanaka M, 2012, AMINO ACIDS, V43, P1811, DOI 10.1007/s00726-012-1384-x; Salem AA, 2012, J CHROMATOGR B, V908, P27, DOI 10.1016/j.jchromb.2012.09.026; Piraud M, 2003, RAPID COMMUN MASS SP, V17, P1297, DOI 10.1002/rcm.1054; Miller JH, 2011, ANAL BIOANAL CHEM, V400, P237, DOI 10.1007/s00216-011-4740-x; Zhang T, 2014, J CHROMATOGR A, V1363, P191, DOI 10.1016/j.chroma.2014.06.012; NAGATA Y, 1992, J CHROMATOGR-BIOMED, V575, P147, DOI 10.1016/0378-4347(92)80516-S; McAllan L, 2013, J PHYSIOL BIOCHEM, V69, P155, DOI 10.1007/s13105-012-0170-2; Hoffmann CV, 2008, ANAL CHEM, V80, P8780, DOI 10.1021/ac801384f; Visser WF, 2011, J CHROMATOGR A, V1218, P7130, DOI 10.1016/j.chroma.2011.07.087; Hamase K, 2002, J CHROMATOGR B, V781, P73, DOI 10.1016/S1570-0232(02)00690-6; Tojo M, 2012, J CHROMATOGR SCI, V50, P393, DOI 10.1093/chromsci/bmr004; Hamase K, 2001, ANAL BIOCHEM, V298, P253, DOI 10.1006/abio.2001.5382; Simek P, 2012, METHODS MOL BIOL, V828, P137, DOI 10.1007/978-1-61779-445-2_13; Hamase K, 2007, J CHROMATOGR A, V1143, P105, DOI 10.1016/j.chroma.2006.12.078; ARMSTRONG DW, 1993, AMINO ACIDS, V5, P299, DOI 10.1007/BF00805992; Ham DJ, 2014, CLIN NUTR, V33, P937, DOI 10.1016/j.clnu.2014.09.016; Hamase K, 1997, BBA-GEN SUBJECTS, V1334, P214, DOI 10.1016/S0304-4165(96)00095-5; Waldhier Magdalena C, 2011, J Chromatogr A, V1218, P4537, DOI 10.1016/j.chroma.2011.05.039	29	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	OCT	2015	407	26					7889	7898		10.1007/s00216-015-8999-1		10	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CT0UM	WOS:000362512800005		
J	Ogawa, T; Oikawa, S; Hirose, T				Ogawa, Takahiro; Oikawa, Shimpei; Hirose, Tadaki			Leaf dynamics in growth and reproduction of Xanthium canadense as influenced by stand density	ANNALS OF BOTANY			English	Article						Leaf dynamics; leaf longevity; leaf productivity; mean residence time; nitrogen resorption; nitrogen use efficiency; stand density; Xanthium canadense; cocklebur; Asteraceae	NITROGEN-USE-EFFICIENCY; NUTRIENT USE EFFICIENCY; MEAN RESIDENCE TIME; CARBON GAIN; LIFE-SPAN; CANOPY PHOTOSYNTHESIS; ANNUAL HERB; RESORPTION EFFICIENCY; HERBACEOUS PLANTS; INDIVIDUAL PLANTS	Background and Aims Leaf longevity is controlled by the light gradient in the canopy and also by the nitrogen (N) sink strength in the plant. Stand density may influence leaf dynamics through its effects on light gradient and on plant growth and reproduction. This study tests the hypothesis that the control by the light gradient is manifested more in the vegetative period, whereas the opposite is true when the plant becomes reproductive and develops a strong N sink. Methods Stands of Xanthium canadense were established at two densities. Emergence, growth and death of every leaf on the main stem and branches, and plant growth and N uptake were determined from germination to full senescence. Mean residence time and dry mass productivity were calculated per leaf number, leaf area, leaf mass and leaf N (collectively termed 'leaf variables') in order to analyse leaf dynamics and its effect on plant growth. Key Results Branching and reproductive activities were higher at low than at high density. Overall there was no significant difference in mean residence time of leaf variables between the two stands. However, early leaf cohorts on the main stem had a longer retention time at low density, whereas later cohorts had a longer retention time at high density. Branch leaves emerged earlier and tended to live longer at low than at high density. Leaf efficiencies, defined as carbon export per unit investment of leaf variables, were higher at low density in all leaf variables except for leaf number. Conclusions In the vegetative phase of plant growth, the light gradient strongly controls leaf longevity, whereas later the effects of branching and reproductive activities become stronger and over-rule the effect of light environment. As leaf N supports photosynthesis and also works as an N source for plant development, N use is pivotal in linking leaf dynamics with plant growth and reproduction.	[Ogawa, Takahiro; Oikawa, Shimpei; Hirose, Tadaki] Tokyo Univ Agr, Dept Int Agr Dev, Tokyo 1568502, Japan	Hirose, T (reprint author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan.	tadakihirose@gmail.com			Japan Society for the Promotion of Science [KAKENHI-20370015, 21114009, 23770027, 25440230]	We thank Kouki Hikosaka, Toshihiko Kinugasa and Marinus Werger for comments and discussion. The comments of anonymous referees were helpful in improving the manuscript. We are also grateful for the support of the staff members and students of the Laboratory for Agricultural Environmental Studies, Tokyo University of Agriculture. This work was financially supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (KAKENHI-20370015, 21114009, 23770027, 25440230).	Aerts R., 1996, J ECOL, V84, P596; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Hikosaka K, 2005, ANN BOT-LONDON, V95, P521, DOI 10.1093/aob/mci050; BAZZAZ FA, 1977, NEW PHYTOL, V78, P193, DOI 10.1111/j.1469-8137.1977.tb01558.x; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Schieving F, 1999, NEW PHYTOL, V143, P201, DOI 10.1046/j.1469-8137.1999.00431.x; SHITAKA Y, 1993, OECOLOGIA, V95, P334, DOI 10.1007/BF00320985; AERTS R, 1990, OECOLOGIA, V84, P391; Anten NPR, 2005, ANN BOT-LONDON, V95, P495, DOI 10.1093/aob/mci048; DERMAN BD, 1978, AM J BOT, V65, P205, DOI 10.2307/2442454; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; ESASHI Y, 1968, PLANT PHYSIOL, V43, P871, DOI 10.1104/pp.43.6.871; Nishimura E, 2010, ECOL RES, V25, P383, DOI 10.1007/s11284-009-0666-6; Aerts R, 2000, ADV ECOL RES, V30, P1; HIKOSAKA K, 1994, OECOLOGIA, V97, P451, DOI 10.1007/BF00325881; GEBER MA, 1990, EVOLUTION, V44, P799, DOI 10.2307/2409547; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; FIELD C, 1983, OECOLOGIA, V56, P341, DOI 10.1007/BF00379710; Franklin O, 2002, FUNCT ECOL, V16, P727, DOI 10.1046/j.1365-2435.2002.00674.x; SCHMID B, 1994, ECOL MONOGR, V64, P177, DOI 10.2307/2937040; WEINER J, 1990, J ECOL, V78, P459, DOI 10.2307/2261124; Hirose T, 2012, OECOLOGIA, V169, P927, DOI 10.1007/s00442-012-2266-3; WERGER MJA, 1991, VEGETATIO, V97, P11; ACKERLY DD, 1992, OECOLOGIA, V89, P596; Osada N, 2013, PLANT ECOL, V214, P1493, DOI 10.1007/s11258-013-0270-2; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Hirose T, 2012, OECOLOGIA, V169, P591, DOI 10.1007/s00442-011-2223-6; NAGASHIMA H, 1995, ANN BOT-LONDON, V75, P173, DOI 10.1006/anbo.1995.1009; HOCKING PJ, 1983, ANN BOT-LONDON, V51, P787; Yasumura Y, 2007, FUNCT PLANT BIOL, V34, P409, DOI 10.1071/FP06307; HIROSE T, 1988, OECOLOGIA, V77, P145, DOI 10.1007/BF00379180; Oikawa S, 2006, NEW PHYTOL, V172, P104, DOI 10.1111/j.1469-8137.2006.01813.x; Vincent G, 2006, ANN BOT-LONDON, V97, P245, DOI 10.1093/aob/mcj023; Watari R, 2014, ANN BOT-LONDON, V114, P179, DOI 10.1093/aob/mcu088; Silla F, 2004, FUNCT ECOL, V18, P511, DOI 10.1111/j.0269-8463.2004.00872.x; Hikosaka K, 2012, FUNCT ECOL, V26, P1024, DOI 10.1111/j.1365-2435.2012.02042.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Hirose T, 2011, OECOLOGIA, V166, P863, DOI 10.1007/s00442-011-1942-z; Watari R, 2012, PHYSIOL PLANTARUM, V144, P335, DOI 10.1111/j.1399-3054.2011.01563.x; KIKUZAWA K, 1983, CAN J BOT, V61, P2133; INGESTAD T, 1979, PHYSIOL PLANTARUM, V45, P149, DOI 10.1111/j.1399-3054.1979.tb01679.x; Berendse F, 1987, FUNCT ECOL, V1, P293; SINCLAIR TR, 1975, SCIENCE, V189, P565, DOI 10.1126/science.189.4202.565; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Ono K, 1996, PLANT CELL PHYSIOL, V37, P1083; Hikosaka K, 2003, AM NAT, V162, P149, DOI 10.1086/376576; Norby RJ, 2000, PLANT SOIL, V224, P15, DOI 10.1023/A:1004629231766; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; PUGNAIRE FI, 1992, OECOLOGIA, V90, P120, DOI 10.1007/BF00317817; Shitaka Y, 1998, OECOLOGIA, V114, P361, DOI 10.1007/PL00008818; Casper BB, 1998, NEW PHYTOL, V140, P231, DOI 10.1046/j.1469-8137.1998.00271.x; Eckstein RL, 2001, NEW PHYTOL, V150, P641, DOI 10.1046/j.1469-8137.2001.00130.x; CRAFTSBRANDNER SJ, 1987, PLANT PHYSIOL, V85, P662, DOI 10.1104/pp.85.3.662; ANTEN NPR, 1995, OECOLOGIA, V101, P504, DOI 10.1007/BF00329431; Makino A, 2003, PLANT CELL PHYSIOL, V44, P952, DOI 10.1093/pcp/pcg113; Marty C, 2010, NEW PHYTOL, V187, P407, DOI 10.1111/j.1469-8137.2010.03290.x; CHABOT BF, 1982, ANNU REV ECOL SYST, V13, P229, DOI 10.1146/annurev.es.13.110182.001305; CHAPIN FS, 1991, ECOLOGY, V72, P709, DOI 10.2307/2937210; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; Hikosaka K, 2010, AM J BOT, V97, P1944, DOI 10.3732/ajb.1000045; Fischer Andreas M., 2007, V26, P87; Marty C, 2009, NEW PHYTOL, V183, P1114, DOI 10.1111/j.1469-8137.2009.02893.x; Kinugasa T, 2005, ANN BOT-LONDON, V96, P81, DOI 10.1093/aob/mci152; Escudero A, 2003, J ECOL, V91, P880, DOI 10.1046/j.1365-2745.2003.00818.x; Oikawa S, 2005, OECOLOGIA, V143, P517, DOI 10.1007/s00442-005-0007-6; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; KARLSSON PF, 1994, OIKOS, V70, P191, DOI 10.2307/3545630; Oikawa S, 2008, NEW PHYTOL, V178, P617, DOI 10.1111/j.1469-8137.2008.02415.x; Bazzaz FA, 1995, OECOLOGIA, V101, P300; Evans GC, 1972, QUANTITATIVE ANAL PL; Evans JR, 1989, PHOTOSYNTHESIS, P183; Falster D. S., 2011, NEW PHYTOL, V193, P409; FARQUHAR GD, 1989, PHILOS T ROY SOC B, V323, P357, DOI 10.1098/rstb.1989.0016; Field C, 1986, EC PLANT FORM FUNCTI, P25; Garnier E, 1998, INHERENT VARIATION IN PLANT GROWTH, P515; Givnish Thomas J., 1995, P3, DOI 10.1016/B978-012276460-8/50003-5; Givnish TJ, 1982, AM NAT, V120, P743; Harper JL, 1989, PLANT CANOPIES THEIR, P103; HIROSE T, 1975, Journal of the Faculty of Science University of Tokyo Section III Botany, V11, P355; HIROSE T, 1978, Japanese Journal of Ecology, V28, P25; Hirose T, 2005, REPROD ALLOCATION PL, P159, DOI 10.1016/B978-012088386-8/50006-5; HIROSE T, 1971, Japanese Journal of Ecology, V21, P18; HIROSE T, 1984, ANN BOT-LONDON, V54, P695; Jones HG, 2014, PLANTS AND MICROCLIMATE: A QUANTITATIVE APPROACH TO ENVIRONMENTAL PLANT PHYSIOLOGY, 3RD EDITION, P1; Keenan TF, 2014, NEW PHYTOL, V205, P656; Lambers H., 1998, PLANT PHYSL ECOLOGY; MILLARD P, 1988, PLANT CELL ENVIRON, V11, P1, DOI 10.1111/j.1365-3040.1988.tb01769.x; Monsi M., 1960, Bot. Mag., V73, P81; SAEKI T., 1958, BOT MAG [TOKYO], V71, P235; Pons TL, 1989, CAUSES CONSEQUENCES, P175; Poorter Hendrik, 1994, P111; Possato L, 2001, J EXPT BOT, V52, P1655; R Development Core Team, 2010, R LANG ENV STAT COMP; SAKAI S, 1991, J THEOR BIOL, V148, P535, DOI 10.1016/S0022-5193(05)80235-8; Schieving F., 1992, PLANT SOIL, V14, P9; Stoddart JL, 1982, NUCL ACIDS PROTEINS, P592; Hikosaka K, 1996, FUNCT ECOL, V10, P335, DOI 10.2307/2390281	100	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7364	1095-8290		ANN BOT-LONDON	Ann. Bot.	OCT	2015	116	5					807	819		10.1093/aob/mcv114		13	Plant Sciences	Plant Sciences	CT5IO	WOS:000362842400014		
J	Orman, O; Szewczyk, J				Orman, Olga; Szewczyk, Janusz			European beech, silver fir, and Norway spruce differ in establishment, height growth, and mortality rates on coarse woody debris and forest floor-a study from a mixed beech forest in the Western Carpathians	ANNALS OF FOREST SCIENCE			English	Article						Regeneration; Colonization pattern; Decaying wood; Microsite	SUB-ALPINE FOREST; TSUGA-HETEROPHYLLA FORESTS; BAVARIAN LIMESTONE ALPS; TEMPERATE RAIN-FOREST; FALLEN LOGS; SEEDLING RECRUITMENT; TREE REGENERATION; NORTHERN JAPAN; DWARF BAMBOO; MICROSITES	Key message In mixed forests, coarse woody debris promotes the successful establishment and growth of conifers and beech. In contrast to beech and fir, older spruce seedlings were only present on coarse woody debris and not on the forest floor. Context Coarse woody debris (CWD) is considered a suitable seedbed for small-seeded and light-demanding species. Its role in enhancing tree regeneration is well reported in boreal or subalpine spruce forests. Less is known about its role in the establishment, growth, and survival of other species, particularly in mixed forests. Aims We analyzed the role of CWD in seedling establishment, growth, and survival for European beech, silver fir, and Norway spruce. Methods We tracked the growth and survival of all germinants and seedlings over 5 years. Results Conifers were relatively more successful than beech at colonizing on CWD. The density of seedlings was variable in all CWD decay classes but was the highest on well-decomposed CWD. CWD supported the growth of all species. Beech cohorts and older seedlings had similar mortality rates on both microsites. Spruce germinants did not survive on the forest floor for more than a year, and older seedlings were only observed on CWD. Fir cohorts had similar mortality rates on both microsites, but older seedlings survived better on the forest floor. Conclusion Although the three species differed in their preferred microsite for establishment, CWD can be considered a suitable regeneration microsite for all three species by enhancing their growth and, in the case of spruce, both short- and long-term survival.	[Orman, Olga; Szewczyk, Janusz] Univ Agr, Forest Ecol & Silviculture Inst, Dept Forest Biodivers, PL-31425 Krakow, Poland	Orman, O (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778563, Japan.	olaorm@gmail.com; rljszewc@cyf-kr.edu.pl			Polish Ministry of Science and Higher Education [N N304 325436, N N309 716440]	This study was supported by the research grants: N N304 325436 (2009-12) and N N309 716440 (2011-14) of the Polish Ministry of Science and Higher Education.	Zielonka T, 2004, PLANT ECOL, V172, P63, DOI 10.1023/B:VEGE.0000026037.03716.fc; Odor P, 2006, BIOL CONSERV, V131, P58, DOI 10.1016/j.biocon.2006.02.004; Iijima H, 2007, J FOREST RES-JPN, V12, P262, DOI 10.1007/s10310-007-0012-1; Pouska V, 2010, EUR J FOREST RES, V129, P219, DOI 10.1007/s10342-009-0324-0; Mori A, 2004, FOREST ECOL MANAG, V196, P287, DOI 10.1016/j.foreco.2004.03.027; Mori A, 2005, FOREST ECOL MANAG, V210, P461, DOI 10.1016/j.foreco.2005.02.027; Iijima H, 2010, J FOREST RES-JPN, V15, P46, DOI 10.1007/s10310-009-0133-9; Narukawa Y, 2002, FOREST ECOL MANAG, V163, P61, DOI 10.1016/S0378-1127(01)00527-8; Parent S, 2006, CAN J FOREST RES, V36, P1976, DOI 10.1139/X06-091; Baier R, 2007, EUR J FOREST RES, V126, P11, DOI 10.1007/s10342-005-0091-5; Svoboda M, 2010, FOREST ECOL MANAG, V260, P707, DOI 10.1016/j.foreco.2010.05.027; Hunziker U, 2005, FOREST ECOL MANAG, V210, P67, DOI 10.1016/j.foreco.2005.02.019; Ulanova NG, 2000, FOREST ECOL MANAG, V135, P155, DOI 10.1016/S0378-1127(00)00307-8; Holeksa J, 2003, PLANT ECOL, V168, P57, DOI 10.1023/A:1024457303815; McKenny HJA, 1999, AUST J BOT, V47, P745, DOI 10.1071/BT98001; Christie DA, 2003, J ECOL, V91, P776, DOI 10.1046/j.1365-2745.2003.00813.x; Szwagrzyk J, 2001, FOREST ECOL MANAG, V141, P237, DOI 10.1016/S0378-1127(00)00332-7; Carlton GC, 1998, ECOL MONOGR, V68, P99, DOI 10.1890/0012-9615(1998)068[0099:ROTSBS]2.0.CO;2; Bellingham PJ, 2006, CAN J FOREST RES, V36, P910, DOI 10.1139/X05-308; SOLLINS P, 1982, CAN J FOREST RES, V12, P18, DOI 10.1139/x82-003; Iijima H, 2006, CAN J FOREST RES, V36, P664, DOI 10.1139/X05-285; Lusk CH, 2003, NEW PHYTOL, V158, P535, DOI 10.1046/j.1469-8137.2003.00760.x; KNAPP AK, 1982, CAN J BOT, V60, P2753; Takahashi M, 2000, CAN J FOREST RES, V30, P1148, DOI 10.1139/cjfr-30-7-1148; HARMON ME, 1989, AM MIDL NAT, V121, P112, DOI 10.2307/2425662; Bace R, 2011, SILVA FENN, V45, P1065, DOI 10.14214/sf.87; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Baier R, 2006, ANN FOREST SCI, V63, P339, DOI 10.1051/forest:2006014; Simon A, 2011, FOREST ECOL MANAG, V262, P1289, DOI 10.1016/j.foreco.2011.06.028; CHRISTY EJ, 1984, J ECOL, V72, P75, DOI 10.2307/2260007; Laiho R, 2004, CAN J FOREST RES, V34, P763, DOI 10.1139/X03-241; Szewczyk J, 1996, VEGETATIO, V122, P37, DOI 10.1007/BF00052814; Brunner A, 2003, CAN J FOREST RES, V33, P1670, DOI 10.1139/X03-085; Ota T, 2012, CAN J FOREST RES, V42, P1976, DOI 10.1139/x2012-141; Zielonka T, 2006, J VEG SCI, V17, P739, DOI 10.1658/1100-9233(2006)17[739:WDDWTI]2.0.CO;2; Noguchi M, 2004, FOREST ECOL MANAG, V190, P335, DOI 10.1016/j.foreco.2003.10.024; Narukawa Y, 2003, ECOL RES, V18, P267, DOI 10.1046/j.1440-1703.2003.00553.x; Stancioiu PT, 2006, EUR J FOREST RES, V125, P151, DOI 10.1007/s10342-005-0069-3; Bace R, 2012, FOREST ECOL MANAG, V266, P254, DOI 10.1016/j.foreco.2011.11.025; HARMON ME, 1989, CAN J BOT, V67, P1833; Harmon ME, 2004, ADV ECOL RES, V34, P59, DOI DOI 10.1016/S0065-2504(03)34002-4; Jezek K., 2004, Journal of Forest Science (Prague), V50, P405; Maser C, 1988, PNWGTR229 USDA FOR S; Pawlaczek M, 2010, THESIS U AGR CRACOW; Rozanski W, 2006, GORCZANSKI PARK NARO; Saniga M., 2011, Beskydy, V4, P39; GRODZINS.W, 1970, OIKOS, V21, P52, DOI 10.2307/3543838; Stokland JN, 2012, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9781139025843; Vrska T, 2009, FOREST ECOL MANAG, V258, P347, DOI 10.1016/j.foreco.2009.03.007; Zielonka T, 2001, ECOL B, V49, P159	50	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1286-4560	1297-966X		ANN FOREST SCI	Ann. For. Sci.	OCT	2015	72	7					955	965		10.1007/s13595-015-0492-7		11	Forestry	Forestry	CT5WE	WOS:000362881000010		
J	Yoshioka, H; Azuma, K; Yamamoto, N; Takahashi, T; Nishio, M; Katakami, N; Ahn, MJ; Hirashima, T; Maemondo, M; Kim, SW; Kurosaki, M; Akinaga, S; Park, K; Tsai, CM; Tamura, T; Mitsudomi, T; Nakagawa, K				Yoshioka, H.; Azuma, K.; Yamamoto, N.; Takahashi, T.; Nishio, M.; Katakami, N.; Ahn, M. J.; Hirashima, T.; Maemondo, M.; Kim, S. W.; Kurosaki, M.; Akinaga, S.; Park, K.; Tsai, C. M.; Tamura, T.; Mitsudomi, T.; Nakagawa, K.			A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)	ANNALS OF ONCOLOGY			English	Article						tivantinib; erlotinib; phase III study; nonsmall-cell lung cancer; c-Met inhibitor	JAPANESE PATIENTS; MONOTHERAPY; MUTATIONS; GEFITINIB; SURVIVAL; SAFETY; TUMORS; NSCLC; PLUS	Background: A previous randomized phase II study demonstrated that the addition of a c-Met inhibitor tivantinib to an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib might prolong progression-free survival (PFS) in patients with previously treated, nonsquamous nonsmall-cell lung cancer (NSCLC). On a subset analysis, the survival benefit was greater in patients with wild-type EGFR (WT-EGFR) than in those with activating EGFR mutations. Herein, this phase III study compared overall survival (OS) between Asian nonsquamous NSCLC patients with WT-EGFR who received erlotinib plus tivantinib (tivantinib group) or erlotinib plus placebo (placebo group). Methods: A total of 460 NSCLC patients were planned to be randomized to the tivantinib or placebo group. Primary end point was OS. Secondary end points were PFS, tumor response, and safety. Tissue was collected for biomarker analysis, including c-Met and HGF expression. Results: Enrollment was stopped when 307 patients were randomized, following the Safety Review Committee's recommendation based on an imbalance in the interstitial lung disease (ILD) incidence between the groups. ILD developed in 14 patients (3 deaths) and 6 patients (0 deaths) in the tivantinib and the placebo groups, respectively. In the enrolled patients, median OS was 12.7 and 11.1 months in the tivantinib and the placebo groups, respectively [hazard ratio (HR) = 0.891, P = 0.427]. Median PFS was 2.9 and 2.0 months in the tivantinib and the placebo groups, respectively (HR = 0.719, P = 0.019). The commonly observed grade >= 3 adverse events in the tivantinib group were neutropenia (24.3%), leukopenia (18.4%), febrile neutropenia (13.8%), and anemia (13.2%). Conclusions: This study was prematurely terminated due to the increased ILD incidence in the tivantinib group. Although this study lacked statistical power because of the premature termination and did not demonstrate an improvement in OS, our results suggest that tivantinib plus erlotinib might improve PFS than erlotinib alone in nonsquamous NSCLC patients with WT-EGFR.	[Yoshioka, H.] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama 7108602, Japan; [Azuma, K.] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; [Yamamoto, N.] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan; [Takahashi, T.] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka, Japan; [Nishio, M.] Canc Inst Hosp JFCR, Dept Thorac Med Oncol, Tokyo, Japan; [Katakami, N.] Inst Biomed Res, Div Integrated Oncol, Kobe, Hyogo, Japan; [Katakami, N.] Innovat Hosp, Kobe, Hyogo, Japan; [Ahn, M. J.; Park, K.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Hirashima, T.] Osaka Prefectural Hosp Org, Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Habikino, Osaka, Japan; [Maemondo, M.] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan; [Kim, S. W.] Univ Ulsan, Coll Med, ASAN Med Ctr, Dept Oncol, Seoul, South Korea; [Kurosaki, M.; Akinaga, S.] Kyowa Hakko Kirin Co Ltd, R&D Div, Tokyo, Japan; [Tsai, C. M.] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Tamura, T.] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Mitsudomi, T.] Kinki Univ, Fac Med, Dept Thorac Surg, Osakasayama, Japan; [Nakagawa, K.] Kinki Univ, Fac Med, Dept Med Oncol, Osakasayama, Japan	Yoshioka, H (reprint author), Kurashiki Cent Hosp, Dept Resp Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	hirotin@kchnet.or.jp			Kyowa Hakko Kirin, Co., Ltd (Tokyo, Japan)	This work was supported by Kyowa Hakko Kirin, Co., Ltd (Tokyo, Japan), and there is no grant number.	Yamamoto N, 2013, BRIT J CANCER, V109, P2803, DOI 10.1038/bjc.2013.588; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Tanaka A, 2012, LUNG CANCER, V75, P89, DOI 10.1016/j.lungcan.2011.06.004; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740; Yoshioka H, 2010, J THORAC ONCOL, V5, P99, DOI 10.1097/JTO.0b013e3181c20063; Kubota K, 2008, J THORAC ONCOL, V3, P1439, DOI 10.1097/JTO.0b013e31818d6702; Nakagawa K, 2012, J THORAC ONCOL, V7, P1296, DOI 10.1097/JTO.0b013e3182598abb; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Yamamoto N, 2013, ANN ONCOL, V24, P1653, DOI 10.1093/annonc/mdt014; Kang YK, 2014, INVEST NEW DRUG, V32, P355, DOI 10.1007/s10637-013-0057-2; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Aramaki T, 2014, INT LIV CANC ASS ANN; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Jassem J, 2013, LANCET ONCOL, V14, P916, DOI 10.1016/S1470-2045(13)70352-8; Kubota T, 2001, XENOBIO METAB DISPOS, V16, P69; Scagliotti G, 2013, EUR CANC C AMST NETH	21	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	OCT	2015	26	10					2066	2072		10.1093/annonc/mdv288		7	Oncology	Oncology	CT5JF	WOS:000362844300009		
J	Ryu, MH; Baba, E; Lee, KH; Park, YI; Boku, N; Hyodo, I; Nam, BH; Esaki, T; Yoo, C; Ryoo, BY; Song, EK; Cho, SH; Kang, WK; Yang, SH; Zang, DY; Shin, DB; Park, SR; Shinozaki, K; Takano, T; Kang, YK				Ryu, M. -H.; Baba, E.; Lee, K. H.; Park, Y. I.; Boku, N.; Hyodo, I.; Nam, B. -H.; Esaki, T.; Yoo, C.; Ryoo, B. -Y.; Song, E. -K.; Cho, S. -H.; Kang, W. K.; Yang, S. H.; Zang, D. Y.; Shin, D. B.; Park, S. R.; Shinozaki, K.; Takano, T.; Kang, Y. -K.		SOS Study Investigators	Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)	ANNALS OF ONCOLOGY			English	Article						gastric cancer; S-1; cisplatin; chemotherapy	2ND-LINE CHEMOTHERAPY; SUPPORTIVE CARE; ADENOCARCINOMA; NONINFERIORITY; FLUOROURACIL; CAPECITABINE; METAANALYSIS; DOCETAXEL; SURVIVAL; THERAPY	Background: Five-weekly S-1 plus cisplatin (SP5) is one of the standard first-line regimens for advanced gastric cancer (GC), proven in a Japanese phase III study. To enhance the dose intensity of cisplatin, 3-weekly S-1 plus cisplatin (SP3) was developed. Patients and methods: This multicenter, randomized, open-label, phase III study evaluated whether SP3 (S-1 80 mg/m(2)/day on days 1-14 and cisplatin 60 mg/m(2) on day 1) was noninferior/superior to SP5 (S-1 80-120 mg/day on days 1-21 and cisplatin 60 mg/m(2) on day 1 or 8) in terms of progression-free survival (PFS). Chemotherapy-naive patients with metastatic, recurrent gastric or gastroesophageal junction adenocarcinoma were randomized 1 : 1 to receive either SP3 or SP5. The trial is registered at ClinicalTrials.gov (NCT00915382). Results: Between February 2009 and January 2012, 625 patients were randomized at 42 sites in Korea and Japan. With a median follow-up duration of 32.4 months (range, 13.3-48.6 months) in surviving patients, SP3 was not only noninferior but also superior to SP5 in terms of PFS [median 5.5 versus 4.9 months; hazard ratio (HR) = 0.82; 95% confidence interval (CI) 0.68-0.99; P = 0.0418 for superiority). There was no difference in overall survival (OS) between the groups (median 14.1 versus 13.9 months; HR = 0.99; 95% CI 0.81-1.21; P = 0.9068). In patients with measurable disease, the response rates were 60% in the SP3 arm and 50% in the SP5 arm (P = 0.065). Both regimens were generally well tolerated, but grade 3 or higher anemia (19% versus 9%) and neutropenia (39% versus 9%) were more frequent in SP3. Conclusions: SP3 is superior to SP5 in terms of PFS. However, since the improvement in PFS was only slight and there was no difference in OS, both SP3 and SP5 can be recommended as first-line treatments for patients with advanced GC.	[Ryu, M. -H.; Yoo, C.; Ryoo, B. -Y.; Park, S. R.; Kang, Y. -K.] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul 138736, South Korea; [Baba, E.] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 812, Japan; [Lee, K. H.] Yeungnam Univ Hosp, Dept Hematooncol, Daegu, South Korea; [Park, Y. I.] Natl Canc Ctr, Res Inst & Hosp, Ctr Gastr Canc, Goyang, Gyeonggi, South Korea; [Boku, N.] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan; [Hyodo, I.] Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki, Japan; [Nam, B. -H.] Natl Canc Ctr, Biometr Res Branch, Goyang, Gyeonggi, South Korea; [Esaki, T.] Kyushu Natl Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; [Song, E. -K.] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, Jeonju 561756, South Korea; [Cho, S. -H.] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Gwangju, South Korea; [Kang, W. K.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [Yang, S. H.] Korea Canc Ctr Hosp, Dept Internal Med, Seoul, South Korea; [Zang, D. Y.] Hallym Univ, Coll Med, Med Ctr, Div Hematol Oncol,Dept Internal MEd, Anyang, South Korea; [Shin, D. B.] Gachon Univ, Gil Hosp, Dept Internal Med, Div Hematol Oncol, Inchon, South Korea; [Shinozaki, K.] Hiroshima Prefectural Hosp, Div Clin Oncol, Hiroshima, Japan; [Takano, T.] Toranomon Gen Hosp, Dept Med Oncol, Minato Ku, Tokyo, Japan	Kang, YK (reprint author), Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 138736, South Korea.	ykkang@amc.seoul.kr			Jeil and TAIHO Pharmaceutical Co., Ltd	This study was supported in part by Jeil and TAIHO Pharmaceutical Co., Ltd (no grant number).	Freidlin B, 2007, J CLIN ONCOL, V25, P5019, DOI 10.1200/JCO.2007.11.8711; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Bang YJ, 2010, LANCET, V376, P1302; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Kim HS, 2013, ANN ONCOL, V24, P2850, DOI 10.1093/annonc/mdt351; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Lee JL, 2008, CANCER CHEMOTH PHARM, V61, P837, DOI 10.1007/s00280-007-0541-5; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Lee JL, 2008, BRIT J CANCER, V99, P584, DOI 10.1038/sj.bjc.6604536; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060	17	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	OCT	2015	26	10					2097	2101		10.1093/annonc/mdv316		6	Oncology	Oncology	CT5JF	WOS:000362844300014		
J	Ueda, T; Morioka, H; Nishida, Y; Kakunaga, S; Tsuchiya, H; Matsumoto, Y; Asami, Y; Inoue, T; Yoneda, T				Ueda, T.; Morioka, H.; Nishida, Y.; Kakunaga, S.; Tsuchiya, H.; Matsumoto, Y.; Asami, Y.; Inoue, T.; Yoneda, T.			Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial	ANNALS OF ONCOLOGY			English	Article						giant cell tumor of bone; denosumab; RANKL; primary bone tumor; objective tumor response	BISPHOSPHONATES	Background: Giant cell tumor of bone (GCTB) is a rare primary bone tumor, characterized by osteoclast-like giant cells that express receptor activator of nuclear factor-kappa B (RANK), and stromal cells that express RANK ligand (RANKL), a key mediator of osteoclast activation. A RANKL-specific inhibitor, denosumab, was predicted to reduce osteolysis and control disease progression in patients with GCTB. Patients and methods: Seventeen patients with GCTB were enrolled. Patients were treated with denosumab at 120 mg every 4 weeks, with a loading dose of 120 mg on days 8 and 15. To evaluate efficacy, objective tumor response was evaluated prospectively by an independent imaging facility on the basis of prespecified criteria. Results: The proportion of patients with an objective tumor response was 88% based on best response using any tumor response criteria. The proportion of patients with an objective tumor response using individual response criteria was 35% based on the modified Response Evaluation Criteria in Solid Tumors (RECIST) criteria, 82% based on the modified European Organization for Research and Treatment of Cancer (EORTC) criteria, and 71% based on inverse Choi criteria. The median time of study treatment was 13.1 months. Conclusion: The findings demonstrate that denosumab has robust clinical efficacy in the treatment of GCTB.	[Ueda, T.; Kakunaga, S.] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka 5400006, Japan; [Morioka, H.] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Nishida, Y.] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan; [Tsuchiya, H.] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan; [Matsumoto, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 812, Japan; [Asami, Y.; Inoue, T.] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Yoneda, T.] Indiana Univ Sch Med, Div Hematol Oncol, Indianapolis, IN 46202 USA	Ueda, T (reprint author), Osaka Natl Hosp, Dept Orthopaed Surg, Chuo Ku, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	uedat@onh.go.jp			Daiichi Sankyo	This work was supported by Daiichi Sankyo. No grant number is applicable.	Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578; Miller PD, 2011, BONE, V49, P77, DOI 10.1016/j.bone.2010.12.024; Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Chawla S, 2013, LANCET ONCOL, V14, P901, DOI 10.1016/S1470-2045(13)70277-8; Caudell JJ, 2003, INT J RADIAT ONCOL, V57, P158, DOI 10.1016/S0360-3016(03)00416-4; Lin PP, 2002, CANCER, V95, P1317, DOI 10.1002/cncr.10803; Brien EW, 1997, SKELETAL RADIOL, V26, P246; Szendroi M, 2004, J BONE JOINT SURG BR, V86B, P5, DOI 10.1302/0301-620X.86B1.14053; Tse LF, 2008, BONE, V42, P68, DOI 10.1016/j.bone.2007.08.038; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Arbeitsgemeinschaft Knochentumoren, 2008, J Bone Joint Surg Am, V90, P1060, DOI 10.2106/JBJS.D.02771; Cleeland CS, 1991, EFFECT CANC QUALITY, P293; Malawer M, 2008, CANC PRINCIPLES PRAC, P1794	13	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	OCT	2015	26	10					2149	2154		10.1093/annonc/mdv307		7	Oncology	Oncology	CT5JF	WOS:000362844300022		
J	Nakajima, L; Yusof, NNM; Kobayashi, T				Nakajima, Lisa; Yusof, Nor Nadia Mohamad; Kobayashi, Takaomi			Calixarene-Composited Host-Guest Membranes Applied for Heavy Metal Ion Adsorbents	ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING			English	Article						Calixarene; Host-guest chemistry; Membrane; Hybridization; Heavy metal ion; Natural source chemical; Resorcinol; Vanillin	SELECTIVE ADSORPTION; ALPHA-TOCOPHEROL; AQUEOUS-SOLUTION; PHASE INVERSION; LIQUID-MEMBRANE; WASTE-WATER; DERIVATIVES; TRANSPORT; REMOVAL	Calixarene host-guest membranes were prepared with hybridization of calixarene and poly(ethersulfone) (PES) by phase inversion process. Herein, the calixarene, 2,18,14,20-tetra(3-hydroxy-4-methoxybenzyl)calix[4]resorcinarene-4,6,10,12,16,18,22,24-octol, was successfully synthesized from resorcinol and vanillin. The phase inversion process was carried out in phase change of the solution of N-methyl-2-pyrrolidone containing both PES and the vanillin calixarene to solid membrane in water coagulation. The composited membranes having different loading amounts of the vanillin calixarene were prepared with 10, 25, 50 and 60 wt% loading. The observation of SEM pictures indicated porous morphology in the PES scaffold. The porous morphology in the cross section of the membrane caused high water content in the range of 371-375 %, meaning easy accessibility of aqueous solution in the membrane. The adsorption behavior of aqueous heavy metal ions: Pb(II), Ni(II), Cu(II) and Cd(II), was examined for the composited membranes containing 10, 25, 50 and 60 wt% of the calixarene host. It was evidenced that each composited membrane adsorbed effectively Pb2+ ion, as the solution was permeated at 4.0 x 10(4) Pa applied pressure. When the calixarene was loaded at 50 and 60 wt% in the membranes, the Pb2+ capacity was 13 and 15 mu mol/g-membrane, respectively, for the batch experiment. In addition, when the quarterly mixture of the aqueous heavy metal ions was permeated through the membrane, the composited membrane having 50 and 60 wt% of the calixarene loading maintained high retention of the Pb2+ ion.	[Nakajima, Lisa; Yusof, Nor Nadia Mohamad; Kobayashi, Takaomi] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan	Kobayashi, T (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	takaomi@nagaokaut.ac.jp					Ngah WSW, 2008, BIOCHEM ENG J, V39, P521, DOI 10.1016/j.bej.2007.11.006; Minhas FT, 2010, DESALINATION, V262, P215, DOI 10.1016/j.desal.2010.06.014; Johnson PD, 2002, WASTE MANAGE, V22, P471, DOI 10.1016/S0956-053X(01)00036-8; Caira MR, 2006, CRYSTENGCOMM, V8, P275, DOI 10.1039/b601560c; IZATT SR, 1985, J AM CHEM SOC, V107, P63, DOI 10.1021/ja00287a012; Faizal CKM, 2009, J MEMBRANE SCI, V334, P110, DOI 10.1016/j.memsci.2009.02.019; Yusof NNM, 2013, IND ENG CHEM RES, V52, P16951, DOI 10.1021/ie4029158; Yusof NNM, 2014, INT J ENVIRON SCI TE, V11, P1063, DOI 10.1007/s13762-013-0298-9; IZATT RM, 1983, J AM CHEM SOC, V105, P1782, DOI 10.1021/ja00345a016; Faizal CKM, 2008, J MEMBRANE SCI, V322, P503, DOI 10.1016/j.memsci.2008.05.046; Karthikeyan T, 2005, J HAZARD MATER, V124, P192, DOI 10.1016/j.hazmat.2005.05.003; Acemioglu B, 2003, J APPL POLYM SCI, V89, P1537, DOI 10.1002/app.12251; Yusof NNM, 2013, CHEM LETT, V42, P1119, DOI 10.1246/cl.130427; Friberg L., 1979, HDB TOXICOLOGY METAL, P1; Gutsche C.D., 1989, CALIXARENES, P149; ROUQUEROL J, 1994, PURE APPL CHEM, V66, P1739, DOI 10.1351/pac199466081739; Jumina J, 2007, J CHIN CHEM SOC-TAIP, V54, P1167; Mulder M., 1991, BASIC PRINCIPLES MEM; Rengaraj S, 2001, J HAZARD MATER, V87, P273, DOI 10.1016/S0304-3894(01)00291-6; Shammas N.K., 2004, PHYSICOCHEMICAL TREA, P103; Son LT, 2011, J MEMBRANE SCI, V375, P295, DOI 10.1016/j.memsci.2011.03.054; Takeda K, 2006, J MEMBRANE SCI, V275, P61, DOI 10.1016/j.memsci.2005.09.004	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1319-8025	2191-4281		ARAB J SCI ENG	Arab. J. Sci. Eng.	OCT	2015	40	10					2881	2888		10.1007/s13369-015-1796-5		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CT6WP	WOS:000362954000006		
J	Koizumi, M; Oyama, K; Yamakami, Y; Kida, T; Satoh, R; Kato, S; Hidema, S; Oe, T; Goto, T; Clevers, H; Nawa, A; Nishimori, K				Koizumi, Masae; Oyama, Kazunori; Yamakami, Yukiko; Kida, Tomoyo; Satoh, Ryo; Kato, Shigeki; Hidema, Shizu; Oe, Tomoyuki; Goto, Takaaki; Clevers, Hans; Nawa, Akihiro; Nishimori, Katsuhiko			Lgr4 Controls Specialization of Female Gonads in Mice	BIOLOGY OF REPRODUCTION			English	Article						female reproductive tract; sex differentiation; steroid hormones/steroid hormone receptor; testosterone	TRANSCRIPTION FACTOR FOXL2; PROTEIN-COUPLED RECEPTORS; SEX DETERMINATION; SIGNALING PATHWAY; WNT/BETA-CATENIN; HORMONE RECEPTOR; DIFFERENTIATION; OVARY; R-SPONDIN1; LIGANDS	Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is a type of membrane receptor with a seven-transmembrane structure. LGR4 is homologous to gonadotropin receptors, such as follicle-stimulating hormone receptor (Fshr) and luteinizing hormone/choriogonadotropin receptor (Lhcgr). Recently, it has been reported that Lgr4 is a membrane receptor for R-spondin ligands, which mediate Wnt/beta-catenin signaling. Defects of R-spondin homolog (Rspo1) and wingless-type MMTV integration site family, member 4 (Wnt4) cause masculinization of female gonads. We observed that Lgr4(-/-) female mice show abnormal development of the Wolffian ducts and somatic cells similar to that in the male gonads. Lgr4(-/-) female mice exhibited masculinization similar to that observed in Rspo1-deficient mice. In Lgr4(-/-) ovarian somatic cells, the expression levels of lymphoid enhancer-binding factor 1 (Lefl) and Axin2 (Axin2), which are target genes of Wnt/beta-catenin signaling, were lower than they were in wild-type mice. This study suggests that Lgr4 is critical for ovarian somatic cell specialization via the cooperative signaling of Rspo1 and Wnt/beta-catenin.	[Koizumi, Masae; Oyama, Kazunori; Yamakami, Yukiko; Kida, Tomoyo; Kato, Shigeki; Hidema, Shizu; Nishimori, Katsuhiko] Tohoku Univ, Mol Biol Lab, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Satoh, Ryo; Oe, Tomoyuki; Goto, Takaaki] Tohoku Univ, Dept Bioanalyt Chem, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9818555, Japan; [Koizumi, Masae; Nawa, Akihiro] Ehime Univ, Dept Obstet & Gynecol, Sch Med, Toon, Japan; [Clevers, Hans] Univ Med Ctr Utrecht, Hubrecht Inst, Royal Netherlands Acad Arts & Sci, Utrecht, Netherlands	Nishimori, K (reprint author), Tohoku Univ, Mol Biol Lab, Grad Sch Agr Sci, Aoba Ku, Tsutsumidori Amamiyamachi 1-1, Sendai, Miyagi 9818555, Japan.	knishimori@m.tohoku.ac.jp			Japan Society for the Promotion of Science; Japanese Society for the Promotion of Science for Young Scientists	Supported by a Grant-in-Aid for Exploratory Research from the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research on Innovative Areas, and research fellowships of the Japanese Society for the Promotion of Science for Young Scientists to K.O.	de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Mohri Y, 2010, FERTIL STERIL, V94, P2878, DOI 10.1016/j.fertnstert.2010.05.050; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Ji TH, 1997, RECENT PROG HORM RES, V52, P431; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Sone M, 2013, FASEB J, V27, P4917, DOI 10.1096/fj.13-232215; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Vodstrcil LA, 2007, REPROD FERT DEVELOP, V19, P530, DOI 10.1071/RD07007; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; McNamara KM, 2010, J STEROID BIOCHEM, V121, P611, DOI 10.1016/j.jsbmb.2010.02.001; Ng A, 2014, NAT CELL BIOL, V16, P745, DOI 10.1038/ncb3000; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; Chassot AA, 2014, REPRODUCTION, V148, pR97, DOI 10.1530/REP-14-0177; Ji TH, 1997, RECENT PROG HORM RES, V52; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; Kohn L D, 1995, Vitam Horm, V50, P287, DOI 10.1016/S0083-6729(08)60658-5; Maatouk DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047238; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Pan HJ, 2014, ENDOCRINOLOGY, V155, P3624, DOI 10.1210/en.2013-2183; Rastetter RH, 2014, DEV BIOL, V394, P242, DOI 10.1016/j.ydbio.2014.08.013; TANAKA Y, 1962, J Jpn Obstet Gynecol Soc, V14, P273	37	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	OCT 1	2015	93	4							90	10.1095/biolreprod.114.123638		11	Reproductive Biology	Reproductive Biology	CT5YF	WOS:000362886300012		
J	Masuda, H; Maruyama, T; Gargett, CE; Miyazaki, K; Matsuzaki, Y; Okano, H; Tanaka, M				Masuda, Hirotaka; Maruyama, Tetsuo; Gargett, Caroline E.; Miyazaki, Kaoru; Matsuzaki, Yumi; Okano, Hideyuki; Tanaka, Mamoru			Endometrial Side Population Cells: Potential Adult Stem/Progenitor Cells in Endometrium	BIOLOGY OF REPRODUCTION			English	Review						endometriosis; endometrium; endothelial cells; side population; stem/progenitor cells	HEMATOPOIETIC STEM-CELLS; ESTROGEN-RECEPTOR-ALPHA; TUMOR-INITIATING CELLS; PROGENITOR CELLS; MOUSE MODEL; IN-VITRO; ACCUMULATING EVIDENCE; UNRESOLVED QUESTIONS; MURINE ENDOMETRIUM; UTERINE PHYSIOLOGY	Uterine endometrium is one of the most important organs for species preservation. However, the physiology of human endometrium remains poorly understood, because the human endometrium undergoes rapid and large changes during each menstrual cycle and it is very difficult to investigate human endometrium as one organ. This remarkable regenerative capacity of human endometrium strongly suggests the existence of adult stem cells, and physiology of endometrium cannot be explained without adult stem cells. Therefore, investigating endometrial stem/progenitor cells should lead to a breakthrough in understanding the normal endometrial physiology and the pathophysiology of endometrial neoplastic disorders, such as endometriosis and endometrial cancer. Several cell populations have been discovered as putative endometrial stem/progenitor cells. Emerging evidence reveals that the endometrial side population (SP) is one of the potential endometrial stem/progenitor populations. Of all the endometrial stem/progenitor cell candidates, the endometrial SP (ESP) is best investigated in vitro and in vivo, and has the largest number of references. In this review, we provide an overview of the accumulating evidence for the ESP cells, both directly from human endometria and from cultured endometrial cells. Furthermore, SP cells are compared to other potential stem/progenitor cells, and we discuss their stem cell properties. We also discuss the difficulties and unsolved issues in endometrial stem cell biology.	[Masuda, Hirotaka; Maruyama, Tetsuo; Miyazaki, Kaoru; Tanaka, Mamoru] Keio Univ, Dept Obstet & Gynecol, Sch Med, Tokyo 1608582, Japan; [Gargett, Caroline E.] Monash Univ, Ritchie Ctr, Hudson Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Matsuzaki, Yumi] Shimane Univ, Fac Med, Dept Life Sci, Lab Tumor Biol, Izumo, Shimane, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan	Masuda, H (reprint author), Keio Univ, Dept Obstet & Gynecol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hirotaka@a3.keio.jp	Okano, Hideyuki/J-5973-2013		Japan Society for the Promotion of Science; Cell Science Research Foundation; Takeda Science foundation; National Health and Medical Research Council of Australia in the form of Senior Research Fellowship [1042298]; Victorian Government's Operational Infrastructure Support Program	Supported by grants-in-aid from the Japan Society for the Promotion of Science to H.M. and T.M., the Cell Science Research Foundation to H.M., the Takeda Science foundation to H.M., the National Health and Medical Research Council of Australia in the form of Senior Research Fellowship 1042298 to C.E.G., and from the Victorian Government's Operational Infrastructure Support Program to C.E.G.	MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/192276999; Rutella S, 2009, CLIN CANCER RES, V15, P4299, DOI 10.1158/1078-0432.CCR-08-1883; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; WOLF NS, 1993, EXP HEMATOL, V21, P614; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Hyodo S, 2011, TOHOKU J EXP MED, V224, P47, DOI 10.1620/tjem.224.47; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Kyo S, 2011, CANCER LETT, V308, P123, DOI 10.1016/j.canlet.2011.05.015; Kato K, 2010, AM J PATHOL, V176, P381, DOI 10.2353/ajpath.2010.090056; Ness RB, 2003, AM J OBSTET GYNECOL, V189, P280, DOI 10.1067/mob.2003.408; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; PARK CH, 1971, J NATL CANCER I, V46, P411; Behbod F, 2006, STEM CELLS, V24, P1065, DOI 10.1634/stemcells.2005-0375; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Mas A, 2012, FERTIL STERIL, V98, P741, DOI 10.1016/j.fertnstert.2012.04.044; Kubota M, 2010, INVEST OPHTH VIS SCI, V51, P5617, DOI 10.1167/iovs.10-5463; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Pierre-Louis O, 2009, STEM CELLS, V27, P2552, DOI 10.1002/stem.186; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Hu FF, 2010, REPROD SCI, V17, P629, DOI 10.1177/1933719110369180; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; LORD BI, 1986, LYMPHOKINE RES, V5, P59; Critchley HOD, 2009, REPROD SCI, V16, P191, DOI 10.1177/1933719108331121; RASWEILER JJ, 1991, AM J ANAT, V191, P1, DOI 10.1002/aja.1001910102; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433; Nakamura M, 2010, HUM PATHOL, V41, P1516, DOI 10.1016/j.humpath.2010.05.006; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P18350, DOI 10.1073/pnas.0608861103; Inowa T, 2008, INT J UROL, V15, P272, DOI 10.1111/j.1442-2042.2007.01984.x; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Maruyama T, 2014, J OBSTET GYNAECOL RE, V40, P2015, DOI 10.1111/jog.12501; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Kato K, 2011, MOL CANCER THER, V10, P1430, DOI 10.1158/1535-7163.MCT-10-1062; Munksgaard PS, 2011, GYNECOL ONCOL, V123, P157, DOI 10.1016/j.ygyno.2011.06.017; MULLERSIEBURG CE, 1988, J EXP MED, V167, P1825, DOI 10.1084/jem.167.6.1825; Kato K, 2012, ANTICANCER RES, V32, P2283; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hubbard SA, 2010, REPRODUCTION, V140, P23, DOI 10.1530/REP-09-0411; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Critchley HOD, 2001, J CLIN ENDOCR METAB, V86, P1370, DOI 10.1210/jc.86.3.1370; Gotte M, 2011, INT J CANCER, V129, P2042, DOI 10.1002/ijc.25856; Terrace JD, 2009, EXP CELL RES, V315, P2141, DOI 10.1016/j.yexcr.2009.02.004; KAUPPILA AJI, 1986, CANCER RES, V46, P5380; Machado DE, 2010, FERTIL STERIL, V93, P2674, DOI 10.1016/j.fertnstert.2009.11.037; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Vigano P, 2006, HUM REPROD UPDATE, V12, P77, DOI 10.1093/humupd/dmi037; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Martin CM, 2008, CIRC RES, V102, P1075, DOI 10.1161/CIRCRESAHA.107.161729; Mints M, 2008, HUM REPROD, V23, P139, DOI 10.1093/humrep/dem342; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Becker CM, 2008, AM J PATHOL, V172, P534, DOI 10.2353/ajpath.2008.061244; Kusunoki S, 2013, GYNECOL ONCOL, V129, P598, DOI 10.1016/j.ygyno.2013.03.005; Unno K, 2012, CIRC RES, V110, P1355, DOI 10.1161/CIRCRESAHA.111.243014; OGAWA M, 1993, BLOOD, V81, P2844; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Friel AM, 2008, CELL CYCLE, V7, P242; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Gargett CE, 2002, MOL HUM REPROD, V8, P770, DOI 10.1093/molehr/8.8.770; Mylonas I, 2010, ONCOL REP, V24, P385, DOI 10.3892/or_00000871; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; RASWEILER JJ, 1992, J REPROD FERTIL, V95, P231; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Richard V, 2013, BIOMED RES INT, DOI 10.1155/2013/517237; Sampson JA, 1927, AM J PATHOL, V3, P93; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Oberley CC, 2008, EXP CELL RES, V314, P720, DOI 10.1016/j.yexcr.2007.11.002; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005.0116; FINN CA, 1987, PERSPECT BIOL MED, V30, P566; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Cervello I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030260; Chen D, 2015, MOL MED REP, V11, P4309, DOI 10.3892/mmr.2015.3279; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Friel AM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-147; Huang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044285; Kaitu'u-Lino TJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099309; Maruyama T, 2013, PLACENTA, V34, pS68, DOI 10.1016/j.placenta.2012.12.010; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Miyazaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050749; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Wang MJ, 2015, MOL MED REP, V11, P4297, DOI 10.3892/mmr.2015.3291; Xu J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-103	101	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	OCT 1	2015	93	4							84	10.1095/biolreprod.115.131490		8	Reproductive Biology	Reproductive Biology	CT5YF	WOS:000362886300006		
J	Satouh, Y; Nozawa, K; Ikawa, M				Satouh, Yuhkoh; Nozawa, Kaori; Ikawa, Masahito			Sperm Postacrosomal WW Domain-Binding Protein Is Not Required for Mouse Egg Activation	BIOLOGY OF REPRODUCTION			English	Article						acrosome; Ca2+; fertilization; meiotic arrest; spermatogenesis	PLC-ZETA; EMBRYO DEVELOPMENT; CA2+ OSCILLATIONS; OOCYTE ACTIVATION; MALE-INFERTILITY; PAWP; FERTILIZATION; GENERATION; RELEASE; MICE	To begin embryonic development, the zygote must resume the cell cycle correctly after stimulation by sperm-borne oocyte-activating factors (SOAFs). The postacrosomal WW domain-binding protein (PAWP) is one of the strongest SOAF candidates and is widely conserved among eutherian mammals. It has been reported that the microinjection of recombinant PAWP protein can trigger not only Ca2+ oscillations in mammalian eggs but also intracellular Ca2+ release in amphibian eggs. It was also suggested that PAWP is involved in the formation of high-quality spermatozoa. On the other hand, negligible SOAF activity for PAWP cRNA has also been reported. In this study, we generated PAWP null mice and examined the fertilizing ability of male mice. Electron microscopy showed no aberrant morphology in spermatogenesis. Intracytoplasmic injection of a single spermatozoon from the null mouse line showed that depletion of PAWP elicited no quantitative differences in Ca2+ oscillations or in subsequent development of the embryos. We conclude that PAWP does not play an essential role in mouse fertilization.	[Satouh, Yuhkoh; Nozawa, Kaori; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Nozawa, Kaori; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Osaka, Japan; [Ikawa, Masahito] Osaka Univ, Sch Pharmaceut Sci, Osaka, Japan	Ikawa, M (reprint author), Osaka Univ, Microbial Dis Res Inst, Osaka, Japan.	ikawa@biken.osaka-u.ac.jp	Satouh, Yuhkoh/A-9917-2009	Satouh, Yuhkoh/0000-0001-9207-9374	Japan Society for the Promotion of Science KAKENHI [25113714, 24770210]	This work was supported by Japan Society for the Promotion of Science KAKENHI grants 25113714 and 24770210.	Aarabi M, 2014, FASEB J, V28, P4434, DOI 10.1096/fj.14-256495; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Ducibella T, 2008, DEV BIOL, V315, P257, DOI 10.1016/j.ydbio.2007.12.012; Wu ATH, 2007, DEV BIOL, V312, P471, DOI 10.1016/j.ydbio.2007.08.051; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Nomikos M, 2015, MOL HUM REPROD, V21, P702, DOI 10.1093/molehr/gav034; Aarabi M, 2014, FERTIL STERIL, V102, P440, DOI 10.1016/j.fertnstert.2014.05.003; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Backs J, 2010, P NATL ACAD SCI USA, V107, P81, DOI 10.1073/pnas.0912658106; SWANN K, 1990, DEVELOPMENT, V110, P1295; Chang HY, 2009, DEVELOPMENT, V136, P4077, DOI 10.1242/dev.042143; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Kashir J, 2012, HUM REPROD, V27, P222, DOI 10.1093/humrep/der384; Wu ATH, 2007, J BIOL CHEM, V282, P12164, DOI 10.1074/jbc.M609132200; Dale B, 2010, REPROD BIOMED ONLINE, V21, P1, DOI 10.1016/j.rbmo.2010.02.015; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Nomikos M, 2014, MOL HUM REPROD, V20, P938, DOI 10.1093/molehr/gau056; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Nomikos M, 2012, BIOESSAYS, V34, P126, DOI 10.1002/bies.201100127; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Yamagata K, 2005, GENESIS, V43, P71, DOI 10.1002/gene.20158; Aarabi M, 2010, MOL REPROD DEV, V77, P249, DOI 10.1002/mrd.21140; Miao YL, 2012, MOL REPROD DEV, V79, P742, DOI 10.1002/mrd.22078; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; Kennedy CE, 2014, MOL REPROD DEV, V81, P436, DOI 10.1002/mrd.22309; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Wakai T, 2011, COLD SPRING HARB PER, V3, P1	33	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	OCT 1	2015	93	4							94	10.1095/biolreprod.115.131441		7	Reproductive Biology	Reproductive Biology	CT5YF	WOS:000362886300016		
J	Fang, J; Kawano, S; Tajima, K; Kondo, T				Fang, Ju; Kawano, Shin; Tajima, Kenji; Kondo, Tetsuo			In Vivo Curdlan/Cellulose Bionanocomposite Synthesis by Genetically Modified Gluconacetobacter xylinus	BIOMACROMOLECULES			English	Article							CELLULOSE NANOPAPER STRUCTURES; BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM; MICROBIAL CELLULOSE; CURDLAN BIOSYNTHESIS; BIOFILM FORMATION; HIGH TOUGHNESS; ANILINE BLUE; EXOPOLYSACCHARIDES; POLYSACCHARIDES	Bacterial cellulose pellicle produced by Gluconacetobacter xylinus (G. xylinus) is one of the best biobased materials having a unique supernetwork structure with remarkable physiochemical properties for a wide range of medical and tissue-engineering applications. It is still necessary to modify them to obtain materials suitable for biomedical use with satisfactory mechanical strength, biodegradability, and bioactivity. The aim of this research was to develop a gene-transformation route for the production of bacterial cellulose/Curdlan (beta-1,3-glucan) nanocomposites by separate but simultaneous in vivo synthesis of cellulose and Curdlan. Modification of the cellulose-nanofiber-producing system of G. xylinus enabled Curdlan to be synthesized simultaneously with cellulose nanofibers in vivo, resulting in biopreparation of nanocomposites. The obtained Curdlan/cellulose composites were characterized, and their properties were compared with those of normal bacterial cellulose pellicles, indicating that Curdlan mixed with the cellulose nanofibers at the nanoscale without disruption of the nanofiber network structure in the pellicle.	[Fang, Ju; Kondo, Tetsuo] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Kawano, Shin] Res Org Informat & Syst, Database Ctr Life Sci, Kashiwa, Chiba 2770871, Japan; [Tajima, Kenji] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Kondo, T (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tekondo@agr.kyushu-u.ac.jp					Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d; Taajamaa L, 2012, J MATER CHEM, V22, P12072, DOI 10.1039/c2jm30572k; Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378; Duboc P, 2001, INT DAIRY J, V11, P759, DOI 10.1016/S0958-6946(01)00119-4; ZAAR K, 1979, J CELL BIOL, V80, P773, DOI 10.1083/jcb.80.3.773; SAXENA IM, 1994, J BACTERIOL, V176, P5735; Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x; Lee KY, 2009, COMPOS SCI TECHNOL, V69, P2724, DOI 10.1016/j.compscitech.2009.08.016; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; HARADA T, 1968, ARCH BIOCHEM BIOPHYS, V124, P292, DOI 10.1016/0003-9861(68)90330-5; McIntosh M, 2005, APPL MICROBIOL BIOT, V68, P163, DOI 10.1007/s00253-005-1959-5; Karnezis T, 2003, GLYCOBIOLOGY, V13, P693, DOI 10.1093/glycob/cwg093; HALL PE, 1992, PLASMID, V28, P194, DOI 10.1016/0147-619X(92)90051-B; Sutherland IW, 2001, MICROBIOL-UK, V147, P3; Wu CH, 2012, CARBOHYD POLYM, V89, P497, DOI 10.1016/j.carbpol.2012.03.034; Bodin A, 2007, J TISSUE ENG REGEN M, V1, P406, DOI 10.1002/term.51; Larsson PA, 2014, BIOMACROMOLECULES, V15, P2218, DOI 10.1021/bm500360c; SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123; EVANS NA, 1984, CARBOHYD POLYM, V4, P215, DOI 10.1016/0144-8617(84)90012-2; Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97; Svagan AJ, 2007, BIOMACROMOLECULES, V8, P2556, DOI 10.1021/bm0703160; NAKANISHI I, 1976, J GEN APPL MICROBIOL, V22, P1, DOI 10.2323/jgam.22.1; Luo HL, 2008, MATER CHEM PHYS, V110, P193, DOI 10.1016/j.matchemphys.2008.01.040; Zhan XB, 2012, APPL MICROBIOL BIOT, V93, P525, DOI 10.1007/s00253-011-3740-2; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Brown EE, 2007, BIOMACROMOLECULES, V8, P3074, DOI 10.1021/bm700448x; YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032; Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6; Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61; Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0; Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n; Sunagawa N, 2012, CELLULOSE, V19, P1989, DOI 10.1007/s10570-012-9777-2; Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570; Kim DY, 2002, CELLULOSE, V9, P361, DOI 10.1023/A:1021140726936; Blaker JJ, 2009, GREEN CHEM, V11, P1321, DOI 10.1039/b913740h; Sehaqui H, 2012, BIOMACROMOLECULES, V13, P3661, DOI 10.1021/bm301105s; Stasinopoulos SJ, 1999, GLYCOBIOLOGY, V9, P31, DOI 10.1093/glycob/9.1.31; Sehaqui H, 2011, BIOMACROMOLECULES, V12, P3638, DOI 10.1021/bm2008907; Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018; Donot F, 2012, CARBOHYD POLYM, V87, P951, DOI 10.1016/j.carbpol.2011.08.083; Brown RM, 2000, PLANT PHYSIOL BIOCH, V38, P57, DOI 10.1016/S0981-9428(00)00168-6; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980; Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097; Lin K.-W., 2004, J FOOD SCI, V69; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; White D. G., 1989, CELLULOSE WOOD CHEM, P573	46	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	OCT	2015	16	10					3154	3160		10.1021/acs.biomac.5b01075		7	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CT5PW	WOS:000362863500008		
J	Tanaka, Y; Kato, M; Hasegawa, D; Urayama, KY; Nakadate, H; Kondoh, K; Nakamura, K; Koh, K; Komiyama, T; Manabe, A				Tanaka, Yoichi; Kato, Motohiro; Hasegawa, Daisuke; Urayama, Kevin Y.; Nakadate, Hisaya; Kondoh, Kensuke; Nakamura, Kozue; Koh, Katsuyoshi; Komiyama, Takako; Manabe, Atsushi			Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						NUDT15; 6-MP; toxicities; childhood acute lymphoblastic leukaemia; Japanese	MAINTENANCE CHEMOTHERAPY; CHILDHOOD; 6-MERCAPTOPURINE; THERAPY; RISK; INTOLERANCE; DOSAGE; GENE	Genotyping of TPMT prior to 6-mercaptopurine (6-MP) administration in acute lymphoblastic leukaemia (ALL) patients has been integrated into clinical practice in some populations of European ancestry. However, the comparable rates of 6-MP myelotoxicity, but rarity of TPMT variants, in Asians suggest that major determinants have yet to be discovered in this population. We genotyped 92 Japanese paediatric ALL patients for NUDT15 rs116855232, a 6-MP toxicity-related locus discovered in Asians. Logistic regression and survival analysis were used to evaluate its association with leucopenia, hepatotoxicity, 6-MP dose reduction, therapy interruption and event-free survival. The allele frequency of rs116855232 was 0.16, and leucopenia was more common in carriers of the T allele (odds ratio, 7.20; 95% confidence interval, 2.49-20.80; P = 2.7 x 10(-4)). As leucopenia results in 6-MP dose reduction, we observed average doses during maintenance therapy of 40.7, 29.3 and 8.8 mg/m(2) for patients with CC, CT and TT genotypes, respectively (P < 0.001). Hepatotoxicity was observed only in CC genotype patients. Event-free survival did not significantly differ by NUDT15 genotype. rs116855232 is an important determinant of 6-MP myelotoxicity in Japanese children with ALL and may represent the most robust toxicity-related locus in Asians to date. Considerations for clinical application may be warranted.	[Tanaka, Yoichi; Komiyama, Takako] Kitasato Univ, Sch Pharm, Ctr Clin Pharm & Sci, Dept Clin Pharm, Tokyo 1088641, Japan; [Kato, Motohiro] Univ Tokyo, Dept Paediat, Tokyo, Japan; [Hasegawa, Daisuke; Manabe, Atsushi] St Lukes Int Hosp, Dept Paediat, Tokyo, Japan; [Urayama, Kevin Y.] Tokyo Med & Dent Univ, Dept Human Genet & Dis Divers, Tokyo, Japan; [Urayama, Kevin Y.] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Nakadate, Hisaya] Natl Ctr Child Hlth & Dev, Dept Gen Paediat & Interdisciplinary Med, Tokyo, Japan; [Kondoh, Kensuke] St Marianna Univ, Sch Med, Dept Paediat, Kawasaki, Kanagawa, Japan; [Nakamura, Kozue] Teikyo Univ, Dept Paediat, Tokyo 173, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Haematol Oncol, Saitama, Japan	Tanaka, Y (reprint author), Kitasato Univ, Sch Pharm, Ctr Clin Pharm & Sci, Dept Clin Pharm,Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	tanakay@pharm.kitasato-u.ac.jp					Schmiegelow K, 2009, BLOOD, V113, P6077, DOI 10.1182/blood-2008-11-187880; Nygaard U, 2004, CLIN PHARMACOL THER, V75, P274, DOI 10.1016/j.clpt.2003.12.-001; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Toyoda Y, 2000, J CLIN ONCOL, V18, P1508; Relling MV, 1999, J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Stanulla M, 2009, BLOOD, V114, P1314, DOI 10.1182/blood-2008-12-193250; SCHMIEGELOW K, 1991, PEDIATR HEMAT ONCOL, V8, P301, DOI 10.3109/08880019109028803; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Kubota T, 2001, BRIT J CLIN PHARMACO, V51, P475, DOI 10.1046/j.1365-2125.2001.01371.x; SCHMIEGELOW K, 1990, AM J PEDIAT HEMATOL, V12, P462; Relling MV, 1999, BLOOD, V93, P2817; Relling MV, 2013, HEMATOL-AM SOC HEMAT, P126; Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; Schmiegelow K, 2003, J CLIN ONCOL, V21, P1332, DOI 10.1200/JCO.2003.04.039; Kumagai K, 2001, PHARMACOGENETICS, V11, P275, DOI 10.1097/00008571-200104000-00012; LENNARD L, 1989, J CLIN ONCOL, V7, P1816; Tanaka Y, 2012, LEUKEMIA RES, V36, P560, DOI 10.1016/j.leukres.2011.11.015; Tanaka Y., 2014, PHARMACOGENOMICS J, DOI [10.1038/tpj.2014.74, DOI 10.1038/TPJ.2014.74.IN]	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171	1					109	115		10.1111/bjh.13518		7	Hematology	Hematology	CT4LJ	WOS:000362777600013		
J	Sakakibara, Y; Nakazuru, S; Yamada, T; Iwasaki, T; Iwasaki, R; Ishihara, A; Nishio, K; Ishida, H; Kodama, Y; Mita, E				Sakakibara, Yuko; Nakazuru, Shoichi; Yamada, Takuya; Iwasaki, Tetsuya; Iwasaki, Ryuichiro; Ishihara, Akio; Nishio, Kumiko; Ishida, Hisashi; Kodama, Yoshinori; Mita, Eiji			Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma with colon involvement	CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Sakakibara, Yuko; Nakazuru, Shoichi; Yamada, Takuya; Iwasaki, Tetsuya; Iwasaki, Ryuichiro; Ishihara, Akio; Nishio, Kumiko; Ishida, Hisashi; Mita, Eiji] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Osaka 5400006, Japan; [Kodama, Yoshinori] Osaka Natl Hosp, Natl Hosp Org, Dept Pathol, Osaka, Osaka 5400006, Japan	Sakakibara, Y (reprint author), Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Chuo Ku, 2-1-14 Houenzaka, Osaka, Osaka 5400006, Japan.	yuko.s@onh.go.jp					Matsumoto H, 2005, GASTROINTEST ENDOSC, V61, P607, DOI 10.1016/S0016-5107(04)02785-3; Savage KJ, 2008, BLOOD, V111, P5496, DOI 10.1182/blood-2008-01-134270; Ferreri AJM, 2013, CRIT REV ONCOL HEMAT, V85, P206, DOI 10.1016/j.critrevonc.2012.06.004; Shukla T, 2014, CAN J GASTROENTEROL, V28, P11	4	0	0	PULSUS GROUP INC	OAKVILLE	2902 S SHERIDAN WAY, OAKVILLE, ONTARIO L6J 7L6, CANADA	0835-7900			CAN J GASTROENTEROL	Can. J. Gastroenterol. Hepatol.	OCT	2015	29	7					345	346				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CT6BT	WOS:000362896500002		
J	Kuramitsu, S; Ohno, M; Ohka, F; Shiina, S; Yamamichi, A; Kato, A; Tanahashi, K; Motomura, K; Kondo, G; Kurimoto, M; Senga, T; Wakabayashi, T; Natsume, A				Kuramitsu, S.; Ohno, M.; Ohka, F.; Shiina, S.; Yamamichi, A.; Kato, A.; Tanahashi, K.; Motomura, K.; Kondo, G.; Kurimoto, M.; Senga, T.; Wakabayashi, T.; Natsume, A.			Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses	CANCER GENE THERAPY			English	Article							IMMUNOLOGICAL SYNAPSE; ADJUVANT TEMOZOLOMIDE; POTENT INHIBITORS; STEM-CELLS; TNF-ALPHA; EGFRVIII; GLIOBLASTOMA; ACTIVATION; GLIOMA; IMMUNOTHERAPY	The epidermal growth factor receptor variant III (EGFRvIII) is exclusively expressed on the cell surface in similar to 50% of glioblastoma multiforme (GBM). This variant strongly and persistently activates the phosphatidylinositol 3-kinase-Akt signaling pathway in a ligand-independent manner resulting in enhanced tumorigenicity, cellular motility and resistance to chemoradiotherapy. Our group generated a recombinant single-chain variable fragment (scFv) antibody specific to the EGFRvIII, referred to as 3C10-scFv. In the current study, we constructed a lentiviral vector transducing the chimeric antigen receptor (CAR) that consisted of 3C10-scFv, CD3., CD28 and 4-1BB (3C10-CAR). The 3C10-CAR-transduced peripheral blood mononuclear cells (PBMCs) and CD3(+) T cells specifically lysed the glioma cells that express EGFRvIII. Moreover, we demonstrated that CAR CD3(+) T cells migrated to the intracranial xenograft of GBM in the mice treated with 3C10-CAR PBMCs. An important and novel finding of our study was that a thalidomide derivative lenalidomide induced 3C10-CAR PBMC proliferation and enhanced the persistent antitumor effect of the cells in vivo. Lenalidomide also exhibited enhanced immunological synapses between the effector cells and the target cells as determined by CD11a and F-actin polymerization. Collectively, lentiviral-mediated transduction of CAR effectors targeting the EGFRvIII showed specific efficacy, and lenalidomide even intensified CAR cell therapy by enhanced formation of immunological synapses.	[Kuramitsu, S.; Ohno, M.; Ohka, F.; Shiina, S.; Yamamichi, A.; Kato, A.; Tanahashi, K.; Motomura, K.; Kondo, G.; Kurimoto, M.; Wakabayashi, T.; Natsume, A.] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 4668550, Japan; [Kuramitsu, S.] Koujunkai Daido Hosp, Div Neurosurg, Nagoya, Aichi, Japan; [Ohno, M.] Natl Hosp Org, Nagoya Med Ctr, Div Neurosurg, Nagoya, Aichi, Japan; [Senga, T.] Nagoya Univ, Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan	Natsume, A (reprint author), Nagoya Univ, Sch Med, Dept Neurosurg, Show Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	anatsume@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23107010, 25861270]	This work was supported by a Grant-in Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (AN no. 23107010) and a Grant-in-Aid for Young Scientists B (MO no. 25861270). We would like to thank Mr Masamitsu Harada (Cellgene) for his constructive suggestions and Mr Yutaka Hattori (Keyence) for his technical assistance in immunofluorescence imaging.	Johnson LA, 2010, CURR NEUROL NEUROSCI, V10, P259, DOI 10.1007/s11910-010-0111-9; Alexander BM, 2013, J NEURO-ONCOL, V111, P33, DOI 10.1007/s11060-012-0987-0; Sakamaki I, 2014, LEUKEMIA, V28, P329, DOI 10.1038/leu.2013.177; Ramsay AG, 2009, BLOOD, V114, P4713, DOI 10.1182/blood-2009-04-217687; Chung DS, 2014, J IMMUNOL RES, DOI 10.1155/2014/326545; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Lammering G, 2003, ONCOGENE, V22, P5545, DOI 10.1038/sj.onc.1206788; Giglio P, 2012, CANCER-AM CANCER SOC, V118, P3599, DOI 10.1002/cncr.26663; Lu L, 2009, MICROVASC RES, V77, P78, DOI 10.1016/j.mvr.2008.08.003; Lammering G, 2004, CLIN CANCER RES, V10, P6732, DOI 10.1158/1078-0432.CCR-04-0393; Ohno M, 2010, CANCER SCI, V101, P2518, DOI 10.1111/j.1349-7006.2010.01734.x; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Desai Madhav, 2014, Ther Adv Hematol, V5, P91, DOI 10.1177/2040620714532124; Nakayashiki N, 2000, JPN J CANCER RES, V91, P1035; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Montgomery RB, 2000, J BIOL CHEM, V275, P17358, DOI 10.1074/jbc.M000966200; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Idler I, 2010, BRIT J HAEMATOL, V148, P948, DOI 10.1111/j.1365-2141.2009.08014.x; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; Rolle CE, 2012, ADV EXP MED BIOL, V746, P53, DOI 10.1007/978-1-4614-3146-6_5; Morgan RA, 2012, HUM GENE THER, V23, P1043, DOI 10.1089/hum.2012.041; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Muller GW, 1999, BIOORG MED CHEM LETT, V9, P1625, DOI 10.1016/S0960-894X(99)00250-4; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Okamoto S, 1996, BRIT J CANCER, V73, P1366, DOI 10.1038/bjc.1996.260; Corral LG, 1999, J IMMUNOL, V163, P380; Curran KJ, 2012, J GENE MED, V14, P405, DOI 10.1002/jgm.2604; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Luptakova K, 2013, CANCER IMMUNOL IMMUN, V62, P39, DOI 10.1007/s00262-012-1308-3; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Galustian C, 2009, CANCER IMMUNOL IMMUN, V58, P1033, DOI 10.1007/s00262-008-0620-4; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Zoller S, 2007, REV ESP ENFERM DIG, V99, P547, DOI 10.4321/s1130-01082007000900011; Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; LeBlanc R, 2004, BLOOD, V103, P1787, DOI 10.1182/blood-2003-02-0361; Cartellieri M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956304; Ohno Masasuke, 2013, J Immunother Cancer, V1, P21, DOI 10.1186/2051-1426-1-21	45	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0929-1903	1476-5500		CANCER GENE THER	Cancer Gene Ther.	OCT	2015	22	10					487	495		10.1038/cgt.2015.47		9	Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Research & Experimental Medicine	CT6GS	WOS:000362912100004		
J	Oh, DY; Lee, SH; Han, SW; Kim, MJ; Kim, TM; Kim, TY; Heo, DS; Yuasa, M; Yanagihara, Y; Bang, YJ				Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Mi-Jung; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Yuasa, Miyuki; Yanagihara, Yasuo; Bang, Yung-Jue			Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors	CANCER RESEARCH AND TREATMENT			English	Article						OPB-31121; STAT3; STAT3 nhibitor; Solid tumor; Phase I	TYROSINE KINASE JAK2; HUMAN GASTRIC-CANCER; SIGNAL TRANSDUCER; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; GROWTH-FACTOR; ACTIVATOR; MUTATION; TRANSCRIPTION-3; PATHWAY	Purpose OPB-31121 is an oral STAT3 inhibitor with a good preclinica I antitumor activity. This phase I dose-escalation study of OPB-31121 was conducted to determine maximum-tolerated dose (MTD), safety, pharmacokinetics, and preliminary antitumor efficacy in patients with advanced solid tumors. Materials and Methods Patients received OPB-31121 once daily for 28 days of each cycle followed by 2 weeks rest. A standard 3+3 design was used for dose-escalation. Safety and response were evaluated by the National Cancer Institute-Common Terminology Criteria for Adverse Events (NCICTCAE) ver. 3.0 and Response Evaluation Criteria in Solid Tumor (RECIST) ver. 1.0, respectively. Results Twenty-five patients were treated with OPB-31121 at five dose levels: 100 mg (n=4), 200 mg (n=3), 400 mg (n=3), 600 mg (n=7), and 800 mg (n=8). Seven patients discontinued treatment during cycle 1 for various reasons other than study drug-related adverse events. Among 18 patients who were evaluable for dose-limiting toxicity (DLT), three DLTs were observed: one DLT (grade 3 vomiting) at 600 mg and two DLTs (grade 3 vomiting, grade 3 diarrhea) at 800 mg. The MTD was determined as 800 mg/day. Common adverse events were gastrointestinal adverse event including nausea (84%), vomiting (80%), and diarrhea (72%). Pharmacokinetics did not demonstrate dose-proportionality of OPB-31121. Eight patients had stable disease and 10 patients had disease progression. Two patients (1 colon cancer, 1 rectal cancer) showed tumor shrinkage. One gastric cancer patient continued treatment up to cycle 13 before disease progression. Conclusion This study demonstrates feasibility of STAT3 inhibition in patients with advanced solid tumor. OPB-31121, at the MTD of 800 mg/day, was safe and relatively well tolerated, and has a preliminary antitumor activity.	[Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Mi-Jung; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 03080, South Korea; [Kim, Mi-Jung] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; [Yuasa, Miyuki] Otsuka Pharmaceut Co Ltd, Dept Clin Res & Dev, Tokyo, Japan; [Yanagihara, Yasuo] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Tokyo, Japan	Bang, YJ (reprint author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.	bangyj@snu.ac.kr			Otsuka Pharmaceutical	Yung-Jue Bang received research funding from Otsuka Pharmaceutical and Miyuki Yuasa and Yasuo Yanagihar are Employee from Otsuka Pharmaceutical. None of the other investigators have any conflicts of interest to disclose.	Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; MIZUTANI Y, 1995, CANCER RES, V55, P590; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Levy DE, 2006, P NATL ACAD SCI USA, V103, P10151, DOI 10.1073/pnas.0604042103; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Mankan AK, 2011, EXPERT OPIN INV DRUG, V20, P1263, DOI 10.1517/13543784.2011.601739; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Alas S, 2003, CLIN CANCER RES, V9, P316; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Kim MJ, 2013, CANCER LETT, V335, P145, DOI 10.1016/j.canlet.2013.02.010; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Motte N, 2007, INT J CANCER, V121, P2113, DOI 10.1002/ijc.22939; Deng JY, 2010, WORLD J GASTROENTERO, V16, P5380, DOI 10.3748/wjg.v16.i42.5380; Bendell JC, 2014, CANCER CHEMOTH PHARM, V74, P125, DOI 10.1007/s00280-014-2480-2; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Jove R, 2000, ONCOGENE, V19, P2466, DOI 10.1038/sj.onc.1203549; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Verstovsek S., 2009, HEMATOL-AM SOC HEMAT, V2009, P636	25	0	0	KOREAN CANCER ASSOCIATION	SEOUL	RM 1824, GWANGHWAMUN OFFICIA, 92 SAEMUNAN-RO, JONGNO-GU, SEOUL, 110-999, SOUTH KOREA	1598-2998	2005-9256		CANCER RES TREAT	Cancer Res. Treat.	OCT	2015	47	4					607	615		10.4143/crt.2014.249		9	Oncology	Oncology	CT6BN	WOS:000362895800009		
J	Oh, DY; Doi, T; Shirao, K; Lee, KW; Park, SR; Chen, Y; Yang, LQ; Valota, O; Bang, YJ				Oh, Do-Youn; Doi, Toshihiko; Shirao, Kuniaki; Lee, Keun-Wook; Park, Sook Ryun; Chen, Ying; Yang, Liqiang; Valota, Olga; Bang, Yung-Jue			Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer	CANCER RESEARCH AND TREATMENT			English	Article						Axitinib; Stomach neoplasms; Cisplatin; Capecitabine; Pharmacokinetics; Clinical trial; Phase I	ENDOTHELIAL GROWTH-FACTOR; 1ST-LINE THERAPY; DOUBLE-BLIND; OPEN-LABEL; MULTICENTER; CARCINOMA; PLACEBO; TRIAL; PHARMACOLOGY; BEVACIZUMAB	Purpose This phase I trial evaluated the question of whether the standard starting dose of axitinib could be administered in combination with therapeutic doses of cisplatin/capecita bine in patients with previously untreated advanced gastric cancer, and assessed overall safety, pharmacokinetics, and preliminary antitumor activity of this combination. Materials and Methods Patients in dose level (DL) 1 received axitinib 5 mg twice a day (days 1 to 21) with cisplatin 80 mg/m2 (day 1) and capecita bine 1,000 mg/m2 twice a day (days 1 to 14) in 21-day cycles. Maximum tolerated dose (MTD) was the highest dose at which 30% of the first 12 patients experienced a dose-limiting toxicity (DLT) during cycle 1. Ten additional patients were enrolled and treated at the MTD in order to obtain additional safety and pharmacokinetic data Results Three DLTs occurred during cycle 1 in three (25%) of the first 12 patients: ruptured abdominal aortic aneurysm, acute renal failure, and > 5 consecutive days of missed axitinib due to thrombocytopenia. DL1 was established as the MTD, since higher DL cohorts were not planned. Common grade 3/4 non hematologic adverse events in 22 patients treated at DL1 included hypertension (36.4%) and decreased appetite and stomatitis (18.2% each). Cisplatin/capecitabine slightly increased axitinib exposure; axitinib decreased capecitabine and 5-fluorouracil exposure. Eight patients (36.4%) each had partial response or stable disease. Median response duration was 9.1 months; median progression-free survival was 3.8 months. Conclusion In patients with advanced gastric cancer, standard doses of axitinib plus therapeutic doses of cisplatin and capecitabine could be administered in combination. Adverse events were manageable.	[Oh, Do-Youn; Bang, Yung-Jue] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Oh, Do-Youn; Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Doi, Toshihiko] Natl Canc Ctr Hosp East, Div Gastroenterol, Chiba, Japan; [Shirao, Kuniaki] Oita Univ, Fac Med, Dept Med Oncol, Yufu, Japan; [Lee, Keun-Wook] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Songnam, South Korea; [Park, Sook Ryun] Natl Canc Ctr, Res Inst & Hosp, Dept Internal Med, Goyang, South Korea; [Chen, Ying; Yang, Liqiang] Pfizer Oncol, San Diego, CA USA; [Valota, Olga] Pfizer Oncol, Milan, Italy	Bang, YJ (reprint author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.	bangyj@snu.ac.kr			Pfizer Inc.	Ying Chen, Ligiang Yang, and Olga Valota are Pfizer employees and hold Pfizer Inc. stock. Yung-Je Bang has performed consulting services for and received honoraria and research funding from Pfizer Inc. Do-Youn Oh, Toshihiko Doi, Kuniaki Shirao, Sook Ryun Park, and Keun-Wook Lee have no conflicts of interest to disclose. This study was sponsored by Pfizer Inc. Medical writing support was provided by Lilliam Poltorack, PharmD, and Joanna Bloom, PhD, of Engage Scientific Solutions, and was funded by Pfizer Inc.	Schiller JH, 2009, J CLIN ONCOL, V27, P3836, DOI 10.1200/JCO.2008.20.8355; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; Bang YJ, 2010, LANCET, V376, P1302; Spano JP, 2008, LANCET, V371, P2101, DOI 10.1016/S0140-6736(08)60661-3; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Cohen EEW, 2008, J CLIN ONCOL, V26, P4708, DOI 10.1200/JCO.2007.15.9566; Rugo HS, 2011, J CLIN ONCOL, V29, P2459, DOI 10.1200/JCO.2010.31.2975; Fruehauf J, 2011, CLIN CANCER RES, V17, P7462, DOI 10.1158/1078-0432.CCR-11-0534; Shi H, 2003, WORLD J GASTROENTERO, V9, P1421; Kim C, 2012, INVEST NEW DRUG, V30, P306, DOI 10.1007/s10637-010-9531-2; Chen Y, 2013, CLIN PHARMACOKINET, V52, P713, DOI 10.1007/s40262-013-0068-3; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Walko CM, 2005, CLIN THER, V27, P23, DOI 10.1016/j.clinthera.2005.01.005; Bang YJ, 2011, INVEST NEW DRUG, V29, P1449, DOI 10.1007/s10637-010-9438-y; Moehler M, 2011, EUR J CANCER, V47, P1511, DOI 10.1016/j.ejca.2011.04.006; Postel-Vinay S, 2011, J CLIN ONCOL, V29, P1728, DOI 10.1200/JCO.2010.31.9236; VERMORKEN JB, 1984, CANCER TREAT REP, V68, P505; Hu-Lowe DD, 2008, CLIN CANCER RES, V14, P7272, DOI 10.1158/1078-0432.CCR-08-0652; Go RS, 1999, J CLIN ONCOL, V17, P409; Infante JR, 2013, CANCER-AM CANCER SOC, V119, P2555, DOI 10.1002/cncr.28112; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; National Comprehensive Cancer Network Inc, 2014, NCCN CLIN PRACT GUID; Park SR, 2010, 35 ANN C EUR SOC MED	24	0	0	KOREAN CANCER ASSOCIATION	SEOUL	RM 1824, GWANGHWAMUN OFFICIA, 92 SAEMUNAN-RO, JONGNO-GU, SEOUL, 110-999, SOUTH KOREA	1598-2998	2005-9256		CANCER RES TREAT	Cancer Res. Treat.	OCT	2015	47	4					687	696		10.4143/crt.2014.225		10	Oncology	Oncology	CT6BN	WOS:000362895800018		
J	Hashimoto, M; Misaka, T; Ishiguro, M; Masuda, K				Hashimoto, Makoto; Misaka, Takumi; Ishiguro, Masaji; Masuda, Katsuyoshi			Synthesis and property of photoaffinity labeling reagents for functional analysis of taste receptor	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Hashimoto, Makoto] Hokkaido Univ, Grad Sch Agr, Div Appl Sci, Sapporo, Hokkaido 0608589, Japan; [Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Ishiguro, Masaji] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata 9568603, Japan; [Masuda, Katsuyoshi] Suntory Inst Bioorgan Res, Osaka 6188503, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				3	587	588				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500008		
J	Miyazawa, T				Miyazawa, Toshio			Effect of the herb component, spilanthol, on salty taste enhancement	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Miyazawa, Toshio] Ogawa & Co Ltd, Funct Prod R&D Lab, Chiba 2790032, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				2	587	587				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500007		
J	Ueda, H				Ueda, Hiroshi			Involvement of neuroendocrine functions on olfactory imprinting and homing in Pacific salmon	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Ueda, Hiroshi] Hokkaido Univ, Grad Sch Environm Sci, Field Sci Ctr Northern Biosphere, Sapporo, Hokkaido 0600809, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				1	587	587				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500006		
J	Ando, H; Tadokoro, O; Iwasaki, T; Asanuma, N				Ando, Hiroshi; Tadokoro, Osamu; Iwasaki, Takami; Asanuma, Naokazu			Immunoreactivities of calretinin and calbindin in fungiform papilla of frog	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Ando, Hiroshi; Iwasaki, Takami; Asanuma, Naokazu] Matsumoto Dent Univ, Dept Oral Physiol, Shiojiri 3990781, Japan; [Tadokoro, Osamu] Matsumoto Dent Univ, Dept Oral Anat, Shiojiri 3990781, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				4	588	588				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500009		
J	Furuyama, A; Kojima, T; Munakata, Y				Furuyama, Akira; Kojima, Tadayuki; Munakata, Yoshiei			The effect of yeast ingestion on the salt ingestion behavior of Drosophila	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Furuyama, Akira; Munakata, Yoshiei] Ohu Univ, Sch Dent, Div Oral Func Mol Biol, Fukushima 9638611, Japan; [Kojima, Tadayuki] Ohu Univ, Grad Sch Dent, Dept Oral Maxillofacial Surg, Fukushima 9638611, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				6	588	589				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500011		
J	Shibata, M; Suzuki, H				Shibata, Minori; Suzuki, Hideaki			Longitudinal observation of taste sensation and trace elements during pregnancy	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Shibata, Minori; Suzuki, Hideaki] Univ Occupat & Environm Hlth, Dept Otorhinolaryngol Head & Neck Surg, Kitakyushu, Fukuoka 8078555, Japan; [Shibata, Minori] Univ Occupat & Environm Hlth, Hlth Ctr, Kitakyushu, Fukuoka 8078555, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				5	588	588				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500010		
J	Eguchi, K; Kashima, H; Ueoka, H; Endo, MY; Fukuba, Y				Eguchi, Kohei; Kashima, Hideaki; Ueoka, Hatsumi; Endo, Masako Y.; Fukuba, Yoshiyuki			The acute responses of celiac artery blood flow and gastric motility to oral sensation of sweetness	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Eguchi, Kohei] Prefectural Univ Hiroshima, Grad Sch Comprehens Sci Res, Hiroshima 7348558, Japan; [Kashima, Hideaki; Endo, Masako Y.; Fukuba, Yoshiyuki] Prefectural Univ Hiroshima, Dept Hlth Sci, Hiroshima 7348558, Japan; [Ueoka, Hatsumi] Yasuda Womens Univ, Dept Nutr Sci, Hiroshima 7310153, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				8	589	589				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500013		
J	Inui, T; Shimura, T				Inui, Tadashi; Shimura, Tsuyoshi			Approach-avoidance conflict during the retrieval of conditioned taste aversion	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Inui, Tadashi; Shimura, Tsuyoshi] Osaka Univ, Grad Sch Human Sci, Div Behav Physiol, Dept Behav Sci, Suita, Osaka 5650871, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				9	589	590				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500014		
J	Mizutani, S; Kobashi, M; Shimatani, Y; Fujita, M; Mitoh, Y; Mizutani, M; Matsuo, R				Mizutani, Satoshi; Kobashi, Motoi; Shimatani, Yuichi; Fujita, Masako; Mitoh, Yoshihiro; Mizutani, Masatoshi; Matsuo, Ryuji			Identification of the effective site of GLP-1 to suppress reflex swallowing	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Mizutani, Satoshi; Kobashi, Motoi; Fujita, Masako; Mitoh, Yoshihiro; Matsuo, Ryuji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Physiol, Okayama 7008525, Japan; [Shimatani, Yuichi] Tokyo City Univ, Dept Biomed Engn, Tokyo 1588557, Japan; [Mizutani, Masatoshi] Kibi Int Univ, Sch Hlth Sci & Social Welf, Dept Phys Therapy, Okayama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				7	589	589				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500012		
J	Cao, L; Kawai, M; Uneyama, H				Cao, Lili; Kawai, Misako; Uneyama, Hisayuki			Development of an easy taste test using whole mouth tasting procedure	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Cao, Lili; Kawai, Misako; Uneyama, Hisayuki] Ajinomoto Co Inc, Inst Innovat, Yokohama, Kanagawa 2108681, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				10	590	590				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500015		
J	Kato, K; Otake, K				Kato, Kenji; Otake, Keiko			Sensory-specific satiety depending on the appearance of food	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Kato, Kenji] Tohoku Gakuin Univ, Dept Human Sci, Sendai, Miyagi 9803193, Japan; [Otake, Keiko] Kwansei Gakuin Univ, Dept Integrated Psychol Sci, Nishinomiya, Hyogo 6628501, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				12	590	591				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500017		
J	Mitsuda, T; Komatsu, S				Mitsuda, Takashi; Komatsu, Sota			The effects of familiarity on hedonic evaluations of drinks	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Mitsuda, Takashi; Komatsu, Sota] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu 5258577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				11	590	590				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500016		
J	Kawai, M; Yajima, Y; Kobayashi, M; Cao, L; Kikutani, T				Kawai, Misako; Yajima, Yuri; Kobayashi, Minatsu; Cao, Lili; Kikutani, Takeshi			Discrepancy between subjective and objective taste sensitivity in the elderly	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Kawai, Misako; Cao, Lili] Ajinomoto Co Inc, Inst Innovat, Yokohama, Kanagawa 2108681, Japan; [Yajima, Yuri; Kikutani, Takeshi] Nippon Dent Univ Tokyo, Grad Sch Life Dent, Div Oral Rehabil, Tokyo 1028158, Japan; [Kobayashi, Minatsu] Otsuma Womens Univ, Fac Home Econ, Dept Food Sci, Tokyo 1028357, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				14	591	591				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500019		
J	Onuma, T; Sakai, N				Onuma, Takuya; Sakai, Nobuyuki			Taste-odor learning and hedonic transfer in rats	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Onuma, Takuya; Sakai, Nobuyuki] Tohoku Univ, Grad Sch Arts & Letters, Sendai, Miyagi 9808576, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				15	591	592				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500020		
J	Tamura, K; Yamazaki, M; Shimizu, T; Miyamoto, M; Otsuka, Y; Sugasawa, T; Ohta, M				Tamura, Kyoko; Yamazaki, Madoka; Shimizu, Tomomi; Miyamoto, Masahide; Otsuka, Yuko; Sugasawa, Takehito; Ohta, Makoto			The sense of taste is influenced by visual information	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Tamura, Kyoko; Yamazaki, Madoka; Miyamoto, Masahide; Otsuka, Yuko; Ohta, Makoto] Daito Bunka Univ, Dept Hlth Sci, Tokyo 1758571, Japan; [Shimizu, Tomomi] Toin Univ Yokohama, Dept Biomed Engn, Yokohama, Kanagawa 2258503, Japan; [Sugasawa, Takehito] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				13	591	591				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500018		
J	Nishioka, H; Yamaguchi, E; Yasoshima, Y; Shimura, T				Nishioka, Haruna; Yamaguchi, Erina; Yasoshima, Yasunobu; Shimura, Tsuyoshi			Taste-guided behaviors in mice carrying mutated dopamine transporter gene	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Nishioka, Haruna; Yamaguchi, Erina; Yasoshima, Yasunobu; Shimura, Tsuyoshi] Osaka Univ, Div Behav Physiol, Grad Sch Human Sci, Suita, Osaka 5650871, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				17	592	592				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500022		
J	Shoji, Y; Miyazawa, T; Togawa, M; Sakuma, K; Muranishi, S; Hamaguchi, T; Wise, P; Bryant, B				Shoji, Yasutaka; Miyazawa, Toshio; Togawa, Makoto; Sakuma, Katsuya; Muranishi, Shuichi; Hamaguchi, Takashi; Wise, Paul; Bryant, Bruce			Evaluation of enhancing effect of spilanthol on carbonation bite using half-tongue test	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Shoji, Yasutaka; Miyazawa, Toshio; Togawa, Makoto; Sakuma, Katsuya; Muranishi, Shuichi; Hamaguchi, Takashi] Ogawa & Co Ltd, Chiba 2790032, Japan; [Wise, Paul; Bryant, Bruce] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				16	592	592				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500021		
J	Yamaguchi, E; Yasoshima, Y; Shimura, T				Yamaguchi, Erina; Yasoshima, Yasunobu; Shimura, Tsuyoshi			Peptide YY fails to induce conditioned taste aversion in mice	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Yamaguchi, Erina; Yasoshima, Yasunobu; Shimura, Tsuyoshi] Osaka Univ, Div Behav Physiol, Grad Sch Human Sci, Suita, Osaka 5650871, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				18	592	593				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500023		
J	Inui-Yamamoto, C; Inui, T; Yamamoto, T; Ueda, K; Nakatsuka, M; Kumabe, S; Iwai, Y; Yoshioka, Y				Inui-Yamamoto, Chizuko; Inui, Tadashi; Yamamoto, Takashi; Ueda, Katsura; Nakatsuka, Michiko; Kumabe, Shunji; Iwai, Yasutomo; Yoshioka, Yoshichika			Brain activation of age-related changes in taste hedonics of bitter taste in rats	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Inui-Yamamoto, Chizuko; Ueda, Katsura; Nakatsuka, Michiko; Kumabe, Shunji; Iwai, Yasutomo] Osaka Dent Univ, Dept Oral Anat, Osaka 5731144, Japan; [Inui, Tadashi] Osaka Univ, Grad Sch Human Sci, Suita, Osaka 5650871, Japan; [Yamamoto, Takashi] Kio Univ, Fac Hlth Sci, Nara 6350832, Japan; [Inui-Yamamoto, Chizuko; Yoshioka, Yoshichika] Osaka Univ, WPI IFReC, Suita, Osaka 5650871, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				21	593	594				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500026		
J	Murata, Y; Kimura, M; Kato, T; Touhata, K				Murata, Yuko; Kimura, Meiko; Kato, Tomomi; Touhata, Ken			Effect of trimethylamine (TMA) on the taste preference in mice	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Murata, Yuko; Kimura, Meiko; Kato, Tomomi; Touhata, Ken] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				19	593	593				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500024		
J	Ueji, K; Minematsu, Y; Yamamoto, T				Ueji, Kayoko; Minematsu, Yuji; Yamamoto, Takashi			Conditioned flavor preference with saccharin solutions in weanling rats	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Ueji, Kayoko; Minematsu, Yuji; Yamamoto, Takashi] Kio Univ, Dept Hlth & Nutr, Fac Hlth Sci, Nara 6350832, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				20	593	593				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500025		
J	Kobayashi, M; Horiguchi, M; Cao, L; Kawai, M				Kobayashi, Minatsu; Horiguchi, Mieko; Cao, Lili; Kawai, Misako			High concentration solution intake experience prior to a taste sensitivity test affects tasting performance	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Kobayashi, Minatsu] Otsuma Womens Univ, Fac Home Econ, Dept Food Sci, Chiyoda Ku, Tokyo 1028357, Japan; [Horiguchi, Mieko] Otsuma Womens Univ, Dept Domest Sci, Jr Coll Div, Chiyoda Ku, Tokyo 1028357, Japan; [Cao, Lili; Kawai, Misako] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				24	594	595				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500029		
J	Makita, Y; Ishida, T; Kobayashi, N; Fujio, M; Fujimoto, K; Moritomo, R; Fujiwara, S				Makita, Yoshimasa; Ishida, Tomoko; Kobayashi, Noriko; Fujio, Mai; Fujimoto, Kyoko; Moritomo, Rina; Fujiwara, Shin-ichi			Study of bitterness masking effect using Kinako	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Makita, Yoshimasa; Fujiwara, Shin-ichi] Osaka Dent Univ, Dept Chem, Osaka 5731121, Japan; [Ishida, Tomoko; Kobayashi, Noriko; Fujio, Mai; Fujimoto, Kyoko; Moritomo, Rina] Osaka Dent Univ, Osaka 5731121, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				22	594	594				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500027		
J	Minematsu, Y; Ueji, K; Yamamoto, T				Minematsu, Yuji; Ueji, Kayoko; Yamamoto, Takashi			Detection of brain activities reflecting hedonic aspects of taste: a fNIRS study	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Minematsu, Yuji; Ueji, Kayoko; Yamamoto, Takashi] Kio Univ, Dept Hlth & Nutr, Fac Hlth Sci, Nara 6350832, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				23	594	594				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500028		
J	Shimazaki, N; Yamamori, T; Tazaki, T; Kawamura, K; Toyoda, K; Takebe, J; Kondo, H				Shimazaki, Nobuko; Yamamori, Tetsuo; Tazaki, Tomoko; Kawamura, Kenichi; Toyoda, Katsuhiko; Takebe, Jun; Kondo, Hisatomo			Screening of taste dysfunction using zinc-binding protein in saliva	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Shimazaki, Nobuko; Takebe, Jun; Kondo, Hisatomo] Iwate Med Univ, Sch Dent, Dept Prosthodont & Oral Implantol, Morioka, Iwate 0208505, Japan; [Yamamori, Tetsuo] Ohu Univ, Sch Dent, Dept Prosthet Dent, Fukushima 9638611, Japan; [Tazaki, Tomoko; Kawamura, Kenichi; Toyoda, Katsuhiko] NIPPUN ENGN CO LTD, Tokyo 1510051, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				26	595	596				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500031		
J	Takao, T; Kogomori, C; Oyama, Y; Yonezawa, K; Maekawa, I; Aoki, M; Koike, F; Takao, K; Shiga, S				Takao, Tetsuya; Kogomori, Chieko; Oyama, Yuka; Yonezawa, Kaori; Maekawa, Iwao; Aoki, Mieko; Koike, Fumihiko; Takao, Kyoichi; Shiga, Seigo			The expression of hTAS2Rs in suckling infants	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Takao, Tetsuya; Kogomori, Chieko; Shiga, Seigo] Showa Womens Univ, Grad Sch Human Life Sci, Tokyo 1548533, Japan; [Takao, Tetsuya; Oyama, Yuka; Yonezawa, Kaori; Shiga, Seigo] Showa Womens Univ, Fac Human Life & Environm Sci, Tokyo 1548533, Japan; [Maekawa, Iwao] Maekawasanfujinka Clin, Shizuoka 4110934, Japan; [Aoki, Mieko] Sanyo Gakuen Coll, Dept Food & Nutr, Okayama 7038501, Japan; [Koike, Fumihiko; Takao, Kyoichi] Nippon Univ, Sch Med, Tokyo 1738610, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				25	595	595				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500030		
J	Kosaka, K; Kosaka, T				Kosaka, Katsuko; Kosaka, Toshio			A review of three newly identified nonprincipal neurons in the rodent olfactory bulb	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Kosaka, Katsuko] Int Univ Hlth & Welf, Fac Hlth & Welf Sci Fukuoka, Dept Med Sci Technol, Fukuoka 8318501, Japan; [Kosaka, Toshio] Kyushu Univ, Grad Sch Med Sci, Dept Anat & Neurobiol, Fukuoka 8128582, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				29	596	597				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500034		
J	Nakai, M; Sugiura, M; Yajima, T; Hiranuma, K				Nakai, Mari; Sugiura, Motohiko; Yajima, Toshiyuki; Hiranuma, Kota			Prediction of international standards cupping evaluation of Guatemalan Arabica coffee by Electronic Tongue and Electronic Nose	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Nakai, Mari; Sugiura, Motohiko] Tokyo Allied Coffee Roasters Co LTD, Tokyo 1460081, Japan; [Yajima, Toshiyuki] Alpha MOS Japan KK, Tokyo 1080074, Japan; [Hiranuma, Kota] TASTE TECHNOL INC, Tokyo 2030023, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				27	596	596				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500032		
J	Okazaki, H; Yasuura, M; Tahara, Y; Ikezaki, H; Toko, K				Okazaki, Hirotaka; Yasuura, Masato; Tahara, Yusuke; Ikezaki, Hidekazu; Toko, Kiyoshi			A study on development of a sweetness sensor for high potency sweeteners with negative charge and measurement of the commercial drinks	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Okazaki, Hirotaka; Yasuura, Masato] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan; [Yasuura, Masato] Kyushu Univ, Fukuoka 8190395, Japan; [Tahara, Yusuke; Toko, Kiyoshi] Kyushu Univ, Fac Informat Sci & Elect Engn, Fukuoka 8190395, Japan; [Ikezaki, Hidekazu] Intelligent Sensor Technol Inc, Atsugi, Kagawa 2430032, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				28	596	596				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500033		
J	Miyazono, S; Osada, K; Kashiwayanagi, M				Miyazono, Sadaharu; Osada, Kazumi; Kashiwayanagi, Makoto			Pyrazine analogs in wolf urine induced fear-associated aversive behaviors in deer	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Miyazono, Sadaharu; Kashiwayanagi, Makoto] Asahikawa Med Univ, Dept Sensory Physiol, Sapporo, Hokkaido 0788510, Japan; [Osada, Kazumi] Hlth Sci Univ Hokkaido, Div Physiol, Dept Oral Biol, Sch Dent, Sapporo, Hokkaido 0610293, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				31	597	597				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500036		
J	Nakazawa, H; Suzuki, AC; Nagai, T				Nakazawa, Hideo; Suzuki, Atsushi C.; Nagai, Takatoshi			Subdivisions of the olfactory epithelium in Japanese toads with distinct cell types and odor responsiveness	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Nakazawa, Hideo; Suzuki, Atsushi C.; Nagai, Takatoshi] Keio Univ, Sch Med, Dept Biol, Yokohama, Kanagawa 2238521, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				30	597	597				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500035		
J	Taniguchi, M; Namba, T; Kaba, H				Taniguchi, Mutsuo; Namba, Toshiharu; Kaba, Hideto			Suppressive action of vasopressin on the reciprocal synaptic transmission between mitral and granule cells in the mouse accessory olfactory bulb	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Taniguchi, Mutsuo; Namba, Toshiharu; Kaba, Hideto] Kochi Med Sch, Dept Physiol, Kochi 7838505, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				32	597	598				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500037		
J	Hara, C; Tomi, K; Hayashi, T				Hara, Chiaki; Tomi, Kenichi; Hayashi, Takahiro			Effects of the major component limonene and the other minor components of citrus essential oils on the psychology and physiology of human	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Hara, Chiaki; Tomi, Kenichi; Hayashi, Takahiro] Kinki Univ, Fac Agr, Nara 6318505, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				33	598	598				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500038		
J	Taniguchi, G; Hamakawa, M; Uozumi, T; Kiriyama, K; Kamizaki, T; Hirotsu, T				Taniguchi, Gun; Hamakawa, Masayuki; Uozumi, Takayuki; Kiriyama, Keisuke; Kamizaki, Tomoko; Hirotsu, Takaaki			Different olfactory receptors function depending on odor concentrations in C. elegans	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Taniguchi, Gun; Hamakawa, Masayuki; Uozumi, Takayuki; Kiriyama, Keisuke; Hirotsu, Takaaki] Kyushu Univ, Fac Sci, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan; [Kamizaki, Tomoko; Hirotsu, Takaaki] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				35	598	599				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500040		
J	Uozumi, T; Deno, YK; Hirotsu, T				Uozumi, Takayuki; Deno, Yu-Ki; Hirotsu, Takaaki			Voltage-dependent anion channel (VDAC-1) plays a key role in olfactory sensory signaling in C. elegans	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Uozumi, Takayuki; Deno, Yu-Ki; Hirotsu, Takaaki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8120053, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				34	598	598				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500039		
J	Fujiwara, S; Matsumoto, T; Ohmori, Y; Nakamura, A; Nammoku, T; Mori, K				Fujiwara, Satoshi; Matsumoto, Tomona; Ohmori, Yuichiro; Nakamura, Akio; Nammoku, Takashi; Mori, Kensaku			Sensation of carbonated water and its enhancement by a flavor compound accompany enhanced salivary hemodynamic responses	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Fujiwara, Satoshi; Matsumoto, Tomona; Ohmori, Yuichiro; Nakamura, Akio; Nammoku, Takashi] T Hasegawa Co Ltd, R&D Ctr, Kawasaki, Kanagawa 2110022, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				38	599	600				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500043		
J	Iizumi, K; Matsumoto, T; Nakamura, A; Nammoku, T; Mori, K				Iizumi, Kana; Matsumoto, Tomona; Nakamura, Akio; Nammoku, Takashi; Mori, Kensaku			High palatability of pungent spices accompanies larger salivary hemodynamic responses	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Iizumi, Kana; Matsumoto, Tomona; Nakamura, Akio; Nammoku, Takashi] T Hasegawa Co Ltd, R&D Ctr, Kawasaki, Kanagawa 2110022, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				37	599	599				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500042		
J	Iwamatsu, T; Mitsuno, H; Sakurai, T; Kanzaki, R				Iwamatsu, Takuma; Mitsuno, Hidefumi; Sakurai, Takeshi; Kanzaki, Ryohei			Behavioral responses of body lice, Pediculus humanus corporis, to human body-odor components.	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Iwamatsu, Takuma; Kanzaki, Ryohei] Univ Tokyo, Grad Sch Engn, Meguro Ku, Tokyo 1538904, Japan; [Mitsuno, Hidefumi; Sakurai, Takeshi; Kanzaki, Ryohei] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				36	599	599				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500041		
J	Abe, Y; Takamizawa, T; Miyagi, K; Liu, CJ; Hayashi, K				Abe, Yosuke; Takamizawa, Tadashi; Miyagi, Kazuki; Liu, Chuanjun; Hayashi, Kenshi			Development of odor sensing system using the odor clustering based on molecular size	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Abe, Yosuke; Takamizawa, Tadashi; Miyagi, Kazuki] USE Co Ltd, Shibuya Ku, Tokyo 1500013, Japan; [Liu, Chuanjun; Hayashi, Kenshi] Kyushu Univ, Grad Sch Informat Sci, Dept Elect, Fukuoka 8190395, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				41	600	601				2	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500046		
J	Takoi, K; Itoga, Y; Takayanagi, J; Matsumoto, I; Nakamura, T				Takoi, Kiyoshi; Itoga, Yutaka; Takayanagi, Junji; Matsumoto, Ichiro; Nakamura, Takeshi			Evaluation of synergy among characteristic flavor compounds derived from Flavor Hops	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Takoi, Kiyoshi; Matsumoto, Ichiro; Nakamura, Takeshi] Sapporo Breweries Ltd, Prod & Technol Innovat Dept, Shizuoka 4250013, Japan; [Itoga, Yutaka] Sapporo Breweries Ltd, Bioresources Res & Dev Dept, Sapporo, Hokkaido 0710551, Japan; [Takayanagi, Junji] Pokka Sapporo Food & Beverage Ltd, Cent Lab, Nagoya, Aichi 4818515, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				39	600	600				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500044		
J	Yoshioka, M; Ono, Y; Nakazawa, Y; Komasa, Y				Yoshioka, Masataka; Ono, Yoshiaki; Nakazawa, Yuri; Komasa, Yutaka			Evaluation of the smell of dental materials	CHEMICAL SENSES			English	Meeting Abstract	48th Annual Meeting of the Japanese-Association-for-the-Study-of-Taste-and-Smell (JASTS)	OCT 02-04, 2014	Shijouka, JAPAN						[Yoshioka, Masataka; Ono, Yoshiaki; Nakazawa, Yuri; Komasa, Yutaka] Osaka Dent Univ, Dept Geriatr Dent, Osaka 5400008, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	OCT	2015	40	8				40	600	600				1	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	CT5LS	WOS:000362852500045		
J	Noyori, R				Noyori, Ryoji			Vibrant Science Needed for Future Society	CHEMISTRY-AN ASIAN JOURNAL			English	Editorial Material									[Noyori, Ryoji] Nagoya Univ, Nagoya, Aichi 4648602, Japan; [Noyori, Ryoji] RIKEN, Wako, Saitama 3510198, Japan	Noyori, R (reprint author), Nagoya Univ, Nagoya, Aichi 4648602, Japan.	noyori@riken.jp						0	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2006	2007		10.1002/asia.201500618		2	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200002		
J	Shigemitsu, H; Hamachi, I				Shigemitsu, Hajime; Hamachi, Itaru			Supramolecular Assemblies Responsive to Biomolecules toward Biological Applications	CHEMISTRY-AN ASIAN JOURNAL			English	Article						biological applications; biomolecules; hydrogels; stimuli responsiveness; supramolecular assembly	AGGREGATION-INDUCED EMISSION; SMALL MOLECULES; IN-VIVO; RATIONAL DESIGN; ENZYMATIC FORMATION; PROTEIN-DETECTION; GENE DELIVERY; CELL-CULTURE; HYDROGELS; NANOPROBES	Stimuli-responsive supramolecular assemblies consisting of small molecules are attractive functional materials for biological applications such as drug delivery, medical diagnosis, enzyme immobilization, and tissue engineering. By use of their dynamic and reversible properties, many supramolecular assemblies responsive to a variety of biomolecules have been designed and synthesized. This review focuses on promising strategies for the construction of such dynamic supramolecular assemblies and their functions. While studies of biomolecule-responsive supramolecular assemblies have mainly been performed in vitro, it has recently been demonstrated that some of them can work in live cells. Supramolecular assemblies now open up new avenues in chemical biology and biofunctional materials.	[Shigemitsu, Hajime; Hamachi, Itaru] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Katsura, Kyoto 6158510, Japan; [Hamachi, Itaru] JST, CREST, Chiyoda Ku, Tokyo, Japan	Hamachi, I (reprint author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Katsura, Kyoto 6158510, Japan.	ihamachi@sbchem.kyoto-u.ac.jp					Liu J, 2011, J AM CHEM SOC, V133, P17370, DOI 10.1021/ja2057924; Liang GL, 2010, NAT CHEM, V2, P54, DOI [10.1038/nchem.480, 10.1038/NCHEM.480]; Lee MH, 2013, CHEM REV, V113, P5071, DOI 10.1021/cr300358b; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030; Takaoka Y, 2013, CHEM LETT, V42, P1426, DOI 10.1246/cl.130697; Zhang XL, 2012, ANGEW CHEM INT EDIT, V51, P4388, DOI 10.1002/anie.201108612; Guo DS, 2012, J AM CHEM SOC, V134, P10244, DOI 10.1021/ja303280r; Gao Y, 2013, ACS NANO, V7, P9055, DOI 10.1021/nn403664n; Guo DS, 2013, CHEM COMMUN, V49, P6779, DOI 10.1039/c3cc41918e; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Ikeda M, 2012, CHEM COMMUN, V48, P2716, DOI 10.1039/c2cc17503g; Ye DJ, 2014, NAT CHEM, V6, P519, DOI [10.1038/nchem.1920, 10.1038/NCHEM.1920]; Ikeda M, 2011, J AM CHEM SOC, V133, P1670, DOI 10.1021/ja109692z; Ikeda M, 2014, NAT CHEM, V6, P511, DOI [10.1038/nchem.1937, 10.1038/NCHEM.1937]; Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340; Anees P, 2014, J AM CHEM SOC, V136, P13233, DOI 10.1021/ja503850b; Yang ZM, 2007, J AM CHEM SOC, V129, P266, DOI 10.1021/ja0675604; Jiang LX, 2012, CHEM COMMUN, V48, P7347, DOI 10.1039/c2cc32533k; Komatsu H, 2009, J AM CHEM SOC, V131, P5580, DOI 10.1021/ja8098239; Kuang Y, 2014, ANGEW CHEM INT EDIT, V53, P8104, DOI 10.1002/anie.201402216; Mizusawa K, 2012, J AM CHEM SOC, V134, P13386, DOI 10.1021/ja304239g; Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k; Li JY, 2013, J AM CHEM SOC, V135, P9907, DOI 10.1021/ja404215g; Wang YX, 2013, RSC ADV, V3, P8058, DOI 10.1039/c3ra40453f; Wang M, 2009, ANAL CHEM, V81, P4444, DOI 10.1021/ac9002722; Yang ZM, 2007, SMALL, V3, P558, DOI 10.1002/smll.200700015; Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k; Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b; Yang CH, 2012, J PHYS CHEM B, V116, P633, DOI 10.1021/jp209441r; Wada A, 2009, J AM CHEM SOC, V131, P5321, DOI 10.1021/ja900500j; Guo J, 2014, J AM CHEM SOC, V136, P2220, DOI 10.1021/ja4108676; Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l; Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914; Boekhoven J, 2012, J AM CHEM SOC, V134, P12908, DOI 10.1021/ja3051876; Takaoka Y, 2011, J AM CHEM SOC, V133, P11725, DOI 10.1021/ja203996c; Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034; Huang P, 2014, J AM CHEM SOC, V136, P11748, DOI 10.1021/ja505212y; Hu JM, 2012, CHEM SOC REV, V41, P5933, DOI 10.1039/c2cs35103j; Tsukiji S, 2009, NAT CHEM BIOL, V5, P341, DOI 10.1038/nchembio.157; Busseron E, 2013, NANOSCALE, V5, P7098, DOI 10.1039/c3nr02176a; Kasai H, 2012, ANGEW CHEM INT EDIT, V51, P10315, DOI 10.1002/anie.201204596; Ren CH, 2011, CHEM COMMUN, V47, P1619, DOI 10.1039/c0cc04135a; Cash KJ, 2010, TRENDS MOL MED, V16, P584, DOI 10.1016/j.molmed.2010.08.002; Takaoka Y, 2009, NAT CHEM, V1, P557, DOI [10.1038/nchem.365, 10.1038/NCHEM.365]; Gao Y, 2009, J AM CHEM SOC, V131, P13576, DOI 10.1021/ja904411z; Blum AP, 2015, J AM CHEM SOC, V137, P2140, DOI 10.1021/ja510147n; Mizusawa K, 2010, J AM CHEM SOC, V132, P7291, DOI 10.1021/ja101879g; Miao XM, 2013, ANGEW CHEM INT EDIT, V52, P7781, DOI 10.1002/anie.201303199; Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y; Takaoka Y, 2011, CHEM SCI, V2, P511, DOI 10.1039/c0sc00513d; Ikeda M, 2011, ADV MATER, V23, P2819, DOI 10.1002/adma.201004658; Matsuo K, 2013, CHEM-EUR J, V19, P12875, DOI 10.1002/chem.201300817; Shi HB, 2012, J AM CHEM SOC, V134, P17972, DOI 10.1021/ja3064588; Yang ZM, 2006, ADV MATER, V18, P3043, DOI 10.1002/adma.200600400; Micklitsch CM, 2011, ANGEW CHEM INT EDIT, V50, P1577, DOI 10.1002/anie.201006652; Bhuniya S, 2006, CHEM COMMUN, P1842, DOI 10.1039/b516632b; Cohen-Stuart M. A., 2010, NAT MATER, V9, P101; Fleming S, 2014, CHEM SOC REV, V43, P8150, DOI 10.1039/c4cs00247d; Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040; Kasai H, 2012, ANGEW CHEM, V124, P10461; Kuang Y., 2014, ANGEW CHEM, V126, P8242; Kumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6793; Miao X. M., 2013, ANGEW CHEM, V125, P7935; Qi ZH, 2014, ACCOUNTS CHEM RES, V47, P2222, DOI 10.1021/ar500193z; Qiu ZJ, 2009, CHEM COMMUN, P3342, DOI 10.1039/b822840j; Ren CH, 2014, CHEM SOC REV, V43, P7257, DOI 10.1039/c4cs00161c; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106968; Yoshii T, 2014, J AM CHEM SOC, V136, P16635, DOI 10.1021/ja508955y; You Jin-Oh, 2010, J Biol Eng, V4, P15, DOI 10.1186/1754-1611-4-15; Zhang X, 2012, ANGEW CHEM, V124, P4464	71	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2026	2038		10.1002/asia.201500563		13	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200003		
J	Wang, C; Yamamoto, H				Wang, Chuan; Yamamoto, Hisashi			Asymmetric Epoxidation Using Hydrogen Peroxide as Oxidant	CHEMISTRY-AN ASIAN JOURNAL			English	Article						asymmetric synthesis; catalysis; epoxidation; hydrogen peroxide; olefins	ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; HIGHLY ENANTIOSELECTIVE EPOXIDATION; TERMINAL NONCONJUGATED OLEFINS; ELECTRON-DEFICIENT OLEFINS; STEREOSELECTIVE EPOXIDATION; UNFUNCTIONALIZED OLEFINS; MANGANESE COMPLEXES; SYNTHETIC ENZYMES; SALALEN CATALYSTS; TRIPHASE SYSTEM	Asymmetric epoxidation is one of the most important transformations in organic synthesis. Although tremendous progress was achieved in this field in the 1980s and 1990s, it is still desirable from both economical and ecological views to develop environmentally friendly catalytic epoxidation with a broad substrate scope. Hydrogen peroxide is a safe and cheap oxidant, which is easy to handle and generates water as the sole byproduct. Therefore, asymmetric epoxidation of olefins using hydrogen peroxide as oxidant has been a very active research field and has been investigated by many research groups in recent years. In this review, the exciting very recent developments of this rapidly growing area are surveyed and organized according to the catalyst systems.	[Wang, Chuan; Yamamoto, Hisashi] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yamamoto, Hisashi] Chubu Univ, Mol Catalyst Res Ctr, Kasugai, Aichi 4878501, Japan	Yamamoto, H (reprint author), Univ Chicago, Dept Chem, 5735 South Ellis Ave, Chicago, IL 60637 USA.	yamamoto@uchicago.edu			Japan Science Promotion Foundation (JSP-ACT-C); National Institutes of Health (NIH) [2R01M068433]; Alexander von Humboldt Foundation	Japan Science Promotion Foundation (JSP-ACT-C) and the National Institutes of Health (NIH, 2R01M068433) are greatly appreciated for providing financial support. C.W. thanks the Alexander von Humboldt Foundation for his postdoctoral fellowship.	Abascal NC, 2014, CHEM SCI, V5, P4504, DOI 10.1039/c4sc01440e; Adam W, 2005, SYNLETT, P1047, DOI 10.1055/s-2005-865214; Amiri N, 2014, TETRAHEDRON, V70, P8836, DOI 10.1016/j.tet.2014.10.001; COLONNA S, 1983, TETRAHEDRON, V39, P1635, DOI 10.1016/S0040-4020(01)88574-4; Weyer A, 2012, CHEMCATCHEM, V4, P337, DOI 10.1002/cctc.201100243; Lichtor PA, 2014, J AM CHEM SOC, V136, P5301, DOI 10.1021/ja410567a; Maity NC, 2014, CATAL SCI TECHNOL, V4, P208, DOI 10.1039/c3cy00528c; Burke CP, 2007, J ORG CHEM, V72, P6320, DOI 10.1021/jo0708644; Russo A, 2012, CHEMCATCHEM, V4, P901, DOI 10.1002/cctc.201200139; Lifchits O, 2013, J AM CHEM SOC, V135, P6677, DOI 10.1021/ja402058v; Matsumoto K, 2011, TETRAHEDRON, V67, P6474, DOI 10.1016/j.tet.2011.06.022; Wang X, 2008, J AM CHEM SOC, V130, P6070, DOI 10.1021/ja801181u; IRIE R, 1991, TETRAHEDRON-ASYMMETR, V2, P481, DOI 10.1016/S0957-4166(00)86102-9; Wang QF, 2015, CHEM-EUR J, V21, P247, DOI 10.1002/chem.201404639; Wu SX, 2013, ADV SYNTH CATAL, V355, P1917, DOI 10.1002/adsc.201300249; Sawada Y, 2006, ANGEW CHEM INT EDIT, V45, P3478, DOI 10.1002/anie.200600636; Lee A, 2012, ADV SYNTH CATAL, V354, P1701, DOI 10.1002/adsc.201200072; Reisinger CM, 2008, ANGEW CHEM INT EDIT, V47, P8112, DOI 10.1002/anie.200803238; Murphy A, 2003, J AM CHEM SOC, V125, P5250, DOI 10.1021/ja0299962r; Jat JL, 2015, ORG LETT, V17, P1058, DOI 10.1021/acs.orglett.5b00281; Xia QH, 2005, CHEM REV, V105, P1603, DOI 10.1021/cr0406458; McGarrigle EM, 2005, CHEM REV, V105, P1563, DOI 10.1021/cr0306945; Chu YY, 2014, ADV SYNTH CATAL, V356, P2214, DOI 10.1002/adsc.201400341; Wang C, 2014, J AM CHEM SOC, V136, P1222, DOI 10.1021/ja411379e; BANFI S, 1984, TETRAHEDRON, V40, P5207, DOI 10.1016/S0040-4020(01)91272-4; Matsumoto K, 2005, ANGEW CHEM INT EDIT, V44, P4935, DOI 10.1002/anie.200501318; Berkessel A, 2001, ORG LETT, V3, P3839, DOI 10.1021/oi0166451; Berkessel A, 2007, ADV SYNTH CATAL, V349, P2385, DOI 10.1002/adse.200700221; Dai W, 2013, ORG LETT, V15, P4138, DOI 10.1021/ol401812h; Cusso O, 2013, J AM CHEM SOC, V135, P14871, DOI 10.1021/ja4078446; GROVES JT, 1983, J AM CHEM SOC, V105, P5791, DOI 10.1021/ja00356a016; Talsi EP, 2014, CHEM-EUR J, V20, P14329, DOI 10.1002/chem.201404157; Marigo M, 2005, J AM CHEM SOC, V127, P6964, DOI 10.1021/ja051808s; Matsumoto K, 2008, PURE APPL CHEM, V80, P1071, DOI 10.1351/pac200880051071; Romney DK, 2012, ORG LETT, V14, P1138, DOI 10.1021/ol3000712; Garcia-Bosch I, 2012, ADV SYNTH CATAL, V354, P65, DOI 10.1002/adsc.201100409; Davis RL, 2014, CHEM-EUR J, V20, P64, DOI 10.1002/chem.201303942; Grigoropoulou G, 2003, GREEN CHEM, V5, P1, DOI 10.1039/b208925b; Wong OA, 2008, CHEM REV, V108, P3958, DOI 10.1021/cr068367v; Ottenbacher RV, 2014, ACS CATAL, V4, P1599, DOI 10.1021/cs500333c; Tu Y, 1996, J AM CHEM SOC, V118, P9806, DOI 10.1021/ja962345g; Shu LH, 2001, TETRAHEDRON, V57, P5213, DOI 10.1016/S0040-4020(01)00362-3; Cusso O, 2013, ORG LETT, V15, P6158, DOI 10.1021/ol403018x; Li Z, 2013, ACCOUNTS CHEM RES, V46, P506, DOI 10.1021/ar300216r; Dai W, 2014, J ORG CHEM, V79, P6688, DOI 10.1021/jo501178k; Wang X, 2013, CHEMCATCHEM, V5, P2489, DOI 10.1002/cctc.201300102; Lane BS, 2003, CHEM REV, V103, P2457, DOI 10.1021/cr020471z; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Chu YY, 2012, CHEM SCI, V3, P1996, DOI 10.1039/c2sc20218b; De Faveri G, 2011, CHEM SOC REV, V40, P1722, DOI 10.1039/c0cs00077a; Ottenbacher RV, 2011, ADV SYNTH CATAL, V353, P885, DOI 10.1002/adsc.201100030; Buckley BR, 2013, SYNLETT, V24, P2266, DOI 10.1055/s-0033-1339681; Le Maux P, 2012, TETRAHEDRON, V68, P5824, DOI 10.1016/j.tet.2012.05.014; Lyakin OY, 2012, ACS CATAL, V2, P1196, DOI 10.1021/a300205n; Demizu Y, 2011, TETRAHEDRON, V67, P6155, DOI 10.1016/j.tet.2011.06.075; Matsumoto K, 2009, ANGEW CHEM INT EDIT, V48, P7432, DOI 10.1002/anie.200903567; Arends IWCE, 2002, TOP CATAL, V19, P133, DOI 10.1023/A:1013897703249; Shu LH, 1999, TETRAHEDRON LETT, V40, P8721, DOI 10.1016/S0040-4039(99)01814-6; JULIA S, 1980, ANGEW CHEM INT EDIT, V19, P929, DOI 10.1002/anie.198009291; ZHANG W, 1990, J AM CHEM SOC, V112, P2801, DOI 10.1021/ja00163a052; Weitz E, 1921, BER DTSCH CHEM GES, V54, P2327, DOI 10.1002/cber.19210540922; Berkessel A., 2013, ANGEW CHEM, V125, P8625; Berkessel A, 2013, ANGEW CHEM INT EDIT, V52, P8467, DOI 10.1002/anie.201210198; Cusso O, 2015, ANGEW CHEM INT EDIT, V54, P2729, DOI 10.1002/anie.201410557; Cusso O., 2015, ANGEW CHEM, V127, P2767; JULIA S, 1982, J CHEM SOC PERK T 1, P1317, DOI 10.1039/p19820001317; Julia S., 1980, ANGEW CHEM, V92, P968, DOI 10.1002/ange.19800921137; Katsuki T., 1996, ORG REACTIONS, V48, P1; Katsuki T., 1999, COMPREHENSIVE ASYMME, V2, P621; Lichtor PA, 2012, NAT CHEM, V4, P990, DOI [10.1038/nchem.1469, 10.1038/NCHEM.1469]; Matsu-moto K., 2005, ANGEW CHEM, V117, P5015, DOI 10.1002/ange.200501318; Matsumoto K., 2009, ANGEW CHEM, V121, P7568; Matsumoto K, 2006, SYNLETT, P3545, DOI 10.1055/s-2006-956496; Reisinger C. M., 2008, ANGEW CHEM, V120, P8232, DOI 10.1002/ange.200803238; Sawada Y., 2006, ANGEW CHEM, V118, P3558, DOI 10.1002/ange.200600636; Shen DY, 2014, EUR J INORG CHEM, P5777, DOI 10.1002/ejic.201402663; Shimada Y, 2007, SYNLETT, P2445, DOI 10.1055/s-2007-985605; Xiong DL, 2011, EUR J ORG CHEM, P4289, DOI 10.1002/ejoc.201100512	78	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2056	2068		10.1002/asia.201500293		13	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200005		
J	Moteki, SA; Maruyama, H; Nakayama, K; Li, HB; Petrova, G; Maeda, S; Morokuma, K; Maruoka, K				Moteki, Shin A.; Maruyama, Hiroki; Nakayama, Keiji; Li, Hai-Bei; Petrova, Galina; Maeda, Satoshi; Morokuma, Keiji; Maruoka, Keiji			Positive Effect of Water in Asymmetric Direct Aldol Reactions with Primary Amine Organocatalyst: Experimental and Computational Studies	CHEMISTRY-AN ASIAN JOURNAL			English	Article						aldol; amine; computation; organocatalysis; water	ENAMINE CATALYSIS; AQUEOUS-MEDIA; ALDEHYDES; ACID; DESIGN; STEREOSELECTIVITIES; PREDICTIONS; MOLECULES; MECHANISM; ENERGIES	The origin of higher reactivity in water-accelerated asymmetric aldol reactions with our designed primary amine organocatalyst was elucidated by both computational and experimental methods. As suggested by the calculated transition-state structures for water-promoted imine-enamine isomerization, anti-selective aldol reaction and hemiaminal formation, the rate of this aldol reaction was found experimentally to be even more accelerated by the addition of cis-2-butene-1,4-diol as additive.	[Moteki, Shin A.; Maruyama, Hiroki; Nakayama, Keiji; Maruoka, Keiji] Kyoto Univ, Grad Sch Sci, Lab Synthet Organ Chem, Dept Chem, Sakyo, Kyoto 6068502, Japan; [Moteki, Shin A.; Maruyama, Hiroki; Nakayama, Keiji; Maruoka, Keiji] Kyoto Univ, Grad Sch Sci, Special Lab Organocatalyt Chem, Dept Chem, Sakyo, Kyoto 6068502, Japan; [Li, Hai-Bei; Petrova, Galina; Morokuma, Keiji] Kyoto Univ, Fukui Inst Fundamental Chem, Sakyo, Kyoto 6068103, Japan; [Li, Hai-Bei] Shandong Univ, Sch Ocean, Weihai 264209, Peoples R China; [Maeda, Satoshi] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Morokuma, K (reprint author), Kyoto Univ, Fukui Inst Fundamental Chem, Sakyo, Kyoto 6068103, Japan.	morokuma@fukui.kyoto-u.ac.jp; maruoka@kuchem.kyoto-u.ac.jp	Maeda, Satoshi/H-3613-2014		MEXT, Japan	This work was partially supported by a Grant-in-Aid for Scientific Research from the MEXT, Japan. The computer resources at the Academic Center for Computing and Media Studies (ACCMS) at Kyoto University and Research Center of Computer Science (RCCS) at the Institute for Molecular Science are acknowledged.	Groger H, 1998, CHEM-EUR J, V4, P1137; Markert M, 2009, J AM CHEM SOC, V131, P16642, DOI 10.1021/ja907054y; Kano T, 2006, CHEM-ASIAN J, V1, P210, DOI 10.1002/asia.200600077; Butler RN, 2010, CHEM REV, V110, P6302, DOI 10.1021/cr100162c; Allemann C, 2004, ACCOUNTS CHEM RES, V37, P558, DOI 10.1021/ar0300524; Matsunaga S, 2011, CHEM REC, V11, P260, DOI 10.1002/tcr.201100020; Hayashi Y, 2006, ANGEW CHEM INT EDIT, V45, P958, DOI 10.1002/anie.200502488; Lindstrom UM, 2002, CHEM REV, V102, P2751, DOI 10.1021/cr010122p; Tanaka F, 2005, BIOCHEMISTRY-US, V44, P7583, DOI 10.1021/bi050216j; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Palomo C, 2004, CHEM SOC REV, V33, P65, DOI 10.1039/b202901d; Zhang X, 2012, ASIAN J CHEM, V24, P751; Cordova A, 2006, CHEM-EUR J, V12, P5383, DOI 10.1002/chem.200501639; Bisai V, 2012, TETRAHEDRON, V68, P4541, DOI 10.1016/j.tet.2012.03.099; Kano T, 2006, TETRAHEDRON LETT, V47, P7423, DOI 10.1016/j.tetlet.2006.08.051; Kano T, 2007, ANGEW CHEM INT EDIT, V46, P1738, DOI 10.1002/anie.200604640; Zhu XY, 2009, J AM CHEM SOC, V131, P18206, DOI 10.1021/ja907271a; Zotova N, 2007, J AM CHEM SOC, V129, P15100, DOI 10.1021/ja0738881; Dickerson TJ, 2004, J ORG CHEM, V69, P6603, DOI 10.1021/jo048894j; Kano T, 2012, CHEM COMMUN, V48, P7037, DOI 10.1039/c2cc32772d; Gruttadauria M, 2009, ADV SYNTH CATAL, V351, P33, DOI 10.1002/adsc.200800731; Bahmanyar S, 2003, J AM CHEM SOC, V125, P2475, DOI 10.1021/ja028812d; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Heravi MM, 2012, TETRAHEDRON-ASYMMETR, V23, P1431, DOI 10.1016/j.tetasy.2012.10.002; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Mlynarski J, 2008, CHEM SOC REV, V37, P1502, DOI 10.1039/b710577k; Jiang ZQ, 2010, ORG BIOMOL CHEM, V8, P1368, DOI 10.1039/b921460g; Xu LW, 2008, ORG BIOMOL CHEM, V6, P2047, DOI 10.1039/b803116a; Ma X, 2009, TETRAHEDRON-ASYMMETR, V20, P1419, DOI 10.1016/j.tetasy.2009.05.032; Amedjkouh M, 2005, TETRAHEDRON-ASYMMETR, V16, P1411, DOI 10.1016/j.tetasy.2005.02.031; Clapes P, 2011, ADV SYNTH CATAL, V353, P2263, DOI 10.1002/adsc.201100236; Wu XY, 2007, ADV SYNTH CATAL, V349, P812, DOI 10.1002/adsc.200600564; Miura T, 2009, TETRAHEDRON LETT, V50, P2632, DOI 10.1016/j.tetlet.2009.03.053; Mangion IK, 2004, ANGEW CHEM INT EDIT, V43, P6722, DOI 10.1002/anie.200461851; Geary LM, 2009, TETRAHEDRON-ASYMMETR, V20, P131, DOI 10.1016/j.tetasy.2008.12.030; Nakayama K, 2008, J AM CHEM SOC, V130, P17666, DOI 10.1021/ja807807p; Maeda S, 2013, PHYS CHEM CHEM PHYS, V15, P3683, DOI 10.1039/c3cp44063j; Clemente FR, 2005, J AM CHEM SOC, V127, P11294, DOI 10.1021/ja0507620; Peng FZ, 2008, ADV SYNTH CATAL, V350, P2199, DOI 10.1002/adsc.200800335; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; List B, 2004, P NATL ACAD SCI USA, V101, P5839, DOI 10.1073/pnas.0307979101; Kano T, 2005, ANGEW CHEM INT EDIT, V44, P3055, DOI 10.1002/anie.200500408; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Trost BM, 2010, CHEM SOC REV, V39, P1600, DOI 10.1039/b923537j; Zhao QQ, 2012, J ORG CHEM, V77, P4784, DOI 10.1021/jo300569c; Fu AP, 2006, J ORG CHEM, V71, P320, DOI 10.1021/jo052088a; Mlynarski J, 2014, CHEM SOC REV, V43, P577, DOI 10.1039/c3cs60202h; Liu J, 2008, J AM CHEM SOC, V130, P5654, DOI [10.1021/ja800839w, 10.1021/ja800839W]; Clemente Fernando R, 2004, Angew Chem Int Ed Engl, V43, P5765; Clemente FR, 2004, ANGEW CHEM, V116, P5890, DOI 10.1002/ange.200460916; Cordova A, 2005, CHEM COMMUN, P3586, DOI 10.1039/b507968n; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hayashi Y, 2008, SYNLETT, P1565, DOI 10.1055/s-2008-1077789; Hayashi Y., 2006, ANGEW CHEM, V118, P972, DOI 10.1002/ange.200502488; Heathcock C. H., 1991, COMPREHENSIVE ORGANI, V2, P99; Jiang ZQ, 2006, CHEM COMMUN, P2801, DOI 10.1039/b606154k; Jung YS, 2007, J AM CHEM SOC, V129, P5492, DOI 10.1021/ja068120f; Kano T., 2007, ANGEW CHEM, V119, P1768, DOI 10.1002/ange.200604640; Kano T., 2005, ANGEW CHEM, V117, P3115, DOI 10.1002/ange.200500408; Lu LQ, 2012, SYNLETT, P490, DOI 10.1055/s-0031-1290131; Machajewski T. D., 2000, ANGEW CHEM, V112, P1406, DOI DOI 10.1002/(SICI)1521-3757(20000417)112:8<1406::AID-ANGE1406>3.0.CO;2-R; Mahrwald R., 2004, MODERN ALDOL REACTIO, V1; Mahrwald R., 2013, MODERN METHODS STERE; Mahrwald R., 2004, MODERN ALDOL REACTIO, V2; Mangion I. K., 2004, ANGEW CHEM, V116, P6890, DOI 10.1002/ange.200461851; Mase N, 2006, J AM CHEM SOC, V128, P734, DOI 10.1021/ja0573312; MUKAIYAMA T, 1982, ORG REACTIONS, V28, P203; Raj M, 2009, CHEM COMMUN, P6687, DOI 10.1039/b910861k; Xu LW, 2009, CHEM COMMUN, P1807, DOI 10.1039/b821070e; Zhang L, 2012, SYNLETT, P1575, DOI 10.1055/s-0031-129068	70	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2112	2116		10.1002/asia.201500078		5	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200009		
J	Yamashita, Y; Sato, I; Suzuki, H; Kobayashi, S				Yamashita, Yasuhiro; Sato, Io; Suzuki, Hirotsugu; Kobayashi, Shu			Catalytic Asymmetric 1,4-Addition Reactions of Simple Alkylnitriles	CHEMISTRY-AN ASIAN JOURNAL			English	Article						1,4-addition; asymmetric synthesis; catalyst; nitrile; strong base	ALDOL-TYPE REACTION; ENANTIOSELECTIVE SYNTHESIS; COOPERATIVE CATALYSIS; ORGANIC-SYNTHESIS; NICKEL-CATALYST; ACETONITRILE; ALDEHYDES; NITRILES; PROAZAPHOSPHATRANES; ACTIVATION	The development of catalytic asymmetric carbon-carbon bond-forming reactions of alkylnitriles that do not have an activating group at the alpha-position, under proton-transfer conditions, is a challenging research topic. Here, we report catalytic asymmetric direct-type 1,4-addition reactions of alkylnitriles with alpha,beta-unsaturated amides by using a catalytic amount of potassium hexamethyldisilazide (KHMDS) with a chiral macro crown ether. The desired reactions proceeded in high yields with good diastereo- and enantioselectivities. To our knowledge, this is the first example of catalytic asymmetric direct-type 1,4-addition reaction of alkylnitriles without any activating group at the alpha-position.	[Yamashita, Yasuhiro; Sato, Io; Suzuki, Hirotsugu; Kobayashi, Shu] Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo, Japan	Kobayashi, S (reprint author), Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Kobayashi, Shu/E-9214-2012		Japan Society for the Promotion of Science (JSPS); Global COE Program; University of Tokyo; MEXT, Japan; Japan Science and Technology Agency (JST); MERIT program, The University of Tokyo	This work was partially supported by a Grant-in-Aid for Science Research from the Japan Society for the Promotion of Science (JSPS), Global COE Program, The University of Tokyo, MEXT, Japan, and the Japan Science and Technology Agency (JST). I.S. and H.S. thank the MERIT program, The University of Tokyo for financial support.	Anastas P. T., 2009, HDB GREEN CHEM; Chakraborty S, 2013, ANGEW CHEM INT EDIT, V52, P7523, DOI 10.1002/anie.201302613; Yamashita Y, 2012, ORG BIOMOL CHEM, V10, P5750, DOI 10.1039/c2ob25522g; Sureshkumar D, 2014, CHEM-EUR J, V20, P15723, DOI 10.1002/chem.201404808; Kumagai N, 2007, TETRAHEDRON, V63, P8598, DOI 10.1016/j.tet.2007.04.051; Kisanga P, 1999, J ORG CHEM, V64, P3090, DOI 10.1021/jo981858y; D'Sa BA, 1998, J ORG CHEM, V63, P3961, DOI 10.1021/jo972343u; Chen JP, 2010, J AM CHEM SOC, V132, P15493, DOI 10.1021/ja106703y; Kumagai N, 2011, ANGEW CHEM INT EDIT, V50, P4760, DOI 10.1002/anie.201100918; Kisanga PB, 2000, J ORG CHEM, V65, P5431, DOI 10.1021/jo000427o; Poisson T, 2009, J ORG CHEM, V74, P3516, DOI 10.1021/jo802763b; Rodriguez AL, 2000, ORG LETT, V2, P3285, DOI 10.1021/ol0001741; Goto A, 2011, CHEM-ASIAN J, V6, P1740, DOI 10.1002/asia.201000921; HEATHCOCK CH, 1985, J ORG CHEM, V50, P3022, DOI 10.1021/jo00216a051; Verkade JG, 2004, ALDRICHIM ACTA, V37, P3; HEATHCOCK CH, 1985, J AM CHEM SOC, V107, P2797, DOI 10.1021/ja00295a037; Suto Y, 2003, ORG LETT, V5, P3147, DOI 10.1021/ol035206u; Kisanga PB, 2001, TETRAHEDRON, V57, P467, DOI 10.1016/S0040-4020(00)01016-4; Kumagai N, 2004, J AM CHEM SOC, V126, P13632, DOI 10.1021/ja0450509; Kawato Y, 2013, CHEM COMMUN, V49, P11227, DOI 10.1039/c3cc47117a; Verkade JG, 2003, TETRAHEDRON, V59, P7819, DOI 10.1016/S0040-4020(03)01204-3; Amat M, 2001, ORG LETT, V3, P611, DOI 10.1021/ol007010p; Suzuki H, 2015, J AM CHEM SOC, V137, P4336, DOI 10.1021/jacs.5b01943; Kobayashi S, 2009, CHEM-EUR J, V15, P10694, DOI 10.1002/chem.200901515; Suto Y, 2005, ORG LETT, V7, P3757, DOI 10.1021/ol051423e; Fleming FF, 2002, TETRAHEDRON, V58, P1, DOI 10.1016/S0040-4020(01)01134-6; Arseniyadis S., 1984, ORG REACTIONS, V31, P1, DOI DOI 10.1002/0471264180.OR031.01; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Chakraborty S., 2013, ANGEW CHEM, V125, P7671; Deng T, 2014, EUR J ORG CHEM, P7259, DOI 10.1002/ejoc.201402852; ENDERS D, 1994, SYNLETT, P1054; Fan L, 2005, CHEM COMMUN, P4450, DOI 10.1039/b505778g; Goto A, 2008, CHEM COMMUN, P2212, DOI 10.1039/b800634b; Knochel P., 2014, COMPREHENSIVE ORGANI; Kumagai N., 2011, ANGEW CHEM, V123, P4856; Kumagai N, 2005, CHEM COMMUN, P3600, DOI 10.1039/b504519c; Larock R. C., 1999, COMPREHENSIVE ORGANI; Trost B. M., 1991, COMPREHENSIVE ORGANI	38	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2143	2146		10.1002/asia.201500405		4	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200016		
J	Egami, H; Usui, Y; Kawamura, S; Nagashima, S; Sodeoka, M				Egami, Hiromichi; Usui, Yoshihiko; Kawamura, Shintaro; Nagashima, Sayoko; Sodeoka, Mikiko			Product Control in Alkene Trifluoromethylation: Hydrotrifluoromethylation, Vinylic Trifluoromethylation, and Iodotrifluoromethylation using Togni Reagent	CHEMISTRY-AN ASIAN JOURNAL			English	Article						additive effect; alkenes; difunctionalization; Togni reagent; trifluoromethylation	COPPER-CATALYZED TRIFLUOROMETHYLATION; C-H TRIFLUOROMETHYLATION; P450-CATALYZED HYDROXYLATION REACTIONS; HYPERSENSITIVE MECHANISTIC PROBE; FLUORINATED AMINO-ACIDS; BOND FORMATION; ELECTROPHILIC TRIFLUOROMETHYLATION; RADICAL TRIFLUOROMETHYLATION; PERFLUOROALKYL IODIDES; SODIUM TRIFLUOROMETHANESULFINATE	Hydrotrifluoromethylation, vinylic trifluoromethylation, and iodotrifluoromethylation of simple alkenes have been achieved by using Togni reagent in the absence of any transition metal catalyst. These reactions were readily controllable by selection of appropriate salts and solvents. The addition of K2O3 afforded the hydrotrifluoromethylation product, with DMF acting not only as a solvent, but also as the hydrogen source. In contrast, the use of tetra-n-butylammonium iodide (TBAI) in 1,4-dioxane resulted in vinylic trifluoromethylation, while the use of KI afforded the iodotri-fluoromethylation product. The vinylic trifluoromethylation product was obtained by treatment of the iodotrifluoromethylation product with ammonium 2-iodobenzoate, indicating that it was formed through an elimination reaction of the in-situ-generated iodotrifluoromethylation product, and the solubility of the resulting 2-iodobenzoate salt plays a key role in the product switching. A radical-clock experiment showed that these reactions proceed via radical intermediates.	[Egami, Hiromichi; Usui, Yoshihiko; Kawamura, Shintaro; Sodeoka, Mikiko] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan; [Egami, Hiromichi; Kawamura, Shintaro; Sodeoka, Mikiko] Japan Sci & Technol Agcy, ERATO, Sodeoka Live Cell Chem Project, Wako, Saitama 3510198, Japan; [Usui, Yoshihiko; Nagashima, Sayoko; Sodeoka, Mikiko] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Kawamura, Shintaro; Sodeoka, Mikiko] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; [Egami, Hiromichi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Sodeoka, M (reprint author), RIKEN, Synthet Organ Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sodeoka@riken.jp	Sodeoka, Mikiko/A-9952-2008; Egami, Hiromichi/F-7744-2012; 	Sodeoka, Mikiko/0000-0002-1344-364X; Egami, Hiromichi/0000-0002-7784-4987	RIKEN	This work was supported in part by Project Funding from RIKEN. We are grateful to Prof. Teiji Chihara and Prof. Hideki Kurokawa of Saitama University for helpful discussions.	Jiang XY, 2013, ANGEW CHEM INT EDIT, V52, P14177, DOI 10.1002/anie.201307595; Janson PG, 2012, ORG LETT, V14, P2882, DOI 10.1021/ol3011419; Liu TF, 2011, ORG LETT, V13, P2342, DOI 10.1021/ol2005903; Cao XH, 2014, CHEM COMMUN, V50, P3359, DOI 10.1039/c3cc49689a; Dubbaka SR, 2005, CHEM-EUR J, V11, P2633, DOI 10.1002/chem.200400838; Lin QY, 2014, J ORG CHEM, V79, P10434, DOI 10.1021/jo502040t; Zhu R, 2012, J AM CHEM SOC, V134, P12462, DOI 10.1021/ja305840g; Lu DF, 2013, CHEM SCI, V4, P2478, DOI 10.1039/c3sc50582k; UNEYAMA K, 1990, J ORG CHEM, V55, P3909, DOI 10.1021/jo00299a039; FUJITA M, 1986, TETRAHEDRON LETT, V27, P3655, DOI 10.1016/S0040-4039(00)84873-X; Wang F, 2014, ANGEW CHEM INT EDIT, V53, P1881, DOI 10.1002/anie.201309991; Hirotaki K, 2015, J FLUORINE CHEM, V171, P169, DOI 10.1016/j.jfluchem.2014.07.018; Eisenberger P, 2006, CHEM-EUR J, V12, P2579, DOI 10.1002/chem.200501052; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P7841, DOI 10.1002/anie.201303350; Gao P, 2013, CHEM-EUR J, V19, P14420, DOI 10.1002/chem.201303025; Xu T, 2014, ANGEW CHEM INT EDIT, V53, P4910, DOI 10.1002/anie.201402511; Mizuta S, 2012, CHEM-EUR J, V18, P8583, DOI 10.1002/chem.201201707; Xu J, 2011, J AM CHEM SOC, V133, P15300, DOI 10.1021/ja206330m; Matousek V, 2013, J ORG CHEM, V78, P6763, DOI 10.1021/jo400774u; Parsons AT, 2012, ANGEW CHEM INT EDIT, V51, P2947, DOI 10.1002/anie.201108267; Ignatowska J, 2007, J FLUORINE CHEM, V128, P997, DOI 10.1016/j.jfluchem.2007.04.028; Mu X, 2012, J AM CHEM SOC, V134, P878, DOI 10.1021/ja210614y; Wu XY, 2013, ANGEW CHEM INT EDIT, V52, P2198, DOI 10.1002/anie.201208971; Kong WQ, 2013, ANGEW CHEM INT EDIT, V52, P13086, DOI 10.1002/anie.201307377; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Egami H, 2013, CHEM COMMUN, V49, P7346, DOI 10.1039/c3cc43936d; Egami H, 2012, TETRAHEDRON LETT, V53, P5503, DOI 10.1016/j.tetlet.2012.07.134; Iqbal N, 2012, J ORG CHEM, V77, P11383, DOI 10.1021/jo3022346; Zhang B, 2013, ANGEW CHEM INT EDIT, V52, P10792, DOI 10.1002/anie.201306082; Newcomb M, 2000, ACCOUNTS CHEM RES, V33, P449, DOI 10.1021/ar960058b; Roy S, 2011, TETRAHEDRON, V67, P2161, DOI 10.1016/j.tet.2011.01.002; Chu LL, 2012, ORG LETT, V14, P2106, DOI 10.1021/ol300639a; Oh SH, 2014, ORG LETT, V16, P1310, DOI 10.1021/ol403716t; FUCHIKAMI T, 1984, TETRAHEDRON LETT, V25, P303, DOI 10.1016/S0040-4039(00)99868-X; Kawamura S, 2015, J AM CHEM SOC, V137, P4865, DOI 10.1021/jacs.5b02046; Pitre SP, 2014, ACS CATAL, V4, P2530, DOI 10.1021/cs5005823; Prakash GKS, 2012, ORG LETT, V14, P1146, DOI 10.1021/ol300076y; Liu XW, 2013, ANGEW CHEM INT EDIT, V52, P6962, DOI 10.1002/anie.201302673; Yajima T, 2007, ORG LETT, V9, P2513, DOI 10.1021/ol0707620; Ilchenko NO, 2013, J ORG CHEM, V78, P11087, DOI 10.1021/jo401831t; Li Y, 2012, ANGEW CHEM INT EDIT, V51, P8221, DOI 10.1002/anie.201202623; Feng C, 2012, CHEM SCI, V3, P3458, DOI 10.1039/c2sc21164e; Kobayashi T, 2002, J ORG CHEM, V67, P3156, DOI 10.1021/jo0111311; Wang F, 2014, J AM CHEM SOC, V136, P10202, DOI 10.1021/ja504458j; UNEYAMA K, 1991, TETRAHEDRON, V47, P555, DOI 10.1016/S0040-4020(01)87045-9; Chen ZM, 2013, ANGEW CHEM INT EDIT, V52, P9781, DOI 10.1002/anie.201304557; Erdbrink H, 2012, ORG BIOMOL CHEM, V10, P8583, DOI 10.1039/c2ob26810h; Wang X, 2013, ORG LETT, V15, P3730, DOI 10.1021/ol4016095; Shimizu R, 2010, TETRAHEDRON LETT, V51, P5947, DOI 10.1016/j.tetlet.2010.09.027; Besset T, 2014, J ORG CHEM, V79, P413, DOI 10.1021/jo402385g; Yasu Y, 2012, ANGEW CHEM INT EDIT, V51, P9567, DOI 10.1002/anie.201205071; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Hang ZJ, 2014, ORG LETT, V16, P3648, DOI 10.1021/ol501380e; ANDRIEUX CP, 1989, TETRAHEDRON LETT, V30, P4961, DOI 10.1016/S0040-4039(01)80554-2; Billard T, 2000, TETRAHEDRON LETT, V41, P3069, DOI 10.1016/S0040-4039(00)00337-3; Wallentin CJ, 2012, J AM CHEM SOC, V134, P8875, DOI 10.1021/ja300798k; Omote M, 2012, ORG LETT, V14, P2286, DOI 10.1021/ol300670n; Shimizu M, 2001, J AM CHEM SOC, V123, P6947, DOI 10.1021/ja016077k; Wang XP, 2013, BEILSTEIN J ORG CHEM, V9, P2635, DOI 10.3762/bjoc.9.299; UNEYAMA K, 1992, B CHEM SOC JPN, V65, P1976, DOI 10.1246/bcsj.65.1976; Kim E, 2013, CHEM-EUR J, V19, P6209, DOI 10.1002/chem.201300564; Kieltsch I, 2007, ANGEW CHEM INT EDIT, V46, P754, DOI 10.1002/anie.200603497; Parsons AT, 2011, ANGEW CHEM INT EDIT, V50, P9120, DOI 10.1002/anie.201104053; Wang X, 2011, J AM CHEM SOC, V133, P16410, DOI 10.1021/ja207775a; Wilger DJ, 2013, CHEM SCI, V4, P3160, DOI 10.1039/c3sc51209f; He ZB, 2012, ANGEW CHEM INT EDIT, V51, P3944, DOI 10.1002/anie.201200140; Fiederling N, 2013, ORG PROCESS RES DEV, V17, P318, DOI 10.1021/op400035b; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P4000, DOI 10.1002/anie.201210250; Egami H, 2013, J FLUORINE CHEM, V152, P51, DOI 10.1016/j.jfluchem.2013.03.009; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Ilchenko NO, 2013, CHEM COMMUN, V49, P6614, DOI 10.1039/c3cc43357a; Phipps RJ, 2012, J AM CHEM SOC, V134, P10773, DOI 10.1021/ja3039807; Wu XF, 2012, CHEM-ASIAN J, V7, P1744, DOI 10.1002/asia.201200211; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Merino E, 2014, CHEM SOC REV, V43, P6598, DOI 10.1039/c4cs00025k; Feng C, 2013, ANGEW CHEM INT EDIT, V52, P12414, DOI 10.1002/anie.201307245; UMEMOTO T, 1987, B CHEM SOC JPN, V60, P3307, DOI 10.1246/bcsj.60.3307; Toy PH, 1998, J AM CHEM SOC, V120, P7719, DOI 10.1021/ja981157i; Mizuta S, 2013, J AM CHEM SOC, V135, P2505, DOI 10.1021/ja401022x; Isanbor C, 2006, J FLUORINE CHEM, V127, P303, DOI 10.1016/j.jfluchem.2006.01.011; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Sato K, 2004, ORG LETT, V6, P4359, DOI 10.1021/ol048134v; Kong W, 2013, J AM CHEM SOC, V135, P14480, DOI 10.1021/ja403954g; Xu J, 2011, CHEM COMMUN, V47, P4300, DOI 10.1039/c1cc10359h; NEWCOMB M, 1994, J AM CHEM SOC, V116, P9753, DOI 10.1021/ja00100a052; Egami H, 2014, CHEM-EUR J, V20, P12061, DOI 10.1002/chem.201403447; Fang ZX, 2014, ORG LETT, V16, P1522, DOI 10.1021/ol5004498; Miyazaki A, 2012, HETEROCYCLES, V86, P979, DOI 10.3987/COM-12-S(N)101; Tsuchii K, 2004, J ORG CHEM, V69, P6658, DOI 10.1021/jo0495889; TAKEYAMA Y, 1989, TETRAHEDRON LETT, V30, P3159, DOI 10.1016/S0040-4039(00)99190-1; Barata-Vallejo S, 2014, CHEM-EUR J, V20, P16806, DOI 10.1002/chem.201404005; Begue J.-P., 2008, BIOORGANIC MED CHEM; BROOKES CJ, 1978, J CHEM SOC PERK T 1, P202, DOI 10.1039/p19780000202; Charpentier J, 2015, CHEM REV, V115, P650, DOI 10.1021/cr500223h; Chen Z.-M., 2013, ANGEW CHEM, V125, P9963; Egami H., 2013, ANGEW CHEM, V125, P7995; Egami H, 2014, J FLUORINE CHEM, V167, P172, DOI 10.1016/j.jfluchem.2014.05.009; Egami H, 2014, ANGEW CHEM INT EDIT, V53, P8294, DOI 10.1002/anie.201309260; Egami H., 2013, ANGEW CHEM, V125, P4092; Feng C., 2013, ANGEW CHEM, V725, P12640; FUCHIKAMI T, 1981, SYNTHESIS-STUTTGART, P365; Gouverneur V., 2012, PHARM MED CHEM BIOPH; Hanamoto T, 2003, EUR J ORG CHEM, P4279, DOI 10.1002/ejoc.200300395; He Z.-B., 2012, ANGEW CHEM, V124, P4010; Jiang X.-Y., 2013, ANGEW CHEM, V125, P14427; KAMIGATA N, 1991, J CHEM SOC PERK T 1, P627, DOI 10.1039/p19910000627; Kieltsch I., 2007, ANGEW CHEM, V119, P768, DOI 10.1002/ange.200603497; Kirsch P., 2004, MODERN FLUOROORGANIC; KITAZUME T, 1982, CHEM LETT, P1453, DOI 10.1246/cl.1982.1453; Kong W., 2013, ANGEW CHEM, V125, P13324; Li L, 2014, ORG LETT, V16, P6032, DOI 10.1021/ol503067g; Li Y., 2012, ANGEW CHEM, V124, P8345; Liang T., 2013, ANGEW CHEM, V125, P8372, DOI DOI 10.1002/ANGE.201206566; Liu TF, 2012, EUR J ORG CHEM, P6679, DOI 10.1002/ejoc.201200648; Liu X., 2013, ANGEW CHEM, V125, P7100; Mace Y, 2012, EUR J ORG CHEM, P2479, DOI 10.1002/ejoc.201101535; MARUOKA K, 1985, CHEM LETT, P1689, DOI 10.1246/cl.1985.1689; MULLER N, 1986, J ORG CHEM, V51, P263, DOI 10.1021/jo00352a032; Ojima I., 2009, FLUORINE MED CHEM CH; Parsons A. T., 2012, ANGEW CHEM, V124, P3001; Parsons A. T., 2011, ANGEW CHEM, V123, P9286; Schlosser M., 2006, ANGEW CHEM, V118, P5558, DOI 10.1002/ange.200600449; Schlosser M, 2006, ANGEW CHEM INT EDIT, V45, P5432, DOI 10.1002/anie.200600449; Shimizu M., 2005, ANGEW CHEM, V117, P218, DOI 10.1002/ange.200460441; Shimizu R, 2012, ANGEW CHEM INT EDIT, V51, P4577, DOI 10.1002/anie.201201095; Shimizu R., 2012, ANGEW CHEM, V124, P4655; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Studer A., 2012, ANGEW CHEM, V124, P9082; Tommasino T.-B., 2002, SYNLETT, P1697; Tonoi T, 2008, EUR J ORG CHEM, P1331, DOI 10.1002/ejoc.200701052; Wu X., 2013, ANGEW CHEM, V125, P2254; Yajima T, 2010, EUR J ORG CHEM, P2461, DOI 10.1002/ejoc.201000017; Yang XY, 2015, CHEM REV, V115, P826, DOI 10.1021/cr500277b; Yasu Y., 2012, ANGEW CHEM, V124, P9705, DOI DOI 10.1135/CCCC2011078; Ye YD, 2012, SYNLETT, P2005, DOI 10.1055/s-0032-1316988; Zhang B., 2013, ANGEW CHEM, V125, P10992; Zhu R., 2013, ANGEW CHEM, V125, P12887; Zhu R, 2013, ANGEW CHEM INT EDIT, V52, P12655, DOI 10.1002/anie.201307790	141	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2190	2199		10.1002/asia.201500359		10	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200023		
J	Ishida, S; Osuka, A				Ishida, Shin-ichiro; Osuka, Atsuhiro			meso-Aryl [28]Hexaphyrin Silicon Complexes Bearing Various Si-Substituents and 1,16-Dihydrohexaphyrin bis-Chlorosilicon Complex	CHEMISTRY-AN ASIAN JOURNAL			English	Article						Mobius aromaticity; porphyrins; silane reduction; silicon complexes; substituent effects	EXPANDED PORPHYRINS; ORGANOSILICON PORPHYRINS; MOBIUS AROMATICITY; METAL-COMPLEXES; REACTIVITY; HEXAPHYRIN(1.1.1.1.1.1); REARRANGEMENT; SUBPORPHYRIN; CHEMISTRY; INSERTION	Herein, the synthesis of Mobius aromatic [28]hexaphyrin silicon complexes bearing various Si-substituents from reactions of [28]hexaphyrin 1 with suitable silicon sources in the presence of a base is reported. Si-substituents newly introduced are vinyl (4), phenyl (6), hydroxy (7), and hydride groups (8). X-ray crystallographic analysis of complexes 6 and 7 has shown trigonal bipyramidal penta-coordinated silicon atoms, which are favorable for the hexaphyrin ligands to take on smoothly twisted Mobius conformations. N-fused Si-vinyl complex 5 was also isolated and structurally well characterized. Through these studies, the Si-substituent effect has been shown to be relatively small. Reaction of 1 with HSiCl3 in CH2Cl2 gave 1,16-dihydrohexaphyrin bis-chlorosilicon complex 9, probably through intramolecular hydride transfer from the silane to the pyrrolic alpha-carbon.	[Ishida, Shin-ichiro; Osuka, Atsuhiro] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	Osuka, A (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan.	osuka@kuchem.kyoto-u.ac.jp			JSPS KAKENHI [25220802, 25620031]; JSPS	This work was supported by JSPS KAKENHI Grant Numbers 25220802 and 25620031. S.I. acknowledges a JSPS Fellowship for Young Scientists.	Higashino T, 2010, ANGEW CHEM INT EDIT, V49, P4950, DOI 10.1002/anie.201001765; Osuka A, 2011, CHEM COMMUN, V47, P4330, DOI 10.1039/c1cc10534e; Higashino T, 2012, ANGEW CHEM INT EDIT, V51, P13105, DOI 10.1002/anie.201208147; Moriya K, 2010, ANGEW CHEM INT EDIT, V49, P4297, DOI 10.1002/anie.201001052; Mori S, 2007, INORG CHEM, V46, P4374, DOI 10.1021/ic7004216; Inoue M, 2010, ANGEW CHEM INT EDIT, V49, P9488, DOI 10.1002/anie.201005334; Tokuji S, 2011, CHEM-EUR J, V17, P7154, DOI 10.1002/chem.201100872; Sessler JL, 2007, ACCOUNTS CHEM RES, V40, P371, DOI 10.1021/ar600006n; Naoda K, 2013, CHEM-ASIAN J, V8, P1395, DOI 10.1002/asia.201300320; Suzuki M, 2014, ORG LETT, V16, P327, DOI 10.1021/ol403242z; Chandrashekar TK, 2003, ACCOUNTS CHEM RES, V36, P676, DOI 10.1021/ar020284n; Higashino T, 2012, CHEM SCI, V3, P103, DOI 10.1039/c1sc00653c; Herrero-Garcia N, 2011, CHEM-EUR J, V17, P7327, DOI 10.1002/chem.201003511; Mori S, 2007, J AM CHEM SOC, V129, P11344, DOI 10.1021/ja0744908; Sakamoto R, 2010, CHEM LETT, V39, P439, DOI 10.1246/cl.2010.439; Kane KM, 1998, INORG CHEM, V37, P669, DOI 10.1021/ic9710925; Mori S, 2008, INORG CHEM, V47, P3937, DOI 10.1021/ic8004147; Tanaka Y, 2008, ANGEW CHEM INT EDIT, V47, P681, DOI 10.1002/anie.200704407; Saito S, 2011, ANGEW CHEM INT EDIT, V50, P4342, DOI 10.1002/anie.201003909; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Zheng JY, 1998, INORG CHEM, V37, P2591, DOI 10.1021/ic971266i; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; Yoon MC, 2013, CHEM SCI, V4, P1756, DOI 10.1039/c3sc22151b; KANE KM, 1995, INORG CHEM, V34, P4085, DOI 10.1021/ic00120a012; Mori S, 2005, J AM CHEM SOC, V127, P8030, DOI 10.1021/ja051662x; Yoon ZS, 2009, NAT CHEM, V1, P113, DOI [10.1038/nchem.172, 10.1038/NCHEM.172]; Sessler JL, 2003, ANGEW CHEM INT EDIT, V42, P5134, DOI 10.1002/anie.200200561; Kane KM, 1997, INORG CHEM, V36, P1354, DOI 10.1021/ic960639x; Miura T, 2010, CHEM-EUR J, V16, P55, DOI 10.1002/chem.200902708; Stepien M, 2011, ANGEW CHEM INT EDIT, V50, P4288, DOI 10.1002/anie.201003353; Saito S, 2007, ANGEW CHEM INT EDIT, V46, P5591, DOI 10.1002/anie.200701682; KADISH KM, 1988, INORG CHEM, V27, P1191, DOI 10.1021/ic00280a020; Ishida S, 2014, CHEM-EUR J, V20, P8274, DOI 10.1002/chem.201402929; Ishida S, 2009, CHEM LETT, V38, P362, DOI 10.1246/cl.2009.362; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Herrero-Garcia N, 2012, EUR J ORG CHEM, P2643, DOI 10.1002/ejoc.201200159; Higashino T., 2012, HETEROCYCLES, V87, P31; Higashino T., 2010, ANGEW CHEM, V49, P4950; Higashino T., 2012, ANGEW CHEM, V124, P13282; Inoue M., 2010, ANGEW CHEM, V122, P9678, DOI 10.1002/ange.201005334; Moriya K., 2010, ANGEW CHEM, V122, P4393; Rath H, 2009, CHEM COMMUN, P3762, DOI 10.1039/b905859a; Saito S., 2007, ANGEW CHEM, V119, P5687, DOI 10.1002/ange.200701682; Saito S., 2011, ANGEW CHEM, V50, P4342, DOI DOI 10.1002/ANIE.201003909; Sessler J. L., 2003, ANGEW CHEM, V42, P5134, DOI 10.1002/ange.200200561; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shimizu S, 2006, EUR J INORG CHEM, P1319, DOI 10.1002/ejic.200501097; Soya T, 2015, CHEM-ASIAN J, V10, P231, DOI 10.1002/asia.201402933; Stpien M., 2011, ANGEW CHEM, V723, P4376, DOI DOI 10.1002/ANIE.201003353; Tanaka Y., 2008, ANGEW CHEM, V47, P681, DOI 10.1002/ange.200704407; Yoneda T., 2014, ANGEW CHEM, V126, P13385, DOI DOI 10.1002/ANGE.201408506; Yoneda T, 2014, ANGEW CHEM INT EDIT, V53, P13169, DOI 10.1002/anie.201408506; Zheng JY, 1998, CHEM LETT, P453, DOI 10.1246/cl.1998.453	53	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2200	2206		10.1002/asia.201500381		7	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200024		
J	Sasaki, T; Tada, M; Wang, LS; Malwadkar, S; Iwasawa, Y				Sasaki, Takehiko; Tada, Mizuki; Wang, Linsheng; Malwadkar, Sachin; Iwasawa, Yasuhiro			Structure of the Active Platinum Cluster and Reaction Pathway of the Selective Synthesis of Phenol from Benzene and Oxygen Regulated with Ammonia on a Platinum Cluster/beta-Zeolite Catalyst Studied by DFT Calculations	CHEMISTRY-AN ASIAN JOURNAL			English	Article						density functional theory; indispensable ammonia effect; oxidation; phenol synthesis; zeolites	MODIFIED TITANIUM SILICALITE; DIRECT HYDROXYLATION; MOLECULAR-OXYGEN; HYDROGEN-PEROXIDE; MEMBRANE REACTOR; NITROUS-OXIDE; GAS-PHASE; PALLADIUM MEMBRANE; AROMATIC-COMPOUNDS; TRANSITION-STATES	DFT calculations were used to investigate the structure of the active Pt cluster and the catalytic reaction pathway for the selective synthesis of phenol from benzene and molecular oxygen regulated with ammonia on a Pt cluster/beta-zeolite catalyst that was reported to be active for the selective hydroxylation of benzene only in the coexistence of ammonia. It was found that Pt-5-Pt-6 clusters were active for the direct synthesis of phenol, and they provided the reaction sites for bond rearrangements among ammonia, oxygen, and benzene; furthermore, the coexistence of ammonia was crucial for the selective oxidation of benzene to phenol, as it suppressed benzene combustion to CO2 and promoted the selective synthesis of phenol. It was further found that water coexisting in the system also played a significant role in desorbing phenol on the Pt cluster surface, which resulted in promotion of the overall selective synthesis of phenol. The energy diagram for the reaction sequences and the structures of the transition states were obtained, which indicated the origin of the Pt/b catalysis.	[Sasaki, Takehiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Tada, Mizuki] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Wang, Linsheng; Malwadkar, Sachin; Iwasawa, Yasuhiro] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Iwasawa, Yasuhiro] Univ Electrocommun, Innovat Res Ctr Fuel Cells, Chofu, Tokyo 1828585, Japan	Sasaki, T (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan.	takehiko@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26120509]; Institute for Quantum Chemical Exploration (IQCE)	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research on Innovative Areas "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" (No. 26120509) and a Grant-in-Aid for Scientific Research (S). M.T. acknowledges the Japan Society for the Promotion of Science (JSPS) Funding Program for Next Generation World-Leading Researchers. T.S. thanks the Institute for Quantum Chemical Exploration (IQCE) for financial support.	Kubacka A, 2007, J CATAL, V250, P184, DOI 10.1016/j.jcat.2007.05.017; Song SQ, 2010, APPL CATAL A-GEN, V375, P265, DOI 10.1016/j.apcata.2010.01.008; KUNAI A, 1989, B CHEM SOC JPN, V62, P2613, DOI 10.1246/bcsj.62.2613; Choi JS, 2005, APPL CATAL A-GEN, V290, P1, DOI 10.1016/j.apcata.2005.04.060; Bhaumik A, 1998, J CATAL, V178, P101, DOI 10.1006/jcat.1998.2131; Bianchi D, 2007, ADV SYNTH CATAL, V349, P979, DOI 10.1002/adsc.200600371; Gao XH, 2006, APPL CLAY SCI, V33, P1, DOI 10.1016/j.clay.2005.12.002; Cornils B, 2003, J CATAL, V216, P23, DOI 10.1016/S0021-9517(02)00128-8; Hensen EJM, 2005, J CATAL, V233, P136, DOI 10.1016/j.jcat.2005.04.008; Centi G, 2004, CATAL TODAY, V91-2, P17, DOI 10.1016/j.cattod.2004.03.004; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Neidig ML, 2011, CATAL COMMUN, V12, P480, DOI 10.1016/j.catcom.2010.10.024; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Tada M, 2007, J PHYS CHEM C, V111, P10095, DOI 10.1021/jp072928k; Kollmer F, 2004, J CATAL, V227, P398, DOI 10.1016/j.jcat.2004.07.008; Sato K, 2006, CATAL TODAY, V118, P57, DOI 10.1016/j.cattod.2005.11.090; HALGREN TA, 1977, CHEM PHYS LETT, V49, P225, DOI 10.1016/0009-2614(77)80574-5; Molinari R, 2006, CATAL TODAY, V118, P52, DOI 10.1016/j.cattod.2005.11.089; Lemke K, 2003, APPL CATAL A-GEN, V243, P41, DOI 10.1016/S0926-860X(02)00535-5; Bahidsky M, 2005, CATAL TODAY, V99, P187, DOI 10.1016/j.cattod.2004.09.039; Dittmeyer R, 2011, APPL CATAL A-GEN, V391, P311, DOI 10.1016/j.apcata.2010.07.024; Liptakova B, 2000, CATAL TODAY, V61, P143, DOI 10.1016/S0920-5861(00)00359-X; Watari N, 1998, PHYS REV B, V58, P1665, DOI 10.1103/PhysRevB.58.1665; Mita S, 2005, TETRAHEDRON LETT, V46, P7729, DOI 10.1016/j.tetlet.2005.09.016; Tani M, 2005, ANGEW CHEM INT EDIT, V44, P2586, DOI 10.1002/anie.200462769; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Sasaki T, 2009, TOP CATAL, V52, P880, DOI 10.1007/s11244-009-9225-1; Hamada R, 2003, PHYS CHEM CHEM PHYS, V5, P956, DOI 10.1039/b209706k; Liang P, 2010, CATAL COMMUN, V11, P560, DOI 10.1016/j.catcom.2009.12.019; Sato K, 2005, CATAL TODAY, V104, P260, DOI 10.1016/j.cattod.2005.03.067; Orita H, 2004, APPL CATAL A-GEN, V258, P17, DOI 10.1016/j.apcata.2003.08.001; Santra S, 2010, PHYS CHEM CHEM PHYS, V12, P6345, DOI 10.1039/b921531j; Sumimoto S, 2006, IND ENG CHEM RES, V45, P7444, DOI 10.1021/ie060743e; Ivanov AA, 2003, APPL CATAL A-GEN, V249, P327, DOI 10.1016/S0926-860X(03)00224-2; Hoelderich WF, 2000, CATAL TODAY, V62, P115, DOI 10.1016/S0920-5861(00)00413-2; Motz JL, 1998, J MOL CATAL A-CHEM, V136, P175, DOI 10.1016/S1381-1169(98)00048-X; Bahidsky M, 2004, CATAL TODAY, V91-2, P13, DOI 10.1016/j.cattod.2004.03.003; Ene AB, 2011, J PHYS CHEM C, V115, P3688, DOI 10.1021/jp1104664; Bal R, 2006, ANGEW CHEM INT EDIT, V45, P448, DOI 10.1002/anie.200502940; Shiota Y, 2005, ORGANOMETALLICS, V24, P3532, DOI 10.1021/om050136b; Yoshizawa K, 2000, J PHYS CHEM B, V104, P734, DOI 10.1021/jp991844b; Wang LS, 2013, CHEMCATCHEM, V5, P2203, DOI 10.1002/cctc.201300166; PANOV GI, 1992, APPL CATAL A-GEN, V82, P31, DOI 10.1016/0926-860X(92)80003-U; Li Y, 2008, J CATAL, V255, P190, DOI 10.1016/j.jcat.2008.02.001; Lucke B, 2004, ADV SYNTH CATAL, V346, P1407, DOI 10.1002/adsc.200404027; Ichihashi Y, 2010, CATAL LETT, V134, P324, DOI 10.1007/s10562-009-0240-4; Castagnola NB, 2005, APPL CATAL A-GEN, V290, P110, DOI 10.1016/j.apcata.2005.05.022; BELL S, 1984, J CHEM PHYS, V80, P2464, DOI 10.1063/1.446996; Centi G, 2006, APPL CATAL A-GEN, V307, P30, DOI 10.1016/j.apcata.2006.03.018; Niwa S, 2002, SCIENCE, V295, P105, DOI 10.1126/science.1066527; Balducci L, 2003, ANGEW CHEM INT EDIT, V42, P4937, DOI 10.1002/anie.200352184; Passoni LC, 1997, J MOL CATAL A-CHEM, V120, P117, DOI 10.1016/S1381-1169(96)00440-2; Jensen C, 2013, J PHYS CHEM C, V117, P22732, DOI 10.1021/jp406303x; Kuznetsova NI, 2005, CATAL TODAY, V99, P193, DOI 10.1016/j.cattod.2004.09.040; Chammingkwan P, 2009, APPL CATAL A-GEN, V352, P1, DOI 10.1016/j.apcata.2008.09.009; MIYAKE T, 1995, APPL CATAL A-GEN, V131, P33, DOI 10.1016/0926-860X(95)00134-4; Watari N, 1997, J CHEM PHYS, V106, P7531, DOI 10.1063/1.473751; Tada M, 2010, PHYS CHEM CHEM PHYS, V12, P5701, DOI 10.1039/c000843p; Bahidsky M, 2004, PETROL COAL, V46, P49; Bal R., 2006, ANGEW CHEM, V118, P462, DOI 10.1002/ange.200502940; Balducci L., 2003, ANGEW CHEM, V115, P5087, DOI 10.1002/ange.200352184; Ehrich H, 2002, APPL CATAL A-GEN, V230, P271, DOI 10.1016/S0926-860X(02)00040-6; HAGGIN J, 1993, CHEM ENG NEWS, V71, P23, DOI 10.1021/cen-v071n022.p023; JINTOKU T, 1987, CHEM LETT, P1865, DOI 10.1246/cl.1987.1865; Kusakari T, 2004, CHEM COMMUN, P992, DOI 10.1039/b401373e; Laufer W, 2002, CHEM COMMUN, P1684, DOI 10.1039/b204033f; Liptakov B, 2004, APPL CATAL A-GEN, V263, P33, DOI 10.1016/j.apcata.2003.12.002; Mizuno T, 2005, J CHEM ENG JPN, V38, P849, DOI 10.1252/jcej.38.849; Panov G. I., 2000, CATTECH, V4, P18, DOI 10.1023/A:1011991110517; TANEV PT, 1994, NATURE, V368, P321, DOI 10.1038/368321a0; Tani M., 2005, ANGEW CHEM, V117, P2642, DOI 10.1002/ange.200462769; THANGARAJ A, 1990, APPL CATAL, V57, pL1, DOI 10.1016/S0166-9834(00)80718-6	72	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2283	2291		10.1002/asia.201500323		9	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200034		
J	Yokoyama, H; Ueda, Y; Fujita, D; Sato, S; Fujita, M				Yokoyama, Hiroyuki; Ueda, Yoshihiro; Fujita, Daishi; Sato, Sota; Fujita, Makoto			Finely Resolved Threshold for the Sharp M12L24/M24L48 Structural Switch in Multi-Component MnL2n Polyhedral Assemblies: X-ray, MS, NMR, and Ultracentrifugation Analyses	CHEMISTRY-AN ASIAN JOURNAL			English	Article						cage compounds; nanostructures; polyhedera; self-assembly; supramolecular chemistry	IONIZATION MASS-SPECTROMETRY; METAL-ORGANIC POLYHEDRA; COORDINATION CHEMISTRY; M24L48 POLYHEDRA; DESIGN; PRINCIPLES; COMPLEXES; LIGANDS; CAPSULE; FINITE	In the self-assembly of MnL2n polyhedra, the bend angle (theta) of the divalent ligand components determines the final structure. The threshold for the sharp structural switch between M12L24 and M24L48 was finely resolved to within just 4 degrees by demonstrating the exclusive formation of M12L24 cuboctahedra or M24L48 rhombicuboctahedra from two similar ligands with theta values of 130 degrees and 134 degrees. This sharp structural switch was fully confirmed by X-ray crystallography, mass spectrometry, NMR spectroscopy, and ultracentrifugation analyses.	[Yokoyama, Hiroyuki; Ueda, Yoshihiro; Fujita, Daishi; Sato, Sota; Fujita, Makoto] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Yokoyama, Hiroyuki; Ueda, Yoshihiro; Fujita, Daishi; Sato, Sota; Fujita, Makoto] Japan Sci & Technol Agcy JST, ACCEL, Bunkyo Ku, Tokyo 1138656, Japan	Fujita, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, 7-3-1 Hongo, Tokyo 1138656, Japan.	mfujita@appchem.t.u-tokyo.ac.jp			KAKENHI (MEXT) [24685010, 25102007]	We thank Prof. Fumio Arisaka and Prof. Shuichi Hiraoka for experimental support and helpful discussion on AUC. This research was in part supported by KAKENHI (MEXT) (24685010 and 25102007). The synchrotron X-ray crystallography was performed at the NE3A beamline at the KEK Photon Factory (2011G522, 2013G640) and at the BL38B1 beamline at SPring-8 (2012B0039, 2013A0039).	Sakamoto S, 2000, TETRAHEDRON, V56, P955, DOI 10.1016/S0040-4020(99)01092-3; Yamaguchi K, 2003, J MASS SPECTROM, V38, P473, DOI 10.1002/jms.488; Bilbeisi RA, 2013, ANGEW CHEM INT EDIT, V52, P9027, DOI 10.1002/anie.201302976; Fujita M, 2005, ACCOUNTS CHEM RES, V38, P369, DOI 10.1021/ar040153h; Muller A, 1999, CHEM COMMUN, P1347, DOI 10.1039/a901436e; Caulder DL, 1999, ACCOUNTS CHEM RES, V32, P975, DOI 10.1021/ar970224v; Bunzen J, 2012, ANGEW CHEM INT EDIT, V51, P3161, DOI 10.1002/anie.201108731; Hiraoka S, 2006, ANGEW CHEM INT EDIT, V45, P6488, DOI 10.1002/anie.200601431; Abrahams BF, 1999, J AM CHEM SOC, V121, P3535, DOI 10.1021/ja990016t; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; Tominaga M, 2004, ANGEW CHEM INT EDIT, V43, P5621, DOI 10.1002/anie.200461422; Harris K, 2013, CHEM COMMUN, V49, P6703, DOI 10.1039/c3cc43191f; Saalfrank RW, 2008, ANGEW CHEM INT EDIT, V47, P8794, DOI 10.1002/anie.200702075; Young NJ, 2013, CHEM COMMUN, V49, P1354, DOI 10.1039/c2cc37776d; Smulders MMJ, 2013, CHEM SOC REV, V42, P1728, DOI 10.1039/c2cs35254k; Eddaoudi M, 2001, J AM CHEM SOC, V123, P4368, DOI 10.1021/ja0104352; SAALFRANK RW, 1988, ANGEW CHEM INT EDIT, V27, P851, DOI 10.1002/anie.198808511; FUJITA M, 1995, NATURE, V378, P469, DOI 10.1038/378469a0; Saalfrank RW, 2008, ANGEW CHEM INT EDIT, V47, P8941, DOI 10.1002/anie.200804225; Schuck P, 2000, BIOPHYS J, V78, P1606; Meng WJ, 2011, ANGEW CHEM INT EDIT, V50, P3479, DOI 10.1002/anie.201100193; Al-Rasbi NK, 2008, J AM CHEM SOC, V130, P11641, DOI 10.1021/ja803847w; Chakrabarty R, 2011, CHEM REV, V111, P6810, DOI 10.1021/cr200077m; Olenyuk B, 1999, NATURE, V398, P796; Li JR, 2010, NAT CHEM, V2, P893, DOI [10.1038/nchem.803, 10.1038/NCHEM.803]; Caulder DL, 1998, ANGEW CHEM INT EDIT, V37, P1840, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1840::AID-ANIE1840>3.0.CO;2-D; Peixoto TP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041908; Wang XS, 2012, CHEM SCI, V3, P2823, DOI 10.1039/c2sc20330h; Bilbeisi R. A., 2013, ANGEW CHEM, V125, P9197, DOI DOI 10.1002/ANGE.201302976; Bunzen J., 2012, ANGEW CHEM, V124, P3215; Caulder D. L., 1998, ANGEW CHEM, V110, P1940, DOI 10.1002/(SICI)1521-3757(19980703)110:13/14<1940::AID-ANGE1940>3.0.CO;2-J; Fujita D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2093; Fultz B, 2014, PHASE TRANSITIONS IN MATERIALS, P1; Gale P. A., 2012, SUPRAMOLECULAR CHEM; Granzhan A., 2010, ANGEW CHEM, V122, P5647; Granzhan A, 2010, ANGEW CHEM INT EDIT, V49, P5515, DOI 10.1002/anie.201002748; Hiraoka S., 2006, ANGEW CHEM, V118, P6638, DOI 10.1002/ange.200601431; Jensen H. J., 1998, CAMBRIDGE LECT NOTES; Meng W. J., 2011, ANGEW CHEM, V123, P3541, DOI 10.1002/ange.201100193; Mitra-Delmotte G, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00366; Moulton B, 2001, CHEM COMMUN, P863, DOI 10.1039/b102714j; Onuki A., 2002, PHASE TRANSITION DYN; Pasquale S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1793; Saalfrank R. W., 2008, ANGEW CHEM, V120, P8924, DOI 10.1002/ange.200702075; Saalfrank R. W., 2008, ANGEW CHEM, V120, P9073, DOI 10.1002/ange.200804225; Saalfrank R. W., 1988, ANGEW CHEM, V100, P878, DOI 10.1002/ange.19881000623; Sole R. V., 2011, PHASE TRANSITIONS PR; Tominaga M., 2004, ANGEW CHEM, V116, P5739, DOI 10.1002/ange.200461422	48	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	OCT	2015	10	10			SI		2292	2295		10.1002/asia.201500519		4	Chemistry, Multidisciplinary	Chemistry	CT5CE	WOS:000362824200035		
J	Yang, J; Zhou, R; Wei, LL; Yang, HX; Li, JQ; Zhao, ZX; Zheng, GQ				Yang Jie; Zhou Rui; Wei Lin-Lin; Yang Huai-Xin; Li Jian-Qi; Zhao Zhong-Xian; Zheng Guo-Qing			New Superconductivity Dome in LaFeAsO1-xFx Accompanied by Structural Transition	CHINESE PHYSICS LETTERS			English	Article							PHASE-DIAGRAM; IRON; ORDER	High-temperature superconductivity is often found in the vicinity of antiferromagnetism. This is also true in LaFeAsO1-xFx (x <= 0.2) and many other iron-based superconductors, which leads to proposals that superconductivity is mediated by fluctuations associated with the nearby magnetism. Here we report the discovery of a new superconductivity dome without low-energy magnetic fluctuations in LaFeAsO1-xFx with 0.25 <= x <= 0.75, where the maximal critical temperature T-c at x(opt) = 0.5-0.55 is even higher than that at x <= 0.2. By nuclear magnetic resonance and transmission electron microscopy, we show that a C4 rotation symmetry-breaking structural transition takes place for x > 0.5 above T-c. Our results point to a new paradigm of high temperature superconductivity.	[Yang Jie; Zhou Rui; Wei Lin-Lin; Yang Huai-Xin; Li Jian-Qi; Zhao Zhong-Xian; Zheng Guo-Qing] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Yang Jie; Zhou Rui; Wei Lin-Lin; Yang Huai-Xin; Li Jian-Qi; Zhao Zhong-Xian; Zheng Guo-Qing] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Zheng Guo-Qing] Okayama Univ, Dept Phys, Okayama 7008530, Japan	Zheng, GQ (reprint author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.	gqzheng@iphy.ac.cn	Zheng, Guo-qing/B-1524-2011; yang, jie/F-4389-2012	yang, jie/0000-0002-5549-6926	Chinese Academy of Sciences [XDB07020200]; National Basic Research Program of China [2012CB821402, 2011CBA00109, 2011CBA00101]; National Natural Science Foundation of China [11204362]	Supported by the Strategic Priority Research Program of the Chinese Academy of Sciences under Grant No XDB07020200, the National Basic Research Program of China under Grant Nos 2012CB821402, 2011CBA00109 and 2011CBA00101, and the National Natural Science Foundation of China under Grant No 11204362.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Hiraishi M, 2014, NAT PHYS, V10, P300, DOI [10.1038/nphys2906, 10.1038/NPHYS2906]; NARATH A, 1967, PHYS REV, V162, P320, DOI 10.1103/PhysRev.162.320; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Lv WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224506; MORIYA T, 1991, J MAGN MAGN MATER, V100, P261, DOI 10.1016/0304-8853(91)90824-T; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Nakai Y, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045004; Yuan HQ, 2003, SCIENCE, V302, P2104, DOI 10.1126/science.1091648; Kontani H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157001; Mathur ND, 1998, NATURE, V394, P39; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Luetkens H, 2009, NAT MATER, V8, P305, DOI [10.1038/nmat2397, 10.1038/NMAT2397]; Sefat AS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117004; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Lee CC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267001; Fernandes RM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.137001; Graser S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214503; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Lu W, 2008, SOLID STATE COMMUN, V148, P168, DOI 10.1016/j.ssc.2008.07.032; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Chen CC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.100504; Fernandes RM, 2014, NAT PHYS, V10, P97; Fu M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.247001; Iimura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1913; Li Z, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.140506; Ma C, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/47002; Matano K, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/57001; Ning FL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.037001; Oka T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.047001; Ren ZA, 2008, CHINESE PHYS LETT, V25, P2215, DOI 10.1088/0256-307X/25/6/080; Ren ZA, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/17002; Yamase H, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.180502; Zhou R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3265	36	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0256-307X	1741-3540		CHINESE PHYS LETT	Chin. Phys. Lett.	OCT	2015	32	10							107401	10.1088/0256-307X/32/10/107401		6	Physics, Multidisciplinary	Physics	CT6SZ	WOS:000362944000030		
J	Ohishi, S; Sugimoto, S; Hanawa, K				Ohishi, Shun; Sugimoto, Shusaku; Hanawa, Kimio			Zonal movement of the Mascarene High in austral summer	CLIMATE DYNAMICS			English	Article						Mascarene High; Indian Ocean Subtropical Dipole; Southern Annular Mode; El Nino-Southern Oscillation; Storm track activity	SOUTHERN INDIAN-OCEAN; SST DIPOLE EVENTS; VARIABILITY; TEMPERATURE; CIRCULATION; HEMISPHERE; ATLANTIC; MODES	Temporal variations in the Mascarene High (MH), defined by the sea level pressure (SLP) maximum within the region of [40A degrees-120A degrees E, 50A degrees-10A degrees S] in austral summer (November-January), were investigated using atmospheric reanalysis datasets. The MH longitudinal position has a dominant timescale at about 6 years, which appears to be independent of the MH intensity variation. The MH longitudinal movement is caused by a combination of SLP variations in the eastern South Indian Ocean (ESIO) and in the western South Indian Ocean (WSIO), as follows. (1) Pressure variations in the ESIO region are confined to the lower atmosphere up to the mid-troposphere, and are associated with the El Nio-Southern Oscillation events. (2) Pressure variations in the WSIO region, characterized by a quasi-barotropic structure throughout the troposphere, are related to the meridional movement of storm track. Sea surface temperature anomalies associated with the longitudinal movement of the MH show a southwest-northeast dipole structure, but this is shifted 10A degrees westward in longitude compared with that associated with the MH intensity.	[Ohishi, Shun] Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sugimoto, Shusaku; Hanawa, Kimio] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 980, Japan	Ohishi, S (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ohishi@eps.s.u-tokyo.ac.jp			Sasakawa Scientific Research Grant from Japan Science Society	The authors express their sincere gratitude to the members of the Physical Oceanography Group at Tohoku University. Numerous comments from and discussions with Dr. Tozuka and Dr. Morioka were very useful and appreciated. We are also grateful to two anonymous reviewers for their constructive comments, which helped improved our manuscript. The first author was financially supported by the Sasakawa Scientific Research Grant from the Japan Science Society.	Reason CJC, 2001, GEOPHYS RES LETT, V28, P2225, DOI 10.1029/2000GL012735; Nakamura H, 2004, J CLIMATE, V17, P1828, DOI 10.1175/1520-0442(2004)017<1828:SVITSH>2.0.CO;2; Ogawa F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049922; Behera SK, 2001, GEOPHYS RES LETT, V28, P327, DOI 10.1029/2000GL011451; Nan S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018381; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; Morioka Y, 2013, CLIM DYNAM, V41, P1955, DOI 10.1007/s00382-012-1584-9; Ashok K, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038847; Chiodi AM, 2007, J CLIMATE, V20, P4835, DOI 10.1175/JCLI4271.1; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Tozuka T, 2014, CLIM DYNAM, V43, P2197, DOI 10.1007/s00382-013-2044-x; Hermes JC, 2005, J CLIMATE, V18, P2864, DOI 10.1175/JCLI3422.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; Fauchereau N, 2003, INT J CLIMATOL, V23, P663, DOI 10.1002/joc.905; Miyasaka T, 2010, J CLIMATE, V23, P2115, DOI 10.1175/2009JCLI3008.1; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1000:AMITEC>2.0.CO;2; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Suzuki R, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001974; Morioka Y, 2012, J CLIMATE, V25, P4029, DOI 10.1175/JCLI-D-11-00396.1; Manatsa D, 2014, CLIM DYNAM, V42, P1259, DOI 10.1007/s00382-013-1848-z; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Morioka Y, 2010, CLIM DYNAM, V35, P1075, DOI 10.1007/s00382-010-0843-x	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	OCT	2015	45	7-8					1739	1745		10.1007/s00382-014-2427-7		7	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2WV	WOS:000362667100003		
J	Abe, M; Shiogama, H; Yokohata, T; Emori, S; Nozawa, T				Abe, Manabu; Shiogama, Hideo; Yokohata, Tokuta; Emori, Seita; Nozawa, Toru			Asymmetric impact of the physiological effect of carbon dioxide on hydrological responses to instantaneous negative and positive CO2 forcing	CLIMATE DYNAMICS			English	Article						Carbon dioxide physiological effect; Hydrological response; Carbon dioxide forcing; Land surface model; General circulation model	STOMATAL CONDUCTANCE; CLIMATE-CHANGE; MODEL; PHOTOSYNTHESIS; ADJUSTMENT; RUNOFF; LEAVES	We conducted sensitivity experiments using a coupled atmosphere-ocean general circulation model to examine the asymmetry between the hydrological responses to instantaneous positive and negative CO2 forcing and the impact of the CO2 physiological effects (CDPEs) on these responses. This study focuses on the fast response occurring on time scales shorter than 1 year after imposing CO2 forcing. Experiments investigating the CO2 physiological effect show that the fast response of precipitation to positive CO2 forcing is a decrease in the global and annual mean, whereas that of negative forcing is an increase the global and annual mean precipitation. The fast global precipitation response to negative forcing is stronger than the response to positive forcing. In contrast, the experiments without the CDPE reveal similar magnitudes of the fast global precipitation responses to negative and positive CO2 forcing. Significant differences in the magnitudes of the fast precipitation response due to the CDPE are found in tropical regions such as the Amazon Basin, the Maritime Continents, and tropical Africa, where C3-type plants are common. The stomatal conductance of plant leaves is decreased by both positive and negative CO2 forcing, which suppress the transpiration from the leaves. Consequently, the CDPE enhances the asymmetry of the fast precipitation responses to positive and negative CO2 forcing. The asymmetric impact of CDPE requires a careful evaluation of future hydrological changes which is constrained by paleoclimate evidence.	[Abe, Manabu] Japan Agcy Marine Earth Sci & Technol, Dept Integrated Climate Change Predict Res, Yokohama, Kanagawa 2360001, Japan; [Shiogama, Hideo; Yokohata, Tokuta; Emori, Seita] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Nozawa, Toru] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Abe, M (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Integrated Climate Change Predict Res, Yokohama, Kanagawa 2360001, Japan.	abe.mnb@gmail.com	Shiogama, Hideo/B-9598-2012		Program for Risk Information on Climate Change (SOUSEI program) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Environment Research and Technology Development Fund of the Ministry of the Environment of Japan [S-10]	This work was supported by the Program for Risk Information on Climate Change (SOUSEI program) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Environment Research and Technology Development Fund (S-10) of the Ministry of the Environment of Japan. The Earth Simulator at JAMSTEC and an NEC SX at NIES were employed to perform the AOGCM simulations. We thank two anonymous reviewers for helping to significant improve this paper.	Chadwick R, 2013, GEOPHYS RES LETT, V40, P4911, DOI 10.1002/grl.50932; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Boucher O, 2009, CLIM DYNAM, V32, P237, DOI 10.1007/s00382-008-0459-6; Andrews T, 2011, CLIM DYNAM, V36, P783, DOI 10.1007/s00382-010-0742-1; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Andrews T, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011749; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Andrews T, 2009, J CLIMATE, V22, P2557, DOI 10.1175/2008JCLI2759.1; Sellers PJ, 1996, SCIENCE, V271, P1402, DOI 10.1126/science.271.5254.1402; Joshi M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036234; Dong BW, 2009, J CLIMATE, V22, P3079, DOI 10.1175/2009JCLI2652.1; Gregory J, 2008, J CLIMATE, V21, P58, DOI 10.1175/2007JCLI1834.1; Betts RA, 1997, NATURE, V387, P796, DOI 10.1038/42924; Good P, 2012, CLIM DYNAM, V39, P2789, DOI 10.1007/s00382-012-1571-1; COLLATZ GJ, 1992, AUST J PLANT PHYSIOL, V19, P519; Yoshimori M, 2009, J CLIMATE, V22, P3374, DOI 10.1175/2009JCLI2801.1; Chadwick R, 2013, CLIM DYNAM, V40, P295, DOI 10.1007/s00382-012-1287-2; Bala G, 2008, P NATL ACAD SCI USA, V105, P7664, DOI 10.1073/pnas.0711648105; COLLATZ GJ, 1990, PLANT CELL ENVIRON, V13, P219, DOI 10.1111/j.1365-3040.1990.tb01306.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Cao L, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034015; Doutriaux-Boucher M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036273; Emori S, 2004, 1 K 1 MOD DEV; Gregory J. M., 2004, GEOPHYS RES LETT, V31, DOI DOI 10.1029/2003GL018747; Sellers PJ, 1996, J CLIMATE, V9, P676, DOI 10.1175/1520-0442(1996)009<0676:ARLSPF>2.0.CO;2	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	OCT	2015	45	7-8					2181	2192		10.1007/s00382-014-2465-1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2WV	WOS:000362667100030		
J	Duan, WL; He, B; Takara, K; Luo, PP; Hu, MC; Alias, NE; Nover, D				Duan, Weili; He, Bin; Takara, Kaoru; Luo, Pingping; Hu, Maochuan; Alias, Nor Eliza; Nover, Daniel			Changes of precipitation amounts and extremes over Japan between 1901 and 2012 and their connection to climate indices	CLIMATE DYNAMICS			English	Article						Precipitation variation; Extreme indices; Climate indices; Continuous wavelet transform; Japan	PACIFIC DECADAL OSCILLATION; SUMMER MONSOON; DAILY TEMPERATURE; RAINFALL; TRENDS; EVENTS; SERIES; FREQUENCY; WEATHER; REGION	Annual and seasonal precipitation amounts and annual precipitation extreme indices for Japan were characterized for the period 1901-2012 using the Mann-Kendall Tau test, regional analysis, and probability distribution functions, and possible correlations with climate indices including the Atlantic Multidecadal Oscillation, the Pacific Decadal Oscillation, the Southern Oscillation Index (SOI), and the sea surface temperature were explored using wavelet analysis. The results indicate that precipitation amounts exhibited a substantial dec rease at both the annual and seasonal scales, and the fluctuation became more frequent and stronger in the recent decades. Precipitation tended to be concentrated in summer and autumn throughout Japan and the southwest had higher precipitation than the southeast in the spring, summer, and autumn, with precipitation concentrated in the southeast in the winter. On a regional scale, the number of heavy precipitation days, consecutive wet days and total wet-day precipitation indicated a decreasing trend, while an increasing trend for maximum 1- and 5-day precipitation amount, precipitation in very wet days and the number of consecutive dry days. These changes have been an important issue for supplying the demand of water resources in Japan. Continuous wavelet analysis shows that there were significant periodic variations at 2-3 and 5-13 years frequency in extreme precipitation. In addition, climate indices have significant correlations with extreme precipitation, for example, there is statistically significant association between the increasing extreme precipitation and SOI.	[Duan, Weili] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Duan, Weili; He, Bin; Luo, Pingping] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Duan, Weili; He, Bin] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing 210008, Jiangsu, Peoples R China; [Duan, Weili; Luo, Pingping; Hu, Maochuan] Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Kyoto, Japan; [Duan, Weili; Takara, Kaoru; Alias, Nor Eliza] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Nover, Daniel] US Agcy Int Dev, Accra, Ghana	Duan, WL (reprint author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China.	duan.scut.cn@gmail.com; hebin@niglas.ac.cn			National Natural Science Foundation of China [41471460, 41130750]; "One Hundred Talents Program" of the Chinese Academy of Sciences; Kyoto University Global COE program; China Scholarship Council (CSC)	This study was sponsored by the National Natural Science Foundation of China (Nos. 41471460, 41130750), the "One Hundred Talents Program" of the Chinese Academy of Sciences, and the Kyoto University Global COE program "Sustainability/Survivability Science for a Resilient Society Adaptable to Extreme Weather Conditions" and "Global Center for Education and Research on Human Security Engineering for Asian Megacities". We also wish to acknowledge Dr. Enric Aguilar and Dr. Masahito Ishihara for their comments. The first author would like to thank China Scholarship Council (CSC) for his PhD scholarships.	Aguilar E, 2003, WMO TD, V1186, P53; Aguilar E, 2009, J GEOPHYS RES, V114, P10; Alexander L., 2006, J GEOPHYS RES-ATMOS, V1984-2012, P111, DOI DOI 10.1029/2005JD006290; Li ZX, 2012, GLOBAL PLANET CHANGE, V80-81, P255, DOI 10.1016/j.gloplacha.2011.06.008; Manton MJ, 2001, INT J CLIMATOL, V21, P269, DOI 10.1002/joc.610; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Jin YH, 2005, J HYDROL, V301, P54, DOI 10.1016/j.jhydrol.2004.06.026; Giorgi F, 2000, GEOPHYS RES LETT, V27, P1295, DOI 10.1029/1999GL011016; Vincent LA, 2005, J CLIMATE, V18, P5011, DOI 10.1175/JCLI3589.1; Zalina MD, 2002, WATER SCI TECHNOL, V45, P63; Krishnan R, 2003, CLIM DYNAM, V21, P233, DOI 10.1007/s00382-003-0330-8; Sillmann J, 2013, J GEOPHYS RES-ATMOS, V118, P1716, DOI 10.1002/jgrd.50203; Zhai PM, 2005, J CLIMATE, V18, P1096, DOI 10.1175/JCLI-3318.1; Nakamura H, 2002, J CLIMATE, V15, P1855, DOI 10.1175/1520-0442(2002)015<1855:IADMRO>2.0.CO;2; Kimoto M, 2005, SOLA, V1, P85, DOI 10.2151/sola.2005.023; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Villarini G, 2011, J HYDROL, V400, P103, DOI 10.1016/j.jhydrol.2011.01.027; Fujibe F, 2013, ATMOS SCI LETT, V14, P127, DOI 10.1002/asl2.428; Jung HS, 2002, INT J CLIMATOL, V22, P1327, DOI 10.1002/joc.797; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561; Duan WL, 2014, NAT HAZARDS, V73, P1255, DOI 10.1007/s11069-014-1134-3; Kuo YM, 2011, J HYDROL, V409, P749, DOI 10.1016/j.jhydrol.2011.09.015; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Haylock M, 2000, INT J CLIMATOL, V20, P1533, DOI 10.1002/1097-0088(20001115)20:13<1533::AID-JOC586>3.0.CO;2-J; Wang XLL, 2008, J APPL METEOROL CLIM, V47, P2423, DOI 10.1175/2008JAMC1741.1; Qian W, 2002, THEOR APPL CLIMATOL, V73, P151, DOI 10.1007/s00704-002-0679-3; Saito H, 2010, GEOMORPHOLOGY, V118, P167, DOI 10.1016/j.geomorph.2009.12.016; del Rio S, 2011, INT J CLIMATOL, V31, P656, DOI 10.1002/joc.2111; Wang B, 2013, P NATL ACAD SCI USA, V110, P5347, DOI 10.1073/pnas.1219405110; Lee SM, 2012, J APPL METEOROL CLIM, V51, P1087, DOI 10.1175/JAMC-D-11-0157.1; Rajczak J, 2013, J GEOPHYS RES-ATMOS, V118, P3610, DOI 10.1002/jgrd.50297; Miyajima J, 2011, SOLA, V7, P157, DOI 10.2151/sola.2011-040; Kawamoto N, 2011, INT GEOSCI REMOTE SE, P2590, DOI 10.1109/IGARSS.2011.6049771; Choi G, 2009, INT J CLIMATOL, V29, P1906, DOI 10.1002/joc.1979; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Fujibe F, 2006, J METEOROL SOC JPN, V84, P1033, DOI 10.2151/jmsj.84.1033; Fujibe F, 2005, SOLA, V1, P41, DOI 10.2151/sola.2005.012; Duan WL, 2013, CHEMOSPHERE, V93, P946, DOI [10.1016/j.chemosphere.2013.05.060, 10.1016/j.chemoshere.2013.05.060]; Chang CP, 2000, J CLIMATE, V13, P4310, DOI 10.1175/1520-0442(2000)013<4310:IAIVOT>2.0.CO;2; Iwasaki H, 2009, SOLA, V5, P157, DOI 10.2151/sola.2009-040; Sen Roy S, 2004, INT J CLIMATOL, V24, P457, DOI 10.1002/joc.995; Wang XL, 2003, J CLIMATE, V16, P3383, DOI 10.1175/1520-0442(2003)016<3383:CODOUC>2.0.CO;2; Krishnamurthy CKB, 2009, J CLIMATE, V22, P4737, DOI 10.1175/2009JCLI2896.1; Suzuki Kenji, 2006, Journal of Agricultural Meteorology, V62, P127, DOI 10.2480/agrmet.62.127; Yamaguchi K, 2006, J METEOROL SOC JPN, V84, P221, DOI 10.2151/jmsj.84.221; Villafuerte MQ, 2014, ATMOS RES, V137, P1, DOI 10.1016/j.atmosres.2013.09.021; Sugiyama M, 2010, P NATL ACAD SCI USA, V107, P571, DOI 10.1073/pnas.0903186107; Bertacchi UC, 2001, HYDROL EARTH SYST SC, V5, P259, DOI 10.5194/hess-5-259-2001; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031601; Guttman NB, 1998, HOMOGENEITY DATA ADJ; Hipel KW, 2005, TIME SERIES MODELLIN; Latif M, 2003, GEOPHYS RES LETT, V30, P10; Press W. H., 2007, NUMERICAL RECIPES; Rowell DP, 2012, CLIM DYNAM, V39, P1929, DOI 10.1007/s00382-011-1210-2; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; Stocker T. F., 2013, CLIMATE CHANGE 2013; Takeshita S., 2010, Bulletin of the Faculty of Agriculture, Miyazaki University, V56, P73; Wang YQ, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL023344, 10.1029/2005GL022574]; Zhang X, 2004, RCLIMDEX 1 0 USER MA; Zhang XB, 2011, WIRES CLIM CHANGE, V2, P851, DOI 10.1002/wcc.147	62	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	OCT	2015	45	7-8					2273	2292		10.1007/s00382-015-2778-8		20	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2WV	WOS:000362667100035		
J	Takei, K; Mitoma, C; Hashimoto-Hachiya, A; Takahara, M; Tsuji, G; Nakahara, T; Furue, M				Takei, K.; Mitoma, C.; Hashimoto-Hachiya, A.; Takahara, M.; Tsuji, G.; Nakahara, T.; Furue, M.			Galactomyces fermentation filtrate prevents T helper 2-mediated reduction of filaggrin in an aryl hydrocarbon receptor-dependent manner	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Article							ATOPIC-DERMATITIS; DIOXIN RECEPTOR; SKIN BARRIER; KERATINOCYTE DIFFERENTIATION; EXPRESSION; MECHANISMS; AHR	Background. The aryl hydrocarbon receptor (AhR) recognizes diverse small molecules such as dioxins, tryptophan photoproducts and phytochemicals. It also plays crucial roles in epidermal homeostasis by upregulating epidermal barrier proteins. In preliminary screening, we found that Galactomyces fermentation filtrate (GFF), a cosmetic compound, was capable of activating AhR. Aim. To examine whether GFF upregulates the expression of the filaggrin and loricrin genes, FLG and LOR, in an AhR-dependent manner. Methods. The activation (cytoplasmic to nuclear translocation) of AhR was confirmed by immunofluorescence study and by upregulation of an AhR-specific marker, cytochrome P450-1A1 (CYP1A1). Gene expression levels were compared by quantitative reverse transcription PCR with or without GFF, interleukin (IL)-4 or IL-13 in normal human keratinocytes. AhR or control knockdown was carried out by transfection with AhR or control small interfering RNA. The protein expression of FLG and LOR was examined by immunohistochemistry using a three-dimensional epidermal equivalent treated with or without GFF or T helper (Th) 2 cytokines. Results. GFF induced the nuclear translocation of AhR with significant and dose-dependent upregulation of CYP1A1, FLG and LOR gene expression. The enhancing effects of GFF were abolished in AhR-knockdown keratinocytes. Th2 cytokines decreased expression of genes for FLG and LOR, and this expression was completely restored in the presence of GFF. The downregulated expression of the FLG gene with its restoration by GFF was also evident in the epidermal equivalent. GFF also upregulated the gene expression of genes encoding occludin, claudin-1 and 4, and kallikrein 5 and 7. Conclusions. Use of GFF is feasible to prevent the Th2-mediated reduction of FLG in an AhR-dependent fashion.	[Takei, K.; Mitoma, C.; Hashimoto-Hachiya, A.; Takahara, M.; Tsuji, G.; Nakahara, T.; Furue, M.] Kyushu Univ, Dept Dermatol, Fukuoka 8128582, Japan; [Mitoma, C.; Furue, M.] Kyushu Univ, Res & Clin Ctr Yusho & Dioxin, Fukuoka 8128582, Japan; [Nakahara, T.; Furue, M.] Kyushu Univ, Div Skin Surface Sensing, Fukuoka 8128582, Japan	Furue, M (reprint author), Kyushu Univ, Dept Dermatol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	furue@dermatol.med.kyushu-u.ac.jp			P&G Innovation Godo Kaisha; Ministry of Health, Labour and Welfare; Environment Technology Development Fund of the Ministry of the Environment, Japan	This work was partly supported by research grants from P&G Innovation Godo Kaisha, the Ministry of Health, Labour and Welfare, and the Environment Technology Development Fund of the Ministry of the Environment, Japan.	Ray SS, 2003, TOXICOL APPL PHARM, V192, P131, DOI 10.1016/S0041-008X(03)00277-1; McLean WHI, 2013, J CLIN INVEST, V123, P551, DOI 10.1172/JCI67438; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Kim B, 2014, PHYTOTHER RES, V28, P1359, DOI 10.1002/ptr.5138; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Magiatis P, 2013, J INVEST DERMATOL, V133, P2023, DOI 10.1038/jid.2013.92; Kohda F, 2013, J DERMATOL SCI, V72, P75, DOI 10.1016/j.jdermsci.2013.05.008; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Loertscher JA, 2001, TOXICOL APPL PHARM, V175, P121, DOI 10.1006/taap.2001.9202; Loertscher JA, 2002, TOXICOL SCI, V68, P465, DOI 10.1093/toxsci/68.2.465; Rico-Leo EM, 2013, J BIOL CHEM, V288, P7841, DOI 10.1074/jbc.M112.425009; Elias PM, 2014, J ALLERGY CLIN IMMUN, V134, P781, DOI 10.1016/j.jaci.2014.05.048; Furue M, 2014, ARCH DERMATOL RES, V306, P769, DOI 10.1007/s00403-014-1481-7; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Mohammadi-Bardbori A, 2012, CHEM RES TOXICOL, V17, P1878; Wong WR, 2011, J COSMET DERMATOL SC, V1, P15	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	OCT	2015	40	7					786	793		10.1111/ced.12635		8	Dermatology	Dermatology	CT5JS	WOS:000362846300015		
J	Imaizumi, T; Aizawa, T; Segawa, C; Shimada, M; Tsuruga, K; Kawaguchi, S; Matsumiya, T; Yoshida, H; Joh, K; Tanaka, H				Imaizumi, Tadaatsu; Aizawa, Tomomi; Segawa, Chihiro; Shimada, Michiko; Tsuruga, Kazushi; Kawaguchi, Shogo; Matsumiya, Tomoh; Yoshida, Hidemi; Joh, Kensuke; Tanaka, Hiroshi			Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						CXCL1; Human mesangial cells; IFN-beta; Inflammatory renal diseases; Lupus nephritis; Psuedoviral immunity; TLR3	POLYINOSINIC-POLYCYTIDYLIC ACID; INDUCIBLE GENE-I; LUPUS NEPHRITIS; INNATE IMMUNITY; GLOMERULAR EXPRESSION; ENDOTHELIAL-CELLS; PATHOGENESIS; INVOLVEMENT; PROTEIN-1; INFECTION	Mesangial proinflammatory chemokine/cytokine expressions via innate immunity play a pivotal role in the pathogenesis of glomerulonephritis. CXCL1/GRO alpha is a strong neutrophil chemoattractant cytokine and reportedly plays an important role in regional inflammatory reactions. However, detailed signaling of mesangial CXCL1 expression induced by viral or "pseudoviral" immunity remains to be determined. We treated normal human mesangial cells (MCs) in culture with polyinosinic-polycytidylic acid (poly IC), an authentic double-stranded RNA, and analyzed the expression of CXCL1 by reverse transcription-polymerase chain reaction (RT-PCR), real-time quantitative RT-PCR and enzyme-linked immunosorbent assay. To elucidate the poly IC-induced signaling pathway for CXCL1 expression, we subjected the cells to RNA interference against Toll-like receptor (TLR) 3, retinoic acid-inducible gene-I (RIG-I), melanoma differentiation-associated gene 5 (MDA5), interferon (IFN)-beta, nuclear factor (NF)-kappa B p65 and IFN regulatory factor (IRF) 3. We also conducted an immunofluorescence study to examine mesangial CXCL1 expression in biopsy specimens from patients with lupus nephritis (LN) and IgA nephropathy (IgAN). We found that activation of TLR3 signaling could induce the expression of CXCL1 in MCs. NF-kappa B, IRF3 and IFN-beta, but neither RIG-I nor MDA5, were found to be involved in mesangial CXCL1 expression in this setting. Induction of CXCL1 by poly IC was inhibited by pretreatment of cells with dexamethasone. Intense glomerular CXCL1 expression was observed in biopsy specimens from patients with LN, whereas only a trace staining occurred in specimens from patients with IgAN. TLR3 signaling also contributes to the CXCL1 expression in MCs. These observations further support the implication of viral and "pseudoviral" immunity in the pathogenesis of inflammatory renal diseases, especially in LN.	[Imaizumi, Tadaatsu; Segawa, Chihiro; Matsumiya, Tomoh; Yoshida, Hidemi] Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan; [Aizawa, Tomomi; Tsuruga, Kazushi; Tanaka, Hiroshi] Hirosaki Univ Hosp, Dept Pediat, Hirosaki, Aomori 0368563, Japan; [Shimada, Michiko] Hirosaki Univ, Grad Sch Med, Dept Cardiol Resp Med & Nephrol, Hirosaki, Aomori 0368562, Japan; [Kawaguchi, Shogo] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Hirosaki, Aomori 0368562, Japan; [Joh, Kensuke] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Tanaka, Hiroshi] Hirosaki Univ, Dept Sch Hlth Sci, Fac Educ, Hirosaki, Aomori 0368560, Japan	Tanaka, H (reprint author), Hirosaki Univ, Dept Sch Hlth Sci, Fac Educ, 1 Bunkyo Cho, Hirosaki, Aomori 0368560, Japan.	hirotana@cc.hirosaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant for Hirosaki University Institutional Research	This work was supported by grants-in-aid for Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T. I., M. S. and H. T.), and by Grant for Hirosaki University Institutional Research (T. I. and T. M.). The authors thank A. Yamamoto, K. Nakata, A. Ono and K. Munakata for assistance.	Flur K, 2009, AM J PATHOL, V175, P2014, DOI 10.2353/ajpath.2009.080585; Aizawa-Yashiro T, 2013, PEDIATR RES, V73, P180, DOI 10.1038/pr.2012.165; Imaizumi T, 2002, BIOCHEM BIOPH RES CO, V292, P274, DOI 10.1006/bbrc.2002.6650; Imaizumi T, 2012, TOHOKU J EXP MED, V228, P17, DOI 10.1620/tjem.228.17; Coppo R, 2010, J NEPHROL, V23, P626; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Imaizumi T, 2010, NEPHROL DIAL TRANSPL, V25, P3534, DOI 10.1093/ndt/gfq270; Wood LD, 1995, J BIOL CHEM, V270, P30619; Imaizumi T, 2011, NEPHRON EXP NEPHROL, V119, pE40, DOI 10.1159/000328923; Watanabe S, 2013, NEPHROLOGY, V18, P833, DOI 10.1111/nep.12155; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Carrigan SO, 2010, J IMMUNOL, V185, P3602, DOI 10.4049/jimmunol.0903429; Tanaka H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/984708; Yamashita M, 2013, J INNATE IMMUN, V5, P231, DOI 10.1159/000345255; Zernecke A, 2001, J IMMUNOL, V166, P5755; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Anders HJ, 2009, TRENDS MOL MED, V15, P553, DOI 10.1016/j.molmed.2009.10.004; Migliorini A, 2013, J NEPHROL, V26, P437, DOI 10.5301/jn.5000247; Aizawa T, 2014, NEPHROLOGY, V19, P47, DOI 10.1111/nep.12171; Kanapathippillai P, 2013, CYTOKINE, V62, P244, DOI 10.1016/j.cyto.2013.03.016; Robson MG, 2009, NEPHRON EXP NEPHROL, V113, pE1, DOI 10.1159/000228077; Zhu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054028	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					761	770		10.1007/s10157-014-1060-4		10	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700001		
J	Yasuoka, Y; Sato, Y; Healy, JM; Nonoguchi, H; Kawahara, K				Yasuoka, Yukiko; Sato, Yuichi; Healy, Jillian M.; Nonoguchi, Hiroshi; Kawahara, Katsumasa			pH-sensitive expression of calcium-sensing receptor (CaSR) in type-B intercalated cells of the cortical collecting ducts (CCD) in mouse kidney	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Calcium-sensing receptor; Neomycin; Urinary calcium concentration; Acid/base diet; Kidney collecting duct intercalated cell	EXTRACELLULAR CA2+-SENSING RECEPTOR; VASOPRESSIN V1A RECEPTOR; RAT-KIDNEY; URINARY ACIDIFICATION; PTH/PTHRP RECEPTOR; CL-/HCO3-EXCHANGER; METABOLIC-ACIDOSIS; LOCALIZATION; PENDRIN; CLONING	The localization and role of the calcium-sensing receptor (CaSR) along the nephron including the collecting ducts is still open to debate. Using the quantitative, highly sensitive in situ hybridization technique and a double-staining immunohistochemistry technique, we investigated the axial distribution and expression of CaSR along the nephron in mice (C57B/6J) treated for 6 days with acid or alkali diets. Under control condition, CaSR was specifically localized in the cortical and medullary thick ascending limb of Henle's loop (CTAL and MTAL), macula densa (MD), distal convoluted tubule (DCT), and CCD (TALs, MD > DCT, CCD). Along the CCD, CaSR was co-localized with an anion exchanger type 4 (AE4), a marker of the basolateral membrane of type-B intercalated cell (IC-B) in mice. On the contrary, CaSR was not detected either in principal cells (PC) or in type-A intercalated cell (IC-A). CaSR expression levels in IC-B significantly (P < 0.005) decreased when mice were fed NH4Cl (acid) diets and increased when animals were given NaHCO3 (alkali) diets. As expected, cell heights of IC-A and IC-B significantly (P < 0.005) increased in the above experimental conditions. Surprisingly, single infusion (ip) of neomycin, an agonist of CaSR, significantly (P < 0.005) increased urinary Ca excretion without further increasing the hourly urine volume and significantly (P < 0.05) decreased urine pH. CaSR, cloned from rat kidney, was localized in the basolateral membrane of IC-B and was more expressed during alkali-loading. Its alkali-sensitive expression may promote urinary alkali secretion for body acid-base balance.	[Yasuoka, Yukiko; Kawahara, Katsumasa] Kitasato Univ, Sch Med, Dept Physiol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Yasuoka, Yukiko; Kawahara, Katsumasa] Kitasato Univ, Grad Sch Med Sci, Dept Cellular & Mol Physiol, Sagamihara, Kanagawa 2520374, Japan; [Sato, Yuichi] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa 2520374, Japan; [Healy, Jillian M.] Univ Tokyo, Coll Art & Sci, ALESS Program, Komaba Org Educ Excellence,Meguro Ku, Tokyo 1538902, Japan; [Nonoguchi, Hiroshi] Kitasato Univ, Div Internal Med, Med Ctr, Kitamoto 3648501, Japan	Kawahara, K (reprint author), Kitasato Univ, Sch Med, Dept Physiol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	kawahara@kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24790222, 23591224, 26461259]	This study was supported by grants from the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Y.Y. (No. 24790222) and to K.K. (No. 23591224, 26461259). Special thanks are given to Y. Nakabayashi (Kitasato Univ Sch of Med) for her technical assistance. Parts of this study were presented at the meetings of American Society of Nephrology (Philadelphia, 2011) and International Union of Physiological Sciences (Birmingham (UK), 2013).	Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Brown EM, 2001, PHYSIOL REV, V81, P239; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; KERSTENS HMJ, 1995, J HISTOCHEM CYTOCHEM, V43, P347; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Yasuoka Y, 2013, CLIN EXP NEPHROL, V17, P783, DOI 10.1007/s10157-013-0783-y; Quinn SJ, 2004, J BIOL CHEM, V279, P37241, DOI 10.1074/jbc.M404520200; Yasuoka Y, 2013, CLIN EXP NEPHROL, V17, P183, DOI 10.1007/s10157-012-0686-3; MADSEN KM, 1984, LAB INVEST, V51, P268; Chambrey R, 2013, P NATL ACAD SCI USA, V110, P7928, DOI 10.1073/pnas.1221496110; KRIZ W, 1988, KIDNEY INT, V33, P1; Wagner CA, 2002, KIDNEY INT, V62, P2109, DOI 10.1046/j.1523-1755.2002.00671.x; Loretz CA, 2008, COMP BIOCHEM PHYS A, V149, P225, DOI 10.1016/j.cbpa.2008.01.037; Brown D, 2012, J AM SOC NEPHROL, V23, P774, DOI 10.1681/ASN.2012010029; Loupy A, 2012, J CLIN INVEST, V122, P3355, DOI 10.1172/JCI57407; Toka HR, 2012, J AM SOC NEPHROL, V23, P1879, DOI 10.1681/ASN.2012030323; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Sands JM, 1997, J CLIN INVEST, V99, P1399, DOI 10.1172/JCI119299; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Hebert SC, 1997, J EXP BIOL, V200, P295; Houillier P, 2013, CURR OPIN NEPHROL HY, V22, P566, DOI 10.1097/MNH.0b013e328363ff5f; BROWN EM, 1994, NEPHROL DIAL TRANSPL, V9, P1703; Bergsland KJ, 2009, AM J PHYSIOL-RENAL, V297, pF1017, DOI 10.1152/ajprenal.00223.2009; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; Tsuganezawa H, 2001, J BIOL CHEM, V276, P8180, DOI 10.1074/jbc.M004513200; Kobayashi M, 2011, CLIN EXP NEPHROL, V15, P355, DOI 10.1007/s10157-011-0414-4; Suzuki T, 2003, ARCH HISTOL CYTOL, V66, P347, DOI 10.1679/aohc.66.347; Ikebe M, 2001, J AM SOC NEPHROL, V12, P423; Casare F, 2014, CAN J PHYSIOL PHARM, V92, P181, DOI 10.1139/cjpp-2013-0256; Alfadda TI, 2014, AM J PHYSIOL-CELL PH, V307, pC221, DOI 10.1152/ajpcell.00139.2014; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Sumida K, 2013, AM J NEPHROL, V37, P405, DOI 10.1159/000350211; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611; Chattopadhyay N, 1996, AM J PHYSIOL-RENAL, V271, pF736; Ko SBH, 2002, AM J PHYSIOL-CELL PH, V283, pC1206, DOI 10.1152/ajpcell.00512.2001; Purkerson JM, 2014, AM J PHYSIOL-RENAL, V307, pF601, DOI 10.1152/ajprenal.00404.2013; Riccardi D, 1996, AM J PHYSIOL-RENAL, V271, pF951; Xu J, 2003, AM J PHYSIOL-GASTR L, V285, pG1225, DOI 10.1152/ajpgi.00236.2003; Yang TX, 1997, AM J PHYSIOL-RENAL, V272, pF751	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					771	782		10.1007/s10157-014-1063-1		12	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700002		
J	Sato, Y; Fujimoto, S; Konta, T; Iseki, K; Moriyama, T; Yamagata, K; Tsuruya, K; Kimura, K; Narita, I; Kondo, M; Asahi, K; Kurahashi, I; Ohashi, Y; Watanabe, T				Sato, Yuji; Fujimoto, Shouichi; Konta, Tsuneo; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Kimura, Kenjiro; Narita, Ichiei; Kondo, Masahide; Asahi, Koichi; Kurahashi, Issei; Ohashi, Yasuo; Watanabe, Tsuyoshi			Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Specific Health Checkup; Estimated GFR; Body mass index; Cardiovascular disease; Cerebrovascular disease	CHRONIC KIDNEY-DISEASE; METABOLIC SYNDROME; RISK-FACTOR; PROTEINURIA; ATHEROSCLEROSIS; GLUCOSE; SYSTEM	The Japanese Specific Health Checkup mainly focuses on metabolic syndrome for preventing cardiovascular events. Subjects are stratified by measuring waist circumference, body mass index, blood pressure, triglycerides, and fasting plasma glucose. However, estimated glomerular filtration rate (eGFR) is not considered essential. A longitudinal cohort study assessed the association of eGFR with new-onset brain or heart attacks in a large Japanese nationwide Specific Health Checkup database. A total of 109,349 Japanese subjects (mean age 63.2 years, 39.5 % men) were examined for the events 2 years later. The odds ratios were calculated for new events in the total and subgroup populations divided by BMI < or a parts per thousand yen25 kg/m(2), obese and non-obese, respectively. Obese subjects were more often male and had proteinuria (dipstick test a parts per thousand yen1+), lower eGFR, and higher systolic and diastolic BP, fasting plasma glucose, hemoglobin A1c, and triglycerides (TG). Rates of new-onset brain or heart attacks were 3.1 and 4.0 % in the groups of non-obese and obese subjects, respectively. In the total population, eGFR as well as higher BMI (a parts per thousand yen25 kg/m(2)), higher BP (high-normal hypertension or greater), higher TG (a parts per thousand yen150 mg/dl), and proteinuria were significant risk factors for developing brain or heart attacks. The eGFR was significant in non-obese subjects, but not in the obese. As the ultimate aim of 'Specific Health Checkup' is to prevent cardiovascular events, our study suggests that eGFR should be evaluated in non-obese subjects.	[Sato, Yuji] Univ Miyazaki Hosp, Dialysis Div, Kiyotake, Miyazaki 8891692, Japan; [Fujimoto, Shouichi] Miyazaki Univ, Fac Med, Dept Hemovasc Med & Artificial Organs, Miyazaki, Japan; [Konta, Tsuneo; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Kimura, Kenjiro; Narita, Ichiei; Kondo, Masahide; Asahi, Koichi; Watanabe, Tsuyoshi] Steering Comm Design Comprehens Hlth Care Syst CK, Individual Risk Assessment Specif Hlth Checkups, Fukushima, Japan; [Kurahashi, Issei] iAnalysis LLC, Tokyo, Japan; [Ohashi, Yasuo] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan	Sato, Y (reprint author), Univ Miyazaki Hosp, Dialysis Div, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	ysato@med.miyazaki-u.ac.jp			Ministry of Health, Labour and Welfare of Japan [20230601]	This work was supported by Health and Labour Sciences Research Grants for "Research on the Positioning of Chronic Kidney Disease in Specific Health Check and Guidance in Japan" (20230601) from the Ministry of Health, Labour and Welfare of Japan.	American Diabetes Association, 2011, DIABETES CARE S1, V34, pS62, DOI DOI 10.2337/DC11-S062; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Iseki K, 2012, CLIN EXP NEPHROL, V16, P244, DOI 10.1007/s10157-011-0551-9; Nagai K, 2014, NEPHROLOGY, V19, P574, DOI 10.1111/nep.12286; Palatini P, 2006, KIDNEY INT, V70, P578, DOI 10.1038/sj.ki.5001603; Sato Y, 2012, NEPHROL DIAL TRANSPL, V27, P3862, DOI 10.1093/ndt/gfs324; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Kohro T, 2008, INT HEART J, V49, P193, DOI 10.1536/ihj.49.193; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Yano Y, 2012, DIABETES CARE, V35, P1310, DOI 10.2337/dc11-2245; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Konta T, 2007, CLIN EXP NEPHROL	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					790	796		10.1007/s10157-014-1062-2		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700004		
J	Hayashi, N; Akiyama, S; Okuyama, H; Matsui, Y; Adachi, H; Yamaya, H; Maruyama, S; Imai, E; Matsuo, S; Yokoyama, H				Hayashi, Norifumi; Akiyama, Shin'ichi; Okuyama, Hiroshi; Matsui, Yuki; Adachi, Hiroki; Yamaya, Hideki; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi; Yokoyama, Hitoshi			Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Electron microscopic findings; IgG subclass staining; Membranous nephropathy; Phospholipase A2 receptor; Western blotting	RENAL BIOPSIES; AUTOANTIBODIES; ANTIBODIES; SUBCLASS; GLOMERULONEPHRITIS; MALIGNANCY; DEPOSITS; OUTCOMES; IGG4	Recent studies have suggested that assessments of serum antibodies against M-type phospholipase A2 receptor (PLA2R) and the glomerular expression of PLA2R antigen in biopsy specimens are useful for the diagnosis of primary membranous nephropathy (MN). In this study, we assessed both of them and investigated the clinicopathological characteristics of PLA2R-related Japanese MN. We retrospectively enrolled 22 primary and 3 secondary Japanese patients whose serum samples and renal specimens were collected before treatment. According to the findings of serum antibodies and antigen in glomeruli, the primary MN patients were classified into PLA2R-related or -unrelated MN. We compared their clinicopathological findings, including IgG subclass staining, and electron microscopic findings, and evaluated the predictors of proteinuria remission. In primary MN, 16 patients (73 %) were classified into the PLA2R-related group, and 6 patients into the PLA2R-unrelated group. There was no significant difference in baseline laboratory data and electron microscopic findings, except for eGFR and serum IgG levels. IgG4-dominant deposition was more common in the related group (63 vs. 0 %). The 10 PLA2R-related patients with dominant IgG4 deposition had a lower rate and prolonged time in remission compared with the 6 PLA2R-related patients with non-dominant IgG4 (log-rank, p = 0.032). Furthermore, dominant IgG4 deposition was an unfavorable predictor of remission by multivariable Cox proportional hazard analysis. Assessments of both serum PLA2R antibodies and PLA2R antigen in glomeruli were more sensitive for the diagnosis of PLA2R-related MN, and among affected Japanese patients, those with dominant IgG4 deposition had worse clinical outcomes.	[Hayashi, Norifumi; Okuyama, Hiroshi; Matsui, Yuki; Adachi, Hiroki; Yamaya, Hideki; Yokoyama, Hitoshi] Kanazawa Med Univ, Div Nephrol, Uchinada, Ishikawa 9200293, Japan; [Akiyama, Shin'ichi; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Nephrol,Showa Ku, Nagoya, Aichi 4668550, Japan	Yokoyama, H (reprint author), Kanazawa Med Univ, Div Nephrol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	h-yoko@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [25461237, 24406029, 2530502]; Ministry of Health, Labour, and Welfare of Japan	We are grateful to the staff members of the Division of Nephrology for their cooperation and support. This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; (C) No. 25461237 (HY), (B) No. 24406029 (HY), and (B) No. 2530502 (HY, SM), and a Grant-in-Aid for Progressive Renal Disease Research and Intractable Renal Disease Research, Research on Rare and Intractable Diseases, and Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare of Japan.	Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Rahimi S, 2004, AM J TRANSPLANT, V4, P326, DOI 10.1111/j.1600-6143.2004.00334.x; Yokoyama H, 1999, NEPHROL DIAL TRANSPL, V14, P2379, DOI 10.1093/ndt/14.10.2379; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Ohtani H, 2004, NEPHROL DIAL TRANSPL, V19, P574, DOI 10.1093/ndt/gfg616; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Yoshimoto K, 2004, KIDNEY INT, V65, P148, DOI 10.1111/j.1523-1755.2004.00403.x; EHRENREICH T, 1976, NEW ENGL J MED, V295, P741, DOI 10.1056/NEJM197609302951401; Huang CC, 2013, MODERN PATHOL, V26, P799, DOI 10.1038/modpathol.2012.237; Kuroki A, 2005, KIDNEY INT, V68, P302, DOI 10.1111/j.1523-1755.2005.00415.x; Qu Z, 2012, NEPHROL DIAL TRANSPL, V27, P1931, DOI 10.1093/ndt/gfr534; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Debiec H, 2012, J AM SOC NEPHROL, V23, P1949, DOI 10.1681/ASN.2012060577; Larsen CP, 2013, MODERN PATHOL, V26, P709, DOI 10.1038/modpathol.2012.207; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Salant DJ, 2013, J AM SOC NEPHROL, V24, P525, DOI 10.1681/ASN.2013020166; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.x; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					797	803		10.1007/s10157-014-1064-0		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700005		
J	Fujimoto, K; Imura, J; Atsumi, H; Matsui, Y; Adachi, H; Okuyama, H; Yamaya, H; Yokoyama, H				Fujimoto, Keiji; Imura, Junko; Atsumi, Hirokatsu; Matsui, Yuki; Adachi, Hiroki; Okuyama, Hiroshi; Yamaya, Hideki; Yokoyama, Hitoshi			Clinical significance of serum and urinary soluble urokinase receptor (suPAR) in primary nephrotic syndrome and MPO-ANCA-associated glomerulonephritis in Japanese	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						suPAR; Nephrotic syndrome; MPO-ANCA-associated glomerulonephritis	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PLASMINOGEN-ACTIVATOR RECEPTOR; PRIMARY FSGS; CHILDREN	The soluble urokinase receptor (suPAR) has been implicated as a cause of primary focal segmental glomerulosclerosis (FSGS). However, the clinical significance of suPAR in glomerular diseases currently remains unclear. In this retrospective single-center cohort study, we investigated serum (s-) and urinary (u-) suPAR in patients with primary nephrotic syndrome (NS) (serum/urine: 37/32 cases) and MPO-ANCA-associated glomerulonephritis (ANCA-GN) (serum/urine: 13/11 cases). In pretreatment s- and u-suPAR, no significant differences were observed between the primary NS and ANCA-GN groups or among the pathological types of primary NS. An inverse correlation was noted between pretreatment s-suPAR and eGFR in the primary NS and ANCA-GN groups. A positive correlation was noted between pretreatment u-suPAR and proteinuria in the primary NS group. Furthermore, time-course changes in s- and u-suPAR over 2 months after therapy were associated with the therapeutic responsiveness of primary NS, particularly the differentiation of MCNS from FSGS (s-suPAR: AUC-ROC = 0.905, p = 0.007; u-suPAR: AUC-ROC = 0.816, p = 0.048). In the ANCA-GN group, a positive correlation was found between pretreatment s-suPAR and clinical severity or crescent formation, whereas u-suPAR was not correlated with these parameters. S- and u-suPAR after therapy may serve as clinical markers to judge the treatment response of untreated NS and differentiate MCNS from FSGS, but not in pretreatment patients. S-, but not u-suPAR may predict the severity of and crescent formation in ANCA-GN.	[Fujimoto, Keiji; Imura, Junko; Atsumi, Hirokatsu; Matsui, Yuki; Adachi, Hiroki; Okuyama, Hiroshi; Yamaya, Hideki; Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Div Nephrol, Uchinada, Ishikawa 9200293, Japan	Yokoyama, H (reprint author), Kanazawa Med Univ, Sch Med, Div Nephrol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	h-yoko@kanazawa-med.ac.jp			Ministry of Health, Labour, and Welfare of Japan; Japan Society for the Promotion of Science [25461237, 24406029, 25305028]	The authors gratefully acknowledge the help and assistance of their colleagues at the Division of Nephrology. This study was supported, in part, by a Grant-in-Aid for Progressive Renal Disease Research from the Ministry of Health, Labour, and Welfare of Japan and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (HY, (C) No. 25461237; (B) No. 24406029, No. 25305028).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Maas RJH, 2012, KIDNEY INT, V81, P1043, DOI 10.1038/ki.2012.32; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Sinha A, 2014, KIDNEY INT, V85, P649, DOI 10.1038/ki.2013.546; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Backes Y, 2012, INTENS CARE MED, V38, P1418, DOI 10.1007/s00134-012-2613-1; Maas RJH, 2013, PEDIATR NEPHROL, V28, P1041, DOI 10.1007/s00467-013-2452-5; Bock ME, 2013, CLIN J AM SOC NEPHRO, V8, P1304, DOI 10.2215/CJN.07680712; Wada T, 2014, KIDNEY INT, V85, P641, DOI 10.1038/ki.2013.544; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Yilmaz G, 2011, CLIN BIOCHEM, V44, P1227, DOI 10.1016/j.clinbiochem.2011.07.006; BARALDI A, 1995, NEPHROL DIAL TRANSPL, V10, P1155; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; The Japanese Society of Nephrology, 2011, NIHON JINZO GAKKAI S, V53, P78; The Japanese Society of Nephrology, 2011, NIHON JINZO GAKKAI S, V53, P509; Zang B, 2012, J MOL MED BERL, V90, P1407	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					804	814		10.1007/s10157-014-1067-x		11	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700006		
J	Tanaka, K; Moriyama, T; Iwasaki, C; Takei, T; Nitta, K				Tanaka, Kayu; Moriyama, Takahito; Iwasaki, Chihiro; Takei, Takashi; Nitta, Kosaku			Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						IgA nephropathy; Hematuria; Urinary red blood cells; Mild proteinuria; Renal function	ISOLATED MICROSCOPIC HEMATURIA; IMMUNOGLOBULIN-A NEPHROPATHY; NATURAL-HISTORY; PROGNOSTIC-FACTORS; OXFORD CLASSIFICATION; RENAL SURVIVAL; RISK-FACTORS; PATHOLOGY	The effects of hematuria on the outcome of IgA nephropathy (IgAN) remain unknown and treatment of IgAN with severe hematuria is controversial. Eighty-eight IgAN patients with proteinuria < 0.5 g/day and who had not received corticosteroids, immunosuppressive agents, or undergone a tonsillectomy were divided into two groups: (1) patients with low (< 20/high-power field [HPF]) urinary red blood cell (U-RBC) counts (L-RBC group, n = 48); and (2) patients with high (a parts per thousand yen20/HPF) U-RBC counts (H-RBC group, n = 40). Clinical and histological findings, renal survival rate and risk factors for progression were analyzed. The male ratio and blood pressure were significantly higher in the L-RBC group. Median proteinuria, mean estimated glomerular filtration rate and histological findings according to Oxford classifications were similar. During the 5 years after renal biopsy, the median amount of proteinuria remained at < 0.5 g/day or g/g creatinine in both groups, and the median U-RBC decreased to < 10/HPF in both groups without any intensive therapy. The 15-year renal survival rate, estimated using the Kaplan-Meier method, was 100 % in the H-RBC group, but decreased to 83.4 % in the L-RBC group, although it was not significant. The treatment of inhibitors of renin-angiotensin system (RAS inhibitors) decreased the risk for progression by Cox regression analysis (hazard ratio: 0.14, p = 0.027). Severe hematuria at the time of biopsy naturally improved without any intensive therapy, and there were no negative effects of hematuria on the outcome of IgAN with mild proteinuria. Its prognosis was relatively good, and the treatment of RAS inhibitors might prevent from progression.	[Tanaka, Kayu; Moriyama, Takahito; Iwasaki, Chihiro; Takei, Takashi; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjyuku Ku, Tokyo 1628666, Japan	Moriyama, T (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjyuku Ku, Kawada Cho 8-1, Tokyo 1628666, Japan.	takamori@kc.twmu.ac.jp					Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P481, DOI 10.1007/s10157-013-0849-x; Shen P, 2008, NETH J MED, V66, P242; ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12; Kim Byung Soo, 2009, Korean Journal of Internal Medicine, V24, P356, DOI 10.3904/kjim.2009.24.4.356; Manno C, 2007, AM J KIDNEY DIS, V49, P763, DOI 10.1053/j.ajkd.2007.03.013; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Rauta V, 2002, CLIN NEPHROL, V58, P85; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; Shen PC, 2007, NEPHRON CLIN PRACT, V106, P157, DOI 10.1159/000104426; Harmankaya Ozlem, 2002, International Urology and Nephrology, V33, P167, DOI 10.1023/A:1014424723466; Jalalah SM, 2002, NEPHROL DIAL TRANSPL, V17, P2586; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Moriyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091756	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					815	821		10.1007/s10157-014-1068-9		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700007		
J	Ogawa, S; Takiguchi, J; Nako, K; Okamura, M; Sakamoto, T; Kabayama, S; Mori, T; Kinouchi, Y; Ito, S				Ogawa, Susumu; Takiguchi, Junko; Nako, Kazuhiro; Okamura, Masashi; Sakamoto, Takuya; Kabayama, Shigeru; Mori, Takefumi; Kinouchi, Yoshitaka; Ito, Sadayoshi			Elucidation of the etiology and characteristics of pink urine in young healthy subjects	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Pink urine syndrome; Urinary pH; Oxidative stress; Angiotensinogen; Methylglyoxal	GLYCATION END-PRODUCTS; PROXIMAL-TUBULE; OXIDATIVE STRESS; METABOLIC-ACIDOSIS; NA+/H+ EXCHANGER; KIDNEY-DISEASE; BLOOD-PRESSURE; METHYLGLYOXAL; CELLS; DIETARY	Pink urine syndrome (PUS) is attributed to the precipitation of uric acid caused by low urinary pH (U-pH). However, the reasons for the lower U-pH are unclear. To investigate the occurrence of PUS and verified the cause of U-pH reduction. Participants comprised 4,940 students who had undergone a physical examination. Data on the presence [PUS (+)] or absence [PUS (-)] of PUS, as well as age, gender, body mass index (BMI), blood pressure (BP), heart rate (HR), and U-pH were collected. Of these participants, 300 randomly selected individuals were evaluated for their waist circumference, as well as their levels of urinary C-peptide, angiotensinogen, methylglyoxal, thiobarbituric acid-reactive substances (TBARS), and Na+ excretion. Independent risk factors of lower U-pH were decided by a multiple-regression analysis. PUS was observed in 216 students (4.4 %). A greater number of men comprised the PUS (+) group compared with the PUS (-) group, and subjects in this group had high BMI, BP, and HR values, as well as low U-pH. A logistic regression analysis revealed that the BMI and U-pH were independent risk factors for PUS (+). The decrease of U-pH was closely related to the progress of chronic kidney disease (CKD). BMI value was related to PUS (+) in the CKD (-) subjects. On the other hand, low U-pH was related to PUS (+) in the CKD (+) subjects. All factors other than HR showed a significant negative correlation with U-pH. However, multiple-regression analysis revealed that TBARS and angiotensinogen were independent risk factors. Obesity and lower U-pH were each independently related to PUS, whereas increased intrarenal oxidative stress and exacerbation of the renin-angiotensin system activation were associated with the lowering of U-pH. U-pH low value is related to potential CKD.	[Ogawa, Susumu; Nako, Kazuhiro; Okamura, Masashi; Sakamoto, Takuya; Mori, Takefumi; Ito, Sadayoshi] Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Ogawa, Susumu; Takiguchi, Junko; Kinouchi, Yoshitaka] Tohoku Univ, Sect Clin Med, Div Res Student Support, Inst Excellence Higher Educ, Sendai, Miyagi 980, Japan; [Kabayama, Shigeru] Trim Med Inst Co Ltd, Osaka, Japan	Ogawa, S (reprint author), Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	ogawa-s@hosp.tohoku.ac.jp			21st Century Center of Excellence Program Special Research Grant from the Ministry of Education, Sports and Culture; Tohoku University's Center for the Advancement of Higher Education President's Research Fund	The authors acknowledge the editorial assistance and clinical support of Miss Manami Shimizu for her help with preparing the references and for her expert assistance in the preparation of the tables and figures. The authors wish to thank Miss Manami Shimizu, Miss Asako Chiba and Mrs. Yasuko Sato for their assistance with gathering the urine samples for the study. We also wish to thank nurses Eiko Mitsui, Yoko Hasegawa, Michiko Ota, Megumi Ito and Hiromi Sato for their efforts in gathering student data. This work was supported by a 21st Century Center of Excellence Program Special Research Grant from the Ministry of Education, Sports and Culture, and Tohoku University's Center for the Advancement of Higher Education President's Research Fund.	Saito A, 2005, ANN NY ACAD SCI, V1043, P637, DOI 10.1196/annals.1333.072; Mandel EI, 2013, CLIN J AM SOC NEPHRO, V8, P901, DOI 10.2215/CJN.07190712; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Miyazawa N, 2010, FREE RADICAL RES, V44, P101, DOI 10.3109/10715760903321788; Biemesderfer D, 1999, J BIOL CHEM, V274, P17518, DOI 10.1074/jbc.274.25.17518; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Li XC, 2009, AM J PHYSIOL-RENAL, V297, pF1342, DOI 10.1152/ajprenal.90734.2008; Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; Odunewu A, 2013, AM J PHYSIOL-RENAL, V305, pF370, DOI 10.1152/ajprenal.00598.2012; Otsuki M, 2011, ENDOCR J, V58, P363, DOI 10.1507/endocrj.K10E-319; Guo Q, 2009, J HYPERTENS, V27, P1664, DOI 10.1097/HJH.0b013e32832c419a; Krupp D, 2014, KIDNEY INT, V85, P204, DOI 10.1038/ki.2013.331; Saran R, 1998, NEPHROL DIAL TRANSPL, V13, P1579, DOI 10.1093/ndt/13.6.1579; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Archibeque SL, 2007, J ANIM SCI, V85, P1496, DOI 10.2527/jas.2006-208; Gaens KHJ, 2013, CURR OPIN LIPIDOL, V24, P4, DOI 10.1097/MOL.0b013e32835aea13; Scialla JJ, 2013, ADV CHRONIC KIDNEY D, V20, P141, DOI 10.1053/j.ackd.2012.11.001; Ozdemir AM, 2008, AM J NEPHROL, V28, P14, DOI 10.1159/000108757; DEITEL M, 1984, CAN MED ASSOC J, V130, P1007; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj/jhh/1001307; Yamagishi S, 2003, KIDNEY INT, V63, P464, DOI 10.1046/j.1523-1755.2003.00752.x; Azuma K, 2007, J CLIN BIOCHEM NUTR, V40, P131, DOI 10.3164/jcbn.40.131; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Goraya N, 2013, CLIN J AM SOC NEPHRO, V8, P371, DOI 10.2215/CJN.02430312; Ogawa S, 2010, HYPERTENSION, V56, P471, DOI 10.1161/HYPERTENSIONAHA.110.156786; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Dhar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074212; Ogawa Susumu, 2009, Biomark Insights, V4, P97; Zuckerman Jack M, 2009, Rev Urol, V11, P134	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					822	829		10.1007/s10157-014-1066-y		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700008		
J	Yamada, K; Doi, S; Nakashima, A; Kawaoka, K; Ueno, T; Doi, T; Yokoyama, Y; Arihiro, K; Kohno, N; Masaki, T				Yamada, Kyoko; Doi, Shigehiro; Nakashima, Ayumu; Kawaoka, Koichiro; Ueno, Toshinori; Doi, Toshiki; Yokoyama, Yukio; Arihiro, Koji; Kohno, Nobuoki; Masaki, Takao			Expression of age-related factors during the development of renal damage in patients with IgA nephropathy	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Aging; Oxidative DNA damage; Cell cycle arrest; Klotho; IgA nephropathy	UNILATERAL URETERAL OBSTRUCTION; CHRONIC KIDNEY-DISEASE; OXFORD CLASSIFICATION; CELL CARCINOMA; RISK-FACTORS; FIBROSIS; INJURY; PROGRESSION; SENESCENCE; BIOPSY	Chronic kidney disease patients share clinical and pathological features with the general aging population. Increased oxidative DNA damage, accumulation of cell cycle-arrested cells and decreased Klotho expression are assumed to be age-related factors that are reportedly linked to kidney disease. This study sought to determine the association between these age-related factors and renal damage in patients with IgA nephropathy (IgAN). We performed a cross-sectional analysis of 71 patients who were diagnosed with IgAN by renal biopsy. Expression of 8-hydroxydeoxyguanosine (8-OHdG, a marker of oxidative DNA damage), p16 (a marker of cell cycle-arrest) and Klotho (an anti-aging protein) were evaluated by immunohistochemical staining of renal biopsy samples. We correlated the changes in expression of these markers with Lee's pathologic grades and the Oxford classification. We also investigated the independent association between these markers and interstitial fibrosis using multiple linear regression analysis. 8-OHdG and p16 increased but Klotho decreased with progression of pathologic grade. Expression of 8-OHdG and p16 increased with the deterioration of mesangial hypercellularity and segmental glomerulosclerosis. In addition, p16 increased but Klotho decreased with progression of tubular atrophy/interstitial fibrosis. In univariate regression analysis, age, body mass index, systolic blood pressure, urinary protein excretion and expression of 8-OHdG, p16 and Klotho showed significant correlations with interstitial fibrosis. Multivariable regression analyses revealed that aging, increased renal expression of p16 and decreased expression of Klotho were independently correlated with interstitial fibrosis. The age-related factors might play important roles in the development of IgAN.	[Yamada, Kyoko; Doi, Shigehiro; Nakashima, Ayumu; Kawaoka, Koichiro; Ueno, Toshinori; Doi, Toshiki; Yokoyama, Yukio; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Minami Ku, Hiroshima 7348551, Japan; [Nakashima, Ayumu] Hiroshima Univ Hosp, Dept Regenerat & Med, Hiroshima 7348551, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima 7348551, Japan; [Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Hiroshima, Japan	Doi, S (reprint author), Hiroshima Univ Hosp, Dept Nephrol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	sdoi@hiroshima-u.ac.jp			Tsuchiya Memorial Medical Foundation; Ryokufukai Medical Foundation	This work was supported by Tsuchiya Memorial Medical Foundation (to S.D.), and Ryokufukai Medical Foundation (to K.K.)	Pat B, 2005, KIDNEY INT, V67, P931, DOI 10.1111/j.1523-1755.2005.00157.x; Hsu RK, 2011, CURR OPIN NEPHROL HY, V20, P211, DOI 10.1097/MNH.0b013e3283454f8d; Klatte T, 2011, CURR OPIN UROL, V21, P376, DOI 10.1097/MOU.0b013e32834962bf; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Yang HC, 2010, J AM SOC NEPHROL, V21, P1436, DOI 10.1681/ASN.2010020205; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Miyake H, 2004, UROLOGY, V64, P1057, DOI 10.1016/j.urology.2004.06.019; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Lee HS, 2005, NEPHROL DIAL TRANSPL, V20, P342, DOI 10.1093/ndt/gfh633; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Zhu Y, 2013, CANCER SCI, V104, P663, DOI 10.1111/cas.12134; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; LEE SMK, 1982, HUM PATHOL, V13, P314, DOI 10.1016/S0046-8177(82)80221-9; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; Terada Y, 1997, J AM SOC NEPHROL, V8, P51; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1053/ajkd.2001.22834; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					830	837		10.1007/s10157-014-1070-2		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700009		
J	Misaki, T; Naka, S; Kuroda, K; Nomura, R; Shiooka, T; Naito, Y; Suzuki, Y; Yasuda, H; Isozaki, T; Nakano, K				Misaki, Taro; Naka, Shuhei; Kuroda, Keiko; Nomura, Ryota; Shiooka, Tempei; Naito, Yoshitaka; Suzuki, Yumiko; Yasuda, Hideo; Isozaki, Taisuke; Nakano, Kazuhiko			Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						IgA nephropathy; cnm; Collagen-binding protein; Streptococcus mutans	OXFORD CLASSIFICATION; INDUCED NEPHRITIS; GLOMERULONEPHRITIS; RABBITS; ADHESIN; SAMPLES; GENES	IgA nephropathy (IgAN) is the most common primary chronic glomerulonephritis; however, its precise initiating pathogenesis remains unclear. Streptococcus mutans is a major pathogen of human dental caries. S. mutans strains with the cnm gene encoding Cnm, a collagen-binding protein, have been reported to contribute to the development of systemic diseases. However, the contribution of S. mutans with Cnm in the development of IgAN has not been reported. The aim of this study was to investigate the prevalence of cnm-positive S. mutans in IgAN patients and clarify the effects of cnm-positive S. mutans on the histological pathology of IgAN. We identified the cnm gene in S. mutans isolated in saliva specimens, which were collected from IgAN patients (n = 53) and control subjects (n = 50). We evaluated the collagen-binding properties of S. mutans in IgAN patients and controls. The clinical parameters and histological scores were also assessed in IgAN patients. The rates of S. mutans isolation in IgAN and control groups were 84.0 and 84.9 %, respectively, not significantly dfferent. cnm-positive strains were significantly more prevalent in the IgAN group than in controls (32.1 vs. 14.0 %, p < 0.05). With regard to collagen-binding assays, the binding rates of cnm-positive strains were significantly higher in the IgAN group than in controls (96.6 vs. 30.0, p < 0.05). In addition, the segmental glomerulosclerosis scores were significantly higher in cnm-positive patients with IgAN than in cnm-negative patients with IgAN (0.94 vs. 0.57, p < 0.05). cnm-positive S. mutans strains are potentially associated with the pathogenesis of IgAN.	[Misaki, Taro; Shiooka, Tempei; Naito, Yoshitaka; Suzuki, Yumiko; Isozaki, Taisuke] Seirei Hamamatsu Gen Hosp, Div Nephrol, Naka Ku, Hamamatsu, Shizuoka 4308558, Japan; [Naka, Shuhei; Kuroda, Keiko; Nomura, Ryota; Nakano, Kazuhiko] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Osaka, Japan; [Yasuda, Hideo] Hamamatsu Univ, Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4312102, Japan	Misaki, T (reprint author), Seirei Hamamatsu Gen Hosp, Div Nephrol, Naka Ku, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan.	misakitar@sis.seirei.or.jp			Osaka University Graduate School of Dentistry	The authors thank Prof. Howard K. Kuramitsu, State University of New York at Buffalo, for editing the manuscript. This study was supported by Osaka University Graduate School of Dentistry.	Abrahamson, 2013, J HISTOCHEM CYTOCHEM, V61, P706; Park KS, 2014, HUM PATHOL, V45, P236, DOI 10.1016/j.humpath.2013.08.019; Nomura R, 2009, J MED MICROBIOL, V58, P469, DOI 10.1099/jmm.0.007559-0; SUZUKI S, 1994, LANCET, V343, P12, DOI 10.1016/S0140-6736(94)90875-3; Kokubo T, 1998, J AM SOC NEPHROL, V9, P2048; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; Lee H, 2012, KOREAN J INTERN MED, V27, P293, DOI 10.3904/kjim.2012.27.3.293; ALBINI B, 1985, AM J PATHOL, V118, P408; Nakano K, 2004, J CLIN MICROBIOL, V42, P198, DOI 10.1128/JCM.421.1.198-202.2004; Kusano K, 2007, HUM PATHOL, V38, P1788, DOI 10.1016/j.humpath.2007.04.012; Lapirattanakul J, 2014, FUTURE MICROBIOL, V9, P807, DOI [10.2217/fmb.14.37, 10.2217/FMB.14.37]; Sato Y, 2004, J DENT RES, V83, P534; DAMICO G, 1987, Q J MED, V64, P709; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Iwama H, 1998, AM J KIDNEY DIS, V32, P785, DOI 10.1016/S0272-6386(98)70134-9; MIYATA M, 1995, INT ARCH ALLERGY IMM, V108, P360; Nakano K, 2007, J CLIN MICROBIOL, V45, P2616, DOI 10.1128/JCM.02343-06; Nomura R, 2013, ARCH ORAL BIOL, V58, P1627, DOI 10.1016/j.archoralbio.2013.06.008; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; Narita I, 2008, CLIN EXP NEPHROL, V12, P332, DOI 10.1007/s10157-008-0054-5; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Kojima Ayuchi, 2012, Sci Rep, V2, P332, DOI 10.1038/srep00332; Nagasawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081636; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; Waterhouse JC, 2006, MICROBIOL-SGM, V152, P1777, DOI 10.1099/mic.028647-0	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					844	850		10.1007/s10157-014-1072-0		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700011		
J	Ohashi, N; Ishigaki, S; Kitajima, K; Tsuji, N; Isobe, S; Iwakura, T; Ono, M; Fujikura, T; Tsuji, T; Sakao, Y; Kato, A; Yasuda, H				Ohashi, Naro; Ishigaki, Sayaka; Kitajima, Kazuto; Tsuji, Naoko; Isobe, Shinsuke; Iwakura, Takamasa; Ono, Masafumi; Fujikura, Tomoyuki; Tsuji, Takayuki; Sakao, Yukitoshi; Kato, Akihiko; Yasuda, Hideo			The level of urinary alpha 1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Antineutrophil cytoplasmic antibody associated vasculitis; Necrotizing crescentic glomerulonephritis; Peritubular capillaritis; Arteriolitis; Urinary alpha 1 microglobulin	GLOMERULONEPHRITIS; CLASSIFICATION; NEPHRITIS; DIAGNOSIS; PATHOLOGY; INJURY	Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis affects small vessels in the kidney (i.e., arterioles, glomerular or peritubular capillaries, or venules). Although crescentic glomerulonephritis is a common histological finding, the incidence of peritubular capillaritis (PTC) or arteriolitis is unclear. Moreover, the laboratory data that reflect the degree of renal histological damage and distinguish between PTC and arteriolitis have not yet been clarified. We investigated laboratory data and histological findings from 11 patients diagnosed with ANCA-associated vasculitis (2 men and 9 women, mean age 70.3 +/- A 3.3 years) whose renal biopsies were performed between 2009 and 2014. All patients were positive for myeloperoxidase (MPO)-ANCA. PTC or arteriolitis was detected in six patients (54.5 %), respectively. The only significant positive relationship between laboratory data and histological findings observed was that between levels of urinary alpha 1 microglobulin (u-alpha 1MG) excretion and the percentage of tubular atrophy and interstitial fibrosis (r = 0.67, p = 0.035). No significant differences in laboratory data were found between patients with or without arteriolitis. However, the levels of u-alpha 1MG excretion were significantly higher in patients with PTC than in those without PTC (75.2 +/- A 19.5 vs. 15.0 +/- A 3.6 mg/dl, p = 0.035). PTC or arteriolitis occurs at a high rate independently of crescentic glomerulonephritis in ANCA-associated vasculitis patients. The levels of u-alpha 1MG excretion reflect the degrees of tubular atrophy and interstitial fibrosis. Moreover, high levels of u-alpha 1MG excretion suggest that PTC is more likely than arteriolitis in ANCA-associated vasculitis patients.	[Ohashi, Naro; Ishigaki, Sayaka; Kitajima, Kazuto; Tsuji, Naoko; Isobe, Shinsuke; Iwakura, Takamasa; Ono, Masafumi; Fujikura, Tomoyuki; Tsuji, Takayuki; Yasuda, Hideo] Hamamatsu Univ, Sch Med, Internal Med 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Sakao, Yukitoshi; Kato, Akihiko] Hamamatsu Univ, Sch Med, Blood Purificat Unit, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Ohashi, N (reprint author), Hamamatsu Univ, Sch Med, Internal Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ohashi-n@hama-med.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Banerjee A, 2001, J CLIN PATHOL, V54, P787; Ohashi R, 2000, J AM SOC NEPHROL, V11, P47; Hauer HA, 2002, KIDNEY INT, V61, P80, DOI 10.1046/j.1523-1755.2002.00089.x; Kallenberg CGM, 2014, J AUTOIMMUN, V48-49, P90, DOI 10.1016/j.jaut.2014.01.023; ARIMURA Y, 1993, CLIN NEPHROL, V40, P256; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Roth R, 2013, AM J NEPHROL, V37, P249, DOI 10.1159/000347219; FINE LG, 1993, EUR J CLIN INVEST, V23, P259, DOI 10.1111/j.1365-2362.1993.tb00771.x; Penders J, 2004, CLIN CHIM ACTA, V346, P107, DOI 10.1016/j.cccn.2004.03.037; Joh K, 2008, CLIN EXP NEPHROL, V12, P277, DOI 10.1007/s10157-008-0052-7; Wen YK, 2006, RENAL FAILURE, V28, P189, DOI 10.1080/08860220500531559; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Nakabayashi K, 2009, CLIN EXP NEPHROL, V13, P605, DOI 10.1007/s10157-009-0200-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Yamagata K, 2012, CLIN EXP NEPHROL, V16, P580, DOI 10.1007/s10157-012-0598-2; Everaert K, 1998, CLIN CHEM LAB MED, V36, P309, DOI 10.1515/CCLM.1998.052; Jennette JC, 2007, HEPTINSTALLS PATHOLO, P643; Vestweber D, 1999, GUIDEBOOK EXTRACELLU, P301	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					851	858		10.1007/s10157-014-1073-z		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700012		
J	Muto, S; Kawano, H; Higashihara, E; Narita, I; Ubara, Y; Matsuzaki, T; Ouyang, J; Torres, VE; Horie, S				Muto, Satoru; Kawano, Haruna; Higashihara, Eiji; Narita, Ichiei; Ubara, Yoshifumi; Matsuzaki, Takayuki; Ouyang, John; Torres, Vicente E.; Horie, Shigeo			The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Tolvaptan; Japanese population; Autosomal dominant polycystic kidney disease; TEMPO 3:4 trial; Total kidney volume; Kidney function decline	GENE; PROGRESSION; PREVALENCE; PROTEIN; ENCODES	Japan is the first country in the world to approve tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD), which was based on the results of Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes (TEMPO) 3:4 trial. To evaluate the safety and efficacy of tolvaptan, we performed a subgroup analysis in the participating Japanese ADPKD patient population. The primary outcome was the annual rate of percentage change in the total kidney volume (TKV). The secondary endpoint was the rate of kidney function change. The tolvaptan and placebo groups included 118 and 59 patients, respectively. The annual rate of percentage changes in TKV were 1.3 % [95 % confidence interval (CI) 0.4-2.1] in the tolvaptan group, and 5.0 % (95 % CI 3.9-6.2) in the placebo group (P < 0.001). The annual estimated glomerular filtration rate change was -3.83 mL/min/1.73 m(2) in the tolvaptan group and -5.05 mL in the placebo group for a treatment effect of +1.22 mL/min/1.73 m(2) (95 % CI 0.41-2.02: P = 0.003). Hepatic function abnormal as a serious adverse event was observed in 3 patients (2.5 %) in the tolvaptan group. Administration of tolvaptan in the Japanese sub-population reduced the annual rate of TKV growth and slowed the rate of kidney function decline over 36 months compared to patients on placebo, thus providing a novel and effective therapy for the treatment of ADPKD. (TEMPO 3:4 ClinicalTrials.gov number, NCT00428948).	[Muto, Satoru] Teikyo Univ, Sch Med, Dept Urol, Tokyo 173, Japan; [Kawano, Haruna; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Bunkyo Ku, Tokyo 1138431, Japan; [Higashihara, Eiji] Kyorin Univ, Sch Med, Dept ADPKD Res, Tokyo, Japan; [Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Ubara, Yoshifumi] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan; [Matsuzaki, Takayuki] Otsuka Pharmaceut Co Ltd, Tokyo, Japan; [Ouyang, John] Otsuka Pharmaceut Dev & Commercializat Inc, Rockville, MD USA; [Torres, Vicente E.] Mayo Clin, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN USA	Horie, S (reprint author), Juntendo Univ, Grad Sch Med, Dept Urol, Bunkyo Ku, Hongo 3-1-3, Tokyo 1138431, Japan.	shorie@juntendo.ac.jp			Otsuka Pharmaceutical	SH has received honoraria for presentations and research funding from and has consulted and been an advisory board member for Otsuka Pharmaceutical. EH has received research funding from Otsuka Pharmaceutical and is a member of the Steering Committee for several Otsuka studies involving the TEMPO 3:4 trial. TM and JO are employees of Otsuka. VET is an investigator and Chair of the Steering Committee for several Otsuka studies involving the TEMPO 3:4 trial. All the other authors declared no competing interests.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Parikh CR, 2012, KIDNEY INT, V81, P784, DOI 10.1038/ki.2011.465; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Torres VE, 2011, AM J KIDNEY DIS, V57, P692, DOI 10.1053/j.ajkd.2010.11.029; Higashihara E, 1998, NEPHRON, V80, P421, DOI 10.1159/000045214; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Levy M, 2000, KIDNEY INT, V58, P925, DOI 10.1046/j.1523-1755.2000.00250.x; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Mochizuki T, 2013, CLIN EXP NEPHROL, V17, P317, DOI 10.1007/s10157-012-0741-0; Masoumi Amirali, 2008, Ther Clin Risk Manag, V4, P393; Matsuzaki Masunori, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS33, DOI 10.1007/s10557-011-6304-x; Sakaida I, 2014, HEPATOL RES, V44, P73, DOI 10.1111/hepr.12098; The International Society of Nephrology, 2013, KIDNEY INT S, V3, P5	18	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					867	877		10.1007/s10157-015-1086-2		11	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700014		
J	Yamamoto, T; Nakayama, M; Miyazaki, M; Matsushima, M; Sato, T; Taguma, Y; Sato, H; Ito, S				Yamamoto, Tae; Nakayama, Masaaki; Miyazaki, Mariko; Matsushima, Masato; Sato, Toshinobu; Taguma, Yoshio; Sato, Hiroshi; Ito, Sadayoshi			Relationship between low blood pressure and renal/cardiovascular outcomes in Japanese patients with chronic kidney disease under nephrologist care: the Gonryo study	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Blood pressure; Cardiovascular disease; Hypertension; Kidney failure; Outcome; Proteinuria	CARDIOVASCULAR EVENTS; RENAL-DISEASE; RISK; STROKE; TRIAL; PROGRESSION; METAANALYSIS; PROTEINURIA; NEPHROPATHY; INHIBITION	Previous studies established a J-shaped association between blood pressure (BP) and cardiovascular disease (CVD) in chronic kidney disease (CKD), and the different clinical profiles of CVD by ethnicity. However, the adequately lower BP target remains unclear in Asian patients with CKD. This prospective observational study included 2,655 Japanese outpatients with CKD under nephrologist care who met the inclusion criteria, namely estimated glomerular filtration rate < 60 mL/min and/or presenting proteinuria. The patients were divided by 10-mmHg BP increments by clinical data. The end points were death, cardiovascular events (CVEs), and end-stage kidney disease (ESKD) that requires renal replacement therapy. During a 3.02-year median follow-up, 64 patients died, 120 developed CVEs, and 225 progressed to ESKD. In the adjusted Cox models, the risks of CVEs and all-cause mortality were higher in the patients with systolic BPs (SBPs) < 110 mmHg than in those with SBPs of 130-139 mmHg. Moreover, the risk was higher in those with diastolic BPs (DBPs) < 70 mmHg than in those with DBPs of 80-89 mmHg. Although SBPs a parts per thousand yen 140 mmHg were associated with higher incidence rates of ESKD, no significant increased risk was associated with BPs < 130/80 mmHg. SBPs < 110 mmHg and DBPs < 70 mmHg were independent risk factors of CVEs and all-cause mortality. No lower BPs were observed as significant risk factors of progression to ESKD. This study suggests that the lower BP target in Asian patients with CKD should be a parts per thousand yen110/70 mmHg.	[Yamamoto, Tae; Miyazaki, Mariko; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Nakayama, Masaaki; Miyazaki, Mariko; Matsushima, Masato; Taguma, Yoshio; Sato, Hiroshi; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Ctr Adv Integrated Renal Sci, Sendai, Miyagi 9808574, Japan; [Nakayama, Masaaki] Fukushima Med Univ, Div Nephrol Endocrinol Vasc Med & Diabetol, Fukushima, Japan; [Matsushima, Masato] Jikei Univ, Sch Med, Dept Clin Res, Tokyo, Japan; [Sato, Toshinobu; Taguma, Yoshio] Japan Community Hlth Care Org, Kidney Ctr, Sendai Hosp, Sendai, Miyagi, Japan; [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Clin Pharmacol & Therapeut, Sendai, Miyagi 9808574, Japan	Yamamoto, T (reprint author), Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	tae.yamamoto@med.tohoku.ac.jp			Astellas Pharm Inc.; Miyagi Kidney Foundation	This study was supported by grants from Astellas Pharm Inc. and the Miyagi Kidney Foundation. The authors express special thanks to Ms. Makiko Nakayama and to Ms. Ayuko Momoi for administrative and secretarial assistance. Study contributors: Yuji Yamaguchi (Japanese Red Cross Sendai Hospital), Katsuya Obara (Tohoku Kosai Hospital), Isao Kurihara (Tohoku Kosai Miyagino Hospital), Yasumichi Kinoshita and Kazuto Sato (Japanese Red Cross Ishinomaki Hospital), Kazuro Kaise (Sendai Medical Center), Akira Sugiura and Masahiro Miyata (Osaki Citizen Hospital), Kazuhisa Takeuchi (Koujinkai Central Clinic), Kenji Nakayama and Naoki Akiu (Sendai City Hospital) and Tetsuya Otaka (Katta General Hospital).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; Hyun KK, 2013, INT J STROKE, V8, P606, DOI 10.1111/ijs.12166; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Nakayama M, 2011, HYPERTENS RES, V34, P1106, DOI 10.1038/hr.2011.96; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Reynolds JC, 2010, PREHOSP EMERG CARE, V14, P78, DOI 10.3109/10903120903349796; Mann JFE, 2013, J HYPERTENS, V31, P414, DOI 10.1097/HJH.0b013e32835bf7b0; Sleight P, 2009, J HYPERTENS, V27, P1360, DOI 10.1097/HJH.0b013e32832d7370; Nakayama M, 2010, CLIN EXP NEPHROL, V14, P333, DOI 10.1007/s10157-010-0295-y; Ogihara T, 2009, HYPERTENS RES, V32, P248, DOI 10.1038/hr.2008.34; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Ninomiya T, 2008, KIDNEY INT, V73, P963, DOI 10.1038/ki.2008.5; [Anonymous], 1990, STROKE, V21, P637; PETERSON JC, 1995, ANN INTERN MED, V123, P754; Banach M, 2012, CURR HYPERTENS REP, V14, P556, DOI 10.1007/s11906-012-0314-3; Agarwal R, 2009, CLIN J AM SOC NEPHRO, V4, P830, DOI 10.2215/CJN.06201208; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Weiner DE, 2007, J AM SOC NEPHROL, V18, P960, DOI 10.1681/ASN.2006080858; Jafar TH, 2003, ANN INTERN MED, V139, P244; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S8, V2	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					878	886		10.1007/s10157-015-1084-4		9	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700015		
J	Nakade, Y; Toyama, T; Furuichi, K; Kitajima, S; Miyajima, Y; Fukamachi, M; Sagara, A; Shinozaki, Y; Hara, A; Shimizu, M; Iwata, Y; Oe, H; Nagahara, M; Horita, H; Sakai, Y; Kaneko, S; Wada, T				Nakade, Yusuke; Toyama, Tadashi; Furuichi, Kengo; Kitajima, Shinji; Miyajima, Yoshiyasu; Fukamachi, Mihiro; Sagara, Akihiro; Shinozaki, Yasuyuki; Hara, Akinori; Shimizu, Miho; Iwata, Yasunori; Oe, Hiroyasu; Nagahara, Mikio; Horita, Hiroshi; Sakai, Yoshio; Kaneko, Shuichi; Wada, Takashi			Impact of kidney function and urinary protein excretion on intima-media thickness in Japanese patients with type 2 diabetes	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Carotid ultrasonography; Chronic kidney disease; Intima-media thickness; Type 2 diabetes	GLOMERULAR-FILTRATION-RATE; CAROTID-ARTERY INTIMA; INSULIN-RESISTANCE ATHEROSCLEROSIS; PRIOR MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; RISK-FACTORS; FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR RISK; INCIDENT STROKE; ALL-CAUSE	Carotid echo indexes [intima-media thickness (IMT)] are commonly used surrogate markers for cardiovascular disease; however, the impacts of chronic kidney disease (CKD) on changes in IMT are unclear. We examined associations between CKD and IMT in participants with and without type 2 diabetes through longitudinal analysis. In total, 424 subjects were enrolled in this study. IMT was measured as per carotid echo indexes. Relationships between IMT and risk factors were analyzed using multiple linear regression analysis, in which we defined IMT as the dependent variable and atherosclerosis-related factors (age, sex, systolic pressure, total cholesterol, body mass index, estimated glomerular filtration rate (eGFR), uric acid, smoking index, number of antihypertensive drugs, statin use, urinary protein levels, past cardiovascular event, glycated hemoglobin, and diabetes duration) as independent variables. The study population was composed of 70.3 % male subjects. Participants with diabetes accounted for 64.4 % of the total population. The mean follow-up duration was 2.2 +/- A 1.5 years. Alterations in IMT tended to be associated with systolic blood pressure (+10 mmHg) (beta = -0.0084, p = 0.09) and eGFR (+10 mL/min/1.73 m(2)) (beta = -0.0049, p = 0.06) in all participants. In participants without diabetes, alterations in IMT were associated with eGFR (+10 mL/min/1.73 m(2)) (beta = -0.0104, p = 0.03) and tended to be associated with systolic blood pressure (+10 mmHg) (beta = 0.0094, p = 0.06). No significant relationships were found in participants with diabetes. Low eGFR was associated with progression of carotid thickness independent of common cardiovascular risk factors in non-diabetic participants.	[Nakade, Yusuke; Miyajima, Yoshiyasu; Fukamachi, Mihiro; Oe, Hiroyasu; Nagahara, Mikio; Horita, Hiroshi; Sakai, Yoshio; Wada, Takashi] Kanazawa Univ Hosp, Clin Lab, Kanazawa, Ishikawa 9208641, Japan; [Nakade, Yusuke; Miyajima, Yoshiyasu; Iwata, Yasunori; Sakai, Yoshio; Wada, Takashi] Kanazawa Univ Hosp, Dept Lab Med, Kanazawa, Ishikawa 9208641, Japan; [Toyama, Tadashi; Furuichi, Kengo; Kitajima, Shinji; Sagara, Akihiro; Shinozaki, Yasuyuki; Hara, Akinori; Shimizu, Miho; Iwata, Yasunori; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa 9208641, Japan; [Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan	Furuichi, K (reprint author), Kanazawa Univ Hosp, Div Nephrol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	kfuruichi@m-kanazawa.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science, Sports and Culture, Japan	We wish to thank the staff of the Clinical Laboratory at Kanazawa University Hospital for their technical assistance in this study. This study was supported by Grants-in-Aid for Diabetic Nephropathy, Diabetic Nephropathy Research, and Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan and the Ministry of Education, Science, Sports and Culture, Japan.	Ono H, 2008, HYPERTENS RES, V31, P271, DOI 10.1291/hypres.31.271; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Wada T, 2012, CLIN EXP NEPHROL, V16, P96, DOI 10.1007/s10157-011-0508-z; Ishizaka N, 2007, HYPERTENS RES, V30, P1035, DOI 10.1291/hypres.30.1035; Zanchetti A, 1998, J HYPERTENS, V16, P949, DOI 10.1097/00004872-199816070-00008; Nakano T, 2010, AM J KIDNEY DIS, V55, P21, DOI 10.1053/j.ajkd.2009.06.034; Vaccaro O, 1998, INT J EPIDEMIOL, V27, P636, DOI 10.1093/ije/27.4.636; Polak JF, 1998, RADIOLOGY, V208, P649; Wagenknecht LE, 1998, DIABETES CARE, V21, P1812, DOI 10.2337/diacare.21.11.1812; Wagenknecht LE, 2003, ARTERIOSCL THROM VAS, V23, P1035, DOI 10.1161/01.ATV.0000072273.67342.6D; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Hirano M, 2010, ATHEROSCLEROSIS, V211, P451, DOI 10.1016/j.atherosclerosis.2010.03.003; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Bouchi R, 2010, HYPERTENS RES, V33, P1298, DOI 10.1038/hr.2010.170; Khaw KT, 2001, BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Zhang LX, 2007, AM J KIDNEY DIS, V49, P786, DOI 10.1053/j.ajkd.2007.03.011; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Mitsuhashi N, 2002, DIABETES CARE, V25, P1308, DOI 10.2337/diacare.25.8.1308; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; Taniwaki H, 1998, DIABETES CARE, V21, P1848, DOI 10.2337/diacare.21.11.1848; Wada T, 2014, CLIN EXP NEPHROL, V18, P613, DOI 10.1007/s10157-013-0879-4; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Yamasaki Y, 2000, DIABETES CARE, V23, P1310, DOI 10.2337/diacare.23.9.1310; HANDA N, 1995, STROKE, V26, P1781; OLEARY DH, 1992, STROKE, V23, P1752; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Silvestrini M, 2010, ATHEROSCLEROSIS, V210, P452, DOI 10.1016/j.atherosclerosis.2009.12.033; Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298; Wiegman A, 2004, JAMA-J AM MED ASSOC, V292, P331, DOI 10.1001/jama.292.3.331; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Yokoyama H, 2006, STROKE, V37, P2420, DOI 10.1161/01.STR.0000236632.58323.cd; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Mykkanen L, 1997, STROKE, V28, P1710; Selvin E, 2004, ANN INTERN MED, V141, P421; WOFFORD JL, 1991, ARTERIOSCLER THROMB, V11, P1786; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Kume S, 2010, NEUROSURG REV, V33, P419, DOI 10.1007/s10143-010-0270-9; Nakanishi S, 2005, DIABETOLOGIA, V48, P230, DOI 10.1007/s00125-004-1643-9; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Kawamoto R, 2008, INTERNAL MED, V47, P391, DOI 10.2169/internalmedicine.47.0552; YAMASAKI Y, 1994, DIABETES, V43, P634, DOI 10.2337/diabetes.43.5.634; Atsunori K, 2012, J DIABETES INVEST, V3, P39; Ishizakaa Y, 2008, KIDNEY BLOOD PRESS R, V31, P164, DOI 10.1159/000131750; Nakade Y, 2014, CLIN EXP NEPHROL, V18, P763, DOI 10.1007/s10157-013-0920-7; Temelkova-Kurktschiev TS, 1999, DIABETES CARE, V22, P333, DOI 10.2337/diacare.22.2.333; Terminology and Diagnostic Criteria Committee, 2009, JPN J MED ULTRASON, V36, P501; Toyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071810	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					909	917		10.1007/s10157-015-1088-0		9	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700019		
J	Hoshino, Y; Kaga, T; Abe, Y; Endo, M; Wakai, S; Tsuchiya, K; Nitta, K				Hoshino, Yoshie; Kaga, Toshie; Abe, Yasutomo; Endo, Mariko; Wakai, Sachiko; Tsuchiya, Ken; Nitta, Kosaku			Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Hematuria without overt proteinuria; Renal biopsy; IgA nephropathy	ISOLATED MICROSCOPIC HEMATURIA; TERM-FOLLOW-UP; NATURAL-HISTORY; IGA NEPHROPATHY; AND/OR PROTEINURIA; PROGNOSIS; ADULTS; DISEASE	Whether to perform a renal biopsy for isolated hematuria remains a matter of controversy. We performed renal biopsy in hematuria without overt proteinuria patients and reported the proportion of glomerulonephritis, pathological activities, and statistical analysis of indicators associated with glomerulonephritis. Among 203 patients who underwent renal biopsy in Okubo Hospital, Japan, between January 2008 and October 2013, we identified 56 patients who fulfilled the criteria: (1) urine dipstick examination shows equal to or greater than +/- blood on three or more visits, (2) proteinuria < 0.3 g/day (g/g Cr), (3) eGFR a parts per thousand 60 ml/min/1.73 m(2), and (4) no current medication for renal disease. We investigated biopsy findings and compared the clinical indicators in the IgA nephropathy (IgAN) and non-IgAN group. The pathological diagnosis was IgAN in 35 cases (62 %), thin basement membrane disease (TBMD) in 7 (13 %), minor glomerular abnormality (MGA) in 6 (11 %), glomerular basement membrane (GBM) abnormality in 5 (9 %), and others in 3 (5 %). The histological grade of IgAN was I in 90 % and II in 10; 31 % of patients had some crescentic lesions. Comparisons between the IgAN and non-IgAN group revealed significant differences in age of onset (26 +/- A 13 vs. 34 +/- A 17 years, p = 0.04), serum IgA (340 +/- A 114 vs. 220 +/- A 101 mg/dl, p < 0.01), proteinuria (0.08 [0-0.25] vs. 0 [0-0.23] g/day [g/gCr], p < 0.01), and the presence of poikilocytes (40 vs. 10 %, p = 0.02). The proportion of IgAN in hematuria without overt proteinuria was high and the pathological activities were variable. Patients with hematuria without overt proteinuria should continue their medical follow-up and the best timing of biopsy may be controversial for these patients who have multiple risk factors of IgAN.	[Hoshino, Yoshie; Tsuchiya, Ken; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan; [Kaga, Toshie; Abe, Yasutomo; Endo, Mariko; Wakai, Sachiko] Tokyo Metropolitan Hlth & Med Treatment Corp, Okubo Hosp, Dept Nephrol, Tokyo, Japan	Hoshino, Y (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yhoshino@kc.twmu.ac.jp					SCHENA FP, 1990, AM J MED, V89, P209; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; TIEBOSCH ATMG, 1989, NEW ENGL J MED, V320, P14, DOI 10.1056/NEJM198901053200103; McGregor DO, 1998, CLIN NEPHROL, V49, P345; Tomson C, 2002, BJU INT, V90, P185, DOI 10.1046/j.1464-410X.2002.02841.x; Chow KM, 2004, QJM-INT J MED, V97, P739, DOI 10.1093/qjmed/hch125; Yamagata K, 2002, NEPHRON, V91, P34, DOI 10.1159/000057602; Ieiri N, 2012, CLIN EXP NEPHROL, V16, P122, DOI 10.1007/s10157-011-0530-1; Shen P, 2007, INT J CLIN PRACT, V61, P789, DOI 10.1111/j.1742-1241.2006.01159.x; Iseki K, 1996, KIDNEY INT, V49, P800, DOI 10.1038/ki.1996.111; Maeda A, 2003, J CLIN LAB ANAL, V17, P73, DOI 10.1002/jcla.10071; TOPHAM PS, 1994, Q J MED, V87, P329; Yamagata K, 1996, CLIN NEPHROL, V45, P281; Nieuwhof C, 1996, KIDNEY INT, V49, P222, DOI 10.1038/ki.1996.30; KOHLER H, 1991, KIDNEY INT, V40, P115, DOI 10.1038/ki.1991.188; Fuiano G, 2000, AM J KIDNEY DIS, V35, P448, DOI 10.1016/S0272-6386(00)70197-1; Feng CY, 2013, WORLD J PEDIATR, V9, P163, DOI 10.1007/s12519-013-0415-3; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; Churg J, 1995, WHO MONOGRAPH RENAL; Hirakata Hideki, 2005, Nihon Jinzo Gakkai Shi, V47, P73; Imai E, 2012, NIHON JINZO GAKKAI S, V54, P1031; Japanese Society of Nephrology, 2009, CLIN EXP NEPHROL, V13, P537, DOI 10.1007/s10157-009-0237-8; Lee H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-94; Matsuo S, 2011, NIHON JINZO GAKKAI S, V53, P123; Miura Hideto, 2003, Rinsho Byori, V51, P740; Tomino Yasuhiko, 2003, Clin Exp Nephrol, V7, P93, DOI 10.1007/s10157-003-0232-4; Topham PS, 2004, FAM PRACT, V21, P18, DOI 10.1093/fampra/cmh105	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					918	924		10.1007/s10157-015-1090-6		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700020		
J	Hayashi, M; Uchida, S; Kawamura, T; Kuwahara, M; Nangaku, M; Iino, Y				Hayashi, Matsuhiko; Uchida, Shunya; Kawamura, Tetsuya; Kuwahara, Michio; Nangaku, Masaomi; Iino, Yasuhiko		The PROTECT-CKD Study Group	Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Chronic kidney disease; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; Calcium channel blocker; Diuretics	RENAL OUTCOMES; RISK; MULTICENTER; AMLODIPINE; DIURETICS; TRIAL	We conducted a randomized, open-label trial to determine which of the antihypertensive drugs was most beneficial for CKD patients with hypertension in spite of treatment with an angiotensin receptor blocker (ARB). Patients 20-75 years of age who had CKD according to the definition in the K/DOQI Guidelines and hypertension (systolic blood pressure a parts per thousand yen130 mmHg and/or diastolic blood pressure a parts per thousand yen80 mmHg) with the usual dose of an ARB were randomly assigned to receive losartan 50 mg plus 5 mg of the calcium channel blocker amlodipine (CCB group, n = 37), 5 mg of the angiotensin-converting enzyme inhibitor enalapril (ACEI group, n = 36), or 12.5 mg of the thiazide diuretic hydrochlorothiazide (HCTZ group, n = 36). The primary endpoints were changes in blood pressure (BP), ratio of urinary excretion of protein to creatinine (UPCR), tolerability, and eGFR during the 12-month treatment period compared with control period. There were no significant differences in BP and tolerability between the three groups. The percentage changes in UPCR at 12 months after start of the combination therapy were significantly different in the HCTZ group (-26.3 +/- A 11.1 %, mean +/- A SE) and CCB group (+46.7 +/- A 33.6 %, p < 0.05), while eGFR was significantly lower in the HCTZ group than in the ACEI group or CCB group at 4 months but not at 12 months. Addition of diuretics, CCB, or ACEI to ARB was equally effective for the control of hypertension in CKD, while, in terms of urinary excretion of protein, diuretics may be better than CCB.	[Hayashi, Matsuhiko] Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Shinjuku Ku, Tokyo 1608582, Japan; [Uchida, Shunya] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Kawamura, Tetsuya] Jikei Univ, Sch Med, Tokyo, Japan; [Kuwahara, Michio] Shuwa Gen Hosp, Kasukabe, Japan; [Nangaku, Masaomi] Univ Tokyo, Sch Med, Tokyo 113, Japan; [Iino, Yasuhiko] Nippon Med Sch, Tokyo 113, Japan	Hayashi, M (reprint author), Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	matuhiko@z3.keio.jp			Kidney Foundation, Japan	The results presented in this paper have not been published previously in whole or part, but parts of this manuscript were presented in abstract form at Kidney Week 2013 of the American Society of Nephrology, Atlanta. This work was funded by a research grant from The Kidney Foundation, Japan.	Bakris GL, 2008, KIDNEY INT, V73, P1303, DOI 10.1038/ki.2008.102; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Iino Y, 2004, HYPERTENS RES, V27, P21, DOI 10.1291/hypres.27.21; Strippoli GFM, 2004, BRIT MED J, V329, P828, DOI 10.1136/bmj.38237.585000.7C; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Shimosawa T, 2007, HYPERTENS RES, V30, P831, DOI 10.1291/hypres.30.831; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Matsui Y, 2011, AM J HYPERTENS, V24, P466, DOI 10.1038/ajh.2010.240; Sato N, 2013, J HYPERTENS, V31, P1245, DOI 10.1097/HJH.0b013e32835fdf60; Ernst ME, 2009, NEW ENGL J MED, V361, P2153, DOI 10.1056/NEJMra0907219; Japanese Society of Nephrology, 2009, CLIN EXP NEPHROL, V13, P537, DOI 10.1007/s10157-009-0237-8; Khosla N, 2006, CLIN J AM SOC NEPHRO, V1, P22; National Kidney Foundation, 2002, AM J KIDNEY DIS S1, V39, pS1	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					925	932		10.1007/s10157-015-1091-5		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700021		
J	Hattori, M; Sako, M; Kaneko, T; Ashida, A; Matsunaga, A; Igarashi, T; Itami, N; Ohta, T; Gotoh, Y; Satomura, K; Honda, M; Igarashi, T				Hattori, Motoshi; Sako, Mayumi; Kaneko, Tetsuji; Ashida, Akira; Matsunaga, Akira; Igarashi, Tohru; Itami, Noritomo; Ohta, Toshiyuki; Gotoh, Yoshimitsu; Satomura, Kenichi; Honda, Masataka; Igarashi, Takashi			End-stage renal disease in Japanese children: a nationwide survey during 2006-2011	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						End-stage renal disease; Children; Epidemiology; Renal replacement therapy; Japan	CHRONIC KIDNEY-DISEASE; REPLACEMENT THERAPY; REGISTRY; DIALYSIS; TRANSPLANTATION; SURVIVAL; OUTCOMES; QUALITY; SOCIETY; EUROPE	End-stage renal disease (ESRD) in children is considered a rare, but serious condition. Epidemiological and demographic information on pediatric ESRD patients around the world is important to better understand this disease and to improve patient care. The Japanese Society for Pediatric Nephrology (JSPN) reported epidemiological and demographic data in 1998. Since then, however, there has been no nationwide survey on Japanese children with ESRD. The JSPN conducted a cross-sectional nationwide survey in 2012 to update information on the incidence, primary renal disease, initial treatment modalities, and survival in pediatric Japanese patients with ESRD aged less than 20 years during the period 2006-2011. The average incidence of ESRD was 4.0 per million age-related population. Congenital anomalies of the kidney and urinary tract were the most common cause of ESRD, present in 39.8 % of these patients. In addition, 12.2 % had focal segmental glomerulosclerosis and 5.9 % had glomerulonephritis. Initial treatment modalities in patients who commenced renal replacement therapy (RRT) consisted of peritoneal dialysis, hemodialysis, and pre-emptive transplantation (Tx) in 61.7, 16.0, and 22.3 %, respectively. The Japanese RRT mortality rate was 18.2 deaths per 1000 person-years of observation. The incidence of ESRD is lower in Japanese children than in children of other high-income countries. Since 1998, notably, there has been a marked increase in pre-emptive Tx as an initial treatment modality for Japanese children with ESRD.	[Hattori, Motoshi] Tokyo Womens Med Univ, Sch Med, Dept Pediat Nephrol, Shinjuku Ku, Tokyo 1628666, Japan; [Sako, Mayumi] Natl Ctr Child Hlth & Dev, Ctr Social & Clin Res, Dept Dev Strategy, Div Clin Trials, Tokyo, Japan; [Kaneko, Tetsuji] Tokyo Metropolitan Childrens Med Ctr, Div Clin Res Support Ctr, Tokyo, Japan; [Ashida, Akira] Osaka Med Coll, Dept Pediat, Osaka, Japan; [Matsunaga, Akira] Matsunaga Kids Clin, Yamagata, Japan; [Igarashi, Tohru] Nippon Med Univ, Dept Pediat, Tokyo, Japan; [Itami, Noritomo] Nikko Mem Hosp, Kidney Ctr, Sapporo, Hokkaido, Japan; [Ohta, Toshiyuki] Hiroshima Prefectural Hosp, Dept Pediat Nephrol, Hiroshima, Japan; [Gotoh, Yoshimitsu] Nagoya Daini Red Cross Hosp, Dept Pediat, Aichi, Japan; [Satomura, Kenichi] Osaka Med Ctr, Dept Pediat Nephrol & Metab, Osaka, Japan; [Satomura, Kenichi] Res Inst Maternal & Child Hlth, Osaka, Japan; [Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Tokyo, Japan; [Igarashi, Takashi] Natl Ctr Child Hlth & Dev, Tokyo, Japan	Hattori, M (reprint author), Tokyo Womens Med Univ, Sch Med, Dept Pediat Nephrol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	hattori@kc.twmu.ac.jp			Japanese Society for Pediatric Nephrology (JSPN)	The JSPN ESRD Survey is funded by the Japanese Society for Pediatric Nephrology (JSPN). The authors thank all patients, families, physicians, and institutes who contributed to the JSPN ESRD Survey. The authors also thank Drs. Yuko Akioka, Kenji Ishikura, and Yuko Hamazaki for being members of the JSPN ESRD Survey Committee, and Drs. Shuich Ito, Osamu Uemura, Yoshihiko Ueda, Satoshi Sasaki, Ken Hatae, Hiroshi Hataya, Misako Hiramatsu, Mikiya Fujieda, and Hiroshi Yoshimura and the members of the JSPN, the Japanese Society for Dialysis Therapy (JSDT), and the Japanese Society for Clinical Renal Transplantation (JSCRT) for their contributions to data collection. The authors also thank Prof. Yasuo Ohashi, Mr. Masayuki Kurihara, and Ms. Chie Matsuda of the Japan Clinical Research Support Unit (Tokyo) for their help with data management.	van der Heijden BJ, 2004, PEDIATR NEPHROL, V19, P213, DOI 10.1007/s00467-003-1376-x; Harambat J, 2012, PEDIATR NEPHROL, V27, P363, DOI 10.1007/s00467-011-1939-1; Yamada A, 2014, PEDIATR TRANSPLANT, V18, P453, DOI 10.1111/petr.12299; Orr NIT, 2009, PEDIATR NEPHROL, V24, P1719, DOI 10.1007/s00467-009-1181-2; van Stralen KJ, 2014, KIDNEY INT, V86, P168, DOI 10.1038/ki.2013.561; Tizard EJ, 2009, NEPHROL DIAL TRANSPL, V24, P2615, DOI 10.1093/ndt/gfp275; Schoenmaker NJ, 2013, NEPHROL DIAL TRANSPL, V28, P3052, DOI 10.1093/ndt/gft303; Andreoli SP, 2005, J AM SOC NEPHROL, V16, P2263, DOI 10.1681/ASN.2005020186; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Hattori S, 2002, PEDIATR NEPHROL, V17, P456; van Stralen KJ, 2010, PEDIATR NEPHROL, V25, P1379, DOI 10.1007/s00467-010-1472-7; Mitsnefes MM, 2013, JAMA-J AM MED ASSOC, V309, P1921, DOI 10.1001/jama.2013.4208; Bock ME, 2010, PEDIATR TRANSPLANT, V14, P561, DOI 10.1111/j.1399-3046.2010.01347.x; Borzych D, 2012, KIDNEY INT, V78, P1295; Warady BA, 2007, PEDIATR NEPHROL, V22, P1999, DOI 10.1007/s00467-006-0410-1; Schaefer F, 2012, PERITON DIALYSIS INT, V32, P399, DOI 10.3747/pdi.2012.00126; United States Renal Data System (USRDS), ANN DAT REP ATL CHRO	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					933	938		10.1007/s10157-014-1077-8		6	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700022		
J	Nagatoya, K; Nishimoto, K; Shibahara, N; Takahashi, T; Kanehara, H; Ueno, N; Yasuda, H; Okada, S; Ueda, H; Hirai, K; Inoue, T				Nagatoya, Katsuyuki; Nishimoto, Kazuhiko; Shibahara, Nobuhisa; Takahashi, Toshikazu; Kanehara, Hironori; Ueno, Nobuyuki; Yasuda, Hideaki; Okada, Shigeki; Ueda, Haruhiko; Hirai, Kei; Inoue, Toru		Hokusetsu Renal Osteodystrophy Stu	Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Postmenopausal woman; End-stage renal failure; Raloxifene; Bone metabolism; Vitamin D	CLINICAL-PRACTICE GUIDELINE; DIALYSIS PATIENTS; MINERAL DENSITY; MAINTENANCE HEMODIALYSIS; RENAL OSTEODYSTROPHY; BIOCHEMICAL MARKERS; HIP FRACTURE; RISK-FACTORS; OSTEOPOROSIS; PHOSPHATASE	Postmenopausal women with end-stage renal failure are at an increased risk of fracture because of the effects of secondary hyperparathyroidism and postmenopausal osteoporosis. In the present study, we investigated the feasibility of using raloxifene to prevent fractures in postmenopausal women with end-stage renal failure on hemodialysis. This study was conducted using a multicenter, single-arm, prospective design. Raloxifene was administered to postmenopausal women aged a parts per thousand yen50 years who were on maintenance hemodialysis and met any of the following criteria after a 24-week run-in period: an alkaline phosphatase level (bone formation marker) of a parts per thousand yen6.18 A mu kat/L (a parts per thousand yen370 U/L), a bone-specific alkaline phosphatase (BAP; bone formation marker) level of a parts per thousand yen0.59 A mu kat/L (a parts per thousand yen35.4 U/L), or a bone-derived tartrate-resistant acid phosphatase (TRACP-5b; bone resorption marker) level of a parts per thousand yen4.2 U/L. A total of 48 individuals were eligible for study inclusion. Of them, 30 individuals participated in this study. The BAP levels were significantly decreased at week 4, but returned to the baseline levels at week 24. Similarly, the TRACP-5b levels were significantly decreased at week 4, but returned to the baseline levels at week 24. The serum calcium value decreased consistently after the start of raloxifene therapy. The intact parathyroid hormone (iPTH) levels were likely increased at week 4. The ratio of BAP to iPTH levels and the ratio of TRACP-5b to iPTH levels both showed significant decreases over time. During the raloxifene therapy, no thrombosis or other drug-related adverse events developed. The study results indicated that raloxifene can transiently reduce the levels of bone metabolism markers and might be useful for preventing fractures in postmenopausal women with end-stage renal failure, although raloxifene use over the long term may not have adequate efficacy in the absence of appropriate concomitant active vitamin D therapy.	[Nagatoya, Katsuyuki] Osaka Med Coll Hosp, Blood Purificat Ctr, Takatsuki, Osaka, Japan; [Nagatoya, Katsuyuki] Osaka Rosai Hosp, Dept Lab Med, Sakai, Osaka 5918025, Japan; [Nishimoto, Kazuhiko] Nishimoto Clin, Hirakata, Osaka, Japan; [Shibahara, Nobuhisa] Arisawa Gen Hosp, Hirakata, Osaka, Japan; [Takahashi, Toshikazu] Takatsuki Gen Hosp, Dept Nephrol, Takatsuki, Osaka, Japan; [Kanehara, Hironori] Kanehara Clin, Takatsuki, Osaka, Japan; [Ueno, Nobuyuki] Sanko Clin, Ibaraki, Japan; [Yasuda, Hideaki] Sanko Fuzoku Clin, Takatsuki, Osaka, Japan; [Okada, Shigeki] Okada Clin, Osaka, Japan; [Ueda, Haruhiko] Kamo Hosp, Kyoto, Japan; [Hirai, Kei] Sanko Clin, Takatsuki, Osaka, Japan; [Inoue, Toru] Gen Hosp Higashikouri, Dept Internal Med, Hirakata, Osaka, Japan	Nagatoya, K (reprint author), Osaka Rosai Hosp, Dept Lab Med, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.	katsuyuki@orh.go.jp			Chugai Pharmaceutical Co., Ltd.	Katsuyuki Nagatoya and Toru Inoue report receiving Grant support from Chugai Pharmaceutical Co., Ltd.	PAYNE RB, 1973, BRIT MED J, V4, P643; Hamano T, 2009, BONE, V45, pS19, DOI 10.1016/j.bone.2009.03.663; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Hernandez E, 2003, KIDNEY INT, V63, P2269, DOI 10.1046/j.1523-1755.2003.00005.x; Saito O, 2011, CLIN EXP NEPHROL, V15, P126, DOI 10.1007/s10157-010-0366-0; Tanaka M, 2011, THER APHER DIAL, V15, P62, DOI 10.1111/j.1744-9987.2011.00929.x; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Chu PL, 2003, AM J KIDNEY DIS, V41, P1052, DOI 10.1016/S0272-6386(03)00203-8; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Arneson TJ, 2013, AM J KIDNEY DIS, V62, P747, DOI 10.1053/j.ajkd.2013.02.368; Urena P, 2003, NEPHROL DIAL TRANSPL, V18, P2325, DOI 10.1093/ndt/gfg403; Eriguchi R, 2009, CLIN NEPHROL, V72, P423; Jadoul M, 2006, KIDNEY INT, V70, P1358, DOI 10.1038/sk.ki.5001754; Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Fletcher S, 1997, NEPHRON, V75, P412; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, KIDNEY INT S, V113, pS1, DOI DOI 10.1038/KI.2009.188; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					939	946		10.1007/s10157-014-1065-z		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700023		
J	Tsutsui, H; Ohkubo, T; Tsuruta, Y; Kato, S; Yasuda, Y; Oshida, Y				Tsutsui, Hideyo; Ohkubo, Takayoshi; Tsuruta, Yoshinari; Kato, Sawako; Yasuda, Yoshinari; Oshida, Yoshiharu			Development and validation of a short-version checklist for patients undergoing hemodialysis based on the International Classification of Functioning, Disability and Health	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Short-version checklist; Hemodialysis; International Classification of Functioning, Disability and Health; Validity evaluation	QUALITY-OF-LIFE; KIDNEY-DISEASE; MAINTENANCE HEMODIALYSIS; DIALYSIS POPULATION; ASSOCIATION; AMYLOIDOSIS; INSTRUMENT; SECONDARY; SYMPTOMS; THERAPY	In 2009, we developed a "100-category checklist" for patients undergoing hemodialysis (HD) based on the International Classification of Functioning, Disability and Health, and we confirmed its validity. However, we found that for patients' daily assessment, 100 categories were too many. The purpose of the present study was to develop and validate a short version of the "100-category checklist." A total of 100 outpatients undergoing HD were recruited. They were interviewed using the "100-category checklist" and asked whether they had experienced problems after starting HD. From the "100-category checklist," we extracted categories that had greater than a 50 % rate of "yes" responses. Content validity was evaluated using the frequency of patients who had a problem in each category. Criterion validity was evaluated based on the correlation of the score from the "short-version checklist" categories with that from the Kidney Disease Quality of Life (KDQOL (TM)) questionnaire. Construct validity was evaluated using Spearman correlation coefficients between the number of problem categories and the presence of HD-related complications. Cronbach's coefficient alpha was calculated to evaluate internal consistency. Twenty-two categories were identified as problem categories. Criterion validity showed that 12 categories were significantly correlated with subscales of the KDQOL (TM). Construct validity showed that the presence of complications contributed to an increased number of problems associated with HD. Cronbach's coefficient alpha of this checklist was 0.79. The "short-version checklist" had a certain degree of validity, suggesting its usefulness in a simplified assessment of patients undergoing HD.	[Tsutsui, Hideyo; Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Itabashi Ku, Tokyo 1738605, Japan; [Tsutsui, Hideyo; Oshida, Yoshiharu] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tsuruta, Yoshinari] Meiyo Clin, Toyohashi, Aichi 4418023, Japan; [Kato, Sawako] Nagoya Univ, Grad Sch Med, Dept Nephrol, Showa Ku, Nagoya, Aichi 4660064, Japan; [Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept Chron Kidney Dis Initiat, Showa Ku, Nagoya, Aichi 4660064, Japan	Tsutsui, H (reprint author), Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	htsutsui@med.teikyo-u.ac.jp			Kidney Foundation, Japan [JKF10-5]; Kidney Foundation, Aichi, Japan	This study was supported by a Grant from the Kidney Foundation, Japan (JKF10-5) and by a Grant from the Kidney Foundation, Aichi, Japan. The authors would like to thank M. Ogi, Y. Nagata, K. Kita, M. Natsume, F. Ito, and S. Ozaki; head nurse at Meiyo Clinic, for their support with respect to the interviews.	Chan R, 2012, QUAL LIFE RES, V21, P563, DOI 10.1007/s11136-011-9973-9; Farag YMK, 2011, CLIN NEPHROL, V75, P524, DOI 10.5414/CNP75524; Malindretos P, 2012, CLIN NEPHROL, V77, P196, DOI 10.5414/CN107030; [Anonymous], 2004, J REHABIL MED S; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Green J, 2001, QUAL LIFE RES, V10, P93, DOI 10.1023/A:1016630825992; Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; Carmichael P, 2000, QUAL LIFE RES, V9, P195, DOI 10.1023/A:1008933621829; Cofan F, 2002, RHEUMATOLOGY, V41, P701, DOI 10.1093/rheumatology/41.6.701-a; Gejyo F, 2003, NEPHROLOGY, V8, pS45, DOI 10.1046/j.1440-1797.8.s.10.x; Tsutsui H, 2009, THER APHER DIAL, V13, P186, DOI 10.1111/j.1744-9987.2009.00683.x; Wu YY, 2014, J INT MED RES, V42, P718, DOI 10.1177/0300060513509037; Chertow GM, 2012, HEMODIAL INT, V16, P188, DOI 10.1111/j.1542-4758.2011.00642.x; Kim JY, 2013, QUAL LIFE RES, V22, P753, DOI 10.1007/s11136-012-0203-x; BOSANAC PR, 1977, T AM SOC ART INT ORG, V23, P162; Otsubo S, 2009, NEPHROL DIAL TRANSPL, V24, P1593, DOI 10.1093/ndt/gfn706; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Moreira AC, 2013, NUTR HOSP, V28, P951, DOI 10.3305/nh.2013.28.3.6454; Cavalcante Milady Cutrim Vieira, 2013, J Bras Nefrol, V35, P79, DOI 10.5935/0101-2800.20130014; Tamura MK, 2012, NEUROLOGY, V79, P981, DOI 10.1212/WNL.0b013e31826845e9; Nakai S, 2014, NIHON TOSEKI IGAKKAI, V47, P1; Peter MF, 2009, QUALITY LIFE ASSESSM; Stucki A, 2004, J REHABIL MED S, V44, P107; Suwabe T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-179; Tsutsui H, 2014, THER APHER DIAL, V18, P473, DOI 10.1111/1744-9987.12163	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					953	960		10.1007/s10157-014-1075-x		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700025		
J	Yamahatsu, A; Hamada, C; Kaneko, K; Io, H; Nakata, J; Tomino, Y				Yamahatsu, Aya; Hamada, Chieko; Kaneko, Kayo; Io, Hiroaki; Nakata, Junichiro; Tomino, Yasuhiko			Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Encapsulating peritoneal sclerosis; Peritoneal dialysis; Long-term outcome; Enterolysis; Laparoscopy	DIALYSIS; DIAGNOSIS; MANAGEMENT; JAPAN	Encapsulating peritoneal sclerosis (EPS) is the most serious complication of peritoneal dialysis (PD) with a high mortality rate. The objective of the present study was to determine the clinical characteristics, the incidence rate, and the long-term outcome of EPS patients compared with control patients. Two hundred and seventy patients with end-stage kidney disease were started on PD from 1987 to 2013 in the Juntendo University Hospital. EPS was diagnosed by clinical findings, radiological findings, and macroscopic inspection at the time of laparoscopy or surgical operation. Patient medical records were analyzed retrospectively, including clinical characteristics, laboratory findings, treatment modality, and outcomes. Using a Kaplan-Meier analysis, we compared the survival rate between EPS patients and control PD patients, matched for age, gender, diabetes, and duration of PD. Among 270 PD patients, 13 patients (4.8 %) developed EPS. The mean duration of PD was 120.5 +/- A 42.8 months. There were no significant difference in demographic findings between EPS and control PD patients. Among the EPS patients, seven patients died, of which four deaths were directly attributed to EPS. All four patients that had had surgical enterolysis were doing well and had no recurrences. No significant difference in the survival rate between EPS and control PD patients was observed in the Kaplan-Meier analysis. There was no significant difference in the survival rate between EPS patients and control PD patients. It appears that an early diagnosis by laparoscopy and accurate treatment, including surgical enterolysis, might improve mortality.	[Yamahatsu, Aya; Hamada, Chieko; Kaneko, Kayo; Io, Hiroaki; Nakata, Junichiro; Tomino, Yasuhiko] Juntendo Univ, Div Nephrol, Dept Internal Med, Fac Med,Bunkyo Ku, Tokyo 1138421, Japan	Tomino, Y (reprint author), Juntendo Univ, Div Nephrol, Dept Internal Med, Fac Med,Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yasu@juntendo.ac.jp					Kropp J, 2009, SEMIN DIALYSIS, V22, P304, DOI 10.1111/j.1525-139X.2008.00546.x; Brown MC, 2009, CLIN J AM SOC NEPHRO, V4, P1222, DOI 10.2215/CJN.01260209; Kawanishi H, 2004, AM J KIDNEY DIS, V44, P729, DOI 10.1053/j.ajkd.2004.06.020; Tarzi RM, 2008, CLIN J AM SOC NEPHRO, V3, P1702, DOI 10.2215/CJN.01820408; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; Kawanishi H, 2005, PERITON DIALYSIS INT, V25, pS39; Kawaguchi Y, 2005, PERITON DIALYSIS INT, V25, pS83; Brown EA, 2009, PERITON DIALYSIS INT, V29, P595; Nomoto Y, 1996, AM J KIDNEY DIS, V28, P420, DOI 10.1016/S0272-6386(96)90501-6; Trigka K, 2011, INT UROL NEPHROL, V43, P519, DOI 10.1007/s11255-010-9848-y; Habib AM, 2010, NEPHROL DIAL TRANSPL, V25, P1633, DOI 10.1093/ndt/gfp677; Lindic J, 2009, THER APHER DIAL, V13, P282, DOI 10.1111/j.1744-9987.2009.00725.x; Johnson DW, 2010, KIDNEY INT, V77, P904, DOI 10.1038/ki.2010.16; Cho Y, 2013, KIDNEY INT, V84, P969, DOI 10.1038/ki.2013.190; Summers AM, 2005, KIDNEY INT, V68, P2381, DOI 10.1111/j.1523-1755.2005.00701.x; Ulmer C, 2013, SURGERY, V153, P219, DOI 10.1016/j.surg.2012.07.033; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; Bansal Saurabh, 2010, Adv Perit Dial, V26, P75; Kawanishi Hideki, 2008, Adv Perit Dial, V24, P51; Lo WK, 2009, PERITON DIAL INT S2, V29, P211; Nakayama M, 2014, PERITON DIALYSIS INT, V34, P766, DOI 10.3747/pdi.2013.00074; Sonikian M, 2014, CLIN NEPHROL, V81, P283, DOI 10.5414/CN107542; Spence Robert, 2013, Ulster Med J, V82, P11	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					961	967		10.1007/s10157-015-1081-7		7	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700026		
J	Kawano, H; Muto, S; Ohmoto, Y; Iwata, F; Fujiki, H; Mori, T; Yan, L; Horie, S				Kawano, Haruna; Muto, Satoru; Ohmoto, Yasukazu; Iwata, Fusako; Fujiki, Hiroyuki; Mori, Toyoki; Yan, Lu; Horie, Shigeo			Exploring urinary biomarkers in autosomal dominant polycystic kidney disease	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Autosomal dominant polycystic kidney disease; Urinary biomarker; DBA/2FG-pcy mouse	MONOCYTE CHEMOATTRACTANT PROTEIN-1; GELATINASE-ASSOCIATED LIPOCALIN; NEUTROPHIL GELATINASE; EPITHELIAL-CELLS; RENAL INJURY; ENCODES; GENE; NGAL	Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited kidney disease, is a progressive disease characterized by a bilateral proliferation and enlargement of renal cysts. Recent reports have shown that tolvaptan, a vasopressin V2 receptor antagonist, has been effective in inhibiting renal cyst proliferation and enlargement in ADPKD patients, although no biomarker has identified to predict the effects of tolvaptan. We explored the effective urinary biomarkers in ADPKD in human and in an animal model. We measured 28 biomarkers in urine taken from ADPKD patients to compare with that of healthy subjects. Next, a gene expression analysis of the kidney from DBA/2FG-pcy mice (ADPKD model animals) was performed to identify prospective biomarkers. Additionally, we investigated the DBA/2FG-pcy mouse urine samples to determine the biomarkers' efficacy. There were statistically significant differences in 12 of the 28 prospective urinary biomarkers between urine from ADPKD patients and that from healthy subjects. Six of these matched with highly expressed gene products of DBA/sFG-pcy mouse kidneys. Among those 6 biomarkers, NGAL, M-CSF, and MCP-1 showed significantly higher values in the urine of DBA/2FG-pcy mice than that of wild type. This study suggests that NGAL, M-CSF, MCP-1 are potential candidates of urinary biomarkers in ADPKD.	[Kawano, Haruna; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan; [Kawano, Haruna; Muto, Satoru; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Adv Therapeut Polycyst Kidney Dis, Tokyo, Japan; [Muto, Satoru; Yan, Lu; Horie, Shigeo] Teikyo Univ, Sch Med, Dept Urol, Tokyo 173, Japan; [Ohmoto, Yasukazu; Iwata, Fusako; Fujiki, Hiroyuki; Mori, Toyoki] Otsuka Pharmaceut Co Ltd, Res Inst Pharmacol Therapeut Dev, Tokushima 77101, Japan	Horie, S (reprint author), Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan.	shorie@juntendo.ac.jp			Ministry of Health, Labour and Welfare of Japan [Ippan-042]; Japan Society for the Promotion of Science (JSPS) [24592439]	The authors thank Dr. Okada Keiko and Dr. Muraguchi Masahiro for their technical assistance in our experiments. This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, from the Ministry of Health, Labour and Welfare of Japan (Grant No. Ippan-042) and a Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (JSPS) (24592439).	Belibi FA, 2004, KIDNEY INT, V66, P964, DOI 10.1111/j.1523-1755.2004.00843.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Tokiwa S, 2011, CLIN EXP NEPHROL, V15, P539, DOI 10.1007/s10157-011-0428-y; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; LeMeur Y, 1996, KIDNEY INT, V50, P1007; Zheng D, 2003, J AM SOC NEPHROL, V14, P2588, DOI 10.1097/01.ASN.0000088720.61783.19; Grantham JJ, 2010, CLIN J AM SOC NEPHRO, V5, P889, DOI 10.2215/CJN.00550110; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179; Cowley BD, 2001, KIDNEY INT, V60, P2087, DOI 10.1046/j.1523-1755.2001.00065.x; Le Meur Y, 2004, NEPHROL DIAL TRANSPL, V19, P1862, DOI 10.1093/ndt/fgh257; Nagao S, 2012, EXP ANIM TOKYO, V61, P477; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; TAKAHASHI H, 1991, J AM SOC NEPHROL, V1, P980; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Qamar S, 2007, BIOCHEM SOC T, V35, P124; Chirag RP, 2012, KIDNEY INT, V81, P784; Gianluca A, 2013, AM J NEPHROL, V37, P175; Schiffl H, 2012, MOL DIAGN THER, V16, P199, DOI 10.2165/11634310-000000000-00000; WARD CJ, 1994, CELL, V77, P881	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					968	973		10.1007/s10157-014-1078-7		6	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700027		
J	Isotani, S; Shimoyama, H; Yokota, I; Noma, Y; Kitamura, K; China, T; Saito, K; Hisasue, S; Ide, H; Muto, S; Yamaguchi, R; Ukimura, O; Gill, IS; Horie, S				Isotani, Shuji; Shimoyama, Hirofumi; Yokota, Isao; Noma, Yasuhiro; Kitamura, Kousuke; China, Toshiyuki; Saito, Keisuke; Hisasue, Shin-ichi; Ide, Hisamitsu; Muto, Satoru; Yamaguchi, Raizo; Ukimura, Osamu; Gill, Inderbir S.; Horie, Shigeo			Novel prediction model of renal function after nephrectomy from automated renal volumetry with preoperative multidetector computed tomography (MDCT)	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Chronic kidney disease; Volumetry; Multidetector computed tomography; Nephrectomy; Prediction model; Renal cortex; Renal function	CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; CT ANGIOGRAMS; DONORS	The predictive model of postoperative renal function may impact on planning nephrectomy. To develop the novel predictive model using combination of clinical indices with computer volumetry to measure the preserved renal cortex volume (RCV) using multidetector computed tomography (MDCT), and to prospectively validate performance of the model. Total 60 patients undergoing radical nephrectomy from 2011 to 2013 participated, including a development cohort of 39 patients and an external validation cohort of 21 patients. RCV was calculated by voxel count using software (Vincent, FUJIFILM). Renal function before and after radical nephrectomy was assessed via the estimated glomerular filtration rate (eGFR). Factors affecting postoperative eGFR were examined by regression analysis to develop the novel model for predicting postoperative eGFR with a backward elimination method. The predictive model was externally validated and the performance of the model was compared with that of the previously reported models. The postoperative eGFR value was associated with age, preoperative eGFR, preserved renal parenchymal volume (RPV), preserved RCV, % of RPV alteration, and % of RCV alteration (p < 0.01). The significant correlated variables for %eGFR alteration were %RCV preservation (r = 0.58, p < 0.01) and %RPV preservation (r = 0.54, p < 0.01). We developed our regression model as follows: postoperative eGFR = 57.87 - 0.55(age) - 15.01(body surface area) + 0.30(preoperative eGFR) + 52.92(%RCV preservation). Strong correlation was seen between postoperative eGFR and the calculated estimation model (r = 0.83; p < 0.001). The external validation cohort (n = 21) showed our model outperformed previously reported models. Combining MDCT renal volumetry and clinical indices might yield an important tool for predicting postoperative renal function.	[Isotani, Shuji; Shimoyama, Hirofumi; Noma, Yasuhiro; Kitamura, Kousuke; Saito, Keisuke; Ide, Hisamitsu; Muto, Satoru; Yamaguchi, Raizo] Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, Tokyo 173, Japan; [Yokota, Isao] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Biostat, Tokyo, Japan; [China, Toshiyuki; Hisasue, Shin-ichi; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan; [Ukimura, Osamu; Gill, Inderbir S.] Univ So Calif, Inst Urol, Los Angeles, CA USA	Isotani, S (reprint author), Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, Kaga 2-11-1, Tokyo 173, Japan.	sisotan@med.teikyo-u.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Kato F, 2011, EUR J RADIOL, V79, P15, DOI 10.1016/j.ejrad.2009.11.013; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Yano M, 2012, RADIOLOGY, V265, P151, DOI 10.1148/radiol.12112338; Kang SK, 2013, AM J ROENTGENOL, V200, P1204, DOI 10.2214/AJR.12.10276; Breau RH, 2013, CUAJ-CAN UROL ASSOC, V7, P189, DOI 10.5489/cuaj.1338; Tsushima Y, 2001, J UROLOGY, V165, P382, DOI 10.1097/00005392-200102000-00007; Mir MC, 2013, UROLOGY, V82, P263, DOI 10.1016/j.urology.2013.03.068; Jeon HG, 2010, J UROLOGY, V184, P1057, DOI 10.1016/j.juro.2010.04.079; van den Dool SW, 2005, RADIOLOGY, V236, P189, DOI 10.1148/radiol.2361021463; Funahashi Y, 2009, UROLOGY, V74, P708, DOI 10.1016/j.urology.2008.11.008; Fowler JC, 2006, BRIT J RADIOL, V79, P935, DOI 10.1259/bjr/53140218; Herts BR, 2009, RADIOLOGY, V252, P109, DOI 10.1148/radiol.2521081873; Beland MD, 2010, AM J ROENTGENOL, V195, pW146, DOI 10.2214/AJR.09.4104; Summerlin AL, 2008, AM J ROENTGENOL, V191, P1552, DOI 10.2214/AJR.07.4023; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; DAWSON P, 1993, INVEST RADIOL, V28, P1039, DOI 10.1097/00004424-199311000-00014; Muto NS, 2011, EUR J RADIOL, V78, P151, DOI 10.1016/j.ejrad.2009.10.005; Muto NS, 2013, ADV COMPUT TOMOGR, V2, P55; Yokoyama M, 2013, INT J UROL, V21, P238	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					974	981		10.1007/s10157-015-1082-6		8	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700028		
J	Takeda, K; Minota, S				Takeda, Koichi; Minota, Seiji			Gross hematuria caused by the nutcracker syndrome	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Editorial Material						Hematuria; Nutcracker syndrome			[Takeda, Koichi; Minota, Seiji] Jichi Med Univ, Div Rheumatol & Clin Immunol, Dept Med, Shimotsuke, Tochigi 3290498, Japan	Takeda, K (reprint author), Jichi Med Univ, Div Rheumatol & Clin Immunol, Dept Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	r0734kt@jichi.ac.jp					Gulleroglu Kaan, 2014, World J Nephrol, V3, P277, DOI 10.5527/wjn.v3.i4.277	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					982	983		10.1007/s10157-015-1112-4		2	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700029		
J	Imashuku, Y; Kojima, A; Takahashi, K; Kitagawa, H				Imashuku, Yasuhiko; Kojima, Akiko; Takahashi, Kan; Kitagawa, Hirotoshi			Washing out potassium absorption filters with normal saline after use	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Letter						Potassium absorption filter; Hyperkalemia; Renal dysfunctions	ADSORPTION FILTER		[Imashuku, Yasuhiko; Kojima, Akiko; Takahashi, Kan; Kitagawa, Hirotoshi] Shiga Univ Med Sci, Dept Anesthesiol, Otsu, Shiga 5202192, Japan	Imashuku, Y (reprint author), Shiga Univ Med Sci, Dept Anesthesiol, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	imashuku@belle.shiga-med.ac.jp					Nakagawa M, 2004, CAN J ANAESTH, V51, P639; Yamada C, 2010, TRANSFUSION, V50, P1926, DOI 10.1111/j.1537-2995.2010.02742.x; Cid J, 2008, TRANSFUSION, V48, P1966, DOI 10.1111/j.1537-2995.2008.01776.x; Kohno Yumiko, 2006, Masui, V55, P1490	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	OCT	2015	19	5					984	984		10.1007/s10157-015-1093-3		1	Urology & Nephrology	Urology & Nephrology	CT6EK	WOS:000362904700030		
J	Asaga, S; Kinoshita, T; Hojo, T; Jimbo, K; Yoshida, M				Asaga, Sota; Kinoshita, Takayuki; Hojo, Takashi; Jimbo, Kenjiro; Yoshida, Masayuki			Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients With Clinically Node-Negative Ipsilateral Multiple Breast Cancer Treated With Total Mastectomy	CLINICAL BREAST CANCER			English	Article						Multiple breast cancer; Non-sentinel node metastasis; Predictive factor; Sentinel node metastasis; Total mastectomy	NUCLEIC-ACID AMPLIFICATION; AXILLARY DISSECTION; BLUE-DYE; BIOPSY; WOMEN; TRIAL; IDENTIFICATION; INVOLVEMENT; INJECTION; NOMOGRAM	We investigated the predictive factors for non-sentinel lymph node (SN) metastasis in ipsilateral multiple breast cancer and compared them with solitary breast cancer. The significant and potential factors in multiple breast cancer were pathologic invasion size and the number of positive SNs. These 2 could differentiate patients with positive non-SNs from those with negative non-SNs with high sensitivity. Background: Recent clinical trials have shown that axillary lymph node dissection can be omitted even with positive sentinel nodes (SN) unless the patient undergoes total mastectomy without irradiation. The aim of our study was to identify predictive factors for non-SN metastasis among patients with solitary or multiple breast cancer treated with total mastectomy. Patients and Methods: Clinically node-negative breast cancer patients with pathologically node-positive disease treated with total mastectomy and axillary dissection after SN biopsy were retrospectively analyzed. Significant pathologic predictive factors for positive non-SN metastasis were also examined. Results: There were 47 multiple and 143 solitary breast cancer patients. Pathologic diagnosis demonstrated that smaller invasion size but larger tumor size, including adjacent noninvasive cancer, was observed in multiple breast cancer. The number of involved SNs and the rate of non-SN metastasis were similar between the multiple and solitary groups. Regarding predictive factors for non-SN metastasis, lymphatic invasion and SN macrometastasis were significant factors in the solitary group, and pathologic invasion size > 2 cm was the only significant factor in the multiple group. Conclusion: Larger pathologic invasion size was important for predicting non-SN metastasis in multiple breast cancer.	[Asaga, Sota; Kinoshita, Takayuki; Hojo, Takashi; Jimbo, Kenjiro] Natl Canc Ctr, Dept Breast Surg, Tokyo 1040045, Japan; [Yoshida, Masayuki] Natl Canc Ctr, Dept Pathol, Tokyo 1040045, Japan	Asaga, S (reprint author), Natl Canc Ctr, Dept Breast Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	soasaga@ncc.go.jp					Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Zhu LL, 2013, BREAST CANCER RES TR, V137, P783, DOI 10.1007/s10549-012-2360-6; Borgstein PJ, 1997, LANCET, V349, P1668, DOI 10.1016/S0140-6736(05)62634-7; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Pal A, 2008, BRIT J SURG, V95, P302, DOI 10.1002/bjs.5943; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Jinno H, 2008, BREAST J, V14, P551, DOI 10.1111/j.1524-4741.2008.00646.x; Barranger E, 2005, BREAST CANCER RES TR, V91, P113, DOI 10.1007/s10549-004-5781-z; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Bolster MJ, 2007, ANN SURG ONCOL, V14, P181, DOI 10.1245/s10434-006-9065-1; Klimberg VS, 1999, ANN SURG, V229, P860, DOI 10.1097/00000658-199906000-00013; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goyal A, 2004, EJSO, V30, P475, DOI 10.1016/j.ejso.2004.02.009; Linehan DC, 1999, ANN SURG ONCOL, V6, P450, DOI 10.1007/s10434-999-0450-4; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Hwang RF, 2003, ANN SURG ONCOL, V10, P248, DOI 10.1245/ASO.2003.05.020; Weiser MR, 2001, ANN SURG ONCOL, V8, P145, DOI 10.1245/aso.2001.8.2.145; Jimbo K, 2013, BREAST, V22, P1194, DOI 10.1016/j.breast.2013.08.003; Hilton JF, 2013, BREAST CANCER RES TR, V142, P143, DOI 10.1007/s10549-013-2714-8; Veronesi U, 2006, LANCET ONCOL, V7, P983, DOI 10.1016/S1470-2045(06)70947-0; Donker M, 2013, EUR J CANCER, V49, P2093, DOI 10.1016/j.ejca.2013.02.017; Saiz IB, 2014, REV ESP MED NUCL IMA, V33, P199, DOI 10.1016/j.remn.2013.10.010; Duraker N, 2014, BREAST J, V20, P61, DOI 10.1111/tbj.12205; Kohrt HE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-66; KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6	25	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	OCT	2015	15	5					362	369		10.1016/j.clbc.2015.01.009		8	Oncology	Oncology	CT6PF	WOS:000362934200009		
J	Shiohara, T; Ushigome, Y; Kano, Y; Takahashi, R				Shiohara, Tetsuo; Ushigome, Yukiko; Kano, Yoko; Takahashi, Ryo			Crucial Role of Viral Reactivation in the Development of Severe Drug Eruptions: a Comprehensive Review	CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY			English	Review						Regulatory T cells; Herpesviruses; Resident memory T cells; Fixed drug eruption; Drug-induced hypersensitivity syndrome; Immune reconstitution syndrome; Graft-versus-host disease	INDUCED HYPERSENSITIVITY SYNDROME; REGULATORY T-CELLS; VERSUS-HOST-DISEASE; RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RECONSTITUTION; TCR REPERTOIRE; LOCAL ANTIGEN; RM CELLS; IN-VIVO; INFECTION	A growing number of cells, mediators, and pathways have been implicated in severe drug eruptions. Fifteen years ago, we published landmark studies that sparked the current advances in our understanding of the role of viral reactivations in severe drug eruptions. Viral reactivations then became critically important as diagnostic tools, but how precisely they participated in the pathogenesis remained less well-defined. The question of whether viral reactivations are pathogenic or are instead as epiphenomenon of severe tissue damage has plagued the field of drug allergy for some decades. Recent evidence points to a crucial role for tissue-resident memory T (TRM) cells in immune protection against viral infections. Yet immune protection against viral infections is but one side of a coin, the other side of which comprises effector cells capable of mediating severe immunopathology: Once drug antigen is cross-recognized by these T cells, they could be activated to kill surrounding epidermal cells, resulting in drug-induced tissue damage. Such TRM cells could persistently reside in the skin lesions of fixed drug eruptions (FDE) and are most likely a major cell type responsible for the development of FDE. We also discuss the role of regulatory T (Treg) cells in the setting of drug allergy, in which herpesviruses are reactivated in sequence. Although many details of the complicated interactions among viruses, anti-viral immune responses, TRM cells, and Treg cells remain to be elucidated, we review the current status of this rapidly advancing field.	[Shiohara, Tetsuo; Ushigome, Yukiko; Kano, Yoko] Kyorin Univ, Sch Med, Dept Dermatol, Mitaka, Tokyo 1818611, Japan; [Shiohara, Tetsuo; Takahashi, Ryo] Kyorin Univ, Sch Med, Div Flow Cytometry, Mitaka, Tokyo 1818611, Japan	Takahashi, R (reprint author), Kyorin Univ, Sch Med, Div Flow Cytometry, Mitaka, Tokyo 1818611, Japan.	ryo@ks.kyorin-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (to T.S.) and the Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan (to T.S.).	SIGALNAHUM M, 1988, BRIT J DERMATOL, V118, P849, DOI 10.1111/j.1365-2133.1988.tb02604.x; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; LEVY M, 1984, MED HYPOTHESES, V14, P293, DOI 10.1016/0306-9877(87)90131-9; Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804; Komatsu T, 1996, CLIN EXP IMMUNOL, V104, P343, DOI 10.1046/j.1365-2249.1996.30738.x; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Kano Y, 2006, BRIT J DERMATOL, V155, P301, DOI 10.1111/j.1365-2133.2006.07238.x; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Mizukawa Y, 2002, DERMATOLOGY, V205, P159, DOI 10.1159/000063892; Hirahara K, 2010, CLIN EXP DERMATOL, V35, P863, DOI 10.1111/j.1365-2230.2010.03820.x; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Arend SM, 2007, CLIN INFECT DIS, V45, P1470, DOI 10.1086/522993; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Mizukawa Y, 2002, AM J PATHOL, V161, P1337, DOI 10.1016/S0002-9440(10)64410-0; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Legrand F, 2008, CLIN INFECT DIS, V46, P696, DOI 10.1086/527390; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Yu XL, 2008, J IMMUNOL, V181, P7356; Shiohara T, 2007, BRIT J DERMATOL, V156, P1083, DOI 10.1111/j.1365-2133.2007.07807.x; Shiohara T, 2007, CLIN REV ALLERG IMMU, V33, P124, DOI 10.1007/s12016-007-8010-9; Tohyama M, 2007, BRIT J DERMATOL, V157, P934, DOI 10.1111/j.1365-2133.2007.08167.x; Takahashi R, 2009, J IMMUNOL, V182, P8071, DOI 10.4049/jimmunol.0804002; Hall BM, 2011, CURR OPIN IMMUNOL, V23, P641, DOI 10.1016/j.coi.2011.07.012; Miceli MH, 2007, CANCER, V110, P112, DOI 10.1002/cncr.22738; Mizukawa Y, 2008, BRIT J DERMATOL, V158, P1230, DOI 10.1111/j.1365-2133.2008.08516.x; Belknap R, 2005, INT J TUBERC LUNG D, V9, P1057; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Aota N, 2009, DERMATOLOGY, V218, P275, DOI 10.1159/000187619; Senturk N, 2002, J EUR ACAD DERMATOL, V16, P414, DOI 10.1046/j.1468-3083.2002.00570_3.x; Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; PULLEN H, 1967, LANCET, V2, P1176; Suzuki Y, 1998, ARCH DERMATOL, V134, P1108, DOI 10.1001/archderm.134.9.1108; Smith KJ, 1997, CLIN EXP DERMATOL, V22, P118, DOI 10.1046/j.1365-2230.1997.2130642.x; Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005; Shiohara Tetsuo, 2010, Allergology International, V59, P333, DOI 10.2332/allergolint.10-RAI-0260; Ushigome Y, 2013, J AM ACAD DERMATOL, V68, P721, DOI 10.1016/j.jaad.2012.10.017; Aota N, 2009, AUTOIMMUN REV, V8, P488, DOI 10.1016/j.autrev.2009.02.029; Shiohara T, 2009, CURR OPIN ALLERGY CL, V9, P316, DOI 10.1097/ACI.0b013e32832cda4c; AGUT H, 1993, NEW ENGL J MED, V329, P203, DOI 10.1056/NEJM199307153290311; Kano Y, 2007, BRIT J DERMATOL, V156, P1061, DOI 10.1111/j.1365-2133.2007.07784.x; Shiohara T, 2012, CHEM IMMUNOL ALLERGY, V97, P106, DOI 10.1159/000335623; Asano Y, 2009, ARCH DERMATOL, V145, P1030, DOI 10.1001/archdermatol.2009.195; Garcia VC, 2005, CLIN INFECT DIS, V40, P756; Ishida T, 2014, ALLERGY IN PRESS; Koehn B, 2006, J IMMUNOL, V176; Kubota Y, 2005, JPN J DERMATOL, V116, P927; Marais Suzaan, 2009, Curr HIV/AIDS Rep, V6, P162, DOI 10.1007/s11904-009-0022-z; Picard DJB, 2010, SCI TRANSL MED, V2, DOI DOI 10.1126/SCITRANSLMED.3001116; Shiohara Tetsuo, 2007, P251, DOI 10.1159/000104205; Shiohara T, 2012, EXPERT REV DERMATOL, V7, P539; Tohyama H, 1998, ARCH DERMATOL, V134, P1113	57	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1080-0549	1559-0267		CLIN REV ALLERG IMMU	Clin. Rev. Allergy Immunol.	OCT	2015	49	2					192	202		10.1007/s12016-014-8421-3		11	Allergy; Immunology	Allergy; Immunology	CT6DS	WOS:000362902500006		
J	Suganuma, K				Suganuma, Keiko			Improvement of the standard method for assessing colour fastness to wet rubbing	COLORATION TECHNOLOGY			English	Article								Colour fastness to rubbing is evaluated by the degree of staining of a standard adjacent cotton cloth. However, some kinds of dye usually stain other textiles to a greater extent than cotton under wet conditions. In this work, rubbing fastness tests were carried out with various kinds of adjacent cloth in order to examine the factors affecting the wet rubbing fastness, and a more practical evaluation method using adjacent rubbing cloth was proposed. Dye transfer from the dyed fabric to the adjacent cloth depended on the affinity of the dyes for the fibre material of the dyed fabric and the adjacent cloth under wet conditions, in addition to the friction coefficient between the fabrics. A standard adjacent cloth should have a high staining property. The nylon staple cloth is preferred for fabrics dyed with vat, disperse, and acid dyes because it receives the most dye from rubbing with them.	Shohoku Coll, Sony Inst Higher Educ, Dept Creat Lifestyle Management, Atsugi, Kanagawa, Japan	Suganuma, K (reprint author), Shohoku Coll, Sony Inst Higher Educ, Dept Creat Lifestyle Management, Nurumizu 428, Atsugi, Kanagawa, Japan.	suganuma@shohoku.ac.jp					[Anonymous], 2009, 105F022009 ISO; [Anonymous], 2009, 105F092009 ISO; [Anonymous], 2001, 105F072001 ISO; [Anonymous], 2001, 105F052001 ISO; [Anonymous], 2001, 105F032001 ISO; [Anonymous], 2001, 105F012001 ISO; [Anonymous], 2000, 105F062000 ISO; [Anonymous], 2011, L0803 JIS JAP STAND; [Anonymous], 2015, TEXT HDB 2015, V2015, P26; [Anonymous], 2010, 105D012010 ISO; [Anonymous], 2005, L08052005 JIS JAP ST; [Anonymous], 1989, 105F101989 ISO; [Anonymous], 2004, L0849 JIS JAP STAND; [Anonymous], 2001, 105X122001 ISO; [Anonymous], 1989, 105C041989 ISO; Suganuma K, 2010, SEN-I GAKKAISHI, V66, P194; [Anonymous], 2001, 105F042001 ISO; [Anonymous], 2010, 1162010 AATCC; Consumer Product End-Use Research Institute Co. Ltd, 2011, DYEING REP, V264, P4; Nishikawa T, 2013, DYEING REP, V284, P7; Suganuma K, 2013, COLOR TECHNOL, V129, P443, DOI 10.1111/cote.12053; Suganuma K, 2013, ANN M 2013 JAP	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1472-3581	1478-4408		COLOR TECHNOL	Color. Technol.	OCT	2015	131	5					403	411		10.1111/cote.12170		9	Chemistry, Applied; Engineering, Chemical; Materials Science, Textiles	Chemistry; Engineering; Materials Science	CT7EG	WOS:000362976000008		
J	Sun, ZY; Teng, HH; Xiao, F				Sun, Ziyao; Teng, Honghui; Xiao, Feng			A Slope Constrained 4th Order Multi-Moment Finite Volume Method with WENO Limiter	COMMUNICATIONS IN COMPUTATIONAL PHYSICS			English	Article						Multi-moment finite volume method; WENO; flux reconstruction; compressible flow; conservative method; oscillation-suppressing	ESSENTIALLY NONOSCILLATORY SCHEMES; NAVIER-STOKES EQUATIONS; OSCILLATION PREVENTING SCHEME; DISCONTINUOUS GALERKIN METHOD; HYPERBOLIC CONSERVATION-LAWS; SHOCK-CAPTURING SCHEMES; UNSTRUCTURED GRIDS; ELEMENT-METHOD; EFFICIENT IMPLEMENTATION; ADVECTION EQUATION	This paper presents a new and better suited formulation to implement the limiting projection to high-order schemes that make use of high-order local reconstructions for hyperbolic conservation laws. The scheme, so-called MCV-WENO4 (multimoment Constrained finite Volume with WENO limiter of 4th order) method, is an extension of the MCV method of Ii & Xiao (2009) by adding the 1st order derivative (gradient or slope) at the cell center as an additional constraint for the cell-wise local reconstruction. The gradient is computed from a limiting projection using the wrii7,No (weighted essentially non-oscillatory) reconstruction that is built from the nodal values at 5 solution points within 3 neighboring cells. Different from other existing methods where only the cell-average value is used in the WINO reconstruction, the present method takes account of the solution structure within each mesh cell, and thus minimizes the stencil for reconstruction. The resulting scheme has 4th-order accuracy and is of significant advantage in algorithmic simplicity and computational efficiency. Numerical results of one and two dimensional benchmark tests for scalar and Euler conservation laws are shown to verify the accuracy and oscillation-less property of the scheme.	[Sun, Ziyao; Xiao, Feng] Tokyo Inst Technol, Dept Energy Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Teng, Honghui] Chinese Acad Sci, Inst Mech, State Key Lab High Temp Gas Dynam, Beijing 100190, Peoples R China	Xiao, F (reprint author), Tokyo Inst Technol, Dept Energy Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	sun.z.ab@m.titech.ac.jp; hhteng@imech.ac.cn; xiao@es.titech.ac.jp			JSPS [24560187, 15H03916]	This work is supported in part by JSPS KAKENHI (24560187, 15H03916).	Li XL, 2013, MON WEATHER REV, V141, P1216, DOI 10.1175/MWR-D-12-00144.1; Hu CQ, 1999, J COMPUT PHYS, V150, P97, DOI 10.1006/jcph.1998.6165; Xiao F, 2001, J COMPUT PHYS, V170, P498, DOI 10.1006/jcph.2001.6746; Yee HC, 1999, J COMPUT PHYS, V150, P199, DOI 10.1006/jcph.1998.6177; Toro EF, 2006, J COMPUT PHYS, V212, P150, DOI 10.1016/j.jcp.2005.06.018; COCKBURN B, 1990, MATH COMPUT, V54, P545, DOI 10.2307/2008501; Shen YQ, 2014, COMPUT FLUIDS, V96, P1, DOI 10.1016/j.compfluid.2014.02.010; Zhong XH, 2013, J COMPUT PHYS, V232, P397, DOI 10.1016/j.jcp.2012.08.028; Chen CG, 2008, J COMPUT PHYS, V227, P5019, DOI 10.1016/j.jcp.2008.01.033; Borges R, 2008, J COMPUT PHYS, V227, P3191, DOI 10.1016/j.jcp.2007.11.038; Shu CW, 2009, SIAM REV, V51, P82, DOI 10.1137/070679065; Yabe T, 2001, J COMPUT PHYS, V169, P556, DOI 10.1006/jcph.2000.6625; Xiao F, 2013, APPL MATH MODEL, V37, P5092, DOI 10.1016/j.apm.2012.10.050; Xiao F, 1996, COMPUT PHYS COMMUN, V94, P103, DOI 10.1016/0010-4655(96)00008-2; Wang ZJ, 2002, J COMPUT PHYS, V179, P665, DOI 10.1006/jcph.2002.7082; Jiang GS, 1996, J COMPUT PHYS, V126, P202, DOI 10.1006/jcph.1996.0130; Wang ZJ, 2002, J COMPUT PHYS, V178, P210, DOI 10.1006/jcph.2002.7041; Kopriva DA, 1996, J COMPUT PHYS, V125, P244, DOI 10.1006/jcph.1996.0091; Xie B, 2014, J COMPUT PHYS, V277, P138, DOI 10.1016/j.jcp.2014.08.011; Qiu JX, 2005, SIAM J SCI COMPUT, V26, P907, DOI 10.1137/S1064827503425298; Titarev VA, 2002, J SCI COMPUT, V17, P609, DOI 10.1023/A:1015126814947; LIU XD, 1994, J COMPUT PHYS, V115, P200, DOI 10.1006/jcph.1994.1187; SOD GA, 1978, J COMPUT PHYS, V27, P1, DOI 10.1016/0021-9991(78)90023-2; COCKBURN B, 1989, MATH COMPUT, V52, P411, DOI 10.2307/2008474; ROE PL, 1981, J COMPUT PHYS, V43, P357, DOI 10.1016/0021-9991(81)90128-5; Qiu JX, 2004, J COMPUT PHYS, V193, P115, DOI 10.1016/j.jcp.2003.07.026; WOODWARD P, 1984, J COMPUT PHYS, V54, P115, DOI 10.1016/0021-9991(84)90142-6; Chen CG, 2014, J COMPUT PHYS, V271, P191, DOI 10.1016/j.jcp.2013.10.026; Ii S, 2009, J COMPUT PHYS, V228, P3669, DOI 10.1016/j.jcp.2009.02.009; Henrick AK, 2005, J COMPUT PHYS, V207, P542, DOI 10.1016/j.jcp.2005.01.023; SHU CW, 1988, J COMPUT PHYS, V77, P439, DOI 10.1016/0021-9991(88)90177-5; Xiao F, 1996, COMPUT PHYS COMMUN, V93, P1, DOI 10.1016/0010-4655(95)00124-7; SHU CW, 1989, J COMPUT PHYS, V83, P32, DOI 10.1016/0021-9991(89)90222-2; Wang ZJ, 2009, J COMPUT PHYS, V228, P8161, DOI 10.1016/j.jcp.2009.07.036; Ii S, 2007, J COMPUT PHYS, V222, P849, DOI 10.1016/j.jcp.2006.08.015; Sun YZ, 2007, COMMUN COMPUT PHYS, V2, P310; Spiteri RJ, 2002, SIAM J NUMER ANAL, V40, P469, DOI 10.1137/S0036142901389025; COCKBURN B, 1989, J COMPUT PHYS, V84, P90, DOI 10.1016/0021-9991(89)90183-6; Du J., 2014, APPL NUMERI IN PRESS; Hesthaven JS, 2008, TEXTS APPL MATH, V54, P1; Huang CS, 2015, J SCI COMPUT, V64, P477, DOI 10.1007/s10915-014-9940-z; Huynh H.T., 2007, 40792007 AIAA, V4079, P2007; PATERA AT, 1984, J COMPUT PHYS, V54, P468, DOI 10.1016/0021-9991(84)90128-1; Shen Y. Q., 2009, 19 AIAA COMP FLUID D, P2009; Toro E.F., 2009, RIEMANN SOLVERS NUME; Xiao F, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001532; Xie B, 2014, COMPUT FLUIDS, V104, P40, DOI 10.1016/j.compfluid.2014.08.002; YABE T, 1991, COMPUT PHYS COMMUN, V66, P219, DOI 10.1016/0010-4655(91)90071-R	48	0	0	GLOBAL SCIENCE PRESS	WANCHAI	ROOM 3208, CENTRAL PLAZA, 18 HARBOUR RD, WANCHAI, HONG KONG 00000, PEOPLES R CHINA	1815-2406	1991-7120		COMMUN COMPUT PHYS	Commun. Comput. Phys.	OCT	2015	18	4					901	930		10.4208/cicp.081214.250515s		30	Physics, Mathematical	Physics	CT7DQ	WOS:000362974400006		
J	Takahashi, T; Kadobayashi, Y				Takahashi, Takeshi; Kadobayashi, Youki			Reference Ontology for Cybersecurity Operational Information	COMPUTER JOURNAL			English	Article						cybersecurity; ontology design; information structure; knowledge model; information schema; knowledge base; information exchange		As our cyber society develops and expands, the importance of cybersecurity operations is growing in response to cybersecurity threats coming from beyond national borders. Efficient cybersecurity operations require information exchanges that go beyond organizational borders. Various industry specifications defining information schemata for such exchanges are thus emerging. These specifications, however, define their own schemata since their objectives and the types of information they deal with differ, and desirable schemata differ depending on the purposes. They need to be organized and orchestrated so that individual organizations can fully exchange information and collaborate with one another. To establish the foundations of such orchestration and facilitate information exchanges, this paper proposes a reference ontology for cybersecurity operational information. The ontology structures cybersecurity information and orchestrates industry specifications. We built it from the standpoint of cybersecurity operations in close collaboration with cybersecurity organizations including security operation centers handling actual cybersecurity operations in the USA, Japan and South Korea. This paper demonstrates its usability by discussing the coverage of industry specifications. It then defines an extensible information structure that collaborates with such specifications by using the ontology and describes a prototype cybersecurity knowledge base we constructed that facilitates cybersecurity information exchanges among various parties. Finally, it discusses the usage scenarios of the ontology and knowledge base in cybersecurity operations. Through this work, we wish to contribute to the advancement of cybersecurity information exchanges.	[Takahashi, Takeshi] Natl Inst Informat & Commun Technol, Network Secur Res Inst, Tokyo 1848795, Japan; [Kadobayashi, Youki] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 89165, Japan	Takahashi, T (reprint author), Natl Inst Informat & Commun Technol, Network Secur Res Inst, Tokyo 1848795, Japan.	takeshi_takahashi@ieee.org			JSPS KAKENHI [24700083]	This work was supported by JSPS KAKENHI [grant number 24700083]. Funding to pay the Open Access publication charges for this article was provided by JSPS KAKENHI [grant number 24700083].	[Anonymous], 2012, 270322012 ISOIEC; [Anonymous], 2009, 1977022009 ISOIEC; Rutkowski A, 2010, ACM SIGCOMM COMP COM, V40, P59, DOI 10.1145/1880153.1880163; [Anonymous], 2012, SPEC PUBL NAT I STAN, V800-61; [Anonymous], 2004, RES DESCR FRAM RDF C; Blanco C, 2011, COMPUT STAND INTER, V33, P372, DOI 10.1016/j.csi.2010.12.002; [Anonymous], 2012, COMM WEAKN EN; [Anonymous], 1992, C92188FINAL ORG EC C; [Anonymous], 2011, 7695 NIST; [Anonymous], 2014, COMM VULN EXP INT TE; [Anonymous], 2003, SPEC PUBL NAT I STAN, V800-35; Wang JA, 2012, INF SYST E-BUS MANAG, V10, P455, DOI 10.1007/s10257-011-0173-5; [Anonymous], 2011, 7692 NIST; [Anonymous], 2011, SPARQL QUER LANG RDF; [Anonymous], 2012, DSP0004 DISTR MAN TA; [Anonymous], 1995, SPEC PUBL NAT I STAN, V800-12; Lin RR, 2011, SIGMOD REC, V40, P5, DOI 10.1145/2007206.2007208; [Anonymous], 2008, SPEC PUBL NAT I STAN, V800-115; [Anonymous], 2011, 7694 NIST; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; [Anonymous], 2013, 181802013 ISOIEC; [Anonymous], 2014, LANG OP DEF VULN ASS; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; [Anonymous], 2014, MALW ATTR EN CHAR; [Anonymous], 2013, EXTENSIBLE ACC CONTR; [Anonymous], 2004, 1333511996 ISOIEC; [Anonymous], 2010, 7502 NIST; [Anonymous], 2006, SPEC PUBL NAT I STAN, V800-86; [Anonymous], 2012, OWL 2 WEB ONT LANG D; [Anonymous], 2013, COMM ATT PATT EN CLA; [Anonymous], 2011, OV CYB INF EXCH CYBE; [Anonymous], 2004, INC ORG SEC INC HAND; [Anonymous], GFDR192; [Anonymous], 2011, COMM VULN SCOR SYST; Baader F, 2003, LECT NOTES ARTIF INT, V2605, P228; Brownlee N., 1998, REQUEST COMMENTS 235; COBIT 5, 2012, 5 COBIT ISACA; Danyliw R., 2014, INCIDENT OBJECT DESC; Danyliw R., 2007, REQUEST COMMENTS 507; Decker S., 1999, P DS 8, P351; Denker G., 2005, Information Security Technical Report, V10, DOI 10.1016/j.istr.2004.11.002; Fenz S., 2009, P 4 INT S INF COMP C, P183, DOI DOI 10.1145/1533057.1533084; Guo L., 2003, P 2003 ACM SIGMOD IN, P16, DOI DOI 10.1145/872757.872762; IBM X-Force, 2013, IBM X FORC 2013 MID; IEEE ICSG Malware Metadata Exchange Format Working Group, 2014, MALW MET EXCH FORM V; Industry Consortium for Advancement of Security on the Internet, 2014, COMM VULN REP FRAM V; Jena Apache, 2014, SDB PERS TRIPL STOR; JPCERT/CC and IPA, 2014, JAP VULN NOT; Kesh S, 2007, COMMUN ACM, V50, P103, DOI 10.1145/1272516.1272521; Liu Z., 2007, P 33 INT C VER LARG, P1330; Martin R. A., 2009, CROSSTALK J DEF SOFT, V22, P26; Masoumzadeh A., 2013, P 8 ACM SIGSAC S INF, P149; Moreaus L, 2008, COMMUN ACM, V51, P52, DOI 10.1145/1330311.1330323; National Institute of Standards and Technology, 2014, NAT I STAND TECHN SP, V800; National Institute of Standards and Technology, 2014, FRAM IMPR CRIT INFR; National Institute of Standards and Technology, 2014, COMM CONF EN CCE; National Institute of Standards and Technology, 2014, NAT VULN DAT VERS 2; OECD, 2012, OECD DIG EC PAP, V211; Open Security Foundation, 2014, OP SOURC VULN DAT; Parkin S. E., 2009, P 2 INT C SEC INF NE, P46, DOI 10.1145/1626195.1626209; Red Hat Inc, 2014, SEC MEAS; Schmitt MN, 2013, TALLINN MANUAL INT L; Stanford Center for Biomedical Informatics Research, 2014, PROT ONT ED KNOWL AC; Symantec Corporation, 2014, INT SEC THREAT REP 2; The MITRE Corporation, 2014, MAK SEC MEAS; The MITRE Corporation, 2014, COMM RES FORM SPEC V; The MITRE Corporation, 2014, COMM EV EXPR; The MITRE Corporation, 2014, CYB OBS EXPRESSION; The MITRE Corporation, 2014, COMM WEAKN SCOR SYST; The White House, 2013, FED REG, V78; Tsoumas B., 2006, P 20 INT C ADV INF N, V1, P985; Wang JX, 2009, AUTOM TECHNOL, V10, P1	73	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0010-4620	1460-2067		COMPUT J	Comput. J.	OCT	2015	58	10					2297	2312		10.1093/comjnl/bxu101		16	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CT6YG	WOS:000362959000008		
J	Attrapadung, N; Emura, K; Hanaoka, G; Sakai, Y				Attrapadung, Nuttapong; Emura, Keita; Hanaoka, Goichiro; Sakai, Yusuke			Revocable Group Signature with Constant-Size Revocation List	COMPUTER JOURNAL			English	Article						revocable group signature; identity-based revocation	VERIFIER-LOCAL REVOCATION; PUBLIC-KEY ENCRYPTION; BACKWARD UNLINKABILITY; RANDOM ORACLES; BILINEAR MAPS; BROADCAST ENCRYPTION; SCHEMES; CIPHERTEXTS; FOUNDATIONS; ASSUMPTIONS	It is essential that a multi-user cryptographic primitive be revocable since a legitimate user may quit the organization, or may act on malicious intent, or the relevant key may be leaked. In the group signature context, usually the group manager publishes the revocation list that contains revocation tokens. Since signers/verifiers need to obtain the revocation list in each revocation epoch to generate/verify a group signature, a small-size revocation list is really important in practice. However, all previous revocable group signatures require at least an Omicron(r)-size revocation list, where r is the number of revoked users. In this paper, we propose the first revocable group signature scheme with a constant-size revocation list using identity-based revocation (IBR) techniques. We use an IBR scheme proposed by Attrapadung-Libert-Panafieu (PKC 2011) as a building block. As in the Libert-Peters-Yung schemes (EUROCRYPT 2012/CRYPTO 2012), no signing key update is required. In addition, the verification cost does not depend on the number of revoked users r. Although the maximum number of revoked users needs to be fixed in the setup phase, the maximum number of group members is potentially unbounded as in IBR. This property has not been achieved in the recent scalable revocable group signature schemes and seems to be of independent interest.	[Attrapadung, Nuttapong; Hanaoka, Goichiro; Sakai, Yusuke] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Emura, Keita] Natl Inst Informat & Commun Technol NICT, Network Secur Res Inst, Secur Fundamentals Lab, Koganei, Tokyo 1848795, Japan	Emura, K (reprint author), Natl Inst Informat & Commun Technol NICT, Network Secur Res Inst, Secur Fundamentals Lab, 4-2-1 Nukui Kitamachi, Koganei, Tokyo 1848795, Japan.	k-emura@nict.go.jp					Abe M., 2010, IACR CRYPTOL EPRINT, V2010, P133; Acar T., 2013, LECT NOTES COMPUTER, V7859, P189; Groth J, 2008, LECT NOTES COMPUT SC, V4965, P415; Ohtake G, 2009, LECT NOTES COMPUT SC, V5580, P149, DOI 10.1007/978-3-642-02384-2_10; Emura K, 2014, J APPL MATH, DOI 10.1155/2014/983040; Libert B, 2010, LECT NOTES COMPUT SC, V5978, P499, DOI 10.1007/978-3-642-11799-2_30; Nakanishi T, 2005, LECT NOTES COMPUT SC, V3788, P533; Boneh D, 2008, J CRYPTOL, V21, P149, DOI 10.1007/s00145-007-9005-7; Bellare M, 2005, LECT NOTES COMPUT SC, V3376, P136; Attrapadung N, 2011, LECT NOTES COMPUT SC, V6571, P90, DOI 10.1007/978-3-642-19379-8_6; Kiayias A, 2004, LECT NOTES COMPUT SC, V3027, P571; Abdalla M, 2004, LECT NOTES COMPUT SC, V3269, P1; Fan CI, 2011, LECT NOTES COMPUT SC, V7092, P214; Kiltz E, 2006, LECT NOTES COMPUT SC, V3876, P581; Choi SG, 2006, LECT NOTES COMPUT SC, V4266, P88; Groth J, 2006, LECT NOTES COMPUT SC, V4284, P444; Benjumea V, 2007, LECT NOTES COMPUT SC, V4856, P265; Damgard I, 2008, LECT NOTES COMPUT SC, V4964, P239, DOI 10.1007/978-3-540-79263-5_15; Attrapadung N, 2012, THEOR COMPUT SCI, V422, P15, DOI 10.1016/j.tcs.2011.12.004; Attrapadung N, 2010, LECT NOTES COMPUT SC, V6056, P384; Boneh D, 2005, LECT NOTES COMPUT SC, V3621, P258; Abe M, 2010, LECT NOTES COMPUT SC, V6223, P209, DOI 10.1007/978-3-642-14623-7_12; Nguyen L, 2005, LECT NOTES COMPUT SC, V3376, P275; Libert B, 2009, LECT NOTES COMPUT SC, V5888, P498, DOI 10.1007/978-3-642-10433-6_34; Furukawa J, 2006, IEICE T FUND ELECTR, VE89A, P1328, DOI 10.1093/ietfec/e89-a.5.1328; Boneh D, 2005, LECT NOTES COMPUT SC, V3494, P440; Naor M, 2002, LECT NOTES COMPUT SC, V2442, P481; Nakanishi T, 2006, LECT NOTES COMPUT SC, V4266, P17; Camenisch J, 2009, LECT NOTES COMPUT SC, V5443, P481; Groth J, 2007, LECT NOTES COMPUT SC, V4833, P164; Dodis Y, 2002, LECT NOTES COMPUT SC, V2696, P61; Nakanishi T, 2009, LECT NOTES COMPUT SC, V5443, P463; Boneh D, 2004, LECT NOTES COMPUT SC, V3152, P41; Wei LB, 2010, LECT NOTES COMPUT SC, V6487, P136; Kwon T, 2011, INFORM SCIENCES, V181, P2906, DOI 10.1016/j.ins.2011.02.016; Zhou SJ, 2006, LECT NOTES COMPUT SC, V4301, P126; Lewko A, 2010, P IEEE S SECUR PRIV, P273, DOI 10.1109/SP.2010.23; Benjumea V, 2004, LECT NOTES COMPUT SC, V2947, P402; Bellare M, 2003, LECT NOTES COMPUT SC, V2656, P614; Emura K, 2014, INT J INF SECUR, V13, P51, DOI 10.1007/s10207-013-0204-y; Ateniese G., 2005, IACR CRYPTOL EPRINT, V2005, P385; Attrapadung Nuttapong, 2012, Journal of Mathematical Cryptology, V5, DOI 10.1515/JMC.2011.009; Attrapadung N, 2014, LECT NOTES COMPUT SC, V8479, P419, DOI 10.1007/978-3-319-07536-5_25; Begum N., 2012, LNCS, V7839, P495; Boneh D, 2008, LECT NOTES COMPUT SC, V5350, P455, DOI 10.1007/978-3-540-89255-7_28; Boneh D., 2004, P 11 ACM C COMP COMM, P168, DOI 10.1145/1030083.1030106; Boneh D, 2004, LECT NOTES COMPUT SC, V3027, P223; Boyen X, 2006, LECT NOTES COMPUT SC, V4004, P427; Bringer J., 2012, SECRYPT, P215; Chaum D., 1991, P EUROCRYPT 91 BRIGH, P257; Chu C., 2012, 7 ACM S INF COMP COM, P26; Delerablee C, 2006, LECT NOTES COMPUT SC, V4341, P193; Diaz J, 2014, COMPUT SECUR, V46, P111, DOI 10.1016/j.cose.2014.06.009; Diaz J., 2012, PUBL KEY INFR SERV A, P112; Kiayias A., 2006, International Journal of Security and Networks, V1, DOI 10.1504/IJSN.2006.010821; Kiayias A., 2004, IACR CRYPTOL EPRINT, V2004, P76; Libert B., 2012, LNCS, V7417, P571; Libert B., 2012, ADV CRYPT EUROCRYPT, V7237, P609; Nakanishi T., 2013, INF SEC CRYPT ICISC, P435; Naor D., 2001, ADV CRYPT CRYPTO 200, V2139, P41, DOI 10.1007/3-540-44647-8_3; Sakai Y., 2012, LNCS, V7293, P715; Yamada S., 2012, LECT NOTES COMPUT SC, V7293, P243	62	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0010-4620	1460-2067		COMPUT J	Comput. J.	OCT	2015	58	10					2698	2715		10.1093/comjnl/bxv026		18	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CT6YG	WOS:000362959000035		
J	Pereira, M; Dowsley, R; Nascimento, ACA; Hanaoka, G				Pereira, Mayana; Dowsley, Rafael; Nascimento, Anderson C. A.; Hanaoka, Goichiro			Public-Key Encryption Schemes with Bounded CCA Security and Optimal Ciphertext Length Based on the CDH and HDH Assumptions	COMPUTER JOURNAL			English	Article						public-key encryption; bounded chosen ciphertext security; computational Diffie-Hellman assumption; hashed Diffie-Hellman assumption	COMPUTATIONAL DIFFIE-HELLMAN; STANDARD MODEL; ATTACK; CRYPTOSYSTEM; PARADIGM	In Cramer et al. (2007, Bounded CCA2-Secure Encryption. In Kurosawa, K. (ed.), Advances in Cryptology - ASIACRYPT 2007, Kuching, Malaysia, December 2-6, Lecture Notes in Computer Science, Vol. 4833, pp. 502-518. Springer, Berlin, Germany) proposed a public-key encryption scheme secure against adversaries with a bounded number of decryption queries based on the decisional Diffie-Hellman problem. In this paper, we show that the same result can be obtained based on weaker computational assumptions, namely: the computational Diffie-Hellman and the hashed Diffie-Hellman assumptions.	[Pereira, Mayana] Univ Brasilia, Dept Elect Engn, BR-70910900 Brasilia, DF, Brazil; [Dowsley, Rafael] Karlsruhe Inst Technol, Inst Theoret Informat, D-76131 Karlsruhe, Germany; [Nascimento, Anderson C. A.] Univ Washington, Inst Technol, Tacoma, WA 98402 USA; [Hanaoka, Goichiro] Natl Inst Adv Ind Sci & Technol, Chyioda Ku, Tokyo 1010021, Japan	Dowsley, R (reprint author), Karlsruhe Inst Technol, Inst Theoret Informat, Fasanengarten 5,Geb 50-34, D-76131 Karlsruhe, Germany.	rafael.dowsley@kit.edu					Hanaoka G, 2008, LECT NOTES COMPUT SC, V5350, P308, DOI 10.1007/978-3-540-89255-7_19; Cramer R, 2002, LECT NOTES COMPUT SC, V2332, P45; RACKOFF C, 1992, LECT NOTES COMPUT SC, V576, P433; Peikert C, 2008, ACM S THEORY COMPUT, P187; Cramer R, 1998, LECT NOTES COMPUT SC, V1462, P13; Lindell Y, 2006, J CRYPTOL, V19, P359, DOI 10.1007/s00145-005-0345-x; Hofheinz D, 2007, LECT NOTES COMPUT SC, V4622, P553; Cramer R, 2010, LECT NOTES COMPUT SC, V5978, P146; Haralambiev K, 2010, LECT NOTES COMPUT SC, V6056, P1; Cramer R, 2003, SIAM J COMPUT, V33, P167, DOI 10.1137/S0097539702403773; Dottling N, 2012, IEEE T INFORM THEORY, V58, P6672, DOI 10.1109/TIT.2012.2203582; Peikert C, 2009, ACM S THEORY COMPUT, P333; Cash D, 2009, J CRYPTOL, V22, P470, DOI 10.1007/s00145-009-9041-6; Herranz J, 2010, INFORM COMPUT, V208, P1243, DOI 10.1016/j.ic.2010.07.002; Rosen A, 2009, LECT NOTES COMPUT SC, V5444, P419; Hofheinz D, 2009, LECT NOTES COMPUT SC, V5479, P313, DOI 10.1007/978-3-642-01001-9_18; Cramer R, 2007, LECT NOTES COMPUT SC, V4833, P502; Dowsley R, 2009, LECT NOTES COMPUT SC, V5473, P240, DOI 10.1007/978-3-642-00862-7_16; Boneh D., 2001, LNCS, V2139, p[213, 27], DOI DOI 10.1007/3-540-44647-8_13; Boneh D., 2007, SIAM J COMPUT, V36, P1301, DOI 10.1137/S009753970544713X; Dolev D, 1991, 23 ANN ACM S THEOR C, P542; Goldreich O., 1989, 21 ACM S THEOR COMP, P25; Hanaoka G., 2006, 2006408 CRYPT EPRINT; Naor M, 1990, 22 ANN ACM S THEOR C, P427; Pereira M., 2010, LECT NOTES COMPUTER, V6531, P299; Sahai A., 1999, 40th Annual Symposium on Foundations of Computer Science (Cat. No.99CB37039), DOI 10.1109/SFFCS.1999.814628; Shoup V., 2004, 2004332 CRYPT EPRINT	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0010-4620	1460-2067		COMPUT J	Comput. J.	OCT	2015	58	10					2738	2746		10.1093/comjnl/bxv040		9	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CT6YG	WOS:000362959000037		
J	Guidotti, LG; Isogawa, M; Chisari, FV				Guidotti, Luca G.; Isogawa, Masanori; Chisari, Francis V.			Host-virus interactions in hepatitis B virus infection	CURRENT OPINION IN IMMUNOLOGY			English	Review							TRANSGENIC MOUSE MODEL; REPLICATION IN-VIVO; T-CELLS; HEPATOCELLULAR-CARCINOMA; IMMUNE-RESPONSE; NATURAL-KILLER; VIRAL-HEPATITIS; HBV INFECTION; LIVER-DAMAGE; RECEPTOR	Hepatitis B virus (HBV) is a noncytopathic, hepatotropic, double-stranded DNA virus that causes acute and chronic hepatitis. Although HBV does not induce a measurable innate immune response in the infected liver, the outcome of infection is determined by the kinetics, breadth, vigor, trafficking, and effector functions of HBV-specific adaptive T cell responses, and the development of neutralizing antibodies. Dysregulation of one or more of these events leads to persistent HBV infection and a variably severe chronic necroinflammatory liver disease that fosters the development of hepatocellular carcinoma. Deeper understanding of the mechanisms responsible for immunological tolerance to HBV is needed in order to devise immunotherapeutic strategies to cure chronic HBV infection and prevent its life-threatening sequelae.	[Guidotti, Luca G.] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Isogawa, Masanori] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Chisari, Francis V.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Chisari, FV (reprint author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	fchisari@scripps.edu		Guidotti, Luca G./0000-0002-0205-2678	European Research Council (ERC) [250219]; JSPS [KAKENHI 26461015]; AMED; NIH [R01-AI-020001, R01-CA-040489]	This work was supported by grants: 250219 (LGG) from the European Research Council (ERC), KAKENHI 26461015 (MI) from JSPS, and Research Program on Hepatitis (MI) from AMED, and R01-AI-020001 and R01-CA-040489 (FVC) from the NIH.	Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Boni C, 2012, GASTROENTEROLOGY, V143, P963, DOI 10.1053/j.gastro.2012.07.014; Pallett LJ, 2015, NAT MED, V21, P591, DOI 10.1038/nm.3856; Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Billerbeck E, 2007, WORLD J GASTROENTERO, V13, P4858; Di Bisceglie AM, 2009, HEPATOLOGY, V49, pS56, DOI 10.1002/hep.22962; Reignat S, 2002, J EXP MED, V195, P1089, DOI 10.1084/jem.20011723; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003; Krebs K, 2013, GASTROENTEROLOGY, V145, P456, DOI 10.1053/j.gastro.2013.04.047; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; Qasim W, 2015, J HEPATOL, V62, P486, DOI 10.1016/j.jhep.2014.10.001; REHERMANN B, 1995, J CLIN INVEST, V96, P1527, DOI 10.1172/JCI118191; Vilarinho S, 2007, P NATL ACAD SCI USA, V104, P18187, DOI 10.1073/pnas.0708968104; Nakamoto Y, 2004, CANCER RES, V64, P3326, DOI 10.1158/0008-5472.CAN-03-3817; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Publicover J, 2013, J CLIN INVEST, V123, P3728, DOI 10.1172/JCI68182; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Kimura K, 2002, J IMMUNOL, V169, P5188; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Bottcher JP, 2013, CELL REP, V3, P779, DOI 10.1016/j.celrep.2013.02.008; Guidotti LG, 2002, J VIROL, V76, P2617, DOI 10.1128/JVI.76.6.2617-2621.2002; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Burns GS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a024935; Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730; Durantel D, 2015, COLD SPRING HARB PER, P5; Guidotti Luca G, 2015, Cell, V161, P486, DOI 10.1016/j.cell.2015.03.005; Isogawa M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003490; Jo J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004210; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Lanford RE, 2013, GASTROENTEROLOGY, V144, pe1501; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; PURCELL RH, 1976, LANCET, V2, P757; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schurich A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003208	58	1	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0952-7915	1879-0372		CURR OPIN IMMUNOL	Curr. Opin. Immunol.	OCT	2015	36						61	66		10.1016/j.coi.2015.06.016		6	Immunology	Immunology	CT8MF	WOS:000363070000011		
J	Murakami, K; Yamamoto, K; Sugiura, T; Kawakami, M; Horita, S; Kirita, T				Murakami, Kazuhiro; Yamamoto, Kazuhiko; Sugiura, Tsutomu; Kawakami, Masayoshi; Horita, Satoshi; Kirita, Tadaaki			Biomechanical analysis of poly-L-lactic acid and titanium plates fixated for mandibular symphyseal fracture with a conservatively treated unilateral condylar fracture using the three-dimensional finite element method	DENTAL TRAUMATOLOGY			English	Article						mandibular fracture; condyle; symphysis; poly-L-lactic acid; titanium; finite element method	BITE FORCES; OSTEOSYNTHESIS; ANGLE	The purpose of this study was to investigate stress on poly-L-lactic acid (PLLA) plates with a thickness of 1.4 mm and titanium plates with a thickness of 1.0 and 1.4 mm placed for mandibular symphyseal fractures with or without conservatively treated, unilateral condylar fractures using finite element analysis. The symphyseal fracture region was defined by the following three conditions: the defect, the callus, and the contact condition. Stress on the plates was analyzed by an applying occlusal force of 478.1 N on the first molar of the non-condylar fracture side. In the model of isolated symphyseal fracture, the maximal stresses were below the material strength in all plate types and conditions. In the models with condylar fracture, the maximal stresses on these plates were much higher than those in the models of isolated symphyseal fracture, especially for the defect condition. Although the maximal stresses on all types of plates in the contact condition were below the material strengths, some of those in the defect condition were higher than these strengths. These results suggest that a PLLA plate can theoretically withstand stress under good reductions of symphyseal fractures, even for condylar fractures; however, both the PLLA plate and titanium miniplate may be at risk of fracture under poor reduction.	[Murakami, Kazuhiro; Yamamoto, Kazuhiko; Sugiura, Tsutomu; Kawakami, Masayoshi; Horita, Satoshi; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara 6348522, Japan	Murakami, K (reprint author), Nara Med Univ, Dept Oral & Maxillofacial Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	murakami@naramed-u.ac.jp					TATE GS, 1994, J ORAL MAXIL SURG, V52, P734, DOI 10.1016/0278-2391(94)90489-8; Sawazaki R, 2010, J ORAL MAXIL SURG, V68, P1252, DOI 10.1016/j.joms.2009.03.064; Ellis E, 2013, J ORAL MAXIL SURG, V71, P726, DOI 10.1016/j.joms.2012.09.017; Lovald S, 2010, J ORAL MAXIL SURG, V68, P1833, DOI 10.1016/j.joms.2009.09.108; Ji BH, 2010, ORAL SURG ORAL MED O, V109, pE21, DOI 10.1016/j.tripleo.2009.11.003; Wagner A, 2002, ORAL SURG ORAL MED O, V94, P678, DOI 10.1067/moe.2002.126451; Vajgel A, 2013, J ORAL MAXIL SURG, V71, P335, DOI 10.1016/j.joms.2012.09.019; Ellis ED, 2001, J ORAL MAXIL SURG, V59, P389, DOI 10.1053/joms.2001.21873; Sugiura T, 2009, J ORAL MAXIL SURG, V67, P2397, DOI 10.1016/j.joms.2008.08.042; Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5; Murakami K, 2009, J ORAL MAXIL SURG, V67, P83, DOI 10.1016/j.joms.2008.08.002; Champy M, 1975, Zahn Mund Kieferheilkd Zentralbl, V63, P339; Keyak JH, 1998, J BIOMECH, V31, P125; Korioth Tom W. P., 1994, Journal of Orofacial Pain, V8, P178; Murakami K, 2014, J ORAL MAXILLOFAC SU, V72, pe1; Nishimura N., 1960, MECH PROPERTY IND MA, P141; Sugiura T, 2001, J ORAL MAXIL SURG, V59, P1161, DOI 10.1053/joms.2001.26718; Sugiura T., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P165	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2015	31	5					396	402		10.1111/edt.12179		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7HG	WOS:000362985000010		
J	Takagi, M; Babazono, T; Uchigata, Y				Takagi, M.; Babazono, T.; Uchigata, Y.			Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease	DIABETIC MEDICINE			English	Article							RENAL-INSUFFICIENCY; MICROALBUMINURIA; NEPHROPATHY; PROGRESSION; JAPAN; CHOLESTEROL; HEMOGLOBIN; IMPAIRMENT; PREVALENCE; PREDICTORS	Aims To determine differences in predictors of albuminuria and decreased estimated GFR in Japanese people with Type 2 diabetes mellitus without chronic kidney disease. Methods This single-centre observational cohort study involved 1802 Japanese people with Type 2 diabetes with normoalbuminuria and estimated GFR >= 60 ml/min/1.73 m(2) (740 women; mean +/- SD age 58 +/- 12 years). Two separate outcomes were evaluated: onset of albuminuria (>= 30 mg/g creatinine, albuminuria cohort; n = 1655) and decrease in estimated GFR (< 60 ml/min/1.73 m(2); estimated GFR cohort; n = 1777). A Cox proportional hazards model was used to identify significant predictors for each outcome. Results During a median follow-up period of 6.9 years for the albuminuria cohort and 8.0 years for the estimated GFR cohort, 181 and 316 individuals reached the respective outcome. The 5-year cumulative incidence of albuminuria was 8.3%, and that of decreased estimated GFR was 10.4%. In the multivariate Cox model, greater urinary albumin-to-creatinine ratio, presence of diabetic retinopathy and higher HbA(1c) levels were associated with both outcomes. Unique risk factors for onset of albuminuria were male gender and higher uric acid levels; those for decreased estimated GFR were older age, greater systolic blood pressure, and lower baseline estimated GFR and HDL cholesterol levels. Conclusions Identification of both common and distinct predictive factors for onset of albuminuria and decreased estimated GFR support the hypothesis that both common and distinct pathophysiological mechanisms are involved in the development of these two manifestations of chronic kidney disease in diabetes.	[Takagi, M.; Babazono, T.; Uchigata, Y.] Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Dept Med, Tokyo, Japan	Babazono, T (reprint author), Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Dept Med, Tokyo, Japan.	babazono@dmc.twmu.ac.jp					Park JY, 1998, DIABETES CARE, V21, P530, DOI 10.2337/diacare.21.4.530; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ohta M, 2010, DIABETIC MED, V27, P1017, DOI 10.1111/j.1464-5491.2010.03049.x; Afghahi H, 2011, NEPHROL DIAL TRANSPL, V26, P1236, DOI 10.1093/ndt/gfq535; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711; Forsblom CM, 1998, DIABETES CARE, V21, P1932, DOI 10.2337/diacare.21.11.1932; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Yokoyama H, 2009, NEPHROL DIAL TRANSPL, V24, P1212, DOI 10.1093/ndt/gfn603; Araki S, 2005, DIABETES, V54, P2983, DOI 10.2337/diabetes.54.10.2983; Tabaei BP, 2001, DIABETES CARE, V24, P1560, DOI 10.2337/diacare.24.9.1560; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Cederholm J, 2005, DIABETES RES CLIN PR, V67, P258, DOI 10.1016/j.diabres.2004.07.021; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Thomas MC, 2009, DIABETES CARE, V32, P1497, DOI 10.2337/dc08-2186; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Jardine MJ, 2012, AM J KIDNEY DIS, V60, P770, DOI 10.1053/j.ajkd.2012.04.025; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Mogensen CE, 1984, NEW ENGL J MED, V310, P356; Mongensen CE, 1983, DIABETES S2, V32, P64; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Toya K, 2014, J DIABETES INVEST, V5, P228, DOI 10.1111/jdi.12134; VIBERTI GC, 1982, LANCET, V1, P1430	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3071	1464-5491		DIABETIC MED	Diabetic Med.	OCT	2015	32	10					1354	1360		10.1111/dme.12793		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CT8DB	WOS:000363044100017		
J	Dirr, G; Ito, H; Rantzer, A; Ruffer, BS				Dirr, Gunther; Ito, Hiroshi; Rantzer, Anders; Rueffer, Bjoern S.			SEPARABLE LYAPUNOV FUNCTIONS FOR MONOTONE SYSTEMS: CONSTRUCTIONS AND LIMITATIONS	DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B			English	Article						Monotone systems; separable Lyapunov functions; converse Lyapunov theorems; explicit formulas; ordinary differential equations	TO-STATE STABILITY; LARGE-SCALE SYSTEMS; SMALL-GAIN THEOREM; DIFFERENTIAL-EQUATIONS; 3-DIMENSIONAL SYSTEMS; ISS SYSTEMS; IISS SYSTEMS; NETWORKS; CONVERGENCE	For monotone systems evolving on the positive orthant of R-+(n) two types of Lyapunov functions are considered: Sum- and max-separable Lyapunov functions. One can be written as a sum, the other as a maximum of functions of scalar arguments. Several constructive existence results for both types are given. Notably, one construction provides a max-separable Lyapunov function that is defined at least on an arbitrarily large compact set, based on little more than the knowledge about one trajectory. Another construction for a class of planar systems yields a global sum-separable Lyapunov function, provided the right hand side satisfies a small-gain type condition. A number of examples demonstrate these methods and shed light on the relation between the shape of sublevel sets and the right hand side of the system equation. Negative examples show that there are indeed globally asymptotically stable systems that do not admit either type of Lyapunov function.	[Dirr, Gunther] Univ Wurzburg, Inst Math, D-97074 Wurzburg, Germany; [Ito, Hiroshi] Kyushu Inst Technol, Dept Syst Design & Informat, Iizuka, Fukuoka 8208502, Japan; [Rantzer, Anders] Lund Univ, Automat Control LTH, SE-22100 Lund, Sweden; [Rueffer, Bjoern S.] Univ Newcastle UON, Fac Sci & IT, Sch Math & Phys Sci, Callaghan, NSW 2308, Australia	Dirr, G (reprint author), Univ Wurzburg, Inst Math, Campus Hubland Nord,Emil Fischer Str 40, D-97074 Wurzburg, Germany.	dirr@mathematik.uni-wuerzburg.de; hiroshi@ces.kyutech.ac.jp; rantzer@control.lth.se; bjoern@rueffer.info			JSPS KAKENHI [26420422]; LCCC Linnaeus Center; eLLIIT Excellence Center at Lund University	Hiroshi Ito has been supported by JSPS KAKENHI Grant Number 26420422.; Anders Rantzer is supported by the LCCC Linnaeus Center and the eLLIIT Excellence Center at Lund University.	HIRSCH MW, 1990, SIAM J MATH ANAL, V21, P1225, DOI 10.1137/0521067; Sontag ED, 1998, SYST CONTROL LETT, V34, P93, DOI 10.1016/S0167-6911(98)00003-6; Jiang ZP, 1996, AUTOMATICA, V32, P1211, DOI 10.1016/0005-1098(96)00051-9; [Anonymous], 2010, P 49 IEEE C DEC CONT; Angeli D, 2007, SYST CONTROL LETT, V56, P87, DOI 10.1016/j.sysconle.2006.08.003; Ito H, 2009, IEEE T AUTOMAT CONTR, V54, P2389, DOI 10.1109/TAC.2009.2028980; Dashkovskiy SN, 2010, SIAM J CONTROL OPTIM, V48, P4089, DOI 10.1137/090746483; Hirsch MW, 2003, LECT NOTES CONTR INF, V294, P183; De Leenheer P, 2007, J MATH CHEM, V41, P295, DOI 10.1007/s10910-006-9075-z; Rantzer A, 2013, IEEE DECIS CONTR P, P4590, DOI 10.1109/CDC.2013.6760604; Bacciotti A, 2000, SET-VALUED ANAL, V8, P299, DOI 10.1023/A:1008763931789; HIRSCH MW, 1985, SIAM J MATH ANAL, V16, P423, DOI 10.1137/0516030; Ito H, 2012, AUTOMATICA, V48, P1197, DOI 10.1016/j.automatica.2012.03.018; Margaliot M, 2012, IEEE ACM T COMPUT BI, V9, P1545, DOI 10.1109/TCBB.2012.88; Rantzer A, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P6608, DOI 10.1109/CDC.2011.6161293; Ito H, 2006, IEEE T AUTOMAT CONTR, V51, P1626, DOI 10.1109/TAC.2006.882930; Angeli D, 2000, IEEE T AUTOMAT CONTR, V45, P1082, DOI 10.1109/9.863594; HIRSCH MW, 1982, SIAM J MATH ANAL, V13, P167, DOI 10.1137/0513013; Ruffer BS, 2010, IEEE T AUTOMAT CONTR, V55, P1732, DOI 10.1109/TAC.2010.2048053; Ito H, 2013, IEEE T AUTOMAT CONTR, V58, P1192, DOI 10.1109/TAC.2012.2231552; Ruffer BS, 2010, POSITIVITY, V14, P257, DOI 10.1007/s11117-009-0016-5; SONTAG ED, 1989, IEEE T AUTOMAT CONTR, V34, P435, DOI 10.1109/9.28018; Hirsch MW, 1988, NONLINEARITY, V1, P51, DOI 10.1088/0951-7715/1/1/003; Ruffer BS, 2010, AUTOMATICA, V46, P1019, DOI 10.1016/j.automatica.2010.03.012; Ito H, 2010, IEEE T AUTOMAT CONTR, V55, P702, DOI 10.1109/TAC.2009.2037457; Rantzer A, 2012, IEEE DECIS CONTR P, P272, DOI 10.1109/CDC.2012.6426312; YORKE JA, 1968, B AM MATH SOC, V74, P322, DOI 10.1090/S0002-9904-1968-11940-8; Berman A., 1979, NONNEGATIVE MATRICES; Bhatia N. P., 1970, GRUNDLEHREN MATH WIS, V161; Clarke F. N., 1998, NONSMOOTH ANAL CONTR; Como G., 2014, IEEE T CONTR NETWORK, V2, P57; Hinrichsen D., 2005, MATH SYSTEMTHEORY, V1; Hirsch MW, 2005, HBK DIFF EQUAT ORDIN, V2, P239; HIRSCH MW, 1991, ERGOD THEOR DYN SYST, V11, P443; HIRSCH MW, 1989, J DIFFER EQUATIONS, V80, P94, DOI 10.1016/0022-0396(89)90097-1; Ito H., 2014, P 53 IEEE C DEC CONT, P2371; Khalil H.K., 2002, NONLINEAR SYSTEMS; Lakshmikantham V., 1969, DIFFERENTIAL INTEGRA, VI; Ruffer B. S., 2010, P 10 SICE ANN C CONT; Smith H.L., 1995, MATH SURVEYS MONOGRA, V41; Sontag Eduardo D, 2007, Syst Synth Biol, V1, P59, DOI 10.1007/s11693-007-9005-9; Sontag E. D., 2010, CONTROL SYSTEMS HDB, P1034; SONTAG ED, 1995, SYST CONTROL LETT, V24, P351, DOI 10.1016/0167-6911(94)00050-6; Yoshizawa T., 1966, PUBLICATIONS MATH SO	44	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1531-3492	1553-524X		DISCRETE CONT DYN-B	Discrete Contin. Dyn. Syst.-Ser. B	OCT	2015	20	8					2497	2526		10.3934/dcdsb.2015.20.2497		30	Mathematics, Applied	Mathematics	CT4AD	WOS:000362747200009		
J	Okumura, T; Shimada, Y; Sakurai, T; Hori, R; Nagata, T; Sakai, Y; Tsukada, K				Okumura, T.; Shimada, Y.; Sakurai, T.; Hori, R.; Nagata, T.; Sakai, Y.; Tsukada, K.			Abnormal cell proliferation in the p75NTR-positive basal cell compartment of the esophageal epithelium during squamous carcinogenesis	DISEASES OF THE ESOPHAGUS			English	Article						basal layer; esophageal carcinogenesis; p75NTR; stem cell	NEUROTROPHIN RECEPTOR; TELOMERASE ACTIVITY; HTERT PROTEIN; IN-VITRO; CARCINOMA; P53; EXPRESSION; P63; DYSPLASIA; KERATINOCYTES	The low affinity neurotrophin receptor p75NTR is known to be expressed in the mitotically quiescent basal layer (BL) of the normal esophageal epithelium. The aim of the present study was to detect oncogenic changes in the p75NTR-positive BL during esophageal squamous carcinogenesis. The normal epithelium (NE), low-grade intraepithelial neoplasia (LGN), high-grade intraepithelial neoplasia (HGN), and esophageal squamous carcinoma (SCC), in which invasion was limited to the muscularis mucosa, were obtained from surgically removed esophagi. The expression of p75NTR, the proliferation marker ki67, hTERT, p53, and p63 was examined immunohistochemically. The expression of p75NTR was detected in these tissues with average staining indexes (number of stained cells/100 nucleated cells; SI) of 1.00, 0.99, 0.81, and 0.73, respectively. The expression of ki67 in the BL significantly increased with the progression from LGN to HGN. The expression of hTERT and p53 significantly increased with the progression from NE to LGN, and then increased in a stepwise manner in HGN and SCC, with SI (hTERT/p53) of 0.10/0.11, 0.32/0.45, 0.50/0.72, and 0.65/0.61, respectively. The expression of p63 showed no significant difference among NE, LGN, HGN, and SCC, with SI of 0.82, 0.77, 0.85, and 0.87, respectively. A correlation was observed between the expression of ki67 and p53 (P = 0.005), while a negative correlation was found between p75NTR and hTERT (P = 0.01). Our results demonstrated that phenotypic changes from quiescent to active proliferation in the p75NTR-positive BL occurred during the progression from LGN to HGN. The altered expression of hTERT and p53 in the BL was detected in LGN, which suggested that additional oncogenic events that disrupt mitotic regulation in the p75NTR-positive quiescent BL may play a crucial role in malignant transformation. Further investigations using the isolation and tracing of p75NTR-positive cells in precancerous epithelia may provide us with a better understanding of squamous carcinogenesis.	[Okumura, T.; Hori, R.; Nagata, T.; Tsukada, K.] Toyama Univ, Dept Surg & Sci, Grad Sch Med & Pharmaceut Sci, Toyama, Toyama 9300194, Japan; [Hori, R.] Toyama Univ, Dept Pathol 1, Grad Sch Med & Pharmaceut Sci, Toyama, Toyama 9300194, Japan; [Shimada, Y.] Kyoto Univ, Dept Nanobio Drug Discovery, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Sakai, Y.] Kyoto Univ, Grad Sch Med, Div Gastrointestinal Surg, Dept Surg, Kyoto, Japan; [Sakurai, T.] Kyoto Univ Hosp, Dept Clin Pathol, Kyoto 606, Japan	Okumura, T (reprint author), Toyama Univ, Dept Surg & Sci, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	okumura@med.u-toyama.ac.jp			MEXT KAKENHI [23591920]	The authors wish to thank Ms Sakiko Shimada for her technical assistance. This work was partly supported by a Grant-in-Aid for Scientific Research (C) MEXT KAKENHI Grant Number 23591920.	Irwin MS, 2001, APOPTOSIS, V6, P17, DOI 10.1023/A:1009663809458; Itakura Y, 1996, ANTICANCER RES, V16, P201; Okumura T, 2006, CLIN CANCER RES, V12, P5096, DOI 10.1158/1078-0432.CCR-05-2852; Kunimura C, 1998, ONCOGENE, V17, P187, DOI 10.1038/sj.onc.1201916; Tominaga T, 2002, J GASTROENTEROL, V37, P418, DOI 10.1007/s005350200061; Ramires M, 1997, J PATHOL, V182, P62; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Amioka T, 2004, ONCOL REP, V11, P51; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Nakamura T, 2007, STEM CELLS, V25, P628, DOI 10.1634/stemcells.2006-0494; DAWSEY SM, 1994, CANCER, V74, P1686, DOI 10.1002/1097-0142(19940915)74:6<1686::AID-CNCR2820740608>3.0.CO;2-V; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Okumura T, 2014, INT J ONCOL, V44, P1923, DOI 10.3892/ijo.2014.2365; Harada H, 2003, MOL CANCER RES, V1, P729; Dixon MF, 2002, GUT, V51, P130, DOI 10.1136/gut.51.1.130; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Kuwano H, 1998, INT J CANCER, V78, P149, DOI 10.1002/(SICI)1097-0215(19981005)78:2<149::AID-IJC4>3.0.CO;2-Z; Yan P, 2004, HISTOCHEM CELL BIOL, V121, P391, DOI 10.1007/s00418-004-0465-5; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Kawamura T, 1996, CANCER, V77, P843, DOI 10.1002/(SICI)1097-0142(19960301)77:5<843::AID-CNCR6>3.0.CO;2-F; Shimizu Y, 2010, J GASTROEN HEPATOL, V25, P314, DOI 10.1111/j.1440-1746.2009.06032.x; Schlemper RJ, 2000, CANCER, V88, P996, DOI 10.1002/(SICI)1097-0142(20000301)88:5<996::AID-CNCR8>3.0.CO;2-Q; Frost M, 2000, AM J CLIN PATHOL, V114, P726, DOI 10.1309/XWFE-ARMN-HG2D-AJYV; Gurgel CAS, 2008, J MOL HISTOL, V39, P311, DOI 10.1007/s10735-008-9167-0; Okumura T, 2003, ONCOGENE, V22, P4017, DOI 10.1038/sj.onc.1206525; HONG MK, 1995, CANCER, V75, P423, DOI 10.1002/1097-0142(19950115)75:2<423::AID-CNCR2820750202>3.0.CO;2-5; Gaur D, 1997, CLIN CANCER RES, V3, P2129; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; Cheung PY, 2010, CANCER LETT, V293, P41, DOI 10.1016/j.canlet.2009.12.015; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Takubo K, 2007, HISTOPATHOLOGY, V51, P733, DOI 10.1111/j.1365-2559.2007.02766.x; Hamilton SR, 2000, WHO CLASSIFICATION T; Huang SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-9; Kuwano H, 2008, ESOPHAGUS, V5, P61, DOI [10.1007/s10388-008-0151-2, DOI 10.1007/S10388-008-0151-2]; Ratovitski EA, 2001, P NATL ACAD SCI USA, V98, P1817, DOI 10.1073/pnas.98.4.1817	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1120-8694	1442-2050		DIS ESOPHAGUS	Dis. Esophagus	OCT	2015	28	7					634	643		10.1111/dote.12245		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CT5ZU	WOS:000362890600005		
J	Xue, L; Furusawa, Y; Yu, D				Xue, Lian; Furusawa, Yoshiya; Yu, Dong			ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam	DNA REPAIR			English	Article						Ionizing radiation; High LET; Early G2/M checkpoint; Low dose hyper-radiosensitivity; ATR	DOUBLE-STRAND BREAK; REPAIR PATHWAY CHOICE; DEPENDENT PROTEIN-KINASE; CELL-CYCLE ARREST; HYPER-RADIOSENSITIVITY; DNA-DAMAGE; V79 CELLS; MAMMALIAN-CELLS; AURORA-B; INCREASED RADIORESISTANCE	Little work has been done on the mechanism of low dose hyper-radiosensitivity (HRS) and later appeared radioresistance (termed induced radioresistance (IRR)) after irradiation with medium and high linear energy transfer (LET) particles. The aim of this study was to find out whether ATR pathway is involved in the mechanism of HRS induced by high LET radiation. GM0639 cells and two ATM deficient/mutant cells, AT5BIVA and AT2KY were irradiated by carbon ion beam. Thymidine block technique was developed to enrich the G2-phase population. Radiation induced early G2/M checkpoint was quantitatively assess with dual-parameter flow cytometry by detecting the cells positive for phospho-histone H3. The involvement of ATR pathway in HRS/IRR response was detected with pretreatment of specific inhibitors prior to carbon ion beam. The link between the early G2/M checkpoint and HRS/IRR under carbon ion beam was first confirmed in GM0639 cells, through the enrichment of cell population in G2-phase or with Aurora kinase inhibitor that attenuates the transition from G2 to M phase. Interestingly, the early G2/M arrest could still be observed in ATM deficient/mutant cells with an effect of ATR signaling, which was discovered to function in an LET-dependent manner, even as low as 0.2 Gy for carbon ion radiation. The involvement of ATR pathway in heavy particles induced HRS/IRR was determined with the specific ATR inhibitor in GM0639 cells, which affected the HRS/IRR occurrence similarly as ATM inhibitor. These data demonstrate that ATR pathway may cooperate with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam. (C) 2015 Elsevier B.V. All rights reserved.	[Xue, Lian] Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou 215123, Peoples R China; [Xue, Lian] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Sch Publ Hlth, Suzhou 215123, Peoples R China; [Furusawa, Yoshiya] Natl Inst Radiol Sci, Res Dev Support Ctr, Microbeam Dev Off, Chiba 260, Japan; [Yu, Dong] Soochow Univ, Coll Med, Sch Radiol Med & Protect, Suzhou 215123, Peoples R China	Yu, D (reprint author), Soochow Univ, Coll Med, Sch Radiol Med & Protect, 199 Renai Rd,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	yudong@suda.edu.com			National Natural Scientific Foundation of China [81102076, 11475125]; Universities Natural Science Foundation of Jiangsu Province [BK20131165]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Scientific Research Foundation for Returned Scholars, Soochow University [Q412600711]	We give our thanks to Dr. Hirohiko Yajima, Dr. Ryuichi Okayasu, Dr. Masahiko Miura, Dr. Bing Wang, Dr. Yasuharu Ninomiya, Dr. Akira Fujimori, Dr. Xing Cui, Dr. Cuihua Liu, Dr. Ryoichi Hirayama, Dr. Yoshitaka Matsumoto, Dr. Hiroshi Fujisawa, Dr. Ayako Kariya and Dr. Huizi Li for their technical help. We thank Dr. Penny Jeggo for helping us with the preparation of the manuscript. This work was supported by 'National Natural Scientific Foundation of China (Nos. 81102076 and 11475125)', 'Universities Natural Science Foundation of Jiangsu Province (No. BK20131165)', 'Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)' and 'Scientific Research Foundation for Returned Scholars, Soochow University (No. Q412600711)'.	Krueger SA, 2007, INT J RADIAT ONCOL, V69, P1262, DOI 10.1016/j.ijrobp.2007.08.012; Bohrnsen G, 2002, RADIAT PROT DOSIM, V99, P255; Marples B, 2002, INT J RADIAT BIOL, V78, P1139, DOI 10.1080/09553000210166606; Fernet M, 2010, DNA REPAIR, V9, P48, DOI 10.1016/j.dnarep.2009.10.006; Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; MARPLES B, 1993, RADIAT RES, V133, P41, DOI 10.2307/3578255; Tsoulou E, 2002, RADIAT PROT DOSIM, V99, P237; Marples B, 2003, RADIAT RES, V160, P38, DOI 10.1667/RR3013; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700; Tsoulou E, 2001, INT J RADIAT BIOL, V77, P1133, DOI 10.1080/09553000110073439; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Marples B, 2008, INT J RADIAT ONCOL, V70, P1310, DOI 10.1016/j.ijrobp.2007.11.071; Bower JJ, 2010, CELL CYCLE, V9, P1617, DOI 10.4161/cc.9.8.11470; Xue L, 2009, MUTAT RES-FUND MOL M, V670, P15, DOI 10.1016/j.mrfmmm.2009.06.016; Thomas C, 2008, INT J RADIAT BIOL, V84, P533, DOI 10.1080/09553000802195331; Okayasu R, 2006, RADIAT RES, V165, P59, DOI 10.1667/RR3489.1; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Xue L, 2009, INT J RADIAT ONCOL, V75, P235, DOI 10.1016/j.ijrobp.2009.04.088; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; Vaganay-Juery S, 2000, BRIT J CANCER, V83, P514, DOI 10.1054/bjoc.2000.1258; Zhao YX, 2012, J RADIAT RES, V53, P686, DOI 10.1093/jrr/rrs024; Heuskin AC, 2013, RADIAT RES, V180, P491, DOI 10.1667/RR13358.1; Krueger SA, 2007, RADIAT RES, V167, P260, DOI 10.1667/RR0776.1; Marples B, 2004, RADIAT RES, V161, P247, DOI 10.1667/RR3130; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Krueger SA, 2010, INT J RADIAT ONCOL, V77, P1509, DOI 10.1016/j.ijrobp.2010.01.028; Grabarz A, 2013, CELL REP, V5, P21, DOI 10.1016/j.celrep.2013.08.034; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Crosio C, 2002, MOL CELL BIOL, V22, P874; Yajima H, 2013, DNA REPAIR, V12, P936, DOI 10.1016/j.dnarep.2013.08.009; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Gupta A., 2013, RADIAT RES, V181, P1; Heuskin AC, 2014, INT J RADIAT BIOL, V90, P81, DOI 10.3109/09553002.2013.835503; Lee KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212969; Wera AC, 2013, RADIAT RES, V179, P273, DOI 10.1667/RR3008.1; Xue L, 2015, DNA REPAIR, V25, P72, DOI 10.1016/j.dnarep.2014.11.004	47	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	OCT	2015	34						1	8		10.1016/j.dnarep.2015.07.001		8	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CT8LO	WOS:000363068300001		
J	Watanabe, M; Watanabe, N; Maruyama, S; Kawashiro, T				Watanabe, Miyuki; Watanabe, Noriko; Maruyama, Sakiko; Kawashiro, Takashi			Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Toremifene; Tamoxifen; Metabolite kinetics; Bioactivation; CYP2D6; CYP3A4; CYP2C9; Pharmacogenomics; Polymorphisms	BREAST-CANCER PATIENTS; RECEIVING ADJUVANT TAMOXIFEN; CYTOCHROME-P450 ENZYMES; CLINICAL-OUTCOMES; CYP2D6; POLYMORPHISMS; 2D6; THERAPY; CYP2C19; IMPACT	Toremifene (TOR) and Tamoxifen (TAM) are widely used as endocrine therapy for estrogen receptor positive breast cancer. Poor metabolizers of TAM are likely to have worse clinical outcomes than patients who exhibit normal TAM metabolism due to lower plasma level of its active metabolite, 4-hydroxy-N-desmethyl (4OH-NDM) tamoxifen (endoxifen). In this study, we examined the role of individual cytochrome P450 (CYP) isoforms in the metabolism of TOR to N-desmethyl (NDM), 4-hydroxy (4OH) and 4OH-NDM metabolites in comparison with TAM using human liver microsomes (HLMs) with selective chemical inhibitors for each CYP isoform and recombinant CYP proteins. Similar levels of NDM metabolites were formed for both TOR and TAM, and N-demethylation of both compounds was primarily carried out by CYP3A4. We found that the formation of 4OH-NDM-TOR was catalyzed both by CYP2C9 and CYP2D6, whereas the formation of 4OH-TAM and endoxifen was specifically catalyzed by CYP2D6 in HLMs. Our results suggest that the potential contribution of CYP2D6 in the bioactivation pathway of TOR may be lower compared to TAM, and may have a different impact on clinical outcome than CYP2D6 polymorphisms. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Watanabe, Miyuki; Watanabe, Noriko; Maruyama, Sakiko; Kawashiro, Takashi] Nippon Kayaku Co Ltd, Pharmaceut Res Labs, Kita Ku, Tokyo 1158588, Japan	Watanabe, N (reprint author), Nippon Kayaku Co Ltd, Pharmaceut Res Labs, Kita Ku, 31-12 Shimo, Tokyo 1158588, Japan.	miyuki.watanabe@nipponkayaku.co.jp; noriko.watanabe@nipponkayaku.co.jp; sakiko.maruyama@nipponkayaku.co.jp; takashi.kawashiro@nipponkayaku.co.jp					Crewe HK, 2002, DRUG METAB DISPOS, V30, P869, DOI 10.1124/dmd.30.8.869; [Anonymous], 2010, BMC CANCER; Crewe HK, 1997, BIOCHEM PHARMACOL, V53, P171, DOI 10.1016/S0006-2952(96)00650-8; Garcia-Martin E, 2006, MOL DIAGN THER, V10, P29; Lu JH, 2011, ANALYST, V136, P467, DOI 10.1039/c0an00487a; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; COEZY E, 1982, CANCER RES, V42, P317; Kiyotani K, 2010, J CLIN ONCOL, V28, P1287, DOI 10.1200/JCO.2009.25.7246; Kim J, 2013, INT J CANCER, V132, P1475, DOI 10.1002/ijc.27794; Pyrhonen S, 1999, BREAST CANCER RES TR, V56, P133; Shimada T, 1999, DRUG METAB DISPOS, V27, P1274; Stearns V, 2003, J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Fujita K, 2006, CURR DRUG METAB, V7, P23, DOI 10.2174/138920006774832587; Jin Y, 2005, J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; BERTHOU F, 1994, BIOCHEM PHARMACOL, V47, P1883, DOI 10.1016/0006-2952(94)90319-0; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Arvanitidis K, 2007, FUND CLIN PHARMACOL, V21, P419, DOI 10.1111/j.1472-8206.2007.00510.x; Pyrhonen S, 1997, BRIT J CANCER, V76, P270, DOI 10.1038/bjc.1997.375; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; BORGNA JL, 1981, J BIOL CHEM, V256, P859; Kitada M, 2003, INT J CLIN PHARM RES, V23, P31; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Rodrigues AD, 1999, BIOCHEM PHARMACOL, V57, P465; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Lim JSL, 2011, BRIT J CLIN PHARMACO, V71, P737, DOI 10.1111/j.1365-2125.2011.03905.x; Kelly CM, 2010, BMJ-BRIT MED J, V8, P340; Murdter TE, 2011, CLIN PHARMACOL THER, V89, P1	32	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					325	333		10.1016/j.dmpk.2015.05.004		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900001		
J	Mikkaichi, T; Nakai, D; Yoshigae, Y; Imaoka, T; Okudaira, N; Izumi, T				Mikkaichi, Tsuyoshi; Nakai, Daisuke; Yoshigae, Yasushi; Imaoka, Tomoki; Okudaira, Noriko; Izumi, Takashi			Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Organic anion transporting polypeptide; Drug interaction; Hepatic uptake; Tissue distribution; Regulatory science	TISSUE DISTRIBUTION; TRANSPLANT RECIPIENTS; PRAVASTATIN; PHARMACOKINETICS; DISPOSITION; REPAGLINIDE; INHIBITOR; SINGLE; BASES	Organic anion transporting polypeptide (OATP) 1B1 and 1B3 are key molecules that are involved in hepatic uptake related to drug elimination, and OATP-mediated drug interactions are of clinical concern. In this study, with an aim to determine a cutoff value for the potential involvement of OATP, we collected data on the distribution of 12 human OATP and 24 non-OATP radiolabeled substrates in rats. The OATP substrates exhibited a higher tissue-to-plasma ratio (K-p) in the liver than that in the other tissues. As an index of liver-specific distribution, a hepatic Kp ratio (the ratio of Kp in the liver to that in other tissues) was introduced, and a hepatic Kp ratio <10 was proposed as a criterion for excluding the involvement of OATP in vivo. Approximately 20% of the non-OATP substrates as well as 100% of the OATP substrates exceeded the cutoff value of 10; therefore, further in vitro transport studies will be required to decide whether to conduct clinical drug interaction studies. Since distribution studies are usually conducted in rats during drug development, the use of a hepatic Kp ratio is practical and could refine the current decision tree for selecting OATP substrates in the drug interaction guidance/guidelines. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Mikkaichi, Tsuyoshi; Nakai, Daisuke; Yoshigae, Yasushi; Imaoka, Tomoki; Okudaira, Noriko; Izumi, Takashi] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo 1408710, Japan	Mikkaichi, T (reprint author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	mikkaichi.tsuyoshi.da@daiichisankyo.co.jp					Niemi M, 2005, CLIN PHARMACOL THER, V77, P468, DOI 10.1016/j.cplt.2005.01.018; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Smith DA, 2015, J MED CHEM, V58, P5691, DOI 10.1021/acs.jmedchem.5b00201; Niemi M, 2003, DIABETOLOGIA, V46, P347, DOI 10.1007/s00125-003-1034-7; Niemi M, 2004, PHARMACOGENETICS, V14, P429, DOI 10.1097/01.fpc.0000114750.08559.32; REGAZZI MB, 1993, TRANSPLANT P, V25, P2732; Muck W, 1999, CLIN PHARMACOL THER, V65, P251, DOI 10.1016/S0009-9236(99)70104-9; Murakami T, 2011, EXPERT OPIN DRUG MET, V7, P353, DOI 10.1517/17425255.2011.548805; Marciante KD, 2011, PHARMACOGENET GENOM, V21, P280, DOI 10.1097/FPC.0b013e328343dd7d; Watanabe T, 2010, DRUG METAB DISPOS, V38, P215, DOI 10.1124/dmd.109.030254; Nezasa K, 2002, XENOBIOTICA, V32, P715, DOI 10.1080/00498250210144820; Imaoka T, 2013, DRUG METAB DISPOS, V41, P1442, DOI 10.1124/dmd.113.051052; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; Mwinyi J, 2004, CLIN PHARMACOL THER, V75, P415, DOI 10.1016/j.clpt.2003.12.016; Nakai D, 2001, J PHARMACOL EXP THER, V297, P861; Rodgers T, 2006, J PHARM SCI-US, V95, P1238, DOI 10.1002/jps.20502; KOMAI T, 1992, EUR J DRUG METAB PH, V17, P103; Rodgers T, 2005, J PHARM SCI-US, V94, P1259, DOI 10.1002/jps.20322; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Tornio A, 2012, TRENDS PHARMACOL SCI, V33, P312, DOI 10.1016/j.tips.2012.03.001; Uchiyama N, 1990, YAKUBUTSUDOUTAI, V5, P133	21	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					334	340		10.1016/j.dmpk.2015.06.003		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900002		
J	Yamashiro, T; Ohta, K; Inoue, K; Furumiya, M; Hayashi, Y; Yuasa, H				Yamashiro, Takahiro; Ohta, Kinya; Inoue, Katsuhisa; Furumiya, Mai; Hayashi, Yayoi; Yuasa, Hiroaki			Kinetic and time-dependent features of sustained inhibitory effect of myricetin on folate transport by proton-coupled folate transporter	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Proton-coupled folate transporter; Folate; Flavonoid; Myricetin; Drug interaction; Sustained inhibition; Intestinal transport	GRAPEFRUIT JUICE; DRUG-INTERACTIONS; FUNCTIONAL-CHARACTERIZATION; CARRIER; MALABSORPTION; MODULATION; ABSORPTION; CELLS; RAT	Myricetin is a flavonoid that has recently been suggested to induce sustained inhibition of proton-coupled folate transporter (PCFT/SLC46A1), which operates for intestinal folate uptake. The present study was conducted to characterize the inhibitory effect in more detail, using human PCFT stably expressed in Madin-Darby canine kidney II cells, to gain information to cope with problems potentially arising from that. The kinetics of saturable folate transport was first assessed in the absence of myricetin in the cells pretreated with the flavonoid for 60 min. The pretreatment induced PCFT inhibition in a manner dependent on the concentration of myricetin, where the maximum transport rate was reduced by 35.5% and 83.1%, respectively, at its concentrations of 20 mu M and 50 mu M. The inhibitory effect was, however, less extensive at lower folate concentrations, because the Michaelis constant was also reduced similarly in a manner dependent on myricetin concentration. The inhibition was induced depending on the time of pretreatment and, after removal of myricetin (50 mM) upon the manifestation of an extensive inhibition at 60 min, reversed almost completely in 90 min. This rather short time required for recovery may suggest that the sustained inhibition of PCFT is of a reversible type. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Yamashiro, Takahiro; Ohta, Kinya; Yuasa, Hiroaki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Inoue, Katsuhisa] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biopharmaceut, Hachioji, Tokyo 1920392, Japan; [Furumiya, Mai; Hayashi, Yayoi] Kinjo Gakuin Univ, Coll Pharm, Dept Biopharmaceut, Moriyama Ku, Nagoya, Aichi 4638521, Japan	Yuasa, H (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	yuasa@phar.nagoya-cu.ac.jp					Grimm SW, 2009, DRUG METAB DISPOS, V37, P1355, DOI 10.1124/dmd.109.026716; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Furumiya M, 2014, DRUG METAB PHARMACOK, V29, P312, DOI 10.2133/dmpk.DMPK-13-RG-107; Hamid A, 2007, FEBS J, V274, P6317, DOI 10.1111/j.1742-4658.2007.06150.x; Vuorinen H, 2000, J AGR FOOD CHEM, V48, P2675, DOI 10.1021/jf991388o; Huang SM, 2004, CLIN PHARMACOL THER, V75, P1, DOI 10.1016/j.clpt.2003.07.002; SchmiedlinRen P, 1997, DRUG METAB DISPOS, V25, P1228; Brantley SJ, 2014, DRUG METAB DISPOS, V42, P301, DOI 10.1124/dmd.113.055236; Lemos C, 2007, EUR J NUTR, V46, P329, DOI 10.1007/s00394-007-0670-y; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Greenblatt DJ, 2003, CLIN PHARMACOL THER, V74, P121, DOI 10.1016/S0009-9236(03)00118-8; Yuasa H, 2009, J PHARM SCI-US, V98, P1608, DOI 10.1002/jps.21515; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Guo LQ, 2000, DRUG METAB DISPOS, V28, P766; Bailey DG, 2010, BRIT J CLIN PHARMACO, V70, P645, DOI 10.1111/j.1365-2125.2010.03722.x; Dolton MJ, 2012, CLIN PHARMACOL THER, V92, P622, DOI 10.1038/clpt.2012.159; Shitara Y, 2012, DRUG METAB PHARMACOK, V27, P368, DOI 10.2133/dmpk.DMPK-11-RG-096; Bailey DG, 1998, BRIT J CLIN PHARMACO, V46, P101, DOI 10.1046/j.1365-2125.1998.00764.x; Alvarez AI, 2010, J PHARM SCI-US, V99, P598, DOI 10.1002/jps.21851; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Lemos C, 2005, ALCOHOL CLIN EXP RES, V29, P664, DOI 10.1097/01.ALC.0000159114.86360.B5; Shirasaka Y, 2013, DRUG METAB DISPOS, V41, P615, DOI 10.1124/dmd.112.049635; Furumiya M, 2015, DRUG METAB PHARMACOK, V30, P154, DOI 10.1016/j.dmpk.2014.11.001; Halsted CH, 2002, J NUTR, V132, p2367S; Shitara Y, 2013, J PHARM SCI-US, V102, P3427, DOI 10.1002/jps.23477	25	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					341	346		10.1016/j.dmpk.2015.06.002		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900003		
J	Akamine, Y; Miura, M; Komori, H; Tamai, I; Ieiri, I; Yasui-Furukori, N; Uno, T				Akamine, Yumiko; Miura, Masatomo; Komori, Hisakazu; Tamai, Ikumi; Ieiri, Ichiro; Yasui-Furukori, Norio; Uno, Tsukasa			The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Enantiomer; Fexofenadine; Grapefruit juice; OATP2B1; Pharmacokinetics	DRUG-INTERACTIONS; HEALTHY-SUBJECTS; P-GLYCOPROTEIN; PLASMA-CONCENTRATIONS; FRUIT JUICES; ORANGE; APPLE; TRANSPORTERS; INHIBITION; ITRACONAZOLE	The stereoselective pharmacokinetics of fexofenadine are associated with OATP2B1-mediated transport, and grapefruit juice (GFJ) is an inhibitor of OATP2B1. Therefore, in this study, we aimed to investigate whether and to what extent GFJ ingestion affected the pharmacokinetics of fexofenadine enantiomers in healthy subjects. In a randomized, two-phase, open-label, crossover study, 14 subjects received 60 mg of racemic fexofenadine simultaneously with water or GFJ. Ingestion of GFJ significantly decreased the areas under the plasma concentration-time curve (AUC(0-24)) for (R)- and (S)-fexofenadine by 39% and 52%, respectively. Subsequently, GFJ increased the mean R/S ratio of the AUC(0-24) from 1.58 to 1.96 (P < 0.05). Although GFJ greatly reduced the amounts of (R)- and (S)-fexofenadine excreted into the urine (Ae(0-24)) by 52% and 61%, respectively, the mean R/S ratios of Ae(0-24) and the renal clearances of both enantiomers were unchanged between the control and GFJ phases. GFJ, an OATP2B1 inhibitor, significantly reduced the plasma concentrations of fexofenadine enantiomers, exhibiting clinically moderate effects. The present results suggested that changes in OATP2B1 activity by GFJ may alter the stereoselective pharmacokinetics of fexofenadine and that reduced intestinal OATP2B1 activity may affect the stereo-selectivity of fexofenadine. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Akamine, Yumiko; Miura, Masatomo] Akita Univ Hosp, Dept Pharm, Akita 0108543, Japan; [Komori, Hisakazu; Tamai, Ikumi] Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Ieiri, Ichiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan; [Yasui-Furukori, Norio] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan; [Uno, Tsukasa] Zikeikai Aoimori Hosp, Dept Pharm, Aomori, Japan	Miura, M (reprint author), Akita Univ Hosp, Akita 0108543, Japan.	m-miura@hos.akita-u.ac.jp					Akamine Y, 2015, J CLIN PHARM THER, V40, P98, DOI 10.1111/jcpt.12213; Shirasaka Y, 2011, DRUG METAB PHARMACOK, V26, P171, DOI 10.2133/dmpk.DMPK-10-RG-073; Neuhofel AL, 2002, J CLIN PHARMACOL, V42, P461, DOI 10.1177/0091270002424013; Tateishi T, 2008, BRIT J CLIN PHARMACO, V65, P693, DOI 10.1111/j.1365-2125.2008.03116.x; Seden K, 2010, DRUGS, V70, P2373, DOI 10.2165/11585250-000000000-00000; Shirasaka Y, 2013, J PHARM SCI-US, V102, P280, DOI 10.1002/jps.23357; Shirasaka Y, 2011, J PHARM SCI-US, V100, P3843, DOI 10.1002/jps.22586; Kusuhara H, 2013, DRUG METAB DISPOS, V41, P206, DOI 10.1124/dmd.112.048330; Glaeser H, 2007, CLIN PHARMACOL THER, V81, P362, DOI 10.1038/sj.clpt.6100056; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Miura M, 2007, CHIRALITY, V19, P223, DOI 10.1002/chir.20370; Lilja JJ, 2003, CLIN PHARMACOL THER, V73, P192, DOI 10.1067/mcp.2003.26; Akamine Y, 2010, XENOBIOTICA, V40, P782, DOI 10.3109/00498254.2010.515318; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Tapaninen T, 2011, BRIT J CLIN PHARMACO, V71, P718, DOI 10.1111/j.1365-2125.2010.03898.x; Sakugawa T, 2009, BRIT J CLIN PHARMACO, V67, P535, DOI 10.1111/j.1365-2125.2009.03396.x; Groer C, 2013, J PHARMACEUT BIOMED, V85, P253, DOI 10.1016/j.jpba.2013.07.031; Dresser GK, 2002, CLIN PHARMACOL THER, V71, P11, DOI 10.1067/mcp.2002.121152; Shitara Y, 2011, DRUG METAB PHARMACOK, V26, P220, DOI 10.2133/dmpk.DMPK-10-RV-094; Tamai I, 2012, ADV DRUG DELIVER REV, V64, P508, DOI 10.1016/j.addr.2011.07.007; Bailey DG, 2007, CLIN PHARMACOL THER, V81, P495, DOI 10.1038/sj.clpt.6100104; Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866; Bailey DG, 2010, BRIT J CLIN PHARMACO, V70, P645, DOI 10.1111/j.1365-2125.2010.03722.x; Dolton MJ, 2012, CLIN PHARMACOL THER, V92, P622, DOI 10.1038/clpt.2012.159; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664; Hanley MJ, 2011, EXPERT OPIN DRUG MET, V7, P267, DOI 10.1517/17425255.2011.553189; Schwarz UI, 2005, CLIN PHARMACOL THER, V77, P291, DOI 10.1016/j.clpt.2004.11.111; Meier Y, 2007, DRUG METAB DISPOS, V35, P590, DOI 10.1124/dmd.106.013342; Miura M, 2007, J PHARMACEUT BIOMED, V43, P741, DOI 10.1016/j.jpba.2006.07.033; Prasad B, 2014, DRUG METAB DISPOS, V42, P78, DOI 10.1124/dmd.113.053819; Rebello S, 2012, EUR J CLIN PHARMACOL, V68, P697, DOI 10.1007/s00228-011-1167-4; Akamine Y, 2012, BRIT J CLIN PHARMACO, V73, P478, DOI 10.1111/j.1365-2125.2011.04106.x; Akamine Y, 2014, EUR J CLIN PHARMACOL, V70, P1087, DOI 10.1007/s00228-014-1705-y; Shirasaka Y, 2013, DRUG METAB DISPOS, V41, P615, DOI 10.1124/dmd.112.049635; Shirasaka Y, 2014, PHARM RES-DORDR, V31, P2035, DOI 10.1007/s11095-014-1305-7; Robbins DK, 1998, BIOPHARM DRUG DISPOS, V19, P455, DOI 10.1002/(SICI)1099-081X(199810)19:7<455::AID-BDD130>3.3.CO;2-N; Bailey David G, 2004, Am J Cardiovasc Drugs, V4, P281, DOI 10.2165/00129784-200404050-00002; Rodriguez-Fragoso L., 2011, J FOOD SCI, V76, P112; Uno Tsukasa, 2006, Curr Clin Pharmacol, V1, P157, DOI 10.2174/157488406776872550	39	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					352	357		10.1016/j.dmpk.2015.06.005		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900005		
J	Tsukada, C; Saito, T; Maekawa, M; Mano, N; Oda, A; Hirasawa, N; Hiratsuka, M				Tsukada, Chiharu; Saito, Takahiro; Maekawa, Masamitsu; Mano, Nariyasu; Oda, Akifumi; Hirasawa, Noriyasu; Hiratsuka, Masahiro			Functional characterization of 12 allelic variants of CYP2C8 by assessment of paclitaxel 6 alpha-hydroxylation and amodiaquine N-deethylation	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Cytochrome P450; CYP2C8; Genetic polymorphisms; Paclitaxel; Amodiaquine	IN-VITRO; JAPANESE POPULATION; DRUG-METABOLISM; OVARIAN-CANCER; POLYMORPHISMS; CYTOCHROME-P450; CYP2C8-ASTERISK-3; PHARMACOKINETICS; RHABDOMYOLYSIS; CERIVASTATIN	Cytochrome P450 2C8 (CYP2C8) is one of the enzymes primarily responsible for the metabolism of many drugs, including paclitaxel and amodiaquine. CYP2C8 genetic variants contribute to interindividual variations in the therapeutic efficacy and toxicity of paclitaxel. Although it is difficult to investigate the enzymatic function of most CYP2C8 variants in vivo, this can be investigated in vitro using recombinant CYP2C8 protein variants. The present study used paclitaxel to evaluate 6 alpha-hydroxylase activity and amodiaquine for the N-deethylase activity of wild-type and 11 CYP2C8 variants resulting in amino acid substitutions in vitro. The wild-type and variant CYP2C8 proteins were heterologously expressed in COS-7 cells. Paclitaxel 6 alpha-hydroxylation and amodiaquine N-deethylation activities were determined by measuring the concentrations of 6 alpha-hydroxypaclitaxel and N-desethylamodiaquine, respectively, and the kinetic parameters were calculated. Compared to the wild-type enzyme (CYP2C8.1), CYP2C8.11 and CYP2C8.14 showed little or no activity with either substrate. In addition, the intrinsic clearance values of CYP2C8.8 and CYP2C8.13 for paclitaxel were 68% and 67% that of CYP2C8.1, respectively. In contrast, the CLint values of CYP2C8.2 and CYP2C8.12 were 1.4 and 1.9 times higher than that of CYP2C8.1. These comprehensive findings could inform for further genotype-phenotype studies on interindividual differences in CYP2C8-mediated drug metabolism. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Tsukada, Chiharu; Saito, Takahiro; Hirasawa, Noriyasu; Hiratsuka, Masahiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 9808578, Japan; [Maekawa, Masamitsu; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi 9808574, Japan; [Oda, Akifumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Hiratsuka, M (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 9808578, Japan.	mhira@m.tohoku.ac.jp			Ministry of Health, Labour and Welfare (MHLW) of Japan; Smoking Research Foundation; Japan Research Foundation for Clinical Pharmacology	This study was supported in part by a grant from the Ministry of Health, Labour and Welfare (MHLW) of Japan ('Initiative to facilitate development of innovative drug, medical devices, and cellular & tissue-based product'), the Smoking Research Foundation, and the Japan Research Foundation for Clinical Pharmacology. We thank the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support.	Green H, 2009, BASIC CLIN PHARMACOL, V104, P130, DOI 10.1111/j.1742-7843.2008.00351.x; Soyama A, 2001, BIOL PHARM BULL, V24, P1427, DOI 10.1248/bpb.24.1427; Kaspera R, 2010, PHARMACOGENET GENOM, V20, P619, DOI 10.1097/FPC.0b013e32833ecace; Steed H, 2007, PHARMACOGENOMICS, V8, P803, DOI 10.2217/14622416.8.7.803; Ishikawa C, 2004, J HUM GENET, V49, P582, DOI 10.1007/s10038-004-0188-6; Dai D, 2001, PHARMACOGENETICS, V11, P597, DOI 10.1097/00008571-200110000-00006; Soyama A, 2002, PHARMACOL TOXICOL, V91, P174, DOI 10.1034/j.1600-0773.2002.910404.x; SONNICHSEN DS, 1995, J PHARMACOL EXP THER, V275, P566; Hertz DL, 2014, BREAST CANCER RES TR, V145, P245, DOI 10.1007/s10549-014-2910-1; Bergmann TK, 2011, PHARMACOGENOMICS J, V11, P113, DOI 10.1038/tpj.2010.19; Hertz DL, 2012, BREAST CANCER RES TR, V134, P401, DOI 10.1007/s10549-012-2054-0; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Afzelius L, 2004, DRUG METAB DISPOS, V32, P1218; Parikh S, 2007, CLIN PHARMACOL THER, V82, P197, DOI 10.1038/sj.clpt.2007.6100122; Abraham JE, 2014, CLIN CANCER RES, V20, P2466, DOI 10.1158/1078-0432.CCR-13-3232; Leskela S, 2011, PHARMACOGENOMICS J, V11, P121, DOI 10.1038/tpj.2010.13; Gao YW, 2010, XENOBIOTICA, V40, P467, DOI 10.3109/00498254.2010.487163; Hanioka N, 2011, BASIC CLIN PHARMACOL, V108, P359, DOI 10.1111/j.1742-7843.2010.00669.x; Kaspera R, 2011, BIOCHEM PHARMACOL, V82, P681, DOI 10.1016/j.bcp.2011.06.027; Jiang HL, 2011, AMINO ACIDS, V40, P1195, DOI 10.1007/s00726-010-0743-8; Yeo CW, 2011, DRUG METAB DISPOS, V39, P711, DOI 10.1124/dmd.110.035899; Saito Y, 2007, PHARMACOGENET GENOM, V17, P461, DOI 10.1097/FPC.0b013e32805b72c1; Lai XS, 2009, CURR DRUG METAB, V10, P1009; Hanioka N, 2010, BASIC CLIN PHARMACOL, V107, P565, DOI 10.1111/j.1742-7843.2010.00543.x; Aquilante CL, 2013, PHARMACOGENET GENOM, V23, P721, DOI 10.1097/FPC.0b013e3283653b27; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Hichiya H, 2005, DRUG METAB DISPOS, V33, P630, DOI 10.1124/dmd.105.003830; Singh R, 2008, DRUG METAB PHARMACOK, V23, P165, DOI 10.2133/dmpk.23.165; Dravid PV, 2008, J CHROMATOGR B, V863, P129, DOI 10.1016/j.jchromb.2008.01.017; Aquilante CL, 2013, PHARMACOTHERAPY, V33, P1000, DOI 10.1002/phar.1292; Green H, 2011, J PHARM SCI-US, V100, P4205, DOI 10.1002/jps.22680; Lewis D. F. V., 2002, Xenobiotica, V32, P305, DOI 10.1080/00498250110112015; Soyama Akiko, 2002, Drug Metab Pharmacokinet, V17, P374, DOI 10.2133/dmpk.17.374; Taniguchi R, 2005, J PHARMACOL SCI, V97, P83, DOI 10.1254/jphs.FP0040603; Yu LS, 2013, BIOPHARM DRUG DISPOS, V34, P278, DOI 10.1002/bdd.1842	35	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	OCT	2015	30	5					366	373		10.1016/j.dmpk.2015.07.003		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT7DV	WOS:000362974900007		
J	Sato, K; Ono, T; Yoshida, K; Ito, T; Kashiwagi, Y				Sato, Katsuhiko; Ono, Tetsuya; Yoshida, Kentaro; Ito, Toshinori; Kashiwagi, Yoshitomo			Electrochemical Determination of D-Glucose Using Nortropine-N-oxyl under Physiological Conditions	ELECTROANALYSIS			English	Article						Mediator; Nitroxyl radical; Electrocatalytic oxidation; Diabetes treatment	MODIFIED ELECTRODES; OXIDATION; ALCOHOLS; ACID; DIOL	Nortropine-N-oxyl (NNO) was synthesized in a single step from nortropine. The electrocatalytical activity of NNO was evaluated by cyclic voltammetry in pH7.0 phosphate buffer solution. The anodic peak current for ethanol, isopropanol and glucose was enhanced, showing these alcohols were oxidized by electrocatalytic effect of NNO. On the other hand, TEMPO derivative (4-hydroxy-2,2,6,6,-terramethylpiperidine N-oxyl free radical) could not oxidize the alcohols under the same condition. The electrochemical response of the NNO to glucose was investigated. The anodic peak current increased with an increase in the concentration of glucose. A linear response to the glucose concentration ranging from 0.1 to 10mM was obtained.	[Sato, Katsuhiko] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ono, Tetsuya; Yoshida, Kentaro; Ito, Toshinori; Kashiwagi, Yoshitomo] Ohu Univ, Sch Pharmaceut Sci, Koriyama, Fukushima 9638611, Japan	Kashiwagi, Y (reprint author), Ohu Univ, Sch Pharmaceut Sci, 31-1 Misumido, Koriyama, Fukushima 9638611, Japan.	y-kashiwagi@pha.ohu-u.ac.jp			JSPS KAKENHI [26670083, 26860111]; Foundation for Ohu University Joint Research Fund	This work was supported by JSPS KAKENHI Grant Numbers 26670083, 26860111. The Foundation for Ohu University Joint Research Fund is also acknowledged for financial support.	Demizu Y, 2008, TETRAHEDRON LETT, V49, P48, DOI 10.1016/j.tetlet.2007.11.016; Takahashi S, 2005, LANGMUIR, V21, P5102, DOI 10.1021/la050171n; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Shibuya M, 2009, J ORG CHEM, V74, P4619, DOI 10.1021/jo900486w; SEMMELHACK MF, 1986, TETRAHEDRON LETT, V27, P1119, DOI 10.1016/S0040-4039(00)84193-3; Takahashi S, 2011, J ENVIRON SCI-CHINA, V23, P1027, DOI 10.1016/S1001-0742(10)60509-8; Ibert M, 2010, ELECTROCHIM ACTA, V55, P3589, DOI 10.1016/j.electacta.2009.11.041; MURRAY RW, 1984, ELECTROANAL CHEM, V13, P191; Arimori S, 2002, CHEM COMMUN, P2368, DOI 10.1039/b207643h; Kashiwagi Y, 1996, CHEM COMMUN, P2345; Murray R. W., 1992, TECHNIQUES CHEM 22, V22	11	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	OCT	2015	27	10					2272	2274		10.1002/elan.201500059		3	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	CT6DU	WOS:000362902700003		
J	Zhang, ZP; Xiao, TF; Hao, J; Yu, P; Ohsaka, T; Mao, LQ				Zhang, Zipin; Xiao, Tongfang; Hao, Jie; Yu, Ping; Ohsaka, Takeo; Mao, Lanqun			An Online Electrochemical System for Continuous Measurement of Glutamate with Signal Amplification by Enzymatic Substrate Cycling	ELECTROANALYSIS			English	Article						OECS; In vivo microdialysis; Enzymatic substrate cycling; Glutamate	CAPILLARY-ELECTROPHORESIS; CARBON NANOTUBES; BRAIN MICRODIALYSIS; SENSITIVE DETECTION; MASS-SPECTROMETRY; DUAL-ENZYME; RAT-BRAIN; RELEASE; ISCHEMIA; NEUROTRANSMITTERS	This study demonstrates a new online electrochemical system (OECS) for continuous monitoring of glutamate by efficiently integrating in vivo microdialysis and selective electrochemical detection with an enhanced sensitivity through enzymatic substrate cycling. We find that the involvement of enzymatic substrate cycling in the biosensing scheme remarkably increases the sensitivity of the OECS toward the measurements of glutamate. Moreover, the OECS demonstrated here is stable, reproducible, and selective and could thus be potentially useful for continuous monitoring of glutamate release in central nervous system. This study essentially offers a new approach to the continuous measurements of cerebral glutamate release, which is believed to find interesting applications in understanding the molecular basis underlying brain functions.	[Zhang, Zipin; Xiao, Tongfang; Hao, Jie; Yu, Ping; Mao, Lanqun] Chinese Acad Sci, Key Lab Analyt Chem Living Biosyst, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China; [Ohsaka, Takeo] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Mao, LQ (reprint author), Chinese Acad Sci, Key Lab Analyt Chem Living Biosyst, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.	lqmao@iccas.ac.cn			NSF of China [21321003, 21210007, 91213305, 21322503]; National Basic Research Program of China (973 programs) [2013CB933704]	This research was financially supported by the NSF of China (Grant Nos. 21321003, 21210007, and 91213305 for L. Mao; 21322503 for P. Yu), and the National Basic Research Program of China (973 programs, 2013CB933704).	Ahmed I., 2011, BRAIN; Zhang MN, 2012, ACCOUNTS CHEM RES, V45, P533, DOI 10.1021/ar200196h; Emre FB, 2014, ELECTROANAL, V26, P1354, DOI 10.1002/elan.201400048; Niwa O, 1998, ANAL CHEM, V70, P1126, DOI 10.1021/ac970257o; Liu K, 2009, BRAIN RES, V1253, P161, DOI 10.1016/j.brainres.2008.11.096; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Yao T, 2001, ELECTROANAL, V13, P1361, DOI 10.1002/1521-4109(200111)13:16<1361::AID-ELAN1361>3.3.CO;2-4; Yao T, 1998, TALANTA, V45, P917, DOI 10.1016/S0039-9140(97)00193-8; SZERB JC, 1991, BRAIN RES, V542, P259, DOI 10.1016/0006-8993(91)91576-M; Lin YQ, 2007, ANAL CHEM, V79, P9577, DOI 10.1021/ac070966u; Niwa O, 1998, ANAL CHEM, V70, P89, DOI 10.1021/ac970740z; Upadhyay S, 2006, SENSOR ACTUAT B-CHEM, V119, P570, DOI 10.1016/j.snb.2006.01.008; Lin YQ, 2009, ANAL CHEM, V81, P2067, DOI 10.1021/ac801946s; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Hogerton AL, 2013, ANAL CHEM, V85, P9070, DOI 10.1021/ac401631k; Gligor D, 2009, ELECTROANAL, V21, P360, DOI 10.1002/elan.200804397; ZHOU SY, 1995, ANAL CHEM, V67, P594, DOI 10.1021/ac00099a017; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Liu K, 2013, ANAL CHEM, V85, P9947, DOI 10.1021/ac402620c; Kaul S, 2011, ELECTROPHORESIS, V32, P284, DOI 10.1002/elps.201000463; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Gao Y, 2013, ANAL CHEM, V85, P11494, DOI 10.1021/ac402728d; Khampha W, 2004, ANAL CHIM ACTA, V518, P127, DOI 10.1016/j.aca.2004.05.048; Brun MA, 2012, J AM CHEM SOC, V134, P7676, DOI 10.1021/ja3002277; Lu XL, 2013, ANAL CHEM, V85, P4007, DOI 10.1021/ac303743a; Zhu KY, 2011, J CHROMATOGR B, V879, P737, DOI 10.1016/j.jchromb.2011.02.011; WANG AJ, 1992, ANAL CHEM, V64, P1051, DOI 10.1021/ac00033a016; Rossi DJ, 2000, NATURE, V403, P316; Lin YQ, 2014, ANAL CHEM, V86, P3895, DOI 10.1021/ac4042087; Lawrence NS, 2006, ELECTROCHEM COMMUN, V8, P71, DOI 10.1016/j.elecom.2005.10.026; Jiang BY, 2013, BIOSENS BIOELECTRON, V43, P289, DOI 10.1016/j.bios.2012.12.038; Zhuang XM, 2012, ANAL CHEM, V84, P1900, DOI 10.1021/ac202748s; Yang L, 2009, ELECTROPHORESIS, V30, P3527, DOI 10.1002/elps.200900195; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Kim KC, 2014, MOL NEUROBIOL, V49, P512, DOI 10.1007/s12035-013-8535-2; Yu P, 2015, ANAL CHEM, V87, P1373, DOI 10.1021/ac504249k; Cudjoe E, 2014, J CHROMATOGR A, V1341, P1, DOI 10.1016/j.chroma.2014.03.035; Lin Y., ANALYST IN PRESS, DOI [10.1039/C4AN02089H, DOI 10.1039/C4AN02089H]; Marsman A, 2013, SCHIZOPHRENIA BULL, V39, P120, DOI 10.1093/schbul/sbr069; Paquet M., 2013, MOL BRAIN, V6; Park H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0097-y	42	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	OCT	2015	27	10					2406	2411		10.1002/elan.201500122		6	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	CT6DU	WOS:000362902700021		
J	Takahashi, M; Shigeto, J; Sakamoto, A; Izumi, S; Asada, K; Morikawa, H				Takahashi, Misa; Shigeto, Jun; Sakamoto, Atsushi; Izumi, Shunsuke; Asada, Kozi; Morikawa, Hiromichi			Dual selective nitration in Arabidopsis: Almost exclusive nitration of PsbO and PsbP, and highly susceptible nitration of four non-PSII proteins, including peroxiredoxin II E	ELECTROPHORESIS			English	Article						Arabidopsis; Peroxiredoxin II E; Protein tyrosine nitration; PsbO; PsbP	PHOTOSYSTEM-II; TYROSINE NITRATION; NITROGEN-DIOXIDE; NITRIC-OXIDE; THALIANA CHLOROPLASTS; THYLAKOID MEMBRANES; MASS-SPECTROMETRY; PROTEOME; PLANTS; LUMEN	Protein tyrosine nitration is a selective process, as revealed in studies of animals. However, evidence for selective protein nitration in plants is scarce. In this study, Arabidopsis plants were exposed to air with or without nitrogen dioxide at 40 ppm for 8 h in light. Proteins extracted from whole leaves or isolated chloroplasts were subjected to 2D PAGE followed by SYPRO Ruby staining and immunoblotting using an anti-3-nitrotyrosine antibody. We determined the relative intensity of a spot on an immunoblot (designated RISI), and relative intensity of the corresponding spot on SYPRO Ruby gel (designated RISS). Proteins that exhibited a high RISI value and/or a high RISI/RISS ratio were considered selectively nitrated. In whole leaf proteins from exposed plants, all immunopositive spots were identified as PsbO1, PsbO2 or PsbP1 by PMF. Thus, nitration was exclusive to PsbO and PsbP, extrinsic proteins of photosystem II (PSII). Their RISI/RISS ratio was <= 1.5. Non-exposed plants showed very faint nitration. In purified chloroplast proteins, PsbO and PsbP accounted for >80% of the total RISI values, while four non-PSII proteins, including peroxiredoxin II E, exhibited high RISI/RISS ratios (2.5 similar to 6.6). Tyr(9) of PsbO1 was identified as a nitration site. Thus, nitration is selective for two PSII and four non-PSII proteins in Arabidopsis.	[Takahashi, Misa; Shigeto, Jun; Sakamoto, Atsushi; Izumi, Shunsuke; Morikawa, Hiromichi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima, Japan; [Asada, Kozi] Fukuyama Univ, Fac Engn, Fukuyama, Hiroshima 72902, Japan	Takahashi, M (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.	mtakahas@sci.hiroshima-u.ac.jp		Sakamoto, Atsushi/0000-0001-5710-1900	Nippon Life Insurance Foundation; Nissan Science Foundation; Japan Science and Technology Agency [13GS0023]; Japan Society for the Promotion of Science [15710149]	This work was supported by a grant from the Nippon Life Insurance Foundation (to MT); by a grant from the Nissan Science Foundation (to MT); by a Grant-in-Aid for Creative Scientific Research from the Japan Science and Technology Agency no. 13GS0023 (to HM); and by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science no. 15710149 (to MT).	Allahverdiyeva Y, 2009, BBA-BIOENERGETICS, V1787, P1230, DOI 10.1016/j.bbabio.2009.05.013; Takahashi M, 2005, NEW PHYTOL, V168, P149, DOI 10.1111/j.1469-8137.2005.01493.x; Wyman AJ, 2008, BIOCHEMISTRY-US, V47, P6490, DOI 10.1021/bi800225m; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; Jasid S, 2006, PLANT PHYSIOL, V142, P1246, DOI 10.1104/pp.106.086918; Koeck T, 2004, J BIOL CHEM, V279, P27257, DOI 10.1074/jbc.M401586200; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; He XD, 2000, J BIOL CHEM, V275, P13250, DOI 10.1074/jbc.275.18.13250; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Cheng TL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00030; Lozano-Juste J, 2011, J EXP BOT, V62, P3501, DOI 10.1093/jxb/err042; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Dietz KJ, 2011, ANTIOXID REDOX SIGN, V15, P1129, DOI 10.1089/ars.2010.3657; Morikawa H, 2004, PLANTA, V219, P14, DOI 10.1007/s00425-003-1200-7; Shapiro AD, 2005, VITAM HORM, V72, P339, DOI 10.1016/S0083-6729(05)72010-0; Matsuo E, 2006, PROTEOMICS, V6, P2042, DOI 10.1002/pmic.200500575; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Cecconi D, 2009, ELECTROPHORESIS, V30, P2460, DOI 10.1002/elps.200800826; Signorelli S, 2011, ARCH BIOCHEM BIOPHYS, V512, P190, DOI 10.1016/j.abb.2011.06.003; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Chaki M, 2009, J EXP BOT, V60, P4221, DOI 10.1093/jxb/erp263; Takahashi M, 2001, PLANT PHYSIOL, V126, P731, DOI 10.1104/pp.126.2.731; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; TAKAHASHI M, 1985, PLANT CELL PHYSIOL, V26, P1093; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Anderson JM, 2008, PHOTOSYNTH RES, V98, P575, DOI 10.1007/s11120-008-9381-3; Rubbo H, 2008, BBA-GEN SUBJECTS, V1780, P1318, DOI 10.1016/j.bbagen.2008.03.007; Ischiropoulos H, 2009, ARCH BIOCHEM BIOPHYS, V484, P117, DOI 10.1016/j.abb.2008.10.034; Galetskiy D, 2011, RAPID COMMUN MASS SP, V25, P184, DOI 10.1002/rcm.4855; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Takahashi M, 2014, NEW PHYTOL, V201, P1304, DOI 10.1111/nph.12609; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438; Beckman J. S., 1996, NITRIC OXIDE PRINCIP, P1, DOI 10.1016/B978-012435555-2/50002-4; GORG A, 1985, ELECTROPHORESIS, V6, P599, DOI 10.1002/elps.1150061206; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Takahashi M., 2014, PLANT SIG BEHAV, V9; Weigel D, 2002, ARABIDOPSIS LAB MANU	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	OCT	2015	36	20					2569	2578		10.1002/elps.201500145		10	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CT7VW	WOS:000363023600010		
J	Nicholas, A				Nicholas, Allan			A concept-based approach to teaching speech acts in the EFL classroom	ELT JOURNAL			English	Article							CONVERSATION ANALYSIS; PRAGMATICS	While concept-based instruction (CBI), grounded in sociocultural theory, has been the subject of increased attention in recent years, it is still a relatively unknown methodology in language teaching contexts. In this approach, the emphasis is on helping learners develop a deep, conceptual understanding of a skill or knowledge area, so that this knowledge can then be applied in a variety of situations. This article reports on a study in which elements of CBI were combined with findings from conversation analysis research to create a short course on speech acts and the act of requesting. By combining these two areas, the author addresses some of the challenges facing teachers wishing to teach pragmatics in the classroom. The article discusses key features of the course, and proposes a number of principles for effective concept-based speech act instruction.	Kanda Univ, External Language Consultancy Ctr, Chiba, Japan	Nicholas, A (reprint author), Kanda Univ, External Language Consultancy Ctr, Chiba, Japan.	allannicholas@me.com					McConachy T, 2013, ELT J, V67, P294, DOI 10.1093/elt/cct017; Barraja-Rohan AM, 2011, LANG TEACH RES, V15, P479, DOI 10.1177/1362168811412878; Kasper G, 2006, AILA REV, V19, P83, DOI 10.1075/aila.19.07kas; Huth T, 2006, LANG TEACH RES, V10, P53, DOI 10.1191/1362168806lr184oa; Austin John L., 1962, DO THINGS WORDS; Barraja-Rohan A. M., 1997, TALK COURSE COMMUNIC; Brown P., 1987, POLITENESS SOME UNIV; Di Pietro R. J., 1987, STRATEGIC INTERACTIO; Fukushima S., 2000, REQUESTS AND CULTURE; Gal'perin P. Y., 1979, SOV PSYCHOL, V18, P19; Gibbs R. W., 2005, EMBODIMENT COGNITIVE; LoCastro V., 2012, PRAGMATICS LANGUAGE; Mey J. L., 1993, PRAGMATICS INTRO; Negueruela E., 2008, SOCIOCULTURAL THEORY; Vygotsky L, 1978, MIND SOC DEV HIGHER	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0951-0893	1477-4526		ELT J	ELT J.	OCT	2015	69	4					383	394		10.1093/elt/ccv034		12	Education & Educational Research; Linguistics; Language & Linguistics	Education & Educational Research; Linguistics	CT7AA	WOS:000362964200004		
J	Das, J; Das, SK; Ahmed, S; Ferdous, F; Farzana, FD; Sarker, MHR; Ahmed, AMS; Chisti, MJ; Malek, MA; Rahman, A; Faruque, ASG; Mamun, AA				Das, J.; Das, S. K.; Ahmed, S.; Ferdous, F.; Farzana, F. D.; Sarker, M. H. R.; Ahmed, A. M. S.; Chisti, M. J.; Malek, M. A.; Rahman, A.; Faruque, A. S. G.; Mamun, A. A.			Determinants of percent expenditure of household income due to childhood diarrhoea in rural Bangladesh	EPIDEMIOLOGY AND INFECTION			English	Article						Bangladesh; diarrhoea; health economics; paediatrics; rotavirus; rural; Shigella	DISEASE; BURDEN; COST	There is limited information on percent expenditure of household income due to childhood diarrhoea especially in rural Bangladesh. A total of 4205 children aged < 5 years with acute diarrhoea were studied. Percent expenditure was calculated as total expenditure for the diarrhoeal episode divided by monthly family income, multiplied by 100. Overall median percent expenditure was 3.04 (range 0.01-94.35). For Vibrio cholerae it was 6.42 (range 0.52-82.85), for enterotoxigenic Escherichia coli 3.10 (range 0.22-91.87), for Shigella 3.17 (range 0.06-77.80), and for rotavirus 3.08 (range 0.06-48.00). In a multinomial logistic regression model, for the upper tertile of percent expenditure, significant higher odds were found for male sex, travelling a longer distance to reach hospital (>= median of 4 miles), seeking care elsewhere before attending hospital, vomiting, higher frequency of purging (>= 10 times/day), some or severe dehydration and stunting. V. cholerae was the highest and rotavirus was the least responsible pathogen for percent expenditure of household income due to childhood diarrhoea.	[Das, J.; Das, S. K.; Ahmed, S.; Ferdous, F.; Farzana, F. D.; Sarker, M. H. R.; Chisti, M. J.; Malek, M. A.; Rahman, A.; Faruque, A. S. G.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Das, S. K.; Ahmed, A. M. S.; Mamun, A. A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Ferdous, F.] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki 305, Japan	Das, SK (reprint author), Univ Queensland, Sch Populat Hlth, Herston Rd, Herston, Qld 4006, Australia.	sumon.das@uqconnect.edu.au			Government of Australia; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	icddr,b acknowledges with gratitude the commitment of Sida to its research efforts. icddr, b is also grateful to the Governments of Australia, Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. Our heartfelt thanks go to the Medical Director of Kumudini Women's Medical College and Hospital for his sincere support to the research team. We also acknowledge all the research personnel for their sincere efforts in data collection, and the laboratory personnel for their quality performance.	Alvis Guzman N, 2013, VACCINE, V31, pC58; Qadri F, 2005, EMERG INFECT DIS, V11, P1104; Aikins M, 2010, J INFECT DIS, V202, pS126, DOI 10.1086/653573; Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Bhuiyan MU, 2014, AM J TROP MED HYG, V91, P165, DOI 10.4269/ajtmh.13-0484; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Ciccarelli Simona, 2013, Infect Drug Resist, V6, P133, DOI 10.2147/IDR.S12718; Das SK, 2013, J INFECT DEV COUNTR, V7, P900, DOI 10.3855/jidc.3003; Das SK, 2013, AM J TROP MED HYG, V89, P62, DOI 10.4269/ajtmh.13-0107; Ferdous F, 2013, SCI J PUBLIC HLTH, V1, P69; Onyango AW, 2008, TRANING COURSE CHILD; Rheingans A, 2012, CLIN INFECT DIS S4, V55, P5327; Rheingans R, 2012, CLIN INFECT DIS, V55, P317; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; [孙立梅 Sun Limei], 2013, [中华流行病学杂志, Chinese Journal of Epidemiology], V34, P989; Walker C.L., 2013, LANCET, V38, P1405, DOI DOI 10.1016/S0140-6736(13)60222-6	17	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	OCT	2015	143	13					2700	2706		10.1017/S0950268814003781		7	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CT6XA	WOS:000362955200002		
J	Yahata, Y; Misaki, T; Ishida, Y; Nagira, M; Watahiki, M; Isobe, J; Terajima, J; Iyoda, S; Mitobe, J; Ohnishi, M; Sata, T; Taniguchi, K; Tada, Y; Okabe, N				Yahata, Y.; Misaki, T.; Ishida, Y.; Nagira, M.; Watahiki, M.; Isobe, J.; Terajima, J.; Iyoda, S.; Mitobe, J.; Ohnishi, M.; Sata, T.; Taniguchi, K.; Tada, Y.; Okabe, N.		E coli O111 Outbreak Invest Team	Epidemiological analysis of a large enterohaemorrhagic Escherichia coli O111 outbreak in Japan associated with haemolytic uraemic syndrome and acute encephalopathy	EPIDEMIOLOGY AND INFECTION			English	Article						Escherichia coli infection; foodborne diseases; infectious disease outbreaks	MULTISTATE OUTBREAK; O157-H7 INFECTIONS; UNITED-STATES; RISK-FACTORS; CONSUMPTION; DIVERSITY; FEATURES; STRAINS; DEATH; CHAIN	A large outbreak of enterohaemorrhagic Escherichia coli (EHEC) O111 and O157 occurred in Japan in April 2011. We conducted an unmatched case-control study and trace-back investigation to determine the source of EHEC O111 infection and risk factors for severe complications. Pulsed-field gel electrophoresis was performed to help define cases. A total of 86 individuals met the case definition. Of these, 40% experienced haemolytic uraemic syndrome (HUS), 24% acute encephalopathy, and 6% died. Illness was significantly associated with eating the raw beef dish yukhoe (odds ratio 19.64, 95% confidence interval 7.03-54.83), the likely food vehicle. EHEC O111 and its closely related stx-negative variants were found in the beef. HUS occurred most frequently in individuals aged 5-9 years, and this age group was significantly associated with acute encephalopathy. The prevalence of HUS and acute encephalopathy was higher than in previous non-O157-related outbreaks, indicating a high risk of severe complications.	[Yahata, Y.; Misaki, T.; Nagira, M.; Terajima, J.; Iyoda, S.; Mitobe, J.; Ohnishi, M.; Taniguchi, K.; Tada, Y.; Okabe, N.] Natl Inst Infect Dis, Tokyo, Japan; [Ishida, Y.] Toyama City Hosp, Toyama, Japan; [Watahiki, M.; Isobe, J.; Sata, T.] Toyama Inst Hlth, Toyama, Japan	Yahata, Y (reprint author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	yahata@nih.go.jp			Ministry of Health, Labour and Welfare of Japan [H23-TOKUBETU-SHITEI-004]	This work was supported by a Health Labour Sciences Research Grant for Special Research from the Ministry of Health, Labour and Welfare (grant number: H23-TOKUBETU-SHITEI-004) of Japan.	Chang HGH, 2004, EMERG INFECT DIS, V10, P928; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Takanashi J, 2014, NEUROLOGY, V82, P564, DOI 10.1212/WNL.0000000000000120; Watahiki M, 2014, J CLIN MICROBIOL, V52, P2757, DOI 10.1128/JCM.00420-14; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Beutin L, 2007, J CLIN MICROBIOL, V45, P333, DOI 10.1128/JCM.01627-06; Nakano T, 1998, PEDIATR INFECT DIS J, V17, P534, DOI 10.1097/00006454-199806000-00026; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Rangel JM, 2005, EMERG INFECT DIS, V11, P603; Jay MT, 2004, CLIN INFECT DIS, V39, P1, DOI 10.1086/421088; Parry SM, 1998, LANCET, V351, P1019, DOI 10.1016/S0140-6736(97)08376-1; Piercefield EW, 2010, ARCH INTERN MED, V170, P1656, DOI 10.1001/archinternmed.2010.346; Sodha SV, 2011, EPIDEMIOL INFECT, V139, P309, DOI 10.1017/S0950268810000920; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Tserenpuntsag B, 2005, EMERG INFECT DIS, V11, P1955; Nathanson S, 2010, CLIN J AM SOC NEPHRO, V5, P1218, DOI 10.2215/CJN.08921209; Bradley KK, 2012, EPIDEMIOL INFECT, V140, P1644, DOI 10.1017/S0950268811002329; Terajima J, 2002, JPN J INFECT DIS, V55, P19; BRANDT JR, 1994, J PEDIATR-US, V125, P519, DOI 10.1016/S0022-3476(94)70002-8; Centers for Disease Control and Prevention (CDC), 1996, MMWR-MORBID MORTAL W, V45, P249; Gould LH, 2000, CLIN INFECT DIS, V49, P1480, DOI DOI 10.1086/644621; Isobe J, 2014, J CLIN MICROBIOL, V52, P1112, DOI 10.1128/JCM.03469-13; National Institute of Infectious Diseases, 2010, IASR, V31, P151; National Institute of Infectious Diseases, 2007, INFECT AGENTS SURVEI, V28, P131; National Institute of Infectious Diseases, 2008, INFECT AGENTS SURVEI, V29, P117; National Institute of Infectious Diseases, 2009, INFECT AGENTS SURVEI, V30, P119; National Institute of Infectious Diseases, 2011, INFECT AGENTS SURVEI, V32, P125; National Institute of Infectious Diseases, 2013, IASR, V34, P123; Office of Public Health Science Office of Policy and Program Development Food Safety and Inspection Service United States Department of Agriculture, RISK PROF PATH NONO1; PAVIA AT, 1990, J PEDIATR-US, V116, P544, DOI 10.1016/S0022-3476(05)81600-2; Robert Koch-Institute, OUTBR CAS DEF EHEC H; Saitou T, 2012, IASR, V33, P128; Shefer AM, 1996, WESTERN J MED, V165, P15; Wendel A. M., 2006, CLIN INFECT DIS, V48, P1079, DOI [10.1086/597399, DOI 10.1086/597399]	34	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	OCT	2015	143	13					2721	2732		10.1017/S0950268814003641		12	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CT6XA	WOS:000362955200004		
J	Hoa, LNM; Bryant, JE; Choisy, M; Nguyet, LA; Bao, NT; Trang, NH; Chuc, NTK; Toan, TK; Saito, T; Takemae, N; Horby, P; Wertheim, H; Fox, A				Hoa, L. N. M.; Bryant, J. E.; Choisy, M.; Nguyet, L. A.; Bao, N. T.; Trang, N. H.; Chuc, N. T. K.; Toan, T. K.; Saito, T.; Takemae, N.; Horby, P.; Wertheim, H.; Fox, A.			Population susceptibility to a variant swine-origin influenza virus A(H3N2) in Vietnam, 2011-2012	EPIDEMIOLOGY AND INFECTION			English	Article						Influenza A; virology (human) and epidemiology; zoonoses	A VIRUS; EVOLUTION; VACCINE; H3N2V	A reassortant swine-origin A(H3N2) virus (A/swine/BinhDuong/03-9/2010) was detected through swine surveillance programmes in southern Vietnam in 2010. This virus contains haemagglutinin and neuraminidase genes from a human A(H3N2) virus circulating around 2004-2006, and the internal genes from triple-reassortant swine influenza A viruses (IAVs). To assess population susceptibility to this virus we measured haemagglutination inhibiting (HI) titres to A/swine/BinhDuong/03-9/2010 and to seasonal A/Perth/16/2009 for 947 sera collected from urban and rural Vietnamese people during 2011-2012. Seroprevalence (HI >= 40) was high and similar for both viruses, with 62.6% [95% confidence interval (CI) 59.4-65.7] against A/Perth/16/2009 and 54.6% (95% CI 51.4-57.8%) against A/swine/BinhDuong/03-9/2010, and no significant differences between urban and rural participants. Children aged <5 years lacked antibodies to the swine origin H3 virus despite high seroprevalence for A/Perth/16/2009. These results reveal vulnerability to infection to this contemporary swine IAV in children aged <5 years; however, cross-reactive immunity in adults would likely limit epidemic emergence potential.	[Hoa, L. N. M.; Bryant, J. E.; Choisy, M.; Nguyet, L. A.; Bao, N. T.; Trang, N. H.; Horby, P.; Wertheim, H.; Fox, A.] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Hoa, L. N. M.; Bryant, J. E.; Choisy, M.; Nguyet, L. A.; Bao, N. T.; Trang, N. H.; Horby, P.; Wertheim, H.; Fox, A.] Univ Oxford, Wellcome Trust Major Overseas Programme, Hanoi, Vietnam; [Bryant, J. E.; Horby, P.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Choisy, M.] Univ Montpellier I, MIVEGEC, UMR, Montpellier, France; [Choisy, M.] Univ Montpellier 2, CNRS 5290, IRD 224, Montpellier, France; [Chuc, N. T. K.; Toan, T. K.] Hanoi Med Univ, Hanoi, Vietnam; [Saito, T.; Takemae, N.] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Ibaraki, Japan; [Fox, A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Bryant, JE (reprint author), Univ Oxford, Clin Res Unit Vietnam, Natl Hosp Trop Dis, 78 Giai Phong St, Hanoi, Vietnam.	jbryant@oucru.org			'Biodiversity and Infectious Diseases in Southeast Asia' GDRI; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Wellcome Trust of Great Britain VIZIONS project [WT/093724]	M.C. is supported by the 'Biodiversity and Infectious Diseases in Southeast Asia' GDRI. T.S. and N.T. are supported by a programme of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The authors thank Dr Sabrina L. Swenson, National Veterinary Services Laboratories, Ames, IA, USA, for providing A/swine/Indiana/A00968373/2012 (H3N2v). Funding was obtained from the Wellcome Trust of Great Britain VIZIONS project (WT/093724).	Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Harder TC, 2013, J VIROL, V87, P10460, DOI 10.1128/JVI.00381-13; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Houser KV, 2013, J VIROL, V87, P1261, DOI 10.1128/JVI.02625-12; Dao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091999; Fonville JM, SCIENCE IN PRESS; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Ngo LT, 2011, INFLUENZA OTHER RESP, V2, P1	10	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	OCT	2015	143	14					2959	2964		10.1017/S0950268815000187		6	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CT6XD	WOS:000362955500005		
J	Kagami, M; Kurosawa, K; Miyazaki, O; Ishino, F; Matsuoka, K; Ogata, T				Kagami, Masayo; Kurosawa, Kenji; Miyazaki, Osamu; Ishino, Fumitoshi; Matsuoka, Kentaro; Ogata, Tsutomu			Comprehensive clinical studies in 34 patients with molecularly defined UPD(14)pat and related conditions (Kagami-Ogata syndrome)	EUROPEAN JOURNAL OF HUMAN GENETICS			English	Article							PATERNAL UNIPARENTAL DISOMY; GENE-EXPRESSION; IMPRINTED GENE; NONCODING RNA; HYPOMETHYLATION; CHROMOSOME-14; ENDOCRINE; PHENOTYPE; COMPLEX; REGION	Paternal uniparental disomy 14 (UPD(14)pat) and epimutations and microdeletions affecting the maternally derived 14q32.2 imprinted region lead to a unique constellation of clinical features such as facial abnormalities, small bell-shaped thorax with a coat-hanger appearance of the ribs, abdominal wall defects, placentomegaly, and polyhydramnios. In this study, we performed comprehensive clinical studies in patients with UPD(14) pat (n=23), epimutations (n=5), and microdeletions (n=6), and revealed several notable findings. First, a unique facial appearance with full cheeks and a protruding philtrum and distinctive chest roentgenograms with increased coat-hanger angles to the ribs constituted the pathognomonic features from infancy through childhood. Second, birth size was well preserved, with a median birth length of +/- 0 SD (range, -1.7 to +3.0 SD) and a median birth weight of +2.3 SD (range, +0.1 to +8.8 SD). Third, developmental delay and/or intellectual disability was invariably present, with a median developmental/intellectual quotient of 55 (range, 29-70). Fourth, hepatoblastoma was identified in three infantile patients (8.8%), and histological examination in two patients showed a poorly differentiated embryonal hepatoblastoma with focal macrotrabecular lesions and well-differentiated hepatoblastoma, respectively. These findings suggest the necessity of an adequate support for developmental delay and periodical screening for hepatoblastoma in the affected patients, and some phenotypic overlap between UPD(14)pat and related conditions and Beckwith-Wiedemann syndrome. On the basis of our previous and present studies that have made a significant contribution to the clarification of underlying (epi)genetic factors and the definition of clinical findings, we propose the name 'Kagami-Ogata syndrome' for UPD(14)pat and related conditions.	[Kagami, Masayo; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; [Miyazaki, Osamu] Natl Ctr Child Hlth & Dev, Dept Radiol, Tokyo, Japan; [Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Tokyo, Japan; [Matsuoka, Kentaro] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	Ogata, T (reprint author), Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan.	tomogata@hama-med.ac.jp			Japan Society for the Promotion of Science (JSPS) [25253023, 23390083]; Grants for Health Research on Children, Youth, and Families [H25-001]; Ministry of Health, Labor and Welfare (MHLW) [H22-161]; National Center for Child Health and Development [23A-1, 25-10]; Takeda Science Foundation	We are grateful to all patients and their parents for their cooperation. We thank Drs Haruhiko Sago, Aiko Sasaki, Jun Shibasaki, Rika Kosaki, Michiko Hayashidani, Toshio Takeuchi, Shinya Tanaka, Mika Noguchi, Goro Sasaki, Kouji Matsumoto, Takeshi Utsunomiya, Yumiko Komatsu, Hirofumi Ohashi, Hiroshi Kishimoto, Maureen J O'Sullivan, Andrew J Green, Yoshiyuki Watabe, Tsuyako Iwai, Hitoshi Kawato, Akiko Yamamoto, Nobuhiro Suzumori, Hiroko Ueda, Makoto Kuwajima, Kiyoko Samejima, Hiroshi Yoshihashi, Yoriko Watanabe, Jin Nishimura, Shuku Ishikawa, Michiko Yamanaka, Machiko Nakagawa, Hiroharu Inoue, Takashi Imamura, Keiichi Motoyama and Ryoko Yoshinare for providing us with detailed clinical data and materials for molecular studies, Dr Gen Nishimura for interpretation of roentgengraphic findings, and Drs Tadayuki Ayabe, Keiko Matsubara, Yoichi Sekita and Maki Fukami for their support in molecular analyses. We also thank Ms. Emma Barber for her editorial assistance with the final draft of this paper. This work was supported by: Grants-in-Aid for Scientific Research (A) (25253023) and Research (B) (23390083) from the Japan Society for the Promotion of Science (JSPS), and by Grants for Health Research on Children, Youth, and Families (H25-001) and for Research on Intractable Diseases (H22-161) from the Ministry of Health, Labor and Welfare (MHLW), by Grants from the National Center for Child Health and Development (23A-1, 25-10), and by a Grant from Takeda Science Foundation.	Miyazaki O, 2011, PEDIATR RADIOL, V41, P1013, DOI 10.1007/s00247-011-2132-1; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Ioannides Y, 2014, J MED GENET, V51, P495, DOI 10.1136/jmedgenet-2014-102396; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Hurst LD, 1997, TRENDS GENET, V13, P436, DOI 10.1016/S0168-9525(97)01273-0; Yamazawa K, 2008, J HUM GENET, V53, P950, DOI 10.1007/s10038-008-0329-4; WANG JCC, 1991, AM J HUM GENET, V48, P1069; Horii M, 2012, CONGENIT ANOM, V52, P219, DOI 10.1111/j.1741-4520.2012.00364.x; Parveen Z, 2007, ARCH PATHOL LAB MED, V131, P131; Kagami M, 2005, AM J MED GENET A, V138A, P127, DOI 10.1002/ajmg.a.30941; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Berend SA, 2000, AM J HUM GENET, V66, P1787, DOI 10.1086/302916; Kurosawa K, 2002, AM J MED GENET, V110, P268, DOI 10.1002/ajmg.10404; Kagami M, 2012, EPIGENETICS-US, V7, P1142, DOI 10.4161/epi.21937; Falix FA, 2012, PEDIATR BLOOD CANCER, V59, P743, DOI 10.1002/pbc.24024; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Hoffmann K, 2011, BEST PRACT RES CL EN, V25, P77, DOI 10.1016/j.beem.2010.09.004; Kang ER, 2011, EPIGENETICS-US, V6, P937, DOI 10.4161/epi.6.7.16067; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.04.043; Kagami M, 2012, EUR J HUM GENET, V20, P928, DOI 10.1038/ejhg.2012.26; Kagami M, 2008, PLACENTA, V29, P760, DOI 10.1016/j.placenta.2008.06.001; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Beall MH, 2007, PLACENTA, V28, P816, DOI 10.1016/j.placenta.2006.11.009; Williams DH, 2005, PRENATAL DIAG, V25, P879, DOI 10.1002/pd.1155; Azzi S, 2014, HUM MUTAT, V35, P1211, DOI 10.1002/humu.22623; Beygo J, 2015, EUR J HUM GENET, V23, P180, DOI 10.1038/ejhg.2014.72; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Hosoki K, 2009, J PEDIATR-US, V155, P900, DOI 10.1016/j.jpeds.2009.06.045; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Modena Alberto Bacchi, 2004, Acta Biomed, V75 Suppl 1, P11; Riordan JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003441	34	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1018-4813	1476-5438		EUR J HUM GENET	Eur. J. Hum. Genet.	OCT	2015	23	11					1488	1498		10.1038/ejhg.2015.13		11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CT6IH	WOS:000362916200012		
J	Chopin, N; Yanai, H; Iikawa, S; Pilet, G; Bouillon, JP; Medebielle, M				Chopin, Nicolas; Yanai, Hikaru; Iikawa, Shinya; Pilet, Guillaume; Bouillon, Jean-Philippe; Medebielle, Maurice			A Rapid Entry to Diverse gamma-Ylidenetetronate Derivatives through Regioselective Bromination of Tetronic Acid Derived gamma-Lactones and Metal-Catalyzed Postfunctionalization	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Halogenation; Cross-coupling; Cycloaddition; Lactones; Oxygen heterocycles	PULVINIC ACIDS; ANTIOXIDANT PROPERTIES; ORGANIC-SYNTHESIS; ENOL ETHERS; CYCLOADDITION; BIOSYNTHESIS; INHIBITORS; CHEMISTRY	The synthesis of a series of diverse methyl and benzyl gamma-ylidenetetronate derivatives was accomplished through the condensation of methyl and benzyl tetronates with (hetero)-aryl aldehydes in a new two- or three-step aldolisation/dehydration sequence. The bromination of methyl and benzyl gamma-ylidenetetronates occurred under mild conditions to provide the corresponding C-3-brominated gamma-unsaturated lactones. Di- and tribrominated gamma-lactones were prepared under slightly different conditions. Some brominated materials were employed in representative Stille, Suzuki-Miyaura, and Sonogashira cross-coupling reactions to yield functionalized methyl and benzyl gamma-ylidenetetronate derivatives. Compounds that resulted from the Sonogashira cross-coupling reactions were desilylated and converted into 1,2,3-triazole derivatives through a copper(I)-catalyzed 1,3-dipolar cycloaddition reaction with benzyl azide.	[Chopin, Nicolas; Iikawa, Shinya; Medebielle, Maurice] Univ Lyon 1, Inst Chim & Biochim Mol & Supramol ICBMS, UMR CNRS UCBL INSA Lyon 5246, F-69622 Villeurbanne, France; [Yanai, Hikaru] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Pilet, Guillaume] Univ Lyon 1, Lab Multimat & Interfaces LMI, UMR CNRS UCBL 5615, F-69622 Villeurbanne, France; [Bouillon, Jean-Philippe] Univ Rouen, UMR CNRS Univ Rouen INSA Rouen 6014, Chim Organ Bioorgan Reactivite & Anal COBRA, IRCOF, F-76821 Mont St Aignan, France	Bouillon, JP (reprint author), Univ Rouen, UMR CNRS Univ Rouen INSA Rouen 6014, Chim Organ Bioorgan Reactivite & Anal COBRA, IRCOF, F-76821 Mont St Aignan, France.	yanai@toyaku.ac.jp; guillaume.pilet@univ-lyon1.fr; jean-philippe.bouillon@univ-rouen.fr; maurice.medebielle@univ-lyon1.fr			Agence Nationale de la Recherche (ANR) [ANR-11-EMMA-04-QUINOLAC]; Ministere de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique (CNRS); Universite Claude Bernard Lyon 1 (UCBL); PICS exchange program of CNRS [05871]	This work was supported by the Agence Nationale de la Recherche (ANR) (ANR-11-EMMA-04-QUINOLAC) and the Ministere de l'Enseignement Superieur et de la Recherche (Ph. D. fellowship to S. I.). Additional support was provided by the Centre National de la Recherche Scientifique (CNRS) and the Universite Claude Bernard Lyon 1 (UCBL). H. Y. and M. M. are grateful to the PICS exchange program of CNRS (grant number 05871) for fostering our international collaboration. The authors also thank Julien Bosson and Clement de Saint Jores for some materials syntheses and Florian Albrieux, Christian Duchet, Nathalie Enriques, and Reynald Helye from the Centre Commun de Spectrometrie de Masse (CCSM) of Universite Claude Bernard Lyon 1 for assistance and access to the mass spectrometry facility.	Nadal B, 2011, TETRAHEDRON, V67, P2605, DOI 10.1016/j.tet.2011.02.011; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Uenishi J, 1997, J ORG CHEM, V62, P1691, DOI 10.1021/jo961993f; Weixler R, 2011, J ORG CHEM, V76, P5924, DOI 10.1021/jo201066d; Habrant D, 2009, J MED CHEM, V52, P2454, DOI 10.1021/jm801500h; Rouleau J, 2013, TETRAHEDRON, V69, P10842, DOI 10.1016/j.tet.2013.10.087; ROYLES BJL, 1995, CHEM REV, V95, P1981, DOI 10.1021/cr00038a009; POSS AJ, 1989, TETRAHEDRON LETT, V30, P2505, DOI 10.1016/S0040-4039(01)80436-6; [Anonymous], 2009, CRYSALISPRO V 1 171; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Hou JL, 2012, EXPERT OPIN DRUG DIS, V7, P489, DOI 10.1517/17460441.2012.682725; Chinchilla R, 2007, CHEM REV, V107, P874, DOI 10.1021/cr050992x; Bidon-Chanal A, 2013, EUR J MED CHEM, V60, P479, DOI 10.1016/j.ejmech.2012.12.014; Dubois S, 2012, ORG BIOMOL CHEM, V10, P4712, DOI 10.1039/c2ob25299f; Kotha S, 2002, TETRAHEDRON, V58, P9633, DOI 10.1016/S0040-4020(02)01188-2; Mansour TS, 2007, CHEMMEDCHEM, V2, P1414, DOI 10.1002/cmdc.200700094; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Selig R, 2011, TETRAHEDRON, V67, P9204, DOI 10.1016/j.tet.2011.09.053; Bourdreux Y, 2008, TETRAHEDRON, V64, P8930, DOI 10.1016/j.tet.2008.06.058; Antane S, 2006, BIOORG MED CHEM LETT, V16, P176, DOI 10.1016/j.bmcl.2005.09.021; Iikawa S, 2013, TETRAHEDRON LETT, V54, P4577, DOI 10.1016/j.tetlet.2013.06.106; Katakawa K, 2014, HETEROCYCLES, V88, P817, DOI 10.3987/COM-13-S(S)66; Albrecht D, 2008, J ORG CHEM, V73, P2345, DOI 10.1021/jo7027129; Kende AS, 2002, TETRAHEDRON, V58, P61, DOI 10.1016/S0040-4020(01)01138-3; Nadal B, 2010, BIOORGAN MED CHEM, V18, P7931, DOI 10.1016/j.bmc.2010.09.037; Schobert R, 2008, BIOORGAN MED CHEM, V16, P4203, DOI 10.1016/j.bmc.2008.02.069; Nadal B, 2009, TETRAHEDRON LETT, V50, P2430, DOI 10.1016/j.tetlet.2009.03.011; Chinchilla R, 2011, CHEM SOC REV, V40, P5084, DOI 10.1039/c1cs15071e; Gao HQ, 2013, BIOORG MED CHEM LETT, V23, P1776, DOI 10.1016/j.bmcl.2013.01.051; REHSE K, 1985, ARCH PHARM, V318, P11, DOI 10.1002/ardp.19853180104; Boschi A, 2000, J ORG CHEM, V65, P8470, DOI 10.1021/jo000799x; Boquet D., 2005, CHEMBIOCHEM, V6, P1234; CAMPBELL AC, 1985, J CHEM SOC PERK T 1, P1567, DOI 10.1039/p19850001567; Cascarano G., 1996, ACTA CRYSTALLOGR A, VA52, pC79; DEMEULEN.J, 1965, ACTA CRYSTALLOGR, V19, P1014, DOI 10.1107/S0365110X65004802; Fleck M., 2010, CHEM-EUR J, V167, P6015; Georgiadis D., 2013, NATURAL LACTONES LAC, P1; Zografos AL, 2006, SYNTHESIS-STUTTGART, P3157, DOI 10.1055/s-2006-950202; Ghobril C, 2011, EUR J ORG CHEM, P3416, DOI 10.1002/ejoc.201100491; Giordano C., 1992, J ORG CHEM, V57, P2766; Lacoske MH, 2015, J NAT PROD, V78, P562, DOI 10.1021/np500757w; PELTER A, 1987, J CHEM SOC PERK T 1, P717, DOI 10.1039/p19870000717; Rostovsev V. V., 2002, ANGEW CHEM, V114, P2708, DOI DOI 10.1002/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0; Ruasse M.-F., 1993, ADV PHYS ORG CHEM, V28, P2072; SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467; Stachel H.-D., 1994, LIEBIGS ANN CHEM, V9, P961; Vieweg L, 2014, NAT PROD REP, V31, P1554, DOI 10.1039/c4np00015c; Watkin D. J., 1999, CRYSTALS ISSUE 11; Weixler R, 2014, SYNTHESIS-STUTTGART, V46, P2663, DOI 10.1055/s-0034-1378282; Yanai H., 2015, GREEN SYNTHETIC APPR, P257; Yang SH, 2009, SYNLETT, P1351, DOI 10.1055/s-0029-1216645; Yin X., 2010, DALTON T, V41, P9929	52	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	OCT	2015		28					6259	6269		10.1002/ejoc.201500663		11	Chemistry, Organic	Chemistry	CT4AK	WOS:000362747900016		
J	Ono, F; Hirata, O; Ichimaru, K; Saruhashi, K; Watanabe, H; Shinkai, S				Ono, Fumiyasu; Hirata, Osamu; Ichimaru, Keiko; Saruhashi, Koichiro; Watanabe, Hisayuki; Shinkai, Seiji			Mild One-Step Synthesis of 4,6-Benzylideneglycopyranosides from Aromatic Aldehydes and Gelation Abilities of the Glucose Derivatives	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Carbohydrates; Protecting groups; Self-assembly; Gels; Nanostructures	SUGAR-INTEGRATED GELATORS; GEL-PHASE MATERIALS; SUPRAMOLECULAR GELS; ORGANIC-SOLVENTS; OIL-SPILLS; ORGANOGELS; DIVERSITY; ACETALS; SCAFFOLDS; WATER	We report herein an efficient one-step synthesis of 4,6-benzylidene glycoside derivatives from aromatic aldehydes bearing electron-donating or -withdrawing groups as well as polymerisable monomer groups. Glucose, mannose and galactose derivatives could also be used successfully. Several of the glucose derivatives thus obtained acted as gelators for various solvents, including water. 4-(n-Butoxybenzylidene)glucose derivative 3a produced both a clear squalane gel and a hydrogel at 0.1 wt.-%. Furthermore, 3-(n-butoxybenzylidene)glucose derivative 3i produced a clear organogel and an opaque hydrogel. The critical gelation concentration (CGC) of 3i in squalane was determined to be 0.02 wt.-%, which is one of the lowest CGC values reported so far. The organogels, hydrogels and aqueous solution gels produced from 3a and 3d exhibited thixotropy. The strength and thixotropy of the organo- and hydrogel produced from 3a were estimated by a rheometer. The gel morphologies were observed by field-emission and wet-scanning electron microscopy, and the self-assembly modes were analysed by XRD. We have concluded that super-gelators can be created by this method.	[Ono, Fumiyasu; Ichimaru, Keiko; Watanabe, Hisayuki] Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Collaborat Res Div, Adv Mat Res Lab,Nishi Ku, Fukuoka, Fukuoka 8190388, Japan; [Hirata, Osamu; Saruhashi, Koichiro; Watanabe, Hisayuki] Nissan Chem Ind Co Ltd, Funabashi, Chiba 2748507, Japan; [Shinkai, Seiji] Inst Syst Informat Technol & Nanotechnol ISIT, Nishi Ku, Fukuoka, Fukuoka 8190388, Japan	Ono, F (reprint author), Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Collaborat Res Div, Adv Mat Res Lab,Nishi Ku, 4-1 Kyudai Shinmachi, Fukuoka, Fukuoka 8190388, Japan.				Nissan Chemical Industries, Ltd.	The authors thank Ms. Makiko Fukuda for support with the rheological measurements. The authors thank Dr. Midori Watanabe, Center of Advanced Instrumental Analysis, Kyushu University, for support with the wet-SEM observations. The authors thank Mr. Taisuke Matsumoto, Evaluation Center of Materials Properties and Function, Institute for Materials Chemistry and Engineering, Kyushu University, for assistance with the XRD measurements and Mr. Yoshiaki Otani, Analytical Center in the Fukuoka Industry-Academia Symphonicity facility, for support with the NMR measurements. This work was financially supported by Nissan Chemical Industries, Ltd.	Alberts B., 2008, MOL BIOL CELL, P1505; Amanokura N., 1998, J CHEM SOC PERK T, V2, P2585; Yu GC, 2013, CHEM SOC REV, V42, P6697, DOI 10.1039/c3cs60080g; Yoza K, 1999, CHEM-EUR J, V5, P2722, DOI 10.1002/(SICI)1521-3765(19990903)5:9<2722::AID-CHEM2722>3.0.CO;2-N; Binatti I, 2002, J BRAZIL CHEM SOC, V13, P570, DOI 10.1590/S0103-50532002000500005; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Smith DK, 2009, CHEM SOC REV, V38, P684, DOI 10.1039/b800409a; Abreu MF, 2012, CARBOHYD RES, V353, P69, DOI 10.1016/j.carres.2012.03.021; Cipolla L, 2003, J CARBOHYD CHEM, V22, P631, DOI 10.1081/CAR-120026464; BAKER CW, 1974, CARBOHYD RES, V33, P372, DOI 10.1016/S0008-6215(00)82818-9; Cardona F, 2014, EUR J ORG CHEM, V2014, P2549, DOI 10.1002/ejoc.201400028; [Anonymous], 2008, ANGEW CHEM, P120; Chen Q, 2010, LANGMUIR, V26, P3165, DOI 10.1021/la903102z; BROWN MA, 1995, J ORGANOMET CHEM, V498, P275, DOI 10.1016/0022-328X(95)05529-X; Geng Y, 2013, EUR J ORG CHEM, V2013, P7035, DOI 10.1002/ejoc.201301116; Hoshizawa H, 2013, LANGMUIR, V29, P14666, DOI 10.1021/la402333h; Shundo A, 2011, CHEM COMMUN, V47, P8844, DOI 10.1039/c1cc12733k; Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049; Prathap A, 2012, CHEM COMMUN, V48, P5250, DOI 10.1039/c2cc31631e; Chen CT, 2005, ORG LETT, V7, P3343, DOI 10.1021/ol051178z; KIM S, 1989, TETRAHEDRON LETT, V30, P6279, DOI 10.1016/S0040-4039(01)93872-9; Gronwald O, 2001, CARBOHYD RES, V331, P307, DOI 10.1016/S0008-6215(01)00035-0; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; Gronwald O, 2002, CURR OPIN COLLOID IN, V7, P148, DOI 10.1016/S1359-0294(02)00016-X; Lobbel M, 2000, TETRAHEDRON-ASYMMETR, V11, P393, DOI 10.1016/S0957-4166(99)00504-2; Raeburn J, 2013, CHEM SOC REV, V42, P5143, DOI 10.1039/c3cs60030k; Gronwald O, 2001, CHEM-EUR J, V7, P4328, DOI 10.1002/1521-3765(20011015)7:20<4328::AID-CHEM4328>3.0.CO;2-S; Piepenbrock MOM, 2010, CHEM REV, V110, P1960, DOI 10.1021/cr9003067; BLOW DM, 1960, J AM CHEM SOC, V82, P3566, DOI 10.1021/ja01499a023; Lee SH, 2002, TETRAHEDRON LETT, V43, P2699, DOI 10.1016/S0040-4039(02)00387-8; Matsumoto K, 2015, PHYS CHEM CHEM PHYS, V17, P2192, DOI 10.1039/c4cp04395b; Tanaka A, 2015, J AM CHEM SOC, V137, P770, DOI 10.1021/ja510156v; Bourdreux Y, 2011, CHEM COMMUN, V47, P2146, DOI 10.1039/c0cc04398b; Brinksma J, 2000, LANGMUIR, V16, P9249, DOI 10.1021/la000839s; Buerkle LE, 2012, CHEM SOC REV, V41, P6089, DOI 10.1039/c2cs35106d; Ono F, 2014, RSC ADV, V4, P25940, DOI 10.1039/c4ra03096f; COLLINS PM, 1974, CARBOHYD RES, V33, P35, DOI 10.1016/S0008-6215(00)82938-9; Probert MA, 1997, TETRAHEDRON LETT, V38, P5861, DOI 10.1016/S0040-4039(97)01304-X; HODOSI G, 1994, TETRAHEDRON LETT, V35, P6129, DOI 10.1016/0040-4039(94)88095-6; Tanaka N, 2008, CARBOHYD RES, V343, P2675, DOI 10.1016/j.carres.2008.07.017; Mangan D, 2014, CARBOHYD RES, V395, P47, DOI 10.1016/j.carres.2014.05.002; Huang X, 2006, J AM CHEM SOC, V128, P15341, DOI 10.1021/ja0657206; Hou XY, 2011, LANGMUIR, V27, P12156, DOI 10.1021/la2022819; Sangeetha NM, 2005, CHEM SOC REV, V34, P821, DOI 10.1039/b417081b; CHITTENDEN GJF, 1988, RECL TRAV CHIM PAY B, V107, P607; EVANS ME, 1972, CARBOHYD RES, V21, P473, DOI 10.1016/S0008-6215(00)84931-9; Shirosaki T, 2006, J MATER RES, V21, P1274, DOI 10.1557/JMR.2006.0156; Luboradzki R, 2000, TETRAHEDRON, V56, P9595, DOI 10.1016/S0040-4020(00)00915-7; MILLER VP, 1989, J ORG CHEM, V54, P4175, DOI 10.1021/jo00278a035; Capozzi G, 2001, J ORG CHEM, V66, P8787, DOI 10.1021/jo010522c; Jadhav SR, 2010, ANGEW CHEM INT EDIT, V49, P7695, DOI 10.1002/anie.201002095; Dawn A, 2011, CHEM-ASIAN J, V6, P266, DOI 10.1002/asia.201000217; Liptak A, 2000, TETRAHEDRON LETT, V41, P4949, DOI 10.1016/S0040-4039(00)00735-8; Ajayaghosh A, 2008, CHEM SOC REV, V37, P109, DOI 10.1039/b704456a; Giri SK, 2008, J CARBOHYD CHEM, V27, P464, DOI 10.1080/07328300802458970; Cox D. J., 2014, EUR J ORG CHEM, V79, P4624; Gronwald O., 2001, J CHEM SOC P2, V10, P1933; Gronwald O, 2001, J CHEM SOC PERK T 2, P1933, DOI 10.1039/b104366h; Lescanne M, 2004, LANGMUIR, V20, P3032, DOI 10.1021/la035219g; Lindhorst T. K., 2007, ESSENTIAL CORBOHYDRA, P241; Luboradzki R, 2000, CHEM LETT, P1148, DOI 10.1246/cl.2000.1148; Munenobu K, 2014, ANAL CHEM, V86, P9924, DOI 10.1021/ac5026539; Neugebauer D, 2013, J POLYM SCI POL CHEM, V51, P2483, DOI 10.1002/pola.26642; Paquette LA, 2002, SYNTHESIS-STUTTGART, P2105; Richtmyer N. K., 1962, METHODS CARBOHYD CHE, V1, P107; Shirakawa M, 2005, J AM CHEM SOC, V127, P4164, DOI 10.1021/ja042869d; Yoza K, 1998, CHEM COMMUN, P907, DOI 10.1039/a800825f	67	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	OCT	2015		29					6439	6447		10.1002/ejoc.201500658		9	Chemistry, Organic	Chemistry	CT4AV	WOS:000362749100007		
J	Cacho, A; Ono, T; Kuboki, T; Martin, C				Cacho, Alberto; Ono, Tsuyoshi; Kuboki, Takuo; Martin, Conchita			Changes in joint space dimension after the correction of Class II division 1 malocclusion	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							CONDYLE-FOSSA RELATIONSHIP; FRANKEL APPLIANCE THERAPY; TEMPOROMANDIBULAR-JOINT; HERBST TREATMENT; ORTHODONTIC TREATMENT; ASYMPTOMATIC POPULATION; COMPUTED-TOMOGRAPHY; ACTIVATOR TREATMENT; MANDIBULAR CONDYLE; MIXED DENTITION	Objective: The aim of this prospective longitudinal investigation was to compare the relationship between the temporomandibular joint (TMJ) condyles and the temporal fossae by means of tomography before and after the orthodontic correction of Class II, division 1 malocclusion using the activator appliance. Materials and methods: The final sample consisted of 26 consecutively treated Class II, division 1 patients (19 boys and 7 girls with an average pre-treatment age of 11 years) who underwent orthodontic treatment by means of an activator appliance. Before treatment all patients were free of signs and symptoms associated to TMJ disorders. Bilateral tomographic records before and after treatment were taken and analyzed. Outlines of the condyle and temporal fossa were automatically determined by an edge-detection protocol, and the minimum joint space dimension was automatically measured every 2 degrees. For further analysis, the joint space was divided into anterior, superior, and posterior joint spaces. Results: The average treatment time with the activator appliance was 366 days. In all subjects, activator treatment resulted in a Class I dental arch relationship. After activator treatment, no differences were found in the joint space measurements in any direction. Comparisons between the right and left condyles were not significantly different. Conclusions: Joint space dimension in Class II division I children was similar before and after treatment in both TMJs.	[Cacho, Alberto; Martin, Conchita] Univ Complutense, Fac Odontol, Dept Prevent Dent Pedodont & Orthodont, E-28040 Madrid, Spain; [Ono, Tsuyoshi; Kuboki, Takuo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Rehabil, Okayama 7008530, Japan	Martin, C (reprint author), Univ Complutense, Fac Odontol, Pl Ramon & Cajal S-N, E-28040 Madrid, Spain.	conchitamartin@odon.ucm.es	Martin, Conchita/G-3599-2015	Martin, Conchita/0000-0003-3997-6900			Katsavrias EG, 2004, ANGLE ORTHOD, V74, P79; Kuboki T, 1999, J OROFAC PAIN, V13, P38; Arat ZM, 2001, AM J ORTHOD DENTOFAC, V119, P316, DOI 10.1067/mod.2001.110245; Ruf S, 2000, ANGLE ORTHOD, V70, P183; KUNDINGER KK, 1991, AM J ORTHOD DENTOFAC, V100, P110, DOI 10.1016/S0889-5406(05)81517-3; Hansson LG, 1996, ORAL SURG ORAL MED O, V82, P698, DOI 10.1016/S1079-2104(96)80446-X; Pancherz H, 1999, AM J ORTHOD DENTOFAC, V116, P207, DOI 10.1016/S0889-5406(99)70219-2; PULLINGER A, 1986, ORAL SURG ORAL MED O, V62, P719, DOI 10.1016/0030-4220(86)90270-7; Voudouris JC, 2003, AM J ORTHOD DENTOFAC, V124, P13, DOI 10.1016/S0889-5406(03)00150-1; Ruf S, 1998, EUR J ORTHODONT, V20, P375, DOI 10.1093/ejo/20.4.375; Wadhawan N, 2008, ORTHOD CRANIOFAC RES, V11, P235, DOI 10.1111/j.1601-6343.2008.00436.x; Cohlmia JT, 1996, ANGLE ORTHOD, V66, P27; PULLINGER AG, 1985, J PROSTHET DENT, V53, P706, DOI 10.1016/0022-3913(85)90029-0; HAMILTON SD, 1987, AM J ORTHOD DENTOFAC, V92, P427, DOI 10.1016/0889-5406(87)90264-2; Croft RS, 1999, AM J ORTHOD DENTOFAC, V116, P435, DOI 10.1016/S0889-5406(99)70230-1; Pancherz H, 2004, AM J ORTHOD DENTOFAC, V126, P153, DOI 10.1016/j.ajodo.2003.07.015; Kinzinger GSM, 2006, DENTOMAXILLOFAC RAD, V35, P339, DOI 10.1259/dmfr/53048233; Kamelchuk LS, 1996, CRANIO, V14, P23; VARGERVIK K, 1985, AM J ORTHOD DENTOFAC, V88, P242, DOI 10.1016/S0002-9416(85)90219-2; Kinzinger G, 2007, J OROFAC ORTHOP, V68, P124, DOI 10.1007/s00056-007-0650-0; Vitral RWF, 2004, AM J ORTHOD DENTOFAC, V126, P48, DOI 10.1016/j.ajodo.2003.06.012; Ruf S, 1999, AM J ORTHOD DENTOFAC, V115, P607, DOI 10.1016/S0889-5406(99)70285-4; Ikeda K, 2009, AM J ORTHOD DENTOFAC, V135, P495, DOI 10.1016/j.ajodo.2007.05.021; PAULSEN HU, 1995, EUR J ORTHODONT, V17, P165; GIANELLY AA, 1983, ANGLE ORTHOD, V53, P131; Ruf S, 2002, ANGLE ORTHOD, V72, P527; Katsavrias EG, 2003, ANGLE ORTHOD, V73, P647; Chintakanon K, 2000, AM J ORTHOD DENTOFAC, V118, P494, DOI 10.1067/mod.2000.109839; ARTUN J, 1992, AM J ORTHOD DENTOFAC, V101, P48; PULLINGER AG, 1987, AM J ORTHOD DENTOFAC, V91, P200, DOI 10.1016/0889-5406(87)90447-1; GIANELLY AA, 1989, AM J ORTHOD DENTOFAC, V96, P428, DOI 10.1016/0889-5406(89)90328-4; MCNAMARA JA, 1982, AM J ORTHOD DENTOFAC, V82, P288, DOI 10.1016/0002-9416(82)90463-8; CREEKMORE TD, 1983, AM J ORTHOD DENTOFAC, V83, P89, DOI 10.1016/S0002-9416(83)90294-4; WOODSIDE DG, 1983, AM J ORTHOD DENTOFAC, V83, P460, DOI 10.1016/S0002-9416(83)90244-0; BACON W, 1992, European Journal of Orthodontics, V14, P224; LOGSDON LC, 1975, J DENT RES, V54, P184; Dalili Zahra, 2012, Dent Res J (Isfahan), V9, P607; Kuboki Takuo, 1997, Journal of Orofacial Pain, V11, P67; McNamara J, 2003, SEMIN ORTHOD, V9, P12, DOI 10.1053/sodo.2003.34021; McNamara J. A., 2003, SEMIN ORTHOD, V9, P26, DOI 10.1053/sodo.2003.34022; PANCHERZ H, 1985, AM J ORTHOD DENTOFAC, V88, P273, DOI 10.1016/0002-9416(85)90126-5; PANCHERZ H, 1979, AM J ORTHOD DENTOFAC, V76, P423, DOI 10.1016/0002-9416(79)90227-6; PANCHERZ H, 1982, AM J ORTHOD DENTOFAC, V82, P104, DOI 10.1016/0002-9416(82)90489-4; Prabhat K. C., 2012, ISRN DENT, V2012; Ronquillo H I, 1988, J Craniomandib Disord, V2, P137; Sarai T, 1994, T JAPAN SOC MECH ENG, V60, P285; WIESLANDER L, 1984, AM J ORTHOD DENTOFAC, V86, P1, DOI 10.1016/0002-9416(84)90271-9; Decrue A, 1990, Zahnarztl Prax, V41, P360	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	OCT	2015	37	5					467	473		10.1093/ejo/cju091		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7BD	WOS:000362967200004		
J	Cordova, L; Furuichi, N; Lederer, T				Cordova, L.; Furuichi, N.; Lederer, T.			Qualification of an ultrasonic flow meter as a transfer standard for measurements at Reynolds numbers up to 4 x 10(6) between NMIJ and PTB	FLOW MEASUREMENT AND INSTRUMENTATION			English	Article						Inter laboratory comparison; Ultrasonic flow meter; Reynolds number dependence; Flow traceability; Transducer cavity	FLOWMETERS	The quality of any laboratory intercomparison depends to a large extent on the performance of the used flow meter. To find a flow meter that is capable of reaching a reproducibility better than 0.05% requires bounding all involved influence quantities down to the required level. The present paper describes the efforts performed while qualifying a time-of-flight ultrasonic flow meter as a transfer standard. It was determined that the most relevant influence quantity besides the flow profile within the bulk flow is the effect caused by the transducer pockets in the meter body. By taking advantage of a specially designed window chamber, it was possible to determine the magnitude of the errors introduced by the transducer pockets and to define, based on the findings, a procedure to perform a bilateral comparison between the hot water calibration facilities of the Physikalisch-Technische Bundesanstalt and the National Institute of Advanced Industrial Science and Technology. The results of the bilateral comparison are presented. (C) 2015 The Authors. Published by Elsevier Ltd.	[Cordova, L.; Lederer, T.] Phys Tech Bundesanstalt, Braunschweig, Germany; [Furuichi, N.] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan	Cordova, L (reprint author), Phys Tech Bundesanstalt, Braunschweig, Germany.	cordova.leopoldo@gmail.com					Alexandre Voser, 1999, THESIS ETH ZURICH; [Anonymous], 2011, 182011 PTC ASME; Zheng DD, 2011, FLOW MEAS INSTRUM, V22, P488, DOI 10.1016/j.flowmeasinst.2011.08.003; [Anonymous], 2003, 516722003 ISO; [Anonymous], 2012, 122422012 ISO; Tawackolian K, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/7/075304; [Anonymous], 1998, 9 AGA; YEH TT, 1994, FLOW MEAS INSTRUM, V5, P181, DOI 10.1016/0955-5986(94)90017-5; [Anonymous], 2009, 1434 EN; Brown GJ, 2013, P FLOMEKO 2013 PAR; Cousins T, 2004, N SEA FLOW MEAS WORK; Drenthen J, 2009, 7 INT S FLUID FLOW M; Furuichi N, 2009, FLOW MEAS INSTRUM, V20, P38, DOI 10.1016/j.flowmeasinst.2008.11.001; Furuichi N, 2014, P ASME 2014 POW C PO; Gersten K., 2005, FLUID MECH FLOW METE; Lunde P, 2000, GERG PROJECT ULTRASO; Mathies N., 2005, THESIS TU BERLIN; Mattingly GE, 1990, P 2 INT S FLUID FLOW, P271; Moore PI, 2000, MEAS SCI TECHNOL, V11, P1802, DOI 10.1088/0957-0233/11/12/321; Pannell CN, 1990, FLOW MEAS INSTRUM, V216, P224; Peter Lau, 1995, CALIBRATION INTERCOM, P77; Richard Paton, CCMFFK2; Shimada T, 2010, SYNTHESIOLOGY, V3; Takeda Y, 2012, ULTRASONIC DOPPLER V; Thorns J., 2010, THESIS TU BERLIN; Yeh TT, 1997, P ASME FEDSM 97	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-5986	1873-6998		FLOW MEAS INSTRUM	Flow Meas. Instrum.	OCT	2015	45						28	42		10.1016/j.flowmeasinst.2015.04.006		15	Engineering, Mechanical; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CT2AR	WOS:000362604900004		
J	Othman, NTA; Obara, H; Sapkota, A; Takei, M				Othman, Nur Tantiyani Ali; Obara, Hiromichi; Sapkota, Achyut; Takei, Masahiro			Measurement of particle migration in micro-channel by multi-capacitance sensing method	FLOW MEASUREMENT AND INSTRUMENTATION			English	Article						Particle concentration; Micro-channel; Multi-layered sensor electrodes; Multi-capacitance sensing; Particle migration; Streamwise migration ratio; Cross-sectional migration ratio	PRESSURE-DRIVEN FLOW; BROWNIAN SUSPENSION	Study of particle migration is important to enhance and increase the efficiency of the positioning and sorting process in order to produce the high yield of desired product especially in microfluidic applications. In this study, in order to study particle migration, normalized particle concentration in a micro-channel has been calculated for high initial particle concentrations (xi=3.0, 5.0 and 10.0%) and the small particle diameters (d(p)=1.3, 1.5 and 2.1 mu m) by using capacitance data measured by a multi-capacitance sensing method. From the calculations, it has been observed that the particle concentration at the wall vicinity area is increased as xi and d(p) are increased while the particle concentration at the center area is decreased. To analyze the tendency of the particle migration, two quantitative indicators are introduced, viz., streamwise migration ratio (psi) which is the ratio of particle concentration at the downstream to the upstream cross-section position, and the cross-sectional migration ratio (phi) which is the ratio of the particle concentration at the wall to the center area at the same cross-sectional position. The result shows that the psi at the center area is decreased as the particles move along the channel irrespective of xi and d(p) while the psi at the wall vicinity area is increased. Based on psi and phi, it has been observed that the particle migrate from the center area towards the wall vicinity area in the case of low xi and small d(p) while the particles tend to concentrate on the center area in the case of high xi and the large d(p). As a result, the particle concentration at center is higher in the case of the lower xi and the smaller d(p) than that in the case of higher xi and the larger d(p). (C) 2015 Elsevier Ltd. All rights reserved.	[Othman, Nur Tantiyani Ali] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Ukm Bangi 46300, Selangor, Malaysia; [Obara, Hiromichi] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Mech Engn, Hachioji 1920397, Japan; [Sapkota, Achyut; Takei, Masahiro] Chiba Univ, Grad Sch Mech Engn, Div Artificial Syst Sci, Inage Ku, Chiba 2638522, Japan	Othman, NTA (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Ukm Bangi 46300, Selangor, Malaysia.	tantiyani@ukm.edu.my			Japan Science and Technology Agency [AS2311054B]	This study is supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-Step) of Japan Science and Technology Agency (#AS2311054B). Also, the authors express sincere thanks to Mr. M. Ichishima and Mr. H. Goto of Covalent Materials Corporation in Japan for the fabricating microchannel.	Othman NTA, 2013, FLOW MEAS INSTRUM, V31, P47, DOI 10.1016/j.flowmeasinst.2012.12.003; Liang LT, 2010, J COLLOID INTERF SCI, V347, P142, DOI 10.1016/j.jcis.2010.03.039; Semwogerere D, 2007, J FLUID MECH, V581, P437, DOI 10.1017/S0022112007006088; Butler JE, 1999, PHYS FLUIDS, V11, P2865, DOI 10.1063/1.870145; Chun B, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2176587; Matas JP, 2009, J FLUID MECH, V621, P59, DOI 10.1017/S0022112008004977; Oakey J, 2010, ANAL CHEM, V82, P3862, DOI 10.1021/ac100387b; Pasquino R, 2010, RHEOL ACTA, V49, P993, DOI 10.1007/s00397-010-0466-5; LOUGE M, 1990, POWDER TECHNOL, V62, P85, DOI 10.1016/0032-5910(90)80026-U; Yang WQ, 1996, MEAS SCI TECHNOL, V7, P1073, DOI 10.1088/0957-0233/7/7/012; Zheng X, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3237159; Allende M, 2000, J RHEOL, V44, P79, DOI 10.1122/1.551074; Frank M, 2003, J FLUID MECH, V493, P363, DOI 10.1017/S0022112003006001; Hampton RE, 1997, J RHEOL, V41, P621, DOI 10.1122/1.550863; Asgar A, 2008, LAB CHIP, P1906; Asgar A.B.S., 2008, PHYS FLUIDS, V20; Carlo D.D., 2007, P NATL ACAD SCI USA, V104, P18892; Semwogerere D, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2907378; Yong-Seok Choi, 2011, Lab on a Chip, V11, DOI 10.1039/c01c00212g	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-5986	1873-6998		FLOW MEAS INSTRUM	Flow Meas. Instrum.	OCT	2015	45						162	169		10.1016/j.flowmeasinst.2015.06.015		8	Engineering, Mechanical; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CT2AR	WOS:000362604900019		
J	Honma, M				Honma, Masamitsu			Evaluation of the in vivo genotoxicity of Allura Red AC (Food Red No. 40)	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Allura Red AC (Food Red No. 40); Comet assay; Micronucleus test; Transgenic gene mutation assay; OECD guidelines	COMET ASSAY; CHEMICAL-STRUCTURE; MUTAGENICITY; SALMONELLA; CARCINOGENICITY; DYES; MICE	Allura Red AC (Food Red No. 40) is a red azo dye that is used for food coloring in beverage and confectionary products. However, its genotoxic properties remain controversial. To clarify the in vivo gentoxicity, we treated mice with Allura Red AC and investigated the induction of DNA damage (liver, glandular stomach), clastogenicity/anuegenicity (bone marrow), and mutagenicity (liver, glandular stomach) using Comet assays, micronucleus tests, and transgenic gene mutation assays, respectively. All studies were conducted in accordance with the Organization for Economic Co-operation and Development (OECD) guideline. Although Allura Red AC was administered up to the maximum doses recommended by the OECD guideline, no genotoxic effect was observed in any of the genotoxic endpoints. These data clearly show no evidence of in vivo genotoxic potential of Allura Red AC administered up to the maximum doses in mice. (C) 2015 Elsevier Ltd. All rights reserved.	Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan	Honma, M (reprint author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	honma@nihs.go.jp			Standard and Evaluation Division of the Ministry of Health, Labor and Welfare, Japan	The in vivo genotoxicity tests in this study were conducted by the Food and Drug Safety Center, Hadano Institute, Kanagawa, Japan (Comet assay), the Safety Research Institute for Chemical Compounds, Hokkaido, Japan (micronucleus test), and the BioSafety Research Center, Shizuoka, Japan (TGR assay) under the direction of the Division of Genetics and Mutagenesis, National Institute of Health Sciences, Japan. This study was supported by the Standard and Evaluation Division of the Ministry of Health, Labor and Welfare, Japan.	Abramsson-Zetterberg L, 2013, FOOD CHEM TOXICOL, V59, P86, DOI 10.1016/j.fct.2013.05.047; TENNANT RW, 1991, MUTAT RES, V257, P209, DOI 10.1016/0165-1110(91)90002-D; Speit G, 2015, MUTAT RES-GEN TOX EN, V783, P6, DOI 10.1016/j.mrgentox.2014.09.006; BROWN JP, 1978, MUTAT RES, V56, P249, DOI 10.1016/0027-5107(78)90192-6; JUNG R, 1992, FOOD CHEM TOXICOL, V30, P635, DOI 10.1016/0278-6915(92)90199-U; Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45; Tsuda S, 2001, TOXICOL SCI, V61, P92, DOI 10.1093/toxsci/61.1.92; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; ASHBY J, 1988, MUTAT RES, V204, P17, DOI 10.1016/0165-1218(88)90114-0; Sasaki YF, 2002, MUTAT RES-GEN TOX EN, V519, P103, DOI 10.1016/S1383-5718(02)00128-6; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Jakubczak JL, 1996, P NATL ACAD SCI USA, V93, P9073, DOI 10.1073/pnas.93.17.9073; Zeiger E, 2000, REGUL TOXICOL PHARM, V32, P219, DOI 10.1006/rtph.2000.1422; EFSA (European Food Safety Authority) ECDC (European Centre for Disease Prevention and Control) EMEA (European Medicines Agency), 2009, EFSA J, V7; Fujita H., 1995, Annual Report of Tokyo Metropolitan Research Laboratory of Public Health, V46, P258; JECFA, 1980, WHO FOOD ADDITIVES S, V15; Matsumoto M, 2014, MUTAT RES-GEN TOX EN, V775, P94, DOI 10.1016/j.mrgentox.2014.10.009; MUZZALL JM, 1979, MUTAT RES, V67, P1, DOI 10.1016/0165-1218(79)90093-4; Nakajima M., 2012, GENES ENV, V34, P50; OECD, 2013, TG488 OECD GUID TEST; OECD, 1997, TG474 OECD GUID TEST; OECD, 2014, TG489 OECD GUID TEST; SFC, 1984, REP SCI COMM FOOD OP; SFC, 1989, REP SCI COMM FOOD OP	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	OCT	2015	84						270	275		10.1016/j.fct.2015.09.007		6	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	CT5OR	WOS:000362860200027		
J	Ishiga, T; Kiso, F; Suetsugu, A; Utano, M; Yamashita, H; Ueki, Y; Yoshiie, R; Naruse, I				Ishiga, Takuya; Kiso, Fumihiko; Suetsugu, Akinori; Utano, Masakazu; Yamashita, Hiroshi; Ueki, Yasuaki; Yoshiie, Ryo; Naruse, Ichiro			Heating technique of slag-tapping hole in high-temperature coal gasifier	FUEL PROCESSING TECHNOLOGY			English	Article						IGCC; Coal gasification; Entrained bed; Ash fusing; Slag	ASH DEPOSITION	The integrated coal gasification combined cycle (IGCC) is expected to improve the thermal efficiency of coal-fired power generation more. In Japan, coal gasifiers will be required to handle various coals imported from many countries, just as existing pulverized coal-fired boilers do. In the coal gasifier, ash contained in coal is fused into liquid slag, and the fused slag flows through a slag-tapping hole separately from the syngas. The hole must be heated adequately to maintain the flow of the fused slag. In this study, a heating technique that works by supplying additional oxygen and nitrogen just below the slag-tapping hole was developed to handle coals with high ash fusing temperature. In gasification tests conducted in a 150 t/d coal gasifier, the fused slag was separated stably from coal at 1783 K which was the highest temperature handled without using flux or auxiliary fuel. This technique can expand the versatility of coal gasifiers as far as the coal types that can be used. (C) 2015 Elsevier B.V. All rights reserved.	[Ishiga, Takuya; Kiso, Fumihiko] Hitachi Ltd, Mat Res Ctr, Hitachi Res Lab, Hitachinaka, Ibaraki 3120034, Japan; [Suetsugu, Akinori] Mitsubishi Hitachi Power Syst Ltd, Boiler Prod Headquarters, Kure Shi, Hiroshima 7378508, Japan; [Utano, Masakazu; Yamashita, Hiroshi] Elect Power Dev Co Ltd, Wakamatsu Res Inst, Dept Res & Dev, Wakamatsu Ku, Kitakyushu, Fukuoka 8080111, Japan; [Ueki, Yasuaki; Naruse, Ichiro] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yoshiie, Ryo] Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ishiga, T (reprint author), Hitachi Ltd, Mat Res Ctr, Hitachi Res Lab, 832-2 Horiguchi, Hitachinaka, Ibaraki 3120034, Japan.	takuya.ishiga.wm@hitachi.com					Naruse I, 2010, J CHEM ENG JPN, V43, P872; [Anonymous], 2012, Japanese Patent Publication, Patent No. 5139714; Wang J, 2013, FUEL PROCESS TECHNOL, V106, P704, DOI 10.1016/j.fuproc.2012.10.005; Naruse I, 2005, FUEL, V84, P405, DOI 10.1016/j.fuel.2004.09.007; Koyama S, 1996, FUEL, V75, P459, DOI 10.1016/0016-2361(95)00266-9; Kiso F, 2011, ENERGY, V36, P4032, DOI 10.1016/j.energy.2011.04.047; Akiyama T, 2008, KAGAKU KOGAKU RONBUN, V34, P477, DOI 10.1252/kakoronbunshu.34.477; Hashimoto T., 2009, MITSUBISHI HEAVY IND, V46, P5; Ishiga T., 2009, P 47 S JAP COMB 2009, P376; Ito O., 2008, HITACHI REV, V57, P166; JCOAL, JAP COAL PROD SUPPL; Jcoal, GEN AN STAND COAL SA; Kaneko S., 2010, ENERGY RESOURCES, V31, P92; Mahagaokar U., 1990, 90JPGCFACT16 ASME, P1; Miyadera H., 1995, J JAPAN I ENERGY, V74, P691; Nagasaki N., 2010, HITACHI REV, V59, P77; Naruse I., 2013, CLEAN COMBUST SUST W, P771; R. Clean Coal Power D Co. Ltd, TERM NAK IGCC DEM TE; Tominaga H., 2006, J JPN I ENERGY, V85, P36; Tominaga H., 2000, IFRF COMBUST J; Wasaka S., P INT C POW ENG; Watanabe T., GAS TECHN C	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						100	108		10.1016/j.fuproc.2015.05.017		9	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200012		
J	Uemura, Y; Matsumoto, R; Saadon, S; Matsumura, Y				Uemura, Yoshimitsu; Matsumoto, Ryunosuke; Saadon, Shazleen; Matsumura, Yukihiko			A study on torrefaction of Laminaria japonica	FUEL PROCESSING TECHNOLOGY			English	Article						Torrefaction; Laminaria japonica; Mass yield; Energy yield; Elementary analysis; Ash	SYNTHETIC INDICATOR; BIOFUEL PRODUCTION; KERNEL SHELL; MASS-LOSS; BIOMASS; MACROALGAE; RESIDUES; IMPACT; WOOD; DECOMPOSITION	Torrefaction of a macroalga Laminaria japonica, a representative macroalga, was carried out in a fixed-bed tubular reactor under nitrogen atmosphere at 423 to 573 K. Three useful findings were obtained for torrefaction of L japonica from this study. Firstly, the major reaction of the microalga may be decomposition of alginate, while the major reaction for torreterrestrial biomass is known to be decomposition of hemicellulose. Even so, H/C vs. O/C (so-called the van Krevelen plot) showed a similar trend between the macroalga and terrestrial biomass. Secondly, an extremely low temperature is effective to obtain a satisfactory energy yield of torrefied macroalga. Thirdly, the ash, nitrogen and sulfur can be considerably eliminated from the macroalga by torrefaction. (C) 2015 Elsevier B.V. All rights reserved.	[Uemura, Yoshimitsu; Saadon, Shazleen] Univ Teknol Petronas, Ctr Biofuel & Biochem Res, Tronoh 31750, Perak, Malaysia; [Matsumoto, Ryunosuke; Matsumura, Yukihiko] Hiroshima Univ, Dept Mech Engn, Hiroshima 724, Japan	Uemura, Y (reprint author), Univ Teknol Petronas, Ctr Biofuel & Biochem Res, Tronoh 31750, Perak, Malaysia.	yoshimitsu_uemura@petronas.com.my			International Collaboration Program, Graduate School of Engineering, Hiroshima University; Mitsubishi Corporation Education Trust Fund	This work was financially supported by two grants: the International Collaboration Program, Graduate School of Engineering, Hiroshima University and the Mitsubishi Corporation Education Trust Fund.	[Anonymous], 2014, INT J BIOMASS RENEWA; Uslu A, 2008, ENERGY, V33, P1206, DOI 10.1016/j.energy.2008.03.007; Repellin V, 2010, BIOMASS BIOENERG, V34, P602, DOI 10.1016/j.biombioe.2010.01.002; Bastianoni S, 2008, BIOMASS BIOENERG, V32, P619, DOI 10.1016/j.biombioe.2007.12.010; Prins MJ, 2006, ENERGY, V31, P3458, DOI 10.1016/j.energy.2006.03.008; Brachi P, 2015, FUEL PROCESS TECHNOL, V130, P147, DOI 10.1016/j.fuproc.2014.09.043; Sabil KM, 2013, BIOMASS BIOENERG, V56, P351, DOI 10.1016/j.biombioe.2013.05.015; Chen WH, 2010, ENERGY, V35, P2580, DOI 10.1016/j.energy.2010.02.054; Deng J, 2009, J ANAL APPL PYROL, V86, P331, DOI 10.1016/j.jaap.2009.08.006; Toscano G, 2015, FUEL, V143, P89, DOI 10.1016/j.fuel.2014.11.039; Sabil KM, 2013, APPL ENERG, V111, P821, DOI 10.1016/j.apenergy.2013.05.067; Arias B, 2008, FUEL PROCESS TECHNOL, V89, P169, DOI 10.1016/j.fuproc.2007.09.002; Uemura Y, 2015, FUEL, V144, P171, DOI 10.1016/j.fuel.2014.12.050; Couhert C, 2009, FUEL, V88, P2286, DOI 10.1016/j.fuel.2009.05.003; Uemura Y, 2013, FUEL, V103, P156, DOI 10.1016/j.fuel.2011.11.018; Basu P, 2010, BIOMASS GASIFICATION AND PYROLYSIS: PRACTICAL DESIGN AND THEORY, P65, DOI 10.1016/B978-0-12-374988-8.00003-9; Almeida G, 2010, BIORESOURCE TECHNOL, V101, P9778, DOI 10.1016/j.biortech.2010.07.026; Bridgeman TG, 2008, FUEL, V87, P844, DOI 10.1016/j.fuel.2007.05.041; Anastasakis K, 2011, FUEL, V90, P598, DOI 10.1016/j.fuel.2010.09.023; Phanphanich M, 2011, BIORESOURCE TECHNOL, V102, P1246, DOI 10.1016/j.biortech.2010.08.028; Adams JMM, 2011, BIORESOURCE TECHNOL, V102, P226, DOI 10.1016/j.biortech.2010.06.152; Uemura Y, 2011, FUEL, V90, P2585, DOI 10.1016/j.fuel.2011.03.021; Yazdani P, 2015, BIORESOURCE TECHNOL, V176, P196, DOI 10.1016/j.biortech.2014.10.141; Suzuki S, 2006, J EXP MAR BIOL ECOL, V339, P15, DOI 10.1016/j.jembe.2006.06.009; Prins MJ, 2006, J ANAL APPL PYROL, V77, P28, DOI 10.1016/j.jaap.2006.01.002; Aitken D, 2014, J CLEAN PROD, V75, P45, DOI 10.1016/j.jclepro.2014.03.080; Marquez GPB, 2014, RENEW SUST ENERG REV, V38, P1056, DOI 10.1016/j.rser.2014.07.056; Chen WH, 2014, BIORESOURCE TECHNOL, V169, P258, DOI 10.1016/j.biortech.2014.06.086; Kaewpanha M, 2014, FUEL PROCESS TECHNOL, V120, P106, DOI 10.1016/j.fuproc.2013.12.013; PENTANANUNT R, 1990, ENERGY, V15, P1175, DOI 10.1016/0360-5442(90)90109-F; Felfri FF, 2005, ENERGY SUSTAIN DEV, V9, P19; Imanishi H., 2006, P REN EN; Jung KW, 2011, BIORESOURCE TECHNOL, V102, P2745, DOI 10.1016/j.biortech.2010.11.042; Kiel J.H.A., 2008, P 16 EUR BIOM C EXH; Pahang H.K., 2014, P REG S CHEM ENG 201; Poudel J, 2015, FUEL, V140, P275, DOI 10.1016/j.fuel.2014.09.120; Prakobboon N., 2013, INT J BIOMASS RENEW, V2, P14; Prins MJ, 2006, J ANAL APPL PYROL, V77, P34; Rajab AH, 2013, INT J BIOMASS RENEW, V2, P13; Shibata K., 1992, BIOMASS PRODUCTION C, V1, P16; The Society of Chemical Engineers Japan, 2012, BIOM PROC HDB, P75; Uemura Y, 2010, Journal of Applied Sciences, V10	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						133	138		10.1016/j.fuproc.2015.05.016		6	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200016		
J	Jia, DN; Cathary, O; Peng, JH; Bi, XT; Lim, CJ; Sokhansanj, S; Liu, YP; Wang, RX; Tsutsumi, A				Jia, Dening; Cathary, Oceane; Peng, Jianghong; Bi, Xiaotao; Lim, C. Jim; Sokhansanj, Shahab; Liu, Yuping; Wang, Ruixu; Tsutsumi, Atsushi			Fluidization and drying of biomass particles in a vibrating fluidized bed with pulsed gas flow	FUEL PROCESSING TECHNOLOGY			English	Article						Fluidized bed; Gas-solid flow; Drying; Biomass; Vibration; Pulsation	DRYER; KINETICS; SAWDUST; QUALITY; SEEDS	Fluidization of biomass particles in the absence of inert bed materials has been tested in a pulsed fluidized bed with vibration, with the pulsation frequency ranging from 033 to 6.67 Hz. Intermittent fluidization at 033 Hz and apparently 'normal' fluidization at 6.67 Hz with regular bubble patterns were observed. Pulsation has proven to be effective in overcoming the bridging of irregular biomass particles induced by strong inter-particle forces. The vibration is only effective when the pulsation is inadequate, either at too low a frequency or too low in amplitude. Drying of biomass has been carried out to quantify the effectiveness of gas pulsation for fluidized bed dryers and torrefiers in terms of gas-solid contact efficiency and heat and mass transfer rates. The effects of gas flow rate, bed temperature, pulsation frequency and vibration intensity on drying performance have been systematically investigated. While higher temperature and gas flow rate are favored in drying, there exists an optimal range of pulsation frequency between 0.75 Hz and 1.5 Hz where gas-solid contact is enhanced in both the constant rate drying and falling rate drying periods. (C) 2015 Elsevier B.V. All rights reserved.	[Jia, Dening; Peng, Jianghong; Bi, Xiaotao; Lim, C. Jim; Sokhansanj, Shahab; Wang, Ruixu] Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC V6T 1Z3, Canada; [Cathary, Oceane] Ecole Natl Super Tech Avancees, F-92120 Palaiseau, France; [Sokhansanj, Shahab] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Liu, Yuping; Tsutsumi, Atsushi] Univ Tokyo, Inst Ind Sci, Collaborat Res Ctr Energy Engn, Meguro Ku, Tokyo 1538505, Japan	Bi, XT (reprint author), Univ British Columbia, Dept Chem & Biol Engn, 2360 East Mall, Vancouver, BC V6T 1Z3, Canada.				Natural Sciences and Engineering Research Council of Canada (NSERC)	The authors are grateful to the Natural Sciences and Engineering Research Council of Canada (NSERC) for the financial support in the form of a Canada-Japan joint Strategic Project, Tolko Industries Ltd. for the generous donation of tested biomass samples, and Noram Engineering and Constructions for its in-kind contribution to the project.	Akhavan A., 2008, IND ENG CHEM RES, V48, P302; Bubnovich V, 2008, NUMER HEAT TR A-APPL, V54, P255, DOI 10.1080/10407780802084728; Bi HTT, 2007, CHEM ENG SCI, V62, P3473, DOI 10.1016/j.ces.2006.12.092; Liu YP, 2014, FUEL PROCESS TECHNOL, V122, P170, DOI 10.1016/j.fuproc.2014.01.036; Gawrzynski Z, 1996, DRY TECHNOL, V14, P1121, DOI 10.1080/07373939608917142; Hao BG, 2005, POWDER TECHNOL, V149, P51, DOI 10.1016/j.powtec.2004.10.004; Liu CP, 2012, POWDER TECHNOL, V221, P192, DOI 10.1016/j.powtec.2012.01.001; ECCLES ERA, 1992, DRY TECHNOL, V10, P139, DOI 10.1080/07373939208916418; Nitz M, 2007, J FOOD ENG, V80, P249, DOI 10.1016/j.jfoodeng.2006.05.025; Ciro-Velasquez HJ, 2010, DRY TECHNOL, V28, P389, DOI 10.1080/07373931003645116; Li ZY, 2004, J CHEM ENG JPN, V37, P1179, DOI 10.1252/jcej.37.1179; Meili L, 2010, DRY TECHNOL, V28, P402, DOI 10.1080/07373931003645298; ROY R, 1990, CHEM ENG SCI, V45, P3233, DOI 10.1016/0009-2509(90)80216-2; Stakic M, 2011, CHEM ENG PROCESS, V50, P428, DOI 10.1016/j.cep.2011.02.006; Coppens MO, 2003, CHEM ENG J, V96, P117, DOI [10.1016/j.cej.2003.08.007, 10.1016/j/cej.2003.08.007]; HASATANI M, 1991, DRY TECHNOL, V9, P349, DOI 10.1080/07373939108916670; LEGROS R, 1994, DRY TECHNOL, V12, P517, DOI 10.1080/07373939408959976; TURNBULL JH, 1993, BIOMASS BIOENERG, V4, P75, DOI 10.1016/0961-9534(93)90030-8; Reyes A, 2007, DRY TECHNOL, V25, P581, DOI 10.1080/07373930701227011; Zhao GB, 2003, AICHE J, V49, P869, DOI 10.1002/aic.690490407; van der Stelt MJC, 2011, BIOMASS BIOENERG, V35, P3748, DOI 10.1016/j.biombioe.2011.06.023; Wang XS, 2005, POWDER TECHNOL, V159, P142, DOI 10.1016/j.powtec.2005.08.007; Reyes A, 2006, DRY TECHNOL, V24, P1469, DOI 10.1080/07373930600952818; Renstrom R, 2002, DRY TECHNOL, V20, P449, DOI 10.1081/DRT-120002551; Kudra T, 2002, DRY TECHNOL, V20, P917, DOI 10.1081/DRT-120003769; GUPTA R, 1980, CAN J CHEM ENG, V58, P332; de Souza LFG, 2010, CHEM ENG TECHNOL, V33, P2015, DOI 10.1002/ceat.200900565; Moreno R, 2006, BIOSYST ENG, V94, P47, DOI 10.1016/j.biosystemseng.2006.01.011; KANTZAS A, 1994, AICHE J, V40, P1254, DOI 10.1002/aic.690400716; Seville JPK, 2000, POWDER TECHNOL, V113, P261, DOI 10.1016/S0032-5910(00)00309-0; Li H, 2012, BIORESOURCE TECHNOL, V103, P453, DOI 10.1016/j.biortech.2011.10.009; Cui HP, 2007, CHEM ENG SCI, V62, P45, DOI 10.1016/j.ces.2006.08.006; Daleffe R.V., 2005, DRYING TECHNOLOGY, V23, P1765, DOI 10.1080/07373930500209681; Davidson J.F., 1963, FLUIDISED PARTICLES; Drinkenburg A.A.H., 1967, P INT S FLUID JUN 6; Godoi FC, 2011, CHEM ENG PROCESS, V50, P623, DOI 10.1016/j.cep.2011.03.005; Harbaum K.L., 1962, J APPL CHEM-USSR, V12, P234; Mani S., 2006, APPL ENG AGR, V22; Massimilla G.V.L., 1966, CHEM ENG PROGR S SER, P63; Secretariat R., 2014, RENEWABLE GLOBAL STA; Tasirin SM, 2014, IND CROP PROD, V61, P193, DOI 10.1016/j.indcrop.2014.07.004; WAGNER W, 1993, J PHYS CHEM REF DATA, V22, P783; Wong H.W., 1971, CHEM ENG J, V2, P104, DOI 10.1016/0300-9467(71)80004-7; Zhang D., 2005, HYDRODYNAMICS HEAT T, P214	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						471	482		10.1016/j.fuproc.2015.06.023		12	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200055		
J	Li, CY; Appari, S; Zhang, LX; Huang, AN; Kuo, HP; Kudo, S; Hayashi, J; Norinaga, K				Li, Cheng-Yi; Appari, Srinivas; Zhang, Li-Xin; Huang, An-Ni; Kuo, Hsiu-Po; Kudo, Shinji; Hayashi, Jun-ichiro; Norinaga, Koyo			Modeling of gas/particle flow in coal conversion with a drop tube reactor using a lumped kinetic model accounting volatiles-char interaction	FUEL PROCESSING TECHNOLOGY			English	Article						Lumped kinetic model; Tar decomposition; Steam gasification; Volatiles-char interaction; CFD modeling	BIOMASS GASIFICATION PROCESSES; CIRCULATING FLUIDIZED-BED; VICTORIAN BROWN-COAL; VAPOR-PHASE CRACKING; GAS-SOLID FLOW; RAPID PYROLYSIS; STEAM GASIFICATION; TAR ELIMINATION; NASCENT CHAR; HEAVY OIL	Coal conversion including reforming of nascent tar over the char surface in a drop tube reactor (DTR) was studied both experimentally and numerically. Victorian brown coal and char prepared from the same coal were co-fed into an atmospheric DTR. The effects of reaction temperature (973-1173 K), solid hold-up (8.31 x 10(-6)-2.50 x 10(-4)), residence time (0-4.6 s for gas; 0-0.78 s for solid particles), and steam partial pressure (0-0.05 MPa) on the conversion characteristics were investigated. A 4-lump kinetic model consisting of tar, gases, char, and soot with 6 global reactions was developed based on the experimental results. The lumped kinetic model was integrated with a computational fluid dynamics (CFD) simulation using an Eulerian-Eulerian approach for mixed phase flow to simulate the coal conversion experiments in the DTR. The CFD results for product distribution during coal conversion in the DTR showed reasonable agreement with the experimental results. The CFD approach presented is suitable for use in designing and optimizing a pyrolyzer for a triple-bed combined circulating fluidized-bed coal gasifier, consisting of a downer (pyrolyzer), a bubbling fluidized bed (gasifier), and a riser (combustor). (C) 2015 Elsevier B.V. All rights reserved.	[Li, Cheng-Yi; Hayashi, Jun-ichiro; Norinaga, Koyo] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Appari, Srinivas; Kudo, Shinji; Hayashi, Jun-ichiro; Norinaga, Koyo] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan; [Zhang, Li-Xin] Xian Thermal Power Res Inst Co Ltd, Xian 710032, Peoples R China; [Huang, An-Ni; Kuo, Hsiu-Po] Chang Gung Univ, Dept Chem & Mat Engn, Taoyuan 333, Taiwan; [Hayashi, Jun-ichiro] Kyushu Univ, Res & Educ Ctr Carbon Resources, Kasuga, Fukuoka 8168580, Japan	Norinaga, K (reprint author), Kyushu Univ, Inst Chem & Engn, Kasuga, Fukuoka 8168580, Japan.	norinaga@cm.kyushu-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan; MOST-JST, Strategic International Collaborative Research Program, SICORP; China Scholarship Council (CSC Program); Kyushu University Global COE program (G-COE Program)	This work was carried out as a part of the Energy Innovation Program: Strategic Technical Platform for Clean Coal Technology (STEP-CCT), and was in part supported financially by the New Energy and Industrial Technology Development Organization (NEDO), Japan and MOST-JST, Strategic International Collaborative Research Program, SICORP. In addition, Chengyi Li gratefully acknowledges the partial financial support given by the China Scholarship Council (CSC Program) and the Kyushu University Global COE program (G-COE Program).	Norinaga K, 2013, FUEL, V103, P141, DOI 10.1016/j.fuel.2011.07.045; Hayashi JI, 2006, PROCESS SAF ENVIRON, V84, P409, DOI 10.1205/psep06004; Shu Z, 2014, IND ENG CHEM RES, V53, P3378, DOI 10.1021/ie403496a; Hayashi J, 2000, FUEL, V79, P439, DOI 10.1016/S0016-2361(99)00179-9; Ropelato K, 2005, POWDER TECHNOL, V154, P179, DOI 10.1016/j.powtec.2005.05.005; Li CZ, 2013, FUEL, V112, P609, DOI 10.1016/j.fuel.2013.01.031; Masek O, 2009, ENERG FUEL, V23, P4496, DOI 10.1021/ef900285e; Sathe C, 1999, ENERG FUEL, V13, P748, DOI 10.1021/ef980240o; MOSBY JF, 1986, CHEM ENG SCI, V41, P989, DOI 10.1016/0009-2509(86)87184-6; Devi L, 2003, BIOMASS BIOENERG, V24, P125, DOI 10.1016/S0961-9534(02)00102-2; Balasubramanian P, 2008, FUEL, V87, P1660, DOI 10.1016/j.fuel.2007.08.009; Lussier MG, 1998, CARBON, V36, P1361, DOI 10.1016/S0008-6223(98)00123-7; Bayarsaikhan B, 2006, FUEL, V85, P340, DOI 10.1016/j.fuel.2005.06.001; UNGER PE, 1984, FUEL, V63, P606, DOI 10.1016/0016-2361(84)90154-6; Leckel D, 2006, ENERG FUEL, V20, P1761, DOI 10.1021/ef060034d; Zhang LX, 2013, FUEL PROCESS TECHNOL, V113, P1, DOI 10.1016/j.fuproc.2013.03.009; Guan GQ, 2011, CHEM ENG SCI, V66, P4212, DOI 10.1016/j.ces.2011.06.006; Vaishali S, 2008, CHEM ENG SCI, V63, P5107, DOI 10.1016/j.ces.2008.06.014; DAVE NC, 1993, FUEL, V72, P1331, DOI 10.1016/0016-2361(93)90133-M; Lee JG, 1996, FUEL, V75, P1035; Lan XY, 2009, CHEM ENG SCI, V64, P3847, DOI 10.1016/j.ces.2009.05.019; Kim YN, 2011, CHEM ENG SCI, V66, P5357, DOI 10.1016/j.ces.2011.07.036; Zhang L, 2013, FUEL, V112, P681, DOI 10.1016/j.fuel.2011.12.030; Hayashi J, 2014, ENERG FUEL, V28, P4, DOI 10.1021/ef401617k; Guan GQ, 2010, PARTICUOLOGY, V8, P602, DOI 10.1016/j.partic.2010.07.013; Jamil K, 2004, FUEL, V83, P833, DOI 10.1016/j.fuel.2003.09.017; Abu El-Rub Z, 2004, IND ENG CHEM RES, V43, P6911, DOI 10.1021/ie0498403; Zhang S, 2011, FUEL, V90, P1529, DOI 10.1016/j.fuel.2010.11.010; Matsuhara T, 2010, ENERG FUEL, V24, P76; Authayanun S, 2008, J IND ENG CHEM, V14, P771, DOI 10.1016/j.jiec.2008.05.007; Shi SP, 2006, J ENERGY INST, V79, P217, DOI 10.1179/174602206X148865; Li CZ, 2006, PROCESS SAF ENVIRON, V84, P407, DOI 10.1205/psep.ed.0606; [Anonymous], 2011, ANSYS FLUENT THEOR G; Vascellari M, 2014, FUEL, V118, P369, DOI 10.1016/j.fuel.2013.11.004; Hayashi JI, 2002, FUEL, V81, P1977, DOI 10.1016/S0016-2361(02)00128-X; Jeong HJ, 2014, APPL ENERG, V123, P29, DOI 10.1016/j.apenergy.2014.02.026; Guan GQ, 2010, CHEM ENG J, V164, P221, DOI 10.1016/j.cej.2010.08.005; THEOLOGOS KN, 1993, AICHE J, V39, P1007, DOI 10.1002/aic.690390610; Fushimi C, 2011, BIOMASS BIOENERG, V35, P179, DOI 10.1016/j.biombioe.2010.08.017; Elizalde I, 2009, APPL CATAL A-GEN, V365, P237, DOI 10.1016/j.apcata.2009.06.018; Masuda H., 2007, POWDER TECHNOLOGY FU; Norinaga K, 2014, BIOMASS BIOENERG, V69, P144, DOI 10.1016/j.biombioe.2014.07.008; Simell P., 1997, CATAL TODAY, V27, P3	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						588	594		10.1016/j.fuproc.2015.06.043		7	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200067		
J	Mochizuki, Y; Tsubouchi, N; Akiyama, T				Mochizuki, Yuuki; Tsubouchi, Naoto; Akiyama, Tomohiro			Reduction behavior and crushing strength of carbon-containing iron ore sinters prepared from tar recovered from coke oven gas	FUEL PROCESSING TECHNOLOGY			English	Article						Sinter; Carbon; COG tar; Reduction behavior; Crushing strength	COMBINED WATER-CONTENT; IRONMAKING APPLICATIONS; BLAST-FURNACE; COMPOSITE; TEMPERATURE; OXIDE; DECOMPOSITION; DEPOSITION; HEMATITE; ENHANCEMENT	The reduction behavior and crushing strength of carbon-containing iron ore sinters (SI-C) prepared from coke oven gas (COG) tar have been examined with a quartz-made fixed bed reactor and with a tensile and compression testing machine, respectively. When an as-received iron ore sinter (SI) is heated at 10 degrees C/min up to 600 degrees C in 55% H-2/He, the resulting sample (SI/600) gives a very small, broad pore size distribution profile, the surface area (S-BET) and pore volume (V-BJH) being 1.5 m(2)/g and 0.005 cm(3)/g, respectively. On the other hand, SI-pretreated in 55% H-2/He at 450 degrees C for 4 h (SI-450) provides the pore distribution profile peaking around 10 nm, and S-BET and V-BJH are 4 m(2)/g and 0.02 cm(3)/g, respectively. When carbon-containing iron ore sinters (SI/600-C and SI-450-C) are prepared by pyrolysis of the mixture of the pretreated SI and COG tar, no measurable amounts of S-BET and V-BJH are detectable in any case. The crushing strength of SI-450 is improved significantly by the deposition of tarderived carbonaceous materials into the pores formed during the pre-treatment. In a temperature-programed heat treatment in He, the evolution of CO, CO2 and H2O from the SI-450-C samples start after 600 degrees C, and each rate profile observed shows a large peak around 700-850 degrees C. The extent of reduction of SI-C, SI/600-C or SI450-C is 3, 19 or 55% on SI basis, respectively, and it depends on S-BET and/or V-BJH of the feed sample. (C) 2015 Elsevier B.V. All rights reserved.	[Mochizuki, Yuuki; Tsubouchi, Naoto; Akiyama, Tomohiro] Hokkaido Univ, Fac Engn, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan	Mochizuki, Y (reprint author), Hokkaido Univ, Fac Engn, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan.	mochi@eng.hokudai.ac.jp	Tsubouchi, Naoto/D-8112-2012	Tsubouchi, Naoto/0000-0001-8236-8252	CO<INF>2</INF> Ultimate Reduction in Steel-making process by innovative technology for cool Earth 50 (COURSE50) project - New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was supported by the CO<INF>2</INF> Ultimate Reduction in Steel-making process by innovative technology for cool Earth 50 (COURSE50) project sponsored by the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Watakabe S, 2013, ISIJ INT, V53, P2065, DOI 10.2355/isijinternational.53.2065; Weiss B, 2011, IRONMAK STEELMAK, V38, P65, DOI 10.1179/030192310X12700328926065; Kawanari M, 2011, ISIJ INT, V51, P1227, DOI 10.2355/isijinternational.51.1227; Nogami H, 2014, TETSU TO HAGANE, V100, P227, DOI 10.2355/tetsutohagane.100.227; Murakami T, 2011, ISIJ INT, V51, P1220, DOI 10.2355/isijinternational.51.1220; Cahyono RB, 2014, FUEL PROCESS TECHNOL, V119, P272, DOI 10.1016/j.fuproc.2013.11.006; Pineau A, 2006, THERMOCHIM ACTA, V447, P89, DOI 10.1016/j.tca.2005.10.004; Konishi H, 2006, TETSU TO HAGANE, V92, P802; Rozhan AN, 2012, ENERG FUEL, V26, P7340, DOI 10.1021/ef301409f; Hata Y, 2009, ENERG FUEL, V23, P1128, DOI 10.1021/ef800967h; Cahyono RB, 2013, FUEL PROCESS TECHNOL, V113, P84, DOI 10.1016/j.fuproc.2013.03.012; Miura K, 2011, ISIJ INT, V51, P1234, DOI 10.2355/isijinternational.51.1234; Murakami T, 2009, ISIJ INT, V49, P1686; Kasai E, 1995, ISIJ INT, V35, P1444, DOI 10.2355/isijinternational.35.1444; Murakami T, 2011, ISIJ INT, V51, P9, DOI 10.2355/isijinternational.51.9; KASAOKA S, 1982, KAGAKU KOGAKU RONBUN, V8, P168; Cahyono RB, 2014, ENERG FUEL, V28, P2129, DOI 10.1021/ef500201m; Hosokai S, 2012, ENERG FUEL, V26, P7274, DOI 10.1021/ef3013272; Cahyono RB, 2013, ENERG FUEL, V27, P2687, DOI 10.1021/ef400322w; Kasai A, 2003, TETSU TO HAGANE, V89, P1212; Hata Y., 2008, CAMP ISIJ, V21, P212; Hata Y., 2007, CAMP ISIJ, V20, P923; Kosuge T., 1966, TETSU TO HAGANE, V3, P501; Kosuge T., 1966, TETSU TO HAGANE, V3, P498; Miwa T., 2010, J JPN I ENERGY, V89, P28; Shigaki I., 1982, TETSU TO HAGANE, V10, P1513; Sugahara K., 1969, TETSU TO HAGANE, V13, P1107; Takahashi R., 1986, B RES I MINER DRESSI, V41, P109; Takahashi R., 1980, TETSU TO HAGANE, V66, P1985; Yokoyama H., 2014, TETSU TO HAGANE, V100, P601	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	OCT	2015	138						704	713		10.1016/j.fuproc.2015.07.012		10	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CT6JV	WOS:000362920200081		
J	Hirooka, Y; Mazzitelli, G; Mirnov, S; Ono, M; Shimada, M; Tabares, FL				Hirooka, Y.; Mazzitelli, G.; Mirnov, S.; Ono, M.; Shimada, M.; Tabares, F. L.			A REVIEW OF THE PRESENT STATUS AND FUTURE PROSPECTS OF THE APPLICATION OF LIQUID METALS FOR PLASMA-FACING COMPONENTS IN MAGNETIC FUSION DEVICES	FUSION SCIENCE AND TECHNOLOGY			English	Article							LITHIUM DIVERTOR; TUNGSTEN; FIELDS	The application of liquid metals for plasma-facing components draws increasing interest as a potential means to resolve the technical issues assciated with exhaust power and particle handling in magnetic fusion devices beyond the International Thermonuclear Reactor Experiment (ITER). However, our knowledge is extremely limited at present about the physics as well as chemistry of the interactions between liquid metals and edge plasmas in a strong magnetic field. This paper is intended to provide a review of the present status and future propects of this subject.	[Hirooka, Y.] Grad Univ Adv Studies, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Mazzitelli, G.] Assoc EURATOM ENEA Fus, Ctr Ric Frascati, I-00044 Frascati, Italy; [Mirnov, S.] TRINITI, Troitsk 142190, Moscow Reg, Russia; [Ono, M.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Shimada, M.] JAEA Int Fus Res Ctr, IFERC Obuchi, Rokkasho, Aomori, Japan; [Tabares, F. L.] As EURATOM CIEMAT, Natl Inst Fus, Madrid 28040, Spain	Hirooka, Y (reprint author), Grad Univ Adv Studies, Natl Inst Fus Sci, 322-6 Oroshi, Toki, Gifu 5095292, Japan.	hirooka.yoshihiko@nifs.ac.jp			Japanese Government JSPS [24360387, 26630475]	This research has been supported by the Japanese Government JSPS Grants # 24360387 and #26630475.	Doerner RP, 2001, J NUCL MATER, V290, P166, DOI 10.1016/S0022-3115(00)00568-7; Morley NB, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2930813; STRACHAN JD, 1994, NUCL FUSION, V34, P1017, DOI 10.1088/0029-5515/34/7/I07; Gilbert MR, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/4/043005; Jaworski MA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.094503; Narula M, 2006, FUSION ENG DES, V81, P1543, DOI 10.1016/j.fusengdes.2005.08.071; Sanchez J, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/10/104018; Mirnov S, 2009, J NUCL MATER, V390-91, P876, DOI 10.1016/j.jnucmat.2009.01.228; Kugel HW, 2012, FUSION ENG DES, V87, P1724, DOI 10.1016/j.fusengdes.2011.07.010; Majeski R, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4802195; Abdou MA, 2001, FUSION ENG DES, V54, P181, DOI 10.1016/S0920-3796(00)00433-6; Tamura S, 2002, J NUCL MATER, V307, P735, DOI 10.1016/S0022-3115(02)01042-5; Ruzic DN, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/102002; Ying AY, 2004, FUSION ENG DES, V72, P35, DOI 10.1016/j.fusengdes.2004.07.004; Tamura S, 2005, J NUCL MATER, V337, P1043, DOI 10.1016/j.jnucmat.2004.10.103; Hirooka Y, 2006, NUCL FUSION, V46, pS56, DOI 10.1088/0029-5515/46/3/S08; Pitts RA, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014001; BADGER B., 1974, UWFDM68 U WISC, V68; BRAGINSKII SI, 1958, SOV PHYS JETP-USSR, V6, P358; Davis JW, 1998, J NUCL MATER, V258, P308, DOI 10.1016/S0022-3115(98)00285-2; HIROOKA Y., 2005, J NUCL MATER, V585, P337, DOI [http://dx.doi.org/10.1016/j.jnucmat.2004.09.065, DOI 10.1016/JJNUCMAT.2004.09.065]; HIROOKA Yoshi, 2014, NUCL FUSION, V54, DOI DOI 10.1088/0029-5515/54/12/122002; HIROOKA Yoshi, 2014, FUSION ENG DES, V89, P2833, DOI [http://dx.doi.org/10.1016/j.fusengdes.2014.04.014, DOI 10.1016/J.FUSENGDES.2014.04.014]; Kaita R, 2013, J NUCL MATER, V438, pS488, DOI 10.1016/j.jnucmat.2013.01.100; LOARTE A., 2014, PSI C KAN MAY 26 30; Mazzitelli G, 2011, FUSION ENG DES, V86, P580, DOI 10.1016/j.fusengdes.2010.11.007; SHIMADA Michiya, 2014, P 41 EPS C PLASM PHY; ZUI G. Z., 2014, FUSION ENG DES, V89, P2845, DOI DOI 10.1016/J.FUSENGDES.2014.05.020	28	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					477	483				7	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400003		
J	Iwai, Y; Kubo, H; Ohshima, Y; Noguchi, H; Edao, Y; Taniuchi, J				Iwai, Yasunori; Kubo, Hitoshi; Ohshima, Yusuke; Noguchi, Hiroshi; Edao, Yuki; Taniuchi, Junichi			HYDROPHOBIC PLATINUM HONEYCOMB CATALYST TO BE USED FOR TRITIUM OXIDATION REACTORS	FUSION SCIENCE AND TECHNOLOGY			English	Article							HYDROGEN	We have developed two types of hydrophobic platinum honeycomb catalyst to be used for tritium oxidation reactors. One is the hydrophobic platinum catalyst on a metal honeycomb. The other is the hydrophobic platinum catalyst on a ceramic honeycomb made of silicon carbide. The activity of these catalysts was evaluated with tritium. The effects of hydrogen concentration (0.02 to 1000 ppm) and water concentration (100 or 22000 ppm) in the gaseous feed on the activity were investigated. The fine platinum particles around a few nanometers significantly improve the catalytic activity for the oxidation tritium at a very small concentration. The hydrogen concentration in the gaseous feed slightly affects the overall reaction rate constant for hydrogen oxidation. Due to the competitive adsorption of hydrogen and water molecules on platinum surface, the overall reaction rate constant has the bottom value at the hydrogen concentration of 100 ppm with the dry feed gas. We have experimentally confirmed the activity of these honeycomb catalysts is as good as that of granular hydrophobic catalyst. The results support the hydrophobic honeycomb catalysts can be used for tritium oxidation reactors.	[Iwai, Yasunori; Edao, Yuki] Japan Atom Energy Agcy, Naka, Ibaraki 3191195, Japan; [Kubo, Hitoshi; Ohshima, Yusuke; Noguchi, Hiroshi; Taniuchi, Junichi] Tanaka Kikinzoku Kogyo KK, Tsukuba, Ibaraki 3004247, Japan	Iwai, Y (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki 3191195, Japan.	iwai.yasunori@jaea.go.jp			JSPS KAKANHI [25420894]	Part of this work was supported by JSPS KAKANHI Grant-in-Aid for Scientific Research C (Grant Number 25420894). The authors wish to acknowledge this funding support.	Iwai Y, 2011, J NUCL SCI TECHNOL, V48, P1184, DOI 10.3327/jnst.48.1184; NARUSE Y, 1990, FUSION ENG DES, V12, P293, DOI 10.1016/0920-3796(90)90003-O; SCHIRA P, 1991, FUSION ENG DES, V18, P19, DOI 10.1016/0920-3796(91)90101-U; Iwai Y, 2014, FUSION SCI TECHNOL, V66, P214; Morfin F, 2004, APPL CATAL B-ENVIRON, V47, P47, DOI 10.1016/j.apcatb.2003.07.001; Popescu I, 2005, FUSION SCI TECHNOL, V48, P108	6	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					596	600				5	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400023		
J	Rinkwitz, S; Geng, FS; Manning, E; Suster, M; Kawakami, K; Becker, TS				Rinkwitz, Silke; Geng, Fan-Suo; Manning, Elizabeth; Suster, Maximiliano; Kawakami, Koichi; Becker, Thomas S.			BAC Transgenic Zebrafish Reveal Hypothalamic Enhancer Activity Around Obesity Associated SNP rs9939609 Within the Human FTO Gene	GENESIS			English	Article						mammal; organism; genetics; genomics; GWAS; tissue	GENOMIC REGULATORY BLOCKS; ADULT OBESITY; IDENTIFICATION; EXPRESSION; CHILDHOOD; MICE; IRX3	Single Nucleotide Polymorphisms in FTO intron 1 have been associated with obesity risk, leading to the hypothesis that FTO is the obesity-related gene. However, other studies have shown that the FTO gene is part of the regulatory domain of the neighboring IRX3 gene and that enhancers in FTO intron 1 regulate IRX3. While Irx3 activity was shown to be necessary in the hypothalamus for the metabolic function of Irx3 in mouse, no enhancers with hypothalamic activity have been demonstrated in the risk-associated region within FTO. In order to identify potential enhancers at the human FTO locus in vivo, we tested regulatory activity in FTO intron 1 using BAC transgenesis in zebrafish. A minimal gata2 promoter-GFP cassette was inserted 1.3 kb upstream of the obesity associated SNP rs9939609 in a human FTO BAC plasmid. In addition to the previously identified expression domains in notochord and kidney, human FTO BAC: GFP transgenic zebrafish larvae expressed GFP in the ventral posterior tuberculum, the posterior hypothalamus and the anterior brainstem, which are also expression domains of zebrafish irx3a. In contrast, an in-frame insertion of a GFP cassette at the FTO start codon resulted in weak ubiquitous GFP expression indicating that the promoter of FTO does likely not react to enhancers located in the obesity risk-associated region. (C) 2015 The Authors. genesis Published by Wiley Periodicals, Inc.	[Rinkwitz, Silke; Geng, Fan-Suo; Manning, Elizabeth; Becker, Thomas S.] Univ Sydney, Sch Med, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia; [Rinkwitz, Silke; Becker, Thomas S.] Univ Sydney, Sch Med, Dept Physiol, Sydney, NSW 2006, Australia; [Suster, Maximiliano] Uni Res AS, Neural Circuits & Behav Grp, Bergen, Norway; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 411, Japan	Rinkwitz, S (reprint author), Univ Sydney, Sydney Med Sch, Brain & Mind Res Inst, Dept Physiol, Camperdown, NSW 2050, Australia.	silke.rinkwitz@sydney.edu.au			NHMRC [GNT1010713]; Medical Foundation of the University of Sydney; Norwegian Research Council [1753723/S 10]; EU ZF-HEALTH project, (EC) [HEALTH-F4-2010-242048]	Contract grant sponsor: NHMRC, Contract grant number: GNT1010713; Contract grant sponsor: Medical Foundation of the University of Sydney; Contract grant sponsor: Norwegian Research Council, Contract grant number: NFR Project 1753723/S 10; Contract grant sponsor: EU ZF-HEALTH project, (EC Grant Agreement HEALTH-F4-2010-242048)	Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; WILSON SW, 1990, DEVELOPMENT, V108, P121; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Navratilova Pavla, 2009, Briefings in Functional Genomics & Proteomics, V8, P333, DOI 10.1093/bfgp/elp019; Ishibashi M, 2013, METHODS, V62, P216, DOI 10.1016/j.ymeth.2013.03.018; Kokubu C, 2009, NAT GENET, V41, P946, DOI 10.1038/ng.397; Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Punnamoottil B, 2008, DEV DYNAM, V237, P2195, DOI 10.1002/dvdy.21618; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Flint J, 2013, CURR BIOL, V23, pR265, DOI 10.1016/j.cub.2013.01.040; Tung YCL, 2014, CELL METAB, V20, P710, DOI 10.1016/j.cmet.2014.09.010; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Kikuta H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S4; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Suster ML, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-477; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Gestel van MA, 2014, PHYSL REP, V2; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Mueller T, 2005, ATLAS EARLY ZEBRAFIS, P183; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	OCT	2015	53	10					640	651		10.1002/dvg.22884		12	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	CT8HD	WOS:000363054800002		
J	Watanabe, T; Kanai, Y; Matsukawa, S; Michiue, T				Watanabe, Tomoko; Kanai, Yuna; Matsukawa, Shinya; Michiue, Tatsuo			Specific Induction of Cranial Placode Cells From Xenopus Ectoderm by Modulating the Levels of BMP, Wnt, and FGF Signaling	GENESIS			English	Article						Xenopus; cranial placode; prepracodal ectoderm; BMP; Wnt; FGF; patterning	NEURAL CREST INDUCTION; HOMEOBOX GENES; PLATE BORDER; STEM-CELLS; MESODERM; LAEVIS; FATE; DIFFERENTIATION; EXPRESSION; GRADIENT	The neural-epidermal boundary tissues include the neural crest and preplacodal ectoderm (PPE) as primordial constituents. The PPE region is essential for the development of various sensory and endocrine organs, such as the anterior lobe of the pituitary, olfactory epithelium, lens, trigeminal ganglion, and otic vesicles. During gastrulation, a neural region is induced in ectodermal cells that interacts with mesendodermal tissue and responds to several secreted factors. Among them, inhibition of bone morphogenetic protein (BMP) in the presumptive neuroectoderm is essential for the induction of neural regions, and formation of a Wnt and fibroblast growth factor (FGF) signaling gradient along the midline determines anterior-posterior patterning. In this study, we attempted to specifically induce PPE cells from undifferentiated Xenopus cells by regulating BMP, Wnt, and FGF signaling. We showed that the proper level of BMP inhibition with an injection of truncated BMP receptor or treatment with a chemical antagonist triggered the expression of PPE genes. In addition, by varying the amount of injected chordin, we optimized specific expression of the PPE genes. PPE gene expression is increased by adding an appropriate dose of an FGF receptor antagonist. Furthermore, co-injection with either wnt8 or the Wnt inhibitor dkk-1 altered the expression levels of several region-specific genes according to the injected dose. We specifically induced PPE cell differentiation in animal cap cells from early-stage Xenopus embryos by modulating BMP, Wnt, and FGF signaling. This is not the first research on placode induction, but our simple method could potentially be applied to mammalian stem cell systems. (C) 2015 Wiley Periodicals, Inc.	[Watanabe, Tomoko; Kanai, Yuna; Matsukawa, Shinya; Michiue, Tatsuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Tokyo 1538902, Japan; [Matsukawa, Shinya] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan	Michiue, T (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, 8-3-1 Komaba, Tokyo 1538902, Japan.	tmichiue@bio.c.u-tokyo.ac.jp			KAKENHI, Japan Society for the Promotion of Science [25127704, 22570200]	Contract grant sponsor: Grants-in-Aid for Scientific Research, KAKENHI, Japan Society for the Promotion of Science, Contract grant number: 25127704 and 22570200	LaBonne C, 1998, DEVELOPMENT, V125, P2403; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Glavic A, 2004, DEV BIOL, V272, P89, DOI 10.1016/j.ydbio.2004.04.020; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Schlosser G, 2010, INT REV CEL MOL BIO, V283, P129, DOI 10.1016/S1937-6448(10)83004-7; Zhou XL, 2000, MECH DEVELOP, V91, P327, DOI 10.1016/S0925-4773(99)00270-1; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Hardcastle Z, 2000, CURR BIOL, V10, P1511, DOI 10.1016/S0960-9822(00)00825-3; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Christen B, 1997, DEV BIOL, V192, P455, DOI 10.1006/dbio.1997.8732; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev01516; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; MAYOR R, 1995, DEVELOPMENT, V121, P767; Heller N, 1999, DEV GENET, V24, P208, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<208::AID-DVG4>3.0.CO;2-J; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; Leung AW, 2013, DEV BIOL, V379, P208, DOI 10.1016/j.ydbio.2013.04.023; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Pandur PD, 2000, MECH DEVELOP, V96, P253, DOI 10.1016/S0925-4773(00)00396-8; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Morita M, 2013, INT J DEV BIOL, V57, P779, DOI 10.1387/ijdb.130161tm; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Dincer Z, 2013, CELL REP, V5, P1387, DOI 10.1016/j.celrep.2013.10.048; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; Ghanbari H, 2001, MECH DEVELOP, V101, P271, DOI 10.1016/S0925-4773(00)00572-4; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Glinka A, 1998, NATURE, V391, P357; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Park BY, 2008, DEV BIOL, V324, P108, DOI 10.1016/j.ydbio.2008.09.009; Fletcher RB, 2006, DEVELOPMENT, V133, P1703, DOI 10.1242/dev.02342; Brivanlou PA. AH, 1995, NATURE, V376, P331; David R, 2001, MECH DEVELOP, V103, P189, DOI 10.1016/S0925-4773(01)00355-0; Matsukawa S, 2015, DEV BIOL, V399, P164, DOI 10.1016/j.ydbio.2014.12.028; Nieuwkoop P., 1994, NORMAL TABLE XENOPUS; Saint-Jeannet Jean-Pierre, 2014, Dev Biol, V389, P13, DOI 10.1016/j.ydbio.2014.02.011	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	OCT	2015	53	10					652	659		10.1002/dvg.22881		8	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	CT8HD	WOS:000363054800003		
J	Chen, ATY; Guo, CF; Itani, OA; Budaitis, BG; Williams, TW; Hopkins, CE; McEachin, RC; Pande, M; Grant, AR; Yoshina, S; Mitani, S; Hu, PJ				Chen, Albert Tzong-Yang; Guo, Chunfang; Itani, Omar A.; Budaitis, Breane G.; Williams, Travis W.; Hopkins, Christopher E.; McEachin, Richard C.; Pande, Manjusha; Grant, Ana R.; Yoshina, Sawako; Mitani, Shohei; Hu, Patrick J.			Longevity Genes Revealed by Integrative Analysis of Isoform-Specific daf-16/FoxO Mutants of Caenorhabditis elegans	GENETICS			English	Article						C. elegans; aging; longevity; insulin-like growth factor signaling; FoxO transcription factors	TRANSCRIPTION FACTOR FOXO1; LIFE-SPAN; C-ELEGANS; OXIDATIVE STRESS; INSULIN-RECEPTOR; REGULATES LONGEVITY; SIGNALING PATHWAY; INTERACTING GENES; RNA INTERFERENCE; GENOMICS VIEWER	FoxO transcription factors promote longevity across taxa. How they do so is poorly understood. In the nematode Caenorhabditis elegans, the A- and F-isoforms of the FoxO transcription factor DAF-16 extend life span in the context of reduced DAF-2 insulin-like growth factor receptor (IGFR) signaling. To elucidate the mechanistic basis for DAF-16/FoxO-dependent life span extension, we performed an integrative analysis of isoform-specific daf-16/FoxO mutants. In contrast to previous studies suggesting that DAF-16F plays a more prominent role in life span control than DAF-16A, isoform-specific daf-16/FoxO mutant phenotypes and whole transcriptome profiling revealed a predominant role for DAF-16A over DAF-16F in life span control, stress resistance, and target gene regulation. Integration of these datasets enabled the prioritization of a subset of 92 DAF-16/FoxO target genes for functional interrogation. Among 29 genes tested, two DAF-16A-specific target genes significantly influenced longevity. A loss-of-function mutation in the conserved gene gst-20, which is induced by DAF-16A, reduced life span extension in the context of daf-2/IGFR RNAi without influencing longevity in animals subjected to control RNAi. Therefore, gst-20 promotes DAF-16/FoxO-dependent longevity. Conversely, a loss-of-function mutation in srr-4, a gene encoding a seven-transmembrane-domain receptor family member that is repressed by DAF-16A, extended life span in control animals, indicating that DAF-16/FoxO may extend life span at least in part by reducing srr-4 expression. Our discovery of new longevity genes underscores the efficacy of our integrative strategy while providing a general framework for identifying specific downstream gene regulatory events that contribute substantially to transcription factor functions. As FoxO transcription factors have conserved functions in promoting longevity and may be dysregulated in aging-related diseases, these findings promise to illuminate fundamental principles underlying aging in animals.	[Chen, Albert Tzong-Yang; Guo, Chunfang; Itani, Omar A.; Budaitis, Breane G.; Williams, Travis W.; Hu, Patrick J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [McEachin, Richard C.; Pande, Manjusha; Grant, Ana R.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Hu, Patrick J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Hu, Patrick J.] Univ Michigan, Sch Med, Inst Gerontol, Ann Arbor, MI 48109 USA; [Hopkins, Christopher E.] Knudra Transgen, Murray, UT 84123 USA; [Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan	Hu, PJ (reprint author), 3027 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	pathu@umich.edu			National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; Biology of Aging training grant by the National Institute on Aging [T32AG000114]; Functional Assessment Core of the UM Nathan Shock Center of Excellence in the Basic Biology of Aging from the American Cancer Society [DDC-119640]; R01 grant from the NIH [AG041177]	We thank Robert Lyons and Jeanne Geskes at the University of Michigan (UM) DNA Sequencing Core for their assistance with whole transcriptome profiling, the UM Bioinformatics Core and Mallory Freeberg for help with analysis of transcriptome profiling data, and John Kim and Colin Delaney for comments on the manuscript. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440). This work was supported by the Biology of Aging training grant T32AG000114, awarded to the UM Geriatrics Center by the National Institute on Aging (A.T.-Y.C.), the Functional Assessment Core of the UM Nathan Shock Center of Excellence in the Basic Biology of Aging, research scholar grant DDC-119640 from the American Cancer Society (P.J.H.), and R01 grant AG041177 from the NIH (P.J.H.).	Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; FRIEDMAN DB, 1988, GENETICS, V118, P75; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Riesen M, 2014, AGING-US, V6, P98; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Yamamoto R, 2011, AGING CELL, V10, P729, DOI 10.1111/j.1474-9726.2011.00716.x; Ashburner M, 2000, NAT GENET, V25, P25; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Tazearslan C, 2011, AGING CELL, V10, P551, DOI 10.1111/j.1474-9726.2011.00697.x; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Chen ATY, 2013, AGING CELL, V12, P932, DOI 10.1111/acel.12120; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; VOWELS JJ, 1992, GENETICS, V130, P105; Murakami S, 1996, GENETICS, V143, P1207; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Tsuchiya K, 2013, CIRC RES, V112, P992, DOI 10.1161/CIRCRESAHA.112.300749; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Honda Y, 1999, FASEB J, V13, P1385; Gems D, 1998, GENETICS, V150, P129; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Chen D, 2013, CELL REP, V5, P1600, DOI 10.1016/j.celrep.2013.11.018; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kwon ES, 2010, NATURE, V466, P498, DOI 10.1038/nature09184; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.13.029; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; O'Rourke EJ, 2013, NAT CELL BIOL, V15, P668, DOI 10.1038/ncb2741; Bansal Ankita, 2014, Longev Healthspan, V3, P5, DOI 10.1186/2046-2395-3-5; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; GOTTLIEB S, 1994, GENETICS, V137, P107; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Jünger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Langmead B., 2010, CURR PROTOC BIOINFOR, V11, P7, DOI DOI 10.1002/0471250953.BI1107S32; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Murphy C. T., 2013, WORMBOOK, V26, P1, DOI DOI 10.1895/WORMBOOK.1.164.1; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tullet JMA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004109; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wood W. B., 1988, NEMATODE CAENORHABDI, P393	95	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2015	201	2					613	+		10.1534/genetics.115.177998		60	Genetics & Heredity	Genetics & Heredity	CT5HB	WOS:000362838500021		
J	Liu, GJ; Sanghavi, P; Bollinger, KE; Perry, L; Marshall, B; Roon, P; Tanaka, T; Nakamura, A; Gonsalvez, GB				Liu, Guojun; Sanghavi, Paulomi; Bollinger, Kathryn E.; Perry, Libby; Marshall, Brendan; Roon, Penny; Tanaka, Tsubasa; Nakamura, Akira; Gonsalvez, Graydon B.			Efficient Endocytic Uptake and Maturation in Drosophila Oocytes Requires Dynamitin/p50	GENETICS			English	Article						microtubule motors; endocytosis; cell polarity; kinesin; dynactin	OSKAR MESSENGER-RNA; EXOCYST COMPONENT SEC5; GROWTH-FACTOR RECEPTOR; CLATHRIN HEAVY-CHAIN; POSTERIOR LOCALIZATION; CYTOPLASMIC DYNEIN; CELL-FORMATION; GERM PLASM; TRANSPORT; PROTEIN	Dynactin is a multi-subunit complex that functions as a regulator of the Dynein motor. A central component of this complex is Dynamitin/p50 (Dmn). Dmn is required for endosome motility in mammalian cell lines. However, the extent to which Dmn participates in the sorting of cargo via the endosomal system is unknown. In this study, we examined the endocytic role of Dmn using the Drosophila melanogaster oocyte as a model. Yolk proteins are internalized into the oocyte via clathrin-mediated endocytosis, trafficked through the endocytic pathway, and stored in condensed yolk granules. Oocytes that were depleted of Dmn contained fewer yolk granules than controls. In addition, these oocytes accumulated numerous endocytic intermediate structures. Particularly prominent were enlarged endosomes that were relatively devoid of Yolk proteins. Ultrastructural and genetic analyses indicate that the endocytic intermediates are produced downstream of Rab5. Similar phenotypes were observed upon depleting Dynein heavy chain (Dhc) or Lis1. Dhc is the motor subunit of the Dynein complex and Lis1 is a regulator of Dynein activity. We therefore propose that Dmn performs its function in endocytosis via the Dynein motor. Consistent with a role for Dynein in endocytosis, the motor colocalized with the endocytic machinery at the oocyte cortex in an endocytosis-dependent manner. Our results suggest a model whereby endocytic activity recruits Dynein to the oocyte cortex. The motor along with its regulators, Dynactin and Lis1, functions to ensure efficient endocytic uptake and maturation.	[Liu, Guojun; Sanghavi, Paulomi; Perry, Libby; Marshall, Brendan; Roon, Penny; Gonsalvez, Graydon B.] Georgia Regents Univ, Cellular Biol & Anat, Augusta, GA 30912 USA; [Bollinger, Kathryn E.] Georgia Regents Univ, James & Jean Culver Vision Discovery Inst, Augusta, GA 30912 USA; [Tanaka, Tsubasa; Nakamura, Akira] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Germline Dev, Div Organogenesis, Kumamoto 8600811, Japan	Gonsalvez, GB (reprint author), Georgia Regents Univ, Cellular Biol & Anat, Augusta, GA 30912 USA.	ggonsalvez@gru.edu			National Institutes of Health [1R01GM100088-01]	We thank Simon Bullock, Anne Ephrussi, Vladimir Gelfand, Antoine Guichet, and Daniel St. Johnston for providing antibodies and fly strains that were essential for completing this work; Linton Traub for providing the GST-mRFP-RAP construct used in the endocytosis assays; Catherine Rabouille for advice on preparing Drosophila egg chambers for electron microscopy; Silvia Corvera for the TagRFP-T-EEA1 plasmid; the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for providing numerous fly strain and antibodies that were critical in completing this work; and Paul McNeil, Anna McNeil, and Tim Kurtz for assistance with various imaging experiments. This work was supported by a grant (1R01GM100088-01) from the National Institutes of Health (to G.B.G.).	EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Ramachandran R, 2011, SEMIN CELL DEV BIOL, V22, P10, DOI 10.1016/j.semcdb.2010.09.001; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Terenzio M, 2014, EMBO J, V33, P1582, DOI 10.15252/embj.201387579; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Compagnon J, 2009, J CELL SCI, V122, P25, DOI 10.1242/jcs.033027; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Vanzo N, 2007, DEV CELL, V12, P543, DOI 10.1016/j.devcel.2007.03.002; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Li X, 2010, EMBO J, V29, P992, DOI 10.1038/emboj.2009.410; Jha A, 2012, MOL BIOL CELL, V23, P1742, DOI 10.1091/mbc.E11-11-0939; Sanghavi P, 2012, DEV BIOL, V367, P66, DOI 10.1016/j.ydbio.2012.04.024; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Yousefian J, 2013, J CELL SCI, V126, P1583, DOI 10.1242/jcs.114934; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; TSURUHARA T, 1990, CELL TISSUE RES, V259, P199, DOI 10.1007/BF00318441; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; Zhao TT, 2012, SCIENCE, V336, P999, DOI 10.1126/science.1219147; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Murthy M, 2004, DEVELOPMENT, V131, P377, DOI 10.1242/dev.00931; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Sommer B, 2005, J CELL BIOL, V169, P953, DOI 10.1083/jcb.200411053; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Valetti C, 1999, MOL BIOL CELL, V10, P4107; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/nmeth.1592, 10.1038/NMETH.1592]; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Girard E, 2014, TRAFFIC, V15, P309, DOI 10.1111/tra.12143; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; DIMARIO PJ, 1987, J CELL BIOL, V105, P199, DOI 10.1083/jcb.105.1.199; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Morais-de-Sa E, 2014, DEVELOPMENT, V141, P2984, DOI 10.1242/dev.109827; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Lee S, 2007, J CELL BIOL, V176, P941, DOI 10.1083/jcb.200701048; STENMARK H, 1994, EMBO J, V13, P1287; Zimyanin V, 2007, CURR BIOL, V17, P353, DOI 10.1016/j.cub.2006.12.044; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vazquez-Pianzola P, 2014, DEVELOPMENT, V141, P1915, DOI 10.1242/dev.099432; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Flores-Rodriguez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024479; Koch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004552; Long R. M., 2012, BIOL REP, V4, P16; Sanghavi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080605; Spradling A. C., 1994, DEV DROSOPHILA MELAN, P1; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Yu YXV, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-9	72	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2015	201	2					631	+		10.1534/genetics.115.180018		26	Genetics & Heredity	Genetics & Heredity	CT5HB	WOS:000362838500022		
J	Taguchi-Shiobara, F; Ota, T; Ebana, K; Ookawa, T; Yamasaki, M; Tanabata, T; Yamanouchi, U; Wu, JZ; Ono, N; Nonoue, Y; Nagata, K; Fukuoka, S; Hirabayashi, H; Yamamoto, T; Yano, M				Taguchi-Shiobara, Fumio; Ota, Tatsuya; Ebana, Kaworu; Ookawa, Taiichiro; Yamasaki, Masanori; Tanabata, Takanari; Yamanouchi, Utako; Wu, Jianzhong; Ono, Nozomi; Nonoue, Yasunori; Nagata, Kazufumi; Fukuoka, Shuichi; Hirabayashi, Hideyuki; Yamamoto, Toshio; Yano, Masahiro			Natural Variation in the Flag Leaf Morphology of Rice Due to a Mutation of the NARROW LEAF 1 Gene in Oryza sativa L.	GENETICS			English	Article						rice; flag leaf width; natural variation; Oryza sativa L.; NARROW LEAF 1	INCREASES YIELD; GRAIN-YIELD; GENOME; ASSOCIATION; REVEALS; NAL1; POPULATION; LANDRACE; MAP	We investigated the natural variations in the flag leaf morphology of rice. We conducted a principal component analysis based on nine flag leaf morphology traits using 103 accessions from the National Institute of Agrobiological Sciences Core Collection. The first component explained 39% of total variance, and the variable with highest loading was the width of the flag leaf (WFL). A genome-wide association analysis of 102 diverse Japanese accessions revealed that marker RM6992 on chromosome 4 was highly associated with WFL. In analyses of progenies derived from a cross between Takanari and Akenohoshi, the most significant quantitative trait locus (QTL) for WFL was in a 10.3-kb region containing the NARROW LEAF 1 (NAL1) gene, located 0.4 Mb downstream of RM6992. Analyses of chromosomal segment substitution lines indicated that a mutation (G1509A single-nucleotide mutation, causing an R233H amino acid substitution in NAL1) was present at the QTL. This explained 13 and 20% of total variability in WFL and the distance between small vascular bundles, respectively. The mutation apparently occurred during rice domestication and spread into japonica, tropical japonica, and indica subgroups. Notably, one accession, Phulba, had a NAL1 allele encoding only the N-terminal, or one-fourth, of the wild-type peptide. Given that the Phulba allele and the histidine-type allele showed essentially the same phenotype, the histidine-type allele was regarded as malfunctional. The phenotypes of transgenic plants varied depending on the ratio of histidine-type alleles to arginine-type alleles, raising the possibility that H-233-type products function differently from and compete with R-233-type products.	[Taguchi-Shiobara, Fumio; Ebana, Kaworu; Tanabata, Takanari; Yamanouchi, Utako; Wu, Jianzhong; Nonoue, Yasunori; Nagata, Kazufumi; Fukuoka, Shuichi; Yamamoto, Toshio; Yano, Masahiro] Agrogenom Res Ctr, Natl Inst Agrobiol Sci, Rice Appl Genom Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Ota, Tatsuya] Grad Univ Adv Studies, SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan; [Ookawa, Taiichiro] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Yamasaki, Masanori] Kobe Univ, Grad Sch Agr Sci, Food Resources Educ & Res Ctr, Kasai, Hyogo 6752103, Japan; [Ono, Nozomi] Inst Soc Tech Innovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; [Hirabayashi, Hideyuki] NARO Inst Crop Sci, Rice Res Div, Tsukuba, Ibaraki 3058518, Japan	Taguchi-Shiobara, F (reprint author), Agrogenom Res Ctr, Natl Inst Agrobiol Sci, Rice Appl Genom Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	fstagu@affrc.go.jp			National Bioresource Project, Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institute of Agrobiological Sciences technical support system; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation) [NVR-0001, QTL-1002]; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [IVG-2003]	We thank Akemi Tagiri for thin sectioning and Haruko Onodera for production of transgenic plants. The wild rice accessions used in this study were obtained from the National Institute of Genetics, which is supported by the National Bioresource Project, Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was supported by the National Institute of Agrobiological Sciences technical support system and by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation NVR-0001 and QTL-1002 and Genomics-based Technology for Agricultural Improvement IVG-2003).	Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ebana K, 2011, THEOR APPL GENET, V122, P1199, DOI 10.1007/s00122-010-1524-1; CHURCHILL GA, 1994, GENETICS, V138, P963; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Ebana K, 2008, BREEDING SCI, V58, P281, DOI 10.1270/jsbbs.58.281; Chen ML, 2012, PLANT CELL REP, V31, P863, DOI 10.1007/s00299-011-1207-7; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; WATSON DJ, 1952, ADV AGRON, V4, P101, DOI 10.1016/S0065-2113(08)60307-7; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Yamasaki M, 2013, BREEDING SCI, V63, P49, DOI 10.1270/jsbbs.63.49; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055; LANGDALE JA, 1989, DEV BIOL, V133, P128, DOI 10.1016/0012-1606(89)90304-7; ESAU K., 1977, ANATOMY SEED PLANTS; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Hoshikawa K., 1989, GROWING RICE PLANT A; INOSAKA MASAYUKI, 1962, BULL FAC AGRIC UNIV MIYAZAKI, V7, P15; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Iwata H, 2007, THEOR APPL GENET, V114, P1437, DOI 10.1007/s00122-007-0529-x; Jiang D., 2015, PLOS ONE, V10; MATSUO T., 1952, BULL NATL INST AGRIC SCI [JAPAN] SER D PLANT PHYSIOL, V3, P1; Nagata K, 2015, BREEDING SCI, V65, P308, DOI 10.1270/jsbbs.65.308; Sinclair TR, 1999, SCIENCE, V283, P1455, DOI DOI 10.1126/SCIENCE.283.5407.1455C; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Tanaka A., 1958, J SCI SOIL MANURE, V29, P327; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	33	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2015	201	2					795	+		10.1534/genetics.115.181040		30	Genetics & Heredity	Genetics & Heredity	CT5HB	WOS:000362838500033		
J	Watanabe, T; Tani, M; Ishibashi, Y; Endo, I; Okino, N; Ito, M				Watanabe, Takashi; Tani, Motohiro; Ishibashi, Yohei; Endo, Ikumi; Okino, Nozomu; Ito, Makoto			Ergosteryl-beta-glucosidase (Egh1) involved in sterylglucoside catabolism and vacuole formation in Saccharomyces cerevisiae	GLYCOBIOLOGY			English	Article						ergosteryl-beta-glucosidase; glycolipid; Saccharomyces cerevisiae; sterylglucoside	CHOLESTEROL GLUCOSYLATION; CRYPTOCOCCUS-NEOFORMANS; PICHIA-PASTORIS; HEAT-SHOCK; FUSION; PROTEINS; STEROL; FUNGI; ENDOGLYCOCERAMIDASE; STRESS	Sterylglucosides (SGs) are composed of a glucose and sterol derivatives, and are distributed in fungi, plants and mammals. We recently identified EGCrP1 and EGCrP2 (endoglycoceramidase-related proteins 1 and 2) as a beta-glucocerebrosidase and steryl-beta-glucosidase, respectively, in Cryptococcus neoformans. We herein describe an EGCrP2 homologue (Egh1; ORF name, Yir007w) involved in SG catabolism in Saccharomyces cerevisiae. The purified recombinant Egh1 hydrolyzed various beta-glucosides including ergosteryl beta-glucoside (EG), cholesteryl beta-glucoside, sitosteryl beta-glucoside, para-nitrophenyl beta-glucoside, 4-methylumberifellyl beta-glucoside and glucosylceramide. The disruption of EGH1 in S. cerevisiae BY4741 (egh1 Delta) resulted in the accumulation of EG and fragmentation of vacuoles. The expression of EGH1 in egh1 Delta (revertant) reduced the accumulation of EG, and restored the morphology of vacuoles. The accumulation of EG was not detected in EGH1 and UGT51(ATG26) double-disrupted mutants (ugt51 Delta egh1 Delta), indicating that EG was synthesized by Ugt51(Atg26) and degraded by Egh1 in vivo. These results clearly demonstrated that Egh1 is an ergosteryl-beta-glucosidase that is functionally involved in the EG catabolic pathway and vacuole formation in S. cerevisiae.	[Watanabe, Takashi; Ishibashi, Yohei; Endo, Ikumi; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fac Sci,Higashi Ku, Fukuoka 8128581, Japan; [Tani, Motohiro] Kyushu Univ, Fac Sci, Dept Chem, Higashi Ku, Fukuoka 8128581, Japan	Ito, M (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fac Sci,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24380058, 15H04488]; Japan Foundation for Applied Enzymology	This work was supported in part by the Grant-in-Aid for Scientific Research B (# 24380058, # 15H04488) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Japan Foundation for Applied Enzymology (to M.I.).	Oku M, 2003, EMBO J, V22, P3231, DOI 10.1093/emboj/cdg331; Mayer A, 2000, MOL BIOL CELL, V11, P807; Cao Y, 2007, AUTOPHAGY, V3, P17; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142; Sakaki T, 2001, YEAST, V18, P679, DOI 10.1002/yea.720; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; ITO M, 1989, J BIOL CHEM, V264, P9510; Kunimoto S, 2000, CELL STRESS CHAPERON, V5, P3, DOI 10.1379/1466-1268(2000)005<0003:EOCGBH>2.0.CO;2; Kunimoto S, 2002, CELL STRUCT FUNCT, V27, P157, DOI 10.1247/csf.27.157; Brachmann CB, 1998, YEAST, V14, P115; Nakagawa T, 1999, J BIOCHEM-TOKYO, V126, P604; ITO M, 1986, J BIOL CHEM, V261, P14278; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Ishibashi Y, 2012, J BIOL CHEM, V287, P368, DOI 10.1074/jbc.M111.311340; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Hayashi Y, 2008, ANAL BIOCHEM, V383, P122, DOI 10.1016/j.ab.2008.07.024; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Watanabe T, 2015, J BIOL CHEM, V290, P1005, DOI 10.1074/jbc.M114.616300; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; NAEWBANIJ M, 1984, CEREAL CHEM, V61, P385; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Kunimoto S, 2003, CELL STRUCT FUNCT, V28, P179; Akiyama H, 2013, BIOCHEM BIOPH RES CO, V441, P838, DOI 10.1016/j.bbrc.2013.10.145; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; MurakamiMurofushi K, 1997, J BIOL CHEM, V272, P486; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899	35	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	OCT	2015	25	10					1079	1089		10.1093/glycob/cwv045		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7JL	WOS:000362990900005		
J	Wang, N; Seko, A; Takeda, Y; Kikuma, T; Ito, Y				Wang, Ning; Seko, Akira; Takeda, Yoichi; Kikuma, Takashi; Ito, Yukishige			Cooperative role of calnexin and TigA in Aspergillus oryzae glycoprotein folding	GLYCOBIOLOGY			English	Article						Aspergillus oryzae; calnexin; N-linked glycoprotein; protein disulfide isomerase; ribonuclease	BETA-N-ACETYLGLUCOSAMINIDASE; MANNOSE-TYPE OLIGOSACCHARIDE; DOWN CHEMOENZYMATIC APPROACH; PROTEIN-DISULFIDE-ISOMERASE; QUALITY-CONTROL; HOMOGENEOUS GLYCOPROTEINS; ENDOPLASMIC-RETICULUM; RIBONUCLEASE B; MOLECULAR CHAPERONE; EFFICIENT SYNTHESIS	Calnexin (CNX), known as a lectin chaperone located in the endoplasmic reticulum (ER), specifically recognizes G(1)M(9)GN(2)-proteins and facilitates their proper folding with the assistance of ERp57 in mammalian cells. However, it has been left unidentified how CNX works in Aspergillus oryzae, which is a filamentous fungus widely exploited in biotechnology. In this study, we found that a protein disulfide isomerase homolog TigA can bind with A. oryzae CNX (AoCNX), which was revealed to specifically recognize monoglucosylated glycans, similarly to CNX derived from other species, and accelerate the folding of G(1)M(9)GN(2)-ribonuclease (RNase) in vitro. For refolding experiments, a homogeneous monoglucosylated high-mannose-type glycoprotein G(1)M(9)GN(2)-RNase was chemoenzymatically synthesized from G(1)M(9)GN-oxazoline and GN-RNase. Denatured G(1)M(9)GN(2)-RNase was refolded with highest efficiency in the presence of both soluble form of AoCNX and TigA. TigA contains two thioredoxin domains with CGHC motif, mutation analysis of which revealed that the one in N-terminal regions is involved in binding to AoCNX, while the other in catalyzing protein refolding. The results suggested that in glycoprotein folding process of A. oryzae, TigA plays a similar role as ERp57 in mammalian cells, as a partner protein of AoCNX.	[Wang, Ning; Seko, Akira; Takeda, Yoichi; Ito, Yukishige] Japan Sci & Technol Agcy JST, ERATO, Ito Glycotril Project, Wako, Saitama 3510198, Japan; [Wang, Ning; Ito, Yukishige] RIKEN, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; [Kikuma, Takashi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Ito, Y (reprint author), Japan Sci & Technol Agcy JST, ERATO, Ito Glycotril Project, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yukito@riken.jp	Ito, Yukishige/M-5119-2014; 	Ito, Yukishige/0000-0001-6251-7249; Takeda, Yoichi/0000-0002-7146-3585			Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Unverzagt C, 2013, CHEM SOC REV, V42, P4408, DOI 10.1039/c3cs35485g; Sakono M, 2014, BBA-GEN SUBJECTS, V1840, P2904, DOI 10.1016/j.bbagen.2014.04.012; Sakamoto I, 2012, J AM CHEM SOC, V134, P5428, DOI 10.1021/ja2109079; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; OHTA M, 1991, GLYCOCONJUGATE J, V8, P400, DOI 10.1007/BF00731292; Fujikawa K, 2015, CHEM-EUR J, V21, P3224, DOI 10.1002/chem.201405781; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; Jeenes DJ, 1997, GENE, V193, P151, DOI 10.1016/S0378-1119(97)00098-X; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Amin MN, 2011, J AM CHEM SOC, V133, P14404, DOI 10.1021/ja204831z; Izumi M, 2012, J AM CHEM SOC, V134, P7238, DOI 10.1021/ja3013177; Dedola S, 2014, ANGEW CHEM INT EDIT, V53, P2883, DOI 10.1002/anie.201309665; Park C, 2001, METHOD ENZYMOL, V341, P81; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Watanabe T, 2007, BIOSCI BIOTECH BIOCH, V71, P2688, DOI 10.1271/bbb.70289; Matsuo I, 2003, J AM CHEM SOC, V125, P3402, DOI 10.1021/ja021288q; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/nchembio.314, 10.1038/NCHEMBIO.314]; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Yamamoto K, 2001, J BIOSCI BIOENG, V92, P493, DOI 10.1263/jbb.92.493; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Gouka RJ, 1997, APPL MICROBIOL BIOT, V47, P1; MINOBE S, 1979, J BIOCHEM-TOKYO, V86, P1851; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochems.73.011303.074043; Arai MA, 2005, CHEMBIOCHEM, V6, P2281, DOI 10.1002/cbic.200500143; Aikawa J, 2012, GLYCOCONJUGATE J, V29, P35, DOI 10.1007/s10719-011-9362-1; Archer DB, 2000, CURR OPIN BIOTECH, V11, P478, DOI 10.1016/S0958-1669(00)00129-4; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Yuan Y, 2010, BIOPOLYMERS, V94, P373, DOI 10.1002/bip.21374; Whitley P, 1996, J BIOL CHEM, V271, P6241; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3; Koizumi A, 2013, ANGEW CHEM INT EDIT, V52, P7426, DOI 10.1002/anie.201301613; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586; Sims AH, 2004, MYCOL RES, V108, P853, DOI 10.1017/S09537562040067X; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Takeda Y, 2013, CARBOHYD RES, V375, P112, DOI 10.1016/j.carres.2013.04.032; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Makimura Y, 2012, CARBOHYD RES, V364, P41, DOI 10.1016/j.carres.2012.10.011; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; NAKAO Y, 1987, J BIOCHEM-TOKYO, V102, P171; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang N, 2015, CARBOHYD RES, V411, P37, DOI 10.1016/j.carres.2015.04.011; Yin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004658	54	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	OCT	2015	25	10					1090	1099		10.1093/glycob/cwv043		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7JL	WOS:000362990900006		
J	Hane, M; Matsuoka, S; Ono, S; Miyata, S; Kitajima, K; Sato, C				Hane, Masaya; Matsuoka, Shuhei; Ono, Sayaka; Miyata, Shinji; Kitajima, Ken; Sato, Chihiro			Protective effects of polysialic acid on proteolytic cleavage of FGF2 and proBDNF/BDNF	GLYCOBIOLOGY			English	Article						BDNF; FGF2; NCAM; plasmin; polysialic acid; polysialyltransferase; proBDNF; SPR; ST8SIA2/STX; Trypsin	CELL-ADHESION MOLECULE; FIBROBLAST-GROWTH-FACTOR; NEUROTROPHIC FACTOR; MUTATED POLYSIALYLTRANSFERASE; FUNCTIONAL IMPAIRMENTS; MAMMALIAN BRAIN; SCHIZOPHRENIA; EXPRESSION; PLASTICITY; MICE	Polysialic acid (polySia) is a linear polymer of sialic acid that modifies neural cell adhesion molecule (NCAM) in the vertebrate brain. PolySia is a large and exclusive molecule that functions as a negative regulator of cell-cell interactions. Recently, we demonstrated that polySia can specifically bind fibroblast growth factor 2 (FGF2) and BDNF; however, the protective effects of polySia on the proteolytic cleavage of these proteins remain unknown, although heparin/heparan sulfate has been shown to impair the cleavage of FGF2 by trypsin. Here, we analyzed the protective effects of polySia on the proteolytic cleavage of FGF2 and proBDNF/BDNF. We found that polySia protected intact FGF2 from tryptic activity via the specific binding of extended polySia chains on NCAM to FGF2. Oligo/polySia also functioned to impair the processing of proBDNF by plasmin via binding of oligo/polySia chains on NCAM. In addition, the polySia structure synthesized by mutated polysialyltransferase, ST8SIA2/STX(SNP7), which was previously identified from a schizophrenia patient, was impaired for these functions compared with polySia produced by normal ST8SIA2. Taken together, these data suggest that the protective effects of polySia toward FGF2 and proBDNF may be involved in the regulation of the concentrations of these neurologically active molecules.	[Hane, Masaya; Matsuoka, Shuhei; Ono, Sayaka; Miyata, Shinji; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Hane, Masaya; Matsuoka, Shuhei] Nagoya Univ, Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Sato, C (reprint author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	chi@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014		Ministry of Education, Science, Sports and Culture [15K06995, 23110002, 26110708]	This research was supported in part by Grants-in-Aid for Scientific Research (C) (15K06995) and Scientific Research on Innovative Areas (No. 23110002, Deciphering sugar chain-based signals regulating integrative neural functions) (26110708) from the Ministry of Education, Science, Sports and Culture.	Buckley PF, 2011, CURR OPIN PSYCHIATR, V24, P122, DOI 10.1097/YCO.0b013e3283436eb7; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Hane M, 2012, PURE APPL CHEM, V84, P1895, DOI 10.1351/PAC-CON-11-12-10; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; Angata K, 2004, J BIOL CHEM, V279, P25883, DOI 10.1074/jbc.M401562200; COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005-08.016; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Woodbury ME, 2014, J NEUROIMMUNE PHARM, V9, P92, DOI 10.1007/s11481-013-9501-5; Turner CA, 2009, PHARMACOL BIOCHEM BE, V92, P100, DOI 10.1016/j.pbb.2008.10.018; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Hildebrandt H, 2010, ADV EXP MED BIOL, V663, P95, DOI 10.1007/978-1-4419-1170-4_6; BARDE YA, 1982, EMBO J, V1, P549; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; TARDIEU M, 1994, GROWTH FACTORS, V11, P291, DOI 10.3109/08977199409011002; Perez JA, 2009, J NEUROSCI, V29, P6379, DOI 10.1523/JNEUROSCI.4829-08.2009; YANG PF, 1994, J BIOL CHEM, V269, P23039; Kamien B, 2014, AM J MED GENET A, V164, P782, DOI 10.1002/ajmg.a.36345; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Fumagalli F, 2005, NEUROBIOL DIS, V20, P731, DOI 10.1016/j.nbd.2005.05.005; Weltrowski A, 2012, MACROMOL BIOSCI, V12, P740, DOI 10.1002/mabi.201100518; Graham BM, 2010, NEUROPSYCHOPHARMACOL, V35, P1348, DOI 10.1038/npp.2010.3; Bush MA, 2001, J CLIN PHARMACOL, V41, P378, DOI 10.1177/00912700122010230; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Kozisek ME, 2008, PHARMACOL THERAPEUT, V117, P30, DOI 10.1016/j.pharmthera.2007.07.001; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Krocher T, 2015, BRAIN STRUCT FUNCT, V220, P71, DOI 10.1007/s00429-013-0638-z; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Nagae M, 2013, J BIOL CHEM, V288, P33784, DOI 10.1074/jbc.M113.496224; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Eckhardt M, 2000, J NEUROSCI, V20, P5234; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; Colley KJ, 2014, CRIT REV BIOCHEM MOL, V49, P498, DOI 10.3109/10409238.2014.976606; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SATO C, 1993, J BIOL CHEM, V268, P23675; Shaw AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092556	51	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	OCT	2015	25	10					1112	1124		10.1093/glycob/cwv049		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7JL	WOS:000362990900008		
J	Kanie, O				Kanie, Osamu			Introduction to the special issue on chemical glycobiology: all the aspects are important	GLYCOCONJUGATE JOURNAL			English	Editorial Material									Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan	Kanie, O (reprint author), Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan.	kanie@tokai-u.jp						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					421	423		10.1007/s10719-015-9623-5		3	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600001		
J	Toshima, K; Takahashi, D				Toshima, Kazunobu; Takahashi, Daisuke			Chemical approach for target-selective degradation of oligosaccharides using photoactivatable organic molecules	GLYCOCONJUGATE JOURNAL			English	Review						Photodegradation; Lectin; Boronic acid; Kemp's acid; Anthraquinone; Anthracene	CONVERGENT FUNCTIONAL-GROUPS; CELL-WALL; MYCOBACTERIUM-TUBERCULOSIS; ACID; RECOGNITION; BINDING; LECTIN; COMPLEXES; DNA; PHOTOCLEAVAGE	Molecular design, chemical synthesis, and biological evaluation of several organic molecules, which can target-selectively photodegrade oligosaccharides by irradiation with a specific wavelength of light under mild conditions without any additives, are introduced. These novel class of photochemical agents promise bright prospects for finding not only molecular-targeted bioprobes for understanding of the structure-activity relationships of oligosaccharides but also novel therapeutic drugs targeting biologically important oligosaccharides.	[Toshima, Kazunobu; Takahashi, Daisuke] Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Toshima, K (reprint author), Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	toshima@applc.keio.ac.jp	Takahashi, Daisuke /F-7647-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23310153, 26282212, 24102528, 26102738, 22710220]	The authors wish to sincerely thank all of the co-authors of the references cited in this review article. This research was supported in part by Scientific Research (B) (No. 23310153 and 26282212), Scientific Research on Innovative Areas "Chemical Biology of Natural Products" (No. 24102528 and 26102738), and Grants-in-Aid for Young Scientists (B) (No. 22710220) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Nishibu M, 2012, ORG BIOMOL CHEM, V10, P8393, DOI 10.1039/c2ob26417j; Hayashi N, 2004, BIOSCI BIOTECH BIOCH, V68, P2512, DOI 10.1271/bbb.68.2512; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; AQUINO AM, 1990, J AM CHEM SOC, V112, P5819, DOI 10.1021/ja00171a022; LORAND JP, 1959, J ORG CHEM, V24, P769, DOI 10.1021/jo01088a011; WILLIAMS K, 1989, J AM CHEM SOC, V111, P1090, DOI 10.1021/ja00185a045; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SIMKOVIC I, 1990, CARBOHYD RES, V201, P346, DOI 10.1016/0008-6215(90)84251-O; Takahashi D, 2010, ANGEW CHEM INT EDIT, V49, P10096, DOI 10.1002/anie.201005161; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174; Hirose K, 2001, J INCL PHENOM MACRO, V39, P193, DOI 10.1023/A:1011117412693; Djanashvili K, 2005, CHEM-EUR J, V11, P4010, DOI 10.1002/chem.200401335; Springsteen G, 2001, CHEM COMMUN, P1608, DOI 10.1039/b104895n; Toshima K, 2000, BIOORG MED CHEM LETT, V10, P2163, DOI 10.1016/S0960-894X(00)00410-8; KOCH T, 1993, PHOTOCHEM PHOTOBIOL, V58, P554, DOI 10.1111/j.1751-1097.1993.tb04931.x; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Toshima K, 2004, ARKIVOC, P28; KEMP DS, 1981, J ORG CHEM, V46, P5140, DOI 10.1021/jo00338a014; NORRILD JC, 1995, J AM CHEM SOC, V117, P1479, DOI 10.1021/ja00110a003; Scherman MS, 2003, ANTIMICROB AGENTS CH, V47, P378, DOI 10.1128/AAC.47.1.378-382.2003; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Ravishankar R, 1997, CURR SCI INDIA, V72, P855; Ishii M, 2007, ANGEW CHEM INT EDIT, V46, P8396, DOI 10.1002/anie.200702127; ASKEW B, 1989, J AM CHEM SOC, V111, P1082, DOI 10.1021/ja00185a044; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Hamachi I, 2000, J AM CHEM SOC, V122, P12065, DOI 10.1021/ja002044d; Bender M. L., 1978, CYCLODEXTRIN CHEM; Bycroft B.W., 1988, DICT ANTIBIOTICS REL; Ernst B., 2000, CARBOHYDRATE CHEM BI; Gibson A.R., 1974, CAN J CHEM, V52, P3095; James T.D, 2006, BORONIC ACIDS PREPAR, P441; Kamerling J.P., 2007, COMPREHENSIVE GLYCOS	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					475	482		10.1007/s10719-015-9591-9		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600006		
J	Taichi, M; Kitazume, S; Vong, K; Imamaki, R; Kurbangalieva, A; Taniguchi, N; Tanaka, K				Taichi, Misako; Kitazume, Shinobu; Vong, Kenward; Imamaki, Rie; Kurbangalieva, Almira; Taniguchi, Naoyuki; Tanaka, Katsunori			Cell surface and in vivo interaction of dendrimeric N-glycoclusters	GLYCOCONJUGATE JOURNAL			English	Article						Asparagine-linked glycans (N-Glycan); Dendrimer; Platelet endothelial cell adhesion molecule (PECAM); Glycocluster; In vivo imaging; Lectin	ADHESION MOLECULE PECAM; ASIALOGLYCOPROTEIN RECEPTOR; INNATE IMMUNITY; DRUG-DELIVERY; NEOGLYCOPROTEINS; BIODISTRIBUTION; INFLAMMATION; GLYCANS; BINDING; VITRO	While many examples have been reported that glycoclusters interact with target lectins more strongly than single molecules of glycans, through multivalency effects, literature examples to support lectin interactions/modulations on cell surface and in live animals is quite rare. Our N-glycoclusters, which were efficiently prepared by immobilizing 16 molecules of the asparagine-linked glycans (N-glycans) onto a lysine-based dendron template through histidine-mediated Huisgen cycloaddition, were shown to efficiently detect platelet endothelial cell adhesion molecule (PECAM) on human umbilical vein endothelial cells (HUVEC) as a alpha(2-6)-sialylated oligosaccharides recognizing lectin. Furthermore, the identity of the N-glycans on our N-glycoclusters allowed control over organ-selective accumulation and serum clearance properties when intravenously injected into mice.	[Taichi, Misako; Vong, Kenward; Tanaka, Katsunori] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama 3510198, Japan; [Kitazume, Shinobu; Imamaki, Rie; Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, RIKEN Global Res Cluster, Wako, Saitama 3510198, Japan; [Kurbangalieva, Almira; Tanaka, Katsunori] Kazan Fed Univ, Biofunct Chem Lab, A Butlerov Inst Chem, Kazan 420008, Russia; [Tanaka, Katsunori] JST PRESTO, Wako, Saitama 3510198, Japan	Tanaka, K (reprint author), RIKEN, Biofunct Synthet Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kotzenori@riken.jp			Japan Society for the Promotion of Science [23681047, 25560410, 26560438, 26870859]; Mizutani Foundation for Glycoscience; MEXT [25430122, 26102743]	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, No. 23681047, 25560410, 26560438, and 26870859; by a Research Grant from the Mizutani Foundation for Glycoscience; and by a MEXT Grant-in-Aid for Scientific Research (C) (No. 25430122) and on Innovative Areas "Chemical Biology of Natural Products: Target ID and Regulation of Bioactivity" (No. 26102743). This work was also performed under the Russian Government Program of Competitive Growth of Kazan Federal University.	Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; van Kasteren SI, 2009, P NATL ACAD SCI USA, V106, P18, DOI 10.1073/pnas.0806787106; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Ikehara Y, 2006, CANCER RES, V66, P8740, DOI 10.1158/0008-5472.CAN-06-0470; Tanaka K, 2008, ORG BIOMOL CHEM, V6, P815, DOI 10.1039/b718157b; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Wong CWY, 2000, MOL BIOL CELL, V11, P3109; Bird IN, 1999, J CELL SCI, V112, P1989; Unverzagt C, 2002, J MED CHEM, V45, P478, DOI 10.1021/jm0110237; MORELL AG, 1968, J BIOL CHEM, V243, P155; Tanaka K, 2010, ANGEW CHEM INT EDIT, V49, P8195, DOI 10.1002/anie.201000892; Davicino RC, 2011, INT IMMUNOPHARMACOL, V11, P1457, DOI 10.1016/j.intimp.2011.05.002; Chabre YM, 2010, ADV CARBOHYD CHEM BI, V63, P165, DOI 10.1016/S0065-2318(10)63006-5; Leeuwenburgh MA, 2003, CURR OPIN CHEM BIOL, V7, P757, DOI 10.1016/j.cbpa.2003.10.009; Andre S, 1997, BIOCONJUGATE CHEM, V8, P845, DOI 10.1021/bc970164d; Fukase K, 2012, CURR OPIN CHEM BIOL, V16, P614, DOI 10.1016/j.cbpa.2012.09.005; Tanaka K, 2008, ANGEW CHEM INT EDIT, V47, P102, DOI 10.1002/anie.200702989; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Serres S, 2009, J NEUROSCI, V29, P4820, DOI 10.1523/JNEUROSCI.0406-09.2009; Chabre YM, 2008, CURR TOP MED CHEM, V8, P1237, DOI 10.2174/156802608785848987; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Nieda M, 2001, IMMUNOLOGY, V102, P137, DOI 10.1046/j.1365-2567.2001.01175.x; Chen WC, 2010, BLOOD, V115, P4778, DOI 10.1182/blood-2009-12-257386; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Renaudet O, 2008, MINI-REV ORG CHEM, V5, P274, DOI 10.2174/157019308786242142; Hirai M, 2007, BIOCHEM BIOPH RES CO, V353, P553, DOI 10.1016/j.bbrc.2006.12.060; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Ogura A, 2014, GLYCOCONJUGATE J, V31, P273, DOI 10.1007/s10719-014-9520-3; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Tanaka K, 2007, TETRAHEDRON LETT, V48, P6475, DOI 10.1016/j.tetlet.2007.07.055; Kikkeri R, 2009, J AM CHEM SOC, V131, P2110, DOI 10.1021/ja807711w; Kamerling J. P., 2007, COMPREHENSIVE GLYCOS, VIII; Kamerling J. P., 2007, COMPREHENSIVE GLYCOS, VII; Kitazume S, 2014, J BIOL CHEM, V289, P27604, DOI 10.1074/jbc.M114.563585; Ogura A, 2014, MINI-REV MED CHEM, V14, P1072; Roy R., 2002, REV MOL BIOTECHNOL, V90, P291; Vyas SP, 2001, CRIT REV THER DRUG, V18, P1; Willis M, 1998, ADV DRUG DELIV REV, V29, P249, DOI DOI 10.1016/S0169-409X(97)00083-5	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					497	503		10.1007/s10719-015-9594-6		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600008		
J	Kato, K; Yamaguchi, T				Kato, Koichi; Yamaguchi, Takumi			Paramagnetic NMR probes for characterization of the dynamic conformations and interactions of oligosaccharides	GLYCOCONJUGATE JOURNAL			English	Review						Nuclear magnetic resonance spectroscopy; Paramagnetic effect; Conformational dynamics; Oligosaccharide; Lanthanide ion; Spin label	RESIDUAL DIPOLAR COUPLINGS; NUCLEAR-MAGNETIC-RESONANCE; N-LINKED OLIGOSACCHARIDES; METHYL-D-GLUCOPYRANOSIDE; SPIN-LABEL ANTIBODY; CONCANAVALIN-A; PSEUDOCONTACT SHIFTS; STRUCTURAL BIOLOGY; ADHESION DOMAIN; HUMAN CD2	Paramagnetism-assisted nuclear magnetic resonance (NMR) techniques have recently been applied to a wide variety of biomolecular systems, using sophisticated immobilization methods to attach paramagnetic probes, such as spin labels and lanthanide-chelating groups, at specific sites of the target biomolecules. This is also true in the field of carbohydrate NMR spectroscopy. NMR analysis of oligosaccharides is often precluded by peak overlap resulting from the lack of variability of local chemical structures, by the insufficiency of conformational restraints from nuclear Overhauser effect (NOE) data due to low proton density, and moreover, by the inherently flexible nature of carbohydrate chains. Paramagnetic probes attached to the reducing ends of oligosaccharides cause paramagnetic relaxation enhancements (PREs) and/or pseudocontact shifts (PCSs) resolve the peak overlap problem. These spectral perturbations can be sources of long-range atomic distance information, which complements the local conformational information derived from J couplings and NOEs. Furthermore, paramagnetic NMR approaches, in conjunction with computational methods, have opened up possibilities for the description of dynamic conformational ensembles of oligosaccharides in solution. Several applications of paramagnetic NMR techniques are presented to demonstrate their utility for characterizing the conformational dynamics of oligosaccharides and for probing the carbohydrate-recognition modes of proteins. These techniques can be applied to the characterization of transient, non-stoichiometric interactions and will contribute to the visualization of dynamic biomolecular processes involving sugar chains.	[Kato, Koichi; Yamaguchi, Takumi] Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi; Yamaguchi, Takumi] Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi; Yamaguchi, Takumi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan	Kato, K (reprint author), Inst Mol Sci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	kkatonmr@ims.ac.jp			Okazaki ORION project; JSPS/MEXT [25102008, 24249002, 26560451, 24750170, 15 K17889]; Nanotechnology Platform Program	This study was partly supported by the Okazaki ORION project, JSPS/MEXT Grants-in-Aid for Scientific Research (25102008, 24249002, 26560451, 24750170 and 15 K17889) and the Nanotechnology Platform Program (Molecule and Material Synthesis).	DeMarco ML, 2010, J AM CHEM SOC, V132, P1334, DOI 10.1021/ja907518x; Bertini I, 2001, J AM CHEM SOC, V123, P4181, DOI 10.1021/ja0028626; Jones DH, 2010, J BIOMOL NMR, V46, P89, DOI 10.1007/s10858-009-9365-4; Su XC, 2010, J BIOMOL NMR, V46, P101, DOI 10.1007/s10858-009-9331-1; Jain NU, 2001, PROTEIN SCI, V10, P2393, DOI 10.1110/ps.17401; Mallagaray A, 2011, CHEM COMMUN, V47, P7179, DOI 10.1039/c1cc11860a; Yamamoto S, 2011, CHEM-EUR J, V17, P9280, DOI 10.1002/chem.201100856; Allegrozzi M, 2000, J AM CHEM SOC, V122, P4154, DOI 10.1021/ja993691b; Yamaguchi T, 2013, CHEM LETT, V42, P544, DOI 10.1246/cl.130040; Tolman JR, 2001, J AM CHEM SOC, V123, P1416, DOI 10.1021/ja002500y; Otting G, 2008, J BIOMOL NMR, V42, P1, DOI 10.1007/s10858-008-9256-0; Zhuang TD, 2008, PROTEIN SCI, V17, P1220, DOI 10.1110/ps.034561.108; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Kamiya Y, 2011, J BIOMOL NMR, V50, P397, DOI 10.1007/s10858-011-9525-1; BARRY CD, 1971, NATURE, V232, P236, DOI 10.1038/232236a0; Kamiya Y, 2012, BBA-GEN SUBJECTS, V1820, P1327, DOI 10.1016/j.bbagen.2011.12.017; MARTINEZYAMOUT M, 1994, J MOL BIOL, V244, P301, DOI 10.1006/jmbi.1994.1731; HOMANS SW, 1987, BIOCHEMISTRY-US, V26, P6649, DOI 10.1021/bi00395a014; ANGLISTER J, 1984, BIOCHEMISTRY-US, V23, P1138, DOI 10.1021/bi00301a016; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Shishmarev D, 2013, J BIOMOL NMR, V56, P203, DOI 10.1007/s10858-013-9738-6; HOMANS SW, 1986, BIOCHEMISTRY-US, V25, P6342, DOI 10.1021/bi00368a076; WOODS RJ, 1995, CURR OPIN STRUC BIOL, V5, P591, DOI 10.1016/0959-440X(95)80049-2; Su XC, 2008, J AM CHEM SOC, V130, P10486, DOI 10.1021/ja803741f; GRIMALDI JJ, 1975, J BIOL CHEM, V250, P1618; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Canales A, 2012, MAGN RESON CHEM, V50, pS80, DOI 10.1002/mrc.3888; BREWER CF, 1973, P NATL ACAD SCI USA, V70, P1007, DOI 10.1073/pnas.70.4.1007; Sato S, 2004, CARBOHYD RES, V339, P2425, DOI 10.1016/j.carres.2004.07.014; Zhang Y, 2013, CHEM LETT, V42, P1455, DOI 10.1246/cl.130789; LEAHY DJ, 1988, P NATL ACAD SCI USA, V85, P3661, DOI 10.1073/pnas.85.11.3661; Saio T, 2009, J BIOMOL NMR, V44, P157, DOI 10.1007/s10858-009-9325-z; KOENIG SH, 1973, P NATL ACAD SCI USA, V70, P475, DOI 10.1073/pnas.70.2.475; Enoki S, 2015, ANAL CHEM, V87, P2079, DOI 10.1021/ac502408c; Doi T, 2014, CHEM SCI, V5, P1860, DOI 10.1039/c3sc53237b; Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124; WYSS DF, 1995, BIOCHEMISTRY-US, V34, P1622, DOI 10.1021/bi00005a019; Lebel P, 2014, NAT METHODS, V11, P456, DOI 10.1038/nmeth.2854; Torizawa T, 2000, NUCLEIC ACIDS RES, V28, P944, DOI 10.1093/nar/28.4.944; Arnesano F, 2005, Q REV BIOPHYS, V38, P167, DOI 10.1017/S0033583506004161; Gonzalez L, 2000, ARCH BIOCHEM BIOPHYS, V383, P17, DOI 10.1006/abbi.2000.2031; Zhang Y, 2012, MOLECULES, V17, P6658, DOI 10.3390/molecules17066658; Bini D, 2012, CARBOHYD RES, V354, P21, DOI 10.1016/j.carres.2012.03.002; Kamiya Y, 2014, CURR OPIN STRUC BIOL, V26, P44, DOI 10.1016/j.sbi.2014.03.008; Peters T, 1996, CURR OPIN STRUC BIOL, V6, P710, DOI 10.1016/S0959-440X(96)80039-X; WOOTEN EW, 1990, EUR BIOPHYS J, V18, P139, DOI 10.1007/BF02427373; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; Canales A, 2013, ANGEW CHEM INT EDIT, V52, P13789, DOI 10.1002/anie.201307845; Satoh T, 2015, MOLECULES, V20, P2475, DOI 10.3390/molecules20022475; Bertini I, 2002, PROG NUCL MAG RES SP, V40, P249, DOI 10.1016/S0079-6565(02)00002-X; Su XC, 2008, J AM CHEM SOC, V130, P1681, DOI [10.1021/ja076564l, 10.1021/ja0765641]; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Canales A, 2014, J AM CHEM SOC, V136, P8011, DOI 10.1021/ja502406x; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Yagi-Utsumi M, 2010, FEBS LETT, V584, P831, DOI 10.1016/j.febslet.2010.01.005; Yamamoto S, 2012, CHEM COMMUN, V48, P4752, DOI 10.1039/c2cc30353a; Liu S, 2009, BIOCHEMISTRY-US, V48, P11211, DOI 10.1021/bi9015154; MCDONALD CC, 1969, BIOCHEM BIOPH RES CO, V35, P43, DOI 10.1016/0006-291X(69)90480-X; Wohnert J, 2003, J AM CHEM SOC, V125, P13338, DOI 10.1021/ja036022d; Henry B, 1999, CARBOHYD RES, V315, P48, DOI 10.1016/S0008-6215(98)00301-2; Keizers PHJ, 2008, J AM CHEM SOC, V130, P14802, DOI 10.1021/ja8054832; BYRD JC, 1982, J BIOL CHEM, V257, P4657; Dwek R.A, 1973, NUCL MAGNETIC RESONA; Erdelyi M, 2011, CHEM-EUR J, V17, P9368, DOI 10.1002/chem.201100854; Hansel R, 2014, ANGEW CHEM INT EDIT, V53, P10300, DOI 10.1002/anie.201311320; Kamiya Yukiko, 2013, Biomolecules, V3, P108, DOI 10.3390/biom3010108; Luchinat C., 2010, ENCY NMR, V6, P3317, DOI [10.1002/9780470034590.emrstm1088, DOI 10.1002/9780470034590.EMRSTM1088]; Rodriguez-Castaneda F, 2006, MAGN RESON CHEM, V44, pS10, DOI 10.1002/mrc.1811; Satoh T, 2014, FEBS LETT, V588, P4422, DOI 10.1016/j.febslet.2014.10.013; Sharp R.R., 2003, NUCL MAGN RESON SPEC, V32, P473, DOI 10.1039/9781847553881-00473; VILLAFRA.JJ, 1974, ARCH BIOCHEM BIOPHYS, V160, P465, DOI 10.1016/0003-9861(74)90422-6; Vliegenthart J F, 1980, Adv Exp Med Biol, V125, P77; Wuthrich K., 1976, NMR BIOL RES PEPTIDE; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Yamaguchi T, 2014, ANGEW CHEM INT EDIT, V53, P10941, DOI 10.1002/anie.201406145; Yamaguchi T., 2014, GLYCOSCI BIOL MED, V1, P137, DOI [10.1007/978-4-431-54841-6101, DOI 10.1007/978-4-431-54841-6101]; Yamaguchi Yoshiki, 2014, Adv Neurobiol, V9, P165, DOI 10.1007/978-1-4939-1154-7_8; Zhang Y, 2015, ADV EXP MED BIOL, V842, P217, DOI 10.1007/978-3-319-11280-0_14	79	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					505	513		10.1007/s10719-015-9599-1		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600009		
J	Miyagawa-Yamaguchi, A; Kotani, N; Honke, K				Miyagawa-Yamaguchi, Arisa; Kotani, Norihiro; Honke, Koichi			Each GPI-anchored protein species forms a specific lipid raft depending on its GPI attachment signal	GLYCOCONJUGATE JOURNAL			English	Article						EMARS; HRP; Fluorescein tyramide; Visualization of co-clustering molecules; N-glycosylation	ENZYME-MEDIATED ACTIVATION; DECAY-ACCELERATING FACTOR; HORSERADISH-PEROXIDASE; LIVING CELLS; EMARS METHOD; SITE; AMPLIFICATION; TRANSDUCTION; COMPLEXES; THY-1	We previously reported a method, termed enzyme-mediated activation of radical sources (EMARS) for analysis of co-clustered molecules with horseradish peroxidase (HRP) fusion proteins expressed in living cells. This method is featured by radical formation of labeling reagents by HRP. In the current study, we have employed another labeling reagent, fluorescein-conjugated tyramide (FT) instead of the original arylazide compounds. Although hydrogen peroxide is required for the activation of FT, the labeling efficiency by HRP and the nonspecific reactions by endogenous enzyme(s) have been dramatically improved compared with the original fluorescein arylazide. This revised EMARS method has enabled visualization of co-clustered molecules in the endoplasmic reticulum and Golgi membranes with confocal microscopy. By using this method, we have found that GPI-anchored proteins, decay accelerating factor (DAF) and Thy-1 are exclusively co-clustered with HRP-DAFGPI and HRP-Thy1GPI, in which GPI attachment signals of DAF and Thy-1 have been connected to HRP, respectively. Furthermore, the N-glycosylation types of DAF and Thy-1 have been found to correspond to those of HRP-DAFGPI and HRP-Thy1GPI, respectively. These results indicate that each GPI-anchored protein species forms a specific lipid raft depending on its GPI attachment signal, and that the EMARS method can segregate individual lipid rafts.	[Miyagawa-Yamaguchi, Arisa; Honke, Koichi] Kochi Univ, Sch Med, Ctr Innovate & Translat Med, Nankoku, Kochi 7838505, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Saitama 3500495, Japan; [Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan	Honke, K (reprint author), Kochi Univ, Sch Med, Ctr Innovate & Translat Med, Nankoku, Kochi 7838505, Japan.	khonke@kochi-u.ac.jp					ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457; Honke K, 2011, J NEUROCHEM, V116, P690, DOI 10.1111/j.1471-4159.2010.07027.x; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Schikorski T, 2010, METHODS MOL BIOL, V657, P315, DOI 10.1007/978-1-60761-783-9_25; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; PAREKH RB, 1987, EMBO J, V6, P1233; Jiang SL, 2012, PROTEOMICS, V12, P54, DOI 10.1002/pmic.201100551; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Matsui T, 2003, APPL MICROBIOL BIOT, V62, P517, DOI 10.1007/s00253-003-1273-z; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Honke K, 2012, SENSORS-BASEL, V12, P16037, DOI 10.3390/s121216037; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Harris TJC, 2002, BIOESSAYS, V24, P996, DOI 10.1002/bies.10172; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Brodbeck WG, 2000, IMMUNOLOGY, V101, P104, DOI 10.1046/j.1365-2567.2000.00086.x; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Devasahayam M, 1999, GLYCOBIOLOGY, V9, P1381, DOI 10.1093/glycob/9.12.1381; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Bendayan M, 2001, SCIENCE, V291, P1363, DOI 10.1126/science.291.5507.1363; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Miyagawa-Yamaguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093054; Miyagawa-Yamaguchi A, 2014, TRENDS GLYCOSCI GLYC, V26, P59	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					531	540		10.1007/s10719-015-9595-5		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600011		
J	Sakamoto, Y; Ohta, T; Ito, Y				Sakamoto, Yasuharu; Ohta, Tsuyoshi; Ito, Yukishige			Stereoselective synthesis of UDP-2-(2-ketopropyl)galactose aided by di-tert-butylsilylene protecting group	GLYCOCONJUGATE JOURNAL			English	Article						Stereoselective synthesis; Galactose derivative; Di-tert-butylsilylene; Iodination; Radical methallylation	BETA-N-ACETYLGLUCOSAMINE; O-LINKED GLCNAC; DYNAMIC INTERPLAY; HISTONE H3; PROTEINS; GLYCOSYLATION; GLCNACYLATION; IDENTIFICATION; PHOSPHATE; RESIDUES	UDP-2-(2-ketopropyl)galactose (1) has been utilized as a valuable probe for profiling proteins modified by O-GlcNAc. In this work, we developed a protocol for efficient synthesis of 1. Thus, 2-methallylgalactose derivative 11, a synthetic intermediate for the compound 1, was prepared by stereoselective iodination and methallylation at C-2 position, through exploitation of 4,6-O-di-tert-butylsilylene protecting group.	[Sakamoto, Yasuharu; Ohta, Tsuyoshi; Ito, Yukishige] RIKEN, Synthet Cellular Chem, Wako, Saitama 3510198, Japan; [Ito, Yukishige] Japan Sci & Technol Agcy JST, ERATO Glycotril Project, Wako, Saitama 3510198, Japan	Sakamoto, Y (reprint author), RIKEN, Synthet Cellular Chem, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	ysakamot@riken.jp; yukito@riken.jp	Ito, Yukishige/M-5119-2014	Ito, Yukishige/0000-0001-6251-7249	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation, Osaka, Japan (NIBIO) [09-01]	We thank Dr. Yayoi Hongo and Dr. Takemichi Nakamura for ESI mass measurements. We also thank Ms. Akemi Takahashi and Ms. Satoko Shirahata for technical assistance. This research was supported by the Advanced Research for Medical Products Mining Program (09-01) of the National Institute of Biomedical Innovation, Osaka, Japan (NIBIO).	Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; CHOU CF, 1992, J BIOL CHEM, V267, P3901; KECK GE, 1985, TETRAHEDRON, V41, P4079, DOI 10.1016/S0040-4020(01)97185-6; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/nchembio.412, 10.1038/NCHEMBIO.412]; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Dulcey AE, 2011, TETRAHEDRON, V67, P2013, DOI 10.1016/j.tet.2011.01.081; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Hang HC, 2001, J AM CHEM SOC, V123, P1242, DOI 10.1021/ja002962b; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Imamura A, 2003, TETRAHEDRON LETT, V44, P6725, DOI 10.1016/S0040-4039(03)01647-2; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Imamura A, 2005, ORG LETT, V7, P4415, DOI 10.1021/ol051592z; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Imamura A, 2006, CHEM-EUR J, V12, P8862, DOI 10.1002/chem.200600832; Kesrse K.P., 1991, P NATL ACAD SCI USA, V88, P1701	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	OCT	2015	32	7					541	548		10.1007/s10719-015-9581-y		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT6FA	WOS:000362906600012		
J	Han, XT; Ping, B; Morita, M; Ebi, R; Inoue, J; Tanaka, Y; Chen, Y; Wan, XC; Yang, WT; Chang, B; Wu, XH				Han, Xiaotian; Ping, Bo; Morita, Masakatsu; Ebi, Ryuichiro; Inoue, Junya; Tanaka, Yosuke; Chen, Ying; Wan, Xiaochun; Yang, Wentao; Chang, Bin; Wu, Xiaohua			A novel highly sensitive and specific flow cytometry system for cervical cancer screening	GYNECOLOGIC ONCOLOGY			English	Article						Cervical cancer; Flow cytometry; Human papillomavirus	HUMAN-PAPILLOMAVIRUS DNA; HISTOLOGICAL SUBTYPES; TUMOR-CELLS; CYTOLOGY; HPV; ADENOCARCINOMA; LESIONS; RISK; IDENTIFICATION; PREVALENCE	Purpose. This study assessed the performance of a novel flow cytometry (FCM) cervical cancer screening system compared with human papillomavirus (HPV) Hybrid Capture 2 (HC2). Methods. Chinese women aged 20 years or older were enrolled in this study at Fudan University Shanghai Cancer Center. All participants underwent cytology/pathology testing (gold standard), HPV HC2 testing and FCM testing involving analysis of cell proliferation index (CPIx). Results. Among 437 women enrolled in this study, 185 women (42.3%) were diagnosed as "gold standard positive" by pathology with diseases including cervical intraepithelial neoplasia (CIN) grade 2 (n = 11), CIN3 (n = 41), squamous cell carcinoma (SCC; n = 115), adenocarcinoma in situ (n = 2) and adenocarcinoma (n = 16). The remaining 252 cases were deemed "gold standard negative". The sensitivity was 87.6% (95% Cl, 82.8-923) for FCM testing and 89.7% (95% CI, 85.4-94.1; p = 0.5121) for HPV HC2 testing. The specificity of FCM testing was 90.5% (95% CI, 86.2-94.7), which was superior to the specificity of HPV HC2 testing (84.5%, 95% CI, 79.3-89.7; p = 0.04). In the 20-29 years old group, the sensitivity and the specificity of FCM testing were 90.0% (95% Cl, 71.4-100.0) and 92.9% (95% CI, 76.9-100.0), respectively. The FCM testing CPIx statistically increased with the transition from normal cervical specimens to SCC specimens. Conclusions. Our results showed that the FCM screening system had high sensitivity and specificity for women of various ages. The FCM CPIx was able to evaluate the severity of disease quantitatively. (C) 2015 Elsevier Inc. All rights reserved.	[Han, Xiaotian; Wu, Xiaohua] Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Han, Xiaotian; Ping, Bo; Chen, Ying; Wan, Xiaochun; Yang, Wentao; Chang, Bin; Wu, Xiaohua] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Ping, Bo; Chen, Ying; Wan, Xiaochun; Yang, Wentao; Chang, Bin] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China; [Morita, Masakatsu; Ebi, Ryuichiro; Inoue, Junya; Tanaka, Yosuke] Sysmex Corp, HU Business Unit, UB Prod Engn, Prod Dev, Kobe, Hyogo, Japan	Wu, XH (reprint author), Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, 270 DongAn Rd, Shanghai 200032, Peoples R China.	docwuxh@hotmail.com			"Clinical study of cervical cancer FCM screening system" project of Sysmex Corporation UB Product Engineering through Fudan University Shanghai Cancer Center [2012-66-625]	We are grateful to the staff of the Department of Gynecologic Oncology of Fudan University Shanghai Cancer Center for specimen collection and the staff of the Department of Pathology for specimen identification. This research is sponsored by the "Clinical study of cervical cancer FCM screening system" project of Sysmex Corporation UB Product Engineering through Fudan University Shanghai Cancer Center (Num. 2012-66-625).	An HJ, 2005, MODERN PATHOL, V18, P528, DOI 10.1038/modpathol.3800316; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; KIMMIG R, 1995, J CANCER RES CLIN, V121, P107, DOI 10.1007/BF01202222; Melsheimer P, 2001, CYTOMETRY, V46, P166, DOI 10.1002/cyto.1101; Bulk S, 2006, BRIT J CANCER, V94, P171, DOI 10.1038/sj.bjc.6602915; Lorenzato M, 2002, AM J CLIN PATHOL, V118, P708; de Cremoux P, 2003, AM J CLIN PATHOL, V120, P492, DOI 10.1309/XFUCPP6M5XUA94B8; Guo M, 2004, AM J CLIN PATHOL, V122, P894, DOI 10.1309/0DGGQAMJCJBXB; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Bollmann R, 2001, CANCER CYTOPATHOL, V93, P222, DOI 10.1002/cncr.9033; Leinonen M, 2009, J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; PEREZ DJ, 1981, BRIT J CANCER, V43, P526, DOI 10.1038/bjc.1981.75; Tong H, 2009, CLIN CANCER RES, V15, P6438, DOI 10.1158/1078-0432.CCR-09-1689; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Clavel C, 2001, BRIT J CANCER, V84, P1616, DOI 10.1054/bjoc.2001.1845; Steinbeck RG, 1997, ACTA ONCOL, V36, P3; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Guillaud M, 2006, CANCER, V107, P309, DOI 10.1002/cncr.21993; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Arbyn M, 2013, COCHRANE DB SYST REV, V3, P8054, DOI DOI 10.1002/14651858.CD008054.PUB2; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Ebi R., 2013, US Patent Application, Publication, Patent No. [US20130217110 A12013, 20130217110A1]; Ebi R., 2014, US Patent Application, Publication, Patent No. [US20140199702 A12014, 20140199702A1]; Fukuda M., 2009, US Patent Application, Publication, Patent No. [US2009/0091746 A12009, 20090091746A1]; Jastania R, 2006, AM J CLIN PATHOL, V125, P223, DOI 10.1309/QEJBY77YMTEVJ66; Morisaki H., 2014, CYTOMETRY RES, V24, P41; Moyer A.V., 2012, ANN INTERN MED, V156, P880; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI 10.1309/AJCPTGD94EVRSJCG; Shirasuna K., 2015, K SHIRASUNA, P1, Patent No. EP2860263A1; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh M., 2008, J CANC EPIDEMIOL, V2008; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wright TC, 2015, GYNECOL ONCOL, V136, P189, DOI 10.1016/j.ygyno.2014.11.076	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	OCT	2015	139	1					52	58		10.1016/j.ygyno.2015.07.102		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CT6ND	WOS:000362928800009		
J	Todo, Y; Yamazaki, H; Takeshita, S; Ohba, Y; Sudo, S; Minobe, S; Okamoto, K; Kato, H				Todo, Yukiharu; Yamazaki, Hiroyuki; Takeshita, Sho; Ohba, Yoko; Sudo, Satoko; Minobe, Shinichiro; Okamoto, Kazuhira; Kato, Hidenori			Close relationship between removal of circumflex iliac nodes to distal external iliac nodes and postoperative lower-extremity lymphedema in uterine corpus malignant tumors	GYNECOLOGIC ONCOLOGY			English	Article						Cancer survivor; Lymphadenectomy; Leg edema; Circumflex iliac node; Endometrial cancer	ENDOMETRIAL CANCER; METASTASIS; LYMPHADENECTOMY; COMPLICATIONS; STATISTICS; CARCINOMA	Objective. The aim of this study was to confirm a causal relationship between removal of circumflex iliac nodes to the distal external iliac nodes (CINDEIN) and lower-extremity lymphedema after systematic lymphadenectomy in patients with uterine corpus malignancies. Methods. A retrospective chart review was carried out for all patients with uterine corpus malignant tumor managed at Hokkaido Cancer Center between 1991 and 2013. All 318 patients underwent CINDEIN dissection as a part of initial surgery and 217 patients did not. Patients had undergone hysterectomy, bilateral salpingooophorectomy and lymphadenectomy and their medical records were reviewed. The type of lymphadenectomy gradually shifted from pelvic lymphadenectomy with removal of CINDEIN to full lymphadenectomy without CINDEIN dissection during this period. We identified patients with postoperative lower-extremity lymphedema (POLEL). Logistic regression analysis was used to select the risk factors for POLEL Results. Of 535 patients evaluated, POLEL was noted in the medical records of 126 patients (23.6%), with median follow-up of 71 months. The occurrence of POLEL was significantly higher in the CINDEIN-dissection group than in the CINDEIN-sparing group (34.3% vs. 7.8%, P < 0.0001). Multivariate analysis confirmed that adjuvant radiation therapy [odds ratio (OR) = 6.3, 95% confidence interval (CI) = 2.6-14.9], resection of more than 31 lymph nodes (OR = 2.0, 95% CI = 1.2-3.5), and removal of CINDEIN (OR = 5.4,95% Cl = 3.1-93) were independent risk factors for POLEL. Conclusions. Elimination of CINDEIN dissection can be helpful in reducing the incidence of POLEL. (C) 2015 Elsevier Inc. All rights reserved.	[Todo, Yukiharu; Yamazaki, Hiroyuki; Takeshita, Sho; Ohba, Yoko; Sudo, Satoko; Minobe, Shinichiro; Okamoto, Kazuhira; Kato, Hidenori] Natl Hosp Org, Hokkaido Canc Ctr, Div Gynecol Oncol, Sapporo, Hokkaido 0030804, Japan	Todo, Y (reprint author), Natl Hosp Org, Hokkaido Canc Ctr, Div Gynecol Oncol, Shiroishi Ku, 4-2 Kikusui, Sapporo, Hokkaido 0030804, Japan.	yukiharu@sap-cc.go.jp					Yin YJ, 2014, INT J GYNECOL CANCER, V24, P935, DOI 10.1097/IGC.0000000000000138; Hareyama H, 2012, ANN SURG ONCOL, V19, P268, DOI 10.1245/s10434-011-1863-4; Konno Y, 2011, INT J GYNECOL CANCER, V21, P385, DOI 10.1097/IGC.0b013e3182094e09; Todo Y, 2011, GYNECOL ONCOL, V122, P55, DOI 10.1016/j.ygyno.2011.03.031; Matsumoto K, 2002, CANCER LETT, V180, P83, DOI 10.1016/S0304-3835(01)00803-5; Ohba Y, 2011, INT J CLIN ONCOL, V16, P238, DOI 10.1007/s10147-010-0171-5; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; Abu-Rustum NR, 2007, GYNECOL ONCOL, V106, P4, DOI 10.1016/j.ygyno.2007.03.026; Kodama J, 2006, EUR J OBSTET GYN R B, V124, P222, DOI 10.1016/j.ejogrb.2005.06.027; Ohba Y, 2012, GYNECOL ONCOL, V126, P387, DOI 10.1016/j.ygyno.2012.05.031; Hoffman MS, 1999, OBSTET GYNECOL, V94, P391, DOI 10.1016/S0029-7844(99)00310-5; Niikura H, 2004, GYNECOL ONCOL, V92, P669, DOI 10.1016/j.ygyno.2003.10.039; Todo Y, 2010, GYNECOL ONCOL, V119, P60, DOI 10.1016/j.ygyno.2010.06.018; International Society of Lymphology, 2003, LYMPHOLOGY, V36, P84; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254	15	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	OCT	2015	139	1					160	164		10.1016/j.ygyno.2015.07.003		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CT6ND	WOS:000362928800025		
J	Kaneko, Y; Kato, R; Nakahara, S; Tobiume, T; Morishima, I; Tanaka, K; Nakajima, T; Irie, T; Kusano, KF; Kamakura, S; Nagase, T; Takayanagi, K; Matsumoto, K; Kurabayashi, M				Kaneko, Yoshiaki; Kato, Ritsushi; Nakahara, Shiro; Tobiume, Takeshi; Morishima, Itsuro; Tanaka, Kazuhiko; Nakajima, Tadashi; Irie, Tadanobu; Kusano, Kengo Fukushima; Kamakura, Shiro; Nagase, Takahiko; Takayanagi, Kan; Matsumoto, Kazuo; Kurabayashi, Masahiko			Characteristics and Catheter Ablation of Focal Atrial Tachycardia Originating From the Interatrial Septum	HEART LUNG AND CIRCULATION			English	Article						Ectopic atrial tachycardia; Electrical catheter ablation; Cardiac electrophysiology; Atrial septum; Electrocardiogram	LEFT-HEART CATHETERIZATION; INTRACARDIAC ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHIC CHARACTERISTICS; ELECTROPHYSIOLOGIC CHARACTERIZATION; RADIOFREQUENCY ABLATION; CORONARY-SINUS; FIBRILLATION; CONDUCTION; SITE; MECHANISMS	Background Ablation of focal atrial tachycardia (AT) originating from the interatrial septum (IAS) is challenging because of its complex anatomy. Methods We studied the electrocardiographic and electrophysiologic characteristics of focal, septal AT in seven patients who underwent successful ablation. Results The site of successful ablation was at the site of earliest activation on the right side of the IAS in three patients and on the left side in four patients, >1 cm away from the centre of the fossa ovalis in the septum secundum. A negative or +/-versus a positive or -/+P wave in lead V-1 during AT accurately predicted a right-versus left-sided origin of the AT, respectively. In the four left septal AT cases, right atrial activation mapping opposite the site of successful ablation revealed the presence of a small, low-frequency potential followed by a larger, high-frequency potential. In contrast, a high-frequency potential was not preceded by a low-frequency potential in the three right septal AT cases. Conclusions Septal AT may originate from either side of the septum secundum. The P wave polarity in lead V1 accurately predicted the side of the IAS that the AT originated from. Left septal AT is characterised by the recording of double potentials reflecting far-field activation of the left-sided IAS, followed by near-field activation of the right-sided IAS, when recording from its right side, opposite the AT origin. These observations are particularly relevant when mapping an apparent right septal AT.	[Kaneko, Yoshiaki; Nakajima, Tadashi; Irie, Tadanobu; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 3718511, Japan; [Kato, Ritsushi; Nagase, Takahiko; Matsumoto, Kazuo] Saitama Med Univ, Div Cardiol, Int Med Ctr, Hidaka, Saitama, Japan; [Nakahara, Shiro; Takayanagi, Kan] Dokkyo Med Univ, Koshigaya Hosp, Dept Cardiol, Koshigaya, Saitama, Japan; [Tobiume, Takeshi] Univ Tokushima, Dept Cardiol, Tokushima 770, Japan; [Morishima, Itsuro] Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Gifu, Japan; [Tanaka, Kazuhiko] Kasukabe Chuo Gen Hosp, Heart Ctr Arrhythmia Unit, Kazukabe, Saitama, Japan; [Kusano, Kengo Fukushima; Kamakura, Shiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan	Kaneko, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	kanekoy@gunma-u.ac.jp			 [25461043]	This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 25461043).	Saoudi N, 2001, EUR HEART J, V22, P1162, DOI 10.1053/euhj.2001.2658; Tung S, 2003, J AM COLL CARDIOL, V42, P110, DOI 10.1016/S0735-1097(03)00563-1; Kalman JM, 1998, J AM COLL CARDIOL, V31, P451, DOI 10.1016/S0735-1097(97)00492-0; Lemery R, 2004, CIRCULATION, V110, P2083, DOI 10.1161/01.CIR.0000144461.83835.A1; Hachiya H, 2005, CIRC J, V69, P205, DOI 10.1253/circj.69.205; Marrouche NF, 2002, J AM COLL CARDIOL, V40, P1133, DOI 10.1016/S0735-1097(02)02071-5; Chen CC, 2000, J CARDIOVASC ELECTR, V11, P744, DOI 10.1111/j.1540-8167.2000.tb00045.x; Yamaguchi T, 2010, EUROPACE, V12, P1698, DOI 10.1093/europace/euq326; Tada H, 1998, PACE, V21, P2431, DOI 10.1111/j.1540-8159.1998.tb01196.x; Morton JB, 2001, J CARDIOVASC ELECTR, V12, P653, DOI 10.1046/j.1540-8167.2001.00653.x; Chae S, 2007, J AM COLL CARDIOL, V50, P1781, DOI 10.1016/j.jacc.2007.07.044; Kistler PM, 2006, J AM COLL CARDIOL, V48, P1010, DOI 10.1016/j.jacc.2006.03.058; Wong MCG, 2013, J CARDIOVASC ELECTR, V24, P413, DOI 10.1111/jce.12049; Ren JF, 2007, ECHOCARDIOGR-J CARD, V24, P533, DOI 10.1111/j.1540-8175.2007.00426.x; Roberts-Thomson KC, 2006, PACE, V29, P643, DOI 10.1111/j.1540-8159.2006.00413.x; Daoud EG, 1999, J CARDIOVASC ELECTR, V10, P358, DOI 10.1111/j.1540-8167.1999.tb00683.x; Kistler PM, 2005, J AM COLL CARDIOL, V45, P1488, DOI 10.1016/j.jacc.2005.01.042; Akiyama M, 2004, J CARDIOVASC ELECTR, V15, P1371, DOI 10.1046/j.1540-8167.2004.04422.x; Kumagai K, 2006, J CARDIOVASC ELECTR, V17, P907, DOI 10.1111/j.1540-8167.2006.00518.x; Anderson RH, 1996, ANAT REC, V246, P1, DOI 10.1002/(SICI)1097-0185(199609)246:1<1::AID-AR1>3.0.CO;2-Y; Hanaoka T, 2003, JPN HEART J, V44, P673, DOI 10.1536/jhj.44.673; Dong J, 2005, HEART RHYTHM, V2, P578, DOI 10.1016/j.hrthm.2005.03.014; Kistler PM, 2003, J AM COLL CARDIOL, V41, P2212, DOI 10.1016/S0735-1097(03)00484-4; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Anderson RH, 1999, CLIN ANAT, V12, P362, DOI 10.1002/(SICI)1098-2353(1999)12:5<362::AID-CA6>3.0.CO;2-F; TANG CW, 1995, J AM COLL CARDIOL, V26, P1315, DOI 10.1016/0735-1097(95)00307-X; Schernthaner C, 2013, ECHOCARDIOGR-J CARD, V30, P402, DOI 10.1111/echo.12067; Kistler PM, 2003, CIRCULATION, V108, P1968, DOI 10.1161/01.CIR.0000095269.36984.75	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1443-9506	1444-2892		HEART LUNG CIRC	Heart Lung Circ.	OCT	2015	24	10					988	995		10.1016/j.hlc.2015.03.009		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT6FJ	WOS:000362907800011		
J	Kobayashi, K; Kuroda, M; Shigemura, Y				Kobayashi, Kazuhiro; Kuroda, Minami; Shigemura, Yuuho			Synthesis of 1,3-Dihydro-3-oxo-2-benzofuran-1-carboxylates via Intramolecular Cyclization of 2-[2-(Dimethoxymethyl)phenyl]-2-hydroxyalkanoates Followed by Oxidation	HELVETICA CHIMICA ACTA			English	Article						1; 3-Dihydro-3-oxo-2-benzofuran-1-carboxylates; [2-(Dimethoxymethyl)phenyl]lithiums; 2-[2-(Dimethoxymethyl)phenyl]-2-hydroxyalkanoates; Pyridinium chlorochromate oxidation; Phthalides	3-SUBSTITUTED PHTHALIDES	A novel and efficient method for the preparation of 1,3-dihydro-3-oxo-2-benzofuran-1-carboxylates 4 under mild conditions has been developed. Thus, the reaction of [2-(dimethoxymethyl)phenyl]lithiums, generated easily from 1-bromo-2-(dimethoxymethyl)benzenes 1, with -keto esters gives the corresponding 2-[2-(dimethoxymethyl)phenyl]-2-hydroxyalkanoates 2. The TsOH-catalyzed cyclization of these hydroxy acetals is followed by the oxidation of the resulting cyclic acetals 3 with PCC to give the desired products in satisfactory yields. The reaction of [2-(dimethoxymethyl)-4,5-dimethoxyphenyl]lithium with (MeOCO)(2), followed by treatment with NaBH4 or organolithiums, affords 2-[2-(dimethoxymethyl)-4,5-dimethoxyphenyl]-2-hydroxyalkanoates 6, which can similarly be transformed into the corresponding 1,3-dihydro-3-oxo-2-benzofuran-1-carboxylates 7 in reasonable yields.	[Kobayashi, Kazuhiro; Kuroda, Minami; Shigemura, Yuuho] Tottori Univ, Grad Sch Engn, Div Appl Chem, Dept Chem & Biotechnol, Tottori 6808552, Japan	Kobayashi, K (reprint author), Tottori Univ, Grad Sch Engn, Div Appl Chem, Dept Chem & Biotechnol, 4-101 Koyama Minami, Tottori 6808552, Japan.	kkoba@chem.tottori-u.ac.jp					Youn SW, 2014, ORG BIOMOL CHEM, V12, P2388, DOI 10.1039/c3ob42546k; Martin C, 2001, J ORG CHEM, V66, P3797, DOI 10.1021/jo0100188; HARRIS TM, 1988, J AM CHEM SOC, V110, P6186, DOI 10.1021/ja00226a038; GRIBBLE GW, 1980, TETRAHEDRON LETT, V21, P4137, DOI 10.1016/S0040-4039(00)93671-2; Kobayashi K, 2013, HELV CHIM ACTA, V96, P1894, DOI 10.1002/hlca.201300112; Yue D, 2006, J ORG CHEM, V71, P3381, DOI 10.1021/jo0524573; Mizutani Y, 2012, TETRAHEDRON LETT, V53, P5903, DOI 10.1016/j.tetlet.2012.08.091; KEAY BA, 1983, CAN J CHEM, V61, P1987, DOI 10.1139/v83-343; Pfeiffer P, 1941, J PRAKTISCHE CHEMIE, V159, P241, DOI 10.1002/prac.19411590803; Hoshimoto Y, 2012, ANGEW CHEM INT EDIT, V51, P10812, DOI 10.1002/anie.201206186; Kobayashi K, 2014, HELV CHIM ACTA, V97, P1055; Shi XY, 2012, ADV SYNTH CATAL, V354, P2933, DOI 10.1002/adsc.201200690; Hubschwerlen C., 2014, PCT Int. Appl, Patent No. [WO 2014181266, 2014181266]; Ishibashi M., 2009, Kokai Tokkyo Koho, Patent No. [JP 20098178052, 20098178052]; Ishibashi M., 2012, Kokai Tokkyo Koho, Patent No. [JP 2012171907, 2012171907]; Kuroda M, 2015, HELV CHIM ACTA, V98, P279, DOI 10.1002/hlca.201400333	16	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	OCT	2015	98	10					1364	1371		10.1002/hlca.201500175		8	Chemistry, Multidisciplinary	Chemistry	CT6XY	WOS:000362958200003		
J	Mao, TL; Ayhan, A; Kuo, KT; Lin, MC; Tseng, LH; Ogawa, H				Mao, Tsui-Lien; Ayhan, Ayse; Kuo, Kuang-Ting; Lin, Ming-Chieh; Tseng, Li-Hui; Ogawa, Hiroshi			Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: implications for pathogenetic and survival differences	HISTOPATHOLOGY			English	Article						ARID1A; endometrioid carcinoma; high-grade; immunohistochemistry	NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; ARID1A EXPRESSION; P53 EXPRESSION; DEFICIENCY; DIAGNOSIS; MUTATION; OUTCOMES; UTILITY	Aims: To compare the clinical and pathogenetic differences between high-grade (HG) endometrioid carcinomas with and without concurrent low-grade (LG) components. Methods and results: The expression of ARID1A, PTEN, p53 and mismatch repair (MMR) proteins in HG endometrioid carcinomas without (n = 19) or with (n = 22) concurrent LG endometrioid carcinomas was studied by immunohistochemistry. Microsatellite instability (MSI) was also tested in 31 cases. The frequencies of ARID1A loss, PTEN loss, MMR deficiency or MSI and aberrant p53 expression were 58%, 37%, 37% and 47% in pure HG tumours, and 77%, 45%, 55% and 32% in HG tumours with concurrent LG components (P = 0.07 for ARID1A; P > 0.1 for other proteins). Pure HG tumours had a higher frequency of the type II phenotype (positive for ARID1A, PTEN and MMR proteins; aberrant p53 expression) than HG tumours with concurrent LG components (21% versus 5%) (P = 0.2). The 5-year overall survival rate was worse for pure HG tumours (61.7%) than for HG tumours with concurrent LG components (93.3%) (P = 0.07). Conclusions: HG endometrioid carcinomas are heterogeneous in pathogenesis: some arise from LG endometrioid carcinomas via the type I pathway, whereas others may arise de novo through either the type I pathway or the type II pathway, and have a different prognosis. Thus, HG endometrioid carcinomas should be subclassified properly and treated accordingly.	[Mao, Tsui-Lien; Kuo, Kuang-Ting; Lin, Ming-Chieh] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Mao, Tsui-Lien; Kuo, Kuang-Ting; Lin, Ming-Chieh] Coll Med, Taipei, Taiwan; [Ayhan, Ayse; Ogawa, Hiroshi] Seirei Mikatahara Gen Hosp, Hamamatsu, Shizuoka, Japan; [Tseng, Li-Hui] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan	Mao, TL (reprint author), 7 Chung Shan South Rd, Taipei 100, Taiwan.	tlmao@ntu.edu.tw		TSENG, LI-HUI/0000-0002-8308-6772	NSC [100-2320-B-002-081]	This work was supported by NSC 100-2320-B-002-081. We thank Ms. Jenny Chen for her help in producing the tables and figures.	Modica I, 2007, AM J SURG PATHOL, V31, P744, DOI 10.1097/01.pas.0000213428.61374.06; Lax SF, 2004, VIRCHOWS ARCH, V444, P213, DOI 10.1007/s00428-003-0947-3; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Shia J, 2008, J MOL DIAGN, V10, P293, DOI 10.2353/jmoldx.2008.080031; Soslow RA, 2007, AM J SURG PATHOL, V31, P979, DOI 10.1097/PAS.0b013e31802ee494; Brinton LA, 2013, GYNECOL ONCOL, V129, P277, DOI 10.1016/j.ygyno.2013.02.023; Watson N, 2007, J MOL DIAGN, V9, P472, DOI 10.2353/jmoldx.2007.060162; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; Llobet D, 2009, J CLIN PATHOL, V62, P777, DOI 10.1136/jcp.2008.056101; Mutter GL, 2000, J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Allo G, 2014, MODERN PATHOL, V27, P255, DOI 10.1038/modpathol.2013.144; Zannoni GF, 2010, VIRCHOWS ARCH, V457, P27, DOI 10.1007/s00428-010-0939-z; Voss MA, 2012, GYNECOL ONCOL, V124, P15, DOI 10.1016/j.ygyno.2011.07.030; Alkushi A, 2010, INT J GYNECOL PATHOL, V29, P343, DOI 10.1097/PGP.0b013e3181cd6552; Le Gallo M, 2014, CLIN CHEM, V60, P98, DOI 10.1373/clinchem.2013.205740; Shia J, 2013, MODERN PATHOL, V26, P131, DOI 10.1038/modpathol.2012.138; Werner HMJ, 2013, MODERN PATHOL, V26, P428, DOI 10.1038/modpathol.2012.174; Bosse T, 2013, MODERN PATHOL, V26, P1525, DOI 10.1038/modpathol.2013.96; Kobel M, 2010, J PATHOL, V222, P191, DOI 10.1002/path.2744; Alvarez T, 2012, AM J SURG PATHOL, V36, P753, DOI 10.1097/PAS.0b013e318247b7bb; Garg K, 2012, INT J GYNECOL PATHOL, V31, P48, DOI 10.1097/PGP.0b013e3182230d00; Soslow RA, 2010, SEMIN DIAGN PATHOL, V27, P261, DOI 10.1053/j.semdp.2010.09.003; Gilks CB, 2013, AM J SURG PATHOL, V37, P874, DOI 10.1097/PAS.0b013e31827f576a; Reid-Nicholson M, 2006, MODERN PATHOL, V19, P1091, DOI 10.1038/modpathol.3800620; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Djordjeyic B, 2012, MODERN PATHOL, V25, P699, DOI 10.1038/modpathol.2011.208; Hoang LN, 2013, AM J SURG PATHOL, V37, P1421, DOI 10.1097/PAS.0b013e31828c63ed; Joost P, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-126; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Mao TL, 2013, AM J SURG PATHOL, V37, P1342, DOI 10.1097/PAS.0b013e3182889dc3; Samarnthai N, 2010, OBSTET GYNECOL INT, V2010, DOI DOI 10.1155/2010/162363; Zaino R, 2014, WHO CLASSIFICATION T, P121	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	OCT	2015	67	4					474	482		10.1111/his.12664		9	Cell Biology; Pathology	Cell Biology; Pathology	CT3TS	WOS:000362730400006		
J	Nishiyama, H; Togashi, K; Kawamoto, Y; Kato, N				Nishiyama, Hiroki; Togashi, Ko; Kawamoto, Yuichi; Kato, Nei			A Cooperative ONU Sleep Method for Reducing Latency and Energy Consumption of STA in Smart-FiWi Networks	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Passive optical network (PON); wireless local area network (WLAN); fiber wireless (FiWi) network; Optical network unit (ONU) sleep; power saving mode (PSM); adaptive PSM (APSM); and energy efficiency	POWER SAVING MECHANISM; OPTICAL NETWORKS; EFFICIENT; CAPACITY	Fiber-Wireless (FiWi) network is a classification of network that combines the massive bandwidth of the optical network and the reach of the wireless network. FiWi networks are usually composed of an optical and a wireless component. Since both components are designed to work independently, some mechanisms, such as the different power saving methods in both components, may not cooperate with each other and this may result in an undesirable performance. In this paper, we identify that the conflicting power saving mechanisms cause unnecessary energy consumption and introduce additional delay to the overall FiWi network. To cope with this problem, we propose a novel ONU sleep method, which dynamically control the ONU sleep period based on the STAs energy control mechanism. Finally, we demonstrate that our proposed method has shorter latency and is more efficient in term of energy consumption than the existing method.	[Nishiyama, Hiroki; Togashi, Ko; Kawamoto, Yuichi; Kato, Nei] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan	Nishiyama, H (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	bigtree@it.ecei.tohoku.ac.jp; Togashi@it.ecei.tohoku.ac.jp; youpsan@it.ecei.tohoku.ac.jp; Kato@it.ecei.tohoku.ac.jp			JSPS KAKENHI	This work was supported by JSPS KAKENHI.	Kubo R, 2010, J OPT COMMUN NETW, V2, P716, DOI 10.1364/JOCN.2.000716; Ding N, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P2821; He Y, 2008, IEEE WCNC, P1362; Togashi K, 2013, IEEE ICC, P6225, DOI 10.1109/ICC.2013.6655603; Fadlullah ZM, 2013, IEEE INTELL SYST, V28, P86, DOI 10.1109/MIS.2013.46; Tucker RS, 2011, IEEE J SEL TOP QUANT, V17, P261, DOI 10.1109/JSTQE.2010.2051217; Manweiler J, 2012, IEEE T MOBILE COMPUT, V11, P739, DOI [10.1109/TMC.2011.269, 10.1109/TMC.2011.268]; Shumate PW, 2008, J LIGHTWAVE TECHNOL, V26, P1093, DOI 10.1109/JLT.2008.923601; He S, 2013, 2013 IEEE MILITARY COMMUNICATIONS CONFERENCE (MILCOM 2013), P928, DOI 10.1109/MILCOM.2013.161; Aurzada F, 2011, IEEE T COMMUN, V59, P1378, DOI 10.1109/TCOMM.2011.030411.100418; Nag A, 2012, J OPT COMMUN NETW, V4, P1018, DOI 10.1364/JOCN.4.001018; Pack S, 2005, J COMMUN NETW-S KOR, V7, P126; IEEE Computer Society, 2007, WIR LAN MED ACC CONT; IEEE Computer Society LAN MAN Standards Committee, 1999, 80211 IEEE COMP SOC; Jardosh A. P., 2007, P 8 IEEE WORKSH MOB, V15, P85; Kubo R., 2009, P IEEE GLOBECOM, P1; Rozner E., 2010, P 8 INT C MOB SYST A, P91, DOI DOI 10.1145/1814433.1814445; Yi X., 2013, P 10 IEEE INT C SENS, P568; Yong H., 2008, P IEEE WIR COMM NETW, P1362	19	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	OCT	2015	26	10					2621	2629		10.1109/TPDS.2014.2360405		9	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CT4QJ	WOS:000362791400001		
J	Nishiyama, H; Takahashi, A; Kato, N; Nakahira, K; Sugiyama, T				Nishiyama, Hiroki; Takahashi, Asato; Kato, Nei; Nakahira, Katsuya; Sugiyama, Takatoshi			Dynamic Replication and Forwarding Control Based on Node Surroundings in Cooperative Delay-Tolerant Networks	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Delay-tolerant networks (DTNs); routing; replication control; forwarding control	MESSAGE DISSEMINATION	Delay-tolerant networks (DTNs) are a promising network architecture which can provide reliable multi-hop message transmission between participating mobile nodes in an unfavorable environment that is prone to link disruption and disconnection by replicating and relaying messages without any need of physical infrastructure. Additionally, DTNs can also operate as cooperative DTNs to extend the coverage of other type of networks by carrying the messages that originate from farther away base station in a multi-hop fashion to the base station. In this paper, we focus on these cooperative DTNs and propose a novel routing scheme, ring distribution routing (RDR), that controls the replication and forwarding based on the source node surroundings. This paper also analyzes the reliability and buffer efficiency in RDR. Furthermore, we show that RDR provides the reliable and immediate message delivery in any environment through extensive computer simulations.	[Nishiyama, Hiroki; Takahashi, Asato; Kato, Nei] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Nakahira, Katsuya; Sugiyama, Takatoshi] Nippon Telegraph & Tel Corp, Access Network Serv Syst Labs, Yokosuka, Kanagawa, Japan	Nishiyama, H (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	bigtree@it.ecei.tohoku.ac.jp; asato@it.ecei.tohoku.ac.jp; kato@it.ecei.tohoku.ac.jp; nakahira.katsuya@lab.ntt.co.jp; sugiyama.takatoshi@lab.ntt.co.jp					[Anonymous], 2015, THE ONE; Pereira PR, 2012, IEEE COMMUN SURV TUT, V14, P1166, DOI 10.1109/SURV.2011.081611.00102; Izumikawa H, 2013, 2013 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P2196; Tseng YC, 2013, AD HOC NETW, V11, P1150, DOI 10.1016/j.adhoc.2013.01.001; He SB, 2013, IEEE J SEL AREA COMM, V31, P75, DOI 10.1109/JSAC.2013.SUP.0513007; Zhu HJ, 2014, IEEE T PARALL DISTR, V25, P22, DOI 10.1109/TPDS.2013.36; Bujari A, 2012, 2012 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), P344, DOI 10.1109/WCNCW.2012.6215519; Luiz DF, 2012, 2012 IEEE SYMPOSIUM ON COMPUTERS AND COMMUNICATIONS (ISCC), P394, DOI 10.1109/ISCC.2012.6249328; Feng ZX, 2012, IEEE SYM PARA DISTR, P1484, DOI 10.1109/IPDPSW.2012.187; Mei HB, 2011, 2011 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P516; Caini C, 2011, P IEEE, V99, P1980, DOI 10.1109/JPROC.2011.2158378; Ehsan S, 2012, IEEE T WIREL COMMUN, V11, P1220, DOI 10.1109/TWC.2012.012412.111405; Wang TY, 2013, IEEE J SEL AREA COMM, V31, P538, DOI 10.1109/JSAC.2013.SUP.0513048; Liang H, 2012, IEEE T COMMUN, V60, P2644, DOI 10.1109/TCOMM.2012.082812.110813; Zhuang YY, 2011, IEEE J SEL AREA COMM, V29, P187, DOI 10.1109/JSAC.2011.110118; Ochiai H, 2011, IEEE SENS J, V11, P2861, DOI 10.1109/JSEN.2011.2170562; Fall K, 2003, ACM SIGCOMM COMP COM, V33, P27; Cerf V., 2007, 4838 RFC; El Gamal A., IEEE T INF THEORY, V52, P2568; Keranen A., 2009, P 2 INT C SIM TOOLS, P55; Kim S.-E., 2012, P VLSI TECHN SYST AP, P1, DOI 10.1109/IPIN.2012.6418947; Spyropoulos T., 2005, P ACM SIGCOMM WORKSH, P252, DOI DOI 10.1145/1080139.1080143; Spyropoulos T., 2004, P 1 ANN IEEE COMM SO, P235; Takahashi A., 2013, P INT C COMP NETW CO, P890; Takahashi A, 2014, IEEE T VEH TECHNOL, V63, P3223, DOI 10.1109/TVT.2014.2299288	25	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	OCT	2015	26	10					2711	2719		10.1109/TPDS.2014.2359889		9	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CT4QJ	WOS:000362791400008		
J	Anderson, DF; Koyama, M				Anderson, David F.; Koyama, Masanori			An asymptotic relationship between coupling methods for stochastically modeled population processes	IMA JOURNAL OF NUMERICAL ANALYSIS			English	Article						stochastic modeling; biochemical network; continuous time Markov chain; couplings; random time change; stochastic simulation	MULTILEVEL MONTE-CARLO; TIME MARKOV-CHAINS; CHEMICAL-REACTIONS; SIMULATION	This paper is concerned with elucidating a relationship between two common coupling methods for the continuous time Markov chain models utilized in the cell biology literature. The couplings considered here are primarily used in a computational framework by providing reductions in variance for different Monte Carlo estimators, thereby allowing for significantly more accurate results for a fixed amount of computational time. Common applications of the couplings include the estimation of parametric sensitivities via finite difference methods and the estimation of expectations via multi-level Monte Carlo algorithms. While a number of coupling strategies have been proposed for the models considered here, and a number of articles have experimentally compared the different strategies, to date there has been no mathematical analysis describing the connections between them. Such analyses are critical in order to determine the best use for each. In the current paper, we show a connection between the common reaction path (CRP) method and the split coupling (SC) method, which is termed coupled finite differences in the parametric sensitivities literature. In particular, we show that the two couplings are both limits of a third coupling strategy we call the 'local-CRP' coupling, with the SC method arising as a key parameter goes to infinity, and the CRP coupling arising as the same parameter goes to zero. The analysis helps explain why the SC method often provides a lower variance than does the CRP method, a fact previously shown experimentally.	[Anderson, David F.] Univ Wisconsin, Dept Math, Madison, WI 53706 USA; [Koyama, Masanori] Kyoto Univ, Dept Syst Sci, Grad Sch Informat, Integrated Syst Biol Lab, Kyoto, Japan	Koyama, M (reprint author), Kyoto Univ, Dept Syst Sci, Grad Sch Informat, Integrated Syst Biol Lab, Kyoto, Japan.	anderson@math.wisc.edu; koyama.masanori@gmail.com			NSF [DMS-1009275, DMS-1318832, DMS-0805793]; Army Research Office [W911NF-14-1-0401]	D.F.A. was supported by NSF grants DMS-1009275 and DMS-1318832 and Army Research Office grant W911NF-14-1-0401. M.K. was supported by NSF grants DMS-1009275, DMS-1318832 and DMS-0805793.	Anderson D. F., 2012, J CHEM PHYS, V137; Anderson D. F., 2014, ARXIV13102676; Anderson DF, 2011, DESIGN AND ANALYSIS OF BIOMOLECULAR CIRCUITS:ENGINEERING APPROACHES TO SYSTEMS AND SYNTHETIC BIOLOGY, P3, DOI 10.1007/978-1-4419-6766-4_1; Rathinam M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3280166; Anderson DF, 2012, MULTISCALE MODEL SIM, V10, P146, DOI 10.1137/110840546; Anderson DF, 2012, SIAM J NUMER ANAL, V50, P2237, DOI 10.1137/110849079; Anderson DF, 2011, ANN APPL PROBAB, V21, P2226, DOI 10.1214/10-AAP756; Diaconis P, 2013, BERNOULLI, V19, P1294, DOI 10.3150/12-BEJSP09; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Arampatzis G, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4868649; Giles MB, 2008, OPER RES, V56, P607, DOI 10.1287/opre.1070.0496; Srivastava R, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790650; Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; ETHIER S.N., 1986, MARKOV PROCESSES CHA; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Koyama M., 2013, THESIS U WISCONSIN M; Kurtz T. G., 1981, CBMS NSF REGIONAL C, V36; Kurtz T.G., 1982, LECT NOTES CONTROL I, V42, P177	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0272-4979	1464-3642		IMA J NUMER ANAL	IMA J. Numer. Anal.	OCT	2015	35	4					1757	1778		10.1093/imanum/dru044		22	Mathematics, Applied	Mathematics	CT5CV	WOS:000362826000010		
J	Takano, M; Ohkusa, M; Otani, M; Min, KS; Kadoyama, K; Minami, K; Sano, K; Matsuyama, S				Takano, Masaoki; Ohkusa, Mami; Otani, Mieko; Min, Kyong-Son; Kadoyama, Keiichi; Minami, Katori; Sano, Keiji; Matsuyama, Shogo			Lipid A-activated inducible nitric oxide synthase expression via nuclear factor-kappa B in mouse choroid plexus cells	IMMUNOLOGY LETTERS			English	Article						Choroid plexus; iNOS; Lipid A; NF kappa B; I kappa B; RNAi	EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; INNATE IMMUNE-RESPONSE; CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE RECEPTOR-4; BACTERIAL-MENINGITIS; IN-VITRO; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; BRAIN; RAT	Choroid plexus (CP) which is responsible for the inflammatory mediators including nitric oxide (NO) are thought to play a crucial role in the process of bacterial meningitis. The present study investigated the mechanisms regulating inducible nitric oxide synthase (iNOS) expression in the choroid plexus epithelium (CPe) in mice. Initially, the expression of iNOS in mouse CPe was strengthened by intracerebroventriclar (i.c.v.) administration of lipid A, which is part of a Gram-negative bacterial endotoxin located at one end of the lipopolysaccharide (LPS) molecule. Next, the expression of iNOS in the CP epithelial cell line ECPC-4 cells was increased from 24 to 48 h after lipid A treatment, although mRNA and proteins of toll-like receptor (TLR)-2 and -4 expressed in ECPC-4 cells were not changed by lipid A. The expression of total nuclear factor kappa B (NF kappa B), an inflammatory transcriptional factor, in ECPC-4 cells was not changed for 72 h after lipid A treatment, while cytoplasmic NF kappa B was decreased and nuclear NF kappa B was increased from 1 to 2 h. In addition, the phosphorylation of inhibitor kappa B (I kappa B) was peaked at 10 min, and the level of I kappa B was attenuated from 10 to 45 min after lipid A treatment. Moreover, the RNA interference (RNAi) of NF kappa B suppressed the expression of iNOS induced by lipid A. We demonstrated that lipid A-induced iNOS expression in ECPC-4 cells was mainly regulated by the activation of NF kappa B-I kappa B intracellular signaling pathway. Thus, we propose that the CPe plays a pivotal role in innate immunity responses of the brain, that is, the signal pathway TLRs on the CPe following inflammatory stimulation such as meningitis is activated, leading to iNOS expression through NF kappa B. (C) 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.	[Takano, Masaoki; Ohkusa, Mami; Otani, Mieko; Minami, Katori; Sano, Keiji] Kobe Gakuin Univ, Mol Cell Biol Lab, Sch Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan; [Min, Kyong-Son] Osaka Ohtani Univ, Toxicol Lab, Fac Pharm, Tondabayashi, Osaka 5848540, Japan; [Kadoyama, Keiichi; Matsuyama, Shogo] Himeji Dokkyo Univ, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan	Takano, M (reprint author), Kobe Gakuin Univ, Mol Cell Biol Lab, Sch Pharmaceut Sci, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.	takano@pharm.kobegakuin.ac.jp			Smoking Research Foundation; Kobe Gakuin University; Ministry of Education, Culture, Sports, Science and Technology of Japan [18023033, 21500352, 21390271, 20023027]	This work was supported by grants from the Smoking Research Foundation, Kobe Gakuin University for Collaborative Research B, and the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 18023033, 21500352, 21390271, 20023027).	Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Milhavet O, 2003, PHARMACOL REV, V55, P629, DOI 10.1124/pr.55.4.1; PFISTER HW, 1995, J NEUROL NEUROSUR PS, V58, P384, DOI 10.1136/jnnp.58.3.384; Balyasnikova IV, 2000, J CEREBR BLOOD F MET, V20, P688; Boje KMK, 1996, BRAIN RES, V720, P75, DOI 10.1016/0006-8993(96)00142-4; TUNKEL AR, 1993, ANNU REV MED, V44, P103, DOI 10.1146/annurev.med.44.1.103; Liu SB, 2000, SHOCK, V14, P361, DOI 10.1097/00024382-200014030-00021; CAMPBELL IL, 1994, J IMMUNOL, V153, P3622; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7; Korytko PJ, 1996, NEUROPHARMACOLOGY, V35, P231, DOI 10.1016/0028-3908(95)00162-X; Speake T, 2001, MICROSC RES TECHNIQ, V52, P49, DOI 10.1002/1097-0029(20010101)52:1<49::AID-JEMT7>3.0.CO;2-C; Enjoji M, 1996, JPN J CANCER RES, V87, P893; BUSTER BL, 1995, INFECT IMMUN, V63, P3835; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; ENJOJI M, 1995, J NEUROCHEM, V64, P961; Olin MR, 2008, J INFECT DIS, V198, P886, DOI 10.1086/591097; Leitner DF, 2012, BBA-GEN SUBJECTS, V1820, P393, DOI 10.1016/j.bbagen.2011.10.016; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; VISSER JJ, 1994, ANN INTERN MED, V120, P345; Koedel U, 1997, NEUROSCI LETT, V225, P33, DOI 10.1016/S0304-3940(97)00177-8; Shenep JL, 1998, J INFECT DIS, V177, P766; Stridh L, 2013, TRANSL STROKE RES, V4, P220, DOI 10.1007/s12975-012-0248-8; Braun J, 2009, INT J NEUROSCI, V119, P455, DOI 10.1080/00207450802479970; Takano M, 2008, NEUROSCI LETT, V434, P310, DOI 10.1016/j.neulet.2008.01.072; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Schwerk C, 2011, MICROBES INFECT, V13, P953, DOI 10.1016/j.micinf.2011.05.012; Leib SL, 1998, J INFECT DIS, V177, P692; Adam RA, 2004, INFECT IMMUN, V72, P3084, DOI 10.1128/IAI.72.5.3084-3087.2004; LU J, 1995, BRAIN RES, V699, P275, DOI 10.1016/0006-8993(95)00919-H; HABERL RL, 1994, NEUROL RES, V16, P108; Faure E, 2001, J IMMUNOL, V166, P2018; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; XIE QW, 1994, J BIOL CHEM, V269, P4705	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	OCT	2015	167	2					57	62		10.1016/j.imlet.2015.07.007		6	Immunology	Immunology	CT2JQ	WOS:000362628200001		
J	Nakagawa, Y; Negishi, Y; Shimizu, M; Takahashi, M; Ichikawa, M; Takahashi, H				Nakagawa, Yohko; Negishi, Yasuyuki; Shimizu, Masumi; Takahashi, Megumi; Ichikawa, Masao; Takahashi, Hidemi			Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes	IMMUNOLOGY LETTERS			English	Article						Cytotoxic T lymphocytes; Hypoxia; Extracellular pH; Low pH	HEMATOPOIETIC STEM-CELLS; INDUCIBLE FACTOR-I; MHC MOLECULE; OXYGEN LEVELS; LACTIC-ACID; CANCER; INDUCTION; MICROENVIRONMENT; REQUIREMENTS; METABOLISM	The major effector cells for cellular adaptive immunity are CD8(+) cytotoxic T lymphocytes (CTLs), which can recognize and kill virus-infected cells and tumor cells. Although CTLs exhibit strong cytolytic activity against target cells in vitro, a number of studies have demonstrated that their function is often impaired within tumors. Nevertheless, CTLs can regain their cytotoxic ability after escaping from the tumor environment, suggesting that the milieu created by tumors may affect the function of CTLs. As for the tumor environment, the patho-physiological situation present in vivo has been shown to differ from in vitro experimental conditions. In particular, low pH and hypoxia are the most important microenvironmental factors within growing tumors. In the present study, to determine the effect of these factors on CTL function in vivo, we examined the cytolytic activity of CTLs against their targets using murine CTL lines and the induction of these cells from memory cells under low pH or hypoxic conditions using antigen-primed spleen cells. The results indicated that both cytotoxic activity and the induction of functional CTLs were markedly inhibited under low pH. In contrast, in hypoxic conditions, although cytotoxic activity was almost unchanged, the induction of CTLs in vitro showed a slight enhancement, which was completely abrogated in low pH conditions. Therefore, antigen-specific CTL functions may be more vulnerable to low pH than to the oxygen concentration in vivo. The findings shown here provide new therapeutic approaches for controlling tumor growth by retaining CM cytotoxicity through the maintenance of higher pH conditions. (C) 2015 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.	[Nakagawa, Yohko; Negishi, Yasuyuki; Shimizu, Masumi; Takahashi, Megumi; Takahashi, Hidemi] Nippon Med Sch, Dept Microbiol & Immunol, Tokyo 1138602, Japan; [Ichikawa, Masao] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 1138602, Japan	Nakagawa, Y (reprint author), Nippon Med Sch, Dept Microbiol & Immunol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	tanuki@nms.ac.jp			Ministry of Education, Science, Sport, and Culture from the Ministry of Health and Labor and Welfare, Japan [25461715]; Japanese Health Sciences Foundation; Promotion and Mutual Aid Corporation for Private Schools of Japan; MEXT-supported Program for the Strategic Research Foundation at Private Universities, Japan	This study was supported in part by grants from the Ministry of Education, Science, Sport, and Culture from the Ministry of Health and Labor and Welfare, Japan (25461715 to H.T.); from the Japanese Health Sciences Foundation; from the Promotion and Mutual Aid Corporation for Private Schools of Japan; and from a MEXT-supported Program for the Strategic Research Foundation at Private Universities, Japan.	Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Warburg O, 1925, SCIENCE, V61, P575, DOI 10.1126/science.61.1588.575; TAKAHASHI H, 1989, J EXP MED, V170, P2023, DOI 10.1084/jem.170.6.2023; ROTSTEIN OD, 1988, J SURG RES, V45, P298, DOI 10.1016/0022-4804(88)90079-0; VAUPEL P, 1989, CANCER RES, V49, P6449; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Mendler AN, 2012, INT J CANCER, V131, P633, DOI 10.1002/ijc.26410; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; Neumann AK, 2005, P NATL ACAD SCI USA, V102, P17071, DOI 10.1073/pnas.0506070102; TAKESHITA T, 1995, J IMMUNOL, V154, P1973; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Warburg O, 1923, BIOCHEM Z, V142, P317; Yokosuka T, 2002, J EXP MED, V195, P991, DOI 10.1084/jem.20010809; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; LOEFFLER DA, 1992, BRIT J CANCER, V66, P619, DOI 10.1038/bjc.1992.326; Imai N, 2009, EUR J IMMUNOL, V39, P241, DOI 10.1002/eji.200838824; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Harimoto H, 2013, IMMUNOL CELL BIOL, V91, P545, DOI 10.1038/icb.2013.38; Nakagawa Y, 2013, INT IMMUNOL, V25, P11, DOI 10.1093/intimm/dxs086; SIMCHOWITZ L, 1986, J BIOL CHEM, V261, P6492; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Caldwell CC, 2001, J IMMUNOL, V167, P6140; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi SB, 2011, INT J MOL MED, V28, P449, DOI 10.3892/ijmm.2011.719; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Choi SYC, 2013, J PATHOL, V230, P350, DOI 10.1002/path.4218; Kaida A, 2012, BIOCHEM BIOPH RES CO, V421, P855, DOI 10.1016/j.bbrc.2012.04.102; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Kraus M, 1996, TUMOR BIOL, V17, P133; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCl200421086; Andrikopoulou E, 2011, CURR MOL MED, V11, P218; REDEGELD F, 1991, J IMMUNOL, V147, P3638; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Itoi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047512; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Semenza GL, 2011, NEW ENGL J MED, V365, P537, DOI 10.1056/NEJMra1011165	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	OCT	2015	167	2					72	86		10.1016/j.imlet.2015.07.003		15	Immunology	Immunology	CT2JQ	WOS:000362628200004		
J	Takenouchi, T; Tsukimoto, M; Iwamaru, Y; Sugama, S; Sekiyama, K; Sato, M; Kojima, S; Hashimoto, M; Kitani, H				Takenouchi, Takato; Tsukimoto, Mitsutoshi; Iwamaru, Yoshifumi; Sugama, Shuei; Sekiyama, Kazunari; Sato, Mitsuru; Kojima, Shuji; Hashimoto, Makoto; Kitani, Hiroshi			Extracellular ATP induces unconventional release of glyceraldehyde-3-phosphate dehydrogenase from microglial cells	IMMUNOLOGY LETTERS			English	Article						Glyceraldehyde-3-phosphate dehydrogenase; Microglial cells; P2X7 receptor; Unconventional release	TRANSFERRIN RECEPTOR; ANTIMICROBIAL PEPTIDE; IL-1-BETA SECRETION; P2X(7) RECEPTOR; ACTIVATION; GAPDH; PROTEIN; MATURATION; INTERLEUKIN-1-BETA; MECHANISMS	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key glycolytic enzyme that is predominantly localized in the cytoplasm. However, recent studies have suggested that GAPDH is released by various cells and that extracellular GAPDH is involved in the regulation of neuritogenesis in neuronal cells. It has also been reported that GAPDH is expressed on the surfaces of macrophages and functions as a transferrin receptor. However, since GAPDH is a leaderless protein the mechanisms by which it reaches the extracellular environment remain unclear. Here, we examined the role of P2X7 receptor (P2X7R), an ATP-gated cation channel, in the unconventional release of GAPDH from microglial cells, the resident macrophages in the brain. The activation of P2X7R by ATP triggered GAPDH release from lipopolysaccharide (LPS)-primed microglial cells. ATP-induced microvesicle formation, exosome release, and K+ efflux followed by caspase-1 activation are likely involved in the GAPDH release, but ATP-induced dilatation of membrane pores and lysosome exocytosis are not. It was also demonstrated that exogenous GAPDH facilitated LPS-induced phosphorylation of p38 MAP kinase in microglial cells. These findings suggest that P2X7R plays an important role in the unconventional release of GAPDH from microglial cells, and the GAPDH released into the extracellular space might be involved in the regulation of the neuroinflammatory response in the brain. (C) 2015 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.	[Takenouchi, Takato; Sato, Mitsuru; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Div Anim Sci, Tsukuba, Ibaraki 3058634, Japan; [Tsukimoto, Mitsutoshi; Kojima, Shuji] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Iwamaru, Yoshifumi] Natl Inst Anim Hlth, Pr Dis Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Sugama, Shuei] Nippon Med Sch, Dept Physiol, Bunkyo Ku, Tokyo 1138602, Japan; [Sekiyama, Kazunari; Hashimoto, Makoto] Tokyo Metropolitan Inst Med Sci, Div Sensory & Motor Syst, Tokyo 1560057, Japan	Takenouchi, T (reprint author), Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Div Anim Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.	ttakenou@affrc.go.jp; kitani@affrc.go.jp			Japan Society for the Promotion of Science (JSPS) [25450521]; NIAS Strategic Research Fund from National Institute of Agrobiological Sciences; Ministry of Agriculture, Forestry and Fisheries of Japan [AGB-1002]	This study was supported by a Grant-in-Aid for Scientific Research (Category C: Grant #25450521) from the Japan Society for the Promotion of Science (JSPS), the NIAS Strategic Research Fund from National Institute of Agrobiological Sciences, and a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomic-based Technology for Agricultural Improvement, AGB-1002).	Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Takenouchi T, 2011, J NEUROCHEM, V117, P712, DOI 10.1111/j.1471-4159.2011.07240.x; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Takenouchi T, 2008, J IMMUNOL, V180, P7827; Qu Y, 2007, J IMMUNOL, V179, P1913; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Aguilera L, 2012, INT J BIOCHEM CELL B, V44, P955, DOI 10.1016/j.biocel.2012.03.002; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; Takenouchi T, 2005, BBA-GEN SUBJECTS, V1726, P177, DOI 10.1016/j.bbagen.2005.08.001; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; Kumar S, 2012, INT J BIOCHEM CELL B, V44, P189, DOI 10.1016/j.biocel.2011.10.016; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Madureira P, 2007, J IMMUNOL, V178, P1379; Yanagitai M, 2012, BIOCHEM BIOPH RES CO, V418, P22, DOI 10.1016/j.bbrc.2011.12.087; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Takenouchi T, 2009, J IMMUNOL, V182, P2051, DOI 10.4049/jimmunol.0802577; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Seo JK, 2014, FISH SHELLFISH IMMUN, V36, P571, DOI 10.1016/j.fsi.2014.01.003; Yang Y, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/352371; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; Seo JM, 2012, FISH SHELLFISH IMMUN, V33, P743, DOI 10.1016/j.fsi.2012.06.023; Rawat P, 2012, BIOCHEM CELL BIOL, V90, P329, DOI [10.1139/o11-058, 10.1139/O11-058]; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; Sahoo S, 2013, PARASITE IMMUNOL, V35, P457, DOI 10.1111/pim.12058; Seidler NW, 2013, ADV EXP MED BIOL, V985, P149, DOI 10.1007/978-94-007-4716-6_5; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; Wagener J, 2013, J INVEST DERMATOL, V133, P144, DOI 10.1038/jid.2012.254; Kawada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119415; Sheokand N, 2013, BBA-GEN SUBJECTS, V1830, P3816, DOI 10.1016/j.bbagen.2013.03.019; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; VEDIA LM, 1992, J BIOL CHEM, V267, P24929	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	OCT	2015	167	2					116	124		10.1016/j.imlet.2015.08.002		9	Immunology	Immunology	CT2JQ	WOS:000362628200008		
J	Matsui, T; Joo, HD; Lee, JM; Ju, SM; Tao, WH; Higashimoto, Y; Fukami, K; Yamagishi, SI				Matsui, Takanori; Joo, Hoo Don; Lee, Jae Min; Ju, Sung Mi; Tao, Wang Hong; Higashimoto, Yuichiro; Fukami, Kei; Yamagishi, Sho-ichi			Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products	IMMUNOLOGY LETTERS			English	Article						AGEs; Monoclonal antibody; Endothelial cells; Diabetes; ELISA	INDUCED DIABETIC-RATS; ENDOTHELIAL-CELLS; IMMUNOLOGICAL DETECTION; SERUM-LEVELS; EXPRESSION; AGES; PROTEIN; ASSAY; RAGE	We have previously found that glyceraldehyde-derived advanced glycation end products (glycer-AGEs) elicit oxidative stress generation and evoke inflammatory and thrombotic reactions through their higher binding affinity to RAGE (receptor for AGEs), thereby playing a role in vascular complications in diabetes. Furthermore, circulating levels of glycer-AGEs are elevated in diabetes. We characterized a monoclonal antibody (mAb) raised against glycer-AGEs and prepared its specific ELISA system in human serum. We developed here mAb reacted specifically with glycer-AGEs or glyceraldehyde-derived pyridinium, but not other structurally identified AGEs or AGE precursors. The mAb not only completely neutralized the deleterious effects of glycer-AGEs on endothelial cells, but also detected glycer-AGEs in the aorta of type 2 diabetic rats. Intra and inter-assay coefficient variations of the ELISA were 6 and 2.6%, respectively. ELISA linearity was shown intact within 5-fold dilution, and recovery ratio of added glycer-AGEs was 88-117%. Results of serum and plasma were comparable, and repeated freeze-thawing of samples did not affect the results (90.1-112.4%). Serum glycer-AGEs levels in 30 healthy subjects evaluated by the ELISA were strongly correlated with those by polyclonal Ab-based one (r=0.82). Our present study suggests the clinical utility of mAb for evaluating glycer-AGE levels in both tissue and serum. (C) 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.	[Matsui, Takanori; Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan; [Joo, Hoo Don; Lee, Jae Min; Ju, Sung Mi; Tao, Wang Hong] Boditech Med Inc, Chunchon, South Korea; [Higashimoto, Yuichiro] Kurume Univ, Sch Med, Dept Chem, Kurume, Fukuoka 830, Japan; [Fukami, Kei] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 830, Japan	Yamagishi, SI (reprint author), Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390111]	This work was supported in part by Grants-in-Aid for Scientific Research (B) 22390111 (SY) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Matsui T, 2011, PHARMACOL RES, V63, P383, DOI 10.1016/j.phrs.2011.02.003; Ahn JS, 2003, CLIN CHIM ACTA, V332, P51, DOI 10.1016/S0009-8981(03)00113-X; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Takeuchi M, 2000, J NEUROPATH EXP NEUR, V59, P1094; Ahmed N, 2005, MOL NUTR FOOD RES, V49, P691, DOI 10.1002/mnfr.200500008; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2006.04943.x; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P442, DOI 10.1271/bbb.60497; Higashimoto Y, 2013, MICROVASC RES, V90, P64, DOI 10.1016/j.mvr.2013.08.010; Ueda S, 2012, CARDIOVASC THER, V30, P249, DOI 10.1111/j.1755-5922.2011.00264.x; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Vlassara H, 1996, DIABETES, V45, pS65; Rahbar S, 2007, CELL BIOCHEM BIOPHYS, V48, P147, DOI 10.1007/s12013-07-0021-x; Jinnouchi Y, 2006, CLIN EXP MED, V6, P191, DOI 10.1007/s10238-006-0115-6; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Takeuchi M, 2010, LAB INVEST, V90, P1117, DOI 10.1038/labinvest.2010.62; Takeuchi M, 2001, MOL MED, V7, P783; Yamamoto Y, 2007, DIABETES RES CLIN PR, V77, pS30, DOI 10.1016/j.diabres.2007.01.030; Ha S.G., 1999, HYBRIDOMA, V18, P37; Ishibashi Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-60; Kajikawa M, 2015, DIABETES CARE, V38, P119, DOI 10.2337/dc14-1435; Matsui T, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-014-0162-3; Ojima A., 2014, LAB INVEST, V94, P42; Ojima A, 2013, AM J PATHOL, V182, P132, DOI 10.1016/j.ajpath.2012.09.016	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478	1879-0542		IMMUNOL LETT	Immunol. Lett.	OCT	2015	167	2					141	146		10.1016/j.imlet.2015.08.008		6	Immunology	Immunology	CT2JQ	WOS:000362628200011		
J	Azuma, K; Ikeda, K; Kagi, N; Yanagi, U; Osawa, H				Azuma, K.; Ikeda, K.; Kagi, N.; Yanagi, U.; Osawa, H.			Prevalence and risk factors associated with nonspecific building-related symptoms in office employees in Japan: relationships between work environment, Indoor Air Quality, and occupational stress	INDOOR AIR			English	Article						Epidemiology; Building-related symptoms; Indoor Air Quality; Sick Building Syndrome; Work environment; Occupational stress	PRINTER TONER PARTICLES; US-EPA BASE; SWEDISH WORKFORCE; ORGANIC-COMPOUNDS; OXIDATIVE STRESS; ROOM-TEMPERATURE; SYNDROME SBS; SICK; HEALTH; DAMPNESS	A nationwide cross-sectional study of 3335 employees was conducted in 320 offices in Japan to estimate the prevalence of building-related symptoms (BRSs) and determine the risk factors related to work environment, Indoor Air Quality, and occupational stress. Data were collected through self-administered questionnaires. The prevalences of general symptoms, eye irritation, and upper respiratory symptoms were 14.4%, 12.1%, and 8.9%, respectively. Multiple logistic regression analyses revealed that eye irritation was significantly associated with carpeting [odds ratio (OR), 1.73; 95% confidence interval (CI), 1.24-2.41], coldness perception (OR, 1.28; 95% CI, 1.13-1.45), and air dryness perception (OR, 1.61; 95% CI, 1.42-1.82). General symptoms were significantly associated with unpleasant odors (OR, 1.37; 95% CI, 1.13-1.65), amount of work (OR, 1.24; 95% CI, 1.06-1.45), and interpersonal conflicts (OR, 1.44; 95% CI, 1.23-1.69). Upper respiratory symptoms were significantly associated with crowded workspaces (OR, 1.36; 95% CI, 1.13-1.63), air dryness perception (OR, 2.07; 95% CI, 1.79-2.38), and reported dustiness on the floor (OR, 1.39; 95% CI, 1.16-1.67). Although psychosocial support is important to reduce and control BRSs, maintaining appropriate air-conditioning and a clean and uncrowded workspace is of equal importance.	[Azuma, K.] Kinki Univ, Fac Med, Dept Environm Med & Behav Sci, Osaka 5898511, Japan; [Ikeda, K.] Nihon Univ, Dept Architecture, Coll Sci & Technol, Chiyoda Ku, Tokyo, Japan; [Kagi, N.] Tokyo Inst Technol, Dept Mech & Environm Informat, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan; [Yanagi, U.] Kogakuin Univ, Dept Architecture, Sch Architecture, Shinjuku Ku, Tokyo, Japan; [Osawa, H.] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan	Azuma, K (reprint author), Kinki Univ, Fac Med, Dept Environm Med & Behav Sci, 377-2 Ohnohigashi, Osaka 5898511, Japan.	kenazuma@med.kindai.ac.jp			Japanese Ministry of Health, Labour and Welfare [H23-health/crisis-009]	This study was financially supported by a Grant-in-Aid for Health and Labour Sciences Research Grant (H23-health/crisis-009) provided by the Japanese Ministry of Health, Labour and Welfare. We would like to extend our sincere thanks to Takayuki Nakamura, Tomoko Shimodaira, and the staff of the Japan Building Maintenance Association for their help in conducting the survey. We thank Daichi Takano and Yuma Nakagawa (formerly of the Department of Architecture, College of Science and Technology, Nihon University) for their assistance in the laboratory. We also thank all participants for their collaboration.	Wolkoff P, 2008, ENVIRON INT, V34, P1204, DOI 10.1016/j.envint.2008.04.005; Apte MG, 2000, INDOOR AIR, V10, P246, DOI 10.1034/j.1600-0668.2000.010004246.x; Chao HJ, 2003, ENVIRON HEALTH PERSP, V111, P1242, DOI 10.1289/ehp.5697; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Niven RM, 2000, OCCUP ENVIRON MED, V57, P627, DOI 10.1136/oem.57.9.627; Zhang X, 2012, SCI TOTAL ENVIRON, V430, P75, DOI 10.1016/j.scitotenv.2012.04.040; Konczol M, 2013, TOXICOL LETT, V216, P171, DOI 10.1016/j.toxlet.2012.11.018; Fisk WJ, 2009, INDOOR AIR, V19, P159, DOI 10.1111/j.1600-0668.2008.00575.x; APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Runeson R, 2004, INDOOR AIR, V14, P394, DOI 10.1111/j.1600-0668.2004.00261.x; Mendell MJ, 2008, INDOOR AIR, V18, P301, DOI 10.1111/j.1600-0668.2008.00531.x; Hansen AM, 2008, INDOOR AIR, V18, P440, DOI 10.1111/j.1600-0668.2008.00571.x; Khatri M, 2013, NANOTOXICOLOGY, V7, P1014, DOI 10.3109/17435390.2012.691998; JAAKKOLA JJK, 1989, ENVIRON INT, V15, P163, DOI 10.1016/0160-4120(89)90022-6; Hosmer DW, 1997, STAT MED, V16, P965; Wolkoff P, 2010, TOXICOL LETT, V199, P203, DOI 10.1016/j.toxlet.2010.09.001; Kanazawa A, 2010, INDOOR AIR, V20, P72, DOI 10.1111/j.1600-0668.2009.00629.x; Erdmann CA, 2004, INDOOR AIR, V14, P127, DOI 10.1111/j.1600-0668.2004.00298.x; Burge PS, 2004, OCCUP ENVIRON MED, V61, P185, DOI 10.1136/oem.2003.008813; Marmot AF, 2006, OCCUP ENVIRON MED, V63, P283, DOI 10.1136/oem.2005.022889; Ozaki K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-253; Reijula K, 2004, OCCUP ENVIRON MED, V61, P33; Ooi PL, 1998, OCCUP ENVIRON MED, V55, P188; Nafiu OO, 2014, J PERIANESTH NURS, V29, P84, DOI 10.1016/j.jopan.2013.03.010; Allermann L, 2007, INDOOR AIR, V17, P458, DOI 10.1111/j.1600-0668.2007.00493.x; TEEUW KB, 1994, ARCH INTERN MED, V154, P2339, DOI 10.1001/archinte.154.20.2339; Bai R, 2010, TOXICOL LETT, V199, P288, DOI 10.1016/j.toxlet.2010.09.011; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Brightman HS, 2008, INDOOR AIR, V18, P335, DOI 10.1111/j.1600-0668.2008.00557.x; Wada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056319; Nakazawa H, 2005, IND HEALTH, V43, P341, DOI 10.2486/indhealth.43.341; [Anonymous], 1998, INDOOR AIR S; Ogasawara K, 2011, J AFFECT DISORDERS, V128, P33, DOI 10.1016/j.jad.2010.06.015; FINNEGAN MJ, 1984, BRIT MED J, V289, P1573; Norback D, 2008, INT ARCH OCC ENV HEA, V82, P21, DOI 10.1007/s00420-008-0301-9; RUOTSALAINEN R, 1995, INT ARCH OCC ENV HEA, V66, P369, DOI 10.1007/BF00383142; Runeson R, 2006, INDOOR AIR, V16, P445, DOI 10.1111/j.1600-0668.2006.00438.x; Azuma K., 2012, T SOC HEAT AIR COND, V179, P19; Azuma K., 2011, P 12 INT C IND AIR Q; BMEC, 2007, LAW MAINT SAN BUILD; MHLW, 2002, REP COMM MAINT SAN B; Mizoue T, 2001, AM J EPIDEMIOL, V154, P803, DOI 10.1093/aje/154.9.803; NORBACK D, 1990, BRIT J IND MED, V47, P733; Runeson-Broberg R, 2013, INT ARCH OCC ENV HEA, V86, P915, DOI 10.1007/s00420-012-0827-8; Santos IS, 2014, EUR J PAIN, V18, P1290, DOI 10.1002/j.1532-2149.2014.489.x; Shimomitsu T, 2000, INVESTIGATION RES RE, P101; USEPA, 2003, STAND EPA PROT CHAR; WHO, 2009, GUID IND QUAL DAMPN; Zweers T, 1992, INDOOR AIR, V2, P127, DOI 10.1111/j.1600-0668.1992.00001.x	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-6947	1600-0668		INDOOR AIR	Indoor Air	OCT	2015	25	5					499	511		10.1111/ina.12158		13	Construction & Building Technology; Engineering, Environmental; Public, Environmental & Occupational Health	Construction & Building Technology; Engineering; Public, Environmental & Occupational Health	CT5KH	WOS:000362848000005		
J	Takaki, S; Shehabi, Y; Pickering, JW; Endre, Z; Miyashita, T; Goto, T				Takaki, Shunsuke; Shehabi, Yahya; Pickering, John W.; Endre, Zoltan; Miyashita, Tetsuya; Goto, Takahisa			Perioperative change in creatinine following cardiac surgery with cardiopulmonary bypass is useful in predicting acute kidney injury: a single-centre retrospective cohort study	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Dilution of creatinine; Cardiopulmonary bypass; Acute kidney injury	ACUTE-RENAL-FAILURE; SURGICAL-PATIENTS; SERUM CREATININE; ASSOCIATION; KINETICS; RISK; CLEARANCE; BIOMARKER; PROGNOSIS; MORTALITY	OBJECTIVES: Acute kidney injury is common following cardiac surgery. Experimental models of acute kidney injury suggest that successful therapy should be implemented within 24-48 h of renal injury. However, it is difficult to detect acute kidney injury shortly after cardiac surgery, because creatinine concentration is diluted by cardiopulmonary bypass. We hypothesized that, following cardiopulmonary bypass, creatinine reduction ratios would correlate with haematocrit reduction ratios and would be associated with the incidence of acute kidney injury. METHODS: We collected demographic and blood test data from consecutive patients (n = 1137) who had undergone cardiac surgery with cardiopulmonary bypass. The creatinine reduction ratio was calculated as follows: (preoperative creatinine-postoperative creatinine)/preoperative creatinine. Patients were assigned to either of two groups. The first group (Group 1) was used to determine the threshold for acute kidney injury, and the second group (Group 2) was used to assess diagnostic performance. Acute kidney injury was defined as an increase in serum creatinine level >0.3 mg/dl or >150% from baseline. RESULTS: The incidence of acute kidney injury was 14.5% (79/545) in Group 1 and 15.5% (92/592) in Group 2. Postoperatively, creatinine concentration correlated strongly with haematocrit concentration (Pearson's r(2): 0.91). In Group 1, the area under the receiver operating characteristic curve, sensitivity and specificity were 0.71, 64.1 and 66.4%, respectively, for creatinine reduction ratios of <20%. In Group 2, the odds ratio, positive predictive value, negative predictive value and relative risk for creatinine reduction ratio performance were 4.3 (95% confidence interval 2.6-7.0), 0.27 (0.21-0.32), 0.92 (0.89-0.95) and 3.42 (2.22-5.27), respectively. CONCLUSIONS: The creatinine reduction ratio may be associated with perioperative renal injury. Therefore, it is a good diagnostic indicator with high performance, and may be useful in detecting acute kidney injury at an earlier stage relative to conventional means. In addition, using creatinine reduction ratios in this manner is financially feasible.	[Takaki, Shunsuke; Miyashita, Tetsuya; Goto, Takahisa] Yokohama City Univ Med, Dept Anesthesiol, Yokohama, Kanagawa, Japan; [Takaki, Shunsuke; Miyashita, Tetsuya; Goto, Takahisa] Yokohama City Univ Med, Intens Care Unit, Yokohama, Kanagawa, Japan; [Shehabi, Yahya] Prince Wales Hosp, Dept Intens Care, Sydney, NSW, Australia; [Pickering, John W.] Univ Otago, Christchurch Hosp, Christchurch & Emergency Dept, Christchurch, New Zealand; [Endre, Zoltan] Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia	Takaki, S (reprint author), 3-9 Fukuura, Yokohama, Kanagawa, Japan.	shunty5323@gmail.com	Endre, Zoltan/A-3331-2009	Endre, Zoltan/0000-0002-4782-8695			Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Rivers EP, 2006, CHEST, V129, P217, DOI 10.1378/chest.129.2.217; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Swaminathan M, 2003, ANN THORAC SURG, V76, P784, DOI 10.1016/S0003-4975(03)00558-7; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Huybregts RAJM, 2009, ANESTH ANALG, V109, P331, DOI 10.1213/ane.0b013e3181ac52b2; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Bloor GK, 1996, J CARDIOTHOR VASC AN, V10, P899, DOI 10.1016/S1053-0770(96)80053-X; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Loef BG, 2005, J AM SOC NEPHROL, V16, P195; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Chertow GM, 1997, CIRCULATION, V95, P878; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Pickering JW, 2013, CRIT CARE, V17, DOI 10.1186/cc11931; Pickering JW, 2015, AM J KIDNEY DIS, V65, P283, DOI 10.1053/j.ajkd.2014.09.008	24	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	OCT	2015	21	4					465	469		10.1093/icvts/ivv184		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT8HU	WOS:000363056800014		
J	Mizuno, Y; Uchinaka, A; Horii, Y; Mori, S; Hamada, Y; Miyagawa, S; Saito, A; Sawa, Y; Matsuura, N; Kawaguchi, N				Mizuno, Yoko; Uchinaka, Ayako; Horii, Yoshihito; Mori, Seiji; Hamada, Yoshinosuke; Miyagawa, Shigeru; Saito, Atsuhiro; Sawa, Yoshiki; Matsuura, Nariaki; Kawaguchi, Naomasa			Improvement of cardiac function after implanting the osteopontin-derived peptide SVVYGLR in a hamster model of dilated cardiomyopathy	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Smooth muscle actin; Collagen type III; Osteopontin-derived peptide SVVYGLR; Dilated cardiomyopathic hearts	SMOOTH MUSCLE ACTIN; CONTRACTILE ACTIVITY; COLLAGEN; MYOFIBROBLAST; DISEASE; J2N-K; HEART; RATIO	OBJECTIVES: Osteopontin is a multifunctional cytokine that can modulate a variety of cellular activities, such as fibrotic response and inflammation. Osteopontin-derived peptide Ser-Val-Val-Tyr-Gly-Leu-Arg (SVVYGLR; SV) induces angiogenesis and the expression of smooth muscle actin (SMA) in fibroblasts. In this study, we determined the effects of SV peptide on dilated cardiomyopathy (DCM). METHODS: Gels containing SV peptide (SV group), a random SV peptide (GYRVLSV) (random group) or a simple phosphate-buffered saline solution (PBS group) were transplanted on to the left ventricular (LV) anterior wall of a DCM hamster model. A control group simply underwent chest opening and closing. We used echocardiography to measure cardiac function before gel implantation (week 0) and 2, 4, 6 and 8 weeks after gel implantation. Changes in histology and myocardial remodelling were evaluated 8 weeks after the gel implantation. RESULTS: At 8 weeks post-treatment, the SV group had significantly better maintained cardiac function compared with the other groups. Histological analysis showed that LV chamber dilatation and cardiomyocyte hypertrophy were significantly attenuated, and the distribution of SMA-positive cells in the LV anterior wall area was greater in the SV group. The capillary density in the epicardial aspect of the anterior wall in the SV group was also significantly increased, indicating that the SV peptide released from the implanted gel had promoted angiogenesis. Furthermore, Western blotting and histological analyses showed that the level of expression of collagen type III at the gelimplanted anterior wall in the SV group was significantly increased, and the type III/type I collagen ratio was higher in the SV group than in the control or PBS groups. CONCLUSIONS: SV peptide treatment improved cardiac function, and inhibited the dilatation of the LV chamber and cardiomyocyte hypertrophy. By inducing the differentiation of fibroblasts to SMA-positive muscle-like cells and increasing type III collagen, SV peptide conferred a contractile property on the gel-implanted wall. We believe that the SVVYGLR peptide treatment could be used as a bridge to a left ventricular assist device and heart transplantation and for cardiac regeneration therapy without cell transplantation in the future.	[Mizuno, Yoko; Uchinaka, Ayako; Horii, Yoshihito; Kawaguchi, Naomasa] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Cardiovasc Pathol, Suita, Osaka 5650871, Japan; [Mori, Seiji; Hamada, Yoshinosuke; Matsuura, Nariaki] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan; [Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Saito, Atsuhiro] Osaka Univ, Grad Sch Med, Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan	Kawaguchi, N (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Cardiovasc Pathol, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	kawaguch@sahs.med.osaka-u.ac.jp					Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; YOSHIKANE H, 1992, JPN CIRC J, V56, P899; Uchinaka A, 2013, CARDIOVASC RES, V99, P102, DOI 10.1093/cvr/cvt088; Hinz B, 2001, MOL BIOL CELL, V12, P2730; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Pauschinger M, 1999, CIRCULATION, V99, P2750; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637; Hamada Y, 2004, DENT MATER J, V23, P650; Hamada Y, 2007, DENT MATER J, V26, P487; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Mitsuhashi S, 2003, J BIOCHEM, V134, P269, DOI 10.1093/jb/mvg140; LAPIERE CM, 1977, CONNECT TISSUE RES, V5, P21, DOI 10.3109/03008207709152608; Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Takeda N, 2003, INT J MOL MED, V11, P13; Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032; Hamada Y, 2003, BIOCHEM BIOPH RES CO, V310, P153, DOI 10.1016/j.bbrc.2003.09.001; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; MARIJIANOWSKI MMH, 1995, J AM COLL CARDIOL, V25, P1263, DOI 10.1016/0735-1097(94)00557-7; BISHOP JE, 1990, J MOL CELL CARDIOL, V22, P1157, DOI 10.1016/0022-2828(90)90079-H; Babick AP, 2004, AM J PHYSIOL-CELL PH, V287, pC1202, DOI 10.1152/ajpcell.00155.2004; Kis K, 2011, EXPERT REV MOL MED, V13, pe27; Uchinaka A, 2014, TISSUE ENG PT A, V20, P3073, DOI [10.1089/ten.TEA.2013.0763, 10.1089/ten.tea.2013.0763]	25	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	OCT	2015	21	4					506	514		10.1093/icvts/ivv197		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT8HU	WOS:000363056800025		
J	Kozu, Y; Takamochi, K; Oh, S; Suzuki, K				Kozu, Yoshiki; Takamochi, Kazuya; Oh, Shiaki; Suzuki, Kenji			Long-term survival after superior vena cava resection and reconstruction for bulky local recurrence from lung cancer	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Superior vena cava; Reconstruction; Recurrent disease; Subclavian vein; Graft occlusion	TUMORS	A 65-year old man who had undergone right pneumonectomy for lung cancer presented with superior vena cava (SVC) syndrome due to recurrent bulky disease on follow-up after 14 months. Complete resection of the tumour was achieved, and the SVC system was reconstructed with separated double grafts. The right graft was anastomosed between the SVC and the right subclavian vein, because the right brachiocephalic vein was involved by the tumour. Graft-subclavian vein anastomosis was created in the extra-thoracic portion. Although postoperative right graft occlusion occurred, right arm oedema improved conservatively. He is alive, well and has been disease-free for 39 months since the second surgery. This is the first report of SVC resection and reconstruction for 'recurrent' disease from lung cancer. Extended resection for recurrent disease should not be excluded as a treatment option.	[Kozu, Yoshiki; Takamochi, Kazuya; Oh, Shiaki; Suzuki, Kenji] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 1138431, Japan	Suzuki, K (reprint author), Juntendo Univ, Sch Med, Div Gen Thorac Surg, Bunkyo Ku, 1-3 Hongo 3 Chome, Tokyo 1138431, Japan.	kjsuzuki@juntendo.ac.jp			Ministry of Health, Labour and Welfare, Japan; Smoking Research Foundation	This work was supported by a grant-in-aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan and the Smoking Research Foundation.	Spaggiari L, 2004, LUNG CANCER-J IASLC, V44, P339, DOI 10.1016/j.lungcan.2003.11.010; Chan RCL, 2013, INTERACT CARDIOV TH, V16, P455, DOI 10.1093/icvts/ivs562; Shintani Y, 2005, J THORAC CARDIOV SUR, V129, P809, DOI 10.1016/j.jtcvs.2004.05.001; Grunenwald D, 1997, ANN THORAC SURG, V63, P563	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	OCT	2015	21	4					545	547		10.1093/icvts/ivv188		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT8HU	WOS:000363056800032		
J	Takagi, H; Watanabe, T; Umemoto, T				Takagi, H.; Watanabe, T.; Umemoto, T.			Mesenteric malperfusion complicated with type A acute aortic dissection	INTERNATIONAL ANGIOLOGY			English	Article						Dissection; Mesenteric veins; Aorta	RISK-FACTORS; INTERNATIONAL REGISTRY; CLINICAL PRESENTATION; REPAIR; EXPERIENCE; MORTALITY; ISCHEMIA; OUTCOMES; SURGERY; INTERVENTION	Type A acute aortic dissection (AAAD), involving the ascending aorta, is one of life-threatening disorders. Emergent surgery, such as graft replacement of the aortic root, ascending aorta, aortic arch, or these combinations, is routinely performed to avoid sudden death due to free rupture, cardiac tamponade, or coronary obstruction. Even though appropriate surgery is immediately completed, however, operative mortality remains high, between 15% and 30%. Furthermore, mesenteric malperfusion, bringing about enteric ischemia, occurs unusually in AAAD with far and away higher mortality In the present article, we reviewed contemporary evidence regarding incidence, mortality, and treatment of mesenteric malperfusion complicated with AAAD. The incidence and early mortality rate of mesenteric malperfusion complicated with AAAD was 4% and 68%, respectively. Patients with mesenteric malperfusion had a 9.7-fold risk of mortality relative to those without it. Evidence regarding optimal treatment of mesenteric malperfusion complicated with AAAD is very limited.	[Takagi, H.; Watanabe, T.; Umemoto, T.] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shizuoka, Japan	Takagi, H (reprint author), 762-1 Nagasawa, Sunto, Shizuoka 4118611, Japan.	kfgth973@ybb.ne.jp					Caus T, 2002, EUR J CARDIO-THORAC, V22, P211, DOI 10.1016/S1010-7940(02)00275-0; Di Luozzo G, 2007, ANN THORAC SURG, V84, P2097, DOI 10.1016/j.athoracsur.2007.06.077; Geirsson A, 2007, EUR J CARDIO-THORAC, V32, P255, DOI 10.1016/j.ejcts.2007.04.012; Moizumi Y, 2005, ANN THORAC SURG, V80, P77, DOI 10.1016/j.athoracsur.2005.01.058; Kazui T, 2002, ANN THORAC SURG, V74, P75, DOI 10.1016/S0003-4975(02)03603-2; Di Eusanio M, 2013, J THORAC CARDIOV SUR, V145, P385, DOI 10.1016/j.jtcvs.2012.01.042; Yagdi T, 2006, J CARDIAC SURG, V21, P363, DOI 10.1111/j.1540-8191.2006.00246.x; Girdauskas E, 2009, J THORAC CARDIOV SUR, V138, P1363, DOI 10.1016/j.jtcvs.2009.04.059; Fabre O, 2002, ANN THORAC SURG, V73, P950, DOI 10.1016/S0003-4975(02)03402-1; Tsagakis K, 2013, EUR J CARDIO-THORAC, V43, P397, DOI 10.1093/ejcts/ezs287; Hata M, 2013, J THORAC CARDIOV SUR, V146, P119, DOI 10.1016/j.jtcvs.2012.06.047; Santini F, 2007, INT J CARDIOL, V115, P305, DOI 10.1016/j.ijcard.2006.03.013; Piccardo A, 2013, ANN THORAC SURG, V96, P851, DOI 10.1016/j.athoracsur.2013.04.066; Aalberts JJJ, 2009, NETH HEART J, V17, P226; Apaydin AZ, 2002, ANN THORAC SURG, V74, P2034, DOI 10.1016/S0003-4975(02)04096-1; Meriggi F, 2011, ANN THORAC CARDIOVAS, V17, P631, DOI 10.5761/atcs.cr.10.01649; Ferlan G, 2011, INTERACT CARDIOV TH, V12, P835, DOI 10.1510/icvts.2010.257824; Kimura N, 2008, CIRC J, V72, P1751, DOI 10.1253/circj.CJ-08-0306; Hofferberth SC, 2014, J THORAC CARDIOV SUR, V147, P1240, DOI 10.1016/j.jtcvs.2013.03.036; Tshomba Y, 2012, EUR J VASC ENDOVASC, V43, P690, DOI 10.1016/j.ejvs.2012.03.017; Pacini D, 2013, EUR J CARDIO-THORAC, V43, P820, DOI 10.1093/ejcts/ezs500; Tsagakis K, 2008, THORAC CARDIOV SURG, V56, P298, DOI 10.1055/s-2008-1038512; Midulla M, 2011, J THORAC CARDIOV SUR, V142, P66, DOI 10.1016/j.jtcvs.2010.07.081; Trimarchi S, 2005, J THORAC CARDIOV SUR, V129, P112, DOI 10.1016/j.jtcvs.2004.09.005; Chiappini B, 2005, EUR HEART J, V26, P180, DOI 10.1093/eurheartj/ehi024; Girardi LN, 2004, ANN THORAC SURG, V77, P1309, DOI 10.1016/j.athoracsur.2003.09.056; Okada Y, 2007, ANN THORAC SURG, V83, P293, DOI 10.1016/j.athoracsur.2006.04.024; Immer Franz F, 2006, Interact Cardiovasc Thorac Surg, V5, P187, DOI 10.1510/icvts.2005.125484; Iwaki H, 2008, J CARDIOVASC SURG, V23, P171; Kazui T, 2002, ANN THORAC SURG, V74; Lee SJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-46; Ma Wei-Guo, 2013, Ann Cardiothorac Surg, V2, P621, DOI 10.3978/j.issn.2225-319X.2013.09.06; Muraki Satoshi, 2003, Ann Thorac Cardiovasc Surg, V9, P79; Shiiya Norihiko, 2007, Gen Thorac Cardiovasc Surg, V55, P85, DOI 10.1007/s11748-006-0080-8; Suehiro Kotaro, 2006, Heart Lung Circ, V15, P105, DOI 10.1016/j.hlc.2006.01.003; Suliman A, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-4; Totsugawa Toshinori, 2010, Gen Thorac Cardiovasc Surg, V58, P134, DOI 10.1007/s11748-009-0500-7; Yamashiro Satoshi, 2002, Ann Thorac Cardiovasc Surg, V8, P231	38	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0392-9590	1827-1839		INT ANGIOL	Int. Angiol.	OCT	2015	34	5					445	453				9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CT7NP	WOS:000363002100005		
J	Takagi, H; Watanabe, T; Umemoto, T				Takagi, H.; Watanabe, T.; Umemoto, T.		ALICE Grp	Aortoduodenal syndrome	INTERNATIONAL ANGIOLOGY			English	Article						Aortic aneurysm, abdominal; Superior mesenteric artery syndrome; Duodenal obstruction	ABDOMINAL AORTIC-ANEURYSM; MESENTERIC-ARTERY SYNDROME; DUODENAL OBSTRUCTION; URETERAL OBSTRUCTION	Duodenal obstruction caused by abdominal aortic aneurysm (AAA), i.e. "aortoduodenal syndrome," first described by Osier in 1905 is a rare clinical entity, with only several dozens of cases reported in the literature. In the present paper, we systematically searched literature and reviewed them. Databases including MEDLINE and EMBASE were searched from January 1981 to April 2014 using Web-based search engines (PubMed and OVID). Eighteen papers reported 21 cases with aortoduodenal syndrome. Mean age of patients was 74.5 +/- 8.4 years, 71.4% of patients were men, and mean AAA diameter was 7.2 +/- 2.1 cm. We also discussed confusion between aortoduodenal syndrome and "superior mesenteric artery syndrome" associated with AAA.	[Takagi, H.; Watanabe, T.; Umemoto, T.; ALICE Grp] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shizuoka, Japan	Takagi, H (reprint author), 762-1 Nagasawa, Shimizu, Shizuoka 4118611, Japan.	kf-gth973@ybb.ne.jp					Bhama JK, 2001, J VASC SURG, V34, P1130, DOI 10.1067/mva.2001.118594; REDMOND PL, 1987, CLIN RADIOL, V38, P513, DOI 10.1016/S0009-9260(87)80137-X; Ouyang CX, 2010, J VASC SURG, V52, P1048, DOI 10.1016/j.jvs.2010.05.009; Torella M, 2003, TEX HEART I J, V30, P311; SOSTEK M, 1993, AM J MED, V94, P220, DOI 10.1016/0002-9343(93)90188-U; Saraya T, 2009, INTERNAL MED, V48, P1065, DOI 10.2169/internalmedicine.48.1684; Wilkie DPD, 1927, AM J MED SCI, V173, P643, DOI 10.1097/00000441-192705000-00006; EDWARDS KC, 1984, AM J GASTROENTEROL, V79, P72; Osler W, 1905, LANCET, V2, P1089; Takagi H, 2006, J VASC SURG, V43, P851, DOI 10.1016/j.jvs.2004.12.025; COSTER DD, 1988, AM J GASTROENTEROL, V83, P981; HOUGH DR, 1981, AM J GASTROENTEROL, V76, P538; Kaneda T, 1999, JPN CIRC J, V63, P567, DOI 10.1253/jcj.63.567; Merrett ND, 2009, J GASTROINTEST SURG, V13, P287, DOI 10.1007/s11605-008-0695-4; Deitch JS, 2004, J VASC SURG, V40, P543, DOI 10.1016/j.jvs.2004.04.028; GEER DA, 1990, MIL MED, V155, P321; Khan AA, 2007, DIGEST SURG, V24, P15, DOI 10.1159/000100912; Komai H, 1999, J VASC SURG, V29, P1162, DOI 10.1016/S0741-5214(99)70255-7; Welsch T, 2007, DIGEST SURG, V24, P149, DOI 10.1159/000102097; HODGSON KJ, 1986, J VASC SURG, V3, P364, DOI 10.1067/mva.1986.avs0030364; Cahill K, 2009, VASCULAR, V17, P168, DOI 10.2310/6670.2008.00068; Kim HR, 2002, J KOREAN MED SCI, V17, P552; HENNIGAN TW, 1992, J ROY SOC MED, V85, P573; Cieri E, 2013, EUR J VASC ENDOVASC, V46, P192, DOI 10.1016/j.ejvs.2013.05.012; Pal A, 2009, Ann R Coll Surg Engl, V91, pW6, DOI 10.1308/147870809X450575; Dharmendran R, 2003, Med J Malaysia, V58, P135; Okuyama Yusuke, 2011, Case Rep Gastroenterol, V5, P278, DOI 10.1159/000328442; QUIGLEY F G, 1988, Australian and New Zealand Journal of Surgery, V58, P909, DOI 10.1111/j.1445-2197.1988.tb01002.x	28	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0392-9590	1827-1839		INT ANGIOL	Int. Angiol.	OCT	2015	34	5					454	458				5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CT7NP	WOS:000363002100006		
J	Huang, BY; Lejarraga, C; Franco, CS; Kang, YL; Lee, A; Abbott, J; Takahashi, K; Bessho, K; Pumtang-On, P				Huang, Boyen; Lejarraga, Carla; Franco, Christopher S.; Kang, Yunlong; Lee, Andrew; Abbott, John; Takahashi, Katsu; Bessho, Kazuhisa; Pumtang-On, Pongthorn			Influence of non-orthodontic intervention on digit sucking and consequent anterior open bite: a preliminary study	INTERNATIONAL DENTAL JOURNAL			English	Article						Digit sucking; anterior open bite; non-orthodontic intervention; incisive papilla; orofacial myology; stomahesive wafer	FINGER-SUCKING; TONGUE-THRUST; THUMB-SUCKING; ORAL HABITS; CHILDREN; MALOCCLUSION; APPLIANCES; PRESSURE; THERAPY; ADULTS	Objectives: This study aimed to assess behavioural and occlusal outcomes of non-orthodontic intervention (NOI) in a sample of children, 4-12 years of age, in Australia, in order to establish clinical relevance. Materials and methods: Data from 91 patient records of 4- to 12-year-old children reporting a habit of digit sucking, from two clinics in north-eastern Australia, were de-identified and used. Each patient had been examined at two visits, separated by an interval of 4 months, using standard clinical procedures. Results: Of the 77 children who received a 4-month NOI, 69 (89.6%) had ceased their digit sucking habit by the end of the NOI period [chi(2) = 67.0, degrees of freedom (d.f.) = 1, P < 0.001]. Of the 72 subjects who had front teeth, the number with anterior open bite decreased from 37 (51.4%) to 12 (16.7%) upon completion of NOI (chi(2) = 21.3, d.f. = 1, P < 0.001). Among the 32 patients with a measurable overjet, the mean overjet was found to decrease from 4.2 +/- 2.4 mm to 3.1 +/- 1.9 mm after implementation of NOI (t = 5.8, d.f. = 31, P < 0.001). Children who received NOI were more likely to quit the digit sucking habit in the 4-month period (P < 0.001, OR = 51.8, 95% CI: 9.8-273.9) and were more likely to appear without anterior open bite at a 4-month recall (P < 0.001, OR = 30.0, 95% CI: 5.9-151.6). Conclusions: This study demonstrated clinical relevance of NOI on the cessation of a digit sucking habit, closure of anterior open bite and reduction of overjet. Further investigations are indicated.	[Huang, Boyen] Charles Sturt Univ, Sch Dent & Hlth Sci, Orange, NSW, Australia; [Lejarraga, Carla] Thumbsucking Clin, Townsville, Qld, Australia; [Franco, Christopher S.; Lee, Andrew; Abbott, John] James Cook Univ, Sch Med & Dent, Cairns, Qld, Australia; [Kang, Yunlong] Univ Melbourne, Melbourne Dent Sch, Dept Orthodont, Melbourne, Vic, Australia; [Takahashi, Katsu; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Pumtang-On, Pongthorn] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	Huang, BY (reprint author), CSU Sch Dent & Hlth Sci, Orange, NSW 2800, Australia.	bhuang@csu.edu.au					Altman DG, 1991, PRACTICAL STAT MED R; American Dental Association (ADA), 2007, J AM DENT ASSOC, V138, P1176; Smithpeter J, 2010, AM J ORTHOD DENTOFAC, V137, P605, DOI 10.1016/j.ajodo.2008.07.016; Giuntini V, 2008, AM J ORTHOD DENTOFAC, V133, P77, DOI 10.1016/j.ajodo.2007.07.012; Emerich K, 2010, EUR J PEDIATR, V169, P651, DOI 10.1007/s00431-009-1098-6; Srinivasan J, 2001, J HAND SURG-BRIT EUR, V26, P584, DOI 10.1054/jhsb.2001.0679; Taslan S, 2010, ANGLE ORTHOD, V80, P533, DOI 10.2319/070209-370.1; Durdu M, 2014, J AM ACAD DERMATOL, V70, P120, DOI 10.1016/j.jaad.2013.09.042; GROSS E, 1977, BRIT J SURG, V64, P258, DOI 10.1002/bjs.1800640409; Cozza P, 2006, AM J ORTHOD DENTOFAC, V129, P734, DOI 10.1016/j.ajodo.2006.02.004; VANWILLIGEN JD, 1984, ARCH ORAL BIOL, V29, P7, DOI 10.1016/0003-9969(84)90035-9; FRIMAN PC, 1989, CLIN PEDIATR, V28, P438, DOI 10.1177/000992288902801001; Avins AL, 1998, J MED ETHICS, V24, P401, DOI 10.1136/jme.24.6.401; Byrd MR, 2002, BEHAV MODIF, V26, P400, DOI 10.1177/01445502026003006; Levrini L, 2012, EUR J PAEDIATR DENT, V13, P155; Kulkarni GV, 2010, PEDIATR DENT, V32, P61; ORTMAN HR, 1979, J PROSTHET DENT, V42, P492, DOI 10.1016/0022-3913(79)90240-3; Castro-Fornieles J, 2011, EUR EAT DISORD REV, V19, P46, DOI 10.1002/erv.1045; dos Santos RR, 2012, ORAL HLTH PREV DENT, V10, P311; Buchanan S, 1997, AUST DENT J, V42, P225, DOI 10.1111/j.1834-7819.1997.tb00125.x; KOHLER L, 1973, ACTA PAEDIATR SCAND, V62, P373; WEISS CE, 1972, AMER J ORTHODONTICS, V62, P499, DOI 10.1016/0002-9416(72)90025-5; Torgersbraten N, 2012, ACTA ODONTOL SCAND, V70, P635, DOI 10.3109/00016357.2011.645065; Thuer U, 1999, EUR J ORTHODONT, V21, P299, DOI 10.1093/ejo/21.3.299; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Knosel M, 2012, DYSPHAGIA, V27, P401, DOI 10.1007/s00455-011-9383-8; Yousefzadeh F, 2010, AM J ORTHOD DENTOFAC, V137, P236, DOI 10.1016/j.ajodo.2008.03.033; Artese Alderico, 2011, Dental Press J. Orthod., V16, P136, DOI 10.1590/S2176-94512011000300016; Baker C., 2001, ORAL HLTH, V91, P25; Campbell P M, 1984, J Clin Orthod, V18, P254; Centers for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P584; Fukumoto E, 2013, PEDIATR DENT, V35, P506; Harila V, 2007, J Dent Child (Chic), V74, P165; HASKELL B S, 1991, Pediatric Dentistry, V13, P83; Huang B, 2012, ANGLE ORTHOD, V83, P527; Jann H., 1960, NY STATE DENT J, V26, P72; Koch G, 2001, PEDIAT DENT CLIN APP; Luzzi Valeria, 2011, Prog Orthod, V12, P114, DOI 10.1016/j.pio.2011.03.002; Mistry Paroo, 2010, J Orthod, V37, P87, DOI 10.1179/14653121042939; Moschik CE, 2013, INFLUENCE OROFACIAL; Myers RL., 2006, BASICS PHYS; Ritto A K, 1998, J Clin Orthod, V32, P318; Sah Ram Bilakshan, 2013, Trop Parasitol, V3, P140, DOI 10.4103/2229-5070.122143; SASSOUNI V, 1969, AMER J ORTHODONTICS, V55, P109, DOI 10.1016/0002-9416(69)90122-5; Jang SJ, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2009.07.017; Trawitzki Luciana Vitaliano Voi, 2005, Braz J Otorhinolaryngol, V71, P747; Verrastro Anna Paula, 2007, Int J Orthod Milwaukee, V18, P19; Yonezu Takuro, 2013, Bull Tokyo Dent Coll, V54, P215	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-6539	1875-595X		INT DENT J	Int. Dent. J.	OCT	2015	65	5					235	241		10.1111/idj.12178		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT5KP	WOS:000362848900002		
J	MaruYama, T				MaruYama, Takashi			The nuclear I kappa B family of proteins controls gene regulation and immune homeostasis	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Review						Nuclear I kappa B family proteins; Immune homeostasis; Transcriptional factor; NF-kappa B; Gene regulation	INDUCED IL-6 PRODUCTION; CANDIDATE PROTOONCOGENE BCL-3; ZETA MESSENGER-RNA; TRANSCRIPTION FACTOR; CELL DEVELOPMENT; INFLAMMATORY RESPONSE; SIGNALING PATHWAY; ONCOPROTEIN BCL-3; DEFICIENT MICE; DNA-BINDING	The inhibitory I kappa B family of proteins is subdivided into two groups based on protein localization in the cytoplasm or in the nucleus. These proteins interact with NF-kappa B, a major transcription factor regulating the expression of many inflammatory cytoldnes, by modulating its transcriptional activity. However, nuclear I kappa B family proteins not only interact with NF-kappa B to change its transcriptional activity, but they also bind to chromatin and control gene expression. This review provides an overview of nuclear I kappa B family proteins and their role in immune homeostasis. (C) 2015 Elsevier B.V. All rights reserved.	[MaruYama, Takashi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [MaruYama, Takashi] Gifu Univ, Sch Med, Gifu 5011194, Japan	MaruYama, T (reprint author), Gifu Univ, Sch Med, Gifu 5011194, Japan.	ta-maru@umin.ac.jp			Ministry of Education [25118702]; Astellas Foundation for Research on Metabolic Disorders [3225]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas [Grant Numbers 25118702] from the Ministry of Education to T.M.Y.; and research grants to T.M.Y. from the Astellas Foundation for Research on Metabolic Disorders [Grant Numbers 3225].	Ikeda S, 2014, J IMMUNOL, V192, P1449, DOI 10.4049/jimmunol.1300387; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Touma M, 2007, J IMMUNOL, V179, P1681; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Memet S, 1999, J IMMUNOL, V163, P5994; O'Carroll C, 2013, CLIN EXP IMMUNOL, V173, P332, DOI 10.1111/cei.12119; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Corn RA, 2005, J IMMUNOL, V175, P2102; Dagvadorj J, 2009, INNATE IMMUN, V15, P217, DOI 10.1177/1753425909103738; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.06.041; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Collins PE, 2014, J BIOL CHEM, V289, P7059, DOI 10.1074/jbc.M114.551986; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Simeonidis S, 1997, P NATL ACAD SCI USA, V94, P14372, DOI 10.1073/pnas.94.26.14372; Garcia I, 2013, HUM CELL, V26, P47, DOI 10.1007/s13577-012-0056-1; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V356, P785, DOI 10.1016/j.bbrc.2007.03.044; Lindenblatt C, 2009, CELL CYCLE, V8, P2019, DOI 10.4161/cc.8.13.8816; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Ge BS, 2003, J IMMUNOL, V171, P4210; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P132; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Pene F, 2011, J IMMUNOL, V186, P2412, DOI 10.4049/jimmunol.1001331; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Arnold CN, 2012, P NATL ACAD SCI USA, V109, P12286, DOI 10.1073/pnas.1209134109; Dhamija S, 2010, J BIOL CHEM, V285, P29165, DOI 10.1074/jbc.M110.146365; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Annemann M, 2015, J IMMUNOL, V194, P2888, DOI 10.4049/jimmunol.1401964; Hovelmeyer N, 2014, EUR J IMMUNOL, V44, P545, DOI 10.1002/eji.201343655; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Touma M, 2011, J IMMUNOL, V187, P3942, DOI 10.4049/jimmunol.1002109; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; Pedersen GK, 2014, P NATL ACAD SCI USA, V111, pE4119, DOI 10.1073/pnas.1415866111; Hanihara F, 2013, INT IMMUNOL, V25, P531, DOI 10.1093/intimm/dxt017; Zhang XR, 2013, J IMMUNOL, V191, P5984, DOI 10.4049/jimmunol.1300611; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Hirotani T, 2005, J IMMUNOL, V174, P3650; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Li Z, 1997, MOL CELL BIOL, V17, P6184; Ferreiro DU, 2010, BIOCHEMISTRY-US, V49, P1560, DOI 10.1021/bi901948j; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Yamauchi S, 2010, P NATL ACAD SCI USA, V107, P11924, DOI 10.1073/pnas.0913179107; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P114; Ishikawa C, 2011, CARCINOGENESIS, V32, P110, DOI 10.1093/carcin/bgq222; FRANZOSO G, 1993, EMBO J, V12, P3893; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Cardone M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114516; Hanihara-Tatsuzawa F, 2014, J BIOL CHEM, V289, P30925, DOI 10.1074/jbc.M114.553230; Jackman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051478; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; KERR LD, 1991, GENE DEV, V5, P1464, DOI 10.1101/gad.5.8.1464; Kobayashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110838; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Schott J., 2014, PLOS GENET, V10; Tang WH, 2014, IMMUNITY, V41, P555, DOI 10.1016/j.immuni.2014.09.017; Tartey S, 2014, EMBO J, V33, P2332, DOI 10.15252/embj.201488447; Walker T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077015; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0	85	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2015	28	2			SI		836	840		10.1016/j.intimp.2015.03.053		5	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CT5NT	WOS:000362857800005		
J	Zhao, MY; Chen, JJ; Zhu, P; Fujino, M; Takahara, T; Toyama, S; Tomita, A; Zhao, LL; Yang, ZC; Hei, MY; Zhong, L; Zhuang, J; Kimura, S; Li, XK				Zhao, Mingyi; Chen, Jiajie; Zhu, Ping; Fujino, Masayuki; Takahara, Terumi; Toyama, Sumika; Tomita, Amy; Zhao, Lingling; Yang, Zuocheng; Hei, Mingyan; Zhong, Liang; Zhuang, Jian; Kimura, Shuichi; Li, Xiao-Kang			Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK/Nrf2 antioxidant pathway in RAW cells	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Antioxidant; ConA; DHQ; Hepatitis; Mitogen-activated protein kinases; HO-1; Nrf2	ISCHEMIA-REPERFUSION INJURY; HEME OXYGENASE-1 EXPRESSION; OXIDATIVE STRESS; PROTECTS MICE; LIVER-INJURY; NRF2; INFLAMMATION; MACROPHAGES; DEFICIENCY; ACTIVATION	Autoimmune hepatitis represents a ubiquitous human health problem and has a poor prognosis. Dihydroquercetin (DHQ), a well-known antioxidant, significantly inhibits fulminant hepatitis through antioxidant and anti-inflammation mechanisms. In this study, we show that administration of DHQ ameliorated concanavalin A (ConA)-induced mouse liver injury by increasing the survival rate, reducing the serum ALT and AST level, preventing histopathological injuries and decreasing pro-inflammatory cytokine mRNA expression in hepatic tissue. As macrophages/Kupffer cells in oxidative stress and pro-inflammatory mediators play an important role in the pathogenesis of immune-mediated hepatitis, we further exposed mouse RAW264 macrophage cell lines to ConA in vitro and found that DHQ significantly inhibited mRNA expression and secretion of IFN-gamma and TNF-alpha in cell culture supernatant. In addition, DHQ significantly enhanced heme oxygenase-1 (HO-1) expression in a dose-and time-dependent manner via increased Nrf2 expression in cytoplasm and nuclear translocation. Furthermore, DHQ enhanced phosphorylation of three members of the mitogen-activated protein kinase (MAPK) family, and cell treatment with MEK/ERK (PD98059), p38 (SE203580) and JNK (SP600125) inhibitors reduced DHQ-induced HO-1 expression. These results indicate that DHQ possesses hepatoprotective properties against ConA-induced liver injury, which are attributed to its ability to scavenge oxidative stress and to inhibit the release of inflammatory mediators via upregulation of HO-1 activity through the MAPK/Nrf2 signaling pathway in macrophages/Kupffer cells. (C) 2015 Elsevier B.V. All rights reserved.	[Zhao, Mingyi; Chen, Jiajie; Zhu, Ping; Fujino, Masayuki; Toyama, Sumika; Tomita, Amy; Li, Xiao-Kang] Natl Res Inst Child Hlth & Dev, Div Transplantat Immunol, Tokyo, Japan; [Zhao, Mingyi; Zhao, Lingling; Yang, Zuocheng; Hei, Mingyan] Cent S Univ, Xiangya Hosp 3, Dept Pediat, Changsha, Hunan, Peoples R China; [Chen, Jiajie; Zhuang, Jian] Fudan Univ, Huashan Hosp, Dept Gastroenterol, Shanghai 200040, Peoples R China; [Zhu, Ping; Zhuang, Jian] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Fujino, Masayuki] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Takahara, Terumi] Toyama Univ, Dept Internal Med 3, Toyama 930, Japan; [Tomita, Amy; Kimura, Shuichi] Res Inst Nutr & Aging, Tokyo, Japan	Zhong, L (reprint author), Fudan Univ, Huashan Hosp, Dept Gastroenterol, 12 Wulumuqi Middle Rd, Shanghai 200040, Peoples R China.	zhongniping@163.com; ri-k@ncchd.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20390349, 21659310, 22591418, 20790929, 2109739, 22/00830]; National Center for Child Health and Development [22-10]	We thank Emma Barber for editorial assistance. This study was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid 20390349, 21659310, 22591418, 20790929, 2109739 and 22/00830) and the National Center for Child Health and Development (22-10).	Williams K, 2013, MUTAT RES-FUND MOL M, V743, P1, DOI 10.1016/j.mrfmmm.2013.04.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Wahl C, 2009, J IMMUNOL, V182, P4521, DOI 10.4049/jimmunol.0802810; Medina J, 2003, ALIMENT PHARM THERAP, V17, P1, DOI 10.1046/j.0269-2813.2003.01389.x; Park SY, 2011, IMMUNOL LETT, V139, P93, DOI 10.1016/j.imlet.2011.05.007; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1127/JCI25790; Rushworth SA, 2005, J IMMUNOL, V175, P4408; Luo XY, 2013, AM J PHYSIOL-GASTR L, V305, pG891, DOI 10.1152/ajpgi.00193.2013; Li Y, 2012, CELL PHYSIOL BIOCHEM, V29, P31, DOI 10.1159/000337584; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Yang Y, 2013, EXP THER MED, V6, P459, DOI 10.3892/etm.2013.1152; Nakaya M, 2009, J IMMUNOL, V183, P7047, DOI 10.4049/jimmunol.0900547; Liang L, 2013, J AGR FOOD CHEM, V61, P2755, DOI 10.1021/jf304768p; Kim NH, 2010, J PHARMACOL SCI, V113, P246, DOI 10.1254/jphs.09330FP; Nishio Y, 2014, INT IMMUNOPHARMACOL, V19, P300, DOI 10.1016/j.intimp.2014.02.003; Hou JG, 2013, AM J PHYSIOL-RENAL, V305, pF1149, DOI 10.1152/ajprenal.00275.2013; Lee JW, 2014, MOL CELL BIOCHEM, V390, P143, DOI 10.1007/s11010-014-1965-y; Li BF, 2006, HEPATOLOGY, V43, P1211, DOI 10.1002/hep.21174; Lee DS, 2010, INT IMMUNOPHARMACOL, V10, P850, DOI 10.1016/j.intimp.2010.04.019; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Gebhardt R, 2002, PLANTA MED, V68, P289, DOI 10.1055/s-2002-26761; Fujino M, 2003, GENE THER, V10, P1781, DOI 10.1038/sj.gt.3302067; Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439; Osburn WO, 2008, TOXICOL SCI, V104, P218, DOI 10.1093/toxsci/kfn079; Ma CH, 2012, INT J MOL SCI, V13, P8789, DOI 10.3390/ijms13078789; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Vrba Jiri, 2002, Biomedical Papers (Olomouc), V146, P15; Zhang Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep03979	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2015	28	2			SI		938	944		10.1016/j.intimp.2015.04.032		7	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CT5NT	WOS:000362857800021		
J	Ueda, F; Iizuka, K; Tago, K; Narukawa, Y; Kiuchi, F; Kasahara, T; Tamura, H; Funakoshi-Tago, M				Ueda, Fumihito; Iizuka, Keito; Tago, Kenji; Narukawa, Yuji; Kiuchi, Fumiyuki; Kasahara, Tadashi; Tamura, Hiroomi; Funakoshi-Tago, Megumi			Nepetaefuran and leonotinin isolated from Leonotis nepetaefolia R. Br. potently inhibit the LPS signaling pathway by suppressing the transactivation of NF-kappa B	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Leonotis nepetifolia R. Br; Nepetaefuran; Leonotinin; Leonotin; LPS; NF-kappa B	NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-4; BACTERIAL LIPOPOLYSACCHARIDE; DIABETIC-NEUROPATHY; TRANSCRIPTIONAL ACTIVITY; OXIDATIVE STRESS; INTERFERON-GAMMA; ALPHA GENE; IKK-BETA	Leonotis nepetaefolia R. Br., also known as Klip Dagga or Lion's Ear, has traditionally been used as a folk medicine to treat inflammatory diseases such as rheumatism, bronchitis, and asthma; however, the components that exhibit its anti-inflammatory activity have not yet been identified. In the present study, we investigated the effects of three types of diterpenoids, nepetaefuran, leonotinin, and leonotin, which were isolated from L. nepetaefolia R. Br., on the LPS signaling pathway in order to elucidate the anti-inflammatory mechanism involved. Nepetaefuran more potently inhibited the LPS-induced production of NO and CCL2 than leonotinin by suppressing the expression of iNOS mRNA and CCL2 mRNA. On the other hand, leonotin failed to inhibit the production of NO and CCL2 induced by LPS. Although nepetaefuran and leonotinin had no effect on the LPS-induced degradation of I kappa B alpha or nuclear translocation of NF-kappa B p65, they markedly inhibited the transcriptional activity of NF-kappa B. Nepetaefuran and leonotinin also inhibited the transcriptional activity of the GAL4-NF-kappa B p65 fusion protein. On the other hand, nepetaefuran, leonotinin and leonotin did not affect the LPS-induced activation of MAP kinase family members such as ERK, p38, and JNK In addition, inhibitory effect of nepetaefuran and leonotinin on NF-kappa B activation is well correlated with their ability to induce activation of Nrf2 and ER stress. Taken together, these results demonstrated that nepetaefuran and leonotinin could be the components responsible for the anti-inflammatory activity of L nepetaefolia R. Br. by specifically inhibiting the LPS-induced activation of NF-kappa B. (C) 2015 Elsevier B.V. All rights reserved.	[Ueda, Fumihito; Iizuka, Keito; Narukawa, Yuji; Kiuchi, Fumiyuki; Kasahara, Tadashi; Tamura, Hiroomi; Funakoshi-Tago, Megumi] Keio Univ, Fac Pharm, Minato Ku, Tokyo 1058512, Japan; [Tago, Kenji] Jichi Med Univ, Sch Med, Dept Biochem, Div Struct Biochem, Shimotsuke, Tochigi 3290498, Japan	Funakoshi-Tago, M (reprint author), Keio Univ, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	tago-mg@pha.keio.ac.jp					Abubacker M. N., 2003, Indian Journal of Experimental Biology, V41, P1473; Liu HT, 2000, J IMMUNOL, V164, P4277; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; CHENSUE SW, 1991, AM J PATHOL, V138, P395; Ianaro A, 2009, MINI-REV MED CHEM, V9, P306; Oshima N, 2013, J NAT MED-TOKYO, V67, P281, DOI 10.1007/s11418-012-0679-2; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Negi G, 2011, J PINEAL RES, V50, P124, DOI 10.1111/j.1600-079X.2010.00821.x; O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Pacheco P, 2007, J IMMUNOL, V179, P8500; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; WESTENBERGER U, 1990, FREE RADICAL RES COM, V11, P167, DOI 10.3109/10715769009109680; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Liu SF, 1997, J IMMUNOL, V159, P3976; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Furusawa JI, 2009, CELL SIGNAL, V21, P778, DOI 10.1016/j.cellsig.2009.01.021; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Heyninck K, 2014, BIOCHEM PHARMACOL, V91, P501, DOI 10.1016/j.bcp.2014.08.004; HSUEH W, 1990, IMMUNOLOGY, V70, P309; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Hu J, 2002, J IMMUNOL, V168, P3910; BRACH MA, 1992, MOL PHARMACOL, V42, P63; Foca A, 1998, MICROBIOLOGICA, V21, P123; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; DiDonato JA, 1997, NATURE, V388, P548; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; UEDA A, 1994, J IMMUNOL, V153, P2052; Negi G, 2011, CURR NEUROVASC RES, V8, P294; Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Soares MP, 2004, J IMMUNOL, V172, P3553; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; SUNG SSJ, 1991, J IMMUNOL, V147, P2047; Mukherjee S, 2013, J NUTR BIOCHEM, V24, P2040, DOI 10.1016/j.jnutbio.2013.07.005; Yerra VG, 2013, REDOX BIOL, V1, P394, DOI 10.1016/j.redox.2013.07.005; Gopal R H, 1994, Anc Sci Life, V14, P68; Iwarsson Mattias, 2003, Kew Bulletin, V58, P597, DOI 10.2307/4111146; O'Connell MA, 1998, J BIOL CHEM, V273, P30410, DOI 10.1074/jbc.273.46.30410; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Shi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059330; Turler A, 2002, AM J PHYSIOL-GASTR L, V282, pG145; Watt J. M., 1962, MEDICINAL POISONOUS, P520; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2015	28	2			SI		967	976		10.1016/j.intimp.2015.08.015		10	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CT5NT	WOS:000362857800025		
J	Nishimoto, T; Mlakar, L; Takihara, T; Feghali-Bostwick, C				Nishimoto, Tetsuya; Mlakar, Logan; Takihara, Takahisa; Feghali-Bostwick, Carol			An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Pulmonary fibrosis; Oral administration; Endostatin	SYSTEMIC-SCLEROSIS; PIRFENIDONE; NINTEDANIB; COLLAGEN; DELIVERY; SKIN	Objective: Pulmonary fibrosis causes high morbidity and mortality in affected individuals. Recently, we showed that parenteral or intratracheal administration of a peptide derived from endostatin, called E4, prevents and ameliorates fibrosis using different models of dermal and pulmonary disease. No marketed orally delivered peptide drugs are currently available for progressive pulmonary fibrosis: however oral delivery of drugs is the preferred route for treating most chronic diseases. Thus, we investigated whether oral administration of E4 peptide exerted anti-fibrotic activity in a murine pulmonary fibrosis model. Methods: Bleomycin (1.2 mU/g body weight) was intratracheally administrated to male 6-8-week-old C57BL/6J mice. E4 peptide (20, 10, 5, and 1 mu g/mouse) or scrambled control peptide (20 mu g/mouse) was orally administered on the same day as bleomycin. In some experiments, E4 peptide (10 and 5 mu g/mouse) was orally administered three times on days 0, 3, and 6 post-bleomycin treatment. Lungs were harvested on day 21 for histological analysis and hydroxyproline assay. Results: Histological analysis and hydroxyproline assay revealed that bleomycin successfully induced pulmonary fibrosis, and that 20 mu g of oral E4 peptide ameliorated the fibrosis. The lower doses of E4 peptide (10, 5, and 1 mu g) were insufficient to exert anti-fibrotic activity when given as a single dose. Multiple doses of E4 peptide efficiently exerted anti-fibrotic activity even at lower doses. Conclusion: E4 peptide shows oral bioavailability and exerts anti-fibrotic activity in a bleomycin-induced pulmonary fibrosis model. We suggest that E4 peptide is a novel oral drug for fibroproliferative disorders. (C) 2015 Elsevier B.V. All rights reserved.	[Nishimoto, Tetsuya; Mlakar, Logan; Feghali-Bostwick, Carol] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; [Takihara, Takahisa] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa 25912, Japan	Feghali-Bostwick, C (reprint author), Med Univ S Carolina, Div Rheumatol & Immunol, 96 Jonathan Lucas St,MSC 637, Charleston, SC 29425 USA.	feghalib@musc.edu			NIH [K24 AR060297]	This work is supported by a grant from iBio Inc., and in part by NIH K24 AR060297 awarded to C.F.B. The authors would like to thank Robert Erwin and Terence Ryan for helpful discussions.	Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; McKown KM, 2000, ARTHRITIS RHEUM, V43, P1054, DOI 10.1002/1529-0131(200005)43:5<1054::AID-ANR14>3.0.CO;2-W; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Almeida I, 2011, AUTOIMMUN REV, V10, P693, DOI 10.1016/j.autrev.2011.04.025; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Proksch E, 2014, SKIN PHARMACOL PHYS, V27, P113, DOI 10.1159/000355523; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Hill TA, 2014, ACS MED CHEM LETT, V5, P1148, DOI 10.1021/ml5002823; Smart AL, 2014, EXPERT OPIN DRUG DEL, V11, P1323, DOI 10.1517/17425247.2014.917077; Keating GM, 2015, DRUGS, V75, P1131, DOI 10.1007/s40265-015-0418-6; Kim ES, 2015, DRUGS, V75, P219, DOI 10.1007/s40265-015-0350-9; Shinde P., 2013, ASIAN J PHARM TECHNO, V1, P1; Soltero R, 2001, INNOVATIONS PHARM TE, V1, P106; Wang J, 2015, MOL PHARMACEUT, V12, P966, DOI 10.1021/mp500809f; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Yang IV, 2015, TRANSL RES, V165, P48, DOI 10.1016/j.trsl.2014.03.011	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2015	28	2			SI		1102	1105		10.1016/j.intimp.2015.07.039		4	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CT5NT	WOS:000362857800042		
J	Kori, T; Imai, Y				Kori, Tosiaki; Imai, Yuto			Lie algebra extensions of current algebras on S-3	INTERNATIONAL JOURNAL OF GEOMETRIC METHODS IN MODERN PHYSICS			English	Article						Infinite-dimensional Lie algebras; current algebra; Lie algebra extensions; quaternion analysis		An affine Kac-Moody algebra is a central extension of the Lie algebra of smooth mappings from S-1 to the complexification of a Lie algebra. In this paper, we shall introduce a central extension of the Lie algebra of smooth mappings from S-3 to the quaternization of a Lie algebra and investigate its root space decomposition. We think this extension of current algebra might give a mathematical tool for four-dimensional conformal field theory as Kac-Moody algebras give it for two-dimensional conformal field theory.	[Kori, Tosiaki; Imai, Yuto] Waseda Univ, Grad Sch Sci & Engn, Dept Math, Tokyo 1698555, Japan	Kori, T (reprint author), Waseda Univ, Grad Sch Sci & Engn, Dept Math, Tokyo 1698555, Japan.	kori@waseda.jp; y.imai@aoni.waseda.jp					Kori T, 1996, J MATH KYOTO U, V36, P45; Kori T, 2014, J MATH SOC JPN, V66, P819, DOI 10.2969/jmsj/06630819; BELAVIN AA, 1984, NUCL PHYS B, V241, P333, DOI 10.1016/0550-3213(84)90052-X; Brackx F., 1982, CLIFFORD ANAL; Carter R. W., 2005, CAMBRIDGE STUDIES AD, V96; Dixmier J., 1974, CAHIERS SCI, V37; GILBERT JE, 1991, CLIFFORD ALGEBRAS DI; Kac V., 1983, INFINITE DIMENSIONAL; KHESIN B., 2009, ERGEBNISSE MATH IHRE, V51; Kori T., 1996, JAPANESE J MATH, V22, P1; Kori T., 2013, ARXIV13065030MATHPH; Kori T., 2002, JAPANSES J MATH, V28, P1; Mickelsson J., 1987, COMMUN MATH PHYS, V110, P175; Pressley A., 1986, OXFORD MATH MONOGRAP; Wakimoto M., 2001, TRANSLATIONS MATH MO, V195	15	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-8878	1793-6977		INT J GEOM METHODS M	Int. J. Geom. Methods Mod. Phys.	OCT	2015	12	9							1550087	10.1142/S0219887815500875		7	Physics, Mathematical	Physics	CT5JZ	WOS:000362847100006		
J	Lundqvist, EA; Fujiwara, K; Seoud, M				Lundqvist, Elisabeth Avail; Fujiwara, Keiichi; Seoud, Muhieddine			Principles of chemotherapy	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Article							CLINICAL-PRACTICE GUIDELINE; UPDATE; PREVENTION; GROWTH		[Lundqvist, Elisabeth Avail] Linkoping Univ, Dept Oncol, Linkoping, Sweden; [Lundqvist, Elisabeth Avail] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Fujiwara, Keiichi] Saitama Med Univ, Dept Gynecol Oncol, Int Med Ctr, Hidaka City, Japan; [Seoud, Muhieddine] Amer Univ Beirut, Med Ctr, Dept Obstet & Gynecol, Gynecol Oncol, Beirut, Lebanon	Lundqvist, EA (reprint author), Linkoping Univ, Dept Oncol, Linkoping, Sweden.				Roche	M. Seoud received travel grants and honoraria from Roche for presenting at conferences. E. Lundqvist received honoraria from Roche, Boehringer-Ingelheim, and Merck Sharp & Dohme for presentations and from Astra Zeneca for participation on an advisory board.	Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Amant F, 2014, INT J GYNECOL CANCER, V24, P394, DOI 10.1097/IGC.0000000000000062; Jacobson JO, 2009, J CLIN ONCOL, V27, P5469, DOI 10.1200/JCO.2009.25.1264; Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Grevelman EG, 2005, ANN ONCOL, V16, P352, DOI 10.1093/annonc/mdi088; NORTON L, 1988, CANCER RES, V48, P7067; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI 10.1200/JCO.2010.34.4614; Peccatori FA, 2013, ANN ONCOL, V24, P160, DOI 10.1093/annonc/mdt199; Rizzo JD, 2010, J CLIN ONCOL, V28, P4996, DOI 10.1200/JCO.2010.29.2201; Basch E, 2011, J NATL CANCER I, V103, P1808, DOI 10.1093/jnci/djr493; BERENBAU.MC, 1972, CANCER CHEMOTH REP 1, V56, P563; Ezzo JM, 2006, COCHRANE DB SYST REV, V19, P2285; National Cancer Institute, COMM TERM CRIT ADV E	14	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0020-7292	1879-3479		INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	OCT	2015	131			2			S146	S149		10.1016/j.ijgo.2015.06.011		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CT5NI	WOS:000362856700011		
J	Seoud, M; Lundqvist, EA; Fujiwara, K				Seoud, Muhieddine; Lundqvist, Elisabeth Avail; Fujiwara, Keiichi			Targeted therapy in gynecologic cancers: Ready for prime time?	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Article							PHASE-II TRIAL; ENDOTHELIAL GROWTH-FACTOR; RECURRENT ENDOMETRIAL CARCINOMA; ONCOLOGY-GROUP; OVARIAN-CANCER; OPEN-LABEL; EPITHELIAL OVARIAN; CERVICAL-CANCER; BEVACIZUMAB; PERSISTENT		[Seoud, Muhieddine] Amer Univ Beirut, Dept Obstet & Gynecol, Gynecol Oncol, Med Ctr, Beirut, Lebanon; [Lundqvist, Elisabeth Avail] Linkoping Univ, Dept Oncol, Linkoping, Sweden; [Lundqvist, Elisabeth Avail] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka, Japan	Seoud, M (reprint author), Amer Univ Beirut, Dept Obstet & Gynecol, Gynecol Oncol, Med Ctr, Beirut, Lebanon.				Roche	M. Seoud received travel grants and honoraria from Roche for presenting at conferences. E. Lundqvist received honoraria from Roche, Boehringer-Ingelheim, and Merck Sharp & Dohme for presentations and from Astra Zeneca for participation on an advisory board.	McMeekin DS, 2007, GYNECOL ONCOL, V105, P508, DOI 10.1016/j.ygyno.2007.01.019; Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Tang XD, 2007, CLIN CANCER RES, V13, P2568, DOI 10.1158/1078-0432.CCR-06-2704; Akram T, 2005, AM J OBSTET GYNECOL, V192, P1365, DOI 10.1016/j.ajog.2004.12.032; Takahashi K, 2009, INT J ONCOL, V35, P725, DOI 10.3892/ijo_00000385; Coleman RL, 2012, GYNECOL ONCOL, V127, P538, DOI 10.1016/j.ygyno.2012.08.020; Monk BJ, 2009, J CLIN ONCOL, V27, P1069, DOI 10.1200/JCO.2008.18.9043; Aghajanian C, 2011, J CLIN ONCOL, V29, P2259, DOI 10.1200/JCO.2010.32.6397; Matulonis UA, 2009, J CLIN ONCOL, V27, P5601, DOI 10.1200/JCO.2009.23.2777; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Mazzoletti M, 2010, CURR MED CHEM, V17, P4433, DOI 10.2174/092986710794182999; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Monk BJ, 2010, J CLIN ONCOL, V28, P3562, DOI 10.1200/JCO.2009.26.9571; McDonald DM, 2002, CANCER RES, V62, P5381; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Thigpen JT, 2004, J CLIN ONCOL, V22, P3902, DOI 10.1200/JCO.2004.02.088; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Nimeiri HS, 2010, GYNECOL ONCOL, V117, P37, DOI 10.1016/j.ygyno.2010.01.013; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; TROPE C, 1984, AM J OBSTET GYNECOL, V149, P379; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100; Michener CM, 2005, J CANCER RES CLIN, V131, P581, DOI 10.1007/s00432-005-0676-x; Miller CR, 2014, GYNECOL ONCOL, V133, P128, DOI 10.1016/j.ygyno.2014.01.008; Leslie KK, 2013, GYNECOL ONCOL, V129, P486, DOI 10.1016/j.ygyno.2013.02.019; Friedlander M, 2010, GYNECOL ONCOL, V119, P32, DOI 10.1016/j.ygyno.2010.05.033; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Thigpen T, 2001, J CLIN ONCOL, V19, P364; Fleming GF, 2010, GYNECOL ONCOL, V116, P15, DOI 10.1016/j.ygyno.2009.09.025; Elsahwi KS, 2011, OBSTET GYNECOL INT, V2011; Fleming, 2010, GYNECOL ONCOL, V118, P95; Sill MW, 2010, GYNECOL ONCOL, V118, P96, DOI 10.1016/j.ygyno.2010.03.005; Fleming, 2010, GYNECOL ONCOL, V116, P15; Gourley C, 2014, P AN M AM SOC CLIN, V32, P5502; Jasas KV, 2004, J CLIN ONCOL, V22; Lavoue V, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-147; Oza AM, 2006, J CLIN ONCOL, V24; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Santin AD, COMMUNICATION; Tewari KS., 2011, CLIN OVARIAN CANC, V4, P90; Tewari KS., 2010, AM J HEMATOL, V9, P31; Vale CL, COCHRANE DATABASE SY, V201; Winterhoff BJN, 2014, P AN M AM SOC CLIN, V32, P5509; Zagouri F., 2010, OBSTET GYNECOL INT, V2010, DOI [10.1155/2010/749579, DOI 10.1155/2010/749579]	46	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0020-7292	1879-3479		INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	OCT	2015	131			2			S150	S152		10.1016/j.ijgo.2015.06.012		3	Obstetrics & Gynecology	Obstetrics & Gynecology	CT5NI	WOS:000362856700012		
J	Ago, Y; Hasebe, S; Nishiyama, S; Oka, S; Onaka, Y; Hashimoto, H; Takuma, K; Matsuda, T				Ago, Yukio; Hasebe, Shigeru; Nishiyama, Saki; Oka, Satoshi; Onaka, Yusuke; Hashimoto, Hitoshi; Takuma, Kazuhiro; Matsuda, Toshio			The Female Encounter Test: A Novel Method for Evaluating Reward-Seeking Behavior or Motivation in Mice	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						Depression model; dopamine; encounter test; nucleus accumbens; sexual motivation	ISOLATION-REARED MICE; CHRONIC MILD STRESS; SEROTONIN REUPTAKE INHIBITORS; NUCLEUS-ACCUMBENS SHELL; FORCED SWIMMING TEST; SEXUAL MOTIVATION; MALE RATS; SUCROSE CONSUMPTION; ABNORMAL BEHAVIORS; DOPAMINE D1	Background: Reduced motivation is an important marker of psychiatric disorders, including depression. We describe the female encounter test, a novel method of evaluating reward-seeking behavior in mice. Methods: The test apparatus consists of three open chambers, formed with partitions that allow the animal to move freely from one chamber to another. A test male mouse is habituated in the apparatus, and subsequently a female and male mouse are introduced into a wire-mesh box in the left and right chamber, respectively. The time the test male mouse spends in the female or male area is measured for 10 min. Results: All six strains of mice tested showed a significant preference for female encounters. The preference was observed in 7-30-week-old mice. The preference was blocked by castration of the resident male test mouse, and was not affected by the phase of the menstrual cycle of the female intruder. The preference was impaired in mouse models of depression, including social isolation-reared, corticosterone-treated, and lipopolysaccharide-treated mice. The impairment was alleviated by fluvoxamine in isolation-reared and lipopolysaccharide-treated mice, and it was improved by the metabotropic glutamate 2/3 receptor antagonist LY341495 in corticosterone-treated mice. Encounter with a female, but not male, mouse increased c-Fos expression in the nucleus accumbens shell of test male mice. Furthermore, both the preference and encounter-induced increases in c-Fos expression were blocked by dopamine D-1 and D-2 receptor antagonists. Conclusions: These findings indicate that motivation in adult male mice can be easily evaluated by quantitating female encounters.	[Ago, Yukio; Hasebe, Shigeru; Nishiyama, Saki; Oka, Satoshi; Onaka, Yusuke; Takuma, Kazuhiro; Matsuda, Toshio] Osaka Univ, Lab Med Pharmacol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi] Osaka Univ, Lab Mol Neuropharmacol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Chiba Univ, Hamamatsu Univ Sch Med, Kanazawa Univ, United Grad Sch Child Dev,Osaka Univ, Suita, Osaka, Japan; [Hashimoto, Hitoshi; Matsuda, Toshio] Univ Fukui, Suita, Osaka, Japan; [Takuma, Kazuhiro] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Suita, Osaka 5650871, Japan	Matsuda, T (reprint author), Osaka Univ, Lab Med Pharmacol, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	matsuda@phs.osaka-u.ac.jp			KAKENHI [25460099, 15K18874, 26293020, 26670122, 15H01288]; Neuropsychiatry Drug Discovery Consortium established by Dainippon Sumitomo Pharma Co., Ltd. (Japan); Osaka University; Takeda Science Foundation (Japan); Research Foundation for Pharmaceutical Sciences (Japan); JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2603]	This study was supported in part by KAKENHI (25460099 to Dr Ago; 15K18874 to Mr Onaka; 26293020 to Dr Hashimoto; 26670122 to Dr Hashimoto; and 15H01288 to Dr Hashimoto), the Neuropsychiatry Drug Discovery Consortium established by Dainippon Sumitomo Pharma Co., Ltd. (Japan) with Osaka University (Drs Matsuda and Hashimoto), Takeda Science Foundation (Japan; Dr Ago), Research Foundation for Pharmaceutical Sciences (Japan; Dr Ago), and the JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (S2603; Drs Hashimoto and Matsuda).	Reynolds SM, 2002, J NEUROSCI, V22, P7308; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2; Nicola SM, 2007, PSYCHOPHARMACOLOGY, V191, P521, DOI 10.1007/s00213-006-0510-4; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Price KL, 2004, ALCOHOL CLIN EXP RES, V28, P1666, DOI 10.1097/01.ALC.0000145783.39748.E6; MEREDITH GE, 1993, PROG BRAIN RES, V99, P3; Fish EW, 2014, J PHARMACOL EXP THER, V350, P322, DOI 10.1124/jpet.114.216135; Agmo A, 2003, BEHAV NEUROSCI, V117, P55, DOI 10.1037/0735-7044.117.1.55; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; MENDELSON SD, 1989, PHYSIOL BEHAV, V45, P337, DOI 10.1016/0031-9384(89)90136-4; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Ago Y, 2013, NEUROPHARMACOLOGY, V65, P29, DOI 10.1016/j.neuropharm.2012.09.008; Renard CE, 2001, PSYCHOPHARMACOLOGY, V159, P42, DOI 10.1007/s002130100836; ROGARD M, 1993, NEUROSCI LETT, V155, P81, DOI 10.1016/0304-3940(93)90678-E; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Araki R, 2014, INT J NEUROPSYCHOPH, V17, P883, DOI 10.1017/S1461145713001582; Ago Y, 2011, PSYCHOPHARMACOLOGY, V217, P377, DOI 10.1007/s00213-011-2293-5; Ago Y, 2013, NEUROPSYCHOPHARMACOL, V38, P1535, DOI 10.1038/npp.2013.52; MUCHA RF, 1984, PSYCHOPHARMACOLOGY, V82, P241, DOI 10.1007/BF00427782; Schmidt HD, 2006, NEUROSCIENCE, V142, P451, DOI 10.1016/j.neuroscience.2006.06.004; Kawasaki T, 2011, NEUROPHARMACOLOGY, V60, P397, DOI 10.1016/j.neuropharm.2010.10.009; Forbes NF, 1996, PHYSIOL BEHAV, V60, P1481, DOI 10.1016/S0031-9384(96)00305-8; Ikemoto S, 1997, J NEUROSCI, V17, P8580; Ohgi Y, 2013, PHARMACOL BIOCHEM BE, V103, P853, DOI 10.1016/j.pbb.2012.12.003; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Koda K, 2010, J NEUROCHEM, V114, P259, DOI 10.1111/j.1471-4159.2010.06750.x; Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; Koike H, 2009, BEHAV BRAIN RES, V202, P114, DOI 10.1016/j.bbr.2009.03.028; Redrobe JP, 1998, PSYCHOPHARMACOLOGY, V138, P198, DOI 10.1007/s002130050663; DAVIES VJ, 1972, J ENDOCRINOL, V55, P11, DOI 10.1677/joe.0.0550011; Hiramatsu N, 2013, NEUROPHARMACOLOGY, V75, P53, DOI 10.1016/j.neuropharm.2013.06.026; MATTHEWS K, 1995, PHYSIOL BEHAV, V57, P241, DOI 10.1016/0031-9384(94)00286-E; KALIVAS PW, 1995, BRAIN RES, V675, P325, DOI 10.1016/0006-8993(95)00013-G; Smith RJ, 2013, CURR OPIN NEUROBIOL, V23, P546, DOI 10.1016/j.conb.2013.01.026; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Agmo A, 2004, PHARMACOL BIOCHEM BE, V78, P379, DOI 10.1016/j.pbb.2004.04.013; Hou GL, 2014, J SEX MED, V11, P653, DOI 10.1111/jsm.12416; Stefanik P, 2015, PHARMACOL BIOCHEM BE, V131, P42, DOI 10.1016/j.pbb.2015.01.021; Ago Y, 2014, J PHARMACOL SCI, V125, P237, DOI 10.1254/jphs.14R05CP; Bai YJ, 2009, PHARMACOL BIOCHEM BE, V91, P581, DOI 10.1016/j.pbb.2008.09.018; Ago Y, 2008, NEUROPHARMACOLOGY, V55, P1355, DOI 10.1016/j.neuropharm.2008.08.026; Lu XY, 1998, NEUROSCIENCE, V82, P767; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; Haba R, 2012, BEHAV BRAIN RES, V228, P423, DOI 10.1016/j.bbr.2011.12.027; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; du Hoffmann J, 2014, J NEUROSCI, V34, P14349, DOI 10.1523/JNEUROSCI.3492-14.2014; Felix-Ortiz AC, 2014, J NEUROSCI, V34, P586, DOI 10.1523/JNEUROSCI.4257-13.2014; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; Langley EA, 2015, BEHAV BRAIN RES, V278, P210, DOI 10.1016/j.bbr.2014.09.043; Lehmann ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069822; Mateus-Pinheiro A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00074; National Research Council, 1996, GUIDE CARE USE LAB A; Perreault ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033348; REYNOLDS E, 1971, NATURE, V234, P481, DOI 10.1038/234481a0; Steru L, 1985, PSYCHOPHARMACOLOGY B, V853, P367; Viitamaa Timo, 2006, Pharmacol Biochem Behav, V83, P360, DOI 10.1016/j.pbb.2006.02.015; WILLNER P, 1991, TRENDS PHARMACOL SCI, V12, P131, DOI 10.1016/0165-6147(91)90529-2; Zhang JC, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu077	61	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	OCT	2015	18	11								10.1093/ijnp/pyv062		12	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CT8JT	WOS:000363062700007		
J	Murase, C; Kono, M; Nakanaga, K; Md, NI; Akiyama, M				Murase, Chiaki; Kono, Michihiro; Nakanaga, Kazue; Md, Norihisa Ishii; Akiyama, Masashi			Buruli Ulcer Successfully Treated With Negative-Pressure Wound Therapy	JAMA DERMATOLOGY			English	Letter									[Murase, Chiaki; Kono, Michihiro; Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4668550, Japan; [Nakanaga, Kazue; Md, Norihisa Ishii] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan	Kono, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	miro@med.nagoya-u.ac.jp					Saaiq M, 2010, JCPSP-J COLL PHYSICI, V20, P675, DOI 04.2010/JCPSP.675679; O'Brien DP, 2014, LANCET INFECT DIS, V14, P435, DOI 10.1016/S1473-3099(13)70201-9; Nakanaga K, 2007, J CLIN MICROBIOL, V45, P3840, DOI 10.1128/JCM.01041-07; WHO, 2012, TREATM MYC ULC DIS B; WHO, 2014, LAB DIAGN BUR ULC MA; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6068	2168-6084		JAMA DERMATOL	JAMA Dermatol.	OCT	2015	151	10					1137	1139		10.1001/jamadermatol.2015.1567		4	Dermatology	Dermatology	CT6XF	WOS:000362955700025		
J	Shibata, T				Shibata, Tatsuhiro			Current and future molecular profiling of cancer by next-generation sequencing	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						sequencing; driver gene; immunotherapy; tumor heterogeneity; liquid biopsy	CELL LUNG-CANCER; SOMATIC MUTATIONS; BREAST-CANCER; PD-1 BLOCKADE; ACQUIRED-RESISTANCE; ONCOGENE ADDICTION; COLORECTAL CANCERS; COLON-CANCER; EGFR; EVOLUTION	Advances in the new sequencing technologies have enabled us to explore global genetic alterations including driver genes in a wide range of cancers. Concordantly, successes of molecular target therapy promoted the validity of tumor classification based on the combination of targetable genetic abnormalities, and next-generation sequencing-based genetic profiling using target gene capturing or multiplex-polymerase chain reaction has already been tested or adapted in many cancer centers. Driver gene-based classification may be applicable beyond organs, and clinical trials incorporating this genomic information, called as a basket trial, have been executed, although it should be considered that similar therapeutic efficacies against driver mutations are not invariably maintained among different cancer types. Research efforts to identify still missing driver genes in rare cancers, to complete functional annotation of infrequent driver genes, and multiple-layered omics approaches are further expected for better classification of tumor. Emerging clinical interests in the development of immunotherapies postulate a new molecular classification of tumors. Recent studies reported that total number of mutations and the frequent appearance of neo-antigens by protein-coding mutations were associated with a better response, and genetic evaluation of both tumor and host immune system by sequencing is expected to contribute to the personalized immunotherapies in the near future. Lastly intratumoral molecular heterogeneity challenges the current 'static' molecular classification of tumor. For example, dynamic change in clonal constitution within tumor plays an important role in acquired drug resistance. It has been extensively explored whether liquid biopsy-based molecular profiling can resolve currently confronting difficulties.	[Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Lab Mol Med, Tokyo, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo 104, Japan	Shibata, T (reprint author), 4-6-1 Shirokanedai,Minato Ku, Tokyo, Japan.	tshibata@ims.u-tokyo.ac.jp			Ministry of Health, Labor and Welfare; Japan Agency for Medical Research and Development (Health and Labor Sciences Research Expenses for Commission); Japan Agency for Medical Research and Development (Applied Research for Innovative Treatment of Cancer); National Cancer Center Research and Development Funds [26-A-5]	This work was supported by Grants-in-Aid from the Ministry of Health, Labor and Welfare, and Japan Agency for Medical Research and Development (Health and Labor Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer), and National Cancer Center Research and Development Funds (26-A-5).	Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Zardavas D, 2015, NAT REV CLIN ONCOL, V12, P381, DOI 10.1038/nrclinonc.2015.73; Xiao YP, 2015, CANCER DISCOV, V5, P16, DOI 10.1158/2159-8290.CD-14-1397; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Kohno T, 2013, CANCER SCI, V104, P1396, DOI 10.1111/cas.12275; Smith AG, 2012, TISSUE ANTIGENS, V79, P359, DOI 10.1111/j.1399-0039.2012.01868.x; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Brahmer JR, 2013, J CLIN ONCOL, V31, P1021, DOI 10.1200/JCO.2012.45.8703; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Chen X, 2015, ONCOGENE, DOI [10.1038/onc.2014.474, DOI 10.1038/0NC.2014.474]; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Jamal-Hanjani M, 2015, CLIN CANCER RES, V21, P1258, DOI 10.1158/1078-0432.CCR-14-1429; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Llovet Josep M, 2015, Nat Rev Clin Oncol, V12, P436, DOI 10.1038/nrclinonc.2015.121; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roychowdhury S, 2011, SCI TRANSL MED, V3; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289	45	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					895	899		10.1093/jjco/hyv122		5	Oncology	Oncology	CT5EH	WOS:000362830300001		
J	Matsuda, T; Ono, A; Kakugawa, Y; Matsumoto, M; Saito, Y				Matsuda, Takahisa; Ono, Akiko; Kakugawa, Yasuo; Matsumoto, Minori; Saito, Yutaka			Impact of screening colonoscopy on outcomes in colorectal cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						colorectal cancer; population-based screening; opportunistic screening; total colonoscopy	FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; AVERAGE-RISK POPULATION; SERVICES TASK-FORCE; CT COLONOGRAPHY; FLEXIBLE SIGMOIDOSCOPY; ASYMPTOMATIC ADULTS; ADENOMATOUS POLYPS; ADVANCED NEOPLASIA; CAPSULE ENDOSCOPY	Colorectal cancer is one of the most common cancers in both men and women worldwide and a good candidate for screening programs. There are two modalities of colorectal cancer screening: (i) population-based screening and (ii) opportunistic screening. The first one is based on organized, well-coordinated, monitored and established programs with a systematic invitation covering the entire target population. In contrast, opportunistic screening tests are offered to people who are being examined for other reasons. Recently, a variety of colorectal cancer screening tests have become available; each country should make a choice, based on national demographics and resources, on the screening method to be used. Fecal occult blood test, especially the fecal immunochemical test, would be the best modality for decreasing colorectal cancer mortality through population-based screening. In contrast, if the aim includes the early detection of colorectal cancer and adenomas, endoscopic methods are more appropriate.	[Matsuda, Takahisa] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Div, Tokyo 104, Japan; [Matsuda, Takahisa; Kakugawa, Yasuo; Matsumoto, Minori; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo 1040045, Japan; [Ono, Akiko] Hosp Clin Univ Virgen de la Arrixaca, Dept Gastroenterol, Murcia, Spain	Matsuda, T (reprint author), Natl Canc Ctr, Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Div,Endoscopy Div,Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tamatsud@ncc.go.jp			National Cancer Center Research and Development Fund [27-A-5]	This work was supported in part by the National Cancer Center Research and Development Fund (27-A-5).	Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Rathgaber SW, 2006, GASTROINTEST ENDOSC, V64, P556, DOI 10.1016/j.gie.2006.03.014; Pox CP, 2014, DIGESTION, V89, P274, DOI 10.1159/000363287; Kronborg O, 2006, SCAND J GASTROENTERO, V41, P737, DOI 10.1080/00365520500442666; Baxter NN, 2009, ANN INTERN MED, V150, P1; Ko CW, 2007, GASTROENTEROLOGY, V132, pA149; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Kato J, 2009, CLIN GASTROENTEROL H, V7, P1341, DOI 10.1016/j.cgh.2009.04.025; Van Gossum A, 2009, NEW ENGL J MED, V361, P264, DOI 10.1056/NEJMoa0806347; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Heresbach D, 2008, ENDOSCOPY, V40, P284, DOI 10.1055/s-2007-995618; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Pox CP, 2010, GUT, V59, P692, DOI 10.1136/gut.2009.183046; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI 10.1056/NEJMoa1108895; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Kaminski MF, 2012, ENDOSCOPY, V44, P695, DOI 10.1055/s-0032-1306895; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Hassan C, 2012, ALIMENT PHARM THER, V36, P929, DOI 10.1111/apt.12071; HIXSON LJ, 1990, J NATL CANCER I, V82, P1769, DOI 10.1093/jnci/82.22.1769; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Segnan N, 2005, J NATL CANCER I, V97, P347, DOI 10.1093/jnci/dji050; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Soetikno RM, 2008, JAMA-J AM MED ASSOC, V299, P1027, DOI 10.1001/jama.299.9.1027; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Whitlock EP, 2008, ANN INTERN MED, V149, P638; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Hoff G, 2010, GUT, V59, P407, DOI 10.1136/gut.2009.192948; Sanduleanu S, 2012, NAT REV GASTRO HEPAT, V9, P550, DOI 10.1038/nrgastro.2012.136; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Spada C, 2011, GASTROINTEST ENDOSC, V74, P581, DOI 10.1016/j.gie.2011.03.1125; Khalid-de Bakker C, 2011, ENDOSCOPY, V43, P1059, DOI 10.1055/s-0031-1291430; Papamichael D, 2009, ANN ONCOL, V20, P5, DOI 10.1093/annonc/mdn532; Guittet L, 2009, BRIT J CANCER, V100, P1230, DOI 10.1038/sj.bjc.6604996; Levi Z, 2011, INT J CANCER, V128, P2415, DOI 10.1002/ijc.25574; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Hoff G, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1846; International Agency for Research on Cancer, 2012, COL CANC EST INC MOR; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Sano Y, 2014, OPEN ACCESS J CLIN T, V6, P37; Segnan N, 2010, EUROPEAN GUIDELINES; Calonge N, 2008, ANN INTERN MED, V149, P627; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301	63	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					900	905		10.1093/jjco/hyv117		6	Oncology	Oncology	CT5EH	WOS:000362830300002		
J	Okita, Y; Narita, Y; Miyahara, R; Miyakita, Y; Ohno, M; Shibui, S				Okita, Yoshiko; Narita, Yoshitaka; Miyahara, Ruriko; Miyakita, Yasuji; Ohno, Makoto; Shibui, Soichiro			Health-related quality of life in long-term survivors with Grade II gliomas: the contribution of disease recurrence and Karnofsky Performance Status	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						Grade II glioma; long-term survivor; quality of life; QLQ-C30; BN20	EUROPEAN-ORGANIZATION; CLINICAL-TRIALS; CANCER-PATIENTS; BRAIN-TUMORS; CHEMOTHERAPY; RADIOTHERAPY; OLIGODENDROGLIOMA; SYMPTOMS; ONCOLOGY; STROKE	Although the number of long-term survivors of glioma has increased, there has been little research on the health-related quality of life of long-term survivors of Grade II glioma following treatment with surgery, radiotherapy and chemotherapy. In this study, we aimed to document the health-related quality of life of people diagnosed with Grade II glioma who had survived > 10 years with no evidence of disease at the time of the health-related quality of life survey. To investigate the health-related quality of life of Grade II glioma survivors without evidence of disease, we surveyed 50 patients 0-20 years after their initial treatments. Each patient completed a multi-part health-related quality of life questionnaire. Based on these surveys, we examined the relationships between health-related quality of life scores and time since initial treatment, Karnofsky Performance Scale scores at the time of the survey, and history of recurrence, radiotherapy and chemotherapy. Excepting bladder control, long-term survivors maintained their quality of life as determined by comparing patients surveyed < 5 and >= 10 years after their initial treatment (P < 0.05). Neither radiotherapy nor chemotherapy at the initial treatment was observed to affect health-related quality of life. However, a history of recurrence was significantly associated with deteriorations in many health-related quality of life functional and symptom scores. The Karnofsky Performance Scale scores of patients with a history of recurrence were significantly lower than those without it (P = 0.02). This deterioration was observed in both univariate and multivariate analyses. Our results indicate that declines in health-related quality of life among long-term survivors of Grade II glioma mainly result from impaired Karnofsky Performance Scale, which is a consequence of disease recurrence.	[Okita, Yoshiko; Narita, Yoshitaka; Miyahara, Ruriko; Miyakita, Yasuji; Ohno, Makoto; Shibui, Soichiro] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Tokyo 1040045, Japan; [Okita, Yoshiko] Natl Hosp Org, Osaka Natl Hosp, Dept Neurosurg, Osaka, Japan; [Shibui, Soichiro] Teikyo Univ, Sch Med, Dept Neurosurg, Univ Hosp, Kawasaki, Kanagawa, Japan	Narita, Y (reprint author), Natl Canc Ctr, Dept Neurosurg & Neurooncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yonarita@ncc.go.jp			Ministry of Education, Science and Culture of Japan [24592180]	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (No. 24592180 to Y.N.).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Gustafsson M, 2006, SUPPORT CARE CANCER, V14, P1205, DOI 10.1007/s00520-006-0080-3; Mauer M, 2007, BRIT J CANCER, V97, P302, DOI 10.1038/sj.bjc.6603876; Budrukkar A, 2009, J NEURO-ONCOL, V95, P413, DOI 10.1007/s11060-009-9939-8; Armstrong GT, 2011, NEURO-ONCOLOGY, V13, P223, DOI 10.1093/neuonc/noq178; Reijneveld JC, 2001, NEUROLOGY, V56, P618; Aaronson NK, 2011, J CLIN ONCOL, V29, P4430, DOI 10.1200/JCO.2011.35.5750; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Pace A, 2003, ANN ONCOL, V14, P1722, DOI 10.1093/annonc/mdg502; Taphoorn MJB, 2010, ONCOLOGIST, V15, P618, DOI 10.1634/theoncologist.2009-0291; Storch A, 2013, NEUROLOGY, V80, P800, DOI 10.1212/WNL.0b013e318285c0ed; Dhamoon MS, 2010, NEUROLOGY, V75, P328, DOI 10.1212/WNL.0b013e3181ea9f03; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; MOSTOW EN, 1991, J CLIN ONCOL, V9, P592; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Taphoorn MJB, 2007, J CLIN ONCOL, V25, P5723, DOI 10.1200/JCO.2007.12.7514; Patel MD, 2007, AGE AGEING, V36, P316, DOI 10.1093/ageing/afm014; Surma-aho O, 2001, NEUROLOGY, V56, P1285; Taphoorn MJB, 2010, EUR J CANCER, V46, P1033, DOI 10.1016/j.ejca.2010.01.012; Calvio L, 2009, OCCUP MED-OXFORD, V59, P406, DOI 10.1093/occmed/kqp094; Scheibel RS, 1996, J NEURO-ONCOL, V30, P61; Crom Deborah B, 2007, J Cancer Surviv, V1, P237, DOI 10.1007/s11764-007-0026-x; Giovagnoli AR, 2014, J NEUROL, V261, P894, DOI 10.1007/s00415-014-7273-3; Muller B, 2011, MOVEMENT DISORD, V26, P65, DOI 10.1002/mds.23387; Okita Y, 2012, INT J ONCOL, V41, P1325, DOI 10.3892/ijo.2012.1564	25	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					906	913		10.1093/jjco/hyv115		8	Oncology	Oncology	CT5EH	WOS:000362830300003		
J	Maeshima, AM; Taniguchi, H; Nomoto, J; Makita, S; Kitahara, H; Fukuhara, S; Munakata, W; Suzuki, T; Maruyama, D; Kobayashi, Y; Tobinai, K				Maeshima, Akiko Miyagi; Taniguchi, Hirokazu; Nomoto, Junko; Makita, Shinichi; Kitahara, Hideaki; Fukuhara, Suguru; Munakata, Wataru; Suzuki, Tatsuya; Maruyama, Dai; Kobayashi, Yukio; Tobinai, Kensei			Clinicopathological features of classical Hodgkin lymphoma in patients a parts per thousand yen40 years old, with special reference to composite cases	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						aged; B-cell lymphoma; composite lymphoma; Epstein-Barr virus; Hodgkin diseases	EPSTEIN-BARR-VIRUS; CENTER B-CELL; FOLLICULAR LYMPHOMA; HIGH-FREQUENCY; DISEASE; CLL	Classical Hodgkin lymphoma shows a peak incidence at 15-35 years, and a second peak in elderly patients; however, pathological characteristics of elderly patients with classical Hodgkin lymphoma have not been analyzed enough. In a total of 154 patients with classical Hodgkin lymphoma, we analyzed the clinicopathological characteristics of classical Hodgkin lymphoma patients aged >= 40 years old, with special reference to the incidence, histopathology and outcome of patients with composite classical Hodgkin lymphoma. Of 154 patients with classical Hodgkin lymphoma, 50 (32%) were >= 40 years old. The 5-year progression-free and overall survival rates were 59 and 86%, respectively. Thirty-eight patients (76%) had non-composite classical Hodgkin lymphoma, 10 patients (20%) had composite (6 simultaneous and 4 consecutive) classical Hodgkin lymphoma and B-cell non-Hodgkin lymphoma and 2 patients (4%) had methotrexate-associated classical Hodgkin lymphoma. Of 10 patients with composite classical Hodgkin lymphoma, composite lymphomas were detected throughout the staging procedure of the upper gastrointestinal tract or bone marrow in 4 patients. Fluorescence in situ hybridization revealed that the composite lymphomas of 4, 1 and 5 patients were related, unrelated and of unknown correlation status, respectively. The treatments after the diagnosis of a classical Hodgkin lymphoma component varied, and three patients died of lymphoma. We found that the incidence of composite classical Hodgkin lymphoma in patients >= 40 years old was 20%. Correct diagnosis and optimal treatment for patients with composite classical Hodgkin lymphoma and B-cell non-Hodgkin lymphoma is highly important in this patient population.	[Maeshima, Akiko Miyagi; Taniguchi, Hirokazu] Natl Canc Ctr, Dept Pathol, Tokyo 1040045, Japan; [Nomoto, Junko; Makita, Shinichi; Kitahara, Hideaki; Fukuhara, Suguru; Munakata, Wataru; Suzuki, Tatsuya; Maruyama, Dai; Kobayashi, Yukio; Tobinai, Kensei] Natl Canc Ctr, Dept Hematol, Tokyo 1040045, Japan	Maeshima, AM (reprint author), Natl Canc Ctr, Dept Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	akmaeshi@ncc.go.jp	Kobayahi, Yukio/F-2901-2015	Kobayahi, Yukio/0000-0003-2378-7865	National Cancer Center Research and Development Fund [23-A-17, 23-A-23, 26-A-4, 26-A-24]; JSPS in Japan [C-25461442]	This work was supported in part by the National Cancer Center Research and Development Fund (23-A-17, 23-A-23, 26-A-4 and 26-A-24), and JSPS Grand-in-Aid for Scientific Research (C-25461442) in Japan.	Jarrett RF, 2005, BLOOD, V106, P2444, DOI 10.1182/blood-2004-09-3759; Zettl A, 2005, HISTOPATHOLOGY, V46, P217, DOI 10.1111/j.1365-2559.2005.02046.x; BRECHER M, 1990, AM J CLIN PATHOL, V93, P333; Rosenquist R, 2004, EUR J HAEMATOL, V73, P210, DOI 10.1111/j.1600-0609.2004.00283.x; Araujo I, 2006, VIRCHOWS ARCH, V449, P315, DOI 10.1007/s00428-006-0244-z; van den Berg A, 2002, BLOOD, V100, P1425; Brauninger A, 1999, NEW ENGL J MED, V340, P1239, DOI 10.1056/NEJM199904223401604; Sekiguchi N, 2005, CANCER SCI, V96, P77, DOI 10.1111/j.1349-7006.2005.00014.x; Yoshida M, 2012, PATHOL INT, V62, P518, DOI 10.1111/j.1440-1827.2012.02835.x; Marafioti T, 1999, J CLIN ONCOL, V17, P3804; Engert A, 2005, J CLIN ONCOL, V23, P5052, DOI 10.1200/JCO.2005.11.080; Weinreb M, 1996, BLOOD, V87, P3828; Stark GL, 2002, BRIT J HAEMATOL, V119, P432, DOI 10.1046/j.1365-2141.2002.03815.x; Clarke CA, 2001, CANCER, V91, P1579, DOI 10.1002/1097-0142(20010415)91:8<1579::AID-CNCR1169>3.0.CO;2-L; Kuppers R, 2001, MOL MED, V7, P285; Nomoto J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-457; Swerdlow S, 2008, WHO CLASSIFICATION T	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					921	928		10.1093/jjco/hyv101		8	Oncology	Oncology	CT5EH	WOS:000362830300005		
J	Akechi, T; Momino, K; Miyashita, M; Sakamoto, N; Yamashita, H; Toyama, T				Akechi, Tatsuo; Momino, Kanae; Miyashita, Mitsunori; Sakamoto, Nobuhiro; Yamashita, Hiroko; Toyama, Tatsuya			Anxiety in disease-free breast cancer patients might be alleviated by provision of psychological support, not of information	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						anxiety; survivors; need; quality of life; supportive care	QUALITY-OF-LIFE; UNCERTAINTY MANAGEMENT INTERVENTION; PREDICTIVE FACTORS; LUNG-CANCER; EUROPEAN-ORGANIZATION; PSYCHIATRIC-DISORDERS; AFRICAN-AMERICAN; FOLLOW-UP; SURVIVORS; DEPRESSION	This study investigates the prevalence of clinical anxiety, the possible impact of patients' anxiety on quality of life and the association between their anxiety levels and patients' perceived needs. Randomly selected disease-free patients with breast cancer who survived > 2 years were invited to participate in the study. The participants were asked to complete the Hospital Anxiety and Depression Scale, the European Organization for Research and Treatment of Cancer QLQ-C 30 and the Short-form Supportive Care Needs Survey questionnaire, which covers five domains of need (health system and information, psychological, physical, care and support and sexuality needs). Complete data were available for 146 of the patients, and 14% of them suffered from clinical anxiety. Anxiety score had a statistically significant correlation with all domains of quality-of-life measures. The only perceived need that was significantly associated with anxiety was the psychological domain. Not negligible patients may suffer from clinical anxiety > 2 years after their initial cancer diagnoses. Anxiety can impact on patients' quality of life, and unmet psychological needs are expected to increase anxiety levels. Management of anxiety could be one of the key components to improving the quality of life for breast cancer survivors and that reducing their unmet psychological needs may contribute to alleviating anxiety.	[Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi 4678601, Japan; [Akechi, Tatsuo; Sakamoto, Nobuhiro] Nagoya City Univ Hosp, Div Palliat Care & Psychooncol, Nagoya, Aichi, Japan; [Momino, Kanae] Nagoya City Univ, Grad Sch Nursing, Nagoya, Aichi 4678601, Japan; [Miyashita, Mitsunori] Tohoku Univ, Grad Sch Med, Dept Palliat Nursing, Hlth Sci, Sendai, Miyagi 980, Japan; [Sakamoto, Nobuhiro] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Nagoya, Aichi 4678601, Japan; [Yamashita, Hiroko; Toyama, Tatsuya] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol, Immunol & Surg, Nagoya, Aichi 4678601, Japan; [Yamashita, Hiroko] Hokkaido Univ Hosp, Breast Surg, Sapporo, Hokkaido 060, Japan	Akechi, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Mizuho Ku, Mizuho Cho, Nagoya, Aichi 4678601, Japan.	takechi@med.nagoya-cu.ac.jp			Japanese Ministry of Education, Culture, Science, and Technology	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Science, and Technology and a Grant-in-Aid for Kidani Memorial Trust Cancer Treatment Project.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Akechi T., 2003, JPN J BREAST CANC JA, V18, P212; Osse BHP, 2005, SUPPORT CARE CANCER, V13, P722, DOI 10.1007/s00520-004-0771-6; Minton O, 2008, BREAST CANCER RES TR, V112, P5, DOI 10.1007/s10549-007-9831-1; McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757; Kugaya A, 2000, CANCER, V88, P2817, DOI 10.1002/1097-0142(20000615)88:12<2817::AID-CNCR22>3.0.CO;2-N; Lam WWT, 2012, PSYCHO-ONCOLOGY, V21, P90, DOI 10.1002/pon.1876; Thompson J, 2013, PSYCHO-ONCOLOGY, V22, P1866, DOI 10.1002/pon.3229; Weitzner MA, 1997, SUPPORT CARE CANCER, V5, P241, DOI 10.1007/s005200050067; Gordon NH, 2010, J PSYCHOSOC ONCOL, V28, P589, DOI 10.1080/07347332.2010.516806; Okuyama T, 2009, PSYCHO-ONCOL, V18, P1003, DOI 10.1002/pon.1482; Akechi T, 2004, J CLIN ONCOL, V22, P1957, DOI 10.1200/JCO.2004.08.149; Mitchell AJ, 2013, LANCET ONCOL, V14, P721, DOI 10.1016/S1470-2045(13)70244-4; Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Boyes A, 2009, J EVAL CLIN PRACT, V15, P602, DOI 10.1111/j.1365-2753.2008.01057.x; Akechi T, 2014, BREAST CANCER RES TR, V145, P205, DOI 10.1007/s10549-014-2929-3; Okamura H, 2000, BREAST CANCER RES TR, V61, P131, DOI 10.1023/A:1006491417791; Hartl K, 2010, PSYCHOSOMATICS, V51, P112, DOI 10.1176/appi.psy.51.2.112; Hodgkinson K, 2007, SUPPORT CARE CANCER, V15, P515, DOI 10.1007/s00520-006-0170-2; Vaidya R, 2011, ONCOLOGY-BASEL, V81, P9, DOI 10.1159/000330814; Mishel MH, 2005, PSYCHO-ONCOL, V14, P962, DOI 10.1002/pon.909; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Mols F, 2005, EUR J CANCER, V41, P2613, DOI 10.1016/j.ejca.2005.05.017; Hung YP, 2013, PSYCHO-ONCOLOGY, V22, P2227, DOI 10.1002/pon.3277; Endo C, 2008, JPN J CLIN ONCOL, V38, P653, DOI 10.1093/jjco/hyn088; Akechi T, 2001, BREAST CANCER RES TR, V65, P195, DOI 10.1023/A:1010661530585; Akechi T, 2011, PSYCHO-ONCOLOGY, V20, P497, DOI 10.1002/pon.1757; Kobayashi K, 1998, EUR J CANCER, V34, P810, DOI 10.1016/S0959-8049(97)00395-X; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Akechi T, 2001, CANCER, V92, P2609, DOI 10.1002/1097-0142(20011115)92:10<2609::AID-CNCR1614>3.0.CO;2-K; Germino BB, 2013, ONCOL NURS FORUM, V40, P82, DOI 10.1188/13.ONF.82-92; Champion VL, 2014, CANCER-AM CANCER SOC, V120, P2237, DOI 10.1002/cncr.28737; Uchitomi Y, 2003, J CLIN ONCOL, V21, P69, DOI 10.1200/JCO.2003.12.139; Association AP, 2013, DIAGN STAT MAN MENT; Chopra I, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-14; Greer JA, 2010, J COGN PSYCHOTHER, V24, P294; Ito Y, 2014, CANCER SCI, V105, P1480, DOI 10.1111/cas.12525; McAuley E, 2015, SUPPORT CARE CANCER, V23, P15967; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					929	933		10.1093/jjco/hyv112		5	Oncology	Oncology	CT5EH	WOS:000362830300006		
J	Uchida, M; Okuyama, T; Ito, Y; Nakaguchi, T; Miyazaki, M; Sakamoto, M; Kamiya, T; Sato, S; Takeyama, H; Joh, T; Meagher, D; Akechi, T				Uchida, Megumi; Okuyama, Toru; Ito, Yoshinori; Nakaguchi, Tomohiro; Miyazaki, Mikinori; Sakamoto, Masaki; Kamiya, Takeshi; Sato, Shigeki; Takeyama, Hiromitsu; Joh, Takashi; Meagher, David; Akechi, Tatsuo			Prevalence, course and factors associated with delirium in elderly patients with advanced cancer: a longitudinal observational study	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						delirium; advanced cancer; prevalence; associated factor; course	MOTOR SUBTYPE; RATING-SCALE; ILL PATIENTS; INPATIENTS; NURSES; COHORT; REVERSIBILITY; MEDICATIONS; PREVENTION; REVISED-98	The aim of this study was to investigate the prevalence of delirium on admission, the course of delirium during a 2-week period after admission and factors associated with delirium on admission, among elderly patients with advanced cancer. Patients aged a parts per thousand yen65 years with incurable lung or gastroenterological cancer and the Eastern Cooperative Oncology Group Performance Status 2 or greater were continuously sampled after admission to a university hospital. Participants were evaluated for DSM-IV-TR delirium by trained psychiatrists and the delirium subtype was assessed using the Delirium Motor Subtype Scale within 4 days after admission and again 2 weeks later. In addition, we assessed associated factors with delirium on admission. Among 73 eligible patients, complete data were available from 61 on admission and 49 after 2 weeks. Twenty-six patients (43%) met delirium criteria on admission (hypoactive: 58%, unspecified: 35%, hyperactive: 4%, mixed: 4%). Of these, 19 (73%) remained delirious 2 weeks later. Of 35 patients without delirium on admission, 21 (60%) remained delirium-free 2 weeks later and 7(20%) became delirious. Overall, 33/61 (54%) developed delirium at some point during the study. Patients receiving steroids at admission were more likely to have delirium (odds ratio = 5.0; 95% confidence interval = 1.5-16). Given the high prevalence of the delirium, all patients with advanced cancer should be screened for delirium both on admission and regularly thereafter. In addition, medical staff should be aware that steroid use on admission is an additional indicator of elevated risk for delirium.	[Uchida, Megumi; Okuyama, Toru; Ito, Yoshinori; Nakaguchi, Tomohiro; Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi 4678601, Japan; [Uchida, Megumi; Okuyama, Toru; Ito, Yoshinori; Nakaguchi, Tomohiro; Sakamoto, Masaki; Akechi, Tatsuo] Nagoya City Univ Hosp, Div Palliat Care & Psychooncol, Nagoya, Aichi, Japan; [Miyazaki, Mikinori; Sato, Shigeki] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi 4678601, Japan; [Sakamoto, Masaki; Takeyama, Hiromitsu] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Nagoya, Aichi 4678601, Japan; [Kamiya, Takeshi; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan; [Meagher, David] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland	Okuyama, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Mizuho Ku, Mizuho Cho, Nagoya, Aichi 4678601, Japan.	okuyama@med.nagoya-cu.ac.jp			Japanese Ministry of Education, Culture, and Science; Grant for Research on Hospice Palliative Care, Japan Hospice Palliative Care Foundation [2014.4-2015.3 (13001)]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, and Science and Grant for Research on Hospice Palliative Care, Japan Hospice Palliative Care Foundation, 2014.4-2015.3 (13001).	Milisen K, 2004, EUR J CANCER CARE, V13, P494, DOI 10.1111/j.1365-2354.2004.00545.x; Meagher D, 2008, J NEUROPSYCH CLIN N, V20, P185, DOI 10.1176/appi.neuropsych.20.2.185; Godfrey A, 2010, PSYCHIAT RES, V178, P186, DOI 10.1016/j.psychres.2009.04.010; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Gonzalez M, 2009, PSYCHOSOMATICS, V50, P234, DOI 10.1176/appi.psy.50.3.234; Morita T, 2001, J PAIN SYMPTOM MANAG, V22, P997, DOI 10.1016/S0885-3924(01)00360-8; Kato M, 2010, PSYCHOSOMATICS, V51, P425, DOI 10.1176/appi.psy.51.5.425; Meagher D, 2009, INT REV PSYCHIATR, V21, P59, DOI 10.1080/09540260802675460; Bruera E, 2009, CANCER, V115, P2004, DOI 10.1002/cncr.24215; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Leonard M, 2009, PSYCHOSOMATICS, V50, P506, DOI 10.1176/appi.psy.50.5.506; Grover S, 2013, PSYCHIAT RES, V206, P68, DOI 10.1016/j.psychres.2012.08.034; Gaudreau JD, 2005, J CLIN ONCOL, V23, P6712, DOI 10.1200/JCO.2005.05.140; Meagher DJ, 2012, J PSYCHOSOM RES, V72, P236, DOI 10.1016/j.jpsychores.2011.11.013; Leslie DL, 2005, ARCH INTERN MED, V165, P1657, DOI 10.1001/archinte.165.14.1657; Minagawa H, 1996, CANCER, V78, P1131, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1131::AID-CNCR26>3.3.CO;2-J; van den Boogaard M, 2012, INT J NURS STUD, V49, P775, DOI 10.1016/j.ijnurstu.2011.11.016; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Gagnon P, 2002, B CANCER, V89, P1093; Holtta E, 2011, AM J GERIAT PSYCHIAT, V19, P1034, DOI 10.1097/JGP.0b013e31820dcbb6; Fang CK, 2008, JPN J CLIN ONCOL, V38, P56, DOI 10.1093/jjco/hym155; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Gaudreau JD, 2007, CANCER, V109, P2365, DOI 10.1002/cncr.22665; MASSIE MJ, 1983, AM J PSYCHIAT, V140, P1048; Akechi T, 2010, PSYCHOSOMATICS, V51, P106, DOI 10.1176/appi.psy.51.2.106; Sagawa R, 2009, JPN J CLIN ONCOL, V39, P175, DOI 10.1093/jjco/hyn157; Breitbart W, 2002, PSYCHOSOMATICS, V43, P183, DOI 10.1176/appi.psy.43.3.183; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P267, DOI 10.1016/0885-3924(92)90060-U; Leonard M, 2008, PALLIATIVE MED, V22, P848, DOI 10.1177/0269216308094520; Buurman BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026951; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Sarhill N, 2001, Am J Hosp Palliat Care, V18, P335, DOI 10.1177/104990910101800509; Vollmer Charlene M, 2010, Urol Nurs, V30, P235; Young J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3704; ZW L, 1990, DELIRIUM ACUTE CONFU, P109	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					934	940		10.1093/jjco/hyv100		7	Oncology	Oncology	CT5EH	WOS:000362830300007		
J	Asao, T; Nokihara, H; Yoh, K; Niho, S; Goto, K; Ohmatsu, H; Kubota, K; Yamamoto, N; Sekine, I; Kunitoh, H; Fujiwara, Y; Ohe, Y				Asao, Tetsuhiko; Nokihara, Hiroshi; Yoh, Kiyotaka; Niho, Seiji; Goto, Koichi; Ohmatsu, Hironobu; Kubota, Kaoru; Yamamoto, Noboru; Sekine, Ikuo; Kunitoh, Hideo; Fujiwara, Yutaka; Ohe, Yuichiro			Phase II study of amrubicin at a dose of 45 mg/m(2) in patients with previously treated small-cell lung cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						small-cell lung cancer; salvage chemotherapy; amrubicin; Phase II	TOPOTECAN; TRIAL; 9-AMINOANTHRACYCLINE; CHEMOTHERAPY; THERAPY	Most of the previous studies of amrubicin in patients with previously treated small-cell lung cancer were conducted at a dose of 40 mg/m(2). The aim of this study was to assess the efficacy and safety of amrubicin at a dose of 45 mg/m(2) in patients with relapsed or refractory small-cell lung cancer. Previously treated small-cell lung cancer patients were eligible. Amrubicin at a dose of 45 mg/m(2) was administered on Days 1-3 every 3 weeks. The primary endpoint was the response rate. From June 2003 to January 2005, 35 patients were enrolled, of whom 34 received this study treatment. Four cycles or more could be administered in 21 patients (62%). Dose reduction was required in 15 (52%) of the 29 patients who had received two cycles or more. Three complete responses and 15 partial responses were observed among the 34 treated patients, yielding a response rate of 53% (95% confidence interval, 35-71%). Median progression-free survival of the patients was 4.4 months (95% confidence interval, 2.4-5.1 months). Median survival time was 8.2 months (95% confidence interval, 6.6-10.0 months) and 1-year survival rate was 24% (95% confidence interval, 9-39%). Grade 3/4 leukopenia, neutropenia and thrombocytopenia were observed in 76, 97 and 38% of the patients, respectively. Febrile neutropenia occurred in 12 patients (35%), and one patient died from pneumonia. While amrubicin at a dose of 45 mg/m(2) showed high response rate for both sensitive and refractory relapse, the incidence of febrile neutropenia was also high. The utility of amrubicin at 45 mg/m(2) might accordingly be limited.	[Asao, Tetsuhiko; Nokihara, Hiroshi; Kubota, Kaoru; Yamamoto, Noboru; Sekine, Ikuo; Kunitoh, Hideo; Fujiwara, Yutaka; Ohe, Yuichiro] Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan; [Yoh, Kiyotaka; Niho, Seiji; Goto, Koichi; Ohmatsu, Hironobu] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan; [Kubota, Kaoru] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 113, Japan; [Sekine, Ikuo] Univ Tsukuba, Fac Med, Dept Med Oncol, Tsukuba, Ibaraki, Japan; [Kunitoh, Hideo] Japanese Red Cross Med Ctr, Div Chemotherapy, Dept Internal Med, Tokyo, Japan	Fujiwara, Y (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yutakafu@ncc.go.jp			Ministry of Health Labour and Welfare of Japan [14S-2]	This study was supported by the Grant-in-Aid for Cancer Research from the Ministry of Health Labour and Welfare of Japan (Grant no. 14S-2).	O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Jotte R, 2011, J CLIN ONCOL, V29, P287, DOI 10.1200/JCO.2010.29.8851; Inoue A, 2008, J CLIN ONCOL, V26, P5401, DOI 10.1200/JCO.2008.18.1974; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; TAKIGAWA N, 1992, ACTA MED OKAYAMA, V46, P249; von Pawel J, 2014, J CLIN ONCOL, V32, P4012, DOI 10.1200/JCO.2013.54.5392; POSTMUS PE, 1987, EUR J CANCER CLIN ON, V23, P1409, DOI 10.1016/0277-5379(87)90128-3; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; GIACCONE G, 1987, EUR J CANCER CLIN ON, V23, P1697, DOI 10.1016/0277-5379(87)90452-4; von Pawel J, 1999, J CLIN ONCOL, V17, P658; Murakami H, 2014, LUNG CANCER, V84, P67, DOI 10.1016/j.lungcan.2014.01.012; Onoda S, 2006, J CLIN ONCOL, V24, P5448, DOI 10.1200/JCO.2006.08.4145; Noguchi T, 1998, JPN J CANCER RES, V89, P1061; Goto K, 2004, BRIT J CANCER, V91, P659, DOI 10.1038/sj.bjc.6602056; Sugiura T, 2005, INVEST NEW DRUG, V23, P331, DOI 10.1007/s10637-005-1441-3; Goto K, 2014, ASCO M ABSTRACTS S, V32, P7504; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					941	946		10.1093/jjco/hyv107		6	Oncology	Oncology	CT5EH	WOS:000362830300008		
J	Nishiyama, K; Kodama, K; Teshima, T; Tada, H				Nishiyama, Kinji; Kodama, Ken; Teshima, Teruki; Tada, Hirohito			Stereotactic body radiotherapy for second pulmonary nodules after operation for an initial lung cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						stereotactic body radiation therapy; second lung cancer; operation for the index lung cancer	RADIATION-THERAPY; ABLATIVE RADIOTHERAPY; CARCINOMA; EXPERIENCE; RESECTION; OUTCOMES; VOLUME	A second lung cancer is occasionally observed in patients who underwent surgical resection of the index lung cancer. The purpose of this study is to evaluate stereotactic body radiation therapy for second lung cancer. Fifty-one medically inoperable patients who underwent stereotactic body radiation therapy for second lung cancer were the subjects: 31 cases of multiple primary lung cancer and 20 of pulmonary metastasis from the index cancer. Clinical stage was T1a in 27 patients, T1b in 13 patients and T2a in 11 patients, and 70% of subjects had impaired respiratory function. Histology of second lung cancer was adenocarcinoma in 16 patients, squamous cell carcinoma in 9 patients and not assessed in 25 patients. The interval between index cancer operation and stereotactic body radiation therapy was 31 months (range: 4-171). The total stereotactic body radiation therapy doses were 48 Gy in 4 fractions or 60 Gy in 10 fractions. With the median follow-up of 36 months, 3-year overall survival rates were 62% with the median survival time of 46 months. Cause-specific survival was 73% at 3 years. Overall survival for multiple primary lung cancer and pulmonary metastasis was quite similar: 62 and 61% at 3 years, respectively. Three-year overall survival was 77% for T1a and 43% for T1b or T2a. Grade 2 pulmonary toxicities occurred in five patients and one patient died of Grade 5 pneumonitis. Even though the subjects were medically inoperable, the survival outcomes of stereotactic body radiation therapy were favorable. Furthermore, having acceptable toxicity, stereotactic body radiation therapy is feasible and could be an option for multiple primary lung cancer and pulmonary metastasis after surgical resection for the index cancer.	[Nishiyama, Kinji; Teshima, Teruki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Osaka, Japan; [Kodama, Ken] Yao Municipal Hosp, Dept Thorac Surg, Yao, Japan; [Tada, Hirohito] Suita Tokusyukai Hosp, Dept Thorac Surg, Suita, Osaka, Japan	Nishiyama, K (reprint author), 1-3-1 Ryuge Cho, Osaka 5810069, Japan.	nisiyama2288@gmail.com					Chang JY, 2013, CANCER-AM CANCER SOC, V119, P3402, DOI 10.1002/cncr.28217; Beitler JJ, 2006, INT J RADIAT ONCOL, V65, P100, DOI 10.1016/j.ijrobp.2005.11.028; Matsuo Y, 2012, INT J RADIAT ONCOL, V83, pE545, DOI 10.1016/j.ijrobp.2012.01.018; Qiao XY, 2003, LUNG CANCER-J IASLC, V41, P1, DOI 10.1016/S0169-5002(03)00152-1; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Adebonojo SA, 1997, CHEST, V112, P693, DOI 10.1378/chest.112.3.693; Creach KM, 2012, RADIOTHER ONCOL, V104, P19, DOI 10.1016/j.radonc.2011.12.005; Takeda A, 2012, LUNG CANCER, V77, P77, DOI 10.1016/j.lungcan.2012.01.006; Johnson BE, 1998, J NATL CANCER I, V90, P1335, DOI 10.1093/jnci/90.18.1335; ANTAKLI T, 1995, ANN THORAC SURG, V59, P863, DOI 10.1016/0003-4975(95)00067-U; Ricardi U, 2010, LUNG CANCER, V68, P72, DOI 10.1016/j.lungcan.2009.05.007; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Stephans KL, 2009, J THORAC ONCOL, V4, P976, DOI 10.1097/JTO.0b013e3181adf509; Onishi H, 2004, CANCER-AM CANCER SOC, V101, P1623, DOI 10.1002/cncr.20539; Hamaji M, 2013, J THORAC CARDIOV SUR, V145, P683, DOI 10.1016/j.jtcvs.2012.12.051; Bradley JD, 2002, INT J RADIAT ONCOL, V52, P49, DOI 10.1016/S0360-3016(01)01772-2; Verstegen NE, 2011, RADIOTHER ONCOL, V101, P250, DOI 10.1016/j.radonc.2011.09.017; Battafarano RJ, 2004, J THORAC CARDIOV SUR, V127, P836, DOI 10.1016/j.jtcvs.2003.08.055; BLOMGREN H, 1995, ACTA ONCOL, V34, P861; Bodegom PC, 1989, THORAX, V44, P788; Shen KR, 2007, CHEST, V132, p290S, DOI 10.1378/chest.07-1382; Voltolini L, 2000, EUR J CARDIO-THORAC, V18, P529, DOI 10.1016/S1010-7940(00)00572-8	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					947	952		10.1093/jjco/hyv113		6	Oncology	Oncology	CT5EH	WOS:000362830300009		
J	Akaza, H; Oya, M; Iijima, M; Hyodo, I; Gemma, A; Itoh, H; Adachi, M; Okayama, Y; Sunaya, T; Inuyama, L				Akaza, Hideyuki; Oya, Mototsugu; Iijima, Masafumi; Hyodo, Ichinosuke; Gemma, Akihiko; Itoh, Hiroshi; Adachi, Masatoshi; Okayama, Yutaka; Sunaya, Toshiyuki; Inuyama, Lyo			A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						molecularly targeted therapy; post-marketing surveillance; renal cell carcinoma; sorafenib tosylate	PHASE-III TRIAL; TUMOR-SUPPRESSOR PROTEIN; PROGNOSTIC-FACTORS; INTERFERON-ALPHA; EXPANDED-ACCESS; DOUBLE-BLIND; SURVIVAL; CANCER; MUTATIONS; AXITINIB	Real-life safety and efficacy of sorafenib in advanced renal cell carcinoma in a nationwide patient population were evaluated by post-marketing all-patient surveillance. All patients with unresectable or metastatic renal cell carcinoma in Japan who started sorafenib therapy from February 2008 to September 2009 were registered and followed for up to 12 months. Baseline characteristics, treatment status, tumor response, survival and safety data were recorded by the prescribing physicians. Safety and efficacy were evaluated in 3255 and 3171 patients, respectively. The initial daily dose was 800 mg in 78.2% of patients. Median duration of treatment was 6.7 months and the mean relative dose intensity was 68.4%. Overall, 2227 patients (68.4%) discontinued the treatment by 12 months, half of which (52.0% of discontinued patients) were due to adverse events. The most common adverse drug reactions were hand-foot skin reaction (59%), hypertension (36%), rash (25%) and increase in lipase/amylase (23%). The median progression-free survival was 7.3 months (95% confidence intervals: 6.7-8.1), and the overall survival rate at 1 year was 75.4% (73.5-77.1). Prognostic factors for overall survival were mostly consistent with those in previous clinical trials in the univariate analysis and largely similar to those for progression-free survival and duration of treatment in the multivariate analysis. Sorafenib for the treatment of advanced renal cell carcinoma under the labeled dose was feasible in daily medical practice, for its acceptable toxicity profile and favorable clinical benefit that were consistent with those in clinical trials.	[Akaza, Hideyuki] Univ Tokyo, Grad Sch Interdisciplinary Informat Studies, Interfac Initiat Informat Studies, Dept Strateg Investigat Comprehens Canc Network, Tokyo, Japan; [Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; [Iijima, Masafumi] Showa Univ, Sch Med, Tokyo 142, Japan; [Hyodo, Ichinosuke] Univ Tsukuba, Inst Clin Med, Grad Sch Comprehens Human Sci, Dept Gastroenterol & Hepatol, Tsukuba, Ibaraki 305, Japan; [Gemma, Akihiko] Nippon Med Sch, Internal Med, Dept Pulm Med Infect & Oncol, Tokyo 113, Japan; [Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol, Tokyo, Japan; [Adachi, Masatoshi] Bayer Yakuhin Ltd, Med Affairs Oncol & Hematol, Osaka, Japan; [Okayama, Yutaka; Inuyama, Lyo] Bayer Yakuhin Ltd, Med Affairs, Pharmacovigilance, Osaka, Japan; [Sunaya, Toshiyuki] Bayer Yakuhin Ltd, Clin Stat, Osaka, Japan	Akaza, H (reprint author), 4-6-1 Komaba,Meguro Ku, Tokyo 1538904, Japan.	akazah@med.rcast.u-tokyo.ac.jp			Bayer Yakuhin Ltd	This work was supported and funded by Bayer Yakuhin Ltd, the manufacturer of the Nexavar. Funding to pay the Open Access publication charges for this article was provided by Bayer Yakuhin, Ltd.	Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Gitlitz BJ, 2003, UROL CLIN N AM, V30, P589, DOI 10.1016/S0094-0143(03)00027-2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Winkelmayer WC, 2003, AM J KIDNEY DIS, V41, P84, DOI 10.1053/ajkd.2003.50026; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Furniss D, 2008, CANCER TREAT REV, V34, P407, DOI 10.1016/j.ctrv.2007.12.008; Saavedra E, 2014, INVEST NEW DRUG, V32, P774, DOI 10.1007/s10637-013-0049-2; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Di Lorenzo G, 2011, EUR UROL, V59, P526, DOI 10.1016/j.eururo.2011.01.002; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710; Na X, 2003, J UROLOGY, V170, P588, DOI 10.1097/01.ju.0000074870.54671.98; Drucker BJ, 2005, CANCER TREAT REV, V31, P536, DOI 10.1016/j.ctrv.2005.07.009; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Stadler WM, 2010, CANCER-AM CANCER SOC, V116, P1272, DOI 10.1002/cncr.24864; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Maxwell PH, 1999, NATURE, V399, P271; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Akaza H, 2007, JPN J CLIN ONCOL, V37, P755, DOI 10.1093/jjco/hym095; Motzer RJ, 2004, J CLIN ONCOL, V22, P454; Iijima M, 2011, J DERMATOL, V38, P261, DOI 10.1111/j.1346-8138.2010.01059.x; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Naito S, 2011, BJU INT, V108, P1813, DOI 10.1111/j.1464-410X.2011.10281.x; [Anonymous], 2011, JNCI-J NATL CANCER I; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Beck J, 2011, ANN ONCOL, V22, P1812, DOI 10.1093/annonc/mdq651; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Carlomagno F, 2006, J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Horiuchi-Yamamoto Y, 2013, INT J CLIN ONCOL, V18, P743, DOI 10.1007/s10147-012-0438-0; Hyodo Ichinosuke, 2012, Gan To Kagaku Ryoho, V39, P1651; The Japanese Urological Association, 1999, GEN RUL CLIN PATH ST	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					953	962		10.1093/jjco/hyv099		10	Oncology	Oncology	CT5EH	WOS:000362830300010		
J	Tabata, M; Ikeda, M; Urakami, S; Takahashi, S; Sakaguchi, K; Kurosawa, K; Okaneya, T				Tabata, Mariko; Ikeda, Masaomi; Urakami, Shinji; Takahashi, Shintaro; Sakaguchi, Kazushige; Kurosawa, Kazuhiro; Okaneya, Toshikazu			Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						adjuvant chemotherapy; urothelial carcinoma; pT3 bladder cancer	UROTHELIAL CARCINOMA; METAANALYSIS; CISPLATIN	To evaluate the effectiveness of adjuvant chemotherapy in patients with pathological Stage T3 bladder cancer who had undergone radical cystectomy, and to determine the prognostic survival factors for adjuvant chemotherapy treatment. From January 1990 to October 2013, 202 patients underwent radical cystectomy and pelvic lymphadenectomy. Among them, 65 patients with non-organ-confined disease (pT3, N0-3, M0) diagnosed were investigated in this study. Thirty-one patients (48%) were treated with adjuvant chemotherapy and the remaining 34 patients (52%) were not. Median age of all patients was 66 years, and median follow-up was 26.1 months. For all pT3 patients, overall survival and disease-free survival times were similar in the adjuvant chemotherapy and non-adjuvant chemotherapy groups. However, in the pT3b subgroup, median overall survival (47.0 vs. 10.6 months) and median disease-free survival (35.5 vs. 5.3 months) times were significantly prolonged for those who underwent adjuvant chemotherapy (P = 0.009 and 0.025). In patients with pathological lymph node metastatic (pN+), median overall survival (30.1 vs. 6.4 months) and median disease-free survival (15.7 vs. 3.5 months) times were significantly prolonged in the adjuvant chemotherapy group (P = 0.016 and 0.027). In addition, according to multivariate analysis in pT3b and/or pN+ subgroup patients, adjuvant chemotherapy status was an independent predictive factor for overall survival and disease-free survival. Adjuvant chemotherapy did not significantly improve overall survival and disease-free survival when compared with all patients with pT3 who had received radical cystectomy in the non-adjuvant chemotherapy group. However, in the pT3b and pN+ subgroup, adjuvant chemotherapy demonstrated statistically significant benefits regarding overall survival and disease-free survival. Although these results could not support adjuvant chemotherapy use for all pT3 patients, the pT3b substage and/or pN+ may help identify patients with pT3 who could benefit from adjuvant chemotherapy.	Toranomon Gen Hosp, Dept Urol, Tokyo 1058470, Japan; Okinaka Mem Inst Med Res, Tokyo, Japan	Ikeda, M (reprint author), Toranomon Gen Hosp, Dept Urol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	ikeda.masaomi@grape.plala.or.jp					Advanced Bladder Cancer ( ABC), 2005, EUR UROL, V48, P202, DOI DOI 10.1016/J.EURUR0.2005.04.006; Bono AV, 2005, EUR UROL, V48, P189, DOI 10.1016/j.eururo.2005.04.005; RICHARDS B, 1983, BRIT J UROL, V55, P386, DOI 10.1111/j.1464-410X.1983.tb03328.x; Svatek RS, 2010, CLIN CANCER RES, V16, P4461, DOI 10.1158/1078-0432.CCR-10-0457; Hautmann RE, 2012, EUR UROL, V61, P1039, DOI 10.1016/j.eururo.2012.02.028; Shariat SF, 2006, J UROLOGY, V176, P2414, DOI 10.1016/j.juro.2006.08.004; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Cognetti F, 2012, ANN ONCOL, V23, P695, DOI 10.1093/annonc/mdr354; Sonpavde G, 2011, J UROLOGY, V185, P1216, DOI 10.1016/j.juro.2010.11.082; Sternberg CN, 2014, EUR UROL, V66, P55, DOI 10.1016/j.eururo.2014.01.008; May M, 2012, J UROLOGY, V187, P1210, DOI 10.1016/j.juro.2011.11.104; Leow JJ, 2014, EUR UROL, V66, P42, DOI 10.1016/j.eururo.2013.08.033; EINSTEIN AB, 1984, UROLOGY, V23, P110; Neuzillet Y, 2012, BJU INT, V110, P1736, DOI 10.1111/j.1464-410X.2012.11104.x; Clark PE, 2013, J NATL COMPR CANC NE, V11, P446; Kanatani A, 2015, CLIN GENITOURIN CANC, V13, P107; Paz-Ares LG, 2010, J CLIN ONCOL, V28, P18; Stein JP, 2001, J CLIN ONCOL, V19, P666; Yelfimov DA, 2014, WORLD J UROL, V32, P1463, DOI 10.1007/s00345-014-1236-2	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					963	967		10.1093/jjco/hyv098		5	Oncology	Oncology	CT5EH	WOS:000362830300011		
J	Sakano, S; Inamoto, T; Inoue, R; Matsumoto, H; Nagao, K; Yamamoto, Y; Azuma, H; Matsuyama, H				Sakano, Shigeru; Inamoto, Teruo; Inoue, Ryo; Matsumoto, Hiroaki; Nagao, Kazuhiro; Yamamoto, Yoshiaki; Azuma, Haruhito; Matsuyama, Hideyasu			Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						cytology; pathology; upper urinary tract; urothelial carcinoma	TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; NEOADJUVANT CHEMOTHERAPY; SURVIVAL; DISEASE; BIOPSY; GRADE	After radical nephroureterectomy, substantial numbers of patients with upper tract urothelial carcinoma are ineligible for adjuvant chemotherapy owing to diminished renal function. Accurate pre-operative prediction of worse pathological findings in radical nephroureterectomy specimens can guide appropriate patient selection for neoadjuvant chemotherapy. Herein, we evaluated pre-operative voided urine cytology and the additional efficacy of selective ureteral cytology for predicting pathological features in upper tract urothelial carcinoma patients. This retrospective cohort study comprised 722 patients with upper tract urothelial carcinoma who underwent radical nephroureterectomy. Patients with concomitant bladder cancer and those who received neoadjuvant therapy were excluded. Finally, 437 patients with urinary cytology data were enrolled in the study. We assessed the positive voided urine and selective ureteral cytology for predicting higher pathological T stage (>= pT3), higher tumor grade (3) and positive lymphovascular invasion. Previous bladder cancer, tumor location, clinical T stage and voided urine cytology (P = 0.029) were independently associated with >= pT3, whereas selective ureteral cytology was not. Gender, clinical N category and voided urine cytology (P = 0.017) were independently associated with tumor Grade 3, whereas selective ureteral cytology was not. Hydronephrosis, clinical T stage, clinical N category and voided urine cytology (P = 0.0021) were independently associated with lymphovascular invasion, whereas selective ureteral cytology was not. Pre-operative positive voided urine cytology was an independent predictor for worse pathological findings in radical nephroureterectomy specimens, while selective ureteral cytology had no additional efficacy. However, further studies with larger numbers of patients and complete data sets are needed to select patients for more aggressive treatments including neoadjuvant chemotherapy.	[Sakano, Shigeru] Kokura Mem Hosp, Dept Urol, Kokurakita Ku, Kitakyushu, Fukuoka 8028555, Japan; [Sakano, Shigeru; Inoue, Ryo; Matsumoto, Hiroaki; Nagao, Kazuhiro; Yamamoto, Yoshiaki; Matsuyama, Hideyasu] Yamaguchi Univ, Dept Urol, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Inamoto, Teruo; Azuma, Haruhito] Osaka Med Coll, Dept Urol, Takatsuki, Osaka 569, Japan	Sakano, S (reprint author), Kokura Mem Hosp, Dept Urol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8028555, Japan.	shigerus@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [24592393]	This study was supported, in part, by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science [24592393].	Suttmann H, 2007, BJU INT, V100, P1225, DOI 10.1111/j.1464-410X.2007.07113.x; Kikuchi E, 2009, J CLIN ONCOL, V27, P612, DOI 10.1200/JCO.2008.17.2361; Sakano S, 2013, ANN SURG ONCOL, V20, P4389, DOI 10.1245/s10434-013-3259-0; Kaag MG, 2010, EUR UROL, V58, P581, DOI 10.1016/j.eururo.2010.06.029; Porten S, 2014, CANCER-AM CANCER SOC, V120, P1794, DOI 10.1002/cncr.28655; Favaretto RL, 2012, BJU INT, V109, P77, DOI 10.1111/j.1464-410X.2011.10288.x; Messer J, 2011, BJU INT, V108, P701, DOI 10.1111/j.1464-410X.2010.09899.x; Kitamura H, 2012, JPN J CLIN ONCOL, V42, P1192, DOI 10.1093/jjco/hys166; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Scolieri MJ, 2000, UROLOGY, V56, P930, DOI 10.1016/S0090-4295(00)00800-1; Brown GA, 2007, UROLOGY, V70, P252, DOI 10.1016/j.urology.2007.03.051; Brien JC, 2010, J UROLOGY, V184, P69, DOI 10.1016/j.juro.2010.03.030; Smith AK, 2011, UROLOGY, V78, P82, DOI 10.1016/j.urology.2011.02.038; Akao J, 2008, BJU INT, V102, P572, DOI 10.1111/j.1464-410X.2008.07749.x; Margulis V, 2009, CANCER, V115, P1224, DOI 10.1002/cncr.24135; Margulis V, 2010, J UROLOGY, V184, P453, DOI 10.1016/j.juro.2010.03.142; Hellenthal NJ, 2009, J UROLOGY, V182, P900, DOI 10.1016/j.juro.2009.05.011; Matin SF, 2010, CANCER-AM CANCER SOC, V116, P3127, DOI 10.1002/cncr.25050; Mostofi FK, 1973, INT CLASSIFICATION T, V19; Sakano S, 2015, INT J CLIN ONCOL, V20, P362, DOI 10.1007/s10147-014-0721-3; Tanaka N, 2014, UROL ONCOL, V32, p[e19, 48]	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					968	972		10.1093/jjco/hyv114		5	Oncology	Oncology	CT5EH	WOS:000362830300012		
J	Kashino, I; Mizoue, T; Tanaka, K; Tsuji, I; Tamakoshi, A; Matsuo, K; Wakai, K; Nagata, C; Inoue, M; Tsugane, S; Sasazuki, S				Kashino, Ikuko; Mizoue, Tetsuya; Tanaka, Keitaro; Tsuji, Ichiro; Tamakoshi, Akiko; Matsuo, Keitaro; Wakai, Kenji; Nagata, Chisato; Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka		Res Grp Dev Evaluation Canc	Vegetable consumption and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						colorectal cancer; epidemiology; Japanese; systematic review; vegetable	COLON-CANCER; CRUCIFEROUS VEGETABLES; FRUIT; FOLATE; COHORT; HEALTH; DIET	The association between vegetable consumption and colorectal cancer risk remains unclear and may differ by region. We performed a systematic review and meta-analysis of epidemiologic studies on this issue among the Japanese population. A systematic review and meta-analysis was performed by searching MEDLINE through PubMed and the Ichushi database for cohort and case-control studies that were published by the end of December 2014. Associations were evaluated based on their magnitude and the strength of the evidence. Meta-analysis was performed by using the random effects model to estimate the summary relative risk with 95% confidence interval according to the study design. The final judgment was made based on a consensus of the research group members with consideration for both epidemiological evidence and biological plausibility. We identified six cohort studies and 11 case-control studies on vegetable intake and colorectal cancer among the Japanese population. Of the cohort studies, one study showed a weak inverse association with colon cancer and another study showed a weak positive association with rectal cancer in men, but other studies found no associations between vegetable consumption and colon and rectal cancers. With regard to case-control studies, one study found a strong inverse association with colon cancer, and three studies showed a weak-to-strong inverse association with rectal cancer. In meta-analysis, the summary relative risk (95% confidence interval) for the highest vs. the lowest categories of vegetable consumption were 1.00 (0.92-1.10) and 0.75 (0.59-0.96) for cohort and case-control studies, respectively. There was insufficient evidence to support an association between intake of vegetables and the risk of colorectal cancer among the Japanese population.	[Kashino, Ikuko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo 1628655, Japan; [Tanaka, Keitaro] Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan; [Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Tamakoshi, Akiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Wakai, Kenji] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi 4648601, Japan; [Nagata, Chisato] Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu, Japan; [Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan	Mizoue, T (reprint author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Shinjuku Ku, Toyama 1-21-1, Tokyo 1628655, Japan.	mizoue@ri.ncgm.go.jp			National Cancer Center Research and Development Fund	This study was supported by the National Cancer Center Research and Development Fund.	Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Murata M, 1999, JPN J CANCER RES, V90, P711; Vargas AJ, 2012, NUTR CLIN PRACT, V27, P613, DOI 10.1177/0884533612454885; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Tsubono Y, 2005, BRIT J CANCER, V92, P1782, DOI 10.1038/sj.bjc.6602566; Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; KATO I, 1990, JPN J CANCER RES, V81, P1101; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Lin MC, 2011, J AGR FOOD CHEM, V59, P11304, DOI 10.1021/jf202433f; Lipkin M, 1999, ANNU REV NUTR, V19, P545, DOI 10.1146/annurev.nutr.19.1.545; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Sato Y, 2005, PUBLIC HEALTH NUTR, V8, P309, DOI 10.1079/PHN2004681; Okuyama Y, 2014, INT J CLIN ONCOL, V19, P87, DOI 10.1007/s10147-013-0520-2; Tang FY, 2011, J AGR FOOD CHEM, V59, P9011, DOI 10.1021/jf2017644; Nishi M, 1997, ONCOL REP, V4, P995; Uchida K, 2010, SCAND J GASTROENTERO, V45, P1223, DOI 10.3109/00365521.2010.492528; KOTAKE K, 1995, JPN J CLIN ONCOL, V25, P195; INOUE M, 1995, CANCER CAUSE CONTROL, V6, P14, DOI 10.1007/BF00051676; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Hara M, 2003, NUTR CANCER, V46, P138, DOI 10.1207/S15327914NC4602_06; Vogtmann E, 2013, CANCER CAUSE CONTROL, V24, P1935, DOI 10.1007/s10552-013-0268-z; Doyle VC, 2007, GASTROENTEROL NURS, V30, P178, DOI 10.1097/01.SGA.0000278165.05435.c0; Aoyama N, 2014, J EPIDEMIOL, V24, P353, DOI 10.2188/jea.JE20130195; Sauvaget C, 2003, BRIT J CANCER, V88, P689, DOI 10.1038/sj.bjc.6600775; HOSHIYAMA Y, 1993, TOHOKU J EXP MED, V171, P153, DOI 10.1620/tjem.171.153; Lee JE, 2011, GASTROENTEROLOGY, V141, P16, DOI 10.1053/j.gastro.2011.05.020; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; Choi SW, 2002, J NUTR, V132, p2413S; Doyle VC, 2007, GASTROENTEROL NURS, V30, P82; [FAOSTAT Food and Agriculture Organization of United Nations], FAOSTAT; Health and Welfare Statistics Association, 2014, J HLTH WELFARE STAT; Hirayama T, 1990, LIFE STYLE MORTALITY; Khan M M H, 2004, Asian Pac J Cancer Prev, V5, P58; Leenders M, 2014, INT J CANCER, V135, P2930, DOI 10.1002/ijc.28938; Ping Y, 1998, Environ Health Prev Med, V3, P146, DOI 10.1007/BF02931705; Watanabe Y, 1984, Nihon Shokakibyo Gakkai Zasshi, V81, P185; WCRF. World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P; World Cancer Research Fund/American Institute of Cancer Research, 1997, CANC RES; World Health Organization, 2003, WHO TECHN REP SER; World Health Organization/International Agency for Research on Cancer, 2003, IARC HDB CANC PREV	43	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					973	979		10.1093/jjco/hyv111		7	Oncology	Oncology	CT5EH	WOS:000362830300013		
J	Hojo, T; Masuda, N; Mizutani, T; Shibata, T; Kinoshita, T; Tamura, K; Hara, F; Fujisawa, T; Inoue, K; Saji, S; Nakamura, K; Fukuda, H; Iwata, H				Hojo, Takashi; Masuda, Norikazu; Mizutani, Tomonori; Shibata, Taro; Kinoshita, Takayuki; Tamura, Kenji; Hara, Fumikata; Fujisawa, Tomomi; Inoue, Kenichi; Saji, Shigehira; Nakamura, Kenichi; Fukuda, Haruhiko; Iwata, Hiroji			Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						breast surgery; clinical trial-trial design; diagnostic radiology	FOLLOW-UP; SURVIVAL; TRIAL	This Phase III trial aims to determine the superiority of intensive follow-up to standard follow-up in terms of overall survival in high-risk breast cancer patients, who are expected to have recurrence rates of over 30% within 5 years after surgery. Eligible patients are randomized either to the intensive follow-up group or to the standard follow-up group; the former will undergo physical examination, bone scintigraphy, chest computed tomography, abdominal computed tomography, brain magnetic resonance imaging/computed tomography and frequent tumor marker evaluations, whereas the latter will undergo physical examination at the same frequency and tumor markers will be evaluated once a year. Mammography once a year is planned for both groups. The primary endpoint is overall survival. Patient accrual was started in November 2013. A total of 1700 patients will be enrolled for 3 years and followed up for 7 years after closure of accrual. This trial has been registered at the UMIN Clinical Trials Registry as UMIN000012429.	[Hojo, Takashi; Kinoshita, Takayuki] Natl Canc Ctr, Dept Breast Surg, Tokyo 1040045, Japan; [Masuda, Norikazu] Osaka Natl Hosp, Dept Breast Surg, Osaka, Japan; [Mizutani, Tomonori; Shibata, Taro; Nakamura, Kenichi; Fukuda, Haruhiko] Natl Canc Ctr, Ctr Res Adm & Support, JCOG Data Ctr, Tokyo 1040045, Japan; [Tamura, Kenji] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan; [Hara, Fumikata] Shikoku Canc Ctr, Breast & Med Oncol, Dept Breast Surg, Matsuyama, Ehime, Japan; [Fujisawa, Tomomi] Gunma Prefectural Canc Ctr, Dept Breast Oncol, Gunma, Japan; [Inoue, Kenichi] Saitama Canc Ctr, Dept Breast Oncol, Saitama, Japan; [Saji, Shigehira] Fukushima Med Univ, Dept Med Oncol, Fukushima, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan	Hojo, T (reprint author), Natl Canc Ctr, Dept Breast Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tahojo@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-16, 23-A-17, 26-A-4]; Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare [H26-applied-general-046]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED [15ck0106049h0002]	This study is supported by the National Cancer Center Research and Development Fund (23-A-16, 23-A-17, 26-A-4) and Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare (H26-applied-general-046). This research is supported by the Practical Research for Innovative Cancer Control (15ck0106049h0002) from Japan Agency for Medical Research and Development, AMED.	LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Allred DC, 1998, MODERN PATHOL, V11, P155; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Aebi S, 2010, ANN ONCOL, V21, pv9, DOI 10.1093/annonc/mdq159; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Hahn EE, 2013, CANCER-AM CANCER SOC, V119, P4316, DOI 10.1002/cncr.28363; GHEZZI P, 1994, JAMA-J AM MED ASSOC, V271, P1587; New Zealand Guidelines Group, 2009, MAN EARL BREAST CANC; Rojas MP, 2005, COCHRANE DB SYST REV, V25; Rosselli Del Turco M, 1994, JAMA-J AM MED ASSOC, V271, P1593; Watanabe T, SABCS 2008	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					983	986		10.1093/jjco/hyv110		4	Oncology	Oncology	CT5EH	WOS:000362830300015		
J	Nomura, S; Fujimoto, Y; Yamamoto, N; Sato, Y; Ashihara, Y; Kita, M; Yamaguchi, J; Ishikawa, Y; Ueno, M; Arai, M				Nomura, Sachio; Fujimoto, Yoshiya; Yamamoto, Noriko; Sato, Yuri; Ashihara, Yuumi; Kita, Mizuho; Yamaguchi, Junya; Ishikawa, Yuichi; Ueno, Masashi; Arai, Masami			A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						PMS2; PMS2CL; Lynch syndrome; frameshift mutation	DNA MISMATCH REPAIR; COLORECTAL-CANCER; GENE; PREDISPOSITION; INSTABILITY; DIAGNOSIS; VARIANTS	Heterozygous deleterious mutation of the PMS2 gene is a cause of Lynch syndrome, an autosomal dominant cancer disease. However, the frequency of PMS2 mutation is rare compared with that of the other causative genes; MSH2, MLH1 and MSH6. PMS2 mutation has so far only been reported once from a Japanese facility. Detection of PMS2 mutation is relatively complicated due to the existence of 15 highly homologous pseudogenes, and its gene conversion event with the pseudogene PMS2CL. Therefore, for PMS2 mutation analysis, it is crucial to clearly distinguish PMS2 from its pseudogenes. We report here a novel deleterious 11 bp deletion mutation of exon 11 of PMS2 distinguished from PMS2CL in a 34-year-old Japanese female with rectal cancer. PMS2 mutated at c.1492del11 results in a truncated 500 amino acid protein rather than the wild-type protein of 862 amino acids. This is supported by the fact that, although there is usually concordance between MLH1 and PMS2 expression, cells were immunohistochemically positive for MLH1, whereas PMS2 could not be immunohistochemically stained using an anti-C-terminal PMS2 antibody, or effective PMS2 mRNA degradation with NMD caused by the frameshift mutation.	[Nomura, Sachio; Sato, Yuri; Ashihara, Yuumi; Kita, Mizuho; Yamaguchi, Junya; Arai, Masami] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Genet Oncol, Tokyo 1358550, Japan; [Nomura, Sachio] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Clin Res, Tokyo 1358550, Japan; [Fujimoto, Yoshiya; Ueno, Masashi] Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo, Japan; [Yamamoto, Noriko; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 1358550, Japan	Arai, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Clin Genet Oncol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	marai@jfcr.or.jp			Japanese Foundation for Cancer Research	This work was supported by a Japanese Foundation for Cancer Research donation.	Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; De Vos M, 2004, AM J HUM GENET, V74, P954, DOI 10.1086/420796; Hayward BE, 2007, HUM MUTAT, V28, P424, DOI 10.1002/humu.20457; Ali H, 2012, HUM MUTAT, V33, P642, DOI 10.1002/humu.22038; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Peltomaki P, 2004, DIS MARKERS, V20, P269; Hendriks YMC, 2006, GASTROENTEROLOGY, V130, P312, DOI 10.1053/j.gastro.2005.10.052; Drost M, 2013, HUM MUTAT, V34, P1477, DOI 10.1002/humu.22426; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Miyaki M, 1997, ONCOGENE, V15, P2877, DOI 10.1038/sj.onc.1201668; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; van der Klift HM, 2010, HUM MUTAT, V31, P578, DOI 10.1002/humu.21229; Miyakura Y, 2012, JPN J CLIN ONCOL, V42, P78, DOI 10.1093/jjco/hyr162; Boland CR, 1998, CANCER RES, V58, P5248; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Niessen RC, 2009, GENE CHROMOSOME CANC, V48, P322, DOI 10.1002/gcc.20642; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Talseth-Palmer BA, 2010, HERED CANCER CLIN PR, V8, DOI 10.1186/1897-4287-8-5; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					987	992		10.1093/jjco/hyv108		6	Oncology	Oncology	CT5EH	WOS:000362830300016		
J	Yamaguchi, J; Sato, Y; Kita, M; Nomura, S; Yamamoto, N; Kato, Y; Ishikawa, Y; Arai, M				Yamaguchi, Junya; Sato, Yuri; Kita, Mizuho; Nomura, Sachio; Yamamoto, Noriko; Kato, Yo; Ishikawa, Yuichi; Arai, Masami			A novel deletion in the splice donor site of MLH1 exon 6 in a Japanese colon cancer patient with Lynch syndrome	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						Lynch syndrome; MLH1; splice site mutation	NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH REPAIR; MUTATIONS; HNPCC; HMLH1; MSH2	Lynch syndrome is an autosomal dominantly inherited disease that is characterized by a predisposition to cancers, mainly colorectal cancer. Germline mutations of DNA mismatch repair genes such as MLH1, MSH2, MSH6 and PMS2 have been described in patients with Lynch syndrome. Here, we report deletion of 2 bp in the splice donor site of the MLH1 exon 6 (c.545+4_545+5delCA) in a 48-year-old Japanese woman with Lynch syndrome. RT-PCR direct sequencing analysis revealed that this mutation led to an increase in the level of an MLH1 transcript in which exon 6 was skipped, and may cause a frameshift (p.E153FfsX8). Therefore, this mutation appears to be pathogenic and is responsible for Lynch syndrome. Additionally, analysis of the patient's tumor cells indicated microsatellite instability high phenotype and loss of the MLH1 and PMS2 proteins. To our knowledge, this is a germline splice site mutation of MLH1 that has not been reported previously.	[Yamaguchi, Junya; Sato, Yuri; Kita, Mizuho; Nomura, Sachio; Arai, Masami] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Genet Oncol, Tokyo 1358550, Japan; [Nomura, Sachio] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Clin Res, Tokyo 1358550, Japan; [Yamamoto, Noriko; Kato, Yo; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 1358550, Japan	Arai, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Clin Genet Oncol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	marai@jfcr.or.jp			Cancer Institute Hospital, the Japanese Foundation for Cancer Research	This work was supported by funding from the Cancer Institute Hospital, the Japanese Foundation for Cancer Research.	Clarke LA, 2000, GENE CHROMOSOME CANC, V29, P367, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1051>3.0.CO;2-V; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; Nomura S, 2000, BIOCHEM BIOPH RES CO, V271, P120, DOI 10.1006/bbrc.2000.2547; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Genuardi M, 1998, HUM GENET, V102, P15, DOI 10.1007/s004390050648; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Pensotti V, 1997, GENE CHROMOSOME CANC, V19, P135; Lynch HT, 2003, NEW ENGL J MED, V348, P919; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0	16	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					993	997		10.1093/jjco/hyv103		5	Oncology	Oncology	CT5EH	WOS:000362830300017		
J	Sugiura, T; Kohga, A; Uesaka, K				Sugiura, Teiichi; Kohga, Atsushi; Uesaka, Katsuhiko			Intraductal papillary mucinous neoplasm of the pancreas spontaneously ruptured into the peritoneal cavity	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Sugiura, Teiichi; Kohga, Atsushi; Uesaka, Katsuhiko] Shizuoka Canc Ctr, Div Hepatobiliary Pancreat Surg, Shizuoka, Japan	Sugiura, T (reprint author), Shizuoka Canc Ctr, Div Hepatobiliary Pancreat Surg, Shizuoka, Japan.	t.sugiura@scchr.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					998	998		10.1093/jjco/hyv104		1	Oncology	Oncology	CT5EH	WOS:000362830300018		
J	Niino, M; Matsuda, T				Niino, Mariko; Matsuda, Tomohiro			Morphological distribution of bladder cancer from Cancer Incidence in Five Continents Vol. X	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Niino, Mariko; Matsuda, Tomohiro] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Div Surveillance, Tokyo, Japan	Niino, M (reprint author), Natl Canc Ctr, Ctr Canc Control & Informat Serv, Div Surveillance, Tokyo, Japan.							0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	OCT	2015	45	10					999	999		10.1093/jjco/hyv147		1	Oncology	Oncology	CT5EH	WOS:000362830300019		
J	Cuello-Garcia, CA; Brozek, JL; Fiocchi, A; Pawankar, R; Yepes-Nunez, JJ; Terracciano, L; Gandhi, S; Agarwal, A; Zhang, Y; Schunemann, HJ				Cuello-Garcia, Carlos A.; Brozek, Jan L.; Fiocchi, Alessandro; Pawankar, Ruby; Yepes-Nunez, Juan Jose; Terracciano, Luigi; Gandhi, Shreyas; Agarwal, Arnav; Zhang, Yuan; Schuenemann, Holger J.			Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; prevention; probiotics systematic reviews	PLACEBO-CONTROLLED TRIAL; 1ST 6 MONTHS; DOUBLE-BLIND; ATOPIC DISEASE; FOLLOW-UP; ECZEMA; SUPPLEMENTATION; PREGNANCY; LIFE; CHILDREN	Background: Allergic diseases are considered a health burden because of their high and constantly increasing prevalence, high direct and indirect costs, and undesirable effects on quality of life. Probiotics have been suggested as an intervention to prevent allergic diseases. Objective: We sought to synthesize the evidence supporting use of probiotics for the prevention of allergies and inform World Allergy Organization guidelines on probiotic use. Methods: We performed a systematic review of randomized trials assessing the effects of any probiotic administered to pregnant women, breast-feeding mothers, and/or infants. Results: Of 2403 articles published until December 2014 identified in Cochrane Central Register of Controlled Trials, MEDLINE, and Embase, 29 studies fulfilled a priori specified inclusion criteria for the analyses. Probiotics reduced the risk of eczema when used by women during the last trimester of pregnancy (relative risk [RR], 0.71; 95% CI, 0.60-0.84), when used by breast-feeding mothers (RR, 0.57; 95% CI, 0.47-0.69), or when given to infants (RR, 0.80; 95% CI, 0.68-0.94). Evidence did not support an effect on other allergies, nutrition status, or incidence of adverse effects. The certainty in the evidence according to the Grading of Recommendation Assessment Development and Evaluation approach is low or very low because of the risk of bias, inconsistency and imprecision of results, and indirectness of available research. Conclusion: Probiotics used by pregnant women or breast-feeding mothers and/or given to infants reduced the risk of eczema in infants; however, the certainty in the evidence is low. No effect was observed for the prevention of other allergic conditions.	[Cuello-Garcia, Carlos A.; Brozek, Jan L.; Yepes-Nunez, Juan Jose; Zhang, Yuan; Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Brozek, Jan L.; Gandhi, Shreyas; Agarwal, Arnav; Schuenemann, Holger J.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Cuello-Garcia, Carlos A.] Tecnol Monterrey Sch Med, Monterrey, Mexico; [Fiocchi, Alessandro] Pediat Hosp Bambino Gesu, Vatican City, Japan; [Pawankar, Ruby] Nippon Med Sch, Dept Pediat, Tokyo 113, Japan; [Yepes-Nunez, Juan Jose] Univ Antioquia, Sch Med, Medellin, Colombia; [Terracciano, Luigi] Univ Milan, Sch Med, Dept Child & Maternal Med, Melloni Hosp, Milan, Italy; [Gandhi, Shreyas; Agarwal, Arnav] Univ Toronto, Fac Med, Toronto, ON M5S 1A1, Canada	Brozek, JL (reprint author), McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Rm 2C19,1200 Main St, West Hamilton, ON L8N 3Z5, Canada.	brozekj@mcmaster.ca					Allen SJ, 2012, ARCH DIS CHILD, V97, pA2, DOI DOI 10.1136/ARCHDISCHILD-2012-301885.5; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Ebert CS, 2011, OTOLARYNG CLIN N AM, V44, P537, DOI 10.1016/j.otc.2011.03.001; Kukkonen AK, 2011, PEDIAT ALLERG IMM-UK, V22, P249, DOI 10.1111/j.1399-3038.2010.01079.x; Huurre A, 2008, CLIN EXP ALLERGY, V38, P1342, DOI 10.1111/j.1365-2222.2008.03008.x; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Prescott SL, 2008, ALLERGY, V63, P1481, DOI 10.1111/j.1398-9995.2008.01778.x; Doege K, 2012, BRIT J NUTR, V107, P1, DOI 10.1017/S0007114511003400; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Soh SE, 2009, CLIN EXP ALLERGY, V39, P571, DOI 10.1111/j.1365-2222.2008.03133.x; Ou CY, 2012, CLIN EXP ALLERGY, V42, P1386, DOI 10.1111/j.1365-2222.2012.04037.x; Tang MLK, 2010, CURR OPIN PEDIATR, V22, P626, DOI 10.1097/MOP.0b013e32833d9728; Wickens K, 2012, CLIN EXP ALLERGY, V42, P1071, DOI 10.1111/j.1365-2222.2012.03975.x; Kopp MV, 2008, PEDIATRICS, V121, pE850, DOI 10.1542/peds.2007-1492; Dotterud CK, 2010, BRIT J DERMATOL, V163, P616, DOI 10.1111/j.1365-2133.2010.09889.x; West CE, 2009, PEDIATR ALLERGY IMMU, V20, P430, DOI 10.1111/j.1399-3038.2009.00745.x; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036; Allen SJ, 2010, J NUTR, V140, P483, DOI 10.3945/jn.109.117093; Rautava S, 2002, J ALLERGY CLIN IMMUN, V109, P119, DOI 10.1067/mai.2002.120273; Elazab N, 2013, PEDIATRICS, V132, pE666, DOI 10.1542/peds.2013-0246; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Boyle RJ, 2011, ALLERGY, V66, P509, DOI 10.1111/j.1398-9995.2010.02507.x; Prokesova L, 2006, PEDIATR ALLERGY IMMU, V17, P175, DOI 10.1111/j.1399-3038.2006.00395.x; Rautava S, 2012, J ALLERGY CLIN IMMUN, V130, P1355, DOI 10.1016/j.jaci.2012.09.003; Hascoet JM, 2011, J PEDIATR GASTR NUTR, V52, P756, DOI 10.1097/MPG.0b013e3182105850; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Niers L, 2009, ALLERGY, V64, P1349, DOI 10.1111/j.1398-9995.2009.02021.x; Holgate ST, 1999, NATURE, V402, pB2; Asher MI, 2012, ALLERGOL IMMUNOPATH, V40, P267, DOI 10.1016/j.aller.2011.11.004; Wickens K, 2008, J ALLERGY CLIN IMMUN, V122, P788, DOI 10.1016/j.jaci.2008.07.011; Morisset M, 2011, EUR J CLIN NUTR, V65, P175, DOI 10.1038/ejcn.2010.250; Kim JY, 2010, PEDIAT ALLERG IMM-UK, V21, pE386, DOI 10.1111/j.1399-3038.2009.00958.x; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Marschan E, 2008, CLIN EXP ALLERGY, V38, P611, DOI 10.1111/j.1365-2222.2008.02942.x; Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Azad MB, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6471; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Fiocchi A, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0055-2; Food and Agriculture Organization of the United Nations World Health Organization, 2006, PROB FOOD HLTH NUTR; Hempel S., 2011, EVID REP TECHNOL ASS, V200, P1; Lodinova-Zadnikova R, 2010, INT ARCH ALLERGY IMM, V153, P201, DOI 10.1159/000312638; Ortiz-Andrellucchi A, 2008, BRIT J NUTR, V100, P834, DOI 10.1017/S0007114508959183; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006475.pub2; Saengtawesin Varaporn, 2014, J Med Assoc Thai, V97 Suppl 6, pS20	47	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					952	961		10.1016/j.jaci.2015.04.031		10	Allergy; Immunology	Allergy; Immunology	CT7EJ	WOS:000362976300014		
J	Ma, CS; Wong, N; Rao, G; Avery, DT; Torpy, J; Hambridge, T; Bustamante, J; Okada, S; Stoddard, JL; Deenick, EK; Pelham, SJ; Payne, K; Boisson-Dupuis, S; Puel, A; Kobayashi, M; Arkwright, PD; Kilic, SS; El Baghdadi, J; Nonoyama, S; Minegishi, Y; Mahdaviani, SA; Mansouri, D; Bousfiha, A; Blincoe, AK; French, MA; Hsu, P; Campbell, DE; Stormon, MO; Wong, M; Adelstein, S; Smart, JM; Fulcher, DA; Cook, MC; Phan, TG; Stepensky, P; Boztug, K; Kansu, A; Ikinciogullari, A; Baumann, U; Beier, R; Roscioli, T; Ziegler, JB; Gray, P; Picard, C; Grimbacher, B; Warnatz, K; Holland, SM; Casanova, JL; Uzel, G; Tangye, SG				Ma, Cindy S.; Wong, Natalie; Rao, Geetha; Avery, Danielle T.; Torpy, James; Hambridge, Thomas; Bustamante, Jacinta; Okada, Satoshi; Stoddard, Jennifer L.; Deenick, Elissa K.; Pelham, Simon J.; Payne, Kathryn; Boisson-Dupuis, Stephanie; Puel, Anne; Kobayashi, Masao; Arkwright, Peter D.; Kilic, Sara Sebnem; El Baghdadi, Jamila; Nonoyama, Shigeaki; Minegishi, Yoshiyuki; Mahdaviani, Seyed Alireza; Mansouri, Davood; Bousfiha, Aziz; Blincoe, Annaliesse K.; French, Martyn A.; Hsu, Peter; Campbell, Dianne E.; Stormon, Michael O.; Wong, Melanie; Adelstein, Stephen; Smart, Joanne M.; Fulcher, David A.; Cook, Matthew C.; Phan, Tri Giang; Stepensky, Polina; Boztug, Kaan; Kansu, Aydan; Ikinciogullari, Aydan; Baumann, Ulrich; Beier, Rita; Roscioli, Tony; Ziegler, John B.; Gray, Paul; Picard, Capucine; Grimbacher, Bodo; Warnatz, Klaus; Holland, Steven M.; Casanova, Jean-Laurent; Uzel, Gulbu; Tangye, Stuart G.			Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Follicular helper T cells; humoral immunity; primary immunodeficiencies; cytokine signaling	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTOR STAT3; CLASS-SWITCH RECOMBINATION; ANTIBODY-RESPONSES; HUMORAL IMMUNITY; B-CELLS; INTERFERON-GAMMA; IL-21 RECEPTOR; TH17 CELLS; IFN-GAMMA	Background: Follicular helper T (T-FH) cells underpin T cell-dependent humoral immunity and the success of most vaccines. T-FH cells also contribute to human immune disorders, such as autoimmunity, immunodeficiency, and malignancy. Understanding the molecular requirements for the generation and function of T-FH cells will provide strategies for targeting these cells to modulate their behavior in the setting of these immunologic abnormalities. Objective: We sought to determine the signaling pathways and cellular interactions required for the development and function of T-FH cells in human subjects. Methods: Human primary immunodeficiencies (PIDs) resulting from monogenic mutations provide a unique opportunity to assess the requirement for particular molecules in regulating human lymphocyte function. Circulating follicular helper T (cT(FH)) cell subsets, memory B cells, and serum immunoglobulin levels were quantified and functionally assessed in healthy control subjects, as well as in patients with PIDs resulting from mutations in STAT3, STAT1, TYK2, IL21, IL21R, IL10R, IFNGR1/2, IL12RB1, CD40LG, NEMO, ICOS, or BTK. Results: Loss-of-function (LOF) mutations in STAT3, IL10R, CD40LG, NEMO, ICOS, or BTK reduced cT(FH) cell frequencies. STAT3 and IL21/R LOF and STAT1 gain-of-function mutations skewed cT(FH) cell differentiation toward a phenotype characterized by overexpression of IFN-gamma and programmed death 1. IFN-gamma inhibited cT(FH) cell function in vitro and in vivo, as corroborated by hypergammaglobulinemia in patients with IFNGR1/2, STAT1, and IL12RB1 LOF mutations. Conclusion: Specific mutations affect the quantity and quality of cT(FH) cells, highlighting the need to assess T-FH cells in patients by using multiple criteria, including phenotype and function. Furthermore, IFN-gamma functions in vivo to restrain T-FH cell-induced B-cell differentiation. These findings shed new light on T-FH cell biology and the integrated signaling pathways required for their generation, maintenance, and effector function and explain the compromised humoral immunity seen in patients with some PIDs.	[Ma, Cindy S.; Wong, Natalie; Rao, Geetha; Avery, Danielle T.; Torpy, James; Hambridge, Thomas; Deenick, Elissa K.; Pelham, Simon J.; Payne, Kathryn; Phan, Tri Giang; Tangye, Stuart G.] Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW, Australia; [Ma, Cindy S.; Deenick, Elissa K.; Pelham, Simon J.; Phan, Tri Giang; Roscioli, Tony; Tangye, Stuart G.] UNSW Australia, St Vincents Clin Sch, Melbourne, Vic, Australia; [Bustamante, Jacinta; Boisson-Dupuis, Stephanie; Puel, Anne; Picard, Capucine; Casanova, Jean-Laurent] Univ Paris 05, Necker Med Sch, Inst IMAGINE, Lab Human Genet Infect Dis,Necker Branch,INSERMU1, Paris, France; [Bustamante, Jacinta; Picard, Capucine] Necker Hosp Sick Children, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Okada, Satoshi; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima, Japan; [Stoddard, Jennifer L.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Arkwright, Peter D.] Univ Manchester, Royal Manchester Childrens Hosp, Manchester M13 9PL, Lancs, England; [Kilic, Sara Sebnem] Uludag Univ, Fac Med, Dept Pediat Immunol, Gorukle, Bursa, Turkey; [El Baghdadi, Jamila] Mil Hosp Mohamed V, Genet Unit, Rabat, Morocco; [Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 359, Japan; [Minegishi, Yoshiyuki] Univ Tokushima, Inst Genome Res, Div Mol Med, Tokushima, Japan; [Mahdaviani, Seyed Alireza; Mansouri, Davood] Shahid Beheshti Univ Med Sci, NRITLD, Pediat Resp Dis Res Ctr, Tehran, Iran; [Bousfiha, Aziz] King Hasan II Univ, Averroes Univ Hosp, Pediat Infect Dis Dept, Clin Immunol Unit, Casablanca, Morocco; [Blincoe, Annaliesse K.] Starship Childrens Hosp, Auckland, New Zealand; [French, Martyn A.] Royal Perth Hosp, Dept Clin Immunol, Perth, WA, Australia; [French, Martyn A.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Hsu, Peter; Campbell, Dianne E.; Stormon, Michael O.; Wong, Melanie] Childrens Hosp Westmead, Westmead, NSW, Australia; [Adelstein, Stephen] Royal Prince Alfred Hosp, Clin Immunol, Sydney, NSW, Australia; [Smart, Joanne M.] Royal Childrens Hosp Melbourne, Dept Allergy & Immunol, Melbourne, Vic, Australia; [Fulcher, David A.] Univ Sydney, Westmead Hosp, Dept Immunol, Sydney, NSW 2006, Australia; [Cook, Matthew C.] Australian Natl Univ, Sch Med, Canberra, ACT 0200, Australia; [Cook, Matthew C.] Australian Natl Univ, John Curtin Sch Med Res, Acton, ACT, Australia; [Cook, Matthew C.] Canberra Hosp, Dept Immunol, Acton, ACT, Australia; [Stepensky, Polina] Hebrew Univ Jerusalem, Med Ctr, Pediat Hematol Oncol & Bone Marrow Transplantat H, Jerusalem, Israel; [Boztug, Kaan] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria; [Kansu, Aydan] Ankara Univ, Sch Med, Dept Pediat Gastroenterol, TR-06100 Ankara, Turkey; [Ikinciogullari, Aydan] Ankara Univ, Sch Med, Dept Pediat Immunol & Allergy, TR-06100 Ankara, Turkey; [Baumann, Ulrich] Hannover Med Sch, Paediat Pulmonol Allergy & Neonatol, Hannover, Germany; [Beier, Rita] Univ Hosp Essen, Pediat Haematol & Oncol, Essen, Germany; [Roscioli, Tony] Kinghorn Ctr Clin Genom, Darlinghurst, NSW, Australia; [Roscioli, Tony] Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW, Australia; [Ziegler, John B.; Gray, Paul] Sydney Childrens Hosp, Randwick, NSW, Australia; [Ziegler, John B.; Gray, Paul] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Grimbacher, Bodo; Warnatz, Klaus] Univ Freiburg, Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Holland, Steven M.; Uzel, Gulbu] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Hematol & Immunol Unit, Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA	Tangye, SG (reprint author), Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW, Australia.	c.ma@garvan.org.au; s.tangye@garvan.org.au		Arkwright, Peter/0000-0002-7411-5375			Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Kim JR, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-3; Romberg N, 2013, J ALLERGY CLIN IMMUN, V131, P1691, DOI 10.1016/j.jaci.2013.01.004; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; MILLER JFA, 1965, NATURE, V208, P1332, DOI 10.1038/2081332a0; Martini H, 2011, CLIN EXP IMMUNOL, V164, P381, DOI 10.1111/j.1365-2249.2011.04377.x; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; KING CL, 1993, J IMMUNOL, V151, P458; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; KING CL, 1989, P NATL ACAD SCI USA, V86, P10085, DOI 10.1073/pnas.86.24.10085; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Lee CE, 2014, BLOOD, V124, P2964, DOI 10.1182/blood-2014-06-578542; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Haynes NM, 2007, J IMMUNOL, V179, P5099; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Bossaller L, 2006, J IMMUNOL, V177, P4927; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Linterman MA, 2012, IMMUNOL REV, V247, P143, DOI 10.1111/j.1600-065X.2012.01121.x; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Boisson B, 2013, J CLIN INVEST, V123, P4781, DOI 10.1172/JCI71927; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Hussain R, 1999, IMMUNOLOGY, V98, P238; Marinova E, 2006, INT IMMUNOL, V18, P1337, DOI 10.1093/intimm/dxl066; Arroyo-Villa I, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0500-6; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Choi JY, 2015, ARTHRITIS RHEUMATOL, V67, P988, DOI 10.1002/art.39020; Coffman RL, 2006, NAT IMMUNOL, V7, P539, DOI 10.1038/ni0606-539; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Herati RS, 2014, J IMMUNOL, V193, P3528, DOI 10.4049/jimmunol.1302503; Khan AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6997; Le Coz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075319; Ma CS, 2014, CURR OPIN PEDIATR, V26, P720, DOI 10.1097/MOP.0000000000000157; Moens L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00065; Paulos CM, 2010, SCI TRANSL MED, V2, P55, DOI DOI 10.1126/SCITRANSLMED.3000448; Wang CW, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-53	61	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					993	+		10.1016/j.jaci.2015.05.036		15	Allergy; Immunology	Allergy; Immunology	CT7EJ	WOS:000362976300018		
J	Guo, CW; Nakazawa, Y; Woodbine, L; Bjorkman, A; Shimada, M; Fawcett, H; Jia, N; Ohyama, K; Li, TS; Nagayama, Y; Mitsutake, N; Pan-Hammarstrom, Q; Gennery, AR; Lehmann, AR; Jeggo, PA; Ogi, T				Guo, Chaowan; Nakazawa, Yuka; Woodbine, Lisa; Bjorkman, Andrea; Shimada, Mayuko; Fawcett, Heather; Jia, Nan; Ohyama, Kaname; Li, Tao-Sheng; Nagayama, Yuji; Mitsutake, Norisato; Pan-Hammarstrom, Qiang; Gennery, Andrew R.; Lehmann, Alan R.; Jeggo, Penny A.; Ogi, Tomoo			XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						DNA double-strand break repair; nonhomologous end-joining; double-strand break repair deficiency; XRCC4/LIG4; immunodeficiency; microcephaly	DNA-LIGASE-IV; STRAND BREAK REPAIR; CLASS SWITCH RECOMBINATION; END-JOINING PATHWAYS; V(D)J RECOMBINATION; GENOMIC INSTABILITY; EMBRYONIC LETHALITY; PRIMORDIAL DWARFISM; COCKAYNE-SYNDROME; PROTEIN XRCC4	Background: Nonhomologous end-joining (NHEJ) is the major DNA double-strand break (DSB) repair mechanism in human cells. The final rejoining step requires DNA ligase IV (LIG4) together with the partner proteins X-ray repair cross-complementing protein 4 (XRCC4) and XRCC4-like factor. Patients with mutations in genes encoding LIG4, XRCC4-like factor, or the other NHEJ proteins DNA-dependent protein kinase catalytic subunit and Artemis are DSB repair defective and immunodeficient because of the requirement for NHEJ during V(D)J recombination. Objective: We found a patient displaying microcephaly and progressive ataxia but a normal immune response. We sought to determine pathogenic mutations and to describe the molecular pathogenesis of the patient. Methods: We performed next-generation exome sequencing. We evaluated the DSB repair activities and V(D) J recombination capacity of the patient's cells, as well as performing a standard blood immunologic characterization. Results: We identified causal mutations in the XRCC4 gene. The patient's cells are radiosensitive and display the most severe DSB repair defect we have encountered using patient-derived cell lines. In marked contrast, a V(D) J recombination plasmid assay revealed that the patient's cells did not display the junction abnormalities that are characteristic of other NHEJ-defective cell lines. The mutant protein can interact efficiently with LIG4 and functions normally in in vitro assays and when transiently expressed in vivo. However, the mutation makes the protein unstable, and it undergoes proteasome-mediated degradation. Conclusion: Our findings reveal a novel separation of impact phenotype: there is a pronounced DSB repair defect and marked clinical neurological manifestation but no clinical immunodeficiency.	[Guo, Chaowan; Nakazawa, Yuka; Jia, Nan; Ogi, Tomoo] Nagoya Univ, Res Inst Environm Med RIeM, Dept Genet, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Guo, Chaowan; Nakazawa, Yuka; Shimada, Mayuko; Jia, Nan; Ohyama, Kaname; Mitsutake, Norisato; Ogi, Tomoo] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis NRGIC, Nagasaki, Japan; [Guo, Chaowan; Nakazawa, Yuka; Shimada, Mayuko; Jia, Nan; Nagayama, Yuji; Ogi, Tomoo] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Mol Med, Nagasaki, Japan; [Li, Tao-Sheng] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Stem Cell Biol, Nagasaki, Japan; [Mitsutake, Norisato] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki, Japan; [Ohyama, Kaname] Nagasaki Univ, Grad Sch Biomed Sci, Course Pharmaceut Sci, Nagasaki, Japan; [Woodbine, Lisa; Fawcett, Heather; Lehmann, Alan R.; Jeggo, Penny A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Bjorkman, Andrea; Pan-Hammarstrom, Qiang] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Stockholm, Sweden; [Gennery, Andrew R.] Newcastle Univ, Newcastle Upon Tyne Hosp NHS Fdn Trust, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ogi, Tomoo] Natl Inst Genet, Microbial Genet Lab, Genet Strains Res Ctr, Mishima, Shizuoka 411, Japan	Ogi, T (reprint author), Nagoya Univ, Res Inst Environm Med RIeM, Dept Genet, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	p.a.jeggo@sussex.ac.uk; togi@riem.nagoya-u.ac.jp		Ogi, Tomoo/0000-0002-5492-9072; Mitsutake, Norisato/0000-0002-2744-8046			Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Oh S, 2014, DNA REPAIR, V21, P97, DOI 10.1016/j.dnarep.2014.04.015; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Girard PM, 2004, HUM MOL GENET, V13, P2369, DOI 10.1093/hmg/ddh274; Mahaney BL, 2013, BIOCHEM CELL BIOL, V91, P31, DOI 10.1139/bcb-2012-0058; Neilan EG, 2008, ARCH NEUROL-CHICAGO, V65, P1117, DOI 10.1001/archneur.65.8.1117; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Modesti M, 2003, J MOL BIOL, V334, P215, DOI 10.1016/j.jmb.2003.09.031; Enervald E, 2013, J EXP MED, V210, P2503, DOI 10.1084/jem.20130168; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Gigi V, 2014, NUCLEIC ACIDS RES, V42, P6352, DOI 10.1093/nar/gku295; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Andres SN, 2012, NUCLEIC ACIDS RES, V40, P1868, DOI 10.1093/nar/gks022; Stavnezer J, 2010, ADV IMMUNOL, V108, P45, DOI [10.1016/B978-0-12-380995-7.00003-3, 10.1016/S0065-2776(10)08003_X]; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; de Bruin C, 2015, J CLIN ENDOCR METAB, V100, pE789, DOI 10.1210/jc.2015-1098; Radhakrishnan SK, 2014, DNA REPAIR, V17, P2, DOI 10.1016/j.dnarep.2014.01.009; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Riballo E, 2001, J BIOL CHEM, V276, P31124, DOI 10.1074/jbc.M103866200; Woodbine L, 2014, DNA REPAIR, V16, P84, DOI 10.1016/j.dnarep.2014.02.011; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Pan Q, 2001, EUR J IMMUNOL, V31, P3622, DOI 10.1002/1521-4141(200112)31:12<3622::AID-IMMU3622>3.0.CO;2-H; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Ochi T, 2015, SCIENCE, V347, P185, DOI 10.1126/science.1261971; Woodbine L, 2013, J CLIN INVEST, V123, P2969, DOI 10.1172/JCI67349; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Wu Q, 2011, BIOCHEM SOC T, V39, P1387, DOI 10.1042/BST0391387; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604; Du LK, 2012, J EXP MED, V209, P291, DOI 10.1084/jem.20110325; Murray JE, 2014, HUM MUTAT, V35, P76, DOI 10.1002/humu.22461; Windhofer F, 2007, J CELL PHYSIOL, V213, P475, DOI 10.1002/jcp.21120; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Hammel M, 2011, J BIOL CHEM, V286, P32638, DOI 10.1074/jbc.M111.272641; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Rosin N, 2015, HUM MOL GENET, V24, P3708, DOI 10.1093/hmg/ddv115; Bee L, 2015, EMBO MOL MED; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Jia N, 2015, NAT PROTOC, V10, P12, DOI 10.1038/nprot.2014.194; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Murray JE, 2015, AM J HUM GENET, V96, P412, DOI 10.1016/j.ajhg.2015.01.013; Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113	50	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					1007	1017		10.1016/j.jaci.2015.06.007		11	Allergy; Immunology	Allergy; Immunology	CT7EJ	WOS:000362976300019		
J	Mitsui-Sekinaka, K; Imai, K; Sato, H; Tomizawa, D; Kajiwara, M; Nagasawa, M; Morio, T; Nonoyama, S				Mitsui-Sekinaka, Kanako; Imai, Kohsuke; Sato, Hiroki; Tomizawa, Daisuke; Kajiwara, Michiko; Nagasawa, Masayuki; Morio, Tomohiro; Nonoyama, Shigeaki			Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CD40 ligand; hematopoietic stem cell transplantation; Pneumocystis jirovecii; Cryptosporidium parvum; Cryptococcus neoformans; primary immunodeficiency; hyper-IgM syndrome; combined immunodeficiency; class-switch recombination	HYPER-IGM SYNDROME; X-LINKED IMMUNODEFICIENCY; DENDRITIC CELLS; MUTATIONS; GENE; EXPERIENCE; EXPRESSION	Background: The long-term outcome of X-linked hyper-IgM syndrome (XHIM) caused by mutations in CD40LG is poor, and the only curative treatment is hematopoietic stem cell transplantation (HSCT). Objective: We sought to determine the clinical features and factors affecting outcomes in patients with XHIM. Methods: We enrolled and retrospectively analyzed data from 56 Japanese patients with XHIM, including 29 patients who received HSCT. Results: The long-term survival rate was poor in those not undergoing HSCT (overall survival rate at 40 years of age, 28.2%). The overall survival rate of patients undergoing HSCT (n = 29) was significantly higher than that of those not undergoing HSCT (n = 27, P = .0231). Moreover, event-free and disease-free survival rates were significantly greater in patients 5 years old or younger at the time of transplantation (n = 14) than in older patients (n = 15). Conclusion: On the basis of these results, we concluded that HSCT improved the outcomes of patients with XHIM and that an age of 5 years or younger was optimal for the timing of HSCT because persistent infections and severe organ damage were frequently observed in patients older than 6 years.	[Mitsui-Sekinaka, Kanako; Imai, Kohsuke; Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Saitama, Japan; [Sato, Hiroki] Natl Def Med Coll, Dept Publ Hlth, Saitama, Japan; [Imai, Kohsuke; Tomizawa, Daisuke; Nagasawa, Masayuki; Morio, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Kajiwara, Michiko] Tokyo Med & Dent Univ, Hosp Med, Dept Transfus Med, Tokyo, Japan	Imai, K (reprint author), Tokyo Med & Dent Univ, Dept Pediat, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan.	kimai.ped@tmd.ac.jp		Sato, Hiroki/0000-0002-6061-1511; Tomizawa, Daisuke/0000-0003-1520-7007			Notarangelo LD, 1996, IMMUNOL TODAY, V17, P511, DOI 10.1016/0167-5699(96)30059-5; Bhushan A, 2001, IMMUNOL RES, V24, P311, DOI 10.1385/IR:24:3:311; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Jain A, 2011, BLOOD, V118, P3811, DOI 10.1182/blood-2011-04-351254; Seyama K, 1998, BLOOD, V92, P2421; Tomizawa D, 2004, AM J HEMATOL, V76, P33, DOI 10.1002/ajh.20044; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Winkelstein JA, 2003, MEDICINE, V82, P373, DOI 10.1097/01.md.0000100046.06009.b0; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Fan XY, 2012, CLIN IMMUNOL, V143, P152, DOI 10.1016/j.clim.2012.01.014; Hayward AR, 1997, J IMMUNOL, V158, P977; Nonoyama S, 1997, HUM GENET, V99, P624, DOI 10.1007/s004390050417; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330; Tsuji Y, 2007, HAEMATOL-HEMATOL J, V92, P1727, DOI 10.3324/haematol.11531; Gennery AR, 2004, BLOOD, V103, P1152, DOI 10.1182/blood-2003-06-2014; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Hoshino A, 2014, PEDIATR INT, V56, P510, DOI 10.1111/ped.12325	19	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					1018	1024		10.1016/j.jaci.2015.02.020		7	Allergy; Immunology	Allergy; Immunology	CT7EJ	WOS:000362976300020		
J	Sato, S; Utsunomiya, T; Imai, T; Yanagida, N; Asaumi, T; Ogura, K; Koike, Y; Hayashi, N; Okada, Y; Shukuya, A; Ebisawa, M				Sato, Sakura; Utsunomiya, Tomohiro; Imai, Takanori; Yanagida, Noriyuki; Asaumi, Tomoyuki; Ogura, Kiyotake; Koike, Yumi; Hayashi, Noriko; Okada, Yu; Shukuya, Akinori; Ebisawa, Motohiro			Wheat oral immunotherapy for wheat-induced anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							TOLERANCE INDUCTION; CHILDREN		[Sato, Sakura; Utsunomiya, Tomohiro; Imai, Takanori; Ogura, Kiyotake; Koike, Yumi; Hayashi, Noriko; Shukuya, Akinori; Ebisawa, Motohiro] Sagamihara Natl Hosp, Dept Allergy, Clin Res Ctr Allergol & Rheumatol, Sagamihara, Kanagawa, Japan; [Utsunomiya, Tomohiro] Takasaki Natl Hosp, Dept Pediat, Gunma, Japan; [Imai, Takanori] Showa Univ, Dept Pediat, Tokyo, Japan; [Yanagida, Noriyuki; Asaumi, Tomoyuki; Okada, Yu] Sagamihara Natl Hosp, Dept Pediat, Sagamihara, Kanagawa, Japan	Sato, S (reprint author), Sagamihara Natl Hosp, Dept Allergy, Clin Res Ctr Allergol & Rheumatol, Sagamihara, Kanagawa, Japan.	m-ebisawa@sagamihara-hosp.gr.jp					Akiyama H, 2001, ADV FOOD NUTR RES, V62, P140; Jones Stacie M, 2009, J Allergy Clin Immunol, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Vetander M, 2011, PEDIAT ALLERG IMM-UK, V22, P369, DOI 10.1111/j.1399-3038.2010.01115.x; Longo G, 2008, J ALLERGY CLIN IMMUN, V121, P343, DOI 10.1016/j.jaci.2007.10.029; Sato S, 2014, INT ARCH ALLERGY IMM, V164, P1, DOI 10.1159/000361025; Itoh Naoka, 2010, Allergology International, V59, P43, DOI 10.2332/allergolint.09-OA-0107; Jones SM, 2009, J ALLERGY CLIN IMMUN, V124, pe1; del Rio PR, 2014, J INVEST ALLERG CLIN, V24, P240; Takahashi M, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-3	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					1131	+		10.1016/j.jaci.2015.07.019		11	Allergy; Immunology	Allergy; Immunology	CT7EJ	WOS:000362976300046		
J	Xhafa, F; Chen, XF; Barolli, L				Xhafa, Fatos; Chen, Xiaofeng; Barolli, Leonard			Editorial preface for the special issue "Advances in security, privacy and trust technologies"	JOURNAL OF AMBIENT INTELLIGENCE AND HUMANIZED COMPUTING			English	Editorial Material									[Xhafa, Fatos] Univ Politecn Cataluna, Barcelona, Spain; [Chen, Xiaofeng] Xidian Univ, Xian, Peoples R China; [Barolli, Leonard] Fukuoka Inst Technol, Fukuoka, Japan	Xhafa, F (reprint author), Univ Politecn Cataluna, Barcelona, Spain.	fatos@cs.upc.edu; xfchen@xidian.edu.cn; barolli@fit.ac.jp						0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-5137	1868-5145		J AMB INTEL HUM COMP	J. Ambient Intell. Humaniz. Comput.	OCT	2015	6	5			SI		531	532		10.1007/s12652-015-0324-5		2	Computer Science, Artificial Intelligence; Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CT8CF	WOS:000363041900001		
J	Elmazi, D; Kulla, E; Oda, T; Spaho, E; Sakamoto, S; Barolli, L				Elmazi, Donald; Kulla, Elis; Oda, Tesuya; Spaho, Evjola; Sakamoto, Shinji; Barolli, Leonard			A comparison study of two fuzzy-based systems for selection of actor node in wireless sensor actor networks	JOURNAL OF AMBIENT INTELLIGENCE AND HUMANIZED COMPUTING			English	Article						Wireless networks; WSAN; Fuzzy logic; Actor mobility; Intelligent systems	LOGIC	In wireless sensor and actor networks, sensors and actors collaborate to get the information about the physical environment and perform appropriate actions. In order to provide effective sensing and acting, a distributed local coordination mechanism is necessary among sensors and actors. In this work, we implement and compare two Fuzzy-Based Systems (FBS1 and FBS2) for actor selection problem. These systems decide whether the actor will be selected for the required job or not, based on data supplied by sensors and actual actor condition. For FBS1, we use three input parameters: job type (JT), remaining energy of actor (REA) and distance of actor from job place (DAJP). The output parameter is actor selection decision (ASD). The simulation results show that the FBS1 decides the actor selection in order to have short delays, low energy consumption, and proper task assignment. For FBS2, we consider four input parameters: JT, REA, DAJP and actor node speed (ANS). The output parameter is the ASD. Comparing complexity of FBS1 and FBS2, the FBS2 is more complex than FBS1. However, it also considers mobility of actor nodes. Thus, the FBS2 is more flexible system than FBS1.	[Elmazi, Donald; Spaho, Evjola] Polytech Univ Tirana, Tirana, Albania; [Kulla, Elis] Okayama Univ Sci, Kita Ku, Okayama 7000005, Japan; [Oda, Tesuya; Sakamoto, Shinji; Barolli, Leonard] FIT, Higashi Ku, Fukuoka 8110295, Japan	Sakamoto, S (reprint author), FIT, Higashi Ku, 3-30-1 Wajiro Higashi, Fukuoka 8110295, Japan.	donald.elmazi@gmail.com; kulla@ice.ous.ac.jp; oda.tetsuya.fit@gmail.com; evjolaspaho@hotmail.com; shinji.t.sakamoto@gmail.com; barolli@fit.ac.jp					Akbas M, 2010, IEEE 35 C LOC COMP N, P806; Akkaya K, 2006, IEEE P VEH TECHN C S, P1, DOI 10.1109/VTCF.2006.544; Akyildiz I. F., 2004, AD HOC NETW, V2, P351, DOI DOI 10.1016/J.ADH0C.2004.04.003]; Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Haider N, 2013, 2013 IEEE MALAYSIA INTERNATIONAL CONFERENCE ON COMMUNICATIONS (MICC), P490, DOI 10.1109/MICC.2013.6805879; Gungor VC, 2008, IEEE ACM T NETWORK, V16, P359, DOI 10.1109/TNET.2007.900413; ZADEH LA, 1994, COMMUN ACM, V37, P77, DOI 10.1145/175247.175255; Nakayama H, 2011, IEEE T AUTOMAT CONTR, V56, P2381, DOI 10.1109/TAC.2011.2163872; Selvaradjou K, 2010, IET COMMUN, V4, P102, DOI 10.1049/iet-com.2008.0745; Akbas MI, 2011, C LOCAL COMPUT NETW, P563, DOI 10.1109/LCN.2011.6115518; Chen CL, 2013, COMPUT SCI INF SYST, V10, P589, DOI 10.2298/CSIS120907025C; Abbasi AA, 2009, IEEE T PARALL DISTR, V20, P1366, DOI 10.1109/TPDS.2008.246; Esposito C, 2015, IEEE T COMPUT THEORY, DOI [10.1109/TC.2015.2389952, DOI 10.1109/TC.2015.2389952]; Kakarla J, 2013, IEEE INT C ADV NETW, P1; Li X, 2011, IEEE 8 INT C MOB ADH, P351; Melodia T, 2007, IEEE T MOBILE COMPUT, V6, P1126; MENDEL JM, 1995, P IEEE, V83, P345, DOI 10.1109/5.364485	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-5137	1868-5145		J AMB INTEL HUM COMP	J. Ambient Intell. Humaniz. Comput.	OCT	2015	6	5			SI		635	645		10.1007/s12652-015-0279-6		11	Computer Science, Artificial Intelligence; Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CT8CF	WOS:000363041900013		
J	Shibata, N; Toraya, T				Shibata, Naoki; Toraya, Tetsuo			Molecular architectures and functions of radical enzymes and their (re)activating proteins	JOURNAL OF BIOCHEMISTRY			English	Review						adenosylcobalamin; protein radical; radical enzyme; (re)activase; S-adenosylmethionine	PYRUVATE FORMATE-LYASE; X-RAY-STRUCTURE; B-12-DEPENDENT DIOL DEHYDRATASE; IB RIBONUCLEOTIDE REDUCTASE; ELECTRON-PARAMAGNETIC-RESONANCE; ETHANOLAMINE AMMONIA-LYASE; SULFUR INSERTION REACTIONS; S-ADENOSYLMETHIONINE SAM; THIOETHER BOND FORMATION; SUBSTRATE-FREE FORM	Certain proteins utilize the high reactivity of radicals for catalysing chemically challenging reactions. These proteins contain or form a radical and therefore named 'radical enzymes'. Radicals are introduced by enzymes themselves or by (re)activating proteins called (re)activases. The X-ray structures of radical enzymes and their (re)activases revealed some structural features of these molecular apparatuses which solved common enigmas of radical enzymes-i.e. how the enzymes form or introduce radicals at the active sites, how they use the high reactivity of radicals for catalysis, how they suppress undesired side reactions of highly reactive radicals and how they are (re)activated when inactivated by extinction of radicals. This review highlights molecular architectures of radical B-12 enzymes, radical SAM enzymes, tyrosyl radical enzymes, glycyl radical enzymes and their (re)activating proteins that support their functions. For generalization, comparisons of the recently reported structures of radical enzymes with those of canonical radical enzymes are summarized here.	[Shibata, Naoki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Toraya, Tetsuo] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Kita Ku, Okayama 7008530, Japan	Toraya, T (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Kita Ku, Okayama 7008530, Japan.	toraya@cc.okayama-u.ac.jp			Priority Areas 753 and 513 from Japan Society for Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; Natural Sciences Research from Asahi Glass Foundation, Tokyo, Japan;  [13480195];  [17370038]	Our studies of radical B<INF>12</INF> enzymes were supported in part by Grants-in-Aid for Scientific Research [(B) 13480195, (B) 17370038, and Priority Areas 753 and 513 from the Japan Society for Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a Grant-in-Aid for Natural Sciences Research from the Asahi Glass Foundation, Tokyo, Japan to T.T.	Allen KD, 2014, BBA-PROTEINS PROTEOM, V1844, P2135, DOI 10.1016/j.bbapap.2014.09.009; Ronning DR, 2010, PROTEIN SCI, V19, P2498, DOI 10.1002/pro.524; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Gruber K, 2001, ANGEW CHEM INT EDIT, V40, P3377, DOI 10.1002/1521-3773(20010917)40:18<3377::AID-ANIE3377>3.0.CO;2-8; Kamachi T, 2004, J AM CHEM SOC, V126, P16207, DOI 10.1021/ja045572o; Liao DI, 2003, STRUCTURE, V11, P109, DOI 10.1016/S0969-2126(02)00935-8; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Toraya T, 2000, CELL MOL LIFE SCI, V57, P106, DOI 10.1007/s000180050502; Kwak Y, 2013, J AM CHEM SOC, V135, P17573, DOI 10.1021/ja409510d; Lehtio L, 2006, J MOL BIOL, V357, P221, DOI 10.1016/j.jmb.2005.12.049; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Toraya T, 2010, BIOCHEMISTRY-US, V49, P7210, DOI 10.1021/bi100561m; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Yamanishi M, 2012, FEBS J, V279, P793, DOI 10.1111/j.1742-4658.2012.08470.x; NORDLUND P, 1992, FEBS LETT, V307, P257, DOI 10.1016/0014-5793(92)80690-I; Whittaker JW, 2003, CHEM REV, V103, P2347, DOI 10.1021/cr020425z; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; PARAST CV, 1995, BIOCHEMISTRY-US, V34, P5712, DOI 10.1021/bi00017a002; Nicolet Y, 2014, ANGEW CHEM INT EDIT, V53, P11840, DOI 10.1002/anie.201407320; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Arragain S, 2010, J BIOL CHEM, V285, P5792, DOI 10.1074/jbc.M109.065516; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; Nicolet Y, 2009, P NATL ACAD SCI USA, V106, P14867, DOI 10.1073/pnas.0904385106; Tamarit J, 2000, J BIOL CHEM, V275, P15669, DOI 10.1074/jbc.275.21.15669; Baik MH, 2003, CHEM REV, V103, P2385, DOI 10.1021/cr950244f; Mori K, 2010, FEBS J, V277, P4931, DOI 10.1111/j.1742-4658.2010.07898.x; Masuda J, 2000, STRUCT FOLD DES, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Banerjee R, 2003, CHEM REV, V103, P2081, DOI 10.1021/cr010216z; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; LING JS, 1994, J BIOL CHEM, V269, P5595; Lobo SAL, 2014, BBA-PROTEINS PROTEOM, V1844, P1238, DOI 10.1016/j.bbapap.2014.03.016; Kamachi T, 2011, J INORG BIOCHEM, V105, P850, DOI 10.1016/j.jinorgbio.2011.03.013; Jensen KP, 2005, J AM CHEM SOC, V127, P9117, DOI 10.1021/ja050744i; Huang W, 2012, J AM CHEM SOC, V134, P8831, DOI 10.1021/ja211098r; Kudo F, 2014, J AM CHEM SOC, V136, P13909, DOI 10.1021/ja507759f; Zhang WH, 2001, BIOCHEMISTRY-US, V40, P4123, DOI 10.1021/bi002589k; WONG KK, 1993, BIOCHEMISTRY-US, V32, P14102, DOI 10.1021/bi00214a005; Reitzer R, 1999, STRUCT FOLD DES, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Shibata N, 2005, STRUCTURE, V13, P1745, DOI 10.1016/j.str.2005.08.011; Suzuki Y, 2007, J MOL BIOL, V372, P1204, DOI 10.1016/j.jmb.2007.07.024; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; Dowling DP, 2014, NAT CHEM BIOL, V10, P106, DOI 10.1038/nchembio.1426; Mori K, 2013, BIOCHEMISTRY-US, V52, P8677, DOI 10.1021/bi401290j; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Marsh ENG, 2012, BBA-PROTEINS PROTEOM, V1824, P1154, DOI 10.1016/j.bbapap.2012.03.012; Shibata N, 1999, STRUCT FOLD DES, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; Goto-Ito S, 2007, ACTA CRYSTALLOGR D, V63, P1059, DOI 10.1107/S0907444907040668; Wang SC, 2007, BIOCHEMISTRY-US, V46, P12889, DOI 10.1021/bi701745h; Boal AK, 2012, BIOCHEMISTRY-US, V51, P3861, DOI 10.1021/bi201925t; Kamachi T, 2011, INORG CHEM, V50, P2944, DOI 10.1021/ic102352b; BOOKER S, 1994, BIOCHEMISTRY-US, V33, P12676, DOI 10.1021/bi00208a019; Buckel W, 1996, CHEM SOC REV, V25, P329, DOI 10.1039/cs9962500329; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI 10.1080/10409230701829169 ; Mahanta N, 2013, J AM CHEM SOC, V135, P15318, DOI 10.1021/ja408594p; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Martins BM, 2011, J AM CHEM SOC, V133, P14666, DOI 10.1021/ja203344x; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Shibata N, 2011, BIOCHEMISTRY-US, V50, P591, DOI 10.1021/bi101696h; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Liao DI, 2003, J INORG BIOCHEM, V93, P84, DOI 10.1016/S0162-0134(02)00523-8; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Shibata N, 2003, J BIOL CHEM, V278, P22717, DOI 10.1074/jbc.M301513200; Fontecave M, 2003, CHEM REV, V103, P2149, DOI 10.1021/cr020427j; Selvaraj B, 2013, J BIOL INORG CHEM, V18, P633, DOI 10.1007/s00775-013-1008-2; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P15949, DOI 10.1073/pnas.1312228110; Dowling DP, 2012, ANNU REV BIOPHYS, V41, P403, DOI 10.1146/annurev-biophys-050511-102225; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1016/S0168-6445(05)80006-3; Tollinger M, 1998, STRUCTURE, V6, P1021, DOI 10.1016/S0969-2126(98)00103-8; MOSS M, 1987, J BIOL CHEM, V262, P14859; Makhlynets O, 2014, J BIOL CHEM, V289, P6259, DOI 10.1074/jbc.M113.533554; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; HALPERN J, 1984, J AM CHEM SOC, V106, P8317, DOI 10.1021/ja00338a065; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; KESSLER D, 1992, J BIOL CHEM, V267, P18073; Toraya T, 2014, ARCH BIOCHEM BIOPHYS, V544, P40, DOI 10.1016/j.abb.2013.11.002; Benjdia A, 2012, NUCLEIC ACIDS RES, V40, P9308, DOI 10.1093/nar/gks603; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032; Quitterer F, 2012, ANGEW CHEM INT EDIT, V51, P1339, DOI 10.1002/anie.201106765; Yamanishi M, 2002, EUR J BIOCHEM, V269, P4484, DOI 10.1046/j.1432-1033.2002.03151.x; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; KUNG HF, 1971, J BIOL CHEM, V246, P3378; Larsson KM, 2010, ACS CHEM BIOL, V5, P933, DOI 10.1021/cb1000845; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/nchembio.1091, 10.1038/NCHEMBIO.1091]; Sawers G, 1998, MOL MICROBIOL, V29, P945, DOI 10.1046/j.1365-2958.1998.00941.x; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Wolthers KR, 2010, J BIOL CHEM, V285, P13942, DOI 10.1074/jbc.M109.068908; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Coquille S, 2013, J STRUCT BIOL, V184, P438, DOI 10.1016/j.jsb.2013.10.005; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; FREY M, 1994, J BIOL CHEM, V269, P12432; Kurteva-Yaneva N, 2015, J BIOL CHEM, V290, P9727, DOI 10.1074/jbc.M115.645689; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Kajiura H, 2001, J BIOL CHEM, V276, P36514, DOI 10.1074/jbc.M105182200; BABIOR B, 1969, BIOCHEM BIOPH RES CO, V34, P441, DOI 10.1016/0006-291X(69)90401-X; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Lieder KW, 1998, BIOCHEMISTRY-US, V37, P2578, DOI 10.1021/bi972417w; Voegtli WC, 2001, P NATL ACAD SCI USA, V98, P10073, DOI 10.1073/pnas.181336398; FREY PA, 1993, FASEB J, V7, P662; Buckel W, 2004, CURR OPIN CHEM BIOL, V8, P462, DOI 10.1016/j.cvpa.2004.07.001; Leppanen VM, 1999, STRUCT FOLD DES, V7, P733, DOI 10.1016/S0969-2126(99)80098-7; Wei YF, 2014, P NATL ACAD SCI USA, V111, pE3756, DOI 10.1073/pnas.1414396111; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Shibata N, 2010, J BIOL CHEM, V285, P26484, DOI 10.1074/jbc.M110.125112; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Shibata N, 2002, BIOCHEMISTRY-US, V41, P12607, DOI 10.1021/bi026104z; Uppsten M, 2004, FEBS LETT, V569, P117, DOI 10.1016/j.febslet.2004.05.059; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Craciun S, 2014, ACS CHEM BIOL, V9, P1408, DOI 10.1021/cb500113p; Toraya T, 1999, J BIOL CHEM, V274, P3372, DOI 10.1074/jbc.274.6.3372; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; BALLINGER MD, 1992, BIOCHEMISTRY-US, V31, P10782, DOI 10.1021/bi00159a020; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138; Mishra V, 2012, BIOCHEMISTRY-US, V51, P9763, DOI 10.1021/bi301221k; Mori K, 2004, J BACTERIOL, V186, P6845, DOI 10.1128/JB.186.20.6845-6854.2004; RETEY J, 1990, ANGEW CHEM INT EDIT, V29, P355, DOI 10.1002/anie.199003551; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Banerjee R., 1999, CHEM BIOCH B12; Blakley R. L., 1982, B12, VII, P381; Dinis P, 2015, P NATL ACAD SCI USA, V112, P1362, DOI 10.1073/pnas.1417252112; EHRENBER.A, 1972, J BIOL CHEM, V247, P3485; Feng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068545; Fenwick MK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7480; Fontecave M., 1992, ADV ENZYMOL RELAT AR, V65, P147; Frey PA, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P501; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Groves J. T., 2005, CYTOCHROME P450 STRU, P1, DOI DOI 10.1007/0-387-27447-2_1; Hammerstad M, 2014, ACS CHEM BIOL, V9, P526, DOI 10.1021/cb400757h; Harmer JE, 2014, BIOCHEM J, V464, P123, DOI 10.1042/BJ20140895; KNAPPE J, 1984, P NATL ACAD SCI-BIOL, V81, P1332, DOI 10.1073/pnas.81.5.1332; Kuhner M., 2014, ARCHAEA, V2014; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Nicolet Y, 2015, CHEMBIOCHEM, V16, P397, DOI 10.1002/cbic.201402661; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; SAHLIN M, 1989, BIOCHEMISTRY-US, V28, P2618, DOI 10.1021/bi00432a039; Sigel H., 1994, METAL IONS BIOL SYST, V30; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674	158	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	OCT	2015	158	4					271	292		10.1093/jb/mvv078		22	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7OV	WOS:000363005300001		
J	Komori, H; Higuchi, Y				Komori, Hirofumi; Higuchi, Yoshiki			Structural insights into the O-2 reduction mechanism of multicopper oxidase	JOURNAL OF BIOCHEMISTRY			English	Review						laccase; multicopper oxidase; oxygen reduction; three-dimensional structure; X-ray crystallography	X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; MELANOCARPUS-ALBOMYCES; ANGSTROM RESOLUTION; SMALL LACCASE; BLUE LACCASE; COPPER; STREPTOMYCES; SITE; EVOLUTION	Multicopper oxidases are ubiquitous enzymes that catalyse the oxidation of various substrates via the reduction of O-2 to H2O. The enzymes contain a common active centre consisting of four copper ions. The key component for O-2 reduction is the trinuclear copper centre comprising one type II and a pair of type III copper ions. Although the crystal structures of many multicopper oxidases have been determined by X-ray crystallography, the geometric parameters in the trinuclear copper centre are different for each study. Recent studies have revealed that the redox state of copper ions is altered by X-ray irradiation. The reported crystal structures may represent mixtures of different stages of the catalytic reactions. In this review, we discuss recent findings related to the structure of the active site in multicopper oxidases.	[Komori, Hirofumi] Kagawa Univ, Fac Educ, Takamatsu, Kagawa 7608522, Japan; [Komori, Hirofumi; Higuchi, Yoshiki] RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan	Komori, H (reprint author), Kagawa Univ, Fac Educ, 1-1 Saiwai, Takamatsu, Kagawa 7608522, Japan.	komori@ed.kagawa-u.ac.jp; hig@sci.u-hyogo.ac.jp			Kagawa University Young Scientists	This research was supported by the fund for Kagawa University Young Scientists 2013.	Majumdar S, 2014, BIOCHEMISTRY-US, V53, P4047, DOI 10.1021/bi500285t; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Blakeley MP, 2015, IUCRJ, V2, P464, DOI 10.1107/S2052252515011239; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; De la Mora E, 2012, ACTA CRYSTALLOGR D, V68, P564, DOI 10.1107/S0907444912005343; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Ferraroni M, 2012, J INORG BIOCHEM, V111, P203, DOI 10.1016/j.jinorgbio.2012.01.011; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Skalova T, 2009, J MOL BIOL, V385, P1165, DOI 10.1016/j.jmb.2008.11.024; GUSS JM, 1983, J MOL BIOL, V169, P521; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Komori H, 2009, FEBS LETT, V583, P1189, DOI 10.1016/j.febslet.2009.03.008; MESSERSCHMIDT A, 1989, J MOL BIOL, V206, P513, DOI 10.1016/0022-2836(89)90498-1; Hakulinen N, 2006, BIOCHEM BIOPH RES CO, V350, P929, DOI 10.1016/j.bbrc.2006.09.144; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Augustine AJ, 2010, J AM CHEM SOC, V132, P6057, DOI 10.1021/ja909143d; Polyakov KM, 2009, ACTA CRYSTALLOGR D, V65, P611, DOI 10.1107/S0907444909011950; Komori H, 2014, ACTA CRYSTALLOGR D, V70, P772, DOI 10.1107/S1399004713033051; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; ADMAN ET, 1978, J MOL BIOL, V123, P35, DOI 10.1016/0022-2836(78)90375-3; Lawton TJ, 2009, J BIOL CHEM, V284, P10174, DOI 10.1074/jbc.M900179200; Ferraroni M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-60; Gunne M, 2014, FEBS J, V281, P4307, DOI 10.1111/febs.12755; Komori Hirofumi, 2010, Biomol Concepts, V1, P31, DOI 10.1515/bmc.2010.004; Mizutani K, 2010, ACTA CRYSTALLOGR F, V66, P765, DOI 10.1107/S1744309110018828; Smith AW, 2006, BIOCHEMISTRY-US, V45, P4378, DOI 10.1021/bi0525526	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	OCT	2015	158	4					293	298		10.1093/jb/mvv079		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7OV	WOS:000363005300002		
J	Mizutani, N; Inoue, M; Omori, Y; Ito, H; Tamiya-Koizumi, K; Takagi, A; Kojima, T; Nakamura, M; Iwaki, S; Nakatochi, M; Suzuki, M; Nozawa, Y; Murate, T				Mizutani, Naoki; Inoue, Minami; Omori, Yukari; Ito, Hiromi; Tamiya-Koizumi, Keiko; Takagi, Akira; Kojima, Tetsuhito; Nakamura, Mitsuhiro; Iwaki, Soichiro; Nakatochi, Masahiro; Suzuki, Motoshi; Nozawa, Yoshinori; Murate, Takashi			Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP	JOURNAL OF BIOCHEMISTRY			English	Article						acid ceramidase; androgen receptor; prostate cancer cell line; protein degradation; ubiquitin-specific protease 2	P21-DEPENDENT MECHANISM; APOPTOSIS; SYNTHASE; RESISTANCE; UBIQUITIN; CHEMOTHERAPY; THERAPY; ENZYME; SKP2; SPHINGOMYELINASE	Acid ceramidase (ACDase) metabolizes ceramide to sphingosine, leading to sphingosine 1-phosphate production. Reportedly, ACDase has been upregulated in prostate cancer. However, its regulatory mechanism remains unclear. LNCaP (androgen-sensitive prostate cancer cell line) but not PC3 and DU-145, (androgen-unresponsive cell lines) exhibited the highest ACDase protein. Among three cell lines, ASAH1 mRNA level was not correlated with ACDase protein expression, and the 5'-promoter activity did not show androgen dependency, suggesting the post-transcriptional regulation of ACDase in LNCaP cells. Based on these results, LNCaP was analysed further. Casodex, androgen receptor antagonist, and charcoal-stripped FCS (CS-FCS) decreased ACDase protein and activity, whereas dihydrotestosterone in CS-FCS culture increased ACDase protein and enzyme activity. MG132, a proteasome inhibitor, prevented the decrease of ACDase protein when cultured in CS-FCS, suggesting the involvement of ubiquitin/proteasome system. Reportedly, USP2, a deubiquitinase, plays an important role in LNCaP cells. USP2 siRNA decreased ACDase protein, whereas USP2 overexpression increased ACDase protein of LNCaP cells. However, SKP2, an ubiquitin E3 ligase known to be active in prostate cancer, did not affect androgen-dependent ACDase expression in LNCaP cells. Thus, ACDase regulation by androgen in androgen-sensitive LNCaP cells is mainly due to its prolonged protein half-life by androgen-stimulated USP2 expression.	[Mizutani, Naoki; Inoue, Minami; Omori, Yukari; Ito, Hiromi; Tamiya-Koizumi, Keiko; Takagi, Akira; Kojima, Tetsuhito; Murate, Takashi] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4618673, Japan; [Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Dept Drug Informat, Gifu 5011196, Japan; [Iwaki, Soichiro] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pathophysiol & Therapeut, Nagoya, Aichi 4678603, Japan; [Nakatochi, Masahiro] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Bioinformat Sect, Nagoya, Aichi 4668550, Japan; [Suzuki, Motoshi] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Nagoya, Aichi 4668560, Japan; [Nozawa, Yoshinori] Tokai Gakuin Univ, Dept Food & Hlth Sci, Kakamigahara 5048511, Japan	Murate, T (reprint author), Chubu Univ, Coll Life & Hlth Sci, Matumoto Cho 1200, Kasugai, Aichi 4878501, Japan.	murate@met.nagoya-u.ac.jp	Nakatochi, Masahiro/Q-1247-2015	Nakatochi, Masahiro/0000-0002-1838-4837	Ministry of Education, Culture, Sports, Science and Technology [23590667]; Medical Science Promotion Fund	Basic Research C from Ministry of Education, Culture, Sports, Science and Technology, Grant No. 23590667, and Medical Science Promotion Fund.	Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Wang XZ, 1999, CANCER RES, V59, P5842; Ito H, 2011, BBA-MOL CELL BIOL L, V1811, P119, DOI 10.1016/j.bbalip.2010.12.005; Norris JS, 2006, CANCER GENE THER, V13, P1045, DOI 10.1038/sj.cgt.7700965; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Jiang JT, 2012, PROSTATE, V72, P225, DOI 10.1002/pros.21430; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Lucki NC, 2011, J BIOL CHEM, V286, P19399, DOI 10.1074/jbc.M110.195826; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Lashinger LM, 2005, CANCER RES, V65, P4902, DOI 10.1158/0008-5472.CAN-04-3701; van Duijn PW, 2006, PROSTATE, V66, P749, DOI 10.1002/pros.20398; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Eto M, 2006, INT J UROL, V13, P148, DOI 10.1111/j.1442-2042.2006.01249.x; Selzner M, 2001, CANCER RES, V61, P1233; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Canfield SE, 2006, MOL CANCER THER, V5, P2043, DOI 10.1158/1535-7163.MCT-05-0437; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Migita T, 2009, J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Eto M, 2003, PROSTATE, V57, P66, DOI 10.1002/pros.10275; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Shi Y, 2011, J BIOL CHEM, V286, P38960, DOI 10.1074/jbc.M111.231498; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Alayoubi AM, 2013, EMBO MOL MED, V5, P827, DOI 10.1002/emmm.201202301; MOMOI T, 1982, BIOCHEM J, V205, P419; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Singh S, 2002, J CLIN MICROBIOL, V40, P2823, DOI 10.1128/JCM.40.8.2823-2827.2002; Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Ito H, 2012, J BIOCHEM, V151, P599, DOI 10.1093/jb/mvs037; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Rossi S, 2003, MOL CANCER RES, V1, P707; Hsieh HY, 2012, BRIT J PHARMACOL, V166, P2095, DOI 10.1111/j.1476-5381.2012.01921.x; VANSTEENBRUGGE GJ, 1989, UROL RES, V17, P71; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Tanaka K, 2012, J BIOCHEM, V151, P611, DOI 10.1093/jb/mvs033; Haimerl F, 2009, J BIOL CHEM, V284, P495, DOI 10.1074/jbc.M803533200; Beckham TH, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.14; COFFEY DS, 1993, CANCER, V71, P880, DOI 10.1002/1097-0142(19930201)71:3+<880::AID-CNCR2820711403>3.0.CO;2-6; Reiner T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056234	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	OCT	2015	158	4					309	319		10.1093/jb/mvv039		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7OV	WOS:000363005300004		
J	Morita, M; Sekine, A; Urano, Y; Nishimura, T; Takabe, W; Arai, H; Hamakubo, T; Kodama, T; Noguchi, N				Morita, Mayuko; Sekine, Azusa; Urano, Yasuomi; Nishimura, Taki; Takabe, Wakako; Arai, Hiroyuki; Hamakubo, Takao; Kodama, Tatsuhiko; Noguchi, Noriko			Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells	JOURNAL OF BIOCHEMISTRY			English	Article						cholesterol; cytokine; 25-hydroxycholesterol; lysophosphatidylcholine; SREBP	STEROL-REGULATORY-ELEMENT; LOW-DENSITY-LIPOPROTEIN; ENDOPLASMIC-RETICULUM; OXIDATIVE MODIFICATION; PARAOXONASE-1 PON1; BINDING PROTEINS; ASSOCIATION; SCAP; 25-HYDROXYCHOLESTEROL; 7-KETOCHOLESTEROL	Lysophosphatidylcholine (LPC) and oxysterols which are major components in oxidized low-density lipoprotein have been shown to possess an opposite effect on the expression of sterol regulatory element-binding protein-2 (SREBP-2) target genes in endothelial cells. In this study, we aimed at elucidating the mechanisms of activation of SREBP-2 by LPC and evaluating the effects of LPC and 25-hydroxycholesterol (25-HC) on the release of inflammatory cytokines. Human umbilical vein endothelial cells were treated with LPC or oxysterols including 25-HC. LPC activated SREBP-2 within 15 min, resulting in induction of expression of SREBP-2 target genes which were involved in intracellular cholesterol homeostasis. The rapid activation of SREBP-2 was caused by enhanced efflux of intracellular cholesterol, which was evaluated using C-14-acetate. The LPC-induced activation of SREBP-2 was inhibited by addition of 25-HC. In contrast, both LPC and 25-HC increased release of interleukin-6 (IL-6) and IL-8, respectively and additively. In conclusion, LPC activated SREBP-2 via enhancement of cholesterol efflux, which was suppressed by 25-HC. The release of inflammatory cytokines such as IL-6 and IL-8 in endothelial cells was SREBP-2-independent. LPC and 25-HC may act competitively in cholesterol homeostasis but additively in inflammatory cytokine release.	[Morita, Mayuko] Kyoto Prefectural Univ Med, Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Sekine, Azusa; Hamakubo, Takao; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1530061, Japan; [Urano, Yasuomi; Takabe, Wakako; Noguchi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Kyoto 6100321, Japan; [Nishimura, Taki; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1138655, Japan	Morita, M (reprint author), Kyoto Prefectural Univ Med, Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan.	nnoguchi@mail.doshisha.ac.jp			Special Coordination Fund for Promoting Science and Technology; New Energy and Industrial Technology Development Organization; National Institute of Biomedical Innovation of Japan	This work was supported by the Special Coordination Fund for Promoting Science and Technology and by grants from New Energy and Industrial Technology Development Organization and from National Institute of Biomedical Innovation of Japan.	Gharavi NM, 2006, CIRC RES, V98, P768, DOI 10.1161/01.RES.0000215343.89308.93; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Field FJ, 2001, J LIPID RES, V42, P1687; Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; Yeh M, 2004, CIRC RES, V95, P780, DOI 10.1161/01.RES.0000146030.53089.18; Noguchi N, 2008, J CLIN BIOCHEM NUTR, V43, P131, DOI 10.3164/jcbn.2008068; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Rosenblat M, 2005, ATHEROSCLEROSIS, V179, P69, DOI 10.1016/j.atherosclerosis.2004.10.028; STEIN O, 1979, BIOCHIM BIOPHYS ACTA, V574, P495, DOI 10.1016/0005-2760(79)90246-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Hayden JM, 2002, J LIPID RES, V43, P26; SALGO MG, 1992, BIOCHIM BIOPHYS ACTA, V1127, P131, DOI 10.1016/0005-2760(92)90268-Z; Ishimoto K, 2010, BIOCHEM J, V429, P347, DOI 10.1042/BJ20091511; Hou M, 2007, CELL BIOCHEM FUNCT, V25, P33, DOI 10.1027/cbf.1374; Nishimura T, 2005, GENES CELLS, V10, P793, DOI 10.1111/j.1365-2443.2005.00879.x; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; SAKAI M, 1994, J BIOL CHEM, V269, P31430; Son Y, 2012, J CARDIOVASC PHARM, V60, P199, DOI 10.1097/FJC.0b013e31825c3ddc; Qiu GS, 2009, ARTERIOSCL THROM VAS, V29, P84, DOI 10.1161/ATVBAHA.108.176487; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; RAMSAMMY LS, 1983, CHEM PHYS LIPIDS, V32, P83, DOI 10.1016/0009-3084(83)90044-0; RAND RP, 1975, CAN J BIOCHEM CELL B, V53, P189; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Hua XX, 1996, J BIOL CHEM, V271, P10379; Kostopoulou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035753; NOGUCHI N, 1993, BIOCHIM BIOPHYS ACTA, V1168, P348; STEINBERG D, 1989, NEW ENGL J MED, V320, P915	34	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	OCT	2015	158	4					331	338		10.1093/jb/mvv044		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7OV	WOS:000363005300006		
J	Fujiwara, M; Nagatomo, A; Tsuda, M; Obata, S; Sakuma, T; Yamamoto, T; Suzuki, ST				Fujiwara, Miwako; Nagatomo, Azusa; Tsuda, Megumi; Obata, Shuichi; Sakuma, Tetsushi; Yamamoto, Takashi; Suzuki, Shintaro T.			Desmocollin-2 alone forms functional desmosomal plaques, with the plaque formation requiring the juxtamembrane region and plakophilins	JOURNAL OF BIOCHEMISTRY			English	Article						Cas9; CRISPR; desmocollin-2; desmo some; DLD-1 cells; juxtamembrane domain; knockout; plakophilin	PLAKOGLOBIN BINDING; CYTOPLASMIC DOMAIN; E-CADHERIN; ADHESION; DISEASE; DESMOPLAKIN; CELLS; INTERNALIZATION; IDENTIFICATION; MORPHOGENESIS	The role of the juxtamembrane region of the desmocollin-2 cytoplasmic domain in desmosome formation was investigated by using gene knockout and reconstitution experiments. When a deletion construct of the desmocollin-2 juxtamembrane region was expressed in HaCaT cells, the mutant protein became localized linearly at the cell cell boundary, suggesting the involvement of this region in desmosomal plaque formation. Then, desmocollin-2 and desmoglein-2 genes of epithelial DLD-1 cells were ablated by using the CRISPR/Cas9 system. The resultant knockout cells did not form desmosomes, but re-expression of desmocollin-2 in the cells formed desmosomal plaques in the absence of desmoglein-2 and the transfectants showed significant cell adhesion activity. Intriguingly, expression of desmocollin-2 lacking its juxtamembrane region did not form the plaques. The results of an immunoprecipitation and GST-fusion protein pull-down assay suggested the binding of plakophilin-2 and -3 to the region. Ablation of plakophilin-2 and -3 genes resulted in disruption of the plaque-like accumulation and linear localization of desmocollin-2 at intercellular contact sites. These results suggest that the juxtamembrane region of desmocollin-2 and plakophilins are involved in the desmosomal plaque formation, possibly through the interaction between this region and plakophilins.	[Fujiwara, Miwako; Nagatomo, Azusa; Tsuda, Megumi; Suzuki, Shintaro T.] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan; [Obata, Shuichi] Kitasato Univ, Dept Liberal Arts, Sagamihara, Kanagawa 2520373, Japan; [Obata, Shuichi] Yokohama City Univ, Sch Med, Dept Histol & Cell Biol, Yokohama, Kanagawa 2360004, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Hiroshima 7398511, Japan	Suzuki, ST (reprint author), Kwansei Gakuin Univ, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	stsuzuki@kwansei.ac.jp			Ministry of Education and Culture (KAKENHI) [24240062]; Kwansei Gakuin University	This study was supported in part by grants-in-aid from Ministry of Education and Culture (KAKENHI 24240062 to S.O) and from Kwansei Gakuin University (to S.T.S.).	Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Marcozzi C, 1998, J CELL SCI, V111, P495; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P760, DOI 10.2741/3956; Bornslaeger EA, 2001, J CELL SCI, V114, P727; Koeser J, 2003, EXP CELL RES, V285, P114, DOI 10.1016/S0014-4827(03)00016-8; Campuzano O, 2013, J MED GENET, V50, P280, DOI 10.1136/jmedgenet-2013-101523; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Burdett IDJ, 2002, EXP CELL RES, V276, P296, DOI 10.1006/excr.2002.5509; Incontro S, 2014, NEURON, V83, P1051, DOI 10.1016/j.neuron.2014.07.043; KAWAMURA K, 1994, J BIOL CHEM, V269, P26295; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; ARNEMANN J, 1993, J CELL SCI, V104, P741; Lowndes M, 2014, J CELL SCI, V127, P2339, DOI 10.1242/jcs.146316; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Godsel LM, 2010, MOL BIOL CELL, V21, P2844, DOI 10.1091/mbc.E10-02-0131; PASDAR M, 1991, J CELL BIOL, V113, P645, DOI 10.1083/jcb.113.3.645; Chitaev NA, 1996, J CELL BIOL, V133, P359, DOI 10.1083/jcb.133.2.359; Chen J, 2012, J CELL BIOL, V199, P699, DOI 10.1083/jcb.201202105; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; Hatzfeld M, 2014, CELL COMMUN ADHES, V21, P25, DOI 10.3109/15419061.2013.876017; Tai K, 2010, BRAIN RES, V1344, P13, DOI 10.1016/j.brainres.2010.04.065; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Kanno M, 2008, EXP CELL RES, V314, P1683, DOI 10.1016/j.yexcr.2008.01.031; TROYANOVSKY SM, 1994, P NATL ACAD SCI USA, V91, P10790, DOI 10.1073/pnas.91.23.10790; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Garrod D, 2014, CELL COMMUN ADHES, V21, P249, DOI 10.3109/15419061.2014.930133; Neuber S, 2010, DERMATOL RES PRACT, V2010; Peng Y, 2014, DEVELOPMENT, V141, P4042, DOI 10.1242/dev.102186; Todorovic V, 2014, MOL BIOL CELL, V25, P3749, DOI 10.1091/mbc.E14-05-0968	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	OCT	2015	158	4					339	353		10.1093/jb/mvv048		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT7OV	WOS:000363005300007		
J	Alwi, RS; Tamura, K				Alwi, Ratna Surya; Tamura, Kazuhiro			Measurement and Correlation of Derivatized Anthraquinone Solubility in Supercritical Carbon Dioxide	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							DISPERSE DYES; EQUATION; STATE; PRESSURE; LIQUIDS; SOLIDS; MODEL	Solubilites of 1,4-diamino-2,3-dichloroanthraquinone (C.I. Disperse Violet 28) and 1,8-dihydroxy-4,5-dinitroanthraquinone in supercritical carbon dioxide (sc-CO2) were measured at the temperature of (323.15, 353.15 and 383.15) K and over pressure ranges (12.5 to 25.0) MPa by a flow-type apparatus. Mole fraction solubility of 1,4-diamino-2,3-dichloroanthraquinone (C.I. Disperse Violet 28) is found significantly higher than that of 1,8-dihydroxy-4,5-dinitroanthraquinone. It was found that 2,3-dichloro group addition onto 1,4-diaminoanthraquione leads to higher solubility of 1,4-diaminoanthraquinone and the addition of 8-hydroxy-5-nitro group on 1-hydroxy-4-nitroanthraquione causes lower solubility than that of 1-hydroxy-4-nitroanthraquinone. Three semiempirical density-based models, Mendez-Santiago-Teja, Sung-Shim, and Bartle et al., were used to correlate the experimental results. Moreover, the solubilities of anthraquinone derivatives were analyzed thermodynamically by the regular solution model with the Flory-Huggins theory and by the Peng-Robinson equation of state with a modification of Stryjek and Vera (PRSV-EOS). The calculated solubilities of anthraquinone derivatives were in good agreement with the experimental results.	[Alwi, Ratna Surya; Tamura, Kazuhiro] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Nat Syst, Kanazawa, Ishikawa 9201192, Japan	Tamura, K (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Nat Syst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tamura@se.kanazawa-u.ac.jp			Japan Society for the Promotion Science [23560905]	This work was partially supported by the Japan Society for the Promotion Science, Grant-in-Aid for Scientific Research (C) No. 23560905.	STRYJEK R, 1986, CAN J CHEM ENG, V64, P323; Coelho JP, 2011, IND ENG CHEM RES, V50, P4618, DOI 10.1021/ie102028x; PENG D, 1976, IND ENG CHEM FUND, V15, P59, DOI 10.1021/i160057a011; IWAI Y, 1992, J CHEM ENG JPN, V25, P757, DOI 10.1252/jcej.25.757; Tsai CC, 2008, J CHEM ENG DATA, V53, P2163, DOI 10.1021/je8003673; BARTLE KD, 1991, J PHYS CHEM REF DATA, V20, P713; Mishima K, 2002, FLUID PHASE EQUILIBR, V194, P895, DOI 10.1016/S0378-3812(01)00720-8; FOSTER NR, 1991, IND ENG CHEM RES, V30, P1955, DOI 10.1021/ie00056a044; Marrero J, 2001, FLUID PHASE EQUILIBR, V183, P183, DOI 10.1016/S0378-3812(01)00431-9; Khansary MA, 2015, CHEM ENG RES DES, V93, P355, DOI 10.1016/j.cherd.2014.05.004; Tamura K, 2015, DYES PIGMENTS, V113, P351, DOI 10.1016/j.dyepig.2014.09.003; Span R, 1996, J PHYS CHEM REF DATA, V25, P1509; GIDDINGS JC, 1968, SCIENCE, V162, P67, DOI 10.1126/science.162.3849.67; Shinoda T, 2003, FLUID PHASE EQUILIBR, V213, P115, DOI 10.1016/S0378-3812(03)00240-1; Draper SL, 2000, DYES PIGMENTS, V45, P177, DOI 10.1016/S0143-7208(00)00008-5; Alwi RS, 2014, J CHEM THERMODYN, V74, P119, DOI 10.1016/j.jct.2014.01.015; Lin HM, 2001, J SUPERCRIT FLUID, V21, P1, DOI 10.1016/S0896-8446(01)00075-4; Coelho JP, 2011, J CHEM ENG DATA, V56, P4686, DOI 10.1021/je2006521j; Shinoda T, 2003, J CHEM ENG DATA, V48, P869, DOI 10.1021/je0256131; Mendez-Santiago J, 1999, FLUID PHASE EQUILIBR, V158, P501, DOI 10.1016/S0378-3812(99)00154-5; Shamsipur M, 2004, J SUPERCRIT FLUID, V32, P47, DOI 10.1016/j.supflu.2004.01.006; Jain A, 2004, IND ENG CHEM RES, V43, P7618, DOI 10.1021/ie049378m; Sung HD, 1999, J CHEM ENG DATA, V44, P985, DOI 10.1021/je990018t; FEDORS RF, 1974, POLYM ENG SCI, V14, P147, DOI 10.1002/pen.760140211; Tamura K, 2004, FLUID PHASE EQUILIBR, V219, P25, DOI 10.1016/j.fluid.2004.01.009; Bach E., 2002, REV PROG COLOR, V32, P88; Goi K., 1960, OSAKA FURITSU KOGYO, V24, P51; Lyman W. J., 1982, HDB CHEM PROPERTY ES; Poling B.E., 2001, PROPERTIES GASES LIQ; Torrisi A., 2010, J CHEM PHYS, V132	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	OCT	2015	60	10					3046	3052		10.1021/acs.jced.5b00480		7	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CT3IV	WOS:000362701300026		
J	Sommerfeld, T; Ehara, M				Sommerfeld, Thomas; Ehara, Masahiro			Complex Absorbing Potentials with Voronoi Isosurfaces Wrapping Perfectly around Molecules	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							SAC CI THEORIES; COUPLED-CLUSTER METHOD; TEMPORARY ANIONS; WAVE-FUNCTION; EXCITED-STATES; RESONANCE; EXPANSION; ENERGIES	Complex absorbing potentials (CAPs) are imaginary potentials that are added to a Hamiltonian to change the boundary conditions of the problem from scattering to square-integrable. In other words, with a CAP, standard bound-state methods can be used in problems involving unbound states such as identifying resonance states and predicting their energies and lifetimes. Although in wave packet dynamics, many CAP forms are used, in electronic structure theory, the so-called box-CAP is used almost exclusively, because of the ease of evaluating its integrals in a Gaussian basis set. However, the box-CAP does has certain disadvantages. First, it will, e.g., break the symmetry of C-nv, molecules if n is odd and the main axis is placed along the z-axis by the "standard orientation" of the electronic structure code. Second, it provides a CAP starting at the smallest box around the entire molecular system. For larger molecules or clusters, which do not fill the space efficiently, that implies that much "dead space" within the molecule will be left, where there is neither a CAP nor a sufficient description with basis functions. Here, two new CAP forms are introduced and systematically explored: first, a Voronoi-CAP (that is, a CAP defined in each atom's Voronoi cell), and second, a smooth Voronoi-CAP (which is similar to the Voronoi-CAP; however, the noncontinuously differentiable behavior at the surfaces between the Voronoi cells is smoothed out). Both have isosurfaces that are similar to the cavities used in solvation modeling. An obvious disadvantage of these two CAPs is that the integrals cannot be obtained analytically, but must be computed numerically. However, Voronoi-CAPs share the advantage of having the same symmetry as the molecular system, and, more importantly, considerably facilitate the treatment of larger molecules with asymmetric side chains and of molecular clusters.	[Sommerfeld, Thomas] SE Louisiana Univ, Dept Chem & Phys, Hammond, LA 70402 USA; [Ehara, Masahiro] Res Ctr Computat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Sommerfeld, T (reprint author), SE Louisiana Univ, Dept Chem & Phys, SLU 10878, Hammond, LA 70402 USA.	Thomas.Sommerfeld@selu.edu; ehara@ims.ac.jp			American Chemical Society	Acknowledgment is made to the donors of the American Chemical Society Petroleum Research Fund for support of this research.	NOOIJEN M, 1995, J CHEM PHYS, V102, P3629, DOI 10.1063/1.468592; NAKATSUJI H, 1979, CHEM PHYS LETT, V67, P329, DOI 10.1016/0009-2614(79)85172-6; [Anonymous], 1989, CHEM PHYS; Ghosh A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4729464; Riss UV, 1998, J PHYS B-AT MOL OPT, V31, P2279, DOI 10.1088/0953-4075/31/10/016; NAKATSUJI H, 1983, CHEM PHYS, V75, P425, DOI 10.1016/0301-0104(83)85209-4; Ehara M, 2012, CHEM PHYS LETT, V537, P107, DOI 10.1016/j.cplett.2012.03.104; STANTON JF, 1993, J CHEM PHYS, V98, P7029, DOI 10.1063/1.464746; NAKATSUJI H, 1979, CHEM PHYS LETT, V67, P334, DOI 10.1016/0009-2614(79)85173-8; Sajeev Y, 2014, INT REV PHYS CHEM, V33, P397, DOI 10.1080/0144235X.2014.935585; Jagau TC, 2014, J PHYS CHEM LETT, V5, P310, DOI 10.1021/jz402482a; Horacek J, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.032713; Sommerfeld T, 2000, J CHEM PHYS, V112, P6635, DOI 10.1063/1.481236; Feuerbacher S, 2003, J CHEM PHYS, V118, P6188, DOI 10.1063/1.1557452; Sommerfeld T, 1998, J PHYS B-AT MOL OPT, V31, P4107, DOI 10.1088/0953-4075/31/18/009; Riss UV, 1996, J CHEM PHYS, V105, P1409, DOI 10.1063/1.472003; Sommerfeld T, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4905560; Zuev D, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4885056; Krause P, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4874156; Santra R, 1999, CHEM PHYS LETT, V303, P413, DOI 10.1016/S0009-2614(99)00226-2; Mertins F, 1996, PHYS REV A, V53, P2153, DOI 10.1103/PhysRevA.53.2153; Ghosh A, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4903827; Santra R, 2002, PHYS REP, V368, P1, DOI 10.1016/S0370-1573(02)00143-6; RISS UV, 1993, J PHYS B-AT MOL OPT, V26, P4503, DOI 10.1088/0953-4075/26/23/021; Sommerfeld T, 2001, INT J QUANTUM CHEM, V82, P218, DOI 10.1002/qua.1042; Ghosh A, 2013, PHYS CHEM CHEM PHYS, V15, P17915, DOI 10.1039/c3cp52552j; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fukuda R, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2832867; Krause P, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4900576; Lebedev V.I., 1999, DOKL MATH, V59, P477	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	OCT	2015	11	10					4627	4633		10.1021/acs.jctc.5b00465		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CT6KK	WOS:000362921700012		
J	Shiozaki, T; Mizukami, W				Shiozaki, Toru; Mizukami, Wataru			Relativistic Internally Contracted Multireference Electron Correlation Methods	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							2ND-ORDER PERTURBATION-THEORY; FIELD REFERENCE FUNCTION; COUPLED-CLUSTER; CONFIGURATION-INTERACTION; QUANTUM-CHEMISTRY; THALLIUM HYDRIDE; STATE; IMPLEMENTATION	We report internally contracted relativistic multireference configuration interaction (ic-MRCI), complete active space second-order perturbation (CASPT2), and strongly contracted n-electron valence state perturbation theory (NEVPT2) on the basis of the four-component Dirac Hamiltonian, enabling accurate simulations of relativistic, quasi-degenerate electronic structure of molecules containing transition-metal and heavy elements. Our derivation and implementation of ic-MRCI and CASPT2 are based on an automatic code generator that translates second-quantized ansatze to tensor-based equations, and to efficient computer code. NEVPT2 is derived and implemented manually. The rovibrational transition energies and absorption spectra of HI and TlH are presented to demonstrate the accuracy of these methods.	[Shiozaki, Toru] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Mizukami, Wataru] Kyushu Univ, Dept Energy & Mat Sci, Fac Engn Sci, Fukuoka 8168580, Japan	Shiozaki, T (reprint author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	shiozaki@northwestern.edu			Air Force Office of Scientific Research (AFOSR) [FA9550-15-1-0031]; National Science Foundation CAREER [CHE-1351598]; Ministry of Education, Culture, Sports, Science and Technology Japan (MEXT) [15K17815]	T.S. has been supported by the Air Force Office of Scientific Research Young Investigator Program (AFOSR Grant No. FA9550-15-1-0031). The development of the relativistic CASSCF program, on which this work is based, has been supported by the National Science Foundation CAREER Award (CHE-1351598). W.M. has been supported by Grant-in-Aid for Young Scientists (B) (Grant No. 15K17815) from the Ministry of Education, Culture, Sports, Science and Technology Japan (MEXT).	Abe M, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2404666; Angeli C, 2001, J CHEM PHYS, V114, P10252, DOI 10.1063/1.1361246; Angeli C, 2002, J CHEM PHYS, V117, P9138, DOI 10.1063/1.1515317; ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; WERNER HJ, 1988, J CHEM PHYS, V89, P5803, DOI 10.1063/1.455556; Visscher L, 1997, ATOM DATA NUCL DATA, V67, P207, DOI 10.1006/adnd.1997.0751; Nataraj HS, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3518712; [Anonymous], 1989, CHEM PHYS; Aquilante F, 2008, J CHEM THEORY COMPUT, V4, P694, DOI 10.1021/ct700263h; Faegri K, 2001, THEOR CHEM ACC, V105, P265; Fleig T, 2007, THEOR CHEM ACC, V118, P347, DOI 10.1007/s00214-007-0265-y; Alexander MH, 2002, SCIENCE, V296, P715, DOI 10.1126/science.1070472; Hirata S, 2006, THEOR CHEM ACC, V116, P2, DOI 10.1007/s00214-005-0029-5; Pulay P, 2011, INT J QUANTUM CHEM, V111, P3273, DOI 10.1002/qua.23052; Wu T, 2004, SCIENCE, V306, P2227, DOI 10.1126/science.1104085; Jensen HJA, 1996, J CHEM PHYS, V104, P4083; URBAN RD, 1989, CHEM PHYS LETT, V158, P443, DOI 10.1016/0009-2614(89)87368-3; Hansson A, 2005, J MOL SPECTROSC, V233, P169, DOI 10.1016/j.jms.2005.06.009; Hirata S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2423005; Ard SG, 2014, J PHYS CHEM A, V118, P6789, DOI 10.1021/jp5055815; Knecht S, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862495; ANDERSSON K, 1990, J PHYS CHEM-US, V94, P5483, DOI 10.1021/j100377a012; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Harvey JN, 2007, PHYS CHEM CHEM PHYS, V9, P331, DOI 10.1039/b614390c; Malmqvist PA, 2002, CHEM PHYS LETT, V357, P230, DOI 10.1016/S0009-2614(02)00498-0; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P4, DOI 10.1016/j.jqsrt.2013.07.002; Saue T, 2011, CHEMPHYSCHEM, V12, P3077, DOI 10.1002/cphc.201100682; DAVIDSON ER, 1975, J COMPUT PHYS, V17, P87, DOI 10.1016/0021-9991(75)90065-0; WERNER HJ, 1982, J CHEM PHYS, V76, P3144, DOI 10.1063/1.443357; Dyall KG, 2006, THEOR CHEM ACC, V115, P441, DOI 10.1007/s00214-006-0126-0; Yorke L, 2014, MON NOT R ASTRON SOC, V445, P1383, DOI 10.1093/mnras/stu1854; Shuman NS, 2015, CHEM REV, V115, P4542, DOI 10.1021/cr5003479; Li G, 2013, J QUANT SPECTROSC RA, V121, P78, DOI 10.1016/j.jqsrt.2013.02.005; DYALL KG, 1995, J CHEM PHYS, V102, P4909, DOI 10.1063/1.469539; Zeng T, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3297887; Kelley MS, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4807612; Shiozaki T, 2008, PHYS CHEM CHEM PHYS, V10, P3358, DOI 10.1039/b803704n; Hirata S, 2003, J PHYS CHEM A, V107, P9887, DOI 10.1021/jp034596z; Fleig T, 2012, CHEM PHYS, V395, P2, DOI 10.1016/j.chemphys.2011.06.032; Liu WJ, 2010, MOL PHYS, V108, P1679, DOI 10.1080/00268971003781571; Nakajima T, 2012, CHEM REV, V112, P385, DOI 10.1021/cr200040s; Bates JE, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4906344; Bernath P. F., 2005, SPECTRA ATOMS MOL, P275; Calvin J. A., TILEDARRAY MASSIVELY; Cox RM, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4916396; Huber K. P., 1979, MOL SPECTRA MOL STRU, VIV, p[324, 652]; Kim I, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4898153; Langhoff S. R., 1974, INT J QUANTUM CHEM, V8, P61; Le Roy R. J., 2014, CP668 U WAT; Lischka H, 2011, WIRES COMPUT MOL SCI, V1, P191, DOI 10.1002/wcms.25; MacLeod MK, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4907717; Reiher M., 2009, RELATIVISTIC QUANTUM; Saitow M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816627; Schroder D, 2000, ACCOUNTS CHEM RES, V33, P139, DOI 10.1021/ar990028j; Shamasundar KR, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3609809; Shiozaki T, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4795430	56	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	OCT	2015	11	10					4733	4739		10.1021/acs.jctc.5b00754		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CT6KK	WOS:000362921700022		
J	De Nicola, A; Kawakatsu, T; Rosano, C; Celino, M; Rocco, M; Milano, G				De Nicola, Antonio; Kawakatsu, Toshihiro; Rosano, Camillo; Celino, Massimo; Rocco, Mattia; Milano, Giuseppe			Self-Assembly of Triton X-100 in Water Solutions: A Multiscale Simulation Study Linking Mesoscale to Atomistic Models	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CRITICAL MICELLE CONCENTRATION; NONIONIC SURFACTANT MICELLES; PHASE-TRANSITION BOUNDARY; COARSE-GRAINED MODELS; AQUEOUS-SOLUTION; POLYMER MELTS; MEMBRANE-PROTEINS; LIPID-BILAYERS; SINGLE-CHAIN	A multiscale scheme is proposed and validated for Triton X-100 (TX-100), which is a detergent widely employed in biology. The hybrid particle field formulation of the model allows simulations of large-scale systems. The coarse-grained (CG) model, accurately validated in a wide range of concentrations, shows a critical micelle concentration, shape transition in isotropic micellar phase, and appearance of hexagonal ordered phase in the experimental ranges reported in the literature. The fine resolution of the proposed CG model allows one to obtain, by a suitable reverse mapping procedure, atomistic models of micellar assemblies and of the hexagonal phase. In particular, atomistic models of the micelles give structures in good agreement with experimental pair distance distribution functions and hydrodynamic measurements. The picture emerging by detailed analysis of simulated systems is quite complex. Polydisperse mixtures of spherical-, oblate-, and prolate-shaped aggregates have been found. The shape and the micelle behavior are mainly dictated by the aggregation number (N-agg). Micelles with low N-agg values (similar to 40) are spherical, while those with high N-agg values (similar to 140 or larger) are characterized by prolate ellipsoidal shapes. For intermediate N-agg values (similar to 70), fluxional micelles alternating between oblate and prolate shapes are found. The proposed model opens the way to investigations of several mechanisms involving TX-100 assembly in protein and membrane biophysics.	[De Nicola, Antonio; Milano, Giuseppe] Univ Salerno, Dipartimento Chim & Biol, I-84084 Salerno, Italy; [Kawakatsu, Toshihiro] Tohoku Univ, Dept Phys, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Rosano, Camillo; Rocco, Mattia] Ist Nazl Ric Sul Cancro, Biopolimeri & Proteom, IRCCS AOU San Martino IST, I-16132 Genoa, Italy; [Celino, Massimo] ENEA, I-00123 Rome, Italy; [Milano, Giuseppe] IMAST Scarl Technol Dist Polymer & Composite Engn, I-80133 Naples, Italy	Milano, G (reprint author), Univ Salerno, Dipartimento Chim & Biol, Via Ponte Melillo, I-84084 Salerno, Italy.	gmilano@unisa.it	Rosano, Camillo/D-5386-2011; 	Rosano, Camillo/0000-0003-2949-9215; De Nicola, Antonio/0000-0002-9581-6226	MIUR (FIRB "RETE ITALNANONET")	G.M. thanks MIUR (FIRB "RETE ITALNANONET") for financial support.	Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Milano G, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045007; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Heerklotz H, 2000, BIOPHYS J, V78, P2435; Daful AG, 2012, LANGMUIR, V28, P3730, DOI 10.1021/la204132c; Brocos P, 2012, SOFT MATTER, V8, P9005, DOI 10.1039/c2sm25877c; Kang EH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031918; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Denkova PS, 2008, J PHYS CHEM B, V112, P10935, DOI 10.1021/jp802830g; Rajagopal A, 2002, CANCER RES, V62, P391; KARPEN ME, 1993, BIOCHEMISTRY-US, V32, P412, DOI 10.1021/bi00053a005; Milano G, 2011, J PHYS CHEM C, V115, P15154, DOI 10.1021/jp201374h; De Nicola A, 2014, PHYS CHEM CHEM PHYS, V16, P5093, DOI 10.1039/c3cp54242d; Marrink SJ, 2000, J PHYS CHEM B, V104, P12165, DOI 10.1021/jp001898h; Jorge M, 2008, LANGMUIR, V24, P5714, DOI 10.1021/la800291p; Wang Y, 2010, CHEMSUSCHEM, V3, P435, DOI 10.1002/cssc.200900284; Muddana HS, 2012, BIOPHYS J, V102, P489, DOI 10.1016/j.bpj.2011.12.033; Yordanova D, 2015, J CHEM THEORY COMPUT, V11, P2329, DOI 10.1021/acs.jctc.5b00026; Molina-Bolivar JA, 2002, J PHYS CHEM B, V106, P870, DOI 10.1021/jp0119936; Sevink GJA, 2013, SOFT MATTER, V9, P2816, DOI 10.1039/c2sm27492b; Casadei BR, 2014, BIOPHYS J, V106, P2417, DOI 10.1016/j.bpj.2014.04.039; Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Lichtenberg D, 2013, BIOPHYS J, V105, P289, DOI 10.1016/j.bpj.2013.06.007; Anand U, 2011, J COLLOID INTERF SCI, V364, P400, DOI 10.1016/j.jcis.2011.08.047; Sudbrack TP, 2011, J PHYS CHEM B, V115, P269, DOI 10.1021/jp108653e; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Serra A, 2013, PHYS CHEM CHEM PHYS, V15, P14653, DOI 10.1039/c3cp52021h; Ingelmo-Torres M, 2009, BIOCHEM J, V420, P373, DOI 10.1042/BJ20090051; Al-Anber ZA, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1860558; Derecskei-Kovacs A, 1998, J MOL GRAPH MODEL, V16, P206, DOI 10.1016/S1093-3263(98)80005-3; Shi Q, 2005, BIOPHYS J, V89, P2385, DOI 10.1529/biophysj.105.063784; Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749; Wallace EJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/4/045101; Spyriouni T, 2007, MACROMOLECULES, V40, P3876, DOI 10.1021/ma0700983; Santangelo G, 2007, J PHYS CHEM B, V111, P2765, DOI 10.1021/jp0662121; Sammalkorpi M, 2011, J PHYS CHEM B, V115, P1403, DOI 10.1021/jp109882r; Zhao Y, 2012, J COMPUT CHEM, V33, P868, DOI 10.1002/jcc.22883; Stoykovich MP, 2005, SCIENCE, V308, P1442, DOI 10.1126/science.1111041; Peter C, 2010, FARADAY DISCUSS, V144, P9, DOI 10.1039/b919800h; Petrov PG, 2002, LANGMUIR, V18, P9133, DOI 10.1021/la025792k; Jodar-Reyes AB, 2006, J PHYS CHEM B, V110, P6300, DOI 10.1021/jp056737y; BROWN W, 1989, J PHYS CHEM-US, V93, P2512, DOI 10.1021/j100343a055; BEYER K, 1982, J COLLOID INTERF SCI, V86, P73, DOI 10.1016/0021-9797(82)90042-X; Jones MN, 1999, INT J PHARM, V177, P137, DOI 10.1016/S0378-5173(98)00345-7; Rocco M, 2015, EUR BIOPHYS J BIOPHY, V44, P417, DOI 10.1007/s00249-015-1042-9; Sevink GJA, 2005, MACROMOLECULES, V38, P7502, DOI 10.1021/ma0506740; Brasiello A, 2010, COMPUT-AIDED CHEM EN, V28, P625; Mansfield ML, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046712; Chen XY, 2009, PHYS CHEM CHEM PHYS, V11, P1977, DOI 10.1039/b817895j; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Hassan N, 2011, LANGMUIR, V27, P9719, DOI 10.1021/la2019346; Milano G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3142103; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; De Nicola A, 2013, MACROMOL CHEM PHYS, V214, P1940, DOI 10.1002/macp.201300214; Kirkensgaard JJK, 2014, SOFT MATTER, V10, P7182, DOI 10.1039/c4sm01052c; Tschop W, 1998, ACTA POLYM, V49, P75; Jose BJ, 2009, J PHYS CHEM B, V113, P13257, DOI 10.1021/jp9055544; Brookes E, 2013, J APPL CRYSTALLOGR, V46, P1823, DOI 10.1107/S0021889813027751; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; Galatanu AN, 2000, LANGMUIR, V16, P4922, DOI 10.1021/la991668y; HIRSCH JE, 1983, PHYS REV B, V28, P4059, DOI 10.1103/PhysRevB.28.4059; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Gennuso F, 2004, P NATL ACAD SCI USA, V101, P2470, DOI 10.1073/pnas.0308452100; Saez-Cirion A, 2000, LANGMUIR, V16, P1960, DOI 10.1021/la9908889; Velinova M, 2011, LANGMUIR, V27, P14071, DOI 10.1021/la203055t; Brasiello A, 2012, FARADAY DISCUSS, V158, P479, DOI 10.1039/c2fd20037f; Daoulas KC, 2006, SOFT MATTER, V2, P573, DOI 10.1039/b602610a; Daoulas KC, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2364506; Ruiz CC, 2001, LANGMUIR, V17, P6831, DOI 10.1021/la010529p; Milano G, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3506776; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Tschop W, 1998, ACTA POLYM, V49, P61, DOI 10.1002/(SICI)1521-4044(199802)49:2/3<61::AID-APOL61>3.0.CO;2-V; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Peter C, 2009, SOFT MATTER, V5, P4357, DOI 10.1039/b912027k; De Nicola A, 2011, J CHEM THEORY COMPUT, V7, P2947, DOI 10.1021/ct200132n; Mani G, 2014, MATER RES BULL, V51, P228, DOI 10.1016/j.materresbull.2013.12.037; SALLEN L, 1995, J PHYS II, V5, P937, DOI 10.1051/jp2:1995222; Nevidimov AV, 2009, MOL PHYS, V107, P2169, DOI 10.1080/00268970903203736; Langner KM, 2012, SOFT MATTER, V8, P5102, DOI 10.1039/c2sm07293a; May S, 2001, J PHYS CHEM B, V105, P630, DOI 10.1021/jp003021o; Prete PSC, 2011, BBA-BIOMEMBRANES, V1808, P164, DOI 10.1016/j.bbamem.2010.10.016; HIPFNER DR, 1994, CANCER RES, V54, P5788; Oswald P, 1996, J PHYS II, V6, P281, DOI 10.1051/jp2:1996182; Birdi K. S, 1985, SURFACE ACTIVE AGENT, V70, P23, DOI 10.1007/BFb0114301; Brookes E., 2015, ANAL ULTRAC IN PRESS, pChapter 10; De Nicola A, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1167-1; De Nicola A, 2014, J CHEM THEORY COMPUT, V10, P5651, DOI 10.1021/ct500492h; Frenkel D., 2002, UNDERSTANDING MOL SI; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81; Glatter O., 1982, SMALL ANGLE XRAY SCA; Khalatur P. G., 2012, POLYM SCI COMPREHENS, P417; LASCH J, 1990, BIOCHIM BIOPHYS ACTA, V1022, P171, DOI 10.1016/0005-2736(90)90111-Z; Li Z, 2014, SOFT MATTER, V10, P8758, DOI 10.1039/c4sm01395f; Muller-Plathe F., 2002, SOFT MATER, V1, P1; PARADIES HH, 1980, J PHYS CHEM-US, V84, P599, DOI 10.1021/j100443a008; Ahir SV, 2002, LANGMUIR, V18, P9140, DOI 10.1021/la025793c; Ramirez-Hernandez A, 2014, MACROMOLECULES, V47, P3520, DOI 10.1021/ma500411q; ROBSON RJ, 1977, J PHYS CHEM-US, V81, P1075, DOI 10.1021/j100526a010; Stubicar N., 1989, SURFACTANTS SOLUTION, P181	103	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	OCT	2015	11	10					4959	4971		10.1021/acs.jctc.5b00485		13	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CT6KK	WOS:000362921700044		
J	Hata, K; Ishihara, S; Watanabe, T				Hata, Keisuke; Ishihara, Soichiro; Watanabe, Toshiaki			Successful Surveillance Colonoscopy for Patients with Ulcerative Colitis After Ileorectal Anastomosis	JOURNAL OF CROHNS & COLITIS			English	Letter							COLORECTAL-CANCER		[Hata, Keisuke; Ishihara, Soichiro; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Tokyo 1138655, Japan	Hata, K (reprint author), Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	khata-tky@umin.ac.jp					Myrelid P, 2015, J CROHNS COLITIS, V9, P433, DOI 10.1093/ecco-jcc/jjv060; Hata K, 2003, BRIT J CANCER, V89, P1232, DOI 10.1038/sj.bjc.6601247; Hata K, 2004, GUT, V53, P1722; Matsuda K, 1999, JPN J CLIN ONCOL, V29, P448, DOI 10.1093/jjco/29.9.448; Shuno Y, 2011, ISRN GASTROENTEROL, V2011	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	OCT 1	2015	9	10					937	938		10.1093/ecco-jcc/jjv124		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CT6ZT	WOS:000362963300015		
J	Chinnathambi, S; Pi, XD; Xu, MS; Hanagata, N				Chinnathambi, Shanmugavel; Pi, Xiaodong; Xu, Mingsheng; Hanagata, Nobutaka			Regulation of bifurcated cytokine induction by surface charge of nanoparticles during interaction between CpG oligodeoxynucleotides and toll-like receptor 9	JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY			English	Article						CpG oligodeoxynucleotides; Delivery; Immunostimulation; Silicon nanoparticles; Surface charge	PLASMACYTOID DENDRITIC CELLS; INTERFERON-ALPHA INDUCTION; SILICON NANOCRYSTALS; BACTERIAL-DNA; IN-VIVO; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSES; QUANTUM DOTS; ACTIVATION; MOTIFS	Toll-like receptor 9 recognizes CpG oligodeoxynucleotides (ODNs) and induces immune-mediator cytokines. Natural phosphodiester class B CpG ODNs induce interleukin-6 (IL-6), but not interferon-alpha (IFN-alpha). We prepared silicon nanoparticles (Si NPs) with different positive surface charge density and bound negatively charged class B CpG ODN molecules electrostatically. No significant differences in the amount of class B CpG ODN molecules or negative surface charge after binding of the molecules onto naked NPs was observed. However, the profile of cytokine induction from peripheral blood mononuclear cells was correlated with a positive surface charge density of naked NPs prior to binding of CpG ODN molecules. The level of IL-6 induction slightly decreased as the positive surface charge density was increased, while the IFN-alpha induction significantly increased as the positive surface charge density was increased. This observation demonstrates that the bifurcated cytokine induction can be regulated by the surface charge of naked NPs. (C) 2015 Elsevier B.V. All rights reserved.	[Chinnathambi, Shanmugavel; Hanagata, Nobutaka] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki 3050047, Japan; [Pi, Xiaodong] Zhejiang Univ, Dept Mat Sci & Engn, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China; [Xu, Mingsheng] Zhejiang Univ, State Key Lab Silicon Mat, MOE Key Lab Macromol Synth & Functionalizat, Hangzhou 310027, Zhejiang, Peoples R China; [Xu, Mingsheng] Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Hanagata, Nobutaka] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hanagata, N (reprint author), Natl Inst Mat Sci, Nanotechnol Innovat Stn, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	HANAGATA.Nobutaka@nims.go.jp			Japan Society for the Promotion of Science [C-22560777]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Nanotechnology Platform Program Japan from MEXT	This work was supported by a Grant-in-Aid for Scientific Research (C-22560777) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to NH, and by the Nanotechnology Platform Program Japan from MEXT.	KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Zi J, 1996, APPL PHYS LETT, V69, P200, DOI 10.1063/1.117371; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; de Boer WDAM, 2010, NAT NANOTECHNOL, V5, P878, DOI [10.1038/nnano.2010.236, 10.1038/NNANO.2010.236]; Hartmann G, 2000, J IMMUNOL, V164, P1617; Yasuda K, 2005, J IMMUNOL, V174, P6129; Shen P, 2011, CHEM COMMUN, V47, P8409, DOI 10.1039/c1cc12713f; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Pi XD, 2011, SOL ENERG MAT SOL C, V95, P2941, DOI 10.1016/j.solmat.2011.06.010; Takeshita F, 2001, J IMMUNOL, V167, P3555; Hessel CM, 2010, SMALL, V6, P2026, DOI 10.1002/smll.201000825; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Hemmi H, 2000, NATURE, V408, P740; Liu YC, 2010, J IMMUNOL, V184, P3367, DOI 10.4049/jimmunol.0903079; Leifer CA, 2004, J IMMUNOL, V173, P1179; Choi SH, 2006, BIOMACROMOLECULES, V7, P1864, DOI 10.1021/bm060182a; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/nmat2398, 10.1038/NMAT2398]; Erogbogbo F, 2011, ACS NANO, V5, P413, DOI 10.1021/nn1018945; Veinot JGC, 2006, CHEM COMMUN, P4160, DOI 10.1039/b607476f; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Shen P, 2010, J MATER CHEM, V20, P1669, DOI 10.1039/b919412f; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Manoharan Y, 2012, INT J NANOMED, V7, P3625, DOI 10.2147/IJN.S32592; Pi XD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/29/295602; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Kortshagen U, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/11/113001; Klein DCG, 2010, ULTRAMICROSCOPY, V110, P689, DOI 10.1016/j.ultramic.2010.02.033; Chinnathambi S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00534; Hass T., 2008, IMMUNOLOGY, V126, P290; Mangolini L, 2005, NANO LETT, V5, P655, DOI 10.1021/nl050066y; Meng W, 2011, BMC BIOTECHNOL, V11, P88	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1773-2247			J DRUG DELIV SCI TEC	J. Drug Deliv. Sci. Technol.	OCT	2015	29						251	260		10.1016/j.jddst.2015.08.008		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT2CF	WOS:000362608900030		
J	Tsusaka, TW; Kajisa, K; Pede, VO; Aoyagi, K				Tsusaka, Takuji W.; Kajisa, Kei; Pede, Valerien O.; Aoyagi, Keitaro			Neighborhood effects and social behavior: The case of irrigated and rainfed farmers in Bohol, the Philippines	JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION			English	Article						Behavioral games; Spatial econometrics; Dictator game; Public goods game; Irrigation; Social norms	RISK-SHARING NETWORKS; COLLECTIVE ACTION; SPATIAL ECONOMETRICS; COMMONS MANAGEMENT; PUBLIC-GOODS; COOPERATION; TRUST; NORMS; IDENTIFICATION; PUNISHMENT	Artifactual field experiments, spatial econometrics, and household surveys are combined in a single study to investigate the neighborhood effects of social behaviors. The dictator and public goods games are conducted among rice farmers in irrigated and non-irrigated areas in the Philippines. We find the neighborhood effects but the magnitude and statistical significance of endogenous social effects vary with the irrigation availability, type of social behavior, and type of neighborhood. Altruistic and cooperative behaviors are significantly influenced by the behaviors of neighbors only in the irrigated area, where social ties are strengthened through collective irrigation management. Through this effect, irrigated farmers' social behaviors become similar to those of one another. Neighborhood effects for cooperative behavior are stronger among farm plot neighbors than among residential neighbors, which may reflect their interactions in irrigation management. Although non-dynamic, these findings are consistent with the theory of social norm evolution through common pool resource management. (C) 2015 Elsevier B.V. All rights reserved.	[Tsusaka, Takuji W.; Kajisa, Kei; Pede, Valerien O.] Int Rice Res Inst, Los Banos, Philippines; [Tsusaka, Takuji W.] Int Crops Res Inst Semi Arid Trop, Lilongwe, Malawi; [Kajisa, Kei] Aoyama Gakuin Univ, Tokyo, Japan; [Aoyagi, Keitaro] Univ Tokyo, Tokyo, Japan	Tsusaka, TW (reprint author), Int Crops Res Inst Semi Arid Trop, POB 1096, Lilongwe, Malawi.	takuji.tsusaka@gmail.com; k.kajisa@sipeb.aoyama.ac.jp; v.pede@irri.org; aoyagikeitaro@gmail.com			Japan International Cooperation Agency; Japan International Research Center for Agricultural Science	We are grateful to the Japan International Cooperation Agency and Japan International Research Center for Agricultural Science for their financial support in survey data collection, Shigeki Yokoyama as co-manager of the project, Modesto Membreve, Franklyn Fusingan, Cesar Niluag, Baby Descallar, and Felipa Danoso of the National Irrigation Administration for arranging interviews with farmers, and Edmund Mendez, Pie Moya, Lolit Garcia, Shiela Valencia, Elmer Sunaz, Evangeline Austria, Ma. Indira Jose, Neale Paguirigan, Arnel Rala, Cornelia Garcia, Cristina Obusan, and Victoria Rodriguez for implementing the experimental games and collecting and processing the filed data. For helpful comments we thank the editor William Neilson, the editors of the special issue Shachar Kariv, Bertil Tungodden, and Jane Zhang, the two anonymous referees, seminar participants at the National Graduate Institute for Policy Studies, and Akinori Tomohara. We also thank Keijiro Otsuka and Samarendu Mohanty for their encouragement. The first and second authors worked for the International Rice Research Institute (IRRI) when this research project was conducted.	Abreu M., 2005, REGION DEV, V21, P13; Alatas V., 2012, 18351 NBER; Fafchamps M, 2002, OXFORD ECON PAP, V54, P173, DOI 10.1093/oep/54.2.173; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; Krishnan P, 2014, AM J AGR ECON, V96, P308, DOI 10.1093/ajae/aat017; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; Bramoulle Y, 2007, J ECON BEHAV ORGAN, V64, P275, DOI 10.1016/j.jebo.2006.10.004; Ben-Ner A, 2001, BOSTON U LAW REV, V81, P523; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; Lin X, 2010, J ECONOMETRICS, V157, P34, DOI 10.1016/j.jeconom.2009.10.035; Sampson RJ, 1999, AM SOCIOL REV, V64, P633, DOI 10.2307/2657367; Bowles S, 2002, ECON J, V112, pF419, DOI 10.1111/1468-0297.00077; Yamauchi F, 2007, J DEV ECON, V83, P37, DOI 10.1016/j.jdeveco.2005.10.005; Kelejian HH, 2013, J DEV ECON, V101, P297, DOI 10.1016/j.jdeveco.2012.12.003; Binzel C, 2013, J DEV ECON, V103, P99, DOI 10.1016/j.jdeveco.2013.01.009; Conley TG, 2010, AM ECON REV, V100, P35, DOI 10.1257/aer.100.1.35; Balafoutas L, 2012, EUR ECON REV, V56, P1773, DOI 10.1016/j.euroecorev.2012.09.008; Dufwenberg M, 2006, J ECON BEHAV ORGAN, V61, P50, DOI 10.1016/j.jebo.2005.01.002; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Lee LF, 2007, J ECONOMETRICS, V137, P489, DOI 10.1016/j.jeconom.2005.10.004; Hayami Y, 2009, J DEV STUD, V45, P96, DOI 10.1080/00220380802468595; Etang A, 2011, EXP ECON, V14, P15, DOI 10.1007/s10683-010-9255-3; Autant-Bernard C, 2011, J REGIONAL SCI, V51, P471, DOI 10.1111/j.1467-9787.2010.00705.x; Chao LW, 2009, JUDGM DECIS MAK, V4, P1; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Elhorst JP, 2010, SPAT ECON ANAL, V5, P9, DOI 10.1080/17421770903541772; Anselin L, 2003, INT REGIONAL SCI REV, V26, P147, DOI 10.1177/0160017602250971; Carpenter J, 2011, ECON INQ, V49, P612, DOI 10.1111/j.1465-7295.2009.00268.x; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Fujiie M, 2005, AGR ECON-BLACKWELL, V33, P179, DOI 10.1111/j.1574-0862.2005.00351.x; Aldy JE, 2007, REV ENV ECON POLICY, V1, P241, DOI 10.1093/reep/rem014; Carpenter JP, 2004, J ECON BEHAV ORGAN, V55, P533, DOI 10.1016/j.jebo.2003.11.007; Fafchamps M, 2003, J DEV ECON, V71, P261, DOI 10.1016/S0304-3878(03)00029-4; Cardenas JC, 2008, J DEV STUD, V44, P311, DOI 10.1080/00220380701848327; Schechter L, 2007, J ECON BEHAV ORGAN, V62, P272, DOI 10.1016/j.jebo.2005.03.006; Ones U, 2007, J ECON BEHAV ORGAN, V62, P495, DOI 10.1016/j.jebo.2005.04.018; Gachter S, 2013, J EUR ECON ASSOC, V11, P548, DOI 10.1111/jeea.12015; Ferraro PJ, 2011, AM ECON REV, V101, P318, DOI 10.1257/aer.101.3.318; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Bramoulle Y, 2009, J ECONOMETRICS, V150, P41, DOI 10.1016/j.jeconom.2008.12.021; Anselin L, 1996, REG SCI URBAN ECON, V26, P77, DOI 10.1016/0166-0462(95)02111-6; Anselin L, 2010, PAP REG SCI, V89, P3, DOI 10.1111/j.1435-5957.2010.00279.x; Kajisa K, 2007, ECON DEV CULT CHANGE, V55, P669, DOI 10.1086/516766; Goette L, 2012, AM ECON J-MICROECON, V4, P101, DOI 10.1257/mic.4.1.101; ANSELIN L, 1988, PAP REG SCI ASSOC, V65, P11; Aoki M., 2001, COMP I ANAL; Aoyagi K., 2014, 65 JICARI; Baland J. -M., 1996, HALTING DEGRADATION; Bandiera O., 2006, ECON J, V116, P869; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Barrett C.B., 2008, WHAT DO WE LEARN SOC; Blume L.E., 2011, HDB SOCIAL EC B, V1, P853, DOI DOI 10.1016/B978-0-444-53707-2.00001-3; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Brock William, 2001, HDB ECONOMETRICS, V5, P3297, DOI DOI 10.1016/S1573-4412; CASE A, 1992, REG SCI URBAN ECON, V22, P491, DOI 10.1016/0166-0462(92)90041-X; Cook KS, 2003, RUSSELL SAGE TRUST, V6, P209; Fafchamps M, 2000, J DEV ECON, V61, P205, DOI 10.1016/S0304-3878(99)00068-1; Hayami Y., 2005, DEV EC POVERTY WEALT; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Kremer M, 2008, J ECON PERSPECT, V22, P189, DOI 10.1257/jep.22.3.189; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; MOFFITT R., 2001, SOCIAL DYNAMICS, P45; Munshi K., 2000, 0008 MIT DEP EC; Nakano Y., 2015, 90 JICARI; Ord J., 1975, J AM STAT ASSOC, V70, P120, DOI DOI 10.1080/01621459.1975.10480272; Pede VO, 2014, REG SCI URBAN ECON, V49, P118, DOI 10.1016/j.regsciurbeco.2014.07.001; Ioannides YM, 2010, J REGIONAL SCI, V50, P343, DOI 10.1111/j.1467-9787.2009.00638.x	70	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2681	1879-1751		J ECON BEHAV ORGAN	J. Econ. Behav. Organ.	OCT	2015	118				SI		227	246		10.1016/j.jebo.2015.04.022		20	Economics	Business & Economics	CT6IM	WOS:000362916700017		
J	Matsumura, T; Okamura, M				Matsumura, Toshihiro; Okamura, Makoto			Competition and privatization policies revisited: the payoff interdependence approach	JOURNAL OF ECONOMICS			English	Article						Partial privatization; Relative profit; Mixed oligopoly; Competition policy	RESEARCH-AND-DEVELOPMENT; MIXED OLIGOPOLY; FOREIGN PENETRATION; MARKET-STRUCTURE; PRIVATE FIRMS; DUOPOLY; ENTRY; BEHAVIOR; TAXATION	We investigate the relationship between competition and privatization policies. Existing studies measure the strength of competition based on the number of firms, and show that the optimal degree of privatization is higher in more competitive markets. We introduce an interdependent payoff structure into a mixed oligopoly and revisit this problem. Here, we assume that firms consider their own and other firms' profits. In the model, competition increases when firms are negatively affected by rivals' profits. We find that under the assumption of quadratic production costs, which is popular in mixed oligopolies, the optimal degree of privatization is higher when there is less market competition. This finding contrasts with those of prior studies. However, this result may be reversed when we adopt alternative model formulation. Furthermore, in the constant marginal cost case, the optimal degree of privatization is always lower when there is less market competition, which is opposite to the result in the quadratic cost case. Our results suggest that the relationship between an optimal privatization policy and the strength of competition crucially depends on the market structure, including the cost conditions.	[Matsumura, Toshihiro] Univ Tokyo, Inst Social Sci, Tokyo, Japan; [Okamura, Makoto] Hiroshima Univ, Dept Econ, Higashihiroshima, Hiroshima 7398525, Japan	Okamura, M (reprint author), Hiroshima Univ, Dept Econ, 1-2-1 Kagamiyama, Higashihiroshima, Hiroshima 7398525, Japan.	andrew-uf@galaxy.plala.or.jp	Matsumura, Toshihiro/F-3997-2010	Matsumura, Toshihiro/0000-0003-0572-6516	Murata Science Foundation; JSPS KAKENHI [15k03347]	We are indebted to two anonymous referees and the editor for their valuable and constructive suggestions. We also thank seminar participants at annual meeting of Japanese Economic Association, National Dong Hwa University, Osaka University, and The University of Tokyo for their helpful comments. Needless to say, we are responsible for any remaining errors. This work was supported by Murata Science Foundation and JSPS KAKENHI Grant Numbers 15k03347.	Barcena-Ruiz JC, 2003, J ECON, V80, P27, DOI 10.1007/s00712-002-0605-2; Han L, 2008, FINANZARCHIV, V64, P352, DOI 10.1628/001522108X374179; Cato S, 2012, J INST THEOR ECON, V168, P444; Mukherjee A, 2009, J IND ECON, V57, P870; Matsumura T, 2013, ECON MODEL, V31, P541, DOI 10.1016/j.econmod.2012.12.016; Barcena-Ruiz JC, 2010, PORT ECON J, V9, P97, DOI 10.1007/s10258-010-0054-8; Kockesen L, 2000, J ECON THEORY, V92, P274, DOI 10.1006/jeth.1999.2587; Ishida J, 2011, J IND ECON, V59, P484, DOI 10.1111/j.1467-6451.2011.00461.x; Kato K, 2013, J ECON, V110, P165, DOI 10.1007/s00712-012-0316-2; Matsumura T, 2004, ECONOMICA, V71, P671, DOI 10.1111/j.0013-0427.2004.00394.x; Matsumura T, 2012, JPN ECON REV, V63, P244, DOI 10.1111/j.1468-5876.2012.00572.x; Matsumura T, 2005, J ECON, V84, P27, DOI 10.1007/s00712-004-0098-z; Bose A, 2013, J ECON, V110, P141, DOI 10.1007/s00712-012-0310-8; Matsumura T, 2003, SOUTH ECON J, V70, P403, DOI 10.2307/3648977; Tomaru Y, 2010, J INST THEOR ECON, V166, P591, DOI 10.1628/093245610793524893; Ishibashi I, 2006, EUR ECON REV, V50, P1347, DOI 10.1016/j.euroecorev.2005.04.002; Ishibashi K, 2008, J ECON, V95, P213, DOI 10.1007/s00712-008-0020-4; Wang LFS, 2013, ECON MODEL, V30, P729, DOI 10.1016/j.econmod.2012.11.007; Kato K, 2006, J ECON, V88, P263, DOI 10.1007/s00712-006-0206-6; Matsumura T, 2010, AUST ECON PAP, V49, P149, DOI 10.1111/j.1467-8454.2010.00393.x; Barcena-Ruiz JC, 2012, ECON MODEL, V29, P1019, DOI 10.1016/j.econmod.2012.03.011; Gil-Molto MJ, 2011, SOUTH ECON J, V78, P233; Fujiwara K, 2007, J ECON, V92, P51, DOI 10.1007/s00712-007-0267-1; Matsumura T, 2010, MANCH SCH, V78, P609, DOI 10.1111/j.1467-9957.2009.02147.x; DEFRAJA G, 1989, OXFORD ECON PAP, V41, P302; Cato S, 2013, FINANZARCHIV, V69, P215, DOI 10.1628/001522113X666944; Matsumura T, 2012, B ECON RES, V64, ps22, DOI 10.1111/j.1467-8586.2012.00439.x; VegaRedondo F, 1997, ECONOMETRICA, V65, P375, DOI 10.2307/2171898; Pal D, 1998, ECON LETT, V61, P181, DOI 10.1016/S0165-1765(98)00115-3; Cato S, 2015, ECON REC, V91, P309, DOI 10.1111/1475-4932.12189; Mujumdar S, 1998, ECON LETT, V58, P199, DOI 10.1016/S0165-1765(97)00264-4; Matsumura T, 2013, ECON LETT, V119, P183, DOI 10.1016/j.econlet.2013.02.021; Wang LFS, 2010, J ECON, V100, P33, DOI 10.1007/s00712-010-0117-4; Armstrong M, 2010, 2937 CESIFO; Fjell K, 1996, CAN J ECON, V29, P737, DOI 10.2307/136260; Gibbons R., 1990, IND LABOR RELATIONS, V43, P30; Haraguchi J., 2014, RES EC, V68, P338; Lin MH, 2012, J ECON, V107, P71, DOI 10.1007/s00712-011-0254-4; Matsumura T, 2013, CAN J ECON, V46, P526, DOI 10.1111/caje.12022; Matsumura T, 1998, J PUBLIC ECON, V70, P473, DOI 10.1016/S0047-2727(98)00051-6; MERRILL WC, 1966, Q J ECON, V80, P400, DOI 10.2307/1880727; Naya JM, 2015, J ECON, V116, P165, DOI 10.1007/s00712-014-0416-2; Nishimori A., 2002, AUST ECON PAP, V41, P185, DOI 10.1111/1467-8454.00158; FUMAS VS, 1992, INT J IND ORGAN, V10, P473, DOI 10.1016/0167-7187(92)90008-M	44	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0931-8658	1617-7134		J ECON	J. Econ.	OCT	2015	116	2					137	150		10.1007/s00712-015-0445-5		14	Economics	Business & Economics	CT7ZM	WOS:000363034500003		
J	Vo, HT; Imai, T; Ho, TT; Dang, TLT; Hoang, SA				Huy Thanh Vo; Imai, Tsuyoshi; Truc Thanh Ho; Thanh-Loc Thi Dang; Son Anh Hoang			Potential application of high pressure carbon dioxide in treated wastewater and water disinfection: Recent overview and further trends	JOURNAL OF ENVIRONMENTAL SCIENCES-CHINA			English	Article						High pressure CO2; Inactivation effect; Inactivation mechanism	ESCHERICHIA-COLI INACTIVATION; MICRO-BUBBLE METHOD; LISTERIA-MONOCYTOGENES; PHYSIOLOGICAL SALINE; SUPERCRITICAL CO2; DRINKING-WATER; SACCHAROMYCES-CEREVISIAE; LACTOBACILLUS-PLANTARUM; AMBIENT-TEMPERATURE; BY-PRODUCTS	Recently emerging disadvantages in conventional disinfection have heightened the need for finding a new solution. Developments in the use of high pressure carbon dioxide for food preservation and sterilization have led to a renewed interest in its applicability in wastewater treatment and water disinfection. Pressurized CO2 is one of the most investigated methods of antibacterial treatment and has been used extensively for decades to inhibit pathogens in dried food and liquid products. This study reviews the literature concerning the utility of CO2 as a disinfecting agent, and the pathogen inactivation mechanism of CO2 treatment is evaluated based on all available research. In this paper, it will be argued that the successful application and high effectiveness of CO2 treatment in liquid foods open a potential opportunity for its use in wastewater treatment and water disinfection. The findings from models with different operating conditions (pressure, temperature, microorganism, water content, media ...) suggest that most microorganisms are successfully inhibited under CO2 treatment. It will also be shown that the bacterial deaths under CO2 treatment can be explained by many different mechanisms. Moreover, the findings in this study can help to address the recently emerging problems in water disinfection, such as disinfection by-products (resulting from chlorination or ozone treatment). (C) 2015 The Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences. Published by Elsevier B.V.	[Huy Thanh Vo; Truc Thanh Ho; Son Anh Hoang] Mien Trung Univ Civil Engn, Div Urban Infrastruct Engn, Phu Yen 56000, Vietnam; [Imai, Tsuyoshi; Thanh-Loc Thi Dang] Yamaguchi Univ, Div Environm Sci & Engn, Yamaguchi 7558611, Japan	Vo, HT (reprint author), Mien Trung Univ Civil Engn, Div Urban Infrastruct Engn, Phu Yen 56000, Vietnam.	huypocrisy@gmail.com					Cinquemani C, 2007, J SUPERCRIT FLUID, V42, P392, DOI 10.1016/j.supflu.2006.11.001; HOIGNE J, 1988, WATER RES, V22, P313, DOI 10.1016/S0043-1354(88)90120-0; Kobayashi F, 2009, T ASABE, V52, P1621; Erkmen O, 2000, FOOD MICROBIOL, V17, P225, DOI 10.1006/fmic.1999.0308; Park SJ, 2002, J FOOD SCI, V67, P1827, DOI 10.1111/j.1365-2621.2002.tb08730.x; Shimoda M, 2002, APPL ENVIRON MICROB, V68, P4162, DOI 10.1128/AEM.68.8.4162-4167.2002; Spilimbergo S, 2003, ITAL J FOOD SCI, V15, P115; Ferrentino G, 2010, J SUPERCRIT FLUID, V52, P151, DOI 10.1016/j.supflu.2009.07.005; Debs-Louka E, 1999, APPL ENVIRON MICROB, V65, P626; Gunes G, 2005, J SCI FOOD AGR, V85, P2362, DOI 10.1002/jsfa.2260; Yoshimura T, 2002, J FOOD SCI, V67, P3227, DOI 10.1111/j.1365-2621.2002.tb09570.x; Zhai HY, 2014, ENVIRON SCI TECHNOL, V48, P2579, DOI 10.1021/es4034765; Wimmer Z, 2010, INT J MOL SCI, V11, P233, DOI 10.3390/ijms11010233; Spilimbergo S, 2009, J SUPERCRIT FLUID, V48, P93, DOI 10.1016/j.supflu.2008.07.023; Garcia-Gonzalez L, 2010, FOOD MICROBIOL, V27, P541, DOI 10.1016/j.fm.2009.12.004; HAAS GJ, 1989, J FOOD SAFETY, V9, P253, DOI 10.1111/j.1745-4565.1989.tb00525.x; Spilimbergo S, 2007, J SUPERCRIT FLUID, V40, P485, DOI 10.1016/j.supflu.2006.07.013; Spilimbergo S, 2003, BIOTECHNOL BIOENG, V82, P118, DOI 10.1002/bit.10554; Enomoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1133; Watanabe T, 2003, FOOD SCI TECHNOL RES, V9, P342, DOI 10.3136/fstr.9.342; Erkmen O, 2001, INT J FOOD MICROBIOL, V65, P131, DOI 10.1016/S0168-1605(00)00499-2; Enomoto A, 1997, J FERMENT BIOENG, V83, P305, DOI 10.1016/S0922-338X(97)80999-3; Wu Y, 2007, IND ENG CHEM RES, V46, P6345, DOI 10.1021/ie0702330; LIN HM, 1992, BIOTECHNOL PROGR, V8, P165, DOI 10.1021/bp00014a012; Liu JQ, 2014, WATER RES, V65, P64, DOI 10.1016/j.watres.2014.07.024; Erkmen O, 2000, J SCI FOOD AGR, V80, P1365, DOI 10.1002/1097-0010(200007)80:9<1365::AID-JSFA652>3.3.CO;2-G; Hong SI, 2001, INT J FOOD MICROBIOL, V63, P19, DOI 10.1016/S0168-1605(00)00393-7; Kobayashi F, 2012, INT J FOOD SCI TECH, V47, P1151, DOI 10.1111/j.1365-2621.2012.02954.x; Cheng XH, 2011, APPL MICROBIOL BIOT, V90, P1493, DOI 10.1007/s00253-011-3163-0; Mun S, 2011, INT J FOOD MICROBIOL, V144, P372, DOI 10.1016/j.ijfoodmicro.2010.10.022; Noma S, 2010, FOOD SCI TECHNOL RES, V16, P389, DOI 10.3136/fstr.16.389; Kobayashi F, 2007, FOOD SCI TECHNOL RES, V13, P20, DOI 10.3136/fstr.13.20; Vo HT, 2014, J ENVIRON SCI-CHINA, V26, P1301, DOI 10.1016/S1001-0742(13)60603-8; WEI CI, 1991, J FOOD PROTECT, V54, P189; LIN HM, 1993, CHEM ENG J BIOCH ENG, V52, pB29; Li J, 2013, INDIAN J MICROBIOL, V53, P352, DOI 10.1007/s12088-013-0373-4; Klangpetch W, 2011, BIOSCI BIOTECH BIOCH, V75, P1945, DOI 10.1271/bbb.110325; FRASER D, 1951, NATURE, V167, P33, DOI 10.1038/167033b0; Oule MK, 2006, CAN J MICROBIOL, V52, P1208, DOI 10.1139/W06-078; Shimoda M, 1998, J FOOD SCI, V63, P709; HUTKINS RW, 1993, J DAIRY SCI, V76, P2354, DOI 10.3168/jds.S0022-0302(93)77573-6; Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344; Sirisee U, 1998, J FOOD PROCESS PRES, V22, P387, DOI 10.1111/j.1745-4549.1998.tb00358.x; Hong SI, 1999, J FOOD SCI, V64, P728, DOI 10.1111/j.1365-2621.1999.tb15120.x; LIN HM, 1994, J FOOD SCI, V59, P657, DOI 10.1111/j.1365-2621.1994.tb05587.x; Erkmen O, 2000, J SCI FOOD AGR, V80, P465, DOI 10.1002/(SICI)1097-0010(200003)80:4<465::AID-JSFA550>3.0.CO;2-E; Krasner SW, 2006, ENVIRON SCI TECHNOL, V40, P7175, DOI 10.1021/es060353j; Kobayashi F, 2010, T ASABE, V53, P1217; Zhang J, 2006, J MICROBIOL METH, V66, P479, DOI 10.1016/j.mimet.2006.01.012; Ishikawa H, 1997, BIOSCI BIOTECH BIOCH, V61, P1022; Boorman GA, 1999, ENVIRON HEALTH PERSP, V107, P207, DOI 10.2307/3434484; Garcia-Gonzalez L, 2007, INT J FOOD MICROBIOL, V117, P1, DOI 10.1016/j.ijfoodmicro.2007.02.018; NAKAMURA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1297; Erkmen O, 2001, J BIOSCI BIOENG, V92, P39, DOI 10.1263/jbb.92.39; Erkmen O, 2000, FOOD MICROBIOL, V17, P589, DOI 10.1006/fmic.2000.0361; Kim SR, 2007, J MICROBIOL METH, V70, P132, DOI 10.1016/j.mimet.2007.04.003; Jung WY, 2009, INT J FOOD MICROBIOL, V136, P66, DOI 10.1016/j.ijfoodmicro.2009.08.014; Spilimbergo S, 2005, BIOTECHNOL BIOENG, V92, P447, DOI 10.1002/bit.20606; Mun S, 2012, INT J FOOD MICROBIOL, V153, P15, DOI 10.1016/j.ijfoodmicro.2011.10.008; Erkmen O, 2001, J FOOD ENG, V47, P7, DOI 10.1016/S0260-8774(00)00091-1; Takahashi M, 2007, J PHYS CHEM B, V111, P11443, DOI 10.1021/jp074727m; ISHIKAWA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1949; Ballestra P, 1998, FOOD SCI TECHNOL-LEB, V31, P84; Hong SI, 1999, INT J FOOD SCI TECH, V34, P125, DOI 10.1046/j.1365-2621.1999.00241.x; Kobayashi F, 2012, LWT-FOOD SCI TECHNOL, V48, P330, DOI 10.1016/j.lwt.2012.04.011; Schmidt A, 2005, J CLEAN PROD, V13, P881, DOI [10.1016/j.jclepro.2004.03.003, 10.1016/j.jcelpro.2004.03.003]; Kim SR, 2008, J MICROBIOL METH, V75, P47, DOI 10.1016/j.mimet.2008.04.012; KAMIHIRA M, 1987, AGR BIOL CHEM TOKYO, V51, P407; Kobayashi Fumiyuki, 2009, Journal of Water and Environmental Technology, V7, DOI 10.2965/jwet.2009.241; Kuhne K., 1990, EUROPEAN FOOD SCI, V41, P55; Kumugai H., 1997, BIOSCIENCE BIOTECHNO, V61, P931; Lide D. R., 1991, HDB CHEM PHYS; LIN HM, 1992, BIOTECHNOL PROGR, V8, P458, DOI 10.1021/bp00017a013; Spilimbergo S., 2002, J SUPERCRIT FLUID, V22, P55063; Spilimbergo S, 2003, BIOTECHNOL BIOENG, V84, P627, DOI 10.1002/bit.10783; Spilimbergo S., 2003, EMERGING TECHNOL, V4, P161; Vo H. T., 2013, WATER RES, V47, P4286; Vo H.T., 2013, J WATER ENV TECHNOL, V16, P497	78	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1001-0742	1878-7320		J ENVIRON SCI-CHINA	J. Environ. Sci.	OCT 1	2015	36						38	47		10.1016/j.jes.2015.04.006		10	Environmental Sciences	Environmental Sciences & Ecology	CT7GT	WOS:000362983500005		
J	Choi, PG; Ohno, T; Masui, T; Imanaka, N				Choi, Pil-Gyu; Ohno, Takanobu; Masui, Toshiyuki; Imanaka, Nobuhito			Catalytic liquid-phase oxidation of acetaldehyde to acetic acid over a Pt/CeO2-ZrO2-SnO2/gamma-alumina catalyst	JOURNAL OF ENVIRONMENTAL SCIENCES-CHINA			English	Article						Liquid-phase oxidation; Acetaldehyde; Rare earths; Catalyst	WET AIR OXIDATION; CARBON; WATER; GOLD	Pt/CeO2-ZrO2-SnO2/gamma-Al2O3 catalysts were prepared by co-precipitation and wet impregnation methods for catalytic oxidation of acetaldehyde to acetic acid in water. In the present catalysts, Pt and CeO2-ZrO2-SnO2 were successfully dispersed on the gamma-Al2O3 support. Dependences of platinum content and reaction time on the selective oxidation of acetaldehyde to acetic acid were investigated to optimize the reaction conditions for obtaining both high acetaldehyde conversion and highest selectivity to acetic acid. Among the catalysts, a Pt(6.4 wt.%)/Ce0.68Zr0.17Sn0.15O2.0(16 wt.%)/gamma-Al2O3 catalyst showed the highest acetaldehyde oxidation activity. On this catalyst, acetaldehyde was completely oxidized after the reaction at 0 degrees C for 8 hr, and the selectivity to acetic acid reached to 95% and higher after the reaction for 4 hr and longer. (C) 2015 The Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences. Published by Elsevier B.V.	[Choi, Pil-Gyu; Ohno, Takanobu; Masui, Toshiyuki; Imanaka, Nobuhito] Osaka Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Imanaka, N (reprint author), Osaka Univ, Fac Engn, Dept Appl Chem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	CHOI-PG@chem.eng.osaka-u.ac.jp; imanaka@chem.eng.osaka-u.ac.jp					Yasuda K, 2012, B CHEM SOC JPN, V85, P522, DOI 10.1246/bcsj.20110382; Kokoh KB, 2004, ELECTROCHIM ACTA, V49, P2077, DOI 10.1016/j.electacta.2003.11.015; Demirel-Gulen S, 2005, CATAL TODAY, V102, P166, DOI 10.1016/j.cattod.2005.02.033; MISHRA VS, 1995, IND ENG CHEM RES, V34, P2, DOI 10.1021/ie00040a001; Prati L, 1998, J CATAL, V176, P552, DOI 10.1006/jcat.1998.2078; Keav S, 2014, APPL CATAL B-ENVIRON, V150, P402, DOI 10.1016/j.apcatb.2013.12.028; Lei L, 2007, APPL CATAL A-GEN, V327, P287, DOI 10.1016/j.apcata.2007.05.027; Suprun WY, 2006, CHEM ENG TECHNOL, V29, P1376, DOI 10.1002/ceat.200600099; Mohamed AA, 2008, TALANTA, V74, P578, DOI 10.1016/j.talanta.2007.06.020; Munoz-Batista MJ, 2014, CHEM ENG J, V255, P297, DOI 10.1016/j.cej.2014.06.056; Kim KH, 2011, J HAZARD MATER, V186, P16, DOI 10.1016/j.jhazmat.2010.11.011; Saleh TA, 2011, CHEM ENG J, V166, P407, DOI 10.1016/j.cej.2010.10.070; WANG SQ, 1992, COMPUT IND, V18, P213; VENUGOPA.B, 1967, IND ENG CHEM PROC DD, V6, P139, DOI 10.1021/i260021a024	14	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1001-0742	1878-7320		J ENVIRON SCI-CHINA	J. Environ. Sci.	OCT 1	2015	36						63	66		10.1016/j.jes.2015.04.017		4	Environmental Sciences	Environmental Sciences & Ecology	CT7GT	WOS:000362983500008		
J	Yamaguchi, K; Tomiyama, S; Metugi, H; Ii, H; Ueda, A				Yamaguchi, Kohei; Tomiyama, Shingo; Metugi, Hideya; Ii, Hiroyuki; Ueda, Akira			Flow and geochemical modeling of drainage from Tomitaka mine, Miyazaki, Japan	JOURNAL OF ENVIRONMENTAL SCIENCES-CHINA			English	Article						Mine drainage; Hydrogen isotope; Oxygen isotope; Rock-water interaction; Water movement	GROUNDWATER CHEMISTRY; PYRITE OXIDATION; ROCK; WATER; KINETICS; SURFACE; KOREA; AREA	The chemistry and flow of water in the abandoned Tomitaka mine of Miyazaki, western Japan were investigated. This mine is located in a non-ferrous metal deposit and acid mine drainage issues from it. The study was undertaken to estimate the quantities of mine drainage that needs to be treated in order to avoid acidification of local rivers, taking into account seasonal variations in rainfall. Numerical models aimed to reproduce observed water levels and fluxes and chemical variations of groundwater and mine drainage. Rock-water interactions that may explain the observed variations in water chemistry are proposed. The results show that: (1) rain water infiltrates into the deeper bedrock through a highly permeable zone formed largely by stopes that are partially filled with spoil from excavations (ore minerals and host rocks); (2) the water becomes acidic (pH from 3 to 4) as dissolved oxygen oxidizes pyrite; (3) along the flow path through the rocks, the redox potential of the water becomes reducing, such that pyrite becomes stable and pH of the mine drainage becomes neutral; and (4) upon leaving the mine, the drainage becomes acidic again due to oxidation of pyrite in the rocks. The present numerical model with considering of the geochemical characteristics can simulate the main variations in groundwater flow and water levels in and around the Tomitaka mine, and apply to the future treatment of the mine drainage. (C) 2015 The Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences. Published by Elsevier B.V.	[Yamaguchi, Kohei] Mitsubishi Mat Corp, Omiya, Saitama 3300835, Japan; [Tomiyama, Shingo] Mitsubishi Mat Techno Corp, Chiyoda Ku, Tokyo 1028205, Japan; [Tomiyama, Shingo] Wakayama Univ, Fac Syst Engn, Wakayama 1130033, Japan; [Metugi, Hideya] Japan Oil Gas & Met Natl Corp, Tokyo 1050001, Japan; [Ueda, Akira] Toyama Univ, Grad Sch, Div Sci & Engn, Toyama 9308555, Japan	Yamaguchi, K (reprint author), Mitsubishi Mat Corp, 1-297 Kitabukuro, Omiya, Saitama 3300835, Japan.	kyama@mmc.co.jp					Gammons CH, 2010, CHEM GEOL, V269, P100, DOI 10.1016/j.chemgeo.2009.05.026; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; Wunsch DR, 1999, INT J COAL GEOL, V41, P73, DOI 10.1016/S0166-5162(99)00012-9; Iwatsuki T, 1999, GEOCHEM J, V33, P19; Lee JS, 2006, J GEOCHEM EXPLOR, V88, P37, DOI 10.1016/j.gexplo.2005.08.012; DANSGAARD W, 1964, TELLUS, V16, P436; Bain JG, 2000, J CONTAM HYDROL, V41, P23, DOI 10.1016/S0169-7722(99)00069-8; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Molson JW, 2005, J CONTAM HYDROL, V78, P343, DOI 10.1016/j.jconhyd.2005.06.005; Tomiyama S, 2009, BUNSEKI KAGAKU, V58, P865; LASAGA AC, 1984, J GEOPHYS RES, V89, P4009, DOI 10.1029/JB089iB06p04009; Castendyk DN, 2007, CHEM GEOL, V244, P56, DOI 10.1016/j.chemgeo.2007.06.005; COLEMAN ML, 1982, ANAL CHEM, V54, P993, DOI 10.1021/ac00243a035; Razowska L, 2001, J HYDROL, V244, P17, DOI 10.1016/S0022-1694(00)00420-0; Hazen JM, 2002, ENVIRON GEOCHEM HLTH, V24, P1, DOI 10.1023/A:1013956700322; Sracek O, 2004, J CONTAM HYDROL, V69, P45, DOI 10.1016/S0169-7722(03)00150-5; MIZOTA C, 1994, GEOCHEM J, V28, P387; Garrels R M, 1965, SOLUTIONS MINERALS E, P450; Hishiya T., 1999, J CONSTR MANAG ENG, V638, P59; Inai N., 1963, REPORT GEOLOGICAL SU, V72, P1; Kageyama S., 2010, Journal of Japan Society of Hydrology and Water Resources, V23, P301, DOI 10.3178/jjshwr.23.301; Kinoshita K., 1961, JAPAN LOCAL MINE DEP, P415; Krauskopf K. B., 1979, INTRO GEOCHEMISTRYIN, P545; Lawrence J. R., 1991, SPECIAL PUBLICATION, V3, P169; Mahara Y., 2006, J GROUNDWATER HYDRO, V48, P17; Matsubaya O., 1975, B GEOL SURV JAPAN, V26, P375; Okumura T., 2003, RESOUR GEOL, V53, P173; Parkhurst D.L., 1999, USERS GUIDE PHREEQC, P99; Stumm W., 1995, AQUATIC CHEM CHEM EQ, P1022; Tomiyama S., 2010, J MMIJ, V126, P31, DOI 10.2473/journalofmmij.126.31; Tomiyama S., 2010, J JAPAN ASS GROUNDW, V52, P261; Tomiyama S., 2008, P 36 IAH C 2008 TOYA; Tomiyama S., 2010, J JPN SOC ANAL CHEM, V60, P131; U. S. Geological Survey, 2004, 20045001 US GEOL SUR, P1; Ueda H., 2005, J MIN MAT PROCESS I, V121, P323; WILLIAMSON MA, 1994, GEOCHIM COSMOCHIM AC, V58, P5443, DOI 10.1016/0016-7037(94)90241-0	36	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1001-0742	1878-7320		J ENVIRON SCI-CHINA	J. Environ. Sci.	OCT 1	2015	36						130	143		10.1016/j.jes.2015.05.012		14	Environmental Sciences	Environmental Sciences & Ecology	CT7GT	WOS:000362983500016		
J	Kuriya, S; Hattori, M; Nagano, Y; Itino, T				Kuriya, S.; Hattori, M.; Nagano, Y.; Itino, T.			Altitudinal flower size variation correlates with local pollinator size in a bumblebee-pollinated herb, Prunella vulgaris L. (Lamiaceae)	JOURNAL OF EVOLUTIONARY BIOLOGY			English	Article						flower-pollinator size match; local adaptation; male fitness; pollen removal and deposition; selection mosaic	FLORAL ADAPTATION; DARWINS RACE; SELECTION; EVOLUTION; TRAITS; ORCHID; DIFFERENTIATION; COEVOLUTION; DIVERGENCE; MORPHOLOGY	The influence of locally different species interactions on trait evolution is a focus of recent evolutionary studies. However, few studies have demonstrated that geographically different pollinator-mediated selection influences geographic variation in floral traits, especially across a narrow geographic range. Here, we hypothesized that floral size variation in the Japanese herb Prunella vulgaris L. (Lamiaceae) is affected by geographically different pollinator sizes reflecting different pollinator assemblages. To evaluate this hypothesis, we posed two questions. (1) Is there a positive correlation between floral length and the proboscis length of pollinators (bumblebees) across altitude in a mountain range? (2) Does the flower-pollinator size match influence female and male plant fitness? We found geographic variation in the assemblage of pollinators of P.vulgaris along an altitudinal gradient, and, as a consequence, the mean pollinator proboscis length also changed altitudinally. The floral corolla length of P.vulgaris also varied along an altitudinal gradient, and this variation strongly correlated with the local pollinator size but did not correlate with altitude itself. Furthermore, we found that the size match between the floral corolla length and bee proboscis length affected female and male plant fitness and the optimal size match (associated with peak fitness) was similar for the female and male fitness. Collectively, these results suggest that pollinator-mediated selection influences spatial variation in the size of P.vulgaris flowers at a fine spatial scale.	[Kuriya, S.; Hattori, M.; Nagano, Y.; Itino, T.] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan; [Itino, T.] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 3908621, Japan	Itino, T (reprint author), Shinshu Univ, Fac Sci, Dept Biol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	itinot@shinshu-u.ac.jp			Global Environmental Research Fund of Ministry of the Environment, Japan [D-0904]; Japanese Alps Inter-Universities Cooperative Project, MEXT, Japan	We thank A. S. Hirao and S. Ueda for technical support and helpful discussion, S. Egawa for drawing the figures and S. Duhon for English editing. This study was supported by the Global Environmental Research Fund (D-0904) of the Ministry of the Environment, Japan, and by Research and Education Funding for Japanese Alps Inter-Universities Cooperative Project, MEXT, Japan. We thank the Chubu Regional Office for Nature Conservation and the Nagano Prefectural government for permission to work in the area.	Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Sun M, 2014, ANN BOT-LONDON, V113, P289, DOI 10.1093/aob/mct219; Toju H, 2008, EVOLUTION, V62, P1086, DOI 10.1111/j.1558-5646.2008.00341.x; Gomez JM, 2009, ECOL MONOGR, V79, P245, DOI 10.1890/08-0511.1; Nagano Y, 2014, ECOL EVOL, V4, P3395, DOI 10.1002/ece3.1191; JOHNSON SG, 1995, OECOLOGIA, V102, P174, DOI 10.1007/BF00333249; Scobell SA, 2002, AM MIDL NAT, V147, P1, DOI 10.1674/0003-0031(2002)147[0001:VAFTOA]2.0.CO;2; NELSON AP, 1967, NEW PHYTOL, V66, P707, DOI 10.1111/j.1469-8137.1967.tb05441.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Pauw A, 2009, EVOLUTION, V63, P268, DOI 10.1111/j.1558-5646.2008.00547.x; Cosacov A, 2014, ANN BOT-LONDON, V113, P251, DOI 10.1093/aob/mct239; Kulbaba MW, 2012, EVOLUTION, V66, P1344, DOI 10.1111/j.1558-5646.2011.01536.x; LAVERTY TM, 1994, ANIM BEHAV, V47, P531, DOI 10.1006/anbe.1994.1077; Newman E, 2014, ANN BOT-LONDON, V113, P373, DOI 10.1093/aob/mct203; WINN AA, 1993, OECOLOGIA, V93, P55; Sahli HF, 2011, EVOLUTION, V65, P1457, DOI 10.1111/j.1558-5646.2011.01229.x; Zhang F, 2013, EVOLUTION, V67, P548, DOI 10.1111/j.1558-5646.2012.01796.x; Dohzono Ikumi, 2011, International Journal of Insect Science, V3, P1; Peter CI, 2014, ANN BOT-LONDON, V113, P277, DOI 10.1093/aob/mct216; Anderson B, 2008, EVOLUTION, V62, P220, DOI 10.1111/j.1558-5646.2007.00275.x; Galen C, 1996, EVOLUTION, V50, P120, DOI 10.2307/2410786; Gomez JM, 2009, ECOL LETT, V12, P672, DOI 10.1111/j.1461-0248.2009.01324.x; WINN AA, 1987, ECOLOGY, V68, P1224, DOI 10.2307/1939206; Boberg E, 2014, ANN BOT-LONDON, V113, P267, DOI 10.1093/aob/mct217; Gomez JM, 2006, AM NAT, V168, P531, DOI 10.1086/507048; Chittka L., 2001, COGNITIVE ECOLOGY PO; Endler J A, 1977, Monogr Popul Biol, V10, P1; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; Hattori M., 2014, American Journal of Plant Sciences, V5, P2686, DOI 10.4236/ajps.2014.518283; Hayashi Y., 1989, WILD FLOWERS JAPAN P, P162; Hayashi Y., 2009, WILD FLOWERS JAPAN, P212; Herrera CM, 2006, ECOLOGY EVOLUTION FL, P278; Kato Makoto, 1993, Honeybee Science, V14, P110; Miyajima Y., 2007, VEG SCI, V24, P174; Nakamura J, 1980, DIAGNOSTIC CHARACT 1; Nakamura J., 1980, DIAGNOSTIC CHARACT 2; Ollerton J., 2006, PLANT POLLINATOR INT; Pellmyr Olle, 2002, P157; Strauss SY, 2006, ECOLOGY EVOLUTION FL, P120; Tomono Tatsuya, 1997, Japanese Journal of Entomology, V65, P237	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1010-061X	1420-9101		J EVOLUTION BIOL	J. Evol. Biol.	OCT	2015	28	10					1761	1769		10.1111/jeb.12693		9	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	CT6AI	WOS:000362892300003		
J	Hori, H; Yokota, H				Hori, Hisao; Yokota, Hiroaki			Efficient oxygen-induced decomposition of triphenylsulfonium trifluoromethanesulfonate to fluoride ions in subcritical water	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Recovery; Supercritical water; Iron; Mineralization; PFOS	DISPROPORTIONATION; DESTRUCTION; LITHOGRAPHY; WUSTITE; IRON	Decomposition of [(C6H5)(3)S][CF3SO3] in subcritical water, specifically, in the presence of either an iron-based reducing agent (zerovalent iron or FeO) or an oxidizing agent (O-2), was investigated with the aim of developing a technique to recover the fluorine component from the liquid waste. This is the first report on the decomposition of salts consisting of perfluoroalkanesulfonates and organic cations, which are widely used in the electronics industry as photoacid generators. The highest F- yield was achieved by the reaction in the presence of O-2 at a temperature close to the critical point: when the reaction was carried out at 372 degrees C for 6 h, the F- yield reached 93.6%, indicating that almost all the fluorine atoms in the anionic moiety, CF3SO3-, were transformed into F- ions. In addition, the formation of CHF3 and benzene was suppressed by the use of O-2. Whereas the CF3SO3- in [(C6H5)(3)S][CF3SO3] was efficiently decomposed to F- ions in the presence of O-2, the CF3SO3- in the corresponding potassium salt, CF3SO3K, was less reactive: the F- yield of the reaction in the presence of O-2 at 373 degrees C for 6 h was only 57.1%, indicating that the cation in these salts affects the reactivity of the anion. (C) 2015 Elsevier B.V. All rights reserved.	[Hori, Hisao; Yokota, Hiroaki] Kanagawa Univ, Dept Chem, Fac Sci, Hiratsuka, Kanagawa 2591293, Japan	Hori, H (reprint author), Kanagawa Univ, Dept Chem, Fac Sci, 2946 Tsuchiya, Hiratsuka, Kanagawa 2591293, Japan.	h-hori@kanagawa-u.ac.jp			Japan Society from the Promotion of Science [24310061, 15H02841]	This work was supported by grants from the Japan Society from the Promotion of Science (nos. 24310061 and 15H02841).	Kawasaki SI, 2006, PROCESS SAF ENVIRON, V84, P317, DOI 10.1205/psep.05187; Ahrens L, 2011, J ENVIRON MONITOR, V13, P20, DOI 10.1039/c0em00373e; Pawloski AR, 2002, J PHOTOPOLYM SCI TEC, V15, P731, DOI 10.2494/photopolymer.15.731; Hori H, 2006, ENVIRON SCI TECHNOL, V40, P1049, DOI 10.1021/es0517419; Hawthorne SB, 2000, ENVIRON SCI TECHNOL, V34, P3224, DOI 10.1021/es991431o; STOLEN S, 1995, THERMOCHIM ACTA, V256, P91, DOI 10.1016/0040-6031(94)02166-L; Hori H, 2013, IND ENG CHEM RES, V52, P13622, DOI 10.1021/ie4017573; Dammel RR, 2005, J PHOTOPOLYM SCI TEC, V18, P593, DOI 10.2494/photopolymer.18.593; BROUSSAR.L, 1969, J PHYS CHEM-US, V73, P1848, DOI 10.1021/j100726a035; Giesy J. P., 2002, ENVIRON SCI TECHNOL, V36, p146A, DOI DOI 10.1021/ES022253T; IPCC, 2013, 5 ASS REP CLIM CHANG; Leitner W., 1999, CHEM SYNTHESIS USING; TESTER JW, 1993, ACS SYM SER, V518, P35; UNEP, 2009, 4 M C PART STOCKH CO; UNEP, 2011, PERS ORG POLL REV CO	15	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	OCT	2015	178						1	5		10.1016/j.jfluchem.2015.06.012		5	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CT6NL	WOS:000362929600001		
J	Kasuya, MC; Isozaki, K; Miyamura, K; Hatanaka, K				Kasuya, Maria Carmelita; Isozaki, Katsuya; Miyamura, Kazuo; Hatanaka, Kenichi			Fluorous solvent effect on cells cultured on collagen membrane at the interface	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Fluorous solvent; Anchorage-dependent cells; Collagen membrane; Liquid-liquid interface culture; Cell spreading	LIQUID INTERFACES; OXYGEN; PERFLUOROCARBON; GROWTH; ATTACHMENT; SYSTEM	The culture of various kinds of anchorage-dependent cells (mouse melanoma B16, Mardin Darby canine kidney (MDCK), mouse embryonic fibroblast 3T3, and human hepatocarcinoma HepG2) on collagen membrane at the interface between the aqueous culture medium layer and fluorous solvent layer was investigated. Results showed that collagen membrane supported cell adhesion and proliferation during liquid-liquid interface culture. An increase in cell viability was observed, when cells were grown on a collagen membrane as compared with cells cultured in the absence of a solid scaffold. This research also confirmed that the fluorous solvent has an effect on cell morphology on collagen surface. Cells were rounded on collagen surface, when dodecafluoroheptanol was used. On the other hand, cell spreading was observed when cultured on collagen surface at the interface using perfluorohexane. The cells exhibited typical spreading on collagen surface in contact with the culture medium and also at the reverse side of the collagen surface in contact with perfluorohexane. (C) 2015 Elsevier B.V. All rights reserved.	[Kasuya, Maria Carmelita; Isozaki, Katsuya; Hatanaka, Kenichi] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Isozaki, Katsuya; Miyamura, Kazuo] Tokyo Univ Sci, Shinjuku Ku, Tokyo 1628601, Japan	Hatanaka, K (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	hatanaka@iis.u-tokyo.ac.jp					Miyajima H, 2014, J FLUORINE CHEM, V163, P46, DOI 10.1016/j.jfluchem.2014.04.010; SCHOR SL, 1979, J CELL SCI, V38, P267; Rappaport C, 2002, BIOTECHNIQUES, V32, P142; CHO MH, 1988, BIOTECHNOL LETT, V10, P855, DOI 10.1007/BF01026995; KEESE CR, 1983, P NATL ACAD SCI-BIOL, V80, P5622, DOI 10.1073/pnas.80.18.5622; DYATKIN BL, 1965, TETRAHEDRON, V21, P2991, DOI 10.1016/S0040-4020(01)96918-2; ANDO J, 1991, IN VITRO CELL DEV B, V27, P525; Lowe KC, 2001, J FLUORINE CHEM, V109, P59, DOI 10.1016/S0022-1139(01)00374-8; TSUKAMOTO K, 1992, BIOCHEM J, V286, P491; AUMAILLEY M, 1986, J CELL BIOL, V103, P1569, DOI 10.1083/jcb.103.4.1569; Shiba Y, 1998, BIOTECHNOL BIOENG, V57, P583, DOI 10.1002/(SICI)1097-0290(19980305)57:5<583::AID-BIT10>3.0.CO;2-D; Lowe KC, 1999, ARTIF CELL BLOOD SUB, V27, P255, DOI 10.3109/10731199909117698; Gao FG, 2004, BIOTECHNOL BIOENG, V86, P425, DOI 10.1002/bit.20010; Davis J. M., 1996, BASIC CELL CULTURE P; GIAEVER I, 1983, P NATL ACAD SCI-BIOL, V80, P219, DOI 10.1073/pnas.80.1.219; Lowe K., 2001, J FLUORINE CHEM, V118, P19; Speeckaert R, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12235; Tanaka Y., 2011, BREAKTHROUGHS MELANO, P642; Vendruscolo F., 2012, ISRN CHEM ENG; Wesseler E., 1977, J FLUORINE CHEM, V9, P136	20	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	OCT	2015	178						183	186		10.1016/j.jfluchem.2015.07.022		4	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CT6NL	WOS:000362929600026		
J	Zhang, N; Zhou, XM; Quan, HD; Sekiya, A				Zhang, Ni; Zhou, Xiaomeng; Quan, Hengdao; Sekiya, Akira			Study on the synthesis of toluene-2,4-diisocyanate via amine and carbonyl fluoride	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Toluene diisocyanate; Carbonyl fluoride; Amine; Synthesis	ISOCYANATES; CHEMISTRY; CATALYSTS	We presented recently a synthesis of toluene-2,4-diisocyanate (TDI) as one of the nine examples to verify the feasibility of an industrial appealing two-step method for isocyanates synthesis via amines and carbonyl fluoride (COF2). Because more investigation was considered to be necessary for future industrial application, the two-step synthesis processes of TDI were studied in detail herein. The total yield of TDI increased 5.6% under the optimized experimental conditions. The influence of the excess COF2 left in the reaction system was studied carefully according to a one-pot method. (C) 2015 Elsevier B.V. All rights reserved.	[Zhang, Ni; Quan, Hengdao] Beijing Inst Technol, Sch Chem Engn & Environm, Beijing 100081, Peoples R China; [Zhou, Xiaomeng; Quan, Hengdao; Sekiya, Akira] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Quan, HD (reprint author), Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	hengdao-quan@aist.go.jp					OZAKI S, 1972, CHEM REV, V72, P457, DOI 10.1021/cr60279a002; Wang YJ, 2001, J CHEM TECHNOL BIOT, V76, P857, DOI 10.1002/jctb.455; FAWCETT FS, 1962, J AM CHEM SOC, V84, P4275, DOI 10.1021/ja00881a017; UGO R, 1991, J ORGANOMET CHEM, V417, P211, DOI 10.1016/0022-328X(91)80175-J; Quan HD, 2015, J FLUORINE CHEM, V176, P26, DOI 10.1016/j.jfluchem.2015.05.007; MANOVYUVENSKII VI, 1980, B ACAD SCI USSR CH+, V29, P117, DOI 10.1007/BF00951891; Biskup K., 2010, U.S. Patent, Patent No. [2010/0152484 A1, 20100152484]; Mitsui Y., 2008, U.S. Patent, Patent No. [7371898 B2, 7371898]; Miyake N., 2014, U.S. Patent, Patent No. [8895774 B2, 8895774]; Murayama K., 2013, U.S. Patent, Patent No. [2013/0109881A1, 20130109881]; Ohno H., 2014, U.S. Patent, Patent No. [8664438 B2, 8664438]; Quan H.D., 2013, J.P. Patent, Patent No. 5322183; Quan H.D., 2007, W.O. Patent, Patent No. [2007/037468, 2007037468]; Richter R.H., 1998, KIRK OTHMER ENCY CHE, V14, P446; Scott JA, 1974, U.S. Patent, Patent No. 3812169; Serrano F.L., 2008, U.S. Patent, Patent No. [7423171 B2, 7423171]; Tan X.S., 2004, CHEM IND TIMES, V18, P14; Woelfert A., 2006, U.S. Patent, Patent No. [7112694 B2, 7112694]	18	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	OCT	2015	178						208	213		10.1016/j.jfluchem.2015.07.025		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CT6NL	WOS:000362929600030		
J	Fujihara, A; Matsuo, S; Tajiri, M; Wada, Y; Hayakawa, S				Fujihara, Akimasa; Matsuo, Sou; Tajiri, Michiko; Wada, Yoshinao; Hayakawa, Shigeo			Hypervalent radical formation probed by electron transfer dissociation of zwitterionic tryptophan and tryptophan-containing dipeptides complexed with Ca2+ and 18-crown-6 in the gas phase	JOURNAL OF MASS SPECTROMETRY			English	Article						fragmentation; ammonium radical; reaction intermediate; hydrogen atom transfer; proton transfer	AROMATIC-AMINO-ACIDS; ENANTIOMER-SELECTIVE PHOTOLYSIS; ION-BEAM SPECTROSCOPY; DOUBLE RYDBERG ANIONS; PROTONATED TRYPTOPHAN; EXCITED-STATE; MOLECULAR CLUSTERS; PHOTOELECTRON-SPECTROSCOPY; CAPTURE DISSOCIATION; HYDROGEN-TRANSFER	The relationship between peptide structure and electron transfer dissociation (ETD) is important for structural analysis by mass spectrometry. In the present study, the formation, structure and reactivity of the reaction intermediate in the ETD process were examined using a quadrupole ion trap mass spectrometer equipped with an electrospray ionization source. ETD product ions of zwitterionic tryptophan (Trp) and Trp-containing dipeptides (Trp-Gly and Gly-Trp) were detected without reionization using non-covalent analyte complexes with Ca2+ and 18-crown-6 (18C6). In the collision-induced dissociation, NH3 loss was the main dissociation pathway, and loss related to the dissociation of the carboxyl group was not observed. This indicated that Trp and its dipeptides on Ca2+(18C6) adopted a zwitterionic structure with an NH3+ group and bonded to Ca2+(18C6) through the COO- group. Hydrogen atom loss observed in the ETD spectra indicated that intermolecular electron transfer from a molecular anion to the NH3+ group formed a hypervalent ammonium radical, R-NH3, as a reaction intermediate, which was unstable and dissociated rapidly through N-H bond cleavage. In addition, N-C bond cleavage forming the z(1) ion was observed in the ETD spectra of Trp-GlyCa(2+)(18C6) and Gly-TrpCa(2+)(18C6). This dissociation was induced by transfer of a hydrogen atom in the cluster formed via an N-H bond cleavage of the hypervalent ammonium radical and was in competition with the hydrogen atom loss. The results showed that a hypervalent radical intermediate, forming a delocalized hydrogen atom, contributes to the backbone cleavages of peptides in ETD. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Fujihara, Akimasa; Matsuo, Sou; Hayakawa, Shigeo] Osaka Prefecture Univ, Dept Chem, Sakai, Osaka 5998531, Japan; [Tajiri, Michiko; Wada, Yoshinao] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Mol Med, Sakai, Osaka 5941101, Japan	Fujihara, A (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Naka Ku, I-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	fujihara@c.s.osakafu-u.ac.jp					Pino GA, 1999, J CHEM PHYS, V111, P10747, DOI 10.1063/1.480437; Lioe H, 2004, J AM SOC MASS SPECTR, V15, P65, DOI 10.1067/j.jasms.2003.09.011; Gregoire G, 2007, J AM CHEM SOC, V129, P6223, DOI 10.1021/ja069050f; Talbot FO, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1850459; Fujihara A, 2008, J PHYS CHEM A, V112, P1457, DOI 10.1021/jp709614e; Ishiuchi S, 2002, J CHEM PHYS, V117, P7077, DOI 10.1063/1.1508103; GELLENE GI, 1984, J PHYS CHEM-US, V88, P6680, DOI 10.1021/j150670a035; Hayakawa S, 2010, J AM SOC MASS SPECTR, V21, P1482, DOI 10.1016/j.jasms.2010.05.010; Fujihara A, 2009, J PHYS CHEM A, V113, P8169, DOI 10.1021/jp902451k; Kang H, 2004, PHYS CHEM CHEM PHYS, V6, P2628, DOI 10.1039/b315425d; Zubarev RA, 2003, MASS SPECTROM REV, V22, P57, DOI 10.1002/mas.10042; Kang H, 2005, PHYS CHEM CHEM PHYS, V7, P394, DOI 10.1039/b414986f; Gregoire G, 2009, EUR PHYS J D, V51, P109, DOI 10.1140/epjd/e2008-00085-3; Gamez F, 2011, INT J MASS SPECTROM, V308, P217, DOI 10.1016/j.ijms.2011.06.015; Dunbar RC, 2009, J PHYS CHEM A, V113, P845, DOI 10.1021/jp8087176; Fujihara A, 2015, J MASS SPECTROM, V50, P451, DOI 10.1002/jms.3547; Fujihara A, 2014, CHEM PHYS LETT, V610, P228, DOI 10.1016/j.cplett.2014.07.045; Snoek LC, 2001, PHYS CHEM CHEM PHYS, V3, P1819, DOI 10.1039/b101296g; Ehlerding A, 2010, J PHYS CHEM A, V114, P299, DOI 10.1021/jp9086317; Okai N, 2004, CHEM PHYS LETT, V386, P442, DOI 10.1016/j.cplett.2004.01.099; Syrstad EA, 2005, J AM SOC MASS SPECTR, V16, P208, DOI 10.1016/j.jasms.2004.11.001; Ehrenfreund P, 2001, ASTROPHYS J, V550, pL95, DOI 10.1086/319491; Gregersen JA, 2010, PHYS CHEM CHEM PHYS, V12, P13434, DOI 10.1039/c0cp00597e; Xu SJ, 2002, J CHEM PHYS, V117, P5742, DOI 10.1063/1.1499491; Yamada Y, 2009, J PHYS CHEM A, V113, P2734, DOI 10.1021/jp810266a; GELLENE GI, 1982, J CHEM PHYS, V77, P3471, DOI 10.1063/1.444291; HERZBERG G, 1987, ANNU REV PHYS CHEM, V38, P27, DOI 10.1146/annurev.physchem.38.1.27; Hayakawa S, 2007, J AM CHEM SOC, V129, P7936, DOI 10.1021/ja0712571; Maclot S, 2013, INT J MASS SPECTROM, V337, P1, DOI 10.1016/j.ijms.2012.12.014; Nonose S, 1999, EUR PHYS J D, V9, P309, DOI 10.1007/s100530050445; Stedwell CN, 2013, J PHYS CHEM A, V117, P1181, DOI 10.1021/jp305263b; Mercier SR, 2006, J AM CHEM SOC, V128, P16938, DOI 10.1021/ja065980n; Fuke K, 1995, B CHEM SOC JPN, V68, P3309, DOI 10.1246/bcsj.68.3309; Cooper HJ, 2005, MASS SPECTROM REV, V24, P201, DOI 10.1002/mas.20014; Ishiuchi S, 2001, CHEM PHYS LETT, V347, P87, DOI 10.1016/S0009-2614(01)01017-X; Kadhane U, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3009222; Radisic D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1950669; Lioe H, 2007, ANAL BIOANAL CHEM, V389, P1429, DOI 10.1007/s00216-007-1535-1; Okai N, 2004, J PHYS CHEM A, V108, P727, DOI 10.1021/jp030784d; JEON SJ, 1985, J AM CHEM SOC, V107, P4129, DOI 10.1021/ja00300a006; Aribi H. E., 2004, J PHYS CHEM A, V108, P3844; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fujihara A, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2014-50302-5; Fujihara A, 2014, ORIGINS LIFE EVOL B, V44, P67, DOI 10.1007/s11084-014-9370-9	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1076-5174	1096-9888		J MASS SPECTROM	J. Mass Spectrom.	OCT	2015	50	10					1124	1129		10.1002/jms.3628		6	Biochemical Research Methods; Chemistry, Analytical; Spectroscopy	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	CT5YN	WOS:000362887100004		
J	Otsuka, Y; Satoh, S; Naito, J; Kyogaku, M; Hashimoto, H				Otsuka, Yoichi; Satoh, Shuya; Naito, Junpei; Kyogaku, Masafumi; Hashimoto, Hiroyuki			Visualization of cancer-related chemical components in mouse pancreas tissue by tapping-mode scanning probe electrospray ionization mass spectrometry	JOURNAL OF MASS SPECTROMETRY			English	Article						mass spectrometry imaging; cancer tissues; ambient ionization; biomarker discovery; cancer-related proteins	JNK ACTIVATION; TOP-DOWN; S100A6; CELLS; CALCYCLIN	Mass spectrometry imaging is an informative approach for the comprehensive analysis of multiple components inside biological specimens. We used novel tapping-mode scanning probe electrospray ionization mass spectrometry method to visualize cancer-related chemical components in the mouse pancreas tissue section at a sampling pitch of 100 mu m. Positive ion mode measurements from m/z 100 to 1500 resulted in the visualization of multiple components that are tentatively assigned as polyamines, lipids and proteins. Their signal intensities inside the cancerous and the non-cancerous regions were found to be significantly different by the two-sample t-test. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Otsuka, Yoichi; Satoh, Shuya; Naito, Junpei; Kyogaku, Masafumi; Hashimoto, Hiroyuki] Canon Inc, Frontier Res Ctr, Ohta Ku, Tokyo 1468501, Japan; [Otsuka, Yoichi] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan	Otsuka, Y (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, I-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	otsuka@chem.sci.osaka-u.ac.jp					UEHARA N, 1980, CANCER, V45, P108, DOI 10.1002/1097-0142(19800101)45:1<108::AID-CNCR2820450120>3.0.CO;2-W; Spengler B, 2015, ANAL CHEM, V87, P64, DOI 10.1021/ac504543v; Li M, 2009, CANCER INVEST, V27, P251, DOI 10.1080/07357900802254016; Kertesz V, 2010, J MASS SPECTROM, V45, P252, DOI 10.1002/jms.1709; Zhang YQ, 2008, CANCER BIOL THER, V7, P419; Schwamborn K, 2010, MOL ONCOL, V4, P529, DOI 10.1016/j.molonc.2010.09.002; Eberlin LS, 2011, BBA-MOL CELL BIOL L, V1811, P946, DOI 10.1016/j.bbalip.2011.05.006; Laskin J, 2012, ANAL CHEM, V84, P141, DOI 10.1021/ac2021322; Calligaris D, 2014, P NATL ACAD SCI USA, V111, P15184, DOI 10.1073/pnas.1408129111; Hsu CC, 2013, P NATL ACAD SCI USA, V110, P14855, DOI 10.1073/pnas.1310618110; Konig S, 2001, J AM SOC MASS SPECTR, V12, P1180, DOI 10.1016/S1044-0305(01)00300-2; Vimalachandran D, 2005, CANCER RES, V65, P3218; Lorenz M, 2014, ANAL CHEM, V86, P3146, DOI 10.1021/ac404249j; Otsuka Y, 2012, RAPID COMMUN MASS SP, V26, P2725, DOI 10.1002/rcm.6399; Weaver EM, 2013, ADV DRUG DELIVER REV, V65, P1039, DOI 10.1016/j.addr.2013.03.006; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Otsuka Y, 2014, ANALYST, V139, P2336, DOI 10.1039/c3an02340k; Hanrieder J, 2011, ANAL BIOANAL CHEM, V401, P135, DOI 10.1007/s00216-011-5043-y; Cooks RG, 2006, SCIENCE, V311, P1566, DOI 10.1126/science.1119426; Eberlin L. S., 2010, ANAL CHEM, V83, P8366; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Nedjadi T, 2009, BRIT J CANCER, V101, P1145, DOI 10.1038/sj.bjc.6605289; Sarsby J, 2014, J AM SOC MASS SPECTR, V25, P1953, DOI 10.1007/s13361-014-0967-z; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Suzuki S, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-76; Zaima N, 2010, INT J MOL SCI, V11, P5041, DOI 10.3390/ijms11125040	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1076-5174	1096-9888		J MASS SPECTROM	J. Mass Spectrom.	OCT	2015	50	10					1157	1162		10.1002/jms.3634		6	Biochemical Research Methods; Chemistry, Analytical; Spectroscopy	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	CT5YN	WOS:000362887100009		
J	Tanaka, T; Matsushita, H; Sugihara, S; Izumi, T; Kato, N; Miyasaka, T; Maeda, Y; Nakajima, Y				Tanaka, Toshiaki; Matsushita, Hidefumi; Sugihara, Syunichi; Izumi, Takashi; Kato, Norio; Miyasaka, Tomoya; Maeda, Yusuke; Nakajima, Yasuhiro			Development of Alert System Using Visual and Auditory Stimuli to Assist Patients with Cognitive Impairment During Wheelchair Operation	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Alarm system; Wheelchair operation; Cognitive impairment; Unilateral spatial neglect; Visual and auditory stimuli		This study develops an alert system to provide support for daily activities to patients with unilateral spatial neglect and cognitive impairment during wheelchair operation. Eight consenting individuals participated in this experiment. All participants were inpatients at a neurosurgery hospital. The proposed system has two specific functions: (a) calling the attention of the user to the proper use of the wheelchair, and (b) warning the user of erroneous use or possible danger. Mechanical sensors are mounted on a conventional manual wheelchair to detect the application of brakes, flipping up of footrests, and getting up from the seat. The signals from the sensors are sent to a microprocessor to assess the state of the brakes, footrests, and whether the user is sitting or standing. Light-emitting diodes (LEDs) on the brakes and footrests and a speaker tell the user what to do next. If an erroneous operation is detected, the LEDs blink and a warning audio message is given. Multiple voice messages are used to lead the user to the proper procedure for operating a wheelchair. A head-mounted display was designed for patients with unilateral spatial neglect cognitive impairment and to provide additional visual information. Experiments were performed with a standard wheelchair and one equipped with the proposed alert system, and the results were compared. A video motion analysis system was used to analyze neck, trunk, and limb joint movements. The time required to complete the trial operations was measured and operational errors were analyzed. The results show that the number of incorrect operations of the brakes and footrests was decreased by the proposed alarm system. The alarm system may be able to assist correcting wheelchair operation for patients with cognitive impairment.	[Tanaka, Toshiaki] Univ Tokyo, Inst Gerontol, Tokyo 1138656, Japan; [Matsushita, Hidefumi; Sugihara, Syunichi] Sapporo Shuyukai Hosp, Dept Rehabil, Sapporo, Hokkaido 0060805, Japan; [Izumi, Takashi] Tokai Univ, Dept Med Care & Welf Engn, Kumamoto 8628652, Japan; [Kato, Norio] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan; [Tanaka, Toshiaki; Miyasaka, Tomoya] Hokkaido Univ Sci, Dept Phys Therapy, Fac Hlth Sci, Sapporo, Hokkaido 0068585, Japan; [Maeda, Yusuke] Mejiro Univ, Dept Phys Therapy, Fac Hlth Sci, Saitama 3398501, Japan; [Nakajima, Yasuhiro] Hokkaido Res Org, Ind Res Inst, Sapporo, Hokkaido 0600819, Japan	Tanaka, T (reprint author), Univ Tokyo, Inst Gerontol, Tokyo 1138656, Japan.	t.tanaka@iog.u-tokyo.ac.jp			SECOM Science and Technology Foundation	This work was partly supported by the SECOM Science and Technology Foundation.	Kirby RL, 1999, ARCH PHYS MED REHAB, V80, P199, DOI 10.1016/S0003-9993(99)90122-3; Martorello L, 2006, ASSIST TECHNOL, V18, P166; LoPresti EF, 2011, J REHABIL RES DEV, V48, P529, DOI 10.1682/JRRD.2010.01.0008; Mihailidis A, 2007, IEEE T NEUR SYS REH, V15, P136, DOI 10.1109/TNSRE.2007.891385; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59; Habu T., 1996, J CLIN REHABILITATIO, V5, P976; Simpson Richard, 2005, J Neuroeng Rehabil, V2, P30, DOI 10.1186/1743-0003-2-30; Vlahov D, 1990, ARCH PHYS MED REHAB, V7, P8	9	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	OCT	2015	35	5					585	593		10.1007/s40846-015-0077-9		9	Engineering, Biomedical	Engineering	CT7WS	WOS:000363026100004		
J	Nakano, Y; Fujimura, S; Sato, T; Kikuchi, T; Ichinose, M; Watanabe, A				Nakano, Yoshihisa; Fujimura, Shigeru; Sato, Takehiko; Kikuchi, Toshiaki; Ichinose, Masakazu; Watanabe, Akira			Sterilization Method Using Plasma Discharge Against Biofilm-Producing Pseudomonas aeruginosa on Surface of Contact Lens	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Plasma; Pseudomonas aeruginosa; Contact lens	MICROBIAL KERATITIS; INFECTIONS; COAGULATION; RESISTANCE; OUTBREAK; UNIT	Pseudomonas aeruginosa is the main causative bacteria of contact lens (CL)-associated microbial keratitis. Generally, multi-purpose solutions (MPSs) are widely used for washing, disinfection, and storage of CLs. However, the sterilization effect of an MPS against biofilm-producing P. aeruginosa is insufficient. The aim of the present study is to evaluate the bactericidal effect against biofilm-producing P. aeruginosa on CLs using plasma discharge. The standard strain of P. aeruginosa, PAO1, was used to make a biofilm-formed contamination model. The bactericidal effect of five MPSs and plasma discharge against biofilm-producing P. aeruginosa was observed using the culture method, scanning electron microscopy, and fluorescence microscopy. Plasma discharge was produced for 3, 5, or 10 min. Temperature, pH, and the concentrations of ozone (O-3), hydrogen peroxide (H2O2), and nitrogen dioxide (NO2) in the discharged water were monitored. None of the tested MPSs showed a bactericidal effect after 4 h. In contrast, biofilm-producing P. aeruginosa strains were sterilized within 10 min using plasma discharge. Moreover, it was confirmed using fluorescence microscopy that there was no viable bacterium on the surface of the contamination model irradiated for 10 min. Although the concentration of O-3 was 5 ppm after 3 min of discharge, it gradually decreased subsequently. Both NO2 and H2O2 concentrations gradually increased. Water temperature rose from 18 to 45 A degrees C, and pH changed from 6 to 2. The results show that plasma discharge may be effective for the sterilization of biofilm-producing P. aeruginosa on CLs.	[Nakano, Yoshihisa; Fujimura, Shigeru; Watanabe, Akira] Tohoku Univ, Res Div Dev Antiinfect Agents, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Fujimura, Shigeru] Tohoku Pharmaceut Univ, Div Clin Infect Dis Chemotherapy, Sendai, Miyagi 9818558, Japan; [Sato, Takehiko] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan; [Kikuchi, Toshiaki; Ichinose, Masakazu] Tohoku Univ, Dept Resp Med, Grad Sch Med, Sendai, Miyagi 9808574, Japan	Fujimura, S (reprint author), Tohoku Univ, Res Div Dev Antiinfect Agents, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan.	sfuji@tohoku-pharm.ac.jp					Abidi SH, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-57; Admoni Marcel M., 1994, CLAO Journal, V20, P246; Moisan M, 2001, INT J PHARM, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; Berthelot P, 2001, INTENS CARE MED, V27, P503, DOI 10.1007/s001340100870; BEUMER GJ, 1994, J MATER SCI-MATER M, V5, P1, DOI 10.1007/BF00121145; Smith K, 2008, J MED MICROBIOL, V57, P966, DOI 10.1099/jmm.0.47668-0; Pagella F, 2013, ACTA OTO-LARYNGOL, V133, P174, DOI 10.3109/00016489.2012.718097; Sato T, 2008, PLASMA PROCESS POLYM, V5, P606, DOI 10.1002/ppap.200800035; Yang CY, 1997, J BIOMED MATER RES, V37, P335; Ferroni A, 1998, J HOSP INFECT, V39, P301, DOI 10.1016/S0195-6701(98)90295-X; Gillespie TA, 2000, CLIN MICROBIOL INFEC, V6, P125, DOI 10.1046/j.1469-0691.2000.00051.x; Lee YS, 2014, AM J OPHTHALMOL, V157, P1090, DOI 10.1016/j.ajo.2014.01.013; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Manner H, 2007, SCAND J GASTROENTERO, V42, P397, DOI 10.1080/00365520600898130; Tachikawa M, 2014, WATER RES, V64, P94, DOI 10.1016/j.watres.2014.06.047; Szczotka-Flynn LB, 2009, CORNEA, V28, P918, DOI 10.1097/ICO.0b013e3181a81835; Vijay AK, 2009, CORNEA, V28, P1153, DOI 10.1097/ICO.0b013e3181a87a0b; Stapleton F, 2012, EYE, V26, P185, DOI 10.1038/eye.2011.288; Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928; International Standards Organization, 2001, 14729 ISO; Pachigolla Gowri, 2007, Eye Contact Lens, V33, P45, DOI 10.1097/01.icl.0000234002.88643.d0; Trentin DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066257	23	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	OCT	2015	35	5					626	633		10.1007/s40846-015-0080-1		8	Engineering, Biomedical	Engineering	CT7WS	WOS:000363026100008		
J	Xie, C; Soeda, Y; Shinzaki, Y; In, Y; Tomoo, K; Ihara, Y; Miyasaka, T				Xie, Ce; Soeda, Yoshiyuki; Shinzaki, Yuki; In, Yasuko; Tomoo, Koji; Ihara, Yasuo; Miyasaka, Tomohiro			Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tau	JOURNAL OF NEUROCHEMISTRY			English	Article						aggregation; inclusion; MAP2; microtubule-associated protein 2; tau; tauopathies	PAIRED HELICAL FILAMENTS; BINDING DOMAIN; 3RD REPEAT; DISEASE; MODEL	The carboxyl-terminal sequence of tau composes the framework for its intracellular inclusions that appear in diverse neurodegenerative disorders known as tauopathies. However, microtubule-associated protein 2 (MAP2), which contains a homologous carboxyl-terminal sequence of tau, is undetectable in the mature tau inclusions. The mechanisms underlying this phenomenon have remained largely unknown. Here, we show that tau and MAP2 have different aggregation properties: tau aggregates to form filaments but MAP2 remains to be granules. Exchanging (YKPV224)-Y-221 of tau (0N3R) near the PHF6 motif for (TKKI343)-T-340 of MAP2c profoundly changed aggregation properties, suggesting that the YKPV motif is important for filament formation, whereas the TKKI motif is for granule formation. Thus, these minimal sequences may determine the different fates of tau and MAP2 in the formation of inclusions in tauopathies.	[Xie, Ce] Dalian Med Univ, Coll Basic Med Sci, Key Lab Cellular & Mol Biol Liaoning Prov, Dalian, Liaoning, Peoples R China; [Xie, Ce; Shinzaki, Yuki; Ihara, Yasuo; Miyasaka, Tomohiro] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kyoto 6100394, Japan; [Soeda, Yoshiyuki] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Obu, Aichi, Japan; [In, Yasuko; Tomoo, Koji] Osaka Univ Pharmaceut Sci, Dept Phys Chem, Takatsuki, Osaka, Japan	Miyasaka, T (reprint author), Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, 1-3 Tatara Miyakodani, Kyoto 6100394, Japan.	tomiyasa@mail.doshisha.ac.jp			KAKENHI [20700324, 24700368, 22650074]; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS);  [26117004]	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI; Grant-in-Aid for Young Scientists (B); 20700324; T.M. and 24700368; C.X. and Grant-in-Aid for Challenging Exploratory Research; 22650074; T.M.), Core Research for Evolutional Science and Technology (CREST; T.M., C.X., and Y. Ihara), the Japan Science and Technology Agency (JST), the Japan Society for the Promotion of Science (JSPS) and Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control; T.M. 26117004).	von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sogawa K, 2012, J BIOCHEM, V152, P221, DOI 10.1093/jb/mvs061; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Nishiura C, 2010, J BIOCHEM, V147, P405, DOI 10.1093/jb/mvp181; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Miyasaka T, 2005, NEUROBIOL DIS, V20, P372, DOI 10.1016/j.nbd.2005.03.017; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cowan Catherine M, 2013, Front Neurol, V4, P114, DOI 10.3389/fneur.2013.00114; Dehmelt L, 2005, GENOME BIOL, V6; Mandelkow E, 2012, PERSPECT MED, V2; Xie C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089796	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2015	135	1					19	26		10.1111/jnc.13228		8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CT5DN	WOS:000362828000003		
J	Kajitani, N; Hisaoka-Nakashima, K; Okada-Tsuchioka, M; Hosoi, M; Yokoe, T; Morioka, N; Nakata, Y; Takebayashi, M				Kajitani, Naoto; Hisaoka-Nakashima, Kazue; Okada-Tsuchioka, Mami; Hosoi, Mayu; Yokoe, Toshiki; Morioka, Norimitsu; Nakata, Yoshihiro; Takebayashi, Minoru			Fibroblast growth factor 2 mRNA expression evoked by amitriptyline involves extracellular signal-regulated kinase-dependent early growth response 1 production in rat primary cultured astrocytes	JOURNAL OF NEUROCHEMISTRY			English	Article						amitriptyline; antidepressants; astrocytes; early growth response 1; fibroblast growth factor 2; matrix metalloproteinase	NEUROTROPHIC-FACTOR-PRODUCTION; EGF RECEPTOR TRANSACTIVATION; SMOOTH-MUSCLE-CELLS; GLIAL-CELLS; TYROSINE PHOSPHORYLATION; MAJOR DEPRESSION; GENE-EXPRESSION; CARCINOMA-CELLS; NERVOUS-SYSTEM; UP-REGULATION	Recently, we demonstrated that several antidepressants including amitriptyline increased fibroblast growth factor 2 (FGF2) mRNA expression slowly over 24 h through de novo protein synthesis in rat primary cultured astrocytes. This study defined the signaling cascade that mediates amitriptyline-induced FGF2 production in rat primary cultured astrocytes. Amitriptyline treatment significantly increased early growth response 1 (EGR1), a transcription factor known to regulate FGF2 expression. Knockdown of EGR1 using siRNA blocked amitriptyline-evoked FGF2 mRNA expression. Treatment with several different classes of antidepressants leads to expression of EGR1 mRNA as well as FGF2 mRNA. These results confirm that EGR1 production is likely to be indispensable for the amitriptyline-evoked FGF2 mRNA expression. Signal transduction inhibitors were used to elaborate the cellular signaling cascade that leads to EGR1-mediated FGF2 expression following amitriptyline treatment. Amitriptyline-evoked EGR1-mediated FGF2 mRNA expression was blocked by mitogenactivated protein kinase/extracellular signal-regulated kinase kinase (MEK) 1/2 inhibitor. Furthermore, extracellular signal-regulated kinase/EGR1-mediated FGF2 mRNA expression evoked by amitriptyline was blocked by inhibitors of the FGF receptor, epidermal growth factor receptor (EGFR), and matrix metalloproteinase. Taken together, these results demonstrate that amitriptyline increases FGF2 mRNA expression through a matrix metalloproteinase/receptor tyrosine kinases (RTK) (FGF receptor and EGFR)/extracellular signal-regulated kinase/EGR1 signaling pathway in rat primary cultured astrocytes.	[Kajitani, Naoto; Hisaoka-Nakashima, Kazue; Yokoe, Toshiki; Morioka, Norimitsu; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, Hiroshima, Japan; [Kajitani, Naoto; Okada-Tsuchioka, Mami; Hosoi, Mayu; Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, Kure, Japan; [Kajitani, Naoto; Okada-Tsuchioka, Mami; Takebayashi, Minoru] Chugoku Canc Ctr, Kure, Japan; [Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Dept Psychiat, Kure, Japan	Hisaoka-Nakashima, K (reprint author), Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.	hisaokak@hiroshima-u.ac.jp; mtakebayashi@kure-nh.go.jp			JSPS [23591686, 24006852, 25870461]; Takeda Science Foundation; Naito Foundation; SENSHIN Medical Research Foundation	This work was supported in part by JSPS KAKENHI Grant Number 23591686, 24006852, 25870461, by grants from the Takeda Science Foundation, by grants from the Naito Foundation, and by grants from SENSHIN Medical Research Foundation. We wish to thank the Analysis Center of Life Science, Hiroshima University for the use of their facilities. We also thank Dr Hiroyuki Okuno for expert advice and Dr Aldric T. Hama for his careful editing of the manuscript. The authors declare no conflicts of interest.	Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; MIYAKE K, 1990, J PHARM SCI, V79, P288, DOI 10.1002/jps.2600790403; Murphy G, 1999, APMIS, V107, P38; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Dhandapani KM, 2007, J NEUROSCI RES, V85, P1033, DOI 10.1002/jnr.21182; Kalmes A, 2000, CIRC RES, V87, P92; Li BM, 2008, PSYCHOPHARMACOLOGY, V201, P443, DOI 10.1007/s00213-008-1306-5; Rauch BH, 2004, CIRC RES, V94, P340, DOI 10.1161/01.RES.0000111805.09592.D8; Park GH, 2009, NITRIC OXIDE-BIOL CH, V21, P110, DOI 10.1016/j.niox.2009.05.007; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Black SM, 2008, AM J PHYSIOL-CELL PH, V294, pC345, DOI 10.1152/ajpcell.00216.2007; Wang D, 1997, ONCOGENE, V14, P2291, DOI 10.1038/sj.onc.1201069; Wu CY, 2008, J NEUROCHEM, V105, P1499, DOI 10.1111/j.1471-4159.2008.05318.x; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Jarosik J, 2011, RESTOR NEUROL NEUROS, V29, P153, DOI 10.3233/RNN-2011-0588; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Elsayed M, 2012, BIOL PSYCHIAT, V72, P258, DOI 10.1016/j.biopsych.2012.03.003; SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275; Bachis A, 2008, NEUROPHARMACOLOGY, V55, P1114, DOI 10.1016/j.neuropharm.2008.07.014; Chung EY, 2007, NEUROSCI LETT, V422, P43, DOI 10.1016/j.neulet.2007.05.057; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1076/pnas.0406788101; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Bethel-Brown C, 2011, J IMMUNOL, V186, P4119, DOI 10.4049/jimmunol.1002235; Biesiada E, 1996, J BIOL CHEM, V271, P18576; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Zechel S, 2010, NEUROSCIENTIST, V16, P357, DOI 10.1177/1073858410371513; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103; Mallei A, 2002, MOL PHARMACOL, V61, P1017, DOI 10.1124/mol.61.5.1017; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Boku S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079371; Chu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068943; Hisaoka-Nakashima K, 2015, J BIOL CHEM, V290, P13678, DOI 10.1074/jbc.M114.622415; Kajitani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051197; Kim Y, 2011, PROG NEURO-PSYCHOPH, V35, P1026, DOI 10.1016/j.pnpbp.2011.02.012; Morioka N, 2014, BRIT J PHARMACOL, V171, P2854, DOI 10.1111/bph.12614; ODonnell J., 2011, GOODMAN GILMANS PHAR, P397; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2015	135	1					27	37		10.1111/jnc.13247		11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CT5DN	WOS:000362828000004		
J	Sawano, E; Iwatani, K; Tominaga-Yoshino, K; Ogura, A; Tashiro, T				Sawano, Erika; Iwatani, Kanako; Tominaga-Yoshino, Keiko; Ogura, Akihiko; Tashiro, Tomoko			Reduction in NPY-positive neurons and dysregulation of excitability in young senescence-accelerated mouse prone 8 (SAMP8) hippocampus precede the onset of cognitive impairment	JOURNAL OF NEUROCHEMISTRY			English	Article						deiodinase 2; epileptiform activity; GABA; hippocampus; NPY-positive neuron; SAMP8	THYROID-HORMONE ACTION; NEUROPEPTIDE-Y; GABAERGIC NEURONS; BRAIN-DEVELOPMENT; RAT HIPPOCAMPUS; GENE-EXPRESSION; DENTATE GYRUS; DEPENDENT DEVELOPMENT; QUANTITATIVE-ANALYSIS; ALZHEIMERS-DISEASE	The senescence-accelerated mouse prone 8 (SAMP8) strain is considered a neurodegeneration model showing age-related cognitive deficits with little physical impairment. Young SAMP8 mice, however, exhibit signs of disturbances in development such as marked hyperactivity and reduced anxiety well before the onset of cognitive impairment. As the key enzyme in local regulation of thyroid hormone (TH) signaling, type 2 deiodinase, was significantly reduced in the SAMP8 hippocampus relative to that of the normally aging SAM-resistant 1 (SAMR1), we used these two strains to compare the development of the hippocampal GABAergic system, which is known to be strongly affected by hypothyroidism. Among GABAergic components, neuronal K+/Cl- co-transporter 2 was down-regulated in SAMP8 transiently at 2weeks. Although distribution of total GABAergic neurons was similar in both strains, 22-30% reduction was observed inthe neuropeptide Y (NPY)-positive subpopulation of GABAergic neurons in SAMP8. Electrophysiological studies on hippocampal slices obtained at 4weeks revealed that epileptiform activity, induced by high-frequency stimulation, lasted four times longer in SAMP8 compared with SAMR1, indicating a dysregulation of excitability that may be linked to the behavioral abnormalities of young SAMP8 and to neurodegeneration later on in life. Local attenuation of TH signaling may thus impact the normal development of the GABAergic system.	[Sawano, Erika; Iwatani, Kanako; Tashiro, Tomoko] Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem & Biol Sci, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Tominaga-Yoshino, Keiko; Ogura, Akihiko] Osaka Univ, Dept Neurosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan	Tashiro, T (reprint author), Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem & Biol Sci, Chuo Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	tashilein@chem.aoyama.ac.jp			Ministry of Health, Labor and Welfare of the Japanese Government; MEXT	We acknowledge the contribution of Ms. Yuka Yuruzume in the analysis of CREB phosphorylation. This work was supported by a Grant from the Ministry of Health, Labor and Welfare of the Japanese Government to T. T. and by MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2013-2017. There is no conflict of interest to declare.	Kovac S, 2013, NEUROPEPTIDES, V47, P467, DOI 10.1016/j.npep.2013.10.015; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Gilbert ME, 2007, ENDOCRINOLOGY, V148, P92, DOI 10.1210/en.2006-0164; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Silva AP, 2001, J NEUROCHEM, V79, P286, DOI 10.1046/j.1471-4159.2001.00560.x; Woldbye DPD, 2010, BRAIN, V133, P2778, DOI 10.1093/brain/awq219; Yilmazer-Hanke DM, 2004, NEUROSCIENCE, V124, P283, DOI 10.1016/j.neuroscience.2003.12.004; Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1; Lewis DA, 2008, NEUROTOX RES, V14, P237, DOI 10.1007/BF03033813; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Karl T, 2010, BEHAV BRAIN RES, V207, P434, DOI 10.1016/j.bbr.2009.10.029; Fukuda T, 1998, J COMP NEUROL, V395, P177, DOI 10.1002/(SICI)1096-9861(19980601)395:2<177::AID-CNE3>3.0.CO;2-#; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Wiens SC, 2006, COMP BIOCHEM PHYS A, V144, P332, DOI 10.1016/j.cbpa.2006.01.033; Williams GR, 2008, J NEUROENDOCRINOL, V20, P784, DOI 10.1111/j.1365-2826.2008.01733.x; TAKEMURA M, 1993, AM J PATHOL, V142, P1887; Wallis K, 2008, J NEUROSCI, V28, P1904, DOI 10.1523/JNEUROSCI.5163-07.2008; Koibuchi N, 2000, TRENDS ENDOCRIN MET, V11, P123, DOI 10.1016/S1043-2760(00)00238-1; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; MIYAMOTO M, 1992, PHYSIOL BEHAV, V51, P979, DOI 10.1016/0031-9384(92)90081-C; Gang BZ, 2011, BRAIN RES, V1389, P183, DOI 10.1016/j.brainres.2011.03.039; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Greco B, 2006, BEHAV BRAIN RES, V169, P325, DOI 10.1016/j.bbr.2006.02.002; Farwell AP, 2006, ENDOCRINOLOGY, V147, P2567, DOI 10.1210/en.2005-1272; Noe F, 2008, BRAIN, V131, P1506, DOI 10.1093/brain/awn079; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Friauf E, 2008, EUR J NEUROSCI, V28, P2371, DOI 10.1111/j.1460-9568.2008.06528.x; Zaben MJ, 2013, NEUROPEPTIDES, V47, P431, DOI 10.1016/j.npep.2013.10.002; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; Fukuda T, 1997, BRAIN RES, V764, P237, DOI 10.1016/S0006-8993(97)00683-5; Thompson CC, 2000, CEREB CORTEX, V10, P939, DOI 10.1093/cercor/10.10.939; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834; Mellios N, 2009, BIOL PSYCHIAT, V65, P1006, DOI 10.1016/j.biopsych.2008.11.019; MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5; Manzano J, 2007, ENDOCRINOLOGY, V148, P5746, DOI 10.1210/en.2007-0567; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Malva JO, 2012, NEUROPEPTIDES, V46, P299, DOI 10.1016/j.npep.2012.09.001; Toledo-Rodriguez M, 2005, J PHYSIOL-LONDON, V567, P401, DOI 10.1113/j.physiol.2005.089250; Jinno S, 2006, NEUROSCI RES, V56, P229, DOI 10.1016/j.neures.2006.07.007; Markowska AL, 1998, PHYSIOL BEHAV, V64, P15, DOI 10.1016/S0031-9384(98)00011-0; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1; Karl T, 2006, BEHAV BRAIN RES, V167, P87, DOI 10.1016/j.bbr.2005.08.019; Sawano E, 2013, INT J DEV NEUROSCI, V31, P751, DOI 10.1016/j.ijdevneu.2013.09.007; Tomobe K, 2007, BRAIN RES, V1141, P214, DOI 10.1016/j.brainres.2006.08.026; Takahashi M, 2008, J NEUROCHEM, V104, P640, DOI 10.1111/j.1471-4159.2007.05049.x; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Dentice M, 2011, J ENDOCRINOL, V209, P273, DOI 10.1530/JOE-11-0002; Tomobe K, 2009, NEUROCHEM RES, V34, P660, DOI 10.1007/s11064-009-9923-x; Kumar VB, 2000, PEPTIDES, V21, P1769, DOI 10.1016/S0196-9781(00)00339-9; Westerholz S, 2010, NEUROSCIENCE, V168, P573, DOI 10.1016/j.neuroscience.2010.03.039; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Silva AP, 2003, FASEB J, V17, P1118, DOI 10.1096/fj.02-0885fje; Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y; Morley JE, 2000, PEPTIDES, V21, P1761, DOI 10.1016/S0196-9781(00)00342-9; Manich G, 2014, AGE, V36, P151, DOI 10.1007/s11357-013-9560-9; Rivera C, 1999, NATURE, V397, P251; BERNAL J, 1995, EUR J ENDOCRINOL, V133, P390; DelsValle J, 2010, J ALZHEIMERS DIS, V19, P1303; Fujiwara-Tsukamoto Y, 2004, J PHYSIOL-LONDON, V557, P961, DOI 10.1113/jphysiol.2003.059915; Oyanagi K, 2015, J NEUROSCI RES, V93, P592, DOI 10.1002/jnr.23519; Sawano E, 2013, J NEUROSCI RES, V91, P382, DOI 10.1002/jnr.23161; Westerholz S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00121	64	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2015	135	2					287	300		10.1111/jnc.13274		14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CT5DP	WOS:000362828200008		
J	Tanaka, Y; Hasegawa, H; Sato, K				Tanaka, Yasuhiro; Hasegawa, Hiroshi; Sato, Ken-ichi			Criteria for Selecting Subsystem Configuration in Creating Large-Scale OXCs	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Hitless expansion; Inter/intra-nodes blocking; OXC; OXC-subsystem; ROADM; Routing and wavelength assignment	NETWORKS	We investigate in detail the performances of different subsystem-based modular optical cross-connect (OXC) architectures that can be expanded to cover large port counts. They include ring, linear, and main/junction types, all of which are proved to substantially reduce total hardware scale compared to the conventional architecture. The reduction in necessary number of wavelength selective switches (WSSs) can be more than 70% for OXCs with about 50 x 50 ports, where the accepted traffic offset is about 2%. The maximum number of WSSs traversed by optical paths is also reduced by more than 50% for Pan-European (26 nodes) and 5 x 5 regular mesh networks.	[Tanaka, Yasuhiro; Hasegawa, Hiroshi; Sato, Ken-ichi] Nagoya Univ, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Tanaka, Y (reprint author), Nagoya Univ, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	ya_tanak@echo.nuee.nagoya-u.ac.jp			NICT (lambda-Reach Project); KAKENHI [26220905]	This work was partly supported by NICT (lambda-Reach Project) and KAKENHI (26220905).	Tanaka Y, 2015, OPT EXPRESS, V23, P5994, DOI 10.1364/OE.23.005994; Woodward SL, 2013, J OPT COMMUN NETW, V5, pA19, DOI 10.1364/JOCN.5.000A19; [Anonymous], 2011, PRESCRIRE INT, V20, P18; Filer M., 2014, OPT FIB COMM C; Inkret R., 2003, ADV INFRASTRUCTURE P; Ishida H., 2014, OPT FIB COMM C; Iwai Y., 2013, OPT FIB COMM C EXP N; Iwai Y., 2012, EUR C EXH OPT COMM; Jensen R., 2010, EUR C EXH OPT COMM; Jensen R. A., 2011, OPT FIB COMM C; Morea A., 2014, OPT FIB COMM C; Pagnan P., 2009, PHOTONICS SWITCHING; Rizzelli G., 2013, OPT FIB COMM C; Sato K, 2009, J OPT COMMUN NETW, V1, pA81, DOI 10.1364/JOCN.1.000A81; Sato K., 2013, OPTOELECTRONICS COMM; Sato K., 2014, OPTICAL NETWORK DESI; Takashina S., 2015, OPT FIB COMM C; Tanaka Y., 2013, EUR C EXH OPT COMM; Tanaka Y., 2014, OPT FIB COMM C; Watanabe T., 2011, OPT FIB COMM C; Woodward S., 2013, OPT FIB COMM C; Younce R, 2013, J OPT COMMUN NETW, V5, pA267, DOI 10.1364/JOCN.5.00A267	22	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	OCT	2015	7	10					1009	1017		10.1364/JOCN.7.001009		9	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CT6SL	WOS:000362942600006		
J	Tanimoto, Y				Tanimoto, Yasuhiro			Dental materials used for metal-free restorations: Recent advances and future challenges	JOURNAL OF PROSTHODONTIC RESEARCH			English	Editorial Material							REMOVABLE PARTIAL DENTURES		Nihon Univ, Sch Dent, Dept Dent Biomat, Matsudo, Chiba 2718587, Japan	Tanimoto, Y (reprint author), Nihon Univ, Sch Dent, Dept Dent Biomat, Matsudo, Chiba 2718587, Japan.	tanimoto.yasuhiro@nihon-u.ac.jp					Baba K, 2014, J PROSTHODONT RES, V58, P1, DOI 10.1016/j.jpor.2013.12.003; Fueki K, 2014, J PROSTHODONT RES, V58, P3, DOI 10.1016/j.jpor.2013.12.002; Miyazaki T, 2013, J PROSTHODONT RES, V57, P236, DOI 10.1016/j.jpor.2013.09.001; Shibata Y, 2015, J PROSTHODONT RES, V59, P20, DOI 10.1016/j.jpor.2014.11.007; Urano S, 2015, INT J PROSTHODONT, V28, P191, DOI 10.11607/ijp.4113; Vallittu PK, 2015, DENT MATER, V31, P1, DOI 10.1016/j.dental.2014.07.009	6	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1883-1958	2212-4632		J PROSTHODONT RES	J. Prosthodont. Res.	OCT	2015	59	4					213	215		10.1016/j.jpor.2015.07.003		3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7JS	WOS:000362991600001		
J	Yatani, H				Yatani, Hirofumi			Esthetic prosthodontic treatment - The state-of-the-art	JOURNAL OF PROSTHODONTIC RESEARCH			English	Editorial Material							PINK		Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka 5650871, Japan	Yatani, H (reprint author), Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	yatani@dent.osaka-u.ac.jp					Belser UC, 2009, J PERIODONTOL, V80, P140, DOI 10.1902/jop.2009.080435 ; Furhauser R, 2005, CLIN ORAL IMPLAN RES, V16, P639, DOI 10.1111/j.1600-0501.2005.01193.x; Ishida Y, 2015, J PROSTHODONT RES, V59, P229, DOI 10.1016/j.jpor.2015.05.002; Li RWK, 2014, J PROSTHODONT RES, V58, P208, DOI 10.1016/j.jpor.2014.07.003; Masaki C, 2015, J PROSTHODONT RES, V59, P220, DOI 10.1016/j.jpor.2015.04.005	5	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1883-1958	2212-4632		J PROSTHODONT RES	J. Prosthodont. Res.	OCT	2015	59	4					216	219		10.1016/j.jpor.2015.08.002		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7JS	WOS:000362991600002		
J	Masaki, C; Nakamoto, T; Mukaibo, T; Kondo, Y; Hosokawa, R				Masaki, Chihiro; Nakamoto, Tetsuji; Mukaibo, Taro; Kondo, Yusuke; Hosokawa, Ryuji			Strategies for alveolar ridge reconstruction and preservation for implant therapy	JOURNAL OF PROSTHODONTIC RESEARCH			English	Review						Ridge alteration; Ridge preservation; Immediate placement; Early placement; Tissue augmentation	CONTROLLED CLINICAL-TRIAL; FRESH EXTRACTION SOCKETS; CONNECTIVE-TISSUE GRAFT; BEAM COMPUTED-TOMOGRAPHY; GUIDED BONE REGENERATION; SINUS FLOOR ELEVATION; AUTOGENOUS BONE; ANTERIOR MAXILLA; DENTAL IMPLANTS; POST-EXTRACTION	Purpose: In dental implant treatment, ridge preservation and immediate or early implant placement are recommended to minimize bone resorption after tooth extraction and achieve esthetic outcomes. However, there is no consensus concerning the efficacy of this surgical method. There is also no consensus on the efficacy of bone and soft tissue grafts and surgical methods for alveolar ridge reconstruction. Study selection: This paper reports ridge alteration in the anterior maxilla after tooth extraction, and summarizes the efficacy of various ridge preservation methods and immediate or early implant placement as alveolar ridge preservation methods to minimize bone resorption after tooth extraction. The advantages and complications of alveolar ridge reconstruction methods, and the efficacy and surgical method of soft tissue graft are reviewed. Results: The anterior maxilla is in the esthetic zone, and the thickness of the bone on the labial side around the natural tooth is less than 1 mm in many cases. Therefore, it is impossible to prevent bone resorption completely, even if ridge preservation and immediate or early implant placement are performed after tooth extraction. It is necessary to obtain stable and long-term esthetics by combining connective tissue and free gingival grafts, in addition to hard tissue augmentation. Conclusions: It is important to consider the burden and level of satisfaction of patients, such as in terms of donor site morbidity in hard and soft tissue grafting, and to pay attention to appropriate indications to avoid overtreatment. (C) 2015 Japan Prosthodontic Society. Published by Elsevier Ireland. All rights reserved.	[Masaki, Chihiro; Mukaibo, Taro; Kondo, Yusuke; Hosokawa, Ryuji] Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Kitakyushu, Fukuoka 8038580, Japan; [Nakamoto, Tetsuji] Matsumoto Dent Univ, Sch Dent, Grad Sch Oral & Maxillofacial Biol, Dept Prosthodont, Shiojiri, Nagano, Japan	Masaki, C (reprint author), Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	masaki@kyu-dent.ac.jp					Aimetti Mario, 2009, Int J Oral Maxillofac Implants, V24, P902; Chung DM, 2006, J PERIODONTOL, V77, P1410, DOI 10.1902/jop.2006.050393; Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x; Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x; Lee CT, 2014, J CLIN PERIODONTOL, V41, P914, DOI 10.1111/jcpe.12276; Akcali A, 2015, CLIN ORAL IMPLAN RES, V26, P688, DOI 10.1111/clr.12368; Lorenzo R, 2012, CLIN ORAL IMPLAN RES, V23, P316, DOI 10.1111/j.1600-0501.2011.02260.x; Nevins M, 2006, INT J PERIODONT REST, V26, P19; Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x; Artzi Z, 1998, J PERIODONTOL, V69, P1062; Velich N, 2004, J CRANIOFAC SURG, V15, P38, DOI 10.1097/00001665-200401000-00013; Gholami GA, 2012, CLIN ORAL IMPLAN RES, V23, P1198, DOI 10.1111/j.1600-0501.2011.02288.x; Merli M, 2013, EUR J ORAL IMPLANTOL, V6, P27; Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x; Blanco J, 2008, J CLIN PERIODONTOL, V35, P640, DOI 10.1111/j.1600-051X.2008.01237.x; Moya-Villaescusa MJ, 2010, CLIN ORAL IMPLAN RES, V21, P237, DOI 10.1111/j.1600-0501.2009.01831.x; Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635; Monnet-Corti V, 2006, J PERIODONTOL, V77, P899, DOI 10.1902/jop.2006.050047; Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P545, DOI 10.1111/j.1600-0501.2008.01703.x; Saldanha JB, 2006, J ORAL MAXIL SURG, V64, P1359, DOI 10.1016/j.joms.2006.05.021; DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004; Anderson LE, 2014, IMPLANT DENT, V23, P416, DOI 10.1097/ID.0000000000000122; Vega LG, 2010, ORAL MAXIL SURG CLIN, V22, P369, DOI 10.1016/j.coms.2010.04.004; Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560; Barone A, 2012, J PERIODONTOL, V83, P836, DOI 10.1902/jop.2011.110205; Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x; Chan HL, 2013, INT J ORAL MAX IMPL, V28, P710, DOI 10.11607/jomi.2913; Januario AL, 2011, CLIN ORAL IMPLAN RES, V22, P1168, DOI 10.1111/j.1600-0501.2010.02086.x; Cardaropoli D, 2012, INT J PERIODONT REST, V32, P421; Bartee B K, 2001, J Oral Implantol, V27, P194, DOI 10.1563/1548-1336(2001)027<0194:ESRFAR>2.3.CO;2; Meijndert L, 2008, CLIN ORAL IMPLAN RES, V19, P1295, DOI 10.1111/j.1600-0501.2008.01523.x; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; Braut V, 2011, INT J PERIODONT REST, V31, P125; Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x; Linkevicius T, 2009, INT J ORAL MAX IMPL, V24, P712; Felice P, 2009, CLIN ORAL IMPLAN RES, V20, P1386, DOI 10.1111/j.1600-0501.2009.01765.x; Schneider D, 2011, CLIN ORAL IMPLAN RES, V22, P28, DOI 10.1111/j.1600-0501.2010.01987.x; Bianchi A, 2008, ORAL SURG ORAL MED O, V105, P282, DOI 10.1016/j.tripleo.2007.07.009; Grunder U, 2005, INT J PERIODONT REST, V25, P113; Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P3; Khojasteh A, 2013, INT J ORAL MAX IMPL, V28, P1076, DOI 10.11607/jomi.2925; Lang NP, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2011.02372.x; Festa VM, 2013, CLIN IMPLANT DENT R, V15, P707, DOI 10.1111/j.1708-8208.2011.00398.x; Klosek SK, 2009, SURG RADIOL ANAT, V31, P245, DOI 10.1007/s00276-008-0432-4; Esposito M, 2009, EUR J ORAL IMPLANTOL, V2, P167; Jung UW, 2008, J PERIODONTOL, V79, P934, DOI 10.1902/jop.2008.070445 ; Simion M, 1997, INT J ORAL MAX IMPL, V12, P159; Lekovic V, 1998, J PERIODONTOL, V69, P1044; Zubillaga G, 2003, J PERIODONTOL, V74, P965, DOI 10.1902/jop.2003.74.7.965; Camargo PM, 2000, ORAL SURG ORAL MED O, V90, P581, DOI 10.1067/moe.2000.110035; Yoshino S, 2014, INT J ORAL MAX IMPL, V29, P432, DOI 10.11607/jomi.3379; WENNSTROM JL, 1994, CLIN ORAL IMPLAN RES, V5, P1, DOI 10.1034/j.1600-0501.1994.050101.x; Buser D, 2004, INT J ORAL MAX IMPL, V19, P43; Al-Nawas B, 2014, EUR J ORAL IMPLANTOL, V7, pS219; Sbordone L, 2011, CLIN ORAL IMPLAN RES, V22, P485, DOI 10.1111/j.1600-0501.2010.02030.x; Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x; Wiesner G, 2010, EUR J ORAL IMPLANTOL, V3, P27; Wennstrom JL, 2012, CLIN ORAL IMPLAN RES, V23, P136, DOI 10.1111/j.1600-0501.2012.02540.x; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x; Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 ; Guarnieri R, 2004, J PERIODONTOL, V75, P902, DOI 10.1902/jop.2004.75.6.902; Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94; Bouri A, 2008, INT J ORAL MAX IMPL, V23, P323; Sanz I, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2011.02339.x; Lopez-Cedrun JL, 2011, INT J ORAL MAX IMPL, V26, P195; Chiapasco M, 2004, CLIN ORAL IMPLAN RES, V15, P82, DOI 10.1111/j.1600-0501.2004.00999.x; Hammerle CHF, 2012, CLIN ORAL IMPLAN RES, V23, P80, DOI 10.1111/j.1600-0501.2011.02370.x; Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990; Studer SP, 1997, J PERIODONTOL, V68, P145; Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x; Chen ST, 2014, INT J ORAL MAX IMPL, V29, P186, DOI 10.11607/jomi.2014suppl.g3.3; Avila-Ortiz G, 2014, J DENT RES, V93, P950, DOI 10.1177/0022034514541127; Azizi A, 2009, J ISFAHAN DENT SCH, V5, P133; Carlsson G E, 1967, Odontol Revy, V18, P27; Chappuis V, 2013, J DENT RES, V92, p195S, DOI 10.1177/0022034513506713; Dellavia C, 2014, INT J PERIODONT REST, V34, P179, DOI 10.11607/prd.1929; Dottore AM, 2014, CLIN IMPLANT DENT R, V16, P330, DOI 10.1111/cid.12010; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Merli M, 2014, INT J ORAL MAX IMPL, V29, P905, DOI 10.11607/jomi.3203; Nozawa Takeshi, 2006, Eur J Esthet Dent, V1, P208; Rakhmatia YD, 2013, J PROSTHODONT RES, V57, P3, DOI 10.1016/j.jpor.2012.12.001; Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P283, DOI 10.1111/j.1600-051X.2006.00907.x; Schropp L, 2015, CLIN ORAL IMPLAN RES, V26, P278, DOI 10.1111/clr.12489; Speroni Stefano, 2010, Indian J Dent Res, V21, P474, DOI 10.4103/0970-9290.74208	84	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1883-1958	2212-4632		J PROSTHODONT RES	J. Prosthodont. Res.	OCT	2015	59	4					220	228		10.1016/j.jpor.2015.04.005		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7JS	WOS:000362991600003		
J	Ishida, Y; Fujimoto, K; Higaki, N; Goto, T; Ichikawa, T				Ishida, Yuichi; Fujimoto, Keiko; Higaki, Nobuaki; Goto, Takaharu; Ichikawa, Tetsuo			End points and assessments in esthetic dental treatment	JOURNAL OF PROSTHODONTIC RESEARCH			English	Review						End point; Assessment; Esthetic dental treatment	PSYCHOSOCIAL IMPACT; PART 2; PRINCIPLES; VALIDATION; APPEARANCE; PARAMETERS; DIAGNOSIS; JAPANESE; SMILE; PINK	Purpose: There are two key considerations for successful esthetic dental treatments. This article systematically describes the two key considerations: the end points of esthetic dental treatments and assessments of esthetic outcomes, which are also important for acquiring clinical skill in esthetic dental treatments. Study selection: The end point and assessment of esthetic dental treatment were discussed through literature reviews and clinical practices. Results: Before designing a treatment plan, the end point of dental treatment should be established. The section entitled "End point of esthetic dental treatment" discusses treatments for maxillary anterior teeth and the restoration of facial profile with prostheses. The process of assessing treatment outcomes entitled "Assessments of esthetic dental treatment" discusses objective and subjective evaluation methods. Conclusions: Practitioners should reach an agreement regarding desired end points with patients through medical interviews, and continuing improvements and developments of esthetic assessments are required to raise the therapeutic level of esthetic dental treatments. (C) 2015 Japan Prosthodontic Society. Published by Elsevier Ireland. All rights reserved.	[Ishida, Yuichi; Fujimoto, Keiko; Higaki, Nobuaki; Goto, Takaharu; Ichikawa, Tetsuo] Univ Tokushima, Inst Hlth Biosci, Dept Oral & Maxillofacial Prosthodont, Tokushima 7708504, Japan	Ishida, Y (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Oral & Maxillofacial Prosthodont, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	junchan@tokushima-u.ac.jp					Yamazaki M, 2007, J ORAL REHABIL, V34, P159, DOI 10.1111/j.1365-2842.2006.01693.x; Owens EG, 2002, INT J PROSTHODONT, V15, P283; Wolfart S, 2005, EUR J ORAL SCI, V113, P159, DOI 10.1111/j.1600-0722.2005.00206.x; Charruel S, 2008, J PERIODONTOL, V79, P795, DOI 10.1902/jop.2008.070488 ; LOMBARDI RE, 1973, J PROSTHET DENT, V29, P358, DOI 10.1016/S0022-3913(73)80013-7; Belser UC, 2009, J PERIODONTOL, V80, P140, DOI 10.1902/jop.2009.080435 ; Brunzel S, 2006, J ORAL REHABIL, V33, P430, DOI 10.1111/j.1365-2842.2005.01573.x; Furhauser R, 2005, CLIN ORAL IMPLAN RES, V16, P639, DOI 10.1111/j.1600-0501.2005.01193.x; Faure JC, 2002, EUR J ORTHODONT, V24, P1, DOI 10.1093/ejo/24.1.1; WHEELER RC, 1961, J PROSTHET DENT, V11, P722, DOI 10.1016/0022-3913(61)90181-0; VIG RG, 1978, J PROSTHET DENT, V39, P502, DOI 10.1016/S0022-3913(78)80179-6; MATTHEWS TG, 1978, J PROSTHET DENT, V39, P128, DOI 10.1016/S0022-3913(78)80008-0; GOLDSTEIN RE, 1977, DENT CLIN N AM, V21, P803; Miyajima K, 1996, AM J ORTHOD DENTOFAC, V110, P431, DOI 10.1016/S0889-5406(96)70047-1; Sarver DM, 2003, AM J ORTHOD DENTOFAC, V124, P116, DOI 10.1016/S0889-5406(03)00307-X; ARNETT GW, 1993, AM J ORTHOD DENTOFAC, V103, P299, DOI 10.1016/0889-5406(93)70010-L; Bucci R, 2015, QUAL LIFE RES, V24, P747, DOI 10.1007/s11136-014-0807-4; Chen P, 2012, BR DENT J, V214, P105; Cho Hae-Lyung, 2010, J Periodontal Implant Sci, V40, P188, DOI 10.5051/jpis.2010.40.4.188; Frush JP, 1957, J PROSTHET DENT, V7, P5, DOI 10.1016/0022-3913(57)90004-5; Frush JP, 1956, J PROSTHET DENT, V6, P441, DOI 10.1016/0022-3913(56)90089-0; Frush JP, 1956, J PROSTHET DENT, V6, P160, DOI 10.1016/0022-3913(56)90110-X; Graber LW, 2012, ORTHODONTICS CURRENT, P94; Ito K, 1977, ORTHODONTIC WAVES, V36, P212; KEELE K D, 1948, Lancet, V2, P6; Mayr Charles, 1882, US NEW ENGLAND J COM, P23; Mori C, 2007, J ESTHETIC DENTIST, V19, P96; Nezu H, 1982, Nihon Kyosei Shika Gakkai Zasshi, V41, P450; Nikgoo Arash, 2009, World J Orthod, V10, P224; Nqom PI, 2013, ORTHOD FR, V84, P319; RICKETTS RM, 1982, AM J ORTHOD DENTOFAC, V81, P351, DOI 10.1016/0002-9416(82)90073-2; Ricketts RM, 1989, LIB C CATALOGUE CARD, V88, P149; Ricketts RM, 1957, ANGLE ORTHOD, V27, P14; Schabel BJ, 2009, AM J ORTHOD DENTOF S, V135, P61; Shimomura T, 2011, AM J ORTHOD DENTOFAC, V139, P291; Singh Varun Pratap, 2014, J Orthod, V41, P6, DOI 10.1179/1465313313Y.0000000079; Slade G D, 1994, Community Dent Health, V11, P3; Spalj S, 2014, QUAL LIFE RES, V23, P1267, DOI 10.1007/s11136-013-0547-x; Tjan AH, 1984, J PROSTHET DENT, V5, P24; Tsuruda H, 1999, J HIROSHIMA U DENT S, V31, P5; Ulrich K, 2006, EUR J ORTHODONT, V28, P103; Yamazaki M., 1999, ESTHETIC RESTRATIVE, P45	42	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1883-1958	2212-4632		J PROSTHODONT RES	J. Prosthodont. Res.	OCT	2015	59	4					229	235		10.1016/j.jpor.2015.05.002		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7JS	WOS:000362991600004		
J	Genkai, S; Kikutani, T; Suzuki, R; Tamura, F; Yamashita, Y; Yoshida, M				Genkai, Sae; Kikutani, Takeshi; Suzuki, Ryo; Tamura, Fumiyo; Yamashita, Yoshihisa; Yoshida, Mitsuyoshi			Loss of occlusal support affects the decline in activities of daily living in elderly people receiving home care	JOURNAL OF PROSTHODONTIC RESEARCH			English	Article						ADL; Cohort study; Elderlies; Home care; Occlusal support	BODY-MASS INDEX; QUALITY-OF-LIFE; DISABILITY; DEMENTIA; ABILITY; MORTALITY; ADULTS	Purpose: This study aimed to clarify whether the absence of occlusal support would lead to a decline in the activities of daily living (ADL) in elderly people receiving home care. Methods: The subjects of this study were 322 elderly individual aged 65 and older who were receiving home care during a one-year observation period. The subjects were divided into two groups according to the change in the total score of the Barthel Index (BI) during the prospective cohort study period (the dependent variable): the maintained/improved activities of daily living group, in which the score was unchanged or improved, and the worsened activities of daily living group, in which the score decreased. The relationship between occlusal status (the presence or absence of occlusal support) at the baseline measurement and each BI score change was evaluated in the slightly, moderately and totally dependent ADL subgroups. Results: The number of subjects in the maintained/improved and the worsened ADL groups was 152 and 170, respectively. The baseline characteristics of cognitive function and occlusal support were significantly different between the maintained/improved and the worsened ADL groups (p < 0.05). Among the ADL subgroups, significantly reduced scores in mobility and toilet use were observed only in the slightly dependent group (p < 0.05). Conclusions: Our results suggest that the loss of occlusal support may be an important factor in the decline of ADL in elderly people receiving home care, especially slightly dependent people. (C) 2015 Japan Prosthodontic Society. Published by Elsevier Ireland. All rights reserved.	[Genkai, Sae; Kikutani, Takeshi] Nippon Dent Univ, Div Clin Oral Rehabil, Grad Sch Life Dent, Koganei, Tokyo 1840011, Japan; [Kikutani, Takeshi; Suzuki, Ryo; Tamura, Fumiyo; Yoshida, Mitsuyoshi] Nippon Dent Univ, Div Rehabil Speech & Swallowing Disorders, Tama Oral Rehabil Clin, Koganei, Tokyo 1840011, Japan; [Yamashita, Yoshihisa] Kyushu Univ, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan; [Yoshida, Mitsuyoshi] Hiroshima City Gen Rehabil Ctr, Dept Dent, Hiroshima, Japan	Kikutani, T (reprint author), Nippon Dent Univ, Div Clin Oral Rehabil, Grad Sch Life Dent, 4-44-19 Higashi Cho, Koganei, Tokyo 1840011, Japan.	kikutani@tokyo.ndu.ac.jp			Japan Agency for Medical Research and development, AMED	This research is partially supported by Japan Agency for Medical Research and development, AMED. We express our sincere gratitude to all of the patients, care managers, doctors and dentists who helped us complete this study.	Tohara H, 2003, DYSPHAGIA, V18, P126, DOI 10.1007/s00455-002-0095-y; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; ZENNER PM, 1995, DYSPHAGIA, V10, P27, DOI 10.1007/BF00261276; Nakazawa A, 2013, ENVIRON HEALTH PREV, V18, P502, DOI 10.1007/s12199-013-0351-9; Hsieh YW, 2007, NEUROREHAB NEURAL RE, V21, P233, DOI 10.1177/1545968306294729; Yamaga T, 2002, J GERONTOL A-BIOL, V57, pM616; Sauvaget C, 2002, GERONTOLOGY, V48, P226, DOI 10.1159/000058355; Ertekin O, 2014, NEUROREHABILITATION, V34, P313, DOI 10.3233/NRE-131037; Sheiham A, 2002, BRIT DENT J, V192, P703, DOI 10.1038/sj.bdj.4801461a; Motl RW, 2010, PHYS MED REH CLIN N, V21, P299, DOI 10.1016/j.pmr.2009.12.006; Fauth EB, 2013, INT J GERIATR PSYCH, V28, P597, DOI 10.1002/gps.3865; BURKE WJ, 1988, ARCH NEUROL-CHICAGO, V45, P31; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Fujinami Y, 2003, PROSTHODONT RES PRAC, V2, P11, DOI 10.2186/prp.2.11; MAHONEY F I, 1965, Md State Med J, V14, P61; Marcenes Wagner, 2003, Cad Saude Publica, V19, P809, DOI 10.1590/S0102-311X2003000300013; Stuck AE, 1999, SOC SCI MED, V48, P45; Tyas SL, 2015, INT J GERIATR PSYCHI; Wakano Shimpachi, 2011, J Prosthodont Res, V55, P228, DOI 10.1016/j.jpor.2011.03.001; Yamamoto T, 2012, BMJ OPEN, P2; Yoshida M, 2006, PROSTHODONT RES PRAC, V5, P52, DOI 10.2186/prp.5.52	21	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1883-1958	2212-4632		J PROSTHODONT RES	J. Prosthodont. Res.	OCT	2015	59	4					243	248		10.1016/j.jpor.2015.06.003		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7JS	WOS:000362991600006		
J	Mori, K; Tsuji, M; Ueda, T; Sakurai, K				Mori, Kazunari; Tsuji, Masashi; Ueda, Takayuki; Sakurai, Kaoru			Color and gloss evaluation of titanium dioxide coating for acrylic resin denture base	JOURNAL OF PROSTHODONTIC RESEARCH			English	Article						Polymethyl methacrylate resin; Denture base; Titanium dioxide; Coating; Primer	STREPTOCOCCUS-ORALIS; SURFACE-ROUGHNESS; BIOFILM FORMATION; STABILITY	Purpose: We examined the clinical appearance (color, gloss, and surface roughness) of TiO2 coating on polymethyl methacrylate (PMMA) resin dentures. Methods: A spraying method, using air brushes, was used to generate thin uniform TiO2 coating. PMMA resin, primer-coated PMMA, and TiO2-coated PMMA (with primer) specimens were compared. Results: The Commission Internationale de l'Eclairage (CIE) color system revealed color variations between the with/without coated samples. The TiO2-coated PMMA specimen displayed high levels of glossiness, highlighting the efficient self-cleansing actions of the denture. The measured surface roughness decreased upon primer coating, and increased following TiO2 coating. Conclusions: The thin TiO2 coating afforded high levels of glossiness while maintaining the color of the denture base material. (C) 2015 Japan Prosthodontic Society. Published by Elsevier Ireland. All rights reserved.	[Mori, Kazunari; Tsuji, Masashi; Ueda, Takayuki; Sakurai, Kaoru] Tokyo Dent Coll, Dept Removable Prosthodont & Gerodontol, Tokyo 1010061, Japan	Ueda, T (reprint author), Tokyo Dent Coll, Dept Removable Prosthodont & Gerodontol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	uedat@tdc.ac.jp					Al-Rifaiy Mohammed Q, 2010, Saudi Dent J, V22, P13, DOI 10.1016/j.sdentj.2009.12.006; Amano D, 2010, DENT MATER J, V29, P97; Charman KM, 2009, LETT APPL MICROBIOL, V48, P472, DOI 10.1111/j.1472-765X.2008.02551.x; Marra J, 2012, J APPL ORAL SCI, V20, P643, DOI 10.1590/S1678-77572012000600009; Shibata T, 2007, DENT MATER J, V26, P437; Keyf F, 2004, DENT MATER, V20, P244, DOI 10.1016/S0109-5641(03)00099-X; Polyzois G, 2013, GERODONTOLOGY, V30, P150, DOI 10.1111/j.1741-2358.2012.00657.x; Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x; Jain V, 2013, J ORAL SCI, V55, P9; Ceruti P, 2013, INT J PROSTHODONT, V26, P487, DOI 10.11607/ijp.3320; Sabatini C, 2012, J ESTHET RESTOR DENT, V24, P185, DOI 10.1111/j.1708-8240.2011.00442.x; Koch C, 2013, GERODONTOLOGY, V30, P309, DOI 10.1111/ger.12056; Arai T, 2009, J ORAL REHABIL, V36, P902, DOI 10.1111/j.1365-2842.2009.02012.x; Marachlioglou CRMZ, 2010, J ORAL REHABIL, V37, P518, DOI 10.1111/j.1365-2842.2010.02072.x; Artopoulos Andreas, 2013, J Prosthet Dent, V110, P481, DOI 10.1016/j.prosdent.2013.07.005; Berger Julie C, 2006, J Prosthodont, V15, P180, DOI 10.1111/j.1532-849X.2006.00098.x; Hayakawa I, 1988, J JPN SOC DENT MAT D, V7, P79; Kado D, 2005, PROSTHODONT RES PRAC, V4, P69, DOI 10.2186/prp.4.69; Kondo K, 2013, J NIPPON DENT U COLL, V2, P20; Tsuji M, 2015, GERODONTOLO IN PRESS; Yamauchi M, 1990, Dent Mater J, V9, P19; Zilinskas J, 2013, MED SCI MONITOR, V19, P1142, DOI 10.12659/MSM.889568	22	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1883-1958	2212-4632		J PROSTHODONT RES	J. Prosthodont. Res.	OCT	2015	59	4					249	253		10.1016/j.jpor.2015.06.001		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7JS	WOS:000362991600007		
J	Kawara, M; Iwasaki, M; Iwata, Y; Komoda, Y; Inoue, S; Komiyama, O; Suzuki, H; Kuroki, T; Hashizaki, K				Kawara, Misao; Iwasaki, Masatoshi; Iwata, Yoshihiro; Komoda, Yoshihiro; Inoue, Sayumi; Komiyama, Osamu; Suzuki, Hiroshi; Kuroki, Toshikazu; Hashizaki, Kaname			Rheological properties of elastomeric impression materials for selective pressure impression technique	JOURNAL OF PROSTHODONTIC RESEARCH			English	Article						Removable denture; Selective pressure impression; Impression materials; Dynamic viscoelasticity; Rheological properties	ORAL-MUCOSA	Purpose: The selective impression technique is recommended for removable prosthodontics. However, the viscoelastic rheological properties of impression materials, particularly the time-dependent viscoelastic changes in impression material immediately after tray seating, are unknown. The objective of this study is to clarify the viscoelastic rheological properties of impression materials by focusing on tray seating. Methods: In this study, eight types of polyvinylsiloxane (PVS), two types of polyether, and two types of alginate impression materials were used. The storage modulus (G'; degree of stiffness) and loss tangent (tan delta; degree of hardening) were determined as functions of time from 0 to 360 s, commencing immediately after the completion of mixing, using a stress control-type rheometer. Thus, G' and tan delta at 0 s and 20 s were compared. Results: Stiffness was found to be widely distributed (4.49-0.26 x 10(4) Pa) among PVS-types, even immediately after mixing the impression material. There was also variation among polyethers (1.55-0.5 x 10(4) Pa) and among alginates (0.64-0.21 x 10(4) Pa). The hardening of all impression materials progresses beyond 20 s after the completion of mixing. Conclusions: The G' values varied with each impression material, even immediately after mixing, and the accurate impression-taking time was determined from the results of tan d. These results provide unique insight into the selective impression technique. (C) 2015 Japan Prosthodontic Society. Published by Elsevier Ireland. All rights reserved.	[Kawara, Misao; Komiyama, Osamu; Suzuki, Hiroshi; Kuroki, Toshikazu] Nihon Univ, Sch Dent Matsudo, Dept Oral Funct & Rehabil, Matsudo, Chiba 2718587, Japan; [Iwasaki, Masatoshi; Iwata, Yoshihiro; Komoda, Yoshihiro; Inoue, Sayumi] Nihon Univ, Grad Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan; [Hashizaki, Kaname] Nihon Univ, Phys Chem Lab, Sch Pharm, Matsudo, Chiba 2718587, Japan	Kawara, M (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Oral Funct & Rehabil, Matsudo, Chiba 2718587, Japan.	kawara.misao@nihon-u.ac.jp					Addison PI, 1944, J AM DENT ASSOC, V31, P941; Al-Ahmad Adel, 2006, J Prosthodont, V15, P95, DOI 10.1111/j.1532-849X.2006.00081.x; Wadhwani CPK, 2005, J PROSTHET DENT, V93, P530, DOI 10.1016/j.prosdent.2005.03.007; FRANK RP, 1969, J PROSTHET DENT, V22, P400, DOI 10.1016/0022-3913(69)90207-8; McCabe JF, 1998, J DENT RES, V77, P1874; Hyde TP, 2010, J DENT, V38, P853, DOI 10.1016/j.jdent.2010.07.003; Berg JC, 2003, J PROSTHET DENT, V90, P150, DOI 10.1016/S0022-3913(03)00297-X; JACOBSON TE, 1983, J PROSTHET DENT, V49, P306, DOI 10.1016/0022-3913(83)90267-6; Hyde TP, 2008, J PROSTHET DENT, V100, P384, DOI 10.1016/S0022-3913(08)60241-3; Duncan JP, 2004, J PROSTHET DENT, V92, P299, DOI 10.1016/j.prosdent.2004.06.001; Hyde TP, 2014, J DENT, V42, P895, DOI 10.1016/j.jdent.2014.02.005; Nishigawa G, 2003, J ORAL REHABIL, V30, P608, DOI 10.1046/j.1365-2842.2003.01056.x; ELKHODARY NM, 1985, J PROSTHET DENT, V53, P543, DOI 10.1016/0022-3913(85)90644-4; KLEIN IE, 1985, J PROSTHET DENT, V54, P660, DOI 10.1016/0022-3913(85)90245-8; Komiyama O, 2004, J PROSTHET DENT, V91, P570, DOI 10.1016/j.prosdent.2004.03.020; Boucher C., 1944, J AM DENT ASSOC, V31, P1174; Gupta A, 2014, J EVOL MED DENT SCI, V29, P8110; Koffi NJ, ODONTOSTOMATOL TROP; Masri Radi, 2002, J Prosthodont, V11, P155, DOI 10.1053/jpro.2002.128004; Nunez MC, 2013, GERODONTOLOGY; Papadogiannis D, 2012, J PROSTHODONT RES, V56, P11, DOI 10.1016/j.jpor.2011.03.002; Petropoulos Vicki C, 2003, J Prosthodont, V12, P280; Tolidis K, 2013, Eur J Prosthodont Restor Dent, V21, P75	23	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1883-1958	2212-4632		J PROSTHODONT RES	J. Prosthodont. Res.	OCT	2015	59	4					254	261		10.1016/j.jpor.2015.07.002		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7JS	WOS:000362991600008		
J	Nishigawa, K; Suzuki, Y; Matsuka, Y				Nishigawa, Keisuke; Suzuki, Yoshitaka; Matsuka, Yoshizo			Masticatory performance alters stress relief effect of gum chewing	JOURNAL OF PROSTHODONTIC RESEARCH			English	Article						Stress; Saliva; Gum chewing; Masticatory performance; Chromogranin-A	SALIVARY CHROMOGRANIN-A; PLASMA HOMOVANILLIC-ACID; MENTAL STRESS; COGNITIVE PERFORMANCE; PSYCHOSOMATIC STRESS; PSYCHOLOGICAL STRESS; SOCIAL STRESS; JAW MOVEMENT; TEST FOOD; HYPOTHALAMUS	Purpose: We evaluated the effects of gum chewing on the response to psychological stress induced by a calculation task and investigated the relationship between this response and masticatory performance. Methods: Nineteen healthy adult volunteers without dental problems undertook the Uchida-Kraepelin (UK) test (30 min of reiterating additions of one-digit numbers). Before and immediately after the test, saliva samples were collected from the sublingual area of the participants. Three min after the UK test, the participants were made to chew flavorless gum for 3 min, and the final saliva samples were collected 10 min after the UK test. The experiment was performed without gum chewing on a different day. Masticatory performance was evaluated using color-changing chewing gum. Results: Salivary CgA levels at immediately and 10 min after the UK test were compared with and without gum chewing condition. Two-way repeated measures analysis of variance revealed significant interaction between gum chewing condition and changes in CgA levels during post 10 min UK test period. A significant correlation was found between changes in CgA levels and masticatory performance in all participants. Conclusion: Our results indicate that gum chewing may relieve stress responses; however, high masticatory performance is required to achieve this effect. (C) 2015 Japan Prosthodontic Society. Published by Elsevier Ireland. All rights reserved.	[Nishigawa, Keisuke; Suzuki, Yoshitaka; Matsuka, Yoshizo] Univ Tokushima, Grad Sch, Dept Stomatognath Funct & Occlusal Reconstruct, Inst Biomed Sci, Tokushima 7708504, Japan	Nishigawa, K (reprint author), Univ Tokushima, Grad Sch, Dept Stomatognath Funct & Occlusal Reconstruct, Inst Biomed Sci, 3 Kuramoto Cho, Tokushima 7708504, Japan.	keisuke@tokushima-u.ac.jp			Japan Society for the Promotion of Science [24592919]	This study was supported by a Grant-in-Aid for Scientific Research No. 24592919 from the Japan Society for the Promotion of Science.	Smith A, 2010, NUTR NEUROSCI, V13, P7, DOI 10.1179/147683010X12611460763526; Kanamaru Y, 2006, STRESS, V9, P127, DOI 10.1080/14769670600909594; Smith A, 2013, STRESS HEALTH, V29, P172, DOI 10.1002/smi.2430; Sato H, 2003, J ORAL REHABIL, V30, P68, DOI 10.1046/j.1365-2842.2003.01049.x; Tucha O, 2004, APPETITE, V42, P327, DOI 10.1016/j.appet.2004.01.003; Li GY, 2004, NEUROPSYCHOBIOLOGY, V50, P336, DOI 10.1159/000080962; Strelets VB, 2006, ZH VYSSH NERV DEYAT+, V56, P219; Scholey A, 2004, APPETITE, V43, P215, DOI 10.1016/j.appet.2004.07.004; Sato S, 2003, J ORAL REHABIL, V30, P146, DOI 10.1046/j.1365-2842.2003.01050.x; Dinca-Panaitescu S, 1999, INTEGR PHYS BEH SCI, V34, P10, DOI 10.1007/BF02688706; Smith AP, 2012, APPETITE, V58, P1083, DOI 10.1016/j.appet.2012.02.052; Sumiyoshi T, 1998, NEUROPSYCHOPHARMACOL, V19, P70; WILDING RJC, 1993, ARCH ORAL BIOL, V38, P589, DOI 10.1016/0003-9969(93)90124-5; Sketchley-Kaye K, 2011, NUTR NEUROSCI, V14, P237, DOI 10.1179/1476830511Y.0000000017; Johnson AJ, 2011, APPETITE, V56, P408, DOI 10.1016/j.appet.2010.12.025; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154; Negoescu R, 1997, INTEGR PHYS BEH SCI, V32, P220, DOI 10.1007/BF02688620; Hasegawa Y, 2007, J DENT RES, V86, P64; Goi Nobuhiro, 2007, Journal of Toxicological Sciences, V32, P121, DOI 10.2131/jts.32.121; Yasumasu T, 2006, PSYCHOPHYSIOLOGY, V43, P41, DOI 10.1111/j.1469-8986.2006.00377.x; Scholey A, 2009, PHYSIOL BEHAV, V97, P304, DOI 10.1016/j.physbeh.2009.02.028; Lee T, 2006, ACTA PAEDIATR, V95, P935, DOI 10.1080/08035250500538940; Yamaguchi M, 2004, BIOSENS BIOELECTRON, V20, P491, DOI 10.1016/j.bios.2004.02.012; Ono T, 2007, J NEUROL, V254, P1427, DOI 10.1007/s00415-007-0570-3; Sugiura T, 2009, J ORAL REHABIL, V36, P159, DOI 10.1111/j.1365-2842.2008.01917.x; Smith AP, 2012, APPETITE, V58, P1037, DOI 10.1016/j.appet.2012.02.054; Shimbo M, 2004, J NUTR SCI VITAMINOL, V50, P283; Kanno T, 1999, EXP PHYSIOL, V84, P1073; Sumiyoshi T, 1999, NEUROPSYCHOPHARMACOL, V20, P365, DOI 10.1016/S0893-133X(98)00095-5; Komagamine Y, 2011, J ORAL REHABIL, V38, P555, DOI 10.1111/j.1365-2842.2011.02204.x; Hori N, 2004, J DENT RES, V83, P124; Wilkinson L, 2002, APPETITE, V38, P235, DOI 10.1006/appe.2002.0473; Gray G, 2012, APPETITE, V58, P554, DOI 10.1016/j.appet.2011.11.013; Hatch JP, 2001, ARCH ORAL BIOL, V46, P641, DOI 10.1016/S0003-9969(01)00023-1; Bates J F, 1976, J Oral Rehabil, V3, P57, DOI 10.1111/j.1365-2842.1976.tb00929.x; Miyakawa Masamitsu, 2006, Noise Health, V8, P108; Nakajo N, 2007, J JPN DENT SOC ANEST, V35, P346; Nakane H, 1998, BIOMED RES-TOKYO, V19, P401; Oishi Kazuo, 1999, Applied Human Science, V18, P101, DOI 10.2114/jpa.18.101; Smith P., 2009, STRESS HEALTH, V25, P445; Soeda R, 2011, J ORAL REHABIL, V39, P261; Tahara Yasuaki, 2007, J Prosthodont, V16, P129, DOI 10.1111/j.1532-849X.2007.00178.x; Tasaka Akinori, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P482; Toda M, 2007, BIOMED RES-TOKYO, V28, P115, DOI 10.2220/biomedres.28.115	44	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1883-1958	2212-4632		J PROSTHODONT RES	J. Prosthodont. Res.	OCT	2015	59	4					262	267		10.1016/j.jpor.2015.07.004		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT7JS	WOS:000362991600009		
J	Wang, ZT; Zheng, J; Tagami, K; Uchida, S				Wang, Z. T.; Zheng, J.; Tagami, K.; Uchida, S.			Newly derived transfer factors for Th, Am, Pu, and Cl since publication of IAEA TRS No. 472: a review	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						TRS 472; Transfer factor; Thorium; Americium; Plutonium; Chlorine	PLANT TRANSFER-FACTORS; NATURALLY-OCCURRING RADIONUCLIDES; NATURAL RADIONUCLIDES; CONCENTRATION RATIOS; STABLE ELEMENTS; TRACE-ELEMENTS; ROOT UPTAKE; RICE PLANT; SOIL; THORIUM	Recently derived soil to plant transfer factors (2008-2014) for Th, Am, Pu and Cl were collected from the literature and were statistically analyzed to compare them with the previously published data in IAEA TRS 472. The comparison showed that these newly obtained transfer factors were able to supplement the TRS 472 database to some extent; however, data for Am, Pu and Cl remain limited and incomplete, pointing to the need for further studies.	[Wang, Z. T.; Zheng, J.; Tagami, K.; Uchida, S.] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 2638555, Japan	Zheng, J (reprint author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, 491 Anagawa, Chiba 2638555, Japan.	jzheng@nirs.go.jp			Agency for Natural Resources and Energy (METI), Japan	We gratefully acknowledge the two reviewers for their valuable suggestions on improving this paper. This work was supported by the Agency for Natural Resources and Energy (METI), Japan.	Alexakhin RM, 1992, AGR RADIOECOLOGY ECO; Uchida S, 2007, J NUCL SCI TECHNOL, V44, P628, DOI 10.3327/jnst.44.628; Velasco H, 2012, J ENVIRON RADIOACTIV, V104, P64, DOI 10.1016/j.jenvrad.2011.09.016; Shanthi G, 2012, RADIAT PROT DOSIM, V149, P327, DOI 10.1093/rpd/ncr235; Ehlken S, 2002, J ENVIRON RADIOACTIV, V58, P97, DOI 10.1016/S0265-931X(01)00060-1; Duffa C, 2002, J RADIOANAL NUCL CH, V252, P247, DOI 10.1023/A:1015797701941; Cerne M, 2010, J RADIOANAL NUCL CH, V286, P323, DOI 10.1007/s10967-010-0708-0; Choi YH, 2014, J ENVIRON RADIOACTIV, V132, P57, DOI 10.1016/j.jenvrad.2014.01.016; Khan HM, 2011, WATER AIR SOIL POLL, V219, P129, DOI 10.1007/s11270-010-0693-5; Kumar A, 2008, WATER AIR SOIL POLL, V192, P293, DOI 10.1007/s11270-008-9656-5; SCHRECKHISE RG, 1980, HEALTH PHYS, V38, P817, DOI 10.1097/00004032-198005000-00009; Shtangeeva I, 2004, WATER AIR SOIL POLL, V154, P19, DOI 10.1023/B:WATE.0000022927.15629.04; Carini F, 2001, J ENVIRON RADIOACTIV, V52, P237, DOI 10.1016/S0265-931X(00)00035-7; ADRIANO DC, 1981, SOIL SCI, V132, P83, DOI 10.1097/00010694-198107000-00012; Sheppard SC, 1999, J ENVIRON RADIOACTIV, V43, P65, DOI 10.1016/S0265-931X(98)00039-3; Kashparov V, 2005, J ENVIRON RADIOACTIV, V79, P233, DOI 10.1016/j.jenvrad.2004.07.001; Ewing RC, 1999, P NATL ACAD SCI USA, V96, P3432, DOI 10.1073/pnas.96.7.3432; Parache V, 2011, ENVIRON SCI TECHNOL, V45, P9998, DOI 10.1021/es202242g; Mheemeed AK, 2014, J RADIOANAL NUCL CH, V302, P87, DOI 10.1007/s10967-014-3259-y; Dragovic S, 2010, J ENVIRON RADIOACTIV, V101, P159, DOI 10.1016/j.jenvrad.2009.09.011; Sokolik GA, 2004, ENVIRON INT, V30, P939, DOI 10.1016/j.envint.2004.03.003; Tsukada H, 2008, J RADIOANAL NUCL CH, V278, P387, DOI 10.1007/s10967-008-0805-5; Khan HM, 2010, WATER AIR SOIL POLL, V213, P353, DOI 10.1007/s11270-010-0390-4; Weng HX, 2009, ENVIRON GEOCHEM HLTH, V31, P401, DOI 10.1007/s10653-008-9193-6; Tsukada H, 2007, J RADIOANAL NUCL CH, V273, P199, DOI 10.1007/s10967-007-0736-6; Mihaylova V, 2013, CR ACAD BULG SCI, V66, P513; Panchal RH, 2011, WATER AIR SOIL POLL, V219, P429, DOI 10.1007/s11270-010-0718-0; Saeed MA, 2012, ROM J PHYS, V57, P1417; Yang GS, 2014, CHEMOSPHERE, V111, P554, DOI 10.1016/j.chemosphere.2014.04.094; Yang GS, 2013, TALANTA, V116, P181, DOI 10.1016/j.talanta.2013.05.015; HANSEN RO, 1969, SOIL SCI, V108, P257, DOI 10.1097/00010694-196910000-00004; Rodriguez PB, 2010, APPL RADIAT ISOTOPES, V68, P1154, DOI 10.1016/j.apradiso.2010.01.045; Uchida S, 2007, J NUCL SCI TECHNOL, V44, P779, DOI 10.3327/jnst.44.779; Weber WJ, 2009, MRS BULL, V34, P46, DOI 10.1557/mrs2009.12; Bhatti IA, 2012, J CHEM SOC PAKISTAN, V34, P1012; Hurtevent P, 2013, J ENVIRON RADIOACTIV, V121, P43, DOI 10.1016/j.jenvrad.2012.04.013; SHEPPARD SC, 1988, J ENVIRON RADIOACTIV, V8, P255, DOI 10.1016/0265-931X(88)90051-3; Lehto J, 2013, J ENVIRON RADIOACTIV, V116, P124, DOI 10.1016/j.jenvrad.2012.08.012; [Anonymous], 2013, LIFE SCI J; Zhang Zhi-qiang, 2011, Huanjing Kexue, V32, P1159; Asaduzzaman K, 2014, J ENVIRON RADIOACTIV, V135, P120, DOI 10.1016/j.jenvrad.2014.04.009; Oufni L, 2011, J RADIOANAL NUCL CH, V287, P403, DOI 10.1007/s10967-010-0888-7; Syed HS, 1999, J RADIOANAL NUCL CH, V241, P11, DOI 10.1007/BF02347283; Hinton TG, 2005, J RADIOANAL NUCL CH, V264, P417, DOI 10.1007/s10967-005-0731-8; Popic JM, 2011, J ENVIRON MONITOR, V13, P1730, DOI 10.1039/c1em10107b; Aswood M, 2013, APPL PHYS RES, V5, P85; Cantrell KJ, 2012, PLUTONIUM AM GEOCHEM; Chakraborty SR, 2013, J PHYS SCI, V24, P95; Choppin GR, 2001, RADIOACTIV ENVIRONM, V1, P91; Commission European, 2004, GEOL DISP RAD WAST P; Eslava-Gomez A, 2013, DETERMINATION ROOT U; Ewers LW, 2003, REV TRANDFER NATURAL; IAEA, 2009, TECDOC1616 IAEA; IAEA, 2009, TECDOC1497 IAEA; IAEA, 2011, IAEA SAF STAND SER; IAEA, 2010, HDB PAR VAL PRED RAD; Clarke Roger, 2009, Annals of the ICRP, V39, P1, DOI 10.1016/j.icrp.2009.05.004; Ishii N, 2015, NUCL BACK END TRANSM, P303; Ishii N, 2009, RADIOPROTECTION, V44, P547; Kritsananuwat R, 2015, J RADIOANAL NUCL CH, V303, P2571, DOI 10.1007/s10967-014-3779-5; Li J, 2011, PROG NUCL SCI TECHNO, V1, P344; Pallavicini N, 2011, ACTIVITY CONCENTRATI; Sheppard MI, 1980, ENV BEHAV URANIUM TH; Singh M, 2014, J SCI IND RES INDIA, V73, P181; Smodis B, 2012, EPJ WEB CONF, V24, DOI 10.1051/epjconf/20122406008; Strok M, 2013, NUCL ENG DES, V261, P279, DOI 10.1016/j.nucengdes.2013.03.036; Xu H, 2009, PROG REP CHINA NUCL, V1, P271; [徐辉 Xu Hui], 2012, [原子能科学技术, Atomic Energy Science and Technology], V46, P524; Zhang JJ, 1989, RES ENV SCI, V2, P27	69	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	OCT	2015	306	1					11	20		10.1007/s10967-015-4260-9		10	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CT6XR	WOS:000362957300002		
J	Tan, YL; Liu, FD; Tokonami, S; Xiao, DT; Shan, J; Zhou, QZ; Tang, Q; Hosoda, M; Kudo-Yokota, H; Pornnumpa, C; Wanabongse, P				Tan, Yanliang; Liu, Fudong; Tokonami, Shinji; Xiao, Detao; Shan, Jian; Zhou, Qingzhi; Tang, Quan; Hosoda, Masahiro; Kudo-Yokota, Hiromi; Pornnumpa, Chanis; Wanabongse, Paitoon			A proposal to evaluate radioactivity of cement containing coal fly ash from China national standard: "Limits of radionuclides in building materials''	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Cement; Concrete; Coal fly ash; Radionuclide; Limit	RADON EXHALATION RATES; RADIATION HAZARDS; CONCRETE; MODEL	This paper is a proposal to evaluate radioactivity of coal fly ash used in cement according the national standard titled "Limits of radionuclides in building materials''. Because concrete includes cement and nature materials with low radioactivity, we propose that the limits of radionuclides in cement contained coal fly ash can be two times relaxed than that of this national standard, and the limit of the internal exposure index on cement may be unnecessary. There is no obviously increase of the Rn-222 exhalation rate from aerated concrete block when the radium content is similar to that of common concrete block.	[Tan, Yanliang] Hengyang Normal Univ, Dept Phys & Elect, Hengyang 421008, Hunan, Peoples R China; [Liu, Fudong] Minist Environm Protect, Nucl & Radiat Safety Ctr, Beijing 100082, Peoples R China; [Tokonami, Shinji; Kudo-Yokota, Hiromi; Pornnumpa, Chanis; Wanabongse, Paitoon] Hirosaki Univ, Inst Radiat Emergency Med, Dept Radiat Phys, Hirosaki, Aomori 0368564, Japan; [Xiao, Detao; Shan, Jian; Zhou, Qingzhi; Tang, Quan] Univ South China, Sch Nucl Sci & Technol, Hengyang 421001, Hunan, Peoples R China; [Hosoda, Masahiro] Hirosaki Univ, Grad Sch Hlth Sci, Hirosaki, Aomori 0368564, Japan	Tan, YL (reprint author), Hengyang Normal Univ, Dept Phys & Elect, Hengyang 421008, Hunan, Peoples R China.	hytyl@163.com			National Natural Science Foundation of China [11075049, 11375058]; Excellent Talents Program of Hengyang Normal University of China; Construct Program of the Key Discipline in Hunan Province; Cooperative Innovation Center for Digitalization of Cultural Heritage in Ancient Villages and Towns	This work was supported by the National Natural Science Foundation of China (Grants # 11075049, 11375058), the Excellent Talents Program of Hengyang Normal University of China, the Construct Program of the Key Discipline in Hunan Province and the Cooperative Innovation Center for Digitalization of Cultural Heritage in Ancient Villages and Towns. The GTX780 used for this research was donated by the NVIDIA Corporation.	Kumar A, 2014, J ENVIRON RADIOACTIV, V127, P50, DOI 10.1016/j.jenvrad.2013.10.004; [Anonymous], GB119682006; Man CK, 1998, J RADIOANAL NUCL CH, V232, P219, DOI 10.1007/BF02383742; Kovler K, 2011, CONSTR BUILD MATER, V25, P3404, DOI 10.1016/j.conbuildmat.2011.03.031; Hameed PS, 2014, J RADIOANAL NUCL CH, V300, P1081, DOI 10.1007/s10967-014-3033-1; Guillen J, 2014, J ENVIRON RADIOACTIV, V132, P81, DOI 10.1016/j.jenvrad.2014.02.004; Taylor-Lange SC, 2012, BUILD ENVIRON, V56, P276, DOI 10.1016/j.buildenv.2012.03.009; [Anonymous], 65662010 GB; Papastefanou C, 2010, J ENVIRON RADIOACTIV, V101, P191, DOI 10.1016/j.jenvrad.2009.11.006; Muntean LE, 2014, J RADIOANAL NUCL CH, V299, P523, DOI 10.1007/s10967-013-2837-8; Sahoo BK, 2011, SCI TOTAL ENVIRON, V409, P2635, DOI 10.1016/j.scitotenv.2011.03.031; Sakoda A, 2011, APPL RADIAT ISOTOPES, V69, P1422, DOI 10.1016/j.apradiso.2011.06.009; Kovler K, 2012, CONSTR BUILD MATER, V29, P158, DOI 10.1016/j.conbuildmat.2011.10.023; [Anonymous], 552011 JGJ; Hussain HH, 2010, J RADIOANAL NUCL CH, V284, P43, DOI 10.1007/s10967-010-0464-1; Antonopoulos-Domis M, 1998, HEALTH PHYS, V74, P574, DOI 10.1097/00004032-199805000-00005; Bao W, 2010, SCI TECHNOL BAOTOU S, V36, P76; Garrabrants A, 2013, CHEMOSPHERE, V103, P131; Han Y, 2011, CHINA PERSONAL PROT, V4, P23; Hu D, 2007, ANHUI ARCHIT, V3, P171; [刘福东 LIU Fu-dong], 2009, [原子能科学技术, Atomic Energy Science and Technology], V43, P271; [刘福东 Liu Fudong], 2010, [辐射防护, Radiation Protection], V30, P108; [刘福东 Liu Fudong], 2007, [辐射防护, Radiation Protection], V27, P171; Nazaroff W, 1988, RADON ITS DECAY PROD; The writing group for the summary report on nationwide survey of environment radioactivity level in china, 1992, RAD PROTECT, V12, P122; [魏林宏 Wei Linhong], 2013, [高校地质学报, Geological Journal of China Universities], V19, P683	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	OCT	2015	306	1					277	281		10.1007/s10967-015-3943-6		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CT6XR	WOS:000362957300033		
J	Biro, L; Polgari, M; Toth, TM; Vigh, T; Kavasi, N; Sahoo, SK				Biro, Lorant; Polgari, Marta; Toth, Tivadar M.; Vigh, Tamas; Kavasi, Norbert; Sahoo, Sarata Kumar			Terrestrial radioisotopes as paleoenvironmental proxies in sedimentary formations	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Urkut; Manganese ore; Paleoredox proxy; Enrichment factor; Microbial mediation	CARBONATE ORE-DEPOSIT; HUNGARY; URKUT; BASIN	The presence of anomalous terrestrial radioisotopes must be suspected in black shale-hosted manganese ore deposits, based on high organic matter content, which is useful tool in genetic, among them paleoenvironmental investigations. Our work aims at the characterization of the paleoredox conditions of the Urkut Manganese Formation based on comparison of terrestrial radioisotopes and selected element ratios. Paleoredox indicators were estimated on U/Th, delta U, Ni/Co, V/Cr, V/(V + Ni) and Ce*. The results of paleoredox indicator element ratios show, that these methods must be used with caution (microbial selective element enrichments, mobilizations), and the complex interpretation using mineralogy and microtexture can be recommended.	[Biro, Lorant; Toth, Tivadar M.] Univ Szeged, Dept Mineral Geochem & Petr, H-6722 Szeged, Hungary; [Biro, Lorant; Polgari, Marta] Hungarian Acad Sci, Res Ctr Astron & Geosci, Inst Geol & Geochem, H-1112 Budapest, Hungary; [Vigh, Tamas] Mangan Ltd, H-8409 Urkut, Hungary; [Kavasi, Norbert; Sahoo, Sarata Kumar] Natl Inst Radiol Sci, Project Environm Dynam & Radiat Effects, Inage Ku, Chiba 2638555, Japan	Polgari, M (reprint author), Hungarian Acad Sci, Res Ctr Astron & Geosci, Inst Geol & Geochem, Budaorsi Str 45, H-1112 Budapest, Hungary.	rodokrozit@gmail.com			European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]	Lorant Biro's research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-12012-0001 'National Excellence Program'.	Polgari M, 2013, SEDIMENT GEOL, V294, P157, DOI 10.1016/j.sedgeo.2013.05.017; Yang BY, 2011, J RARE EARTH, V29, P499, DOI 10.1016/S1002-0721(10)60488-7; Polgari M, 2012, GEOLOGY, V40, P903, DOI 10.1130/G33304.1; Jeans CV, 2000, CLAY MINER, V35, P25, DOI 10.1180/000985500546710; WIGNALL PB, 1988, GEOLOGY, V16, P452, DOI 10.1130/0091-7613(1988)016<0452:IBOLIM>2.3.CO;2; Rimmer SM, 2004, CHEM GEOL, V206, P373, DOI 10.1016/j.chemgeo.2003.12.029; Vigh T, 2013, ACTA GEOPHYS, V61, P831, DOI 10.2478/s11600-013-0124-2; Polgari M, 2012, ORE GEOL REV, V47, P87, DOI 10.1016/j.oregeorev.2011.10.001; Macchour L, 1994, MAR GEOL, V117, P287; Wedepohl KH, 1971, PHYS CHEM EARTH	10	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	OCT	2015	306	1					289	293		10.1007/s10967-014-3861-z		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CT6XR	WOS:000362957300035		
J	Omori, Y; Tokonami, S; Ishikawa, T; Sahoo, SK; Akata, N; Sorimachi, A; Hosoda, M; Pornnumpa, C; Wanabongse, P; Kudo, H; Hu, YJ; Ao, YX; Li, XL; Li, K; Fu, YH; Sun, QF; Akiba, S				Omori, Yasutaka; Tokonami, Shinji; Ishikawa, Tetsuo; Sahoo, Sarata Kumar; Akata, Naofumi; Sorimachi, Atsuyuki; Hosoda, Masahiro; Pornnumpa, Chanis; Wanabongse, Paitoon; Kudo, Hiromi; Hu, Ye-Jing; Ao, Yong-Xiang; Li, Xiao-Liang; Li, Kun; Fu, Ying-Hua; Sun, Quan-Fu; Akiba, Suminori			A pilot study for dose evaluation in high-level natural radiation areas of Yangjiang, China	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Ambient gamma dose rate; External exposure; High background radiation area; Internal exposure; Thoron; Yangjiang	THORON MEASUREMENT; INDOOR RADON; PROGENY; CANCER	A pilot study to measure ambient gamma dose rate and radon and thoron progeny concentrations was made for eight dwellings selected in Yangjiang, China. Indoor and outdoor ambient gamma dose rates were 110-370 and 100-220 nGy h(-1), respectively. Doses received from indoor terrestrial radiation were estimated to be 0.6-1.8 mSv year(-1). Radon, thoron and thoron progeny concentrations were 19-98, 18-1120 and 0.4-10.3 Bq m(-3), respectively. This pilot study showed that the position of passive-type monitors to be placed and the deployment period should be carefully determined for estimating reliable annual average concentrations.	[Omori, Yasutaka; Ishikawa, Tetsuo; Sorimachi, Atsuyuki] Fukushima Med Univ, Dept Radiat Phys & Chem, Fukushima, Fukushima 9601295, Japan; [Tokonami, Shinji; Wanabongse, Paitoon] Hirosaki Univ, Inst Radiat Emergency Med, Hirosaki, Aomori 0368564, Japan; [Sahoo, Sarata Kumar] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 2638555, Japan; [Akata, Naofumi] Natl Inst Fus Sci, Device Engn & Appl Phys Res Div, Toki, Gifu 5095292, Japan; [Hosoda, Masahiro; Pornnumpa, Chanis; Kudo, Hiromi] Hirosaki Univ, Grad Sch Hlth Sci, Hirosaki, Aomori 0368564, Japan; [Hu, Ye-Jing] Yangxi Ctr Dis Prevent & Control, Yangjiang 529800, Guangdong, Peoples R China; [Ao, Yong-Xiang] Yangdong Ctr Dis Prevent & Control, Yangjiang 529900, Guangdong, Peoples R China; [Li, Xiao-Liang; Li, Kun; Fu, Ying-Hua; Sun, Quan-Fu] Chinese Ctr Dis Control & Prevent, Natl Inst Radiol Protect, Beijing 100088, Peoples R China; [Akiba, Suminori] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	Tokonami, S (reprint author), Hirosaki Univ, Inst Radiat Emergency Med, 66-1 Hon Cho, Hirosaki, Aomori 0368564, Japan.	tokonami@hirosaki-u.ac.jp			Ministry of the Environment in Japan	The survey was carried out under kind cooperation of the residents. We would like to acknowledge reviewers for their comments which improved our manuscript. This work was conducted in the grant-in-aid "Dosimetric Studies of Residents in High Natural Background Radiation Areas in India and China'' financially supported from the Ministry of the Environment in Japan.	Tao ZF, 2012, HEALTH PHYS, V102, P173, DOI 10.1097/HP.0b013e31822c7f1e; Tokonami S, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2132270; Tokonami S, 2010, RADIAT PROT DOSIM, V141, P335, DOI 10.1093/rpd/ncq246; Guo QJ, 2005, INT CONGR SER, V1276, P313, DOI 10.1016/j.ics.2004.10.005; Chougaonkar MP, 2004, J ENVIRON RADIOACTIV, V71, P275, DOI 10.1016/S0265-931X(03)00174-7; Wei LX, 1998, RADIAT PROT DOSIM, V77, P113; Tokonami S, 2004, RADIAT RES, V162, P390, DOI 10.1667/RR3237; Sorimachi A, 2010, RADIAT PROT DOSIM, V141, P367, DOI 10.1093/rpd/ncq245; Ramola RC, 2005, J ENVIRON RADIOACTIV, V79, P85, DOI 10.1016/j.jenvrad.2004.05.012; Zhang L, 2015, J RADIOANAL NUCL CH, V303, P1565, DOI 10.1007/s10967-014-3798-2; Yasuoka Y, 2009, J RADIOANAL NUCL CH, V279, P885, DOI 10.1007/s10967-008-7379-0; Nemeth C, 2005, J RADIOANAL NUCL CH, V267, P9, DOI 10.1007/s10967-006-0003-2; CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007; Janik M, 2013, J RADIAT RES, V54, P597, DOI 10.1093/jrr/rrs129; Ishikawa T, 2007, J RADIOL PROT, V27, P447, DOI 10.1088/0952-4746/27/4/005; Zou JM, 2005, INT CONGR SER, V1276, P97, DOI 10.1016/j.ics.2004.11.167; Kitto ME, 2005, J RADIOANAL NUCL CH, V264, P381, DOI 10.1007/s10967-005-0725-6; Hosoda M, 2014, RAD EMERG MED, V3, P59; Japan Meteorological Agency, 2015, WEATH IN THE WORLD; Morishima H, 2000, J RADIAT RES, V41, pS9; Sun Q, 2000, J RADIAT RES, V41, pS43; Tao Z, 2000, J RADIAT RES, V41, pS31; Tokonami S, 2002, JPN J HLTH PHYS, V37, P59; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, UNSCEAR 2008 REP GEN; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, UNSCEAR 2000 REP GEN; Wei L, 2000, J RADIAT RES, V41, pS1; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, DOI 10.1002/2013EO450001; Yonehara H, 2005, P 6 INT C HIGH LEV N; Yuan Y, 2000, J RADIAT RES, V41, pS25	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	OCT	2015	306	1					317	323		10.1007/s10967-015-4286-z		7	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CT6XR	WOS:000362957300039		
J	Yamaguchi, Y; Kanamaru, Y; Fukushima, M; Fujimoto, K; Ito, S				Yamaguchi, Yuki; Kanamaru, Yoshihiro; Fukushima, Minori; Fujimoto, Kenjiro; Ito, Shigeru			Preparation of Highly Crystallized Strontium Titanate Powders at Room Temperature	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							HYDROTHERMAL SYNTHESIS; BARIUM-TITANATE; PHOTOCATALYTIC ACTIVITY; SRTIO3; PRECIPITATION; KINETICS; WATER; GEL; NANOPARTICLES; MECHANISM	Highly crystallized fine powder of strontium titanate (SrTiO3) was obtained at room temperature simply by leaving a vial containing the powder mixture of Sr(OH)(2)8H(2)O and hydrous titania gel (TiO(2<bold>)nH(</bold>2)O) for 10d. Solvent and additive(s) used in the conventional low-temperature process were not used. The crystallinity judged from the FWHM of X-ray diffraction peak was comparable to that obtained by a solid-state reaction. To cause the reaction at room temperature, the titania gel had to contain a considerable amount of H2O (n>0.97). The reaction is considered to be neutralization of titanic acid [H4TiO4 or Ti(OH)(4)] and strontium hydroxide (base). Using similar process, highly crystallized BaTiO3 powder was also obtained at 60 degrees C. In comparison with the formation temperature of BaTiO3, tolerance factor in the perovskite structure was important for the room-temperature synthesis of SrTiO3. SrTiO3 was hardly obtained at room temperature by the addition of saturated strontium hydroxide solution to the hydrous TiO2 gel (n=1.29). Therefore, the reaction seems to proceed in the hydrous titania gel. This process is characterized by three important points; no solvent, no additional reagents, and above all, no heating.	[Yamaguchi, Yuki; Kanamaru, Yoshihiro; Fukushima, Minori; Fujimoto, Kenjiro; Ito, Shigeru] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan; [Yamaguchi, Yuki; Fujimoto, Kenjiro] Tokyo Univ Sci, Sci & Technol Res Inst, Noda, Chiba 2788510, Japan	Yamaguchi, Y (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan.	y-yamaguchi@rs.tus.ac.jp					Eckert JO, 1996, J AM CERAM SOC, V79, P2929, DOI 10.1111/j.1151-2916.1996.tb08728.x; Beier CW, 2010, J MATER CHEM, V20, P5074, DOI 10.1039/c0jm00845a; Zhang QH, 1999, NANOSTRUCT MATER, V11, P1293, DOI 10.1016/S0965-9773(99)00421-3; Hao YA, 2014, NANOSCALE, V6, P7940, DOI 10.1039/c4nr00171k; Frey MH, 1996, PHYS REV B, V54, P3158, DOI 10.1103/PhysRevB.54.3158; Zhang J, 2015, CERAM INT, V41, P5439, DOI 10.1016/j.ceramint.2014.12.110; DIAZGUEMES MI, 1989, J MATER SCI, V24, P1011, DOI 10.1007/BF01148791; CHIEN AT, 1995, J MATER RES, V10, P1784, DOI 10.1557/JMR.1995.1784; Mourao HAJL, 2015, MAT SCI SEMICON PROC, V30, P651, DOI 10.1016/j.mssp.2014.09.022; Ahuja S, 1996, J PHOTOCH PHOTOBIO A, V97, P99, DOI 10.1016/1010-6030(96)04324-9; da Silva LF, 2013, PHYS CHEM CHEM PHYS, V15, P12386, DOI 10.1039/c3cp50643f; Wei X, 2008, J AM CERAM SOC, V91, P299, DOI 10.1111/j.1551-2916.2007.02015.x; Lee DK, 2010, J CERAM SOC JPN, V118, P876, DOI 10.2109/jcersj2.118.876; Jalava JP, 1998, IND ENG CHEM RES, V37, P1317, DOI 10.1021/ie970469b; FUKAI K, 1990, CERAM INT, V16, P285, DOI 10.1016/0272-8842(90)90041-D; Kumar V, 1999, J AM CERAM SOC, V82, P2580; Yu JC, 2003, LANGMUIR, V19, P7673, DOI 10.1021/la0345035; LENCKA MM, 1993, CHEM MATER, V5, P61, DOI 10.1021/cm00025a014; Viviani M, 2003, J EUR CERAM SOC, V23, P1383, DOI 10.1016/S0955-2219(02)00357-6; Yu H, 2011, J MATER CHEM, V21, P11347, DOI 10.1039/c1jm11385b; George CN, 2009, J ALLOY COMPD, V486, P711, DOI 10.1016/j.jallcom.2009.07.045; Wu XZ, 2013, 2013 8TH ANNUAL IEEE INTERNATIONAL CONFERENCE ON NANO/MICRO ENGINEERED AND MOLECULAR SYSTEMS (IEEE NEMS 2013), P399; HERTL W, 1988, J AM CERAM SOC, V71, P879, DOI 10.1111/j.1151-2916.1988.tb07540.x; Ashiri R, 2014, J AM CERAM SOC, V97, P2027, DOI 10.1111/jace.13023; Townsend TK, 2012, ACS NANO, V6, P7420, DOI 10.1021/nn302647u; Joshi UA, 2005, SMALL, V1, P1172, DOI 10.1002/smll.200500055; Kato H, 2004, CHEM LETT, V33, P1348, DOI 10.1246/cl.2004.1348; KOMORNICKI S, 1990, SOLID STATE IONICS, V42, P7, DOI 10.1016/0167-2738(90)90252-M; Chen DR, 2000, J EUR CERAM SOC, V20, P1261, DOI 10.1016/S0955-2219(00)00003-0; CHAPUT F, 1987, J MATER SCI LETT, V6, P1110, DOI 10.1007/BF01729150; AVUDAITHAI M, 1987, MATER RES BULL, V22, P641, DOI 10.1016/0025-5408(87)90113-9; BUNTING EN, 1947, J AM CERAM SOC, V30, P114, DOI 10.1111/j.1151-2916.1947.tb18879.x; Kubo T., 1968, J CHEM SOC JPN, V71, P114; Levin E. M., 1964, PHASE DIAGRAMS CERAM, P83; MATIJEVIC E, 1977, J COLLOID INTERF SCI, V61, P302, DOI 10.1016/0021-9797(77)90393-9; SANTACESARIA E, 1986, J COLLOID INTERF SCI, V111, P44, DOI 10.1016/0021-9797(86)90005-6; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; YAMAMURA H, 1974, NIPPON KAGAKU KAISHI, P1155; Yanagida K., 2014, Key Engineering Materials, V617, DOI 10.4028/www.scientific.net/KEM.617.217; Yanagida K., 2014, J JPN SOC POW POW ME, V61, pS193	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	OCT	2015	98	10					3054	3061		10.1111/jace.13765		8	Materials Science, Ceramics	Materials Science	CT1YK	WOS:000362599000016		
J	Wang, XJ; Li, JG; Zhu, Q; Sun, XD				Wang, Xuejiao; Li, Ji-Guang; Zhu, Qi; Sun, Xudong			Direct Crystallization of Sulfate-Type Layered Hydroxide, Derivation of (Gd,Tb)(2)O-3 Green Phosphor, and Photoluminescence	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							UP-CONVERSION; ENHANCED LUMINESCENCE; GD2O3 NANOCRYSTALS; COLLOIDAL SPHERES; EARTH; PARTICLES; OXIDES; TB3+; GD3+; FABRICATION	The sulfate-type layered hydroxides of (Gd1-xTbx)(2)(OH)(5)(SO4)(0.5<bold>)nH(</bold>2)O (x=0.06-0.10) have been directly crystallized via hydrothermal reaction at 120 degrees C and pH similar to 10.0, without the need of conventional anion exchange. The primary crystallites were found to be thin platelets having lateral sizes of similar to 450-1000nm and thicknesses of similar to 65-85nm. Combined analysis by DTA/TG, FTIR, and XRD revealed that the layered compounds convert into cubic (Gd1-xTbx)(2)O-3 solid-solutions through dehydration, dehydroxylation, and desulfuration up to similar to 1200 degrees C and via a (Gd1-xTbx)(2)O-2.5(SO4)(0.5) intermediate phase. Optical spectroscopies found that the layered compounds and the derived oxides have their strongest 4f(8)4f(7)5d(1) transition excitations at similar to 248 and 305nm and optimal Tb3+ contents of 9at.% (x=0.09) and 8at.%, respectively. Both the types of materials exhibit the strongest emission at similar to 544nm (the (D4F5)-D-5-F-7 transition of Tb3+), but the oxide has an emission intensity similar to 3 times that of the hydroxide. Fluorescence lifetime of the 544nm green emission was found to decrease from 2.45 to 2.15ms along with increasing Tb3+ content for the oxide, and smaller values of similar to 1.55ms were derived for the layered hydroxides.	[Wang, Xuejiao; Li, Ji-Guang; Zhu, Qi; Sun, Xudong] Northeastern Univ, Sch Met & Mat, Key Lab Anisotropy & Texture Mat, Minist Educ, Shenyang 110819, Liaoning, Peoples R China; [Wang, Xuejiao; Li, Ji-Guang] Natl Inst Mat Sci, Adv Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan	Li, JG (reprint author), Northeastern Univ, Sch Met & Mat, Key Lab Anisotropy & Texture Mat, Minist Educ, Shenyang 110819, Liaoning, Peoples R China.	li.jiguang@nims.go.jp			National Natural Science Foundation of China [51172038, 51302032]; Fundamental Research Fund for the Central Universities [N140204002]; KAKENHI [26420686]; China Scholarship Council	This work is supported in part by the National Natural Science Foundation of China (grants no. 51172038 and 51302032), the Fundamental Research Fund for the Central Universities (grant no. N140204002), and Grants-in-Aid for Scientific Research (KAKENHI no. 26420686). X. J. Wang acknowledges the financial support from the China Scholarship Council for overseas Ph. D. study.	Tamrakar RK, 2014, RES CHEM INTERMEDIAT, V40, P1771, DOI 10.1007/s11164-013-1080-9; Tian G, 2011, J PHYS CHEM C, V115, P23790, DOI 10.1021/jp209055t; Lu B, 2015, J AM CERAM SOC, V98, P1413, DOI 10.1111/jace.13488; Mutelet B, 2011, J APPL PHYS, V110, DOI 10.1063/1.3658810; Guo H, 2004, J ALLOY COMPD, V376, P23, DOI 10.1016/j.jallcom.2003.12.020; Dorenbos P, 2000, J LUMIN, V91, P91, DOI 10.1016/S0022-2313(00)00197-6; Wu XL, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015006; Setua S, 2010, BIOMATERIALS, V31, P714, DOI 10.1016/j.biomaterials.2009.09.090; Verma RK, 2010, SOLID STATE SCI, V12, P1146, DOI 10.1016/j.solidstatesciences.2010.04.004; Atabaev TS, 2012, J ALLOY COMPD, V541, P263, DOI 10.1016/j.jallcom.2012.06.119; Guo H, 2004, J PHYS CHEM B, V108, P19205, DOI 10.1021/jp048072q; Hasegawa Y, 2002, ANGEW CHEM INT EDIT, V41, P2073, DOI 10.1002/1521-3773(20020617)41:12<2073::AID-ANIE2073>3.0.CO;2-K; Zhu Q, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/014203; Panda AB, 2007, J PHYS CHEM C, V111, P1861, DOI 10.1021/jp0670283; Wu XL, 2015, J MATER CHEM C, V3, P3428, DOI 10.1039/c4tc02681k; Li GZ, 2006, J NANOSCI NANOTECHNO, V6, P1416, DOI 10.1166/jnn.2006.195; Wu XL, 2012, DALTON T, V41, P1854, DOI 10.1039/c1dt11332a; Li YC, 2007, J PHYS CHEM C, V111, P10682, DOI 10.1021/jp0719107; Li JG, 2008, J PHYS CHEM C, V112, P11707, DOI 10.1021/jp802383a; McIntyre LJ, 2008, CHEM MATER, V20, P335, DOI 10.1021/cm7019284; Zhu Q, 2010, CURR NANOSCI, V6, P496; Zhu Q, 2010, CHEM MATER, V22, P4204, DOI 10.1021/cm1011586; Li JG, 2008, CHEM MATER, V20, P2274, DOI 10.1021/cm7033257; Poudret L, 2008, CHEM MATER, V20, P7447, DOI 10.1021/cm802301a; Kenyon AJ, 2002, PROG QUANT ELECTRON, V26, P225, DOI 10.1016/S0079-6727(02)00014-9; Du PF, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/3/035602; Ramirez ADM, 2010, MATER RES BULL, V45, P40, DOI 10.1016/j.materresbull.2009.09.005; Gadsden JA, 1975, INFRARED SPECTRA MIN; Li JG, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/1/014902; MOHARIL SV, 1994, B MATER SCI, V17, P25, DOI 10.1007/BF02747631; Psuja P., 2007, J NANOMATER, V1155, P81350; Petoral RM, 2009, J PHYS CHEM C, V113, P6913, DOI 10.1021/jp808708m	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	OCT	2015	98	10					3236	3242		10.1111/jace.13752		7	Materials Science, Ceramics	Materials Science	CT1YK	WOS:000362599000038		
J	Hori, S; Kato, M; Suzuki, K; Hirayama, M; Kato, Y; Kanno, R				Hori, Satoshi; Kato, Masahiko; Suzuki, Kota; Hirayama, Masaaki; Kato, Yuki; Kanno, Ryoji			Phase Diagramof the Li4GeS4-Li3PS4 Quasi-Binary System Containing the Superionic Conductor Li10GeP2S12	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							LITHIUM IONIC CONDUCTOR; CRYSTAL-STRUCTURE; THIO-LISICON; BATTERIES; ELECTROLYTES; LI; DYNAMICS; LI3PS4; SN; SI	A phase diagram is constructed for the quasi-binary Li4GeS4-Li3PS4 system containing the lithium superionic conductor Li10GeP2S12 (LGPS), having an LGPS-type structure, and the -Li3PS4-type phase, having a thio-LISICON structure. The LGPS and thio-LISICON intermediate compounds are found to exhibit solid solution ranges and show incongruent melting at 650 degrees C and 560 degrees C, respectively. The end-member Li4GeS4 has a compositional range of 0<k<0.3 in [(1-k) Li4GeS4+k Li3PS4], while the other end-member -Li3PS4 has no solid solution range. The crystal structures appearing in the binary systems are the -, -, and -type Li3PS4 structures and the LGPS-type structure, and these are formed by PS4 tetrahedra with different arrangements in each structure. The phase and structural relationships between the compounds appearing in the Li4GeS4-Li3PS4 system are thus clarified.	[Hori, Satoshi; Kato, Masahiko; Suzuki, Kota; Hirayama, Masaaki; Kanno, Ryoji] Tokyo Inst Technol, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Kato, Yuki] TOYOTA MOTOR EUROPE NV SA, Battery AT, Adv Technol 1, B-1930 Zaventem, Belgium	Kanno, R (reprint author), Tokyo Inst Technol, Dept Elect Chem, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.	kanno@echem.titech.ac.jp	Hirayama, Masaaki/B-5781-2011	Hirayama, Masaaki/0000-0003-4804-4208	Post-LiEAD project of the New Energy and Industry Technology Development Organization (NEDO), Japan	This study was supported by the Post-LiEAD project of the New Energy and Industry Technology Development Organization (NEDO), Japan. The synchrotron radiation experiments were carried out as projects approved by the Japan Synchrotron Radiation Institute (JASRI) (proposals nos. 2011B1697, 2013A1768, and 2013B1807).	Takada K, 2013, ACTA MATER, V61, P759, DOI 10.1016/j.actamat.2012.10.034; Adams S, 2012, J MATER CHEM, V22, P7687, DOI 10.1039/c2jm16688g; Kuhn A, 2013, PHYS CHEM CHEM PHYS, V15, P11620, DOI 10.1039/c3cp51985f; Kwon O, 2015, J MATER CHEM A, V3, P438, DOI 10.1039/c4ta05231e; Robertson AD, 1997, SOLID STATE IONICS, V104, P1, DOI 10.1016/S0167-2738(97)00429-3; Kuhn A, 2013, ENERG ENVIRON SCI, V6, P3548, DOI 10.1039/c3ee41728j; Kato Y, 2014, J POWER SOURCES, V271, P60, DOI 10.1016/j.jpowsour.2014.07.159; Du FM, 2014, J PHYS CHEM C, V118, P10590, DOI 10.1021/jp5000039; Kanno R, 2001, J ELECTROCHEM SOC, V148, pA742, DOI 10.1149/1.1379028; Liu ZC, 2013, J AM CHEM SOC, V135, P975, DOI 10.1021/ja3110895; Hori S, 2014, FARADAY DISCUSS, V176, P83, DOI 10.1039/c4fd00143e; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/nmat3066, 10.1038/NMAT3066]; Ong SP, 2013, ENERG ENVIRON SCI, V6, P148, DOI 10.1039/c2ee23355j; Sakuda A, 2010, J AM CERAM SOC, V93, P765, DOI 10.1111/j.1551-2916.2009.03442.x; HONG HYP, 1978, MATER RES BULL, V13, P117, DOI 10.1016/0025-5408(78)90075-2; Knauth P, 2002, J AM CERAM SOC, V85, P1654; Tatsumisago M, 2012, SOLID STATE IONICS, V225, P342, DOI 10.1016/j.ssi.2012.03.013; Xu M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737397; Whiteley JM, 2014, J ELECTROCHEM SOC, V161, pA1812, DOI 10.1149/2.0501412jes; Murayama M, 2002, J SOLID STATE CHEM, V168, P140, DOI 10.1006/jssc.2002.9701; Izumi F, 2007, SOL ST PHEN, V130, P15; Kato Y, 2012, ELECTROCHEMISTRY, V80, P749, DOI 10.5796/electrochemistry.80.749; Homma K, 2011, SOLID STATE IONICS, V182, P53, DOI 10.1016/j.ssi.2010.10.001; Kuhn A, 2014, PHYS CHEM CHEM PHYS, V16, P14669, DOI 10.1039/c4cp02046d; Takada K, 2013, LANGMUIR, V29, P7538, DOI 10.1021/la3045253; Kanno R, 2004, ELECTROCHEM SOLID ST, V7, pA455, DOI 10.1149/1.1809553; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Kaib T, 2012, CHEM MATER, V24, P2211, DOI 10.1021/cm3011315; Bron P, 2013, J AM CHEM SOC, V135, P15694, DOI 10.1021/ja407393y; Scrosati B, 2010, J POWER SOURCES, V195, P2419, DOI 10.1016/j.jpowsour.2009.11.048; Thackeray MM, 1999, J AM CERAM SOC, V82, P3347; Murayama M, 2002, SOLID STATE IONICS, V154, P789, DOI 10.1016/S0167-2738(02)00492-7; Homma K, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJS.79SA.90; Mo Y., 2011, CHEM MATER, V24, P15; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	OCT	2015	98	10					3352	3360		10.1111/jace.13694		9	Materials Science, Ceramics	Materials Science	CT1YK	WOS:000362599000053		
J	Narisawa, M; Funabiki, F; Iwase, A; Wakai, F; Hosono, H				Narisawa, Masaki; Funabiki, Fuji; Iwase, Akihiro; Wakai, Fumihiro; Hosono, Hideo			Effects of Atmospheric Composition on the Molecular Structure of Synthesized Silicon Oxycarbides	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; POLYCARBOSILANE FIBERS; SI-O-C(-H) CERAMICS; HYDROGEN ATMOSPHERE; CARBON-DIOXIDE; HEAT-TREATMENT; SIOC CERAMICS; CARBIDE FIBER; THIN-FILMS; POLYMER	The dependence of silicon oxycarbides' chemical composition and molecular structure on their reaction conditions was tested by varying the atmosphere under which pyrolysis was performed. To obtain the silicon oxycarbides, densely cross-linked silicone resin particles with an averaged diameter of 2m were pyrolyzed in various atmospheres of H-2, Ar, and CO2, in the temperature range 700 degrees C-1100 degrees C. The residual mass of resin after pyrolysis was almost constant at 700 degrees C, although their apparent colors varied distinctly. The sample obtained from the H-2 atmosphere was white, whereas that obtained from the CO2 atmosphere was dark brown. Fourier-transform infrared (FT-IR) spectra of the residues suggested that the Si-O-Si network evolution was accelerated in the CO2 atmosphere. Beyond 800 degrees C, the chemical compositions of the compounds obtained from a H-2 atmosphere increasingly approached near-stoichiometric SiO2-xSiC composition with increasing the pyrolysis temperature. Compounds from a CO2 atmosphere approached a composition of SiO2-xC with no free SiC as the pyrolysis temperature increased. In the products from an Ar atmosphere, SiO2-xSiC-yC compositions were typically obtained. The observed effects of the pyrolysis atmosphere on the resulting chemical compositions were analyzed in terms of thermodynamic calculations. Electron spin resonance (ESR) spectra revealed broad and intense signals from products obtained from either Ar or CO2. Estimating from the signal intensity, the residual spin concentrations were in the range 10(18)-10(19)g(-1). Meanwhile, the spectra from the samples obtained in H-2 showed weak and sharp signals with estimated spin concentrations ranging from 10(16)-10(17)g(-1). This signal attenuation may have been due to the hydrogen capping of dangling bond formed during pyrolysis.	[Narisawa, Masaki] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Funabiki, Fuji; Iwase, Akihiro] Tokyo Inst Technol, Mat Res Ctr Element Strategy, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Wakai, Fumihiro; Hosono, Hideo] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Narisawa, M (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	nar@mtr.osakafu-u.ac.jp	Hosono, Hideo/J-3489-2013	Hosono, Hideo/0000-0001-9260-6728	Materials and Structures Laboratory, Tokyo Institute of Technology	We would like to thank Mr. Takafumi Tai and Mr. Syu Takeuchi for their effort in the laboratory of the Graduate School of Engineering, Osaka Prefecture University. This work is partly supported by the Collaborative Research Project (General, Category B) of Materials and Structures Laboratory, Tokyo Institute of Technology.	RENLUND GM, 1991, J MATER RES, V6, P2723, DOI 10.1557/JMR.1991.2723; Colombo P, 2010, J AM CERAM SOC, V93, P1805, DOI 10.1111/j.1551-2916.2010.03876.x; Colombo P, 1999, J AM CERAM SOC, V82, P573; Rushkin IL, 1997, MACROMOLECULES, V30, P3141, DOI 10.1021/ma961664p; Takeda M, 2000, J AM CERAM SOC, V83, P1063; SORARU GD, 1995, J AM CERAM SOC, V78, P379, DOI 10.1111/j.1151-2916.1995.tb08811.x; Ruan GD, 2011, ACS NANO, V5, P7601, DOI 10.1021/nn202625c; Narisawa M, 2012, B CHEM SOC JPN, V85, P724, DOI 10.1246/bcsj.20110357; Karakuscu A, 2009, J AM CERAM SOC, V92, P2969, DOI 10.1111/j.1551-2916.2009.03343.x; Cantin JL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.015502; Ferraioli L, 2008, J AM CERAM SOC, V91, P2422, DOI 10.1111/j.1551-2916.2008.02457.x; Menapace I, 2008, J MATER SCI, V43, P5790, DOI 10.1007/s10853-008-2882-9; Narisawa M, 2012, J AM CERAM SOC, V95, P3935, DOI 10.1111/j.1551-2916.2012.05425.x; Narisawa M, 2013, SCRIPTA MATER, V69, P602, DOI 10.1016/j.scriptamat.2013.07.009; LUCOVSKY G, 1987, J VAC SCI TECHNOL B, V5, P530, DOI 10.1116/1.583944; Navarro RM, 2007, CHEM REV, V107, P3952, DOI 10.1021/cr0501994; Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579; Wang SB, 1996, ENERG FUEL, V10, P896, DOI 10.1021/ef950227t; HURWITZ FI, 1993, J MATER SCI, V28, P6622, DOI 10.1007/BF00356406; SUGIMOTO M, 1995, J AM CERAM SOC, V78, P1849, DOI 10.1111/j.1151-2916.1995.tb08898.x; Riedel R, 1996, NATURE, V382, P796, DOI 10.1038/382796a0; Karakuscu A, 2013, J AM CERAM SOC, V96, P2366, DOI 10.1111/jace.12491; Loboda MJ, 1998, J ELECTROCHEM SOC, V145, P2861, DOI 10.1149/1.1838726; Das G, 2007, VIB SPECTROSC, V45, P61, DOI 10.1016/j.vibspec.2007.07.001; Mazo MA, 2014, J NON-CRYST SOLIDS, V391, P23, DOI [10.1016/j.jnoncrysol.2014.03.006, 10.1016/j.jnoncryso1.2014.03.006]; Riedel R, 2010, J AM CERAM SOC, V93, P920, DOI 10.1111/j.1551-2916.2009.03496.x; Cantin JL, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2179128; BURNS GT, 1992, J MATER SCI, V27, P2131, DOI 10.1007/BF01117927; Garcia L, 2001, FUEL PROCESS TECHNOL, V69, P157, DOI 10.1016/S0378-3820(00)00138-7; Tavakoli AH, 2015, J AM CERAM SOC, V98, P242, DOI 10.1111/jace.13233; Prasad BLV, 2000, PHYS REV B, V62, P11209, DOI 10.1103/PhysRevB.62.11209; Glover C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.135502; Wang SB, 1998, APPL CATAL B-ENVIRON, V16, P269, DOI 10.1016/S0926-3373(97)00083-0; RENLUND GM, 1991, J MATER RES, V6, P2716, DOI 10.1557/JMR.1991.2716; Brewer CM, 1999, J SOL-GEL SCI TECHN, V14, P49, DOI 10.1023/A:1008723813991; Xing WB, 1997, J ELECTROCHEM SOC, V144, P2410, DOI 10.1149/1.1837828; DESHMUKH SC, 1995, J VAC SCI TECHNOL A, V13, P2355, DOI 10.1116/1.579521; Grill A, 2003, J APPL PHYS, V94, P6697, DOI 10.1063/1.1618358; Kim YW, 2003, J AM CERAM SOC, V86, P2231; Varga T, 2007, J AM CERAM SOC, V90, P3213, DOI 10.1111/j.1551-2916.2007.01874.x; BURNS GT, 1992, CHEM MATER, V4, P1313, DOI 10.1021/cm00024a035; NARISAWA M, 1995, B CHEM SOC JPN, V68, P1098, DOI 10.1246/bcsj.68.1098; Skuja L, 1998, J NON-CRYST SOLIDS, V239, P16, DOI 10.1016/S0022-3093(98)00720-0; Kajitani S, 2006, FUEL, V85, P163, DOI 10.1016/j.fuel.2005.07.024; GREIL P, 1995, J AM CERAM SOC, V78, P835, DOI 10.1111/j.1151-2916.1995.tb08404.x; Gallis S., 2010, APPL PHYS LETT, V97; Hurwitz F. I., 1987, CERAM ENG SCI P, V8, P732; Hurwitz F. I., 1989, CERAM ENG SCI P, V10, P750, DOI 10.1002/9780470310557.ch25; Ishikawa Y., 2008, J APPL PHYS, V104; Narisawa M., 2014, AIP ADV, V4; YAJIMA S, 1975, CHEM LETT, P931, DOI 10.1246/cl.1975.931	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	OCT	2015	98	10					3373	3380		10.1111/jace.13756		8	Materials Science, Ceramics	Materials Science	CT1YK	WOS:000362599000056		
J	Suzuki, K; Stephens, G; Bodas-Salcedo, A; Wang, MH; Golaz, JC; Yokohata, T; Koshiro, T				Suzuki, Kentaroh; Stephens, Graeme; Bodas-Salcedo, Alejandro; Wang, Minghuai; Golaz, Jean-Christophe; Yokohata, Tokuta; Koshiro, Tsuyoshi			Evaluation of the Warm Rain Formation Process in Global Models with Satellite Observations	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article						Cloud microphysics; Climate models; Cloud parameterizations; Model evaluation; performance; Single column models	CLIMATE MODEL; PART II; PARAMETERIZATION; CLOUDSAT; MICROPHYSICS; SENSITIVITY; MULTISENSOR; SIMULATION; GROWTH; RADAR	This study examines the warm rain formation process over the global ocean in global climate models. Methodologies developed to analyze CloudSat and Moderate Resolution Imaging Spectroradiometer (MODIS) satellite observations are employed to investigate the cloud-to-precipitation process of warm clouds and are applied to the model results to examine how the models represent the process for warm stratiform clouds. Despite a limitation of the present study that compares the statistics for stratiform clouds in climate models with those from satellite observations, including both stratiform and (shallow) convective clouds, the statistics constructed with the methodologies are compared between the models and satellite observations to expose their similarities and differences. A problem common to some models is that they tend to produce rain at a faster rate than is observed. These model characteristics are further examined in the context of cloud microphysics parameterizations using a simplified one-dimensional model of warm rain formation that isolates key microphysical processes from full interactions with other processes in global climate models. The one-dimensional model equivalent statistics reproduce key characteristics of the global model statistics when corresponding autoconversion schemes are assumed in the one-dimensional model. The global model characteristics depicted by the statistics are then interpreted as reflecting behaviors of the autoconversion parameterizations adopted in the models. Comparisons of the one-dimensional model with satellite observations hint at improvements to the formulation of the parameterization scheme, thus offering a novel way of constraining key parameters in autoconversion schemes of global models.	[Suzuki, Kentaroh] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Stephens, Graeme] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Bodas-Salcedo, Alejandro] Met Off Hadley Ctr, Exeter, Devon, England; [Wang, Minghuai] Nanjing Univ, Inst Climate & Global Change Res, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Minghuai] Nanjing Univ, Sch Atmospher Sci, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Minghuai] Collaborat Innovat Ctr Climate Change, Nanjing, Jiangsu, Peoples R China; [Golaz, Jean-Christophe] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Yokohata, Tokuta] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Koshiro, Tsuyoshi] Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan	Suzuki, K (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778568, Japan.	ksuzuki@aori.u-tokyo.ac.jp	Suzuki, Kentaroh/C-3624-2011		National Aeronautics and Space Administration (NASA) [NNN13D455T]; JAXA/EarthCARE project; Joint DECC/Defra Met Office Hadley Centre Climate Programme [GA01101]; Department of Energy Office of Science, Decadal and Regional Climate Prediction; DOE [DE-AC06-76RLO 1830]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23310014, 23340137]; Ministry of the Environment of Japan [S-10]	Part of this study was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration (NASA). Aspects of this study were supported by NASA Grant NNN13D455T and JAXA/EarthCARE project. The authors are grateful to three anonymous reviewers for their valuable comments on earlier versions of this paper. K. Suzuki and A. Bodas-Salcedo would like to thank Ian Boutle at the Met Office for his guidance on microphysical process representation in HadGEM2. A. Bodas-Salcedo was supported by the Joint DECC/Defra Met Office Hadley Centre Climate Programme (GA01101). M. Wang was supported by the Department of Energy Office of Science, Decadal and Regional Climate Prediction using Earth System Models (EaSM) program and the Climate and Earth System Modeling Program. The Pacific Northwest National Laboratory (PNNL) is operated for the DOE by Battelle Memorial Institute under contract DE-AC06-76RLO 1830. T. Yokohata was supported by the Program for Risk Information on Climate Change, Grant-in-Aid 23310014 and Grant-in-Aid 23340137 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Environment Research and Technology Development Fund (S-10) of the Ministry of the Environment of Japan. MIROC simulations were performed by Earth Simulator at JAMSTEC and NEC SX at NIES.	Okamoto H, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007628; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Suzuki K, 2004, J ATMOS SCI, V61, P179, DOI 10.1175/1520-0469(2004)061<0179:ASOTAE>2.0.CO;2; Marchand R, 2008, J ATMOS OCEAN TECH, V25, P519, DOI 10.1175/2007JTECHA1006.1; Wang M, 2011, GEOSCI MODEL DEV, V4, P137, DOI 10.5194/gmd-4-137-2011; Menon S, 2002, J ATMOS SCI, V59, P692, DOI 10.1175/1520-0469(2002)059<0692:GSOTAI>2.0.CO;2; Quaas J, 2009, ATMOS CHEM PHYS, V9, P8697; Beheng KD, 1994, ATMOS RES, V33, P193, DOI 10.1016/0169-8095(94)90020-5; Rotstayn LD, 2000, J GEOPHYS RES-ATMOS, V105, P15495, DOI 10.1029/2000JD900129; Yukimoto S, 2012, J METEOROL SOC JPN, V90A, P23, DOI 10.2151/jmsj.2012-A02; Suzuki K, 2013, GEOPHYS RES LETT, V40, P4464, DOI 10.1002/grl.50874; Grabowski WW, 1998, J ATMOS SCI, V55, P3283, DOI 10.1175/1520-0469(1998)055<3283:TCRMOL>2.0.CO;2; Bodas-Salcedo A, 2011, B AM METEOROL SOC, V92, P1023, DOI 10.1175/2011BAMS2856.1; Masunaga H, 2010, B AM METEOROL SOC, V91, P1625, DOI 10.1175/2010BAMS2809.1; Wang MH, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052204; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Wood R, 2009, J ATMOS SCI, V66, P2973, DOI 10.1175/2009JAS3072.1; Golaz JC, 2011, J CLIMATE, V24, P3145, DOI 10.1175/2010JCLI3945.1; Suzuki K, 2010, J ATMOS SCI, V67, P3019, DOI 10.1175/2010JAS3463.1; Horvath A, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2013JD021355; Suzuki K, 2009, ATMOS RES, V92, P411, DOI 10.1016/j.atmosres.2008.12.010; Kawamoto K, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016412; Posselt R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035796; Martin GM, 2011, GEOSCI MODEL DEV, V4, P723, DOI 10.5194/gmd-4-723-2011; Donner LJ, 2011, J CLIMATE, V24, P3484, DOI 10.1175/2011JCLI3955.1; Wood R, 2005, J ATMOS SCI, V62, P3034, DOI 10.1175/JAS3530.1; L'Ecuyer TS, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011273; Shipway BJ, 2012, Q J ROY METEOR SOC, V138, P2196, DOI 10.1002/qj.1913; Rosenfeld D, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052028; Liu YG, 2004, J ATMOS SCI, V61, P1539, DOI 10.1175/1520-0469(2004)061<1539:POTAPI>2.0.CO;2; Zhang Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012006; Golaz JC, 2013, GEOPHYS RES LETT, V40, P2246, DOI 10.1002/grl.50232; Khairoutdinov M, 2000, MON WEATHER REV, V128, P229, DOI 10.1175/1520-0493(2000)128<0229:ANCPPI>2.0.CO;2; TRIPOLI GJ, 1980, J APPL METEOROL, V19, P1037, DOI 10.1175/1520-0450(1980)019<1037:ANIOSF>2.0.CO;2; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; Nakajima TY, 2010, J ATMOS SCI, V67, P1897, DOI 10.1175/2010JAS3276.1; Lebsock MD, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009876; Suzuki K, 2011, J ATMOS SCI, V68, P2655, DOI 10.1175/JAS-D-10-05026.1; Di Michele S, 2012, Q J ROY METEOR SOC, V138, P2047, DOI 10.1002/qj.1936; Suzuki K, 2013, J GEOPHYS RES-ATMOS, V118, P170, DOI 10.1002/jgrd.50043; Berry EX, 1968, P 1 NAT C WEATH MOD, P81; Kessler E., 1969, METEOR MONOGR, V32; Neale R. B., 2010, NCARTN486STR; Pincus R., 2000, J GEOPHYS RES, V105, P27, DOI [10.1029/2000JD900504, DOI 10.1029/2000JD900504]; Stephens GL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009982; Yukimoto S., 2011, TECH REP METEOROL RE, V64, P1	46	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	OCT	2015	72	10					3996	4014		10.1175/JAS-D-14-0265.1		19	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2MY	WOS:000362637500015		
J	Jeon, H; Lee, C; Park, M; Lee, C; Yi, SN; Yang, M; Ahn, HS; Kim, SW; Yu, YM; Shin, KS; Bae, JS; Sawaki, N				Jeon, Hunsoo; Lee, Chanmi; Park, Minah; Lee, Chanbin; Yi, Sam Nyung; Yang, Min; Ahn, Hyung Soo; Kim, Suck-Whan; Yu, Young Moon; Shin, Kee Sam; Bae, Jong Seong; Sawaki, Nobuhiko			Carbon microspheres grown by using hydride vapor phase epitaxy	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Carbon microsphere; HVPE; SEM; XPS; TEM	21ST-CENTURY; SPHERULES; NANOTUBE; SPHERES	A carbon microsphere of a core-shell type was grown by using a new method of mixed-source hydride vapor phase epitaxy (HVPE). The surface and the cross section of the carbon microsphere grown by using the new method were observed by using scanning electron microscopy (SEM). The characteristics of the carbon microsphere were investigated by using X-ray photoelectron spectroscopy (XPS) and high-resolution transmission electron microscopy (HR-TEM). From these measurements, the diameters of the carbon spheres were about a few hundred micrometers. Furthermore, we showed that carbon microspheres of the core-shell type could be grown successfully by using a mixed-source HVPE method and that they had larger sizes than those grown by using existing methods. This mixed-source HVPE method is proposed as a new method for making carbon microspheres.	[Jeon, Hunsoo; Lee, Chanmi; Park, Minah; Lee, Chanbin; Yi, Sam Nyung; Yang, Min; Ahn, Hyung Soo] Korea Maritime & Ocean Univ, Dept Elect Mat Engn, Busan 49112, South Korea; [Jeon, Hunsoo] Korea Maritime & Ocean Univ, Compound Semicond Fabricat Technol Ctr, Busan 49112, South Korea; [Kim, Suck-Whan] Andong Natl Univ, Dept Phys, Andong 36729, South Korea; [Yu, Young Moon] Pukyong Natl Univ, LED MCT R&BD Ctr, Busan 48513, South Korea; [Shin, Kee Sam] Changwon Natl Univ, Sch Nano & Adv Mat Engn, Chang Won 51140, South Korea; [Bae, Jong Seong] Korea Busan Ctr, Korea Basic Sci Inst, Busan 46742, South Korea; [Sawaki, Nobuhiko] Aichi Inst Technol, Dept Elect & Elect Engn, Toyota, Aichi 4700392, Japan	Jeon, H (reprint author), Korea Maritime & Ocean Univ, Dept Elect Mat Engn, Busan 49112, South Korea.	ahnhs@kmou.ac.kr; swkim@anu.ac.kr			Transfer Machine Specialized Lighting Core Technology Development Professional Manpower Training Project - Ministry of trade, Industry & Energy (MOTIE), Korea [N0001363]	This work was supported by the Transfer Machine Specialized Lighting Core Technology Development Professional Manpower Training Project (Project No: N0001363) funded by the Ministry of trade, Industry & Energy (MOTIE), Korea.	Levesque A, 2004, THIN SOLID FILMS, V464, P308, DOI 10.1016/j.tsf.2004.06.012; Nieto-Marquez A, 2011, J MATER CHEM, V21, P1664, DOI 10.1039/c0jm01350a; Jeon HS, 2009, J KOREAN PHYS SOC, V54, P1262, DOI 10.3938/jkps.54.1262; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Deshmukh AA, 2010, MAT SCI ENG R, V70, P1, DOI 10.1016/j.mser.2010.06.017; Lee S, 2009, J KOREAN PHYS SOC, V55, P957; Pan DY, 2010, CHEM COMMUN, V46, P3681, DOI 10.1039/c000114g; Wang Q, 2001, CARBON, V39, P2211, DOI 10.1016/S0008-6223(01)00040-9; Terrones M, 2003, ANNU REV MATER RES, V33, P419, DOI 10.1146/annurev.matsci.33.012802.100255; Inagaki M, 1997, CARBON, V35, P711, DOI 10.1016/S0008-6223(97)86645-6; Liu RL, 2009, ANGEW CHEM INT EDIT, V48, P4598, DOI 10.1002/anie.200900652; Kang ZC, 1996, J PHYS CHEM-US, V100, P5163, DOI 10.1021/jp9535809; Serp P, 2001, CARBON, V39, P621, DOI 10.1016/S0008-6223(00)00324-9; Terrones M, 2003, PHILOS T ROY SOC A, V361, P2789, DOI 10.1098/rsta.2003.1262; Pol VG, 2004, CARBON, V42, P111, DOI 10.1016/j.carbon.2003.09.005; Li FB, 2006, CARBON, V44, P128, DOI 10.1016/j.carbon.2005.06.049; Pol VG, 2006, CARBON, V44, P1913, DOI 10.1016/j.carbon.2006.02.007; Liu XY, 2002, CARBON, V40, P2791, DOI 10.1016/S0008-6223(02)00193-8; Biro LP, 2004, CARBON, V42, P2561, DOI 10.1016/j.carbon.2004.05.038; Donnet J.B., 1993, CARBON BLACK; Dresselhaus M. S., 1996, SCI FULLERENES CARBO; Inagaki M., 2002, SYNTHETIC MET, V125, P139; Die CH, 2009, J KOREAN PHYS SOC, V54, P1257; Wohler O., 1986, ULLMANNS ENCY IND A, VA5	24	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	OCT	2015	67	7					1268	1272		10.3938/jkps.67.1268		5	Physics, Multidisciplinary	Physics	CT8CJ	WOS:000363042300030		
J	Uraki, Y; Koda, K				Uraki, Yasumitsu; Koda, Keiichi			Utilization of wood cell wall components	JOURNAL OF WOOD SCIENCE			English	Review						Biorefinery; Lignin; Fusibility; Moldability	ACTIVATED CARBON-FIBERS; SOFTWOOD KRAFT LIGNIN; ACETIC-ACID LIGNIN; SUGARCANE BAGASSE HEMICELLULOSES; TEMPO-MEDIATED OXIDATION; BETA-D-GLUCAN; THERMAL-PROPERTIES; GRAFT-COPOLYMERS; XYLAN ESTERS; RADICAL POLYMERIZATION	This article summarizes current utilizations of wood cell wall components in relation to biorefinery of woody biomass as a separation method of its constituents. Especially, utilization of isolated lignins, involving transformation and molding, are demonstrated with respect to productions of carbon fibers and their further functionalization, such as developments of activated carbon fibers and electrodes for second battery and electric double-layer capacitor.	[Uraki, Yasumitsu; Koda, Keiichi] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Uraki, Y (reprint author), Hokkaido Univ, Res Fac Agr, Kita Ku, N-9,W-9, Sapporo, Hokkaido 0608589, Japan.	uraki@for.agr.hokudai.ac.jp					Lindblad MS, 2005, BIOMACROMOLECULES, V6, P684, DOI 10.1021/bm049515z; Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970; Enomoto-Rogers Y, 2012, CARBOHYD POLYM, V87, P1933, DOI 10.1016/j.carbpol.2011.09.092; Hufendiek A, 2014, BIOMACROMOLECULES, V15, P2563, DOI 10.1021/bm500416m; Gao GZ, 2012, BIOMACROMOLECULES, V13, P3602, DOI 10.1021/bm301039f; Fundador NGV, 2013, POLYM DEGRAD STABIL, V98, P1064, DOI 10.1016/j.polymdegradstab.2013.01.010; Godin B, 2014, J AGR FOOD CHEM, V62, P5609, DOI 10.1021/jf500924q; Kubo S, 1997, MOKUZAI GAKKAISHI, V43, P655; Kubo S, 1998, CARBON, V36, P1119, DOI 10.1016/S0008-6223(98)00086-4; Kubo S, 2004, MACROMOLECULES, V37, P6904, DOI 10.1021/ma0490552; Enomoto-Rogers Y, 2013, J WOOD SCI, V59, P489, DOI 10.1007/s10086-013-1367-x; Uraki Y, 1997, HOLZFORSCHUNG, V51, P188, DOI 10.1515/hfsg.1997.51.2.188; Hartman J, 2006, BIOMACROMOLECULES, V7, P1983, DOI 10.1021/bm060129m; Fundador NGV, 2013, POLYM DEGRAD STABIL, V98, P2482, DOI 10.1016/j.polymdegradstab.2013.06.013; Lin J, 2012, BIORESOURCES, V7, P5634; Liu XH, 2015, COLLOID SURFACE B, V125, P230, DOI 10.1016/j.colsurfb.2014.11.018; Uraki Y, 2001, J WOOD SCI, V47, P465, DOI 10.1007/BF00767899; Nordstrom Y, 2013, J APPL POLYM SCI, V129, P1274, DOI 10.1002/app.38795; Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p; Wang M, 2015, CARBOHYD POLYM, V125, P334, DOI 10.1016/j.carbpol.2015.02.060; Hansen NML, 2008, BIOMACROMOLECULES, V9, P1493, DOI [10.1021/bm800053z, 10.1021/bm800053Z]; Fundador NGV, 2012, CARBOHYD POLYM, V87, P170, DOI 10.1016/j.carbpol.2011.07.034; Kondo T, 2014, CARBOHYD POLYM, V112, P284, DOI 10.1016/j.carbpol.2014.05.064; Fundador NGV, 2012, POLYMER, V53, P3885, DOI 10.1016/j.polymer.2012.06.038; Baker DA, 2013, J APPL POLYM SCI, V130, P713, DOI 10.1002/app.39273; URAKI Y, 1995, HOLZFORSCHUNG, V49, P343, DOI 10.1515/hfsg.1995.49.4.343; Ge YY, 2014, BIORESOURCES, V9, P7119; Enomoto-Rogers Y, 2014, CARBOHYD POLYM, V101, P592, DOI 10.1016/j.carbpol.2013.09.103; Kishimoto T, 2005, ORG BIOMOL CHEM, V3, P1067, DOI 10.1039/b416699j; Yang HY, 2011, BIORESOURCE TECHNOL, V102, P7171, DOI 10.1016/j.biortech.2011.03.110; Jin J, 2014, J POWER SOURCES, V272, P800, DOI 10.1016/j.jpowsour.2014.08.119; Buchanan CM, 2003, CARBOHYD POLYM, V52, P345, DOI 10.1016/S0144-8617(02)00290-4; Guo ZB, 2015, MATER LETT, V142, P49, DOI 10.1016/j.matlet.2014.11.068; Norberg I, 2013, J APPL POLYM SCI, V128, P3824, DOI 10.1002/app.38588; Bigand V, 2011, CARBOHYD POLYM, V85, P138, DOI 10.1016/j.carbpol.2011.02.005; Toffey A, 1997, HOLZFORSCHUNG, V51, P71, DOI 10.1515/hfsg.1997.51.1.71; JAIN RK, 1993, HOLZFORSCHUNG, V47, P325, DOI 10.1515/hfsg.1993.47.4.325; Zhang M, 2014, CARBON, V69, P626, DOI 10.1016/j.carbon.2013.12.015; Qiao W, 2015, J IND ENG CHEM, V21, P1417, DOI 10.1016/j.jiec.2014.06.016; Sun XF, 2004, J SCI FOOD AGR, V84, P800, DOI 10.1002/jsfa.1735; Lai CL, 2014, ELECTROCHIM ACTA, V130, P431, DOI 10.1016/j.electacta.2014.03.006; SUDO K, 1993, J APPL POLYM SCI, V48, P1485, DOI 10.1002/app.1993.070480817; Yang TT, 2014, BIORESOURCES, V9, P7267; Glasser WG, 2000, CELLULOSE, V7, P299, DOI 10.1023/A:1009277009836; Sun RC, 1999, IND CROP PROD, V10, P209, DOI 10.1016/S0926-6690(99)00025-4; Uraki Y, 2012, BIOMACROMOLECULES, V13, P867, DOI 10.1021/bm201772v; Nogi M, 2009, ADV MATER, V21, P1595, DOI 10.1002/adma.200803174; Song XL, 2014, HOLZFORSCHUNG, V68, P257, DOI 10.1515/hf-2013-0108; Mochida I, 2001, WORLD CARBON, V1, P221; Hu SX, 2014, J POWER SOURCES, V270, P106, DOI 10.1016/j.jpowsour.2014.07.063; Kuramae R, 2014, REACT FUNCT POLYM, V85, P126, DOI 10.1016/j.reactfunctpolym.2014.06.011; Song XL, 2014, CARBOHYD POLYM, V99, P617, DOI 10.1016/j.carbpol.2013.08.070; Kubo S, 1996, HOLZFORSCHUNG, V50, P144, DOI 10.1515/hfsg.1996.50.2.144; Kishimoto T, 2006, ORG BIOMOL CHEM, V4, P1343, DOI 10.1039/b518005h; Sun XF, 2004, J APPL POLYM SCI, V92, P53, DOI 10.1002/app.13636; Kadla JF, 2002, CARBON, V40, P2913, DOI 10.1016/S0008-6223(02)00248-8; GOLDSTEIN IS, 1975, SCIENCE, V189, P847, DOI 10.1126/science.189.4206.847; Voepel J, 2011, J POLYM SCI POL CHEM, V49, P2366, DOI 10.1002/pola.24666; Sun RC, 2000, POLYM DEGRAD STABIL, V67, P345, DOI 10.1016/S0141-3910(99)00136-6; Kubo S, 2007, CHEM LETT, V36, P502, DOI 10.1246/cl.2007.502; Li Y, 2012, J WOOD CHEM TECHNOL, V32, P210, DOI 10.1080/02773813.2011.652795; Lallave M, 2007, ADV MATER, V19, P4292, DOI 10.1002/adma.200700963; Dallmeyer I, 2010, J WOOD CHEM TECHNOL, V30, P315, DOI 10.1080/02773813.2010.527782; Ismail TNMT, 2010, POLYM INT, V59, P181, DOI 10.1002/pi.2705; Heinze T, 2004, ACS SYM SER, V864, P312; Aoyagi M, 2010, T MAT RES SOC JPN, V35, P967; Danjo T, 2014, POLYM DEGRAD STABIL, V109, P373, DOI 10.1016/j.polymdegradstab.2014.05.023; Formhals A, 1934, US Patent, Patent No. [1975504, 1,975,504]; GIERER J, 1970, SVEN PAPPERSTIDN, V73, P571; Hasegawa T, 2006, Jpn Pat, Patent No. [2006-326943, 2006326943]; Iwamoto S, 2005, APPL PHYS A-MATER, V81, pCP8, DOI 10.1007/s00339-005-3316-z; Jeon JW, 2015, CHEMSUSCHEM, V8, P428, DOI 10.1002/cssc.201402621; Joubert F, 2014, CHEM SOC REV, V43, P7217, DOI 10.1039/c4cs00053f; Kondo Y, 1959, J AM CONCRETE I, V31, P299; Kubota A, 2014, P 59 LIGN S FUK JAP, P46; Li H, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41389; Maeda H, 1942, KOGYO KAGAKU ZASSHI, V45, P267; Rios O, 2014, ENERGY TECHNOL-GER, V2, P773, DOI 10.1002/ente.201402049; Sano Y, 1988, KAMI GIKYOSHI, V42, P487; Sohn AW, 1969, US Pat, Patent No. [3480478 A, 3480478]; SUDO K, 1992, J APPL POLYM SCI, V44, P127, DOI 10.1002/app.1992.070440113; You XY, 2015, HOLZFORSCHUNG, V69, P1097, DOI 10.1515/hf-2014-0262	82	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					447	454		10.1007/s10086-015-1492-9		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600001		
J	Kudo, K; Yasue, K; Hosoo, Y; Funada, R				Kudo, Kayo; Yasue, Koh; Hosoo, Yoshihiro; Funada, Ryo			Relationship between formation of earlywood vessels and leaf phenology in two ring-porous hardwoods, Quercus serrata and Robinia pseudoacacia, in early spring	JOURNAL OF WOOD SCIENCE			English	Article						Deciduous ring-porous hardwoods; Dye introduction; Earlywood vessels; Leaf phenology; Water conduction	MANDSHURICA VAR JAPONICA; X POPULUS-GRANDIDENTATA; CAMBIAL REACTIVATION; CONDUCTING PATHWAYS; SEASONAL-CHANGES; DECIDUOUS TREES; WATER; FOREST; TEMPERATURE; CAVITATION	In deciduous ring-porous hardwoods, three-dimensional networks of the current year's earlywood vessels play an important role in the movement of water. In the present study, we analyzed the formation of earlywood vessels along the main stem and leaf phenology in two deciduous ring-porous hardwoods, Quercus serrata and Robinia pseudoacacia. We introduced a dye in an effort to monitor the timing of initial water conduction through the network of the current year's earlywood vessels. The formation of earlywood vessels began before bud break. At bud break, perforation of the first earlywood vessels was evident at the top of the stem but not at other positions within the stem. Perforations were observed along the entire stem when small leaves became visible and then leaves continued to develop. These results suggest that conduction of water via the network of the first earlywood vessels of the current year might not contribute to the initial growth of buds but might play an important role in the development of the current year's leaves and shoots.	[Kudo, Kayo; Funada, Ryo] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan; [Kudo, Kayo; Yasue, Koh; Hosoo, Yoshihiro] Shinshu Univ, Fac Agr, Minami Minowa, Nagano 3994598, Japan; [Kudo, Kayo] Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita 0160876, Japan; [Yasue, Koh] Shinshu Univ, Mt Res Inst, Minami Minowa, Nagano 3994598, Japan	Funada, R (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan.	funada@cc.tuat.ac.jp	Funada, Ryo/C-2020-2013		Ministry of Education, Science, Sports and Culture of Japan [21380107, 23380097, 24380090, 26292092, 15H04527]	This work was supported, in part, by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (Nos. 21380107, 23380097, 24380090, 26292092 and 15H04527). We are very grateful to referees and an editor for their constructive comments and suggestions.	Aloni R, 1991, PHYSL TREES, P175; Sano Y, 2005, TREE PHYSIOL, V25, P269; Begum S, 2013, PHYSIOL PLANTARUM, V147, P46, DOI 10.1111/j.1399-3054.2012.01663.x; Takahashi S, 2015, BOTANY, V93, P31, DOI 10.1139/cjb-2014-0129; Suzuki M, 1996, IAWA J, V17, P431; COCHARD H, 1990, TREE PHYSIOL, V6, P393; Utsumi Y, 1999, PLANT PHYSIOL, V121, P897, DOI 10.1104/pp.121.3.897; Utsumi Y, 1996, IAWA J, V17, P113; Begum S, 2008, TREE PHYSIOL, V28, P1813; ZASADA JC, 1969, CAN J BOTANY, V47, P1965; Sass-Klaassen U, 2011, DENDROCHRONOLOGIA, V29, P171, DOI 10.1016/j.dendro.2011.01.002; Begum S, 2007, ANN BOT-LONDON, V100, P439, DOI 10.1093/aob/mcm130; CHANEY WR, 1977, ANN BOT-LONDON, V41, P1093; ATKINSON CJ, 1988, ANN BOT-LONDON, V61, P679; Umebayashi T, 2008, IAWA J, V29, P247; Umebayashi T, 2007, TREE PHYSIOL, V27, P993; Takahashi S, 2013, ECOL RES, V28, P615, DOI 10.1007/s11284-013-1053-x; Denne MP, 1981, XYLEM CELL DEV, P236; Fujimoto S., 2007, Journal of the Japanese Forest Society, V89, P253, DOI 10.4005/jjfs.89.253; Gonzalez-Gonzalez BD, 2013, TREES-STRUCT FUNCT, V27, P1571, DOI 10.1007/s00468-013-0905-x; Imagawa K, 1972, RES B COLL EXPT FORE, V29, P55; Kudo K, 2014, ANN BOT-LONDON, V113, P1021, DOI 10.1093/aob/mcu026; Meylan BA, 1982, XYLEM CELL DEV, P96; Yata S, 1970, WOOD RES, V50, P1; Zimmermann MH., 1983, XYLEM STRUCTURE ASCE	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					455	464		10.1007/s10086-015-1487-6		10	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600002		
J	Ogawa, K; Sasaki, Y; Yamasaki, M				Ogawa, Keita; Sasaki, Yasutoshi; Yamasaki, Mariko			Theoretical modeling and experimental study of Japanese "Watari-ago" joints	JOURNAL OF WOOD SCIENCE			English	Article						Timber joint; Mechanical modeling; Moment-deformation angle relationship; Wooden embedment	DIFFERENT WEDGE CONFIGURATIONS; TRADITIONAL NUKI JOINTS; ROTATIONAL PERFORMANCE; TIMBER JOINTS; BEHAVIOR	Timber joints used in traditional Japanese constructions have no metal plates or fasteners. Because these joints resist external force by embedment to each member, they show high ductility. The ductile joints get much attention recently. Japanese "Watari-ago" joint used in horizontal structure is one such ductile joint. The joint consists of two beams with interlocking notches, which build resistance against in-plane shear forces. In this paper, the mechanical behavior of "Watari-ago" joints is studied experimentally and theoretically. Experimental results show that "Watari-ago" joints can retain resistance after reaching their yield strength and that mechanical behavior varies depending upon notch shape and size. In theoretical research, a predicting model of mechanical behavior of the joint is developed by applying wooden embedment theory. The model proposed in this study also identifies the size that gives optimal mechanical performance. By numerical calculation on the basis of the model, the authors find it quantitatively that the increase of the sizes of beam width and notch depth has greatly effect on the moment resistance.	[Ogawa, Keita; Sasaki, Yasutoshi; Yamasaki, Mariko] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biosphere Resources Sci, Nagoya, Aichi 4648601, Japan	Sasaki, Y (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Biosphere Resources Sci, Nagoya, Aichi 4648601, Japan.	ysasaki@nagoya-u.jp					Guan ZW, 2001, J STRUCT ENG-ASCE, V127, P894, DOI 10.1061/(ASCE)0733-9445(2001)127:8(894); [Anonymous], 2009, Z2101 JIS JAP STAND, p[17, 21]; Chang WS, 2006, J WOOD SCI, V52, P58, DOI 10.1007/s10086-005-0734-7; King WS, 1996, ENG STRUCT, V18, P635, DOI 10.1016/0141-0296(96)00203-9; Guan ZW, 2008, ENG STRUCT, V30, P2041, DOI 10.1016/j.engstruct.2008.01.004; MADSEN B, 1982, CAN J CIVIL ENG, V9, P338; Blass HJ, 2011, ENG STRUCT, V33, P3018, DOI 10.1016/j.engstruct.2011.02.001; Pang SJ, 2011, J WOOD SCI, V57, P195, DOI 10.1007/s10086-010-1159-5; [Anonymous], 2011, STRUCT BUIL, DOI DOI 10.1680/STBU.9.00070; Chang WS, 2007, J WOOD SCI, V53, P401, DOI 10.1007/s10086-007-0880-1; Leijten AJM, 2006, J STRUCT ENG-ASCE, V132, P1314, DOI 10.1061/(ASCE)0733-9445(2006)132:8(1314); Pang SJ, 2011, J STRUCT ENG-ASCE, V137, P785, DOI 10.1061/(ASCE)ST.1943-541X.0000323; Guan ZW, 2008, ENG STRUCT, V30, P2032, DOI 10.1016/j.engstruct.2008.01.003; Architectural institute of Japan, 1973, STAND STRUCT DES TIM; Inayama M, 1993, P AIJ 1993 TOK, P907; Inayama M, 1991, THESIS U TOKYO TOKYO; Japan housing and wood technology center, 2008, ALL STRESS DES WOOD; Pang SJ, 2011, HOLZFORSCHUNG, V67, P93; Sadanari M, 2011, P AIJ 2011 TOK, P22165	19	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					481	491		10.1007/s10086-015-1498-3		11	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600005		
J	Kojima, Y; Ishino, A; Kobori, H; Suzuki, S; Ito, H; Makise, R; Higuchi, I; Okamoto, M				Kojima, Yoichi; Ishino, Atsushi; Kobori, Hikaru; Suzuki, Shigehiko; Ito, Hirokazu; Makise, Rie; Higuchi, Itsuro; Okamoto, Masaki			Reinforcement of wood flour board containing ligno-cellulose nanofiber made from recycled wood	JOURNAL OF WOOD SCIENCE			English	Article						Wood-based materials; Wood flour; Cellulose nanofiber; Ligno-cellulose nanofiber; Wet pulverize	CELLULOSE NANOFIBERS; ACID) COMPOSITE; CITRIC-ACID	Wood-based materials are widely used in residential construction. These materials can be made from virgin or recycled wood, and most of the materials are fabricated with chemical adhesives. Finding replacements for such chemical adhesives poses major challenges. This study explored nanofiber technology as an alternative to these adhesives. Previous studies have shown that the three-dimensional binding effects of cellulose nanofiber (CNF) and ligno-cellulose nanofiber (LCNF), when mixed with wood flour, can significantly improve the physical and mechanical properties of wood flour board. We use the word "LCNF" as the surface nanofibrillated wood flour. Previous studies have also highlighted problems that occur during compounding and board manufacturing. In this study, a reliable method was established to mix wood flour and LCNF. The method involved a compounding machine, which facilitated board manufacturing safely. Physical and mechanical properties of the resulting wood flour boards were significantly improved with the addition of LCNF, due to close binding between LCNF and wood flour particles.	[Kojima, Yoichi; Ishino, Atsushi; Kobori, Hikaru; Suzuki, Shigehiko] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan; [Ito, Hirokazu; Makise, Rie; Higuchi, Itsuro; Okamoto, Masaki] Toclas Corp, Shizuoka, Japan	Kojima, Y (reprint author), Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan.	aykojim@ipc.shizuoka.ac.jp					Kojima Y, 2013, J WOOD SCI, V59, P396, DOI 10.1007/s10086-013-1348-0; [Anonymous], 1994, A5905 JIS; Takatani M, 2008, J WOOD SCI, V54, P54, DOI 10.1007/s10086-007-0911-y; Pizzi A, 2006, J ADHES SCI TECHNOL, V20, P829, DOI 10.1163/156856106777638635; Okubo K, 2005, JSME INT J A-SOLID M, V48, P199, DOI 10.1299/jsmea.48.199; Ito H, 2008, POLYM ENG SCI, V48, P415, DOI 10.1002/pen.20963; Sehaqui H, 2011, COMPOS SCI TECHNOL, V71, P382, DOI 10.1016/j.compscitech.2010.12.007; Umemura K, 2012, FOREST PROD J, V62, P63; Kondo T, 2008, MOKUZAI GAKKAISHI, V54, P107, DOI 10.2488/jwrs.54.107; Nakagaito AN, 2005, APPL PHYS A-MATER, V80, P155, DOI 10.1007/s00339-003-2225-2; Lee SH, 2003, J APPL POLYM SCI, V90, P1900, DOI 10.1002/app.12864; Kojima Y, 2014, MATERIALS, V7, P6853, DOI 10.3390/ma7096853; Ikeda K, 2008, HOLZFORSCHUNG, V62, P154, DOI 10.1515/HF.2008.026; Umemura K, 2013, J WOOD SCI, V59, P203, DOI 10.1007/s10086-013-1326-6; Abe K, 2007, BIOMACROMOLECULES, V8, P3276, DOI 10.1021/bm700624p; Umemura K, 2012, J APPL POLYM SCI, V123, P1991, DOI 10.1002/app.34708; Takahashi H, 1972, MOKUZAI GAKKAISHI, V18, P9; Takahashi H, 1972, MOKUZAI GAKKAISHI, V18, P15; Takahashi H., 1974, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V20, P430; Umemura K, 2011, J WOOD SCI, V58, P38; Yano H, 2007, NEW DEV BIOBASED MAT, P63	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					492	499		10.1007/s10086-015-1493-8		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600006		
J	Korai, H; Kojima, Y; Suzuki, S				Korai, Hideaki; Kojima, Yoichi; Suzuki, Shigehiko			Bending strength and internal bond strength of wood-based boards subjected to various exposure conditions	JOURNAL OF WOOD SCIENCE			English	Article						Wood-based board; Durability; Deterioration; Outdoor exposure; Accelerated aging test	OUTDOOR EXPOSURE; CONSTRUCTION PARTICLEBOARD; PANELS; DURABILITY; DETERIORATION; PERFORMANCE; DENSITY	Phenol-formaldehyde resin-bonded particleboard (PF board), methylene diphenyl diisocyanate resin-bonded particleboard (MDI board), aspen oriented strand board (aspen board), Scots pine oriented strand board (pine board), methylene diphenyl diisocyanate resin-bonded medium-density fiberboard (F-MDI board), and melamine-urea-formaldehyde resin-bonded medium-density fiberboard (F-MUF board)-six board types overall-were subjected to high relative humidity (90 %, 20 A degrees C) or cyclic humidity of high/low relative humidity (90/45 %, 20 A degrees C) for 5 years. The PF board and aspen board showed reduction in bending strength [modulus of rupture (MOR)] and internal bond strength (IB); however, the MDI board, pine board, F-MDI board, and F-MUF board showed almost no reduction. Furthermore, the boards were subjected to outdoor exposure and Test B (boiling for 2 h) from the Japanese Industrial Standard (JIS); the results showed large reduction in the MOR and IB of the PF board and aspen board. In contrast, outdoor exposure did not greatly reduce the MOR and IB of the F-MUF board and F-MDI board. Although the IB of the F-MUF board reduced after the JIS Test B because of using low-durability resin, the IB retention was as high as 87.8 % for 5-year outdoor exposure.	[Korai, Hideaki] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Kojima, Yoichi; Suzuki, Shigehiko] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan	Korai, H (reprint author), Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan.	korai@ffpri.affrc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21380108]	This study was supported by a Grant-in-Aid for Scientific Research (21380108) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors are grateful for the grants received. The outdoor exposure test was conducted as part of a project organized by the Research Working Group on Wood-based Panels from the Japan Wood Research Society. The authors express their thanks to all participants in this project. Further, the authors are grateful to Mr. Kakitani of Sumitomo Forestry Co. Ltd. for creating exposure conditions for the boards in the model house.	RIVER BH, 1994, FOREST PROD J, V44, P55; Wu QL, 2002, WOOD FIBER SCI, V34, P125; Kojima Y, 2012, J WOOD SCI, V58, P525, DOI 10.1007/s10086-012-1287-1; SEKINO N, 1986, MOKUZAI GAKKAISHI, V32, P163; Sekino N, 2014, J WOOD SCI, V60, P141, DOI 10.1007/s10086-013-1384-9; Korai H, 2012, MOKUZAI GAKKAISHI, V58, P347; SEKINO N, 1985, MOKUZAI GAKKAISHI, V31, P801; Okkonen EA, 1996, FOREST PROD J, V46, P68; Korai H, 2014, J WOOD SCI, V60, P127, DOI 10.1007/s10086-013-1374-y; Kojima Y, 2011, J WOOD SCI, V57, P7, DOI 10.1007/s10086-010-1131-4; Kojima Y, 2009, FOREST PROD J, V59, P35; Korai H, 2013, J WOOD SCI, V59, P24, DOI 10.1007/s10086-012-1291-5; [Anonymous], 2003, A5908 JIS; [Anonymous], 2003, A2905 JIS; Korai H, 2014, J WOOD SCI, V60, P134, DOI 10.1007/s10086-013-1375-x; Korai H, 2013, MOKUZAI GAKKAISHI, V59, P361; Korai H, 2012, FOREST PROD J, V62, P184; KAWAI S, 1987, MOKUZAI GAKKAISHI, V33, P385; Kojima Y, 2011, J WOOD SCI, V57, P126, DOI 10.1007/s10086-010-1146-x; Hann R. A., 1962, Forest Products Journal, V12, P577; Ikeda M, 1999, B SHIZUOKA U FOR, P25; Korai H, 2014, J WOOD SCI, V61, P151; Korai H, 2014, J ADHES SOC JPN, V50, P260; Korai H, 2012, J ADHESION SOC JPN, V48, P30; Suzuki S, 2001, WOOD IND, V56, P7; The Timber Research and Development Association (TRADA), 1980, TIMBERS WORLD, P182	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					500	509		10.1007/s10086-015-1494-7		10	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600007		
J	Nakagawa, A; Yokoyama, T; Matsumoto, Y				Nakagawa, Akihiko; Yokoyama, Tomoya; Matsumoto, Yuji			Effect of stereo-configurational difference of carbohydrate model compound on the reaction with active oxygen species under oxygen delignification conditions	JOURNAL OF WOOD SCIENCE			English	Article						Bleaching; Cellulose; Hydrogen peroxide; Lignin; Pulp	HYDROGEN ABSTRACTION; METHYL GLUCOSIDE; REACTION SELECTIVITY; DEGRADATION; PEROXIDE; POSITION	We examined how the stereo-configurational difference affects the reaction of a carbohydrate model compound with active oxygen species (AOS) generated in situ by reactions between O-2 and a phenolic compound under conditions similar to those of oxygen delignification or with oxyl anion radical, the conjugate base of hydroxyl radical, generated by the decomposition of H2O2 under alkaline conditions. As the phenolic compound, 2,4,6-trimethylphenol or 4-hydroxy-3-methoxybenzyl alcohol (vanillyl alcohol) was used. The carbohydrate model compounds employed were methyl beta-d-glucopyranoside (MGP beta) and its 4 epimers, methyl alpha-d-glucopyranoside (MGP alpha), methyl beta-d-mannopyranoside (MMP), methyl beta-d-allopyranoside (MAP), and methyl beta-d-galactopyranoside (MGaP). Their stabilities were in the order of MGP alpha > MGP beta > MMP > MGaP > MAP, indicating that the reactivity of the carbohydrate model compound is significantly dependent on where the stereo-configurational difference is. Only the co-existence of MMP enhanced the degradation of MGP beta, when a pair of MGP beta and another carbohydrate model compound was reacted with the AOS. This result suggests that the profile of AOS in the system is dependent not only on the type of phenolic compound, the generator of AOS, but also on that of the carbohydrate model compound.	[Nakagawa, Akihiko; Yokoyama, Tomoya; Matsumoto, Yuji] Univ Tokyo, Grad Sch Agr & Life Sci, Wood Chem Lab, Dept Biomat Sci,Bunkyo Ku, Tokyo 1138657, Japan	Yokoyama, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Wood Chem Lab, Dept Biomat Sci,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	yokoyama@woodchem.fp.a.u-tokyo.ac.jp			Japan Society for the Promotion of Science [24.7723, 25450237]	The authors gratefully acknowledge financial support from the Japan Society for the Promotion of Science [Grant-in-Aid for JSPS Fellows (No. 24.7723) and Grant-in-Aid for Scientific Research (C) (No. 25450237)].	Yokoyama T, 2011, J WOOD SCI, V57, P512, DOI 10.1007/s10086-011-1201-2; Yokoyama T, 2007, J AGR FOOD CHEM, V55, P1301, DOI 10.1021/jf062836c; WEINGES K, 1987, CARBOHYD RES, V164, P453, DOI 10.1016/0008-6215(87)80148-9; Yokoyama T, 2005, HOLZFORSCHUNG, V59, P269, DOI 10.1515/HF.2005.044; Nakagawa A, 2012, J WOOD CHEM TECHNOL, V32, P10, DOI 10.1080/02773813.2011.591958; HEARNE DO, 1991, J WOOD CHEM TECHNOL, V11, P307, DOI 10.1080/02773819108050277; Nakagawa A, 2012, J WOOD SCI, V58, P563, DOI 10.1007/s10086-012-1289-z; Yokoyama T, 1999, J WOOD CHEM TECHNOL, V19, P187, DOI 10.1080/02773819909349607; ERICSSON B, 1971, SVEN PAPPERSTIDN, V74, P757; Konishi F, 2009, HOLZFORSCHUNG, V63, P52, DOI 10.1515/HF.2009.020; Yokoyama T, 2002, J WOOD SCI, V48, P191, DOI 10.1007/BF00771366; Murata A, 2003, J BIOSCI BIOENG, V96, P89, DOI 10.1016/S1389-1723(03)90104-6; GIERER J, 1977, SVEN PAPPERSTIDN, V80, P510; Yokoyama T, 1996, J PULP PAP SCI, V22, pJ151; Yokoyama T, 2015, J WOOD CHEM TECHNOL, V35, P450, DOI 10.1080/02773813.2015.1039134	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					510	516		10.1007/s10086-015-1499-2		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600008		
J	Toba, K; Nakai, T; Shirai, T; Yamamoto, H				Toba, Keisuke; Nakai, Takahisa; Shirai, Tatsuya; Yamamoto, Hiroyuki			Changes in the cellulose crystallinity of moso bamboo cell walls during the growth process by X-ray diffraction techniques	JOURNAL OF WOOD SCIENCE			English	Article						Bamboo shoot; Maturation; Crystallization; Internodal growth; Microfibrils	PHYLLOSTACHYS-PUBESCENS; FIBERS	We investigated the changes in cellulose crystallinity in the cell walls of moso bamboo (Phyllostachys pubescens Mazel) during the growth process. Changes in crystallinity in bamboo cell walls were traced along the longitudinal and radial directions using flat-sawn specimens obtained from each internode using X-ray diffraction measurements. Cellulose crystallinity in cell walls in the same culm was higher around the base of the bamboo culms in less than 10 days after the emergence of bamboo shoots, while the upper internodes remained lower in crystallinity. Thereafter, crystallinity in the upper internodes of bamboo culms became higher. This suggests that cellulose crystallinity within bamboo cell walls has gradually increased from the base to the top with the elongation of the internode during the growth process of bamboo shoots. In addition, cellulose crystallinity in cell walls increased particularly in the outer part of the bamboo culms in all internodes. Moreover, increases of crystallinity occurred after elongation growth of internodes. It is considered that increases in crystallinity in the outer portion of each internode are one of the countermeasures of bamboo culms against increased bending moment due to the elongation growth.	[Toba, Keisuke] Gifu Univ, Ctr Composite Mat, Gifu 5011193, Japan; [Nakai, Takahisa] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan; [Shirai, Tatsuya; Yamamoto, Hiroyuki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Toba, K (reprint author), Gifu Univ, Ctr Composite Mat, Gifu 5011193, Japan.	toba@gifu-u.ac.jp					Xiao Y, 2013, CONSTR BUILD MATER, V44, P765, DOI 10.1016/j.conbuildmat.2013.03.087; LIESE W, 1987, WOOD SCI TECHNOL, V21, P189; Liese W, 1996, WOOD SCI TECHNOL, V30, P77; Wang XQ, 2012, J R SOC INTERFACE, V9, P988, DOI 10.1098/rsif.2011.0462; Toba K, 2013, CELLULOSE, V20, P633, DOI 10.1007/s10570-012-9853-7; Urakami H, 1996, MOKUZAI GAKKAISHI, V42, P832; PARAMESWARAN N, 1976, WOOD SCI TECHNOL, V10, P231; Obataya E, 2007, WOOD SCI TECHNOL, V41, P385, DOI 10.1007/s00226-007-0127-8; Tsubaki T, 2010, HOLZFORSCHUNG, V64, P489, DOI 10.1515/HF.2010.085; Wang YR, 2012, WOOD SCI TECHNOL, V46, P317, DOI 10.1007/s00226-011-0405-3; Li XB, 2007, J TROP FOR SCI, V19, P6; CAVE I. D., 1966, FOREST PRODJ, V16, P37; Fujii T, 2008, BASIC SCI ADV TECHNO; Iguchi Y, 2002, MOKUZAI GAKKAISHI, V48, P413; Mahdavi M, 2011, J MATER CIVIL ENG, V23, P1036, DOI 10.1061/(ASCE)MT.1943-5533.0000253; NOMURA T, 1991, MOKUZAI GAKKAISHI, V37, P1115; Nomura T, 1974, WOOD RES, V57, P23; Nomura T, 1974, WOOD RES, V56, P21; Nomura T, 1980, WOOD RES TECH NOTE, V15, P6; Segal L., 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003]; Taniguchi E, 1956, MOKUZAI GAKKAISHI, V2, P152; Tono T, 1962, MOKUZAI GAKKAISHI, V8, P245	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					517	524		10.1007/s10086-015-1490-y		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600009		
J	Miyoshi, Y; Kiryu, T; Kojiro, K; Furuta, Y				Miyoshi, Yuka; Kiryu, Tomoaki; Kojiro, Keisuke; Furuta, Yuzo			Effects of drying and/or quenching histories on lateral tensile deformation properties of water-swollen wood	JOURNAL OF WOOD SCIENCE			English	Article						Lateral tensile deformation property; Drying history; Quenching history; Different tensile direction	WET WOOD	Lateral tensile deformation properties of wood were studied to clarify the tensile deformation properties of wood with drying and/or quenching histories, and it was discussed whether giving these histories was effective to increase the lateral tensile deformation of wood. The results obtained are as follows. In all of the samples with drying and/or quenching histories, failure strain was increased and elastic modulus was decreased. In all of the measurement conditions, the failure strain of 45A degrees angle sample with history was the largest. This result was caused by the shearing deformation of cells which showed diamond-shaped deformation during increasing tensile stress. This shearing deformation of the cell shape was promoted by increase of fluidity and decrease of elastic modulus which were caused by treatment of drying and/or quenching. These results suggest that giving drying and/or quenching histories is effective for wood to increase the tensile deformation even in water saturated condition at 25 degrees C.	[Miyoshi, Yuka; Kiryu, Tomoaki; Furuta, Yuzo] Kyoto Prefectural Univ, Div Environm Sci, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan; [Kojiro, Keisuke] WithGarden Co Ltd, Suginami Ku, Tokyo 1680072, Japan	Miyoshi, Y (reprint author), Kyoto Prefectural Univ, Div Environm Sci, Grad Sch Life & Environm Sci, Sakyo Ku, Hangi Cho, Kyoto 6068522, Japan.	miyo118mint@yahoo.co.jp					Furuta Y, 1998, MOKUZAI GAKKAISHI, V44, P82; Nakano T, 2005, J WOOD SCI, V51, P112, DOI 10.1007/s10086-004-0628-0; Kojiro K, 2008, J WOOD SCI, V54, P202, DOI 10.1007/s10086-007-0943-3; Kudo M, 2003, MOKUZAI GAKKAISHI, V49, P253; Nakatani T, 2006, MOKUZAI GAKKAISHI, V52, P285, DOI 10.2488/jwrs.52.285; Fujita S., 1972, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V18, P427; Iida I, 2006, MOKUZAI GAKKAISHI, V52, P93; Kanaya N, 1967, WOOD RES, V41, P47; Miyoshi Y, 2014, MOKUZAI GAKKAISHI, V60, P241; Miyoshi Y, 2015, J SOC MAT SCI JPN, V64, P356	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					525	528		10.1007/s10086-015-1496-5		4	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600010		
J	Shimizu, S; Yokoyama, T; Matsumoto, Y				Shimizu, Satoko; Yokoyama, Tomoya; Matsumoto, Yuji			Effect of type of aromatic nucleus in lignin on the rate of the beta-O-4 bond cleavage during alkaline pulping process	JOURNAL OF WOOD SCIENCE			English	Article						Alkyl-aryl ether; Cooking; Delignification; Kraft; Pulp	MODEL COMPOUNDS	Several C-6-C-3 and C-6-C-2-type dimeric non-phenolic beta-O-4 lignin model compounds, whose aromatic nuclei consisting of the carbon skeleton and beta-O-4 linkage are named the A- and B-rings, respectively, were treated under alkaline pulping conditions to examine whether or not the substitution of methoxyl group on the B-ring or of guaiacyl for syringyl A-ring accelerates the beta-O-4 cleavage as a further study of our previous reports. It was suggested that either first or second substitution of methoxyl group on the B-ring accelerates the beta-O-4 cleavage in both C-6-C-3 and C-6-C-2 compounds although the former compounds are more sensitive to the substitution than the latter, suggesting that the lack of the gamma-hydroxymethyl group makes model compound insensitive to the substitution. It was confirmed that the substitution of guaiacyl for syringyl A-ring accelerates the beta-O-4 cleavage in both C-6-C-3 and C-6-C-2 compounds with the degrees similar to each other regardless of the type of the B-ring. It was clarified that the leaving ability of the leaving B-ring phenoxides in the beta-O-4 cleavage does not correlate well with the pK (a) values of the conjugate acids of the phenoxides, which is not in accordance with the common property of a nucleophilic substitution reaction.	[Shimizu, Satoko; Yokoyama, Tomoya; Matsumoto, Yuji] Univ Tokyo, Wood Chem Lab, Grad Sch Agr & Life Sci, Dept Biomat Sci,Bunkyo Ku, Tokyo 1138657, Japan	Yokoyama, T (reprint author), Univ Tokyo, Wood Chem Lab, Grad Sch Agr & Life Sci, Dept Biomat Sci,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	yokoyama@woodchem.fp.a.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [26.11150]	The authors gratefully acknowledge financial support from the Japan Society for the Promotion of Science (JSPS) [Grant-in-Aid for JSPS Fellows (DC2), No. 26.11150].	Adler E, 1952, SVENSK PAPPERSTIDN, V55, P245; Ragnar M, 2000, J WOOD CHEM TECHNOL, V20, P277, DOI 10.1080/02773810009349637; Shimizu S, 2012, J AGR FOOD CHEM, V60, P6471, DOI 10.1021/jf301329v; Shimizu S, 2013, BIORESOURCES, V8, P4312; TSUTSUMI Y, 1993, J WOOD CHEM TECHNOL, V13, P25, DOI 10.1080/02773819308020505; MIKSCHE GE, 1972, ACTA CHEM SCAND, V26, P3275, DOI 10.3891/acta.chem.scand.26-3275; Criss DL, 2002, HOLZFORSCHUNG, V56, P67, DOI 10.1515/HF.2002.011; Fieser LF, 1952, TXB ORGANIC CHEM, P501; Okuyama T, 2014, ORGANIC CHEM MECH AP, P602; Streitwieser A, 1976, INTRO ORGANIC CHEM, P136	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					529	536		10.1007/s10086-015-1488-5		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600011		
J	Ikei, H; Song, CR; Lee, J; Miyazaki, Y				Ikei, Harumi; Song, Chorong; Lee, Juyoung; Miyazaki, Yoshifumi			Comparison of the effects of olfactory stimulation by air-dried and high-temperature-dried wood chips of hinoki cypress (Chamaecyparis obtusa) on prefrontal cortex activity	JOURNAL OF WOOD SCIENCE			English	Article						Dried wood; Odor; Physiological relaxation; Near-infrared spectroscopy; Semantic differential method	ESSENTIAL OIL; INHALATION; RESPONSES; HUMANS; ROSE		[Ikei, Harumi; Song, Chorong; Miyazaki, Yoshifumi] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan; [Lee, Juyoung] Korea Forest Serv Republ Korea, Taejon 302701, South Korea	Miyazaki, Y (reprint author), Chiba Univ, Ctr Environm Hlth & Field Sci, 6-2-1 Kashiwa No Ha, Kashiwa, Chiba 2770882, Japan.	ymiyazaki@faculty.chiba-u.jp			Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next-generation agriculture, forestry and fisheries" - Bio-oriented Technology Research Advancement Institution, NARO	This work was supported by Council for Science, Technology and Innovation (CSTI), by Cross-ministerial Strategic Innovation Promotion Program (SIP), and by "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). In addition, we would like to express our gratitude to Takashi Oyama (Ecoworks Co., Ltd.), Hidefumi Oyama (Shinsan Jutaku Co., Ltd.), and Kenji Oyama (Sumai Koubou Co., Ltd.).	Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Joung D., 2014, Advances in Horticultural Science, V28, P90; Ikei H., 2014, Advances in Horticultural Science, V28, P111; Song C, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-8; Dayawansa S, 2003, AUTON NEUROSCI-BASIC, V108, P79, DOI 10.1016/j.autneu.2003.08.002; Ohmae E, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804931; Park B. -J., 2014, Advances in Horticultural Science, V28, P225; [Anonymous], 1992, J JPN WOOD RES SOC; Igarashi M, 2014, J ALTERN COMPLEM MED, V20, P727, DOI 10.1089/acm.2014.0029; Igarashi M, 2014, J ALTERN COMPLEM MED, V20, P545, DOI 10.1089/acm.2014.0100; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Forestry Agency Ministry of Agriculture Forestry and Fisheries Japan, 2013, ANN REP FOR FOR JAP; Igarashi M, 2014, COMPLEMENT THER MED, V22, P1027, DOI 10.1016/j.ctim.2014.09.003; Igarashi M, 2014, COGN PROCESS, V15, P551, DOI 10.1007/s10339-014-0627-z; Ikei H, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-6; Lee J, 2015, INT J ENV RES PUB HE, V12, P1874, DOI 10.3390/ijerph120201874; Lee J, 2014, EVID-BASED COMPL ALT, V2014; Ohira T, 2008, J WOOD SCI, V55, P144; Osgood C.E., 1957, MEASUREMENT MEANING; Song CR, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-18; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tsunetsugu Y, 2011, FOREST MED, P35; Tsunetsugu Yuko, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P469, DOI 10.2114/jpa.24.469	23	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	OCT	2015	61	5					537	540		10.1007/s10086-015-1495-6		4	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CT6GX	WOS:000362912600012		
J	Sone, S				Sone, Satoru			Comparison of the technologies of the Japanese Shinkansen and Chinese High-speed Railways	JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE A			English	Review						High-speed railway; Medium speed railway; Suburban railway; Distributed traction; Concentrated traction; MT ratio; Power feeding system; Current collection; Electromagnetic compatibility (EMC) problems; Safety and reliability; Coordination		After describing Japanese slow but steady progress and Chinese very rapid progress of high-speed railways, comparison and analysis of ways of development and those of specific components are discussed. By adding descriptions of European developments which are much different to Japanese, comparisons are made between Japanese and Chinese strong and weak points in order to contribute to the improvement of worldwide rail passengers' transport including inferior aspect of both countries systems.	Kogakuin Univ, Tokyo 1138677, Japan	Sone, S (reprint author), Kogakuin Univ, Tokyo 1138677, Japan.	sonesatoru@gmail.com					Akiyama Y., 2014, JRTR, V64, P36; Ehara G., 2015, JAPANESE RAILWAY ENG, V55, P18; Fukunaga H., 2015, JAPANESE RAILWAY ENG, V55, P39; Ishikawa S., 2015, JAPANESE RAILWAY ENG, V55, P9; Kotsu Kyoryoku Kai Foundation, 2015, 50 YEARS SHINK; Kumagai N., 2015, JAPANESE RAILWAY ENG, V55, P5; Oguri A., 2015, JAPANESE RAILWAY ENG, V55, P28; Smith R. A., 2014, JRTR, V64, P6; Sone S., 1994, WORLD C RAILWAY RES, V1, P239; Sone S., 2014, KODANSHA BLUE BACK B, VB1863; Study Group of High-speed Railways, 2003, SANKAIDO         OCT; Takai H., 2015, JAPANESE RAILWAY ENG, V55, P49; Yang Z. P., 2015, TECHNICAL OUTLINE HI; Yang Z. P., 2012, SHINKANSEN JAPANESE; Zhang S. G., 2009, STUDY DESIGN METHODS; Zhang S. G., 2009, STUDY IMPROVING BEIJ	16	0	0	ZHEJIANG UNIV	HANGZHOU	EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA	1673-565X	1862-1775		J ZHEJIANG UNIV-SC A	J. Zhejiang Univ.-SCI A	OCT	2015	16	10					769	780		10.1631/jzus.A1500220		12	Engineering, Multidisciplinary; Physics, Applied	Engineering; Physics	CT6AO	WOS:000362892900001		
J	de Hoon, M; Shin, JW; Carninci, P				de Hoon, Michiel; Shin, Jay W.; Carninci, Piero			Paradigm shifts in genomics through the FANTOM projects	MAMMALIAN GENOME			English	Review							FULL-LENGTH CDNA; LONG NONCODING RNAS; ANALYSIS GENE-EXPRESSION; TRAPPER-SELECTED CDNAS; CAP-ANALYSIS; TRANSCRIPTIONAL REGULATION; FUNCTIONAL ANNOTATION; PROMOTER ARCHITECTURE; MAMMALIAN GENOME; HUMAN-CELLS	Big leaps in science happen when scientists from different backgrounds interact. In the past 15 years, the FANTOM Consortium has brought together scientists from different fields to analyze and interpret genomic data produced with novel technologies, including mouse full-length cDNAs and, more recently, expression profiling at single-nucleotide resolution by cap-analysis gene expression. The FANTOM Consortium has provided the most comprehensive mouse cDNA collection for functional studies and extensive maps of the human and mouse transcriptome comprising promoters, enhancers, as well as the network of their regulatory interactions. More importantly, serendipitous observations of the FANTOM dataset led us to realize that the mammalian genome is pervasively transcribed, even from retrotransposon elements, which were previously considered junk DNA. The majority of products from the mammalian genome are long non-coding RNAs (lncRNAs), including sense-antisense, intergenic, and enhancer RNAs. While the biological function has been elucidated for some lncRNAs, more than 98 % of them remain without a known function. We argue that large-scale studies are urgently needed to address the functional role of lncRNAs.	[de Hoon, Michiel; Shin, Jay W.; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan	Carninci, P (reprint author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan.	michiel.dehoon@riken.jp; jay.shin@riken.jp; carninci@riken.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)	We are indebted with all the members of the FANTOM consortium and RIKEN colleagues, in particular at RIKEN Center for Life Science Technologies and RIKEN PMI. We are mainly supported by a Research Grant from Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to RIKEN Center for Life Science Technologies. This work is also supported by a grant for Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical Research and Development (AMED) to PC. We thank Emi Ito for preparation and editing this manuscript.	Carninci P, 2002, BIOTECHNIQUES, V32, P984; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Shibata Y, 2001, BIOTECHNIQUES, V30, P1250; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Itoh M, 1999, GENOME RES, V9, P463; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Sardar AJ, 2014, MOL BIOL EVOL, V31, P1364, DOI 10.1093/molbev/mst139; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Kawaji H, 2014, GENOME RES, V24, P708, DOI 10.1101/gr.156232.113; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Shibata K, 2000, GENOME RES, V10, P1757, DOI 10.1101/gr.152600; Hurst LD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0413-3; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Okazaki Y, 2003, GENOME RES, V13, P1267, DOI 10.1101/gr.1445603; Patrucco L, 2015, GENE, V569, P287, DOI 10.1016/j.gene.2015.05.070; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Bungeishunju Ltd. Tokyo, 2010, BUNGEISHUNJU, V88, P144; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Furuno M, 2006, PLOS GENET, V2, P537, DOI 10.1371/journal.pgen.0020037; Hirozane-Kishikawa T, 2003, BIOTECHNIQUES, V35, P510; Itoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030809; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Shin JW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks732; St Laurent G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r73; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033474; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Zucchelli S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00174	70	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	OCT	2015	26	9-10			SI		391	402		10.1007/s00335-015-9593-8		12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CT6AT	WOS:000362893400004		
J	Maier, H; Schutt, C; Steinkamp, R; Hurt, A; Schneltzer, E; Gormanns, P; Lengger, C; Griffiths, M; Melvin, D; Agrawal, N; Alcantara, R; Evans, A; Gannon, D; Holroyd, S; Kipp, C; Raj, NP; Richardson, D; LeBlanc, S; Vasseur, L; Masuya, H; Kobayashi, K; Suzuki, T; Tanaka, N; Wakana, S; Walling, A; Clary, D; Gallegos, J; Fuchs, H; de Angelis, MH; Gailus-Durner, V				Maier, Holger; Schuett, Christine; Steinkamp, Ralph; Hurt, Anja; Schneltzer, Elida; Gormanns, Philipp; Lengger, Christoph; Griffiths, Mark; Melvin, David; Agrawal, Neha; Alcantara, Rafael; Evans, Arthur; Gannon, David; Holroyd, Simon; Kipp, Christian; Raj, Navis Pretheeba; Richardson, David; LeBlanc, Sophie; Vasseur, Laurent; Masuya, Hiroshi; Kobayashi, Kimio; Suzuki, Tomohiro; Tanaka, Nobuhiko; Wakana, Shigeharu; Walling, Alison; Clary, David; Gallegos, Juan; Fuchs, Helmut; de Angelis, Martin Hrabe; Gailus-Durner, Valerie			Principles and application of LIMS in mouse clinics	MAMMALIAN GENOME			English	Review							MANAGEMENT; DATABASE; SYSTEM; PROGRAM; MICE; WEB	Large-scale systemic mouse phenotyping, as performed by mouse clinics for more than a decade, requires thousands of mice from a multitude of different mutant lines to be bred, individually tracked and subjected to phenotyping procedures according to a standardised schedule. All these efforts are typically organised in overlapping projects, running in parallel. In terms of logistics, data capture, data analysis, result visualisation and reporting, new challenges have emerged from such projects. These challenges could hardly be met with traditional methods such as pen & paper colony management, spreadsheet-based data management and manual data analysis. Hence, different Laboratory Information Management Systems (LIMS) have been developed in mouse clinics to facilitate or even enable mouse and data management in the described order of magnitude. This review shows that general principles of LIMS can be empirically deduced from LIMS used by different mouse clinics, although these have evolved differently. Supported by LIMS descriptions and lessons learned from seven mouse clinics, this review also shows that the unique LIMS environment in a particular facility strongly influences strategic LIMS decisions and LIMS development. As a major conclusion, this review states that there is no universal LIMS for the mouse research domain that fits all requirements. Still, empirically deduced general LIMS principles can serve as a master decision support template, which is provided as a hands-on tool for mouse research facilities looking for a LIMS.	[Maier, Holger; Schuett, Christine; Steinkamp, Ralph; Hurt, Anja; Schneltzer, Elida; Gormanns, Philipp; Lengger, Christoph; Fuchs, Helmut; de Angelis, Martin Hrabe; Gailus-Durner, Valerie] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Expt Genet, German Mouse Clin, D-85764 Neuherberg, Germany; [Griffiths, Mark; Melvin, David; Agrawal, Neha; Alcantara, Rafael; Evans, Arthur; Gannon, David; Holroyd, Simon; Kipp, Christian; Raj, Navis Pretheeba; Richardson, David] Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge CB10 1SA, Cambs, England; [LeBlanc, Sophie; Vasseur, Laurent] ICS, F-67404 Illkirch Graffenstaden, France; [Masuya, Hiroshi; Kobayashi, Kimio; Suzuki, Tomohiro; Tanaka, Nobuhiko; Wakana, Shigeharu] RIKEN BioResource Ctr, Ibaraki 3060074, Japan; [Walling, Alison] Med Res Council Harwell, Mary Lyon Ctr, Harwell OX11 0RD, Oxon, England; [Clary, David] Univ Calif Davis, Mouse Biol Program, Davis, CA 95618 USA; [Gallegos, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [de Angelis, Martin Hrabe] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Chair Expt Genet, D-85354 Munich, Germany	de Angelis, MH (reprint author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Expt Genet, German Mouse Clin, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	holger.maier@helmholtz-muenchen.de; hrabe@helmholtz-muenchen.de	Hrabe de Angelis, Martin/F-5531-2012; Gailus-Durner, Valerie/M-7337-2014		German Federal Ministry of Education and Research [01KX1012]	We thank Manuela Ostereicher and Susan Marschall for critical reading of the manuscript. This work was funded by the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012).	Ching KA, 2006, MAMM GENOME, V17, P288, DOI 10.1007/s00335-005-0145-5; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Hopley R, 2001, BIOTECHNIQUES, V30, P130; Pargent W, 2000, MAMM GENOME, V11, P590, DOI 10.1007/s003350010112; FRANK N, 1991, J EXP ANIM SCI, V34, P140; Tanaka N, 2010, BIOINFORMATICS, V26, P1133, DOI 10.1093/bioinformatics/btq095; Wakana S, 2009, EXP ANIM TOKYO, V58, P443; Suzuki T, 2013, MAMM GENOME, V24, P473, DOI 10.1007/s00335-013-9482-y; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Milisavljevic M, 2010, MAMM GENOME, V21, P224, DOI 10.1007/s00335-010-9258-6; Masuya H, 2004, MAMM GENOME, V15, P404, DOI 10.1007/s00335-004-2265-8; ASTM International, 1997, E139497 ASTM INT; Boulukos KE, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-4; Maier H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-169; R Core Team, 2013, R LANG ENV STAT COMP	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	OCT	2015	26	9-10			SI		467	481		10.1007/s00335-015-9586-7		15	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CT6AT	WOS:000362893400012		
J	Nikaido, T; Nurrohman, H; Takagaki, T; Sadr, A; Ichinose, S; Tagami, J				Nikaido, Toru; Nurrohman, Hamid; Takagaki, Tomohiro; Sadr, Alireza; Ichinose, Shizuko; Tagami, Junji			Nanoleakage in Hybrid Layer and Acid-Base Resistant Zone at the Adhesive/Dentin Interface	MICROSCOPY AND MICROANALYSIS			English	Article						dentin bonding; self-etch system; TEM; HL; acid-base resistant zone; nanoleakage	DENTIN BONDING PERFORMANCE; SELF-ETCHING PRIMER; FUNCTIONAL MONOMERS; SYSTEMS; DEGRADATION; TEM; DURABILITY; EXPRESSION; STRENGTH; ENAMEL	The aim of interfacial nanoleakage evaluation is to gain a better understanding of degradation of the adhesive-dentin interface. The acid-base resistant zone (ABRZ) is recognized at the bonded interface under the hybrid layer (HL) in self-etch adhesive systems after an acid-base challenge. The purpose of this study was to evaluate nanoleakage in HL and ABRZ using three self-etch adhesives; Clearfil SE Bond (SEB), Clearfil SE One (SEO), and G-Bond Plus (GBP). One of the three adhesives was applied on the ground dentin surface and light cured. The specimens were longitudinally divided into two halves. One half remained as the control group. The others were immersed in ammoniacal silver nitrate solution, followed by photo developing solution under fluorescent light. Following this, the specimens were subjected to acid-base challenges with an artificial demineralization solution (pH4.5) and sodium hypochlorite, and prepared in accordance with common procedures for transmission electron microscopy (TEM) examination. The TEM images revealed silver depositions in HL and ABRZ due to nanoleakage in all the adhesives; however, the extent of nanoleakage was material dependent. Funnel-shaped erosion beneath the ABRZ was observed only in the all-in-one adhesive systems; SEO and GBP, but not in the two-step self-etch adhesive system; SEB.	[Nikaido, Toru; Takagaki, Tomohiro; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Cariol & Operat Dent,Bunkyo Ku, Tokyo 1138549, Japan; [Nurrohman, Hamid] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Sadr, Alireza] Univ Washington, Sch Dent, Dept Restorat Dent, Biomimet Biomat Biophoton & Technol Lab, Seattle, WA 98195 USA; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Bunkyo Ku, Tokyo 1138549, Japan	Nikaido, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Cariol & Operat Dent,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	nikaido.ope@tmd.ac.jp			Japan Society for the Promotion of Sciences [22592116, 15K11105]	This research was supported by the Japan Society for the Promotion of Sciences (22592116 and 15K11105). The authors have no commercial interests in the products herein investigated.	SANO H, 1995, OPER DENT, V20, P160; Tsujimoto M, 2010, DENT MATER J, V29, P655, DOI 10.4012/dmj.2010-004; Tay FR, 2002, J DENT RES, V81, P472; Waidyasekera K, 2009, J DENT, V37, P604, DOI 10.1016/j.jdent.2009.03.021; Yoshida Y, 2004, J DENT RES, V83, P454; Hashimoto M, 2002, J BIOMED MATER RES, V63, P306, DOI 10.1002/jbm.10208; Hariri I, 2012, J ADHES DENT, V14, P235, DOI 10.3290/j.jad.a22192; Inoue G, 2009, DENT MATER J, V28, P717; Tsuchiya S, 2004, J ADHES DENT, V6, P183; Inoue G, 2012, DENT MATER J, V31, P232, DOI 10.4012/dmj.2011-132; NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307; Iida Y, 2009, DENT MATER J, V28, P493; Yoshihara K, 2010, ACTA BIOMATER, V6, P3573, DOI 10.1016/j.actbio.2010.03.024; Tjaderhane L, 2013, DENT MATER, V29, P116, DOI 10.1016/j.dental.2012.08.004; Inoue G, 2006, OPER DENT, V31, P466, DOI 10.2341/05-62; Li N, 2011, J ADHES DENT, V13, P527, DOI 10.3290/j.jad.a21419; Sano H, 1999, J DENT RES, V78, P906; Hashimoto M, 2009, EUR J ORAL SCI, V117, P611, DOI 10.1111/j.1600-0722.2009.00664.x; Nurrohman H, 2012, J ADHES DENT, V14, P339, DOI 10.3290/j.jad.a22764; De Munck J, 2003, J DENT RES, V82, P136; Coutinho E, 2011, J DENT RES, V90, P1019, DOI 10.1177/0022034511408430; Milia E, 2012, CURR PHARM DESIGN, V18, P5542; Li N, 2010, J DENT, V38, P722, DOI 10.1016/j.jdent.2010.05.015; Van Landuyt KL, 2008, J DENT RES, V87, P757; WEFEL JS, 1995, CARIES RES, V29, P204; Ichinose S, 2003, BIO-MED MATER ENG, V13, P125; Nikaido T, 2009, BIO-MED MATER ENG, V19, P163, DOI 10.3233/BME-2009-0576; Nikaido T., 2011, JPN DENT SCI REV, V47, P31, DOI 10.1016/j.jdsr.2010.04.002; Nurrohman H, 2012, DENT MATER, V28, pE89, DOI 10.1016/j.dental.2012.04.025; Van Meerbeek B., 2010, DENT MATER, V27, P17	30	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1431-9276	1435-8115		MICROSC MICROANAL	Microsc. microanal.	OCT	2015	21	5					1271	1277		10.1017/S1431927615015068		7	Materials Science, Multidisciplinary; Microscopy	Materials Science; Microscopy	CT6VK	WOS:000362950300021		
J	Abdelrahman, M; Sawada, Y; Nakabayashi, R; Sato, S; Hirakawa, H; El-Sayed, M; Hirai, MY; Saito, K; Yamauchi, N; Shigyo, M				Abdelrahman, Mostafa; Sawada, Yuji; Nakabayashi, Ryo; Sato, Shusei; Hirakawa, Hideki; El-Sayed, Magdi; Hirai, Masami Yokota; Saito, Kazuki; Yamauchi, Naoki; Shigyo, Masayoshi			Integrating transcriptome and target metabolome variability in doubled haploids of Allium cepa for abiotic stress protection	MOLECULAR BREEDING			English	Article						Allium; RNAseq; Metabolomics; Transcriptomics; Abiotic stress	AMINO-ACID; ARABIDOPSIS-THALIANA; GALACTINOL SYNTHASE; THREONINE SYNTHASE; OXIDATIVE STRESS; GYNOGENIC PLANTS; CELL-WALL; ACCUMULATION; LEAVES; POTATO	Environmental stress conditions such as drought, heat, salinity, or pathogen infection can have a devastating impact on plant growth and yield, resulting in a need for stress-tolerant crop varieties. Crossbreeding tropical and cultivated onion species produced a hybrid F-1 generation possessing genetic and metabolic parental properties that aided abiotic stress tolerance. Targeted metabolite profiling using liquid chromatography-tandem mass spectrometry integrated with transcriptional analysis of their relevant genes provided insights into the metabolic and genomic architecture of the onion doubled haploid (Allium cepa L., DHC), shallot doubled haploid (A. cepa L. Aggregatum group, DHA), and F-1 hybrid. Out of a complete set of 113 targeted metabolites, 49 metabolites were found to be statistically significantly different between genotypes: 11 metabolites were characteristic for DHC, 10 for DHA, 14 for F-1, and 14 metabolites were shared among the three genotypes. Several key genes and metabolites introgressed in abiotic stress response were up-regulated in DHA and F1 genotypes as compared to DHC. Principal component analysis and Volcano plot analysis revealed that metabolic traits and their relevant genes (namely, amino acid, carbohydrate, flavonoid, and phospholipid biosynthesis) were strongly linked with DHA and F-1, reflecting the adaptability of DHA and F1 toward abiotic stress as compared to DHC.	[Abdelrahman, Mostafa; Yamauchi, Naoki; Shigyo, Masayoshi] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Sawada, Yuji; Nakabayashi, Ryo; Hirai, Masami Yokota; Saito, Kazuki] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Sato, Shusei] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Sato, Shusei; Hirakawa, Hideki] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [El-Sayed, Magdi] Aswan Univ, Fac Sci, Dept Bot, Aswan 81528, Egypt; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Yamauchi, Naoki; Shigyo, Masayoshi] Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, Yamaguchi 7538515, Japan	Shigyo, M (reprint author), Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, Yamaguchi 7538515, Japan.	shigyo@yamaguchi-u.ac.jp	Hirai, Masami/D-5319-2009	Hirai, Masami/0000-0003-0802-6208	Japan Science and Technology Agency (JST)	This research was supported in part by Strategic Japan-New Zealand Cooperative Program on Functional Food (Developments of a Metabolic Atlas of Allium Vegetables to Enable Dissection of Functional Properties) from Japan Science and Technology Agency (JST).	Parker D, 2009, PLANT J, V59, P723, DOI 10.1111/j.1365-313X.2009.03912.x; Nuccio ML, 1999, CURR OPIN PLANT BIOL, V2, P128, DOI 10.1016/S1369-5266(99)80026-0; Wood AJ, 1999, BIOL PLANTARUM, V42, P389, DOI 10.1023/A:1002413218691; Sulistyaningsih E, 2006, PLANT CELL TISS ORG, V86, P249, DOI 10.1007/s11240-006-9114-2; Minorsky PV, 2002, PLANT PHYSIOL, V128, P7, DOI 10.1104/pp.900014; Curien G, 1996, FEBS LETT, V390, P85, DOI 10.1016/0014-5793(96)00633-3; Keunen E, 2013, PLANT CELL ENVIRON, V36, P1242, DOI 10.1111/pce.12061; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Zhao JM, 1998, PLANT CELL, V10, P359; BERGLUND T, 1994, FEBS LETT, V351, P145, DOI 10.1016/0014-5793(94)00850-7; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; SARAVITZ DM, 1987, PLANT PHYSIOL, V83, P185, DOI 10.1104/pp.83.1.185; Lima RB, 2013, CARBOHYD POLYM, V93, P135, DOI 10.1016/j.carbpol.2012.05.015; Alan AR, 2003, PLANT SCI, V165, P1201, DOI 10.1016/S0168-9452(03)00327-3; Williamson JD, 2002, J AM SOC HORTIC SCI, V127, P467; Peters S, 2007, J EXP BOT, V58, P1947, DOI 10.1093/jxb/erm056; Liu HL, 2007, J PLANT PHYSIOL, V164, P1384, DOI 10.1016/j.jplph.2007.03.005; Dauwe R, 2012, NEW PHYTOL, V194, P192, DOI 10.1111/j.1469-8137.2011.04027.x; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Gupta AK, 2005, J BIOSCIENCES, V30, P761, DOI 10.1007/BF02703574; Hacham Y, 2008, PLANT J, V54, P260, DOI 10.1111/j.1365-313X.2008.03415.x; Joshi V, 2010, AMINO ACIDS, V39, P933, DOI 10.1007/s00726-010-0505-7; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; RUMPHO ME, 1983, PLANT PHYSIOL, V73, P869, DOI 10.1104/pp.73.4.869; Masamura N, 2011, J JPN SOC HORTIC SCI, V80, P322; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Moore JP, 2006, PLANT PHYSIOL, V141, P651, DOI 10.1104/pp.106.077701; Masuzaki S, 2006, THEOR APPL GENET, V112, P607, DOI 10.1007/s00122-005-0157-2; LEHLE L, 1973, EUR J BIOCHEM, V38, P103, DOI 10.1111/j.1432-1033.1973.tb03039.x; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Yaguchi S, 2008, PLANT CELL PHYSIOL, V49, P730, DOI 10.1093/pcp/pcn048; Newton AC, 2011, EUPHYTICA, V179, P3, DOI 10.1007/s10681-011-0359-4; Zeh M, 2001, PLANT PHYSIOL, V127, P792, DOI 10.1104/pp.127.3.792; Alcazar R, 2010, PLANTA, V231, P1237, DOI 10.1007/s00425-010-1130-0; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; Basu PS, 1999, ENVIRON EXP BOT, V42, P25, DOI 10.1016/S0098-8472(99)00017-9; Zagorchev L, 2013, INT J MOL SCI, V14, P7405, DOI 10.3390/ijms14047405; Brouwer C, 1989, IRRIGATION WATER MAN, V4; Bulens I, 2013, PHYSIOL PLANTARUM, V148, P176; Currah L., 2002, P379, DOI 10.1079/9780851995106.0379; Dancs G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-65; Ghanda B, 2011, NAT GENET, V43, P421; Hoa QV, 2012, GENOME, V55, P797; Mitsuda N, 2009, PLANT CELL PHYSL, V50, P123; Peremarti A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-125; Peshev D, 2013, CROP IMPROVEMENT ADV, P285; Robinson A, 2007, NEW PHYTOL, V147, P762; Sulistyaningsih E, 1997, B FAC AGR SAGA U, V82, P7; Takeda F, 2008, NAT REV GENET, V9, P444	51	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	OCT	2015	35	10							195	10.1007/s11032-015-0378-2		11	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CT6WD	WOS:000362952600008		
J	Diaz, A; Forment, J; Argyris, JM; Fukino, N; Tzuri, G; Harel-Beja, R; Katzir, N; Garcia-Mas, J; Monforte, AJ				Diaz, Aurora; Forment, Javier; Argyris, Jason M.; Fukino, Nobuko; Tzuri, Galil; Harel-Beja, Rotem; Katzir, Nurit; Garcia-Mas, Jordi; Monforte, Antonio J.			Anchoring the consensus ICuGI genetic map to the melon (Cucumis melo L.) genome	MOLECULAR BREEDING			English	Article						Cucumis melo L.; Simple sequence repeat; Single nucleotide polymorphism; Physical map; Genome anchoring; QTL	FRUIT-QUALITY TRAITS; MICROSATELLITE MARKERS; LOCI; IDENTIFICATION; VARIABILITY; LIBRARY; QTLS	Melon (Cucumis melo L.) genetic maps were compiled by the International Cucurbit Genomics Initiative (ICuGI) before the release of the melon genome. However, due to the use of different marker sets, the position of ICuGI markers in the genome remained unknown, complicating the integration of previous genetic mapping studies in the genome. We looked for the genome position of 870 simple sequence repeat and single nucleotide polymorphism (SNP) markers from the ICuGI map, locating 836 of them in the melon pseudochromosomes v3.5.1, and integrating them with previously available SNPs to reach a total of 1850 markers mapped in the genome sequence. The number of markers per scaffold ranged from 1 to 105, with an average of 13, thus improving on the previous studies in melon. Twenty-three of the markers mapped on virtual chromosome "0'', twelve of them being included in the ICuGI map, which could assist in the anchoring of some unanchored contigs and scaffolds. Genetic and physical distance comparison showed a good collinearity between them, confirming the quality of the ICuGI map. A higher recombination rate was also usually found at the ends of the chromosomes, whereas a drastic reduction was observed in the putative pericentromeric regions. Quantitative trait loci (QTL) previously located in the ICuGI map were also anchored in the genome. This work offers the opportunity to supplement the genetic maps available up to now with the genomic resources resulting from the melon genome sequencing to facilitate comparative mapping in melon between past and new studies, and to overcome some of the current limitations in QTL gene identification.	[Diaz, Aurora; Forment, Javier; Monforte, Antonio J.] Univ Politecn Valencia, CSIC, IBMCP, CPI, Valencia 46022, Spain; [Diaz, Aurora] Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Unidad Hortofruticultura, Zaragoza 50059, Spain; [Argyris, Jason M.; Garcia-Mas, Jordi] CSIC IRTA UAB UB, CRAG, IRTA, Barcelona 08193, Spain; [Fukino, Nobuko] NARO Inst Vegetable & Tea Sci NIVTS, Tsu, Mie 5142392, Japan; [Tzuri, Galil; Harel-Beja, Rotem; Katzir, Nurit] Newe Yaar Res Ctr, ARO, Dept Vegetable Res, IL-30095 Ramat Yishay, Israel	Monforte, AJ (reprint author), Univ Politecn Valencia, CSIC, IBMCP, CPI, Ed 8E,C Ingn Fausto Elio S-N, Valencia 46022, Spain.	amonforte@ibmcp.upv.es	MONFORTE, Antonio Jose/B-4784-2009	MONFORTE, Antonio Jose/0000-0003-3461-3094	Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2012-40130-C02-02]	This work was funded in part by the project AGL2012-40130-C02-02 from Spanish Ministry of Economy and Competitiveness (MINECO) to AJM.	Gonzalo MJ, 2005, THEOR APPL GENET, V110, P802, DOI 10.1007/s00122-004-1814-6; Danin-Poleg Y, 2001, THEOR APPL GENET, V102, P61, DOI 10.1007/s001220051618; Eduardo I, 2007, J AM SOC HORTIC SCI, V132, P80; Fukino N, 2008, THEOR APPL GENET, V118, P165, DOI 10.1007/s00122-008-0885-1; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Goff SA, 2014, ADV BOT RES, V69, P47, DOI 10.1016/B978-0-12-417163-3.00003-2; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Perin C, 2002, MOL GENET GENOMICS, V266, P933, DOI 10.1007/s00438-001-0612-y; Vegas J, 2013, THEOR APPL GENET, V126, P1531, DOI 10.1007/s00122-013-2071-3; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Burger Y, 2006, ISR J PLANT SCI, V54, P233, DOI 10.1560/IJPS_54_3_233; Monforte AJ, 2004, THEOR APPL GENET, V108, P750, DOI 10.1007/s00122-003-1483-x; Cuevas HE, 2008, THEOR APPL GENET, V117, P1345, DOI 10.1007/s00122-008-0868-2; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Ritschel Patricia Silva, 2004, BMC Plant Biology, V4, P9, DOI 10.1186/1471-2229-4-9; Argyris JM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1196-3; Diaz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104188; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Fernandez-Trujillo JP, 2011, BREEDING FOR FRUIT QUALITY, P261; Leida C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0183-2; Monforte AJ, 2014, J EXP BOT, V65, P4625, DOI 10.1093/jxb/eru017; PITRAT M., 2008, HDB PLANT BREEDING, P283; Ren Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029453	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	OCT	2015	35	10							188	10.1007/s11032-015-0381-7		7	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CT6WD	WOS:000362952600001		
J	Perchepied, L; Leforestier, D; Ravon, E; Guerif, P; Denance, C; Tellier, M; Terakami, S; Yamamoto, T; Chevalier, M; Lespinasse, Y; Durel, CE				Perchepied, L.; Leforestier, D.; Ravon, E.; Guerif, P.; Denance, C.; Tellier, M.; Terakami, S.; Yamamoto, T.; Chevalier, M.; Lespinasse, Y.; Durel, C. E.			Genetic mapping and pyramiding of two new pear scab resistance QTLs	MOLECULAR BREEDING			English	Article						Pear; Venturia pirina; Venturia nashicola; Quantitative trait locus; Marker-assisted selection; Synteny	X-DOMESTICA BORKH.; MARKER-ASSISTED SELECTION; MICROSATELLITE MARKERS; DISEASE RESISTANCE; VENTURIA-PIRINA; PYRUS-PYRIFOLIA; EUROPEAN PEARS; BROAD-SPECTRUM; LINKAGE MAPS; APPLE	Scab is one of the major fungal diseases infecting pear trees, causing the greatest economic losses. Identifying and pyramiding scab resistance factors should help in breeding new resistant pear cultivars. We have identified and mapped two new pear resistance loci against the fungal pathogen Venturia pirina. The first locus, mapped both as a major gene and as a QTL, is located on linkage group (LG) 01 of the hybrid P3480, deriving from the European pear cultivar 'Wilder.' It colocalizes with the Vnk resistance gene found in the Asian pear cultivar 'Kinchaku' against Venturia nashicola. A second locus, mapped as a QTL, is located on LG04 of the interspecific cultivar 'Euras.' In a small 'Euras' x P3480 progeny, seven seedlings carrying the resistant alleles at both loci have been selected using SSR markers.	[Perchepied, L.; Leforestier, D.; Ravon, E.; Guerif, P.; Denance, C.; Tellier, M.; Chevalier, M.; Lespinasse, Y.; Durel, C. E.] INRA, Inst Rech Hort & Semences, SFR QUASAV 4207, UMR 1345, F-49071 Beaucouze, France; [Perchepied, L.; Leforestier, D.; Ravon, E.; Guerif, P.; Denance, C.; Tellier, M.; Chevalier, M.; Lespinasse, Y.; Durel, C. E.] Univ Angers, Inst Rech Hort & Semences, UMR 1345, F-49045 Angers, France; [Terakami, S.; Yamamoto, T.] NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan	Perchepied, L (reprint author), INRA, Inst Rech Hort & Semences, SFR QUASAV 4207, UMR 1345, 42 Rue Georges Morel, F-49071 Beaucouze, France.	laure.perchepied@angers.inra.fr			University of Angers; young researcher SyntePoirPom project	This work was supported by the University of Angers with the young researcher SyntePoirPom project. The authors thank Helene Muranty for her critical review of the manuscript. They also thank Charles Poncet for the technical assistance delivered by the platform Gentyane of high-throughput genotyping of Clermont-Theix, Laurence Hibrand-Saint Oyant for the technical assistance delivered by the ANAN technical platform of the SFR QUASAV (Structure Federative de Recherche 4207 QUASAV), the INRA Horticultural Experimental Unit 0449 and the IRHS team in charge of the greenhouse management (INEM platform), and particularly, Michel Boucourt and Nicolas Dousset.	Andries N, 2002, ACTA HORTIC, V596, P261; Won K, 2014, MOL BREEDING, V34, P2179, DOI 10.1007/s11032-014-0172-6; Hospital F, 2009, GENETICA, V136, P303, DOI 10.1007/s10709-008-9307-1; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; [Anonymous], 2004, ACTA HORTIC; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Chevalier M, 2008, ACTA HORTIC, P817; Patocchi A, 2009, MOL BREEDING, V24, P337, DOI 10.1007/s11032-009-9295-6; CHURCHILL GA, 1994, GENETICS, V138, P963; Broggini GAL, 2009, GENOME, V52, P129, DOI [10.1139/g08-115, 10.1139/G08-115]; Cho KH, 2009, J HORTIC SCI BIOTECH, V84, P619; Palloix A, 2009, NEW PHYTOL, V183, P190, DOI 10.1111/j.1469-8137.2009.02827.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Gonai T, 2009, J JPN SOC HORTIC SCI, V78, P49, DOI 10.2503/jjshs1.78.49; Costa F, 2008, TREE GENET GENOMES, V4, P575, DOI 10.1007/s11295-008-0133-5; Abe K, 2000, J JPN SOC HORTIC SCI, V69, P1; Szabo T, 1998, ACTA HORTIC, P497; ISHII H, 1992, ACTA PHYTOPATHOL HUN, V27, P293; Lespinasse Y, 2008, ACTA HORTIC, P475; Iwata H, 2013, BREEDING SCI, V63, P125, DOI 10.1270/jsbbs.63.125; Ishii H, 2002, ACTA HORTIC, P613; Pierantoni L, 2007, TREE GENET GENOMES, V3, P311, DOI 10.1007/s11295-006-0070-0; Yamamoto T, 2002, MOL ECOL NOTES, V2, P14, DOI 10.1046/j.1471-8286.2002.00128.x; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; Terakami S, 2006, THEOR APPL GENET, V113, P743, DOI 10.1007/s00122-006-0344-9; Yamamoto T, 2002, THEOR APPL GENET, V106, P9, DOI 10.1007/s00122-002-0966-5; Asins MJ, 2002, PLANT BREEDING, V121, P281, DOI 10.1046/j.1439-0523.2002.730285.x; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Gessler C, 2006, CRIT REV PLANT SCI, V25, P473, DOI 10.1080/07352680601015975; Frey JE, 2004, PLANT BREEDING, V123, P554, DOI 10.1111/j.1439-0523.2004.01033.x; Braniste N, 2008, ACTA HORTIC, P491; Yamamoto T, 2013, ACTA HORTIC, V976, P477; Soufflet-Freslon V, 2008, GENOME, V51, P657, DOI 10.1139/G08-046; Calenge F, 2004, PHYTOPATHOLOGY, V94, P370, DOI 10.1094/PHYTO.2004.94.4.370; Bouvier L, 2012, TREE GENET GENOMES, V8, P53, DOI 10.1007/s11295-011-0419-x; [Anonymous], 2004, ACTA HORTIC; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Poland JA, 2009, TRENDS PLANT SCI, V14, P21, DOI 10.1016/j.tplants.2008.10.006; Vinatzer BA, 2004, PLANT BREEDING, V123, P321, DOI 10.1111/j.1439-0523.2004.00973.x; Belfanti E, 2004, P NATL ACAD SCI USA, V101, P886, DOI 10.1073/pnas.0304808101; van Dyk MM, 2010, TREE GENET GENOMES, V6, P489, DOI 10.1007/s11295-009-0266-1; Ishii H, 2000, MYCOL RES, V104, P755, DOI 10.1017/S0953756299001720; St Clair DA, 2010, ANNU REV PHYTOPATHOL, V48, P247, DOI 10.1146/annurev-phyto-080508-081904; Fournet S, 2013, PLANT PATHOL, V62, P184, DOI 10.1111/j.1365-3059.2012.02617.x; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Cova V, 2015, MOL BREEDING, V35, P1; Croxall HE, 1952, PLANT PATHOL, V1, P3941; Gardiner SE, 2009, 17 PLANT AN MICR GEN; Jansch M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0242-4; Moriya S, 2012, TREE GENET GENOMES, V8, P709, DOI 10.1007/s11295-011-0458-3; Schouten HJ, 2014, TREE GENET GENOMES, V10, P251, DOI 10.1007/s11295-013-0678-9; SHABI E, 1973, PHYTOPATHOLOGY, V63, P41; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Van Ooijen J, 2004, MAPQTL 5 SOFTWARE MA; Van Ooijen JW, 2006, JOINMAP 4 SOFTWARE C	57	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	OCT	2015	35	10							197	10.1007/s11032-015-0391-5		14	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CT6WD	WOS:000362952600010		
J	Suzuki, K; Tasaki, K; Yamagishi, M				Suzuki, Kazuma; Tasaki, Keisuke; Yamagishi, Masumi			Two distinct spontaneous mutations involved in white flower development in Lilium speciosum	MOLECULAR BREEDING			English	Article						Anthocyanin biosynthesis; Agroinfiltration; Dihydroflavonol 4-reductase (DFR); LsMYB12; Oriental hybrid lilies; R2R3-MYB	ANTHOCYANIN BIOSYNTHESIS; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; TULIPA-FOSTERIANA; STRUCTURAL GENES; EXPRESSION; MYB; TEPALS; PIGMENTATION; R2R3-MYB	Lilium speciosum is one of the most important wild species used for breeding Oriental hybrid lily cultivars. Typical L. speciosum flowers possess red tepals and dark red anthers because of anthocyanin accumulation. However, white-flowered L. speciosum with two distinct phenotypes, one with white tepals and dark red anthers and the other with white tepals and yellow anthers, also exists. To elucidate the molecular mechanisms underlying white colouration, we isolated two regulatory genes and eight biosynthetic genes responsible for anthocyanin pigmentation in L. speciosum and compared these in red- and white-flowered lines. In the white tepal line with dark red anthers, we detected an amino acid substitution in the R2 repeat of LsMYB12, the R2R3-MYB that regulates tepal-specific anthocyanin biosynthesis, which led to reduced anthocyanin biosynthetic gene transcription and no tepal pigmentation. This LsMYB12 sequence was identical to that of an LhMYB12 in the white-flowered Oriental hybrid lily cultivar 'Rialto', indicating that this LsMYB12 sequence is present in lines that have been used for breeding. In addition, a nonsense mutation was detected in the dihydroflavonol 4-reductase (DFR) sequence of the white tepal line with yellow anthers, which resulted in a lack of anthocyanin accumulation in tepals and anthers. This mutated DFR has not been used for lily breeding because white tepal Oriental hybrid lily cultivars usually have dark red anthers. These results suggest that several mechanisms generate white flowers in lilies, and provide a substantial foundation for the production of Oriental hybrid lily cultivars with novel flower colour combinations.	[Suzuki, Kazuma] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Tasaki, Keisuke; Yamagishi, Masumi] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Yamagishi, M (reprint author), Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan.	yamagisi@res.agr.hokudai.ac.jp			Japan Society for the Promotion of Science [24380014]	This work was supported by a Grant-In-Aid for Scientific Research (No. 24380014) from the Japan Society for the Promotion of Science.	Nakatsuka T, 2005, PLANT SCI, V169, P949, DOI 10.1016/j.plantsci.2005.06.013; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Yamagishi M, 2011, MOL BREEDING, V28, P381, DOI 10.1007/s11032-010-9490-5; Lai YS, 2011, SCI HORTIC-AMSTERDAM, V132, P59, DOI 10.1016/j.scienta.2011.09.030; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Yamagishi M, 2010, PLANT BREEDING, V129, P100, DOI 10.1111/j.1439-0523.2009.01656.x; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Norbaek R, 1999, PHYTOCHEMISTRY, V50, P1181, DOI 10.1016/S0031-9422(98)00661-X; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Nakatsuka A, 2009, SCI HORTIC-AMSTERDAM, V121, P84, DOI 10.1016/j.scienta.2009.01.008; Yamagishi M, 2012, MOL BREEDING, V30, P913, DOI 10.1007/s11032-011-9675-6; Toda K, 2002, PLANT MOL BIOL, V50, P187, DOI 10.1023/A:1016087221334; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Morita Y, 2006, PLANT CELL PHYSIOL, V47, P457, DOI 10.1093/pcp/pcj012; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Yamagishi M, 2014, SCI HORTIC-AMSTERDAM, V174, P119, DOI 10.1016/j.scienta.2014.05.017; Yamagishi M, 2013, SCI HORTIC-AMSTERDAM, V163, P27, DOI 10.1016/j.scienta.2013.07.024; Schwinn KE, 2004, ANNU PLANT REV, V14, P92; Yuan Y, 2013, SCI HORTIC-AMSTERDAM, V153, P93, DOI 10.1016/j.scienta.2013.02.008; SMYTH DR, 1989, PLANT SYST EVOL, V163, P53, DOI 10.1007/BF00936153; Abe H, 2002, THEOR APPL GENET, V105, P1175, DOI 10.1007/s00122-002-1053-7; Shen GA, 2006, BIOSCIENCE REP, V26, P19, DOI 10.1007/s10540-006-9007-y; Takahashi R, 2011, J HERED, V102, P458, DOI 10.1093/jhered/esr028; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Lai YS, 2012, PLANT SCI, V193, P136, DOI 10.1016/j.plantsci.2012.05.013; Nakano M, 2005, SCI HORTIC-AMSTERDAM, V104, P57, DOI 10.1016/j.scienta.2004.08.007; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Nakatsuka A, 2003, PLANT SCI, V165, P759, DOI 10.1016/S0168-9452(03)00254-1; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Asano Y., 1989, GRAND DICT HORTICULT, V5, P198; Comber HF, 1949, LILY YB ROYAL HORTIC, V13, P85; Du J, 2014, JOVE-J VIS EXP, V83, P50971; Leslie AC, 1982, INT LILY REGISTER; NODA S, 1986, Plant Species Biology, V1, P69, DOI 10.1111/j.1442-1984.1986.tb00016.x; Shimizu M, 1987, THE LILIES IN JAPAN; Yuan Y, 2014, SCI HORTIC-AMSTERDAM, V175, P16, DOI 10.1016/j.scienta.2014.05.032	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	OCT	2015	35	10							193	10.1007/s11032-015-0389-z		14	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CT6WD	WOS:000362952600006		
J	Zhang, J; Ishigaki, Y; Takegami, T				Zhang, Jun; Ishigaki, Yasuhito; Takegami, Tsutomu			Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA	MOLECULAR MEDICINE REPORTS			English	Article						biological behavior; gene transfection; hepatitis C virus; microRNAs; non-structural protein 3	HEPATOCELLULAR-CARCINOMA; NONSTRUCTURAL PROTEINS; TRANSGENIC MICE; MESSENGER-RNA; CORE PROTEIN; CANCER; P21(WAF1); REGION; NS5A; GENE	Chronic hepatitis C virus (HCV) infection is a major cause of hepatocellular carcinoma (HCC) worldwide. The HCV non-structural protein 3 (NS3) protein is considered to affect normal cellular functions and to be involved in HCV carcinogenesis. The expression of microRNA (miRNA) is altered in human HCC, thus implicating its role in hepatocarcinogenesis. To investigate the mechanisms by which the HCV NS3 protein affects the expression of miRNA in malignant hepatocytes, if any, the present study constructed expression vectors encoding the HCV NS3 and NS3/4A proteins, which were stably transfected into HepG2 cells. The biological behaviors of the HepG2 transfectants and their differential expression levels of miRNA expression were investigated. Compared with the HepG2-vector cells, the HepG2-NS3 cells grew at a slower rate, were arrested in the G0/G1 cell cycle phase, formed more colonies and developed larger tumors at a faster rate. Co-expression of HCV NS4A resulted in the inhibition of HCV NS3-stimulated tumorigenicity. A total of 35 miRNAs were dysregulated, 26 of which were downregulated and nine of which were upregulated, in the HepG2-NS3 cells, and 75 miRNAs were altered in HepG2-NS3/4A cells, of which 20 were downregulated and 55 were upregulated). In addition, significant decreases in the mRNA levels of p53 and p21 were observed, which confirmed differential expression of miRNA. These results suggested that differential miRNA profiling in malignant hepatocytes may account for the variable pathophysiological manifestations associated with the HCV NS3 protein. These differentially expressed miRNAs may offer potential as candidates for the development of miRNA-based therapeutics.	[Zhang, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Comprehens Med, Wuhan 430030, Hubei, Peoples R China; [Zhang, Jun; Ishigaki, Yasuhito; Takegami, Tsutomu] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Uchinada, Ishikawa 9200293, Japan	Takegami, T (reprint author), Kanazawa Med Univ, Med Res Inst, Dept Life Sci, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	takegami@kanazawa-med.ac.jp			Kanazawa Medical University	This study was supported in part by a Grant from Collaborative Research from Kanazawa Medical University.	Siavoshian S, 2004, ARCH VIROL, V149, P323, DOI 10.1007/s00705-003-0205-7; Kasprzak A, 2008, HEPATOL RES, V38, P1, DOI 10.1111/j.1872-034X.2007.00261.x; Koike K, 2002, ONCOLOGY-BASEL, V62, P29, DOI 10.1159/000048273; Neddermann P, 1997, BIOL CHEM, V378, P469; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; TAKAMIZAWA A, 1991, J VIROL, V65, P1105; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; He QQ, 2003, WORLD J GASTROENTERO, V9, P474; SAKAMURO D, 1995, J VIROL, V69, P3893; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Hassan M, 2005, VIROLOGY, V333, P324, DOI 10.1016/j.virol.2005.01.008; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; SUZICH JA, 1993, J VIROL, V67, P6152; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; GRAKOUI A, 1989, J VIROL, V63, P5216; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; Kwun HJ, 2001, J GEN VIROL, V82, P2235; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Yoon A, 2011, NUCLEIC ACIDS RES, V39, P8078, DOI 10.1093/nar/gkr492; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Hammond J B, 1988, Methods Mol Biol, V3, P25, DOI 10.1385/0-89603-126-8:25; Hong Z, 1996, J VIROL, V70, P4261; Livak JK, 2001, METHODS, V25, P402, DOI DOI 10.1006/2001.1262	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	A				5109	5115		10.3892/mmr.2015.4041		7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MQ	WOS:000362999200040		
J	Maeda, T; Miura, Y; Fukuda, K; Hayashi, S; Kurosaka, M				Maeda, Toshihisa; Miura, Yasushi; Fukuda, Koji; Hayashi, Shinya; Kurosaka, Masahiro			Decoy receptor 3 regulates the expression of tryptophan hydroxylase 1 in rheumatoid synovial fibroblasts	MOLECULAR MEDICINE REPORTS			English	Article						rheumatoid arthritis; fibroblast-like synoviocyte; decoy receptor 3; tryptophan hydroxylase; serotonin	FAS LIGAND; IN-VITRO; T-CELL; ARTHRITIS; SEROTONIN; APOPTOSIS; OVEREXPRESSION; AMPLIFICATION; BIOLOGY; TUMOR	Decoy receptor 3 (DcR3) is expressed in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) and down-regulates the expression of tryptophan hydroxylase 1 (TPH1), which is the rate-limiting enzyme in serotonin synthesis. The aim of the present study was to determine the specificity of the effects of DcR3 on TPH1 in RA-FLS, and therefore determine whether DcR3 had the potential to modulate the pathogenesis of RA. The present study also aimed to compare the effects of DcR3 and inflammatory cytokines on the expression of TPH1 in RA-FLS and osteoarthritis (OA)-FLS. Primary cultured RA-or OA-FLS were incubated with 1.0 mu g/ml DcR3-Fc protein or 1.0 mu g/ml control immunoglobulin G (IgG)1 for 12 h, or with 1.0 ng/ml tumor necrosis factor (TNF)alpha, 1.0 ng/ml interleukin (IL)-1 beta or serum-free Opti-MEM only, for 24 h. The relative mRNA expression levels of TPH1 were subsequently quantified using reverse transcription-polymerase chain reaction. The expression of serotonin in RA or OA synovial tissue was detected using immunohistochemistry. The mRNA expression of TPH1 was observed in both RA- and OA-FLS and was significantly decreased following treatment with DcR3 in the RA-FLS, however, not in the OA-FLS. The mRNA expression of TPH1 was significantly decreased following treatment with TNF alpha or IL-1 beta in both the RA- and OA-FLS. The expression of serotonin in the multi-layered lining synovial cells of RA and the outer layer lining synovial cells of OA was detected using immunohistochemistry. The present study is the first, to the best of our knowledge, to demonstrate that the expression of TPH1 in FLS is downregulated by inflammatory cytokines, and that DcR3 suppressed the expression of TPH1 in RA-FLS in a disease-specific manner. These results suggested that synovial serotonin may be involved in the pathogenesis of RA, and that TPH1 and DcR3 may be potential therapeutic targets for the treatment of RA.	[Maeda, Toshihisa; Miura, Yasushi; Fukuda, Koji; Hayashi, Shinya; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Miura, Yasushi] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Div Orthoped Sci, Kobe, Hyogo 6540142, Japan; [Fukuda, Koji] Kakogawa City Hosp, Dept Orthopaed Surg, Kakogawa, Hyogo 6758611, Japan	Miura, Y (reprint author), Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Div Orthoped Sci, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	miura@kobe-u.ac.jp			Japanese Ministry of Education, Science, and Culture [24592261]	The present study was supported by a grant-in-aid in the form of a health science research grant from the Japanese Ministry of Education, Science, and Culture (no. 24592261). The findings of the present study were presented at the 2013 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting, October 25-30, 2013 (San Diego, CA, USA).	Takahashi M, 2011, INT J MOL MED, V28, P423, DOI 10.3892/ijmm.2011.687; Gustafsson BI, 2006, J CELL BIOCHEM, V98, P139, DOI 10.1002/jcb.20734; Ducy P, 2010, J CELL BIOL, V191, P7, DOI 10.1083/jcb.201006123; Hayashi S, 2007, ARTHRITIS RHEUM, V56, P1067, DOI 10.1002/art.22494; Geba GP, 1996, J IMMUNOL, V157, P557; Chou CT, 2001, J PATHOL, V193, P110, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH746>3.0.CO;2-K; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199; Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Hayashi S, 2010, MOD RHEUMATOL, V20, P63, DOI 10.1007/s10165-009-0240-7; Pitti RM, 1998, NATURE, V396, P699; Tsuji S, 2003, INT J CANCER, V106, P17, DOI 10.1002/ijc.11170; Shi GX, 2003, J IMMUNOL, V171, P3407; Tateishi K, 2009, BIOCHEM BIOPH RES CO, V389, P593, DOI 10.1016/j.bbrc.2009.09.027; Tak PP, 2000, IMMUNOL TODAY, V21, P78, DOI 10.1016/S0167-5699(99)01552-2; Yang CR, 2004, CELL DEATH DIFFER, V11, pS97, DOI 10.1038/sj.cdd.4401403; Yu KY, 1999, J BIOL CHEM, V274, P13733, DOI 10.1074/jbc.274.20.13733; Hsu MJ, 2004, EXP CELL RES, V292, P241, DOI 10.1016/j.yexcr.2003.09.019; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Yadav VK, 2010, ANN NY ACAD SCI, V1192, P103, DOI 10.1111/j.1749-6632.2009.05312.x; Fukuda K, 2013, INT J MOL MED, V32, P910, DOI 10.3892/ijmm.2013.1461; Zhu P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1899; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Karsenty G, 2011, ANNU REV MED, V62, P323, DOI 10.1146/annurev-med-090710-133426; LOVENBER.W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Voog O, 2000, Life Sci, V68, P591	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	A				5191	5196		10.3892/mmr.2015.4097		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MQ	WOS:000362999200052		
J	Lin, Y; Bai, L; Chen, YL; Zhu, NH; Bai, YP; Li, QW; Zhao, SH; Fan, JL; Liu, EQ				Lin, Yan; Bai, Liang; Chen, Yulong; Zhu, Ninghong; Bai, Yanping; Li, Qianwei; Zhao, Sihai; Fan, Jianglin; Liu, Enqi			Practical assessment of the quantification of atherosclerotic lesions in apoE(-/-) mice	MOLECULAR MEDICINE REPORTS			English	Article						aorta; atherosclerosis; morphometry; mouse	E KNOCKOUT MICE; E-DEFICIENT MICE; MOUSE MODELS; HYDROGEN-SULFIDE; APOLIPOPROTEIN; PROGRESSION; RABBITS; MODIFIERS; CELLS	Genetic manipulations have enabled the mouse to be widely used as an animal model for investigating the mechanisms of human atherosclerotic disease. However, there is no standard method for quantifying atherosclerotic lesions among different laboratories. The present study introduces a thorough and precise quantitative assessment of atherosclerotic lesions in mice. In the present study, 6-week-old apoE(-/-) mice were fed either a chow diet or a high-fat diet (HFD) for 12 weeks. Plasma lipid levels were measured every four weeks. Aortic atherosclerotic lesions were quantified and analyzed using an image analysis system. The aortic tree was isolated and stained with Oil Red O to measure the gross lesion area. The heart was removed and divided into sequential cross sections, which were then assessed for microscopic intimal lesions in the aortic root as follows: (1) Elastic van Gieson staining was performed to determine the area of the atherosclerotic lesion; (2) cross sections were stained with hematoxylin and eosin for histological analysis; and (3) cross sections were stained with Oil Red 0 and immunohistochemical staining for quantitative analysis of the cellular components within the lesions. ApoE mice fed with either the chow diet or HFD developed severe atherosclerosis in the aortic root, however, there were few lesions in the remainder of the aortic tree. Compared with the control group, the HFD apoE-/- mice had increased plasma lipid levels and increases in the gross lesion area in the aortic tree, the microscopic lesion area in the aortic root and the number of macrophages, vascular smooth muscle cells and neutral lipids present within the lesions. HFD feeding in the apoE(-/-) mice accelerated the development of atherosclerosis. The quantitative method described in the present study may be used to assist in future investigations of atherosclerosis in mice.	[Lin, Yan; Bai, Liang; Zhu, Ninghong; Bai, Yanping; Li, Qianwei; Zhao, Sihai; Liu, Enqi] Xi An Jiao Tong Univ, Sch Med, Lab Anim Ctr, Xian 710061, Shaanxi, Peoples R China; [Lin, Yan; Bai, Liang; Zhu, Ninghong; Bai, Yanping; Li, Qianwei; Zhao, Sihai; Liu, Enqi] Xi An Jiao Tong Univ, Res Inst Atherosclerot Dis, Xian 710061, Shaanxi, Peoples R China; [Chen, Yulong; Liu, Enqi] Xian Med Univ, Inst Basic & Translat Med, Shaanxi Key Lab Ischem Cardiovasc Dis, Xian 710021, Shaanxi, Peoples R China; [Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi 4093898, Japan	Liu, EQ (reprint author), Xi An Jiao Tong Univ, Res Inst Atherosclerot Dis, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	liuenqi@mail.xjtu.edu.cn			National Natural Science Foundation of China [81270348]	This study was partly supported by the National Natural Science Foundation of China (grant. no. 81270348).	REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Wrobel TP, 2013, ANALYST, V138, P6645, DOI 10.1039/c3an01050c; Daugherty A, 2009, METHODS MOL BIOL, V573, P1, DOI 10.1007/978-1-60761-247-6_1; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Ni M, 2008, ATHEROSCLEROSIS, V197, P64, DOI 10.1016/j.atherosclerosis.2007.07.039; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Chen YL, 2013, THROMB RES, V132, P565, DOI 10.1016/j.thromres.2013.09.007; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133; Veniant MM, 1997, J CLIN INVEST, V100, P180, DOI 10.1172/JCI119511; Yu Q, 2012, HISTOL HISTOPATHOL, V27, P529; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Liu EQ, 2005, METABOLISM, V54, P132, DOI 10.1016/j.metabol.2004.07.021; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Knowles JW, 2000, ARTERIOSCL THROM VAS, V20, P2336; Zhang C, 2010, J COMP PATHOL, V142, P122, DOI [10.1016/j.jcpa.2009.08.159, 10.1016/j.jcpa.2009.07.159]; McAteer MA, 2004, ARTERIOSCL THROM VAS, V24, P2384, DOI 10.1161/01.ATV.0000146811.19029.fb; FORD A, 2013, INT J VASC MED, V2013; Kapourchali Fatemeh Ramezani, 2014, World J Clin Cases, V2, P126, DOI 10.12998/wjcc.v2.i5.126; US NIH, 2011, GUIDE CARE USE LAB A; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	A				5298	5306		10.3892/mmr.2015.4084		9	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MQ	WOS:000362999200068		
J	Abe, S; Tokoro, F; Matsuoka, R; Arai, M; Noda, T; Watanabe, S; Horibe, H; Fujimaki, T; Oguri, M; Kato, K; Minatoguchi, S; Yamada, Y				Abe, Shintaro; Tokoro, Fumitaka; Matsuoka, Reiko; Arai, Masazumi; Noda, Toshiyuki; Watanabe, Sachiro; Horibe, Hideki; Fujimaki, Tetsuo; Oguri, Mitsutoshi; Kato, Kimihiko; Minatoguchi, Shinya; Yamada, Yoshiji			Association of genetic variants with dyslipidemia	MOLECULAR MEDICINE REPORTS			English	Article						dyslipidemia; hypertriglyceridemia; hypo-high density lipoprotein-cholesterolemia; genetics; polymorphism; hyper-low density lipoprotein-cholesterolemia	CORONARY-ARTERY-DISEASE; INTERLEUKIN-6 RECEPTOR GENE; GENOME-WIDE ASSOCIATION; LIPID-LEVELS; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN A5; PLASMA-LIPIDS; HEART-DISEASE; LOCI	Although genetic variants, which regulate lipid metabolism, have been extensively investigated in Caucasian populations, the genes, which confer susceptibility to dyslipidemia in Japanese individuals, remain to be elucidated. The aim of the present study was to examine a possible association among hypertriglyceridemia, hypo-high density lipoprotein (HDL)-cholesterolemia or hyper-low density lipoprotein (LDL)-cholesterolemia in Japanese individuals with 29 polymorphisms observed to confer susceptibility for coronary heart disease. This was performed through meta-analyses of genome-wide association studies in Caucasian populations. The study population comprised 2,354 individuals with dyslipidemia (hypertriglyceridemia, hypo-HDL-cholesterolemia or hyper-LDL-cholesterolemia) and 3,106 control individuals. To compensate for multiple comparisons of genotypes, a false discovery rate (FDR) of <0.05 was adopted to determine the statistical significance of the associations. Comparisons of allele frequencies using the 7(2 test revealed that rs964184 of zinc finger gene (ZPR1; FDR=2.1x10(-7)), rs4845625 of interleukin 6 receptor (IL6R; FDR=0.032), rs46522 of ubiquitin-conjugating enzyme E2Z gene (UBE2Z; FDR=0.032) and rs17514846 of furin (FDR=0.041) were significantly associated with hypertriglyceridemia. The X-2 test revealed that rs599839 of proline/serine-rich coiled-coil 1 (PSRC1; FDR=0.004) and rs2075650 of translocase of outer mitochondrial membrane 40 homolog (TOMM40; FDR=0.004) were significantly associated with hyper-LDL-cholesterolemia. Multivariate logistic regression analysis with adjustment for age, gender and body mass index revealed that rs964184 of ZPR1 (P=5.1x10(-7); odds ratio, 1.37; dominant model), rs4845625 of IL6R (P=0.0019, odds ratio, 1.25; dominant model) and rs46522 of UBE2Z (P=0.0039, odds ratio, 1.19; dominant model) were significantly associated with hypertriglyceridemia, and that rs599839 of PSRC1 (P=0.0004, odds ratio, 0.70; dominant model) and rs2075650 of TOMM40 (P=0.0004, odds ratio, 1.43; dominant model) were significantly associated with hyper-LDL-cholesterolemia. Therefore, ZPR1, IL6R, and UBE2Z may be susceptibility loci for hypertriglyceridemia, whereas PSRC1 and TOMM40 may be such loci for hyper-LDL-cholesterolemia in Japanese individuals.	[Abe, Shintaro; Tokoro, Fumitaka; Matsuoka, Reiko; Arai, Masazumi; Noda, Toshiyuki; Watanabe, Sachiro] Gifu Prefectural Gen Med Ctr, Dept Cardiol, Gifu, Gifu 5008717, Japan; [Horibe, Hideki] Gifu Prefectural Tajimi Hosp, Dept Cardiovasc Med, Tajimi, Gifu 5078522, Japan; [Fujimaki, Tetsuo] Inabe Gen Hosp, Dept Cardiovasc Med, Inabe, Mie 5110428, Japan; [Oguri, Mitsutoshi] Japanese Red Cross Nagoya First Hosp, Dept Cardiol, Nagoya, Aichi 4538511, Japan; [Kato, Kimihiko] Meitoh Hosp, Dept Internal Med, Nagoya, Aichi 4650025, Japan; [Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Gifu 5011194, Japan; [Yamada, Yoshiji] Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, Tsu, Mie 5148507, Japan	Yamada, Y (reprint author), Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, 1577 Kurima Machiya, Tsu, Mie 5148507, Japan.	yamada@gene.mie-u.ac.jp			Collaborative Research Grant from Gifu Prefectural General Medical Center [H24-26]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590746]	This study was supported by a Collaborative Research Grant from the Gifu Prefectural General Medical Center (no. H24-26) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24590746).	Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Esteve E, 2006, CLIN ENDOCRINOL, V65, P88, DOI 10.1111/j.1365-2265.2006.02553.x; Strong A, 2012, CURR ATHEROSCLER REP, V14, P211, DOI 10.1007/s11883-012-0248-x; Ken-Dror G, 2010, J HUM GENET, V55, P300, DOI 10.1038/jhg.2010.27; Hsieh PC, 2007, ONCOGENE, V26, P4928, DOI 10.1038/sj.onc.1210304; Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Jakel H, 2006, ANN MED, V38, P2, DOI 10.1080/07853890500407488; Gu X, 2007, MOL BIOL REP, V34, P183, DOI 10.1007/s11033-006-9033-7; Hiramatsu M, 2012, INT J MOL MED, V30, P185, DOI 10.3892/ijmm.2012.976; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Kirillova O. O., 2012, Voprosy Pitaniya, V81, P48; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Vincent JB, 2000, DNA RES, V7, P233, DOI 10.1093/dnares/7.3.233; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Jiang CQ, 2010, OBESITY, V18, P1969, DOI 10.1038/oby.2010.31; Yan SK, 2005, CLIN CHEM LAB MED, V43, P607, DOI 10.1515/CCLM.2005.105; Muendlein A, 2009, ATHEROSCLEROSIS, V206, P494, DOI 10.1016/j.atherosclerosis.2009.02.040; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Wang AZ, 2011, ANN HUM GENET, V75, P475, DOI 10.1111/j.1469-1809.2011.00646.x; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Klos KLE, 2006, ARTERIOSCL THROM VAS, V26, P1828, DOI 10.1161/01.ATV.0000231523.19199.45; Nakayama K, 2011, J HUM GENET, V56, P828, DOI 10.1038/jhg.2011.109; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Fujimaki T, 2011, EXP THER MED, V2, P745, DOI 10.3892/etm.2011.266; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEMJoa072366; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Kleber ME, 2010, ATHEROSCLEROSIS, V209, P492, DOI 10.1016/j.atherosclerosis.2009.09.068; Samani NJ, 2008, J MOL MED, V86, P1233, DOI 10.1007/s00109-008-0387-2; Alssema M, 2013, EUR J ENDOCRINOL, V169, P421, DOI 10.1530/EJE-13-0487; Turpeinen H, 2011, ATHEROSCLEROSIS, V219, P799, DOI 10.1016/j.atherosclerosis.2011.08.011; Arvind P, 2014, J CARDIOL, V64, P339, DOI 10.1016/j.jjcc.2014.02.012; Chu NF, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-136; Galernabi M, 2013, CLIN BIOHEM, V46, P12; Hardardottir Ingibjorg, 1994, Current Opinion in Lipidology, V5, P207, DOI 10.1097/00041433-199405030-00008; Horibe H, 2014, MOL MED REP, V9, P808, DOI 10.3892/mmr.2014.1902; Vargas VR, 2013, GENET MOL RES, V12, P3893	48	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	A				5429	5436		10.3892/mmr.2015.4081		8	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MQ	WOS:000362999200086		
J	Hosokawa, Y; Monzen, S; Yoshino, H; Terashima, S; Nakano, M; Toshima, K; Saga, R; Kashiwakura, I				Hosokawa, Yoichiro; Monzen, Satoru; Yoshino, Hironori; Terashima, Shingo; Nakano, Manabu; Toshima, Keisuke; Saga, Ryo; Kashiwakura, Ikuo			Effects of X-ray irradiation in combination with ascorbic acid on tumor control	MOLECULAR MEDICINE REPORTS			English	Article						X-ray irradiation; ascorbic acid; tumor control; cancer therapy	I CLINICAL-TRIAL; VITAMIN-C; ADVANCED CANCER; LEUKEMIA-CELLS; APOPTOSIS; THERAPY; PHASE; PHARMACOKINETICS	Our previous studies demonstrated that the combination of treatment with ascorbic acid (AsA) and X-ray irradiation results in increased apoptosis in HL60 cells. The present study was performed to investigate the effects of the combined use of AsA and X-ray irradiation on epithelial cancer and sarcoma cells, and its potential use in future clinical treatment. X-ray irradiation combined with AsA treatment resulted in increased suppression of cell growth of HT1080, SAS and A549 cells in vitro compared with X-ray irradiation alone. The combined treatment also suppressed tumor growth in implanted HT-1080 cells in vivo. Using annexin V/propidium iodide staining and the detection of activated caspase 3, it was found that X-ray irradiation increased the apoptotic rate of HT1080 cells and resulted in G2/M arrest. However, apoptosis in the HT1080 cells treated with 5 mM AsA remained unchanged, and no changes were observed in the G2/M fraction. By contrast, AsA treatment caused increased suppression of proliferation compared with X-ray irradiation. These results suggested that 5 mM AsA slowed the cell cycle and reduced tumor growth. Therefore, X-ray irradiation combined with AsA treatment may be effective against epithelial cancer and sarcoma cells.	[Hosokawa, Yoichiro; Monzen, Satoru; Yoshino, Hironori; Terashima, Shingo; Saga, Ryo; Kashiwakura, Ikuo] Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiat Sci, Hirosaki, Aomori 0368564, Japan; [Nakano, Manabu] Hirosaki Univ, Grad Sch Hlth Sci, Dept Biosci & Lab Med, Hirosaki, Aomori 0368564, Japan; [Toshima, Keisuke] Akita Univ Hosp, Dept Radiol, Akita, Akita 0108543, Japan	Hosokawa, Y (reprint author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiat Sci, 66-1 Honcho, Hirosaki, Aomori 0368564, Japan.	hosokawa@hirosaki-u.ac.jp	monzen, satoru/F-1468-2013; Terashima, Shingo/G-1300-2013	monzen, satoru/0000-0003-2436-8048; Terashima, Shingo/0000-0002-9255-7150	Japan Society for Promotion of Science [21591603, 24591831]	The present study was supported by the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research, project nos. 21591603 and 24591831).	Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Witenberg B, 1999, RADIAT RES, V152, P468, DOI 10.2307/3580142; Terashima S, 2013, ONCOL REP, V30, P2653, DOI 10.3892/or.2013.2758; Stephenson CM, 2013, CANCER CHEMOTH PHARM, V72, P139, DOI 10.1007/s00280-013-2179-9; Takemura Y, 2010, BIOCHEM BIOPH RES CO, V394, P249, DOI 10.1016/j.bbrc.2010.02.012; Fukumura H, 2012, J PHYSIOL SCI, V62, P251, DOI 10.1007/s12576-012-0204-0; Padayatty SJ, 2006, CAN MED ASSOC J, V174, P937, DOI 10.1503/cmaj.050346; Gupta A, 2014, RADIAT RES, V181, P1, DOI 10.1667/RR13572.1; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; Bordignon B, 2013, BIOCHEM BIOPH RES CO, V439, P137, DOI 10.1016/j.bbrc.2013.08.004; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; Wakasaya T, 2013, INT J ONCOL, V42, P1205, DOI 10.3892/ijo.2013.1804; Ha YM, 2009, CANCER LETT, V277, P48, DOI 10.1016/j.canlet.2008.11.020; Kam WWY, 2013, FREE RADICAL BIO MED, V65, P607, DOI 10.1016/j.freeradbiomed.2013.07.024; Shinozaki K, 2011, J RADIAT RES, V52, P229, DOI 10.1269/jrr.10089; Harakeh S, 2007, ANTICANCER RES, V27, P289; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Duconge J, 2008, P R HEALTH SCI J, V27, P7; Putchala MC, 2013, ARCH ORAL BIOL, V58, P563, DOI 10.1016/j.archoralbio.2013.01.016; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; Klingelhoeffer C, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-61; Padayatty SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011414; Vuyyuri SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067081	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	A				5449	5454		10.3892/mmr.2015.4108		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MQ	WOS:000362999200089		
J	Fukuda, T; Shirane, A; Wada-Hiraike, O; Oda, K; Tanikawa, M; Sakuabashi, A; Hirano, M; Fu, HJ; Morita, Y; Miyamoto, Y; Inaba, K; Kawana, K; Osuga, Y; Fujii, T				Fukuda, Tomohiko; Shirane, Akira; Wada-Hiraike, Osamu; Oda, Katsutoshi; Tanikawa, Michihiro; Sakuabashi, Ayako; Hirano, Mana; Fu, Houju; Morita, Yoshihiro; Miyamoto, Yuichiro; Inaba, Kanako; Kawana, Kei; Osuga, Yutaka; Fujii, Tomoyuki			HAND2-mediated proteolysis negatively regulates the function of estrogen receptor alpha	MOLECULAR MEDICINE REPORTS			English	Article						endometrial cancer; HAND2; estrogen receptor alpha; ubiquitination	HELIX TRANSCRIPTION FACTORS; ENDOMETRIAL CANCER; DIOXIN RECEPTOR; HORMONE-THERAPY; FACTOR HAND2; DHAND; EXPRESSION; BETA; DNA; IDENTIFICATION	A previous study demonstrated that the progesterone-inducible HAND2 gene product is a basic helix-loop-helix transcription factor and prevents mitogenic effects of estrogen receptor alpha (ER alpha) by inhibiting fibroblast growth factor signalling in mouse uteri. However, whether HAND2 directly affects the transcriptional activation function of ER alpha remains to be elucidated. In the present study, the physical interaction between HAND2 and ER alpha was investigating by performing an immunoprecipitation assay and an in vitro pull-down assay. The results demonstrated that HAND2 and ERa interacted in a ligand-independent manner. The in vitro pull-down assays revealed a direct interaction between HAND2 and the amino-terminus of ER alpha, termed the activation function-1 domain. To determine the physiological significance of this interaction, the role of HAND2 as a cofactor of ER alpha was investigated, which revealed that HAND2 inhibited the ligand-dependent transcriptional activation function of ER alpha. This result was further confirmed and the mRNA expression of vascular endothelial growth factor, an ER alpha-downstream factor, was decreased by the overexpression of HAND2. This inhibition of ligand-dependent transcriptional activation function of ER alpha was possibly attributed to the proteasomic degradation of ER alpha by HAND2. These results indicate a novel anti-tumorigenic function of HAND2 in regulating ER alpha-dependent gene expression. Considering that HAND2 is commonly hypermethylated and silenced in endometrial cancer, it is hypothesized that HAND2 may serve as a possible tumor suppressor, particularly in uterine tissue.	[Fukuda, Tomohiko; Shirane, Akira; Wada-Hiraike, Osamu; Oda, Katsutoshi; Tanikawa, Michihiro; Sakuabashi, Ayako; Hirano, Mana; Fu, Houju; Morita, Yoshihiro; Miyamoto, Yuichiro; Inaba, Kanako; Kawana, Kei; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo 1138655, Japan	Wada-Hiraike, O (reprint author), Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	osamuwh-tky@umin.ac.jp			Ministry of Education, Science and Culture [24592505]	The authors would like to thank Professor Murakami (Tokyo University of Science, Tokyo, Japan) for providing the HAND2 expression vector (pcDNA3.1 Myc-His B HAND2). This study was supported by a grant from the Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture (grant no. 24592505).	HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Welboren WJ, 2009, ENDOCR-RELAT CANCER, V16, P1073, DOI 10.1677/ERC-09-0086; Dai YS, 2002, J BIOL CHEM, V277, P12604, DOI 10.1074/jbc.M200283200; WHITE TEK, 1993, BIOCHEM BIOPH RES CO, V193, P956, DOI 10.1006/bbrc.1993.1718; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Morikawa Y, 2005, DEV DYNAM, V234, P613, DOI 10.1002/dvdy.20544; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Burke WM, 2014, GYNECOL ONCOL, V134, P385, DOI 10.1016/j.ygyno.2014.05.018; CULLINANBOVE K, 1993, ENDOCRINOLOGY, V133, P829, DOI 10.1210/en.133.2.829; HENDERSON BE, 1983, BRIT J CANCER, V47, P749, DOI 10.1038/bjc.1983.127; Koyama S, 2010, BIOCHEM BIOPH RES CO, V392, P357, DOI 10.1016/j.bbrc.2010.01.025; Hiraike H, 2010, BRIT J CANCER, V102, P1061, DOI 10.1038/sj.bjc.6605577; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dirkx E, 2013, NAT CELL BIOL, V15, P1282, DOI 10.1038/ncb2866; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Rychlik JL, 2003, J BIOL CHEM, V278, P49652, DOI 10.1074/jbc.M308577200; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Firulli BA, 2000, J BIOL CHEM, V275, P33567, DOI 10.1074/jbc.M005888200; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bondesson M, 2014, BIOCHIM BIOPHYS ACTA, V1849, P142; Fu H, 2014, ENDOCRINOLOGY, V155, P3079, DOI 10.1210/en.2014-1025; GRADY D, 1992, ANN INTERN MED, V117, P1016; Jones A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001551; Koskas M, 2014, FERTIL STERIL, V101, P785, DOI 10.1016/j.fertnstert.2013.11.028; Wada-Hiraike O, 2005, BRIT J CANCER, V92, P2286, DOI 10.1038/sj.bjc.6602614; Zhou W, 2014, NAT REV CANCER, V14, P26, DOI 10.1038/nrc3622	34	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	A				5538	5544		10.3892/mmr.2015.4070		7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MQ	WOS:000362999200102		
J	Shiratake, S; Nakahara, T; Iwahashi, H; Onodera, T; Mizushina, Y				Shiratake, Sawako; Nakahara, Tatsuo; Iwahashi, Hiroyasu; Onodera, Takefumi; Mizushina, Yoshiyuki			Rose myrtle (Rhodomyrtus tomentosa) extract and its component, piceatannol, enhance the activity of DNA polymerase and suppress the inflammatory response elicited by UVB-induced DNA damage in skin cells	MOLECULAR MEDICINE REPORTS			English	Article						rose myrtle; piceatannol; normal human epidermal keratinocytes; ultraviolet B; DNA damage; DNA polymerase; anti-inflammatory activity	PHOTOPROTECTION; PROSTAGLANDIN-E2; SUNSCREEN; EXPOSURE; GROWTH; REPAIR; BETA	A number of naturally occurring agents are hypothesized to protect against ultraviolet (UV)-induced skin damage. The present study screened >50 plant extracts for inhibitors of UVB-induced cytotoxicity, using cultured normal human epidermal keratinocytes (NHEK), and identified that the fruit of rose myrtle (Rhodomyrtus tomentosa) was the most marked inhibitor of cell death. The protective effect of rose myrtle extract and the two key components, piceatannol and piceatannol-4'-Omicron-beta-D-glucopyranoside, on UVB-induced damage and inflammation in cultured NHEK was investigated. The 80% ethanol extract from rose myrtle fruit with piceatannol exhibited protection of UVB-induced cytotoxicity in NHEK; however, piceatannol-4'-Omicron-beta-D-glucopyranoside exhibited no protection, as determined by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. This extract and piceatannol reduced the production of UVB-induced cyclobutane pyrimidine dimers and enhanced the cellular enzyme activity of the DNA polymerases in UVB-irradiated NHEK, suggesting that UVB-stimulated DNA damage was repaired by the polymerases. In addition, the secretion of prostaglandin E-2, which is an inflammatory mediator, was decreased. These results indicated that rose myrtle fruit extract and its key constituent, piceatannol, are potential photoprotective candidates for UV-induced skin damage.	[Shiratake, Sawako; Nakahara, Tatsuo; Iwahashi, Hiroyasu] Maruzen Pharmaceut Co Ltd, Res Ctr, Onomichi, Hiroshima 7220062, Japan; [Onodera, Takefumi; Mizushina, Yoshiyuki] Kobe Gakuin Univ, Cooperat Res Ctr Life Sci, Kobe, Hyogo 6508586, Japan; [Mizushina, Yoshiyuki] Shinshu Univ, Grad Sch Agr, Lab Funct Food Sci, Nagano 3994598, Japan	Mizushina, Y (reprint author), Shinshu Univ, Grad Sch Agr, Lab Funct Food Sci, 8304 Minamiminowa Mura, Nagano 3994598, Japan.	mizushina@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities	This study was supported, in part, by the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016. Dr Yoshiyuki Mizushina received a Grants-in-Aids for the 25th (2014) Cosmetology Research Foundation (Japan).	Gailani MR, 1996, J NATL CANCER I, V88, P349, DOI 10.1093/jnci/88.6.349; KRIPKE ML, 1992, P NATL ACAD SCI USA, V89, P7516, DOI 10.1073/pnas.89.16.7516; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Trompezinski S, 2001, INFLAMM RES, V50, P422, DOI 10.1007/PL00000265; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Servant L, 2002, J BIOL CHEM, V277, P50046, DOI 10.1074/jbc.M207101200; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Rundhaug JE, 2007, MOL CARCINOGEN, V46, P692, DOI 10.1002/mc.20329; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Berneburg M, 2000, PHOTODERMATOL PHOTO, V16, P239, DOI 10.1034/j.1600-0781.2000.160601.x; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Moriwaki S, 2008, J DERMATOL SCI, V50, P169, DOI 10.1016/j.jdermsci.2007.08.011; Mizushina Y, 1996, J ANTIBIOT, V49, P491; Verschooten L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1016, DOI 10.1562/2006-04-27-IR-584; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Matsui MS, 2009, J INVEST DERM SYMP P, V14, P56, DOI 10.1038/jidsymp.2009.14; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Autier P, 2009, BRIT J DERMATOL, V161, P40, DOI 10.1111/j.1365-2133.2009.09448.x; KASHIWADA Y, 1988, CHEM PHARM BULL, V36, P1545; Kabashima K, 2007, LAB INVEST, V87, P49, DOI 10.1038/labinvest.3700491; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Do TL, 2011, MED PLANTS REMEDIES, P434; Kornberg A, 1990, DNA REPLICATION, P197; Marrot L, 2008, J AM ACAD DERMATOL, V58, pS139, DOI 10.1016/j.jaad.2007.12.007; Mizushina Y, 1997, BBA-GEN SUBJECTS, V1336, P509, DOI 10.1016/S0304-4165(97)00067-6; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Schroeder P, 2010, Skin Therapy Lett, V15, P4	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	B				5857	5864		10.3892/mmr.2015.4156		8	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MR	WOS:000362999300033		
J	Hayakawa, T; Yoshimura, Y; Kikuiri, T; Matsuno, M; Hasegawa, T; Fukushima, K; Shibata, K; Deyama, Y; Suzuki, K; Iida, J				Hayakawa, Takako; Yoshimura, Yoshitaka; Kikuiri, Takashi; Matsuno, Mino; Hasegawa, Tomokazu; Fukushima, Kumu; Shibata, Kenjiro; Deyama, Yoshiaki; Suzuki, Kuniaki; Iida, Junichiro			Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells	MOLECULAR MEDICINE REPORTS			English	Article						optimal compressive force; osteoclastogenesis; collagen gel	MECHANICAL-STRESS; DIFFERENTIATION; OSTEOBLAST; EXPRESSION; RECEPTOR; CULTURE; GENE	Mechanical stress produced by orthodontic forces is a factor in the remodeling of periodontal ligaments (PDLs) and alveolar bone. It has been reported that the expression of a number of cytokines associated with osteoclastogenesis is upregulated when compressive forces act on osteoblasts and PDL cells. The present study investigated the effects of compressive forces on the formation of osteoclasts from the macrophage cell line RAW264.7. Compressive forces on osteoclasts were exerted using layers of 3, 5, 7, 9 or 14 glass cover slips on the 4th day of culture for 24 h. The number of osteoclasts was determined by counting the number of cells positive for tartrate-resistant acid phosphatase staining. Osteoclastogenesis advanced rapidly on days four and five. The number of osteoclasts with >8 nuclei peaked when the force of 7 slips was applied, which was therefore regarded as the optimal compressive force. Alterations in the expression of osteoclast-associated genes are associated with changes in the differentiation and fusion of macrophages in response to compressive forces; therefore, osteoclast-associated genes were assessed by reverse transcription quantitative polymerase chain reaction in the present study. The mRNA expression of osteoclast-associated genes increased significantly after 3 h of optimal compression, whereas mRNA expression increased after 24 h in the control group. These findings suggested that osteoclastogenesis of macrophages was accelerated when an optimal compressive force was applied.	[Hayakawa, Takako; Fukushima, Kumu; Shibata, Kenjiro; Iida, Junichiro] Hokkaido Univ, Grad Sch Dent Med, Dept Orthodont, Sapporo, Hokkaido 0608586, Japan; [Hayakawa, Takako; Yoshimura, Yoshitaka; Matsuno, Mino; Deyama, Yoshiaki; Suzuki, Kuniaki] Hokkaido Univ, Grad Sch Dent Med, Dept Mol Cell Pharmacol, Sapporo, Hokkaido 0608586, Japan; [Kikuiri, Takashi] Hokkaido Univ, Grad Sch Dent Med, Dept Pediat Dent, Sapporo, Hokkaido 0608586, Japan; [Hasegawa, Tomokazu] Univ Tokushima, Fac Dent, Dept Pediat Dent, Tokushima 7708504, Japan	Yoshimura, Y (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Mol Cell Pharmacol, Kita Ku, Kita 13 Nishi 7, Sapporo, Hokkaido 0608586, Japan.	yoshi@den.hokudai.ac.jp			Japan Society for Promotion of Science [25463161, 24659906, 24593071, 2586199403, 2586199303]	The authors are grateful to Dr. S. Kameyama (Departments of Orthodontics Dentistry, Hokkaido University Graduate School of Dental Medicine, Sapporo, Japan) for technical advice and support. This study was supported in part by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (nos. 25463161 to Y.Y., 24659906 to T.K. and 24593071 to M.M), and for Young Scientists (nos. 2586199403 to K.F. and 2586199303 to K.S).	Nomura M, 2011, J PHARMACOL SCI, V117, P243, DOI 10.1254/jphs.11099FP; Abe K, 2012, INT J MOL MED, V29, P1007, DOI 10.3892/ijmm.2012.952; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Kameyama S, 2013, INT J MOL MED, V31, P292, DOI 10.3892/ijmm.2012.1220; Tan SD, 2007, BONE, V41, P745, DOI 10.1016/j.bone.2007.07.019; Kadow-Romacker A, 2009, CELLS TISSUES ORGANS, V190, P61, DOI 10.1159/000178022; Shibata K, 2011, INT J MOL MED, V28, P73, DOI 10.3892/ijmm.2011.675; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Suzuki N, 2008, INT J MOL MED, V21, P291; Makihira S, 2008, CELL BIOL INT, V32, P1176, DOI 10.1016/j.cellbi.2008.04.027; Ichimiya H, 2007, ORAL SURG ORAL MED O, V103, P334, DOI 10.1016/j.tripleo.2006.05.026; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Koshihara Y, 1999, J BONE MINER METAB, V17, P98, DOI 10.1007/s007740050071; Rubin J, 1997, J CELL PHYSIOL, V170, P81, DOI 10.1002/(SICI)1097-4652(199701)170:1<81::AID-JCP9>3.0.CO;2-H; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Contractor T, 2005, IN VIVO, V19, P335; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; Hong ZQ, 2013, J CELL BIOCHEM, V114, P388, DOI 10.1002/jcb.24372; Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Bourauel C, 2000, J Orofac Orthop, V61, P266, DOI 10.1007/s000560050012; Graber LW, 2012, ORTHODONTICS CURRENT, P247; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129; Mochizuki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048795; Nishijima Y, 2006, Orthod Craniofac Res, V9, P63, DOI 10.1111/j.1601-6343.2006.00340.x; Proffit W, 2007, CONT ORTHODONTICS, P331; Schwarz A.M., 1932, INT J ORTHODONT, V18, P331	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	B				5879	5885		10.3892/mmr.2015.4141		7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MR	WOS:000362999300036		
J	Ohmoto, T; Nishitsuji, K; Yoshitani, N; Mizuguchi, M; Yanagisawa, Y; Saito, H; Sakashita, N				Ohmoto, Takuji; Nishitsuji, Kazuchika; Yoshitani, Nobuyuki; Mizuguchi, Makoto; Yanagisawa, Yuto; Saito, Hiroyuki; Sakashita, Naomi			K604, a specific acyl-CoA:cholesterol acyltransferase 1 inhibitor, suppresses proliferation of U251-MG glioblastoma Cells	MOLECULAR MEDICINE REPORTS			English	Article						acyl-CoA:cholesterol acyltransferase 1; glioblastoma; acyl-CoA:cholesterol acyltransferase inhibitor; cell proliferation; cholesteryl ester	A-CHOLESTEROL ACYLTRANSFERASE; LIPID RAFTS; MAMMALIAN-CELLS; CANCER CELLS; COENZYME; ACTIVATION; SURVIVAL; GLIOMA; CD44; KINASE	Glioblastoma is the most aggressive type of brain tumor and has a poor prognosis. Increased levels of cholesteryl ester and simultaneous expression of acyl-CoA:cholesterol acyltransferase 1 (ACAT1) in tumor cells indicated that cholesterol esterification is critical to tumor growth. The present study confirmed that human glioblastoma tissues as well as the glioblastoma cell line U251-MG showed significant expression of ACAT1. ACAT1 expression in U251-MG cells increased in a cell proliferation-dependent manner. K604, a selective ACAT1 inhibitor, suppressed the proliferation of U251-MG cells and downregulated the activation of Akt and extracellular signal-regulated kinase in proliferating glioblastoma cells. These results suggested that ACAT1 may be a therapeutic target for the treatment of glioblastoma, with K604 as an effective therapeutic agent.	[Ohmoto, Takuji; Nishitsuji, Kazuchika; Yoshitani, Nobuyuki; Mizuguchi, Makoto; Sakashita, Naomi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Pathol, Tokushima 7708503, Japan; [Yanagisawa, Yuto; Saito, Hiroyuki] Univ Tokushima, Inst Hlth Biosci, Dept Phys Pharmaceut, Tokushima 7708505, Japan; [Yanagisawa, Yuto; Saito, Hiroyuki] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan	Nishitsuji, K (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Pathol, 3-18-15 Kuramotocho, Tokushima 7708503, Japan.	nishitsuji@tokushima-u.ac.jp			Challenging Exploratory Research from Japan Society for the Promotion of Science (JSPS) [26670190]; Center for Advanced Medical Sciences, Institute of Health Biosciences; University of Tokushima Graduate School;  [C-23590448]	The authors would like to thank Ms. Hiroko Akita (Department of Human Pathology, Institute of Health Biosciences, University of Tokushima Graduate School) for her excellent technical assistance. The present study was supported by Grants-in-Aid for Scientific Research (no. C-23590448) and Challenging Exploratory Research (no. 26670190 to N.S) from the Japan Society for the Promotion of Science (JSPS). The present study was also supported by the Support Center for Advanced Medical Sciences, Institute of Health Biosciences, The University of Tokushima Graduate School.	Lawlor MA, 2001, J CELL SCI, V114, P2903; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Yasuda M, 1932, J CLIN INVEST, V11, P677, DOI 10.1172/JCI100442; Nygren C, 1997, BRIT J NEUROSURG, V11, P216; Park YS, 2012, ONCOL REP, V27, P339, DOI 10.3892/or.2011.1532; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Burnett JR, 1999, J LIPID RES, V40, P1317; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Cheng CK, 2009, BRAIN PATHOL, V19, P112, DOI 10.1111/j.1750-3639.2008.00233.x; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Delsing DJM, 2001, CIRCULATION, V103, P1778; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Lopez-Gines C, 2008, NEUROPATHOLOGY, V28, P507, DOI 10.1111/j.1440-1789.2008.00911.x; Zhuang LY, 2002, CANCER RES, V62, P2227; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; Kaba SE, 1997, DRUGS, V53, P235, DOI 10.2165/00003495-199753020-00004; Ringerike T, 2002, J CELL SCI, V115, P1331; Robinson JP, 2011, AM J CANCER RES, V1, P155; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; FREDMAN P, 1986, Neurological Research, V8, P123; Niikura Y, 2002, J BIOCHEM, V132, P53; Huang LH, 2013, ARTERIOSCL THROM VAS, V33, P2081, DOI 10.1161/ATVBAHA.112.301080; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Sakashita N, 2000, AM J PATHOL, V156, P227, DOI 10.1016/S0002-9440(10)64723-2; Wei KC, 2010, ANTICANCER RES, V30, P253; Subramaniam V, 2007, EXP MOL PATHOL, V83, P207, DOI 10.1016/j.yexmp.2007.04.008; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Chen DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087281; Kniipfer MM, 1999, CLIN EXP METASTAS, V17, P71; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; ROFFO A. H., 1933, AMER JOUR CANCER, V17, P42	39	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	B				6037	6042		10.3892/mmr.2015.4200		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MR	WOS:000362999300060		
J	Sato, T; Kita, K; Sato, C; Kaneda, A				Sato, Tetsuo; Kita, Kazuko; Sato, Chihomi; Kaneda, Atsushi			Hochu-ekki-to (Bu-zhong-yi-qi-tang), a herbal medicine, enhances cisplatin-induced apoptosis in HeLa cells	MOLECULAR MEDICINE REPORTS			English	Article						Hochu-ekki-to; apoptosis; anti-cancer effect; caspase-3; Bcl-2/Bax ratio; p53	RECOMBINANT ANNEXIN II; PANCREATIC-CANCER; CHINESE MEDICINE; P53; DRUGS; LINES; MICE; CARCINOGENESIS; ACTIVATION; RESISTANCE	Hochu-ekki-to (HET), a Kampo herbal medicine composed of ten medicinal plants, is traditionally used to improve the general state of patients with malignant diseases such as cancer. Recent studies showed that HET had an anti-cancer effect against several cancer cell lines in vitro by inducing apoptosis. However, high doses of HET may have cytotoxic effects attributed to saponins or detergent-like compounds. Therefore, the present study used low doses of HET (50 mu g/ml, which did not affect cell viability, to evaluate its synergistic anti-cancer effects with cisplatin. HeLa cells were cultured for 24 h with 50 mu g/ml HET, followed by cisplatin treatment for 24 h at various concentrations. Subsequently, the sensitivity of the cells to cisplatin was assessed using a colony survival and a crystal violet cell viability assay. Furthermore, cisplatin-induced apoptosis was analyzed by flow cytometry. Proteins associated with cell viability and apoptosis, including phosphorylated (p-) Akt, p53, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax) and active caspase-3 were analyzed by immunoblotting. The present study revealed that cell survival was decreased and apoptosis was increased in HeLa cells pre-treated with HET prior to cisplatin treatment compared with HET-untreated cells. Furthermore, protein expression of p53 and active caspase-3 was increased, while the expression of p-Akt as well as the Bcl-2/Bax ratio, an index of survival activity in cells, were decreased in the HET-pre-treated cells compared with those in HET-untreated cells following incubation with cisplatin. In conclusion, the present study indicated that HET enhanced cisplatin-induced apoptosis of HeLa cells and that the administration of HET may therefore be clinically beneficial alongside apoptosis-inducing chemotherapy.	[Sato, Tetsuo] Fukurou Home Clin, Res Dept, Ichihara, Chiba 2900143, Japan; [Kita, Kazuko; Sato, Chihomi; Kaneda, Atsushi] Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chuo Ku, Chiba, Chiba 2608670, Japan	Kita, K (reprint author), Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan.	kita@faculty.chiba-u.jp			Japan Society for Promotion of Science [24510065]; Smoking Research Foundation	This study was supported in part by grants-in-aid from the following organizations: The Smoking Research Foundation and the Japan Society for the Promotion of Science (no. 24510065).	Kim SH, 2002, AM J CHINESE MED, V30, P127, DOI 10.1142/S0192415X02000144; Wano C, 2004, EXP CELL RES, V298, P584, DOI 10.1016/j.yexcr.2004.04.048; REDSTON MS, 1994, CANCER RES, V54, P3025; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Zhu K, 2005, GYNECOL ONCOL, V97, P405, DOI 10.1016/j.ygyno.2004.12.063; Utsuyama M, 2001, MECH AGEING DEV, V122, P341, DOI 10.1016/S0047-6374(00)00249-9; Kuroiwa A, 2004, INT IMMUNOPHARMACOL, V4, P317, DOI 10.1016/j.intimp.2003.12.004; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Kao ST, 2001, LIFE SCI, V69, P1485, DOI 10.1016/S0024-3205(01)01226-7; Prokop A, 2000, LEUKEMIA, V14, P1606, DOI 10.1038/sj.leu.2401866; Onogi K, 2006, ONCOL REP, V16, P1343; Normanno N, 2003, J CELL PHYSIOL, V194, P13, DOI 10.1002/jcp.10194; Dong M, 2009, INT J ONCOL, V34, P201, DOI 10.3892/ijo_00000142; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Kaneko M, 1999, IMMUNOPHARMACOLOGY, V44, P223, DOI 10.1016/S0162-3109(99)00050-8; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Tsuneoka N, 2009, J SURG RES, V151, P22, DOI 10.1016/j.jss.2008.01.003; Jeong JS, 2010, INTEGR CANCER THER, V9, P331, DOI 10.1177/1534735410383170; FIELD JK, 1990, ANTICANCER RES, V10, P1; Nakayama M, 2012, INFLAMMATION, V35, P1294, DOI 10.1007/s10753-012-9441-x; King JC, 2012, BBA-MOL CELL RES, V1823, P593, DOI 10.1016/j.bbamcr.2011.12.008; Suzuki T, 2011, ONCOL REP, V25, P879, DOI 10.3892/or.2011.1134; Sato T, 2012, PANCREAS, V41, P1247, DOI 10.1097/MPA.0b013e31824f356f; Satoh H, 2002, J ALTERN COMPLEM MED, V8, P107, DOI 10.1089/107555302317371370; Kita K, 2011, RADIAT RES, V176, P732, DOI 10.1667/RR2561.1; SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8; Tatsumi K, 2009, J AM GERIATR SOC, V57, P169, DOI 10.1111/j.1532-5415.2009.02034.x; de Caires S, 2010, PHYTOTHER RES, V24, P1265, DOI 10.1002/ptr.3146; Tohda M, 2008, NEUROSCI RES, V62, P1, DOI 10.1016/j.neures.2008.05.007; HARADA M, 1995, IMMUNOPHARM IMMUNOT, V17, P687, DOI 10.3109/08923979509037189; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106	34	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	B				6215	6220		10.3892/mmr.2015.4137		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MR	WOS:000362999300086		
J	Tamura, M; Kawano, M; Sato, M; Nashimoto, M				Tamura, Masato; Kawano, Mitsuoki; Sato, Mari; Nashimoto, Masayuki			Involvement of an intracellular vesicular, transport process in naked-sgRNA-mediated TRUE gene silencing	MOLECULAR MEDICINE REPORTS			English	Article						TRUE gene silencing; small guide RNA; vesicular transport	MESSENGER-RNA; CELLS; MECHANISMS; EXPRESSION; TRNASE; OLIGONUCLEOTIDES; ENDORIBONUCLEASE; INHIBITOR; APOPTOSIS; DIRECTION	tRNase ZL-utilizing efficacious gene silencing (TRUE gene silencing) is an RNA-mediated gene expression control technology with therapeutic potential. Recently, our group demonstrated that a heptamer, mh1 (Bcl-2), targeting human Bc1-2 mRNA, can be taken up by cells without the use of any transfection reagents and can induce the apoptosis of leukemia cells. However, little is known regarding the mechanism of naked small guide (sg)RNA uptake by cultured cells. Therefore, in the present study the effects of various inhibitors on the induction of apoptosis by naked sgRNA treatment were investigated in order to identify the uptake pathway required for sgRNA function in cultured cells. Addition of the endocytosis inhibitors chlorpromazine, nystatin or methyl-P-cyclodextrin together with naked effective sgRNA was unable to diminish the apoptosis-inducing effects of naked sgRNA or the reduction in target mRNA, suggesting that functional uptake of sgRNA by cells is clathrin-, caveolae- and raft-independent. Next, chloroquine, an inhibitor of lysosome acidification, and brefeldin A, an inhibitor that blocks protein transport from the Golgi apparatus to the endoplasmic reticulum were administered. In the presence of these compounds, the apoptosis-inducing effects of naked sgRNA were reduced. These results suggest that a vesicular transport process is involved in sgRNA-mediated TRUE gene silencing. A greater understanding of how naked sgRNAs enter cells and how they reach their target RNAs may aid in the design of more specifically-targeted and potent sgRNA drugs.	[Tamura, Masato; Kawano, Mitsuoki; Sato, Mari] Hokkaido Univ, Grad Sch Dent Med, Dept Biochem & Mol Biol, Sapporo, Hokkaido 0608586, Japan; [Kawano, Mitsuoki; Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Niigata 9568603, Japan	Tamura, M (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Biochem & Mol Biol, North 13,West 7, Sapporo, Hokkaido 0608586, Japan.	mtamura@den.hokudai.ac.jp	TAMURA, MASATO/B-7304-2009	TAMURA, MASATO/0000-0003-3700-5203	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency	This study was supported by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency (to Professor Masayuki Nashimoto).	Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; Sano T, 2011, BIOCHEM BIOPH RES CO, V416, P427, DOI 10.1016/j.bbrc.2011.11.091; Nashimoto M, 1996, RNA, V2, P523; Takahashi M, 2013, CANCER LETT, V328, P362, DOI 10.1016/j.canlet.2012.10.016; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Vickers TA, 2006, J IMMUNOL, V176, P3652; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; Uyama M, 2012, GENES CELLS, V17, P548, DOI 10.1111/j.1365-2443.2012.01611.x; Soifer HS, 2012, J BIOL CHEM, V287, P3777, DOI 10.1074/jbc.M111.261933; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; Watanabe N, 2013, LEUKEMIA RES, V37, P580, DOI 10.1016/j.leukres.2013.01.015; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Sato MM, 2009, GENES CELLS, V14, P141, DOI 10.1111/j.1365-2443.2008.01258.x; TONKINSON JL, 1994, NUCLEIC ACIDS RES, V22, P4268, DOI 10.1093/nar/22.20.4268; Dutta D, 2012, CELL LOGIST, V2, P203, DOI DOI 10.4161/CL.23967; Souleimanian N, 2012, MOL THER-NUCL ACIDS, V1, P1, DOI 10.1038/mtna.2012.35; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2015	12	4	B				6365	6369		10.3892/mmr.2015.4160		5	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CT7MR	WOS:000362999300107		
J	Watanabe, K; Petri, WA				Watanabe, Koji; Petri, William A., Jr.			Molecular biology research to benefit patients with Entamoeba histolytica infection	MOLECULAR MICROBIOLOGY			English	Review							AMEBIC LIVER-ABSCESS; INHIBITABLE ADHERENCE PROTEIN; CYST-LIKE STRUCTURES; IN-VITRO INDUCTION; SERINE-RICH GENE; INTESTINAL AMEBIASIS; INVASIVE AMEBIASIS; PRESCHOOL-CHILDREN; PROTOZOAN PARASITE; MOUSE MODEL	The development of molecular microbiology has made it possible for us to deepen our understanding of the pathogenesis of amebiasis. Research using the trophozoite form of Entamoeba histolytica has clearly shown us the importance of the interface between the parasite and host cells in vitro. Immuno-pathogenesis after excystation was similarly well advanced by the use of a novel murine model of amebic colitis. However, it is still challenging to apply these findings to clinical and epidemiological settings. This is mainly because of the lack of a complete infection animal model of amebiasis by oral-fecal infection. Moreover, in vitro experiments have predominantly been performed using the same axenic cultured strain HM-1: IMSS isolated about 50 years ago, whereas highly diverse strains are prevalent all over the world. Translational research informed by clinical observations has the greatest potential for the development of effective interventions. Here, we highlight discoveries of the experiments designed from cohort observation and discuss remaining problems to be solved.	[Watanabe, Koji; Petri, William A., Jr.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA; [Watanabe, Koji] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan	Watanabe, K (reprint author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.	kw2wq@virginia.edu; wap3g@virginia.edu			NIH [5R01 AI026649-25]; Program on Emerging and Re-emerging Infectious Diseases for Medical Research and Development, AMED	Research in the authors' laboratory was supported by NIH grant 5R01 AI026649-25. This article is supported by the Program on Emerging and Re-emerging Infectious Diseases for Medical Research and Development, AMED.	Abd Alla Mohamed D, 2007, Infect Immun, V75, P3812, DOI 10.1128/IAI.00341-07; Aguilar-Diaz H, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000607; Haque R, 2001, J INFECT DIS, V183, P1787, DOI 10.1086/320740; Thibeaux R, 2012, CELL MICROBIOL, V14, P609, DOI 10.1111/j.1462-5822.2012.01752.x; Blessmann J, 2002, AM J TROP MED HYG, V66, P578; Lejeune M, 2011, AM J PATHOL, V179, P807, DOI 10.1016/j.ajpath.2011.05.001; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; GATHIRAM V, 1987, S AFR MED J, V72, P669; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Seguin R, 1997, INFECT IMMUN, V65, P2522; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Marie CS, 2012, INFECT IMMUN, V80, P1934, DOI 10.1128/IAI.06140-11; Lotter H, 2006, INFECT IMMUN, V74, P118, DOI 10.1128/IAI.74.1.118-124.2006; Kumagai M, 1998, EXP PARASITOL, V90, P294, DOI 10.1006/expr.1998.4341; Hamano S, 2006, J IMMUNOL, V177, P1208; Park WB, 2007, EMERG INFECT DIS, V13, P516; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; SIRIJINTAKARN P, 1980, ARCH INVEST MED, V11, P3; Acuna-Soto R, 2000, AM J GASTROENTEROL, V95, P1277, DOI 10.1016/S0002-9270(99)00584-5; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; James R, 2010, AM J TROP MED HYG, V83, P914, DOI 10.4269/ajtmh.2010.10-0231; Houpt E, 2004, VACCINE, V22, P611, DOI 10.1016/j.vaccine.2003.09.003; IRUSEN EM, 1992, CLIN INFECT DIS, V14, P889; Moncada D, 2000, ARCH MED RES, V31, pS224, DOI 10.1016/S0188-4409(00)00227-7; Tsutsumi V, 2006, ARCH MED RES, V37, P210, DOI 10.1016/j.arcmed.2005.09.011; BRAGA LL, 1992, J CLIN INVEST, V90, P1131, DOI 10.1172/JCI115931; Huston CD, 2003, INFECT IMMUN, V71, P964, DOI 10.1128/IAI.71.2.964-972.2003; AVRON B, 1986, J PROTOZOOL, V33, P522, DOI 10.1111/j.1550-7408.1986.tb05655.x; Watanabe K, 2014, J INFECT DIS, V209, P1801, DOI 10.1093/infdis/jit815; Haque R, 2003, AM J TROP MED HYG, V69, P398; Seydel KB, 1997, INFECT IMMUN, V65, P1631; KELSALL BL, 1994, AM J TROP MED HYG, V51, P454; Hellberg A, 2002, PROTEIN EXPRES PURIF, V24, P131, DOI 10.1006/prep.2001.1548; Eichinger D, 1997, BIOESSAYS, V19, P633, DOI 10.1002/bies.950190714; Ayeh-Kumi PF, 2001, EXP PARASITOL, V99, P80, DOI 10.1006/expr.2001.4652; BRACHA R, 1982, INFECT IMMUN, V36, P396; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Korpe PS, 2013, CLIN INFECT DIS, V56, P988, DOI 10.1093/cid/cis1044; Mondal D, 2009, AM J TROP MED HYG, V80, P824; TSAI SH, 1973, AM J TROP MED HYG, V22, P24; Ivory CPA, 2007, INFECT IMMUN, V75, P4917, DOI 10.1128/IAI.00725-07; Abd Alla MD, 2012, VACCINE, V30, P3068, DOI 10.1016/j.vaccine.2012.02.066; Samie A, 2008, EXP PARASITOL, V118, P354, DOI 10.1016/j.exppara.2007.09.008; Simonishvili S, 2005, EXP PARASITOL, V110, P313, DOI 10.1016/j.exppara.2005.02.015; Ehrenkaufer GM, 2009, CELL MICROBIOL, V11, P898, DOI 10.1111/j.1462-5822.2009.01300.x; Ali IKM, 2007, J CLIN MICROBIOL, V45, P285, DOI 10.1128/JCM.01335-06; PETRI WA, 1991, INFECT IMMUN, V59, P97; Rojas-Lopez AE, 2012, IMMUNOBIOLOGY, V217, P795, DOI 10.1016/j.imbio.2012.04.005; Ehrenkaufer GM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r77; Barroso L, 2014, VACCINE, V32, P1218, DOI 10.1016/j.vaccine.2013.06.056; Snow M, 2008, AM J TROP MED HYG, V78, P922; Nagata N, 2012, ENDOSCOPY, V44, P425, DOI 10.1055/s-0031-1291631; Padilla-Vaca F, 1999, INFECT IMMUN, V67, P2096; CRANE PS, 1972, AM J SURG, V123, P332, DOI 10.1016/0002-9610(72)90296-6; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Moncada DM, 2006, GASTROENTEROLOGY, V130, P721, DOI 10.1053/j.gastro.2005.11.012; Houpt ER, 2002, J IMMUNOL, V169, P4496; Eichinger D, 2001, J EUKARYOT MICROBIOL, V48, P17, DOI 10.1111/j.1550-7408.2001.tb00411.x; Mackey-Lawrence NM, 2013, INFECT IMMUN, V81, P1460, DOI 10.1128/IAI.01383-12; Morf L, 2013, NUCLEIC ACIDS RES, V41, P9424, DOI 10.1093/nar/gkt717; Guo X, 2008, MUCOSAL IMMUNOL, V1, P139, DOI 10.1038/mi.2007.18; Haque R, 2010, J CLIN MICROBIOL, V48, P2798, DOI 10.1128/JCM.00152-10; Dey I, 2008, INFECT IMMUN, V76, P5158, DOI 10.1128/IAI.00645-08; Mondal D, 2006, T ROY SOC TROP MED H, V100, P1032, DOI 10.1016/j.trstmh.2005.12.012; Duggal P, 2011, J CLIN INVEST, V121, P1191, DOI 10.1172/JCI45294; ACETI A, 1991, J INFECT DIS, V164, P613; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Barron-Gonzalez MP, 2008, EXP PARASITOL, V118, P600, DOI 10.1016/j.exppara.2007.11.002; Ralston KS, 2014, NATURE, V508, P526, DOI 10.1038/nature13242; Dey I, 2003, P NATL ACAD SCI USA, V100, P13561, DOI 10.1073/pnas.1835863100; Blessmann J, 2003, J CLIN MICROBIOL, V41, P4745, DOI 10.1128/JCM.41.10.4745-4750.2003; Debnath A, 2007, INT J PARASITOL, V37, P897, DOI 10.1016/j.ijpara.2007.01.016; Huston CD, 2000, CELL MICROBIOL, V2, P617, DOI 10.1046/j.1462-5822.2000.00085.x; Kissoon-Singh V, 2013, AM J PATHOL, V182, P852, DOI 10.1016/j.ajpath.2012.11.035; CHADEE K, 1991, GASTROENTEROLOGY, V100, P986; Okamoto M, 2005, AM J TROP MED HYG, V73, P934; SCHAIN DC, 1992, INFECT IMMUN, V60, P2143; Moncada D, 2003, INFECT IMMUN, V71, P838, DOI 10.1128/IAI.71.2.838-844.2003; Haghighi A, 2003, J CLIN MICROBIOL, V41, P3748, DOI 10.1128/JCM.41.8.3748-3756.2003; Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Braun M, 1906, ANIMAL PARASITES MAN; Burgess SL, 2014, MBIO, V5, DOI 10.1128/mBio.01817-14; Cervantes-Rebolledo C, 2009, PARASITE IMMUNOL, V31, P447, DOI 10.1111/j.1365-3024.2009.01120.x; De Cadiz AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074840; delsMuro R., 1990, J INFECT DIS, V162, P1360; Ellenberg Max, 1946, AMER JOUR DIGEST DIS, V13, P356; Galvan-Moroyoqui JM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000266; Gilchrist CA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-151; Girard-Misguich F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028795; Helk E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003096; Hung CC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000175; Kumari V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-432; Lotter H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055694; Lotter H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000434; Manna D, 2014, INT J PARASITOL, V44, P837, DOI 10.1016/j.ijpara.2014.06.008; Nagata Naoyoshi, 2012, Emerg Infect Dis, V18, P717, DOI 10.3201/eid1805.111275; Naylor C, 2014, MBIO, V5, DOI 10.1128/mBio.02046-14; Quach J, 2014, HUM VACC IMMUNOTHER, V10, P1514, DOI 10.4161/hv.27796; Thibeaux R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6142; Thibeaux R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003824; VAZQUEZDELARACISNEROS LG, 1984, J PARASITOL, V70, P629, DOI 10.2307/3281741; Verma AK, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-183; Watanabe K, 2014, AM J TROP MED HYG, V91, P816, DOI 10.4269/ajtmh.14-0278	104	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	OCT	2015	98	2					208	217		10.1111/mmi.13131		10	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CT3SB	WOS:000362726100002		
J	Kolundzic, N; Cujic, D; Abu Rabi, T; Bojic-Trbojevic, Z; Kadoya, T; Vicovac, L				Kolundzic, Nikola; Cujic, Danica; Abu Rabi, Tamara; Bojic-Trbojevic, Zanka; Kadoya, Toshihiko; Vicovac, Ljiljana			Galectin Signature of the Choriocarcinoma JAr Cells: Galectin-1 as a Modulator of Invasiveness In Vitro	MOLECULAR REPRODUCTION AND DEVELOPMENT			English	Article							MATERNAL-FETAL INTERFACE; TROPHOBLAST TUMOR-CELLS; HUMAN PLACENTA; EXTRAVILLOUS TROPHOBLAST; DIFFERENTIAL EXPRESSION; FETOMATERNAL INTERFACE; CARCINOMA-CELLS; CANCER-CELLS; LINES; FIBRONECTIN	Our previous findings showed that galectin-1 (LGALS1) plays an important role in the in vitro invasion of normal human trophoblast cells. In the present study, choriocarcinoma JAr cells were found to express LGALS1, -2, -3, -8, -10, and -13 mRNA and at least LGALS1, -3, and -8 protein, as determined by reverse-transcriptase PCR and Western blot, respectively. The galectin mRNA signature of JAr cells thus differed from that of normal first-trimester extravillous trophoblasts. A Matrigel migration assay was also used to investigate and confirm the relevance and effect of LGALS1 on the invasive potential of JAr cells, as observed in other trophoblast models. This modulation in behavior was achieved by specific lectin-glycan binding. (C) 2015 Wiley Periodicals, Inc.	[Kolundzic, Nikola; Cujic, Danica; Abu Rabi, Tamara; Bojic-Trbojevic, Zanka; Vicovac, Ljiljana] Univ Belgrade, Reprod Biol Lab, Inst INEP, Belgrade, Serbia; [Kadoya, Toshihiko] Maebashi Inst Technol, Dept Biotechnol, Maebashi, Gumma, Japan	Vicovac, L (reprint author), Inst INEP, Banatska 31b, Belgrade 11080, Serbia.	vicovac@inep.co.rs			Ministry of Education, Science and Technological Development of the Republic of Serbia [173004]	Grant sponsor: Ministry of Education, Science and Technological Development of the Republic of Serbia; Grant number: 173004	Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Ellerhorst J, 1999, INT J ONCOL, V14, P217; OZEKI Y, 1995, GLYCOBIOLOGY, V5, P255, DOI 10.1093/glycob/5.2.255; van den Brule F, 2003, LAB INVEST, V83, P377, DOI 10.1097/01.LAB.0000059949.01480.40; Barrientos G, 2014, HUM REPROD UPDATE, V20, P175, DOI 10.1093/humupd/dmt040; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Kolundzic N, 2011, PLACENTA, V32, P909, DOI 10.1016/j.placenta.2011.07.087; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Than NG, 2009, P NATL ACAD SCI USA, V106, P9731, DOI 10.1073/pnas.0903568106; Boscher C, 2013, MOL BIOL CELL, V24, P2134, DOI 10.1091/mbc.E13-02-0095; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Moiseeva EP, 2003, BIOCHEM BIOPH RES CO, V310, P1010, DOI 10.1016/j.bbrc.2003.09.112; Bozic M, 2004, PLACENTA, V25, P797, DOI 10.1016/j.placenta.2004.03.006; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; HOCHBERG A, 1992, CANCER RES, V52, P3713; Morrish DW, 1998, J REPROD IMMUNOL, V39, P179, DOI 10.1016/S0165-0378(98)00021-7; Lee SY, 2014, ARCH PATHOL LAB MED, V138, P643, DOI 10.5858/arpa.2012-0227-OA; Moiseeva EP, 1999, J VASC RES, V36, P47, DOI 10.1159/000025625; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lahm H, 2001, J CANCER RES CLIN, V127, P375, DOI 10.1007/s004320000207; Blidner AG, 2013, AM J REPROD IMMUNOL, V69, P369, DOI 10.1111/aji.12090; Wiest I, 2005, ANTICANCER RES, V25, P1575; Unverdorben L, 2015, PLACENTA, V36, P191, DOI 10.1016/j.placenta.2014.11.019; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Lee BPL, 2001, INT J CANCER, V94, P674; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Vicovac L, 1996, ACTA ANAT, V156, P202; Burleigh DW, 2007, PLACENTA, V28, P383, DOI 10.1016/j.placenta.2006.05.001; Andre S, 1999, J CANCER RES CLIN, V125, P461, DOI 10.1007/s004320050303; Jeschke U, 2006, HISTOCHEM CELL BIOL, V126, P437, DOI 10.1007/s00418-006-0178-1; Kobayashi Y, 2011, AM J PATHOL, V179, P1471, DOI 10.1016/j.ajpath.2011.05.019; Blois SM, 2014, J REPROD IMMUNOL, V101, P127, DOI 10.1016/j.jri.2013.05.005; Bojic-Trbojevic Z, 2014, HISTOCHEM CELL BIOL, V142, P541, DOI 10.1007/s00418-014-1229-7; Bojic-Trbojevic Z, 2005, ARCH ONCOL, V13, P7, DOI 10.2298/AOO0501007B; Hutter S, 2015, PLACENTA, V36, P438, DOI 10.1016/j.placenta.2015.01.198; Jeschke U, 2013, PLACENTA, V34, P863, DOI 10.1016/j.placenta.2013.07.005; Kolundzic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028514; Bidon-Wagner Nathalie, 2004, Glycoconjugate Journal, V19, P557; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V8, P5; Than NG, 2004, EUR J BIOCHEM, V6; Than NG, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00348; Visegrady B, 2001, PROTEIN ENG, V14, P87580	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1040-452X	1098-2795		MOL REPROD DEV	Mol. Reprod. Dev.	OCT	2015	82	10					765	773		10.1002/mrd.22515		9	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	CT7GG	WOS:000362982100006		
J	Bernardo, AD; Heeren, AM; van Iperen, L; Fernandes, MG; He, NN; Anjie, S; Noce, T; Ramos, ES; Lopes, SMCD				Bernardo, Ana de Melo; Heeren, A. Marijne; van Iperen, Liesbeth; Fernandes, Maria Gomes; He, Nannan; Anjie, Stafford; Noce, Toshiaki; Ramos, Ester Silveira; Lopes, Susana M. Chuva de Sousa			Meiotic Wave Adds Extra Asymmetry to the Development of Female Chicken Gonads	MOLECULAR REPRODUCTION AND DEVELOPMENT			English	Article							PRIMORDIAL GERM-CELLS; DOUBLE-STRAND BREAKS; SEXUAL-DIFFERENTIATION; EXPRESSION PATTERN; RETINOIC ACID; MOUSE GONADS; RIGHT OVARY; EMBRYOS; MEIOSIS; MIGRATION	Development of female gonads in the chicken is asymmetric. This asymmetry affects gene expression, morphology, and germ cell development; consequently only the left ovary develops into a functional organ, whereas the right ovary remains vestigial. In males, on the other hand, both gonads develop into functional testes. Here, we revisited the development of asymmetric traits in female (and male) chicken gonads between Hamburger Hamilton stage 16 (HH16) and hatching. At HH16, primordial germ cells migrated preferentially to the left gonad, accumulating in the left coelomic hinge between the gut mesentery and developing gonad in both males and females. Using the meiotic markers SYCP3 and phosphorylated H2AFX, we identified a previously undescribed, pronounced asymmetryc meiotic progression in the germ cells located in the central, lateral, and extreme cortical regions of the left female gonad from HH38 until hatching. Moreover, we observed that-in contrast to the current view-medullary germ cells are not apoptotic, but remain arrested in pre-leptotene until hatching. In addition to the systematic analysis of the asymmetric distribution of germ cells in female chicken gonads, we propose an updated model suggesting that the localization of germ cells-in the left or right gonad; in the cortex or medulla of the left gonad; and in the central part or the extremities of the left cortex-has direct consequences for their development and participation in adult reproduction. (C) 2015 The Authors. Molecular Reproduction and Development Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.	[Bernardo, Ana de Melo; Heeren, A. Marijne; van Iperen, Liesbeth; Fernandes, Maria Gomes; He, Nannan; Anjie, Stafford; Lopes, Susana M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2333 ZC Leiden, Netherlands; [Noce, Toshiaki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Ramos, Ester Silveira] Univ Sao Paulo, Dept Genet, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Lopes, Susana M. Chuva de Sousa] Ghent Univ Hosp, Dept Reprod Med, Ghent, Belgium	Lopes, SMCD (reprint author), Leiden Univ, Med Ctr, Dept Anat & Embryol, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	lopes@lumc.nl		Heeren, Marijne/0000-0002-4158-6058; de Melo Bernardo, Ana/0000-0002-7918-5911	Fundacao Ciencia e Tecnologia, Portugal FCT [SFRH/BD/94387/2013, SFRH/BD/78689/2011]; Netherlands organization of Scientific Research, Netherlands [NWO ASPASIA 015.007.037]; Interuniversity Attraction Poles-Phase VII, Belgium [IUAP/PAI P7/14]	Grant sponsor: Fundacao Ciencia e Tecnologia, Portugal FCT; Grant numbers: SFRH/BD/94387/2013, SFRH/BD/78689/2011; Grant sponsor: Netherlands organization of Scientific Research, Netherlands; Grant number: NWO ASPASIA 015.007.037; Grant sponsor: Interuniversity Attraction Poles-Phase VII, Belgium; Grant number: IUAP/PAI P7/14	Gonzalez-Moran MG, 2011, ANAT REC, V294, P893, DOI 10.1002/ar.21364; Ukeshima A, 1996, ZOOL SCI, V13, P559, DOI 10.2108/zsj.13.559; Naito M, 2009, J POULT SCI, V46, P40, DOI 10.2141/jpsa.46.40; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; UKESHIMA A, 1991, ANAT REC, V230, P378, DOI 10.1002/ar.1092300311; Guo MW, 1997, AM J REPROD IMMUNOL, V37, P391; Zheng YH, 2009, REPRODUCTION, V138, P483, DOI 10.1530/REP-09-0163; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836; HUGHES GC, 1963, J EMBRYOL EXP MORPH, V11, P513; Stone JE, 2008, GENETICS, V178, P1221, DOI 10.1534/genetics.107.085415; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; ZACCANTI F, 1990, DIFFERENTIATION, V43, P71, DOI 10.1111/j.1432-0436.1990.tb00432.x; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; CARLON N, 1985, ARCH ANAT MICROSC MO, V74, P52; Mor G, 2002, BIOCHEM PHARMACOL, V64, P1305, DOI 10.1016/S0006-2952(02)01267-4; del Priore L, 2012, CYTOGENET GENOME RES, V137, P15, DOI 10.1159/000339133; Caetano LC, 2014, GENET MOL RES, V13, P838, DOI 10.4238/2014.February.13.2; Kuerban M, 2012, J ANDROL, V33, P824, DOI 10.2164/jandrol.111.015529; Hunter N, 2001, NAT GENET, V27, P236, DOI 10.1038/85781; Rodriguez-Leon J, 2008, P NATL ACAD SCI USA, V105, P11242, DOI 10.1073/pnas.0804904105; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Hoshino A, 2005, DEV GROWTH DIFFER, V47, P65, DOI 10.1111/j.1440-169x.2004.00783.x; Lavial F, 2009, DEV BIOL, V330, P73, DOI 10.1016/j.ydbio.2009.03.012; Yu ML, 2013, AMINO ACIDS, V44, P405, DOI 10.1007/s00726-012-1343-6; MITTWOCH U, 1980, J REPROD FERTIL, V58, P463; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Nakamura Y, 2007, POULTRY SCI, V86, P2182; Bernardo AD, 2012, BIOL OPEN, V1, P1146, DOI 10.1242/bio.20122592; Guioli S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002560; Guioli S, 2014, SEX DEV; Intarapat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069893; Locher H, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-20; Schoenmakers S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000466; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-85; VANLIMBO.J, 1968, ARCH ANAT MICROSC MO, V57, P79	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1040-452X	1098-2795		MOL REPROD DEV	Mol. Reprod. Dev.	OCT	2015	82	10					774	786		10.1002/mrd.22516		13	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	CT7GG	WOS:000362982100007		
J	Wan, CL; Kodama, Y; Kondo, M; Sasai, R; Qian, X; Gu, XK; Koga, K; Yabuki, K; Yang, RG; Koumoto, K				Wan, Chunlei; Kodama, Yumi; Kondo, Mami; Sasai, Ryo; Qian, Xin; Gu, Xiaokun; Koga, Kenji; Yabuki, Kazuhisa; Yang, Ronggui; Koumoto, Kunihito			Dielectric Mismatch Mediates Carrier Mobility in Organic-Intercalated Layered TiS2	NANO LETTERS			English	Article						Titanium disulfide; transition-metal dichalcogenide; thermoelectrics; hybrid materials; dielectric mismatch	ULTRALOW THERMAL-CONDUCTIVITY; HALL-MOBILITY; SCATTERING; COMPLEXES; CONSTANT; SULFIDES; GRAPHENE; SRTIO3; FILMS; MOS2	The dielectric constant is a key parameter that determines both optical and electronic properties of materials. It is desirable to tune electronic properties though dielectric engineering approach. Here, we present a systematic approach to tune carrier mobilities of hybrid inorganic/organic materials where layered two-dimensional transition-metal dichalcogenide TiS2 is electrochemically intercalated with polar organic molecules. By manipulating the dielectric mismatch using polar organic molecules with different dielectric constants, ranging from 10 to 41, the electron mobility of the TiS2 layers was changed three times due to the dielectric screening of the Coulombimpurity scattering processes. Both the overall thermal conductivity and the lattice thermal conductivity were also found to decrease with an increasing dielectric mismatch. The enhanced electrical mobility along with the decreased thermal conductivity together gave rise to a significantly improved thermoelectric figure of merit of the hybrid inorganic/organic materials at room temperature, which might find applications in wearable electronics.	[Wan, Chunlei] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China; [Wan, Chunlei; Kodama, Yumi; Kondo, Mami; Koumoto, Kunihito] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Sasai, Ryo] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908304, Japan; [Qian, Xin; Gu, Xiaokun; Yang, Ronggui] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Koga, Kenji; Yabuki, Kazuhisa] KOBELCO Res Inst, Kobe, Hyogo 6512271, Japan	Wan, CL (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.	wancl@mail.tsinghua.edu.cn; ronggui.yang@colorado.edu; koumoto@toyotariken.jp	Yang, Ronggui/H-1278-2011; Gu, Xiaokun/H-4069-2011	Gu, Xiaokun/0000-0003-3803-3951	Takahashi Industrial and Economic Foundation; Thermal and Electrical Energy Technology Foundation Research Grant; JSPS KAKENHI grant [26820295]; 1000 Plan Program for Young Talents of China; JSPS [25289226]; TherMat; NSF [1512776]; National Science Foundation [CNS-0821794]; University of Colorado Boulder; University of Colorado Denver; National Center for Atmospheric Research	C.W. acknowledges financial support from Takahashi Industrial and Economic Foundation, Thermal and Electrical Energy Technology Foundation Research Grant, and JSPS KAKENHI grant no. 26820295 and 1000 Plan Program for Young Talents of China. K. Koumoto acknowledges financial support from JSPS KAKENHI grant no. 25289226 and TherMat. R.Y. acknowledges the partial support for this work from the NSF award no. 1512776. This work utilized the Janus supercomputer, which was supported by the National Science Foundation (award no. CNS-0821794), the University of Colorado Boulder, the University of Colorado Denver, and the National Center for Atmospheric Research. The Janus supercomputer is operated by the University of Colorado Boulder.	Shah AV, 2004, PROG PHOTOVOLTAICS, V12, P113, DOI 10.1002/pip.533; Tripathi MN, 2010, PHYSICA B, V405, P4818, DOI 10.1016/j.physb.2010.09.011; GAMBLE FR, 1971, SCIENCE, V174, P493, DOI 10.1126/science.174.4008.493; Barbier T, 2015, DALTON T, V44, P7887, DOI 10.1039/c5dt00551e; Beaumale M, 2014, ACTA MATER, V78, P86, DOI 10.1016/j.actamat.2014.06.032; Ma N, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011043; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; WHITTINGHAM MS, 1978, PROG SOLID STATE CH, V12, P41, DOI 10.1016/0079-6786(78)90003-1; Liu J, 2013, NANO LETT, V13, P5594, DOI 10.1021/nl403244s; Sengwa RJ, 2000, POLYM INT, V49, P599, DOI 10.1002/1097-0126(200006)49:6<599::AID-PI425>3.0.CO;2-K; Wan CL, 2011, J ELECTRON MATER, V40, P1271, DOI 10.1007/s11664-011-1565-5; Losego MD, 2013, NANO LETT, V13, P2215, DOI 10.1021/nl4007326; Guilmeau E, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3621834; Balendhran S, 2013, ADV MATER, V25, P109, DOI 10.1002/adma.201203346; Chen F, 2009, NANO LETT, V9, P2571, DOI 10.1021/nl900725u; Ishiwata S, 2013, NAT MATER, V12, P512, DOI [10.1038/nmat3621, 10.1038/NMAT3621]; Siemons W, 2012, ADV MATER, V24, P3965, DOI 10.1002/adma.201104665; Yoon J, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3115769; LERF A, 1977, INORG CHEM, V16, P2950, DOI 10.1021/ic50177a057; Radisavljevic B, 2013, NAT MATER, V12, P815, DOI [10.1038/nmat3687, 10.1038/NMAT3687]; Wu YG, 2003, J ELECTROCERAM, V11, P227, DOI 10.1023/B:JECR.0000026377.48598.4d; Kong LB, 2010, PROG MATER SCI, V55, P840, DOI 10.1016/j.pmatsci.2010.04.004; OLIVEIRA LE, 1988, PHYS STATUS SOLIDI B, V147, P223, DOI 10.1002/pssb.2221470125; FREDERIK.HP, 1967, PHYS REV, V161, P822, DOI 10.1103/PhysRev.161.822; Jena D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.136805; WEMPLE SH, 1965, PHYS REV, V137, P1575; CHRISTEN HM, 1994, PHYS REV B, V49, P12095, DOI 10.1103/PhysRevB.49.12095; Beaumale M, 2014, J APPL PHYS, V115, DOI 10.1063/1.4863141; Cox P. A., 2005, ELECT STRUCTURE CHEM; Gurusinghe MN, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045316; Imai H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.241104; Kittel C., 2005, INTRO SOLID STATE PH; Konar A, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821265; Newaz AKM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1740; Schollho R., 1974, MAT RES B, V9, P1237; SCHOLLHO.R, 1974, J LESS-COMMON MET, V36, P229, DOI 10.1016/0022-5088(74)90106-4	36	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6302	6308		10.1021/acs.nanolett.5b01013		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100004		
J	Yan, AM; Velasco, J; Kahn, S; Watanabe, K; Taniguchi, T; Wang, F; Crommie, MF; Zettl, A				Yan, Aiming; Velasco, Jairo; Kahn, Salman; Watanabe, Kenji; Taniguchi, Takashi; Wang, Feng; Crommie, Michael F.; Zettl, Alex			Direct Growth of Single- and Few-Layer MoS2 on h-BN with Preferred Relative Rotation Angles	NANO LETTERS			English	Article						Molybdenum disulfide; chemical vapor deposition; heterostructure; hexagonal boron nitride; screw-dislocation driven growth; transition metal dichalcogenides	CHEMICAL-VAPOR-DEPOSITION; HEXAGONAL BORON-NITRIDE; DISLOCATION-DRIVEN GROWTH; TRANSITION-METAL DICHALCOGENIDES; SCANNING-TUNNELING-MICROSCOPY; 2-DIMENSIONAL ATOMIC CRYSTALS; DER-WAALS HETEROSTRUCTURES; ELECTRONIC-PROPERTIES; MOLYBDENUM-DISULFIDE; EPITAXIAL-GROWTH	Monolayer molybdenum disulfide (MoS2) is a promising two-dimensional direct-bandgap semiconductor with potential applications in atomically thin and flexible electronics. An attractive insulating substrate or mate for MoS2 (and related materials such as graphene) is hexagonal boron nitride (h-BN). Stacked heterostructures of MoS2 and h-BN have been produced by manual transfer methods, but a more efficient and scalable assembly method is needed. Here we demonstrate the direct growth of single- and few-layer MoS2 on h-BN by chemical vapor deposition (CVD) method, which is scalable with suitably structured substrates. The growth mechanisms for single-layer and few-layer samples are found to be distinct, and for single-layer samples low relative rotation angles (<5 degrees) between the MoS2 and h-BN lattices prevail. Moreover, MoS2 directly grown on h-BN maintains its intrinsic 1.89 eV bandgap. Our CVD synthesis method presents an important advancement toward controllable and scalable MoS2-based electronic devices.	[Yan, Aiming; Velasco, Jairo; Kahn, Salman; Wang, Feng; Crommie, Michael F.; Zettl, Alex] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Yan, Aiming; Wang, Feng; Crommie, Michael F.; Zettl, Alex] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Yan, Aiming; Velasco, Jairo; Wang, Feng; Crommie, Michael F.; Zettl, Alex] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Yan, Aiming; Velasco, Jairo; Wang, Feng; Crommie, Michael F.; Zettl, Alex] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Zettl, A (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	azettl@berkeley.edu			Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy [DE-AC02-05CH11231]; NSF [DMR-1206512]; Molecular Foundry of the Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	This research was supported in part by the Director, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy under Contract DE-AC02-05CH11231 within the sp2-bonded Materials Program, which provided for postdoctoral support and AFM and PL characterization; by NSF Grant DMR-1206512, which provided for the sample growth, and by the Molecular Foundry of the Lawrence Berkeley National Laboratory, under Contract DE-AC02-05CH11231, which provided for TEM characterization. We acknowledge Karen Bustillo in the Molecular Foundry of the Lawrence Berkeley National Laboratory for TEM technical support and Dr. Wei Chen in the Electrochemical Technologies Group of the Lawrence Berkeley National Laboratory for useful discussion. Illuminating discussions with Ashley Gibb are also acknowledged.	Alem N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.126102; Najmaei S, 2013, NAT MATER, V12, P754, DOI [10.1038/nmat3673, 10.1038/NMAT3673]; Ling X, 2014, NANO LETT, V14, P464, DOI 10.1021/nl4033704; Zhang LM, 2014, NANO LETT, V14, P6418, DOI 10.1021/nl502961e; Xu XD, 2014, NAT PHYS, V10, P343, DOI 10.1038/NPHYS2942; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Chen L, 2014, ACS NANO, V8, P11543, DOI [10.1021/nn504775f, 10.1021/nn504775t]; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; KOMA A, 1992, THIN SOLID FILMS, V216, P72, DOI 10.1016/0040-6090(92)90872-9; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; Kretinin AV, 2014, NANO LETT, V14, P3270, DOI 10.1021/nl5006542; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Zhu J, 2008, NAT NANOTECHNOL, V3, P477, DOI 10.1038/nnano.2008.179; Gibb AL, 2013, J AM CHEM SOC, V135, P6758, DOI 10.1021/ja400637n; Kim K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.246103; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Meng F, 2013, ACCOUNTS CHEM RES, V46, P1616, DOI 10.1021/ar400003q; Morin SA, 2011, NANO LETT, V11, P4449, DOI 10.1021/nl202689m; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/nmat4091, 10.1038/NMAT4091]; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/nmat3633, 10.1038/NMAT3633]; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Yang W, 2013, NAT MATER, V12, P792, DOI [10.1038/nmat3695, 10.1038/NMAT3695]; Morin SA, 2010, NANO LETT, V10, P3459, DOI 10.1021/nl1015409; Azizi A, 2015, ACS NANO, V9, P4882, DOI 10.1021/acsnano.5b01677; Wang SS, 2015, ACS NANO, V9, P5246, DOI 10.1021/acsnano.5b00655; Decker R, 2011, NANO LETT, V11, P2291, DOI 10.1021/nl2005115; Lee GH, 2013, ACS NANO, V7, P7931, DOI 10.1021/nn402954e; Cui X, 2015, NAT NANOTECHNOL, V10, P534, DOI [10.1038/nnano.2015.70, 10.1038/NNANO.2015.70]; Ji QQ, 2015, NANO LETT, V15, P198, DOI [10.1021/nl503373x, 10.1021/n150337321]; Liu Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6246; Lu N, 2014, NANOSCALE, V6, P2879, DOI 10.1039/c3nr06072a; Markov I. V., 2003, CRYSTAL GROWTH BEGIN; Zhuang A., 2014, ANGEW CHEM, V126, P6543	38	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6324	6331		10.1021/acs.nanolett.5b01311		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100007		
J	Wang, P; Cheng, B; Martynov, O; Miao, TF; Jing, L; Taniguchi, T; Watanabe, K; Aji, V; Lau, CN; Bockrath, M				Wang, Peng; Cheng, Bin; Martynov, Oleg; Miao, Tengfei; Jing, Lei; Taniguchi, Takashi; Watanabe, Kenji; Aji, Vivek; Lau, Chun Ning; Bockrath, Marc			Topological Winding Number Change and Broken Inversion Symmetry in a Hofstadter's Butterfly	NANO LETTERS			English	Article						Hofstadter butterfly; topological; quantum Hall effect; graphene; moire superlattice; boron nitride	HEXAGONAL BORON-NITRIDE; GRAPHENE SUPERLATTICES; DIRAC FERMIONS; MAGNETORESISTANCE OSCILLATIONS; SUBBAND STRUCTURE; BLOCH ELECTRONS; SPECTRUM; PHASE	Graphene's quantum Hall features are associated with a pi Berry's phase due to its odd topological pseudospin winding number. In nearly aligned graphenehexagonal BN heterostructures, the lattice and orientation mismatch produce a superlattice potential, yielding secondary Dirac points in graphene's electronic spectrum, and under a magnetic field, a Hofstadter butterfly-like energy spectrum. Here we report an additional pi Berry's phase shift when tuning the Fermi level past the secondary Dirac points, originating from a change in topological winding number from odd to even when the Fermi-surface electron orbit begins to enclose the secondary Dirac points. At large hole doping inversion symmetry breaking generates a distinct hexagonal pattern in the longitudinal resistivity versus magnetic field and charge density. Major Hofstadter butterfly features persist up to similar to 100 K, demonstrating the robustness of the fractal energy spectrum in these systems.	[Wang, Peng; Cheng, Bin; Martynov, Oleg; Miao, Tengfei; Jing, Lei; Aji, Vivek; Lau, Chun Ning; Bockrath, Marc] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan	Bockrath, M (reprint author), Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA.	marc.bockrath@ucr.edu			DOE [ER 46940-DE-SC0010597]; Defense Microelectronics Activity (DMEA) [H94003-10-2-1003]	We thank Leonid Levitov for helpful discussions. P.W., B.C., and O.M. were supported by DOE ER 46940-DE-SC0010597. Additional support for this work for device fabrication was from NSF-DMR-1106358, ONR/DMEA-H94003-10-2-1003, and the UCR CONSEPT Center. This material is based on research sponsored by the Defense Microelectronics Activity (DMEA) under agreement number H94003-10-2-1003. The United States Government is authorized to reproduce and distribute reprints for Government purposes, notwithstanding any copyright notation thereon.	Albrecht C, 1998, PHYSICA B, V249, P914, DOI 10.1016/S0921-4526(98)00344-5; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Yankowitz M, 2012, NAT PHYS, V8, P382, DOI [10.1038/nphys2272, 10.1038/NPHYS2272]; Kindermann M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115415; Mayorov AS, 2011, SCIENCE, V333, P860, DOI 10.1126/science.1208683; Taychatanapat T, 2013, NAT PHYS, V9, P225, DOI [10.1038/nphys2549, 10.1038/NPHYS2549]; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/nphys2954, 10.1038/NPHYS2954]; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; WANNIER GH, 1978, PHYS STATUS SOLIDI B, V88, P757, DOI 10.1002/pssb.2220880243; Geisler MC, 2004, PHYSICA E, V25, P227, DOI 10.1016/j.physe.2004.06.021; CHANG MC, 1995, PHYS REV LETT, V75, P1348, DOI 10.1103/PhysRevLett.75.1348; Yu GL, 2014, NAT PHYS, V10, P525, DOI [10.1038/nphys2979, 10.1038/NPHYS2979]; CLARO FH, 1979, PHYS REV B, V19, P6068, DOI 10.1103/PhysRevB.19.6068; Guinea F, 2010, PHILOS T R SOC A, V368, P5391, DOI 10.1098/rsta.2010.0214; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; MACDONALD AH, 1983, PHYS REV B, V28, P6713, DOI 10.1103/PhysRevB.28.6713; Park CH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.126804; Nakamura Y, 1998, PHYSICA E, V2, P944, DOI 10.1016/S1386-9477(98)00193-3; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Wallbank JR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245408; GERHARDTS RR, 1991, PHYS REV B, V43, P5192, DOI 10.1103/PhysRevB.43.5192; Tsoi VS, 1999, REV MOD PHYS, V71, P1641, DOI 10.1103/RevModPhys.71.1641; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; WEISS D, 1990, SURF SCI, V229, P88, DOI 10.1016/0039-6028(90)90841-U; Chen X., 2013, PHYS REV B, V89; de Gail R, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045407; Luk'yanchuk IA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166402; Pippard A. B., 1969, PHYSICS SOLIDS INTEN, P370; Schlosser T, 1996, SEMICOND SCI TECH, V11, P1582, DOI 10.1088/0268-1242/11/11S/022; Sharapov S. G., 2004, PHYS REV LETT, V69; Song J. C. W., 2014, ARXIV14044019CONDMAT; STREDA P, 1982, J PHYS C SOLID STATE, V15, P1299, DOI 10.1088/0022-3719/15/36/006; ZAK J, 1964, PHYS REV, V134, P1607	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6395	6399		10.1021/acs.nanolett.5b01568		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100016		
J	Klamchuen, A; Suzuki, M; Nagashima, K; Yoshida, H; Kanai, M; Zhuge, F; He, Y; Meng, G; Kai, SC; Takeda, S; Kawai, T; Yanagida, T				Klamchuen, Annop; Suzuki, Masaru; Nagashima, Kazuki; Yoshida, Hideto; Kanai, Masaki; Zhuge, Fuwei; He, Yong; Meng, Gang; Kai, Shoichi; Takeda, Seiji; Kawai, Tomoji; Yanagida, Takeshi			Rational Concept for Designing Vapor-Liquid-Solid Growth of Single Crystalline Metal Oxide Nanowires	NANO LETTERS			English	Article						Metal oxide nanowires; vapor-liquid-solid growth; single crystal	NONVOLATILE; MEMORY; MECHANISM; SURFACE; ARRAYS	Metal oxide nanowires hold great promise for various device applications due to their unique and robust physical properties in air and/or water and also due to their abundance on Earth. Vapor liquid solid (VLS) growth of metal oxide nanowires offers the high controllability of their diameters and spatial positions. In addition, VLS growth has applicability to axial and/or radial heterostructures, which are not attainable by other nanowire growth methods. However, material species available for the VLS growth of metal oxide nanowires are substantially limited even though the variety of material species, which has fascinating physical properties, is the most interesting feature of metal oxides. Here we demonstrate a rational design for the VLS growth of various metal oxide nanowires, based on the "material flux window". This material flux window describes the concept of VLS nanowire growth within a limited material flux range, where nucleation preferentially occurs only at a liquid solid interface. Although the material flux was previously thought to affect primarily the growth rate, we experimentally and theoretically demonstrate that the material flux is the important experimental variable for the VLS growth of metal oxide nanowires. On the basis of the material flux window concept, we discover novel metal oxide nanowires, composed of MnO, CaO, Sm2O3, NiO, and Eu2O3, which were previously impossible to form via the VLS route. The newly grown NiO nanowires exhibited stable memristive properties superior to conventional polycrystalline devices due to the single crystallinity. Thus, this VLS design route offers a useful guideline for the discovery of single crystalline nanowires that are composed of functional metal oxide materials.	[Klamchuen, Annop; Yoshida, Hideto; Takeda, Seiji; Kawai, Tomoji; Yanagida, Takeshi] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Suzuki, Masaru; Kai, Shoichi] Kyushu Univ, Fac Engn, Dept Appl Quantum Phys & Nucl Engn, Nishi Ku, Fukuoka 8190395, Japan; [Nagashima, Kazuki; Kanai, Masaki; Zhuge, Fuwei; He, Yong; Meng, Gang; Yanagida, Takeshi] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Yanagida, T (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	yanagida@cm.kyushu-u.ac.jp	Zhuge, Fuwei/I-7171-2013	Zhuge, Fuwei/0000-0003-3673-2257	NEXT Project	This work was supported by NEXT Project.	Nagashima K, 2010, NANO LETT, V10, P1359, DOI 10.1021/nl9042906; Klamchuen A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3474605; Lauhon LJ, 2004, PHILOS T ROY SOC A, V362, P1247, DOI 10.1098/rsta.2004.1377; Hwang YJ, 2009, NANO LETT, V9, P410, DOI 10.1021/nl8032763; Hochbaum AI, 2005, NANO LETT, V5, P457, DOI 10.1021/nl047990x; Nagashima K, 2011, NANO LETT, V11, P2114, DOI 10.1021/nl200707n; Kodambaka S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.096105; Oka K, 2009, J AM CHEM SOC, V131, P3434, DOI 10.1021/ja8089922; Meng F, 2013, ACCOUNTS CHEM RES, V46, P1616, DOI 10.1021/ar400003q; Persson AI, 2004, NAT MATER, V3, P677, DOI 10.1038/nmat1220; Auer E, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/43/434017; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; Suzuki M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061606; Lee SH, 2007, NAT NANOTECHNOL, V2, P626, DOI 10.1038/nnano.2007.291; Yanagida T, 2008, J PHYS CHEM C, V112, P18923, DOI 10.1021/jp8073893; Hannon JB, 2006, NATURE, V440, P69, DOI 10.1038/nature04574; Oka K, 2010, J AM CHEM SOC, V132, P6634, DOI 10.1021/ja101742f; Comini E, 2009, PROG MATER SCI, V54, P1, DOI 10.1016/j.pmatsci.2008.06.003; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Dai ZR, 2003, ADV FUNCT MATER, V13, P9, DOI 10.1002/adfm.200390013; Klamchuen A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3660246; Moore WJ, 1962, PHYS CHEM; Schneider S. J., 1963, COMPILATION MELTING; Yanagida T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768202	25	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6406	6412		10.1021/acs.nanolett.5b01604		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100018		
J	Chen, CL; Wang, ZC; Lichtenberg, F; Ikuhara, Y; Bednorz, JG				Chen, Chunlin; Wang, Zhongchang; Lichtenberg, Frank; Ikuhara, Yuichi; Bednorz, Johannes Georg			Patterning Oxide Nanopillars at the Atomic Scale by Phase Transformation	NANO LETTERS			English	Article						SrNbOx; nanopillars; phase transformation; transmission electron microscopy	MAGNETIC-PROPERTIES; NIOBIUM; SRNBO3.5-X; MECHANISM; SR2NB2O7; EELS	Phase transformations in crystalline materials are common in nature and often modify dramatically properties of materials. The ability to precisely control them with a high spatial precision represents a significant step forward in realizing new functionalities in confined dimensions. However, such control is extremely challenging particularly at the atomic scale due to the intricacies in governing thermodynamic conditions with a high spatial accuracy. Here, we apply focused electron beam of a scanning transmission electron microscope to irradiate SrNbO3.4 crystals and demonstrate a precise control of a phase transformation from layered SrNbO3.4 to perovskite SrNbO3 at the atomic scale. By purposely squeezing O atoms out of the vertex-sharing NbO6 octahedral slabs, their neighboring slabs zip together, resulting in a patterning of SrNbO3 nanopillars in SrNbO3.4 matrix. Such phase transformations can be spatially manipulated with an atomic precision, opening up a novel avenue for materials design and processing and also for advanced nanodevice fabrication.	[Chen, Chunlin; Wang, Zhongchang; Ikuhara, Yuichi] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Lichtenberg, Frank] ETH, Dept Mat, CH-8093 Zurich, Switzerland; [Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Ikuhara, Yuichi] Japan Fine Ceram Ctr, Nanostruct Res Lab, Atsuta Ku, Nagoya, Aichi 4568587, Japan; [Bednorz, Johannes Georg] Zurich Res Lab, IBM Res Div, CH-8803 Ruschlikon, Switzerland	Wang, ZC (reprint author), Tohoku Univ, Adv Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	zcwang@wpi-aimr.tohoku.ac.jp; ikuhara@sigma.t.u-tokyo.ac.jp	Ikuhara, Yuichi/F-3066-2010; Chen, ChunLin/N-4611-2013		JSPS [26106503, 15H02290]; University of Tokyo from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [12024046]; Challenging Exploratory Research [15K14117]; NSFC [11332013]; JSPS; CAS under Japan-China Scientific Cooperation Program; Shorai Foundation for Science and Technology;  [26820288];  [15H04114]	This work was supported in part by the JSPS Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics" (grant no. 26106503) and A (15H02290), the "Nanotechnology Platform" (project no. 12024046) at the University of Tokyo from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. C.C. acknowledges support from the Grant-in-Aid for Young Scientists (B) (grant no. 26820288). Z.W. thanks the financial supports from the Scientific Research (B) (grant no. 15H04114), the Challenging Exploratory Research (grant no. 15K14117), the NSFC (grant no. 11332013), the JSPS and CAS under Japan-China Scientific Cooperation Program, and the Shorai Foundation for Science and Technology. F.L. thanks Nicola Spaldin for her support.	ISHIZAWA N, 1975, ACTA CRYSTALLOGR B, V31, P1912, DOI 10.1107/S0567740875006462; Song YT, 2013, NATURE, V502, P85, DOI 10.1038/nature12532; Kobayashi W, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085118; Kuntscher CA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245123; WHITNEY TM, 1993, SCIENCE, V261, P1316, DOI 10.1126/science.261.5126.1316; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; Bach D, 2009, MICROSC MICROANAL, V15, P505, DOI 10.1017/S143192760999105X; Khaliullin RZ, 2011, NAT MATER, V10, P693, DOI [10.1038/nmat3078, 10.1038/NMAT3078]; Abrahams SC, 1998, ACTA CRYSTALLOGR B, V54, P399, DOI 10.1107/S0108768197019642; Lichtenberg F, 2001, PROG SOLID STATE CH, V29, P1, DOI 10.1016/S0079-6786(01)00002-4; Bach D, 2009, MICROSC MICROANAL, V15, P524, DOI 10.1017/S1431927609991061; LIU DH, 1992, MATER RES BULL, V27, P387, DOI 10.1016/0025-5408(92)90068-B; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; LICHTENBERG F, 1991, Z PHYS B CON MAT, V84, P369, DOI 10.1007/BF01314010; ISAWA K, 1993, PHYS REV B, V47, P2849, DOI 10.1103/PhysRevB.47.2849; WILLIAMS T, 1993, J SOLID STATE CHEM, V103, P375, DOI 10.1006/jssc.1993.1113; Stipe BC, 2010, NAT PHOTONICS, V4, P484, DOI 10.1038/nphoton.2010.90; Lichtenberg F, 2008, PROG SOLID STATE CH, V36, P253, DOI 10.1016/j.progsolidstchem.2008.10.001; Lee SH, 2007, NAT NANOTECHNOL, V2, P626, DOI 10.1038/nnano.2007.291; Atuchin VV, 2008, J SOLID STATE CHEM, V181, P1285, DOI 10.1016/j.jssc.2008.01.046; Findlay SD, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3265946; NANAMATSU S, 1975, J PHYS SOC JPN, V38, P817, DOI 10.1143/JPSJ.38.817; Kainuma R, 2006, NATURE, V439, P957, DOI 10.1038/nature04493; Kolobov AV, 2004, NAT MATER, V3, P703, DOI 10.1038/nmat1215; Krusin-Elbaum L, 2001, NATURE, V410, P444, DOI 10.1038/35068515; Chen CL, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902970; de Campos A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125117; Kirkland E. J., 1998, ADV COMPUTING ELECT; Kuntscher CA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.236403; Weber JE, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235414	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6469	6474		10.1021/acs.nanolett.5b01847		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100027		
J	Chen, ZH; Liu, J; Qi, YJ; Chen, DY; Hsu, SL; Damodaran, AR; He, XQ; N'Diaye, AT; Rockett, A; Martin, LW				Chen, Zuhuang; Liu, Jian; Qi, Yajun; Chen, Deyang; Hsu, Shang-Lin; Damodaran, Anoop R.; He, Xiaoqing; N'Diaye, Alpha T.; Rockett, Angus; Martin, Lane W.			180 degrees Ferroelectric Stripe Nanodomains in BiFeO3 Thin Films	NANO LETTERS			English	Article						BiFeO3; domain walls; multiferroic; ferroelectric; exchange bias; strain	PHASE MULTIFERROICS; NANOSCALE CONTROL; DOMAIN CONTROL; EXCHANGE BIAS; BATIO3; WALLS; OXIDE	There is growing evidence that domain walls in ferroics can possess emergent properties that are absent in the bulk. For example, 180 degrees ferroelectric domain walls in the ferroelectric-antiferromagnetic BiFeO3 are particularly interesting because they have been predicted to possess a range of intriguing behaviors, including electronic conduction and enhanced magnetization. To date, however, ordered arrays of such domain structures have not been reported. Here, we report the observation of 180 degrees stripe nanodomains in (110)-oriented BiFeO3 thin films grown on orthorhombic GdScO3 (010)(O) substrates and their impact on exchange coupling to metallic ferromagnets. Nanoscale ferroelectric 180 degrees stripe domains with {11 (2) over bar} domain walls were observed in films <32 nm thick. With increasing film thickness, we observed a domain structure crossover from the depolarization field-driven 180 degrees stripe nanodomains to 71 degrees ferroelastic domains determined by the elastic energy. These 180 domain walls (which are typically cylindrical or meandering in nature due to a lack of strong anisotropy associated with the energy of such walls) are found to be highly ordered. Additional studies of Co0.9Fe0.1/BiFeO3 heterostructures reveal exchange bias and exchange enhancement in heterostructures based on BiFeO3 with 180 degrees domain walls and an absence of exchange bias in heterostructures based on BiFeO3 with 71 degrees domain walls; suggesting that the 180 degrees domain walls could be the possible source for pinned uncompensated spins that give rise to exchange bias. This is further confirmed by Xray circular magnetic dichroism studies, which demonstrate that films with predominantly 180 degrees domain walls have larger magnetization than those with primarily 71 degrees domain walls. Our results could be useful to extract the structure of domain walls and to explore domain wall functionalities in BiFeO3.	[Chen, Zuhuang; Chen, Deyang; Hsu, Shang-Lin; Damodaran, Anoop R.; Martin, Lane W.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Liu, Jian] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Liu, Jian; Martin, Lane W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [N'Diaye, Alpha T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Qi, Yajun] Hubei Univ, Hubei Collaborat Innovat Ctr Adv Organ Chem Mat, Dept Mat Sci & Engn, Key Lab Green Preparat & Applicat Mat,Minist Educ, Wuhan 430062, Peoples R China; [He, Xiaoqing; Rockett, Angus] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [He, Xiaoqing; Rockett, Angus] Univ Illinois, Mat Res Lab, Urbana, IL 61801 USA; [Rockett, Angus; Martin, Lane W.] Int Inst Carbon Neutral Res, Nishi Ku, Fukuoka 8190395, Japan	Chen, ZH (reprint author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	zuhuang@berkeley.edu; lwmartin@berkeley.edu	Chen, Zuhuang/E-7131-2011	Chen, Zuhuang/0000-0003-1912-6490	Army Research Office [W911NF-14-1-0104]; Air Force Office of Scientific Research [MURI FA9550-12-1-0471]; Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation of China [11204069, 51472078]; National Science Foundation [DMR-1451219, CMMI-1434147]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; International Institute for Carbon-Neutral Energy Research (WPI I2CNER) - Japanese Ministry of Education, Culture, Sport, Science and Technology	Z.H.C. and L.W.M. acknowledges the support of the Army Research Office under grant W911NF-14-1-0104 and the Air Force Office of Scientific Research under grant MURI FA9550-12-1-0471. J.L. acknowledges support from the Quantum Materials FWP, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Y.Q. acknowledges support of the National Science Foundation of China under grants 11204069 and 51472078. A.R.D. and L.W.M. acknowledge the support of the National Science Foundation under grants DMR-1451219 and CMMI-1434147, respectively. Part of the work was completed at the Advanced Light Source which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. A.R. and L.W.M. acknowledge support by the International Institute for Carbon-Neutral Energy Research (WPI I<SUP>2</SUP>CNER), sponsored by the Japanese Ministry of Education, Culture, Sport, Science and Technology. We are grateful to Ruijuan Xu for the domain schematic drawing.	Heron JT, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4870957; Chu YH, 2009, NANO LETT, V9, P1726, DOI 10.1021/nl900723j; Kornev I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196104; KITTEL C, 1946, PHYS REV, V70, P965, DOI 10.1103/PhysRev.70.965; Lubk A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104110; Chisholm MF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.197602; LAWLESS WN, 1970, J PHYS SOC JPN, V28, P419, DOI 10.1143/JPSJ.28.419; Gu YJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174111; Chen ZH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4875801; Bratkovsky AM, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.132103; Kim IT, 1998, APPL PHYS LETT, V72, P308, DOI 10.1063/1.120720; Trassin M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134426; Nogues J, 1999, J MAGN MAGN MATER, V192, P203, DOI 10.1016/S0304-8853(98)00266-2; Farokhipoor S, 2014, NATURE, V515, P379, DOI 10.1038/nature13918; Zubko P, 2012, FERROELECTRICS, V433, P127, DOI 10.1080/00150193.2012.678159; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Streiffer SK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067601; POMPE W, 1993, J APPL PHYS, V74, P6012, DOI 10.1063/1.355215; TANAKA M, 1964, J PHYS SOC JPN, V19, P954, DOI 10.1143/JPSJ.19.954; Chu YH, 2006, ADV MATER, V18, P2307, DOI 10.1002/adma.200601098; Martin LW, 2008, NANO LETT, V8, P2050, DOI 10.1021/nl801391m; Yang SY, 2010, NAT NANOTECHNOL, V5, P143, DOI [10.1038/nnano.2009.451, 10.1038/NNANO.2009.451]; Nesterov O, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823536; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Schilling A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024115; Daraktchiev M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224118; FOUSEK J, 1965, JPN J APPL PHYS, V4, P403, DOI 10.1143/JJAP.4.403; Schubert J, 2003, APPL PHYS LETT, V82, P3460, DOI 10.1063/1.1575935; Fong DD, 2004, SCIENCE, V304, P1650, DOI 10.1126/science.1098252; Seidel J, 2009, NAT MATER, V8, P229, DOI [10.1038/nmat2373, 10.1038/NMAT2373]; Setter N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336999; Eliseev EA, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054111; Ederer C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.060401; Lichtensteiger C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047603; Kan D, 2010, J APPL PHYS, V108, DOI 10.1063/1.3452360; Chu YH, 2007, ADV MATER, V19, P2662, DOI 10.1002/adma.200602972; Bea H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.017204; Bea H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2402204; Catalan G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127602; Chen ZH, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.054114; Fong DD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127601; He Q, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1221; He Q, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.067203; Jiang ZJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.214113; Luo ZL, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.064103; Martin LW, 2012, CURR OPIN SOLID ST M, V16, P199, DOI 10.1016/j.cossms.2012.03.001; Nakamura M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1923754; ROYTBURD AL, 1993, PHASE TRANSIT, V45, P1, DOI 10.1080/01411599308203516; Tagantsev A. K., 2010, FERROELECTRIC DOMAIN; Takahashi R, 2008, J APPL PHYS, V104, DOI 10.1063/1.2978225; Thompson C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3013512; Vlooswijk AHG, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2783274; Xue F, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.220101	53	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6506	6513		10.1021/acs.nanolett.5b02031		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100033		
J	Deng, GW; Wei, D; Li, SX; Johansson, JR; Kong, WC; Li, HO; Cao, G; Xiao, M; Guo, GC; Nori, F; Jiang, HW; Guo, GP				Deng, Guang-Wei; Wei, Da; Li, Shu-Xiao; Johansson, J. R.; Kong, Wei-Cheng; Li, Hai-Ou; Cao, Gang; Xiao, Ming; Guo, Guang-Can; Nori, Franco; Jiang, Hong-Wen; Guo, Guo-Ping			Coupling Two Distant Double Quantum Dots with a Microwave Resonator	NANO LETTERS			English	Article						Graphene; double quantum dot; resonator; cross-correlation; microwave	SUPERCONDUCTING CIRCUITS; SYSTEMS; CAVITY; ELECTRODYNAMICS; PHOTONS; NOISE; QUBIT; SPIN	We fabricated a hybrid device with two distant graphene double quantum dots (DQDs) and a microwave resonator. A nonlinear response is observed in the resonator reflection amplitude when the two DQDs are jointly tuned to the vicinity of the degeneracy points. This observation can be well fitted by the Tavis-Cummings (T-C) model which describes two two-level systems coupling with one photonic field. Furthermore, the correlation between the DC currents in the two DQDs is studied. A nonzero cross-current correlation is observed which has been theoretically predicted to be an important sign of nonlocal coupling between two distant systems. Our results explore T-C physics in electronic transport and also contribute to the study of nonlocal transport and future implementations of remote electronic entanglement.	[Deng, Guang-Wei; Wei, Da; Li, Shu-Xiao; Kong, Wei-Cheng; Li, Hai-Ou; Cao, Gang; Xiao, Ming; Guo, Guang-Can; Guo, Guo-Ping] Chinese Acad Sci, Univ Sci & Technol China, Key Lab Quantum Informat, Hefei 230026, Peoples R China; [Deng, Guang-Wei; Wei, Da; Li, Shu-Xiao; Kong, Wei-Cheng; Li, Hai-Ou; Cao, Gang; Xiao, Ming; Guo, Guang-Can; Guo, Guo-Ping] Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Hefei 230026, Anhui, Peoples R China; [Johansson, J. R.] RIKEN, iTHES Res Grp, Wako, Saitama 3510198, Japan; [Nori, Franco] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Nori, Franco] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Jiang, Hong-Wen] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	Guo, GP (reprint author), Chinese Acad Sci, Univ Sci & Technol China, Key Lab Quantum Informat, Hefei 230026, Peoples R China.	gpguo@ustc.edu.cn	Cao, Gang/P-1362-2015		National Fundamental Research Programme [2011CBA00200]; National Natural Science Foundation [11222438, 11174267, 11274294, 61306150, 11304301, 91121014]; Chinese Academy of Sciences	We thank M.R. Delbecq and Klaus Ensslin for fruitful discussions. This work was supported by the National Fundamental Research Programme (Grant No. 2011CBA00200), the National Natural Science Foundation (Grant Nos. 11222438, 11174267, 11274294, 61306150, 11304301, and 91121014), and the Chinese Academy of Sciences.	Konstantatos G, 2012, NAT NANOTECHNOL, V7, P363, DOI [10.1038/nnano.2012.60, 10.1038/NNANO.2012.60]; Viennot JJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.165404; Petersson KD, 2012, NATURE, V490, P380, DOI 10.1038/nature11559; Toida H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.066802; TAVIS M, 1968, PHYS REV, V170, P379, DOI 10.1103/PhysRev.170.379; Frey T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046807; Xu CR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035429; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Delbecq MR, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.256804; Manucharyan VE, 2009, SCIENCE, V326, P113, DOI 10.1126/science.1175552; Johansson JR, 2013, COMPUT PHYS COMMUN, V184, P1234, DOI 10.1016/j.cpc.2012.11.019; Li HO, 2014, J APPL PHYS, V116, DOI 10.1063/1.4900915; Bergenfeldt C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.076803; Viennot JJ, 2015, SCIENCE, V349, P408, DOI 10.1126/science.aaa3786; Liu YY, 2015, SCIENCE, V347, P285, DOI 10.1126/science.aaa2501; Flindt C, 2005, EUROPHYS LETT, V69, P475, DOI 10.1209/epl/i2004-10351-x; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Contreras-Pulido LD, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/095008; Wei JA, 2010, NAT PHYS, V6, P494, DOI 10.1038/NPHYS1669; Neder I, 2007, NATURE, V448, P333, DOI 10.1038/nature05955; Wang LJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3533021; Bergenfeldt C, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195427; You JQ, 2011, NATURE, V474, P589, DOI 10.1038/nature10122; Hu XD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035314; Xiang ZL, 2013, REV MOD PHYS, V85, P623, DOI 10.1103/RevModPhys.85.623; Childress L, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042302; Delbecq MR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2407; Deng G.-W., 2013, ARXIV13106118; Frey T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604784; Guo GP, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.020302; Lambert N, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/17005; Lin ZR, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.230501; Liu YY, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.036801; McClure DT, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.056801; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Raith M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.085414; Song XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep08142; Wei Da, 2013, Sci Rep, V3, P3175, DOI 10.1038/srep03175; Zhang ML, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866336	39	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6620	6625		10.1021/acs.nanolett.5b02400		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100050		
J	Jeon, I; Chiba, T; Delacou, C; Guo, YL; Kaskela, A; Reynaud, O; Kauppinen, EI; Maruyama, S; Matsuo, Y				Jeon, Il; Chiba, Takaaki; Delacou, Clement; Guo, Yunlong; Kaskela, Antti; Reynaud, Olivier; Kauppinen, Esko I.; Maruyama, Shigeo; Matsuo, Yutaka			Single-Walled Carbon Nanotube Film as Electrode in Indium-Free Planar Heterojunction Perovskite Solar Cells: Investigation of Electron-Blocking Layers and Dopants	NANO LETTERS			English	Article						perovskite solar cell; carbon nanotube; ITO-free; PEDOT:PSS modification; MoO3 doping; flexible solar cell	ORGANOMETAL HALIDE PEROVSKITES; THIN-FILMS; ORGANIC PHOTOVOLTAICS; HIGH-EFFICIENCY; TRANSPARENT ELECTRODES; GRAPHENE ELECTRODES; TRANSPORT; NETWORKS; ENHANCEMENT; PERFORMANCE	In this work, we fabricated indium-free perovskite solar cells (SCs) using direct- and dry-transferred aerosol single-walled carbon nanotubes (SWNTs). We investigated diverse methodologies to solve SWNTs' hydrophobicity and doping issues in SC devices. These include changing wettability of poly(3,4-ethylenedioxythiophene)/poly(styrenesulfonate) (PEDOT:PSS), MoO3 thermal doping, and HNO3(aq) doping with various dilutions from IS to 70 v/v% to minimize its instability and toxic nature. We discovered that isopropanol (IPA) modified PEDOT:PSS works better than surfactant modified PEDOT:PSS as an electron-blocking layer on SWNTs in perovskite SCs due to superior wettability, whereas MoO3 is not compatible owing to energy level mismatching. Diluted HNO3 (35 v/v%)-doped SWNT-based device produced the highest PCE of 6.32% among SWNT-based perovsldte SCs, which is 70% of an indium tin oxide (ITO)-based device (9.05%). Its flexible application showed a PCE of 5.38% on polyethylene terephthalate (PET) substrate.	[Jeon, Il; Guo, Yunlong; Matsuo, Yutaka] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Chiba, Takaaki; Delacou, Clement; Maruyama, Shigeo] Univ Tokyo, Sch Engn, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kaskela, Antti; Reynaud, Olivier; Kauppinen, Esko I.] Aalto Univ, Sch Sci, Dept Appl Phys, FI-00076 Aalto, Finland; [Maruyama, Shigeo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan	Matsuo, Y (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	matsuo@chem.s.u-tokyo.ac.jp	Matsuo, Yutaka/C-9897-2011	Matsuo, Yutaka/0000-0001-9084-9670	IRENA project by JST-EC DG RTD; Strategic International Collaborative Research Program, SICORP; European Union Seventh Framework Programme [604472, 314068]; Aalto Energy Efficiency (AEF) program through the MOPPI project; TEKES; Academy of Finland via HISCON project;  [15H02219];  [15H05760]	This work was partly supported by Grants-in-Aid for Scientific Research (15H02219 and 15H05760), IRENA project by JST-EC DG RTD, and Strategic International Collaborative Research Program, SICORP. The authors also thank the Funding Program for Next-Generation World-Leading Researchers (Y.M.), Japan Student Services Organization (IJ.), and Project of China Scholarship Council (Y.G.). The research at Aalto University leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 604472 (IRENA project) and no 314068 (TREASORES project), from the Aalto Energy Efficiency (AEF) program through the MOPPI project, and from TEKES via projects CARLA and USG as well as from Academy of Finland via HISCON project.	Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; You JB, 2014, ACS NANO, V8, P1674, DOI 10.1021/nn406020d; Lee JM, 2015, ADV MATER, V27, P1519, DOI 10.1002/adma.201404248; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Park H, 2014, NANO LETT, V14, P5148, DOI 10.1021/nl501981f; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Kim S, 2010, ADV FUNCT MATER, V20, P2310, DOI 10.1002/adfm.200902369; Kazim S, 2014, ANGEW CHEM INT EDIT, V53, P2812, DOI 10.1002/anie.201308719; Godoy A, 2010, SOL ENERG MAT SOL C, V94, P648, DOI 10.1016/j.solmat.2009.11.003; Thompson CV, 2012, ANNU REV MATER RES, V42, P399, DOI 10.1146/annurev-matsci-070511-155048; Tanaka H, 2006, ADV MATER, V18, P2230, DOI 10.1002/adma.200600163; Jeng JY, 2013, ADV MATER, V25, P3727, DOI 10.1002/adma.201301327; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243; Kaskela A, 2010, NANO LETT, V10, P4349, DOI 10.1021/nl101680s; Cui KH, 2014, J MATER CHEM A, V2, P11311, DOI 10.1039/c4ta01353k; Li Z, 2014, ACS NANO, V8, P6797, DOI 10.1021/nn501096h; Jaegermann W, 2009, ADV MATER, V21, P4196, DOI 10.1002/adma.200802457; McGehee MD, 2014, NAT MATER, V13, P845, DOI 10.1038/nmat4050; Park H, 2013, NANOSCALE, V5, P8934, DOI 10.1039/c3nr00611e; Wang JTW, 2014, NANO LETT, V14, P724, DOI 10.1021/nl403997a; Shin DW, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/47/475703; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Zuo LJ, 2015, J AM CHEM SOC, V137, P2674, DOI 10.1021/ja512518r; Tyler TP, 2011, ADV ENERGY MATER, V1, P785, DOI 10.1002/aenm.201100274; Kymakis E, 2006, EUR PHYS J-APPL PHYS, V36, P257, DOI 10.1051/epjap:2006148; Jia Y, 2011, NANO LETT, V11, P1901, DOI 10.1021/nl2002632; Shiraishi M, 2001, CARBON, V39, P1913, DOI 10.1016/S0008-6223(00)00322-5; Zhou YX, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2187945; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Yang X, 2007, MACROMOLECULES, V40, P1353, DOI 10.1021/ma0618732; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Kim BJ, 2015, ENERG ENVIRON SCI, V8, P916, DOI 10.1039/c4ee02441a; Dabera GDMR, 2013, ACS NANO, V7, P556, DOI 10.1021/nn304705t; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Hatton RA, 2008, J MATER CHEM, V18, P1183, DOI 10.1039/b713527k; Park NG, 2013, J PHYS CHEM LETT, V4, P2423, DOI 10.1021/jz400892a; Maiti UN, 2014, ADV MATER, V26, P40, DOI 10.1002/adma.201303265; Lee WJ, 2014, CHEM COMMUN, V50, P6818, DOI 10.1039/c4cc00146j; Hellstrom SL, 2012, NANO LETT, V12, P3574, DOI 10.1021/nl301207e; Shin YR, 2012, CARBON, V50, P1465, DOI 10.1016/j.carbon.2011.11.017; Lim CH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824575; Unalan HE, 2008, J MATER CHEM, V18, P5909, DOI 10.1039/b810748c; Salvatierra RV, 2013, ADV FUNCT MATER, V23, P1490, DOI 10.1002/adfm.201201878; Lee JM, 2011, ADV MATER, V23, P629, DOI 10.1002/adma.201003296; Du JH, 2014, ADV MATER, V26, P1958, DOI 10.1002/adma.201304135; Wang ZS, 2004, COORDIN CHEM REV, V248, P1381, DOI 10.1016/j.ccr.2004.03.006; Jeon I, 2015, J AM CHEM SOC, V137, P7982, DOI 10.1021/jacs.5b03739; Docampo P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3761; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI 10.1038/NPHOTON.2013.80; Jeon I, 2014, J MATER CHEM A, V2, P18754, DOI 10.1039/c4ta04595e; Kim YH, 2012, SOL ENERG MAT SOL C, V96, P244, DOI 10.1016/j.solmat.2011.10.001; Leijtens T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3885; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Liu D., 2013, NAT PHOTONICS, V8, P133, DOI DOI 10.1038/NPHOTON.2013.342; Liu P, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921339; Meyer J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05380; Shrotriya V, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2174093; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Wang CG, 2014, J VAC SCI TECHNOL B, V32, DOI 10.1116/1.4886364; Xiao MD, 2014, ANGEW CHEM INT EDIT, V53, P9898, DOI 10.1002/anie.201405334; Zhao YX, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880899	61	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6665	6671		10.1021/acs.nanolett.5b02490		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100056		
J	Yang, YY; Goetzfried, MA; Hidaka, K; You, MX; Tan, WH; Sugiyama, H; Endo, M				Yang, Yangyang; Goetzfried, Marisa A.; Hidaka, Kumi; You, Mingxu; Tan, Weihong; Sugiyama, Hiroshi; Endo, Masayuki			Direct Visualization of Walking Motions of Photocontrolled Nanomachine on the DNA Nanostructure	NANO LETTERS			English	Article						DNA origami; light-driven; DNA motor; high-speed AFM; single molecule analysis	ATOMIC-FORCE MICROSCOPY; ORIGAMI; MOTOR; SPECTROSCOPY; BIOMOLECULES; MOVEMENT; PATTERNS; DRIVEN; DEVICE	A light-driven artificial molecular nanomachine was constructed based on DNA scaffolding. Pyrene-modified walking strands and disulfide bond-connected stator strands, employed as anchorage sites to support walker movement, were assembled into a 2D DNA tile. Pyrene molecules excited by photoirradiation at 350 nm induced cleavage of disulfide bond-connected stator strands, enabling the DNA walker to migrate from one cleaved stator to the next on the DNA tile. The time-dependent movement of the walker was observed and the entire walking process of the walker was characterized by distribution of the walker-stator duplex at four anchorage sites on the tile under different irradiation times. Importantly, the light-fuelled mechanical movements on DNA tile were first visualized in real time during UV irradiation using high-speed atomic force microscopy (HS-AFM).	[Yang, Yangyang; Sugiyama, Hiroshi; Endo, Masayuki] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Yang, Yangyang; Goetzfried, Marisa A.; Hidaka, Kumi; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [You, Mingxu; Tan, Weihong] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Collaborat Innovat Ctr Mol Engn & Theranost, Mol Sci & Biomed Lab,Coll Chem & Chem Engn,Coll B, Changsha 410082, Hunan, Peoples R China; [You, Mingxu; Tan, Weihong] Univ Florida, Dept Chem & Physiol & Funct Genom, Ctr Res Bio Nano Interface, Shands Canc Ctr,UF Genet Inst, Gainesville, FL 32611 USA	Tan, WH (reprint author), Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Collaborat Innovat Ctr Mol Engn & Theranost, Mol Sci & Biomed Lab,Coll Chem & Chem Engn,Coll B, Changsha 410082, Hunan, Peoples R China.	tan@chem.ufl.edu; hs@kuchem.kyoto-u.ac.jp; endo@kuchem.kyoto-u.ac.jp	Sugiyama, Hiroshi/C-7687-2011; Endo, Masayuki/J-5874-2014		MEXT [24104002]; JSPS KAKENHI [15H03837, 24225005, 26620133]; Sekisui Chemical Research Grant; Kurata Memorial Hitachi Science and Technology Foundation; National Key Scientific Program of China [2011CB911000]; NSFC [NSFC 21221003, NSFC 21327009]; China National Instrumentation Program [2011YQ03012412]; National Institutes of Health [GM079359, CA133086]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (Grant Number 24104002) of MEXT, JSPS KAKENHI (Grant Numbers 15H03837, 24225005, 26620133), the Sekisui Chemical Research Grant, and the Kurata Memorial Hitachi Science and Technology Foundation. This work is also supported by grants awarded by the National Key Scientific Program of China (2011CB911000), NSFC grants (NSFC 21221003 and NSFC 21327009) and China National Instrumentation Program 2011YQ03012412 and by the National Institutes of Health (GM079359 and CA133086). Y.Y. was supported by JSPS research fellow.	Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Greulich KO, 2005, CHEMPHYSCHEM, V6, P2458, DOI 10.1002/cphc.200500038; Endo M, 2012, ANGEW CHEM INT EDIT, V51, P10518, DOI 10.1002/anie.201205247; Bath J, 2005, ANGEW CHEM INT EDIT, V44, P4358, DOI 10.1002/anie.200501262; Rajendran A, 2013, J AM CHEM SOC, V135, P1117, DOI 10.1021/ja310454k; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Ando T, 2013, ANNU REV BIOPHYS, V42, P393, DOI 10.1146/annurev-biophys-083012-130324; Sannohe Y, 2010, J AM CHEM SOC, V132, P16311, DOI 10.1021/ja1058907; Yang YY, 2012, J AM CHEM SOC, V134, P20645, DOI 10.1021/ja307785r; Endo M, 2011, ORG BIOMOL CHEM, V9, P2075, DOI 10.1039/c0ob01093f; You MX, 2012, ACS NANO, V6, P7935, DOI 10.1021/nn302388e; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Endo M, 2014, ACCOUNTS CHEM RES, V47, P1645, DOI 10.1021/ar400299m; Mai J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011102; Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Wickham SFJ, 2011, NAT NANOTECHNOL, V6, P166, DOI [10.1038/nnano.2010.284, 10.1038/NNANO.2010.284]; Suzuki Y, 2014, J AM CHEM SOC, V136, P1714, DOI 10.1021/ja4109819; Voigt NV, 2010, NAT NANOTECHNOL, V5, P200, DOI [10.1038/nnano.2010.5, 10.1038/NNANO.2010.5]; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; You MX, 2010, ACS APPL MATER INTER, V2, P3601, DOI 10.1021/am1007886; You MX, 2012, ANGEW CHEM INT EDIT, V51, P2457, DOI 10.1002/anie.201107733; Suzuki Y, 2014, J AM CHEM SOC, V136, P211, DOI 10.1021/ja408656y; Neuman KC, 2008, NAT METHODS, V5, P491, DOI [10.1038/nmeth.1218, 10.1038/NMETH.1218]; Rajendran A, 2012, ANGEW CHEM INT EDIT, V51, P874, DOI 10.1002/anie.201102113; Endo M, 2013, BIOMATER SCI-UK, V1, P347, DOI 10.1039/c2bm00154c; Ishii Y., 2000, Single Molecules, V1, DOI 10.1002/(SICI)1438-5171(200004)1:1<5::AID-SIMO5>3.0.CO;2-A; Liber M, 2015, SMALL, V11, P568, DOI 10.1002/smll.201402028; Yang YY, 2014, CHEM COMMUN, V50, P4211, DOI 10.1039/c4cc00489b	29	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6672	6676		10.1021/acs.nanolett.5b02502		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100057		
J	Saito, H; Mizuma, S; Yamamoto, N				Saito, Hikaru; Mizuma, Shohei; Yamamoto, Naoki			Confinement of Surface Plasmon Polaritons by Heterostructures of Plasmonic Crystals	NANO LETTERS			English	Article						surface plasmon polariton; plasmonic crystal; heterostructure; cavity; cathodoluminescence; scanning transmission electron microscopy	SIZE DEPENDENCE; NANOMETER-SCALE; BAND-GAP; CAVITIES; LIGHT; CATHODOLUMINESCENCE; EMISSION; LATTICE; ARRAYS; MODES	Square lattice plasmonic crystals (SQP1Cs) composed of silver pillars generate large bandgaps for surface plasmon polaritons (SPPs). SPP confinement is demonstrated using one- and two-dimensional heterostructures of SQP1Cs comprised of cylindrical pillars with different diameters in a common square lattice. Two kinds of localized modes are observed to appear in the heterostructures by photon map imaging using cathodoluminescence (CL) technique combined with a scanning transmission electron microscopy (STEM). Angle-resolved CL spectroscopy reveals contrasting characteristics of the two localized modes in their emission distributions, indicating that they originate from the band-edge A and E modes of the matrix SQ-PIC.	[Saito, Hikaru; Yamamoto, Naoki] Tokyo Inst Technol, Quantum Nanoelect Reserch Ctr, Meguro Ku, Tokyo 1528551, Japan; [Saito, Hikaru] Kyushu Univ, Ctr Adv Instrumental Anal, Kasuga, Fukuoka 8168580, Japan; [Mizuma, Shohei] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528551, Japan; [Mizuma, Shohei; Yamamoto, Naoki] Tokyo Inst Technol, Dept Condensed Matter Phys, Meguro Ku, Tokyo 1528551, Japan; [Yamamoto, Naoki] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Saito, H (reprint author), Tokyo Inst Technol, Quantum Nanoelect Reserch Ctr, Meguro Ku, Tokyo 1528551, Japan.	saito.hikaru.961@m.kyushu-u.ac.jp; yamamoto.n.ac@m.titech.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Nanotechnology Platform [12025014]	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Nanotechnology Platform 12025014.	Boudarham G, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245447; Hohenester U, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.106801; Bozhevolnyi SI, 2001, PHYS REV LETT, V86, P3008, DOI 10.1103/PhysRevLett.86.3008; Gong YY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2431450; Watanabe H, 2014, OPT EXPRESS, V22, P5155, DOI 10.1364/OE.22.005155; Okamoto T, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867259; Kociak M, 2014, CHEM SOC REV, V43, P3865, DOI 10.1039/c3cs60478k; Le Thomas N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155314; Barnes WL, 1996, PHYS REV B, V54, P6227, DOI 10.1103/PhysRevB.54.6227; Takeuchi K, 2011, OPT EXPRESS, V19, P12365, DOI 10.1364/OE.19.012365; van Beijnum F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.206802; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; Saito H, 2015, OPT EXPRESS, V23, P2524, DOI 10.1364/OE.23.002524; Saito H, 2015, NANO LETT, V15, P5764, DOI 10.1021/acs.nanolett.5b01719; Chou SY, 2013, OPT EXPRESS, V21, pA60, DOI 10.1364/OE.21.000A60; Rosenberg J, 2010, OPT EXPRESS, V18, P3672, DOI 10.1364/OE.18.003672; Cai W, 2009, NANO LETT, V9, P1176, DOI 10.1021/nl803825n; von Cube F, 2013, NANO LETT, V13, P703, DOI 10.1021/nl3043757; PURCELL EM, 1946, PHYS REV, V69, P681; Suzuki T, 2009, OPT EXPRESS, V17, P23664, DOI 10.1364/OE.17.023664; Lakhani AM, 2011, OPT EXPRESS, V19, P18237, DOI 10.1364/OE.19.018237; Yamamoto N, 2014, OPT EXPRESS, V22, P29761, DOI 10.1364/OE.22.029761; Knight MW, 2012, NANO LETT, V12, P6000, DOI 10.1021/nl303517v; Zhou W, 2013, NAT NANOTECHNOL, V8, P506, DOI [10.1038/nnano.2013.99, 10.1038/NNANO.2013.99]; Horl A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.076801; Honda M, 2013, OPT EXPRESS, V21, P11973, DOI 10.1364/OE.21.011973; Zhang XP, 2012, SENSORS-BASEL, V12, P12082, DOI 10.3390/s120912082; Sapienza R, 2012, NAT MATER, V11, P781, DOI [10.1038/nmat3402, 10.1038/NMAT3402]; Losquin A, 2015, NANO LETT, V15, P1229, DOI 10.1021/nl5043775; Baudrion AL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.125406; de Abajo FJG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.106804; de Abajo FJG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.143902; Kitson SC, 1996, PHYS REV LETT, V77, P2670, DOI 10.1103/PhysRevLett.77.2670; Kuttge M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.113405; Liu TL, 2014, OPT EXPRESS, V22, P8219, DOI 10.1364/OE.22.008219; Lozano G, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.22; Maier S. A., 2007, PLASMONICS FUNDAMENT; Palik E. D., 1985, HDB OPTICAL CONSTANT; Shen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3381	39	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6789	6793		10.1021/acs.nanolett.5b02623		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100076		
J	Liu, N; Haublein, V; Zhou, XM; Venkatesan, U; Hartmann, M; Mackovic, M; Nakajima, T; Spiecker, E; Osvet, A; Frey, L; Schmuki, P				Liu, Ning; Haeublein, Volker; Zhou, Xuemei; Venkatesan, Umamaheswari; Hartmann, Martin; Mackovic, Mirza; Nakajima, Tomohiko; Spiecker, Erdmann; Osvet, Andres; Frey, Lothar; Schmuki, Patrik			"Black" TiO2 Nanotubes Formed by High-Energy Proton Implantation Show Noble-Metal-co-Catalyst Free Photocatalytic H-2-Evolution	NANO LETTERS			English	Article						Nanotubes; photocatalysts; water-splitting; titania; self-organization; ion-implantation	VISIBLE-LIGHT; TITANIUM-DIOXIDE; HYDROGEN-PRODUCTION; PHONON CONFINEMENT; RAMAN-SPECTROSCOPY; NANOWIRE ARRAYS; WATER; NANOPARTICLES; NANOCRYSTALS; IRRADIATION	We apply high-energy proton ion-implantation to modify TiO2 nanotubes selectively at their tops. In the proton-implanted region, we observe the creation of intrinsic cocatalytic centers for photocatalytic H-2-evolution. We find proton implantation to induce specific defects and a characteristic modification of the electronic properties not only in nanotubes but also on anatase single crystal (001) surfaces. Nevertheless, for TiO2 nanotubes a strong synergetic effect between implanted region (catalyst) and implant-free tube segment (absorber) can be obtained.	[Liu, Ning; Zhou, Xuemei; Schmuki, Patrik] Univ Erlangen Nurnberg, LKO, Dept Mat Sci WW 4, D-91058 Erlangen, Germany; [Haeublein, Volker; Frey, Lothar] Fraunhofer Inst Integrated Syst & Device Technol, D-91058 Erlangen, Germany; [Venkatesan, Umamaheswari; Hartmann, Martin] Univ Erlangen Nurnberg, ECRC, D-91058 Erlangen, Germany; [Mackovic, Mirza; Spiecker, Erdmann] Univ Erlangen Nurnberg, Inst Micro & Nanostruct Res WW9, D-91058 Erlangen, Germany; [Mackovic, Mirza; Spiecker, Erdmann] Univ Erlangen Nurnberg, Ctr Nanoanal & Electron Microscopy CENEM, D-91058 Erlangen, Germany; [Nakajima, Tomohiko] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Osvet, Andres] Univ Erlangen Nurnberg, iMEET, Dept Mat Sci 6, D-91058 Erlangen, Germany	Schmuki, P (reprint author), Univ Erlangen Nurnberg, LKO, Dept Mat Sci WW 4, Martensstr 7, D-91058 Erlangen, Germany.	schmuki@ww.uni-erlangen.de	Hartmann, Martin/C-4720-2011		ERC; DFG; Erlangen DFG cluster of excellence (EAM)	We would like to acknowledge the ERC, the DFG, and the Erlangen DFG cluster of excellence (EAM) for financial support and Yuyun Yang for Raman measurements.	Akpan UG, 2010, APPL CATAL A-GEN, V375, P1, DOI 10.1016/j.apcata.2009.12.023; Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374; CHOYKE WJ, 1983, NUCL INSTRUM METHODS, V209, P407, DOI 10.1016/0167-5087(83)90831-1; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Albu SP, 2008, ADV MATER, V20, P4135, DOI 10.1002/adma.200801189; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Livraghi S, 2006, J AM CHEM SOC, V128, P15666, DOI 10.1021/ja064164c; Liu N, 2014, NANO LETT, V14, P3309, DOI 10.1021/nl500710j; Ni M, 2007, RENEW SUST ENERG REV, V11, P401, DOI 10.1016/j.rser.2005.01.009; Hoang S, 2012, J AM CHEM SOC, V134, P3659, DOI 10.1021/ja211369s; Chen XB, 2011, SCIENCE, V331, P746, DOI 10.1126/science.1200448; Jennings JR, 2008, J AM CHEM SOC, V130, P13364, DOI 10.1021/ja804852z; Naldoni A, 2012, J AM CHEM SOC, V134, P7600, DOI 10.1021/ja3012676; Balaji S, 2006, J RAMAN SPECTROSC, V37, P1416, DOI 10.1002/jrs.1566; Lu XH, 2012, NANO LETT, V12, P1690, DOI 10.1021/nl300173j; Zuo F, 2010, J AM CHEM SOC, V132, P11856, DOI 10.1021/ja103843d; Bruel M, 1996, NUCL INSTRUM METH B, V108, P313, DOI 10.1016/0168-583X(95)01056-4; CHU WK, 1977, PHYS REV B, V16, P3851, DOI 10.1103/PhysRevB.16.3851; Lynch RP, 2010, J ELECTROCHEM SOC, V157, pG76, DOI 10.1149/1.3276455; Anpo M, 2003, J CATAL, V216, P505, DOI 10.1016/S0021-9517(02)00104-5; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Bersani D, 1998, APPL PHYS LETT, V72, P73, DOI 10.1063/1.120648; Tian F, 2012, J PHYS CHEM C, V116, P7515, DOI 10.1021/jp301256h; Sang LX, 2014, CHEM REV, V114, P9283, DOI 10.1021/cr400629p; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; Zheng ZK, 2012, CHEM COMMUN, V48, P5733, DOI 10.1039/c2cc32220j; Zhou W, 2014, J AM CHEM SOC, V136, P9280, DOI 10.1021/ja504802q; Wang GM, 2011, NANO LETT, V11, P3026, DOI 10.1021/nl201766h; Chu W. K., 1976, ION IMPLANTATION SEM, P483; Connelly K, 2012, MAT RENEWABLE SUSTAI, V1, P3; Ivanda M., 1999, Journal of Molecular Structure, V480-481, DOI 10.1016/S0022-2860(98)00921-1; Liu N., 2014, ANGEW CHEM, V126, P14425; ZHIKHAREV VA, 1995, MATER RES SOC SYMP P, V389, P155; Ziegler J. F., 1985, STOPPING RANGE IONS	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6815	6820		10.1021/acs.nanolett.5b02663		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100080		
J	Huang, JW; Pan, C; Tran, S; Cheng, B; Watanabe, K; Taniguchi, T; Lau, CN; Bockrath, M				Huang, Jhao-Wun; Pan, Cheng; Tran, Son; Cheng, Bin; Watanabe, Kenji; Taniguchi, Takashi; Lau, Chun Ning; Bockrath, Marc			Superior Current Carrying Capacity of Boron Nitride Encapsulated Carbon Nanotubes with Zero-Dimensional Contacts	NANO LETTERS			English	Article						Current carrying capacity; carbon nanotube; hBN encapsulation	TRANSPORT; GRAPHENE; DEVICES	We report fabrication and characterization of hexagonal boron nitride (hBN)-encapsulated carbon nanotube (CNT) field effect transistors, which are coupled to electrical leads via zero-dimensional contacts. Device quality is attested by the ohmic contacts and observation of Coulomb blockade with a single periodicity in small bandgap semiconducing nanotubes. Surprisingly, hBN-encapsulated CNT devices demonstrate significantly enhanced current carrying capacity; a single-walled CNT can sustain >180 mu A current or, equivalently, a current density of similar to 2 x 10(10) A/cm(2), which is a factor of 6-7 higher than devices supported on SiO2 substrates. Such dramatic enhancement of current carrying capacity arises from the high thermal conductivity of hBN and lower hBN-CNT interfacial implications for carbon electronic applications. thermal resistance and has implications for carbon electronic applications.	[Huang, Jhao-Wun; Pan, Cheng; Tran, Son; Cheng, Bin; Lau, Chun Ning; Bockrath, Marc] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Lau, CN (reprint author), Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA.	lau@physics.ucr.edu; marc.bockrath@ucr.edu			SHINES, which is an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences [SC0012670]	This work is supported by SHINES, which is an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences under Award #SC0012670. Additional support for nanofabrication is provided by CONSEPT center at UCR.	Baumgartner A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890600; Maune H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2219095; Yao Z, 2000, PHYS REV LETT, V84, P2941, DOI 10.1103/PhysRevLett.84.2941; Bockrath M, 1999, NATURE, V397, P598; Maki H, 2004, JPN J APPL PHYS 1, V43, P2027, DOI 10.1143/JJAP.43.2027; Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; Chiu HY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226101; Jo I, 2013, NANO LETT, V13, P550, DOI 10.1021/nl304060g; Pop E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155505; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Zomer PJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665405; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Deshpande VV, 2009, SCIENCE, V323, P106, DOI 10.1126/science.1165799; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; Tans SJ, 1998, NATURE, V393, P49; Yu J, 2012, NANO LETT, V12, P1603, DOI 10.1021/nl204545q; Palacios JJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.106801; Javey A, 2004, P NATL ACAD SCI USA, V101, P13408, DOI 10.1073/pnas.0404450101; Gillgren N, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/1/011001; Deshpande VV, 2008, NAT PHYS, V4, P314, DOI 10.1038/nphys895; Javey A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.106804; Christou A., 1994, ELECTROMIGRATION ELE	24	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6836	6840		10.1021/acs.nanolett.5b02716		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100083		
J	Liu, TM; Wang, TH; Reid, AH; Savoini, M; Wu, XF; Koene, B; Granitzka, P; Graves, CE; Higley, DJ; Chen, Z; Razinskas, G; Hantschmann, M; Scherz, A; Stohr, J; Tsukarnote, A; Hecht, B; Kimel, AV; Kirilyuk, A; Rasing, T; Durr, HA				Liu, Tian-Min; Wang, Tianhan; Reid, Alexander H.; Savoini, Matteo; Wu, Xiaofei; Koene, Benny; Granitzka, Patrick; Graves, Catherine E.; Higley, Daniel J.; Chen, Zhao; Razinskas, Gary; Hantschmann, Markus; Scherz, Andreas; Stoehr, Joachim; Tsukarnote, Arata; Hecht, Bert; Kimel, Alexey V.; Kirilyuk, Andrei; Rasing, Theo; Duerr, Hermann A.			Nanoscale Confinement of All-Optical Magnetic Switching in TbFeCo - Competition with Nanoscale Heterogeneity	NANO LETTERS			English	Article						All-optical switching; plasmonics; magnetic inhomogeneity; magnetic recording; X-ray holography; X-ray magnetic circular dichroism (XMCD)	REVERSAL	Single femtosecond optical laser pulses, of sufficient intensity, are demonstrated to reverse magnetization in a process known as all-optical switching. Gold two-wire antennas are placed on the all-optical switching film TbFeCo. These structures are resonant with the optical field, and they create a field enhancement in the near-field which confines the area where optical switching can occur. The magnetic switching that occurs around and below the antenna is imaged using resonant X-ray holography and magnetic circular dichroism. The results not only show the feasibility of controllable switching with antenna assistance but also demonstrate the highly inhomogeneous nature of the switching process, which is attributed to the process depending on the material's heterogeneity.	[Liu, Tian-Min; Wang, Tianhan; Reid, Alexander H.; Granitzka, Patrick; Graves, Catherine E.; Higley, Daniel J.; Chen, Zhao; Scherz, Andreas; Stoehr, Joachim; Duerr, Hermann A.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Savoini, Matteo; Koene, Benny; Kimel, Alexey V.; Kirilyuk, Andrei; Rasing, Theo] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Wu, Xiaofei; Razinskas, Gary; Hecht, Bert] Univ Wurzburg, Wilhelm Conrad Rontgen Ctr Complex Mat Syst, Inst Phys, Nanoopt & Biophoton Grp,Expt Phys 5, D-97074 Wurzburg, Germany; [Hantschmann, Markus] Helmholtz Zentrum Berlin, G ISRR, Inst Methods & Instrumentat Synchrotron Rad, D-12489 Berlin, Germany; [Tsukarnote, Arata] Nihon Univ, Coll Sci & Technol, Chiba 2748501, Japan; [Graves, Catherine E.; Higley, Daniel J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Wang, Tianhan] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Liu, Tian-Min; Chen, Zhao] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Wu, Xiaofei] Univ Bayreuth, Expt Phys 3, D-95447 Bayreuth, Germany; [Granitzka, Patrick] Univ Amsterdam, Van Der Waals Zeeman Inst, NL-1018 XE Amsterdam, Netherlands	Reid, AH (reprint author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	alexhmr@slac.stanford.edu; hdurr@slac.stanford.edu	Durr, Hermann/F-6205-2012; 	Hecht, Bert/0000-0002-4883-8676	U.S. DOE, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]; Stichting voor Fundamenteel Onderzoek der Materie (FOM); De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); European Union (EU) Nano Sci-European Research Associates (ERA) project FENOMENA; ERC [257280, 339813]; EC FP7 [281043]	Research is supported by U.S. DOE, Office of Basic Energy Sciences, Materials Sciences and Engineering Division under contract DE-AC02-76SF00515. Stichting voor Fundamenteel Onderzoek der Materie (FOM), De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), the European Union (EU) Nano Sci-European Research Associates (ERA) project FENOMENA, ERC Grant agreement nos. 257280 (Femtomagnetism) and 339813 (EXCHANGE) and EC FP7 no. 281043 (FEMTOSPIN).	Ahlfors L, 1972, PHYS REV B; Wu XF, 2015, CRYST RES TECHNOL, V50, P595, DOI 10.1002/crat.201400429; Graves CE, 2013, NAT MATER, V12, P293, DOI [10.1038/nmat3597, 10.1038/NMAT3597]; Khorsand AR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127205; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Steil D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.224408; Guizar-Sicairos M, 2007, OPT EXPRESS, V15, P17592, DOI 10.1364/OE.15.017592; Zhu DL, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.043901; [Anonymous], 2012, FDTD SOL V8 5 3; Mangin S, 2014, NAT MATER, V13, P287, DOI [10.1038/nmat3864, 10.1038/NMAT3864]; Radu I, 2011, NATURE, V472, P205, DOI 10.1038/nature09901; Stanciu CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047601; Koene B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733292; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Farahani JN, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/12/125506; Finazzi M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.177205; Le Guyader L, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733965; Lambert CH, 2014, SCIENCE, V345, P1337, DOI 10.1126/science.1253493; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Wu AQ, 2013, IEEE T MAGN, V49, P779, DOI 10.1109/TMAG.2012.2219513; Barker J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03262; Le Guyader L., 2014, NAT COMMUN, V6, P5839; Ostler T. A., 2012, NATURE COMMUN, V3, P1; Palik E. D., 1997, HDB OPTICAL CONSTANT; Savoini M., 2014, P SOC PHOTO-OPT INS, P9167; Savoini M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.140404; Vahaplar K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.117201; Schmising CV, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.217203	28	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6862	6868		10.1021/acs.nanolett.5b02743		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100087		
J	Dong, S; Trivedi, D; Chakrabortty, S; Kobayashi, T; Chan, Y; Prezhdo, OV; Loh, ZH				Dong, Shuo; Trivedi, Dhara; Chakrabortty, Sabyasachi; Kobayashi, Takayoshi; Chan, Yinthai; Prezhdo, Oleg V.; Loh, Zhi-Heng			Observation of an Excitonic Quantum Coherence in CdSe Nanocrystals	NANO LETTERS			English	Article						Electronic coherence; quantum dots; femtosecond optical spectroscopy; electron-phonon coupling; charge migration; non-Born-Oppenheimer dynamics	WAVE-PACKET; MOLECULAR-DYNAMICS; ELECTRON INJECTION; AB-INITIO; DOTS; SPECTROSCOPY; TEMPERATURE; NANOSTRUCTURES; PHOTOVOLTAICS; EXCITATION	Recent observations of excitonic coherences within photosynthetic complexes suggest that quantum coherences could enhance biological light harvesting efficiencies. Here, we employ optical pump-probe spectroscopy with few-femtosecond pulses to observe an excitonic quantum coherence in CdSe nanocrystals, a prototypical artificial light harvesting system. This coherence, which encodes the high-speed migration of charge over nanometer length scales, is also found to markedly alter the displacement amplitudes of phonons, signaling dynamics in the non-Born-Oppenheimer regime.	[Dong, Shuo; Loh, Zhi-Heng] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 637371, Singapore; [Dong, Shuo; Loh, Zhi-Heng] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore 637371, Singapore; [Trivedi, Dhara] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Chakrabortty, Sabyasachi; Chan, Yinthai] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Kobayashi, Takayoshi] Univ Electrocommun, Adv Ultrafast Laser Res Ctr, Chofu, Tokyo 1828585, Japan; [Kobayashi, Takayoshi] CREST, JST, Chiyoda Ku, Tokyo 1020076, Japan; [Kobayashi, Takayoshi] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 300, Taiwan; [Kobayashi, Takayoshi] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650971, Japan; [Chan, Yinthai] ASTAR, Inst Mat Res & Engn, Singapore 117602, Singapore; [Prezhdo, Oleg V.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Chan, Y (reprint author), Natl Univ Singapore, Dept Chem, 3 Sci Dr 3, Singapore 117543, Singapore.	chmchany@nus.edu.sg; prezhdo@usc.edu; zhiheng@ntu.edu.sg			NTU start-up grant; A*Star Science and Engineering Research Council Public Sector Funding [122-PSF-0011]; Nanyang Assistant Professorship; U.S. National Science Foundation [CHE-1300118]; National Research Foundation (NRF) Competitive Research Programme [NRF-CRP8-2011-07]; NRF Singapore-Berkeley Research Initiative for Sustainable Energy (SinBer-RISE) CREATE Programme	This work is supported by a NTU start-up grant, the A*Star Science and Engineering Research Council Public Sector Funding (122-PSF-0011), and the award of a Nanyang Assistant Professorship to Z.-H.L. O.V.P. acknowledges financial support from the U.S. National Science Foundation (CHE-1300118). Y.C. acknowledges financial support from the National Research Foundation (NRF) Competitive Research Programme (NRF-CRP8-2011-07) and the NRF Singapore-Berkeley Research Initiative for Sustainable Energy (SinBer-RISE) CREATE Programme.	Falke SM, 2014, SCIENCE, V344, P1001, DOI 10.1126/science.1249771; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Sagar DM, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235321; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Tyagi P, 2010, NANO LETT, V10, P3062, DOI 10.1021/nl101605r; Salvador MR, 2008, CHEM PHYS, V350, P56, DOI 10.1016/j.chemphys.2007.12.020; Asbury JB, 2001, J PHYS CHEM B, V105, P4545, DOI 10.1021/jp003485m; Yuen-Zhou J, 2014, ACS NANO, V8, P5527, DOI 10.1021/nn406107q; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/nchem.1145, 10.1038/NCHEM.1145]; Dekorsy T, 2000, PHYS REV LETT, V85, P1080, DOI 10.1103/PhysRevLett.85.1080; Dworak L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.247401; Li JL, 2013, J PHYS CHEM LETT, V4, P3698, DOI 10.1021/jz401987f; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; EFROS AL, 1992, PHYS REV B, V46, P7448, DOI 10.1103/PhysRevB.46.7448; Romero E, 2014, NAT PHYS, V10, P677, DOI [10.1038/nphys3017, 10.1038/NPHYS3017]; Bardeen CJ, 1997, CHEM PHYS LETT, V280, P127, DOI 10.1016/S0009-2614(97)01082-8; Madrid AB, 2009, ACS NANO, V3, P2487, DOI 10.1021/nn900584p; TENWOLDE A, 1988, PHYS REV LETT, V61, P2099, DOI 10.1103/PhysRevLett.61.2099; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Dobryakov AL, 2003, J CHEM PHYS, V119, P988, DOI 10.1063/1.1579672; STEIGERWALD ML, 1990, ACCOUNTS CHEM RES, V23, P183, DOI 10.1021/ar00174a003; Kuleff AI, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1961341; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Wong CY, 2011, J PHYS CHEM A, V115, P3797, DOI 10.1021/jp1079197; Kasuya A, 2004, NAT MATER, V3, P99, DOI 10.1038/nmat1056; Widulle F, 1999, PHYSICA B, V263, P448, DOI 10.1016/S0921-4526(98)01245-9; Mukamel S, 2013, J PHYS CHEM A, V117, P10563, DOI 10.1021/jp4071086; HUANG K, 1950, PROC R SOC LON SER-A, V204, P406, DOI 10.1098/rspa.1950.0184; MITTLEMAN DM, 1994, PHYS REV B, V49, P14435, DOI 10.1103/PhysRevB.49.14435; Puzder A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217401; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Kilina S, 2009, J AM CHEM SOC, V131, P7717, DOI 10.1021/ja9005749; Duncan WR, 2005, J AM CHEM SOC, V127, P7941, DOI 10.1021/ja042156v; Costi R, 2010, ANGEW CHEM INT EDIT, V49, P4878, DOI 10.1002/anie.200906010; Turner DB, 2012, NANO LETT, V12, P880, DOI 10.1021/nl2039502; Nie ZG, 2014, ACS NANO, V8, P10931, DOI 10.1021/nn504760x; Dorrer C, 2000, J OPT SOC AM B, V17, P1795, DOI 10.1364/JOSAB.17.001795; Caram JR, 2014, J PHYS CHEM LETT, V5, P196, DOI 10.1021/jz402336t; YEAZELL JA, 1990, PHYS REV LETT, V64, P2007, DOI 10.1103/PhysRevLett.64.2007; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Kamat PV, 2013, J PHYS CHEM LETT, V4, P908, DOI 10.1021/jz400052e; Lepine F, 2014, NAT PHOTONICS, V8, P195, DOI 10.1038/nphoton.2014.25; Norris DJ, 1996, PHYS REV B, V53, P16338, DOI 10.1103/PhysRevB.53.16338; Grumstrup EM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.257403; Habenicht BF, 2007, NANO LETT, V7, P3260, DOI 10.1021/nl0710699; Kumar ATN, 2001, J CHEM PHYS, V114, P701, DOI 10.1063/1.1329640; Wu KF, 2015, ACCOUNTS CHEM RES, V48, P851, DOI 10.1021/ar500398g; Graham MW, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3530582; Knowles KE, 2011, ACS NANO, V5, P2026, DOI 10.1021/nn2002689; TAKAGAHARA T, 1993, PHYS REV LETT, V71, P3577, DOI 10.1103/PhysRevLett.71.3577; Rossi F, 2002, REV MOD PHYS, V74, P895, DOI 10.1103/RevModPhys.74.895; Halpin A, 2014, NAT CHEM, V6, P196, DOI [10.1038/nchem.1834, 10.1038/NCHEM.1834]; Cerullo G, 1999, PHYS REV B, V60, P1928, DOI 10.1103/PhysRevB.60.1928; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; SCHULTHEIS L, 1986, PHYS REV B, V34, P9027, DOI 10.1103/PhysRevB.34.9027; Chuang CHM, 2014, NAT MATER, V13, P796, DOI [10.1038/nmat3984, 10.1038/NMAT3984]; SCHOENLEIN RW, 1993, PHYS REV LETT, V70, P1014, DOI 10.1103/PhysRevLett.70.1014; Nie ZG, 2013, J PHYS CHEM LETT, V4, P4260, DOI 10.1021/jz401945m; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Akimov AV, 2013, J PHYS CHEM LETT, V4, P3857, DOI 10.1021/jz402035z; Lunnemann S, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2970088; Benko G, 2002, J AM CHEM SOC, V124, P489, DOI 10.1021/ja016561n; Cassette E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7086; Dorfman KE, 2013, P NATL ACAD SCI USA, V110, P2746, DOI 10.1073/pnas.1212666110; Griffin GB, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4772465; Guo ZY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125415; Kambhampati P, 2011, ACCOUNTS CHEM RES, V44, P1, DOI 10.1021/ar1000428; Klimov V. I., 2000, J PHYS CHEM B, V104, P6112; Klimov VI, 2010, NANOCRYSTAL QUANTUM DOTS, SECOND EDITION, P1, DOI 10.1201/9781420079272; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; LAX M, 1952, J CHEM PHYS, V20, P1752, DOI 10.1063/1.1700283; Mukamel S., 1995, PRINCIPLES NONLINEAR; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Pelzer KM, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4704591; POLLARD WT, 1990, J CHEM PHYS, V92, P4012, DOI 10.1063/1.457815; Remacle F, 2006, P NATL ACAD SCI USA, V103, P6793, DOI 10.1073/pnas.0601855103; Rozzi C. A., 2013, NAT COMMUN, V4, P7; Schatz G. C., 2002, QUANTUM MECH CHEM; Shah J., 2013, ULTRAFAST SPECTROSCO	80	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					6875	6882		10.1021/acs.nanolett.5b02786		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100089		
J	Tanaka, YY; Komatsu, M; Fujiwara, H; Sasaki, K				Tanaka, Yoshito Y.; Komatsu, Masaya; Fujiwara, Hideki; Sasaki, Keiji			Nanoscale Color Sorting of Surface Plasmons in a Double-Nanogap Structure with Multipolar Plasmon Excitation	NANO LETTERS			English	Article						Nanogap; localized surface plasmon; color sorting; plasmonic interference; multipolar plasmon excitation	FIELDS; NANOANTENNA	We demonstrated a new plasmonic nanodevice that spatially sorts photons according to their colors on the nanoscale while maintaining their nano concentration. The properties of this nanoscale color sorting based on constructive and destructive interferences between different multipolar plasmon modes are controlled by tuning the incidence angle of the incoming photons. The added ability of color sorting and its manipulation could significantly influence the development of possible photonic applications, including nanoscale spectroscopy and sensing.	[Tanaka, Yoshito Y.; Komatsu, Masaya; Fujiwara, Hideki; Sasaki, Keiji] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010020, Japan	Sasaki, K (reprint author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010020, Japan.	sasaki@es.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science (JSPS); Nanotechnology Platform (Hokkaido University)	This work was supported by a Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Y.T. received financial support from the Japan Society for the Promotion of Science (JSPS). Part of this work was supported by the Nanotechnology Platform (Hokkaido University).	JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Schuck PJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.017402; Tanaka Y, 2011, OPT EXPRESS, V19, P7726, DOI 10.1364/OE.19.007726; Tanaka Y, 2013, NANO LETT, V13, P2146, DOI 10.1021/nl4005892; Zhang Z, 2009, NANO LETT, V9, P4505, DOI 10.1021/nl902850f; Sonnefraud Y, 2012, LASER PHOTONICS REV, V6, P277, DOI 10.1002/lpor.201100027; Xu HX, 1999, PHYS REV LETT, V83, P4357, DOI 10.1103/PhysRevLett.83.4357; Zhu WQ, 2011, SMALL, V7, P1761, DOI 10.1002/smll.201100371; Hao F, 2009, ACS NANO, V3, P643, DOI 10.1021/nn900012r; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Manjavacas A, 2011, NANO LETT, V11, P2318, DOI 10.1021/nl200579f; Xu HX, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.246802; Imura K, 2006, NANO LETT, V6, P2173, DOI 10.1021/nl061650p; Laux E, 2008, NAT PHOTONICS, V2, P161, DOI 10.1038/nphoton.2008.1; Aubry A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.233901; Holmgaard T, 2008, OPT EXPRESS, V16, P13585, DOI 10.1364/OE.16.013585; Savasta S, 2010, ACS NANO, V4, P6369, DOI 10.1021/nn100585h; Gucciardi PG, 2006, J APPL PHYS, V99, DOI 10.1063/1.2208527; Mayshev AV, 2008, NANO LETT, V8, P2369, DOI 10.1021/nl8011962; Tanaka Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00764; Xu T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1058	22	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	OCT	2015	15	10					7086	7090		10.1021/acs.nanolett.5b03147		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT7NZ	WOS:000363003100122		
J	Suzuki, H; Mod, H				Suzuki, Hidekazu; Mod, Hideki			HELICOBACTER PYLORI Helicobacter pylori gastritis-a novel distinct disease entity	NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY			English	Editorial Material							FUNCTIONAL DYSPEPSIA		[Suzuki, Hidekazu; Mod, Hideki] Keio Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Shinjuku Ku, Tokyo 1608582, Japan	Suzuki, H (reprint author), Keio Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hsuzuki.a6@keio.jp					Suzuki H, 2013, NAT REV GASTRO HEPAT, V10, P168, DOI 10.1038/nrgastro.2013.9; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; Sugano K, 2011, J NEUROGASTROENTEROL, V17, P366, DOI 10.5056/jnm.2011.17.4.366; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Zhao B, 2014, J CLIN GASTROENTEROL, V48, P241, DOI 10.1097/MCG.0b013e31829f2e25; Suzuki H, 2011, J GASTROEN HEPATOL, V26, P42, DOI 10.1111/j.1440-1746.2011.06629.x; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Saito Y, 2011, GASTROENTEROLOGY, V140, P189, DOI 10.1053/j.gastro.2010.08.044; Saka A., DIG ENDOSC; Tack, 2006, ROME 3 FUNCTIONAL GA, P419	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-5045	1759-5053		NAT REV GASTRO HEPAT	Nat. Rev. Gastroenterol. Hepatol.	OCT	2015	12	10					556	557		10.1038/nrgastro.2015.158		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CT6LT	WOS:000362925200004		
J	Motoki, T; Shimizu-Motohashi, Y; Komaki, H; Mori-Yoshimura, M; Oya, Y; Takeshita, E; Ishiyama, A; Saito, T; Nakagawa, E; Sugai, K; Murata, M; Sasaki, M				Motoki, Takahiro; Shimizu-Motohashi, Yuko; Komaki, Hirofumi; Mori-Yoshimura, Madoka; Oya, Yasushi; Takeshita, Eri; Ishiyama, Akihiko; Saito, Takashi; Nakagawa, Eiji; Sugai, Kenji; Murata, Miho; Sasaki, Masayuki			Treatable renal failure found in non-ambulatory Duchenne muscular dystrophy patients	NEUROMUSCULAR DISORDERS			English	Article						Renal failure; Duchenne muscular dystrophy; Non-ambulatory; Cystatin C; Chronic renal hypoperfusion	HOME NOCTURNAL VENTILATION; SERUM CYSTATIN-C; HEART-FAILURE; CREATININE; SURVIVAL; DISEASES; KIDNEY; ANEMIA; IMPACT	Duchenne muscular dystrophy (DMD) is a progressive muscular disorder in which respiratory and heart failures are the main causes of death. Intensive intervention in respiratory and cardiac function has dramatically improved the prognosis; however, dysfunction in other multiple organs may emerge in the later stages of the disease. We report the case of four non-ambulatory DMD patients who presented with renal failure. Common findings included decreased fluid intake, use of diuretics, and presence of chronic heart failure. The levels of serum cystatin C (CysC), a marker of kidney function unaffected by reduced muscle mass, were elevated in all four patients. In two patients, renal failure improved by increasing fluid intake, and discontinuing or reducing the dose of diuretics. The findings suggest that non-ambulatory DMD patients are at a risk of reduced kidney perfusion, which potentially leads to prerenal failure. Therefore, in DMD patients, dehydration signs and CysC levels should be monitored. (C) 2015 Elsevier B.V. All rights reserved.	[Motoki, Takahiro; Shimizu-Motohashi, Yuko; Komaki, Hirofumi; Takeshita, Eri; Ishiyama, Akihiko; Saito, Takashi; Nakagawa, Eiji; Sugai, Kenji; Sasaki, Masayuki] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo 1878551, Japan; [Mori-Yoshimura, Madoka; Oya, Yasushi; Murata, Miho] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo 1878551, Japan	Komaki, H (reprint author), Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Child Neurol, 4-1-1 Ogawahigashi Cho, Tokyo 1878551, Japan.	komakih@ncnp.go.jp			Intramural Research Grant for Neurological and Psychiatry Disorders of NCNP [26-6]	This study was supported by the Intramural Research Grant (26-6) for Neurological and Psychiatry Disorders of NCNP.	Kazama JJ, 2002, NEPHRON, V91, P13, DOI 10.1159/000057599; Cimerman N, 2000, CLIN CHIM ACTA, V300, P83, DOI 10.1016/S0009-8981(00)00298-9; Kimura H, 2010, HEART VESSELS, V25, P306, DOI 10.1007/s00380-009-1201-y; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Wang ZM, 1996, AM J CLIN NUTR, V63, P863; Viollet L, 2012, AM J CARDIOL, V110, P98, DOI 10.1016/j.amjcard.2012.02.064; Viollet L, 2009, MUSCLE NERVE, V40, P438, DOI 10.1002/mus.21420; Loh NY, 2000, J CELL SCI, V113, P2715; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Eagle M, 2007, NEUROMUSCULAR DISORD, V17, P470, DOI 10.1016/j.nmd.2007.03.002; Silverberg DS, 2006, SEMIN NEPHROL, V26, P296, DOI 10.1016/j.semnephrol.2006.05.006; Haenggi T, 2005, CELL TISSUE RES, V319, P299, DOI 10.1007/s00441-004-0999-y; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Braat Elke, 2015, Neuromuscul Disord, V25, P381, DOI 10.1016/j.nmd.2015.01.005; Imai E., 2012, JPN J NEPHROL, V54, P1031; Matsumura Tsuyoshi, 2012, Rinsho Shinkeigaku, V52, P211; Parsons E, 1998, SEMIN NEONATOL, V3, P27; Shimizu-Motohashi Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00050	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25	10					754	757		10.1016/j.nmd.2015.07.006		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6KZ	WOS:000362923200002		
J	Luo, SS; Zhu, WH; Yue, DY; Lin, J; Wang, Y; Zhu, Z; Qiu, WJ; Lu, JH; Hedberg-Oldfors, C; Oldfors, A; Zhao, CB				Luo, Sushan; Zhu, Wenhua; Yue, Dongyue; Lin, Jie; Wang, Yin; Zhu, Zhen; Qiu, Wenjuan; Lu, Jiahong; Hedberg-Oldfors, Carola; Oldfors, Anders; Zhao, Chongbo			Muscle pathology and whole-body MRI in a polyglucosan myopathy associated with a novel glycogenin-1 mutation	NEUROMUSCULAR DISORDERS			English	Article						GYG1 gene; Glycogenin-1; Polyglucosan myopathy; Whole-body imaging; Late-onset myopathy	STORAGE MYOPATHY; DEFICIENCY; METABOLISM; DISEASE	We report a 46-year-old female with late-onset skeletal myopathy affecting proximal limb muscles. Muscle biopsy revealed a polyglucosan myopathy with PAS-positive inclusions predominantly in glycogen-depleted fibers, which were demonstrated as type I fibers by ATPase staining. Whole-body magnetic imaging disclosed that the paravertebral, scapular, and pelvic girdle muscles, the anterior compartment of the arms, and the posterior compartment of the thighs were preferentially involved. Genetic analysis revealed a homozygous novel mutation in exon 6 of the glycogenin-1 gene (GYG1) (c.634C>T, p.His212Tyr). Protein, analysis revealed normal levels of glycogenin-1 even before alpha-amylase digestion indicating preserved protein expression but impaired glucosylation. In vitro functional assay demonstrated that this variant impaired the autoglucosylating ability resulting in a non-functional protein. We report a glycogenin-1 related myopathy with a distinct histopathology and unique muscle imaging pattern. (C) 2015 Elsevier B.V. All rights reserved.	[Luo, Sushan; Zhu, Wenhua; Yue, Dongyue; Lin, Jie; Lu, Jiahong; Zhao, Chongbo] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China; [Zhu, Wenhua] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Wang, Yin] Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai 200040, Peoples R China; [Zhu, Zhen] Shanghai Jiao Tong Univ, Childrens Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Qiu, Wenjuan] Shanghai Jiao Tong Univ, Dept Pediat Endocrinol Genet & Metab Dis, Shanghai Inst Pediat Res, Xinhua Hosp, Shanghai 200030, Peoples R China; [Hedberg-Oldfors, Carola; Oldfors, Anders] Univ Gothenburg, Dept Pathol, Inst Biomed, Gothenburg, Sweden; [Zhao, Chongbo] Jingan Dist Ctr Hosp Shanghai, Dept Neurol, Shanghai, Peoples R China	Oldfors, A (reprint author), Univ Gothenburg, Dept Pathol, Inst Biomed, Gothenburg, Sweden.	anders.oldfors@gu.se; zhao_chongbo@fudan.edu.cn					CALORE EE, 1992, REV NEUROL, V148, P696; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Nilsson J, 2012, BBA-MOL BASIS DIS, V1822, P493, DOI 10.1016/j.bbadis.2011.11.017; Mercuri E, 2002, NEUROMUSCULAR DISORD, V12, P631, DOI 10.1016/S0960-8966(02)00023-8; Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x; Oldfors A, 2013, CURR OPIN NEUROL, V26, P544, DOI 10.1097/WCO.0b013e328364dbdc; Miladi MI, 2005, CLIN NEUROPATHOL, V24, P126; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Raben N, 2001, NEUROLOGY, V56, P1739; Nilsson J, 2013, ANN NEUROL, V74, P914, DOI 10.1002/ana.23963; Gazzerro E, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0333-0; Malfatti E, 2014, ANN NEUROL, V76, P891, DOI 10.1002/ana.24284; Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661	13	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25	10					780	785		10.1016/j.nmd.2015.07.007		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6KZ	WOS:000362923200006		
J	Aartsma-Rus, A; Hoffman, E; Bucella, F; Flanigan, K; Kirschner, J; Kole, A; Mercuri, E; Nishino, I; North, K; Alonso, AP; Rahbek, J; Sejersen, T; Wood, M; Lynn, S; Robertson, A; Lochmuller, H; Straub, V; Bushby, K				Aartsma-Rus, A.; Hoffman, E.; Bucella, F.; Flanigan, K.; Kirschner, J.; Kole, A.; Mercuri, E.; Nishino, I.; North, K.; Alonso, A. Pereda; Rahbek, J.; Sejersen, T.; Wood, M.; Lynn, S.; Robertson, A.; Lochmueller, H.; Straub, V.; Bushby, K.			TREAT-NMD (translational research in Europe, assessment and treatment for neuromuscular disorders)	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Aartsma-Rus, A.] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands; [Hoffman, E.] Children Natl Med Ctr, Washington, DC USA; [Bucella, F.] Parent Project Onlus, Rome, Italy; [Flanigan, K.] Ohio State Univ, Columbus, OH 43210 USA; [Kirschner, J.] Univ Med Ctr Freiburg, Freiburg, Germany; [Kole, A.] EURORDIS, Paris, France; [Mercuri, E.] Univ Cattolica Sacro Cuore, Rome, Italy; [Nishino, I.] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [North, K.] Univ Melbourne, Melbourne, Vic, Australia; [Alonso, A. Pereda] Duchenne Parent Project Spain, Madrid, Spain; [Rahbek, J.] Natl Rehabil Ctr Neuromuscular Dis, Aarhus, Denmark; [Sejersen, T.] Karolinska Inst, Stockholm, Sweden; [Wood, M.] Univ Oxford, Oxford, England; [Lynn, S.; Robertson, A.; Lochmueller, H.; Straub, V.; Bushby, K.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.285	S271	S271		10.1016/j.nmd.2015.06.309		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400305		
J	Arakawa, M; Arakawa, R; Aoki, R; Nomoto, A; Saito, K; Shibasaki, M				Arakawa, M.; Arakawa, R.; Aoki, R.; Nomoto, A.; Saito, K.; Shibasaki, M.			A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Arakawa, M.; Nomoto, A.; Shibasaki, M.] Inst Microbial Chem, Tokyo 141, Japan; [Arakawa, R.; Aoki, R.; Saito, K.] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.24	S193	S194		10.1016/j.nmd.2015.06.039		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400035		
J	Benedetti, S; Hoshiya, H; Ragazzi, M; Uno, N; Kazuki, Y; Ferrari, G; Tonlorenzi, R; Lombardo, A; Mouly, V; Naldini, L; Messina, G; Oshimura, M; Cossu, G; Tedesco, F				Benedetti, S.; Hoshiya, H.; Ragazzi, M.; Uno, N.; Kazuki, Y.; Ferrari, G.; Tonlorenzi, R.; Lombardo, A.; Mouly, V.; Naldini, L.; Messina, G.; Oshimura, M.; Cossu, G.; Tedesco, F.			Reversible immortalization allows human artificial chromosome-mediated gene correction of human dystrophic muscle progenitor cells	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Benedetti, S.; Hoshiya, H.; Ragazzi, M.; Ferrari, G.; Tedesco, F.] UCL, Dept Cell & Dev Biol, London, England; [Uno, N.; Kazuki, Y.; Oshimura, M.] Tottori Univ, Dept Biomed Sci, Yonago, Tottori, Japan; [Tonlorenzi, R.] Hosp San Raffaele, Div Regenerat Med, I-20132 Milan, Italy; [Tonlorenzi, R.] Hosp San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Lombardo, A.; Naldini, L.] Hosp San Raffaele, Telethon Inst Gene Therapy, I-20132 Milan, Italy; [Mouly, V.] Univ Paris 06, Inst Myol, Paris, France; [Messina, G.] Univ Milan, Dept BioSci, Milan, Italy; [Cossu, G.] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.218	S252	S252		10.1016/j.nmd.2015.06.243		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400239		
J	Doki, T; Yamashita, S; Nishikami, T; Nakajou, Y; Matsuo, Y; Tawara, N; Maeda, Y; Hino, H; Uyama, E; Araki, K; Ando, Y				Doki, T.; Yamashita, S.; Nishikami, T.; Nakajou, Y.; Matsuo, Y.; Tawara, N.; Maeda, Y.; Hino, H.; Uyama, E.; Araki, K.; Ando, Y.			Phenotype analysis of transgenic mice expressing mutant PABPN1	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Doki, T.; Yamashita, S.; Nishikami, T.; Nakajou, Y.; Matsuo, Y.; Tawara, N.; Maeda, Y.; Ando, Y.] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan; [Hino, H.] Konan Hosp, Dept Neurol, Kumamoto, Japan; [Uyama, E.] Kumamoto Takumadai Rehabil Hosp, Dept Neurol, Kumamoto, Japan; [Araki, K.] Kumamoto Univ, Inst Resource Dev & Anal, Div Reprod Engn, Kumamoto, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.100	S216	S216		10.1016/j.nmd.2015.06.115		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400111		
J	Endo, Y; Noguchi, S; Dong, M; Ogawa, M; Hayashi, Y; Kuru, S; Sugiyama, K; Nagai, S; Ozasa, S; Nonaka, I; Nishino, I				Endo, Y.; Noguchi, S.; Dong, M.; Ogawa, M.; Hayashi, Y.; Kuru, S.; Sugiyama, K.; Nagai, S.; Ozasa, S.; Nonaka, I.; Nishino, I.			POMGNT2 mutations are associated with milder forms of limb girdle muscular dystrophy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Endo, Y.; Noguchi, S.; Ogawa, M.; Nonaka, I.; Nishino, I.] NCNP, Natl Inst Neurosci, Tokyo, Japan; [Dong, M.] China Japan Friendship Hosp, Beijing, Peoples R China; [Hayashi, Y.] Tokyo Med Univ, Tokyo 1608402, Japan; [Kuru, S.] Suzuka Hosp, Natl Hosp Org, Suzuka, Mie, Japan; [Sugiyama, K.] Mie Prefectual Gen Med Ctr, Yokaichi, Mie, Japan; [Nagai, S.] Shikoku Med Ctr Children & Adults, Kagawa, Japan; [Ozasa, S.] Kumamoto Univ, Kumamoto, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.275	S268	S268		10.1016/j.nmd.2015.06.299		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400295		
J	Gayi, E; Ismail, H; Neff, L; Patthey-Vuadens, O; Saibara, T; Toda, K; Ruegg, U; Scapozza, L; Dorchies, O				Gayi, E.; Ismail, H.; Neff, L.; Patthey-Vuadens, O.; Saibara, T.; Toda, K.; Ruegg, U.; Scapozza, L.; Dorchies, O.			Lack of estrogens aggravates the pathology in dystrophic mice	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Gayi, E.; Ismail, H.; Neff, L.; Patthey-Vuadens, O.; Ruegg, U.; Scapozza, L.; Dorchies, O.] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; [Saibara, T.; Toda, K.] Kochi Univ, Sch Med, Nankoku, Kochi, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.349	S290	S290		10.1016/j.nmd.2015.06.373		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400369		
J	Genno, H; Nishizawa, H; Shiba, N; Nakamura, A				Genno, H.; Nishizawa, H.; Shiba, N.; Nakamura, A.			A newly developed six-minute walking test for Duchenne muscular dystrophy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Genno, H.] Kissei Comtec Co Ltd, Corp Planning, Matsumoto, Nagano, Japan; [Nishizawa, H.] Shinshu Univ, Sch Hlth Sci, Dept Phys Therapy, Matsumoto, Nagano 390, Japan; [Shiba, N.] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Nakamura, A.] Shinshu Univ Hosp, Intractable Dis Care Ctr, Matsumoto, Nagano, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.143	S228	S228		10.1016/j.nmd.2015.06.158		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400154		
J	Inoue, M; Ishiyama, A; Komaki, H; Takeshita, E; Shimizu-Motohashi, Y; Saito, T; Nakagawa, E; Sugai, K; Minami, N; Goto, Y; Sasaki, M				Inoue, M.; Ishiyama, A.; Komaki, H.; Takeshita, E.; Shimizu-Motohashi, Y.; Saito, T.; Nakagawa, E.; Sugai, K.; Minami, N.; Goto, Y.; Sasaki, M.			Type-specific selectivity pattern of skeletal muscle images in spinal muscular atrophy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Inoue, M.; Ishiyama, A.; Komaki, H.; Takeshita, E.; Shimizu-Motohashi, Y.; Saito, T.; Nakagawa, E.; Sugai, K.; Sasaki, M.] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat NCNP, Dept Child Neurol, Tokyo, Japan; [Minami, N.] Natl Ctr Hosp, NCNP, Dept Lab Med, Tokyo, Japan; [Goto, Y.] NCNP, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.27	S194	S194		10.1016/j.nmd.2015.06.042		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400038		
J	Ishigaki, K; Kobayashi, H; Sugie, H; Fulcuda, T; Murakami, T; Sato, T; Ishiguro, K; Shichiji, M; Nagata, S; Osawa, M; Eto, Y; Nonaka, I				Ishigaki, K.; Kobayashi, H.; Sugie, H.; Fulcuda, T.; Murakami, T.; Sato, T.; Ishiguro, K.; Shichiji, M.; Nagata, S.; Osawa, M.; Eto, Y.; Nonaka, I.			Characteristic skeletal muscle imaging patterns in Japanese patients with Pompe disease	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Ishigaki, K.; Murakami, T.; Sato, T.; Ishiguro, K.; Shichiji, M.; Nagata, S.; Osawa, M.] Tokyo Womens Med Univ, Sch Med, Pediat, Tokyo, Japan; [Kobayashi, H.] Jikei Univ, Sch Med, Pediat, Tokyo, Japan; [Sugie, H.] Tokoha Univ, Occupat Therapy, Med Sci, Hamamatsu, Shizuoka, Japan; [Fulcuda, T.] Hamamatsu Univ, Sch Med, Pediat, Hamamatsu, Shizuoka 4312102, Japan; [Eto, Y.] Inst Neurol Disorders, Adv Clin Res Ctr, Kawasaki, Kanagawa, Japan; [Nonaka, I.] Natl Ctr Neurol & Psychiat, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.11	S190	S190		10.1016/j.nmd.2015.06.026		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400022		
J	Ishigruo, K; Ishigaki, K; Sato, T; Murakami, T; Shichiji, M; Saito, K; Osawa, M; Nagata, S				Ishigruo, K.; Ishigaki, K.; Sato, T.; Murakami, T.; Shichiji, M.; Saito, K.; Osawa, M.; Nagata, S.			Correlation between crural muscle fatty change and maximum motor function in Fukuyama congenital muscular dystrophy patients	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Ishigruo, K.; Ishigaki, K.; Sato, T.; Murakami, T.; Shichiji, M.; Osawa, M.; Nagata, S.] Tokyo Womens Med Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Saito, K.] Tokyo Womens Med Univ, Inst Med Genet, Sch Med, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.269	S266	S267		10.1016/j.nmd.2015.06.293		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400289		
J	Ishii, A; Yoshida, M; Ohkoshi, N; Tamaoka, A				Ishii, A.; Yoshida, M.; Ohkoshi, N.; Tamaoka, A.			The effect of antioxidants in muscle regeneration process	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Ishii, A.; Tamaoka, A.] Univ Tsukuba, Neurol, Tsukuba, Ibaraki 3058575, Japan; [Yoshida, M.] Univ Tokyo, Tokyo, Japan; [Ohkoshi, N.] Tsukuba Univ Technol, Neurol, Tsukuba, Ibaraki, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.106	S217	S217		10.1016/j.nmd.2015.06.121		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400117		
J	Ishiyama, A; Sakai, C; Endo, Y; Mitsuhashi, S; Noguchi, S; Matsushima, Y; Hayashi, Y; Komaki, H; Sugai, K; Sasaki, M; Nonaka, I; Goto, Y; Nishino, I				Ishiyama, A.; Sakai, C.; Endo, Y.; Mitsuhashi, S.; Noguchi, S.; Matsushima, Y.; Hayashi, Y.; Komaki, H.; Sugai, K.; Sasaki, M.; Nonaka, I.; Goto, Y.; Nishino, I.			Mutations in iron-sulfur cluster assembly gene IBA57 cause progressive cavitating leukoencephalopathy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Ishiyama, A.; Komaki, H.; Sugai, K.; Sasaki, M.] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Natl Ctr Hosp, Tokyo, Japan; [Sakai, C.; Goto, Y.] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect, Natl Inst Neurosci, Tokyo, Japan; [Endo, Y.; Mitsuhashi, S.; Noguchi, S.; Nonaka, I.; Nishino, I.] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Tokyo, Japan; [Matsushima, Y.] Kyushu Univ, Dept Lab Med, Grad Sch Med Sci, Fukuoka 812, Japan; [Hayashi, Y.] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.60	S204	S204		10.1016/j.nmd.2015.06.075		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400071		
J	Kohashi, K; Ishiyama, A; Takeshita, E; Shimizu-Motohashi, Y; Saito, T; Nakagawa, E; Komaki, H; Sugai, K; Nishino, I; Saito, W; Takaso, M; Sasaki, M				Kohashi, K.; Ishiyama, A.; Takeshita, E.; Shimizu-Motohashi, Y.; Saito, T.; Nakagawa, E.; Komaki, H.; Sugai, K.; Nishino, I.; Saito, W.; Takaso, M.; Sasaki, M.			Early scoliosis surgery may prevent deterioration of respiratory function in Ullrich congenital muscular dystrophy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Kohashi, K.; Ishiyama, A.; Takeshita, E.; Shimizu-Motohashi, Y.; Saito, T.; Nakagawa, E.; Komaki, H.; Sugai, K.; Sasaki, M.] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan; [Nishino, I.] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan; [Saito, W.; Takaso, M.] Kitasato Univ, Sch Med, Dept Orthoped Surg, Yokohama, Kanagawa, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.262	S264	S265		10.1016/j.nmd.2015.06.286		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400282		
J	Komalki, H; Nagata, T; Saito, T; Masuda, S; Takeshita, E; Tachimori, H; Sasaki, M; Takeda, S				Komalki, H.; Nagata, T.; Saito, T.; Masuda, S.; Takeshita, E.; Tachimori, H.; Sasaki, M.; Takeda, S.			Exon 53 skipping of the dystrophin gene in patients with Duchenne muscular dystrophy by systemic administration of NS-065/NCNP-01: A phase 1, dose escalation, first-in-human study	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Komalki, H.; Takeshita, E.; Sasaki, M.] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan; [Nagata, T.; Saito, T.; Masuda, S.; Takeda, S.] Natl Ctr Neurol & Psychiat, Dept Mol Therapy, Tokyo, Japan; [Tachimori, H.] Natl Ctr Neurol & Psychiat, Dept Mental Hlth Policy & Evaluat, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.251	S261	S262		10.1016/j.nmd.2015.06.276		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400272		
J	Kurashige, T; Morino, H; Nagano, Y; Maruyama, H; Matsumoto, M				Kurashige, T.; Morino, H.; Nagano, Y.; Maruyama, H.; Matsumoto, M.			Rimmed vacuoles are positive for RIPK1 and RIPK3	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Kurashige, T.] NHO Kure Med Ctr, Dept Neurol, Kure, Japan; [Morino, H.] Hiroshima Univ, Dept Epidemiol, Res Inst, Hiroshima, Japan; [Nagano, Y.; Maruyama, H.; Matsumoto, M.] Hiroshima Univ, Dept Clin Neurosci & Therapeut, Hiroshima, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.179	S238	S238		10.1016/j.nmd.2015.06.194		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400190		
J	Lee, J; Jang, H; Kim, S; Shin, J				Lee, J.; Jang, H.; Kim, S.; Shin, J.			Genetic profiles in patients with nemaline myopathy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Lee, J.] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan; [Jang, H.; Shin, J.] Pusan Natl Univ, Yangsan Hosp, Dept Neurol, Yangsan, South Korea; [Kim, S.] Ulsan Univ Hosp, Dept Neurol, Ulsan, South Korea								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.343	S289	S289		10.1016/j.nmd.2015.06.367		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400363		
J	Liang, W; Chou, P; Kan, T; Su, Y; Hayashi, Y; Nishino, I; Jong, Y				Liang, W.; Chou, P.; Kan, T.; Su, Y.; Hayashi, Y.; Nishino, I.; Jong, Y.			Probable high prevalence of limb-girdle muscular dystrophy type 2D in the aboriginal tribes settled in southern Taiwan	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Liang, W.] Kaohsiung Med Univ, Coll Med, Sch Med, Pediat, Kaohsiung, Taiwan; [Chou, P.; Kan, T.] Kaohsiung Med Univ, Dept Pediat, Kaohsiung, Taiwan; [Su, Y.] Natl Taiwan Univ Hosp, Dept Genet, Taipei, Taiwan; [Hayashi, Y.] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan; [Nishino, I.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Jong, Y.] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Coll Biol Sci & Technol, Hsinchu, Taiwan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.163	S233	S234		10.1016/j.nmd.2015.06.178		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400174		
J	Matsui, M; Saitou, T; Matsumura, T; Toyooka, K; Inoue, K; Fujimura, H; Sakoda, S				Matsui, M.; Saitou, T.; Matsumura, T.; Toyooka, K.; Inoue, K.; Fujimura, H.; Sakoda, S.			The importance of screening for late onset Pompe disease in neuromuscular disorders	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Matsui, M.; Inoue, K.; Sakoda, S.] Toneyama Natl Hosp, Neurol, Toyonaka, Osaka, Japan; [Saitou, T.; Matsumura, T.; Toyooka, K.; Fujimura, H.] Toneyama Natl Hosp, Toyonaka, Osaka, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.3	S187	S187		10.1016/j.nmd.2015.06.018		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400014		
J	Mitsuhashi, S; Nishikawa, A; Zhu, W; Termglinchan, T; Shin, J; Takayama, K; Uruha, A; Endo, Y; Noguchi, S; Nishino, I				Mitsuhashi, S.; Nishikawa, A.; Zhu, W.; Termglinchan, T.; Shin, J.; Takayama, K.; Uruha, A.; Endo, Y.; Noguchi, S.; Nishino, I.			High-throughput genetic testing for muscle disease and an exome database of the undiagnosed in Japan	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Mitsuhashi, S.; Nishikawa, A.; Zhu, W.; Termglinchan, T.; Shin, J.; Takayama, K.; Uruha, A.; Endo, Y.; Noguchi, S.; Nishino, I.] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.374	S297	S298		10.1016/j.nmd.2015.06.398		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400394		
J	Mori, Y; Yamaji, J; Hiroshima, R; Nakano, T; Watanabe, M; Miyazaki, A				Mori, Y.; Yamaji, J.; Hiroshima, R.; Nakano, T.; Watanabe, M.; Miyazaki, A.			Enhancement of myosin heavy chain class I (MHC I) mRNA expression in C2C12 myocyte by multivalent cations	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Mori, Y.; Hiroshima, R.; Nakano, T.; Watanabe, M.] Kansai Univ Welf Sci, Dept Rehabil, Kashiwara, Japan; [Yamaji, J.] Kansai Univ Welf Sci, Dept Nutr Sci, Kashiwara, Japan; [Miyazaki, A.] Osaka Med Coll, Dept Clin Pathol, Takatsuki, Osaka 569, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.413	S309	S309		10.1016/j.nmd.2015.06.437		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400433		
J	Murakami, T; Uchiyama, T; Nakayama, T; Ishiguro, K; Sato, T; Kuru, S; Ishigaki, K				Murakami, T.; Uchiyama, T.; Nakayama, T.; Ishiguro, K.; Sato, T.; Kuru, S.; Ishigaki, K.			Assessment of growth and development in patients with Fukuyama congenital muscular dystrophy using bioelectrical impedance analysis	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Murakami, T.] Tokyo Womens Med Univ, Pediat, Tokyo, Japan; [Uchiyama, T.] Tanita Body Weight Sci Inst, Tokyo, Japan; [Nakayama, T.] Yokohama Rosai Hosp, Neurol, Yokohama, Kanagawa, Japan; [Ishiguro, K.; Sato, T.; Ishigaki, K.] Tokyo Womens Med Univ, Tokyo, Japan; [Kuru, S.] Suzuka Natl Hosp, Neurol, Suzuka, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.270	S267	S267		10.1016/j.nmd.2015.06.294		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400290		
J	Nakajou, Y; Maeda, Y; Yonemochi, Y; Doki, T; Tawara, N; Yamashita, S; Ando, Y				Nakajou, Y.; Maeda, Y.; Yonemochi, Y.; Doki, T.; Tawara, N.; Yamashita, S.; Ando, Y.			Influence of mesenchymal stem cell on STAT signalling pathway in muscle satellite cell	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Nakajou, Y.; Yonemochi, Y.; Doki, T.; Tawara, N.; Yamashita, S.; Ando, Y.] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan; [Maeda, Y.] Kumamoto Saishunso Natl Hosp, Kumamoto, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.111	S219	S219		10.1016/j.nmd.2015.06.126		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400122		
J	Nishida, A; Minegishi, M; Takeuchi, A; Niba, T; Awano, H; Lee, T; Iijima, K; Takeshima, Y; Matsuo, M				Nishida, A.; Minegishi, M.; Takeuchi, A.; Niba, T.; Awano, H.; Lee, T.; Iijima, K.; Takeshima, Y.; Matsuo, M.			Tissue- and case-specific retention of intron 40 in mature dystrophin mRNA	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Nishida, A.; Niba, T.; Matsuo, M.] Kobegakuin Univ, Kobe, Hyogo, Japan; [Minegishi, M.; Takeuchi, A.] Kobe Pharmaceut Univ, Kobe, Hyogo 658, Japan; [Awano, H.; Lee, T.; Iijima, K.] Kobe Univ, Kobe, Hyogo 657, Japan; [Takeshima, Y.] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.221	S253	S253		10.1016/j.nmd.2015.06.246		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400242		
J	Nishikawa, A; Mitsuhashi, S; Mitsuhashi, H; Uruha, A; Noguchi, S; Nishino, I				Nishikawa, A.; Mitsuhashi, S.; Mitsuhashi, H.; Uruha, A.; Noguchi, S.; Nishino, I.			A novel LMNA mutation causes severe congenital phenotype with cytoplasmic bodies	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Nishikawa, A.; Mitsuhashi, S.; Uruha, A.; Noguchi, S.; Nishino, I.] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan; [Mitsuhashi, H.] Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa 25912, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.311	S279	S279		10.1016/j.nmd.2015.06.335		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400331		
J	Noguchi, S; Dong, M; Endo, Y; Hayashi, Y; Yoshida, S; Nonaka, I; Nishino, I				Noguchi, S.; Dong, M.; Endo, Y.; Hayashi, Y.; Yoshida, S.; Nonaka, I.; Nishino, I.			DAG1 mutations associated with asymptomatic hyperCKemia and hypoglycosylation of alpha-dystroglycan	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Noguchi, S.; Dong, M.; Endo, Y.; Nonaka, I.; Nishino, I.] NCNP, Natl Inst Neurosci, Tokyo, Japan; [Hayashi, Y.] Tokyo Med Univ, Tokyo 1608402, Japan; [Yoshida, S.] Omihachiman Community Med Ctr, Omihachiman, Shiga, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.274	S268	S268		10.1016/j.nmd.2015.06.298		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400294		
J	Ohswa, Y; Fukai, Y; Nishimatsu, S; Fujino, M; Sunada, Y				Ohswa, Y.; Fukai, Y.; Nishimatsu, S.; Fujino, M.; Sunada, Y.			Molecular interaction of caveolin-3 and nNOS: Implication in the pathogenesis of limb-girdle muscular dystrophy 1C	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Ohswa, Y.; Fukai, Y.; Sunada, Y.] Kawasaki Med Univ, Dept Neurol, Kurashiki, Okayama, Japan; [Nishimatsu, S.] Kawasaki Med Univ, Dept Mol & Dev Biol, Kurashiki, Okayama, Japan; [Fujino, M.] Kawasaki Univ Med Welf, Kurashiki, Okayama, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.172	S236	S236		10.1016/j.nmd.2015.06.187		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400183		
J	Saito, T; Takahashi, T; Kura, S; Suzuki, M; Matsumura, T; Fujimura, H; Sakoda, S				Saito, T.; Takahashi, T.; Kura, S.; Suzuki, M.; Matsumura, T.; Fujimura, H.; Sakoda, S.			Changes in clinical condition and causes of death of inpatients with myotonic dystrophy in Japan	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Saito, T.] Toneyama Natl Hosp, Child Neurol, Toyonaka, Osaka 5608552, Japan; [Takahashi, T.] Natl Sendai Nishitaga Hosp, Neurol, Sendai, Miyagi, Japan; [Kura, S.] Natl Suzuka Hosp, Neurol, Suzuka, Japan; [Suzuki, M.] Natl Higashisaitama Hosp, Neurol, Hasuda, Japan; [Matsumura, T.; Fujimura, H.; Sakoda, S.] Toneyama Natl Hosp, Neurol, Toyonaka, Osaka, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.88	S212	S212		10.1016/j.nmd.2015.06.103		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400099		
J	Sato, T; Ishigaki, K; Zushi, M; Adachi, M; Goto, K; Akiduki, M; Ishiguro, K; Shichiji, M; Murakami, T; Saito, K; Osawa, M; Ikai, T; Kondo, I; Nagata, S				Sato, T.; Ishigaki, K.; Zushi, M.; Adachi, M.; Goto, K.; Akiduki, M.; Ishiguro, K.; Shichiji, M.; Murakami, T.; Saito, K.; Osawa, M.; Ikai, T.; Kondo, I.; Nagata, S.			The gross motor function measure is a valid scale for assessing Fukuyama congenital muscular dystrophy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Sato, T.; Ishigaki, K.; Ishiguro, K.; Shichiji, M.; Murakami, T.; Osawa, M.; Nagata, S.] Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan; [Zushi, M.; Adachi, M.; Goto, K.; Akiduki, M.; Ikai, T.] Tokyo Womens Med Univ, Dept Rehabil, Tokyo, Japan; [Saito, K.] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan; [Kondo, I.] Natl Hosp Geriatr Med, Dept Rehabil Med, Nagoya, Aichi, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.271	S267	S267		10.1016/j.nmd.2015.06.295		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400291		
J	Seko, D; Hisamatsu, T; Fujita, R; Yoshioka, K; Urata, Y; Goto, S; Li, T; Taimura, A; Ono, Y				Seko, D.; Hisamatsu, T.; Fujita, R.; Yoshioka, K.; Urata, Y.; Goto, S.; Li, T.; Taimura, A.; Ono, Y.			The FSHD-related protein mu-crystallin controls metabolic and contractile properties in skeletal muscle	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Seko, D.; Hisamatsu, T.; Fujita, R.; Yoshioka, K.; Urata, Y.; Goto, S.; Li, T.; Ono, Y.] Atom Bomb Dis Inst, Dept Stem Cell Biol, Nagasaki, Japan; [Taimura, A.] Nagasaki Univ, Grad Sch Fisheries Sci & Environm, Div Environm Chem & Ecotoxicol, Nagasaki 852, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.97	S215	S215		10.1016/j.nmd.2015.06.112		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400108		
J	Selcen, D; Ohkawara, B; Shen, X; McEvoy, K; Ohno, K; Engel, A				Selcen, D.; Ohkawara, B.; Shen, X.; McEvoy, K.; Ohno, K.; Engel, A.			LRP4 myasthenia: Investigation of a second kinship reveals impaired development and maintenance of the neuromuscular junction	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Selcen, D.; Shen, X.; McEvoy, K.; Engel, A.] Mayo Clin, Neurol, Rochester, MN USA; [Ohkawara, B.; Ohno, K.] Nagoya Univ, Grad Sch Med, Neurogenet, Nagoya, Aichi 4648601, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.O.6	S186	S187		10.1016/j.nmd.2015.06.015		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400011		
J	Shiba, N; Miyazakaki, D; Yoshizawa, T; Fukushima, K; Imamura, M; Takeda, S; Nakamura, A				Shiba, N.; Miyazakaki, D.; Yoshizawa, T.; Fukushima, K.; Imamura, M.; Takeda, S.; Nakamura, A.			Ablation of MMP-9 promotes resolution of inflammation and regeneration by modulating chemotaxis in early stage but exacerbates fibrosis in late stage in mdx mice	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Shiba, N.] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Miyazakaki, D.] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 390, Japan; [Yoshizawa, T.] Shinshu Univ, Div Lab Anim Res, Res C, Matsumoto, Nagano 390, Japan; [Fukushima, K.; Nakamura, A.] Shinshu Univ, Sch Med, Intractable Dis Care Ctr, Matsumoto, Nagano 390, Japan; [Imamura, M.; Takeda, S.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.359	S293	S293		10.1016/j.nmd.2015.06.383		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400379		
J	Shichiji, M; Ishigaki, K; Ishiguro, K; Sato, T; Murakami, T; Muto, A; Osawa, M; Nagata, S				Shichiji, M.; Ishigaki, K.; Ishiguro, K.; Sato, T.; Murakami, T.; Muto, A.; Osawa, M.; Nagata, S.			Perinatal complications in patients with congenital myotonic dystrophy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Shichiji, M.; Ishigaki, K.; Ishiguro, K.; Sato, T.; Murakami, T.; Osawa, M.; Nagata, S.] Tokyo Womens Med Univ, Pediat, Tokyo, Japan; [Muto, A.] Tokyo Womens Med Univ, Yachiyo Med Ctr, Pediat, Chiba, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.85	S211	S211		10.1016/j.nmd.2015.06.100		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400096		
J	Sugie, K; Sugie, M; Taoka, T; Tonomura, Y; Kumazawa, A; Izumi, T; Ueno, S; Kichikawa, K				Sugie, K.; Sugie, M.; Taoka, T.; Tonomura, Y.; Kumazawa, A.; Izumi, T.; Ueno, S.; Kichikawa, K.			Characteristic Mill findings of upper limb muscle involvement in myotonic dystrophy type 1	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Sugie, K.; Tonomura, Y.; Kumazawa, A.; Izumi, T.; Ueno, S.] Nara Med Univ, Neurol, Nara, Japan; [Sugie, M.] Nara Prefectural Rehabil Ctr, Neurol, Nara, Japan; [Taoka, T.; Kichikawa, K.] Nara Med Univ, Radiol, Nara, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.288	S272	S272		10.1016/j.nmd.2015.06.312		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400308		
J	Sunada, Y; Ohsawa, Y; Fukai, Y; Fujino, M; Nishimatsu, S; Ohta, S				Sunada, Y.; Ohsawa, Y.; Fukai, Y.; Fujino, M.; Nishimatsu, S.; Ohta, S.			Taurine supplemental therapy in prevention of stroke-like episodes in MELAS	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Sunada, Y.; Ohsawa, Y.; Fukai, Y.] Kawasaki Med Univ, Neurol, Kurashiki, Okayama, Japan; [Fujino, M.] Kawasaki Univ Med Welf, Hlth & Sports Sci, Kurashiki, Okayama, Japan; [Nishimatsu, S.] Kawasaki Med Univ, Mol & Dev Biol, Kurashiki, Okayama, Japan; [Ohta, S.] Nippon Med Sch, Dev & Aging Sci, Kawasaki, Kanagawa, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.O.19	S313	S313		10.1016/j.nmd.2015.06.452		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400448		
J	Takayama, K; Mitsuhashi, S; Nonaka, I; Noguchi, S; Nishino, I				Takayama, K.; Mitsuhashi, S.; Nonaka, I.; Noguchi, S.; Nishino, I.			Gene mutation screening using whole exome sequencing in lipid storage myopathy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Takayama, K.; Mitsuhashi, S.; Nonaka, I.; Noguchi, S.; Nishino, I.] Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.59	S204	S204		10.1016/j.nmd.2015.06.074		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400070		
J	Takeuchi, F; Komaki, H; Nakamura, H; Yonemoto, N; Kashiwabara, K; Kimura, E; Takeda, S				Takeuchi, F.; Komaki, H.; Nakamura, H.; Yonemoto, N.; Kashiwabara, K.; Kimura, E.; Takeda, S.			Trends of steroid therapy for Duchenne muscular dystrophy in Japan	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Takeuchi, F.] NCNP, TMC, Dept Clin Res Support, Tokyo, Japan; [Komaki, H.] Natl Ctr Hosp, NCNP, Dept Child Neurol, Tokyo, Japan; [Nakamura, H.; Kimura, E.] NCNP, TMC, Dept Clin Res Support, Tokyo, Japan; [Yonemoto, N.] NCNR, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, Tokyo, Japan; [Kashiwabara, K.] NCNP, TMC, Dept Clin Epidemiol, Tokyo, Japan; [Takeda, S.] NCNP, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.43	S199	S199		10.1016/j.nmd.2015.06.058		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400054		
J	Tanboon, J; Noguchi, S; Mitsuhashi, S; Nishino, I				Tanboon, J.; Noguchi, S.; Mitsuhashi, S.; Nishino, I.			Homozygous splicing mutation in ISPD gene in a girl with Walker-Warburg syndrome	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Tanboon, J.; Noguchi, S.; Mitsuhashi, S.; Nishino, I.] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.273	S268	S268		10.1016/j.nmd.2015.06.297		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400293		
J	Tawara, N; Yamashita, S; Nishikami, T; Nakajou, Y; Doki, T; Matsuo, Y; Yonemochi, Y; Maeda, Y; Ando, Y				Tawara, N.; Yamashita, S.; Nishikami, T.; Nakajou, Y.; Doki, T.; Matsuo, Y.; Yonemochi, Y.; Maeda, Y.; Ando, Y.			A single center analysis of the clinicopathological findings of anti-cytosolic 5 '-nucleotidase 1a antibody-positive sporadic inclusion body myositis	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Tawara, N.; Yamashita, S.; Nishikami, T.; Nakajou, Y.; Doki, T.; Matsuo, Y.; Yonemochi, Y.; Maeda, Y.; Ando, Y.] Kumamoto Univ, Dept Neurol, Grad Sch Med Sci, Kumamoto, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.182	S239	S239		10.1016/j.nmd.2015.06.197		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400193		
J	Uruha, A; Noguchi, S; Sato, W; Nishimura, H; Mitsuhashi, S; Yamamura, T; Nishino, I				Uruha, A.; Noguchi, S.; Sato, W.; Nishimura, H.; Mitsuhashi, S.; Yamamura, T.; Nishino, I.			Plasma IP-10 level distinguishes inflammatory myopathy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Uruha, A.; Noguchi, S.; Nishimura, H.; Mitsuhashi, S.; Nishino, I.] Natl Inst Neurosci, NCNP, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan; [Sato, W.; Yamamura, T.] Natl Inst Neurosci, NCNP, Dept Immunol, Kodaira, Tokyo 187, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.209	S249	S249		10.1016/j.nmd.2015.06.234		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400230		
J	Velardo, D; Domi, T; Porrello, E; Capotondo, A; Biffi, A; Tonlorenzi, R; Takeda, S; Amadio, S; Ruegg, M; Previtali, S				Velardo, D.; Domi, T.; Porrello, E.; Capotondo, A.; Biffi, A.; Tonlorenzi, R.; Takeda, S.; Amadio, S.; Ruegg, M.; Previtali, S.			Combined cell and gene therapy to treat merosin deficient congenital muscular dystrophy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Velardo, D.; Domi, T.; Porrello, E.; Tonlorenzi, R.; Previtali, S.] Univ Milan, Osped San Raffaele, Neurosci, I-20127 Milan, Italy; [Capotondo, A.; Biffi, A.] Univ Milan, Osped San Raffaele, Regenerat Med, I-20127 Milan, Italy; [Takeda, S.] Natl Inst Neurosci, Mol Therapy, Tokyo, Japan; [Amadio, S.] Univ Milan, Osped San Raffaele, Neurol, I-20127 Milan, Italy; [Ruegg, M.] Univ Basel, Biozentrum, Basel, Switzerland								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.281	S270	S270		10.1016/j.nmd.2015.06.305		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400301		
J	Yamaji, J; Mori, Y; Hiroshima, R; Watanabe, M; Miyazaki, A				Yamaji, J.; Mori, Y.; Hiroshima, R.; Watanabe, M.; Miyazaki, A.			Contribution of IL-6-dependent signalling mechanism to upregulation of MyHC IIb mRNA but not of MyHC IIa mRNA in mouse myocytes	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Yamaji, J.] Kansai Univ Welf Sci, Dept Nutr Sci, Kashiwara, Japan; [Mori, Y.; Hiroshima, R.; Watanabe, M.] Kansai Univ Welf Sci, Dept Rehabil, Kashiwara, Japan; [Miyazaki, A.] Osaka Med Coll, Dept Clin Pathol, Takatsuki, Osaka 569, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.414	S309	S309		10.1016/j.nmd.2015.06.438		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400434		
J	Yamashita, S; Nishikami, T; Tawara, N; Doki, T; Nakajo, Y; Matsuo, Y; Yonemochi, Y; Nagai, M; Maeda, Y; Ando, Y				Yamashita, S.; Nishikami, T.; Tawara, N.; Doki, T.; Nakajo, Y.; Matsuo, Y.; Yonemochi, Y.; Nagai, M.; Maeda, Y.; Ando, Y.			Analysis of the pathogenesis of vocal cord and pharyngeal weakness with distal myopathy	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Yamashita, S.; Nishikami, T.; Tawara, N.; Doki, T.; Nakajo, Y.; Matsuo, Y.; Yonemochi, Y.; Maeda, Y.; Ando, Y.] Kumamoto Univ, Grad Sch Med Sci, Neurol, Kumamoto, Japan; [Nagai, M.] Kitasato Univ, Sch Med, Neuroregenerat Med, Sagamihara, Kanagawa 228, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.321	S282	S282		10.1016/j.nmd.2015.06.345		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400341		
J	Zhu, W; Mitsuhashi, S; Liang, W; Ito, T; Nishino, I				Zhu, W.; Mitsuhashi, S.; Liang, W.; Ito, T.; Nishino, I.			Novel variant blossom: From pathology to next generation sequencing to cellular biology	NEUROMUSCULAR DISORDERS			English	Meeting Abstract	20th International Congress of the World-Muscle-Society	SEP 30-OCT 04, 2015	Brighton, ENGLAND	World Muscle Soc					[Zhu, W.; Mitsuhashi, S.; Nishino, I.] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan; [Liang, W.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Ito, T.] Matsudo City Hosp, Dept Neurol, Chiba, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	OCT	2015	25			2		G.P.375	S298	S298		10.1016/j.nmd.2015.06.399		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT6LV	WOS:000362925400395		
J	Iwasaki, K; Yabushita, H; Ueno, T; Wakatsuki, A				Iwasaki, Keita; Yabushita, Hiromitsu; Ueno, Taiki; Wakatsuki, Akihiko			Role of hypoxia-inducible factor-1 alpha, carbonic anhydrase-IX, glucose transporter-1 and vascular endothelial growth factor associated with lymph node metastasis and recurrence in patients with locally advanced cervical cancer	ONCOLOGY LETTERS			English	Article						hypoxia-inducible factor-1 alpha; carbonic anhydrase-IX; glucose transporter-1; vascular endothelial growth factor; immunohistochemistry; cervical cancer	CELL LUNG-CANCER; ADVANCED-CARCINOMA; PROGNOSTIC-FACTOR; GENE-EXPRESSION; BREAST-CANCER; FACTOR VEGF; SURVIVAL; THERAPY; OVEREXPRESSION; RADIOTHERAPY	The aim of the present study was to determine whether the expression of hypoxia-inducible factor-la (HIF-1 alpha), carbonic anhydrase-IX (CA-IX), glucose transporter-1 (GLUT-1) or vascular endothelial growth factor (VEGF) was associated with the clinicopathological characteristics, lymph node metastasis or progression-free survival of patients with cervical cancer. Tumor tissue samples were obtained from 54 cervical cancer patients who had undergone radical hysterectomy. The expression of HIF-1 alpha, CA-IX, GLUT-1 and VEGF was analyzed by immunohistochemical staining. Of the 54 cases, 28 were positive for HIF-1 alpha, 35 for CA-IX, 40 for GLUT-1 and 23 for VEGF. It was revealed that HIF-1 alpha expression was correlated with tumor stage and histology, CA-IX expression with tumor stage, tumor size, lymph node metastasis and lymph-vascular space involvement, GLUT-1 expression with tumor stage and lymph-vascular space involvement, and VEGF expression with microvessel density. The multivariate regression analysis indicated that CA-IX expression and lymph-vascular space involvement were independent variables associated with lymph node metastasis. Progression-free survival was shorter for patients who were positive for CA-IX or VEGF expression than for those who were negative for CA-IX or VEGF expression. The progression-free survival of patients treated with radiotherapy or chemo-radiotherapy following radical hysterectomy was also shorter for patients with positive CA-IX expression. These findings suggest that CA-IX expression is a possible risk factor for lymph node metastasis and disease recurrence in locally advanced cervical cancer patients.	[Iwasaki, Keita; Yabushita, Hiromitsu; Ueno, Taiki; Wakatsuki, Akihiko] Aichi Med Univ, Sch Med, Dept Obstet & Gynecol, Nagakute, Aichi 4801195, Japan	Yabushita, H (reprint author), Aichi Med Univ, Sch Med, Dept Obstet & Gynecol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	yab@aichi-med-u.ac.jp					Obermair A, 1997, J NATL CANCER I, V89, P1212, DOI 10.1093/jnci/89.16.1212; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Cheng WF, 2000, OBSTET GYNECOL, V96, P721, DOI 10.1016/S0029-7844(00)01025-5; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Biewenga P, 2009, GYNECOL ONCOL, V115, P277, DOI 10.1016/j.ygyno.2009.08.006; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Hashimoto I, 2001, BRIT J CANCER, V85, P93, DOI 10.1054/bjoc.2001.1846; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Liao SY, 2010, GYNECOL ONCOL, V116, P452, DOI 10.1016/j.ygyno.2009.10.062; Peters WA, 2000, J CLIN ONCOL, V18, P1606; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Vaughan-Jones RD, 2002, BIOCHEM CELL BIOL, V80, P579, DOI 10.1139/O02-157; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Behrooz A, 1999, NEWS PHYSIOL SCI, V14, P105; Creasman WT, 2004, GYNECOL ONCOL, V92, P525, DOI 10.1016/j.ygyno.2003.11.020; Pedersen MWB, 2001, NEOPLASIA, V3, P80, DOI 10.1038/sj.neo.7900133; Airley R, 2001, CLIN CANCER RES, V7, P928; Loncaster JA, 2000, BRIT J CANCER, V83, P620, DOI 10.1054/bjoc.2000.1319; Greijer AE, 2005, CELL ONCOL, V27, P43; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474; Narayan K, 2006, INT J GYNECOL CANCER, V16, P623, DOI 10.1111/j.1525-1438.2006.00379.x; Huang LE, 1996, J BIOL CHEM, V271, P32253; Younes M, 1996, CANCER RES, V56, P1164; Uemura H, 2006, CLIN CANCER RES, V12, P1768, DOI 10.1158/1078-0432.CCR-05-2253; Loncaster JA, 2001, CANCER RES, V61, P6394; Monk BJ, 2007, J CLIN ONCOL, V25, P2952, DOI 10.1200/JCO.2007.10.8324; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Giatromanolaki A, 2001, CANCER RES, V61, P7992; CLAVO AC, 1995, J NUCL MED, V36, P1625; Tewari KS, 2012, CLIN GYNECOLOGIC ONC, P51	33	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					1970	1978		10.3892/ol.2015.3524		9	Oncology	Oncology	CT7MT	WOS:000362999500004		
J	Ikezono, Y; Koga, H; Abe, M; Akiba, J; Kawahara, A; Yoshida, T; Nakamura, T; Iwamoto, H; Yano, H; Kage, M; Sata, M; Tsuruta, O; Torimura, T				Ikezono, Yu; Koga, Hironori; Abe, Mitsuhiko; Akiba, Jun; Kawahara, Akihiko; Yoshida, Takafumi; Nakamura, Toru; Iwamoto, Hideki; Yano, Hirohisa; Kage, Masayoshi; Sata, Michio; Tsuruta, Osamu; Torimura, Takuji			High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors	ONCOLOGY LETTERS			English	Article						carcinoids; neuroendocrine tumor; cancer stem cell; NANOG	DOUBLECORTIN-LIKE; NEUROBLASTOMA-CELLS; PANCREATIC-CANCER; TUFT CELLS; MECHANISM; INTESTINE; MIGRATION; GROWTH	Doublecortin-like kinase 1 (DCLK1), a microtubule-associated protein, is known to regulate neuronal differentiation, migration and neurogenesis. Recent evidence suggests that the protein is a putative marker for intestinal and pancreatic stem cells, including their cancer stem cell counterparts. The present study conducted immunohistochemical analyses for DCLK1 and the sternness marker, NANOG, in human intestinal neuroendocrine tumors (NETs), as their expression had not been previously investigated in these tumors. Eighteen patients with endoscopically resected rectal NETs were enrolled in the study. The mean age of the patients was 51 years old. The mean diameter of the resected tumors was 5.2 mm, and a histological diagnosis of NET grade G1 was formed for all tumors. Immunohistochemical analysis was performed not only for DCLK1, but also for the known NET markers, synaptophysin, chromogranin A and cluster of differentiation (CD)56. The intensity and distribution of staining were scored on a scale of 0-3 and 0-2, respectively. The sum of the scores was calculated for each specimen. Co-expression of DCLK1 and NANOG was also examined. The mean scores for DCLK1 and synaptophysin were significantly higher than those for chromogranin A (P<0.0001) and CD56 (P<0.01). There were no significant differences in the scores between DCLK1 and synaptophysin or between chromogranin A and CD56. Notably, NANOG was expressed in high quantities in all the tumor tissues studied, showing clear co-expression with DCLK1. In conclusion, DCLK1 may be a novel marker for rectal NET, potentially indicating the presence of the sternness gene product, NANOG.	[Ikezono, Yu; Koga, Hironori; Abe, Mitsuhiko; Yoshida, Takafumi; Nakamura, Toru; Iwamoto, Hideki; Sata, Michio; Tsuruta, Osamu; Torimura, Takuji] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka 8300011, Japan; [Ikezono, Yu; Koga, Hironori; Abe, Mitsuhiko; Kawahara, Akihiko; Yoshida, Takafumi; Nakamura, Toru; Iwamoto, Hideki; Kage, Masayoshi; Torimura, Takuji] Kurume Univ, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; [Akiba, Jun; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan; [Kawahara, Akihiko; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan	Koga, H (reprint author), Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	hirokoga@med.kurume-u.ac.jp					Jann H, 2011, CANCER-AM CANCER SOC, V117, P3332, DOI 10.1002/cncr.25855; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Sureban SM, 2009, GASTROENTEROLOGY, V137, P649, DOI 10.1053/j.gastro.2009.05.004; PEARSE AGE, 1977, MED BIOL, V55, P115; Verissimo CS, 2012, J PHARMACOL EXP THER, V342, P119, DOI 10.1124/jpet.111.188813; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Sholl LM, 2010, APPL IMMUNOHISTO M M, V18, P55, DOI 10.1097/PAI.0b013e3181b16b88; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; May R, 2014, STEM CELLS, V32, P822, DOI 10.1002/stem.1566; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Konishi T, 2007, GUT, V56, P863, DOI 10.1136/gut.2006.109157; Ito T, 2015, J GASTROENTEROL, V50, P58, DOI 10.1007/s00535-014-0934-2; Heverhagen AE, 2013, EUR SURG RES, V51, P14, DOI 10.1159/000353612; Sureban SM, 2014, CANCER LETT, V351, P151, DOI 10.1016/j.canlet.2014.05.011; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Soga J, 2003, J EXP CLIN CANC RES, V22, P517; Tsikitis VL, 2012, J CANCER, V3, P292, DOI 10.7150/jca.4502; Gao Wei, 2012, Zhonghua Zhong Liu Za Zhi, V34, P450, DOI 10. 3760/cma.j.issn.0253-3766.2012.06.011; May R, 2010, AM J PHYSIOL-GASTR L, V299, pG303; Obemdorfer S, 1907, FRANKFURT Z PATHOL, V1, P426; Rindi GAR, 2010, WHO CLASSIFICATION T, P13; Sureban SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073940; Weygant N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-103	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2015	2020		10.3892/ol.2015.3513		6	Oncology	Oncology	CT7MT	WOS:000362999500011		
J	Naruse, T; Yanamoto, S; Yamada, SI; Takahashi, H; Matsushita, Y; Imayama, N; Ikeda, H; Shiraishi, T; Fujita, S; Ikeda, T; Asahina, I; Umeda, M				Naruse, Tomofumi; Yanamoto, Souichi; Yamada, Shin-Ichi; Takahashi, Hidenori; Matsushita, Yuki; Imayama, Naomi; Ikeda, Hisazumi; Shiraishi, Takeshi; Fujita, Shuichi; Ikeda, Tohru; Asahina, Izumi; Umeda, Masahiro			Immunohistochemical study of vascular endothelial growth factor-C/vascular endothelial growth factor receptor-3 expression in oral tongue squamous cell carcinoma: Correlation with the induction of lymphangiogenesis	ONCOLOGY LETTERS			English	Article						tongue cancer; vascular endothelial growth factor-C; vascular endothelial growth factor receptor-3; podoplanin; regional recurrence	LYMPH-NODE METASTASIS; PROGNOSTIC-FACTORS; FACTOR (VEGF)-C; STAGE-I; VEGF-C; CERVICAL METASTASIS; TUMOR THICKNESS; VESSEL DENSITY; CANCER; RECURRENCE	The aim of the present study was to elucidate the associations between the expression of the vascular endothelial growth factor-C (VEGF-C)/VEGF receptor-3 (VEGFR-3) axis and lymphangiogenesis, regional lymph node metastasis and clinicopathological factors in oral tongue squamous cell carcinoma (OTSCC) using immunohistochemistry. The expression of VEGF-C, VEGFR-3 and podoplanin was immunohistochemically evaluated in specimens obtained from 65 patients with OTSCC (T1-2, N0) who had undergone radical surgery alone. The associations between the expression of VEGF-C, VEGFR-3 and podoplanin, and lymphangiogenesis, regional lymph node metastasis and clinocopathological factors were determined by immunohisto chemical analysis. VEGF-C, VEGFR-3 and combined VEGF-C/VEGFR-3 expression was significantly higher in cases with regional recurrence compared with those without lymph node involvement (P<0.001). As regards lymphangiogenesis, a significant correlation was observed between podoplanin expression and VEGF-C, VEGFR-3 and combined VEGF-C/VEGFR-3 expression (P<0.001). Therefore, lymphangiogenesis in the peritumoral stroma was associated with lymph node metastasis. However, podoplanin expression did not exhibit a significant correlation with the progression of lymph node metastasis. The results of the present study suggest that the VEGF-C/VEGFR-3 axis may be associated with lymph node metastasis through lymphangiogenesis. Determining the VEGF-C/VEGFR-3 expression status may help predict which patients will develop regional recurrence and provide novel targets for therapies to suppress lymph node metastasis in the treatment of OTSCC.	[Naruse, Tomofumi; Yanamoto, Souichi; Yamada, Shin-Ichi; Takahashi, Hidenori; Matsushita, Yuki; Imayama, Naomi; Umeda, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki, Nagasaki 8528588, Japan; [Ikeda, Hisazumi; Shiraishi, Takeshi; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki, Nagasaki 8528588, Japan; [Fujita, Shuichi; Ikeda, Tohru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Pathol & Bone Metab, Nagasaki, Nagasaki 8528588, Japan	Naruse, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528588, Japan.	naruse12@nagasaki-u.ac.jp					Van Trappen PO, 2003, J PATHOL, V201, P544, DOI 10.1002/path.1467; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Huang SH, 2009, CANCER, V115, P1489, DOI 10.1002/cncr.24161; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Kitadai Y, 2001, INT J CANCER, V93, P662, DOI 10.1002/ijc.1379; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Watanabe S, 2013, YONAGO ACTA MED, V56, P29; Matsumoto K, 2013, JPN J CLIN ONCOL, V43, P1012, DOI 10.1093/jjco/hyt108; Han FH, 2010, EJSO-EUR J SURG ONC, V36, P1172, DOI 10.1016/j.ejso.2010.09.002; Witte D, 2002, ANTICANCER RES, V22, P1463; Naruse T, 2011, ANTICANCER RES, V31, P4429; de Vicente JC, 2013, ORAL ONCOL, V49, P598, DOI 10.1016/j.oraloncology.2013.02.008; Ling W, 2013, J ORAL MAXIL SURG, V71, P775, DOI 10.1016/j.joms.2012.09.026; Sparano A, 2004, OTOLARYNG HEAD NECK, V131, P472, DOI 10.1016/j.otohns.2004.04.008; Shah JP, 2009, ORAL ONCOL, V45, P394, DOI 10.1016/j.oraloncology.2008.05.017; Kurokawa H, 2002, HEAD NECK-J SCI SPEC, V24, P731, DOI 10.1002/hed.10130; Botting SK, 2010, TRANSL ONCOL, V3, P170, DOI 10.1593/tlo.09292; Lim SC, 2004, CLIN CANCER RES, V10, P166, DOI 10.1158/1078-0432.CCR-0533-3; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Bryne M, 1998, ANTICANCER RES, V18, P4757; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Arinaga M, 2003, CANCER, V97, P457, DOI 10.1002/cncr.11073; Suslu N, 2013, J ORAL MAXIL SURG, V71, P1283, DOI 10.1016/j.joms.2013.01.018; Al-Rajhi N, 2000, ORAL ONCOL, V36, P508, DOI 10.1016/S1368-8375(00)00042-7; Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; D'Cruz AK, 2009, HEAD NECK-J SCI SPEC, V31, P618, DOI 10.1002/hed.20988; Jennbacken K, 2005, PROSTATE, V65, P110, DOI 10.1002/pros.20276; Okada Y, 2010, ODONTOLOGY, V98, P153, DOI 10.1007/s10266-010-0131-6; Yanamoto S, 2014, INT J ONCOL, V44, P1153, DOI 10.3892/ijo.2014.2289; Yanamoto S, 2013, PATHOL ONCOL RES, V19, P795, DOI 10.1007/s12253-013-9646-9; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Asakage T, 1998, CANCER, V82, P1443, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A; Ganly I, 2012, CANCER-AM CANCER SOC, V118, P101, DOI 10.1002/cncr.26229; Wakisaka N, 2012, ORAL ONCOL, V48, P703, DOI 10.1016/j.oraloncology.2012.02.003; Omoto I, 2014, ONCOL LETT, V7, P1027, DOI 10.3892/ol.2014.1823; Hirota K, 2012, HISTOPATHOLOGY, V61, P1065, DOI 10.1111/j.1365-2559.2012.04341.x; Pindborg JJ, 1997, WHO INT HISTOLOGICAL, P33	38	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2027	2034		10.3892/ol.2015.3565		8	Oncology	Oncology	CT7MT	WOS:000362999500013		
J	Onoyama, M; Tsuka, T; Imagawa, T; Osaki, T; Sugiyama, A; Azuma, K; Ito, N; Kawashima, K; Okamoto, Y				Onoyama, Masaki; Tsuka, Takeshi; Imagawa, Tomohiro; Osaki, Tomohiro; Sugiyama, Akihiko; Azuma, Kazuo; Ito, Noriihko; Kawashima, Kazuhiko; Okamoto, Yoshiharu			Photodynamic hyperthermal chemotherapy with indocyanine green in feline vaccine-associated sarcoma	ONCOLOGY LETTERS			English	Article						feline vaccine-associated sarcoma; indocyanine green; photodynamic hyperthermal chemotherapy	INJECTION-SITE SARCOMAS; SOFT-TISSUE SARCOMAS; 808-NM DIODE-LASER; PROGNOSTIC-FACTORS; RADIATION-THERAPY; CATS; SURGERY; DOXORUBICIN; EXCISION; NEOPLASMS	The anticancer effects of photodynamic hyperthermal chemotherapy (PHCT), which consists of a combination of indocyanine green photodynamic hyperthermal therapy and local chemotherapy, have previously been reported. The present study investigated the effect of PHCT in six cases of feline vaccine-associated sarcoma (FVAS) following conservative surgical resection. No recurrence was observed in three out of six (50%) cases, while recurrence was observed in the remaining three cases. Of note, each feline with recurrences had previously undergone surgical resection more than three times, whereas those without recurrence had undergone no or one previous resection. In addition, the three animals in which there was no recurrence survived between 893 and 1,797 days following surgery. In conclusion, the results of the present study suggested that PHCT may be a candidate as a novel adjuvant cancer therapy for FVAS.	[Onoyama, Masaki] Onoyama Anim Hosp, Asago 6695213, Japan; [Tsuka, Takeshi; Imagawa, Tomohiro; Osaki, Tomohiro; Sugiyama, Akihiko; Azuma, Kazuo; Ito, Noriihko; Okamoto, Yoshiharu] Tottori Univ, Fac Agr, Sch Vet Med, Dept Clin Med, Tottori 6808553, Japan; [Kawashima, Kazuhiko] Aino Anim Hosp, Fukuroi 4370028, Japan	Okamoto, Y (reprint author), Tottori Univ, Fac Agr, Sch Vet Med, Dept Clin Med, 4-101 Koyama Minami, Tottori 6808553, Japan.	yokamoto@muses.tottori-u.ac.jp					OGILVIE GK, 1991, J AM VET MED ASSOC, V198, P1618; [Anonymous], 2002, J VET INTERN MED; CHEN WR, 1995, CANCER LETT, V94, P125, DOI 10.1016/0304-3835(95)03837-M; OGILVIE GK, 1989, J AM VET MED ASSOC, V195, P1580; Davidson EB, 1997, VET SURG, V26, P265, DOI 10.1111/j.1532-950X.1997.tb01497.x; Kuntz CA, 1997, J AM VET MED ASSOC, V211, P1147; Hershey AE, 2000, J AM VET MED ASSOC, V216, P58, DOI 10.2460/javma.2000.216.58; Bregazzi VS, 2001, J AM VET MED ASSOC, V218, P547, DOI 10.2460/javma.2001.218.547; MCCHESNEY SL, 1986, INT J RADIAT ONCOL, V12, P1957; Ettinger SN, 2003, CLIN TECH SMALL AN P, V18, P118, DOI 10.1053/svms.2003.36628; Kobayashi T, 2002, VET RADIOL ULTRASOUN, V43, P473, DOI 10.1111/j.1740-8261.2002.tb01036.x; Chen WR, 1996, CANCER LETT, V98, P169; Onoyama M, 2014, ONCOL LETT, V7, P1147, DOI 10.3892/ol.2014.1865; Cohen M, 2001, J AM VET MED ASSOC, V219, P1582, DOI 10.2460/javma.2001.219.1582; Radzi R, 2012, J VET MED SCI, V74, P545, DOI 10.1292/jvms.11-0464; Cronin K, 1998, VET RADIOL ULTRASOUN, V39, P51, DOI 10.1111/j.1740-8261.1998.tb00325.x; Giudice C, 2010, VET J, V186, P84, DOI 10.1016/j.tvjl.2009.07.019; Eckstein C, 2009, VET COMP ONCOL, V7, P54, DOI 10.1111/j.1476-5829.2008.00173.x; Martano M, 2005, VET J, V170, P84, DOI 10.1016/j.tvjl.2004.04.004; Banerji N, 2006, AM J VET RES, V67, P1766, DOI 10.2460/ajvr.67.10.1766; Hahn KA, 1999, J AM VET MED ASSOC, V231, P742; Hirano T, 2007, J JPN SOC LASER SURG, V28, P122; Ohguri T, 2007, THERMAL MED, V23, P49, DOI 10.3191/thermalmedicine.23.49; Onoyama M, 2014, J VET SCI, V15, P117, DOI 10.4142/jvs.2014.15.1.117; Phelps HA, 2011, JAVMA-J AM VET MED A, V239, P97, DOI 10.2460/javma.239.1.97; Romanelli G, 2008, JAVMA-J AM VET MED A, V232, P1193, DOI 10.2460/javma.232.8.1193	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2118	2122		10.3892/ol.2015.3557		5	Oncology	Oncology	CT7MT	WOS:000362999500027		
J	Yonenaga, Y; Kushihata, F; Inoue, H; Watanabe, J; Tohyama, T; Sugita, A; Takada, Y				Yonenaga, Yoshikuni; Kushihata, Fumiki; Inoue, Hitoshi; Watanabe, Jota; Tohyama, Taiji; Sugita, Atsuro; Takada, Yasutsugu			Sarcoidosis manifesting as hepatic and splenic nodules mimicking ovarian cancer metastases: A case report	ONCOLOGY LETTERS			English	Article						sarcoidosis; hepatic involvement; splenic involvement; ovarian cancer metastasis; laparoscopic surgery	OF-THE-LITERATURE; INVOLVEMENT; SPLEEN; LIVER	The current study presents a case of sarcoidosis manifesting as hepatic and splenic nodules, which was difficult to differentiate from ovarian cancer metastases. A 24-year-old female, who was previously diagnosed with right ovarian cancer and underwent surgery at the age of 21, was found to have two nodules in the spleen revealed by contrast-enhanced computed tomography (CT). F-18-fluorodeoxyglucose positron emission tomography/CT revealed two abnormal high uptake lesions in the spleen and one abnormal high uptake lesion in the liver. Under a diagnosis of hepatic and splenic metastases from right ovarian cancer, a laparoscopic splenectomy and partial hepatectomy were performed. Histopathological examination showed that a large number of non-caseating epithelioid cell granulomas formed these nodules, which was compatible with sarcoidosis. This case indicates that it is difficult to distinguish sarcoidosis from metastatic disease even using the latest modalities, and that laparoscopic surgery is a minimally invasive and useful tool for forming a differential diagnosis.	[Yonenaga, Yoshikuni; Kushihata, Fumiki; Inoue, Hitoshi; Watanabe, Jota; Tohyama, Taiji; Takada, Yasutsugu] Ehime Univ, Grad Sch Med, Dept Hepatobiliary Pancreat & Breast Surg, Toon, Ehime 7910295, Japan; [Yonenaga, Yoshikuni] Nagahama City Hosp, Dept Surg, Nagahama, Shiga 5268580, Japan; [Sugita, Atsuro] Ehime Univ Hosp, Div Pathol, Toon, Ehime 7910295, Japan	Yonenaga, Y (reprint author), Nagahama City Hosp, Dept Surg, 313 Ooinui Cho, Nagahama, Shiga 5268580, Japan.	yoney@m.ehime-u.ac.jp					Nagai S, 2008, CLIN CHEST MED, V29, P565, DOI 10.1016/j.ccm.2008.03.006; WARSHAUER DM, 1995, RADIOLOGY, V195, P757; SCADDING JG, 1961, BRIT MED J, V2, P1165; Morimoto T, 2008, EUR RESPIR J, V31, P372, DOI 10.1183/09031936.00075307; Rubini G, 2014, RADIOL MED, V119, P64, DOI 10.1007/s11547-013-0306-7; Kennedy PT, 2006, EUR J GASTROEN HEPAT, V18, P721, DOI 10.1097/01.meg.0000223911.85739.38; Lam KY, 2000, ARCH PATHOL LAB MED, V124, P526; Hunt J, 1999, MODERN PATHOL, V12, P325; Judson MA, 1999, SARCOIDOSIS VASC DIF, V16, P75; Alloni R, 2008, SURG TODAY, V38, P1144, DOI 10.1007/s00595-007-3747-6; COUINAUD C, 1954, PRESSE MED, V62, P62; Yano H, 2002, SURG TODAY, V32, P750; Dragosavac S, 2013, ONCOL LETT, V5, P593, DOI 10.3892/ol.2012.1075; WARSHAUER DM, 1994, RADIOLOGY, V192, P93; Sobic-Saranovic D, 2013, SEMIN NUCL MED, V43, P404, DOI 10.1053/j.semnuclmed.2013.06.007; Thanos L, 2002, EUR J RADIOL, V41, P10, DOI 10.1016/S0720-048X(01)00375-8; Warshauer DM, 2004, AM J ROENTGENOL, V182, P15; Scott GC, 1997, J COMPUT ASSIST TOMO, V21, P369, DOI 10.1097/00004728-199705000-00006; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885; IWAI K, 1993, ACTA PATHOL JAPON, V43, P377	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2166	2170		10.3892/ol.2015.3566		5	Oncology	Oncology	CT7MT	WOS:000362999500035		
J	Kubota, Y; Kirimura, N; Shiba, H; Adachi, K; Tsukamoto, Y				Kubota, Yuka; Kirimura, Naoki; Shiba, Hatsuki; Adachi, Kazuhide; Tsukamoto, Yasuhiro			SC1, an immunoglobulin-superfamily cell adhesion molecule, is involved in the brain metastatic activity of lung cancer cells	ONCOLOGY LETTERS			English	Article						lung cancer; SC1; metastasis; cell adhesion molecule	NEURITE EXTENSION; DM-GRASP; TUMOR PROGRESSION; EXPRESSION; MELANOMA; INVASION; NEURONS; DISEASE; PROTEIN; CLONING	SC1 is a cell adhesion molecule that belongs to the immunoglobulin superfamily; this molecule was initially purified from the chick embryonic nervous system and was reported to exhibit homophilic adhesion activity. SC1 is transiently expressed in various organs during development and has been identified in numerous neoplastic tissues, including lung cancer and colorectal carcinomas. The present study. focused on the encephalic metastasis of lung cancer cells with respect to the potential function of SC1, as this molecule is known to be consistently expressed in the central nervous system as well as lung cancers. SC1 complementary DNA was introduced into A549 cells, a human lung cancer-derived cell line. The stable overexpression of the SC1 protein in A549 cells was demonstrated to enhance the self-aggregation of the cells. In addition, the SC1 transfectants enhanced the metastatic and invasive potential to the encephalic parenchyma following implantation into nude mice. In conclusion, the results of the present study demonstrated that cell adhesion due interactions between SC1 on brain tissue and SC1 on lung cancer cells was involved in the malignant aspects of lung cancer, including invasion and metastasis to the brain.	[Kubota, Yuka; Kirimura, Naoki; Shiba, Hatsuki; Adachi, Kazuhide; Tsukamoto, Yasuhiro] Kyoto Prefecture Univ, Grad Sch Environm & Biol Sci, Dept Anim Hyg, Shimogamo, Kyoto 6068522, Japan	Tsukamoto, Y (reprint author), Kyoto Prefecture Univ, Grad Sch Environm & Biol Sci, Dept Anim Hyg, 1-5 Hangi Cho, Shimogamo, Kyoto 6068522, Japan.	ytsuka@kpu.ac.jp					van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; Ihnen M, 2011, J CLIN PATHOL, V64, P146, DOI 10.1136/jcp.2010.082602; ELDEEB S, 1992, DEV BIOL, V149, P213, DOI 10.1016/0012-1606(92)90278-O; Adachi K, 2008, MOL MED REP, V1, P219; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; Tsukamoto Y, 2001, HISTOL HISTOPATHOL, V16, P563; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tsai CM, 2013, MOL PHARMACEUT, V10, P1890, DOI 10.1021/mp3006648; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; KLYMKOWSKY MW, 1995, CELL, V83, P5, DOI 10.1016/0092-8674(95)90226-0; Handharyani E, 2011, AVIAN PATHOL, V40, P111, DOI 10.1080/03079457.2010.541901; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; OBRINK B, 1986, EXP CELL RES, V163, P1, DOI 10.1016/0014-4827(86)90554-9; Tsukamoto Y, 2006, ONCOL REP, V15, P137; ALBELDA SM, 1993, LAB INVEST, V68, P4; Corbel C, 1996, P NATL ACAD SCI USA, V93, P2844, DOI 10.1073/pnas.93.7.2844; van Kempen LCLT, 2004, J INVEST DERMATOL, V122, P1293, DOI 10.1111/j.0022-202X.2004.22531.x; CUNNINGHAM BA, 1995, CURR OPIN CELL BIOL, V7, P628, DOI 10.1016/0955-0674(95)80103-0; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; EDELMAN GM, 1985, ANNU REV BIOCHEM, V54, P135, DOI 10.1146/annurev.bi.54.070185.001031; POURQUIE O, 1992, P NATL ACAD SCI USA, V89, P5261, DOI 10.1073/pnas.89.12.5261	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2214	2218		10.3892/ol.2015.3576		5	Oncology	Oncology	CT7MT	WOS:000362999500043		
J	Tajima, T; Mukai, M; Hasegawa, S; Yamamoto, S; Nomura, E; Tajiri, T; Sadahiro, S; Yasuda, S; Makuuchi, H				Tajima, Takayuki; Mukai, Masaya; Hasegawa, Sayuri; Yamamoto, Souichirou; Nomura, Eiji; Tajiri, Takuma; Sadahiro, Sotaro; Yasuda, Seiei; Makuuchi, Hiroyasu			Early rectal cancer accompanied by multiple systemic abscesses: A case report	ONCOLOGY LETTERS			English	Article						early colorectal cancer; systemic abscess; pyogenic liver abscess	PYOGENIC LIVER-ABSCESS; COLORECTAL-CANCER; COLON; METAANALYSIS; DRAINAGE; OBESITY; RISK	A 70-year-old man undergoing treatment for diabetes presented with a cough and pyrexia that has lasted one week. Laboratory tests demonstrated evidence of inflammation. The patient was hospitalized and antibiotic treatment was initiated, but the condition of the patient did not improve. After 2 weeks, computerized tomography scanning demonstrated the presence of multiple small nodules in the lungs and a liver abscess. The patient also developed neck pain and numbness of the upper extremities and was then transferred to Tokai University Hachioji Hospital (Tokyo, Japan). Percutaneous transhepatic drainage (PTD) of the liver abscess was performed and antibiotic treatment was initiated. Detailed examination revealed there was pyogenic spondylitis of the cervical spine, therefore abscess drainage and an anterior cervical spinal fusion were performed. Culture of each lesion resulted in Klebsiella pneumoniae growth. While continuing antibiotic treatment and rehabilitation, the gastrointestinal tract was investigated and evidence of early rectal cancer was observed. The pulmonary nodules disappeared during treatment, indicating that these were multiple lung abscesses. Four weeks following abscess drainage and anterior cervical spinal fusion, lower anterior resection was performed. The present case report describes a patient who developed multiple abscesses associated with early rectal cancer and discusses the case with reference to the literature.	[Tajima, Takayuki; Sadahiro, Sotaro; Yasuda, Seiei; Makuuchi, Hiroyasu] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 2591193, Japan; [Mukai, Masaya; Hasegawa, Sayuri; Yamamoto, Souichirou; Nomura, Eiji; Makuuchi, Hiroyasu] Tokai Univ, Hachioji Hosp, Dept Surg, Hachioji, Tokyo 1920032, Japan; [Tajiri, Takuma] Tokai Univ, Hachioji Hosp, Dept Pathol, Hachioji, Tokyo 1920032, Japan	Tajima, T (reprint author), Tokai Univ, Sch Med, Dept Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	takayukitajima1970@yahoo.co.jp					Andersson R, 1990, HPB Surg, V2, P185, DOI 10.1155/1990/28345; TEITZ S, 1995, DIS COLON RECTUM, V38, P1220, DOI 10.1007/BF02048342; [Anonymous], 2000, WHO TECH REP SER, P1; Huang WK, 2012, COLORECTAL DIS, V14, pe794, DOI 10.1111/j.1463-1318.2012.03174.x; LONARDO A, 1992, J CLIN GASTROENTEROL, V14, P335, DOI 10.1097/00004836-199206000-00013; [Anonymous], 2014, J HLTH WELFARE STAT, V61, P63; Qu K, 2012, WORLD J GASTROENTERO, V18, P2948, DOI 10.3748/wjg.v18.i23.2948; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; PANWALKER AP, 1988, REV INFECT DIS, V10, P347; COHEN JL, 1989, ARCH SURG-CHICAGO, V124, P561; Larsson SC, 2007, AM J CLIN NUTR, V86, P556; MCDONALD MI, 1984, MEDICINE, V63, P291; [Anonymous], 2002, CAS TREAT 1994, P23; NOSHER JL, 1993, AM SURGEON, V59, P658; Endo H, 2013, GASTRO ENDOSC, V55, P3735; Hiratsuka H, 2012, JJSC, V65, P453; Isohata N, 2007, JJCS, V32, P783; Japanese Society for Cancer of the Colon and Rectum (JSCCR), 2009, GEN RUL CLIN PATH ST; LEGIER JF, 1991, SOUTHERN MED J, V84, P1058; McDonald A P, 1980, World J Surg, V4, P369; Ritchie JD, 1975, REV INFECT DIS, V45, P284; Tanizaki H, 2002, J JPN SURG ASS, V63, P449; Watanabe T, 2015, INT J CLIN ONCOL, V20, P207, DOI 10.1007/s10147-015-0801-z	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2219	2222		10.3892/ol.2015.3500		4	Oncology	Oncology	CT7MT	WOS:000362999500044		
J	Iida, H; Aihara, T; Ikuta, S; Yamanaka, N				Iida, Hiroya; Aihara, Tsukasa; Ikuta, Shinichi; Yamanaka, Naoki			Clinicopathological characteristics of hepatitis B surface antigen-negative and hepatitis C antibody-negative hepatocellular carcinoma	ONCOLOGY LETTERS			English	Article						hepatitis B surface antigen; hepatitis C antibody; hepatocellular carcinoma; non-alcoholic steatohepatitis	CLINICAL CHARACTERISTICS; RISK-FACTORS; MULTIVARIATE-ANALYSIS; CURATIVE THERAPY; VIRAL-INFECTION; VIRUS INFECTION; RESECTION; FEATURES; HEPATECTOMY; CIRRHOSIS	The present study investigated the clinicopathological characteristics of resected hepatitis B virus surface antigen. (HBs-Ag)-negative, hepatitis C virus antibody (HCV-Ab)-negative hepatocellular carcinoma (NBNC HCC). The clinicopathological characteristics of 164 patients with NBNC HCC, 144 patients with HBs-Ag-positive HCC (HBV group) and 550 patients with HCV-Ab-positive HCC (HCV group) were compared. In the NBCN HCC group, 61 patients succumbed after 2 years. Subsequently, NBCN HCC patients were compared according to survival time (<2 years, 39 patients vs. >= 2 years, 64 patients) to identify prognostic factors. Finally, the clinicopathological characteristics of NBNC HCC were compared according to history of alcohol abuse/pathological results: Non-alcoholic steatohepatitis HCC (NASH group, 40 patients), alcohol abuse HCC (AL group, 80 patients) and other HCCs (non-NASH/non-AL group, 44 patients). Age, diabetes prevalence and body mass index were significantly higher for NBNC HCC compared with virus-related HCC. Among stage II cases, the prognosis was significantly better for the NBNC compared with that for the HCV group. A high a-fetoprotein level, poorly differentiated HCC and advanced liver fibrosis were independent risk factors for the prognosis of NBNC HCC. The proportion of female patients was significantly higher among NASH compared with AL HCC patients. The cumulative survival rates following surgery were similar in the NASH, AL and non-NASH/non-AL groups. NBNC HCC is considered to be a lifestyle disease, with better prognosis for stage II patients. The prognostic factors for NBNC HCC patients undergoing hepatectomy were similar to those with virus-related HCC and did not differ according to alcohol abuse history or pathological results.	[Iida, Hiroya; Aihara, Tsukasa; Ikuta, Shinichi; Yamanaka, Naoki] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo 6638186, Japan	Iida, H (reprint author), Meiwa Hosp, Dept Surg, 4-31 Agenaruo Cho, Nishinomiya, Hyogo 6638186, Japan.	iidahiro@hirakata.kmu.ac.jp					Umemura T, 2007, HEPATOL RES, V37, pS95, DOI 10.1111/j.1872-034X.2007.00169.x; Kaibori M, 2012, AM J SURG, V204, P300, DOI 10.1016/j.amjsurg.2011.11.014; Nishikawa H, 2013, ANTICANCER RES, V33, P2211; Nagaoki Y, 2012, HEPATOL RES, V42, P368, DOI 10.1111/j.1872-034X.2011.00929.x; Kaneda K, 2012, HEPATO-GASTROENTEROL, V59, P1889, DOI 10.5754/hge10778; Nakai T, 2006, WORLD J SURG, V30, P1338, DOI 10.1007/s00268-005-0318-0; Shinkawa H, 2010, J HEPATO-BIL-PAN SCI, V17, P291, DOI 10.1007/s00534-009-0186-3; Ikeda K, 2009, J VIRAL HEPATITIS, V16, P437, DOI 10.1111/j.1365-2893.2009.01085.x; Yamanaka N, 1997, CANCER, V79, P1509, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1509::AID-CNCR10>3.0.CO;2-1; Cescon M, 2009, ARCH SURG-CHICAGO, V144, P906, DOI 10.1001/archsurg.2009.99; Hanazaki K, 2001, AM J GASTROENTEROL, V96, P1243; Yokoi Y, 2005, J GASTROENTEROL, V40, P274, DOI 10.1007/s00535-004-1536-1; Shi Y, 2012, LIVER INT, V32, P231, DOI 10.1111/j.1478-3231.2011.02481.x; IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1016/0270-9139(93)90505-H; Takamatsu S, 2008, HEPATO-GASTROENTEROL, V55, P609; Kusakabe A, 2007, J GASTROENTEROL, V42, P298, DOI 10.1007/s00535-006-1999-3; Kawamura Y, 2008, J GASTROEN HEPATOL, V23, P1739, DOI 10.1111/j.1440-1746.2008.05436.x; Yamagishi Y, 2004, HEPATOL RES, V28, P177, DOI 10.1016/j.herpes.2003.11.009; Honda T, 2011, ONCOL LETT, V2, P851, DOI 10.3892/ol.2011.359; Kim SK, 2011, DIGESTION, V84, P43, DOI 10.1159/000333212; Abe H, 2008, J GASTROENTEROL, V43, P967, DOI 10.1007/s00535-008-2264-8; Li T, 2013, CANCER-AM CANCER SOC, V119, P126, DOI 10.1002/cncr.27697; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST, P110	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2233	2238		10.3892/ol.2015.3562		6	Oncology	Oncology	CT7MT	WOS:000362999500047		
J	Kumamoto, K; Ishida, H; Ohsawa, T; Ishibashi, K; Ushiama, M; Yoshida, T; Iwama, T				Kumamoto, Kensuke; Ishida, Hideyuki; Ohsawa, Tomonori; Ishibashi, Keiichiro; Ushiama, Mineko; Yoshida, Teruhiko; Iwama, Takeo			Germline and somatic mutations of the APC gene in papillary thyroid carcinoma associated with familial adenomatous polyposis: Analysis of three cases and a review of the literature	ONCOLOGY LETTERS			English	Review						APC; thyroid cancer; familial adenomatous polyposis	COLI GENE; CANCER; TUMORS; TUMORIGENESIS; PHENOTYPE; MODEL; RISK	Patients with familial adenomatous polyposis (FAP), which is caused by the dysfunction of the adenomatous polyposis coli (APC) protein, have the possibility of developing extracolonic manifestations, including thyroid cancer (TC), congenital hypertrophy of the retinal pigment epithelium, desmoid tumors, and gastric and duodenal adenomas. The pathogenesis of these disorders associated with PAP is considered to be affected by the site of the germline mutation on the APC gene as a genotype-phenotype correlation. Moreover, beta-catenin binding sites consist of 20-amino acid repeats (20-AARs) in the APC protein, and they are essential for the development of colorectal adenomas and certain other extracolonic manifestations. The present study retrospectively analyzed the germline and somatic mutations of the APC gene in three papillary TC patients with FAP to analyze the association between the remaining number of 20-AARs and the development of TC. The mutation sites of two TCs did not include 20-AARs in each allele. In one patient, the remaining number of 20-AARs was two in the germline mutation and zero in the somatic mutation. Together with the data on 13 FAP-associated thyroid cancerous lesions in 3 PAP patients reported previously, the majority of the remaining numbers of 20-AARs was zero in the TC patients with PAP (13/16; 81.3%). Consequently, the APC/beta-catenin signaling pathway may be strongly involved with the pathogenesis of TC with PAP. Further accumulation of FAP patients with TC will be required to confirm the molecular pathogenesis of TC.	[Kumamoto, Kensuke; Ishida, Hideyuki; Ohsawa, Tomonori; Ishibashi, Keiichiro; Iwama, Takeo] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Kawagoe, Saitama 3508550, Japan; [Ushiama, Mineko; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan	Kumamoto, K (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	kumamotk@fmu.ac.jp					Cetta F, 1998, J CLIN ENDOCR METAB, V83, P1003, DOI 10.1210/jc.83.3.1003; Soravia C, 1999, AM J PATHOL, V154, P127, DOI 10.1016/S0002-9440(10)65259-5; Groen EJ, 2008, ANN SURG ONCOL, V15, P2439, DOI 10.1245/s10434-008-9981-3; CAMIEL MR, 1968, NEW ENGL J MED, V278, P1056, DOI 10.1056/NEJM196805092781908; Crabtree M, 2003, ONCOGENE, V22, P4257, DOI 10.1038/sj.onc.1206471; Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Cetta F, 2000, J CLIN ENDOCR METAB, V85, P286, DOI 10.1210/jc.85.1.286; Miyaki M, 2008, INT J CANCER, V122, P2491, DOI 10.1002/ijc.23390; PLAIL RO, 1987, BRIT J SURG, V74, P377, DOI 10.1002/bjs.1800740517; IWAMA T, 1993, ANN SURG, V217, P101, DOI 10.1097/00000658-199302000-00002; ZEKI K, 1994, J CLIN ENDOCR METAB, V79, P1317, DOI 10.1210/jc.79.5.1317; CURTIS L, 1994, EUR J CANCER, V30A, P984, DOI 10.1016/0959-8049(94)90129-5; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rubinfeld B, 1997, CANCER RES, V57, P4624; Romei C, 2012, J CLIN ENDOCR METAB, V97, pE1758, DOI 10.1210/jc.2012-1269; Latchford A, 2007, HUM MOL GENET, V16, P78, DOI 10.1093/hmg/ddl442; Uchino S, 2006, WORLD J SURG, V30, P775, DOI 10.1007/s00268-005-0368-3; COLLETTA G, 1994, BRIT J CANCER, V70, P1085, DOI 10.1038/bjc.1994.452; Lamlum H, 1999, NAT MED, V5, P1071; Bertario L, 2003, J CLIN ONCOL, V21, P1698, DOI 10.1200/JCO.2003.09.118; Miyaki M, 2000, AM J PATHOL, V157, P1825, DOI 10.1016/S0002-9440(10)64821-3; Cetta F, 2007, WORLD J SURG, V31, P1366, DOI 10.1007/s00268-006-0886-7; GIARDIELLO FM, 1993, GUT, V34, P1394, DOI 10.1136/gut.34.10.1394; CRAIL H W, 1949, U S Nav Med Bull, V49, P123; Septer S, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-13	25	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2239	2243		10.3892/ol.2015.3578		5	Oncology	Oncology	CT7MT	WOS:000362999500048		
J	Tokudome, T; Sasaki, A; Tsuji, M; Udaka, Y; Oyamada, H; Tsuchiya, H; Oguchi, K				Tokudome, Takatoshi; Sasaki, Akiko; Tsuji, Mayumi; Udaka, Yuko; Oyamada, Hideto; Tsuchiya, Hiromichi; Oguchi, Katsuji			Reduced PTEN expression and overexpression of miR-17-5p,-19a-3p,-19b-3p,-21-5p,-130b-3p,-221-3p and-222-3p by glioblastoma stem-like cells following irradiation	ONCOLOGY LETTERS			English	Article						microRNA; phosphatase and tensin homolog deleted on chromosome 10; glioblastoma; glioblastoma stem-like cell	CHROMOSOME-10 PTEN; TUMOR; PATHWAY; CANCER; PHOSPHATASE; ACTIVATION; APOPTOSIS; LYMPHOMA; PROTEIN; GROWTH	Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor suppressor gene that induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway. Glioblastoma (GBM) is a brain tumor that is resistant to irradiation and chemotherapy and, thus, is difficult to cure. GBM stem-like cells (GSCs) have been implicated as a cause of this resistance. microRNA (miRNA/miR) inhibits the expression Of proteins. The objective of the present study was to identify miRNAs that target PTEN, which induces apoptosis, in irradiation-resistant GSCs. When the expression of miRNAs was examined in GSCs irradiated at 60 Gy using the human GBM A172 cell line, the expression of PTEN-targeting miR-17-5p, -19a-3p, -19b-3p, -2,1-5p, -130b-3p, -221-3p and -222-3p was significantly higher in irradiated GSCs than in non-irradiated cells, and the PTEN expression levels, as revealed by immunostaining, were lower in the irradiated GSCs than in the non-irradiated cells. These results suggested that the expression of PTEN was suppressed through the overexpression of PTEN-targeting miRNAs in GSCs following irradiation.	[Tokudome, Takatoshi; Sasaki, Akiko; Tsuji, Mayumi; Udaka, Yuko; Oyamada, Hideto; Tsuchiya, Hiromichi; Oguchi, Katsuji] Showa Univ, Sch Med, Dept Pharmacol, Shinagawa Ku, Tokyo 1428666, Japan	Sasaki, A (reprint author), Showa Univ, Sch Med, Dept Pharmacol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	sakiko@med.showa-u.ac.jp					Tagawa H, 2013, CANCER SCI, V104, P801, DOI 10.1111/cas.12160; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Qin J, 2014, ACTA POL PHARM, V71, P537; Asano T, 2007, BIOL PHARM BULL, V30, P1610, DOI 10.1248/bpb.30.1610; Kechagioglou P, 2014, ANTICANCER RES, V34, P1387; Yan K, 2013, CURR OPIN NEUROL, V26, P701, DOI 10.1097/WCO.0000000000000032; Reifenberger G, 2004, J MOL MED-JMM, V82, P656, DOI 10.1007/s00109-004-0564-x; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Hou WM, 2014, ONCOL LETT, V8, P1249, DOI 10.3892/ol.2014.2253; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Lv S, 2012, INT J ONCOL, V41, P1029, DOI 10.3892/ijo.2012.1539; Dahlrot RH, 2014, INT J CLIN EXP PATHO, V7, P3739; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Ristorcelli E, 2008, FASEB J, V22, P3358, DOI 10.1096/fj.07-102855; Appin CL, 2013, BRAIN PATHOL, V23, P454, DOI 10.1111/bpa.12018; Sasaki A, 2013, HUM CELL, V26, P73, DOI 10.1007/s13577-013-0060-0; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Kim SH, 2014, J NEUROSCI RES, V92, P1419, DOI 10.1002/jnr.23431; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Hide T, 2008, BRAIN TUMOR PATHOL, V25, P67, DOI 10.1007/s10014-008-0237-5; Rao E, 2012, LEUKEMIA, V26, P1064, DOI 10.1038/leu.2011.305; Li W, 2014, CURR MOL MED, V14, P185; Morales LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097104; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Xie Q, 2014, NEUROPATHOLOGY, V34, P455, DOI 10.1111/neup.12129	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2269	2272		10.3892/ol.2015.3594		4	Oncology	Oncology	CT7MT	WOS:000362999500054		
J	Nakano, T; Kitagawa, Y; Izumi, K; Ikeda, H; Namiki, M				Nakano, Taito; Kitagawa, Yasuhide; Izumi, Kouji; Ikeda, Hiroko; Namiki, Mikio			Invasive urothelial carcinoma within a calyceal diverticulum associated with renal stones: A case report	ONCOLOGY LETTERS			English	Article						invasive urothelial carcinoma; calyceal diverticula; renal stone		Calyceal diverticula are rare outpouchings of the upper collecting system lying within the renal parenchyma. These often contain stones, however, carcinoma within a calyceal diverticulum is uncommon. The present study reports a case of invasive urothelial carcinoma within a calyceal diverticulum associated with renal stones. A 70-year-old male with a left renal mass identified by abdominal computed tomography was referred to the Department of Urology, Kanazawa University Hospital. Pre-operative diagnosis was difficult owing to an atypical imaging finding of a hypovascular renal mass with calcification. A laparoscopic nephroureterectomy was performed, and the surgical specimens showed invasive high-grade urothelial carcinoma within a calyceal diverticulum, and the calcifications were renal stones consisting of 97% calcium oxalate. Urothelial carcinoma in calyceal diverticula is a rare condition, however, a pre-operative definite diagnosis is difficult and a high potential for invasion of the renal parenchyma is suspected in this disease.	[Nakano, Taito; Kitagawa, Yasuhide; Izumi, Kouji; Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa 9208640, Japan; [Ikeda, Hiroko] Kanazawa Univ, Kanazawa Univ Hosp, Div Pathol, Kanazawa, Ishikawa 9208641, Japan	Kitagawa, Y (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	yasukita@med.kanazawa-u.ac.jp					Adachi T, 1989, Hinyokika Kiyo, V35, P1383; TIMMONS JW, 1975, J UROLOGY, V114, P6; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Sassa N, 2012, HISTOPATHOLOGY, V61, P620, DOI 10.1111/j.1365-2559.2012.04183.x; Yeh CC, 2007, UROL INT, V79, P19, DOI 10.1159/000102907; WULFSOHN MA, 1980, J UROLOGY, V123, P1; Shariat SF, 2012, EUR UROL, V62, P224, DOI 10.1016/j.eururo.2012.01.019; Chow Wong-Ho, 1997, Journal of the National Cancer Institute (Bethesda), V89, P1453, DOI 10.1093/jnci/89.19.1453; MICHEL W, 1985, International Urology and Nephrology, V17, P225, DOI 10.1007/BF02085408; Oya M, 2015, INT J UROL, V22, P3, DOI 10.1111/iju.12630; Sobin L, 2009, TNM CLASSIFICATION M, P258; Waingankar Nikhil, 2014, Rev Urol, V16, P29; Yoshimura K, 1998, Hinyokika Kiyo, V44, P649; Zuckerman Jack M, 2010, Rev Urol, V12, P52	14	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2439	2441		10.3892/ol.2015.3590		3	Oncology	Oncology	CT7MT	WOS:000362999500088		
J	Kokabu, S; Nojima, J; Kayano, H; Yoda, T				Kokabu, Shoichiro; Nojima, Junya; Kayano, Hidekazu; Yoda, Testuya			Low-grade cribriform cystadenocarcinoma of the palatal gland: A case report	ONCOLOGY LETTERS			English	Article						palatal gland; salivary gland tumor; low-grade cribriform cystadenocarcinoma; salivary duct carcinoma	SALIVARY DUCT CARCINOMA; NEOPLASTIC EPITHELIAL DUCT; INTRADUCTAL CARCINOMA; PAROTID-GLAND; DIFFERENTIATION; MARKERS; VARIANT	Low-grade cribriform cystadenocarcinoma (LGCCC) is a malignant salivary gland tumor. LGCCC occurs rarely, with the parotid gland being the most commonly afflicted site. Few cases arise in other sites. The present study reports a case of LGCCC that occurred at the palatal gland of the hard palate. A 56-year-old female was referred to Saitama Medical University Hospital (Moroyama, Saitama, Japan) due to an intraoral mass. Since cytological examination and biopsy led to a diagnosis favoring a neoplasm, but with uncertain malignant potential, the tumor was resected with a safe surgical margin. The specimen was thoroughly examined. Microscopically, there was a well-demarcated, unilocular cyst with the lumen lined by tumor cells. The tumor cells were arranged in tubular, cribriform and solid structures in the area of the intracystic mass lesions. Nuclear atypia was inconspicuous, although mitotic figures were observed throughout the tumor. Neither local nor perineural invasion was present. On immunohistochemistry, the tumor cells were diffusely positive for S-100 protein. Myoepithelial markers, calponin and p63, highlighted the cells rimming the cystic mass. The final histopathological diagnosis was of LGCCC. The tumor was completely resected. At 1 year post-resection, the patient exhibited no recurrence or distant metastasis. LGCCC is regarded as clinically indolent. However, there is little literature available to aid with prognosis prediction due to the rarity of LGCCC cases. Thus, greater experience and longer follow-up periods are necessary to find the optimal/curative treatment for patients with LGCCC and to clarify the pathophysiology.	[Kokabu, Shoichiro; Nojima, Junya; Yoda, Testuya] Saitama Med Univ, Fac Med, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Kokabu, Shoichiro] Kyushu Dent Univ, Dept Hlth Promot, Div Mol Signaling & Biochem, Kitakyushu, Fukuoka 8038580, Japan; [Kayano, Hidekazu] Saitama Med Univ, Fac Med, Dept Pathol, Moroyama, Saitama 3500495, Japan	Kokabu, S (reprint author), Saitama Med Univ, Fac Med, Dept Oral & Maxillofacial Surg, 38 Morohongo, Iruma, Saitama 3500495, Japan.	r14kokabu@fa.kyu-dent.ac.jp					SATO M, 1984, CANCER, V54, P2959, DOI 10.1002/1097-0142(19841215)54:12<2959::AID-CNCR2820541225>3.0.CO;2-5; Obokata A, 2013, ACTA CYTOL, V57, P207, DOI 10.1159/000345910; Laco J, 2010, INT J SURG PATHOL, V18, P369, DOI 10.1177/1066896910367649; Tatemoto Y, 1996, ORAL ONCOL, V32B, P275; Arai A, 2009, AURIS NASUS LARYNX, V36, P725, DOI 10.1016/j.anl.2009.04.005; Nakazawa T, 2011, DIAGN CYTOPATHOL, V39, P218, DOI 10.1002/dc.21405; HAYASHI Y, 1985, CANCER, V55, P2575, DOI 10.1002/1097-0142(19850601)55:11<2575::AID-CNCR2820551109>3.0.CO;2-K; ANDERSON C, 1992, CANCER, V69, P609, DOI 10.1002/1097-0142(19920201)69:3<609::AID-CNCR2820690302>3.0.CO;2-1; Foss RD, 1996, AM J SURG PATHOL, V20, P1440, DOI 10.1097/00000478-199612000-00002; REGEZI JA, 1977, OTOLARYNG CLIN N AM, V10, P297; Weinreb I, 2006, AM J SURG PATHOL, V30, P1014, DOI 10.1097/00000478-200608000-00013; Delgado R, 1996, CANCER, V78, P958, DOI 10.1002/(SICI)1097-0142(19960901)78:5<958::AID-CNCR4>3.0.CO;2-8; TAKAHASHI H, 1992, PATHOL RES PRACT, V188, P692; Kusafuka K, 2010, MED MOL MORPHOL, V43, P178, DOI 10.1007/s00795-009-0479-2; EVERSOLE LR, 1971, ARCH PATHOL, V92, P433; Bahrami A, 2013, HISTOPATHOLOGY, V63, P250, DOI 10.1111/his.12152; Brandwein-Gensler M, 2004, AM J SURG PATHOL, V28, P1040, DOI 10.1097/01.pas.0000128662.66321.be; Brandwein-Gensler MS, 2005, WHO CLASSIFICATION T, P233; Nakatsuka S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-122; Projetti F, 2014, J ORAL PATHOL MED, V44, P244; Wang L, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-28; Weinreb Ilan, 2011, Head Neck Pathol, V5, P321, DOI 10.1007/s12105-011-0256-0	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2453	2457		10.3892/ol.2015.3528		5	Oncology	Oncology	CT7MT	WOS:000362999500092		
J	Kusabe, Y; Kawashima, H; Ogose, A; Sasaki, T; Ariizumi, T; Hotta, T; Endo, N				Kusabe, Yuta; Kawashima, Hiroyuki; Ogose, Akira; Sasaki, Taro; Ariizumi, Takashi; Hotta, Tetsuo; Endo, Naoto			Effect of temozolomide on the viability of musculoskeletal sarcoma cells	ONCOLOGY LETTERS			English	Article						temozolomide; musculoskeletal sarcoma; apoptosis; phosphoinositide 3-kinase/Akt	MALIGNANT GLIOMA-CELLS; SOFT-TISSUE SARCOMA; EPITHELIOID SARCOMA; GLIOBLASTOMA CELLS; EWING SARCOMA; PHASE-II; TUMOR; APOPTOSIS; ESTABLISHMENT; METHYLATION	Musculoskeletal sarcomas (MSS) are a heterogeneous group of malignancies with relatively high mortality rates. The prognosis for patients with MSS is poor, with few drugs inducing measurable activity. Alkylating agents, namely ifosfamide and dacarbazine, which act nonspecifically on proliferating cells, are the typical therapy prescribed for advanced MSS. A novel alkylating agent, temozolomide (TMZ), has several advantages over existing alkylating agents. TMZ induces the formation of O-6-methylguanine in DNA, thereby inducing mismatches during DNA replication and the subsequent activation of apoptotic pathways. However, due to conflicting data in the literature, the mechanism of TMZ action has remained elusive. Therefore, the present study aimed to evaluate apoptosis in MSS cells treated with TMZ, and to evaluate the correlation between TMZ action and survival pathways, including the phosphoinositide 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK)1/2 mitogen activated protein kinase (MAPK) pathways. Cell proliferation was evaluated by performing an XTT (sodium 3'-[1-(phenylaminocarbony1)-3,4-tetrazolium] -bis (4-methoxy-6-nitro) benzene sulfonic acid hydrate) assay. Apoptotic morphological changes, for example chromatin condensation, were evaluated by fluorescence confocal microscopy. The expression of the apoptosis-associated proteins caspase-3, poly adenosine diphosphate ribose polymerase (PARP), Akt and ERK1/2, was determined by western blotting. The results of the present study indicated that, in certain MSS cells, the IC50 value was lower than that in TMZ-sensitive U-87 MG cells. Furthermore, TMZ treatment was associated with apoptotic morphological changes and the expression levels of pro-apoptotic cleaved caspase-3 and PARP were also increased in TMZ-treated MSS cells. In addition, the result indicated that PI3K/Akt and ERK1/2 MAPK were constitutively phosphorylated in MSS cells, and phosphorylation of PI3K/Akt was suppressed in certain cells, and maintained in other cells, by TMZ. These observations emphasized the plasticity of MSS cells, and suggested that this plasticity may contribute to the variance in cell sensitivity to TMZ and TMZ-resistance in MSS.	[Kusabe, Yuta] Niigata Univ, Sch Med, Niigata 9518510, Japan; [Kawashima, Hiroyuki; Ogose, Akira; Sasaki, Taro; Hotta, Tetsuo; Endo, Naoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Niigata 9518510, Japan; [Ariizumi, Takashi] Niigata Canc Ctr Hosp, Dept Orthoped Surg, Niigata 9518566, Japan	Kawashima, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	inskawa@med.niigata-u.ac.jp					AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Wang HY, 2013, CLIN CANCER RES, V19, P2699, DOI 10.1158/1078-0432.CCR-12-2671; De Salvo M, 2011, INT J RADIAT BIOL, V87, P518, DOI 10.3109/09553002.2011.556173; Trent JC, 2003, CANCER, V98, P2693, DOI 10.1002/cncr.11875; GOTTLIEB JA, 1976, CANCER TREAT REP, V60, P199; Raciborska A, 2013, PEDIATR BLOOD CANCER, V60, P1621, DOI 10.1002/pbc.24621; Hoshino M, 2010, J CANCER RES CLIN, V136, P457, DOI 10.1007/s00432-009-0678-1; Mahalingam D, 2009, CURR DRUG TARGETS, V10, P937; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kusakabe H, 2000, ARCH DERMATOL RES, V292, P292, DOI 10.1007/s004030000127; SONOBE H, 1992, LAB INVEST, V67, P498; Stacchiotti S, 2013, CLIN CANCER RES, V19, P5192, DOI 10.1158/1078-0432.CCR-13-0776; STEVENS MFG, 1987, CANCER RES, V47, P5846; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Hirose Y, 2001, CANCER RES, V61, P1957; HOTTA T, 1992, ACTA PATHOL JAPON, V42, P595; Hoshino M, 2009, CANCER GENET CYTOGEN, V190, P75, DOI 10.1016/j.cancergencyto.2008.11.014; Kanzawa T, 2003, BRIT J CANCER, V89, P922, DOI 10.1038/sj.bjc.6601193; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Casey DA, 2009, PEDIATR BLOOD CANCER, V53, P1029, DOI 10.1002/pbc.22206; Imaizumi S, 1998, VIRCHOWS ARCH, V433, P435, DOI 10.1007/s004280050271; del Muro XG, 2005, CANCER, V104, P1706, DOI 10.1002/cncr.21384; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Jakob J, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-180; Liu Hailing, 2014, Glycobiology, V24, P748, DOI 10.1093/glycob/cwu038; Moreira-Gonzalez Andrea, 2010, Cleve Clin J Med, V77 Suppl 1, pS18, DOI 10.3949/ccjm.77.s1.04; Siegel R, 2014, CA-CANCER J CLIN, V2014, P9, DOI DOI 10.3322/CAAC.21208; Wu L, 2014, TUMOR BIOL, V35, P12327, DOI 10.1007/s13277-014-2545-1	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2511	2518		10.3892/ol.2015.3506		8	Oncology	Oncology	CT7MT	WOS:000362999500103		
J	Matsui, T; Ojima, A; Higashimoto, Y; Taira, J; Fukami, K; Yamagishi, SI				Matsui, Takanori; Ojima, Ayako; Higashimoto, Yuichiro; Taira, Junichi; Fukami, Kei; Yamagishi, Sho-Ichi			Pigment epithelium-derived factor inhibits caveolin-induced interleukin-8 gene expression and proliferation of human prostate cancer cells	ONCOLOGY LETTERS			English	Article						Caveolin-1; pigment epithelium-derived factor; interleukin-8; prostate cancer cells; angiogenesis	FACTOR PEDF; ANTIOXIDATIVE PROPERTIES; VEGF EXPRESSION; TUMOR-GROWTH; SECRETED CAVEOLIN-1; ENDOTHELIAL-CELLS; MYELOMA CELLS; DIABETIC-RATS; ANGIOGENESIS; PROGRESSION	Caveolin-1 (Cav), a primary protein component of caveolae, is overexpressed in prostate cancer, thereby promoting growth and metastasis of this tumor. By contrast, pigment epithelium-derived factor (PEDF) has been shown to inhibit tumor growth and metastasis, including that of prostate cancer, via its anti-angiogenic and anti-inflammatory effects. Although it was recently demonstrated that PEDF binds to Cav and blocks its pro-inflammatory actions in endothelial cells, it remains unclear whether PEDF also inhibits the tumor-promoting effects of Cav in cultured prostate cancer cells. The present study examined the effects of PEDF on cell growth, in addition to the gene expression of interleukin-8 (IL-8), which is involved in prostate cancer progression, in the PC-3 human prostate cancer cell line. Exogenous Cav led to a dose-dependent upregulation of the mRNA expression of IL-8 in PC-3 cells, which was blocked by treatment with 1 or 10 nM PEDF, or following the overexpression of small interfering RNAs directed against Cav. Cav (10 nM) increased DNA synthesis in PC-3 cells, which was again suppressed by the administration of 10 nM PEDF. The results of the present study indicated that PEDF may inhibit Cav-induced increases in IL-8 gene expression and proliferation of PC-3 cells. Therefore, the suppressive effects of PEDF in prostate cancer may, in part, be ascribed to its inhibitory actions on Cav.	[Matsui, Takanori; Ojima, Ayako; Yamagishi, Sho-Ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan; [Higashimoto, Yuichiro; Taira, Junichi] Kurume Univ, Sch Med, Dept Chem, Kurume, Fukuoka 8300011, Japan; [Fukami, Kei] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 8300011, Japan	Yamagishi, SI (reprint author), Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25293127]	This study was supported by Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant no. 25293127).	Guan TH, 2013, DIABETOLOGIA, V56, P2068, DOI 10.1007/s00125-013-2968-z; Li LK, 2009, MOL CANCER RES, V7, P1781, DOI 10.1158/1541-7786.MCR-09-0255; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Sugie S, 2013, ANTICANCER RES, V33, P1893; Tahir SA, 2006, CLIN CANCER RES, V12, P4872, DOI 10.1158/1078-0432.CCR-06-0417; Seki R, 2013, BIOCHEM BIOPH RES CO, V431, P693, DOI 10.1016/j.bbrc.2013.01.057; Tahir SA, 2008, CANCER RES, V68, P731, DOI 10.1158/0008-5472.CAN-07-2668; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Fujimura T, 2009, NEPHROL DIAL TRANSPL, V24, P1397, DOI 10.1093/ndt/gfn659; Hirsch J, 2011, CYTOKINE, V55, P202, DOI 10.1016/j.cyto.2011.04.010; Yamagishi S, 2014, CURR PHARM DESIGN, V20, P2377; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Gumulec J, 2012, ONCOL REP, V27, P831, DOI 10.3892/or.2011.1587; Matsui T, 2014, AM J PATHOL, V184, P1094, DOI 10.1016/j.ajpath.2013.12.032; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V296, P877, DOI 10.1016/S0006-291X(02)00940-3; Duh EJ, 2002, INVEST OPHTH VIS SCI, V43, P821; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Thompson TC, 2010, PROSTATE CANCER P D, V13, P6, DOI 10.1038/pcan.2009.29; Takenaka K, 2005, LIFE SCI, V77, P3231, DOI 10.1016/j.lfs.2005.05.048; Yamagishi SI, 2003, MICROVASC RES, V65, P186, DOI 10.1016/S0026-2862(03)00005-0; Mirochnik Y, 2009, CLIN CANCER RES, V15, P1655, DOI 10.1158/1078-0432.CCR-08-2113; Taira J, 2013, BIOCHEM BIOPH RES CO, V431, P724, DOI 10.1016/j.bbrc.2013.01.051; Higashimoto Y, 2013, MICROVASC RES, V90, P64, DOI 10.1016/j.mvr.2013.08.010; Freeman MR, 2012, ADV EXP MED BIOL, V729, P95, DOI 10.1007/978-1-4614-1222-9_7; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Matsui T, 2013, BIOCHEM BIOPH RES CO, V441, P405, DOI 10.1016/j.bbrc.2013.10.074; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Hoshina D, 2010, CURR MOL MED, V10, P292; Tahir SA, 2001, CANCER RES, V61, P3882; Matsui T, 2012, MICROVASC RES, V84, P105, DOI 10.1016/j.mvr.2012.02.006; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Matsui T, 2014, BIOCHEM BIOPH RES CO, V443, P847, DOI 10.1016/j.bbrc.2013.12.060; Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Gong Q, 2014, BIOCHEM PHARMACOL, V92, P425, DOI 10.1016/j.bcp.2014.09.012; Ojima A, 2013, AM J PATHOL, V182, P132, DOI 10.1016/j.ajpath.2012.09.016; Sowa G, FRONT PHYSL, V2, P120	36	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2644	2648		10.3892/ol.2015.3568		5	Oncology	Oncology	CT7MT	WOS:000362999500126		
J	Matsuoka, A; Maeda, O; Inada-Inoue, M; Ohno, E; Hirooka, Y; Yokoyama, Y; Fujii, T; Nagino, M; Goto, H; Ando, Y				Matsuoka, Ayumu; Maeda, Osamu; Inada-Inoue, Megumi; Ohno, Eizaburo; Hirooka, Yoshiki; Yokoyama, Yukihiro; Fujii, Tsutomu; Nagino, Masato; Goto, Hidemi; Ando, Yuichi			FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases	ONCOLOGY LETTERS			English	Review						FOLFIRINOX; dysarthria; irinotecan; oxaliplatin; pancreatic cancer	METASTATIC PANCREATIC-CANCER; NERVOUS-SYSTEM TOXICITY; COLORECTAL-CANCER; IRINOTECAN; OXALIPLATIN	FOLFIRINOX is a standard chemotherapeutic regimen for patients with advanced pancreatic cancer who have a good performance status. In this study, we present the case of a 64-year-old male who developed dysarthria following FOLFIRINOX treatment, and review all four cases of dysarthria encountered among the nine patients who received this treatment in our hospital. In all cases, dysarthria occurred during the infusion of irinotecan in the first course of treatment, persisted for several hours, and then resolved rapidly without any sequelae. Physical and neurological examinations at the onset of dysarthria revealed no other abnormalities. Imaging studies revealed no abnormal findings. Atropine was prophylactically administered in the second and subsequent courses of treatment and effectively prevented or alleviated dysarthria. This acute neurological symptom is surprising and uncommon in traditional cancer chemotherapy, and medical oncologists may initially suspect the onset of stroke or cerebrovascular disease. However, consistent with our experience, all reported cases resolved completely, with no need for dose reduction or treatment interruption.	[Matsuoka, Ayumu; Maeda, Osamu; Inada-Inoue, Megumi; Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi 4668550, Japan; [Matsuoka, Ayumu; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4668550, Japan; [Ohno, Eizaburo; Hirooka, Yoshiki; Goto, Hidemi] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi 4668550, Japan; [Yokoyama, Yukihiro; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4668550, Japan; [Fujii, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan	Matsuoka, A (reprint author), Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	ayumu0611@med.nagoya-u.ac.jp	Ando, Yuichi/Q-1418-2015; MAEDA, Osamu/Q-1016-2015	Ando, Yuichi/0000-0002-6849-2297; 			Hamberg P, 2008, ACTA ONCOL, V47, P974, DOI 10.1080/02841860701666089; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Garcia IS, 1999, JNCI-J NATL CANCER I, V91, P647, DOI 10.1093/jnci/91.7.647; HAXHIU MA, 1984, AM J PHYSIOL, V247, pR939; Lee KA, 2013, AM J HEALTH-SYST PH, V70, P1140, DOI 10.2146/ajhp120542; Falcone A, 2007, J CLIN ONCOL, V25, P1670, DOI 10.1200/JCO.2006.09.0928; CORTES R, 1984, NEUROSCIENCE, V12, P1003, DOI 10.1016/0306-4522(84)90001-0; Park SB, 2009, BRAIN, V132, P2712, DOI 10.1093/brain/awp219; Baz DV, 2001, J NATL CANCER I, V93, P1419, DOI 10.1093/jnci/93.18.1419; Harel M, 2005, MOL PHARMACOL, V67, P1874, DOI 10.1124/mol.104.009944; De Marco S, 2004, ANN ONCOL, V15, P1147, DOI 10.1093/annonc/mdh277; Hamberg P, 2006, J NATL CANCER I, V98, P219, DOI 10.1093/jnci/djj034; Masi G, 2010, LANCET ONCOL, V11, P845, DOI 10.1016/S1470-2045(10)70175-3; Ceccaldi B, 2002, REV MED INTERNE, V23, P950, DOI 10.1016/S0248-8663(02)00707-5; Souglakos J, 2006, BRIT J CANCER, V94, P798, DOI 10.1038/sj.bjc.6603011; Dressel Albertine J, 2012, Case Rep Oncol, V5, P47, DOI 10.1159/000336156; Gomez Jesus A, 2008, Gastrointest Cancer Res, V2, P209; Gunturu KS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0361-2; Okusaka T, 2014, CANCER SCI, V105, P1321, DOI 10.1111/cas.12501; Sogabe Susumu, 2011, Gan To Kagaku Ryoho, V38, P1375	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2662	2664		10.3892/ol.2015.3591		3	Oncology	Oncology	CT7MT	WOS:000362999500130		
J	Ganeev, RA				Ganeev, R. A.			High-order harmonic characterization using different schemes of extended plasma formation	OPTICS AND SPECTROSCOPY			English	Article							LASER-PRODUCED PLASMAS; ATOM CLUSTERS; SPARK SPECTRA; RARE-GASES; GENERATION; PULSES; ABLATION; FREQUENCY; RADIATION; THYMINE	The review of the characterization of the high-order harmonics of ultrashort pulses produced in the extended plasmas is presented. We analyze the spatial and coherence characteristics of the harmonics generated in the extended plasmas produced by 370 ps pulses. We discuss the advanced properties of extended manganese and zinc plasma plumes for the harmonic generation in the shorter and longer wavelength regions of extreme ultraviolet compared with the short-length plasmas used in previous studies. The conversion efficiency of the 11th-19th orders at these conditions was estimated to be 5 x 10(-5). The reviewed studies demonstrate the limits of most extended harmonic cut-off in the plasma media. We also discuss the harmonic generation using the two femtosecond pulses propagating in the vicinity of solid and powdered targets. This method allows the simplified analysis of the high-order nonlinear optical properties of the media.	Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan	Ganeev, RA (reprint author), Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan.	rashid_ganeev@mail.ru					Andreev AV, 2013, EUR PHYS J D, V67, DOI 10.1140/epjd/e2012-30527-0; Lopez-Quintas I, 2014, APPL SURF SCI, V302, P299, DOI 10.1016/j.apsusc.2013.09.120; Ganeev RA, 2005, PHYS LETT A, V339, P103, DOI 10.1016/j.physleta.2005.02.073; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Kan C, 1997, PHYS REV LETT, V79, P2971, DOI 10.1103/PhysRevLett.79.2971; Kurz HG, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063811; Pertot Y, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/7/074017; DiChiara AD, 2009, OPT EXPRESS, V17, P20959, DOI 10.1364/OE.17.020959; Dromey B, 2006, NAT PHYS, V2, P456, DOI 10.1038/nphys338; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Ganeev RA, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891964; Donnelly TD, 1996, PHYS REV LETT, V76, P2472, DOI 10.1103/PhysRevLett.76.2472; KRAUSE JL, 1992, PHYS REV LETT, V68, P3535, DOI 10.1103/PhysRevLett.68.3535; Haessler S, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/7/074012; Ruf H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.083902; Ghimire S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043836; DICK KA, 1968, CAN J PHYS, V46, P1291; CROOKER AM, 1968, CAN J PHYS, V46, P1241; Ganeev RA, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023831; Tisch JWG, 1997, J PHYS B-AT MOL OPT, V30, pL709, DOI 10.1088/0953-4075/30/20/006; Ganeev RA, 2014, J OPT SOC AM B, V31, P911, DOI 10.1364/JOSAB.31.000911; Ganeev RA, 2012, OPT EXPRESS, V20, P25239, DOI 10.1364/OE.20.025239; Seres J, 2007, NAT PHYS, V3, P878, DOI 10.1038/nphys775; Ganeev RA, 2008, J APPL PHYS, V103, DOI 10.1063/1.2887990; Ganeev RA, 2014, J APPL PHYS, V116, DOI 10.1063/1.4905188; Ganeev RA, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/16/165402; Ganeev RA, 2015, OPT SPECTROSC+, V118, P639, DOI 10.1134/S0030400X15030133; Kornilov O, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3443575; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Ganeev RA, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033803; Hutchison C, 2013, PHYS CHEM CHEM PHYS, V15, P12308, DOI 10.1039/c3cp00004d; Tosa V, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025016; Ganeev RA, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861161; Ghimire S, 2011, NAT PHYS, V7, P138, DOI [10.1038/nphys1847, 10.1038/NPHYS1847]; Ganeev RA, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.015807; Ganeev RA, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023805; Ganeev RA, 2015, OPT SPECTROSC+, V118, P574, DOI 10.1134/S0030400X15040050; Ganeev RA, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.013820; Elouga Bom L. B., OPT EXPRESS, V19, P3677; Elouga Bom L B, 2011, Opt Express, V19, P3077, DOI 10.1364/OE.19.003077; Ganeev RA, 2014, J OPT SOC AM B, V31, P3105, DOI 10.1364/JOSAB.31.003105; Ganeev RA, 2013, HIGH-ORDER HARMONIC GENERATION IN LASER PLASMA PLUMES, P1; Ganeev RA, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2014-50175-6; Ganeev RA, 2007, J PHYS B-AT MOL OPT, V40, pR213, DOI 10.1088/0953-4075/40/22/R01; Ganeev R.A., 2009, OPEN SPECTROSC J, V3, P1; Kemper F., 2013, NEW J PHYS, V15; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; Pirri A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.011801	48	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0030-400X	1562-6911		OPT SPECTROSC+	Opt. Spectrosc.	OCT	2015	119	4					682	699		10.1134/S0030400X15100148		18	Optics; Spectroscopy	Optics; Spectroscopy	CT8GK	WOS:000363052800018		
J	Honda, H; Morihara, T; Arai, Y; Horii, M; Ito, H; Furukawa, R; Kida, Y; Sukenari, T; Ikoma, K; Oda, R; Yamada, Y; Fujiwara, H; Kubo, T				Honda, H.; Morihara, T.; Arai, Y.; Horii, M.; Ito, H.; Furukawa, R.; Kida, Y.; Sukenari, T.; Ikoma, K.; Oda, R.; Yamada, Y.; Fujiwara, H.; Kubo, T.			Clinical application of radial magnetic resonance imaging for evaluation of rotator cuff tear	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Shoulder; Rotator cuff; Radial magnetic resonance imaging; Tendon injuries	HUMERAL INSERTION; MR ARTHROGRAPHY; SUPRASPINATUS; SHOULDER; TENDON; INTEGRITY; DIAGNOSIS; ANATOMY; IMAGES; REPAIR	Background: Magnetic resonance imaging is useful for evaluating the rotator cuff, but some tendinous insertions cannot be assessed using oblique sagittal, oblique coronal, and axial magnetic resonance (MR) images because of the presence of the partial volume effect. Hypothesis: The purpose of this study was to determine whether radial-slice MR images could reveal normal rotator cuff insertions and rotator cuff tears more clearly than conventional MR images. Patients and methods: The study included 18 subjects with normal rotator cuffs and 30 with rotator cuff tears. MR images of rotator cuff insertions sliced into radial, oblique coronal, and axial sections were obtained. The extent to which normal rotator cuff insertions and rotator cuff tears were visualized in each of the three MR images was evaluated. Results: The top to posterior portions of the rotator cuff insertions from 0 to 120 could be visualized in the radial MR images. In comparison, the posterior portions of the rotator cuff insertions could not be visualized around 45 in both the oblique coronal and axial MR images. Discussion: These findings demonstrate that radial MR images are superior to the oblique coronal and axial MR images regarding their ability to accurately visualize rotator cuff insertions. Radial MR images also revealed greater detail around 45 in the posterior area of the rotator cuff tears than the oblique coronal and axial MR images. Radial MR images are particularly useful for visualizing clinically important posterosuperior rotator cuff tears. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Honda, H.; Morihara, T.; Arai, Y.; Horii, M.; Furukawa, R.; Kida, Y.; Sukenari, T.; Ikoma, K.; Oda, R.; Fujiwara, H.; Kubo, T.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan; [Yamada, Y.] Kyoto Prefectural Univ Med, Lab Sports & Hlth Sci, Kyoto 6028566, Japan; [Ito, H.] Kajiicho Med imaging Ctr, Dept Radiol, Kyoto, Japan	Fujiwara, H (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan.	fjwr@koto.kpu-m.ac.jp					Sugaya H, 2007, J BONE JOINT SURG AM, V89A, P953, DOI 10.2106/JBJS.F.00512; Nakata W, 2011, RADIOGRAPHICS, V31, P791, DOI 10.1148/rg.313105507; Horii M, 2002, J PEDIATR ORTHOPED, V22, P222, DOI 10.1097/00004694-200203000-00019; Lafosse L, 2007, J BONE JOINT SURG AM, V89A, P1533, DOI 10.2106/JBJS.F.00305; Garavaglia G, 2011, INT J SHOULDER SURG, V5, P90, DOI 10.4103/0973-6042.91000; Foad A, 2012, ARTHROSCOPY, V28, P636, DOI 10.1016/j.arthro.2011.10.006; Mochizuki T, 2009, J BONE JOINT SURG AM, V91A, P1, DOI 10.2106/JBJS.H.01426; Polster JM, 2010, AM J ROENTGENOL, V195, P577, DOI 10.2214/AJR.10.4683; MUNK PL, 1989, RADIOLOGY, V173, P751; Magee T, 2009, AM J ROENTGENOL, V192, P86, DOI 10.2214/AJR.08.1097; Tuite MJ, 2001, SKELETAL RADIOL, V30, P262; Mochizuki T, 2008, J BONE JOINT SURG AM, V90A, P962, DOI 10.2106/JBJS.G.00427; Walz DM, 2007, SKELETAL RADIOL, V36, P411, DOI 10.1007/s00256-006-0265-3; REINUS WR, 1995, AM J ROENTGENOL, V164, P1451; Horii M, 2000, J BONE JOINT SURG BR, V82B, P364, DOI 10.1302/0301-620X.82B3.9923; Parsa M, 1997, AM J ROENTGENOL, V168, P1519; Dugas JR, 2002, J SHOULDER ELB SURG, V11, P498, DOI 10.1067/mse.2002.126208; Magee T, 2006, AM J ROENTGENOL, V187, P881, DOI 10.2214/AJR.05.1047; Furukawa R, 2014, J SHOULDER ELB SURG, V23, P283; Kubo T, 1999, J Orthop Sci, V4, P328, DOI 10.1007/s007760050112; Matsuki K, 2010, ORTHOPEDICS, V33; Schaeffeler C, LESIONS BICEPS PULLE; Stoller DW, 2007, MAGNETIC RESONANCE I	23	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	OCT	2015	101	6					715	719		10.1016/j.otsr.2015.06.007		5	Orthopedics; Surgery	Orthopedics; Surgery	CT7HL	WOS:000362985500012		
J	Tsujii, M; Iida, R; Satonakaa, H; Sudo, A				Tsujii, M.; Iida, R.; Satonakaa, H.; Sudo, A.			Usefulness and complications associated with thenar and standard portals during arthroscopic surgery of thumb carpometacarpal joint	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Thumb carpometacarpal joint; Arthroscopy; Thenar portal; Nerve injury	TRAPEZIOMETACARPAL JOINT; PERCUTANEOUS FIXATION; INTERPOSITION; FLUOROSCOPY; LIGAMENTS; FRACTURES; ACCURACY	Purpose: Advances in small arthroscopy have enabled a minimally invasive surgery for thumb carpometacarpal joints. However, surgery is often difficult using standard CM-radial (CM-R) and CM-ulnar portals ( CM-U). Here, we describe the clinical applications and complications associated with using thenar portal (TP) and standard portals. Methods: Arthroscopic surgeries of thumb carpometacarpal joint were performed in 21 patients including 15 patients with osteoarthritis and six Bennett's fracture-dislocations. Complications and the frequency of use associated with each portal were evaluated. Results: Complications associated with the CM-R portal comprised paresthesia due to damage of the radial nerve branches in two patients. No nerves were damaged but the operation scar became tender at the TP in three patients. The CM-R was used at a lower frequency when the TP was utilized. Conclusion: The clinical use of TP may decrease the risk of radial sensory nerve damage through decreasing frequency of use of the CM-R that is located near the nerve. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Tsujii, M.; Satonakaa, H.; Sudo, A.] Mie Univ, Dept Orthopaed Surg, Grad Sch Med, Tsu, Mie 5148507, Japan; [Iida, R.] Nagai Hosp, Dept Orthopaed Surg, Nagai, Japan	Tsujii, M (reprint author), Mie Univ, Dept Orthopaed Surg, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	m-t727@clin.medic.mie-u.ac.jp					Colman M, 2007, J HAND SURG-AM, V32A, P310, DOI 10.1016/j.jhsa.2006.12.002; Adams JE, 2007, J HAND SURG-BRIT EUR, V32E, P268, DOI 10.1016/j.jhsb.2006.12.003; Greeven APA, 2013, J HAND SURG-EUR VOL, V38, P979, DOI 10.1177/1753193412468565; Furia JP, 2010, ARTHROSCOPY, V26, P34, DOI 10.1016/j.arthro.2009.06.031; Bettinger PC, 1999, J HAND SURG-AM, V24A, P786, DOI 10.1053/jhsu.1999.0786; Gonzalez MH, 1997, J HAND SURG-BRIT EUR, V22B, P574, DOI 10.1016/S0266-7681(97)80347-6; Berger RA, 1997, J HAND SURG-AM, V22A, P1077, DOI 10.1016/S0363-5023(97)80052-4; EATON RG, 1973, J BONE JOINT SURG AM, VA 55, P1655; Menon J, 1996, ARTHROSCOPY, V12, P581, DOI 10.1016/S0749-8063(96)90198-X; Sekiya I, 2002, ARTHROSCOPY, V18, P292, DOI 10.1053/jars.2002.30030; Culp RW, 2010, J HAND SURG-AM, V35A, P137, DOI 10.1016/j.jhsa.2009.10.019; CHEN YC, 1979, ORTHOP CLIN N AM, V10, P723; Barron OA, 2010, GREENS OPERATIVE HAN, P407; Capo JT, 2009, J HAND SURG-AM, V34A, P637, DOI 10.1016/j.jhsa.2008.12.023; Hofmeister Eric P, 2009, Hand (N Y), V4, P24, DOI 10.1007/s11552-008-9130-2; Landstrom JT, 2008, J HAND SURG-AM, V33A, P442, DOI 10.1016/j.jhsa.2007.11.021; Walsh EF, 2005, J HAND SURG-AM, V30A, P373, DOI 10.1016/j.jhsa.2004.11.011; Zemirline A, 2014, HAND SURG, V9, P281	18	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	OCT	2015	101	6					741	744		10.1016/j.otsr.2015.04.009		4	Orthopedics; Surgery	Orthopedics; Surgery	CT7HL	WOS:000362985500016		
J	Minakawa, N; Kongere, JO; Dida, GO; Ikeda, E; Hu, JP; Minagawa, K; Futami, K; Kawada, H; Njenga, SM; Larson, PS				Minakawa, Noboru; Kongere, James O.; Dida, Gabriel O.; Ikeda, Eriko; Hu, Jinping; Minagawa, Kogomi; Futami, Kyoko; Kawada, Hitoshi; Njenga, Sammy M.; Larson, Peter S.			Sleeping on the floor decreases insecticide treated bed net use and increases risk of malaria in children under 5 years of age in Mbita District, Kenya	PARASITOLOGY			English	Article						Malaria; LLIN; sleeping location; children; Kenya; Plasmodium	CASE DEFINITIONS; WESTERN KENYA; INFECTION; TRANSMISSION; PREVALENCE; ANEMIA; AREA	Children who sleep on the floor are less likely to use long-lasting insecticidal nets (LLINs); however, the relationship between sleeping location and Plasmodium falciparum infection has not been investigated sufficiently. This study revealed whether sleeping location (bed vs floor) is associated with P. falciparum infection among children 7-59 months old. More than 60% of children slept on the floor. Younger children were significantly more likely to sleep in beds [odds ratio, OR 2<bold></bold>31 (95% confidence interval (CI) 2.02-2.67)]. Nearly 70% of children slept under LLINs the previous night. LLIN use among children who slept on the floor was significantly less than ones sleeping in beds [OR 0.49 (95% CI 0.35-0.68)]. The polymerase chain reaction (PCR) based P. falciparum infection rate and slide based infection rate were 65.2 and 29.7%, respectively. Both infections were significantly higher among children slept on the floor [OR1.51 (95% CI 1.08-2.10) for PCR base, OR 1.62 (95% CI 1.14-2.30) for slide base] while net availability was not significant. Sleeping location was also significant for slide based infection with fever (>= 37.5 degrees C) [2.03 (95% CI 1.14-3.84)] and high parasitemia cases (parasite >= 2500 mu L-1) [2.07 (95% CI 1.03-4.50)]. The results suggest that sleeping location has a direct bearing on the effectiveness of LLINs.	[Minakawa, Noboru; Dida, Gabriel O.; Hu, Jinping; Minagawa, Kogomi; Futami, Kyoko; Kawada, Hitoshi] Nagasaki Univ, Inst Trop Med, Dept Vector Ecol & Environm, Nagasaki 8528523, Japan; [Kongere, James O.; Larson, Peter S.] Nagasaki Univ, Inst Trop Med NEKKEN, NUITM KEMRI Project, Nairobi, Kenya; [Dida, Gabriel O.; Ikeda, Eriko] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Njenga, Sammy M.] Kenya Govt Med Res Ctr, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya; [Larson, Peter S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Minakawa, N (reprint author), Nagasaki Univ, Inst Trop Med, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	minakawa@nagasaki-u.ac.jp			Global Center of Excellence Program, Nagasaki University, Japan	This study was supported by the Global Center of Excellence Program, Nagasaki University, Japan (there is no grant number).	Ahmed SSSJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011252, 10.1371/journal.pone.0011190, 10.1371/journal.pone.0012660]; Eisele TP, 2011, AM J TROP MED HYG, V84, P152, DOI 10.4269/ajtmh.2011.10-0287; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Gimnig JE, 2009, LANCET, V374, P954, DOI 10.1016/S0140-6736(09)61078-3; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P68; Kawada H, 2012, JPN J INFECT DIS, V65, P243; Mugisha F, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-40; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176; Alaii JA, 2003, AM J TROP MED HYG, V68, P128; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Faraway J. J., 2006, EXTENDING LINEAR MOD; Iwashita H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-52; Larson S. P., 2014, MALARIA J, V13, P486, DOI [10.1186/1475-2875-13-486, DOI 10.1186/1475-2875-13-486]; Nabarro D., 1999, Parassitologia (Rome), V41, P501; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Olotu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015569; RBM Partnership, 2005, GLOB STRAT PLAN 2005; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; West PA, 2013, PLOS ONE, V7, P8, DOI DOI 10.1371/J0URNAL.P0NE.0065787; World Health Organization, 2014, EST POP ACC ITNS VER; World Health Organization, 2000, WHOCDSRBM200017; World Health Organization (WHO), 2010, GUID TREATM MAL	28	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0031-1820	1469-8161		PARASITOLOGY	Parasitology	OCT	2015	142	12					1516	1522		10.1017/S0031182015000955		7	Parasitology	Parasitology	CT6GK	WOS:000362911100006		
J	Bhidayasiri, R; Jitkritsadakul, O; Boonrod, N; Sringean, J; Caine, SM; Hattori, N; Hayashi, A				Bhidayasiri, Roongroj; Jitkritsadakul, Onanong; Boonrod, Nonglak; Sringean, Jirada; Caine, Susan M.; Hattori, Nobutaka; Hayashi, Akito			What is the evidence to support home environmental adaptation in Parkinson's disease? A call for multidisciplinary interventions	PARKINSONISM & RELATED DISORDERS			English	Article						Parkinson's disease; Housing adaptation; Accessibility; Usability; Activity; Person-environmental fit; Home environmental adjustment; Safety; Falls; Rehabilitation; Activities of daily livings	RANDOMIZED CONTROLLED-TRIAL; TERM-CARE FACILITIES; OCCUPATIONAL-THERAPY; FALLS; PEOPLE; PHYSIOTHERAPY; CIRCUMSTANCES; ASSESSMENTS; INJURIES; SCALE	"Home" is where one has a sense of belonging and feels secure, but it can also be a risky place for people with Parkinson's disease (PD). PD patients need assistance making adjustments to their physical environment to maintain appropriate care and provide a safe environment. This relationship is called the "person-environmental fit" (P-E fit). While most PD patients remain in their own homes, little is known about the specific challenges that PD patients and their caregivers encounter in the routine activities of daily living. The aim of our study was to identify the existing evidence on the issue of housing environmental adaptation in PD by performing a systematic review with a proposal of development strategies to integrate a multidisciplinary team into a home environmental research. MEDLINE, and life science journals were searched by querying appropriate key words, but revealed very few publications in this area. However, early evidence suggested that PD patients do not enjoy an adequate P-E fit in their own homes and face more functional limitations compared to matched controls. We concluded that we need to develop research-based evaluation strategies that can provide us with a theoretical and conceptual basis as well as tools for analysis of the P-E fit for PD patients and caregivers. We recommend that individual members of the multidisciplinary team including patients, caregivers, physicians, rehabilitation specialists, and social workers use a team approach to identify the key indicators and solutions for the development of PD-specific solutions for improving the P-E fit. (C) 2015 Elsevier Ltd. All rights reserved.	[Bhidayasiri, Roongroj; Jitkritsadakul, Onanong; Boonrod, Nonglak; Sringean, Jirada] Chulalongkorn Univ, Fac Med, Chulalongkorn Ctr Excellence Parkinson Dis & Rela, Dept Med, Bangkok 10330, Thailand; [Bhidayasiri, Roongroj; Jitkritsadakul, Onanong; Boonrod, Nonglak; Sringean, Jirada] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok 10330, Thailand; [Bhidayasiri, Roongroj; Hayashi, Akito] Juntendo Univ, Dept Rehabil Med, Tokyo, Japan; [Caine, Susan M.] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Hattori, Nobutaka] Juntendo Univ, Dept Neurol, Tokyo, Japan	Bhidayasiri, R (reprint author), Chulalongkorn Univ Hosp, Chulalongkorn Ctr Excellence Parkinson Dis & Rela, 1873 Rama 4 Rd, Bangkok 10330, Thailand.	rbh@chulapd.org		Bhidayasiri, Roongroj/0000-0002-6901-2064	Ratchadapiseksompoj Endowment Fund of Chulalongkorn University [RES560530136, RES560530137-HR]; National Research Council of Thailand; Chulalongkorn University	This study was supported by the Ratchadapiseksompoj Endowment Fund of Chulalongkorn University (RES560530136 & RES560530137-HR), the grant from the National Research Council of Thailand, Ratchadapiseksompoj and research unit grants of Chulalongkorn University.	Andrews J., 2013, DEMENTIA FINDING HOU; Sturkenboom IHWM, 2014, LANCET NEUROL, V13, P557, DOI 10.1016/S1474-4422(14)70055-9; Nijkrake MJ, 2009, MOVEMENT DISORD, V24, P282, DOI 10.1002/mds.22377; Lang AE, 2013, MOVEMENT DISORD, V28, P1980, DOI 10.1002/mds.25671; Hobson JP, 2001, CLIN REHABIL, V15, P241, DOI 10.1191/026921501666767060; Iwarsson S, 1998, CLIN REHABIL, V12, P221; Neyens JC, 2011, J AM MED DIR ASSOC, V12, P410, DOI 10.1016/j.jamda.2010.07.018; Slaug B, 2013, AGING CLIN EXP RES, V25, P667, DOI 10.1007/s40520-013-0165-z; Nieuwboer A, 2002, CLIN REHABIL, V16, P886, DOI 10.1191/0269215502cr573oa; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; McLaughlin D, 2011, PALLIATIVE MED, V25, P177, DOI 10.1177/0269216310385604; van der Marck MA, 2013, MOVEMENT DISORD, V28, P605, DOI 10.1002/mds.25194; Fange A, 2003, DISABIL REHABIL, V25, P1316, DOI 10.1080/09638280310001616286; Nieuwboer A, 2001, J REHABIL MED, V33, P266; Ashburn A, 2008, DISABIL REHABIL, V30, P1205, DOI 10.1080/09638280701828930; Weerkamp NJ, 2014, J AM MED DIR ASSOC, V15, P90, DOI 10.1016/j.jamda.2013.10.007; Sturkenboom IHWM, 2015, MOVEMENT DISORD, V30, P1059, DOI 10.1002/mds.26217; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; GEORGE J, 1988, BRIT MED J, V296, P1365; Calne Susan M, 2003, J Neurosci Nurs, V35, P242; Dahlin-Ivanoff S, 2007, Scand J Occup Ther, V14, P25, DOI 10.1080/11038120601151714; Dyck C., 2013, PARKINSONS DIS, P1205; Fänge Agneta, 2005, Occup Ther Int, V12, P44, DOI 10.1002/oti.14; Gazibara T, 2014, GERIATR NURS, V35, P364, DOI 10.1016/j.gerinurse.2014.05.001; Haak M., 2013, J PARKINSONISM RESTL, V3, P41; International Classification of Functioning, 2001, INT CLASS FUNCT DIS; Keall MD, 2015, LANCET, V385, P231, DOI 10.1016/S0140-6736(14)61006-0; Lawlor D., 2008, LAWS CODES REGULATIO, P21; Lee WJ, 2014, J NEUROL NEUROSUR PS, V85, P969, DOI 10.1136/jnnp-2013-306381; lwarsson S., 2003, DISABIL REHABIL, V25, P57; Martínez-Martín P, 2000, Neurologia, V15, P382; Nilsson M.H., 2013, PARKINSONS DIS, V2013; Ohlen J, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23677; Pierce D., 2012, ACCESSIBLE HOME DESI; Rushford N., 2009, ADAPTING YOUR HOME L; Turner S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003600.pub3; Werngren-Elgström Monica, 2008, Aging Clin Exp Res, V20, P469	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	OCT	2015	21	10					1127	1132		10.1016/j.parkreldis.2015.08.025		6	Clinical Neurology	Neurosciences & Neurology	CT5OB	WOS:000362858600001		
J	Tsujimoto, H; Tsujimoto, Y; Kataoka, Y				Tsujimoto, Hiraku; Tsujimoto, Yasushi; Kataoka, Yuki			Risk of Misinterpretation and Limitation of the Diagnostic Accuracy	PEDIATRICS			English	Letter									[Tsujimoto, Hiraku] Hyogo Prefectural Amagasaki Gen Med Ctr, Okinawa, Japan	Tsujimoto, H (reprint author), Hyogo Prefectural Amagasaki Gen Med Ctr, Okinawa, Japan.	hira_to_ber3598@yahoo.co.jp					Schroeder AR, 2015, PEDIATRICS, V135, P965, DOI 10.1542/peds.2015-0012; Whiting P, 2004, ANN INTERN MED, V140, P189	2	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2015	136	4					E1167	E1167		10.1542/peds.2015-2606A		1	Pediatrics	Pediatrics	CT6TC	WOS:000362944300042		
J	Inoue, S; Phan, TT; Hori, T; Koyama, H; Shimoda, T				Inoue, Satoshi; Tue Trong Phan; Hori, Tomoko; Koyama, Hiroaki; Shimoda, Tatsuya			Electrophoretic displays driven by all-oxide thin-film transistor backplanes fabricated using a solution process	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						amorphous materials; electrophoretic displays; oxide semiconductors; solution processing; thin-film transistors	LOW-TEMPERATURE; IMAGE DISPLAY; PERFORMANCE; SEMICONDUCTORS; ADDRESS	Precursor solutions and a solution process were developed for the fabrication of amorphous oxide thin-film transistors (TFTs). All the layers of the TFTs comprised oxide films prepared from precursor solutions. The gate lines, gate insulator, and channel layer comprised ruthenium oxide, lanthanum zirconium oxide, and zirconium indium zinc oxide films. The polysilazane-based silicon dioxide film was used for the channel stopper layer. The source-line and drain electrode had a double-layer structure comprising indium tin oxide and ruthenium oxide films. The silsesquioxane-based silicon dioxide and ruthenium oxide films were used for the passivation layer and pixel electrodes, respectively. The TFTs exhibited a field effect mobility of 2.68cm(2)V(-1)s(-1), a sub-threshold swing of 1.09V/decade, a threshold voltage of 3.06V, and an on/off ratio of 10(5). Active-matrix electrophoretic displays (EPDs) with a resolution of 101.6ppi were successfully fabricated using the all-solution-processed TFTs. Bi-stable black/white images were confirmed in these TFT-EPDs for the first time.	[Inoue, Satoshi; Tue Trong Phan; Hori, Tomoko; Koyama, Hiroaki; Shimoda, Tatsuya] Japan Adv Inst Sci & Technol, Green Device Res Ctr, Nomi, Ishikawa 9231211, Japan	Inoue, S (reprint author), Japan Adv Inst Sci & Technol, Green Device Res Ctr, 2-13 Asahidai, Nomi, Ishikawa 9231211, Japan.	s-inoue@jaist.ac.jp			ERATO project of Japan Science and Technology Agency (JST); JST-ERATO Shimoda Nano-Liquid Process Project	This work was supported by the ERATO project of the Japan Science and Technology Agency (JST). The authors would like to thank Mr. Yoshimoto and the members of the Green Device Research Center, Japan Advanced Institute of Science and Technology (JAIST) and/or JST-ERATO Shimoda Nano-Liquid Process Project for their support of this study.	Hong TE, 2012, THIN SOLID FILMS, V520, P6100, DOI 10.1016/j.tsf.2012.05.069; QUON WS, 1977, IEEE T ELECTRON DEV, V24, P1121, DOI 10.1109/T-ED.1977.18888; SINGER B, 1977, P SID, V18, P255; Inoue S, 2002, IEEE T ELECTRON DEV, V49, P1532, DOI 10.1109/TED.2002.801432; Kim MG, 2010, J AM CHEM SOC, V132, P10352, DOI 10.1021/ja100615r; Wager JF, 2003, SCIENCE, V300, P1245, DOI 10.1126/science.1085276; SHIFFMAN RR, 1984, P SID, V25, P105; Banger KK, 2011, NAT MATER, V10, P45, DOI [10.1038/nmat2914, 10.1038/NMAT2914]; Tue PT, 2013, IEEE T ELECTRON DEV, V60, P320, DOI 10.1109/TED.2012.2227483; Tressler JF, 1996, J AM CERAM SOC, V79, P525, DOI 10.1111/j.1151-2916.1996.tb08159.x; Yun DJ, 2012, ACS APPL MATER INTER, V4, P4588, DOI 10.1021/am300949h; Wang L, 2006, NAT MATER, V5, P893, DOI 10.1038/nmat1755; Lee DH, 2007, ADV MATER, V19, P843, DOI 10.1002/adma.200600961; Tue PT, 2013, IEEE ELECTR DEVICE L, V34, P1536, DOI 10.1109/LED.2013.2287216; Bhaskar S, 2001, J APPL PHYS, V89, P2987, DOI 10.1063/1.1337588; Pasquarelli RM, 2011, CHEM SOC REV, V40, P5406, DOI 10.1039/c1cs15065k; Kaneda T, 2014, J MATER CHEM C, V2, P40, DOI 10.1039/c3tc31842g; Tu HTC, 2013, IEEE T ELECTRON DEV, V60, P1149, DOI 10.1109/TED.2013.2241440; Beilin S., 1986, SID, V136; Comiskey B., 1997, SID 97, V75; Dalisa A. L., 1986, IEEE SPECTRUM    JUL, P28; Drzaic P., 1998, SID, V1131; Inoue S., 2000, IEDM, V197; Kawai H., 1999, Society for Information Display 1999 International Symposium; Liu GX, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895782; Murakami Y., 2013, IDW, V1573; Nakamura E., 1998, SID, V1014; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Ota I., 1972, U. S. Patent, Patent No. [3 668 109, 3668109]; Shan F., 2015, J DISP TECHNOL, V11, P541; Yudasaka I., 2004, SID INT S SOC INF DI, V964	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	OCT	2015	212	10					2133	2140		10.1002/pssa.201532082		8	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CT6WB	WOS:000362952400004		
J	Muralidhar, M; Kenta, N; Koblischka, MR; Murakami, M				Muralidhar, Miryala; Kenta, Nozaki; Koblischka, Michael R.; Murakami, Masato			High critical current densities in bulk MgB2 fabricated using amorphous boron	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						critical current density; MgB; scanning electron microscopy; superconductors; X-ray diffraction	SUPERCONDUCTORS; OPTIMIZATION; FIELD	We prepared bulk MgB2 from high-purity commercial powders of Mg metal (99.9% purity) and amorphous B (99% purity) powders using a single-step solid state reaction at 775 degrees C for varying sintering duration from 1 to 10h in pure argon atmosphere. X-ray diffraction analysis showed that all the samples were single phase MgB2. The magnetization measurements confirmed a sharp superconducting transition with T-c,T-onset at around 38.2-38.8K. The critical current density (J(c)) values for the MgB2 samples produced at 1h sintering time is the highest one in all processed materials here. Scanning electron microscopy analyses indicated that the sintering time has a crucial influence on the grain size. As a result, the highest J(c) value of 270kAcm(-2) at 20K and self-field was achieved in the sample produced at 775 degrees C for 1h. Our results clearly demonstrate that the optimization of the sintering conditions is essential to improve the bulk MgB2 performance.	[Muralidhar, Miryala; Kenta, Nozaki; Murakami, Masato] Shibaura Inst Technol, Dept Mat Sci & Engn, Superconducting Mat Lab, Tokyo 1358548, Japan; [Koblischka, Michael R.] Univ Saarland, Inst Expt Phys, D-66041 Saarbrucken, Germany	Muralidhar, M (reprint author), Shibaura Inst Technol, Dept Mat Sci & Engn, Superconducting Mat Lab, Tokyo 1358548, Japan.	miryala1@shibaura-it.ac.jp					CHEN DX, 1989, J APPL PHYS, V66, P2489, DOI 10.1063/1.344261; Muralidhar M, 2014, J ALLOY COMPD, V608, P102, DOI 10.1016/j.jallcom.2014.04.017; Yamamoto A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890724; Gao ZS, 2007, J APPL PHYS, V102, DOI 10.1063/1.2748711; Dou SX, 2002, APPL PHYS LETT, V81, P3419, DOI 10.1063/1.1517398; Kim JH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358947; Noudem JG, 2014, J APPL PHYS, V116, DOI 10.1063/1.4900725; Koblischka MR, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2323995; Durrell JH, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/11/112002; Viznichenko RV, 2003, APPL PHYS LETT, V83, P4360, DOI 10.1063/1.1629148; Susner MA, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871578; Murakami M, 2007, INT J APPL CERAM TEC, V4, P225, DOI 10.1111/j.1744-7402.2007.02136.x; Muralidhar M, 2015, ADV ENG MATER, V17, P831, DOI 10.1002/adem.201400583; Shahabuddin M, 2014, AIP ADV, V4, DOI 10.1063/1.4862670; Naito T, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/9/095012; Muralidhar M, 2013, PHYSICA C, V494, P85, DOI 10.1016/j.physc.2013.04.012; Mikheenko P, 2007, SUPERCOND SCI TECH, V20, pS264, DOI 10.1088/0953-2048/20/9/S22; Jun B. H., 2009, SUPERCOND SCI TECH, V21; Kim J. H., 2012, NPG ASIA MATER, V4, P1; Kim J. H., 2015, J ANAL SCI TECHNOL, V6, P11; Kim JH, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/7/075014; Malozemoff A. P., 2009, TECHNA GROUP MONOG M, V8, P279; Muralidhar M., 2015, J ALLOYS COMPD UNPUB; Perini E., 2015, IEEE T APPL SUPRCOND, V21, P2691; Vajpayee A., 2005, SUPERCOND SCI TECH, V18, P116	25	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	OCT	2015	212	10					2141	2145		10.1002/pssa.201532108		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CT6WB	WOS:000362952400005		
J	Tang, ZG; Kosaka, K; Uegaki, H; Chantana, J; Nukui, Y; Hironiwa, D; Minemoto, T				Tang, Zeguo; Kosaka, Kiichi; Uegaki, Hikaru; Chantana, Jakapan; Nukui, Yuki; Hironiwa, Daisuke; Minemoto, Takashi			Investigation on evaporation and suppression of SnS during fabrication of Cu2SnS3 thin films	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						bilayer feature; CTS; high partial pressure; SnS evaporation; thin-film solar cell	SOLAR-CELLS; CU2ZNSNS4; DEPOSITION; ABSORBERS; LAYER	Reaction processes for fabrication of Cu2SnS3 (CTS) thin films by sulfurization of Cu-Sn precursors are investigated by X-ray diffraction (XRD) patterns and scanning electron microscope (SEM) images. The results reveal that the S atoms first react with Cu and Sn atoms to produce Cu2-xS, SnS2 and SnS intermediate phases, and it is noted that the bilayer features, i.e., Cu2-xS is located near the surface while SnS and SnS2 are situated at the bottom, are observed initially with the temperature lower than 400 degrees C. As the temperature increases, these intermediate phases react with each other to form the final CTS phase. Simultaneously, the evaporation of SnS is accompanied by the reaction and consequent voids are formed in the resulting films. In addition, the evaporation of SnS can be suppressed by performing the sulfurization in a sealed space, which is attributed to the increase of partial pressure of SnS and S. A conversion efficiency of 1.2% for a solar cell with structure of Al/ZnO:Al/ZnO/CdS/CTS/Mo/soda lime glass is demonstrated. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Tang, Zeguo; Hironiwa, Daisuke] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Shiga, Japan; [Kosaka, Kiichi; Uegaki, Hikaru; Chantana, Jakapan; Nukui, Yuki; Minemoto, Takashi] Ritsumeikan Univ, Coll Sci & Engn, Shiga, Japan	Tang, ZG (reprint author), Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Shiga, Japan.	tangzg@fc.ritsumei.ac.jp	Minemoto, Takashi/F-9342-2011		Kakenhi [14454434]	This work is supported by the Kakenhi (No. 14454434) supplied by Japan Society for the Promotion of Science (JSPS). The authors would like to thank Prof. Shigeru Ikeda and Dr. Feng Jiang, Research Center for Solar Energy Chemistry, Osaka University for the help of teaching the sulfurization method in a glass ampoule.	Cifuentes C, 2006, BRAZ J PHYS, V36, P1046, DOI 10.1590/S0103-97332006000600066; Scragg JJ, 2011, CHEM MATER, V23, P4625, DOI 10.1021/cm202379s; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Park HH, 2015, PROG PHOTOVOLTAICS, V23, P901, DOI 10.1002/pip.2504; Jackson AJ, 2014, J MATER CHEM A, V2, P7829, DOI 10.1039/c4ta00892h; Siebentritt S, 2012, PROG PHOTOVOLTAICS, V20, P512, DOI 10.1002/pip.2156; Katase T, 2006, ELECTROCHEM SOLID ST, V9, pC69, DOI 10.1149/1.2171814; Nishiwaki S, 1998, JPN J APPL PHYS 2, V37, pL71, DOI 10.1143/JJAP.37.L71; Hironiwa D, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.106502; Schurr R, 2009, THIN SOLID FILMS, V517, P2465, DOI 10.1016/j.tsf.2008.11.019; Berg DM, 2012, THIN SOLID FILMS, V520, P6291, DOI 10.1016/j.tsf.2012.05.085; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Xia YY, 2001, J ELECTROCHEM SOC, V148, pA471, DOI 10.1149/1.1362542; Bouaziz M, 2011, VACUUM, V85, P783, DOI 10.1016/j.vacuum.2010.10.001; Wolfenstine J, 2002, J POWER SOURCES, V109, P230, DOI 10.1016/S0378-7753(02)00061-7; Fernandes PA, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/21/215403; Aihara N, 2013, PHYS STATUS SOLIDI C, V10, P1086, DOI 10.1002/pssc.201200866; Amlouk A, 2010, VACUUM, V85, P60, DOI 10.1016/j.vacuum.2010.04.002; Peng DY, 2001, J CHEM THERMODYN, V33, P1121, DOI 10.1006/jcht.2001.0835; Tang ZG, 2014, J ALLOY COMPD, V608, P213, DOI 10.1016/j.jallcom.2014.04.098; Avellaneda D, 2010, J ELECTROCHEM SOC, V157, pD346, DOI 10.1149/1.3384660; Benagli S., 2009, 24 EUR PHOT SOL EN C; Jiang F, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301381; Kim J, 2014, ADV MATER, V26, P7427, DOI 10.1002/adma.201402373; Manoharan C., 2013, P INT C ADV NAN EM E; Nomura T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW01; Sinsermsuksaku P., 2014, ADV ENERGY MATER, V2014; Tang Z., REACTION PATH UNPUB; Weber A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3273495	29	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	OCT	2015	212	10					2289	2296		10.1002/pssa.201532121		8	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CT6WB	WOS:000362952400027		
J	Onishi, M; Saito, I; Komiyama, K; Takeno, K; Miyazaki, W; Masuzawa, T; Koh, ATT; Chua, DHC; Yamada, T; Mori, Y; Okano, K				Onishi, Masanori; Saito, Ichitaro; Komiyama, Kaoru; Takeno, Kentaro; Miyazaki, Wataru; Masuzawa, Tomoaki; Koh, Angel T. T.; Chua, Daniel H. C.; Yamada, Takatoshi; Mori, Yusuke; Okano, Ken			Characterization of a-Se p-i-n junction fabricated using bidirectional electrolysis in NaCl(aq)	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						amorphous materials; electrochemical doping; optical properties; photoconductors; photovoltaics; selenium	AMORPHOUS SELENIUM	In this article, we introduce an electrochemical doping method of amorphous selenium (a-Se) using NaCl(aq). Recently, an a-Se photovoltaic device fabricated using this method [I. Saito, W. Miyazaki, M. Onishi, Y. Kudo, T. Masuzawa, T. Yamada, A. Koh, D. Chua, K. Soga, M. Overend, M. Aono, G. A. J. Amaratunga, and K. Okano, Appl. Phys. Lett. 98, 152102 (2011)] has been announced and opened up the potential of a new impurity doping method. This study will further explore its possibilities by doping chlorine (Cl) and sodium (Na) and aim to fabricate a p-n junction by reversing the applied voltage during the electrolysis. The device is characterized through photoelectric measurements. The I-V characteristics show rectification under light illumination. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Onishi, Masanori; Saito, Ichitaro; Komiyama, Kaoru; Takeno, Kentaro; Miyazaki, Wataru; Masuzawa, Tomoaki; Okano, Ken] Int Christian Univ, Grad Sch Arts & Sci, Tokyo 1818585, Japan; [Miyazaki, Wataru] Natl Def Acad, Dept Mat Sci & Engn, Yokosuka, Kanagawa 2398686, Japan; [Masuzawa, Tomoaki] Shizuoka Univ, Elect Res Inst, Naka Ku, Shizuoka 4328011, Japan; [Koh, Angel T. T.; Chua, Daniel H. C.] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117576, Singapore; [Yamada, Takatoshi] Natl Inst Adv Ind Sci & Technol, Nanomat Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Mori, Yusuke] Osaka Univ, Grad Sch Engn, Dept Elect Engn, Suita, Osaka 5650871, Japan	Saito, I (reprint author), Int Christian Univ, Grad Sch Arts & Sci, 3-10-2 Osawa Mitaka, Tokyo 1818585, Japan.	ichitaro@icu.ac.jp			MEXT-Support Program for Strategic Research Foundation at Private Universities [S0801012]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [21560053]	The authors would like to thank Prof. Bill Milne of Cambridge University, Dr. Shiva Abbaszadeh of University of Waterloo, and Dr. Habib Mani of Analogic who provided valuable feedback to this work. The present work is financially supported by MEXT-Support Program for the Strategic Research Foundation at Private Universities (S0801012) 2008-2012 and Grants-in-Aid for scientific research (21560053), both from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Belev G, 2004, J NON-CRYST SOLIDS, V345, P484, DOI 10.1016/j.jnoncrysol.2004.08.070; Kasap S, 2009, PHYS STATUS SOLIDI B, V246, P1794, DOI 10.1002/pssb.200982007; Saito I, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3579262; KASAP SO, 1985, J PHYS D APPL PHYS, V18, P703, DOI 10.1088/0022-3727/18/4/015; MOTT NF, 1969, PHILOS MAG, V19, P835, DOI 10.1080/14786436908216338	5	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	OCT	2015	212	10					2322	2325		10.1002/pssa.201532372		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CT6WB	WOS:000362952400032		
J	Nakatani, H; Motokucho, S; Miyazaki, K				Nakatani, Hisayuki; Motokucho, Suguru; Miyazaki, Kensuke			Difference in polystyrene oxo-biodegradation behavior between copper phthalocyanine modified TiO2 and ZnO paint photocatalyst systems	POLYMER DEGRADATION AND STABILITY			English	Article						Oxo-biodegradation; Polystyrene; Photocatalyst; ZnO; TiO2	NANOCOMPOSITE FILM; POLYPROPYLENE; DEGRADATION; OXIDATION; PHOTODEGRADATION; CHEMILUMINESCENCE; PARTICLES; DIOXIDE; PHASES	An oxo-biodegradation of polystyrene (PS) film was performed with copper phthalocyanine modified ZnO (CuPc-ZnO)/polyethylene oxide (PEO)/methyl linoleate (ML) and CuPc-TiO2/PEO/ML paint photocatalyst systems. Difference in the behavior between them was studied in the photodegradation and biodegradation stages, respectively. The CuPc modification brought about the improvement of the photodegradation activity. The smaller particle ZnO (50 nm) showed the less activity due to the ZnO dissolution process. The activity of the CuPc-ZnO/PEO/ML was higher than that with the CuPc-TiO2/PEO/ ML. These systems highly contributed to the initial photodegradation stage. In the biodegradation stage, the dissolved CuPc-ZnO did not inhibit the fungus growth. The fungus was same species regardless of the kind of the photocatalyst system. The respirometric biodegradation profiles showed that the mineralization value reached at the same constant value around the 16 days. However, the initial biodegradation behavior was different. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakatani, Hisayuki; Motokucho, Suguru] Nagasaki Univ, Chem & Mat Program, Polymeri Mat Lab, Nagasaki 8528521, Japan; [Miyazaki, Kensuke] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido 0908507, Japan	Nakatani, H (reprint author), Nagasaki Univ, Chem & Mat Program, Polymeri Mat Lab, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	h-nakatani@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [25740040]	This work was supported by the Grant-in-Aid for Scientific Research, No. 25740040 from Japan Society for the Promotion of Science.	ADAMS JH, 1970, J POLYM SCI A1, V8, P1077, DOI 10.1002/pol.1970.150080505; Zan L, 2004, APPL CATAL A-GEN, V264, P237, DOI 10.1016/j.apcata.2003.12.046; OHTANI B, 1989, POLYM DEGRAD STABIL, V23, P271, DOI 10.1016/0141-3910(89)90101-8; Blakey I, 2000, POLYM DEGRAD STABIL, V70, P269, DOI 10.1016/S0141-3910(00)00126-9; Broska R, 1999, POLYM DEGRAD STABIL, V63, P231, DOI 10.1016/S0141-3910(98)00097-4; Fontanella S, 2010, POLYM DEGRAD STABIL, V95, P1011, DOI 10.1016/j.polymdegradstab.2010.03.009; Chavant P, 2002, APPL ENVIRON MICROB, V68, P728, DOI 10.1128/AEM.68.2.728-737.2002; Shang J, 2003, ENVIRON SCI TECHNOL, V37, P4494, DOI 10.1021/es0209464; Fa WJ, 2010, J APPL POLYM SCI, V118, P378, DOI 10.1002/app.32413; Kemp TJ, 2006, POLYM DEGRAD STABIL, V91, P3010, DOI 10.1016/j.polymdegradstab.2006.08.005; Nakatani H, 2013, J APPL POLYM SCI, V129, P3490, DOI 10.1002/app.39101; Oesch F, 2012, ARCH TOXICOL, V86, P985, DOI 10.1007/s00204-012-0838-y; HATANAKA A, 1978, PHYTOCHEMISTRY, V17, P869, DOI 10.1016/S0031-9422(00)88636-7; Eriksson P, 2002, POLYM DEGRAD STABIL, V78, P183, DOI 10.1016/S0141-3910(02)00132-5; Wang JX, 2014, INT J MOL SCI, V15, P22258, DOI 10.3390/ijms151222258; Motta O, 2009, INT J HYG ENVIR HEAL, V212, P61, DOI 10.1016/j.ijheh.2007.09.014; KATO Y, 1969, J APPL POLYM SCI, V13, P1447, DOI 10.1002/app.1969.070130708; Catano FA, 2012, LAT AM APPL RES, V42, P33; Fa WJ, 2013, J APPL POLYM SCI, V128, P2618, DOI 10.1002/app.37751; Shang J, 2003, J SOLID STATE CHEM, V174, P104, DOI 10.1016/S0022-4596(03)00183-X; Nakatani H, 2005, POLYMER, V46, P12366, DOI 10.1016/j.polymer.2005.10.131; AUDOUIN L, 1995, J POLYM SCI POL CHEM, V33, P921, DOI 10.1002/pola.1995.080330605; CARLSSON DJ, 1969, MACROMOLECULES, V2, P597, DOI 10.1021/ma60012a007; FERIN J, 1992, AM J RESP CELL MOL, V6, P535	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	OCT	2015	120						1	9		10.1016/j.polymdegradstab.2015.06.002		9	Polymer Science	Polymer Science	CT6MJ	WOS:000362926800001		
J	Jaros, J; Takasi, K				Jaros, Jaroslav; Takasi, Kusano			On strongly decreasing solutions of cyclic systems of second-order nonlinear differential equations	PROCEEDINGS OF THE ROYAL SOCIETY OF EDINBURGH SECTION A-MATHEMATICS			English	Article						systems of differential equations; positive solutions; asymptotic behaviour; regularly varying functions	SEMILINEAR ELLIPTIC-SYSTEMS; POSITIVE ENTIRE SOLUTIONS; ASYMPTOTIC-BEHAVIOR; REGULAR VARIATION; EXISTENCE; FRAMEWORK	The n-dimensional cyclic system of second-order nonlinear differential equations (p(i)(t)vertical bar x(i)'vertical bar(alpha i-1) x(i)')' - q(i)(t)vertical bar x(i+1)vertical bar(beta i-1) x(i+1,) i - 1, ... , n, x(n+1) - x(1), is analysed in the framework of regular variation. Under the assumption that alpha(i) and beta(i) are positive constants such that alpha(1) ... alpha(n) > ... beta(1) ... beta(n) and p(i) and q(i) are regularly varying functions, it is shown that the situation in which the system possesses decreasing regularly varying solutions of negative indices can be completely characterized, and moreover that the asymptotic behaviour of such solutions is governed by a unique formula describing their order of decay precisely. Examples are presented to demonstrate that the main results for the system can be applied effectively to some classes of partial differential equations with radial symmetry to provide new accurate information about the existence and the asymptotic behaviour of their radial positive strongly decreasing solutions.	[Jaros, Jaroslav] Comenius Univ, Fac Math Phys & Informat, Dept Math Anal & Numer Math, Bratislava 84248, Slovakia; [Takasi, Kusano] Hiroshima Univ, Fac Sci, Dept Math, Higashihiroshima 7398526, Japan	Jaros, J (reprint author), Comenius Univ, Fac Math Phys & Informat, Dept Math Anal & Numer Math, Bratislava 84248, Slovakia.	jaros@fmph.uniba.sk; kusanot@zj8.so-net.ne.jp					Kusano T, 2012, NONLINEAR ANAL-THEOR, V75, P2474, DOI 10.1016/j.na.2011.10.039; Jaros J, 2013, ELECTRON J QUAL THEO, P1; FURUSHO Y, 1994, J MATH SOC JPN, V46, P449, DOI 10.2969/jmsj/04630449; Furusho Y, 1998, J COMPUT APPL MATH, V88, P161, DOI 10.1016/S0377-0427(97)00214-8; Usami H, 2009, P ROY SOC EDINB A, V139, P1071; Jaros J, 2013, MATH NACHR, V286, P205, DOI 10.1002/mana.201100296; Kusano T, 2012, ACTA APPL MATH, V121, P81, DOI 10.1007/s10440-012-9691-5; Teramoto T, 2002, PAC J MATH, V204, P247; Lair AV, 2000, J DIFFER EQUATIONS, V164, P380, DOI 10.1006/jdeq.2000.3768; Kusano T, 2011, COMPUT MATH APPL, V62, P551, DOI 10.1016/j.camwa.2011.05.019; Lair AV, 2010, J MATH ANAL APPL, V365, P103, DOI 10.1016/j.jmaa.2009.10.026; Lair AV, 2011, J MATH ANAL APPL, V382, P324, DOI 10.1016/j.jmaa.2011.04.051; Azizieh C., 2002, Journal of Differential Equations, V184, DOI 10.1006/jdeq.2001.4149; Bingham N. H., 1987, ENCY MATH ITS APPL, V27; Cirstea F., 2002, J MATH PURE APPL, V81, P827; FURUSHO Y, 1994, ARCH RATION MECH AN, V127, P231, DOI 10.1007/BF00381160; FURUSHO Y, 1992, P ROY SOC EDINB A, V120, P79; Haupt O., 1938, DIFFERENTIAL INTEGRA; Jaros J., 2013, DIFFER EQU APPL, V5, P185; Maric V., 2000, LECT NOTES MATH, V1726; Seneta E., 1976, LECT NOTES MATH, V508; Teramoto T., 2000, HIROSHIMA MATH J, V30, P437; Teramoto T., 1999, FUNKC EKVACIOJ-SER I, V42, P241; Teramoto T., 2002, ELECTRON J QUAL THEO, V16, P1	24	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0308-2105	1473-7124		P ROY SOC EDINB A	Proc. R. Soc. Edinb. Sect. A-Math.	OCT	2015	145	5					1007	1028		10.1017/50308210515000244		22	Mathematics, Applied; Mathematics	Mathematics	CT3QN	WOS:000362721900006		
J	Akiyama, M; Ueda, Y; Watson, MG; Furusawa, H; Takata, T; Simpson, C; Morokuma, T; Yamada, T; Ohta, K; Iwamuro, F; Yabe, K; Tamura, N; Moritani, Y; Takato, N; Kimura, M; Maihara, T; Dalton, G; Lewis, I; Lee, H; Curtis-Lake, E; Macaulay, E; Clarke, F; Silverman, JD; Croom, S; Ouchi, M; Hanami, H; Tello, JD; Yoshikawa, T; Fujishiro, N; Sekiguchi, K				Akiyama, Masayuki; Ueda, Yoshihiro; Watson, Mike G.; Furusawa, Hisanori; Takata, Tadafumi; Simpson, Chris; Morokuma, Tomoki; Yamada, Toru; Ohta, Kouji; Iwamuro, Fumihide; Yabe, Kiyoto; Tamura, Naoyuki; Moritani, Yuuki; Takato, Naruhisa; Kimura, Masahiko; Maihara, Toshinori; Dalton, Gavin; Lewis, Ian; Lee, Hanshin; Curtis-Lake, Emma; Macaulay, Edward; Clarke, Frazer; Silverman, John D.; Croom, Scott; Ouchi, Masami; Hanami, Hitoshi; Diaz Tello, Jorge; Yoshikawa, Tomohiro; Fujishiro, Naofumi; Sekiguchi, Kazuhiro			The Subaru-XMM-Newton Deep Survey (SXDS). VIII. Multi-wavelength identification, optical/NIR spectroscopic properties, and photometric redshifts of X-ray sources	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						catalogs; galaxies: active; quasars: general; surveys; X-rays: galaxies	ACTIVE GALACTIC NUCLEI; SUPERMASSIVE BLACK-HOLES; STAR-FORMING GALAXIES; SPECTRAL ENERGY-DISTRIBUTIONS; BULGE MASS RELATION; DIGITAL SKY SURVEY; WIDE-FIELD SURVEY; SIMILAR-TO 1; LUMINOSITY FUNCTION; HOST GALAXIES	We report on the multi-wavelength identification of the X-ray sources found in the Subaru-XMM-Newton Deep Survey (SXDS) using deep imaging data covering the wavelength range between the far-UV and mid-IR (MIR). We select a primary counterpart of each X-ray source by applying the likelihood ratio method to R-band, 3.6 mu m, near-UV, and 24 mu m source catalogs as well as matching catalogs of active galactic nucleus (AGN) candidates selected in 1.4 GHz radio and i'-band variability surveys. Once candidates for Galactic stars, ultra-luminous X-ray sources in a nearby galaxy, and clusters of galaxies are removed there are 896 AGN candidates in the sample. We conduct spectroscopic observations of the primary counterparts with multi-object spectrographs in the optical and NIR; 65% of the X-ray AGN candidates are spectroscopically identified. For the remaining X-ray AGN candidates, we evaluate their photometric redshift with photometric data in 15 bands. Utilizing the multi-wavelength photometric data of the large sample of X-ray-selected AGNs, we evaluate the stellar masses, M-*, of the host galaxies of the narrow-line AGNs. The distribution of the stellarmass is remarkably constant from z=0.1 to 4.0. The relation between M-* and 2-10 keV luminosity can be explained with strong cosmological evolution of the relationship between the black hole mass and M-*. We also evaluate the scatter of the UV-MIR spectral energy distribution (SED) of the X-ray AGNs as a function of X-ray luminosity and absorption by the nucleus. The scatter is compared with galaxies which have redshift and stellarmass distributionmatched with the X-ray AGN. The UV-NIR (near-IR) SEDs of obscured X-ray AGNs are similar to those of the galaxies in the matched sample. In the NIR-MIR range, the median SEDs of X-ray AGNs are redder, but the scatter of the SEDs of the X-ray AGN broadly overlaps that of the galaxies in the matched sample.	[Akiyama, Masayuki; Yamada, Toru] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ueda, Yoshihiro; Ohta, Kouji; Iwamuro, Fumihide; Maihara, Toshinori] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Watson, Mike G.] Univ Leicester, Dept Phys & Astron, XROA Grp, Leicester LE1 7RH, Leics, England; [Furusawa, Hisanori; Takata, Tadafumi; Yabe, Kiyoto; Takato, Naruhisa; Sekiguchi, Kazuhiro] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Simpson, Chris] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Morokuma, Tomoki] Univ Tokyo, Inst Astron, Grad Sch Sci, Mitaka, Tokyo 1810015, Japan; [Tamura, Naoyuki; Silverman, John D.] Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan; [Moritani, Yuuki] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Kimura, Masahiko] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Dalton, Gavin; Lewis, Ian; Lee, Hanshin; Curtis-Lake, Emma; Macaulay, Edward; Clarke, Frazer] Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England; [Dalton, Gavin] STFC Rutherford Appleton Lab, HSIC, Didcot OX11 0QX, Oxon, England; [Lee, Hanshin] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Curtis-Lake, Emma] Univ Edinburgh, Inst Astron, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland; [Macaulay, Edward] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia; [Croom, Scott] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Ouchi, Masami] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan; [Hanami, Hitoshi] Iwate Univ, Phys Sect, Fac Humanities & Social Sci, Morioka, Iwate 0208550, Japan; [Diaz Tello, Jorge] Univ Nacl Cordoba, Observ Astron Cordoba, IATE, RA-5000 Cordoba, Argentina; [Yoshikawa, Tomohiro] Kyoto Nijikoubou Co Ltd, Sakyo Ku, Kyoto, Kyoto 6060003, Japan; [Fujishiro, Naofumi] Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto, Kyoto 6038047, Japan	Akiyama, M (reprint author), Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan.	akiyama@astr.tohoku.ac.jp			JSPS [18740118, 21340042, 24650145]; National Aeronautics and Space Administration; National Science Foundation	We warmly thank the staff members of the Subaru telescope for their support during the observations. We would like to thank the anonymous referee for valuable comments that improved this paper. MA is supported by JSPS Grant-in-Aid for Young Scientist (B) (18740118), and MA and HH are supported by Grant-in-Aid for Scientific Research (B) (21340042). HH acknowledges the Grant-in-Aid for Challenging Exploratory Research (24650145) from JSPS, which partially supported this research.; This publication makes use of data products from the Two Micron All Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the National Aeronautics and Space Administration and the National Science Foundation.	Akiyama M, 2005, ASTROPHYS J, V629, P72, DOI 10.1086/431291; Alexander DM, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/44; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Morrissey P, 2007, ASTROPHYS J SUPPL S, V173, P682, DOI 10.1086/520512; Ueda Y, 2003, ASTROPHYS J, V598, P886, DOI 10.1086/378940; Bongiorno A, 2014, MON NOT R ASTRON SOC, V443, P2077, DOI 10.1093/mnras/stu1248; Stern J, 2012, MON NOT R ASTRON SOC, V423, P600, DOI 10.1111/j.1365-2966.2012.20901.x; Saito T, 2008, ASTROPHYS J, V675, P1076, DOI 10.1086/527282; Marconi A, 2004, MON NOT R ASTRON SOC, V351, P169, DOI 10.1111/j.1365-2966.2004.07765.x; Kiuchi G, 2009, ASTROPHYS J, V696, P1051, DOI 10.1088/0004-637X/696/1/1051; Luo B, 2010, ASTROPHYS J SUPPL S, V187, P560, DOI 10.1088/0067-0049/187/2/560; Yang Y, 2004, ASTRON J, V128, P1501, DOI 10.1086/423996; Daddi E, 2007, ASTROPHYS J, V670, P173, DOI 10.1086/521820; Yan HJ, 2003, ASTROPHYS J, V585, P67, DOI 10.1086/345998; Watson MG, 2005, ASTRON ASTROPHYS, V437, P899, DOI 10.1051/0004-6361:20053060; Hasinger G, 2005, ASTRON ASTROPHYS, V441, P417, DOI 10.1051/0004-6361:20042134; Bolzonella M, 2000, ASTRON ASTROPHYS, V363, P476; Georgakakis A, 2010, MON NOT R ASTRON SOC, V406, P420, DOI 10.1111/j.1365-2966.2010.16727.x; La Franca F, 2005, ASTROPHYS J, V635, P864, DOI 10.1086/497586; Stern D, 2005, ASTROPHYS J, V631, P163, DOI 10.1086/432523; Merloni A, 2010, ASTROPHYS J, V708, P137, DOI 10.1088/0004-637X/708/1/137; McLure RJ, 2006, MON NOT R ASTRON SOC, V368, P1395, DOI 10.1111/j.1365-2966.2006.10228.x; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Cardamone CN, 2010, ASTROPHYS J SUPPL S, V189, P270, DOI 10.1088/0067-0049/189/2/270; Silverman JD, 2008, ASTROPHYS J, V679, P118, DOI 10.1086/529572; Salvato M, 2009, ASTROPHYS J, V690, P1250, DOI 10.1088/0004-637X/690/2/1250; Sani E, 2011, MON NOT R ASTRON SOC, V413, P1479, DOI 10.1111/j.1365-2966.2011.18229.x; Cappelluti N, 2009, ASTRON ASTROPHYS, V497, P635, DOI 10.1051/0004-6361/200810794; GUNN JE, 1983, ASTROPHYS J SUPPL S, V52, P121, DOI 10.1086/190861; SUTHERLAND W, 1992, MON NOT R ASTRON SOC, V259, P413; Yoshida M, 2008, ASTROPHYS J, V679, P269, DOI 10.1086/586726; Hao H, 2014, MON NOT R ASTRON SOC, V438, P1288, DOI 10.1093/mnras/stt2274; Simpson C, 2012, MON NOT R ASTRON SOC, V421, P3060, DOI 10.1111/j.1365-2966.2012.20529.x; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Silverman JD, 2009, ASTROPHYS J, V696, P396, DOI 10.1088/0004-637X/696/1/396; Aird J, 2008, MON NOT R ASTRON SOC, V387, P883, DOI 10.1111/j.1365-2966.2008.13286.x; Lacy M, 2004, ASTROPHYS J SUPPL S, V154, P166, DOI 10.1086/422816; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581; Aird J, 2010, MON NOT R ASTRON SOC, V401, P2531, DOI 10.1111/j.1365-2966.2009.15829.x; Richards GT, 2003, ASTRON J, V126, P1131, DOI 10.1086/377014; Simpson C, 2006, MON NOT R ASTRON SOC, V372, P741, DOI 10.1111/j.1365-2966.2006.10907.x; Ouchi M, 2009, ASTROPHYS J, V696, P1164, DOI 10.1088/0004-637X/696/2/1164; Ueda Y, 2008, ASTROPHYS J SUPPL S, V179, P124, DOI 10.1086/591083; Brusa M, 2010, ASTROPHYS J, V716, P348, DOI 10.1088/0004-637X/716/1/348; Marconi A, 2003, ASTROPHYS J, V589, pL21, DOI 10.1086/375804; Donley JL, 2005, ASTROPHYS J, V634, P169, DOI 10.1086/491668; Peng CY, 2006, ASTROPHYS J, V649, P616, DOI 10.1086/506266; Smail I, 2008, MON NOT R ASTRON SOC, V389, P407, DOI 10.1111/j.1365-2966.2008.13579.x; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Decarli R, 2010, MON NOT R ASTRON SOC, V402, P2453, DOI 10.1111/j.1365-2966.2009.16049.x; Brammer GB, 2008, ASTROPHYS J, V686, P1503, DOI 10.1086/591786; Fiore F, 2008, ASTROPHYS J, V672, P94, DOI 10.1086/523348; Barger AJ, 2005, ASTRON J, V129, P578, DOI 10.1086/426915; Lonsdale C, 2004, ASTROPHYS J SUPPL S, V154, P54, DOI 10.1086/423206; Yencho B, 2009, ASTROPHYS J, V698, P380, DOI 10.1088/0004-637X/698/1/380; Laird ES, 2009, ASTROPHYS J SUPPL S, V180, P102, DOI 10.1088/0067-0049/180/1/102; Lacy M, 2005, ASTROPHYS J SUPPL S, V161, P41, DOI 10.1086/432894; Mateos S, 2012, MON NOT R ASTRON SOC, V426, P3271, DOI 10.1111/j.1365-2966.2012.21843.x; Schulze A, 2014, MON NOT R ASTRON SOC, V438, P3422, DOI 10.1093/mnras/stt2457; Cardamone CN, 2008, ASTROPHYS J, V680, P130, DOI 10.1086/587800; WOLSTENCROFT RD, 1986, MON NOT R ASTRON SOC, V223, P279; Brusa M, 2009, ASTRON ASTROPHYS, V507, P1277, DOI 10.1051/0004-6361/200912261; Lonsdale CJ, 2003, PUBL ASTRON SOC PAC, V115, P897, DOI 10.1086/376850; Alonso-Herrero A, 2008, ASTROPHYS J, V677, P127, DOI 10.1086/529010; Bennert VN, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/107; Bradshaw EJ, 2013, MON NOT R ASTRON SOC, V433, P194, DOI 10.1093/mnras/stt715; Bruzual A. G., 1993, APJ, V405, P538; Chabrier G, 2002, ASTROPHYS J, V567, P304, DOI 10.1086/324716; Chiappetti L., 2005, ASTROPH0505117; Civano F, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/30; Cowie L. L., 2002, APJ, V566, P5; De Ruiter H. R., 1977, Astronomy and Astrophysics Supplement Series, V28; Diaz Tello J., 2013, APJ, V771, P7; Donley JL, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/142; Ebrero J, 2009, ASTRON ASTROPHYS, V493, P55, DOI 10.1051/0004-6361:200810919; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; Elvis M, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/6; Elvis M, 2009, ASTROPHYS J SUPPL S, V184, P158, DOI 10.1088/0067-0049/184/1/158; Feruglio C, 2008, ASTRON ASTROPHYS, V488, P417, DOI 10.1051/0004-6361:200809571; Finoguenov A, 2010, MON NOT R ASTRON SOC, V403, P2063, DOI 10.1111/j.1365-2966.2010.16256.x; Fioc M, 1997, ASTRON ASTROPHYS, V326, P950; Fiore F, 2003, ASTRON ASTROPHYS, V409, P79, DOI 10.1051/0004-6361:20031031; Furusawa H, 2008, ASTROPHYS J SUPPL S, V176, P1, DOI 10.1086/527321; Hanami H, 2012, PUBL ASTRON SOC JPN, V64; Hao L, 2005, ASTRON J, V129, P1783, DOI 10.1086/428485; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Hiroi K, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/49; Ivison RJ, 2004, ASTROPHYS J SUPPL S, V154, P124, DOI 10.1086/423249; Iwamuro F, 2012, PUBL ASTRON SOC JPN, V64; Jahnke K., 2009, APJ, V706, P215, DOI DOI 10.1088/0004-637X/706/2/L215; Kim DW, 2004, ASTROPHYS J, V600, P59, DOI 10.1086/379820; Kimura M, 2010, PUBL ASTRON SOC JPN, V62, P1135; Koekemoer A. M., 2004, APJL, V600, P123; Leipski C, 2005, ASTRON ASTROPHYS, V440, pL5, DOI 10.1051/0004-6361:200500152; Loaring N. S., 2005, ASTROPH0507408; Lusso E, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/86; MAGDZIARZ P, 1995, MON NOT R ASTRON SOC, V273, P837; Mainieri V, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117259; McLure RJ, 2013, MON NOT R ASTRON SOC, V428, P1088, DOI 10.1093/mnras/sts092; Mignoli M, 2004, ASTRON ASTROPHYS, V418, P827, DOI 10.1051/0004-6361:20035622; MILLER GE, 1979, ASTROPHYS J SUPPL S, V41, P513, DOI 10.1086/190629; Morokuma T, 2008, ASTROPHYS J, V676, P121, DOI 10.1086/528788; Morokuma T, 2008, ASTROPHYS J, V676, P163, DOI 10.1086/527467; Murray S. S., 2005, ASTROPH0504084; Nandra K, 2007, ASTROPHYS J, V660, pL11, DOI 10.1086/517918; Nobuta K, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/143; Oke J. B., 1974, APJS, V27, P210; Ouchi M., 2005, APJ, V620, P1; Ouchi M, 2008, ASTROPHYS J SUPPL S, V176, P301, DOI 10.1086/527673; Pannella M, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/141; Rosario DJ, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/59; Schramm M, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/13; Sekiguchi K, 2005, ESO ASTROPHY SYMP, P82, DOI 10.1007/10995020_12; Takagi T, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913466; Ueda Y, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/104; Xue YQ, 2010, ASTROPHYS J, V720, P368, DOI 10.1088/0004-637X/720/1/368; Yamada T, 2009, ASTROPHYS J, V699, P1354, DOI 10.1088/0004-637X/699/2/1354; Yamada T, 2005, ASTROPHYS J, V634, P861, DOI 10.1086/496954; Zheng W, 2004, ASTROPHYS J SUPPL S, V155, P73, DOI 10.1086/424385	120	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							82	10.1093/pasj/psv050		38	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000004		
J	Asai, K; Mihara, T; Matsuoka, M; Sugizaki, M				Asai, Kazumi; Mihara, Tatehiro; Matsuoka, Masaru; Sugizaki, Mutsumi			X-ray variability with spectral state transitions in NS-LMXBs observed with MAXI/GSC and Swift/BAT	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; stars: neutron; X-rays: binaries	IRRADIATED ACCRETION DISKS; SLIT CAMERA GSC; NEUTRON-STAR; DWARF NOVAE; INSTABILITY MODEL; AQUILA X-1; 4U 1636-53; BINARIES; TRANSIENTS; OUTBURSTS	X-ray variabilities with spectral state transitions in bright low-mass X-ray binaries containing a neutron star are investigated by using the one-day bin light curves of MAXI/GSC (Gas Slit Camera) and Swift/BAT (Burst Alert Telescope). Four sources (4U 1636-536, 4U 1705-44, 4U 1608-52, and GS 1826-238) exhibited small-amplitude X-ray variabilities with spectral state transitions. Such "mini-outbursts" were characterized by smaller amplitudes (several times) and shorter duration (less than several tens of days) than those of "normal outbursts." A theoretical model of disk instability by Mineshige and Osaki (PASJ, 37, 1, 1985) predicts both large-amplitude outbursts and small-amplitude variabilities. We interpret the normal outbursts as the former prediction of this model, and the mini-outbursts as the latter. Here, we can also call the mini-outburst a "purr-type outburst" referring to the theoretical work. We suggest that similar variabilities lasting for several tens of days without spectral state transitions, which are often observed in the hard state, may be repeats of mini-outbursts.	[Asai, Kazumi; Mihara, Tatehiro; Matsuoka, Masaru; Sugizaki, Mutsumi] RIKEN, MAXI Team, Wako, Saitama 3510198, Japan	Asai, K (reprint author), RIKEN, MAXI Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kazumi@crab.riken.jp			JSPS KAKENHI Grant [15H00288]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24340041]	We would like to acknowledge Prof. S. Mineshige for useful comment and discussion on this work. We also would like to acknowledge the MAXI team for MAXI operation and for analyzing realtime data. This research was partially supported by JSPS KAKENHI Grant Number 15H00288. This research was partially supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant-in-Aid for Science Research (24340041).	TUCHMAN Y, 1990, ASTROPHYS J, V359, P164, DOI 10.1086/169045; MINESHIGE S, 1983, PUBL ASTRON SOC JPN, V35, P377; Shih IC, 2011, MON NOT R ASTRON SOC, V412, P120, DOI 10.1111/j.1365-2966.2010.17895.x; Lin DC, 2010, ASTROPHYS J, V719, P1350, DOI 10.1088/0004-637X/719/2/1350; White NE, 2001, ASTROPHYS J, V561, pL101, DOI 10.1086/324561; deJong JA, 1996, ASTRON ASTROPHYS, V314, P484; Revnivtsev M, 2003, ASTRON ASTROPHYS, V399, P699, DOI 10.1051/0004-6361:20021873; Heinke CO, 2010, ASTROPHYS J, V714, P894, DOI 10.1088/0004-637X/714/1/894; MINESHIGE S, 1990, ASTROPHYS J, V351, P47, DOI 10.1086/168443; Yu WF, 2009, ASTROPHYS J, V701, P1940, DOI 10.1088/0004-637X/701/2/1940; Done C, 2007, ASTRON ASTROPHYS REV, V15, P1, DOI 10.1007/s00159-007-0006-1; Galloway DK, 2008, ASTROPHYS J SUPPL S, V179, P360, DOI 10.1086/592044; Lyu M, 2014, MON NOT R ASTRON SOC, V440, P1165, DOI 10.1093/mnras/stu279; WHITE NE, 1988, ASTROPHYS J, V324, P363, DOI 10.1086/165901; MITSUDA K, 1989, PUBL ASTRON SOC JPN, V41, P97; Maccarone TJ, 2003, ASTRON ASTROPHYS, V409, P697, DOI 10.1051/0004-6361:20031146; Altamirano D, 2008, ASTROPHYS J LETT, V674, pL45, DOI 10.1086/528983; Maccarone TJ, 2003, MON NOT R ASTRON SOC, V338, P189, DOI 10.1046/j.1365-8711.2003.06040.x; Hameury JM, 1998, MON NOT R ASTRON SOC, V298, P1048, DOI 10.1046/j.1365-8711.1998.01773.x; Matsuoka M, 2009, PUBL ASTRON SOC JPN, V61, P999; MINESHIGE S, 1990, ASTROPHYS J, V359, P176, DOI 10.1086/169046; HASINGER G, 1989, ASTRON ASTROPHYS, V225, P79; Tang J, 2011, RES ASTRON ASTROPHYS, V11, P434; MIYAMOTO S, 1995, ASTROPHYS J, V442, pL13, DOI 10.1086/187804; Wen LQ, 2006, ASTROPHYS J SUPPL S, V163, P372, DOI 10.1086/500648; Barthelmy SD, 2005, SPACE SCI REV, V120, P143, DOI 10.1007/s11214-005-5096-3; Belloni T, 2007, MON NOT R ASTRON SOC, V379, P247, DOI 10.1111/j.1365-2966.2007.11943.x; Homan J, 2009, ASTROPHYS J, V692, P73, DOI 10.1088/0004-637X/692/1/73; Gehrels N, 2004, ASTROPHYS J, V611, P1005, DOI 10.1086/422091; Muno MP, 2000, ASTROPHYS J, V542, P1016, DOI 10.1086/317031; Liu QZ, 2007, ASTRON ASTROPHYS, V469, P807, DOI 10.1051/0004-6361:20077303; Shih IC, 2005, MON NOT R ASTRON SOC, V361, P602, DOI 10.1111/j.1365-2966.2005.09224.x; MINESHIGE S, 1985, PUBL ASTRON SOC JPN, V37, P1; Asai K, 2012, PUBL ASTRON SOC JPN, V64; Bahramian A, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/127; Cocchi M, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016241; Ferrigno C., 2010, ATEL, V2940, P1; Frank J., 1992, ACCRETION POWER ASTR; Kirsch M. G., 2005, P SOC PHOTO-OPT INS, V5898, P22; Lasota JP, 2001, NEW ASTRON REV, V45, P449, DOI 10.1016/S1387-6473(01)00112-9; Lewin W. H. G., 1997, XRAY BINARIES; Matsuoka M, 2013, PUBL ASTRON SOC JPN, V65; MEYER F, 1984, ASTRON ASTROPHYS, V131, P303; Mihara T, 2011, PUBL ASTRON SOC JPN, V63, pS623; Nakahira S., 2014, ASTRONOMERS TELEGRAM, P6250; Papitto A, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015974; Simon V., 2010, ASTRON ASTROPHYS, V513, P71; SMAK J, 1983, ASTROPHYS J, V272, P234, DOI 10.1086/161284; Smak J., 1982, Acta Astronomica, V32; Smak J., 1984, Acta Astronomica, V34; Sugizaki M, 2011, PUBL ASTRON SOC JPN, V63, pS635; Suzuki M., 2009, ASTRONOMERS TELEGRAM, P2360; Titarchuk L, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/160; Tomida H., 2013, ASTRONOMERS TELEGRAM, P5327; VANDERKLIS M, 1994, ASTROPHYS J SUPPL S, V92, P511, DOI 10.1086/192006; vanParadijs J, 1996, ASTROPHYS J, V464, pL139, DOI 10.1086/310100; Wijnands R., 2012, ASTRONOMERS TELEGRAM, P4242	57	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							92	10.1093/pasj/psv060		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000014		
J	Hatsukade, B; Tamura, Y; Iono, D; Matsuda, Y; Hayashi, M; Oguri, M				Hatsukade, Bunyo; Tamura, Yoichi; Iono, Daisuke; Matsuda, Yuichi; Hayashi, Masao; Oguri, Masamune			High-resolution ALMA observations of SDP.81. II. Molecular clump properties of a lensed submillimeter galaxy at z=3.042	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						galaxies: formation; galaxies: individual (H-ATLAS J090311.6+003906, SDP. 81); galaxies: ISM; gravitational lensing: strong; submillimeter: galaxies	STAR-FORMATION; HIGH-REDSHIFT; HERSCHEL-ATLAS; GRAVITATIONAL LENSES; CONVERSION FACTOR; COSMIC TIME; CO EMISSION; GAS; IMAGES; ARRAY	We present spatially resolved properties of molecular gas and dust in a gravitationally lensed submillimeter galaxy H-ATLAS J090311.6+003906 (SDP. 81) at z = 3.042 revealed by the Atacama Large Millimeter/submillimeter Array (ALMA). We identified 14 molecular clumps in the CO(5-4) line data. The surface density of molecular gas (Sigma(H2)) and star-formation rate (Sigma(SFR)) of the clumps are more than three orders of magnitude higher than those found in local spiral galaxies. The clumps are placed in the "burst" sequence in the Sigma(H2) - Sigma(SFR) plane, suggesting that z similar to 3 molecular clumps follow the star-formation law derived for local starburst galaxies. With our gravitational lens model, the positions in the source plane are derived for the molecular clumps, dust clumps, and stellar components identified in the Hubble Space Telescope image. The molecular and dust clumps are confined within a similar to 2 kpc region, while the spatial extent of the stellar components is as large as similar to 6 kpc and offset toward the west. The molecular clumps have a systematic velocity gradient in the north-south direction, which may indicate a rotating gas disk. One possible scenario is that the components of molecular gas, dust, and stars are distributed in a several-kpc-scale rotating disk, and the stellar emission is heavily obscured by dust in the central star-forming region. Alternatively, SDP. 81 can be explained by a merging system, where dusty starbursts occur in the region where the two galaxies collide, surrounded by tidal features traced in the stellar components.	[Hatsukade, Bunyo; Iono, Daisuke; Matsuda, Yuichi; Hayashi, Masao] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Tamura, Yoichi] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Iono, Daisuke] Grad Univ Adv Studies SOKENDAI, Mitaka, Tokyo 1818588, Japan; [Oguri, Masamune] Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; [Oguri, Masamune] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Oguri, Masamune] Univ Tokyo, Kavli Inst Phys & Math Universe Kavli IPMU, WPI, Kashiwa, Chiba 2778583, Japan	Hatsukade, B (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	bunyo.hatsukade@nao.ac.jp			JSPS KAKENHI Grant [15K17616]; ALMA Japan Research Grant of NAOJ Chile Observatory [NAOJ-ALMA-0136]; KAKENHI [25103503, 20647268]; Inamori Research Grants Program; Japan Society of the Promotion of Science (JSPS); World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; JSPS [26800093]	We are grateful to Rie Miura and Alasdair Thomson for providing data. We thank the referee for helpful comments and suggestions. BH is supported by JSPS KAKENHI Grant Number 15K17616 and the ALMA Japan Research Grant of NAOJ Chile Observatory, NAOJ-ALMA-0136. YT is supported by KAKENHI (No. 25103503). DI is supported by the 2015 Inamori Research Grants Program. YM is supported by KAKENHI (No. 20647268). MH is supported by Research Fellowship for Young Scientists from the Japan Society of the Promotion of Science (JSPS). MO is supported in part by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan and Grant-in-Aid for Scientific Research from the JSPS (26800093). This paper makes use of the following ALMA data: ADS/JAO. ALMA#2011.0.00016.SV. ALMA is a partnership of ESO (representing its member states), NSF (USA), and NINS (Japan), together with NRC (Canada), NSC and ASIAA (Taiwan), and KASI (Republic of Korea), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO, and NAOJ. Data analysis was in part carried out on a common use data analysis computer system at the Astronomy Data Center, ADC, of the National Astronomical Observatory of Japan.	ALMA Partnership, 2015, APJ, V808, pL4; ALMA Partnership, 2015, APJ, V808, pL1; Swinbank AM, 2010, NATURE, V464, P733, DOI 10.1038/nature08880; Hainline LJ, 2004, ASTROPHYS J, V609, P61, DOI 10.1086/420920; Thomson AP, 2015, MON NOT R ASTRON SOC, V448, P1874, DOI 10.1093/mnras/stv118; Hughes DH, 1997, MON NOT R ASTRON SOC, V289, P766; Smail I, 2002, MON NOT R ASTRON SOC, V331, P495, DOI 10.1046/j.1365-8711.2002.05203.x; WILLIAMS JP, 1994, ASTROPHYS J, V428, P693, DOI 10.1086/174279; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Rybak M, 2015, MON NOT R ASTRON SOC, V451, pL40, DOI 10.1093/mnrasl/slv058; Genzel R, 2010, MON NOT R ASTRON SOC, V407, P2091, DOI 10.1111/j.1365-2966.2010.16969.x; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017; Negrello M, 2014, MON NOT R ASTRON SOC, V440, P1999, DOI 10.1093/mnras/stu413; McMullin JP, 2007, ASTR SOC P, V376, P127; Heiderman A, 2010, ASTROPHYS J, V723, P1019, DOI 10.1088/0004-637X/723/2/1019; Symeonidis M, 2013, MON NOT R ASTRON SOC, V431, P2317, DOI 10.1093/mnras/stt330; Tacconi LJ, 2006, ASTROPHYS J, V640, P228, DOI 10.1086/499933; Dunne L, 2003, MON NOT R ASTRON SOC, V341, P589, DOI 10.1046/j.1365-8711.2003.06440.x; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Bothwell MS, 2010, MON NOT R ASTRON SOC, V405, P219, DOI 10.1111/j.1365-2966.2010.16480.x; Dye S, 2014, MON NOT R ASTRON SOC, V440, P2013, DOI 10.1093/mnras/stu305; Eales S, 2010, PUBL ASTRON SOC PAC, V122, P499; Negrello M, 2010, SCIENCE, V330, P800, DOI 10.1126/science.1193420; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Blain AW, 2002, PHYS REP, V369, P111, DOI 10.1016/S0370-1573(02)00134-5; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Bigiel F, 2010, ASTRON J, V140, P1194, DOI 10.1088/0004-6256/140/5/1194; Daddi E, 2010, ASTROPHYS J LETT, V714, pL118, DOI 10.1088/2041-8205/714/1/L118; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Blain AW, 1999, MON NOT R ASTRON SOC, V304, P669, DOI 10.1046/j.1365-8711.1999.02426.x; Bussmann RS, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/25; De Breuck C, 2003, ASTRON ASTROPHYS, V401, P911, DOI 10.1051/0004-6361:20030171; Elmegreen BG, 1999, ASTROPHYS J, V517, P103, DOI 10.1086/307200; Evans NJ, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/114; Hezaveh YD, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/20; HILDEBRAND RH, 1983, Q J ROY ASTRON SOC, V24, P267; Hodge JA, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/1/L18; Iono D, 2006, ASTROPHYS J, V640, pL1, DOI 10.1086/503290; Kennicutt RC, 1998, ASTROPHYS J, V498, P541; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kovac A, 2006, ASTROPHYS J, V650, P592, DOI 10.1086/506341; Miura RE, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/167; Oguri M, 2010, PUBL ASTRON SOC JPN, V62, P1017; Rawle TD, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/59; SCHMIDT M, 1959, ASTROPHYS J, V129, P243, DOI 10.1086/146614; Serjeant S, 2012, MON NOT R ASTRON SOC, V424, P2429, DOI 10.1111/j.1365-2966.2012.20761.x; Sharon CE, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/6; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Tamura Y, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psv040; Whitmore BC, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/156	50	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							93	10.1093/pasj/psv061		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000015		
J	Hayashi, M; Ly, C; Shimasaku, K; Motohara, K; Malkan, MA; Nagao, T; Kashikawa, N; Goto, R; Naito, Y				Hayashi, Masao; Ly, Chun; Shimasaku, Kazuhiro; Motohara, Kentaro; Malkan, Matthew A.; Nagao, Tohru; Kashikawa, Nobunari; Goto, Ryosuke; Naito, Yoshiaki			Physical conditions of the interstellar medium in star-forming galaxies at z similar to 1.5	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						galaxies: evolution; galaxies: high-redshift; galaxies: ISM; galaxies: star formation	MASS-METALLICITY RELATION; NEAR-INFRARED SPECTROSCOPY; EMISSION-LINE GALAXIES; DIGITAL SKY SURVEY; GRAVITATIONALLY LENSED GALAXIES; ALPHA LUMINOSITY FUNCTION; ACTIVE GALACTIC NUCLEI; FRAME OPTICAL-SPECTRA; HIGH IONIZATION STATE; LYMAN-BREAK GALAXIES	We present results from Subaru Fiber Multi Object Spectrograph near-infrared spectroscopy of 118 star-forming galaxies at z similar to 1.5 in the Subaru Deep Field. These galaxies are selected as [O II]lambda 3727 emitters at z approximate to 1.47 and 1.62 from narrow-band imaging. We detect the Ha emission line in 115 galaxies, the [O III]lambda 5007 emission line in 45 galaxies, and H beta, [N II]lambda 6584, and [S II]lambda lambda 6716, 6731 in 13, 16, and 6 galaxies, respectively. Including the [O II] emission line, we use the six strong nebular emission lines in the individual and composite rest-frame optical spectra to investigate the physical conditions of the interstellar medium in star-forming galaxies at z similar to 1.5. We find a tight correlation between Ha and [O II], which suggests that [O II] can be a good star formation rate indicator for galaxies at z similar to 1.5. The line ratios of H alpha/[O II] are consistent with those of local galaxies. We also find that [O II] emitters have strong [O III] emission lines. The [O III]/[O II] ratios are larger than normal star-forming galaxies in the local universe, suggesting a higher ionization parameter. Less massive galaxies have larger [O III]/[O II] ratios. With evidence that the electron density is consistent with local galaxies, the high ionization of galaxies athigh redshifts may be attributed to a harder radiation field by a young stellar population and/or an increase in the number of ionizing photons from each massive star.	[Hayashi, Masao; Kashikawa, Nobunari] Natl Astron Observ, Opt & Infrared Astron Div, Mitaka, Tokyo 1818588, Japan; [Ly, Chun] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Shimasaku, Kazuhiro; Goto, Ryosuke] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Shimasaku, Kazuhiro] Univ Tokyo, Res Ctr Early Univ, Bunkyo Ku, Tokyo 1130033, Japan; [Motohara, Kentaro] Univ Tokyo, Grad Sch Sci, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Malkan, Matthew A.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Nagao, Tohru] Ehime Univ, Res Ctr Space & Cosm Evolut, Matsuyama, Ehime 7908577, Japan; [Kashikawa, Nobunari] Grad Univ Adv Studies, Sch Sci, Dept Astron, Mitaka, Tokyo 1818588, Japan; [Naito, Yoshiaki] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan	Hayashi, M (reprint author), Natl Astron Observ, Opt & Infrared Astron Div, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	masao.hayashi@nao.ac.jp			Japan Society for the Promotion of Science (JSPS) through JSPS Research Fellowship for Young Scientists; NASA	We thank Enrique Perez-Montero for reviewing our manuscript and providing helpful comments, which improved the paper. The data used in this paper were collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. We thank the Subaru Telescope staff for their invaluable help in assisting our observations. MH acknowledges support from the Japan Society for the Promotion of Science (JSPS) through JSPS Research Fellowship for Young Scientists. CL is funded through the NASA Postdoctoral Program.	Amorin R, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201423816; Amorin R, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/1/L4; Amorin RO, 2010, ASTROPHYS J LETT, V715, pL128, DOI 10.1088/2041-8205/715/2/L128; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Tacconi LJ, 2010, NATURE, V463, P781, DOI 10.1038/nature08773; Pettini M, 2004, MON NOT R ASTRON SOC, V348, pL59, DOI 10.1111/j.1365-2966.2004.07591.x; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Christensen L, 2012, MON NOT R ASTRON SOC, V427, P1973, DOI 10.1111/j.1365-2966.2012.22007.x; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; PAGEL BEJ, 1979, MON NOT R ASTRON SOC, V189, P95; OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Erb DK, 2010, ASTROPHYS J, V719, P1168, DOI 10.1088/0004-637X/719/2/1168; Kobulnicky HA, 2004, ASTROPHYS J, V617, P240, DOI 10.1086/425299; SHAW RA, 1994, ASTR SOC P, V61, P327; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Brinchmann J, 2008, MON NOT R ASTRON SOC, V385, P769, DOI 10.1111/j.1365-2966.2008.12914.x; Bian FY, 2010, ASTROPHYS J, V725, P1877, DOI 10.1088/0004-637X/725/2/1877; Kewley LJ, 2001, ASTROPHYS J, V556, P121, DOI 10.1086/321545; Moustakas J, 2006, ASTROPHYS J, V642, P775, DOI 10.1086/500964; Richard J, 2011, MON NOT R ASTRON SOC, V413, P643, DOI 10.1111/j.1365-2966.2010.18161.x; Pettini M, 2001, ASTROPHYS J, V554, P981, DOI 10.1086/321403; Kewley LJ, 2008, ASTROPHYS J, V681, P1183, DOI 10.1086/587500; Denicolo G, 2002, MON NOT R ASTRON SOC, V330, P69, DOI 10.1046/j.1365-8711.2002.05041.x; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; Liu X, 2008, ASTROPHYS J, V678, P758, DOI 10.1086/529030; Garn T, 2010, MON NOT R ASTRON SOC, V409, P421, DOI 10.1111/j.1365-2966.2010.17321.x; Fosbury RAE, 2003, ASTROPHYS J, V596, P797, DOI 10.1086/378228; Charlot S, 2001, MON NOT R ASTRON SOC, V323, P887, DOI 10.1046/j.1365-8711.2001.04260.x; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Christensen L, 2012, MON NOT R ASTRON SOC, V427, P1953, DOI 10.1111/j.1365-2966.2012.22006.x; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Shapley AE, 2005, ASTROPHYS J, V635, P1006, DOI 10.1086/497630; Maier C, 2005, ASTROPHYS J, V634, P849, DOI 10.1086/497091; Sobral D, 2012, MON NOT R ASTRON SOC, V420, P1926, DOI 10.1111/j.1365-2966.2011.19977.x; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Stanway ER, 2014, MON NOT R ASTRON SOC, V444, P3466, DOI 10.1093/mnras/stu1682; Gilbank DG, 2010, MON NOT R ASTRON SOC, V405, P2594, DOI 10.1111/j.1365-2966.2010.16640.x; Erb DK, 2006, ASTROPHYS J, V644, P813, DOI 10.1086/503623; Hopkins PF, 2007, ASTROPHYS J, V654, P731, DOI 10.1086/509629; Kakazu Y, 2007, ASTROPHYS J, V668, P853, DOI 10.1086/521333; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Kewley LJ, 2002, ASTROPHYS J SUPPL S, V142, P35, DOI 10.1086/341326; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P33, DOI 10.1046/j.1365-8711.2003.06291.x; Leroy AK, 2008, ASTRON J, V136, P2782, DOI 10.1088/0004-6256/136/6/2782; Nagao T, 2006, ASTRON ASTROPHYS, V459, P85, DOI 10.1051/0004-6361:20065216; Hayashi M, 2013, MON NOT R ASTRON SOC, V430, P1042, DOI 10.1093/mnras/sts676; Lee JC, 2012, PUBL ASTRON SOC PAC, V124, P782, DOI 10.1086/666528; Salim S, 2007, ASTROPHYS J SUPPL S, V173, P267, DOI 10.1086/519218; Roseboom IG, 2012, MON NOT R ASTRON SOC, V426, P1782, DOI 10.1111/j.1365-2966.2012.21777.x; Nakajima K, 2014, MON NOT R ASTRON SOC, V442, P900, DOI 10.1093/mnras/stu902; Perez-Montero E, 2009, MON NOT R ASTRON SOC, V398, P949, DOI 10.1111/j.1365-2966.2009.15145.x; Hainline KN, 2009, ASTROPHYS J, V701, P52, DOI 10.1088/0004-637X/701/1/52; Yuan TT, 2009, ASTROPHYS J LETT, V699, pL161, DOI 10.1088/0004-637X/699/2/L161; Akiyama M, 2008, P SOC PHOTO-OPT INS, V7018, pV182, DOI 10.1117/12.788968; Atek H, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/96; Belli S, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/141; Cardamone C, 2009, MON NOT R ASTRON SOC, V399, P1191, DOI 10.1111/j.1365-2966.2009.15383.x; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; De Los Reyes MA, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/2/79; Divoy C, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201423911; Dominguez A, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/145; Dopita MA, 2006, ASTROPHYS J, V647, P244, DOI 10.1086/505418; Fogarty LMR, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/169; Geach JE, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L19; Hayashi M, 2009, ASTROPHYS J, V691, P140, DOI 10.1088/0004-637X/691/1/140; Henry A, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/148; Henry A, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L27; Holden B. P., 2014, ARXIV14015490; Hu Esther M, 2009, Astrophysical Journal, V698, DOI 10.1088/0004-637X/698/2/2014; Ilbert O., 2014, APJ, V797, P8; Iwamuro F, 2012, PUBL ASTRON SOC JPN, V64; Kashikawa N, 2004, PUBL ASTRON SOC JPN, V56, P1011; Kashino D, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/1/L8; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kewley LJ, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/100; Kewley LJ, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/1/L10; Kimura M, 2010, PUBL ASTRON SOC JPN, V62, P1135; Ly C, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/122; Ly C, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/1/45; Ly C, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L16; Ly C, 2007, ASTROPHYS J, V657, P738, DOI 10.1086/510828; Ly C, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/63; Ly C, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/109; Maier C, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425224; Maier C, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/3; Mannucci F, 2009, MON NOT R ASTRON SOC, V398, P1915, DOI 10.1111/j.1365-2966.2009.15185.x; Masters D, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/153; MCGAUGH SS, 1991, ASTROPHYS J, V380, P140, DOI 10.1086/170569; Morales-Luis AB, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/81; Nakajima K, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/3; Newman SF, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/21; Osterbrock D. E., 1989, ASTROPHYSICS GASEOUS; Peng YJ, 2010, ASTROPHYS J, V721, P193, DOI 10.1088/0004-637X/721/1/193; Perez-Montero E, 2014, MON NOT R ASTRON SOC, V441, P2663, DOI 10.1093/mnras/stu753; Perez-Montero E, 2005, MON NOT R ASTRON SOC, V361, P1063, DOI 10.1111/j.1365-2966.2005.09263.x; Perez-Montero E, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220070; Price SH, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/86; Queyrel J, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201117718; Queyrel J, 2009, ASTRON ASTROPHYS, V506, P681, DOI 10.1051/0004-6361/200911994; Rich JA, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/87; Richardson M. L. A., 2013, ARXIV13091169; Rigby JR, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/59; Savaglio S, 2005, ASTROPHYS J, V635, P260, DOI 10.1086/497331; Shapley AE, 2015, ASTROPHYS J, V801, DOI [10.1088/0004-637X/801/2/88, 10.1088/004-637X/801/2/88]; Shimakawa R, 2015, MON NOT R ASTRON SOC, V451, P1284, DOI 10.1093/mnras/stv915; Shirazi M, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/120; Speagle JS, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/15; Steidel CC, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/165; Stott JP, 2013, MON NOT R ASTRON SOC, V436, P1130, DOI 10.1093/mnras/stt1641; Tasca LAM, 2015, ASTRON ASTROPHYS, V581, DOI 10.1051/0004-6361/201425379; Teplitz HI, 2000, ASTROPHYS J, V533, pL65, DOI 10.1086/312595; van der Wel A, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/111; Weiner BJ, 2007, ASTROPHYS J, V660, pL39, DOI 10.1086/517925; Whitaker KE, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L29; Whitaker KE, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/104; Wuyts E, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/73; Wuyts E, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/2/L40; Yabe K, 2012, PUBL ASTRON SOC JPN, V64; Yabe K, 2014, MON NOT R ASTRON SOC, V437, P3647, DOI 10.1093/mnras/stt2185; Yuan TT, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/9; Zahid HJ, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/75; Zahid HJ, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/2/L19	125	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							80	10.1093/pasj/psv041		22	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000002		
J	Honda, S; Notsu, Y; Maehara, H; Notsu, S; Shibayama, T; Nogami, D; Shibata, K				Honda, Satoshi; Notsu, Yuta; Maehara, Hiroyuki; Notsu, Shota; Shibayama, Takuya; Nogami, Daisaku; Shibata, Kazunari			High dispersion spectroscopy of solar-type superflare stars. III. Lithium abundances	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						stars: abundances; stars: activity; stars: flare; stars: rotation; stars: solar-type	KEPLER INPUT CATALOG; LI ABUNDANCES; CHROMOSPHERIC ACTIVITY; STELLAR ROTATION; SUBARU TELESCOPE; ANALOG STARS; HALO STARS; FLARES; SUN; NUCLEOSYNTHESIS	We report on the abundance analysis of Li in solar-type (G-type main sequence) superflare stars which were found by the analysis of Kepler photometric data. Li is a key element to understand the evolution of the stellar convection zone, which reflects the age of solar-type stars. We performed the high-dispersion spectroscopy of solar-type superflare stars with Subaru/High Dispersion Spectrograph and confirmed that 34 stars show no evidence of binarity in our previous study. In this study, we derived the Li abundances of these 34 objects. We investigate correlations of Li abundance with stellar atmospheric parameters, rotational velocity, and superflare activities to understand the nature of superflare stars and the possibility of the nucleosynthesis of Li by superflares. We confirm the large dispersion in the Li abundance, and the correlation with stellar parameters is not seen. When compared with the Li abundance in the Hyades cluster, which is younger than the Sun, it is suggested that half of the observed stars are younger than Hyades cluster. The measured value of v sin i (projected rotational velocity) supports that those objects are younger than the Sun. However, there are some objects which show the low Li abundance and slowly rotate on the basis of the estimated v sin i and P (period of brightness variation). This result indicates that superflare stars are not only young stars but also old stars like our Sun. In our observations, we could not find any evidence of Li production by superflares. Further research on Li isotope abundances of superflare stars would clarify the issue of Li production by stellar flares.	[Honda, Satoshi] Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan; [Notsu, Yuta; Notsu, Shota; Nogami, Daisaku] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Maehara, Hiroyuki] Natl Astron Observ Japan, Okayama Astrophys Observ, Kamogatacho, Okayama 7190232, Japan; [Shibayama, Takuya] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nogami, Daisaku; Shibata, Kazunari] Kyoto Univ, Kwasan Observ, Yamashina Ku, Kyoto, Kyoto 6078471, Japan	Honda, S (reprint author), Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, 407-2 Nishigaichi,Sayo Cho, Sayo, Hyogo 6795313, Japan.	honda@nhao.jp			NASA Science Mission Directorate; Ministry of Education, Culture, Sports, Science and Technology of Japan [25287039, 26400231, 26800096]	We would like to thank Dr. Yoichi Takeda for useful comments and providing the analysis tools. This study is based on observational data collected with Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. We are grateful to Dr. Akito Tajitsu and other staff at the Subaru Telescope for making large contributions in carrying out our observation. Funding for this mission is provided by the NASA Science Mission Directorate. The Kepler data presented in this paper were obtained from the Multimission Archive at STScI. This work was supported by the Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 25287039, 26400231, and 26800096).	PALLAVICINI R, 1987, ASTRON ASTROPHYS, V174, P116; Takeda Y, 2005, PUBL ASTRON SOC JPN, V57, P45; Schaefer BE, 2000, ASTROPHYS J, V529, P1026, DOI 10.1086/308325; Notsu S, 2013, PUBL ASTRON SOC JPN, V65; Montes D, 1998, ASTRON ASTROPHYS, V340, pL5; BOESGAARD AM, 1985, ANNU REV ASTRON ASTR, V23, P319; Israelian G, 2009, NATURE, V462, P189, DOI 10.1038/nature08483; LAMBERT DL, 1993, PUBL ASTRON SOC PAC, V105, P568, DOI 10.1086/133195; DELAREZA R, 1981, MON NOT R ASTRON SOC, V194, P829; CARLSSON M, 1994, ASTRON ASTROPHYS, V288, P860; Ryan SG, 2001, ASTROPHYS J, V549, P55, DOI 10.1086/319048; Noguchi K, 2002, PUBL ASTRON SOC JPN, V54, P855; Tatischeff V, 2007, ASTRON ASTROPHYS, V469, P265, DOI 10.1051/0004-6361:20066635; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; KARPEN JT, 1979, ASTRON ASTROPHYS, V71, P92; DUNCAN DK, 1981, ASTROPHYS J, V248, P651, DOI 10.1086/159190; Maehara H, 2012, NATURE, V485, P478, DOI 10.1038/nature11063; Perryman MAC, 1998, ASTRON ASTROPHYS, V331, P81; Takeda Y, 2007, ASTRON ASTROPHYS, V468, P663, DOI 10.1051/0004-6361:20077220; LINSKY JL, 1979, ASTROPHYS J SUPPL S, V41, P481, DOI 10.1086/190627; Datson J, 2012, MON NOT R ASTRON SOC, V426, P484, DOI 10.1111/j.1365-2966.2012.21730.x; Smith VV, 1998, ASTROPHYS J, V506, P405, DOI 10.1086/306238; King JR, 2005, ASTRON J, V130, P2318, DOI 10.1086/452640; Takeda Y, 2009, PUBL ASTRON SOC JPN, V61, P471; Bouvier J, 2008, ASTRON ASTROPHYS, V489, pL53, DOI 10.1051/0004-6361:200810574; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; CANAL R, 1974, ASTROPHYS J, V189, P531, DOI 10.1086/152831; Cayrel R., 1988, IAU S, V132, P345; Frasca A, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116980; GIAMPAPA MS, 1984, ASTROPHYS J, V277, P235, DOI 10.1086/161689; Gonzalez G, 2015, MON NOT R ASTRON SOC, V446, P1020, DOI 10.1093/mnras/stu2156; HERBIG GH, 1965, ASTROPHYS J, V141, P588, DOI 10.1086/148147; Kurucz R, 1993, ATLAS9 STELLAR ATMOS, P13; Maehara H, 2015, EARTH PLANETS SPACE, V67, P1, DOI 10.1186/s40623-015-0217-z; Mishenina TV, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201118412; Nogami D, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu012; Notsu Y, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/127; Notsu Y, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psv002; Notsu Y, 2015, PUBL ASTRON SOC JPN, V67, DOI [10.1093/pasj/psv002, 10.1093/pasj/psv001]; Pinsonneault MH, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/30; Pinsonneault MH, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/12; Shibata K, 2013, PUBL ASTRON SOC JPN, V65; Shibata K, 2011, LIVING REV SOL PHYS, V8; Shibayama T, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/1/5; SKUMANIC.A, 1972, ASTROPHYS J, V171, P565, DOI 10.1086/151310; Spite M., 1982, NATURE, V297, P484; Tajitsu A, 2012, PUBL ASTRON SOC JPN, V64; Takeda Y, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913897; Takeda Y, 2013, PUBL ASTRON SOC JPN, V65; Wichmann R, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201423717	50	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							85	10.1093/pasj/psv054		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000007		
J	Itoh, Y; Fukagawa, M; Shibai, H; Sumi, T; Yamamoto, K				Itoh, Yusuke; Fukagawa, Misato; Shibai, Hiroshi; Sumi, Takahiro; Yamamoto, Kodai			Study of infrared excess from circumstellar disks in binaries with Spitzer/IRAC	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						binaries: general; circumstellar matter; infrared: stars; stars: pre-main sequence	T-TAURI STARS; SOLAR-TYPE STARS; RHO-OPHIUCHI CLOUD; LOW-MASS STARS; FORMING REGIONS; MULTIPLE-STAR; PROTOPLANETARY DISKS; MOLECULAR CLOUDS; PLANET FORMATION; INTERSTELLAR EXTINCTION	The presence of excess emission in the 3.6-8.0 mu m region was investigated in a sample of 27 binary star systems located in two nearby star-forming regions, Taurus and Ophiuchus, by using Spitzer/Infrared Array Camera (IRAC) archival data. Angular (Projected) separations of the binaries are greater than 2 '' (similar to 280 au), which enables us to perform spatially resolved photometry of individual primary and secondary sources. The measured occurrence of infrared excess suggests that binarity plays a role in the evolution of circumstellar disks, even at such wide binary separations. Most of the binaries have excess emission from both the circumprimary and circumsecondary disks, or show photospheric levels for both components at all four wavelengths of IRAC. On the other hand, four binary systems (17(-8)(+11) % , designated by "mixed" systems) exhibit the excess emission from a single binary component. This ratio is significantly smaller than that predicted by the random pairing of single stars, suggesting that circumprimary and circumsecondary disks are synchronously dispersed. In addition, the excess frequencies (EFs) of primary and secondary sources with a projected distance of ap similar or equal to 280-450 au are 100(17)(+0)% and 91(-18)(+8)% , respectively, and significantly higher than that of single stars (70%+/- 5%). We made a simple model describing the EF distribution as a function of the disk outer radius, Rout. Comparisons with observations using the Kolmogorov-Smirnov test show that the observational data are consistent with the model when the EF similar or equal to 100% region is found at R-out similar to 30-100 au. This disk radius is smaller than that typically estimated for single stars. The high EF of circumstellar disks with these radii may indicate a prolonged lifetime of dust in binary systems, possibly because the smaller disks counteract mass loss by photoevaporation.	[Itoh, Yusuke; Fukagawa, Misato; Shibai, Hiroshi; Sumi, Takahiro; Yamamoto, Kodai] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan	Itoh, Y (reprint author), Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	itoh@iral.ess.sci.osaka-u.ac.jp; misato@iral.ess.sci.osaka-u.ac.jp; shibai@iral.ess.sci.osaka-u.ac.jp; sumi@iral.ess.sci.osaka-u.ac.jp; yamamoto@iral.ess.sci.osaka-u.ac.jp			NASA; National Science Foundation	We are grateful to the referee for valuable comments to improve the paper. This work is based on archival data obtained with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration (NASA). Support for this work was provided by NASA. This publication utilizes data products from the Two Micron All Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology and is funded by the NASA and the National Science Foundation.	Akeson RL, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/62; Ratzka T, 2005, ASTRON ASTROPHYS, V437, P611, DOI 10.1051/0004-6361:20042107; Haisch KE, 2004, ASTRON J, V127, P1747, DOI 10.1086/381952; Mayama S, 2010, SCIENCE, V327, P306, DOI 10.1126/science.1179679; WALTER FM, 1994, ASTRON J, V107, P692, DOI 10.1086/116889; Monet DG, 2003, ASTRON J, V125, P984, DOI 10.1086/345888; Bontemps S, 2001, ASTRON ASTROPHYS, V372, P173, DOI 10.1051/0004-6361:20010474; Clarke CJ, 2001, MON NOT R ASTRON SOC, V328, P485, DOI 10.1046/j.1365-8711.2001.04891.x; White RJ, 2004, ASTROPHYS J, V616, P998, DOI 10.1086/425115; FISCHER DA, 1992, ASTROPHYS J, V396, P178, DOI 10.1086/171708; Cieza LA, 2009, ASTROPHYS J LETT, V696, pL84, DOI 10.1088/0004-637X/696/1/L84; HOLLENBACH D, 1994, ASTROPHYS J, V428, P654, DOI 10.1086/174276; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795; Loinard L, 2008, ASTROPHYS J LETT, V675, pL29, DOI 10.1086/529548; Evans NJ, 2003, PUBL ASTRON SOC PAC, V115, P965, DOI 10.1086/376697; Luhman KL, 2010, ASTROPHYS J SUPPL S, V186, P111, DOI 10.1088/0067-0049/186/1/111; Connelley MS, 2010, ASTRON J, V140, P1214, DOI 10.1088/0004-6256/140/5/1214; Kohler R, 1998, ASTRON ASTROPHYS, V331, P977; Andrews SM, 2007, ASTROPHYS J, V659, P705, DOI 10.1086/511741; LEINERT C, 1993, ASTRON ASTROPHYS, V278, P129; Williams JP, 2011, ANNU REV ASTRON ASTR, V49, P67, DOI 10.1146/annurev-astro-081710-102548; Kraus AL, 2009, ASTROPHYS J, V703, P1511, DOI 10.1088/0004-637X/703/2/1511; MARTIN PG, 1990, ASTROPHYS J, V357, P113, DOI 10.1086/168896; Pichardo B, 2005, MON NOT R ASTRON SOC, V359, P521, DOI 10.1111/j.1365-2966.2005.08905.x; Haisch KE, 2002, ASTRON J, V124, P2841; Wahhaj Z, 2010, ASTROPHYS J, V724, P835, DOI 10.1088/0004-637X/724/2/835; SIMON M, 1993, ASTROPHYS J, V408, pL33, DOI 10.1086/186824; DUQUENNOY A, 1991, ASTRON ASTROPHYS, V248, P485; Luhman KL, 1999, ASTROPHYS J, V525, P440, DOI 10.1086/307891; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; Grankin KN, 2007, ASTRON ASTROPHYS, V461, P183, DOI 10.1051/0004-6361:20065489; Delfosse X, 2004, ASTR SOC P, V318, P166; ARTYMOWICZ P, 1994, ASTROPHYS J, V421, P651, DOI 10.1086/173679; GHEZ AM, 1993, ASTRON J, V106, P2005, DOI 10.1086/116782; Schaefer GH, 2009, ASTROPHYS J, V701, P698, DOI 10.1088/0004-637X/701/1/698; Allard F, 2001, ASTROPHYS J, V556, P357, DOI 10.1086/321547; Alexander RD, 2007, MON NOT R ASTRON SOC, V375, P500, DOI 10.1111/j.1365-2966.2006.11341.x; REIPURTH B, 1993, ASTRON ASTROPHYS, V278, P81; Rebull LM, 2010, ASTROPHYS J SUPPL S, V186, P259, DOI 10.1088/0067-0049/186/2/259; Prato L, 1997, ASTROPHYS J, V474, P455, DOI 10.1086/303442; Bouwman J, 2006, ASTROPHYS J, V653, pL57, DOI 10.1086/510365; Sestito P, 2008, ASTRON ASTROPHYS, V487, P965, DOI 10.1051/0004-6361:200810081; Kraus AL, 2007, ASTROPHYS J, V662, P413, DOI 10.1086/516835; Armitage PJ, 2003, MON NOT R ASTRON SOC, V342, P1139, DOI 10.1046/j.1365-8711.2003.06604.x; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Monin JL, 1998, ASTRON ASTROPHYS, V339, P113; Indebetouw R, 2005, ASTROPHYS J, V619, P931, DOI 10.1086/426679; BESSELL MS, 1988, PUBL ASTRON SOC PAC, V100, P1134, DOI 10.1086/132281; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P10, DOI 10.1086/422843; GREENE TP, 1995, ASTROPHYS J, V450, P233, DOI 10.1086/176134; Meyer MR, 1997, ASTRON J, V114, P288, DOI 10.1086/118474; McCabe C, 2006, ASTROPHYS J, V636, P932, DOI 10.1086/498207; Suzuki TK, 2010, ASTROPHYS J, V718, P1289, DOI 10.1088/0004-637X/718/2/1289; White RJ, 2001, ASTROPHYS J, V556, P265, DOI 10.1086/321542; McClure MK, 2010, ASTROPHYS J SUPPL S, V188, P75, DOI 10.1088/0067-0049/188/1/75; ABT HA, 1976, ASTROPHYS J SUPPL S, V30, P273, DOI 10.1086/190363; Prato L, 2003, ASTROPHYS J, V584, P853, DOI 10.1086/345828; Torres CAO, 2006, ASTRON ASTROPHYS, V460, P695, DOI 10.1051/0004-6361:20065602; Baraffe I, 1998, ASTRON ASTROPHYS, V337, P403; LADA CJ, 1992, ASTROPHYS J, V393, P278, DOI 10.1086/171505; Allers KN, 2006, ASTROPHYS J, V644, P364, DOI 10.1086/503355; Wilking BA, 2005, ASTRON J, V130, P1733, DOI 10.1086/432758; Torres RM, 2007, ASTROPHYS J, V671, P1813, DOI 10.1086/522924; Kraus AL, 2009, ASTROPHYS J, V704, P531, DOI 10.1088/0004-637X/704/1/531; MATHIEU RD, 1989, ASTRON J, V98, P987, DOI 10.1086/115191; Correia S, 2006, ASTRON ASTROPHYS, V459, P909, DOI 10.1051/0004-6361:20065545; MONETI A, 1991, ASTRON ASTROPHYS, V242, P428; Chavarria-K C., 2000, A AS, V145, P187; Currie T, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/24; Daemgen S, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118314; Duchene G, 2007, ASTRON ASTROPHYS, V476, P229, DOI 10.1051/0004-6361:20077270; Duchene G, 1999, ASTRON ASTROPHYS, V351, P954; Duchene G, 1999, ASTRON ASTROPHYS, V341, P547; Dupuy TJ, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/122; Furlan E, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/1/3; Harris RJ, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/115; Hartigan H., 2003, APJ, V583, P334; Herbig G. H., 1988, LICK OBSERVATORY B, V1111, P90; KENYON SJ, 1995, ASTROPHYS J SUPPL S, V101, P117, DOI 10.1086/192235; KOORNNEEF J, 1983, ASTRON ASTROPHYS, V128, P84; Kraus AL, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/8; Kraus AL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/19; Kurucz R, 1993, ATLAS9 STELLAR ATMOS, P13; Lada C. J., 1987, IAU S, V115, P1; Mamajek EE, 2009, AIP CONF PROC, V1158, P3, DOI 10.1063/1.3215910; Monin J.-L., 2007, PROTOSTARS PLANETS, P395; NEUHAUSER R, 1995, ASTRON ASTROPHYS, V297, P391; Wichmann R, 2000, ASTRON ASTROPHYS, V359, P181	88	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							88	10.1093/pasj/psv071		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000010		
J	Kamiaka, S; Masuda, K; Xue, Y; Suto, Y; Nishioka, T; Murakami, R; Inayama, K; Saitoh, M; Tanaka, M; Yonehara, A				Kamiaka, Shoya; Masuda, Kento; Xue, Yuxin; Suto, Yasushi; Nishioka, Tsubasa; Murakami, Risa; Inayama, Koichiro; Saitoh, Madoka; Tanaka, Michisuke; Yonehara, Atsunori			Revisiting a gravity-darkened and precessing planetary system PTFO 8-8695: A spin-orbit non-synchronous case	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						eclipses; planetary systems; stars: individual (PTFO 8-8695); techniques: photometric	TIDAL EVOLUTION; TRANSIT LIGHTCURVE; JOINT ANALYSIS; MISALIGNMENT; STARS; VELOCITY; ECLIPSE; HAT-P-7; CURVES; ANGLE	We reanalyse the time-variable light curves of the transiting planetary system PTFO 8-8695, in which a planet of 3 to 4 Jupiter masses orbits a rapidly rotating pre-main-sequence star. Both the planetary orbital period P-orb of 0.448 d and the stellar spin period P-s of less than 0.671 d are unusually short, which makes PTFO 8-8695 an ideal system to check the model of gravity darkening and nodal precession. While the previous analysis of PTFO 8-8695 assumed that the stellar spin and planetary orbital periods are the same, we extend the analysis by discarding the spin-orbit synchronous condition, and find three different classes of solutions roughly corresponding to the nodal precession periods of 199 +/- 16, 475 +/- 21, and 827 +/- 53 d that reproduce the transit light curves observed in 2009 and 2010. We compare the predicted light curves of the three solutions against the photometry data of a few percent accuracy obtained at Koyama Astronomical Observatory in 2014 and 2015, and find that the solution with a precession period of 199 +/- 16 d is preferred even though it is preliminary. Future prospects and implications for other transiting systems are briefly discussed.	[Kamiaka, Shoya; Masuda, Kento; Xue, Yuxin; Suto, Yasushi] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Suto, Yasushi] Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; [Nishioka, Tsubasa; Murakami, Risa; Inayama, Koichiro; Saitoh, Madoka; Tanaka, Michisuke; Yonehara, Atsunori] Kyoto Sangyo Univ, Dept Phys, Kita Ku, Kyoto, Kyoto 6038555, Japan	Kamiaka, S (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kamiaka@utap.phys.s.u-tokyo.ac.jp			Hayakawa Satio Fund, the Astronomical Society of Japan; JSPS (Japan Society for the Promotion of Science) [26-7182]; Leading Graduate Course for Frontiers of Mathematical Sciences and Physics; JSPS [25870893, 24340035]	We are grateful to Julian van Eyken, who kindly provided the photometry data of PTFO 8-8695, and to the referee, Jason W. Barnes, for very constructive comments on the manuscript. We also thank Masahiro Onitsuka for bringing our attention to PTFO 8-8695, and Masahiro Ikoma, Chelsea X. Huang, and Kengo Tomida for fruitful discussion. We are also grateful to Mizuki Isogai, Akira Arai, Nao-fumi Fujishiro, and Hideyo Kawakita for their technical support on observations. Data analysis was in part carried out on PC cluster at Center for Computational Astrophysics, National Astronomical Observatory of Japan. S.K. acknowledges the receipt of a travel grant from the Hayakawa Satio Fund, the Astronomical Society of Japan. K.M. is supported by JSPS (Japan Society for the Promotion of Science) Research Fellowships for Young Scientists (No. 26-7182) and by the Leading Graduate Course for Frontiers of Mathematical Sciences and Physics. Y.S. and A.Y. gratefully acknowledge the support from Grants-in Aid for Scientific Research by JSPS No. 24340035, and for Young Scientists (B) by JSPS No. 25870893, respectively.	Ahlers JP, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/131; EDWARDS S, 1993, ASTRON J, V106, P372, DOI 10.1086/116646; Correia ACM, 2011, CELEST MECH DYN ASTR, V111, P105, DOI 10.1007/s10569-011-9368-9; Barker AJ, 2009, MON NOT R ASTRON SOC, V395, P2268, DOI 10.1111/j.1365-2966.2009.14694.x; Briceno C, 2005, ASTRON J, V129, P907, DOI 10.1086/426911; Ohta Y, 2005, ASTROPHYS J, V622, P1118, DOI 10.1086/428344; Boue G, 2009, ICARUS, V201, P750, DOI 10.1016/j.icarus.2009.02.001; Barnes JW, 2009, ASTROPHYS J, V705, P683, DOI 10.1088/0004-637X/705/1/683; Barnes JW, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/10; Barnes JW, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/53; Benomar O, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu069; Crida A, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201323292; Hirano T, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/2/L36; Lai D, 2012, MON NOT R ASTRON SOC, V423, P486, DOI 10.1111/j.1365-2966.2012.20893.x; LUCY LB, 1967, Z ASTROPHYS, V65, P89; Lund MN, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424326; Markwardt CB, 2009, ASTR SOC P, V411, P251; Masuda K, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/1/28; McLaughlin DB, 1924, ASTROPHYS J, V60, P22, DOI 10.1086/142826; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Philippov AA, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/112; Rogers TM, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/1/L10; Rossiter RA, 1924, ASTROPHYS J, V60, P15, DOI 10.1086/142825; van Eyken JC, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/42; Von Zeipel H., 1924, Monthly Notices of the Royal Astronomical Society, V84; Xue YX, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/66; Zhou G, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L35	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							94	10.1093/pasj/psv063		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000016		
J	Kimura, M; Mineshige, S; Kawanaka, N				Kimura, Mariko; Mineshige, Shin; Kawanaka, Norita			How does a secular instability grow in a hyperaccretion flow?	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; black hole physics; gamma-ray burst: general; neutrinos	GAMMA-RAY BURSTS; NEUTRINO-DOMINATED ACCRETION; BLACK-HOLES; FERMI OBSERVATIONS; DISK ACCRETION; MODELS; STARS; LUMINOSITY; STABILITY	Hyperaccretion flows with mass accretion rates far above the Eddington rate have an N-shaped equilibrium curve on the Sigma-(M) over dot plane (with Sigma and (M) over dot being surface density and mass accretion rate, respectively). The accretion flow on the lower Sigma branch of the N-shape is optically thick, advection-dominated accretion flow, while that on the upper one is neutrino-dominated accretion flow. The middle branch has a negative slope on the Sigma-(M) over dot plane, meaning that the flow on this branch is secularly unstable. To investigate how the instability affects the flow structure and what observable signatures are produced, we study the time evolution of the unstable hyperaccretion flow in response to variable mass injection rates by solving the height-averaged equations for viscous accretion flows. When a transition occurs from the lower branch to the upper branch (or from the upper branch to the lower branch), the surface density rapidly increases (decreases) around that transition region, which induces locally enhanced mass flow (referred to as non-steady mass flow) into (out of) that region. We confirm that the non-steady flow can create a kind of disturbance and that it propagates over the whole disk. However, the non-steady mass flow is not strong enough to induce coherent transition over the whole disk, unless the mass injection rate varies with time. When the injection rate continuously changes, the neutrino luminosity varies intermittently, thus producing step-function-like light curves, as the radiation efficiency discontinuously changes every time the local transition occurs. The effects of changing the N-shape and possible observational consequences on the gamma-ray burst emission are briefly discussed.	[Kimura, Mariko; Mineshige, Shin] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Kawanaka, Norita] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Kimura, M (reprint author), Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto, Kyoto 6068502, Japan.	mkimura@kusastro.kyoto-u.ac.jp; shm@kusastro.kyoto-u.ac.jp; norita@astron.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [26400229]	We are grateful to the anonymous referee for insightful comments. This work is supported in part by Grants-in-Aid of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT: 26400229 SM).	EICHLER D, 1989, NATURE, V340, P126, DOI 10.1038/340126a0; Ackermann M, 2010, ASTROPHYS J, V716, P1178, DOI 10.1088/0004-637X/716/2/1178; Zalamea I, 2011, MON NOT R ASTRON SOC, V410, P2302, DOI 10.1111/j.1365-2966.2010.17600.x; Di Matteo T, 2002, ASTROPHYS J, V579, P706, DOI 10.1086/342832; Narayan R, 2001, ASTROPHYS J, V557, P949, DOI 10.1086/322267; Asano K, 2000, ASTROPHYS J, V531, P949, DOI 10.1086/308513; Kawanaka N, 2012, MON NOT R ASTRON SOC, V419, P713, DOI 10.1111/j.1365-2966.2011.19733.x; Gu WM, 2006, ASTROPHYS J, V643, pL87, DOI 10.1086/505140; LIGHTMAN AP, 1974, ASTROPHYS J, V187, pL1, DOI 10.1086/181377; HONMA F, 1991, PUBL ASTRON SOC JPN, V43, P147; Chen WX, 2007, ASTROPHYS J, V657, P383, DOI 10.1086/508923; Kohri K, 2005, ASTROPHYS J, V629, P341, DOI 10.1086/431354; Popham R, 1999, ASTROPHYS J, V518, P356, DOI 10.1086/307259; Piran T, 1999, PHYS REP, V314, P575, DOI 10.1016/S0370-1573(98)00127-6; Hawley JF, 2006, ASTROPHYS J, V641, P103, DOI 10.1086/500385; Beloborodov AM, 2000, ASTROPHYS J, V535, P158, DOI 10.1086/308836; NARAYAN R, 1992, ASTROPHYS J, V395, pL83, DOI 10.1086/186493; SHAKURA NI, 1976, MON NOT R ASTRON SOC, V175, P613; Liu T, 2007, ASTROPHYS J, V661, P1025, DOI 10.1086/513689; McKinney JC, 2004, ASTROPHYS J, V611, P977, DOI 10.1086/422244; SHIBAZAKI N, 1975, PROG THEOR PHYS, V54, P706, DOI 10.1143/PTP.54.706; MINESHIGE S, 1989, ASTROPHYS J, V343, P241, DOI 10.1086/167701; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433; Kato S., 2008, BLACK HOLE ACCRETION; Kawanaka N, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/1/L15; Kawanaka N., 2007, APJ, V577, P311; Kawanaka N, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/31; Kohri K., 2002, APJ, V662, P1156; OSAKI Y, 1974, PUBL ASTRON SOC JPN, V26, P429; PIRAN T, 1978, ASTROPHYS J, V221, P652, DOI 10.1086/156069; Suwa Y, 2013, MON NOT R ASTRON SOC, V428, P2443, DOI 10.1093/mnras/sts218; Troja E, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/10; Xue L, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/23	33	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							101	10.1093/pasj/psv070		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000023		
J	Li, HN; Aoki, W; Zhao, G; Honda, S; Christlieb, N; Suda, T				Li, Haining; Aoki, Wako; Zhao, Gang; Honda, Satoshi; Christlieb, Norbert; Suda, Takuma			High-resolution spectroscopic studies of ultra metal-poor stars found in the LAMOST survey	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						early universe; stars: abundances; stars: Population II	NEUTRON-CAPTURE ELEMENTS; GALACTIC CHEMICAL EVOLUTION; LESS-THAN -5.0; MILKY-WAY; 1ST STARS; LITHIUM ABUNDANCES; FE/H LESS-THAN-OR-EQUAL-TO-3.5; ATMOSPHERIC PARAMETERS; DETAILED ABUNDANCES; UNEVOLVED STAR	We report on the observations of two ultra metal-poor (UMP) stars with [Fe/H]similar to-4.0, including one new discovery. The two stars are studied in the on-going and quite efficient project to search for extremely metal-poor (EMP) stars with LAMOST and Subaru. Detailed abundances or upper limits of abundances have been derived for 15 elements from Li to Eu based on high-resolution spectra obtained with the High Dispersion Spectrograph (HDS) mounted in the Subaru Telescope. The abundance patterns of both UMP stars are consistent with the "normal population" among the low-metallicity stars. Both of the two program stars show carbon-enhancement without any excess of heavy neutron-capture elements, indicating that they belong to the subclass of (carbon-enhanced metal-poor) CEMP-no stars, as is the case of most UMP stars previously studied. The [Sr/Ba] ratios of both CEMP-no UMP stars are above [Sr/Ba]similar to-0.4, suggesting the origin of the carbon-excess is not compatible with the mass transfer from an asymptotic giant branch companion where the s-process has operated. Lithium abundance is measured in the newly discovered UMP star LAMOST J125346.09+075343.1, making it the second UMP turnoff star with Li detection. The Li abundance of LAMOST J125346.09+075343.1 is slightly lower than the values obtained for less metal-poor stars with similar temperatures, and provides a unique data point at [Fe/H]similar to-4.2 to support the "meltdown" of the Li Spite plateau at extremely low metallicity. Comparison with the other two UMP and HMP (hypermetal-poor, with [Fe/H] < -5.0) turnoff stars suggests that the difference in lighter elements such as CNO and Na might cause notable difference in lithium abundances among CEMP-no stars.	[Li, Haining; Zhao, Gang] Chinese Acad Sci, Key Lab Opt Astron, Natl Astron Observ, Beijing 100012, Peoples R China; [Aoki, Wako] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Aoki, Wako] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Honda, Satoshi] Univ Hyogo, Sayo, Hyogo 6795313, Japan; [Christlieb, Norbert] Heidelberg Univ, Zentrum Astron, D-69117 Heidelberg, Germany; [Suda, Takuma] Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan	Li, HN (reprint author), Chinese Acad Sci, Key Lab Opt Astron, Natl Astron Observ, A20 Datun Rd, Beijing 100012, Peoples R China.	lhn@nao.cas.cn; aoki.wako@nao.ac.jp; gzhao@nao.cas.cn; honda@nhao.jp; N.Christlieb@lsw.uni-heidelberg.de; suda@resceu.s.u-tokyo.ac.jp			NSFC [11103030, 11233004, 11390371]; JSPS [S:23224004, c:26400231]; German Research Foundation (DFG) [Sonderforschungsbereich 881]; National Development and Reform Commission	We are grateful to the anonymous referee who made valuable suggestions and help improve the paper. H.N.L. and G.Z. acknowledge supports by NSFC grants No. 11103030, 11233004, and 11390371. W.A. and T.S. are supported by the JSPS Grant-in-Aid for Scientific Research (S:23224004). S.H. is supported by the JSPS Grant-in-Aid for Scientific Research (c:26400231). N.C. acknowledges support from Sonderforschungsbereich 881 "The Milky Way System" (subproject A4) of the German Research Foundation (DFG). Guoshoujing Telescope (the Large Sky Area Multi-Object Fiber Spectroscopic Telescope, LAMOST) is a National Major Scientific Project built by the Chinese Academy of Sciences. Funding for the project has been provided by the National Development and Reform Commission. LAMOST is operated and managed by the National Astronomical Observatories, Chinese Academy of Sciences.	Bromm V, 2011, ANNU REV ASTRON ASTR, V49, P373, DOI 10.1146/annurev-astro-081710-102608; Lai DK, 2008, ASTROPHYS J, V681, P1524, DOI 10.1086/588811; Keller SC, 2014, NATURE, V506, P463, DOI 10.1038/nature12990; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Cui XQ, 2012, RES ASTRON ASTROPHYS, V12, P1197; Christlieb N, 2008, ASTRON ASTROPHYS, V484, P721, DOI 10.1051/0004-6361:20078748; BOHLIN RC, 1983, ASTROPHYS J SUPPL S, V51, P277, DOI 10.1086/190850; Alonso A, 1999, ASTRON ASTROPHYS SUP, V140, P261, DOI 10.1051/aas:1999521; Umeda H, 2005, ASTROPHYS J, V619, P427, DOI 10.1086/426097; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; BEERS TC, 1992, ASTRON J, V103, P1987, DOI 10.1086/116207; Yanny B, 2009, ASTRON J, V137, P4377, DOI 10.1088/0004-6256/137/5/4377; Luo AL, 2012, RES ASTRON ASTROPHYS, V12, P1243; Wanajo S, 2006, NUCL PHYS A, V777, P676, DOI 10.1016/j.nuclphysa.2005.10.012; Alonso A, 2001, ASTRON ASTROPHYS, V376, P1039, DOI 10.1051/0004-6361:20011095; Bonifacio P, 2009, ASTRON ASTROPHYS, V501, P519, DOI 10.1051/0004-6361/200810610; Zhao G, 2012, RES ASTRON ASTROPHYS, V12, P723; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Beers TC, 1999, ASTRON J, V117, P981, DOI 10.1086/300727; Travaglio C, 2004, ASTROPHYS J, V601, P864, DOI 10.1086/380507; Suda T, 2004, ASTROPHYS J, V611, P476, DOI 10.1086/422135; Christlieb N, 2004, ASTRON ASTROPHYS, V428, P1027, DOI 10.1051/0004-6361:20041536; Nomoto K, 2013, ANNU REV ASTRON ASTR, V51, P457, DOI 10.1146/annurev-astro-082812-140956; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Sivarani T, 2006, ASTRON ASTROPHYS, V459, P125, DOI 10.1051/0004-6361:20065440; Frebel A, 2008, ASTROPHYS J, V684, P588, DOI 10.1086/590327; Lee YS, 2008, ASTRON J, V136, P2022, DOI 10.1088/0004-6256/136/5/2022; Aoki W, 2007, ASTROPHYS J, V655, P492, DOI 10.1086/509817; Aoki W, 2005, ASTROPHYS J, V632, P611, DOI 10.1086/432862; Norris JE, 2007, ASTROPHYS J, V670, P774, DOI 10.1086/521919; Starkenburg E, 2014, MON NOT R ASTRON SOC, V441, P1217, DOI 10.1093/mnras/stu623; Christlieb N, 2002, NATURE, V419, P904, DOI 10.1038/nature01142; Heger A, 2010, ASTROPHYS J, V724, P341, DOI 10.1088/0004-637X/724/1/341; Aoki W, 2009, ASTROPHYS J, V698, P1803, DOI 10.1088/0004-637X/698/2/1803; Aoki W, 2006, ASTROPHYS J, V639, P897, DOI 10.1086/497906; Cayrel R, 2004, ASTRON ASTROPHYS, V416, P1117, DOI 10.1051/0004-6361:20034074; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; Shi JR, 2007, ASTRON ASTROPHYS, V465, P587, DOI 10.1051/0004-6361:20066709; Aoki W, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/2/39; Aoki W, 2013, ASTROPHYS J LETT, V766, DOI 10.1088/2041-8205/766/1/L13; Aoki W, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/13; Bonifacio P, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201219004; Caffau E, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118744; Carollo D, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/180; Carollo D, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/195; Cescutti G, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220809; Cohen JG, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/56; Cyburt RH, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/11/012; Francois P, 2007, ASTRON ASTROPHYS, V476, P935, DOI 10.1051/0004-6361:20077706; Frebel A., 2013, PLANETS STARS STELLA, P55; Frebel A, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/57; Frebel A, 2007, MON NOT R ASTRON SOC, V380, pL40, DOI 10.1111/j.1745-3933.2007.00344.x; Hansen T, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/162; Jacobson HR, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/171; Li HN, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/2/110; Masseron T, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200911744; Masseron T, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/14; McWilliam A, 1997, ANNU REV ASTRON ASTR, V35, P503, DOI 10.1146/annurev.astro.35.1.503; Melendez J, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913047; Meyner G, 2006, ASTRON ASTROPHYS, V447, P623, DOI 10.1051/0004-6361:20053070; Norris JE, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/25; Norris JE, 2013, ASTROPHYS J, V762, DOI [10.1088/0004-637X/762/1/28, 10.1088/0004-637X/762/1]; Norris JE, 1996, ASTROPHYS J SUPPL S, V107, P391, DOI 10.1086/192368; Placco VM, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/21; Placco VM, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/40; Rockosi C., 2009, ARXIV09023484; Roederer IU, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/6/136; Sbordone L, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913282; Sbordone L., 2012, MEM SOC ASTRON IT S, V22, P29; SNEDEN C, 1973, ASTROPHYS J, V184, P839, DOI 10.1086/152374; Sobeck JS, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/6/175; SPITE F, 1982, ASTRON ASTROPHYS, V115, P357; Spite M, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220989; Yong D, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/27; Yong D, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/26	77	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							84	10.1093/pasj/psv053		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000006		
J	Momose, M; Morita, A; Fukagawa, M; Muto, T; Takeuchi, T; Hashimoto, J; Honda, M; Kudo, T; Okamoto, YK; Kanagawa, KD; Tanaka, H; Grady, CA; Sitko, ML; Akiyama, E; Currie, T; Follette, KB; Mayama, S; Kusakabe, N; Abe, L; Brandner, W; Brandt, TD; Carson, JC; Egner, S; Feldt, M; Goto, M; Guyon, O; Hayano, Y; Hayashi, M; Hayashi, SS; Henning, T; Hodapp, KW; Ishii, M; Iye, M; Janson, M; Kandori, R; Knapp, GR; Kuzuhara, M; Kwon, J; Matsuo, T; McElwain, MW; Miyama, S; Morino, JI; Moro-Martin, A; Nishimura, T; Pyo, TS; Serabyn, E; Suenaga, T; Suto, H; Suzuki, R; Takahashi, YH; Takami, M; Takato, N; Terada, H; Thalmann, C; Tomono, D; Turner, EL; Watanabe, M; Wisniewski, J; Yamada, T; Takami, H; Usuda, T; Tamura, M				Momose, Munetake; Morita, Ayaka; Fukagawa, Misato; Muto, Takayuki; Takeuchi, Taku; Hashimoto, Jun; Honda, Mitsuhiko; Kudo, Tomoyuki; Okamoto, Yoshiko K.; Kanagawa, Kazuhiro D.; Tanaka, Hidekazu; Grady, Carol A.; Sitko, Michael L.; Akiyama, Eiji; Currie, Thayne; Follette, Katherine B.; Mayama, Satoshi; Kusakabe, Nobuhiko; Abe, Lyu; Brandner, Wolfgang; Brandt, Timothy D.; Carson, Joseph C.; Egner, Sebastian; Feldt, Markus; Goto, Miwa; Guyon, Olivier; Hayano, Yutaka; Hayashi, Masahiko; Hayashi, Saeko S.; Henning, Thomas; Hodapp, Klaus W.; Ishii, Miki; Iye, Masanori; Janson, Markus; Kandori, Ryo; Knapp, Gillian R.; Kuzuhara, Masayuki; Kwon, Jungmi; Matsuo, Taro; McElwain, Michael W.; Miyama, Shoken; Morino, Jun-Ichi; Moro-Martin, Amaya; Nishimura, Tetsuo; Pyo, Tae-Soo; Serabyn, Eugene; Suenaga, Takuya; Suto, Hiroshi; Suzuki, Ryuji; Takahashi, Yasuhiro H.; Takami, Michihiro; Takato, Naruhisa; Terada, Hiroshi; Thalmann, Christian; Tomono, Daigo; Turner, Edwin L.; Watanabe, Makoto; Wisniewski, John; Yamada, Toru; Takami, Hideki; Usuda, Tomonori; Tamura, Motohide			Detailed structure of the outer disk around HD169142 with polarized light in H-band	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						infrared: planetary systems; planet-disk interactions; protoplanetary disks; stars: individual (HD 169142); stars: pre-main-sequence	2-DIMENSIONAL RADIATIVE-TRANSFER; PLANET-FORMING REGIONS; MAIN-SEQUENCE STARS; HERBIG AE/BE STARS; PROTOPLANETARY DISK; SCATTERED-LIGHT; TRANSITIONAL DISK; PROTOSTELLAR ENVELOPES; CIRCUMSTELLAR DISKS; GIANT PLANET	Coronagraphic imagery of the circumstellar disk around HD 169142 in H-band polarized intensity (PI) with Subaru/HiCIAO is presented. The emission scattered by dust particles at the disk surface in 0".2 <= r <= 1".2, or 29 <= r <= 174 AU, is successfully detected. The azimuthally-averaged radial profile of the PI shows a double power-law distribution, in which the PIs in r=29-52 AU and r=81.2-145 AU respectively show r(-3)-dependence. These two power-law regions are connected smoothly with a transition zone (TZ), exhibiting an apparent gap in r=40-70 AU. The PI in the inner power-law region shows a deep minimum whose location seems to coincide with the point source at lambda = 7 mm. This can be regarded as another sign of a protoplanet in TZ. The observed radial profile of the PI is reproduced by a minimally flaring disk with an irregular surface density distribution or with an irregular temperature distribution or with the combination of both. The depletion factor of surface density in the inner power-law region (r<50 AU) is derived to be >= 0.16 from a simple model calculation. The obtained PI image also shows small scale asymmetries in the outer power-law region. Possible origins for these asymmetries include corrugation of the scattering surface in the outer region, and shadowing effect by a puffed up structure in the inner power-law region.	[Momose, Munetake; Morita, Ayaka; Okamoto, Yoshiko K.] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Fukagawa, Misato] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Muto, Takayuki] Kogakuin Univ, Div Liberal Arts, Shinjuku Ku, Tokyo 1638677, Japan; [Takeuchi, Taku; Kuzuhara, Masayuki] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Hashimoto, Jun; Wisniewski, John] Univ Oklahoma, HL Dodge Dept Phys & Astron, Norman, OK 73019 USA; [Honda, Mitsuhiko] Kanagawa Univ, Dept Math & Phys, Hiratsuka, Kanagawa 2591293, Japan; [Kudo, Tomoyuki; Currie, Thayne; Egner, Sebastian; Guyon, Olivier; Hayano, Yutaka; Hayashi, Saeko S.; Nishimura, Tetsuo; Pyo, Tae-Soo; Takato, Naruhisa; Terada, Hiroshi; Tomono, Daigo] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Kanagawa, Kazuhiro D.; Tanaka, Hidekazu] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Grady, Carol A.; McElwain, Michael W.] NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; [Grady, Carol A.] Eureka Sci, Oakland, CA 96002 USA; [Grady, Carol A.] NASA, Goddard Space Flight Ctr, Goddard Ctr Astrobiol, Greenbelt, MD 20771 USA; [Sitko, Michael L.] Space Sci Inst, Boulder, CO 80301 USA; [Sitko, Michael L.] Univ Cincinnati, Dept Phys, Cincinnati, OH 45221 USA; [Akiyama, Eiji; Kusakabe, Nobuhiko; Hayashi, Masahiko; Ishii, Miki; Iye, Masanori; Kandori, Ryo; Morino, Jun-Ichi; Suenaga, Takuya; Suto, Hiroshi; Suzuki, Ryuji; Takahashi, Yasuhiro H.; Takami, Hideki; Usuda, Tomonori; Tamura, Motohide] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Follette, Katherine B.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Mayama, Satoshi] Grad Univ Adv Studies SOKENDAI, Ctr Promot Integrated Sci, Hayama, Kanagawa 2400193, Japan; [Mayama, Satoshi; Suenaga, Takuya] Grad Univ Adv Studies SOKENDAI, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Abe, Lyu] Univ Nice Sophia Antipolis, Lab Lagrange, CNRS, UMR 7293,Observ Cote Azur, F-06108 Nice 2, France; [Brandner, Wolfgang; Feldt, Markus; Henning, Thomas] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Brandt, Timothy D.] Inst Adv Study, Dept Astrophys, Princeton, NJ 08540 USA; [Carson, Joseph C.] Coll Charleston, Dept Phys & Astron, Charleston, SC 29424 USA; [Goto, Miwa] Univ Munich, Univ Sternwarte Munchen, D-81679 Munich, Germany; [Hodapp, Klaus W.] Univ Hawaii, Inst Astron, Hilo, HI 96720 USA; [Janson, Markus] Stockholm Univ, AlbaNova Univ Ctr, Dept Astron, S-10691 Stockholm, Sweden; [Knapp, Gillian R.; Moro-Martin, Amaya; Turner, Edwin L.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Kwon, Jungmi; Takahashi, Yasuhiro H.; Tamura, Motohide] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Matsuo, Taro] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Miyama, Shoken] Hiroshima Univ, Hiroshima 7398511, Japan; [Moro-Martin, Amaya] CSIC, INTA, CAB, Dept Astrophys, Madrid 28850, Spain; [Serabyn, Eugene] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Takami, Michihiro] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Thalmann, Christian] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Turner, Edwin L.] Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778568, Japan; [Watanabe, Makoto] Hokkaido Univ, Dept Cosmosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamada, Toru] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan	Momose, M (reprint author), Ibaraki Univ, Coll Sci, 2-1-1 Bunkyo, Mito, Ibaraki 3108512, Japan.	momose@mx.ibaraki.ac.jp	Tanaka, Hidekazu/E-1226-2012; MIYAMA, Shoken/A-3598-2015; 	Tanaka, Hidekazu/0000-0001-9659-658X; Kanagawa, Kazuhiro/0000-0001-7235-2417	MEXT KAKENHI [23103004, 23103005]; U.S. National Science Foundation [1009203]	We are grateful to the referee for valuable comments that improved our manuscript. This work is supported by MEXT KAKENHI Nos. 23103004 and 23103005, and by the U.S. National Science Foundation under Award No. 1009203. This research has made use of the SIMBAD database, operated at CDS, Strasbourg, France. Part of this research was carried out during the workshop "Recent Development in Studies of Protoplanetary Disks with ALMA", hosted by the Institute of Low Temperature Science, Hokkaido University.	Andrews SM, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/42; Paardekooper SJ, 2006, ASTRON ASTROPHYS, V453, P1129, DOI 10.1051/0004-6361:20054449; Dunkin SK, 1997, MON NOT R ASTRON SOC, V286, P604; Whitney BA, 2003, ASTROPHYS J, V598, P1079, DOI 10.1086/379068; WHITNEY BA, 1992, ASTROPHYS J, V395, P529, DOI 10.1086/171673; Kanagawa KD, 2015, MON NOT R ASTRON SOC, V448, P994, DOI 10.1093/mnras/stv025; vandenAncker ME, 1997, ASTRON ASTROPHYS, V324, pL33; Casassus S, 2013, NATURE, V493, P191, DOI 10.1038/nature11769; Raman A, 2006, ASTRON J, V131, P2290, DOI 10.1086/500587; Whitney BA, 2004, ASTROPHYS J, V617, P1177, DOI 10.1086/425608; Brown JM, 2009, ASTROPHYS J, V704, P496, DOI 10.1088/0004-637X/704/1/496; Muto T, 2009, ASTROPHYS J, V695, P1132, DOI 10.1088/0004-637X/695/2/1132; van der Marel N, 2013, SCIENCE, V340, P1199, DOI 10.1126/science.1236770; Sylvester RJ, 1996, MON NOT R ASTRON SOC, V279, P915; Suzuki R, 2010, PROC SPIE, V7735, DOI 10.1117/12.857361; Williams JP, 2011, ANNU REV ASTRON ASTR, V49, P67, DOI 10.1146/annurev-astro-081710-102548; Crida A, 2006, ICARUS, V181, P587, DOI 10.1016/j.icarus.2005.10.007; Hodapp KW, 2008, P SOC PHOTO-OPT INS, V7014, P1419, DOI 10.1117/12.788088; Dullemond CP, 2010, ANNU REV ASTRON ASTR, V48, P205, DOI 10.1146/annurev-astro-081309-130932; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Meeus G, 2001, ASTRON ASTROPHYS, V365, P476; SKRUTSKIE MF, 1990, ASTRON J, V99, P1187, DOI 10.1086/115407; STROM KM, 1989, ASTRON J, V97, P1451, DOI 10.1086/115085; Lyra W, 2009, ASTRON ASTROPHYS, V493, P1125, DOI 10.1051/0004-6361:200810797; Hinkley S, 2009, ASTROPHYS J, V701, P804, DOI 10.1088/0004-637X/701/1/804; Manoj P, 2006, ASTROPHYS J, V653, P657, DOI 10.1086/508764; Whitney BA, 2003, ASTROPHYS J, V591, P1049, DOI 10.1086/375415; Regaly Z, 2012, MON NOT R ASTRON SOC, V419, P1701, DOI 10.1111/j.1365-2966.2011.19834.x; Wisniewski JP, 2008, ASTROPHYS J, V682, P548, DOI 10.1086/589629; Panic O, 2008, ASTRON ASTROPHYS, V491, P219, DOI 10.1051/0004-6361:20079261; Inoue AK, 2008, PUBL ASTRON SOC JPN, V60, P557; Avenhaus H, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/87; Biller BA, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/1/L22; Birnstiel T, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220847; Bohren C. F., 1983, ABSORPTION SCATTERIN; Dong R, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/161; Duffell PC, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/41; Follette KB, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/10; Fukagawa M, 2010, PUBL ASTRON SOC JPN, V62, P347; Fukagawa M, 2013, PUBL ASTRON SOC JPN, V65; Grady CA, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/48; Grady CA, 2007, ASTROPHYS J, V665, P1391, DOI 10.1086/519757; Hashimoto J, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/2/L17; Hashimoto J, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L19; Hayano Y, 2004, P SOC PHOTO-OPT INS, V5490, P1088, DOI 10.1117/12.551015; Honda M, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/143; Jang-Condell H, 2009, ASTROPHYS J, V700, P820, DOI 10.1088/0004-637X/700/1/820; Jang-Condell H, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/153; Joos F., 2008, P SOC PHOTO-OPT INS, V7016, P48; Kanagawa KD, 2015, ASTROPHYS J LETT, V806, DOI 10.1088/2041-8205/806/1/L15; Kusakabe N, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/153; Lin D. N. C., 1993, PROTOSTARS PLANETS, P749; Maaskant KM, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321300; Mayama S, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L26; Meeus G, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219225; Meeus G, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014557; Minowa Y, 2010, P SOC PHOTO-OPT INS, V7736, DOI 10.1117/12.857818; Muto T, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/2/L22; Muto T, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/10; Osorio M, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L36; Perez LM, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L13; Quanz SP, 2013, ASTROPHYS J LETT, V766, DOI 10.1088/2041-8205/766/1/L2; Reggiani M, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/1/L23; Tamura M., 2006, P SOC PHOTO-OPT INS, V6269, P28; Tamura M, 2009, AIP CONF PROC, V1158, P11, DOI 10.1063/1.3215811; Wagner KR, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/2/94; Zhu ZH, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/47	67	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							83	10.1093/pasj/psv051		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000005		
J	Nakai, T; Fukue, J				Nakai, Takuya; Fukue, Jun			Escape conditions of radiative-driven strati from luminous accretion disks	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; black hole physics; galaxies: active; radiative transfer	ACTIVE GALACTIC NUCLEI; ABSORPTION-LINES; BLACK-HOLES; OUTFLOWS; PRESSURE; QUASARS; WINDS; FLOW; MODEL; DRAG	We examine the dynamical motion and escape conditions of continuum-driven strati (flat cloud) with finite optical depth from luminous accretion disks around a black hole. We adopt the near-disk approximation, and treat the problem in the framework of special relativity, where the radiation drag force as well as the radiation pressure are included. We find that the optically thin strati are easy to accelerate, compared with the particles, and the escape condition of the stratus is reduced. That is, when the disk luminosity is around the Eddington luminosity, the optically thin strati can escape from the inner disk (less than or similar to 20 r(g); r(g) being the Schwarzschild radius). When the disk luminosity is about half the Eddington luminosity, it can escape at around 5 r(g). This is due to the translucent effect. In addition, the trajectories of the strati are not vertical, but a funnel-like shape due to the centrifugal force. Stratus outflow could easily blow out from usual accretion disks with sub-Eddington luminosities, and this may explain outflows observed in broad absorption line quasars and ultra-fast outflow objects.	[Nakai, Takuya; Fukue, Jun] Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan	Nakai, T (reprint author), Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan.	j149333@ex.osaka-kyoiku.ac.jp					Karas V, 2000, MON NOT R ASTRON SOC, V318, P547; Ohsuga K, 2014, SPACE SCI REV, V183, P353, DOI 10.1007/s11214-013-0017-3; Tajima Y, 1998, PUBL ASTRON SOC JPN, V50, P483; Yuan F, 2014, ANNU REV ASTRON ASTR, V52, P529, DOI 10.1146/annurev-astro-082812-141003; MATHUR S, 1995, ASTROPHYS J, V452, P230, DOI 10.1086/176294; Bowler RAA, 2014, MON NOT R ASTRON SOC, V445, P359, DOI 10.1093/mnras/stu1730; Tajima Y, 1996, PUBL ASTRON SOC JPN, V48, P529; King AR, 2003, MON NOT R ASTRON SOC, V345, P657, DOI 10.1046/j.1365-8711.2003.06980.x; Chelouche D, 2001, MON NOT R ASTRON SOC, V326, P916, DOI 10.1046/j.1365-8711.2001.04586.x; Arav N, 1999, ASTROPHYS J, V516, P27, DOI 10.1086/307073; Hagino K, 2015, MON NOT R ASTRON SOC, V446, P663, DOI 10.1093/mnras/stu2095; Tombesi F, 2014, MON NOT R ASTRON SOC, V443, P2154, DOI 10.1093/mnras/stu1297; Ohsuga K, 2005, ASTROPHYS J, V628, P368, DOI 10.1086/430728; Xie FG, 2008, ASTROPHYS J, V681, P499, DOI 10.1086/588522; Ohsuga K, 2009, PUBL ASTRON SOC JPN, V61, pL7; Elvis M, 2000, ASTROPHYS J, V545, P63, DOI 10.1086/317778; Elvis M, 2012, ASTR SOC P, V460, P186; Fukue J, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psv036; Fukue J, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/pst013; ICKE V, 1989, ASTRON ASTROPHYS, V216, P294; ICKE V, 1980, ASTRON J, V85, P329, DOI 10.1086/112678; Jannuzi BT, 1996, ASTROPHYS J, V470, pL11, DOI 10.1086/310301; Kato S., 2008, BLACK HOLE ACCRETION; King AR, 2010, MON NOT R ASTRON SOC, V402, P1516, DOI 10.1111/j.1365-2966.2009.16013.x; Nomura M, 2013, PUBL ASTRON SOC JPN, V65; Pacynski B., 1980, ASTRON ASTROPHYS, V88, P23; Risaliti G., 2010, ASTRON ASTROPHYS, V516, P89; Spruit HC, 1996, NATO ADV SCI INST SE, V477, P249; Takeuchi S, 2013, PUBL ASTRON SOC JPN, V65; Tombesi F, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/44; Yuan F, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/130	31	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							97	10.1093/pasj/psv065		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000019		
J	Nakashima, J; Sobolev, AM; Salii, SV; Zhang, Y; Yung, BHK; Deguchi, S				Nakashima, Jun-ichi; Sobolev, Andrej M.; Salii, Svetlana V.; Zhang, Yong; Yung, Bosco H. K.; Deguchi, Shuji			Methanol observation of IRAS 19312+1950: A possible new type of class I methanol maser	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						masers; radio lines: stars; stars: individual (IRAS 19312+1950); stars: late-type; stars: winds, outflows	BIPOLAR NEBULA IRAS-19312+1950; SPECTRAL-LINE SURVEY; H2O MASERS; GHZ; SIO; IRC+10216; EMISSION; REGIONS; SAGITTARIUS; EXCITATION	We report the result of a systematic methanol observation toward IRAS 19312+1950. The properties of the SiO, H2O, and OH masers of this object are consistent with those of mass-losing evolved stars, but some other properties are difficult to explain in the standard scheme of stellar evolution in its late stage. Interestingly, a tentative detection of radio methanol lines was suggested toward this object by a previous observation. To date, there are no confirmed detections of methanol emission towards evolved stars, so investigation of this possible detection is important to better understand the circumstellar physical/chemical environment of IRAS 19312+1950. In this study, we systematically observed multiple methanol lines of IRAS 19312+1950 in the lambda = 3 mm, 7 mm, and 13 mm bands, and detected six lines including four thermal lines and two class I maser lines. We derived basic physical parameters, including kinetic temperature and relative abundances, by fitting a radiative transfer model. According to the derived excitation temperature and line profiles, a spherically expanding outflow lying at the center of the nebulosity is excluded from the possibilities for methanol emission regions. The detection of class I methanol maser emission suggests that a shock region is involved in the system of IRAS 19312+1950. If the central star of IRAS 19312+1950 is an evolved star as suggested in the past, the class I maser detected in the present observation is the first case detected in an interaction region between an evolved star outflow and ambient molecular gas.	[Nakashima, Jun-ichi; Salii, Svetlana V.] Ural Fed Univ, Inst Nat Sci, Dept Astron & Geodesy, Ekaterinburg 620000, Russia; [Nakashima, Jun-ichi; Zhang, Yong; Yung, Bosco H. K.] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Sobolev, Andrej M.] Ural Fed Univ, Inst Nat Sci, Astron Observ, Ekaterinburg 620000, Russia; [Zhang, Yong] Univ Hong Kong, Space Astron Lab, Fac Sci, Hong Kong, Hong Kong, Peoples R China; [Deguchi, Shuji] Natl Inst Nat Sci, Natl Astron Observ Japan, Nobeyama Radio Observ, Minamimaki, Nagano 3841305, Japan	Nakashima, J (reprint author), Ural Fed Univ, Inst Nat Sci, Dept Astron & Geodesy, Lenin Ave 51, Ekaterinburg 620000, Russia.	nakashima.junichi@gmail.com			Research Grants Council of Hong Kong [HKU 703308P, HKU 704209P, HKU 704710P]; Russian Science Foundation [15-12-10017]; Ministry of Education and Science of the Russian Federation [3.1781.2014/K]; Hong Kong General Research Fund [HKU 7027/11P, HKU 7062/13P]	This work is supported by a grant awarded to JN from the Research Grants Council of Hong Kong (project code: HKU 703308P; HKU 704209P; HKU 704710P). AMS was supported by the Russian Science Foundation (grant number 15-12-10017). SVS was supported by the Ministry of Education and Science of the Russian Federation (state task No. 3.1781.2014/K). YZ also thanks the Hong Kong General Research Fund (HKU 7027/11P and HKU 7062/13P) for financial support of this study. The model analysis and some of the paper writing were done while JN was staying at the Department of Astronomy and Geodesy in the Ural Federal University in November and December 2013. Nobeyama Radio Observatory is a branch of the National Astronomical Observatory of Japan, National Institutes of Natural Sciences. Part of the data was acquired within telescope time allocated for a project of Daniel Tafoya.	Nakashima JI, 2005, ASTROPHYS J, V633, P282, DOI 10.1086/444609; Deguchi S, 2004, PUBL ASTRON SOC JPN, V56, P1083; Kurtz S, 2004, ASTROPHYS J SUPPL S, V155, P149, DOI 10.1086/423956; Kalenskii SV, 2010, MON NOT R ASTRON SOC, V405, P613, DOI 10.1111/j.1365-2966.2010.16484.x; Groenewegen MAT, 1998, ASTRON ASTROPHYS, V338, P491; HASEGAWA T, 1994, ASTROPHYS J, V429, pL77, DOI 10.1086/187417; Voronkov MA, 2006, MON NOT R ASTRON SOC, V373, P411, DOI 10.1111/j.1365-2966.2006.11047.x; Liechti S, 1996, ASTRON ASTROPHYS, V314, P615; Nakashima J, 2004, PUBL ASTRON SOC JPN, V56, P193; WILSON TL, 1984, ASTRON ASTROPHYS, V134, pL7; Sutton EC, 2001, ASTROPHYS J, V554, P173, DOI 10.1086/321349; Imai H, 2011, PUBL ASTRON SOC JPN, V63, P81; Rabli D, 2010, MON NOT R ASTRON SOC, V403, P2033, DOI 10.1111/j.1365-2966.2010.16240.x; Rabli D, 2010, MON NOT R ASTRON SOC, V406, P95, DOI 10.1111/j.1365-2966.2010.16671.x; Nakashima J, 2000, PUBL ASTRON SOC JPN, V52, pL43; Cragg DM, 2005, MON NOT R ASTRON SOC, V360, P533, DOI 10.1111/j.1365-2966.2005.09077.x; Nakashima J, 2004, ASTROPHYS J, V610, pL41, DOI 10.1086/423240; Voronkov MA, 2011, MON NOT R ASTRON SOC, V413, P2339, DOI 10.1111/j.1365-2966.2011.18297.x; Nakashima J, 2003, PUBL ASTRON SOC JPN, V55, P229; Papadopoulos PP, 2012, MON NOT R ASTRON SOC, V426, P2601, DOI 10.1111/j.1365-2966.2012.21001.x; Kawaguchi K, 1995, PUBL ASTRON SOC JPN, V47, P853; Cernicharo J, 2000, ASTRON ASTROPHYS SUP, V142, P181, DOI 10.1051/aas:2000147; He JH, 2008, ASTROPHYS J SUPPL S, V177, P275, DOI 10.1086/587142; Sutton EC, 2004, ASTROPHYS J, V609, P231, DOI 10.1086/420962; LOVAS FJ, 1992, J PHYS CHEM REF DATA, V21, P181; LAMPTON M, 1976, ASTROPHYS J, V208, P177, DOI 10.1086/154592; Ford KES, 2004, ASTROPHYS J, V614, P990, DOI 10.1086/423886; Murakawa K, 2007, ASTRON ASTROPHYS, V470, P957, DOI 10.1051/0004-6361:20066574; GUELIN M, 1978, ASTROPHYS J, V224, pL27, DOI 10.1086/182751; Meixner M, 1998, ASTROPHYS J, V509, P392, DOI 10.1086/306463; Charnley SB, 1997, MON NOT R ASTRON SOC, V287, P538; Choi Y. K., 2012, IAU S, V287, P407; Ellingsen SP, 2014, ASTROPHYS J LETT, V790, DOI 10.1088/2041-8205/790/2/L28; Hasegawa T., 1986, P MAS MOL MASS OUTFL, P275; Lucas R., 1999, IAU S, V191, P305; Menten K, 1991, ASTRON SOC PAC C SER, V16, P119; Nakashima J, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/76; Pihlstrom YM, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L21; Salii S. V., 2006, STAR FORMATION GALAX, P146; Sherwood W. A., 1980, IAU S, V87, P133	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							95	10.1093/pasj/psv064		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000017		
J	Okamoto, I				Okamoto, Isao			Black hole electrodynamics: How does unipolar induction work in Kerr black holes?	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						ISM: magnetic fields; MHD; stars: winds, outflows	FORCE-FREE MAGNETOSPHERE; PLASMA; WINDS	It is argued that through magnetohydrodynamic couplings with the field-line angular velocity/the cross-field potential gradient Omega(F), the frame-dragging angular velocity omega acquires a new role of the gravito-electric potential gradient, which produces the along-field gradient of the potential gradient. With use of the field-line angular velocity, Omega(F omega) = Omega(F) - omega, measured by fiducial observers living in "absolute space" circulating with omega, it is then shown that the hole's spin rate Omega(H) also has another side of the along-field difference of the potential gradient between the surface-at-infinity S-infinity and the horizon surface S-H, i.e., Omega(H) = Delta Omega(F omega) = ( Omega(F omega))(infinity) -( Omega(F omega))(H), which gives rise to a voltage drop Delta V proportional to Omega(F omega) = Omega(H) at the interface SN with ( Omega(F omega))(N) = 0 between the outer and inner force-free domains, leading to formation of a magnetized gap under S-N. The EMFs due to a pair of unipolar induction batteries, epsilon(out) and epsilon(in), drive currents to a pair of circuits in the two domains, and satisfy relation epsilon(out) - epsilon(in) = Delta V. The eigenvalue Omega(F) is determined by the criticality-boundary condition in MHD wind theory in terms of Omega(H), i.e., approximate to(1/2)Omega(H). The present gap model with a pair of batteries and a strong voltage drop is fundamentally different from any existing pulsar gap models.	[Okamoto, Isao] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Okamoto, Isao] Inst Black Hole Min, Hino, Tokyo 1910034, Japan	Okamoto, I (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	okamoto@nao.ac.jp			gc12 LOC; Foundation for Promotion of Astronomy, Japan	This paper is an extended version of the author's talk with the same title at the Ginzburg Conference on Physics (Okamoto 2012b). The author thanks the gc12 LOC and Foundation for Promotion of Astronomy, Japan for supporting local expenses and flight costs, respectively.	MACDONALD D, 1982, MON NOT R ASTRON SOC, V198, P345; Ciufolini I, 2007, NATURE, V449, P41, DOI 10.1038/nature06071; Lyutikov M, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.084019; Okamoto I, 2006, PUBL ASTRON SOC JPN, V58, P987; Lyutikov M, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.124035; Hirotani K, 1998, ASTROPHYS J, V497, P563, DOI 10.1086/305479; HORIUCHI S, 1995, MON NOT R ASTRON SOC, V275, P1160; Beskin V. S., 2009, MHD FLOWS COMPACT AS, P105; Beskin V. S., 1992, Soviet Astronomy, V36; Blandford R., 2012, P GINZB C PHYS; Blandford R. D., 1979, ACTIVE GALACTIC NUCL, P241; Blandford R. D., 1977, MNRAS, V179, P465; Contopoulos I, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/1/L5; GOLDREIC.P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; Landau L. D., 1972, CLASSICAL THEORY FIE; Landau L D, 1984, ELECTRODYNAMICS CONT; MESTEL L, 1961, MON NOT R ASTRON SOC, V122, P473; MICHEL FC, 1973, ASTROPHYS J, V180, pL133, DOI 10.1086/181169; Misner C.W., 1973, GRAVITATION; Okamoto I., 2012, P GINZB C PHYS; Okamoto I, 2009, PUBL ASTRON SOC JPN, V61, P971; Okamoto I, 2006, PUBL ASTRON SOC JPN, V58, P1047; Okamoto I, 2012, PUBL ASTRON SOC JPN, V64; OKAMOTO I, 1978, MON NOT R ASTRON SOC, V185, P69; OKAMOTO I, 1992, MON NOT R ASTRON SOC, V254, P192; OKAMOTO I, 1974, MON NOT R ASTRON SOC, V167, P457; Phinney S., 1982, P TOR WORKSH ASTR JE; Thorne Kip S., 1986, BLACK HOLES MEMBRANE; ZNAJEK RL, 1978, MON NOT R ASTRON SOC, V185, P833; ZNAJEK RL, 1977, MON NOT R ASTRON SOC, V179, P457	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							89	10.1093/pasj/psv056		18	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000011		
J	Singh, KAP; Hillier, A; Isobe, H; Shibata, K				Singh, K. A. P.; Hillier, Andrew; Isobe, Hiroaki; Shibata, Kazunari			Nonlinear instability and intermittent nature of magnetic reconnection in solar chromosphere	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						Sun: chromosphere; Sun: magnetic fields	PARTIALLY-IONIZED-GASES; INTERSTELLAR-MEDIUM; RESISTIVITY; SIMULATIONS; PLASMA; IONIZATION; ATMOSPHERE; FIELD	The recent observations of Singh et al. (2012, ApJ, 759, 33) have shown multiple plasma ejections and the intermittent nature of magnetic reconnection in the solar chromosphere, highlighting the need for fast reconnection to occur in highly collisional plasma. However, the physical process through which fast magnetic reconnection occurs in partially ionized plasma, like the solar chromosphere, is still poorly understood. It has been shown that for sufficiently high magnetic Reynolds numbers, Sweet-Parker current sheets can become unstable leading to tearing mode instability and plasmoid formation, but when dealing with a partially ionized plasma the strength of coupling between the ions and neutrals plays a fundamental role in determining the dynamics of the system. We propose that as the reconnecting current sheet thins and the tearing instability develops, plasmoid formation passes through strongly, intermediately, and weakly coupled (or decoupled) regimes, with the time scale for the tearing mode instability depending on the frictional coupling between ions and neutrals. We present calculations for the relevant time scales for fractal tearing in all three regimes. We show that as a result of the tearing mode instability and the subsequent non-linear instability due to the plasmoid-dominated reconnection, the Sweet-Parker current sheet tends to have a fractal-like structure, and when the chromospheric magnetic field is sufficiently strong the tearing instability can reach down to kinetic scales, which are hypothesized to be necessary for fast reconnection.	[Singh, K. A. P.] UM DAE Ctr Excellence Basic Sci, Bombay 400098, Maharashtra, India; [Hillier, Andrew] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; [Isobe, Hiroaki] Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Sakyo Ku, Kyoto, Kyoto 6068501, Japan; [Isobe, Hiroaki; Shibata, Kazunari] Kyoto Univ, Kwasan Observ, Yamashina Ku, Kyoto, Kyoto 6078471, Japan; [Isobe, Hiroaki; Shibata, Kazunari] Kyoto Univ, Hida Observ, Yamashina Ku, Kyoto, Kyoto 6078471, Japan	Singh, KAP (reprint author), UM DAE Ctr Excellence Basic Sci, Bombay 400098, Maharashtra, India.	alkendra.singh@cbs.ac.in			Kwasan and Hida Observatories, Kyoto University, Japan; Science and Technology Facilities Council (STFC) Ernest Rutherford Fellowship [ST/L00397X/1]	KAPS acknowledges the support from Kwasan and Hida Observatories, Kyoto University, Japan. KAPS is thankful to Prof. S.M. Chitre, Chairperson of Academic Board, UM-DAE CBS, Mumbai for continuous encouragement and moral support. AH is supported by his Science and Technology Facilities Council (STFC) Ernest Rutherford Fellowship grant number ST/L00397X/1. The authors would also like to thank the anonymous referee for their helpful and insightful comments.	Samtaney R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.105004; Cassak PA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.235002; Vishniac ET, 1999, ASTROPHYS J, V511, P193, DOI 10.1086/306643; Sturrock PA, 1999, ASTROPHYS J, V521, P451, DOI 10.1086/307544; Loureiro NF, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3703318; Drake JF, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2901194; Arber TD, 2009, ASTROPHYS J, V705, P1183, DOI 10.1088/0004-637X/705/2/1183; Loureiro NF, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.013102; Shepherd LS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.015004; Cassak PA, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2734948; Hillier A, 2010, PUBL ASTRON SOC JPN, V62, P1231; Zweibel EG, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3656960; Singh KAP, 2007, SOL PHYS, V243, P163, DOI 10.1007/s11207-007-0464-7; OFMAN L, 1991, PHYS FLUIDS B-PLASMA, V3, P1364, DOI 10.1063/1.859701; Baalrud SD, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3633473; Uzdensky DA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.235002; Oieroset M, 2001, NATURE, V412, P414, DOI 10.1038/35086520; Ren Y, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2936269; Singh KAP, 2010, NEW ASTRON, V15, P119, DOI 10.1016/j.newast.2009.05.013; YOKOYAMA T, 1994, ASTROPHYS J, V436, pL197, DOI 10.1086/187666; Shibata K, 2001, EARTH PLANETS SPACE, V53, P473; Leenaarts J, 2007, ASTRON ASTROPHYS, V473, P625, DOI 10.1051/0004-6361:20078161; FURTH HP, 1963, PHYS FLUIDS, V6, P459, DOI 10.1063/1.1706761; Tanuma S, 2001, ASTROPHYS J, V551, P312, DOI 10.1086/320058; Ni L, 2007, ASTROPHYS SPACE SCI, V312, P139, DOI 10.1007/s10509-007-9662-x; Loureiro NF, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2783986; Huang YM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.265002; Daughton W, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.065004; Leake JE, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4811140; Singh KAP, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3655444; Mirnov VV, 2004, PHYS PLASMAS, V11, P4468, DOI 10.1063/1.1773778; BISKAMP D, 1986, PHYS FLUIDS, V29, P1520, DOI 10.1063/1.865670; Biskamp D., 1992, NONLINEAR MAGNETOHYD; Brandenburg A., 1994, APJ, V431, P689; COWLING TG, 1956, MON NOT R ASTRON SOC, V116, P114; Cox A. N., 2000, ALLENS ASTROPHYSICAL; Dere KP, 1996, ASTROPHYS J, V472, P864, DOI 10.1086/178116; Khomenko E, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/87; Krishan V, 2009, MON NOT R ASTRON SOC, V400, P2200, DOI [10.1111/J.1365-2966.2009.15623.X, 10.1111/j.1365-2966.2009.15623.x]; Leake JE, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/109; Malyshkin LM, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/72; Ni L, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/79; Nishizuka N., 2011, A A LETT, V737, P43; PIDDINGTON JH, 1954, MON NOT R ASTRON SOC, V114, P651; Singh KAP, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/33; Sonnerup B. U. O., 1981, EOS T AGU, V62, P353; Sturrock P. A., 1994, PLASMA PHYS INTRO TH; ZWEIBEL EG, 1989, ASTROPHYS J, V340, P550, DOI 10.1086/167416	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							96	10.1093/pasj/psv066		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000018		
J	Takagi, Y; Itoh, Y; Arai, A; Sai, S; Oasa, Y				Takagi, Yuhei; Itoh, Yoichi; Arai, Akira; Sai, Shoko; Oasa, Yumiko			Rapid dissipation of protoplanetary disks in Ophiuchus	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						protoplanetary disks; stars: formation; stars: pre-main sequence	MAIN-SEQUENCE STARS; PLANET FORMATION; MOLECULAR CLOUD; RHO-OPHIUCHI; LIFETIMES; TRACKS; DUST; SPECTROSCOPY; POPULATION; ISOCHRONES	We present the results of an age determination study for pre-main sequence stars in the Ophiuchus molecular cloud. The ages of eight pre-main sequence stars were estimated from surface gravities derived from high-resolution spectroscopy. The average age of the target stars was 0.7 Myr. By comparing the individual age and the near-infrared color excess, we found that color excess decreases gradually with a constant rate and the lifetime of the inner disk was determined to be 1.2 Myr. The estimated lifetime is nearly a half of the time compared to that of the pre-main sequence stars in the Taurus molecular cloud estimated with the same method. This result indicates that the disk evolution timescale depends on the environment of the star-forming region.	[Takagi, Yuhei; Itoh, Yoichi; Arai, Akira; Sai, Shoko] Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan; [Arai, Akira] Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto, Kyoto 6038555, Japan; Saitama Univ, Fac Educ, Sakura Ku, Saitama, Saitama 3888570, Japan	Takagi, Y (reprint author), Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, 407-2 Nishigaichi, Sayo, Hyogo 6795313, Japan.	takagi@nhao.jp			JSPS KAKENHI [26103708, 26870507, 25870124]	This research was based on data collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. This work was supported by JSPS KAKENHI Grant Numbers 26103708, 26870507, and 25870124.	Takagi Y, 2010, PUBL ASTRON SOC JPN, V62, P501; Andrews SM, 2007, ASTROPHYS J, V671, P1800, DOI 10.1086/522885; Bell CPM, 2013, MON NOT R ASTRON SOC, V434, P806, DOI 10.1093/mnras/stt1075; Thi WF, 2011, MON NOT R ASTRON SOC, V412, P711, DOI 10.1111/j.1365-2966.2010.17741.x; Cieza LA, 2010, ASTROPHYS J, V712, P925, DOI 10.1088/0004-637X/712/2/925; Muzerolle J, 2010, ASTROPHYS J, V708, P1107, DOI 10.1088/0004-637X/708/2/1107; COHEN JG, 1981, ASTROPHYS J, V249, P481, DOI 10.1086/159308; Siess L, 2000, ASTRON ASTROPHYS, V358, P593; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Hog E, 2000, ASTRON ASTROPHYS, V355, pL27; ODELL CR, 1994, ASTROPHYS J, V436, P194, DOI 10.1086/174892; Hernandez J, 2008, ASTROPHYS J, V686, P1195, DOI 10.1086/591224; Noguchi K, 2002, PUBL ASTRON SOC JPN, V54, P855; Hillenbrand LA, 2004, ASTROPHYS J, V604, P741, DOI 10.1086/382021; SKRUTSKIE MF, 1990, ASTRON J, V99, P1187, DOI 10.1086/115407; Sartori MJ, 2003, ASTRON ASTROPHYS, V404, P913, DOI 10.1051/0004-6361:20030581; Ercolano B, 2010, MON NOT R ASTRON SOC, V402, P2735, DOI 10.1111/j.1365-2966.2009.16094.x; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; GREENE TP, 1995, ASTROPHYS J, V450, P233, DOI 10.1086/176134; Meyer MR, 1997, ASTRON J, V114, P288, DOI 10.1086/118474; Suzuki TK, 2010, ASTROPHYS J, V718, P1289, DOI 10.1088/0004-637X/718/2/1289; Lejeune T, 2001, ASTRON ASTROPHYS, V366, P538; McClure MK, 2010, ASTROPHYS J SUPPL S, V188, P75, DOI 10.1088/0067-0049/188/1/75; Wilking BA, 2005, ASTRON J, V130, P1733, DOI 10.1086/432758; Drilling J. S., 2000, ALLENS ASTROPHYSICAL, P389; ESA, 1997, ESA; KENYON SJ, 1995, ASTROPHYS J SUPPL S, V101, P117, DOI 10.1086/192235; Kusune T, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/60; Mamajek EE, 2009, AIP CONF PROC, V1158, P3, DOI 10.1063/1.3215910; MATHIS JS, 1990, ANNU REV ASTRON ASTR, V28, P37; Padgett DL, 1996, ASTROPHYS J, V471, P847, DOI 10.1086/178012; Pecaut MJ, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/9; Petrov P. P., 2011, ASTRON ASTROPHYS, V535, P6; Ribas A ., 2014, ASTRON ASTROPHYS, V561, P54; Takagi Y, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu062; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; Yasui C., 2010, APJ, V723, P113	37	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							87	10.1093/pasj/psv062		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000009		
J	Toba, Y; Nagao, T; Strauss, MA; Aoki, K; Goto, T; Imanishi, M; Kawaguchi, T; Terashima, Y; Ueda, Y; Bosch, J; Bundy, K; Doi, Y; Inami, H; Komiyama, Y; Lupton, RH; Matsuhara, H; Matsuoka, Y; Miyazaki, S; Morokuma, T; Nakata, F; Oi, N; Onoue, M; Oyabu, S; Price, P; Tait, PJ; Takata, T; Tanaka, MM; Terai, T; Turner, EL; Uchida, T; Usuda, T; Utsumi, Y; Yamada, Y; Wang, SY				Toba, Yoshiki; Nagao, Tohru; Strauss, Michael A.; Aoki, Kentaro; Goto, Tomotsugu; Imanishi, Masatoshi; Kawaguchi, Toshihiro; Terashima, Yuichi; Ueda, Yoshihiro; Bosch, James; Bundy, Kevin; Doi, Yoshiyuki; Inami, Hanae; Komiyama, Yutaka; Lupton, Robert H.; Matsuhara, Hideo; Matsuoka, Yoshiki; Miyazaki, Satoshi; Morokuma, Tomoki; Nakata, Fumiaki; Oi, Nagisa; Onoue, Masafusa; Oyabu, Shinki; Price, Paul; Tait, Philip J.; Takata, Tadafumi; Tanaka, Manobu M.; Terai, Tsuyoshi; Turner, Edwin L.; Uchida, Tomohisa; Usuda, Tomonori; Utsumi, Yousuke; Yamada, Yoshihiko; Wang, Shiang-Yu			Hyper-luminous dust-obscured galaxies discovered by the Hyper Suprime-Cam on Subaru and WISE	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						catalogs; galaxies: active; galaxies: luminosity function, mass function; infrared: galaxies; methods: statistical	ACTIVE GALACTIC NUCLEI; DIGITAL-SKY-SURVEY; SIMILAR-TO 2; SUPERMASSIVE BLACK-HOLES; STAR-FORMATION HISTORY; MU-M SPECTROSCOPY; DEEP-FIELD-SOUTH; MIDINFRARED SELECTION; INFRARED GALAXIES; COSMIC EVOLUTION	We present the photometric properties of a sample of infrared (IR) bright dust-obscured galaxies (DOGs). Combining wide and deep optical images obtained with the Hyper Suprime-Cam on the Subaru Telescope and all-skymid-IR (MIR) images taken with Wide-Field Infrared Survey Explorer, we discovered 48 DOGs with i-K-s > 1.2 and i-[22] > 7.0, where i, K-s, and [22] represent AB magnitude in the i-band, K-s-band, and 22 mu m, respectively, in the GAMA 14 hr field (similar to 9 deg(2)). Among these objects, 31 (similar to 65%) show power-law spectral energy distributions (SEDs) in the near-IR (NIR) and MIR regime, while the remainder show an NIR bump in their SEDs. Assuming that the redshift distribution for our DOGs sample is Gaussian, with mean and sigma z = 1.99 +/- 0.45, we calculated their total IR luminosity using an empirical relation between 22 mu m luminosity and total IR luminosity. The average value of the total IR luminosity is (3.5 +/- 1.1) x 10(13) L circle dot, which classifies them as hyper-luminous infrared galaxies. We also derived the total IR luminosity function (LF) and IR luminosity density (LD) for a flux-limited subsample of 18 DOGs with 22 mu m flux greater than 3.0 mJy and with i-band magnitude brighter than 24 AB magnitude. The derived space density for this subsample is log phi = -6.59 +/- 0.11 [Mpc(-3)]. The IR LF for DOGs including data obtained from the literature is fitted well by a double-power law. The derived lower limit for the IR LD for our sample is rho(IR) similar to 3.8 x 10(7) [L circle dot Mpc(-3]) and its contributions to the total IR LD, IR LD of all ultra-luminous infrared galaxies, and that of all DOGs are > 3%, > 9%, and > 15%, respectively.	[Toba, Yoshiki; Nagao, Tohru] Ehime Univ, Res Ctr Space & Cosm Evolut, Matsuyama, Ehime 7908577, Japan; [Strauss, Michael A.; Bosch, James; Lupton, Robert H.; Price, Paul; Turner, Edwin L.] Princeton Univ Observ, Princeton, NJ 08544 USA; [Aoki, Kentaro; Imanishi, Masatoshi; Terashima, Yuichi; Doi, Yoshiyuki; Nakata, Fumiaki; Tait, Philip J.; Terai, Tsuyoshi] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Goto, Tomotsugu] Natl Tsing Hua Univ, Inst Astron, Hsinchu 30013, Taiwan; [Goto, Tomotsugu] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan; [Imanishi, Masatoshi; Komiyama, Yutaka; Matsuoka, Yoshiki; Miyazaki, Satoshi; Onoue, Masafusa; Takata, Tadafumi; Usuda, Tomonori; Yamada, Yoshihiko] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Imanishi, Masatoshi; Komiyama, Yutaka; Miyazaki, Satoshi; Onoue, Masafusa; Takata, Tadafumi; Usuda, Tomonori] SOKENDAI Grad Univ Adv Studies, Sch Sci, Dept Astron, Mitaka, Tokyo 1818588, Japan; [Kawaguchi, Toshihiro] Sapporo Med Univ, Div Phys, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Terashima, Yuichi] Ehime Univ, Dept Phys, Matsuyama, Ehime 7908577, Japan; [Ueda, Yoshihiro] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Bundy, Kevin; Turner, Edwin L.] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe Kavli IPMU, WPI, Kashiwa, Chiba 2778583, Japan; [Inami, Hanae] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Matsuhara, Hideo; Oi, Nagisa] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Matsuhara, Hideo] SOKENDAI Grad Univ Adv Studies, Dept Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Morokuma, Tomoki] Univ Tokyo, Grad Sch Sci, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Oyabu, Shinki] Nagoya Univ, Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tanaka, Manobu M.; Uchida, Tomohisa] Inst Particle & Nucl Studies, High Energy Accelerator Res Org KEK, Tsukuba, Ibaraki 3050801, Japan; [Utsumi, Yousuke] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Wang, Shiang-Yu] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan	Toba, Y (reprint author), Ehime Univ, Res Ctr Space & Cosm Evolut, 2-5 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	toba@cosmos.phys.sci.ehime-u.ac.jp			National Aeronautics and Space Administration; Research Coordination Committee, National Astronomical Observatory of Japan (NAOJ); National Aeronautics and Space Administration [NNX08AR22G]; National Science Foundation [AST-1238877]; Japan Society for the Promotion of Science [25707010]; Yamada Science Foundation; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan	The authors gratefully acknowledge the anonymous referee for a careful reading of the manuscript and very helpful comments. We are also deeply thankful to Drs Hisanori Furusawa, Sogo Mineo, and Michitaro Koike (NAOJ) who kindly helped us regarding the treatment of the HSC data. We also thank Dr Masayuki Akiyama (Tohoku University) for fruitful discussions. This publication makes use of data products from the Wide-field Infrared Survey Explorer, which is a joint project of the University of California, Los Angeles, and the Jet Propulsion Laboratory/California Institute of Technology, funded by the National Aeronautics and Space Administration. This work was achieved by the grant of the Research Assembly supported by the Research Coordination Committee, National Astronomical Observatory of Japan (NAOJ). This work is also based on data obtained from the ESO Science Archive Facility under request number (toba, #136654) regarding the VIKING data. This paper makes use of software developed for the Large Synoptic Survey Telescope. We thank the LSST Project for making their code available as free software at < http://dm.lsstcorp.org >. The Pan-STARRS1 Surveys (PS1) have been made possible through contributions of the Institute for Astronomy, the University of Hawaii, the Pan-STARRS Project Office, the Max-Planck Society and its participating institutes, the Max Planck Institute for Astronomy, Heidelberg and the Max Planck Institute for Extraterrestrial Physics, Garching, The Johns Hopkins University, Durham University, the University of Edinburgh, Queen's University Belfast, the Harvard-Smithsonian Center for Astrophysics, the Las Cumbres Observatory Global Telescope Network Incorporated, the National Central University of Taiwan, the Space Telescope Science Institute, the National Aeronautics and Space Administration under Grant No. NNX08AR22G issued through the Planetary Science Division of the NASA Science Mission Directorate, the National Science Foundation under Grant No. AST-1238877, the University of Maryland, and Eotvos Lorand University (ELTE). T.N. acknowledges financial support from the Japan Society for the Promotion of Science (grant no. 25707010) and from the Yamada Science Foundation. This work was supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan.	Alexander DM, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/44; Alexander DM, 2005, ASTROPHYS J, V632, P736, DOI 10.1086/444342; Andrews S. K., 2014, PASA, V31, P4; Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P356, DOI 10.1086/524362; Ueda Y, 2003, ASTROPHYS J, V598, P886, DOI 10.1086/378940; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Driver Simon P, 2009, Astronomy & Geophysics, V50, DOI 10.1111/j.1468-4004.2009.50512.x; Mateos S, 2013, MON NOT R ASTRON SOC, V434, P941, DOI 10.1093/mnras/stt953; Abazajian K, 2004, ASTRON J, V128, P502, DOI 10.1086/421365; Axelrod T, 2010, PROC SPIE, V7740, DOI 10.1117/12.857297; Stern D, 2005, ASTROPHYS J, V631, P163, DOI 10.1086/432523; Imanishi M, 2010, ASTROPHYS J, V721, P1233, DOI 10.1088/0004-637X/721/2/1233; Driver SP, 2011, MON NOT R ASTRON SOC, V413, P971, DOI 10.1111/j.1365-2966.2010.18188.x; Bouwens RJ, 2011, NATURE, V469, P504, DOI 10.1038/nature09717; Yuan TT, 2010, ASTROPHYS J, V709, P884, DOI 10.1088/0004-637X/709/2/884; Courteau S, 2014, REV MOD PHYS, V86, P47, DOI 10.1103/RevModPhys.86.47; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Donley JL, 2010, ASTROPHYS J, V719, P1393, DOI 10.1088/0004-637X/719/2/1393; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Marconi A, 2003, ASTROPHYS J, V589, pL21, DOI 10.1086/375804; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Lanzuisi G, 2009, ASTRON ASTROPHYS, V498, P67, DOI 10.1051/0004-6361/200811282; Caputi KI, 2007, ASTROPHYS J, V660, P97, DOI 10.1086/512667; Page MJ, 2004, ASTROPHYS J, V611, pL85, DOI 10.1086/423892; Treister E, 2009, ASTROPHYS J, V706, P535, DOI 10.1088/0004-637X/706/1/535; Fiore F, 2008, ASTROPHYS J, V672, P94, DOI 10.1086/523348; Dey A, 2008, ASTROPHYS J, V677, P943, DOI 10.1086/529516; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Mateos S, 2012, MON NOT R ASTRON SOC, V426, P3271, DOI 10.1111/j.1365-2966.2012.21843.x; Richards GT, 2006, ASTRON J, V131, P2766, DOI 10.1086/503559; Arnaboldi M, 2007, MESSENGER, V127, P28; Assef RJ, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/56; Assef RJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/26; Bardelli S, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200912809; Beichman C. A., 1988, INFRARED ASTRONOMI S, V1; Bussmann RS, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/150; Calanog JA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/61; Dalton G. B., 2006, SPIE, V6269; Desai V, 2009, ASTROPHYS J, V700, P1190, DOI 10.1088/0004-637X/700/2/1190; GEHRELS N, 1986, ASTROPHYS J, V303, P336, DOI 10.1086/164079; Goto T, 2011, MON NOT R ASTRON SOC, V410, P573, DOI 10.1111/j.1365-2966.2010.17466.x; Holland WS, 2013, MON NOT R ASTRON SOC, V430, P2513, DOI 10.1093/mnras/sts612; Ichikawa K, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/139; Ishihara D, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913811; Ivezic Z., 2008, ARXIV08052366; Lacy M, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/102; Lacy M, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/24; Le Floc'h E, 2005, ASTROPHYS J, V632, P169, DOI 10.1086/432789; Magnier EA, 2013, ASTROPHYS J SUPPL S, V205, DOI 10.1088/0067-0049/205/2/20; MARSHALL HL, 1987, ASTRON J, V94, P628, DOI 10.1086/114496; Melbourne J, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/5/125; Miyazaki S., 2012, SPIE C P, V8446; Murakami H., 2007, PASJ, V59, P369; Murphy EJ, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/126; Narayanan D, 2010, MON NOT R ASTRON SOC, V407, P1701, DOI 10.1111/j.1365-2966.2010.16997.x; Neugebauer G., 1984, AP J, V278, pL1; Paris I, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322691; Park SQ, 2008, ASTROPHYS J, V678, P744, DOI 10.1086/587136; Penner K, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/28; Pope A, 2008, ASTROPHYS J, V689, P127, DOI 10.1086/592739; Riguccini L, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201116950; Schechter P., 1976, APJ, V203, P29; Schlafly EF, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/158; Schmidt M., 1969, APJ, V151, P393; Smolcic V, 2009, ASTROPHYS J, V696, P24, DOI 10.1088/0004-637X/696/1/24; Stern D, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/30; Taylor MB, 2005, ASTR SOC P, V347, P29; Toba Y, 2013, PUBL ASTRON SOC JPN, V65; Toba Y, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/45; Tonry JL, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/99; Ueda Y, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/104; Wu JW, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/96; Yan L, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/3/55	75	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							86	10.1093/pasj/psv057		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000008		
J	Tonegawa, M; Totani, T; Okada, H; Akiyama, M; Dalton, G; Glazebrook, K; Iwamuro, F; Maihara, T; Ohta, K; Shimizu, I; Takato, N; Tamura, N; Yabe, K; Bunker, AJ; Coupon, J; Ferreira, PG; Frenk, CS; Goto, T; Hikage, C; Ishikawa, T; Matsubara, T; More, S; Okumura, T; Percival, WJ; Spitler, LR; Szapudi, I				Tonegawa, Motonari; Totani, Tomonori; Okada, Hiroyuki; Akiyama, Masayuki; Dalton, Gavin; Glazebrook, Karl; Iwamuro, Fumihide; Maihara, Toshinori; Ohta, Kouji; Shimizu, Ikkoh; Takato, Naruhisa; Tamura, Naoyuki; Yabe, Kiyoto; Bunker, Andrew J.; Coupon, Jean; Ferreira, Pedro G.; Frenk, Carlos S.; Goto, Tomotsugu; Hikage, Chiaki; Ishikawa, Takashi; Matsubara, Takahiko; More, Surhud; Okumura, Teppei; Percival, Will J.; Spitler, Lee R.; Szapudi, Istvan			The Subaru FMOS galaxy redshift survey (FastSound). I. Overview of the survey targeting H alpha emitters at z similar to 1.4	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						cosmology: observations; large-scale structure of universe; galaxies: distances and redshifts; surveys; techniques: spectroscopic	STAR-FORMING GALAXIES; VLT DEEP SURVEY; DARK ENERGY; PHOTOMETRIC REDSHIFTS; COSMIC ACCELERATION; LEGACY SURVEY; GROWTH-RATE; SPACE; DISTORTIONS; TELESCOPE	FastSound is a galaxy redshift survey that uses the near-infrared Fiber Multi-Object Spectrograph (FMOS) mounted on the Subaru Telescope, targeting H alpha emitters at z similar to 1.18-1.54 down to the sensitivity limit of H alpha flux similar to 2 x 10(-16) erg cm(-2) s(-1). The primary goal of the survey is to detect redshift space distortion (RSD), to test the general theory of relativity by measuring the growth rate of large-scale structure and to constrain modified gravity models for the origin of the accelerated expansion of the universe. The target galaxies were selected based on photometric redshifts and H alpha flux estimates calculated by fitting spectral energy distribution (SED) models to the five optical magnitudes of the Canada-France-Hawaii Telescope Legacy Survey (CFHTLS) Wide catalog. The survey started in 2012 March, and all the observations were completed in 2014 July. In total, we achieved 121 pointings of FMOS (each pointing has a 30' diameter circular footprint) covering 20.6 deg(2) by tiling the four fields of the CFHTLS Wide in a hexagonal pattern. Emission lines were detected from similar to 4000 star-forming galaxies by an automatic line detection algorithm applied to 2D spectral images. This is the first in a series of papers based on FastSound data, and we describe the details of the survey design, target selection, observations, data reduction, and emission line detections.	[Tonegawa, Motonari; Totani, Tomonori; Okada, Hiroyuki; Shimizu, Ikkoh] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Totani, Tomonori] Univ Tokyo, Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; [Akiyama, Masayuki] Tohoku Univ, Fac Sci, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Dalton, Gavin; Bunker, Andrew J.; Ferreira, Pedro G.] Univ Oxford, Dept Phys, Astrophys, Oxford OX1 3RH, England; [Dalton, Gavin] HSIC, STFC Rutherford Appleton Lab, RALSpace, Didcot OX11 0QX, Oxon, England; [Glazebrook, Karl] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Iwamuro, Fumihide; Maihara, Toshinori; Ohta, Kouji; Ishikawa, Takashi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Takato, Naruhisa] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Tamura, Naoyuki; Bunker, Andrew J.; More, Surhud; Okumura, Teppei] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Yabe, Kiyoto] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Coupon, Jean] Univ Geneva, Astron Observ, CH-1290 Versoix, Switzerland; [Frenk, Carlos S.] Univ Durham, Dept Phys, Inst Computat Cosmol, Durham DH1 3LE, England; [Goto, Tomotsugu] Natl Tsing Hua Univ, Inst Astron, Hsinchu 30013, Taiwan; [Hikage, Chiaki; Matsubara, Takahiko] Nagoya Univ, Kobayashi Maskawa Inst Origin Particles & Univers, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Percival, Will J.] Univ Portsmouth, Inst Cosmol & Gravitat, Portsmouth PO1 3FX, Hants, England; [Spitler, Lee R.] Australian Astron Observ, N Ryde, NSW 1670, Australia; [Spitler, Lee R.] Macquarie Univ, Dept Phys & Astron, Sydney, NSW 2109, Australia; [Szapudi, Istvan] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA	Tonegawa, M (reprint author), Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tonegawa@astron.s.u-tokyo.ac.jp			MEXT/JSPS KAKENHI [19740099, 19035005, 20040005, 22012005, 23684007, 15J11301]; Australian Research Council [LX0989763]; World Premier International Research Center Initiative (WPI Initiative), MEXT; FIRST program "Subaru Measurements of Images and Redshifts (SuMIRe)," CSTP	We are grateful to C. Blake for useful discussions. The FastSound project was supported in part by MEXT/JSPS KAKENHI Grant Numbers 19740099, 19035005, 20040005, 22012005, 23684007, and 15J11301. KG acknowledges support from Australian Research Council Linkage International Fellowship grant LX0989763. AB gratefully acknowledges the hospitality of the Research School of Astronomy and Astrophysics at the Australian National University, Mount Stromlo, Canberra where some of this work was done under the Distinguished Visitor scheme. SM and TO were supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, by the FIRST program "Subaru Measurements of Images and Redshifts (SuMIRe)," CSTP.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Hawkins E, 2003, MON NOT R ASTRON SOC, V346, P78, DOI 10.1046/j.1365-2966.2003.07063.x; Beutler F, 2014, MON NOT R ASTRON SOC, V443, P1065, DOI 10.1093/mnras/stu1051; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Guzzo L, 2008, NATURE, V451, P541, DOI 10.1038/nature06555; KAISER N, 1987, MON NOT R ASTRON SOC, V227, P1; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Beutler F, 2012, MON NOT R ASTRON SOC, V423, P3430, DOI 10.1111/j.1365-2966.2012.21136.x; Reid BA, 2012, MON NOT R ASTRON SOC, V426, P2719, DOI 10.1111/j.1365-2966.2012.21779.x; Geach JE, 2008, MON NOT R ASTRON SOC, V388, P1473, DOI 10.1111/J.1365-2966.2008.13481.X; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Blake C, 2011, MON NOT R ASTRON SOC, V415, P2876, DOI 10.1111/j.1365-2966.2011.18903.x; Arnouts S, 1999, MON NOT R ASTRON SOC, V310, P540, DOI 10.1046/j.1365-8711.1999.02978.x; Peebles PJE, 2003, REV MOD PHYS, V75, P559, DOI 10.1103/RevModPhys.75.559; Bielby R, 2013, MON NOT R ASTRON SOC, V430, P425, DOI 10.1093/mnras/sts639; Weinberg DH, 2013, PHYS REP, V530, P87, DOI 10.1016/j.physrep.2013.05.001; Samushia L, 2012, MON NOT R ASTRON SOC, V420, P2102, DOI 10.1111/j.1365-2966.2011.20169.x; Ilbert O, 2006, ASTRON ASTROPHYS, V457, P841, DOI 10.1051/0004-6361:20065138; Frieman JA, 2008, ANNU REV ASTRON ASTR, V46, P385, DOI 10.1146/annurev.astro.46.060407.145243; Fernandes RC, 2005, MON NOT R ASTRON SOC, V358, P363, DOI 10.1111/j.1365-2966.2005.08752.x; Cooper MC, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/1/14; Coupon J, 2009, ASTRON ASTROPHYS, V500, P981, DOI 10.1051/0004-6361/200811413; de la Torre S, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321463; Fioc M., 1999, ARXIVASTROPH9912179; Furusawa H, 2008, ASTROPHYS J SUPPL S, V176, P1, DOI 10.1086/527321; Garilli B, 2008, ASTRON ASTROPHYS, V486, P683, DOI 10.1051/0004-6361:20078878; Guzzo L, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201321489; Gwyn SDJ, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/2/38; Iwamuro F, 2012, PUBL ASTRON SOC JPN, V64; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kimura M, 2010, PUBL ASTRON SOC JPN, V62, P1135; Le Fevre O., 2005, ASTRON ASTROPHYS, V439, P845; Linder EV, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.043529; Okada H., 2015, PASJ UNPUB; Scalo J. M., 1986, Fundamentals of Cosmic Physics, V11; Sobral D, 2009, MON NOT R ASTRON SOC, V398, P75, DOI 10.1111/j.1365-2966.2009.15129.x; Song YS, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/10/004; Sumiyoshi M., 2009, ARXIV09022064; Tonegawa M, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu022; Tonegawa M., 2014, PASJ, V67, P31; Yabe K., 2015, PASJ UNPUB	42	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							81	10.1093/pasj/psv044		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000003		
J	Tsuboi, M; Miyazaki, A; Uehara, K				Tsuboi, Masato; Miyazaki, Atsushi; Uehara, Kenta			The Central Molecular Zone in (HCO+)-C-13 and thermal SiO emission lines	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						Galaxy: center; ISM: bubbles; ISM: clouds; ISM: molecules; stars: formation	GALACTIC-CENTER REGION; MASSIVE STAR-FORMATION; CLOUD-CLOUD COLLISION; SAGITTARIUS B2; EXPANDING SHELL; STATISTICAL PROPERTIES; INTERSTELLAR-MEDIUM; MAGNETIC-FIELD; STELLAR ORBITS; BLACK-HOLE	We present results from a high-resolution wide-field imaging observation of the Central Molecular Zone (CMZ) in (HCO)-C-13+ J = 1-0 and SiO v = 0, J = 2-1 emission lines using the 45-m telescope at the Nobeyama Radio Observatory in order to depict the high-density molecular gas mass distribution and explore molecular gas affected by interstellar shocks. By using the clumpfind algorithm we identify 114 molecular clumps in the H13CO+ data cube. The clump mass function (CMF) can be described by a power law (dN/dM proportional to M-gamma, with gamma similar or equal to 2) in the range of 5 x 10(3) < M-clump < 2 x 10(4)M(circle dot). The brightness temperature ratio R-T = T(SiO)/T((HCO+)-C-13) indicates the strength of the shock. The Sgr B2 complex has several expanding shell-like structures with a large velocitywidth (Delta V > 50 km s(-1)). They correspond to the high brightness temperature ratio area (RT less than or similar to 8). A Large Velocity Gradient model analysis with the RADEX program confirms the enhancement of SiO molecules in the shells. On the other hand, there is no such large shell with a high ratio in the SgrA complex. A hollow hemispherical structure is found in the l-b-v data cube of the Sgr B2 complex. The central part of the structure has a high ratio (R-T less than or similar to 8). The ratio decreases with proximity to the outer area. The properties are consistent with those expected from simulations of cloud-cloud collisions. The structure is probably a site of ongoing cloud-cloud collision.	[Tsuboi, Masato] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Tsuboi, Masato; Uehara, Kenta] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Miyazaki, Atsushi] Hosei Univ, Dept Appl Informat, Koganei, Tokyo 1848584, Japan	Tsuboi, M (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	tsuboi@vsop.isas.jaxa.jp					Amo-Baladron MA, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/200913545; HABE A, 1992, PUBL ASTRON SOC JPN, V44, P203; BALLY J, 1987, ASTROPHYS J SUPPL S, V65, P13, DOI 10.1086/191217; Krumholz MR, 2009, SCIENCE, V323, P754, DOI 10.1126/science.1165857; Handa T, 2006, ASTROPHYS J, V636, P261, DOI 10.1086/497881; Figer DF, 1999, ASTROPHYS J, V514, P202, DOI 10.1086/306931; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Pineda JE, 2009, ASTROPHYS J LETT, V699, pL134, DOI 10.1088/0004-637X/699/2/L134; TSUBOI M, 1986, ASTRON J, V92, P818, DOI 10.1086/114215; HASEGAWA T, 1994, ASTROPHYS J, V429, pL77, DOI 10.1086/187417; Dib S, 2008, ASTROPHYS J LETT, V678, pL105, DOI 10.1086/588608; LINKE RA, 1980, ASTROPHYS J, V235, P437, DOI 10.1086/157647; Oka T, 1998, ASTROPHYS J SUPPL S, V118, P455, DOI 10.1086/313138; Sato F, 2000, ASTROPHYS J, V535, P857, DOI 10.1086/308856; WILLIAMS JP, 1994, ASTROPHYS J, V428, P693, DOI 10.1086/174279; PHILLIPS TG, 1979, ASTROPHYS J, V231, P720, DOI 10.1086/157237; Jones PA, 2008, MON NOT R ASTRON SOC, V386, P117, DOI 10.1111/j.1365-2966.2008.13009.X; HANDA T, 1987, PUBL ASTRON SOC JPN, V39, P709; Tsuboi M, 2009, PUBL ASTRON SOC JPN, V61, P29; Gillessen S, 2009, ASTROPHYS J, V692, P1075, DOI 10.1088/0004-637X/692/2/1075; YUSEFZADEH F, 1987, ASTRON J, V94, P1178, DOI 10.1086/114555; HAYNES RF, 1992, ASTRON ASTROPHYS, V264, P500; Tsuboi M, 2011, PUBL ASTRON SOC JPN, V63, P763; Jones PA, 2012, MON NOT R ASTRON SOC, V419, P2961, DOI 10.1111/j.1365-2966.2011.19941.x; Tsuboi M, 1999, ASTROPHYS J SUPPL S, V120, P1, DOI 10.1086/313165; Sunada K, 2000, P SOC PHOTO-OPT INS, V4015, P237, DOI 10.1117/12.390416; Onishi T, 1996, ASTROPHYS J, V465, P815, DOI 10.1086/177465; Smith RJ, 2009, MON NOT R ASTRON SOC, V396, P830, DOI 10.1111/j.1365-2966.2009.14794.x; Oka T, 2008, PUBL ASTRON SOC JPN, V60, P429; Hasegawa T, 2008, ASTROPHYS SPACE SCI, V313, P91, DOI 10.1007/s10509-007-9523-7; Plambeck RL, 2009, ASTROPHYS J LETT, V704, pL25, DOI 10.1088/0004-637X/704/1/L25; Kruijssen JMD, 2013, MON NOT R ASTRON SOC, V435, P2598, DOI 10.1093/mnras/stt1634; LaRosa TN, 2000, ASTRON J, V119, P207, DOI 10.1086/301168; Tsuboi M, 1997, ASTROPHYS J, V481, P263, DOI 10.1086/304053; Usero A, 2004, ASTRON ASTROPHYS, V419, P897, DOI 10.1051/0004-6361:20035774; Stolovy S, 2006, J PHYS CONF SER, V54, P176, DOI [10.1088/1742-6596/54/1/030, 10.1088/1/1742-6596/54/1/030]; Martin CL, 2004, ASTROPHYS J SUPPL S, V150, P239, DOI 10.1086/379661; MARTINPINTADO J, 1992, ASTRON ASTROPHYS, V254, P315; Bergin EA, 1998, ASTROPHYS J, V499, P777, DOI 10.1086/305656; van der Tak FFS, 2007, ASTRON ASTROPHYS, V468, P627, DOI 10.1051/0004-6361:20066820; Kruijssen JMD, 2014, MON NOT R ASTRON SOC, V440, P3370, DOI 10.1093/mnras/stu494; Crutcher RM, 1996, ASTROPHYS J, V462, pL79, DOI 10.1086/310031; Morris M, 1996, ANNU REV ASTRON ASTR, V34, P645, DOI 10.1146/annurev.astro.34.1.645; Yusef-Zadeh F, 2004, ASTROPHYS J SUPPL S, V155, P421, DOI 10.1086/425257; TSUBOI M, 1991, PUBL ASTRON SOC JPN, V43, pL27; Miyazaki A, 2000, ASTROPHYS J, V536, P357, DOI 10.1086/308899; Kruijssen JMD, 2015, MON NOT R ASTRON SOC, V447, P1059, DOI 10.1093/mnras/stu2526; Figer DF, 2002, ASTROPHYS J, V581, P258, DOI 10.1086/344154; Jimenez-Serra I, 2008, ASTRON ASTROPHYS, V482, P549, DOI 10.1051/0004-6361:20078054; Sawada T, 2008, PUBL ASTRON SOC JPN, V60, P445; Ikeda N, 2007, ASTROPHYS J, V665, P1194, DOI 10.1086/519484; AKABANE K, 1988, PUBL ASTRON SOC JPN, V40, P459; Kramer C, 1998, ASTRON ASTROPHYS, V329, P249; Jones PA, 2013, MON NOT R ASTRON SOC, V433, P221, DOI 10.1093/mnras/stt717; Shetty R, 2012, MON NOT R ASTRON SOC, V425, P720, DOI 10.1111/j.1365-2966.2012.21588.x; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; EKERS RD, 1983, ASTRON ASTROPHYS, V122, P143; Zinnecker H, 2007, ANNU REV ASTRON ASTR, V45, P481, DOI 10.1146/annurev.astro.44.051905.092549; Shiki S, 1997, ASTROPHYS J, V478, P206, DOI 10.1086/303796; Ao Y., 2013, ASTRON ASTROPHYS, V550, P135; Bally J, 2010, ASTROPHYS J, V721, P137, DOI 10.1088/0004-637X/721/1/137; Garcia-Burillo S, 2000, ASTRON ASTROPHYS, V355, P499; GOLDREIC.P, 1974, ASTROPHYS J, V189, P441, DOI 10.1086/152821; Goss W. M., 1985, MON NOT R ASTRON SOC, V215, P69; GUSTEN R, 1980, ASTRON ASTROPHYS, V87, P6; Inoue T, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/35; Inoue T, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L31; Koyama K, 2007, PUBL ASTRON SOC JPN, V59, pS221; LARSON RB, 1981, MON NOT R ASTRON SOC, V194, P809; Liu HB, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/44; Longmore S. N., 2014, PROTOSTARS PLANETS, P291; Martin-Pintado J., 1997, APJ, P482; Mills EAC, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/105; Molinari S, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L33; MORRIS M, 1993, ASTROPHYS J, V408, P496, DOI 10.1086/172607; Namekata D, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/57; Pierce-Price D, 2000, ASTROPHYS J, V545, pL121, DOI 10.1086/317884; Riquelme D, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/200913359; Sakamoto K, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/19; Sanders R. H., 1972, AJ, V77, P392; Sodroski T. J., 1995, APJ, V452, pL262; SOFUE Y, 1995, PUBL ASTRON SOC JPN, V47, P527; Stark A. A., 1991, MNRAS, V248; TATEMATSU K, 1993, ASTROPHYS J, V404, P643, DOI 10.1086/172318; Tatematsu K, 1998, ASTROPHYS J SUPPL S, V118, P517, DOI 10.1086/313143; Tsuboi M, 2012, PUBL ASTRON SOC JPN, V64; TSUBOI M, 1989, IAU SYMP, P135; Usero A., 2008, NEW ASTRON REV, V51, P75; Wilson T. L., 2013, TOOLS RADIO ASTRONOM, P507; Yusef-Zadeh F, 2013, ASTROPHYS J LETT, V764, DOI 10.1088/2041-8205/764/2/L19; ZIURYS LM, 1989, ASTROPHYS J, V341, P857, DOI 10.1086/167544	91	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	OCT	2015	67	5							90	10.1093/pasj/psv058		31	Astronomy & Astrophysics	Astronomy & Astrophysics	CT5FL	WOS:000362834000012		
J	Alam, AKMB; Fujii, Y; Fukuda, D; Kodama, J; Kaneko, K				Alam, A. K. M. Badrul; Fujii, Yoshiaki; Fukuda, Daisuke; Kodama, Jun-ichi; Kaneko, Katsuhiko			Fractured Rock Permeability as a Function of Temperature and Confining Pressure	PURE AND APPLIED GEOPHYSICS			English	Article						Temperature-confining pressure coupling; permeability; sealability; pore collapse; plastic deformation; viscous deformation	DAMAGED ZONE; EXCAVATION; PERFORMANCE; REPOSITORY; GRANITE; JAPAN; MINE	Triaxial compression tests were carried out on Shikotsu welded tuff, Kimachi sandstone, and Inada granite under confining pressures of 1-15 MPa at 295 and 353 K. The permeability of the tuff declined monotonically with axial compression. The post-compression permeability became smaller than that before axial compression. The permeability of Kimachi sandstone and Inada granite declined at first, then began to increase before the peak load, and showed values that were almost constant in the residual strength state. The post-compression permeability of Kimachi sandstone was higher than that before axial compression under low confining pressures, but lower under higher confining pressures. On the other hand, the permeability of Inada granite was higher than that before axial compression regardless of the confining pressure values. For the all rock types, the post-compression permeability at 353 K was lower than at 295 K and the influence of the confining pressure was less at 353 K than at 295 K. The above temperature effects were observed apparently for Inada granite, only the latter effect was apparent for Shikotsu welded tuff, and they were not so obvious for Kimachi sandstone. The mechanisms causing the variation in rock permeability and sealability of underground openings were discussed.	[Alam, A. K. M. Badrul; Kaneko, Katsuhiko] H RISE, Northern Adv Ctr Sci & Technol, Sapporo, Hokkaido 0983221, Japan; [Fujii, Yoshiaki; Fukuda, Daisuke; Kodama, Jun-ichi] Hokkaido Univ, Grad Sch Engn, Rock Mech Lab, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Alam, AKMB (reprint author), H RISE, Northern Adv Ctr Sci & Technol, 5-3 Sakaemachi,Horonobe Cho, Sapporo, Hokkaido 0983221, Japan.	rock.hrise.badrul14@gmail.com	Fujii, Yoshiaki/A-5701-2012; FUKUDA, Daisuke/C-5422-2013	Fujii, Yoshiaki/0000-0003-0431-4093; 	KAKENHI [22560804]	This research work was partially supported by KAKENHI (22560804).	Alam AKMB, 2014, INT J ROCK MECH MIN, V65, P49, DOI 10.1016/j.ijrmms.2013.11.006; Fujii Y, 2011, INT J ROCK MECH MIN, V48, P585, DOI 10.1016/j.ijrmms.2011.04.012; Neuzil CE, 2003, HYDROGEOL J, V11, P41, DOI 10.1007/s10040-002-0230-8; Fujii Y, 1998, PURE APPL GEOPHYS, V152, P551; Tsang CF, 2005, INT J ROCK MECH MIN, V42, P109, DOI 10.1016/j.ijrmms.2004.08.003; BRACE WF, 1968, J GEOPHYS RES, V73, P2225, DOI 10.1029/JB073i006p02225; Dhakal G, 2002, ENG GEOL, V65, P31, DOI 10.1016/S0013-7952(01)00101-6; DAROT M, 1992, GEOPHYS RES LETT, V19, P869, DOI 10.1029/92GL00579; Backblom G, 1999, TUNN UNDERGR SP TECH, V14, P377, DOI 10.1016/S0886-7798(99)00053-X; Sato T, 2000, ENG GEOL, V56, P97, DOI 10.1016/S0013-7952(99)00136-2; Rutqvist J, 2005, INT J ROCK MECH MIN, V42, P680, DOI 10.1016/j.ijrmms.2005.03.008; Rutqvist J, 2014, ROCK MECH ROCK ENG, V47, P167, DOI 10.1007/s00603-013-0375-x; Hudson JA, 2005, INT J ROCK MECH MIN, V42, P850, DOI 10.1016/j.ijrmms.2005.03.018; ZAMAN M, 1994, J ENERG RESOUR-ASME, V116, P97, DOI 10.1115/1.2906024; Kwon S, 2008, ENG GEOL, V101, P110, DOI 10.1016/j.enggeo.2008.04.004; Doi S., 1963, PETROLOGICAL PETROCH, V29, P30; FREIMAN SW, 1984, J GEOPHYS RES, V89, P4072, DOI 10.1029/JB089iB06p04072; Heinonen J., 2001, USE SCI TECHNICAL RE, V67; [LIN Weiren 林为人], 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P2463	19	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	OCT	2015	172	10					2871	2889		10.1007/s00024-015-1073-2		19	Geochemistry & Geophysics	Geochemistry & Geophysics	CT3AW	WOS:000362679200025		
J	Shirai, M; Nomura, R; Kato, Y; Murakami, M; Kondo, C; Takahashi, S; Yamasaki, Y; Matsumoto-Nakano, M; Arai, N; Yasuda, H; Nakano, K; Asai, F				Shirai, Mitsuyuki; Nomura, Ryota; Kato, Yukio; Murakami, Masaru; Kondo, Chihiro; Takahashi, Soraaki; Yamasaki, Yoshie; Matsumoto-Nakano, Michiyo; Arai, Nobuaki; Yasuda, Hidemi; Nakano, Kazuhiko; Asai, Fumitoshi			Short communication: Distribution of Porphyromonas gulae fimA genotypes in oral specimens from dogs with mitral regurgitation	RESEARCH IN VETERINARY SCIENCE			English	Article						fimbriae; mitral regurgitation; periodontal disease; Porphyromonas gulae	PERIODONTAL-DISEASE; CARDIOVASCULAR SPECIMENS; VALVE DISEASE; GINGIVALIS; SEVERITY	Porphyromonas gulae, a suspected pathogen for periodontal disease in dogs, possesses approximately 41-kDa fimbriae (FimA) that are encoded by the fimA gene. In the present study, the association of fimA genotypes with mitral regurgitation (MR) was investigated. Twenty-five dogs diagnosed with MR (age range 6-13 years old, average 10.8 years) and 32 healthy dogs (8-15 years old, average 10.8 years) were selected at the participating clinics in a consecutive manner during the same time period. Oral swab specimens were collected from the dogs and bacterial DNA was extracted, then polymerase chain reaction analysis was performed using primers specific for each fimA genotype, with the dominant genotype determined. The rate for genotype C dominant specimens was 48.0% in the MR group, which was significantly higher than that in the control group (18.8%) (P <0.05). These results suggest that P. gulae fimA genotype C is associated with MR. (C) 2015 Elsevier Ltd. All rights reserved.	[Shirai, Mitsuyuki; Kondo, Chihiro; Takahashi, Soraaki; Asai, Fumitoshi] Azabu Univ, Sch Vet Med, Dept Pharmacol, Sagamihara, Kanagawa 2525201, Japan; [Nomura, Ryota; Nakano, Kazuhiko] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Suita, Osaka 5650871, Japan; [Kato, Yukio] Azabu Univ, Sch Vet Med, Dept Vet Publ Hlth 2, Sagamihara, Kanagawa 2525201, Japan; [Murakami, Masaru] Azabu Univ, Sch Vet Med, Dept Mol Biol, Sagamihara, Kanagawa 2525201, Japan; [Yamasaki, Yoshie; Matsumoto-Nakano, Michiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat Dent, Okayama 7008556, Japan; [Arai, Nobuaki; Yasuda, Hidemi] Yasuda Vet Clin, Meguro Ku, Tokyo 1520034, Japan	Nomura, R (reprint author), Osaka Univ, Grad Sch Dent, Dept Pediat Dent, 1-8 Yamada Oka, Suita, Osaka 5650871, Japan.	shirai@azabu-u.ac.jp; rnomura@dentosaka-u.ac.jp; katohy@azabu-u.ac.jp; murakami@azabu-u.ac.jp; v090580@azabu-u.ac.jp; v09083@azabu-u.ac.jp; yoca777@live.jp; mnakano@cc.okayama-u.ac.jp; narai@slj.co.jp; hidemi@yasuda-vet.org; nakano@dent.osaka-u.ac.jp; asai@azabu-u.ac.jp			Japan Society for Promotion of Science [23658256, 25670873]; Promotion and Mutual Aid Corporation of Private Schools of Japan	This study was supported by Grants-in-Aid for Scientific Research for Challenging Exploratory Research (No. 23658256 and 25670873) from the Japan Society for Promotion of Science, the Promotion and Mutual Aid Corporation of Private Schools of Japan, and a Grant-in-Aid for Matching Fund Subsidy for Private Universities. We also thank Prof. Howard K. Kuramitsu (State University of New York at Buffalo) for editing the manuscript.	Glickman LT, 2009, JAVMA-J AM VET MED A, V234, P486, DOI 10.2460/javma.234.4.486; Rawlinson JE, 2011, JAVMA-J AM VET MED A, V238, P601, DOI 10.2460/javma.238.5.601; Hamada N, 2008, VET MICROBIOL, V128, P108, DOI 10.1016/j.vetmic.2007.09.014; Nomura R, 2012, J VET MED SCI, V74, P885, DOI 10.1292/jvms.11-0564; Freeman AR, 1933, ANN INTERN MED, V6, P1371; Pavlica Z, 2008, J VET DENT, V25, P97; Ljungvall I, 2009, AM J VET RES, V70, P604, DOI 10.2460/ajvr.70.5.604; Yamasaki Y, 2012, VET MICROBIOL, V161, P196, DOI 10.1016/j.vetmic.2012.07.026; Kato Y, 2011, J VET DENT, V28, P84; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; Nakano K, 2009, ORAL MICROBIOL IMMUN, V24, P64, DOI 10.1111/j.1399-302X.2008.00479.x; Borgarelli M, 2008, J VET INTERN MED, V22, P120, DOI 10.1111/j.1939-1676.2007.0008.x; Atkins C, 2009, J VET INTERN MED, V23, P1142, DOI 10.1111/j.1939-1676.2009.0392.x; Nakano K, 2008, ORAL MICROBIOL IMMUN, V23, P170, DOI 10.1111/j.1399-302X.2007.00406.x; Harvey C.E., 1993, SMALL ANIMAL DENT, P413; Kate E.I., 1999, WALTHAM FOCUS, V9, P32; Serfass Pierre, 2006, J Vet Cardiol, V8, P11, DOI 10.1016/j.jvc.2005.10.001; Warrick J, 1997, P 11 ANN VET DENT FO, P134; Wolf H.F., 2005, COLOR ATLAS DENT MED	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	OCT	2015	102						49	52		10.1016/j.rvsc.2015.07.009		4	Veterinary Sciences	Veterinary Sciences	CT6JN	WOS:000362919400010		
J	Pinpimai, K; Rodkhum, C; Chansue, N; Katagiri, T; Maita, M; Pirarat, N				Pinpimai, Komkiew; Rodkhum, Channarong; Chansue, Nantarika; Katagiri, Takayuki; Maita, Masashi; Pirarat, Nopadon			The study on the candidate probiotic properties of encapsulated yeast, Saccharomyces cerevisiae JCM 7255, in Nile Tilapia (Oreochromis niloticus)	RESEARCH IN VETERINARY SCIENCE			English	Article						Saccharomyces cerevisiae; Encapsulation; Probiotic; Alginate; Nile Tilapia	X MORONE-SAXATILIS; LIVE BAKERS-YEAST; GROWTH-PERFORMANCE; BACILLUS-SUBTILIS; STREPTOCOCCUS-AGALACTIAE; LACTOBACILLUS-RHAMNOSUS; INTESTINAL MORPHOLOGY; BREWERS-YEAST; RAINBOW-TROUT; FISH	Saccharomyces cerevisiae JCM 7255 was tested as a probiotic candidate in tilapia after encapsulating and freeze drying. Viability and morphology during storage and during transit through simulated gut and bile conditions were determined. Growth performance, anti-streptococcal activity and gut mucosal immune parameters were also tested. The viability of encapsulated yeasts was significantly high in simulated gastric and bile conditions and remained high after storage at room temperature for 14 days. The morphology of free S. cerevisiae revealed rough, bumpy, ruptured surface during incubation in gut and bile conditions. Agar spot anti-streptococcal activity showed inhibition of 20 out of 30 strains of Streptococcus agalactiae. Supplementation improved the intestinal structure and growth performance in tilapias. Intraepithelial lymphocytes in the proximal intestine were significantly observed. Lower cumulative mortality after the oral streptococcal challenge was also seen. The results suggest that encapsulated S. cerevisiae JCM 2755 could be a potential probiotic strain in tilapia culture. (C) 2015 Elsevier Ltd. All rights reserved.	[Pinpimai, Komkiew; Pirarat, Nopadon] Chulalongkorn Univ, Fac Vet Sci, Dept Pathol, Bangkok, Thailand; [Rodkhum, Channarong] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Microbiol, Bangkok, Thailand; [Chansue, Nantarika] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Med, Bangkok, Thailand; [Katagiri, Takayuki; Maita, Masashi] Tokyo Univ Marine Sci & Technol, Lab Fish Hlth Management, Tokyo, Japan	Pirarat, N (reprint author), Chulalongkorn Univ, Fac Vet Sci, Dept Pathol, Bangkok, Thailand.	nopadonpirarat@gmail.com			90th Anniversary of Chulalongkorn University Fund [51/2554]; Ratchadapiseksompot Fund [R001/2555]; Chulalongkorn University; Thailand Research Fund [MRG5480194]	This work was supported by grants from the 90th Anniversary of Chulalongkorn University Fund (51/2554), Ratchadapiseksompot Fund (R001/2555), Chulalongkorn University and Thailand Research Fund (MRG5480194).	Aubin J, 2005, AQUAC RES, V36, P758, DOI 10.1111/j.1365-2109.2005.01280.x; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Chandramouli V, 2004, J MICROBIOL METH, V56, P27, DOI [10.1016/j.mimet.2003.09.002, 10.1016/j.mimet.2003-09.002]; Samanya M, 2002, COMP BIOCHEM PHYS A, V133, P95, DOI 10.1016/S1095-6433(02)00121-6; Mandal S, 2006, INT DAIRY J, V16, P1190, DOI 10.1016/j.idairyj.2005.10.005; Saegusa S, 2004, FEMS IMMUNOL MED MIC, V41, P227, DOI 10.1016/j.femsim.2004.03.006; Gatesoupe FJ, 2007, AQUACULTURE, V267, P20, DOI 10.1016/j.aquaculture.2007.01.005; Ye X, 2011, FISHERIES SCI, V77, P623, DOI 10.1007/s12562-011-0365-4; Rajkowska K, 2012, FOOD TECHNOL BIOTECH, V50, P230; Blottiere HM, 2003, P NUTR SOC, V62, P101, DOI 10.1079/PNS2002215; Picchietti S, 2007, FISH SHELLFISH IMMUN, V22, P57, DOI 10.1016/j.fsi.2006.03.009; Abdel-Tawwab M, 2008, AQUACULTURE, V280, P185, DOI 10.1016/j.aquaculture.2008.03.055; Li P, 2003, AQUACULTURE, V219, P681, DOI 10.1016/S0044-8486(02)00653-1; Wache Y, 2006, AQUACULTURE, V258, P470, DOI 10.1016/j.aquaculture.2006.04.002; Sultana K, 2000, INT J FOOD MICROBIOL, V62, P47, DOI 10.1016/S0168-1605(00)00380-9; Saegusa S, 2009, BIOSCI BIOTECH BIOCH, V73, P2600, DOI 10.1271/bbb.90410; Mian GF, 2009, VET MICROBIOL, V136, P180, DOI 10.1016/j.vetmic.2008.10.016; De BC, 2014, FISH PHYSIOL BIOCHEM, V40, P921, DOI 10.1007/s10695-013-9897-0; Telli GS, 2014, FISH SHELLFISH IMMUN, V39, P305, DOI 10.1016/j.fsi.2014.05.025; Martinez G, 2001, CAN J VET RES, V65, P68; Lazado CC, 2014, FISH SHELLFISH IMMUN, V39, P78, DOI 10.1016/j.fsi.2014.04.015; Pirarat N, 2011, RES VET SCI, V91, pE92, DOI 10.1016/j.rvsc.2011.02.014; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Pirarat N, 2009, THAI J VET MED, V39, P305; Nayak SK, 2011, MICROBIOL MONOGR, V21, P29, DOI 10.1007/978-3-642-20838-6_2; Moslehi-Jenabian S, 2010, NUTRIENTS, V2, P449, DOI 10.3390/nu2040449; Suanyuk N, 2008, AQUACULTURE, V284, P35, DOI 10.1016/j.aquaculture.2008.07.034; Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Selmer-Olsen E, 1999, J APPL MICROBIOL, V87, P429, DOI 10.1046/j.1365-2672.1999.00839.x; Lara-Flores M, 2003, AQUACULTURE, V216, P193, DOI 10.1016/S0044-8486(02)00277-6; Li P, 2004, AQUACULTURE, V231, P445, DOI 10.1016/j.aqauculture.2003.08.021; Nikoskelainen S, 2001, APPL ENVIRON MICROB, V67, P2430, DOI 10.1128/AEM.67.6.2430-2435.2001; Wang YB, 2008, AQUACULTURE, V281, P1, DOI 10.1016/j.aquaculture.2008.06.002; Chiu CH, 2010, FISH SHELLFISH IMMUN, V29, P1053, DOI 10.1016/j.fsi.2010.08.019; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; Sen S, 2012, RES VET SCI, V93, P264, DOI 10.1016/j.rvsc.2011.05.021; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Abdel-Tawwab M, 2010, J WORLD AQUACULT SOC, V41, P214; Bansode S.S., 2010, INT J PHARM SCI REV, V1; Pelicano E. R. L., 2005, Brazilian Journal of Poultry Science, V7, P221, DOI 10.1590/S1516-635X2005000400005; Simon O, 2001, J ANIM FEED SCI, V10, P51; Smith Peter, 1994, Annual Review of Fish Diseases, V4, P273, DOI 10.1016/0959-8030(94)90032-9; Truelstrup Hansen L., 2002, Food Microbiology, V19, P35, DOI 10.1006/fmic.2001.0452; Wang YB, 2006, ANIM FEED SCI TECH, V127, P283, DOI 10.1016/j.anifeedsci.2005.09.003	44	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	OCT	2015	102						103	111		10.1016/j.rvsc.2015.07.021		9	Veterinary Sciences	Veterinary Sciences	CT6JN	WOS:000362919400019		
J	Hayama, Y; Kimura, Y; Yamamoto, T; Kobayashi, S; Tsutsui, T				Hayama, Yoko; Kimura, Yoshinari; Yamamoto, Takehisa; Kobayashi, Sota; Tsutsui, Toshiyuki			Potential risk associated with animal culling and disposal during the foot-and-mouth disease epidemic in Japan in 2010	RESEARCH IN VETERINARY SCIENCE			English	Article						Foot-and-mouth disease; Culling; Carcass disposal; Transmission risk; Japan	VIRUS; CATTLE; PIGS	The large-scale foot-and-mouth (FMD) outbreak in 2010 in Japan presented logistical challenges in conducting animal culling and disposal. During the epidemic, culling of animals on infected farms was delayed owing to the difficulties in finding suitable burial sites. In this study, a retrospective matched case-control study was conducted to investigate the potential transmission risk associated with carcass disposal by considering the geographical relationship between farms and burial sites. The results showed that burial sites and transportation routes used for carcass disposal were not significant infection sources to the neighboring farms. However, infectious farms within 500 m, particularly, pig infected farms, posed a significant transmission risk to the neighboring farms. Implementation of strict bio-security measures during carcass disposal operation is essential to reduce the risk of disease transmission to neighboring farms. (C) 2015 Elsevier Ltd. All rights reserved.	[Hayama, Yoko; Yamamoto, Takehisa; Kobayashi, Sota; Tsutsui, Toshiyuki] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 3050856, Japan; [Kimura, Yoshinari] Osaka City Univ, Dept Geog, Grad Sch Literature & Human Sci, Sumiyoshi Ku, Osaka 5588585, Japan	Hayama, Y (reprint author), Agr & Food Res Org, Natl Res & Dev Agcy, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	hayama@affrc.go.jp; yoshi@lit.osaka-cu.ac.jp; mtbook@affrc.go.jp; sotaco@affrc.go.jp; tsutsui@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries in Japan [2304]	This study was supported by the "Regulatory Research Projects for Food Safety, Animal Health and Plant Projection (2304)," Ministry of Agriculture, Forestry and Fisheries in Japan. The authors thank the Animal Health Authority in the Miyazaki Prefecture and the Miyazaki Livestock Hygiene Service Center for providing the hardcopy map of the epidemic area, including the affected farms and burial sites.	Muroga N, 2012, J VET MED SCI, V74, P399, DOI 10.1292/jvms.11-0271; Cox SJ, 2005, VACCINE, V23, P1106, DOI 10.1016/j.vaccine.2004.08.034; Hayama Y, 2012, RES VET SCI, V93, P631, DOI 10.1016/j.rvsc.2011.09.001; Kitching RP, 2002, REV SCI TECH OIE, V21, P513; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Nishiura H, 2010, TRANSBOUND EMERG DIS, V57, P396, DOI 10.1111/j.1865-1682.2010.01162.x; Yoon H, 2012, TRANSBOUND EMERG DIS, V59, P517, DOI 10.1111/j.1865-1682.2011.01304.x; Alexandersen S, 2002, EPIDEMIOL INFECT, V128, P313, DOI 10.1017/S0950268801006501; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, J GEN VIROL, V83, P1915; HUGHJONES ME, 1976, J HYG-CAMBRIDGE, V77, P141; OIE, 2014, MANUAL DIAGNOSTIC TE	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	OCT	2015	102						228	230		10.1016/j.rvsc.2015.08.017		3	Veterinary Sciences	Veterinary Sciences	CT6JN	WOS:000362919400040		
J	Fujimura, N; Ji, M; Jagers, JS; Katagiri, M; Easton, PA				Fujimura, Naoyuki; Ji, Michael; Jagers, Jenny Suneby; Katagiri, Masato; Easton, Paul A.			Ventilation and diaphragm activity during sustained hypoxia in awake canines	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Hypoxia; Diaphragm; Canine; Hypoxic ventilatory response; Roll-off	METABOLIC-RATE; CENTRAL ORIGIN; NORMAL ADULTS; RATS; TRACHEOSTOMY; CATS; COLD; REDUCTION; RESPONSES; RECOVERY	In humans, isocapnic hypoxia sustained for 20-30 min elicits a biphasic ventilatory response with an initial increased peak followed by a roll-off to a lesser, intermediate plateau. However, it is uncertain if this hypoxic roll-off is common for all mammals, as canines have been a notable exception. We examined the effect of moderate isocapnic hypoxia (SpO(2) 80%) sustained for 20 min in 13 adult, awake, intact canines. The ventilatory response to sustained isocapnic hypoxia in these canines was not maintained: after an initial brisk response, ventilation declined significantly to an intermediate plateau. The hypoxic ventilatory decline occurred via a decrease in tidal volume, without change in breathing frequency. Distinct from airflow, costal diaphragm EMG showed a concurrent decline during sustained isocapnic hypoxia. However, the change in ventilation during sustained hypoxia in canines was very different from the response in humans. Although some decline in ventilation during sustained hypoxia may be common to all mammals, there are notable differences among species. (C) 2015 Elsevier B.V. All rights reserved.	[Ji, Michael; Jagers, Jenny Suneby; Easton, Paul A.] Univ Calgary, Dept Crit Care Med, Calgary, AB T2N 4N1, Canada; [Katagiri, Masato] Kitasato Univ, Sch Allied Hlth Sci, Dept Med Lab Sci, Yokohama, Kanagawa 2520373, Japan; [Fujimura, Naoyuki] St Marys Hosp, Dept Anesthesiol, Fukuoka 8308543, Japan	Easton, PA (reprint author), Univ Calgary, Dept Crit Care Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	peaston@ucalgary.ca					LOWRY TF, 1994, J APPL PHYSIOL, V76, P2147; CAVO J, 1973, ANN OTO RHINOL LARYN, V82, P827; VIZEK M, 1987, J APPL PHYSIOL, V63, P1658; GAUTIER H, 1992, J APPL PHYSIOL, V73, P847; LAFRAMBOISE WA, 1985, J APPL PHYSIOL, V59, P1040; EASTON PA, 1988, J APPL PHYSIOL, V64, P521; EASTON PA, 1989, J APPL PHYSIOL, V66, P613; MAXWELL DL, 1986, J APPL PHYSIOL, V60, P997; EASTON PA, 1986, J APPL PHYSIOL, V61, P906; WEIL JV, 1976, CHEST, V70, P124, DOI 10.1378/chest.70.1_Supplement.124; CULLEN JH, 1963, ANN INTERN MED, V58, P953; EASTON PA, 1988, J APPL PHYSIOL, V64, P1451; EASTON PA, 1988, J APPL PHYSIOL, V64, P1445; AARON EA, 1993, J APPL PHYSIOL, V74, P1635; CRINER G, 1987, CHEST, V91, P139, DOI 10.1378/chest.91.1.139; Davis K, 1999, ARCH SURG-CHICAGO, V134, P59, DOI 10.1001/archsurg.134.1.59; BLATTEIS CM, 1973, J APPL PHYSIOL, V35, P608; LAWSON EE, 1983, J APPL PHYSIOL, V55, P483; OGAWA H, 1995, J PHYSIOL-LONDON, V486, P495; GAUTIER H, 1989, J APPL PHYSIOL, V67, P32; GERSHAN WM, 1994, J APPL PHYSIOL, V76, P2310; CAO KY, 1993, J APPL PHYSIOL, V75, P1247; HEMINGWAY A, 1952, AM J PHYSIOL, V170, P426; CAO KY, 1992, RESP PHYSIOL, V89, P65, DOI 10.1016/0034-5687(92)90071-4; Maxova H, 2001, PHYSIOL RES, V50, P91; Vizek M, 1998, RESP PHYSIOL, V111, P153, DOI 10.1016/S0034-5687(97)00116-3; TATSUMI K, 1992, J APPL PHYSIOL, V72, P1945; Bissonnette J. M., 2000, MECH REGULATING HYPO; FRAPPELL P, 1992, AM J PHYSIOL, V262, pR1040; Mortola J. P., 1995, LUNG BIOL HLTH DIS, V79, P1011; Moscovici da C. V., 2002, EUR RESPIR J, V20, P112; Robinson K. A., 1990, J APPL PHYSIOL, V68, P702	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	OCT	2015	217						32	39		10.1016/j.resp.2015.06.004		8	Physiology; Respiratory System	Physiology; Respiratory System	CT6LN	WOS:000362924600005		
J	Shirakawa, K; Yunoki, T; Afroundeh, R; Lian, CS; Matsuura, R; Ohtsuka, Y; Yano, T				Shirakawa, Kazuki; Yunoki, Takahiro; Afroundeh, Roghayyeh; Lian, Chang-Shun; Matsuura, Ryouta; Ohtsuka, Yoshinori; Yano, Tokuo			Voluntary breathing increases corticospinal excitability of lower limb muscle during isometric contraction	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Voluntary breathing; Lower limb muscle; Motor-evoked potential; Corticospinal excitability; Transcranial magnetic stimulation	TRANSCRANIAL MAGNETIC STIMULATION; HUMAN RESPIRATORY MUSCLES; CEREBRAL-BLOOD-FLOW; SOLEUS H-REFLEX; HAND MOTOR AREA; JENDRASSIK MANEUVER; INHIBITION; DRIVE; TEETH; FACILITATION	The aim of the present study was to determine the effects of voluntary breathing on corticospinal excitability of a leg muscle during isometric contraction. Seven subjects performed 5-s isometric knee extension at the intensity of 10% of maximal voluntary contraction (10% MVC). During the 10% MVC, the subjects were instructed to breath normally (NORM) or to inhale (IN) or exhale (OUT) once as fast as possible. Motor-evoked potentials (MEPs) induced by transcranialmagnetic stimulation in the right vastus lateralis (VL) during the 10% MVC were recorded and compared during the three breathing tasks. MEPs in IN and OUT were significantly higher than that in NORM. Effort sense of breathing was significantly higher in IN and OUT than in NORM. There was a significant positive correlation between MEP and effort sense of breathing. These results suggest that activation of the breathing-associated cortical areas with voluntary breathing is involved in the increase in corticospinal excitability of the VL during isometric contraction. (C) 2015 Elsevier B.V. All rights reserved.	[Shirakawa, Kazuki; Lian, Chang-Shun] Hokkaido Univ, Grad Sch Educ, Sapporo, Hokkaido 0600811, Japan; [Yunoki, Takahiro; Ohtsuka, Yoshinori; Yano, Tokuo] Hokkaido Univ, Fac Educ, Dept Human Dev Sci, Sapporo, Hokkaido 0600811, Japan; [Afroundeh, Roghayyeh] Payame Noor Univ, Dept Sport Sci & Phys Educ, Tehran, Iran; [Matsuura, Ryouta] Joetsu Univ Educ, Dept Hlth & Phys Educ, Joetsu, Japan	Shirakawa, K (reprint author), Hokkaido Univ, Grad Sch Educ, Kita Ku, Kita 11,Nishi 7, Sapporo, Hokkaido 0600811, Japan.	kazuki.shirakawa@edu.hokudai.ac.jp			JSPS [24700606]	This work was supported by JSPS KAKENHI Grant Number 24700606.	Miyahara T, 1996, J NEUROPHYSIOL, V76, P2033; Gandevia SC, 1998, J PHYSIOL-LONDON, V511, P289, DOI 10.1111/j.1469-7793.1998.289bi.x; MACEFIELD G, 1991, J PHYSIOL-LONDON, V439, P545; Li S, 2011, J NEUROPHYSIOL, V105, P512, DOI 10.1152/jn.00946.2010; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; Sugawara K, 2002, HUM MOVEMENT SCI, V21, P203, DOI 10.1016/S0167-9457(02)00099-4; Butler JE, 2007, RESP PHYSIOL NEUROBI, V159, P115, DOI 10.1016/j.resp.2007.06.006; Furubayashi T, 2003, EXP BRAIN RES, V148, P261, DOI 10.1007/s00221-002-1299-y; Hudson AL, 2012, RESP PHYSIOL NEUROBI, V180, P263, DOI 10.1016/j.resp.2011.11.017; Balzamo E, 1997, NEUROSCI LETT, V236, P127, DOI 10.1016/S0304-3940(97)00782-9; Stendardi L, 2005, RESP MED, V99, P933, DOI 10.1016/j.rmed.2005.02.005; DEMEDIUK BH, 1992, AM REV RESPIR DIS, V146, P1222; Sidhu SK, 2009, MUSCLE NERVE, V39, P186, DOI 10.1002/mus.21064; DOWMAN R, 1988, EXP NEUROL, V101, P288, DOI 10.1016/0014-4886(88)90012-X; Andersen B, 1999, MUSCLE NERVE, V22, P857, DOI 10.1002/(SICI)1097-4598(199907)22:7<857::AID-MUS7>3.0.CO;2-B; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; SCHWARTZSTEIN RM, 1989, AM REV RESPIR DIS, V139, P1231; Zehr EP, 1999, EXP BRAIN RES, V124, P474, DOI 10.1007/s002210050643; GANDEVIA SC, 1988, RESP PHYSIOL, V73, P325, DOI 10.1016/0034-5687(88)90054-0; PALMER E, 1992, J PHYSIOL-LONDON, V448, P397; Sugawara K, 2005, NEUROSCI LETT, V377, P25, DOI 10.1016/j.neulet.2004.11.059; Danion F, 2003, CLIN NEUROPHYSIOL, V114, P1445, DOI 10.1016/S1388-2457(03)00105-6; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Petersen NC, 2011, RESP PHYSIOL NEUROBI, V175, P265, DOI 10.1016/j.resp.2010.11.014; Chen R, 1998, J NEUROPHYSIOL, V80, P2870; Lansing RW, 2000, AM J RESP CRIT CARE, V162, P1690; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109; Fontanari P, 1996, NEUROSCI LETT, V210, P130, DOI 10.1016/0304-3940(96)12564-7; DESHPAND.SS, 1970, J PHYSIOL-LONDON, V206, P345; MANNING HL, 1995, NEW ENGL J MED, V333, P1547; PHILLIPS C. G., 1964, PROGR BRAIN RES, V12, P222, DOI 10.1016/S0079-6123(08)60625-1; SCHIEMAN.B, 1972, EXP BRAIN RES, V15, P234	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	OCT	2015	217						40	45		10.1016/j.resp.2015.07.003		6	Physiology; Respiratory System	Physiology; Respiratory System	CT6LN	WOS:000362924600006		
J	Ogura, K; Morioka, K; Hsu, SY; Tsujii, Y; Wagner, MH				Ogura, Koji; Morioka, Kohei; Hsu, Shu-Yao; Tsujii, Yoshinobu; Wagner, Manfred H.			Rheological characterization of H-shaped poly(methyl methacrylate)s	RHEOLOGICA ACTA			English	Article						H-shaped polymer; Rheology; Molecular stress function model; Uniaxial extension; Strain hardening; Poly(methyl methacrylate)	CONCENTRATED POLYMER SYSTEMS; STRESS FUNCTION MODEL; BRANCHED POLYMERS; DYNAMICS; MELTS; POLYSTYRENE; POLYETHYLENE; FLOW	Investigation of the extensional flow behavior and development of constitutive equations for well-characterized H-shaped polymers is important both from an industrial and academic viewpoints. For H-shaped polymer systems, little is known about the extensional flow behavior at constant strain rates. We synthesized H-shaped poly(methyl methacrylate)s (PMMAs) with narrow molecular weight distributions and various ratios of the molecular weight of the backbone, M (b), to that of the arm, M (a), by atom transfer radical polymerization. However, H-1 NMR spectroscopy showed that the resulting PMMA samples contained substantial amounts of linear and star topologies. In spite of the limited purity of the H-shaped PMMAs obtained, the rheological properties in linear viscoelasticity and uniaxial extensional flow revealed interesting results. The zero-shear viscosity of model PMMAs was well described by an exponential relation of the molecular weight. Qualitative agreement was found between the experimental linear-viscoelastic behavior and predictions of the model of McLeish et al. (Macromolecules 32: 6734-6758, 1999) for H-shaped polymers. The elongational flow behavior was also analyzed by the molecular stress function (MSF) model. Surprisingly, the strain-hardening effect for all investigated model PMMAs was weaker than that for pom-pom polystyrene polymers.	[Ogura, Koji; Morioka, Kohei] Sumitomo Chem Co Ltd, Basic Chem Res Lab, Niihama City, Ehime 7928521, Japan; [Hsu, Shu-Yao; Tsujii, Yoshinobu] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Wagner, Manfred H.] Tech Univ Berlin, Berlin Inst Technol, Chair Polymer Engn Polymer Phys, D-10623 Berlin, Germany	Ogura, K (reprint author), Sumitomo Chem Co Ltd, Basic Chem Res Lab, 5-1 Sobiraki Cho, Niihama City, Ehime 7928521, Japan.	ogurak2@sc.sumitomo-chem.co.jp					Bishko G, 1997, PHYS REV LETT, V79, P2352, DOI 10.1103/PhysRevLett.79.2352; Nielsen JK, 2006, MACROMOLECULES, V39, P8844, DOI 10.1021/ma061476r; Liu QC, 2007, J POLYM SCI POL CHEM, V45, P3330, DOI 10.1002/pola.22082; MARRUCCI G, 1980, MACROMOLECULES, V13, P380, DOI 10.1021/ma60074a034; Lohse DJ, 2002, MACROMOLECULES, V35, P3066, DOI 10.1021/ma0117559; Wagner MH, 2001, J RHEOL, V45, P1387, DOI 10.1122/1.1413503; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1802, DOI 10.1039/f29787401802; Wagner MH, 2003, J RHEOL, V47, P779, DOI 10.1122/1.1562155; Wagner MH, 2008, J RHEOL, V52, P1049, DOI 10.1122/1.2957699; Neugebauer D, 2004, POLYMER, V45, P8173, DOI 10.1016/j.polymer.2004.09.069; DOI M, 1979, J CHEM SOC FARAD T 2, V75, P38, DOI 10.1039/f29797500038; ROOVERS J, 1984, MACROMOLECULES, V17, P1196, DOI 10.1021/ma00136a016; Chen W, 2010, CHEM MATER, V22, P6212, DOI 10.1021/cm102129k; Trinkle S, 2002, RHEOL ACTA, V41, P103, DOI 10.1007/s003970200010; Chen X, 2011, MACROMOLECULES, V44, P7799, DOI 10.1021/ma2011377; Fuchs K, 1996, MACROMOLECULES, V29, P5893, DOI 10.1021/ma951385m; McLeish TCB, 1999, MACROMOLECULES, V32, P6734, DOI 10.1021/ma990323j; Chen X, 2012, MACROMOLECULES, V45, P5744, DOI 10.1021/ma300337x; Dealy JM, 2006, STRUCTURE RHEOLOGY M; Ferry JD, 1980, VISCOELASTIC PROPERT; Winter HH, 2007, IRIS DEV; WU S, 1989, J POLYM SCI POL PHYS, V27, P723, DOI 10.1002/polb.1989.090270401; WU S, 1970, J PHYS CHEM-US, V74, P632, DOI 10.1021/j100698a026	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0035-4511	1435-1528		RHEOL ACTA	Rheol. Acta	OCT	2015	54	9-10					793	804		10.1007/s00397-015-0871-x		12	Mechanics	Mechanics	CT8CW	WOS:000363043600004		
J	Verheul, MK; Shiozawa, K; Levarht, EWN; Huizinga, TWJ; Toes, REM; Trouw, LA; Shiozawa, S				Verheul, Marije K.; Shiozawa, Kazuko; Levarht, E. W. Nivine; Huizinga, Tom W. J.; Toes, Rene E. M.; Trouw, Leendert A.; Shiozawa, Shunichi			Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descent	RHEUMATOLOGY			English	Letter							CARP ANTIBODIES; AUTOANTIBODIES; FIBRINOGEN; PREDICT		[Verheul, Marije K.; Levarht, E. W. Nivine; Huizinga, Tom W. J.; Toes, Rene E. M.; Trouw, Leendert A.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Shiozawa, Kazuko] Hohnan Kakogawa Hosp, Ctr Rheumat Dis, Kakogawa, Hyogo, Japan; [Shiozawa, Shunichi] Kyushu Univ, Beppu Hosp, Dept Med, Rheumat Dis Unit, Beppu, Oita, Japan	Trouw, LA (reprint author), Leiden Univ, Med Ctr, Dept Rheumatol, C1-R,Postbus 9600, NL-2300 RC Leiden, Netherlands.	l.a.trouw@lumc.nl					Jiang X, 2014, ANN RHEUM DIS, V73, P1761, DOI 10.1136/annrheumdis-2013-205109; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Auger I, 2005, ARTHRITIS RHEUM, V52, P3424, DOI 10.1002/ART.21391; Shiozawa K, 2012, J RHEUMATOL, V39, P694, DOI 10.3899/jrheum.111152; Scinocca M, 2014, J RHEUMATOL, V41, P270, DOI 10.3899/jrheum.130742; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830	8	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	OCT	2015	54	10					1930	1932		10.1093/rheumatology/kev250		4	Rheumatology	Rheumatology	CT5KS	WOS:000362849200024		
J	Peltan, ID; Shiga, T; Gordon, JA; Currier, PF				Peltan, Ithan D.; Shiga, Takashi; Gordon, James A.; Currier, Paul F.			Simulation Improves Procedural Protocol Adherence During Central Venous Catheter Placement A Randomized Controlled Trial	SIMULATION IN HEALTHCARE-JOURNAL OF THE SOCIETY FOR SIMULATION IN HEALTHCARE			English	Article						Central venous catheter; Simulation; Graduate medical education; Procedure training	INTENSIVE-CARE-UNIT; CENTRAL VEIN CATHETERIZATION; BLOOD-STREAM INFECTIONS; DELIBERATE PRACTICE; MEDICINE RESIDENTS; TRAINING-PROGRAM; TECHNICAL SKILLS; PERFORMANCE; EDUCATION; INSERTION	Background Simulation training may improve proficiency at and reduce complications from central venous catheter (CVC) placement, but the scope of simulation's effect remains unclear. This randomized controlled trial evaluated the effects of a pragmatic CVC simulation program on procedural protocol adherence, technical skill, and patient outcomes. Methods Internal medicine interns were randomized to standard training for CVC insertion or standard training plus simulation-based mastery training. Standard training involved a lecture, a video-based online module, and instruction by the supervising physician during actual CVC insertions. Intervention-group subjects additionally underwent supervised training on a venous access simulator until they demonstrated procedural competence. Raters evaluated interns' performance during internal jugular CVC placement on actual patients in the medical intensive care unit. Generalized estimating equations were used to account for outcome clustering within trainees. Results We observed 52 interns placing 87 CVCs. Simulation-trained interns exhibited better adherence to prescribed procedural technique than interns who received only standard training (P = 0.024). There were no significant differences detected in first-attempt or overall cannulation success rates, mean needle passes, global assessment scores, or complication rates. Conclusions Simulation training added to standard training improved protocol adherence during CVC insertion by novice practitioners. This study may have been too small to detect meaningful differences in venous cannulation proficiency and other clinical outcomes, highlighting the difficulty of patient-centered simulation research in settings where poor outcomes are rare. For high-performing systems, where protocol deviations may provide an important proxy for rare procedural complications, simulation may improve CVC insertion quality and safety.	[Peltan, Ithan D.; Currier, Paul F.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Peltan, Ithan D.] Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA USA; [Shiga, Takashi; Gordon, James A.] Massachusetts Gen Hosp, Dept Emergency Med, Div Med Simulat, Boston, MA 02114 USA; [Shiga, Takashi] Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Emergency Med, Chiba, Japan; [Gordon, James A.] Massachusetts Gen Hosp, MGH Learning Lab, Boston, MA 02114 USA; [Currier, Paul F.] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA	Peltan, ID (reprint author), Univ Washington, Med Ctr, 1959 NE Pacific St,Campus Box 356522, Seattle, WA 98195 USA.	ipeltan@post.harvard.edu			Lucian Leape Foundation for Patient Safety; National Institutes of Health [UL1 TR001102]	Reprints: Ithan D. Peltan, MD, University of Washington Medical Center, 1959 NE Pacific St., Campus Box 356522, Seattle, WA, 98195, (e-mail: ipeltan@post.harvard.edu). Supported by a grant from the Lucian Leape Foundation for Patient Safety and funding from the National Institutes of Health (UL1 TR001102) for the Harvard Catalyst Clinical and Translational Science Center.	ALBERT A, 1984, BIOMETRIKA, V71, P1; American Board of Internal Medicine, 2013, POL PROC CERT; Britt RC, 2009, AM J SURG, V197, P533, DOI 10.1016/j.amjsurg.2008.11.016; Craft C, 2014, AM J SURG, V207, P782, DOI 10.1016/j.amjsurg.2013.06.003; Ma IWY, 2011, ACAD MED, V86, P1137, DOI 10.1097/ACM.0b013e318226a204; Smith CC, 2010, SIMUL HEALTHC, V5, P146, DOI 10.1097/SIH.0b013e3181dd9672; McMillan TR, 2007, CRIT CARE MED, V35, pS59, DOI 10.1097/01.CCM.0000252914.22497.44; Austin PC, 2007, STAT MED, V26, P3550, DOI 10.1002/sim.2813; Moorthy K, 2003, BRIT MED J, V327, P1032, DOI 10.1136/bmj.327.7422.1032; Cook DA, 2013, ACAD MED, V88, P162, DOI 10.1097/ACM.0b013e31827c3d78; CLEARY PD, 1984, J HEALTH SOC BEHAV, V25, P334, DOI 10.2307/2136429; Madenci AL, 2014, SIMUL HEALTHC, V9, P7, DOI 10.1097/SIH.0b013e3182a3df26; Barsuk JH, 2009, ARCH INTERN MED, V169, P1420, DOI 10.1001/archinternmed.2009.215; Cook DA, 2011, JAMA-J AM MED ASSOC, V306, P978, DOI 10.1001/jama.2011.1234; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Zendejas B, 2013, J GEN INTERN MED, V28, P1078, DOI 10.1007/s11606-012-2264-5; DEY EL, 1993, RES HIGH EDUC, V34, P569, DOI 10.1007/BF00991920; Sekiguchi H, 2011, CHEST, V140, P652, DOI 10.1378/chest.10-3319; Khouli H, 2011, CHEST, V139, P80, DOI 10.1378/chest.10-0979; Barsuk JH, 2009, CRIT CARE MED, V37, P2697, DOI 10.1097/CCM.0b013e3181a57bc1; Latif RK, 2012, ANESTH ANALG, V114, P626, DOI 10.1213/ANE.0b013e3182405eb3; Velmahos GC, 2004, AM J SURG, V187, P114, DOI 10.1016/j.amjsurg.2002.12.005; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Cook DA, 2010, SIMUL HEALTHC, V5, P1, DOI 10.1097/SIH.0b013e3181c82aaa; McGaghie WC, 2011, ACAD MED, V86, pE8, DOI 10.1097/ACM.0b013e3182308d37; SINCLAIR JC, 1994, J CLIN EPIDEMIOL, V47, P881, DOI 10.1016/0895-4356(94)90191-0; Barsuk JH, 2009, J HOSP MED, V4, P397, DOI 10.1002/jhm.468; Huang GC, 2009, ACAD MED, V84, P1127, DOI 10.1097/ACM.0b013e3181acf491; SZNAJDER JI, 1986, ARCH INTERN MED, V146, P259, DOI 10.1001/archinte.146.2.259; Evans LV, 2010, ACAD MED, V85, P1462, DOI 10.1097/ACM.0b013e3181eac9a3; McGaghie WC, 2011, ACAD MED, V86, P706, DOI 10.1097/ACM.0b013e318217e119; Wayne DB, 2006, J GEN INTERN MED, V21, P251, DOI 10.1111/j.1525-1497.2006.00341.x; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Millington SJ, 2009, J HOSP MED, V4, P410, DOI 10.1002/jhm.570; Slama M, 1997, INTENS CARE MED, V23, P916, DOI 10.1007/s001340050432; Gaba DM, 2010, SIMUL HEALTHC, V5, P5, DOI 10.1097/SIH.0b013e3181c75ddb; Lenchus Joshua D, 2013, J Grad Med Educ, V5, P605, DOI 10.4300/JGME-D-13-00030.1; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; MGH Infection Control, MGH INF CONTR CENTR; Ortega Rafael, 2010, N Engl J Med, V362, pe57, DOI 10.1056/NEJMvcm0810156; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174; Weiss NS, 2003, EPIDEMIOLOGIC METHOD; Woo MY, 2009, CAN J EMERG MED, V11, P343	45	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1559-2332	1559-713X		SIMUL HEALTHC	Simul. Healthc.	OCT	2015	10	5					270	276		10.1097/SIH.0000000000000096		7	Health Care Sciences & Services	Health Care Sciences & Services	CT3PW	WOS:000362720100003		
J	Jenkins, CSI; Kasaki, M				Jenkins, C. S. I.; Kasaki, Masashi			The traditional conception of the a priori	SYNTHESE			English	Article						A priori; A posteriori; Kant; Williamson; Casullo; Jenkins; Evidence; Empirical		In this paper, we explore the traditional conception of a prioricity as epistemic independence of evidence from sense experience. We investigate the fortunes of the traditional conception in the light of recent challenges by Timothy Williamson. We contend that Williamson's arguments can be resisted in various ways. En route, we argue that Williamson's views are not as distant from tradition (in particular, from Kant) as they might seem at first glance.	[Jenkins, C. S. I.] Univ British Columbia, Dept Philosophy, Vancouver, BC V6T 1Z4, Canada; [Kasaki, Masashi] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Jenkins, CSI (reprint author), Univ British Columbia, Dept Philosophy, 1866 Main Mall, Vancouver, BC V6T 1Z4, Canada.	carrie@carriejenkins.co.uk; kasaki@irl.sys.es.osaka-u.ac.jp			Government of Canada	The authors would like to thank audiences at the Universities of Alberta, Calgary, Georgia and Cologne for valuable feedback on earlier versions of this material. We are particularly indebted to Uygar Abaci and Jonathan Jenkins Ichikawa for comments and discussion on late-stage drafts. Lastly, we thank the Government of Canada for supporting Masashi Kasaki's research for this paper during a Government of Canada Post-Doctoral Research Fellowship.	Malmgren AS, 2011, MIND, V120, P263, DOI 10.1093/mind/fzr039; BURGE T, 1993, PHILOS REV, V102, P457, DOI 10.2307/2185680; Hanna R, 1998, EUR J PHILOS, V6, P115, DOI 10.1111/1468-0378.00054; Williamson T, 2007, GRAZER PHILOS STUD, V74, P89; Neta R, 2010, AUSTRALAS J PHILOS, V88, P685, DOI 10.1080/00048400903225734; Bonjour Laurence, 1998, DEFENSE PURE REASON; Hawthorne John, 2007, INTERNALISM EXTERNAL, P201; Ichikawa J. J., 2013, PRIORI PHILOS, P46; Ichikawa Jonathan, 2013, THE RULES OF THOUGHT; Jenkins C., 2008, PHILOS COMPASS, V3, P436, DOI 10.1111/j.1747-9991.2008.00136.x; Jenkins C. I., 2008, GROUNDING CONCEPTS E; Kant I, 1998, CRITIQUE PURE REASON; Silins N., 2007, OXFORD STUDIES EPIST, V2, P108; Strawson P. F., 1970, IMAGINATION PERCEPTI; WILLIAMSON T., 2000, KNOWLEDGE ITS LIMITS; Williamson T., 2013, PRIORI PHILOS, P291; Williamson Timothy, 2007, PHILOS PHILOS; Wright Crispin, 2004, ARISTOTELIAN SOC S, V78, P167, DOI DOI 10.1111/J.0309-7013.2004.00121.X	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0039-7857	1573-0964		SYNTHESE	Synthese	OCT	2015	192	9					2725	2746		10.1007/s11229-013-0394-x		22	History & Philosophy Of Science; Philosophy	History & Philosophy of Science; Philosophy	CT6CC	WOS:000362897600003		
J	Matsunaga, T; Suzuki, K; Imashimizu, K; Banno, T; Takamochi, K; Oh, S				Matsunaga, Takeshi; Suzuki, Kenji; Imashimizu, Kota; Banno, Takamitsu; Takamochi, Kazuya; Oh, Shiaki			Body Mass Index as a Prognostic Factor in Resected Lung Cancer: Obesity or Underweight, Which Is the Risk Factor?	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						lung cancer treatment (surgery medical); obesity; surgery; complications	NATIONAL PERIOPERATIVE OUTCOMES; 30-DAY MORTALITY; THORACIC MALIGNANCIES; PULMONARY LOBECTOMY; NUTRITIONAL-STATUS; MODELS PREDICTORS; MAJOR RESECTIONS; EARLY DEATH; SURGERY; MORBIDITY	Background In general, obesity is thought to be associated with increased surgical mortality and morbidity. On the other hand, low body mass index (BMI) has recently been reported as a poor prognostic factor for surgical candidates. This study investigated the effect of BMI on lung surgery. Methods A retrospective study was conducted on 1,518 consecutive patients who had malignant pulmonary tumors resected between February 2008 and March 2013. BMI was used to classify patients according to the World Health Organization definition: BMI < 18.5: underweight (UW); BMI 18.5 to < 25: normal weight (NW); BMI 25 to < 30: overweight (OW); and BMI >= 30: obese (OB). We defined surgical resection-related mortality as any patient who died within 90 days after resection or while in the hospital. We analyzed morbidity and surgical resection-related mortality, and logistic regression analysis was used to identify predictors for surgical resection-related mortality. Results Among the four groups, the incidence of cerebrovascular complications was 1.5% in UW, 0.4% in NW, 0% in OW, and 0% in OB, and that of pulmonary complications was 13.1% in UW, 8.4% in NW, 7.3% in OW, and 7.6% in OB. Surgical resection-related mortality was 2.9% in UW, 0.6% in NW, 1.7% in OW, and 0% in OB. Multivariate analysis revealed underweight, diffusing capacity of the lung for carbon monoxide, and male sex as the significant predictors. Conclusions In this study, low BMI was an independent risk factor for mortality, and the incidence of cerebrovascular and pulmonary complications tended to be higher in patients with low BMI than in obese patients. Underweight patients should be closely monitored following pulmonary resection.	[Matsunaga, Takeshi; Suzuki, Kenji; Imashimizu, Kota; Banno, Takamitsu; Takamochi, Kazuya; Oh, Shiaki] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 1138431, Japan	Suzuki, K (reprint author), Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Bunkyo Ku, 1-3,Hongo 3 Chome, Tokyo 1138431, Japan.	kjsuzuki@juntendo.ac.jp			Ministry of Health, Labor and Welfare of Japan	This study was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan.	Lee CT, 2004, J UROLOGY, V172, P1281, DOI 10.1097/01.ju.0000138785.48347.aa; HOLLEY JL, 1990, TRANSPLANTATION, V49, P387, DOI 10.1097/00007890-199002000-00032; Bagan P, 2013, ANN THORAC SURG, V95, P392, DOI 10.1016/j.athoracsur.2012.06.023; Launer H, 2013, J THORAC CARDIOV SUR, V145, P1312, DOI 10.1016/j.jtcvs.2012.10.012; Falcoz PE, 2007, J THORAC CARDIOV SUR, V133, P325, DOI 10.1016/j.jtcvs.2006.09.020; Petrella F, 2011, EUR J CARDIO-THORAC, V39, P738, DOI 10.1016/j.ejcts.2010.09.007; Rabe KF, 2007, NEW ENGL J MED, V356, P851, DOI 10.1056/NEJMe068307; St Julien JB, 2012, ANN THORAC SURG, V94, P1841, DOI 10.1016/j.athoracsur.2012.08.006; Ohtaka K, 2013, ANN THORAC SURG, V95, P1924, DOI 10.1016/j.athoracsur.2013.03.005; Ferguson MK, 2014, EUR J CARDIO-THORAC, V45, pE94, DOI 10.1093/ejcts/ezu008; FASOL R, 1992, THORAC CARDIOV SURG, V40, P126, DOI 10.1055/s-2007-1020129; Attaran S, 2012, EUR J CARDIO-THORAC, V42, P653, DOI 10.1093/ejcts/ezs135; Klasen J, 2004, OBES SURG, V14, P275, DOI 10.1381/096089204322857708; Watanabe S, 2004, ANN THORAC SURG, V78, P999, DOI 10.1016/j.athorascur.2004.04.007; Mullen JT, 2008, ANN SURG ONCOL, V15, P2164, DOI 10.1245/s10434-008-9990-2; Dhakal B, 2013, J THORAC CARDIOV SUR, V146, P379, DOI 10.1016/j.jtcvs.2013.02.083; Bernard A, 2011, J THORAC CARDIOV SUR, V141, P449, DOI 10.1016/j.jtcvs.2010.06.044; Fiorelli A, 2014, THORAC CARDIOV SURG, V62, P578, DOI [10.1055/s-0034-1373733, 10.1055/5-0034-1373733]; Putnam B, 2010, ANN THORAC SURG, V90, P881; Kozower BD, 2010, ANN THORAC SURG, V90, P875, DOI 10.1016/j.athoracsur.2010.03.115; Kim AW, 2014, ANN THORAC SURG, V98, P1774; McMillan RR, 2014, ANN THORAC SURG, V98, P1769, DOI 10.1016/j.athoracsur.2014.06.024; Pezzi CM, 2014, J THORAC CARDIOV SUR, V148, P2269, DOI 10.1016/j.jtcvs.2014.07.077; Smith PW, 2007, ANN THORAC SURG, V84, P1105; Smith PW, 2007, ANN THORAC SURG, V84, P1098, DOI 10.1016/j.athoracsur.2007.04.033; Thomas PA, 2014, EUR J CARDIO-THORAC, V45, P652, DOI 10.1093/ejcts/ezt452; Watanabe S, 2004, ANN THORAC SURG, V78, P1002	27	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	OCT	2015	63	7					551	557		10.1055/s-0035-1554964		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5FE	WOS:000362833200004		
J	Hattori, A; Suzuki, K; Takamochi, K; Oh, S				Hattori, Aritoshi; Suzuki, Kenji; Takamochi, Kazuya; Oh, Shiaki			Is Bilateral Pulmonary Lobectomy Feasible in Patients with Bilateral Lung Cancers?	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						bilateral pulmonary lobectomy; lung cancers; postoperative complication; survival	SURGICAL-TREATMENT; SINGLE-CENTER; RESECTION; EXPERIENCE; MANAGEMENT; ADENOCARCINOMA; CLASSIFICATION; CARCINOMAS; PREDICTOR; MORBIDITY	Background While aggressive surgical resection is an acceptable strategy for bilateral lung cancers, there are still some controversies regarding the appropriate indications of bilateral pulmonary lobectomy. Methods Between 1996 and 2012, 21 patients underwent bilateral pulmonary lobectomy for bilateral lung cancers. Postoperative complications after bilateral pulmonary lobectomy were defined based on the Common Terminology Criteria for Adverse Event Version 4.0 (National Cancer Institute, USA). Results In this study, 21 patients underwent bilateral pulmonary lobectomy by staged surgery for bilateral lung cancers. Thirteen patients (62%) recovered without any complications after the second surgery. Among the eight (38%) patients with postoperative complications, four had relatively minor complications of grade 1 or 2. In contrast, postoperative complications were frequently observed in patients who underwent right lower lobectomy, were age >= 70 years, or had larger tumor size (p = 0.0041, 0.0195, 0.0324). The mean hospital stay after the second surgery was 8.0 days. In-hospital mortality was found in five patients including three of respiratory failure. The median follow-up period for all patients was 40 months. The 5-year survival rate after bilateral pulmonary lobectomy was 61.7%. Conclusion Although appropriate patient selection and careful perioperative management are mandatory, bilateral pulmonary lobectomy could be an acceptable procedure for patients with bilateral lung cancers.	[Hattori, Aritoshi; Suzuki, Kenji; Takamochi, Kazuya; Oh, Shiaki] Juntendo Univ, Dept Gen Thorac Surg, Sch Med, Tokyo 1138432, Japan	Suzuki, K (reprint author), Juntendo Univ, Dept Gen Thorac Surg, Bunkyo Ku, 1-3,3 Chome, Tokyo 1138432, Japan.	kjsuzuki@juntendo.ac.jp			Ministry of Health, Labor and Welfare, Japan; Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare, Japan and the Smoking Research Foundation.	Chang YL, 2007, J THORAC CARDIOV SUR, V134, P630, DOI 10.1016/j.jtcvs.2007.06.001; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; De Leyn P, 2008, EUR J CARDIO-THORAC, V34, P1215, DOI 10.1016/j.ejcts.2008.07.069; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Tsunezuka Y, 2004, EJSO, V30, P781, DOI 10.1016/j.ejso.2004.05.008; Adebonojo SA, 1997, CHEST, V112, P693, DOI 10.1378/chest.112.3.693; Okada M, 1998, J THORAC CARDIOV SUR, V115, P836, DOI 10.1016/S0022-5223(98)70364-2; Shah AA, 2012, ANN THORAC SURG, V93, P1055, DOI 10.1016/j.athoracsur.2011.12.070; Nakata M, 2004, ANN THORAC SURG, V78, P1194, DOI 10.1016/j.athoracsur.2004.03.102; Finley DJ, 2010, J THORAC ONCOL, V5, P197, DOI 10.1097/JTO.0b013e3181c814c5; ROSENGART TK, 1991, ANN THORAC SURG, V52, P773; Zuin A, 2013, EUR J CARDIO-THORAC, V44, pE120, DOI 10.1093/ejcts/ezt219; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Linden PA, 2007, ANN THORAC SURG, V83, P425, DOI 10.1016/j.athoracsur.2006.09.081; Trousse D, 2007, J THORAC CARDIOV SUR, V133, P1193, DOI 10.1016/j.jtcvs.2007.01.012; Rea F, 2001, EUR J CARDIO-THORAC, V20, P489, DOI 10.1016/S1010-7940(01)00858-2; Hattori A, 2012, ANN THORAC SURG, V94, P212, DOI 10.1016/j.athoracsur.2012.03.033; MARKOS J, 1989, AM REV RESPIR DIS, V139, P902; Aziz TM, 2002, EUR J CARDIO-THORAC, V21, P527, DOI 10.1016/S1010-7940(02)00024-6; Deschamps C, 1990, J THORAC CARDIOVASC, V99, P777; DESCHAMPS C, 1990, J THORAC CARDIOV SUR, V99, P769; Hattori A, 2014, EUR J CARDIO-THORAC, V45, P699, DOI 10.1093/ejcts/ezt467; National Cancer Institute, NCI COMM TERM CRIT A; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Rosengart TK, 1991, ANN THORAC SURG, V52, P778	25	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	OCT	2015	63	7					589	596		10.1055/s-0034-1383816		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5FE	WOS:000362833200009		
J	Hattori, A; Suzuki, K; Matsunaga, T; Takamochi, K; Oh, S				Hattori, Aritoshi; Suzuki, Kenji; Matsunaga, Takeshi; Takamochi, Kazuya; Oh, Shiaki			Prognostic Significance of the Standardized Uptake Value on Positron Emission Tomography in Patients with Multiple Clinical-N0 Lung Cancers	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						multiple primary lung cancers; intrapulmonary metastases; positron emission tomography; prognosis	SECTION COMPUTED-TOMOGRAPHY; GUIDELINES 2ND EDITION; PROLONGED SURVIVAL; SURGICAL RESECTION; ADENOCARCINOMA; NODULES; TUMOR; CLASSIFICATION; METASTASES; MANAGEMENT	Background While there have been many attempts to differentiate multiple lung cancers (MLCs) using the clinicopathological presentation and molecular profile, there are still some controversies regarding the prognostic factors for MLCs with clinical-N0 status. Patients and Methods Between 1996 and 2012, 131 patients were diagnosed as MLCs pathologically. The main lesion of MLCs was defined as follows: (1) among synchronous lesions, the radiologically denser or larger tumor on thin-section computed tomography (CT) or (2) the second tumor among metachronous lesions. F-18-fluorodeoxyglucose uptake on positron emission tomography (PET) scan was examined to evaluate maximum standardized uptake value (SUVmax) of the main tumor. Results Among 131 patients with clinical-N0 status, 66 were men and 65 were women and they had an average age of 67 years. One-hundred nine patients were diagnosed as MPLCs, and 22 were intrapulmonary metastases (PMs). Based on multivariate analyses, SUVmax was a significant prognostic factor in both synchronous and metachronous clinical-N0 MLCs (p = 0.0060, 0.0451, respectively). Among the overall patients, while pathological diagnosis, maximum tumor dimension, consolidation status, and SUVmax were all significant prognostic factors by a univariate analysis, SUVmax (p = 0.0016) was superior to pathological diagnosis based on the Martini and Melamed classification (p = 0.2258) based on a multivariate analysis. The 5-year survival rate of MPLCs (78.7%) was significantly greater than that of PMs (30.5%) (p = 0.0036). Furthermore, the 5-year survival rate in patients with low SUVmax (91.1%) was far better than that in patients with high SUVmax (17.9%) (p = 0.0001). Conclusion SUVmax on PET was a significant clinical factor that more precisely reflected the prognosis of MLCs with clinical-N0 status, and could be superior to a pathological diagnosis based on the Martini and Melamed classification.	[Hattori, Aritoshi; Suzuki, Kenji; Matsunaga, Takeshi; Takamochi, Kazuya; Oh, Shiaki] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 1138432, Japan	Suzuki, K (reprint author), Juntendo Univ, Sch Med, Gen Thorac Surg, Bunkyo Ku, 1-3,3 Chome, Tokyo 1138432, Japan.	kjsuzuki@juntendo.ac.jp			Ministry of Health, Labor and Welfare of Japan; Smoking Research Foundation	This study was supported in part by a Grant-in-Aid for the Cancer Research from the Ministry of Health, Labor and Welfare of Japan, and the Smoking Research Foundation.	Vazquez M, 2009, LUNG CANCER, V64, P148, DOI 10.1016/j.lungcan.2008.08.009; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Kim TJ, 2009, LUNG CANCER, V64, P171, DOI 10.1016/j.lungcan.2008.08.002; Girard N, 2009, AM J SURG PATHOL, V33, P1752, DOI 10.1097/PAS.0b013e3181b8cf03; Hattori A, 2014, INTERACT CARDIOV TH, V18, P329, DOI 10.1093/icvts/ivt500; Shah AA, 2012, ANN THORAC SURG, V93, P1055, DOI 10.1016/j.athoracsur.2011.12.070; Tanvetyanon T, 2010, J THORAC ONCOL, V5, P1018, DOI 10.1097/JTO.0b013e3181dd0fb0; ANTAKLI T, 1995, ANN THORAC SURG, V59, P863, DOI 10.1016/0003-4975(95)00067-U; Asamura H, 2010, J THORAC ONCOL, V5, P930, DOI 10.1097/JTO.0b013e3181e15d8c; Park CM, 2008, CHEST, V133, P1402, DOI 10.1378/chest.07-2568; Zell JA, 2006, ANN ONCOL, V17, P1255, DOI 10.1093/annonc/mdl121; Okada M, 2007, J THORAC CARDIOV SUR, V133, P1448, DOI 10.1016/j.jtcvs.2007.02.023; Roberts PF, 2003, J THORAC CARDIOV SUR, V126, P1597, DOI 10.1016/S0022-5223(03)01280-7; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Zell JA, 2008, CANCER, V112, P136, DOI 10.1002/cncr.23146; Trousse D, 2007, J THORAC CARDIOV SUR, V133, P1193, DOI 10.1016/j.jtcvs.2007.01.012; Rea F, 2001, EUR J CARDIO-THORAC, V20, P489, DOI 10.1016/S1010-7940(01)00858-2; Hattori A, 2012, ANN THORAC SURG, V94, P212, DOI 10.1016/j.athoracsur.2012.03.033; Putnam JB, 2002, ANN THORAC SURG, V74, P993; Battafarano RJ, 2002, ANN THORAC SURG, V74, P988, DOI 10.1016/S0003-4975(02)03878-X; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Shen KR, 2007, CHEST, V132, p290S, DOI 10.1378/chest.07-1382	25	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	OCT	2015	63	7					597	603		10.1055/s-0034-1395392		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5FE	WOS:000362833200010		
J	Miyasaka, Y; Suzuki, K; Oh, S; Takamochi, K				Miyasaka, Yoshikazu; Suzuki, Kenji; Oh, Shiaki; Takamochi, Kazuya			Cardiomegaly Is a Significant Predictor of Postoperative Atelectasis following Left Upper Superior Segmentectomy	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						lung cancer treatment; pulmonary function; thoracoscopy	CELL LUNG-CANCER; PULMONARY SEGMENTECTOMY; LIMITED RESECTION; LOBECTOMY; COMPLICATIONS; TORSION; TUMORS	Background Segmentectomy is becoming more common since many lung cancers are small when found. Left upper superior segmentectomy (LUSS) is the most popular procedure for segmentectomy. Atelectasis is a common postoperative complication following segmentectomy. In this study, we sought to better understand atelectasis of the lingular segment following LUSS. Materials and Methods Among 265 patients who underwent segmentectomy of the lung at our institute between February 2008 and August 2012, 60 patients who underwent LUSS were investigated retrospectively. An intersegmental plane was created using a stapler in 41 and by cautery in 19. The relationships between atelectasis of the lingular segment and clinical factors were analyzed by multivariate analysis. The clinical factors examined included body mass index, preoperative cardio/thoracic dimension ratio (CTR), preoperative forced expiratory volume in 1 second (FEV1), the method used to make an intersegmental plane, the interval of thoracic drainage, and the degree of lobulation. Results Atelectasis of the lingular segment was seen in nine (15.0%) patients. Preoperative CTR predicted atelectasis of the lingular segment (p = 0.004). FEV1 was preserved in 73.8% of patients with atelectasis of the lingular segment and in 86.8% of the controls. This difference was significant (p = 0.027). Atelectasis of the middle lobe following RUL was seen in 10/238 (4.2%) within the same period. Conclusions Preoperative CTR was related to atelectasis of the lingular segment. One of the advantages of segmentectomy is that it enables the postoperative preservation of respiratory function. However, in patients with cardiomegaly, respiratory function following LUSS may be preserved less than expected.	[Miyasaka, Yoshikazu; Suzuki, Kenji; Oh, Shiaki; Takamochi, Kazuya] Juntendo Univ, Dept Gen Thorac Surg, Tokyo 1138431, Japan	Suzuki, K (reprint author), Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Bunkyo Ku, 1-3,Hongo 3 Chome, Tokyo 1138431, Japan.	kjsuzuki@juntendo.ac.jp					Oh S, 2013, ANN THORAC SURG, V95, P2188, DOI 10.1016/j.athoracsur.2012.12.068; Eguchi T, 2012, EUR J CARDIO-THORAC, V41, P893, DOI 10.1093/ejcts/ezr127; Tsubota N, 1998, ANN THORAC SURG, V66, P1787, DOI 10.1016/S0003-4975(98)00819-4; Harada H, 2005, ANN THORAC SURG, V80, P2041, DOI 10.1016/j.athoracsur.2005.06.010; Stolz AJ, 2008, SURG TODAY, V38, P987, DOI 10.1007/s00595-008-3767-x; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Cable DG, 2001, J THORAC CARDIOV SUR, V122, P1091, DOI 10.1067/mtc.2001.117839; Kodama K, 1997, J THORAC CARDIOV SUR, V114, P347, DOI 10.1016/S0022-5223(97)70179-X; Okada M, 2007, J THORAC CARDIOV SUR, V133, P753, DOI 10.1016/j.jtcvs.2006.11.005; Yoshikawa K, 2002, ANN THORAC SURG, V73, P1055, DOI 10.1016/S0003-4975(01)03466-X; Miyasaka Y, 2011, INTERACT CARDIOV TH, V12, P426, DOI 10.1510/icvts.2010.253989; WONG PS, 1992, ANN THORAC SURG, V54, P286; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Irani B, 1968, Ann Thorac Surg, V5, P1; Jones DR, 2003, ANN THORAC SURG, V76, P343, DOI 10.1016/S0003-4975(03)00437-5; Cerfolio RJ, 2003, ANN THORAC SURG, V76, P348; Yoshikawa K, 2002, ANN THORAC SURG, V73	17	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	OCT	2015	63	7					609	613		10.1055/s-0034-1377061		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5FE	WOS:000362833200012		
J	Tagawa, T; Morimoto, J; Yoshida, S; Yoshino, I				Tagawa, Tetsuzo; Morimoto, Junichi; Yoshida, Shigetoshi; Yoshino, Ichiro			Sarcomatous Components May Predict Prognosis in Patients with Pulmonary Pleomorphic Carcinoma	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						lung cancer; surgery; sarcoma	GIANT-CELL CARCINOMA; CLINICOPATHOLOGICAL CHARACTERISTICS; LUNG	Objectives and Methods Pulmonary pleomorphic carcinoma often presents with clinically aggressive behavior. We retrospectively reviewed 16 patients who underwent surgery from 1999 to 2013. Results Sarcomatous components included spindle cell type in six (38%) patients, giant cell type in three (19%) patients, and mixed cell type in seven (44%) patients. The 5-year overall survival rate was 40.6%. On univariate analysis, spindle cell type, pN0, and small tumor diameter were associated with better prognosis. The 5-year survival of six patients with spindle cell type was 83.3%. Conclusions Despite the small sample size, we suggest that patients with spindle cell type may have favorable prognoses.	[Tagawa, Tetsuzo; Morimoto, Junichi; Yoshida, Shigetoshi; Yoshino, Ichiro] Chiba Univ, Dept Gen Thorac Surg, Chiba 2608670, Japan	Tagawa, T (reprint author), Chiba Univ, Dept Gen Thorac Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	ttagawa@surg2.med.kyushu-u.ac.jp					Yuki T, 2007, J THORAC CARDIOV SUR, V134, P399, DOI 10.1016/j.jtcvs.2007.04.018; NASH AD, 1958, CANCER, V11, P369, DOI 10.1002/1097-0142(195803/04)11:2<369::AID-CNCR2820110222>3.0.CO;2-8; Mochizuki T, 2008, AM J SURG PATHOL, V32, P1727, DOI 10.1097/PAS.0b013e3181804302; Chen FS, 2012, EUR J CARDIO-THORAC, V41, P1037, DOI 10.1093/ejcts/ezr136; GINSBERG SS, 1992, CANCER, V70, P606, DOI 10.1002/1097-0142(19920801)70:3<606::AID-CNCR2820700311>3.0.CO;2-L; ISHIDA T, 1990, J THORAC CARDIOV SUR, V100, P844; Chang Y L, 2001, Lung Cancer, V34, P91, DOI 10.1016/S0169-5002(01)00224-0; Travis WD, 1999, HISTOLOGICAL TYPING	8	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	OCT	2015	63	7					614	617		10.1055/s-0034-1394161		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5FE	WOS:000362833200013		
J	Isonishi, A; Bennett, CL; Plaimauer, B; Scheiflinger, F; Matsumoto, M; Fujimura, Y				Isonishi, Ayami; Bennett, Charles L.; Plaimauer, Barbara; Scheiflinger, Friedrich; Matsumoto, Masanori; Fujimura, Yoshihiro			Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma	TRANSFUSION			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; ANTI-ADAMTS13 ANTIBODIES; ENZYME-IMMUNOASSAY; FACTOR MULTIMERS; UREMIC SYNDROME; RITUXIMAB; MICROANGIOPATHIES; EFFICACY; SAFETY	BACKGROUNDPlasma exchange (PE) is the first-line treatment for primary acquired thrombotic thrombocytopenic purpura (aTTP) with severe deficiency of ADAMTS13 activity (ADAMTS13:AC). Some patients are poor responders to PE, raising concern over multiple pathogenetic pathways. STUDY DESIGN AND METHODSBased on 52 aTTP patients in our national cohort study, we monitored plasma levels of ADAMTS13, clinical and laboratory findings, and outcomes. In a representative poor responder to PE, we examined an ADAMTS13 inhibitor (ADAMTS13:INH) complex in plasma milieu, by means of a large-pore isoelectric focusing (IEF) analysis. RESULTSOf 52 aTTP patients, 20 were good responders and 32 were poor responders. In the latter group, plasma ADAMTS13:AC levels never increased to more than 10% of normal during 14 days after PE initiation. Mean (SD) plasma ADAMTS13:INH titers (Bethesda unit/mL) were 5.7 (+/- 4.5) before PE, but decreased to 1.4 (+/- 0.8) on the fourth PE day and then remarkably increased to 14.8 (+/- 10.0) on the 10th PE day, termed inhibitor boosting, and then slowly decreased to undetectable level over 1 month. On admission, none of the routinely available clinical and laboratory markers differentiated these two groups. However, elevated pre-PE levels of ADAMTS13:INH were correlated with a poor response. We visualized an ADAMTS13:INH (immunoglobulin G) complex in a patient plasma by an IEF analysis and found proteolytic fragment of ADAMTS13 antigen by a two-dimensional IEF and sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis. CONCLUSIONFindings from this cohort of aTTP patients demonstrated that inhibitor boosting often occurs in aTTP patients in Japan. Poor responders could be predicted by elevated pre-PE ADAMTS13:INH levels on admission, but not by routinely collected clinical or laboratory data.	[Isonishi, Ayami; Matsumoto, Masanori; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 6348522, Japan; [Bennett, Charles L.] South Carolina Coll Pharm, Southern Network Adverse React SONAR, South Carolina Ctr Econ Excellence Medicat Safety, Columbia, SC USA; [Bennett, Charles L.] William Jennings Bryan Dorn Vet Adm Med Ctr, Columbia, SC USA; [Plaimauer, Barbara; Scheiflinger, Friedrich] Baxter Biosci, Dept Discovery Res & Tech Assessment, Vienna, Austria	Fujimura, Y (reprint author), Nara Med Univ, Dept Blood Transfus Med, Shijyo Cho 840, Kashihara, Nara 6348522, Japan.	yosh-ifuji325@naramed-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; National Heart Lung and Blood Institute [1R01 HL-096717]; Doris Levkoff Meddin Center Medication Safety	This study was supported in part by research grants from the Ministry of Health, Labor, and Welfare of Japan; from the Ministry of Education, Culture, Sports, Science and Technology of Japan; from the Takeda Science Foundation; and from the National Heart Lung and Blood Institute (1R01 HL-096717) and the Doris Levkoff Meddin Center Medication Safety.	Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Hori Y, 2013, TRANSFUSION, V53, P3192, DOI 10.1111/trf.12182; Kato S, 2006, TRANSFUSION, V46, P1444, DOI 10.1111/j.1537-2995.2006.00914.x; Soejima K, 2006, J BIOCHEM, V139, P147, DOI 10.1093/jb/mvj013; AMOROSI EL, 1966, MEDICINE, V45, P139; Ferrari S, 2014, HAEMATOLOGICA, V99, P779, DOI 10.3324/haematol.2013.094151; Fujimura Y, 2010, INTERNAL MED, V49, P7, DOI 10.2169/internalmedicine.49.2706; Coppo P, 2003, MEDICINE, V82, P27, DOI 10.1097/00005792-200301000-00003; Bohm M, 2005, BRIT J HAEMATOL, V129, P644, DOI 10.1111/j.1365-2141.2005.05512.x; Coppo P, 2006, BRIT J HAEMATOL, V132, P66, DOI 10.1111/j.1365-2141.2005.05837.x; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Scully M, 2011, BLOOD, V118, P1746, DOI 10.1182/blood-2011-03-341131; Yagi H, 2007, INT J HEMATOL, V85, P403, DOI 10.1532/IJH97.06210; Ferrari S, 2009, J THROMB HAEMOST, V7, P1703, DOI 10.1111/j.1538-7836.2009.03568.x; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P875; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Froissart A, 2012, CRIT CARE MED, V40, P104, DOI 10.1097/CCM.0b013e31822e9d66; Blombery Piers, 2014, J Blood Med, V5, P15, DOI 10.2147/JBM.S46458; Kremer Hovinga JA, 2010, BLOOD, V115, P1500, DOI DOI 10.1182/BL00D-2009-09-243790; Westwood JP, 2013, J THROMB HAEMOST, V11, P481, DOI 10.1111/jth.12114	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	OCT	2015	55	10					2321	2330		10.1111/trf.13182		10	Hematology	Hematology	CT6HQ	WOS:000362914500006		
J	Laperche, S; Nubling, CM; Stramer, SL; Brojer, E; Grabarczyk, P; Yoshizawa, H; Kalibatas, V; El Elkyabi, M; Moftah, F; Girault, A; van Drimmelen, H; Busch, MP; Lelie, N				Laperche, Syria; Nuebling, C. Micha; Stramer, Susan L.; Brojer, Ewa; Grabarczyk, Piotr; Yoshizawa, Hiroshi; Kalibatas, Vytenis; El Elkyabi, Magdy; Moftah, Faten; Girault, Annie; van Drimmelen, Harry; Busch, Michael P.; Lelie, Nico			Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples	TRANSFUSION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CLINICAL UTILITY; HCV INFECTION; BLOOD-DONATIONS; HEMODIALYSIS-PATIENTS; COST-EFFECTIVENESS; RNA; QUANTIFICATION; DIAGNOSIS; DONORS	BACKGROUNDHepatitis C virus (HCV) antigen and antibody combination assays have been launched as a cost-effective alternative to nucleic acid testing (NAT) for reducing the antibody-negative window period (WP). Later, a HCV antigen chemiluminescence immunoassay (CLIA) became available. STUDY DESIGN AND METHODSA panel composed of 337 HCV NAT-yield samples that were characterized for viral load (VL) and genotype was used to compare the sensitivity of two combination enzyme-linked immunosorbent assays (Monolisa, Bio-Rad; and Murex, formerly Abbott) and a HCV antigen CLIA (Abbott). Analytic sensitivity was compared with HCV RNA detection using Ultrio (Grifols) by testing serial dilutions of 10 genotype (gt)1 to gt4 samples. RESULTSHCV antigen CLIA detected 92.4% of samples, whereas Monolisa and Murex detected 38.3 and 47.5%, respectively. In the HCV RNA VL range of 10(5) to 10(7) IU/mL, Monolisa and Murex detected 38% to 56% of gt1, 85% to 78% of gt2, and 21% to 37% of gt3. The overall geometric mean 50% limit of detection (range) of Ultrio on gt1 to gt4 dilution series was 3.5 (1.2-7.7) copies/mL, compared to 3.3 x 10(6) (4.4 x 10(5)-2.7 x 10(7)), 3.4 x 10(6) (2.2 x 10(5)-4.2 x 10(7)), and 2728 (415-7243) copies/mL for Monolisa, Murex, and HCV antigen CLIA, respectively. CONCLUSIONAnalytical sensitivity of NAT was on average 1 million- and 780-fold higher than combination assays and HCV antigen CLIA, respectively. Relative sensitivities of combination assays differed for genotypes with Murex being more sensitive for gt1 and gt3 and Monolisa more sensitive for gt2. Although being less sensitive than NAT, combination assays could be considered in resource-limited settings since they detect 38% to 47% of seronegative WP donations.	[Laperche, Syria; Girault, Annie] INTS, Dept Etud Agents Transmissibles Sang, Ctr Natl Reference Hepatites B&C Transfus, F-75015 Paris, France; [Nuebling, C. Micha] Paul Ehrlich Inst, Sect Mol Virol, Langen, Germany; [Stramer, Susan L.] Amer Red Cross, Sci Support Off, Gaithersburg, MD USA; [Brojer, Ewa; Grabarczyk, Piotr] Inst Haematol & Transfus Med, Warsaw, Poland; [Yoshizawa, Hiroshi] Minist Hlth Labor & Welf Japan, Study Grp NAT Standardizat, Tokyo, Japan; [Kalibatas, Vytenis] Nacl Kraujo Ctr, Vilnius, Lithuania; [El Elkyabi, Magdy; Moftah, Faten] Shabrawishi Hosp, Cairo, Egypt; [van Drimmelen, Harry] Biol Qual Control, Rijswijk, Netherlands; [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Lelie, Nico] Lelie Res, Paris, France	Laperche, S (reprint author), INTS, Dept Etud Agents Transmissibles Sang, Ctr Natl Reference Hepatites B&C Transfus, 6 Rue Alexandre Cabanel, F-75015 Paris, France.	slaperche@ints.fr			ISBT TTID	The study was performed under the auspices of ISBT TTID working party.	Kretzschmar E, 2007, VOX SANG, V92, P297, DOI 10.1111/j.1423-0410.2007.00903.x; Bouvier-Alias M, 2002, HEPATOLOGY, V36, P211, DOI 10.1053/jhep.2002.34130; Krajden M, 2004, J CLIN MICROBIOL, V42, P4054, DOI 10.1128/JCM.42.9.4054-4059.2004; Laperche S, 2005, TRANSFUSION, V45, P1965, DOI 10.1111/j.1537-2995.2005.00648.x; Tagny CT, 2014, J VIROL METHODS, V199, P119, DOI 10.1016/j.jviromet.2014.01.002; Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Laperche S, 2005, J CLIN MICROBIOL, V43, P3877, DOI 10.1128/JCM.43.8.3877-3883.2005; Courouce AM, 2000, TRANSFUSION, V40, P1198, DOI 10.1046/j.1537-2995.2000.40101198.x; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Dow BC, 2004, VOX SANG, V86, P15, DOI 10.1111/j.0042-9007.2004.00387.x; Lunel F, 2003, J HEPATOL, V39, P826, DOI 10.1016/S0168-8278(03)00402-1; Sanz C, 2002, TRANSFUSION, V42, P505, DOI 10.1046/j.1525-1438.2002.00104.x; Roth WK, 2012, VOX SANG, V102, P82, DOI 10.1111/j.1423-0410.2011.01506.x; Letowska M, 2009, TRANSFUSION, V49, P2241, DOI 10.1111/j.1537-2995.2009.02355.x; Bouzgarrou N, 2005, J MED VIROL, V77, P502, DOI 10.1002/jmv.20485; Muerhoff AS, 2002, TRANSFUSION, V42, P349, DOI 10.1046/j.1537-2995.2002.00052.x; Ottiger C, 2013, J CLIN VIROL, V58, P535, DOI 10.1016/j.jcv.2013.08.028; Ross RS, 2010, J CLIN MICROBIOL, V48, P1161, DOI 10.1128/JCM.01640-09; Mederacke I, 2009, J CLIN VIROL, V46, P210, DOI 10.1016/j.jcv.2009.08.014; Vermehren J, 2012, J CLIN VIROL, V55, P17, DOI 10.1016/j.jcv.2012.05.008; Morota K, 2009, J VIROL METHODS, V157, P8, DOI 10.1016/j.jviromet.2008.12.009; Maynard M, 2003, J VIRAL HEPATITIS, V10, P318, DOI 10.1046/j.1365-2893.2003.00430.x; Laperche S, 2003, TRANSFUSION, V43, P958, DOI 10.1046/j.1537-2995.2003.00430.x; Mellor J, 1999, J CLIN MICROBIOL, V37, P2525; Nubling CM, 2002, TRANSFUSION, V42, P1037, DOI 10.1046/j.1537-2995.2002.00166.x; Marshall DA, 2004, VOX SANG, V86, P28, DOI 10.1111/j.0042-9007.2004.00379.x; Gonzalez V, 2005, J VIRAL HEPATITIS, V12, P481, DOI 10.1111/j.1365-2893.2005.00628.x; van Hulst M, 2009, TRANSFUSION, V49, P2729, DOI 10.1111/j.1537-2995.2009.02351.x; Schnuriger A, 2006, J CLIN MICROBIOL, V44, P1561, DOI 10.1128/JCM.44.4.1561-1563.2006; Cagnon L, 2004, J VIROL METHODS, V118, P23, DOI 10.1016/j.jviromet.2004.01.014; Tuke P, 2008, TRANSFUSION, V48, P594, DOI 10.1111/j.1537-2995.2007.01584.x; Kuo YH, 2012, J CLIN MICROBIOL, V50, P1989, DOI 10.1128/JCM.05175-11; Fabrizi F, 2005, ALIMENT PHARM THERAP, V21, P861, DOI 10.1111/j.1365-2036.2005.02416.x; Grabarczyk P, 2013, TRANSFUSION, V53, P2512, DOI 10.1111/trf.12190; Miedouge M, 2010, J CLIN VIROL, V48, P18, DOI 10.1016/j.jcv.2010.02.012; Bruhn R, 2015, TRANSFUSION, V55; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	OCT	2015	55	10					2489	2498		10.1111/trf.13179		10	Hematology	Hematology	CT6HQ	WOS:000362914500026		
J	Fleming, RW; Nishida, S; Gegenfurtner, KR				Fleming, Roland W.; Nishida, Shin'ya; Gegenfurtner, Karl R.			Perception of material properties	VISION RESEARCH			English	Editorial Material							VISUAL-PERCEPTION; GLOSS PERCEPTION; WEIGHT ILLUSION; MOTION; CORTEX; TEXTURE; STATISTICS; QUALITIES; SURFACES; OBJECT		[Fleming, Roland W.; Gegenfurtner, Karl R.] Univ Giessen, Abt Allgemeine Psychol, D-35625 Giessen, Germany; [Nishida, Shin'ya] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa 2430198, Japan	Fleming, RW (reprint author), Univ Giessen, Abt Allgemeine Psychol, Otto Behaghel Str 10F, D-35625 Giessen, Germany.	roland.w.fleming@psychol.uni-giessen.de; shinyanishida@mac.com; gegenfurtner@uni-giessen.de					Kawabe T, 2015, VISION RES, V109, P125, DOI 10.1016/j.visres.2014.07.003; Wiebel CB, 2015, VISION RES, V115, P175, DOI 10.1016/j.visres.2015.04.010; Liu C, 2010, PROC CVPR IEEE, P239, DOI 10.1109/ICCET.2010.5485248; Fleming RW, 2014, VISION RES, V94, P62, DOI 10.1016/j.visres.2013.11.004; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Sakano Y, 2008, PERCEPTION, V37, P77; [Anonymous], 2015, VISION RES, V115, P246; Sun HC, 2015, VISION RES, V109, P149, DOI 10.1016/j.visres.2014.11.012; Fujisaki W, 2015, VISION RES, V109, P185, DOI 10.1016/j.visres.2014.11.020; Pinna B, 2015, VISION RES, V115, P280, DOI 10.1016/j.visres.2015.03.014; Ferwerda JA, 2015, VISION RES, V109, P166, DOI 10.1016/j.visres.2014.10.016; Sakai K, 2015, VISION RES, V115, P188, DOI 10.1016/j.visres.2015.05.001; [Anonymous], 2015, VISION RES B, V115, P163; Balas B, 2015, VISION RES, V115, P271, DOI 10.1016/j.visres.2015.01.022; Lupo J, 2015, VISION RES, V109, P158, DOI 10.1016/j.visres.2014.11.004; Fleming RW, 2015, VISION RES, V109, P123, DOI 10.1016/j.visres.2015.01.014; Nishio A, 2012, J NEUROSCI, V32, P10780, DOI 10.1523/JNEUROSCI.1095-12.2012; Marlow PJ, 2012, CURR BIOL, V22, P1909, DOI 10.1016/j.cub.2012.08.009; Murray DJ, 1999, PERCEPT PSYCHOPHYS, V61, P1681, DOI 10.3758/BF03213127; Wijntjes MWA, 2010, J VISION, V10, DOI 10.1167/10.9.13; Milne JL, 2015, VISION RES, V109, P139, DOI 10.1016/j.visres.2014.07.004; Baumgartner E, 2015, VISION RES, V115, P238, DOI 10.1016/j.visres.2015.02.006; Ho YX, 2008, PSYCHOL SCI, V19, P196, DOI 10.1111/j.1467-9280.2008.02067.x; Tiest WMB, 2015, VISION RES, V109, P178, DOI 10.1016/j.visres.2014.08.002; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; Chadwick AC, 2015, VISION RES, V109, P221, DOI 10.1016/j.visres.2014.10.026; Marlow PJ, 2015, VISION RES, V115, P199, DOI 10.1016/j.visres.2015.05.003; Fleming RW, 2013, J VISION, V13, DOI 10.1167/13.8.9; Masuda T, 2015, VISION RES, V109, P201, DOI 10.1016/j.visres.2014.11.019; Buckingham G, 2015, VISION RES, V115, P231, DOI 10.1016/j.visres.2015.02.005; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Berzhanskaya J, 2005, PERCEPTION, V34, P565, DOI 10.1068/p5401; Sawayama M, 2015, VISION RES, V109, P209, DOI 10.1016/j.visres.2014.11.017; Doerschner K, 2011, CURR BIOL, V21, P2010, DOI 10.1016/j.cub.2011.10.036; Fleming RW, 2012, CURR BIOL, V22, pR865, DOI 10.1016/j.cub.2012.08.030; BLAKE A, 1990, NATURE, V343, P165, DOI 10.1038/343165a0; Qi L, 2015, VISION RES, V115, P209, DOI 10.1016/j.visres.2015.04.014; Okazawa G, 2012, NEUROIMAGE, V63, P1321, DOI 10.1016/j.neuroimage.2012.07.052; Balas B., 2009, J VISION, V9, p[13, 1], DOI DOI 10.1167/9.12.13; Beck J, 1981, ATTENT PERCEPT PSYCH, V30, P407; Beck J., 1983, HUMAN MACHINE VISION, P1; Cholewiak S. A., 2013, J VISION, V13, P1, DOI [10.1167/13.4.12, DOI 10.1167/13.4.12]; Dovencioglu DN, 2015, VISION RES, V115, P218, DOI 10.1016/j.visres.2015.01.008; Gazzaniga M. S., 1999, NEW COGNITIVE NEUROS, P339; Hartung B., 2002, J VISION, V2, P551, DOI DOI 10.1167/2.7.551; Hurlbert A., 1991, INVEST OPHTHALMOL, V32, P105; Nagai T, 2015, VISION RES, V115, P259, DOI 10.1016/j.visres.2014.12.011; Rosenholtz R., 2012, J VISION, V12, p[14, 1], DOI [10.1167/12.4.14, DOI 10.1167/12.4.14.[]; Samuel F., 2010, J EXPT PSYCHOL HUMAN, V37, P529; Wendt G., 2010, J VISION, V10	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	OCT	2015	115		B		SI		157	162		10.1016/j.visres.2015.08.006		6	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CT5PE	WOS:000362861500001		
